PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jiao, K; Zhang, J; Zhang, M; Wei, YY; Wu, YP; Qiu, ZY; He, JJ; Cao, YX; Hu, JT; Zhu, H; Niu, LN; Cao, X; Yang, K; Wang, MQ				Jiao, Kai; Zhang, Jing; Zhang, Mian; Wei, Yuying; Wu, Yaoping; Qiu, Zhong Ying; He, Jianjun; Cao, Yunxin; Hu, Jintao; Zhu, Han; Niu, Li-Na; Cao, Xu; Yang, Kun; Wang, Mei-Qing			The Identification of CD163 Expressing Phagocytic Chondrocytes in Joint Cartilage and Its Novel Scavenger Role in Cartilage Degradation	PLOS ONE			English	Article							DIFFERENTIATION ANTIGEN; CONDYLAR CARTILAGE; RECEPTOR CD163; CELLS; MACROPHAGES; ACTIVATION; INHIBITORS; PROTEIN; MEMBER	Background: Cartilage degradation is a typical characteristic of arthritis. This study examined whether there was a subset of phagocytic chondrocytes that expressed the specific macrophage marker, CD163, and investigated their role in cartilage degradation. Methods: Cartilage from the knee and temporomandibular joints of Sprague-Dawley rats was harvested. Cartilage degradation was experimentally-induced in rat temporomandibular joints, using published biomechanical dental methods. The expression levels of CD163 and inflammatory factors within cartilage, and the ability of CD163(+) chondrocytes to conduct phagocytosis were investigated. Cartilage from the knees of patients with osteoarthritis and normal cartilage from knee amputations was also investigated. Results: In the experimentally-induced degrading cartilage from temporomandibular joints, phagocytes were capable of engulfing neighboring apoptotic and necrotic cells, and the levels of CD163, TNF-alpha and MMPs were all increased (P < 0.05). However, the levels of ACP-1, NO and ROS, which relate to cellular digestion capability were unchanged (P > 0.05). CD163(+) chondrocytes were found in the cartilage mid-zone of temporomandibular joints and knee from healthy, three-week old rats. Furthermore, an increased number of CD163(+) chondrocytes with enhanced phagocytic activity were present in Col-II+ chondrocytes isolated from the degraded cartilage of temporomandibular joints in the eight-week experimental group compared with their age-matched controls. Increased number with enhanced phagocytic activity of CD163(+) chondrocytes were also found in isolated Col-II+ chondrocytes stimulated with TNF-alpha (P < 0.05). Mid-zone distribution of CD163(+) cells accompanied with increased expression of CD163 and TNF-alpha were further confirmed in the isolated Col-II+ chondrocytes from the knee cartilage of human patients with osteoarthritis, in contrast to the controls (both P < 0.05). Conclusions: An increased number of CD163(+) chondrocytes with enhanced phagocytic activity were discovered within degraded joint cartilage, indicating a role in eliminating degraded tissues. Targeting these cells provides a new strategy for the treatment of arthritis.	[Jiao, Kai; Zhang, Jing; Zhang, Mian; Qiu, Zhong Ying; He, Jianjun; Wang, Mei-Qing] Fourth Mil Med Univ, Dept Oral Anat & Physiol, Xian 710032, Peoples R China; [Jiao, Kai; Zhang, Jing; Zhang, Mian; Qiu, Zhong Ying; He, Jianjun; Wang, Mei-Qing] Fourth Mil Med Univ, TMD, Sch Stomatol, Xian 710032, Peoples R China; [Wei, Yuying; Cao, Yunxin; Hu, Jintao; Yang, Kun] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China; [Wu, Yaoping; Zhu, Han] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China; [Niu, Li-Na] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Peoples R China; [Cao, Xu] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Johns Hopkins University	Yang, K (corresponding author), Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China.	yangkunkun@fmmu.edu.cn; mqwang@fmmu.edu.cn	Wang, Meiqing/K-3584-2019; niu, lina/GWR-3585-2022	jiao, kai/0000-0002-1901-8329	National Natural Science Foundation of China [81271169, 30801315, 30872870]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (numbers 81271169, 30801315, 30872870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2006, ADV DRUG DELIVER REV, V58, P212, DOI 10.1016/j.addr.2006.01.008; AREND WP, 1990, ARTHRITIS RHEUM-US, V33, P305, DOI 10.1002/art.1780330302; Bigg Heather F., 2001, Current Opinion in Pharmacology, V1, P314, DOI 10.1016/S1471-4892(01)00055-8; Chang C, 2003, OSTEOARTHR CARTILAGE, V11, P603, DOI 10.1016/S1063-4584(03)00087-6; Cho TJ, 2003, ARTHRITIS RHEUM-US, V48, P2845, DOI 10.1002/art.11390; Cristina E, 2004, MICROSC RES TECHNIQ, V64, P269, DOI 10.1002/jemt.20080; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; GOERDT S, 1993, AM J PATHOL, V142, P1409; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Hogger P, 1998, J IMMUNOL, V161, P1883; Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Jiao K, 2011, BONE, V48, P362, DOI 10.1016/j.bone.2010.09.010; Jiao K, 2009, APOPTOSIS, V14, P22, DOI 10.1007/s10495-008-0279-5; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Ling Y, 2010, BIOORGAN MED CHEM, V18, P3448, DOI 10.1016/j.bmc.2010.03.077; Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528; Maniecki MB, 2011, IMMUNOBIOLOGY, V216, P882, DOI 10.1016/j.imbio.2011.02.001; Martel-Pelletier J, 2001, BEST PRACT RES CL RH, V15, P805, DOI 10.1053/berh.2001.0195; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Sampson ER, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002214; Sanchez C, 1999, J IMMUNOL, V162, P5230; Umlauf D, 2010, CELL MOL LIFE SCI, V67, P4197, DOI 10.1007/s00018-010-0498-0; Wang GW, 2010, ARCH ORAL BIOL, V55, P887, DOI 10.1016/j.archoralbio.2010.07.013; Yatsugi N, 2000, J Orthop Sci, V5, P150, DOI 10.1007/s007760050142; Ye JS, 2010, REGUL PEPTIDES, V161, P58, DOI 10.1016/j.regpep.2009.12.024; ZWADLO G, 1987, EXP CELL BIOL, V55, P295	31	35	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53312	10.1371/journal.pone.0053312	http://dx.doi.org/10.1371/journal.pone.0053312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326413	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800040
J	Lee, S; Paik, SH; Kim, HJ; Ryu, HH; Cha, S; Jo, SJ; Eun, HC; Seo, JS; Kim, JI; Kwon, OS				Lee, Seungbok; Paik, Seung Hwan; Kim, Hyun-Jin; Ryu, Hyeong Ho; Cha, Soeun; Jo, Seong Jin; Eun, Hee Chul; Seo, Jeong-Sun; Kim, Jong-Il; Kwon, Oh Sang			Exomic Sequencing of Immune-Related Genes Reveals Novel Candidate Variants Associated with Alopecia Universalis	PLOS ONE			English	Article							RECEPTOR ANTAGONIST; AREATA; SUSCEPTIBILITY; MUTATIONS; SCLEROSIS; SEVERITY; ALLELES; DISEASE; CANCER; LOCUS	Alopecia areata (AA) is a common autoimmune disorder mostly presented as round patches of hair loss and subclassified into alopecia totalis/alopecia universalis (AT/AU) based on the area of alopecia. Although AA is relatively common, only 5% of AA patients progress to AT/AU, which affect the whole scalp and whole body respectively. To determine genetic determinants of this orphan disease, we undertook whole-exome sequencing of 6 samples from AU patients, and 26 variants in immune-related genes were selected as candidates. When an additional 14 AU samples were genotyped for these candidates, 6 of them remained at the level of significance in comparison with 155 Asian controls (p<1.92610(-3)). Linkage disequilibrium was observed between some of the most significant SNPs, including rs41559420 of HLA-DRB5 (p<0.001, OR 44.57) and rs28362679 of BTNL2 (p<0.001, OR 30.21). While BTNL2 was reported as a general susceptibility gene of AA previously, HLA-DRB5 has not been implicated in AA. In addition, we found several genetic variants in novel genes (HLA-DMB, TLR1, and PMS2) and discovered an additional locus on HLA-A, a known susceptibility gene of AA. This study provides further evidence for the association of previously reported genes with AA and novel findings such as HLA-DRB5, which might represent a hidden culprit gene for AU.	[Lee, Seungbok; Kim, Hyun-Jin; Cha, Soeun; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea; [Lee, Seungbok; Kim, Hyun-Jin; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Paik, Seung Hwan; Ryu, Hyeong Ho; Jo, Seong Jin; Eun, Hee Chul; Kwon, Oh Sang] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Eun, Hee Chul; Kwon, Oh Sang] Seoul Natl Univ Hosp, Clin Res Inst, Lab Cutaneous Aging & Hair Res, Seoul 110744, South Korea; [Eun, Hee Chul; Kwon, Oh Sang] Seoul Natl Univ, Coll Med, Inst Dermatol Sci, Seoul, South Korea; [Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Seo, Jeong-Sun; Kim, Jong-Il] Psoma Therapeut Inc, Seoul, South Korea; [Seo, Jeong-Sun] Macrogen Inc, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Macrogen, Inc.	Kim, JI (corresponding author), Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea.	jongil@snu.ac.kr; oskwon@snu.ac.kr	Seo, Jeong-Sun/J-2763-2012; KIM, JONG-IL/D-1019-2011; Kwon, Ohsang/J-2733-2012	KIM, JONG-IL/0000-0002-7240-3744; Kwon, Ohsang/0000-0003-0464-5124; Seungbok, Lee/0000-0002-3145-8714; Jo, Seong Jin/0000-0002-2501-7672	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Green Cosmetic Research Center) [A092055]; National Research Foundation of Korea [NRF]; Korea government [MESF] [2011-0030738]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Green Cosmetic Research Center); National Research Foundation of Korea [NRF](National Research Foundation of Korea); Korea government [MESF]	This study was partly supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Green Cosmetic Research Center, A092055) and conducted under a research agreement with AmorePacific Corporation, Republic of Korea. This work was partly supported by the National Research Foundation of Korea [NRF] grant funded by the Korea government [MESF] [No. 2011-0030738]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Amigo J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-105; Barahamani N, 2002, J INVEST DERMATOL, V118, P335, DOI 10.1046/j.0022-202x.2001.01676.x; Barahmani N, 2006, J INVEST DERMATOL, V126, P74, DOI 10.1038/sj.jid.5700009; Betterle C, 1998, J CLIN ENDOCR METAB, V83, P1049, DOI 10.1210/jc.83.4.1049; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Caillier SJ, 2008, J IMMUNOL, V181, P5473, DOI 10.4049/jimmunol.181.8.5473; Forstbauer LM, 2011, EUR J HUM GENET; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; HORDINSKY MK, 1984, ARCH DERMATOL, V120, P464, DOI 10.1001/archderm.120.4.464; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kang SH, 2001, J RHEUMATOL, V28, P1577; KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0; Kemp EH, 2006, HUM IMMUNOL, V67, P535, DOI 10.1016/j.humimm.2006.04.006; Kim JJ, 2012, HUM GENET, V131, P471, DOI 10.1007/s00439-011-1096-4; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kudat H, 2006, INT J IMMUNOGENET, V33, P41, DOI 10.1111/j.1744-313X.2006.00562.x; Lien E, 2002, CRIT CARE MED, V30, pS1, DOI 10.1097/00003246-200201001-00001; Martinez-Mir A, 2007, AM J HUM GENET, V80, P316, DOI 10.1086/511442; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Park H, 2012, J MED GENET, V49, P747, DOI 10.1136/jmedgenet-2012-101209; Peron S, 2008, J EXP MED, V205, P2465, DOI 10.1084/jem.20080789; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Price VH, 2003, J INVEST DERM SYMP P, V8, P207, DOI 10.1046/j.1087-0024.2003.00811.x; Redler S, 2010, BRIT J DERMATOL, V162, P866, DOI 10.1111/j.1365-2133.2009.09598.x; SAFAVI KH, 1995, MAYO CLIN PROC, V70, P628, DOI 10.4065/70.7.628; SANCHEZ L, 1992, ARCH DIS CHILD, V67, P657, DOI 10.1136/adc.67.5.657; Shapiro J, 1999, INT J DERMATOL, V38, P19, DOI 10.1046/j.1365-4362.1999.00004.x; Sundberg JP, 2004, J INVEST DERMATOL, V123, P294, DOI 10.1111/j.0022-202X.2004.23222.x; TARLOW JK, 1994, J INVEST DERMATOL, V103, P387, DOI 10.1111/1523-1747.ep12395398; Tazi-Ahnini R, 2002, EUR J IMMUNOGENET, V29, P25, DOI 10.1046/j.1365-2370.2002.00271.x; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; Tosti A, 2006, J AM ACAD DERMATOL, V55, P438, DOI 10.1016/j.jaad.2006.05.008; WALKER SA, 1950, J INVEST DERMATOL, V14, P403, DOI 10.1038/jid.1950.52; WELSH EA, 1994, J INVEST DERMATOL, V103, P758, DOI 10.1111/1523-1747.ep12412584; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	45	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53613	10.1371/journal.pone.0053613	http://dx.doi.org/10.1371/journal.pone.0053613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326468	Green Published, gold			2022-12-27	WOS:000314705800062
J	Liu, ZP; Wan, PX; Duan, HC; Zhou, J; Tan, BW; Liu, Y; Zhou, Q; Zhou, CJ; Huang, ZQ; Tian, BS; Li, CY; Wang, ZC				Liu, Zhiping; Wan, Pengxia; Duan, Hucheng; Zhou, Jin; Tan, Bowei; Liu, Ying; Zhou, Qiang; Zhou, Chenjing; Huang, Zheqian; Tian, Bishan; Li, Chaoyang; Wang, Zhichong			ES Micro-Environment Enhances Stemness and Inhibits Apoptosis in Human Limbal Stem Cells via the Maintenance of Telomerase Activity	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; MITOCHONDRIAL-DNA; ENDOTHELIAL-CELLS; H9C2 CELLS; PROTECTS; DAMAGE; EXPRESSION; CAPACITY; TISSUES; PATHWAY	Our previous work had found that telomerase rejuvenated in the cytoplasm of corneal epithelial cells cultured in embryonic stem cell-conditioned medium, the functional properties of stem-like corneal epithelial cells can be enhanced by co-culturing with embryonic stem cells (ESCs) via activation of the integrin beta 1-FAK-PI3K/Akt signaling pathway. The goal of this study was to explore the potential molecular mechanisms of the ES micro-environment that enhance the stem cell-like phenotype and inhibit apoptosis in human limbal stem cells (LSC). The LSC were cultured in different media, either CnT-20 medium or CnT-20 +20% ES culture supernatant (ESC-CM). We observed that LSC cultured in ESC-CM had an increased proliferative capacity, greater serial passage capacity, higher colony-forming efficiency (CFE) and higher levels of stem cell-associated marker than those cultured in CnT-20. Compared with CnT-20, ESC-CM enhanced the undifferentiated status and inhibited apoptosis in the LSC by promoting the maintenance of telomerase activity, which could reduce the generation of reactive oxygen species (ROS), maintain the membrane potential (Delta psi m) at higher levels and reduce the expression of the p21 protein. Our findings indicated that ESC-CM system induced LSC to maintain a stem cell phenotype and inhibit the process of apoptosis. These effects might partially be achieved via the telomerase-p21-mitochondrial axis and the activation of the FAK/Wnt signaling pathways. This study may have high impact and clinic implication on the expansion of LSC in regenerative medicine, especially for ocular surface reconstruction.	[Liu, Zhiping; Wan, Pengxia; Zhou, Jin; Tan, Bowei; Liu, Ying; Zhou, Qiang; Zhou, Chenjing; Huang, Zheqian; Tian, Bishan; Li, Chaoyang; Wang, Zhichong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Duan, Hucheng] Second Peoples Hosp Foshan, Ophthalm Ctr, Foshan, Guangdong, Peoples R China	Sun Yat Sen University	Li, CY (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	clioffice@yahoo.cn; wzc001@hotmail.com	zhou, qiang/AAJ-7571-2020; Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210	National High Technology Research and Development Program (863 program) of China [2012AA020507]; Guangdong Province e Ministry of Education Industry-University-Research Institute Collaboration Project of China [2011B090400353]; Sun Yat-Sen University 985 Project of China [90035-3283310]; Fundamental Research Funds of State Key Laboratory of Ophthalmology of China	National High Technology Research and Development Program (863 program) of China(National High Technology Research and Development Program of China); Guangdong Province e Ministry of Education Industry-University-Research Institute Collaboration Project of China; Sun Yat-Sen University 985 Project of China; Fundamental Research Funds of State Key Laboratory of Ophthalmology of China	This study was supported by Grant No. 2012AA020507 from the National High Technology Research and Development Program (863 program) of China, Grant No. 2011B090400353 from Guangdong Province e Ministry of Education Industry-University-Research Institute Collaboration Project of China, Grant No. 90035-3283310 from Sun Yat-Sen University 985 Project of China and the Fundamental Research Funds of State Key Laboratory of Ophthalmology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; De Paiva CS, 2006, STEM CELLS, V24, P368, DOI 10.1634/stemcells.2005-0148; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Ferraris C, 2000, DEVELOPMENT, V127, P5487; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Guo Y, 2006, STEM CELLS, V24, P850, DOI 10.1634/stemcells.2005-0457; Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Kawakita T, 2005, AM J PATHOL, V167, P381, DOI 10.1016/S0002-9440(10)62983-5; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Krishan A, 2004, CELL CYCLE, V3, P380; Liu JB, 2007, EXP EYE RES, V84, P599, DOI 10.1016/j.exer.2006.11.014; Liu Y, 2010, TISSUE ENG PART C-ME, V16, P793, DOI [10.1089/ten.tec.2009.0380, 10.1089/ten.TEC.2009.0380]; Liu ZP, 2012, EXP EYE RES, V100, P40, DOI 10.1016/j.exer.2012.04.013; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lu R, 2011, INT J BIOCHEM CELL B, V43, P751, DOI 10.1016/j.biocel.2011.01.018; Lu XY, 2010, MOL VIS, V16, P611; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McGowan SL, 2007, MOL VIS, V13, P1984; Moore JE, 2002, DNA CELL BIOL, V21, P443, DOI 10.1089/10445490260099737; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102; Qin M, 2005, STEM CELLS, V23, P712, DOI 10.1634/stemcells.2004-0195; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Saretzki G, 2009, EXP GERONTOL, V44, P485, DOI 10.1016/j.exger.2009.05.004; Singla DK, 2008, AM J PHYSIOL-HEART C, V295, pH907, DOI 10.1152/ajpheart.00279.2008; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1590, DOI 10.1152/ajpheart.00431.2007; Stepp MA, 2005, OCUL SURF, V3, P15, DOI 10.1016/S1542-0124(12)70119-2; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Tsuji T, 1998, BLOOD, V91, P1263, DOI 10.1182/blood.V91.4.1263; Ulaner GA, 1997, MOL HUM REPROD, V3, P769, DOI 10.1093/molehr/3.9.769; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Wang H, 2009, STEM CELLS, V27, P2516, DOI 10.1002/stem.174; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xiao JH, 2011, BIOMATERIALS, V32, P6962, DOI 10.1016/j.biomaterials.2011.05.084; Yew TL, 2011, AGING CELL, V10, P349, DOI 10.1111/j.1474-9726.2011.00676.x; [张嘉晴 ZHANG Jiaqing], 2006, [中国病理生理杂志, Chinese Journal of Pathophysiology], V22, P7; Zhou J, 2011, INT J BIOCHEM CELL B, V43, P1168, DOI 10.1016/j.biocel.2011.04.010	48	8	9	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53576	10.1371/journal.pone.0053576	http://dx.doi.org/10.1371/journal.pone.0053576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326460	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800056
J	Mason, JM; Hancock, HC; Close, H; Murphy, JJ; Fuat, A; de Belder, M; Singh, R; Teggert, A; Wood, E; Brennan, G; Hussain, N; Kumar, N; Manshani, N; Hodges, D; Wilson, D; Hungin, APS				Mason, James M.; Hancock, Helen C.; Close, Helen; Murphy, Jerry J.; Fuat, Ahmet; de Belder, Mark; Singh, Raj; Teggert, Andrew; Wood, Esther; Brennan, Gill; Hussain, Nehal; Kumar, Nitin; Manshani, Novin; Hodges, David; Wilson, Douglas; Hungin, A. Pali S.			Utility of Biomarkers in the Differential Diagnosis of Heart Failure in Older People: Findings from the Heart Failure in Care Homes (HFinCH) Diagnostic Accuracy Study	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; C-REACTIVE PROTEIN; NATRIURETIC PEPTIDE; PREVALENCE; DISEASE; MISDIAGNOSIS; DYSFUNCTION; GUIDELINES; MANAGEMENT; MORTALITY	Background: The performance of biomarkers for heart failure (HF) in older residents in long-term care is poorly understood and has not differentiated between left ventricular systolic dysfunction (LVSD) and HF with preserved ejection fraction (HFpEF). Methods: This is the first diagnostic accuracy study in this population to assess the differential diagnostic performance and acceptability of a range of biomarkers against a clinical diagnosis using portable echocardiography. A total of 405 residents, aged 65-100 years (mean 84.2), in 33 UK long-term care facilities were enrolled between April 2009 and June 2010. Results: For undifferentiated HF, BNP or NT-proBNP were adequate rule-out tests but would miss one in three cases (BNP: sensitivity 67%, NPV 86%, cut-off 115 pg/ml; NT-proBNP: sensitivity 62%, NPV 87%, cut-off 760 pg/ml). Using higher test cutoffs, both biomarkers were more adequate tests of LVSD, but would still miss one in four cases (BNP: sensitivity 76%, NPV 97%, cut-off 145 pg/ml; NT-proBNP: sensitivity 73%, NPV 97%, cut-off 1000 pg/ml). At these thresholds one third of subjects would test positive and require an echocardiogram. Applying a stricter 'rule out' threshold (sensitivity 90%), only one in 10 cases would be missed, but two thirds of subjects would require further investigation. Biomarkers were less useful for HFpEF (BNP: sensitivity 63%, specificity 61%, cut-off 110 pg/ml; NT-proBNP: sensitivity 68%, specificity 56%, cut-off 477 pg/ml). Novel biomarkers (Copeptin, MR-proADM, and MR-proANP) and common signs and symptoms had little diagnostic utility. Conclusions: No test, individually or in combination, adequately balanced case finding and rule-out for heart failure in this population; currently, in-situ echocardiography provides the only adequate diagnostic assessment. Trial Registration: Controlled-Trials.com ISRCTN19781227	[Mason, James M.; Hancock, Helen C.; Close, Helen; Wilson, Douglas] Univ Durham, Durham Clin Trials Unit, Stockton On Tees, England; [Murphy, Jerry J.; Fuat, Ahmet; Manshani, Novin; Hodges, David; Hungin, A. Pali S.] Univ Durham, Sch Med Pharm & Hlth, Stockton On Tees, England; [Murphy, Jerry J.; Fuat, Ahmet; Singh, Raj; Wood, Esther; Brennan, Gill] Darlington Mem Hosp, Dept Cardiol, Darlington, Durham, England; [de Belder, Mark; Hussain, Nehal; Kumar, Nitin] James Cook Univ Hosp, Dept Cardiol, Middlesbrough, Cleveland, England; [Teggert, Andrew] James Cook Univ Hosp, Dept Pathol, Middlesbrough, Cleveland, England	Durham University; Durham University; James Cook University Hospital; James Cook University Hospital	Mason, JM (corresponding author), Univ Durham, Durham Clin Trials Unit, Queens Campus, Stockton On Tees, England.	j.m.mason@durham.ac.uk	Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; Hancock, Helen/0000-0002-1494-8551; hungin, amritpal Pali/0000-0001-7275-8927	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme [PB-PG-0407-13309]; National Institute for Health Research [PB-PG-0407-13309] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0407-13309). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2002, J AM GERIATR SOC, V50, P1831, DOI 10.1046/j.1532-5415.2002.50512.x; Alexander KP, 2003, AM HEART J, V146, P194, DOI 10.1016/S0002-8703(03)00190-X; Araujo JP, 2009, J CARD FAIL, V15, P256, DOI 10.1016/j.cardfail.2008.10.030; Barents M, 2008, NETH HEART J, V16, P123, DOI 10.1007/BF03086130; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuat A, 2005, HEART, V91, pA22; Fuat A, 2003, BRIT MED J, V326, P196, DOI 10.1136/bmj.326.7382.196; Gegenhuber A, 2007, J CARD FAIL, V13, P42, DOI 10.1016/j.cardfail.2006.09.004; Hamer M, 2010, CLIN CHEM, V56, P132, DOI 10.1373/clinchem.2009.130740; Hancock H, 2012, EUR J HEART FAIL; Hancock H, 2012, BMC GERIATR, V14, P12; Healthcare Commission, 2007, PUSH BOUND IMPR SERV; Hildebrandt P, 2008, AM J CARDIOL, V101, p25A, DOI 10.1016/j.amjcard.2007.11.016; Jong P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4202; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Masani N, 2010, ECHOCARDIOGRAPHY GUI; Masson S, 2010, EUR J HEART FAIL, V12, P338, DOI 10.1093/eurjhf/hfp206; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; Mueller C, 2004, AM J CARDIOL, V94, P1510, DOI 10.1016/j.amjcard.2004.08.029; National Institute Health and Clinical Excellence, 2010, CHRON HEART FAIL MAN; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Szende AGOTA., 2007, EUROQOL GROUP MONOGR, V2; The Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Udelson JE, 2011, CIRCULATION, V124, pE540, DOI 10.1161/CIRCULATIONAHA.111.071696; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Voors AA, 2009, EUR HEART J, V30, P1187, DOI 10.1093/eurheartj/ehp098; Williams ES, 2008, EUR J HEART FAIL, V10, P63, DOI 10.1016/j.ejheart.2007.11.003	34	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53560	10.1371/journal.pone.0053560	http://dx.doi.org/10.1371/journal.pone.0053560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326457	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000314705800055
J	Mazzone, ES; Pane, M; Sormani, MP; Scalise, R; Berardinelli, A; Messina, S; Torrente, Y; D'Amico, A; Doglio, L; Viggiano, E; D'Ambrosio, P; Cavallaro, F; Frosini, S; Bello, L; Bonfiglio, S; De Sanctis, R; Rolle, E; Bianco, F; Magri, F; Rossi, F; Vasco, G; Vita, G; Motta, MC; Donati, MA; Sacchini, M; Mongini, T; Pini, A; Battini, R; Pegoraro, E; Previtali, S; Napolitano, S; Bruno, C; Politano, L; Comi, GP; Bertini, E; Mercuri, E				Mazzone, Elena Stacy; Pane, Marika; Sormani, Maria Pia; Scalise, Roberta; Berardinelli, Angela; Messina, Sonia; Torrente, Yvan; D'Amico, Adele; Doglio, Luca; Viggiano, Emanuela; D'Ambrosio, Paola; Cavallaro, Filippo; Frosini, Silvia; Bello, Luca; Bonfiglio, Serena; De Sanctis, Roberto; Rolle, Enrica; Bianco, Flaviana; Magri, Francesca; Rossi, Francesca; Vasco, Gessica; Vita, GianLuca; Motta, Maria Chiara; Donati, Maria Alice; Sacchini, Michele; Mongini, Tiziana; Pini, Antonella; Battini, Roberta; Pegoraro, Elena; Previtali, Stefano; Napolitano, Sara; Bruno, Claudio; Politano, Luisa; Comi, Giacomo Pietro; Bertini, Enrico; Mercuri, Eugenio			24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy	PLOS ONE			English	Article							6-MINUTE WALK TEST	Objectives: The aim of the study was i) to assess the spectrum of changes over 24 months in ambulant boys affected by Duchenne muscular dystrophy, ii) to establish the difference between the first and the second year results and iii) to identify possible early markers of loss of ambulation. Methods: One hundred and thirteen patients (age range 4.1-17, mean 8.2) fulfilled the inclusion criteria, 67 of the 113 were on daily and 40 on intermittent steroids, while 6 were not on steroids. All were assessed using the 6 Minute Walk Test (6MWT), the North Star Ambulatory Assessment (NSAA) and timed test. Results: On the 6MWT there was an average overall decline of -22.7 (SD 81.0) in the first year and of -64.7 (SD 123.1) in the second year. On the NSAA the average overall decline was of -1.86 (SD 4.21) in the first year and of -2.98 (SD 5.19) in the second year. Fourteen children lost ambulation, one in the first year and the other 13 in the second year of the study. A distance of at least 330 meters on the 6MWT, or a NSAA score of 18 at baseline reduced significantly the risk of losing ambulation within 2 years. Conclusions: These results can be of help at the time of using inclusion criteria for a study in ambulant patients in order to minimize the risk of patients who may lose ambulation within the time of the trial.	[Mazzone, Elena Stacy; Pane, Marika; Scalise, Roberta; De Sanctis, Roberto; Bianco, Flaviana; Vasco, Gessica; Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Dept Paediat Neurol, Rome, Italy; [Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy; [Berardinelli, Angela; Motta, Maria Chiara] C Mondino Fdn, Child Neurol & Psychiat Unit, Pavia, Italy; [Messina, Sonia; Cavallaro, Filippo; Vita, GianLuca] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, Messina, Italy; [Torrente, Yvan; Magri, Francesca; Comi, Giacomo Pietro] Univ Milan, Dept Pathophysiol & Transplantat DEPT, Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr,Neurosci Sect,Neurol Unit, Milan, Italy; [D'Amico, Adele; Bertini, Enrico] Bambino Gesu Pediat Hosp, Mol Med Unit, Dept Lab Med, Rome, Italy; [Doglio, Luca; Bruno, Claudio] G Gaslini Inst Children, Neuromuscular Dis Unit, Genoa, Italy; [Viggiano, Emanuela; D'Ambrosio, Paola; Politano, Luisa] Univ Naples 2, Dipartimento Med Sperimentale, Naples, Italy; [Frosini, Silvia; Battini, Roberta] Univ Pisa, Stella Maris Inst, Dept Dev Neurosci, Pisa, Italy; [Bello, Luca; Pegoraro, Elena] Univ Padua, Dept Neurosci, Padua, Italy; [Bonfiglio, Serena; Pini, Antonella] Maggiore Hosp, Child Neurol & Psychiat Unit, Bologna, Italy; [Rolle, Enrica; Mongini, Tiziana] Univ Turin, Neuromuscular Ctr, SG Battista Hosp, Turin, Italy; [Rossi, Francesca; Donati, Maria Alice; Sacchini, Michele] Meyer Hosp, Metab & Neuromuscular Unit, Florence, Italy; [Previtali, Stefano; Napolitano, Sara] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Genoa; IRCCS Fondazione Casimiro Mondino; University of Messina; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Bambino Gesu; University of Genoa; IRCCS Istituto Giannina Gaslini; Universita della Campania Vanvitelli; IRCCS Fondazione Stella Maris; University of Pisa; University of Padua; AUSL di Bologna; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Dept Paediat Neurol, Rome, Italy.	mercuri@rm.unicatt.it	Vita, Gianluca/AAR-4587-2020; Mazzone, Elena/AAF-4444-2020; Viggiano, Emanuela/T-5332-2019; Previtali, Stefano/Z-1962-2019; pini, antonella/AAB-9171-2020; Bruno, Claudio/A-3148-2015; D'Ambrosio, Paola/AAC-6109-2021; Bertini, Enrico/A-2284-2014; battini, roberta/P-9095-2017; Comi, Giacomo P/K-5702-2016; Berardinelli, angela/AAA-9496-2019; Sormani, Maria Pia/ABH-8756-2020; d'amico, adele/J-9203-2016; POLITANO, LUISA/AAK-6885-2020; Bertini, Enrico/ABG-1278-2020; Scalise, Roberta/AAC-2345-2022; Magri, Francesca/K-5739-2016; vasco, gessica/K-8144-2016; Mercuri, Eugenio/G-1351-2015; TORRENTE, YVAN/A-2964-2015	Vita, Gianluca/0000-0003-4190-8042; Previtali, Stefano/0000-0003-2546-4357; pini, antonella/0000-0003-3603-5478; Bruno, Claudio/0000-0002-3426-2901; D'Ambrosio, Paola/0000-0002-9204-5622; Bertini, Enrico/0000-0001-9276-4590; battini, roberta/0000-0002-7889-1355; Comi, Giacomo P/0000-0002-1383-5248; d'amico, adele/0000-0003-2438-2624; Scalise, Roberta/0000-0002-9141-7842; Magri, Francesca/0000-0001-8974-9453; Messina, Sonia/0000-0001-7994-3391; vasco, gessica/0000-0001-9807-9578; Rossi, Francesca/0000-0002-1335-5121; Pane, Marika/0000-0002-4851-6124; MARIA ALICE, DONATI/0000-0003-4769-5025; Napolitano, Sara/0000-0003-2145-7395; Mercuri, Eugenio/0000-0002-9851-5365; TORRENTE, YVAN/0000-0002-2705-3984; berardinelli, angela/0000-0002-4645-8055; SORMANI, MARIA PIA/0000-0001-6892-104X; Frosini, Silvia/0000-0001-6169-4382; Viggiano, Emanuela/0000-0002-9864-2620; Bello, Luca/0000-0002-3075-6525	Telethon UILDM (Italy) [GUP 09010, GUP 07009]; Telethon; Merck Serono; Genzyme Corporation; AIFA (Italian Government Drug Agency); Telethon Italy; Wellstone; SMA Europe; Italian Telethon; Italian Ministry of Health	Telethon UILDM (Italy)(Fondazione Telethon); Telethon(Fondazione Telethon); Merck Serono(Merck & Company); Genzyme Corporation(Sanofi-AventisGenzyme Corporation); AIFA (Italian Government Drug Agency); Telethon Italy(Fondazione Telethon); Wellstone; SMA Europe; Italian Telethon(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy)	The study was funded by two Telethon UILDM grants (Italy) (GUP 09010 and GUP 07009). Dr. Mazzone is a Telethon funded TREAT NMD fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; E. Mazzone and Dr. Pane report no disclosures. Dr. Sormani serves on a scientific advisory board for Biogen Idec.; has received funding for travel or speaker honoraria from Merck Serono; serves as consultant for Merck Serono, Actelion Pharmaceuticals Lts. Biogen Idec, and Synthon; and serves on the speakers' bureaus of Teva Pharmaceutical Industries Ltd., Merck Serono, and Biogen Idec. Dr. Scalise, Dr. Berardinelli, Dr Messina, Dr. Torrente, Dr. D'Amico, Dr. Doglio, Dr. Viggiano, Dr. D'Ambrosio, F. Cavallaro, S. Frosini, Dr. Bello, Dr. Bonfiglio, R. De Sanctis, E. Rolle, Dr. Bianco, Dr. Magri, F. Rossi, and Dr. Vasco report no disclosures. Dr. Vita serves as an Associate Editor for Neurological Sciences. M. C. Motta, Dr. Donati and Dr. Sacchini report no disclosures. Dr. Mongini has received funding for travel from Genzyme Corporation; and has received research support from AIFA (Italian Government Drug Agency) and Telethon Italy. Dr. Pini and Dr. Battini report no disclosures. Dr. Pegoraro has served on a scientific advisory board for BioMarin Pharmaceutical Inc.; has received funding for travel from Genzyme Corporation; and has received speaker honoraria from MedaPharma; and receives research support from Wellstone and Telethon Italy. Dr. Previtali, Dr. Bruno and Dr. Politano report no disclosures. Dr. Comi is site PI for the PTC extension study of Ataluren in DMD, for the TROPHOS clinical trial on SMA and for the GSK study on exon skipping; receives research support from Telethon Italy and SMA Europe. Dr. Bertini is site PI for the PTC extension study of Ataluren in DMD, for the TROPHOS clinical trial on SMA and for the GSK study on exon skipping. He also receives funds from the Italian Telethon, the Italian Ministry of Health and SMA Europe for observational studies on outcome measures. Dr. Mercuri is site PI for the PTC extension study of Ataluren in DMD, for the TROPHOS clinical trial on SMA and for the GSK study on exon skipping. He also receives funds from the Italian Telethon and SMA Europe. He has acted as advisory board for Shire and PTC Therapeutics, Inc, Prosensa. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bushby Kate, 2011, Clin Investig (Lond), V1, P1217; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Henricson E, PLOS CURR, V4; Mayhew A, 2011, DEV MED CHILD NEUROL, V53, P535, DOI 10.1111/j.1469-8749.2011.03939.x; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mazzone ES, 2009, NEUROMUSCULAR DISORD, V19, P458, DOI 10.1016/j.nmd.2009.06.368; Mazzone E, 2010, NEUROMUSCULAR DISORD, V20, P712, DOI 10.1016/j.nmd.2010.06.014; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Scott E, 2011, PHYSIOTHER RES INT	10	79	85	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52512	10.1371/journal.pone.0052512	http://dx.doi.org/10.1371/journal.pone.0052512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326337	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800021
J	Naranbhai, V; Altfeld, M; Karim, SSA; Ndung'u, T; Karim, QA; Carr, WH				Naranbhai, Vivek; Altfeld, Marcus; Karim, Salim S. Abdool; Ndung'u, Thumbi; Karim, Quarraisha Abdool; Carr, William H.			Changes in Natural Killer Cell Activation and Function during Primary HIV-1 Infection	PLOS ONE			English	Article							NK CELLS; VIREMIA; REPLICATION; RESPONSES; INNATE; BLOOD	Background: Recent reports suggest that Natural Killer (NK) cells may modulate pathogenesis of primary HIV-1 infection. However, HIV dysregulates NK-cell responses. We dissected this bi-directional relationship to understand how HIV impacts NK-cell responses during primary HIV-1 infection. Methodology/Principal Findings: Paired samples from 41 high-risk, initially HIV-uninfected CAPRISA004 participants were analysed prior to HIV acquisition, and during viraemic primary HIV-1 infection. At the time of sampling post-infection five women were seronegative, 11 women were serodiscordant, and 25 women were seropositive by HIV-1 rapid immunoassay. Flow cytometry was used to measure NK and T-cell activation, NK-cell receptor expression, cytotoxic and cytokine-secretory functions, and trafficking marker expression (CCR7, alpha(4)beta(7)). Non-parametric statistical tests were used. Both NK cells and T-cells were significantly activated following HIV acquisition (p = 0.03 and p<0.0001, respectively), but correlation between NK-cell and T-cell activation was uncoupled following infection (pre-infection r = 0.68;p<0.0001; post-infection, during primary infection r = 0.074;p = 0.09). Nonetheless, during primary infection NK-cell and T-cell activation correlated with HIV viral load (r = 0.32'p = 0.04 and r = 0.35;p = 0.02, respectively). The frequency of Killer Immunoglobulin-like Receptor-expressing (KIRpos) NK cells increased following HIV acquisition (p = 0.006), and KIRpos NK cells were less activated than KIRneg NK cells amongst individuals sampled while seronegative or serodiscordant (p = 0.001;p<0.0001 respectively). During HIV-1 infection, cytotoxic NK cell responses evaluated after IL-2 stimulation alone, or after co-culture with 721 cells, were impaired (p = 0.006 and p = 0.002, respectively). However, NK-cell IFN-y secretory function was not significantly altered. The frequency of CCR7+ NK cells was elevated during primary infection, particularly at early time-points (p<0.0001). Conclusions/Significance: Analyses of immune cells before and after HIV infection revealed an increase in both NK-cell activation and KIR expression, but reduced cytotoxicity during acute infection. The increase in frequency of NK cells able to traffic to lymph nodes following HIV infection suggests that these cells may play a role in events in secondary lymphoid tissue.	[Naranbhai, Vivek; Karim, Salim S. Abdool; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, CAPRISA Ctr AIDS Programme Res S Africa, Durban, South Africa; [Naranbhai, Vivek; Altfeld, Marcus; Ndung'u, Thumbi; Carr, William H.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Altfeld, Marcus; Ndung'u, Thumbi; Carr, William H.] Massachusetts Gen Hosp, Massachusetts Inst Technol & Harvard, Ragon Inst, Boston, MA 02114 USA; [Karim, Salim S. Abdool; Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Columbia University	Carr, WH (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa.	wcarr@mec.cuny.edu	Karim, Salim Safurdeen Abdool/N-5947-2013; Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Abdool/AAE-7118-2019; Altfeld, Marcus/AAE-7306-2019; Karim, Salim Abdool/P-3117-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Altfeld, Marcus/0000-0001-5972-2997; Karim, Salim Abdool/0000-0002-4986-2133; Naranbhai, Vivek/0000-0003-4281-8882; Ndung'u, Thumbi/0000-0003-2962-3992	South African HIV/AIDS Research Platform (SHARP); US National Institutes for Health [FIC K01-TW007793]; CONRAD, Eastern Virginia Medical School (USAID) [GP00-08-00005-00, PPA-09-046]; US National Institutes for Health's Comprehensive International Program of Research on AIDS (CIPRA) [AI51794]; LIFELab; Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP) [D43 TW000231]; Massachusetts General Hospital Physician Scientist Development Award; South African National Research Foundation KISC Award; FOGARTY INTERNATIONAL CENTER [D43TW000231, K01TW007793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	South African HIV/AIDS Research Platform (SHARP); US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONRAD, Eastern Virginia Medical School (USAID)(United States Agency for International Development (USAID)); US National Institutes for Health's Comprehensive International Program of Research on AIDS (CIPRA); LIFELab; Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP); Massachusetts General Hospital Physician Scientist Development Award; South African National Research Foundation KISC Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the South African HIV/AIDS Research Platform (SHARP), and US National Institutes for Health FIC K01-TW007793. This study was part of the CAPRISA TRAPS (Tenofovir gel Research for AIDS Prevention Science) Program, which is funded by CONRAD, Eastern Virginia Medical School (USAID co-operative grant #GP00-08-00005-00, subproject agreement # PPA-09-046). The views expressed by the authors do not necessarily reflect the views of USAID, Gilead Sciences, Eastern Virginia Medical School or CONRAD. The authors thank the US National Institutes for Health's Comprehensive International Program of Research on AIDS (CIPRA grant # AI51794) for the research infrastructure. VN was supported by LIFELab and the Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP, grant #D43 TW000231). MA is a Distinguished Clinical Scientist of the Doris Duke Charitable Foundation. WHC was supported by a Massachusetts General Hospital Physician Scientist Development Award. TN holds the South African Research Chair in Systems Biology of HIV/AIDS and is a Howard Hughes Medical Institute International Early Career Scientist. Additional training was supported by the South African National Research Foundation KISC Award. Gilead Sciences did not fund this project, however the drug used in the clinical trial from which samples were used for this study belongs to Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brunetta E, 2010, J LEUKOCYTE BIOL, V88, P1119, DOI 10.1189/jlb.0410225; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Fogli M, 2004, EUR J IMMUNOL, V34, P2313, DOI 10.1002/eji.200425251; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karre K, 2008, NAT IMMUNOL, V9, P477, DOI 10.1038/ni0508-477; Kottilil S, 2003, J INFECT DIS, V187, P1038, DOI 10.1086/368222; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Luteijn R, 2011, EUR J IMMUNOL, V41, P2729, DOI 10.1002/eji.201040886; Marcenaro E, 2009, BLOOD, V114, P4108, DOI 10.1182/blood-2009-05-222265; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Milush JM, 2009, BLOOD, V114, P4823, DOI 10.1182/blood-2009-04-216374; Mureithi MW, 2012, JAIDS-J ACQ IMM DEF, V60, P124, DOI 10.1097/QAI.0b013e31824f53a9; Naranbhai V, 2012, J INFECT DIS; Naranbhai V, 2012, AIDS; Naranbhai V, 2011, J IMMUNOL METHODS, V366, P28, DOI 10.1016/j.jim.2011.01.001; Rivera-Nieves J, 2005, J IMMUNOL, V174, P2343, DOI 10.4049/jimmunol.174.4.2343; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Soares A, 2010, J IMMUNOL METHODS, V362, P43, DOI 10.1016/j.jim.2010.08.007; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165	28	41	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53251	10.1371/journal.pone.0053251	http://dx.doi.org/10.1371/journal.pone.0053251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326405	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500056
J	Al Lawati, A; Ali, I; Al Barwani, M				Al Lawati, Afaf; Ali, Issam; Al Barwani, Muataz			Effect of Temperature and Capsid Tail on the Packing and Ejection of Viral DNA	PLOS ONE			English	Article							DOUBLE-STRANDED DNA; BACTERIOPHAGE; DYNAMICS; FORCES; TWIST	We use a simulation technique based on molecular dynamics and stochastic rotation model to present the effect of temperature and capsid tail on the packaging and ejection processes of semiflexible polymers. We consider two types of solvents, a good solvent, where the polymer is neutral and repulsion interactions among its various sections are favored, and one where the polymer is charged, giving rise to extra electrostatic reaction. For tailless capsids, we find that packing a neutral polymer is slightly slower at higher temperatures whereas its ejection is slightly slower at lower temperatures. We find the same trend for a charged polymer but the effect is noticeably larger. At a high enough temperature, we notice that packing a charged polymer can be stopped. On the other hand, at fixed temperature and regardless whether the polymer is charged, packing is much easier for a capsid with a tail whereas ejection is much slower. The effect of including the tail on the dynamics of a charged polymer, in particular, is rather significant: more packing fraction is facilitated at higher temperatures due to more ordered polymer configuration inside the capsid. In contrast, during ejection the tail traps the last remaining beads for quite some time before allowing full ejection. We interpret these results in terms of entropic and electrostatic forces.	[Al Lawati, Afaf; Ali, Issam; Al Barwani, Muataz] Sultan Qaboos Univ, Coll Sci, Dept Phys, Al Khoud, Oman	Sultan Qaboos University	Ali, I (corresponding author), Sultan Qaboos Univ, Coll Sci, Dept Phys, Al Khoud, Oman.	issam@squ.edu.om	Al Barwani, Muataz/H-5721-2017	Al Barwani, Muataz/0000-0003-2568-0228				Ali I, 2008, BIOPHYS J, V94, P4159, DOI 10.1529/biophysj.107.111963; Ali I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208102; Ali I, 2004, J CHEM PHYS, V121, P8635, DOI 10.1063/1.1798052; Ali I, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3617416; Arsuaga J, 2002, BIOPHYS CHEM, V101, P475, DOI 10.1016/S0301-4622(02)00197-7; de Frutos M, 2005, BIOPHYS J, V88, P1364, DOI 10.1529/biophysj.104.048785; Forrey C, 2006, BIOPHYS J, V91, P25, DOI 10.1529/biophysj.105.073429; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; GABASHVILI IS, 1992, J BIOMOL STRUCT DYN, V9, P911, DOI 10.1080/07391102.1992.10507966; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; LaMarque JC, 2004, BIOPOLYMERS, V73, P348, DOI 10.1002/bip.10529; Lof D, 2007, J MOL BIOL, V368, P55, DOI 10.1016/j.jmb.2007.01.076; Malevanets A, 1999, J CHEM PHYS, V110, P8605, DOI 10.1063/1.478857; Marenduzzo D, 2009, P NATL ACAD SCI USA, V106, P22269, DOI [10.1073/pnas.0907524106, 10.1073/pnas.0907S24106]; Matthews R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088101; Petrov AS, 2007, J STRUCT BIOL, V160, P241, DOI 10.1016/j.jsb.2007.08.012; Rollins GC, 2008, BIOPHYS J, V94, pL38, DOI 10.1529/biophysj.107.126698; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Spakowitz AJ, 2005, BIOPHYS J, V88, P3912, DOI 10.1529/biophysj.104.052738	21	8	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52958	10.1371/journal.pone.0052958	http://dx.doi.org/10.1371/journal.pone.0052958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320080	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429800022
J	Garcia-Robledo, C; Erickson, DL; Staines, CL; Erwin, TL; Kress, WJ				Garcia-Robledo, Carlos; Erickson, David L.; Staines, Charles L.; Erwin, Terry L.; Kress, W. John			Tropical Plant-Herbivore Networks: Reconstructing Species Interactions Using DNA Barcodes	PLOS ONE			English	Article							INSECT HERBIVORES; HISPINE BEETLES; LEAF BEETLES; HOST PLANTS; GINGERS; CHRYSOMELIDAE; GENERALIST; SPECIALIST; DEMOGRAPHY; PHYLOGENY	Plants and their associated insect herbivores, represent more than 50% of all known species on earth. The first step in understanding the mechanisms generating and maintaining this important component of biodiversity is to identify plant-herbivore associations. In this study we determined insect-host plant associations for an entire guild of insect herbivores using plant DNA extracted from insect gut contents. Over two years, in a tropical rain forest in Costa Rica (La Selva Biological Station), we recorded the full diet breadth of rolled-leaf beetles, a group of herbivores that feed on plants in the order Zingiberales. Field observations were used to determine the accuracy of diet identifications using a three-locus DNA barcode (rbcL, trnH-psbA and ITS2). Using extraction techniques for ancient DNA, we obtained high-quality sequences for two of these loci from gut contents (rbcL and ITS2). Sequences were then compared to a comprehensive DNA barcode library of the Zingiberales. The rbcL locus identified host plants to family (success/sequence = 58.8%) and genus (success/sequence = 47%). For all Zingiberales except Heliconiaceae, ITS2 successfully identified host plants to genus (success/sequence = 67.1%) and species (success/sequence = 61.6%). Kindt's sampling estimates suggest that by collecting ca. four individuals representing each plant-herbivore interaction, 99% of all host associations included in this study can be identified to genus. For plants that amplified ITS2, 99% of the hosts can be identified to species after collecting at least four individuals representing each interaction. Our study demonstrates that host plant identifications at the species-level using DNA barcodes are feasible, cost-effective, and reliable, and that reconstructing plant-herbivore networks with these methods will become the standard for a detailed understanding of these interactions.	[Garcia-Robledo, Carlos; Erickson, David L.; Kress, W. John] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Garcia-Robledo, Carlos; Staines, Charles L.; Erwin, Terry L.] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Garcia-Robledo, C (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	garciac@si.edu			Smithsonian Postdoctoral Fellowship; National Geographic-Waitt Institute [W149-11]; Heliconia Society; Rubenstein Fellowship - Encyclopedia of Life	Smithsonian Postdoctoral Fellowship(Smithsonian Institution); National Geographic-Waitt Institute(National Geographic Society); Heliconia Society; Rubenstein Fellowship - Encyclopedia of Life	This research was funded by the Smithsonian Postdoctoral Fellowship, the National Geographic-Waitt Institute grant (W149-11), Heliconia Society Grant and the Rubenstein Fellowship - Encyclopedia of Life to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baldwin BG, 1996, ANN MO BOT GARD, V83, P151, DOI 10.2307/2399971; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; CHAZDON RL, 1984, J ECOL, V72, P553, DOI 10.2307/2260066; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FRY B, 1978, ECOLOGY, V59, P498, DOI 10.2307/1936580; Futuyma D.J., 1983, COEVOLUTION; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Garcia-Robledo C, 2012, J EVOLUTION BIOL, V25, P38, DOI 10.1111/j.1420-9101.2011.02401.x; Garcia-Robledo C, 2008, J PALEONTOL, V82, P1035, DOI 10.1666/07-089.1; Garcia-Robledo C, 2010, ZOOTAXA, P50, DOI 10.11646/zootaxa.2610.1.3; Garcia-Robledo C, 2011, J ANIM ECOL, V80, P976, DOI 10.1111/j.1365-2656.2011.01843.x; Garcia-Robledo C, 2009, ENTOMOL EXP APPL, V131, P115, DOI 10.1111/j.1570-7458.2009.00843.x; GARCIAROBLEDO C, 2010, THESIS U MIAMI; Hartshorn Gary S., 1994, P73; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Johnson DM, 2005, ECOLOGY, V86, P3088, DOI 10.1890/04-1815; Johnson DM, 2004, BIOTROPICA, V36, P352, DOI 10.1111/j.1744-7429.2004.tb00327.x; Johnson DM, 2004, ECOLOGY, V85, P2037, DOI 10.1890/03-0508; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kindt R, 2006, BIODIVERS CONSERV, V15, P3235, DOI 10.1007/s10531-005-0311-9; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Kress WJ, 2005, AM J BOT, V92, P167, DOI 10.3732/ajb.92.1.167; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; MCDADE L. A., 1994, SELVA ECOLOGY NATURA; Navarro SP, 2010, ECOL ENTOMOL, V35, P18, DOI 10.1111/j.1365-2311.2009.01145.x; OTTE D, 1976, P ACAD NAT SCI PHILA, V128, P89; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Prince LM, 2006, TAXON, V55, P281, DOI 10.2307/25065578; R Core Team, 2020, R LANG ENV STAT COMP; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; SMITH JF, 1993, ANN MO BOT GARD, V80, P620, DOI 10.2307/2399850; Staines CL, 2009, ZOOTAXA, P58, DOI 10.11646/zootaxa.2033.1.6; Staines CL, 2011, ZOOKEYS, P45, DOI 10.3897/zookeys.157.1338; Staines CL, 1996, REV BIOL TROP, P3; Staudacher K, 2011, SOIL BIOL BIOCHEM, V43, P346, DOI 10.1016/j.soilbio.2010.10.022; STRONG DR, 1977, BIOTROPICA, V9, P156, DOI 10.2307/2387878; STRONG DR, 1977, EVOLUTION, V31, P854, DOI 10.1111/j.1558-5646.1977.tb01078.x; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Wilf P, 2000, SCIENCE, V289, P291, DOI 10.1126/science.289.5477.291; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	48	114	125	1	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52967	10.1371/journal.pone.0052967	http://dx.doi.org/10.1371/journal.pone.0052967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308128	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429800023
J	Bergmann, R; Kongsbak, K; Sorensen, PL; Sander, T; Balle, T				Bergmann, Rikke; Kongsbak, Kristine; Sorensen, Pernille Louise; Sander, Tommy; Balle, Thomas			A Unified Model of the GABA(A) Receptor Comprising Agonist and Benzodiazepine Binding Sites	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; AMINOBUTYRIC ACID(A) RECEPTORS; ALPHA-SUBUNIT SELECTIVITY; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; A-RECEPTOR; LIGAND-BINDING; STRUCTURAL REQUIREMENTS; EXTRACELLULAR DOMAIN; DIFFERENT RESIDUES	We present a full-length alpha(1)beta(2)gamma(2) GABA receptor model optimized for agonists and benzodiazepine (BZD) allosteric modulators. We propose binding hypotheses for the agonists GABA, muscimol and THIP and for the allosteric modulator diazepam (DZP). The receptor model is primarily based on the glutamate-gated chloride channel (GluCl) from C. elegans and includes additional structural information from the prokaryotic ligand-gated ion channel ELIC in a few regions. Available mutational data of the binding sites are well explained by the model and the proposed ligand binding poses. We suggest a GABA binding mode similar to the binding mode of glutamate in the GluCl X-ray structure. Key interactions are predicted with residues alpha(1)R66, beta(2)T202, alpha(1)T129, beta(2)E155, beta(2)Y205 and the backbone of beta(2)S156. Muscimol is predicted to bind similarly, however, with minor differences rationalized with quantum mechanical energy calculations. Muscimol key interactions are predicted to be alpha(1)R66, beta(2)T202, alpha(1)T129, beta(2)E155, beta(2)Y205 and beta(2)F200. Furthermore, we argue that a water molecule could mediate further interactions between muscimol and the backbone of beta(2)S156 and beta(2)Y157. DZP is predicted to bind with interactions comparable to those of the agonists in the orthosteric site. The carbonyl group of DZP is predicted to interact with two threonines alpha(1)T206 and gamma(2)T142, similar to the acidic moiety of GABA. The chlorine atom of DZP is placed near the important alpha(1)H101 and the N-methyl group near alpha(1)Y159, alpha(1)T206, and alpha(1)Y209. We present a binding mode of DZP in which the pending phenyl moiety of DZP is buried in the binding pocket and thus shielded from solvent exposure. Our full length GABA(A) receptor is made available as Model S1.	[Bergmann, Rikke; Kongsbak, Kristine; Sorensen, Pernille Louise] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Kongsbak, Kristine] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Sander, Tommy] Novo Nordisk AS, Bagsvaerd, Denmark; [Balle, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Copenhagen; Technical University of Denmark; Novo Nordisk; University of Sydney	Balle, T (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	thomas.balle@sydney.edu.au		Bergmann, Rikke/0000-0002-8567-0200; Balle, Thomas/0000-0002-0233-8350	Velux Foundation; NeuroSearch A/S	Velux Foundation(Velux Fonden); NeuroSearch A/S	Financial support was obtained from The Velux Foundation (post doctoral grant to RB) and NeuroSearch A/S (funding ogf research assistant KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Amin J, 1997, MOL PHARMACOL, V51, P833, DOI 10.1124/mol.51.5.833; [Anonymous], 2011, MACROMODEL V 9 9; [Anonymous], 2011, MAESTR V 9 2; [Anonymous], 2011, JAG V 7 8; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Berezhnoy D, 2005, J NEUROCHEM, V92, P859, DOI 10.1111/j.1471-4159.2004.02913.x; Berezhnoy D, 2004, J BIOL CHEM, V279, P3160, DOI 10.1074/jbc.M311371200; Berezhnoy D, 2009, MOL PHARMACOL, V76, P440, DOI 10.1124/mol.109.054650; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bisson WH, 2008, J MOL MODEL, V14, P891, DOI 10.1007/s00894-008-0340-x; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Boileau AJ, 2002, J BIOL CHEM, V277, P2931, DOI 10.1074/jbc.M109334200; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1997, MOL PHARMACOL, V52, P676, DOI 10.1124/mol.52.4.676; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Buhr A, 1996, MOL PHARMACOL, V49, P1080; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chang YC, 2009, ACTA PHARMACOL SIN, V30, P663, DOI 10.1038/aps.2009.51; Cheng J, 2010, EUR J MED CHEM, V45, P3595, DOI 10.1016/j.ejmech.2010.05.004; Ci SQ, 2007, J MOL GRAPH MODEL, V26, P537, DOI 10.1016/j.jmgm.2007.03.007; Ci SQ, 2008, PROTEIN J, V27, P71, DOI 10.1007/s10930-007-9109-9; Clayton T, 2007, CURR MED CHEM, V14, P2755, DOI 10.2174/092986707782360097; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Davies M, 1998, J NEUROCHEM, V70, P2188; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DIAZARAUZO H, 1991, LIFE SCI, V49, P207, DOI 10.1016/0024-3205(91)90005-V; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Ebert B, 1999, NEUROCHEM INT, V34, P427, DOI 10.1016/S0197-0186(99)00038-8; Ernst M, 2003, NEUROSCIENCE, V119, P933, DOI 10.1016/S0306-4522(03)00288-4; FELLEGVARI I, 1989, J LIQ CHROMATOGR, V12, P2719; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Frolund B, 2002, J MED CHEM, V45, P2454, DOI 10.1021/jm020027o; Frolund B, 2000, J MED CHEM, V43, P4930, DOI 10.1021/jm000371q; FROLUND B, 1995, J MED CHEM, V38, P3287, DOI 10.1021/jm00017a014; Gharaghani S, 2011, CHEM BIOL DRUG DES, V78, P612, DOI 10.1111/j.1747-0285.2011.01183.x; Ghoshal N, 2010, EXPERT OPIN DRUG DIS, V5, P441, DOI 10.1517/17460441003789363; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Grant JAA, 2010, BIOORGAN MED CHEM, V18, P909, DOI 10.1016/j.bmc.2009.11.032; GYNTHER BD, 1986, NEUROSCI LETT, V68, P211, DOI 10.1016/0304-3940(86)90144-8; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hanson SM, 2008, J MED CHEM, V51, P7243, DOI 10.1021/jm800889m; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Harrison NJ, 2006, J MOL MODEL, V12, P317, DOI 10.1007/s00894-005-0034-6; He X, 2000, Drug Des Discov, V17, P131; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Holden JH, 2002, J BIOL CHEM, V277, P18785, DOI 10.1074/jbc.M111778200; Huang Q, 1999, Drug Des Discov, V16, P55; Jansen M, 2008, J MED CHEM, V51, P4430, DOI 10.1021/jm701562x; JOHNSTON GA, 1968, BIOCHEM PHARMACOL, V17, P2488, DOI 10.1016/0006-2952(68)90141-X; Johnston GAR, 2005, CURR PHARM DESIGN, V11, P1867, DOI 10.2174/1381612054021024; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kloda JH, 2007, MOL PHARMACOL, V71, P483, DOI 10.1124/mol.106.028662; Krogsgaard-Larsen P, 2002, CHEM REC, V2, P419, DOI 10.1002/tcr.10040; KROGSGAARDLARSEN P, 1977, NATURE, V268, P53, DOI 10.1038/268053a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law RJ, 2009, BIOPHYS J, V97, P1586, DOI 10.1016/j.bpj.2009.06.044; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Madsen C, 2007, J MED CHEM, V50, P4147, DOI 10.1021/jm070447j; MAKSAY G, 1991, MOL PHARMACOL, V39, P725; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Morlock EV, 2011, MOL PHARMACOL, V80, P14, DOI 10.1124/mol.110.069542; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/nchembio.917, 10.1038/NCHEMBIO.917]; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Rosahl TW, 2000, EUR J NEUROSCI, V12, P514; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sancar F, 2007, MOL PHARMACOL, V71, P38, DOI 10.1124/mol.106.029595; Sander T, 2011, PROTEINS, V79, P1458, DOI 10.1002/prot.22975; Sawyer GW, 2002, J BIOL CHEM, V277, P50036, DOI 10.1074/jbc.M209281200; Schaerer MT, 1998, EUR J PHARMACOL, V354, P283, DOI 10.1016/S0014-2999(98)00456-7; Sharkey LM, 2008, MOL PHARMACOL, V74, P203, DOI 10.1124/mol.108.044891; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; Sigel E, 1998, MOL PHARMACOL, V54, P1097, DOI 10.1124/mol.54.6.1097; SIGEL E, 1983, J BIOL CHEM, V258, P6965; SIMONYI M, 1990, ACTA PHARM NORDICA, V2, P145; SIMONYI M, 1990, BIOORG CHEM, V18, P1, DOI 10.1016/0045-2068(90)90010-3; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STERNBACH LH, 1971, ANGEW CHEM INT EDIT, V10, P34, DOI 10.1002/anie.197100341; STEWARD EG, 1973, ACTA CRYSTALLOGR B, V29, P2825, DOI 10.1107/S0567740873007594; Taliani S, 2009, J MED CHEM, V52, P3723, DOI 10.1021/jm9001154; Tan KR, 2007, FEBS LETT, V581, P4718, DOI 10.1016/j.febslet.2007.08.068; Tan KR, 2007, J BIOL CHEM, V282, P26316, DOI 10.1074/jbc.M702153200; Tan KR, 2009, J NEUROCHEM, V111, P1264, DOI 10.1111/j.1471-4159.2009.06419.x; TANNOR DJ, 1994, J AM CHEM SOC, V116, P11875, DOI 10.1021/ja00105a030; Thompson AJ, 2012, NEUROPHARMACOLOGY, V63, P761, DOI 10.1016/j.neuropharm.2012.05.027; Tomita K., 1965, JAP J BRAIN PHYSIOL, V61, P1; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wagner DA, 2004, J NEUROSCI, V24, P2733, DOI 10.1523/JNEUROSCI.4316-03.2004; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; Westh-Hansen SE, 1999, NEUROREPORT, V10, P2417, DOI 10.1097/00001756-199908020-00036; Wingrove PB, 2002, EUR J PHARMACOL, V437, P31, DOI 10.1016/S0014-2999(02)01279-7; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; YOUNG R, 1984, LIFE SCI, V34, P1977, DOI 10.1016/0024-3205(84)90129-2; Zhang W, 1995, Drug Des Discov, V12, P193	113	90	91	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52323	10.1371/journal.pone.0052323	http://dx.doi.org/10.1371/journal.pone.0052323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308109	Green Published, gold			2022-12-27	WOS:000313429100009
J	Foster, NL; Baums, IB; Sanchez, JA; Paris, CB; Chollett, I; Agudelo, CL; Vermeij, MJA; Mumby, PJ				Foster, Nicola L.; Baums, Iliana B.; Sanchez, Juan A.; Paris, Claire B.; Chollett, Iliana; Agudelo, Claudia L.; Vermeij, Mark J. A.; Mumby, Peter J.			Hurricane-Driven Patterns of Clonality in an Ecosystem Engineer: The Caribbean Coral Montastraea annularis	PLOS ONE			English	Article							REEF-BUILDING CORAL; LONG-TERM DECLINE; GENOTYPIC DIVERSITY; ASEXUAL REPRODUCTION; POPULATION-STRUCTURE; PHASE-SHIFTS; RECRUITMENT FAILURE; SEXUAL REPRODUCTION; ACROPORA-PALMATA; LIFE-HISTORIES	K-selected species with low rates of sexual recruitment may utilise storage effects where low adult mortality allows a number of individuals to persist through time until a favourable recruitment period occurs. Alternative methods of recruitment may become increasingly important for such species if the availability of favourable conditions for sexual recruitment decline under rising anthropogenic disturbance and climate change. Here, we test the hypotheses that asexual dispersal is an integral life history strategy not only in branching corals, as previously reported, but also in a columnar, 'K-selected' coral species, and that its prevalence is driven by the frequency of severe hurricane disturbance. Montastraea annularis is a long-lived major frame-work builder of Caribbean coral reefs but its survival is threatened by the consequences of climate induced disturbance, such as bleaching, ocean acidification and increased prevalence of disease. 700 M. annularis samples from 18 reefs within the Caribbean were genotyped using six polymorphic microsatellite loci. We demonstrate that asexual reproduction occurs at varying frequency across the species-range and significantly contributes to the local abundance of M. annularis, with its contribution increasing in areas with greater hurricane frequency. We tested several competing hypotheses that might explain the observed pattern of genotypic diversity. 64% of the variation in genotypic diversity among the sites was explained by hurricane incidence and reef slope, demonstrating that large-scale disturbances combine with local habitat characteristics to shape the balance between sexual and asexual reproduction in populations of M. annularis.	[Foster, Nicola L.; Chollett, Iliana; Mumby, Peter J.] Univ Exeter, Sch BioSci, Marine Spatial Ecol Lab, Exeter, Devon, England; [Baums, Iliana B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Sanchez, Juan A.; Agudelo, Claudia L.] Univ Los Andes, Fac Ciencias, Dept Ciencias Biol, Lab Biol Mol Marina BIOMMAR, Bogota, Colombia; [Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Vermeij, Mark J. A.] Carmabi Fdn, Willemstad, Netherlands; [Vermeij, Mark J. A.] Univ Amsterdam, IBED, Amsterdam, Netherlands	University of Exeter; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidad de los Andes (Colombia); University of Miami; University of Amsterdam	Foster, NL (corresponding author), Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England.	nicolalouise.foster@gmail.com	Vermeij, Mark/B-2752-2013; sanchez, juan/GSD-8167-2022; Mumby, Peter/F-9914-2010; Baums, Iliana Brigitta/G-6435-2010; Vermeij, Mark/AAR-6757-2020; Foster, Nicola L/A-3885-2012	Vermeij, Mark/0000-0001-9612-9527; Mumby, Peter/0000-0002-6297-9053; Baums, Iliana Brigitta/0000-0001-6463-7308; Vermeij, Mark/0000-0001-9612-9527; Foster, Nicola L/0000-0001-9796-1753; Sanchez, Juan Armando/0000-0001-7149-8369; Chollett, Iliana/0000-0003-0536-499X; Chollett, Iliana/0000-0003-4827-1072; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334	Royal Society; Natural Environment Research Council;  [007]; NERC [NE/E010393/1] Funding Source: UKRI; Natural Environment Research Council [NE/E010393/1] Funding Source: researchfish; Directorate For Geosciences [0825979] Funding Source: National Science Foundation	Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by funding from the Royal Society and Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank S. Box, K. Kuran, S. Bejarano, A. Grajales, P. Shears and J. Shears for their assistance in the field. We thank K. Sumner and J. Ball for their guidance and assistance in the laboratory in Exeter, A. Harborne for his assistance in estimating site exposure and reef slope and H. Edwards and I. Elliott for their assistance in calculating hurricane incidence. We would also like to thank Glovers Reef Marine Research Station, Belize; Pura Vida Resort, Honduras; COLCIENCIAS, BIOMMAR and La Tortuga Dive Shop, Colombia; Frankie's Dive Shop, Belize and Custom Aquatics, Bahamas for logistical support in the field. Colombia granted access to genetic resources to J.A.S. for the DNA analyses included in this paper (Contract 007, resolution 634, 14 March 2007).	Andrefouet S, 2004, GLOBAL ASSESSMENT MO, P1732; Ayre DJ, 2004, MAR ECOL PROG SER, V277, P95, DOI 10.3354/meps277095; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Bries JM, 2004, CORAL REEFS, V23, P297, DOI 10.1007/s00338-004-0379-9; Brown BE, 2000, NATURE, V404, P142, DOI 10.1038/35004657; Burke JM, 2000, EVOLUTION, V54, P137, DOI 10.1111/j.0014-3820.2000.tb00014.x; BURNETT WJ, 1995, MAR BIOL, V122, P665, DOI 10.1007/BF00350688; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Carricart-Ganivet JP, 2004, J EXP MAR BIOL ECOL, V302, P249, DOI 10.1016/j.jembe.2003.10.015; Ceplitis A, 2001, EVOLUTION, V55, P1581, DOI 10.1111/j.0014-3820.2001.tb00677.x; Chassignet EP, 2006, OCEAN WEATHER FORECASTING: AN INTEGRATED VIEW OF OCEANOGRAPHY, P413, DOI 10.1007/1-4020-4028-8_16; Chollett I, LIMNOL OCEA IN PRESS; Coffroth MA, 1998, EVOLUTION, V52, P379, DOI 10.1111/j.1558-5646.1998.tb01639.x; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Douhovnikoff V, 2005, ECOLOGY, V86, P446, DOI 10.1890/04-0257; Douhovnikoff V, 2004, AM J BOT, V91, P1140, DOI 10.3732/ajb.91.7.1140; DUSTAN P, 1975, MAR BIOL, V33, P101, DOI 10.1007/BF00390714; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Edmunds PJ, 2002, CORAL REEFS, V21, P357, DOI 10.1007/s00338-002-0258-1; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Eriksson O, 2000, GLOBAL ECOL BIOGEOGR, V9, P443, DOI 10.1046/j.1365-2699.2000.00215.x; ERIKSSON O, 1989, OIKOS, V55, P231, DOI 10.2307/3565427; Foster NL, 2007, J ANIM ECOL, V76, P384, DOI 10.1111/j.1365-2656.2006.01207.x; Foster NL, 2012, MOL ECOL, V21, P1143, DOI 10.1111/j.1365-294X.2012.05455.x; Gardner SN, 1997, AM NAT, V150, P462, DOI 10.1086/286076; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; GLADFELTER EH, 1978, B MAR SCI, V28, P728; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Gourlay MR, 2005, COAST ENG, V52, P353, DOI 10.1016/j.coastaleng.2004.11.007; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; HARMELINVIVIEN ML, 1986, CORAL REEFS, V5, P55, DOI 10.1007/BF00270353; Harper J. L, 1977, POPULATION BIOL PLAN; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hoegh-Guldberg O, 2004, SYMBIOSIS, V37, P1; Holland GJ, 2007, PHILOS T R SOC A, V365, P2695, DOI 10.1098/rsta.2007.2083; Honnay O, 2005, OIKOS, V108, P427, DOI 10.1111/j.0030-1299.2005.13569.x; Hughes R.N., 1985, P153; HUGHES RN, 1990, FUNCTIONAL BIOL CLON; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; HUNTER CL, 1993, EVOLUTION, V47, P1213, DOI 10.1111/j.1558-5646.1993.tb02148.x; Jackson J.B.C., 1985, P297; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; KJERFVE B, 1986, J MAR RES, V44, P119, DOI 10.1357/002224086788460120; Laboute P., 1985, P 5 INT COR REEF S, V3, P323; LASKER HR, 1990, ECOLOGY, V71, P1578, DOI 10.2307/1938293; Le Goff-Vitry MC, 2004, MOL ECOL, V13, P537, DOI 10.1046/j.1365-294X.2004.2079.x; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Lirman D, 2003, ECOL MODEL, V161, P169, DOI 10.1016/S0304-3800(02)00346-0; MASSEL SR, 1993, CORAL REEFS, V12, P153, DOI 10.1007/BF00334475; McFadden CS, 1997, EVOLUTION, V51, P112, DOI 10.1111/j.1558-5646.1997.tb02393.x; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Mercado-Molina AE, 2011, J EXP MAR BIOL ECOL, V407, P355, DOI 10.1016/j.jembe.2011.07.018; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 1999, MAR ECOL PROG SER, V190, P27, DOI 10.3354/meps190027; Namroud MC, 2006, CONSERV GENET, V7, P415, DOI 10.1007/s10592-005-9051-3; NEIGEL JE, 1983, EVOLUTION, V37, P437, DOI 10.1111/j.1558-5646.1983.tb05561.x; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Pianka ER, 1983, EVOLUTIONARY ECOLOGY; POTTS DC, 1984, PALEOBIOLOGY, V10, P48, DOI 10.1017/S0094837300008010; Prati D, 2000, OIKOS, V90, P442, DOI 10.1034/j.1600-0706.2000.900303.x; Reusch TBH, 2006, MOL ECOL, V15, P277, DOI 10.1111/j.1365-294X.2005.02779.x; Richards CL, 2004, ECOL LETT, V7, P1155, DOI 10.1111/j.1461-0248.2004.00674.x; Severance EG, 2004, MOL ECOL NOTES, V4, P74, DOI 10.1046/j.1471-8286.2003.00573.x; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Sheppard C, 2005, ESTUAR COAST SHELF S, V64, P223, DOI 10.1016/j.ecss.2005.02.016; Smith LD, 1999, J EXP MAR BIOL ECOL, V235, P147, DOI 10.1016/S0022-0981(98)00178-6; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Stocklin J, 2004, EVOL ECOL, V18, P563, DOI 10.1007/s10682-004-5144-6; STODDART JA, 1988, GENETICS, V118, P705; Stokes KE, 2008, PLANT ECOL, V197, P91, DOI 10.1007/s11258-007-9363-0; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; Szmant-Froelich A, 1985, P 5 INT COR REEF S, V4, P295; Travis SE, 2005, J ECOL, V93, P417, DOI 10.1111/j.0022-0477.2005.00985.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P221, DOI 10.3354/meps109221; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WARD S, 1995, J EXP MAR BIOL ECOL, V187, P193, DOI 10.1016/0022-0981(94)00180-L; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; Weppler T, 2006, J ECOL, V94, P869, DOI 10.1111/j.1365-2745.2006.01134.x; Williams DE, 2008, CORAL REEFS, V27, P697, DOI 10.1007/s00338-008-0386-3; Winkler E, 1999, PLANT ECOL, V141, P191, DOI 10.1023/A:1009843619713	95	34	34	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53283	10.1371/journal.pone.0053283	http://dx.doi.org/10.1371/journal.pone.0053283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308185	Green Published, gold			2022-12-27	WOS:000313429100050
J	Musella, V; Verderio, P; Reid, JF; Pizzamiglio, S; Gariboldi, M; Callari, M; Milione, M; De Cecco, L; Veneroni, S; Pierotti, MA; Daidone, MG				Musella, Valeria; Verderio, Paolo; Reid, James Francis; Pizzamiglio, Sara; Gariboldi, Manuela; Callari, Maurizio; Milione, Massimo; De Cecco, Loris; Veneroni, Silvia; Pierotti, Marco Alessandro; Daidone, Maria Grazia			Effects of Warm Ischemic Time on Gene Expression Profiling in Colorectal Cancer Tissues and Normal Mucosa	PLOS ONE			English	Article							RNA INTEGRITY; IMPACT	Background: Genome-wide gene expression analyses of tumors are a powerful tool to identify gene signatures associated with biologically and clinically relevant characteristics and for several tumor types are under clinical validation by prospective trials. However, handling and processing of clinical specimens may significantly affect the molecular data obtained from their analysis. We studied the effects of tissue handling time on gene expression in human normal and tumor colon tissues undergoing routine surgical procedures. Methods: RNA extracted from specimens of 15 patients at four time points (for a total of 180 samples) after surgery was analyzed for gene expression on high-density oligonucleotide microarrays. A mixed-effects model was used to identify probes with different expression means across the four different time points. The p-values of the model were adjusted with the Bonferroni method. Results: Thirty-two probe sets associated with tissue handling time in the tumor specimens, and thirty-one in the normal tissues, were identified. Most genes exhibited moderate changes in expression over the time points analyzed; however four of them were oncogenes, and two confirmed the effect of tissue handling by independent validation. Conclusions: Our results suggest that a critical time point for tissue handling in colon seems to be 60 minutes at room temperature. Although the number of time-dependent genes we identified was low, the three genes that already showed changes at this time point in tumor samples were all oncogenes, hence recommending standardization of tissue-handling protocols and effort to reduce the time from specimen removal to snap freezing accounting for warm ischemia in this tumor type.	[Musella, Valeria; Reid, James Francis; Gariboldi, Manuela; Callari, Maurizio; De Cecco, Loris; Veneroni, Silvia; Daidone, Maria Grazia] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Verderio, Paolo; Pizzamiglio, Sara] Fdn IRCCS Ist Nazl Tumori, Unit Med Stat & Biometry, Milan, Italy; [Reid, James Francis; Gariboldi, Manuela] Fdn Ist FIRC Oncol Mol, Milan, Italy; [Milione, Massimo] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy; [Pierotti, Marco Alessandro] Fdn IRCCS Ist Nazl Tumori, Sci Directorate, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Daidone, MG (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	mariagrazia.daidone@istitutotumori.mi.it	Daidone, Maria Grazia/E-9232-2017; Verderio, Paolo/B-5034-2017; Veneroni, Silvia/F-3651-2017; Pizzamiglio, Sara/C-1061-2017; De Cecco, Loris/K-7036-2016; Callari, Maurizio/AAF-7089-2019; Milione, Massimo/B-8644-2017; Musella, Valeria/H-4458-2016; Pierotti, Marco Alessandro/AAC-4728-2022; Gariboldi, Manuela/K-4744-2016	Daidone, Maria Grazia/0000-0002-4786-1321; Verderio, Paolo/0000-0002-9231-1281; Veneroni, Silvia/0000-0001-9223-4151; Pizzamiglio, Sara/0000-0002-7759-0550; De Cecco, Loris/0000-0002-7066-473X; Callari, Maurizio/0000-0001-5239-0918; Milione, Massimo/0000-0002-1202-139X; Musella, Valeria/0000-0001-9517-2670; Pierotti, Marco Alessandro/0000-0002-7431-8332; Gariboldi, Manuela/0000-0001-8406-165X	Fondazione Cariplo-Regione Lombardia; Associazione Italiana Ricerca Cancro; Alleanza Contro il Cancro; EurocanPlatform project	Fondazione Cariplo-Regione Lombardia(Fondazione CariploRegione Lombardia); Associazione Italiana Ricerca Cancro(Fondazione AIRC per la ricerca sul cancro); Alleanza Contro il Cancro; EurocanPlatform project	This work was supported by grants from Fondazione Cariplo-Regione Lombardia (project Title: "Biobanca per il carcinoma colorettale"), Associazione Italiana Ricerca Cancro, Alleanza Contro il Cancro, and EurocanPlatform project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell WC, 2010, METHODS MOL BIOL, V576, P1, DOI 10.1007/978-1-59745-545-9_1; Benjamin D, 2007, EXPERT OPIN BIOL TH, V7, P1515, DOI 10.1517/14712598.7.10.1515; Borgan E, 2011, MOL ONCOL, V5, P564, DOI 10.1016/j.molonc.2011.08.004; Bray SE, 2010, HISTOPATHOLOGY, V56, P240, DOI 10.1111/j.1365-2559.2009.03470.x; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dumur CI, 2008, DIAGN MOL PATHOL, V17, P200, DOI 10.1097/PDM.0b013e318169bfaf; Erickson HS, 2010, AM J TRANSL RES, V2, P210; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Florell SR, 2001, MODERN PATHOL, V14, P116, DOI 10.1038/modpathol.3880267; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hatzis C, 2011, JNCI-J NATL CANCER I, V103, P1871, DOI 10.1093/jnci/djr438; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McHugh SM, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-36; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shima Y, 2006, J PEDIATR SURG, V41, P830, DOI 10.1016/j.jpedsurg.2005.12.025; Webster MJ, 2006, PROG BRAIN RES, V158, P3, DOI 10.1016/S0079-6123(06)58001-X	24	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53406	10.1371/journal.pone.0053406	http://dx.doi.org/10.1371/journal.pone.0053406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308215	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100063
J	Ross, IL; Levitt, NS				Ross, Ian Louis; Levitt, Naomi S.			Addison's Disease Symptoms - A Cross Sectional Study in Urban South Africa	PLOS ONE			English	Article							HEALTH-CARE; PREVALENCE	Background: Addison's disease is a potentially life-threatening disorder, and prompt diagnosis, and introduction of steroid replacement has resulted in near normal life-expectancy. There are limited data describing the clinical presentation of Addison's disease in South Africa. It is hypothesised that patients may present in advanced state of ill-health, compared to Western countries. Patients: A national database of patients was compiled from primary care, referral centres and private practices. 148 patients were enrolled (97 white, 34 mixed ancestry, 5 Asian and 12 black). Methods: Demographic and clinical data were elicited using questionnaires. Biochemical data were obtained from folder reviews and laboratory archived results. Results: The majority of the cohort was women (62%). The median and inter-quartile age range (IQR) of patients at enrolment was 46.0 (32.0-61.0) years, with a wide range from 2.8-88.0 years. The median and IQR age at initial diagnosis was 34.0 (20.0-45.0) years (range 0.02-77.0) years, indicating that at the time of enrolment, the patients, on average, were diagnosed with Addison's disease 12 years previously. Hyperpigmentation was observed in 76%, nausea and vomiting occurred in more than 40%, and weight loss was noted in 25%. Loss of consciousness as a presenting feature was recorded in 20%. with a 95% confidence interval [CI] of (14-28%) and shock occurred in 5% CI (1.5-8.5%). Case-finding was recorded at 3.1 per million. Conclusions: The usual constellation of hyperpigmentation, nausea, vomiting and weight loss suggests Addison's disease, but a significant proportion present with an advanced state of ill-health and Addisonian crises. A lower prevalence rate, compared to Western countries is suggested.	[Ross, Ian Louis; Levitt, Naomi S.] Univ Cape Town, Dept Med, Groote Schuur Hosp, Div Endocrinol, ZA-7925 Cape Town, South Africa	University of Cape Town	Ross, IL (corresponding author), Univ Cape Town, Dept Med, Groote Schuur Hosp, Div Endocrinol, ZA-7925 Cape Town, South Africa.	ian.ross@uct.ac.za	; Ross, Ian Louis/N-7420-2017	Levitt, Naomi/0000-0001-6480-8066; Ross, Ian Louis/0000-0002-5308-7563	Swedish Research Links [65390/2007]	Swedish Research Links	ILR is the recipient of the Swedish Research Links Grant No: 65390/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu S, 2009, DIABETOLOGIA, V52, P1842, DOI 10.1007/s00125-009-1433-5; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; BERGNER GE, 1951, J CLIN ENDOCRINOL, V11, P322, DOI 10.1210/jcem-11-3-322; Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076; Bleicken B, 2010, AM J MED SCI, V339, P525, DOI 10.1097/MAJ.0b013e3181db6b7a; Daviauda E, 2008, B WORLD HEALTH ORGAN, V86, P46, DOI 10.2471/BLT.07.042283; Erichsen MM, 2009, J CLIN ENDOCR METAB, V94, P4882, DOI 10.1210/jc.2009-1368; HOPKINSON ND, 1995, ANN RHEUM DIS, V54, P891, DOI 10.1136/ard.54.11.891; KONG MF, 1994, CLIN ENDOCRINOL, V41, P757, DOI 10.1111/j.1365-2265.1994.tb02790.x; Leelarathna L, 2010, ENDOCRINE, V38, P113, DOI 10.1007/s12020-010-9359-8; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; Matoussi N, 2008, Tunis Med, V86, P890; MEIKLE AW, 1977, AM J MED, V63, P200, DOI 10.1016/0002-9343(77)90233-9; MENGISTU M, 1991, ETHIOPIAN MED J, V29, P185; Naidoo S, 2012, J PUBLIC HEALTH-UK, V34, P149, DOI 10.1093/pubmed/fds008; NERUP J, 1974, DAN MED BULL, V21, P201; Nieman LK, 2006, CLIN DERMATOL, V24, P276, DOI 10.1016/j.clindermatol.2006.04.006; NOMURA K, 1994, INTERNAL MED, V33, P602, DOI 10.2169/internalmedicine.33.602; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; PAPADOPOULOS KI, 1990, ACTA ENDOCRINOL-COP, V122, P472, DOI 10.1530/acta.0.1220472; Ross I, 2010, CLIN ENDOCRINOL, V73, P291, DOI 10.1111/j.1365-2265.2010.03807.x; Simm PJ, 2004, J PAEDIATR CHILD H, V40, P596, DOI 10.1111/j.1440-1754.2004.00482.x; Soule S, 1999, CLIN ENDOCRINOL, V50, P115, DOI 10.1046/j.1365-2265.1999.00625.x; Stallwood Lynda, 2005, J Pediatr Health Care, V19, P400, DOI 10.1016/j.pedhc.2005.09.003; Ten S, 2001, J CLIN ENDOCR METAB, V86, P2909, DOI 10.1210/jc.86.7.2909; Vasikaran SD, 2009, CLIN CHEM LAB MED, V47, P963, DOI 10.1515/CCLM.2009.225; Willis AC, 1997, POSTGRAD MED J, V73, P286, DOI 10.1136/pgmj.73.859.286	28	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53526	10.1371/journal.pone.0053526	http://dx.doi.org/10.1371/journal.pone.0053526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308244	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100082
J	Smeazzetto, S; Saponaro, A; Young, HS; Moncelli, MR; Thiel, G				Smeazzetto, Serena; Saponaro, Andrea; Young, Howard S.; Moncelli, Maria Rosa; Thiel, Gerhard			Structure-Function Relation of Phospholamban: Modulation of Channel Activity as a Potential Regulator of SERCA Activity	PLOS ONE			English	Article							RELEASE CHANNEL; MUTATION; PHOSPHORYLATION; CA2+-ATPASE; STATE; CONDUCTANCE; ORIENTATION; PROTEINS; BILAYERS; PENTAMER	Phospholamban (PLN) is a small integral membrane protein, which binds and inhibits in a yet unknown fashion the Ca2+-ATPase (SERCA) in the sarcoplasmic reticulum. When reconstituted in planar lipid bilayers PLN exhibits ion channel activity with a low unitary conductance. From the effect of non-electrolyte polymers on this unitary conductance we estimate a narrow pore with a diameter of ca. 2.2 angstrom for this channel. This value is similar to that reported for the central pore in the structure of the PLN pentamer. Hence the PLN pentamer, which is in equilibrium with the monomer, is the most likely channel forming structure. Reconstituted PLN mutants, which either stabilize (K27A and R9C) or destabilize (147A) the PLN pentamer and also phosphorylated PLN still generate the same unitary conductance of the wt/non-phosphorylated PLN. However the open probability of the phosphorylated PLN and of the R9C mutant is significantly lower than that of the respective wt/non-phosphorylated control. In the context of data on PLN/SERCA interaction and on Ca2+ accumulation in the sarcoplasmic reticulum the present results are consistent with the view that PLN channel activity could participate in the balancing of charge during Ca2+ uptake. A reduced total conductance of the K+ transporting PLN by phosphorylation or by the R9C mutation may stimulate Ca2+ uptake in the same way as an inhibition of K+ channels in the SR membrane. The R9C-PLN mutation, a putative cause of dilated cardiomyopathy, might hence affect SERCA activity also via its inherent low open probability.	[Smeazzetto, Serena; Moncelli, Maria Rosa] Univ Florence, Dipartimento Chim, I-50144 Florence, Italy; [Saponaro, Andrea] Univ Milan, Dept Biol, Milan, Italy; [Saponaro, Andrea] Univ Milan, CNR IBF Mi, Milan, Italy; [Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Thiel, Gerhard] Tech Univ Darmstadt, Darmstadt, Germany	University of Florence; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Alberta; Technical University of Darmstadt	Thiel, G (corresponding author), Tech Univ Darmstadt, Darmstadt, Germany.	gerhardthiel@me.com	Saponaro, Andrea/AAD-1005-2019	Saponaro, Andrea/0000-0001-5035-5174; Smeazzetto, Serena/0000-0003-3297-569X; Thiel, Gerhard/0000-0002-2335-1351; Young, Howard/0000-0002-5990-8422	Ente Cassa di Risparmio di Firenze; Ministero dell'Istruzione, Universita e Ricerca (PRIN project); Loewe initiative SoftControl	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Ministero dell'Istruzione, Universita e Ricerca (PRIN project); Loewe initiative SoftControl	This work was supported by Ente Cassa di Risparmio di Firenze and Ministero dell'Istruzione, Universita e Ricerca (PRIN project) and Loewe initiative SoftControl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD B, 1992, FEBS LETT, V314, P81, DOI 10.1016/0014-5793(92)81466-Y; Arkin IT, 1997, ANNU REV BIOPH BIOM, V26, P157, DOI 10.1146/annurev.biophys.26.1.157; ARKIN IT, 1995, J MOL BIOL, V248, P824, DOI 10.1006/jmbi.1995.0263; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; FAVERO TG, 1995, J BIOL CHEM, V270, P25557, DOI 10.1074/jbc.270.43.25557; FINK RHA, 1987, PFLUG ARCH EUR J PHY, V409, P374, DOI 10.1007/BF00583791; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Hille B., 1992, IONIC CHANNELS EXCIT; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; KRASILNIKOV OV, 1992, FEMS MICROBIOL IMMUN, V105, P93; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Maffeo C, 2009, BIOPHYS J, V96, P4853, DOI 10.1016/j.bpj.2009.03.053; MONTAL M, 1987, J MEMBRANE BIOL, V98, P101, DOI 10.1007/BF01872123; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Reddy LG, 1999, BIOCHEMISTRY-US, V38, P3954, DOI 10.1021/bi981795d; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Sansom MSP, 1997, BIOPHYS CHEM, V69, P269, DOI 10.1016/S0301-4622(97)00109-9; Schmidt AG, 2001, CARDIOVASC DRUG THER, V15, P387, DOI 10.1023/A:1013381204658; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Smeazzetto S, 2011, PHYS CHEM CHEM PHYS, V13, P12935, DOI 10.1039/c1cp20460b; Stokes DL, 2006, BIOPHYS J, V90, P4213, DOI 10.1529/biophysj.105.079640; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; TATULIAN SA, 1995, BIOCHEMISTRY-US, V34, P4448, DOI 10.1021/bi00013a038; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Verardi R, 2011, P NATL ACAD SCI USA, V108, P9101, DOI 10.1073/pnas.1016535108; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5	36	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52744	10.1371/journal.pone.0052744	http://dx.doi.org/10.1371/journal.pone.0052744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308118	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100012
J	Mavila, N; James, D; Utley, S; Cu, N; Coblens, O; Mak, K; Rountree, CB; Kahn, M; Wang, KS				Mavila, Nirmala; James, David; Utley, Sarah; Nguyen Cu; Coblens, Orly; Mak, Katrina; Rountree, C. Bart; Kahn, Michael; Wang, Kasper S.			Fibroblast Growth Factor Receptor-Mediated Activation of AKT-beta-Catenin-CBP Pathway Regulates Survival and Proliferation of Murine Hepatoblasts and Hepatic Tumor Initiating Stem Cells	PLOS ONE			English	Article							LIVER PROGENITOR CELLS; CREB-BINDING PROTEIN; WNT/BETA-CATENIN; SELF-RENEWAL; CANCER; P300; PHOSPHORYLATION; DIFFERENTIATION; COACTIVATORS; EXPRESSION	Fibroblast Growth Factor (FGF)-10 promotes the proliferation and survival of murine hepatoblasts during early stages of hepatogenesis through a Wnt-beta-catenin dependent pathway. To determine the mechanism by which this occurs, we expanded primary culture of hepatoblasts enriched for progenitor markers CD133 and CD49f from embryonic day (E) 12.5 fetal liver and an established tumor initiating stem cell line from Mat1a(-/-) livers in media conditioned with recombinant (r) FGF10 or rFGF7. FGF Receptor (R) activation resulted in the downstream activation of MAPK, PI3K-AKT, and beta-catenin pathways, as well as cellular proliferation. Additionally, increased levels of nuclear beta-catenin phosphorylated at Serine-552 in cultured primary hepatoblasts, Mat1a(-/-) cells, and also in ex vivo embryonic liver explants indicate AKT-dependent activation of beta-catenin downstream of FGFR activation; conversely, the addition of AKT inhibitor Ly294002 completely abrogated beta-catenin activation. FGFR activation-induced cell proliferation and survival were also inhibited by the compound ICG-001, a small molecule inhibitor of beta-catenin-CREB Binding Protein (CBP) in hepatoblasts, further indicating a CBP-dependent regulatory mechanism of beta-catenin activity. Conclusion: FGF signaling regulates the proliferation and survival of embryonic and transformed progenitor cells in part through AKT-mediated activation of beta-catenin and downstream interaction with the transcriptional co-activator CBP. Citation: Mavila N, James D, Utley S, Cu N, Coblens O, et al. (2012) Fibroblast Growth Factor Receptor-Mediated Activation of AKT-beta-Catenin-CBP Pathway Regulates Survival and Proliferation of Murine Hepatoblasts and Hepatic Tumor Initiating Stem Cells. PLoS ONE 7(11): e50401. doi:10.1371/journal.pone.0050401	[Mavila, Nirmala; James, David; Utley, Sarah; Coblens, Orly; Mak, Katrina; Wang, Kasper S.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Nguyen Cu; Kahn, Michael] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Nguyen Cu; Kahn, Michael] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Rountree, C. Bart] Bon Secours St Marys Hosp, Richmond, VA USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California	Wang, KS (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA.	kwang@chla.usc.edu	Mavila, Nirmala/AAH-6140-2021		National Institutes of Health Grants [K08 AAA01690]; American College of Surgeons Franklin Martin Award; NIH [HL073722]; USC Norris Comprehensive Cancer Center Support Grant [P30 CA014089]; American Cancer Society [MGO-116519]; Penn State Hershey Four Diamonds Fund; California Institute for Regenerative Medicine Bridges to Stem Cell Research Award; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA016290] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons Franklin Martin Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC Norris Comprehensive Cancer Center Support Grant; American Cancer Society(American Cancer Society); Penn State Hershey Four Diamonds Fund; California Institute for Regenerative Medicine Bridges to Stem Cell Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by in part by the National Institutes of Health Grants K08 AAA01690 (to KW), the American College of Surgeons Franklin Martin Award (to KW), NIH HL073722 (to MK), USC Norris Comprehensive Cancer Center Support Grant P30 CA014089 (to MK), American Cancer Society, MGO-116519 (to CBR), and The Penn State Hershey Four Diamonds Fund (to CBR) and the California Institute for Regenerative Medicine Bridges to Stem Cell Research Award (to KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Berg T, 2007, HEPATOLOGY, V46, P1187, DOI 10.1002/hep.21814; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Cairo S, 2008, CANCER CELL, V14, P471, DOI 10.1016/j.ccr.2008.11.002; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Chan WI, 2011, MOL CELL BIOL, V31, P5046, DOI 10.1128/MCB.05830-11; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fiegel HC, 2004, J HISTOCHEM CYTOCHEM, V52, P1495, DOI 10.1369/jhc.4A6297.2004; Goodman RH, 2000, GENE DEV, V14, P1553; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hoppo T, 2004, HEPATOLOGY, V39, P1362, DOI 10.1002/hep.20180; HU ZY, 1995, CELL GROWTH DIFFER, V6, P1019; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Lade AG, 2011, DEV DYNAM, V240, P486, DOI 10.1002/dvdy.22522; Laurson J, 2007, CELLS TISSUES ORGANS, V186, P180, DOI 10.1159/000106360; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Micsenyi A, 2004, GASTROENTEROLOGY, V126, P1134, DOI 10.1053/j.gastro.2003.12.047; Miki T, 2011, STEM CELL REV; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Ponce DP, 2011, MOL CELL BIOCHEM, V356, P127, DOI 10.1007/s11010-011-0965-4; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rountree CB, 2008, HEPATOLOGY, V47, P1288, DOI 10.1002/hep.22141; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Taurin S, 2008, AM J PHYSIOL-CELL PH, V294, pC1169, DOI 10.1152/ajpcell.00096.2008; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Zaret KS, 2000, MECH DEVELOP, V92, P83, DOI 10.1016/S0925-4773(99)00326-3; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	48	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50401	10.1371/journal.pone.0050401	http://dx.doi.org/10.1371/journal.pone.0050401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23308088	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100089
J	Kotak, VC; Takesian, AE; MacKenzie, PC; Sanes, DH				Kotak, Vibhakar C.; Takesian, Anne E.; MacKenzie, Patricia C.; Sanes, Dan H.			Rescue of Inhibitory Synapse Strength following Developmental Hearing Loss	PLOS ONE			English	Article							MEDIAL SUPERIOR OLIVE; OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT REFINEMENT; POSTSYNAPTIC GABA(A) RECEPTORS; AUDITORY CORTICAL DEVELOPMENT; PRIMARY VISUAL-CORTEX; INTRACORTICAL INHIBITION; GABAERGIC TRANSMISSION; HIPPOCAMPAL-NEURONS; BRAIN-STEM	Inhibitory synapse dysfunction may contribute to many developmental brain disorders, including the secondary consequences of sensory deprivation. In fact, developmental hearing loss leads to a profound reduction in the strength of inhibitory postsynaptic currents (IPSCs) in the auditory cortex, and this deficit persists into adulthood. This finding is consistent with the general theory that the emergence of mature synaptic properties requires activity during development. Therefore, we tested the prediction that inhibitory strength can be restored following developmental hearing loss by boosting GABAergic transmission in vivo. Conductive or sensorineural hearing loss was induced surgically in gerbils prior to hearing onset and GABA agonists were then administered for one week. IPSCs were subsequently recorded from pyramidal neurons in a thalamocortical brain slice preparation. Administration of either a GABA(A) receptor a1 subunit specific agonist (zolpidem), or a selective GABA reuptake inhibitor (SGRI), rescued IPSC amplitude in hearing loss animals. Furthermore, this restoration persisted in adults, long after drug treatment ended. In contrast, a GABA(B) receptor agonist baclofen did not restore inhibitory strength. IPSCs could also be restored when SGRI administration began 3 weeks after sensory deprivation. Together, these results demonstrate long-lasting restoration of cortical inhibitory strength in the absence of normal experience. This suggests that in vivo GABA(A) receptor activation is sufficient to promote maturation, and this principle may extend to other developmental disorders associated with diminished inhibitory function.	[Kotak, Vibhakar C.; Takesian, Anne E.; Sanes, Dan H.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [MacKenzie, Patricia C.; Sanes, Dan H.] NYU, Dept Biol, New York, NY 10003 USA	New York University; New York University	Kotak, VC (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	vck1@nyu.edu			National Institutes of Health [DC011284]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funded by the National Institutes of Health (DC011284 to DHS & VCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Bartley AF, 2008, J NEUROPHYSIOL, V100, P1983, DOI 10.1152/jn.90635.2008; Benarroch EE, 2007, NEUROLOGY, V68, P612, DOI 10.1212/01.wnl.0000255669.83468.dd; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chirila FV, 2007, J PHYSIOL-LONDON, V584, P167, DOI 10.1113/jphysiol.2007.137976; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Franklin SR, 2008, NEUROSCIENCE, V154, P346, DOI 10.1016/j.neuroscience.2008.02.011; Gittis AH, 2011, J NEUROSCI, V31, P15727, DOI 10.1523/JNEUROSCI.3875-11.2011; Grantyn R, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00013; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Harrison RV, 2012, ACTA OTO-LARYNGOL, V132, P409, DOI 10.3109/00016489.2011.648271; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Iwai Y, 2003, J NEUROSCI, V23, P6695; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Jiao YY, 2011, P NATL ACAD SCI USA, V108, P12131, DOI 10.1073/pnas.1105296108; KANDLER K, 1995, J NEUROSCI, V15, P6890; Kanold PO, 2009, J PHYSIOL-LONDON, V587, P2857, DOI 10.1113/jphysiol.2009.171215; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katagiri H, 2007, NEURON, V53, P805, DOI 10.1016/j.neuron.2007.02.026; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2000, J NEUROSCI, V20, P7972; Kleppner S R, 2001, Expert Opin Ther Targets, V5, P219, DOI 10.1517/14728222.5.2.219; Kotak VC, 2005, J NEUROSCI, V25, P3908, DOI 10.1523/JNEUROSCI.5169-04.2005; Kotak VC, 2008, CEREB CORTEX, V18, P2098, DOI 10.1093/cercor/bhm233; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Magnusson AK, 2005, J PHYSIOL-LONDON, V568, P497, DOI 10.1113/jphysiol.2005.094763; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Morales B, 2002, J NEUROSCI, V22, P8084; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Oswald AMM, 2011, CEREB CORTEX, V21, P1351, DOI 10.1093/cercor/bhq214; Otto G, 2006, HEARING RES, V220, P27, DOI 10.1016/j.heares.2006.06.014; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Rosen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041514; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sale A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00010; Sanes DH, 2011, HEARING RES, V279, P140, DOI 10.1016/j.heares.2011.03.015; SANES DH, 1993, EUR J NEUROSCI, V5, P570, DOI 10.1111/j.1460-9568.1993.tb00522.x; SANES DH, 1993, J NEUROSCI, V13, P2627, DOI 10.1523/JNEUROSCI.13-06-02627.1993; Sarro EC, 2008, CEREB CORTEX, V18, P2855, DOI 10.1093/cercor/bhn044; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Takesian AE, 2012, J NEUROPHYSIOL, V107, P937, DOI 10.1152/jn.00515.2011; Takesian AE, 2010, J NEUROSCI, V30, P2716, DOI 10.1523/JNEUROSCI.3903-09.2010; Tanaka DH, 2011, J NEUROSCI, V31, P14116, DOI 10.1523/JNEUROSCI.2786-11.2011; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Tucci DL, 2001, HEARING RES, V155, P124, DOI 10.1016/S0378-5955(01)00256-8; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Vale C, 2003, J NEUROSCI, V23, P7516; Vale C, 2000, J NEUROSCI, V20, P1912; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Wenner P, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/489470; Werthat F, 2008, DEV NEUROBIOL, V68, P1454, DOI 10.1002/dneu.20660; Xu H, 2007, J NEUROSCI, V27, P9417, DOI 10.1523/JNEUROSCI.1992-07.2007; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	72	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53438	10.1371/journal.pone.0053438	http://dx.doi.org/10.1371/journal.pone.0053438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326429	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800043
J	Lim, O; Lee, Y; Chung, H; Her, JH; Kang, SM; Jung, MY; Min, B; Shin, H; Kim, TM; Heo, DS; Hwang, YK; Shin, EC				Lim, Okjae; Lee, Yuna; Chung, Hyejin; Her, Jung Hyun; Kang, Sang Mi; Jung, Mi-Young; Min, Bokyung; Shin, Hyejin; Kim, Tae Min; Heo, Dae Seog; Hwang, Yu Kyeong; Shin, Eui-Cheol			GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							TUMOR-CELLS; NK CELLS; LIGAND INCOMPATIBILITY; ADOPTIVE IMMUNOTHERAPY; ACTIVATING RECEPTORS; DENDRITIC CELLS; CLINICAL-GRADE; T-CELLS; EXPANSION; MELANOMA	Ex vivo-expanded, allogeneic natural killer (NK) cells can be used for the treatment of various types of cancer. In allogeneic NK cell therapy, NK cells from healthy donors must be expanded in order to obtain a sufficient number of highly purified, activated NK cells. In the present study, we established a simplified and efficient method for the large-scale expansion and activation of NK cells from healthy donors under good manufacturing practice (GMP) conditions. After a single step of magnetic depletion of CD3(+) T cells, the depleted peripheral blood mononuclear cells (PBMCs) were stimulated and expanded with irradiated autologous PBMCs in the presence of OKT3 and IL-2 for 14 days, resulting in a highly pure population of CD3(-)CD16(+)CD56(+) NK cells which is desired for allogeneic purpose. Compared with freshly isolated NK cells, these expanded NK cells showed robust cytokine production and potent cytolytic activity against various cancer cell lines. Of note, expanded NK cells selectively killed cancer cells without demonstrating cytotoxicity against allogeneic non-tumor cells in coculture assays. The anti-tumor activity of expanded human NK cells was examined in SCID mice injected with human lymphoma cells. In this model, expanded NK cells efficiently controlled lymphoma progression. In conclusion, allogeneic NK cells were efficiently expanded in a GMP-compliant facility and demonstrated potent anti-tumor activity both in vitro and in vivo.	[Lim, Okjae; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, BioMed Sci & Engn Interdisciplinary Program, Taejon 305701, South Korea; [Lim, Okjae; Lee, Yuna; Chung, Hyejin; Her, Jung Hyun; Kang, Sang Mi; Min, Bokyung; Hwang, Yu Kyeong] Mogam Biotechnol Res Inst, Cell Therapy Team, Yongin, Gyeonggi Do, South Korea; [Jung, Mi-Young; Shin, Hyejin] Green Cross LabCell Corp, Cell Therapy Div, Yongin, Gyeonggi Do, South Korea; [Kim, Tae Min; Heo, Dae Seog] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Lim, Okjae; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST)	Hwang, YK (corresponding author), Mogam Biotechnol Res Inst, Cell Therapy Team, Yongin, Gyeonggi Do, South Korea.	ykhwang@mogam.re.kr; ecshin@kaist.ac.kr	Shin, Eui-Cheol/C-1690-2011	Shin, Eui-Cheol/0000-0002-6308-9503	Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A062260]	Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A062260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379123; Arai S, 2008, CYTOTHERAPY, V10, P625, DOI 10.1080/14653240802301872; Berg M, 2009, CYTOTHERAPY, V11, P341, DOI 10.1080/14653240902807034; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Brand JM, 2004, STEM CELLS DEV, V13, P307, DOI 10.1089/154732804323099235; Carlens S, 2001, HUM IMMUNOL, V62, P1092, DOI 10.1016/S0198-8859(01)00313-5; Deguine J, 2010, IMMUNITY, V33, P632, DOI 10.1016/j.immuni.2010.09.016; Farag SS, 2002, BLOOD, V100, P1935, DOI 10.1182/blood-2002-02-0350; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Giebel S, 2003, BLOOD, V102, P814, DOI 10.1182/blood-2003-01-0091; GRIMM EA, 1982, J EXP MED, V155, P1823, DOI 10.1084/jem.155.6.1823; Igarashi T, 2004, BLOOD, V104, P170, DOI 10.1182/blood-2003-12-4438; Koepsell SA, 2012, TRANSFUSION; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lapteva N, 2012, CYTOTHERAPY, V14, P1131, DOI 10.3109/14653249.2012.700767; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; MILLER JS, 1992, BLOOD, V80, P2221; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 2008, IMMUNOL REV, V224, P58, DOI 10.1111/j.1600-065X.2008.00651.x; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; SCHMIDTWOLF IGH, 1993, EXP HEMATOL, V21, P1673; Selewski DT, 2010, AM J NEURORADIOL, V31, P1178, DOI 10.3174/ajnr.A2142; Siegler U, 2010, CYTOTHERAPY, V12, P750, DOI 10.3109/14653241003786155; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Sutlu T, 2009, J INTERN MED, V266, P154, DOI 10.1111/j.1365-2796.2009.02121.x; Sutlu T, 2010, CYTOTHERAPY, V12, P1044, DOI 10.3109/14653249.2010.504770; Syme RM, 2001, J HEMATOTH STEM CELL, V10, P601, DOI 10.1089/152581601753193814; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Wargo JA, 2005, CANCER GENE THER, V12, P516, DOI 10.1038/sj.cgt.7700818; Wong JL, 2011, J IMMUNOTHER, V34, P270, DOI 10.1097/CJI.0b013e31820b370b	34	53	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53611	10.1371/journal.pone.0053611	http://dx.doi.org/10.1371/journal.pone.0053611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326467	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800061
J	Preeti; Tapas, S; Kumar, P; Madhubala, R; Tomar, S				Preeti; Tapas, Satya; Kumar, Pravindra; Madhubala, Rentala; Tomar, Shailly			Structural Insight into DFMO Resistant Ornithine Decarboxylase from Entamoeba histolytica: An Inkling to Adaptive Evolution	PLOS ONE			English	Article							POLYAMINE BIOSYNTHETIC-ENZYMES; TRYPANOSOMA-BRUCEI-RHODESIENSE; ANTIZYME-INHIBITOR; ALPHA-DIFLUOROMETHYLORNITHINE; ANGSTROM RESOLUTION; PROTEIN; EXPRESSION; GROWTH; PURIFICATION; DEGRADATION	Background: Polyamine biosynthetic pathway is a validated therapeutic target for large number of infectious diseases including cancer, giardiasis and African sleeping sickness, etc. alpha-Difluoromethylornithine (DFMO), a potent drug used for the treatment of African sleeping sickness is an irreversible inhibitor of ornithine decarboxylase (ODC), the first rate limiting enzyme of polyamine biosynthesis. The enzyme ODC of E. histolytica (EhODC) has been reported to exhibit resistance towards DFMO. Methodology/Principal Finding: The basis for insensitivity towards DFMO was investigated by structural analysis of EhODC and conformational modifications at the active site. Here, we report cloning, purification and crystal structure determination of C-terminal truncated Entamoeba histolytica ornithine decarboxylase (EhODC Delta 15). Structure was determined by molecular replacement method and refined to 2.8 angstrom resolution. The orthorhombic crystal exhibits P2(1)2(1)2(1) symmetry with unit cell parameters a = 76.66, b = 119.28, c = 179.28 angstrom. Functional as well as evolutionary relations of EhODC with other ODC homologs were predicted on the basis of sequence analysis, phylogeny and structure. Conclusions/Significance: We determined the tetrameric crystal structure of EhODC Delta 15, which exists as a dimer in solution. Insensitivity towards DFMO is due to substitution of key substrate binding residues in active site pocket. Additionally, a few more substitutions similar to antizyme inhibitor (AZI), a non-functional homologue of ODCs, were identified in the active site. Here, we establish the fact that EhODC sequence has conserved PLP binding residues; in contrast few substrate binding residues are mutated similar to AZI. Further sequence analysis and structural studies revealed that EhODC may represent as an evolutionary bridge between active decarboxylase and inactive AZI.	[Preeti; Tapas, Satya; Kumar, Pravindra; Tomar, Shailly] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttar Pradesh, India; [Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Jawaharlal Nehru University, New Delhi	Tomar, S (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttar Pradesh, India.	shailfbt@iitr.ernet.in	KUMAR, PRAVINDRA/AAF-2859-2020	KUMAR, PRAVINDRA/0000-0003-2128-7736; madhubala, rentala/0000-0002-0034-399X	CSIR (Council of Scientific & Industrial Research); DRDO (Defence Research and Development Organisation, Government of India); DST (Department of Science and Technology, Government of India); ICMR (Indian Council of Medical Research)	CSIR (Council of Scientific & Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India); DRDO (Defence Research and Development Organisation, Government of India)(Defence Research & Development Organisation (DRDO)); DST (Department of Science and Technology, Government of India)(Department of Science & Technology (India)); ICMR (Indian Council of Medical Research)(Indian Council of Medical Research (ICMR))	Preeti thanks CSIR (Council of Scientific & Industrial Research), S. Tapas thanks DRDO (Defence Research and Development Organisation, Government of India), PK thanks DST (Department of Science and Technology, Government of India), and S. Tomar thanks ICMR (Indian Council of Medical Research) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Anderson IJ, 2005, EXP PARASITOL, V110, P173, DOI 10.1016/j.exppara.2005.03.010; Arteaga-Nieto P, 2002, EXP PARASITOL, V101, P215, DOI 10.1016/S0014-4894(02)00137-6; ArteagaNieto P, 1996, INT J PARASITOL, V26, P253, DOI 10.1016/0020-7519(95)00134-4; Badolo L, 1999, TALANTA, V48, P127, DOI 10.1016/S0039-9140(98)00228-8; BAKKERGRUNWALD T, 1995, J EUKARYOT MICROBIOL, V42, P346, DOI 10.1111/j.1550-7408.1995.tb01592.x; Bansal Devendra, 2004, Ann Clin Microbiol Antimicrob, V3, P27, DOI 10.1186/1476-0711-3-27; Birkholtz LM, 2011, BIOCHEM J, V438, P229, DOI 10.1042/BJ20110362; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cohavi O, 2009, J MOL BIOL, V390, P503, DOI 10.1016/j.jmb.2009.05.029; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dufe VT, 2007, BIOCHEM J, V405, P261, DOI 10.1042/BJ20070188; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evageliou NF, 2009, CLIN CANCER RES, V15, P5956, DOI 10.1158/1078-0432.CCR-08-3213; Fleidervish IA, 2008, P NATL ACAD SCI USA, V105, P18994, DOI 10.1073/pnas.0803464105; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GILLIN FD, 1984, J PROTOZOOL, V31, P161, DOI 10.1111/j.1550-7408.1984.tb04308.x; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hascilowicz T, 2002, BBA-GENE STRUCT EXPR, V1578, P21, DOI 10.1016/S0167-4781(02)00476-1; Heby O, 2007, AMINO ACIDS, V33, P359, DOI 10.1007/s00726-007-0537-9; Heby O, 2003, BIOCHEM SOC T, V31, P415, DOI 10.1042/BST0310415; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; ITEN M, 1995, TROP MED PARASITOL, V46, P190; Iten M, 1997, ANTIMICROB AGENTS CH, V41, P1922, DOI 10.1128/AAC.41.9.1922; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2010, J MOL EVOL, V70, P289, DOI 10.1007/s00239-010-9331-5; Jackson LK, 2003, BIOCHEMISTRY-US, V42, P2933, DOI 10.1021/bi026795z; Jhingran A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000115; Kahana C, 2009, ESSAYS BIOCHEM, V46, P47, DOI [10.1042/BSE0460004, 10.1042/bse0460004]; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kern A, 1996, PROTEINS, V24, P266, DOI 10.1002/(SICI)1097-0134(199602)24:2<266::AID-PROT15>3.3.CO;2-1; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; KITANI T, 1989, BIOCHIM BIOPHYS ACTA, V991, P44, DOI 10.1016/0304-4165(89)90026-3; Krause T, 2000, BIOCHEM J, V352, P287, DOI 10.1042/0264-6021:3520287; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026835; Lopez-Vallejo F, 2011, J BIOMOL SCREEN, V16, P862, DOI 10.1177/1087057111414902; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Murakami Y, 2009, EXP CELL RES, V315, P2301, DOI 10.1016/j.yexcr.2009.04.024; Myers DP, 2001, BIOCHEMISTRY-US, V40, P13230, DOI 10.1021/bi0155908; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; Oredsson SM, 2003, BIOCHEM SOC T, V31, P366, DOI 10.1042/BST0310366; Osterman AL, 1999, BIOCHEMISTRY-US, V38, P11814, DOI 10.1021/bi9906221; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; PEGG AE, 1988, J BIOL CHEM, V263, P11008; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; POULIN R, 1992, J BIOL CHEM, V267, P150; Preeti, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001559; Rosas-Arreguin P, 2008, EXP PARASITOL, V119, P398, DOI 10.1016/j.exppara.2008.04.003; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Tanyuksel M, 2003, CLIN MICROBIOL REV, V16, P713, DOI 10.1128/CMR.16.4.713-729.2003; TSIRKA SE, 1993, BIOCHEM J, V293, P289, DOI 10.1042/bj2930289; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510	67	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53397	10.1371/journal.pone.0053397	http://dx.doi.org/10.1371/journal.pone.0053397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326423	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800042
J	Lai, CY; Lee, CJ; Lu, CY; Lee, PI; Shao, PL; Wu, ET; Wang, CC; Tan, BF; Chang, HY; Hsia, SH; Lin, JJ; Chang, LY; Huang, YC; Huang, LM				Lai, Chen-Yin; Lee, Chia-Jie; Lu, Chun-Yi; Lee, Ping-Ing; Shao, Pei-Lan; Wu, En-Ting; Wang, Ching-Chia; Tan, Boon-Fatt; Chang, Hsin-Yu; Hsia, Shao-Hsuan; Lin, Jainn-Jim; Chang, Luan-Yin; Huang, Yhu-Chering; Huang, Li-Min		Taiwan Pediat Infect Dis Alliance	Adenovirus Serotype 3 and 7 Infection with Acute Respiratory Failure in Children in Taiwan, 2010-2011	PLOS ONE			English	Article							OUTBREAK; DISEASE	Objective: Increased incidence of adenovirus infection in children was noticed since September 2010 in Taiwan and severe cases requiring intensive care were noted later. We did this study to find the clinical characteristics and risk factors associated with severe adenovirus infection. Patients and Methods: We collected cases of severe adenovirus infection between November 2010 and June 2011 to analyze their clinical characteristics in two medical centers in northern Taiwan. Severe adenovirus infection was defined as laboratory-confirmed adenovirus cases with required intensive care. Hexon gene sequencing was performed for molecular genotyping. Results: 45 patients were included, 22 cases (49%) were infected with serotype 7, 19 (42%) with serotype 3, and 4 with serotype 2. The median age (range) was 2.75 years (0.08-15.43 years); 87% were below 5 years. Male to female ratio was 1.65 (28 to 17). Of these patients, 56% had underlying neurological diseases, 50% experienced fever higher than 40 degrees C and 69% suffered fever longer than one week. The clinical diagnosis included pneumonia in 40 (89%) patients, bronchopneumonia in 5 (11%), and encephalitis in 7 (16%). At least 22 patients had pleural effusion. They had complications of respiratory failure (53%), acute respiratory distress syndrome (24%), hypotension (40%), and 6 (13%) patients needed extracorporeal membranous oxygenation. Ten (22%) patients died, all with underlying major systemic diseases and 7 (70%) infected with serotype 7. Conclusions: Adenovirus serotype 7 and 3 can cause severe disease-even death-in children, especially those with underlying neurological diseases. Patients infected with adenovirus serotype 7 tended to have a higher case-fatality rate.	[Lai, Chen-Yin; Lu, Chun-Yi; Lee, Ping-Ing; Shao, Pei-Lan; Wu, En-Ting; Wang, Ching-Chia; Tan, Boon-Fatt; Chang, Hsin-Yu; Chang, Luan-Yin; Huang, Li-Min] Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Lee, Chia-Jie; Hsia, Shao-Hsuan; Lin, Jainn-Jim; Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital	Chang, LY (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan.	lychang@ntu.edu.tw; ychuang@cgmh.org.tw; lmhuang@ntu.edu.tw		CHANG, LUAN-YIN/0000-0003-2632-1956; WU, EN-TING/0000-0002-1463-8721; LEE, PING-ING/0000-0002-7299-2825; HUANG, LI-MIN/0000-0002-9291-260X; WANG, CHING-CHIA/0000-0002-5954-5684; Huang, Daniel Tsung-Ning/0000-0001-6940-6701; LU, CHUN-YI/0000-0002-5240-2808	National Taiwan University Hospital (A1 program); National Science Council [NSC 99-2321-B-002-025, NSC 100-2321-B-002-012]; Taiwan National Health Research Institutes	National Taiwan University Hospital (A1 program); National Science Council(Ministry of Science and Technology, Taiwan); Taiwan National Health Research Institutes	This work was supported by National Taiwan University Hospital (A1 program), National Science Council (grant number NSC 99-2321-B-002-025 and NSC 100-2321-B-002-012) and the Taiwan National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENYESHMELNICK M, 1964, J PEDIATR-US, V64, P83, DOI 10.1016/S0022-3476(64)80321-8; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Callaway Z, 2011, CLIN RESPIR J, V5, P92, DOI 10.1111/j.1752-699X.2010.00204.x; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Chuang Yu-Yu, 2003, Journal of Microbiology Immunology and Infection, V36, P37; Cooper RJ, 2000, EPIDEMIOL INFECT, V125, P333, DOI 10.1017/S0950268899004550; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Ghanaiem H, 2011, PEDIATR INFECT DIS J, V30, P948, DOI 10.1097/INF.0b013e31822702fe; HERBERT FA, 1977, CAN MED ASSOC J, V116, P274; KUO CY, 1990, ACTA PAED SIN, V31, P40; Laurence AB, 2007, NELSON TXB PEDIAT, P915; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lin Chien-Hui, 2007, Journal of Microbiology Immunology and Infection, V40, P302; Lin KH, 2004, J MED VIROL, V73, P274, DOI 10.1002/jmv.20087; MORRIS DJ, 1993, J INFECTION, V26, P181, DOI 10.1016/0163-4453(93)92896-5; Spaeder MC, 2011, PEDIATR CRIT CARE ME, V12, pE317, DOI 10.1097/PCC.0b013e3182230f6e; Tang LY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-23; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Tsou TP, 2012, EMERG INFECT DIS, V18, P1825, DOI 10.3201/eid1811.120629	20	66	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53614	10.1371/journal.pone.0053614	http://dx.doi.org/10.1371/journal.pone.0053614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326469	Green Submitted, gold, Green Published			2022-12-27	WOS:000313552400030
J	Elul, B; Basinga, P; Nuwagaba-Biribonwoha, H; Saito, S; Horowitz, D; Nash, D; Mugabo, J; Mugisha, V; Rugigana, E; Nkunda, R; Asiimwe, A				Elul, Batya; Basinga, Paulin; Nuwagaba-Biribonwoha, Harriet; Saito, Suzue; Horowitz, Deborah; Nash, Denis; Mugabo, Jules; Mugisha, Veronicah; Rugigana, Etienne; Nkunda, Richard; Asiimwe, Anita			High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda	PLOS ONE			English	Article							SELF-REPORTED ADHERENCE; SUB-SAHARAN AFRICA; IMMUNOLOGICAL OUTCOMES; PREDICTORS; PROGRAM; HAART; TRIAL	Background: Generalizable data are needed on the magnitude and determinants of adherence and virological suppression among patients on antiretroviral therapy (ART) in Africa. Methods: We conducted a cross-sectional survey with chart abstraction, patient interviews and site assessments in a nationally representative sample of adults on ART for 6, 12 and 18 months at 20 sites in Rwanda. Adherence was assessed using 3- and 30-day patient recall. A systematically selected sub-sample had viral load (VL) measurements. Multivariable logistic regression examined predictors of non-perfect (<100%) 30-day adherence and detectable VL (>40 copies/ml). Results: Overall, 1,417 adults were interviewed and 837 had VL measures. Ninety-four percent and 78% reported perfect adherence for the last 3 and 30 days, respectively. Eighty-three percent had undetectable VL. In adjusted models, characteristics independently associated with higher odds of non-perfect 30-day adherence were: being on ART for 18 months (vs. 6 months); younger age; reporting severe (vs. no or few) side effects in the prior 30 days; having no documentation of CD4 cell count at ART initiation (vs. having a CD4 cell count of <200 cells/mu L); alcohol use; and attending sites which initiated ART services in 2003-2004 and 2005 (vs. 2006-2007); sites with >= 600 (vs. <600 patients) on ART; or sites with peer educators. Participation in an association for people living with HIV/AIDS; and receiving care at sites which regularly conduct home-visits were independently associated with lower odds of non-adherence. Higher odds of having a detectable VL were observed among patients at sites with peer educators. Being female; participating in an association for PLWHA; and using a reminder tool were independently associated with lower odds of having detectable VL. Conclusions: High levels of adherence and viral suppression were observed in the Rwandan national ART program, and associated with potentially modifiable factors.	[Elul, Batya; Nuwagaba-Biribonwoha, Harriet; Saito, Suzue; Horowitz, Deborah; Mugisha, Veronicah] Columbia Univ, ICAP, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Elul, Batya; Saito, Suzue; Nash, Denis] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Basinga, Paulin; Rugigana, Etienne] Natl Univ Rwanda, Sch Publ Hlth, Dept Community Hlth, Kigali, Rwanda; [Basinga, Paulin] Bill & Melinda Gates Fdn, Seattle, WA USA; [Nash, Denis] CUNY Hunter Coll, Epidemiol & Biostat Program, Sch Publ Hlth, New York, NY 10021 USA; [Mugabo, Jules; Asiimwe, Anita] Minist Hlth, RBC, Kigali, Rwanda; [Nkunda, Richard] NRL, Kigali, Rwanda	Columbia University; Columbia University; University of Rwanda; Bill & Melinda Gates Foundation; City University of New York (CUNY) System; Hunter College (CUNY)	Elul, B (corresponding author), Columbia Univ, ICAP, Mailman Sch Publ Hlth, New York, NY 10027 USA.	be2124@columbia.edu	Nash, Denis/AFI-7485-2022	Nash, Denis/0000-0002-3280-5386	Global Fund to Fight AIDS, TB and Malaria; Centers for Disease Control and Prevention [5U62PS222407]	Global Fund to Fight AIDS, TB and Malaria(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This article was supported by the Global Fund to Fight AIDS, TB and Malaria, and cooperative agreement number 5U62PS222407 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bhat VG, 2010, EUR J CLIN MICROBIOL, V29, P947, DOI 10.1007/s10096-010-0949-4; Brambatti LP, 2007, PSYCHOL PROGRAM PROC; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Demeester R, 2005, JAIDS-J ACQ IMM DEF, V40, P113, DOI 10.1097/01.qai.0000176590.68430.59; El-Khatib Ziad, 2011, J AIDS Clin Res, V2; Etienne Martine, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P98, DOI 10.1177/1545109710361383; Graham SM, 2010, J INFECT DIS, V202, P1538, DOI 10.1086/656790; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Kalichman Seth C, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P317, DOI 10.1177/1545109708328130; Kashuba AD, 2011, LANCET; Kip E, 2009, J NURS SCHOLARSHIP, V41, P149, DOI 10.1111/j.1547-5069.2009.01266.x; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Mascolini Mark, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P160, DOI 10.1177/1545109708322728; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Ministry of Health GoR, 2011, ANN REP JUL 2010 JUN; Musiime S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027832; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; National Institute of Statistics of Rwanda (NISR) MoHMR ICF International, 2012, RWAND DEM HLTH SURV; Osborn CY, 2010, AIDS BEHAV, V14, P181, DOI 10.1007/s10461-008-9484-z; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Pearson CR, 2007, JAIDS-J ACQ IMM DEF, V46, P238, DOI 10.1097/QAI.0b013e318153f7ba; Peltzer K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-111; Perrine R, 2011, JAIDS-J ACQ IMM DEF, V57, pS40, DOI 10.1097/QAI.0b013e318222b5c2; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rwanda Go, 2010, UN GEN ASS SPEC SESS; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Simoni JM, 2011, AIDS BEHAV, V15, P919, DOI 10.1007/s10461-010-9828-3; Somi G, 2009, Tanzan J Health Res, V11, P136; UNAIDS, 2011, GLOB HIV AIDS RESP E; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; Uzochukwu BSC, 2009, HEALTH POLICY PLANN, V24, P189, DOI 10.1093/heapol/czp006; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Watt MH, 2010, AIDS CARE, V22, P381, DOI 10.1080/09540120903193708; Wise J, 2008, AIDS PATIENT CARE ST, V22, P495, DOI 10.1089/apc.2007.0180; World Health Organization, 2007, ESSENTIAL PREVENTION	44	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53586	10.1371/journal.pone.0053586	http://dx.doi.org/10.1371/journal.pone.0053586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326462	gold, Green Published			2022-12-27	WOS:000313551500086
J	Narayan, KM; Agrawal, N; Du, SX; Muranaka, JE; Bauer, K; Leaman, DP; Phung, P; Limoli, K; Chen, HL; Boenig, RI; Wrin, T; Zwick, MB; Whalen, RG				Narayan, Kristin M.; Agrawal, Nitish; Du, Sean X.; Muranaka, Janelle E.; Bauer, Katherine; Leaman, Daniel P.; Pham Phung; Limoli, Kay; Chen, Helen; Boenig, Rebecca I.; Wrin, Terri; Zwick, Michael B.; Whalen, Robert G.			Prime-Boost Immunization of Rabbits with HIV-1 gp120 Elicits Potent Neutralization Activity against a Primary Viral Isolate	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; HIGH-LEVEL EXPRESSION; CD4 BINDING-SITE; ENVELOPE GLYCOPROTEIN; TYPE-1 GP120; V3 LOOP; LINKED GLYCOSYLATION; STRUCTURAL BASIS; N-GLYCOSYLATION	Development of a vaccine for HIV-1 requires a detailed understanding of the neutralizing antibody responses that can be experimentally elicited to difficult-to-neutralize primary isolates. Rabbits were immunized with the gp120 subunit of HIV-1 JR-CSF envelope (Env) using a DNA-prime protein-boost regimen. We analyzed five sera that showed potent autologous neutralizing activity (IC50s at similar to 10(3) to 10(4) serum dilution) against pseudoviruses containing Env from the primary isolate JR-CSF but not from the related isolate JR-FL. Pseudoviruses were created by exchanging each variable and constant domain of JR-CSF gp120 with that of JR-FL or with mutations in putative N-glycosylation sites. The sera contained different neutralizing activities dependent on C3 and V5, C3 and V4, or V4 regions located on the glycan-rich outer domain of gp120. All sera showed enhanced neutralizing activity toward an Env variant that lacked a glycosylation site in V4. The JR-CSF gp120 epitopes recognized by the sera are generally distinct from those of several well characterized mAbs (targeting conserved sites on Env) or other type-specific responses (targeting V1, V2, or V3 variable regions). The activity of one serum requires specific glycans that are also important for 2G12 neutralization and this serum blocked the binding of 2G12 to gp120. Our findings show that different fine specificities can achieve potent neutralization of HIV-1, yet this strong activity does not result in improved breadth.	[Narayan, Kristin M.; Du, Sean X.; Muranaka, Janelle E.; Chen, Helen; Boenig, Rebecca I.; Whalen, Robert G.] Maxygen Inc, Dept Infect Dis, Redwood City, CA USA; [Narayan, Kristin M.; Du, Sean X.; Muranaka, Janelle E.; Boenig, Rebecca I.; Whalen, Robert G.] Altravax Inc, Sunnyvale, CA USA; [Agrawal, Nitish; Bauer, Katherine; Leaman, Daniel P.; Zwick, Michael B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Pham Phung; Limoli, Kay; Wrin, Terri] Monogram Biosci Inc, San Francisco, CA USA	Scripps Research Institute	Zwick, MB (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	zwick@scripps.edu; robert.whalen@altravax.com	AGRAWAL, NITISH/H-6186-2011; AGRAWAL, NITISH/E-3468-2013	AGRAWAL, NITISH/0000-0003-0823-7355; 	National Institutes of Health [P01 AI056375, R43 AI067058, R43 AI070032, R33 AI077381, T32 AI007606]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI070032, P01AI056375, R43AI067058, R33AI077381, T32AI007606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following grants from the National Institutes of Health: P01 AI056375 to RGW and DR Burton; R43 AI067058 and R43 AI070032 to RGW; R33 AI077381 to MBZ; and T32 AI007606 to DPL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal-Gamse C, 2011, J VIROL, V85, P470, DOI 10.1128/JVI.01349-10; ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; Astronomo RD, 2008, J VIROL, V82, P6359, DOI 10.1128/JVI.00293-08; Astronomo RD, 2010, CHEM BIOL, V17, P357, DOI 10.1016/j.chembiol.2010.03.012; Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; BARBOSA JA, 1987, J EXP MED, V166, P1329, DOI 10.1084/jem.166.5.1329; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; BERNSTEIN HB, 1994, J VIROL, V68, P463, DOI 10.1128/JVI.68.1.463-468.1994; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Carlos MP, 1999, J ACQ IMMUN DEF SYND, V22, P317; Cavacini L, 2003, AIDS, V17, P685, DOI 10.1097/00002030-200303280-00006; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen H, 2008, J GEN VIROL, V89, P2597, DOI 10.1099/vir.0.2008/003491-0; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Ching L, 2010, J VIROL, V84, P9932, DOI 10.1128/JVI.00868-10; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P17107, DOI 10.1073/pnas.1002717107; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Douagi I, 2010, J VIROL, V84, P1683, DOI 10.1128/JVI.01896-09; Du SX, 2008, PROTEIN EXPRES PURIF, V59, P223, DOI 10.1016/j.pep.2008.02.002; Du SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020927; Du SX, 2009, VIROLOGY, V395, P33, DOI 10.1016/j.virol.2009.07.042; Duenas-Decamp MJ, 2008, J VIROL, V82, P5807, DOI 10.1128/JVI.02585-07; Euler Z, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00215; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; FUNG MSC, 1992, J VIROL, V66, P848, DOI 10.1128/JVI.66.2.848-856.1992; GEYER H, 1988, J BIOL CHEM, V263, P11760; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Joyce JG, 2008, P NATL ACAD SCI USA, V105, P15684, DOI 10.1073/pnas.0807837105; Kim M, 2005, AIDS RES HUM RETROV, V21, P58, DOI 10.1089/aid.2005.21.58; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; LoomisPrice LD, 1997, J IND MICROBIOL BIOT, V19, P58, DOI 10.1038/sj.jim.2900410; Malenbaum SE, 2000, J VIROL, V74, P11008, DOI 10.1128/JVI.74.23.11008-11016.2000; McBurney SP, 2007, VIROLOGY, V358, P334, DOI 10.1016/j.virol.2006.08.032; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MONTEFIORI DC, 1988, P NATL ACAD SCI USA, V85, P9248, DOI 10.1073/pnas.85.23.9248; Moore PL, 2009, CURR OPIN HIV AIDS, V4, P358, DOI 10.1097/COH.0b013e32832ea7e8; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Raedler MD, 2009, CLIN VACCINE IMMUNOL, V16, P739, DOI 10.1128/CVI.00478-08; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2007, J MOL BIOL, V372, P16, DOI 10.1016/j.jmb.2007.06.027; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Utachee P, 2010, J VIROL, V84, P4311, DOI 10.1128/JVI.02619-09; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Vaine M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013916; Van Regenmortel MHV, 2011, J MOL RECOGNIT, V24, P741, DOI 10.1002/jmr.1116; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	101	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52732	10.1371/journal.pone.0052732	http://dx.doi.org/10.1371/journal.pone.0052732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326351	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500028
J	Blas, MM; Menacho, LA; Alva, IE; Cabello, R; Orellana, ER				Blas, Magaly M.; Menacho, Luis A.; Alva, Isaac E.; Cabello, Robinson; Orellana, E. Roberto			Motivating Men Who Have Sex with Men to Get Tested for HIV through the Internet and Mobile Phones: A Qualitative Study	PLOS ONE			English	Article							HEALTH-PROMOTION; PERU; RISK; PERCEPTIONS; ACCESS; TOOL	Background: Men who have sex with men (MSM) have the highest HIV prevalence in Peru, yet they are underserved by traditional preventive programs. In Peru, the Internet and mobile phones have emerged as an effective and convenient tool to reach this population. Methods and Findings: From October 2010 to February 2011, we conducted eight focus groups with gay identified MSM (closeted and out-of-the-closet) and with self-identified heterosexual MSM in order to identify key features and preferences to be used to tailor culturally-appropriate messages that could be delivered through Internet and mobile phones to motivate MSM to get tested for HIV. Participants reported that in order to motivate HIV testing among MSM, interventions need to be based on motivational messages that encourage participants to overcome the fear of getting tested. Messages should increase the HIV risk perception (of participants who do not consider themselves at risk) by eliciting risky situations experienced by MSM. Messages should emphasize confidentiality, respect and the professionalism of the personnel conducting the counseling and testing. A thorough explanation of the process of HIV testing and the steps to follow after receiving the results should be provided. Messages should also contain information about the venue where the test will be conducted in terms of client characteristics, location, hours of operation and personnel. Finally, stigmatizing and stereotyping messages or images about "being gay" should not be included, as they act as deterrents for getting tested. Conclusions: Interventions aimed at motivating HIV testing among MSM should include motivational messages that reduce the fear of getting tested and increase the risk perception of participants. They should also market the venue where the testing will be conducted, the professionals who will perform the tests, and the type of tests available. Stigmatizing messages or images should be avoided.	[Blas, Magaly M.; Menacho, Luis A.; Alva, Isaac E.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, STD & HIV Unit, Lima, Peru; [Menacho, Luis A.] Epictr, Lima, Peru; [Orellana, E. Roberto] Portland State Univ, Sch Social Work, Portland, OR 97207 USA; [Orellana, E. Roberto] Portland State Univ, Dept Community Hlth, Portland, OR 97207 USA	Universidad Peruana Cayetano Heredia; Portland State University; Portland State University	Blas, MM (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, STD & HIV Unit, Lima, Peru.	magaly.blas@upch.pe	Orellana, E. Roberto/K-8633-2012; Orellana, E. Roberto/ABD-5735-2021	Orellana, E. Roberto/0000-0003-4444-2321; Orellana, E. Roberto/0000-0003-4444-2321	Fogarty International Center/National Institutes of Health (FIC/NIH) [R01 TW008398]; QUIPU: The Andean Global Health Informatics Research and Training Center; FIC/NIH [D43TW008438-0109]; FOGARTY INTERNATIONAL CENTER [D43TW008438, R01TW008398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080665] Funding Source: NIH RePORTER	Fogarty International Center/National Institutes of Health (FIC/NIH); QUIPU: The Andean Global Health Informatics Research and Training Center; FIC/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Fogarty International Center/National Institutes of Health (FIC/NIH) grant R01 TW008398 to Magaly Blas and QUIPU: The Andean Global Health Informatics Research and Training Center, a FIC/NIH funded grant D43TW008438-0109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blas MM, 2007, SEX TRANSM INFECT, V83, P567, DOI 10.1136/sti.2007.027276; Blas MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027334; Blas MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010448; Curioso WH, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-24; Curioso WH, 2009, AMIA ANN S P, P129; Dowson L, 2012, AIDS CARE, V24, P204, DOI 10.1080/09540121.2011.597711; Glaser B.G., 1968, DISCOV GROUNDED THEO; Grier S, 2005, ANNU REV PUBL HEALTH, V26, P319, DOI 10.1146/annurev.publhealth.26.021304.144610; Lapinski MK, 2008, HEALTH COMMUN, V23, P403, DOI 10.1080/10410230802342093; OSIPTEL, 2012, STAT RES PUBL; Padgett D.K., 2016, QUALITATIVE METHODS, V36; Peinado J, 2007, J SEX RES, V44, P233, DOI 10.1080/00224490701443676; Plant A, 2010, HEALTH PROMOT PRACT, V11, P23, DOI 10.1177/1524839907309376; Rimal RN, 2009, AM J PUBLIC HEALTH, V99, P2224, DOI 10.2105/AJPH.2008.155234; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNGASS, 2012, COUNTR PROGR REP PER	17	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54012	10.1371/journal.pone.0054012	http://dx.doi.org/10.1371/journal.pone.0054012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IY	23320116	gold, Green Published			2022-12-27	WOS:000313429800083
J	Lusk, RW; Eisen, MB				Lusk, Richard W.; Eisen, Michael B.			Spatial Promoter Recognition Signatures May Enhance Transcription Factor Specificity in Yeast	PLOS ONE			English	Article							FACTOR-BINDING-SITES; DNA-BINDING; SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-CHANGES; QUANTITATIVE-ANALYSIS; NUCLEOTIDE-SEQUENCES; REGULATORY ELEMENTS; IN-VIVO; GENOME; ACTIVATION	The short length and high degeneracy of sites recognized by DNA-binding transcription factors limit the amount of information they can carry, and individual sites are rarely sufficient to mediate the regulation of specific targets. Computational analysis of microbial genomes has suggested that many factors function optimally when in a particular orientation and position with respect to their target promoters. To investigate this further, we developed and trained spatial models of binding site positioning and applied them to the genome of the yeast Saccharomyces cerevisiae. We found evidence of non-random organization of sites within promoters, differences in binding site density, or both for thirty-eight transcription factors. We show that these signatures allow transcription factors with substantial differences in binding site specificity to share similar promoter specificities. We illustrate how spatial information dictating the positioning and density of binding sites can in principle increase the information available to the organism for differentiating a transcription factor's true targets, and we indicate how this information could potentially be leveraged for the same purpose in bioinformatic analyses.	[Lusk, Richard W.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of Michigan System; University of Michigan; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Eisen, MB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@berkeley.edu		Eisen, Michael/0000-0002-7528-738X	HHMI; NIH [HG002779]; NSF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by an HHMI investigator award to M. B. E., an NIH grant HG002779 to M. B. E., and an NSF graduate research fellowship to R. W. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Blaiseau PL, 1998, EMBO J, V17, P6327, DOI 10.1093/emboj/17.21.6327; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Erb I., 2006, IEEE P ICCSB, V1, P111; Erb I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024279; Felenbok B, 2001, PROG NUCLEIC ACID RE, V69, P149, DOI 10.1016/S0079-6603(01)69047-0; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Frith MC, 2002, NUCLEIC ACIDS RES, V30, P3214, DOI 10.1093/nar/gkf438; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Gough B., 2009, GNU SCI LIB REFERENC; Granlund T., 2012, GNU MP GNU MULTIPLE, V5th; Gropp W, 1996, PARALLEL COMPUT, V22, P789, DOI 10.1016/0167-8191(96)00024-5; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Idrissi FZ, 2001, J BIOL CHEM, V276, P26090, DOI 10.1074/jbc.M101746200; Kim J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000652; Kim JH, 2009, BIOCHIMIE, V91, P300, DOI 10.1016/j.biochi.2008.09.002; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lin ZG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-581; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; Orzechowski J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-484; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; Shultzaberger RK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001199; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; Tanaka M, 1996, P NATL ACAD SCI USA, V93, P4311, DOI 10.1073/pnas.93.9.4311; Tomovic A, 2007, BIOINFORMATICS, V23, P933, DOI 10.1093/bioinformatics/btm055; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	53	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53778	10.1371/journal.pone.0053778	http://dx.doi.org/10.1371/journal.pone.0053778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320104	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800069
J	Rochat, MK; Laubender, RP; Kuster, D; Braendli, O; Moeller, A; Mansmann, U; von Mutius, E; Wildhaber, J				Rochat, Mascha K.; Laubender, Ruediger P.; Kuster, Daniela; Braendli, Otto; Moeller, Alexander; Mansmann, Ulrich; von Mutius, Erika; Wildhaber, Johannes			Spirometry Reference Equations for Central European Populations from School Age to Old Age	PLOS ONE			English	Article							REFERENCE VALUES; LUNG-FUNCTION; REFERENCE RANGES; ADULTS; OVERWEIGHT; STANDARDS; VOLUMES; OBESITY; CURVES	Background: Spirometry reference values are important for the interpretation of spirometry results. Reference values should be updated regularly, derived from a population as similar to the population for which they are to be used and span across all ages. Such spirometry reference equations are currently lacking for central European populations. Objective: To develop spirometry reference equations for central European populations between 8 and 90 years of age. Materials: We used data collected between January 1993 and December 2010 from a central European population. The data was modelled using "Generalized Additive Models for Location, Scale and Shape" (GAMLSS). Results: The spirometry reference equations were derived from 118'891 individuals consisting of 60'624 (51%) females and 58'267 (49%) males. Altogether, there were 18'211 (15.3%) children under the age of 18 years. Conclusion: We developed spirometry reference equations for a central European population between 8 and 90 years of age that can be implemented in a wide range of clinical settings.	[Rochat, Mascha K.; von Mutius, Erika] Univ Munich, Childrens Hosp, D-80539 Munich, Germany; [Laubender, Ruediger P.; Mansmann, Ulrich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Kuster, Daniela; Moeller, Alexander] Univ Zurich, Childrens Hosp, Div Resp Med, Zurich, Switzerland; [Braendli, Otto] Zurich Lung Assoc, Zurich, Switzerland; [Wildhaber, Johannes] Univ Fribourg, Hosp Fribourg, Dept Paediat, CH-1700 Fribourg, Switzerland; [Wildhaber, Johannes] Univ Fribourg, Fac Med, CH-1700 Fribourg, Switzerland; [Rochat, Mascha K.] Univ Lausanne Hosp, Dept Pediat, Lausanne, Switzerland	University of Munich; University of Munich; University Children's Hospital Zurich; University of Zurich; University of Fribourg; University of Fribourg; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Rochat, MK (corresponding author), Univ Munich, Childrens Hosp, D-80539 Munich, Germany.	wehntaler@gmail.com		Moeller, Alexander/0000-0001-7284-4251; von Mutius, Erika/0000-0002-8893-4515	LMUinnovativ project Munich Center of Health Sciences (McHealth); Lung Association Zurich (Switzerland)	LMUinnovativ project Munich Center of Health Sciences (McHealth); Lung Association Zurich (Switzerland)	The work of R. P. Laubender was partially supported by the LMUinnovativ project Munich Center of Health Sciences (McHealth). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge and thank the Lung Association Zurich (Switzerland) for providing the funding for the spirometry data.	American Thoracic Society, 1991, AM REV RESP DIS, V144, P1202; Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227; Brandli O, 1996, THORAX, V51, P277, DOI 10.1136/thx.51.3.277; Brandli O, 2000, THORAX, V55, P173; Cole TJ, 2009, STAT MED, V28, P880, DOI 10.1002/sim.3504; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; EGGER S, 2001, SCHWEIZ RUNDSCH MED, V90, P531; Golshan M, 2009, ARCH IRAN MED, V12, P256; Johannessen A, 2007, THORAX, V62, P792, DOI 10.1136/thx.2006.071480; Jones RL, 2006, CHEST, V130, P827, DOI 10.1378/chest.130.3.827; Koenker R, 2005, QUANTILE REGREESION; Kunzli N, 2005, SWISS MED WKLY, V135, P503; Kuster SP, 2008, EUR RESPIR J, V31, P860, DOI 10.1183/09031936.00091407; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Liou TG, 2009, CLIN REV ALLERGY IMM; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; OSCHERWITZ M, 1972, AM J EPIDEMIOL, V96, P319, DOI 10.1093/oxfordjournals.aje.a121462; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pistelli F, 2007, RESP MED, V101, P814, DOI 10.1016/j.rmed.2006.06.032; Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861; Stanojevic S, 2010, EUR RESPIR J, V36, P12, DOI 10.1183/09031936.00143209; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Stasinopoulos RARDM, 2007, J STAT SOFTW, V23, P1; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Subbarao P, 2004, PEDIATR PULM, V37, P515, DOI 10.1002/ppul.20015; THOMPSON JE, 1992, MED J AUSTRALIA, V156, P566, DOI 10.5694/j.1326-5377.1992.tb121420.x; 1995, WHO TECH REP SER, V854, P1	28	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52619	10.1371/journal.pone.0052619	http://dx.doi.org/10.1371/journal.pone.0052619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320075	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800017
J	Belknap, R; Weis, S; Brookens, A; Au-Yeung, KY; Moon, G; DiCarlo, L; Reves, R				Belknap, Robert; Weis, Steve; Brookens, Andrew; Au-Yeung, Kit Yee; Moon, Greg; DiCarlo, Lorenzo; Reves, Randall			Feasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy	PLOS ONE			English	Article							SELF-ADMINISTERED THERAPY	Poor adherence to tuberculosis (TB) treatment hinders the individual's recovery and threatens public health. Currently, directly observed therapy (DOT) is the standard of care; however, high sustaining costs limit its availability, creating a need for more practical adherence confirmation methods. Techniques such as video monitoring and devices to time-register the opening of pill bottles are unable to confirm actual medication ingestions. A novel approach developed by Proteus Digital Health, Inc. consists of an ingestible sensor and an on-body wearable sensor; together, they electronically confirm unique ingestions and record the date/time of the ingestion. A feasibility study using an early prototype was conducted in active TB patients to determine the system's accuracy and safety in confirming co-ingestion of TB medications with sensors. Thirty patients completed 10 DOT visits and 1,080 co-ingestion events; the system showed 95.0% (95% CI 93.5-96.2%) positive detection accuracy, defined as the number of detected sensors divided by the number of transmission capable sensors administered. The specificity was 99.7% [95% CI 99.2-99.9%] based on three false signals recorded by receivers. The system's identification accuracy, defined as the number of correctly identified ingestible sensors divided by the number of sensors detected, was 100%. Of 11 adverse events, four were deemed related or possibly related to the device; three mild skin rashes and one complaint of nausea. The system's positive detection accuracy was not affected by the subjects' Body Mass Index (p = 0.7309). Study results suggest the system is capable of correctly identifying ingestible sensors with high accuracy, poses a low risk to users, and may have high patient acceptance. The system has the potential to confirm medication specific treatment compliance on a dose-by-dose basis. When coupled with mobile technology, the system could allow wirelessly observed therapy (WOT) for monitoring TB treatment as a replacement for DOT.	[Belknap, Robert; Reves, Randall] Denver Hlth & Hosp Author, Denver Publ Hlth, Denver, CO USA; [Weis, Steve] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA; [Brookens, Andrew] Univ Washington, Dept Med, Seattle, WA USA; [Au-Yeung, Kit Yee; Moon, Greg; DiCarlo, Lorenzo] Proteus Digital Hlth Inc, Redwood City, CA USA	Denver Health Medical Center; University of North Texas System; University of North Texas Health Science Center; University of Washington; University of Washington Seattle	Belknap, R (corresponding author), Denver Hlth & Hosp Author, Denver Publ Hlth, Denver, CO USA.	robert.belknap@dhha.org			Proteus Digital Health	Proteus Digital Health	Proteus Digital Health which funded the study is also the employer of authors Kit Yee Au-Yeung PhD, Greg Moon M. D. and Lorenzo DiCarlo M. D. A novel RaisinTM is currently under development that electronically confirms medication ingestions using an ingestible event marker (Proteus Digital Health, Inc. Redwood City, CA). There are no further patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Au-Yeung KY, 2012, INT J TUBERC LUNG D, V16, P1498, DOI 10.5588/ijtld.11.0868; Au-Yeung KY, 2011, AM J MANAG CARE, V17, pE277; Broomhead S, 2012, TELEMED E-HEALTH, V18, P24, DOI 10.1089/tmj.2011.0143; Centers for Disease Control and Prevention, 2011, REP TUB US 2010; Centers for Disease Control and Prevention, 2003, MMWR, V52; Chaulk CP, 1998, JAMA-J AM MED ASSOC, V279, P943, DOI 10.1001/jama.279.12.943; DIXON WM, 1957, LANCET, V2, P871; Fallab-Stubi CL, 1998, INT J TUBERC LUNG D, V2, P525; Frieden TR, 2007, B WORLD HEALTH ORGAN, V85, P407, DOI 10.2471/BLT.06.038927; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Haynes RB, 1996, LANCET, V348, P383; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P561, DOI 10.1164/rccm.200401-095OC; Juan G, 2006, INT J TUBERC LUNG D, V10, P215; Krueger K, 2010, INT J TUBERC LUNG D, V14, P779; MOULDING T, 1970, ANN INTERN MED, V73, P559, DOI 10.7326/0003-4819-73-4-559; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9	17	97	104	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53373	10.1371/journal.pone.0053373	http://dx.doi.org/10.1371/journal.pone.0053373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308203	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100058
J	Dilernia, DA; Monaco, DC; Cesar, C; Krolewiecki, AJ; Friedman, SR; Cahn, P; Salomon, H				Dilernia, Dario A.; Monaco, Daniela C.; Cesar, Carina; Krolewiecki, Alejandro J.; Friedman, Samuel R.; Cahn, Pedro; Salomon, Horacio			Estimation of HIV-Testing Rates to Maximize Early Diagnosis-Derived Benefits at the Individual and Population Level	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; VIRAL LOAD; 1ST YEAR; MISSED OPPORTUNITIES; EARLY MORTALITY; AIDS DIAGNOSIS	Background: In HIV infection, initiation of treatment is associated with improved clinical outcom and reduced rate of sexual transmission. However, difficulty in detecting infection in early stages impairs those benefits. We determined the minimum testing rate that maximizes benefits derived from early diagnosis. Methods: We developed a mathematical model of HIV infection, diagnosis and treatment that allows studying both diagnosed and undiagnosed populations, as well as determining the impact of modifying time to diagnosis and testing rates. The model's external consistency was assessed by estimating time to AIDS and death in absence of treatment as well as by estimating age-dependent mortality rates during treatment, and comparing them with data previously reported from CASCADE and DHCS cohorts. Results: In our model, life expectancy of patients diagnosed before 8 years post infection is the same as HIV-negative population. After this time point, age at death is significantly dependent on diagnosis delay but initiation of treatment increases life expectancy to similar levels as HIV-negative population. Early mortality during HAART is dependent on treatment CD4 threshold until 6 years post infection and becomes dependent on diagnosis delay after 6 years post infection. By modifying testing rates, we estimate that an annual testing rate of 20% leads to diagnosis of 90% of infected individuals within the first 8.2 years of infection and that current testing rate in middle-high income settings stands close to 10%. In addition, many differences between low-income and middle-high incomes can be predicted by solely modifying the diagnosis delay. Conclusions: To increase testing rate of undiagnosed HIV population by two-fold in middle-high income settings will minimize early mortality during initiation of treatment and global mortality rate as well as maximize life expectancy. Our results highlight the impact of achieving early diagnosis and the importance of strongly work on improving HIV testing rates.	[Dilernia, Dario A.; Monaco, Daniela C.; Salomon, Horacio] Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina; [Cesar, Carina; Krolewiecki, Alejandro J.; Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Friedman, Samuel R.] Natl Dev & Res Inst Inc, New York, NY USA	University of Buenos Aires; National Development & Research Institutes, Inc	Salomon, H (corresponding author), Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina.	hsalomon@fmed.uba.ar	Krolewiecki, Alejandro/AAK-2047-2021; Cesar, Carina/H-2831-2019	Krolewiecki, Alejandro/0000-0001-9054-1211; Friedman, Sam/0000-0003-2083-1226	Fogarty International Center/National Institutes of Health through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program [D43 TW 001037]; FOGARTY INTERNATIONAL CENTER [D43TW001037] Funding Source: NIH RePORTER	Fogarty International Center/National Institutes of Health through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research has been partially funded by a Fogarty International Center/National Institutes of Health grant through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program (Grant # D43 TW 001037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dilernia DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003429; Ameal F, 2005, ACTUALIZACIONES SIDA, V13, P150; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Badri M, 2006, LANCET, V368, P1254, DOI 10.1016/S0140-6736(06)69117-4; Bassett IV, 2010, CLIN INFECT DIS, V50, pS77, DOI 10.1086/651477; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brannstrom J, 2005, INT J STD AIDS, V16, P702, DOI 10.1258/095646205774357262; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P581; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Delpierre C, 2007, INT J STD AIDS, V18, P312, DOI 10.1258/095646207780749709; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Socias ME, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-40; Fisher M, 2008, CURR OPIN INFECT DIS, V21, P1, DOI 10.1097/QCO.0b013e3282f2d8fb; French N, 1999, J ACQ IMMUN DEF SYND, V22, P509; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Hocking JS, 2000, INT J STD AIDS, V11, P503, DOI 10.1258/0956462001916407; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Manavi K, 2004, INT J STD AIDS, V15, P811, DOI 10.1258/0956462042563585; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; McDonald AM, 2003, AUST NZ J PUBL HEAL, V27, P608, DOI 10.1111/j.1467-842X.2003.tb00607.x; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 2005, AIDS RES HUM RETROV, V21, P527, DOI 10.1089/aid.2005.21.527; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; ROSENBERG PS, 1995, SCIENCE, V270, P1372, DOI 10.1126/science.270.5240.1372; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Stanley B, 2003, BMJ-BRIT MED J, V326, P1174, DOI 10.1136/bmj.326.7400.1174; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Sullivan AK, 2005, BRIT MED J, V330, P1301, DOI 10.1136/bmj.38398.590602.E0; Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action, 2000, RAP ADV ANT THER HIV, V355, P1131; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; van der Loeff MFS, 2002, AIDS, V16, P1775, DOI 10.1097/00002030-200209060-00010; Walensky RP, 2002, ARCH INTERN MED, V162, P887, DOI 10.1001/archinte.162.8.887; White DAE, 2009, AIDS PATIENT CARE ST, V23, P245, DOI 10.1089/apc.2008.0198; World Health Organization, 2008, UN ACC SCAL PRIOR HI; Zala Carlos, 2008, Medscape J Med, V10, P78, DOI 10.1186/1758-2652-10-4-78	56	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53193	10.1371/journal.pone.0053193	http://dx.doi.org/10.1371/journal.pone.0053193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308161	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100037
J	Duan, JH; Hu, CH; Chen, H				Duan, Jinghao; Hu, Chunhong; Chen, Hua			High-Resolution Micro-CT for Morphologic and Quantitative Assessment of the Sinusoid in Human Cavernous Hemangioma of the Liver	PLOS ONE			English	Article							RAY PHASE-CONTRAST; IMAGE-RECONSTRUCTION; RETRIEVAL; VISUALIZATION; TOMOGRAPHY	Hepatic sinusoid plays a vital role in human cavernous hemangioma of the liver (CHL), and its morphologic investigation facilitates the understanding of microcirculation mechanism and pathological change of CHL. However, precise anatomical view of the hepatic sinusoid has been limited by the resolution and contrast available from existing imaging techniques. While liver biopsy has traditionally been the reliable method for the assessment of hepatic sinusoids, the invasiveness and sampling error are its inherent limitations. In this study, imaging of CHL samples was performed using in-line phase-contrast imaging (ILPCI) technique with synchrotron radiation. ILPCI allowed clear visualization of soft tissues and revealed structural details that were invisible to conventional radiography. Combining the computed tomography (CT) technique, ILPCI-CT was used to acquire the high-resolution micro-CT images of CHL, and three dimensional (3D) microstructures of hepatic sinusoids were provided for the morphologic depiction and quantitative assessment. Our study demonstrated that ILPCI-CT could substantially improve the radiographic contrast of CHL tissues in vitro with no contrast agent. ILPCI-CT yielded high-resolution micro-CT image of CHL sample at the micron scale, corresponding to information on actual structures revealed at histological section. The 3D visualization provided an excellent view of the hepatic sinusoid. The accurate view of individual hepatic sinusoid was achieved. The valuable morphological parameters of hepatic sinusoids, such as thrombi, diameters, surface areas and volumes, were measured. These parameters were of great importance in the evaluation of CHL, and they provided quantitative descriptors that characterized anatomical properties and pathological features of hepatic sinusoids. The results highlight the high degree of sensitivity of the ILPCI-CT technique and demonstrate the feasibility of accurate visualization of hepatic sinusoids. Moreover, there is a correlation between the CHL and the size or morphology of hepatic sinusoids, which offers a potential use in noninvasive study and analysis of CHL.	[Duan, Jinghao; Hu, Chunhong] Tianjin Med Univ, Coll Biomed Engn, Tianjin, Peoples R China; [Chen, Hua] Tianjin Med Univ, Canc Hosp, Dept Hepatobiliary Surg, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Hu, CH (corresponding author), Tianjin Med Univ, Coll Biomed Engn, Tianjin, Peoples R China.	chunhong_hu@hotmail.com			National Natural Science Foundation of China [30900333]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 30900333 (to C. H.) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arhatari BD, 2011, PHYS MED BIOL, V56, P5265, DOI 10.1088/0031-9155/56/16/012; Beltran MA, 2011, PHYS MED BIOL, V56, P7353, DOI 10.1088/0031-9155/56/23/002; BORNMAN PC, 1987, SURGERY, V101, P445; Burvall A, 2011, OPT EXPRESS, V19, P10359, DOI 10.1364/OE.19.010359; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Debbaut C, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005545; Hu JZ, 2012, PHYS MED BIOL, V57, pN55, DOI 10.1088/0031-9155/57/5/N55; ISHAK KG, 1975, MED CLIN N AM, V59, P995, DOI 10.1016/S0025-7125(16)31998-8; Laperle CM, 2008, PHYS MED BIOL, V53, P6911, DOI 10.1088/0031-9155/53/23/017; Larsson DH, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3664870; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Liu XX, 2010, PHYS MED BIOL, V55, P2399, DOI 10.1088/0031-9155/55/8/017; Lundstrom U, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2603; Mani H, 2001, Clin Liver Dis, V5, P219, DOI 10.1016/S1089-3261(05)70162-8; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; OCHSNER JL, 1958, SURGERY, V43, P577; Oda M, 2003, CLIN HEMORHEOL MICRO, V29, P167; Papafragkakis H, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/942360; Parsons DW, 2008, J ANAT, V213, P217, DOI 10.1111/j.1469-7580.2008.00950.x; Pogany A, 1997, REV SCI INSTRUM, V68, P2774, DOI 10.1063/1.1148194; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Sidky EY, 2010, OPT EXPRESS, V18, P10404, DOI 10.1364/OE.18.010404; Spanne P, 1999, PHYS MED BIOL, V44, P741, DOI 10.1088/0031-9155/44/3/016; TUNG GA, 1994, AM J ROENTGENOL, V162, P1113, DOI 10.2214/ajr.162.5.8165993; Vagefi PA, 2011, J GASTROINTEST SURG, V15, P209, DOI 10.1007/s11605-010-1248-1; Weitkamp T, 2011, J SYNCHROTRON RADIAT, V18, P617, DOI 10.1107/S0909049511002895; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Wu XZ, 2003, MED PHYS, V30, P2169, DOI 10.1118/1.1593836; Zhang L, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0017400	29	15	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53507	10.1371/journal.pone.0053507	http://dx.doi.org/10.1371/journal.pone.0053507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308240	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100078
J	Kraft, AD; Nguyen, KH; Jimenez-Soto, E; Hodge, A				Kraft, Aleli D.; Nguyen, Kim-Huong; Jimenez-Soto, Eliana; Hodge, Andrew			Stagnant Neonatal Mortality and Persistent Health Inequality in Middle-Income Countries: A Case Study of the Philippines	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; CHILD HEALTH; CONCENTRATION INDEX; UNDER-5 MORTALITY; EQUITY; INTERVENTIONS; COUNTDOWN; SURVIVAL; NEWBORN; COVERAGE	Background: The probability of survival through childhood continues to be unequal in middle-income countries. This study uses data from the Philippines to assess trends in the prevalence and distribution of child mortality and to evaluate the country's socioeconomic-related child health inequality. Methodology: Using data from four Demographic and Health Surveys we estimated levels and trends of neonatal, infant, and under-five mortality from 1990 to 2007. Mortality estimates at national and subnational levels were produced using both direct and indirect methods. Concentration indices were computed to measure child health inequality by wealth status. Multivariate regression analyses were used to assess the contribution of interventions and socioeconomic factors to wealth-related inequality. Findings: Despite substantial reductions in national under-five and infant mortality rates in the early 1990s, the rates of declines have slowed in recent years and neonatal mortality rates remain stubbornly high. Substantial variations across urban-rural, regional, and wealth equity-markers are evident, and suggest that the gaps between the best and worst performing sub-populations will either be maintained or widen in the future. Of the variables tested, recent wealth-related inequalities are found to be strongly associated with social factors (e.g. maternal education), regional location, and access to health services, such as facility-based delivery. Conclusion: The Philippines has achieved substantial progress towards Millennium Development Goal 4, but this success masks substantial inequalities and stagnating neonatal mortality trends. This analysis supports a focus on health interventions of high quality - that is, not just facility-based delivery, but delivery by trained staff at well-functioning facilities and supported by a strong referral system - to re-start the long term decline in neonatal mortality and to reduce persistent within-country inequalities in child health.	[Kraft, Aleli D.] Univ Philippines, Sch Econ, Quezon City 1101, Philippines; [Nguyen, Kim-Huong; Jimenez-Soto, Eliana; Hodge, Andrew] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of the Philippines System; University of the Philippines Diliman; University of Queensland	Hodge, A (corresponding author), Univ Queensland, Sch Populat Hlth, Publ Hlth Bldg,Herston Rd, Brisbane, Qld, Australia.	a.hodge@uq.edu.au	Nguyen, Kim-Huong/C-7260-2017; Nguyen, Kim-Huong/ABA-5902-2020; Hodge, Andrew/C-4779-2014	Nguyen, Kim-Huong/0000-0002-2592-9372; Nguyen, Kim-Huong/0000-0002-2592-9372; Hodge, Andrew/0000-0002-7203-9233; Kraft, Aleli/0000-0002-6883-8817	Bill and Melinda Gates Foundation [52125]; Australian Agency for International Development (AusAID) [47734]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian Agency for International Development (AusAID)(Australian Aid (AusAID))	The research described in this paper is made possible through the Bill and Melinda Gates Foundation, grant ID 52125, URL: www.gatesfoundation.org; and the Australian Agency for International Development (AusAID), grant ID 47734, URL: www.ausaid.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuin CS, 2011, LANCET, V377, P516, DOI 10.1016/S0140-6736(10)62049-1; [Anonymous], 2012, REPORT SECRETARY GEN; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bauze AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037861; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Cleveland W, 1996, STAT THEORY COMPUTAT; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Department of Health, 2005, NAT OBJ HLTH 2005 20; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Erreygers G, 2011, J HLTH EC, DOI [10.1016/j.jhea-leco.2011.10.009, DOI 10.1016/J.JHEA-LECO.2011.10.009]; Erreygers G, 2011, J HEALTH ECON, V30, P685, DOI 10.1016/j.jhealeco.2011.04.004; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Food and Nutrition Research Institute, 2007, PHIL NUTR FACTS FIG; Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303; Hosseinpoor AR, 2006, INT J EPIDEMIOL, V35, P1211, DOI 10.1093/ije/dyl164; Hosseinpoor AR, 2011, B WORLD HEALTH ORGAN, V89, P881, DOI 10.2471/BLT.11.087536; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; KING G, 2000, AM J POLIT SCI, V0044; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195; Morasae EK, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-18; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Mulholland EK, 2008, B WORLD HEALTH ORGAN, V86, P399, DOI 10.2471/BLT.07.044545; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Nedjat S, 2012, J EPIDEMIOL COMMUN H, V66, P495, DOI 10.1136/jech.2010.108977; Ostlin P, 2005, B WORLD HEALTH ORGAN, V83, P948; Ostlin P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001115; Pradhan J, 2010, HEALTH POLICY, V98, P114, DOI 10.1016/j.healthpol.2010.05.010; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Rutstein SO, 2000, B WORLD HEALTH ORGAN, V78, P1256; van Doorslaer E, 2004, HEALTH ECON, V13, P629, DOI 10.1002/hec.919; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A, 2005, HEALTH ECON, V14, P429, DOI 10.1002/hec.953; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Wagstaff A, 2011, HEALTH ECON, V20, P1155, DOI 10.1002/hec.1752; Wagstaff A, 2009, J HEALTH ECON, V28, P516, DOI 10.1016/j.jhealeco.2008.12.003; World Bank, 2011, TRANSF PHIL HLTH SEC; World Bank, 2012, WORLD DEV IND ONL WD; Zere E, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-34	52	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53696	10.1371/journal.pone.0053696	http://dx.doi.org/10.1371/journal.pone.0053696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308278	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100110
J	Richter, M; Zolal, A; Ganslandt, O; Buchfelder, M; Nimsky, C; Merhof, D				Richter, Mirco; Zolal, Amir; Ganslandt, Oliver; Buchfelder, Michael; Nimsky, Christopher; Merhof, Dorit			Evaluation of Diffusion-Tensor Imaging-Based Global Search and Tractography for Tumor Surgery Close to the Language System	PLOS ONE			English	Article							ANATOMO-FUNCTIONAL CONNECTIVITY; WHITE-MATTER TRACTOGRAPHY; DTI-FIBER TRACKING; BRAIN; FASCICULUS; RECONSTRUCTION; VISUALIZATION; DISSECTION; PATHWAYS; INSIGHTS	Pre-operative planning and intra-operative guidance in neurosurgery require detailed information about the location of functional areas and their anatomo-functional connectivity. In particular, regarding the language system, post-operative deficits such as aphasia can be avoided. By combining functional magnetic resonance imaging and diffusion tensor imaging, the connectivity between functional areas can be reconstructed by tractography techniques that need to cope with limitations such as limited resolution and low anisotropic diffusion close to functional areas. Tumors pose particular challenges because of edema, displacement effects on brain tissue and infiltration of white matter. Under these conditions, standard fiber tracking methods reconstruct pathways of insufficient quality. Therefore, robust global or probabilistic approaches are required. In this study, two commonly used standard fiber tracking algorithms, streamline propagation and tensor deflection, were compared with a previously published global search, Gibbs tracking and a connection-oriented probabilistic tractography approach. All methods were applied to reconstruct neuronal pathways of the language system of patients undergoing brain tumor surgery, and control subjects. Connections between Broca and Wernicke areas via the arcuate fasciculus (AF) and the inferior fronto-occipital fasciculus (IFOF) were validated by a clinical expert to ensure anatomical feasibility, and compared using distance-and diffusion-based similarity metrics to evaluate their agreement on pathway locations. For both patients and controls, a strong agreement between all methods was observed regarding the location of the AF. In case of the IFOF however, standard fiber tracking and Gibbs tracking predominantly identified the inferior longitudinal fasciculus that plays a secondary role in semantic language processing. In contrast, global search resolved connections in almost every case via the IFOF which could be confirmed by probabilistic fiber tracking. The results show that regarding the language system, our global search is superior to clinically applied conventional fiber tracking strategies with results similar to time-consuming global or probabilistic approaches.	[Richter, Mirco; Merhof, Dorit] Univ Konstanz, Constance, Germany; [Zolal, Amir] Univ JE Purkyn, Dept Neurosurg, Usti Nad Labem, Czech Republic; [Zolal, Amir] Masaryk Hosp, Usti Nad Labem, Czech Republic; [Ganslandt, Oliver; Buchfelder, Michael] Univ Erlangen Nurnberg, Dept Neurosurg, D-91054 Erlangen, Germany; [Nimsky, Christopher] Univ Marburg, Dept Neurosurg, Marburg, Germany	University of Konstanz; Masaryk Hospital; University of Erlangen Nuremberg; Philipps University Marburg	Richter, M (corresponding author), Univ Konstanz, Constance, Germany.	mirco.richter@uni-konstanz.de	Nimsky, Christopher/E-3702-2014; Merhof, Dorit/AAV-7892-2021; Zolal, Amir/R-5830-2019	Nimsky, Christopher/0000-0002-8216-9410; Zolal, Amir/0000-0003-3729-2513	DFG Research Training Group at the University of Konstanz [GK-1042]	DFG Research Training Group at the University of Konstanz	This study was supported by the DFG Research Training Group GK-1042 "Explorative Analysis and Visualization of Large Information Spaces" at the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2009, I S BIOMED IMAGING, P1398, DOI 10.1109/ISBI.2009.5193327; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bello L, 2008, NEUROIMAGE, V39, P369, DOI 10.1016/j.neuroimage.2007.08.031; Bertani G, 2012, J NEUROSURG SCI, V56, P137; Brun A, 2003, LECT NOTES COMPUT SC, V2809, P518; Cheng P, 2006, NEUROIMAGE, V31, P1075, DOI 10.1016/j.neuroimage.2006.01.028; Corouge I, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P344; DECHTER R, 1985, J ACM, V32, P505, DOI 10.1145/3828.3830; Ding ZH, 2001, IEEE VISUAL, P453, DOI 10.1109/VISUAL.2001.964549; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Duffau H, 2008, NEUROPSYCHOLOGIA, V46, P927, DOI 10.1016/j.neuropsychologia.2007.10.025; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Golby AJ, 2011, NEUROSURGERY, V68, P496, DOI 10.1227/NEU.0b013e3182061ebb; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Jackowski M, 2005, MED IMAGE ANAL, V9, P427, DOI 10.1016/j.media.2005.05.008; Jones D, 2008, PISTE PHANTOM IMAGES; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Kreher B., 2006, P ISMRM 14 INT SCI M; Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023; Kuhnt D, 2012, NEUROSURGERY, V70, P911, DOI 10.1227/NEU.0b013e318237a807; Lagana` M, 2010, COMPUTATIONAL INTELL, V2010; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Lebel C, 2012, MAGN RESON MED, V68, P474, DOI 10.1002/mrm.23254; Maesawa S, 2010, WORLD NEUROSURG, V74, P153, DOI 10.1016/j.wneu.2010.03.022; Mandonnet E, 2007, BRAIN, V130, P623, DOI 10.1093/brain/awl361; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; Merhof D, 2006, LECT NOTES COMPUT SC, V4191, P225; Mohades S, 2012, BRAIN RES, V1435, P137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neher P, 2012, P SPIE MED IMAGING, V8314; Nimsky C, 2005, RADIOLOGY, V234, P218, DOI 10.1148/radiol.2341031984; Nimsky C, 2007, NEUROSURGERY, V61, P178, DOI [10.1227/01.neu.0000279214.00139.3b, 10.1227/01.NEU.0000144842.18771.30]; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Pinotsis DA, 2012, NEUROIMAGE, V59, P1261, DOI [10.1016/j.neuroimage.2011.08.020, 10.1016/j.neuroimage.2010.12.039]; Reisert M, 2009, P MICCAI DIFF MOD WO; Reisert M, 2011, NEUROIMAGE, V54, P955, DOI 10.1016/j.neuroimage.2010.09.016; Saur D, 2010, NEUROIMAGE, V49, P3187, DOI 10.1016/j.neuroimage.2009.11.009; Schmahmann J, 2006, FIBER PATHWAYS BRAIN; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Vandermosten M, 2012, BRAIN, V135, P935, DOI 10.1093/brain/awr363; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Voineskos AN, 2010, BRAIN, V133, P1494, DOI 10.1093/brain/awq040; Westin CF, 1997, ISMRM 97, P1742; Zalesky A, 2008, IEEE T MED IMAGING, V27, P1458, DOI 10.1109/TMI.2008.923644; Zhang S, 2002, CS0218	56	11	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e50132	10.1371/journal.pone.0050132	http://dx.doi.org/10.1371/journal.pone.0050132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308093	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100002
J	Stanton, MC; Bockarie, MJ; Kelly-Hope, LA				Stanton, Michelle C.; Bockarie, Moses J.; Kelly-Hope, Louise A.			Geographical Factors Affecting Bed Net Ownership, a Tool for the Elimination of Anopheles-Transmitted Lymphatic Filariasis in Hard-to-Reach Communities	PLOS ONE			English	Article							INSECTICIDE TREATED NETS; PREGNANT-WOMEN; LOA-LOA; POPULATION; AFRICA; TRANSMISSION; POSSESSION; COVERAGE; MOSQUITO; CHILDREN	Vector control, including the use of bed nets, is recommended as a possible strategy for eliminating lymphatic filariasis (LF) in post-conflict countries such as the Democratic Republic of Congo (DRC). This study examined the geographical factors that influence bed net ownership in DRC in order to identify hard-to-reach communities that need to be better targeted. In particular, urban/rural differences and the influence of population density, proximity to cities and health facilities, plus access to major transport networks were investigated. Demographic and Health Survey geo-referenced cluster level data were used to map bed net coverage (proportion of households with at least one of any type of bed net or at least one insecticide-treated net (ITN)), and ITN density (ITNs per person) for 260 clusters. Bivariate and multiple logistic or Poisson regression analyses were used to determine significant relationships. Overall, bed net (30%) and ITN (9%) coverage were very low with significant differences found between urban and rural clusters. In rural clusters, ITN coverage/density was positively correlated with population density (r = 0.25, 0.27 respectively, p < 0.01), and negatively with the distance to the two largest cities, Kinshasa or Lubumbashi (r = -0.28, -0.30 respectively, p < 0.0001). Further, ownership was significantly negatively correlated with distance to primary national roads and railways (all three measures), distance to main rivers (any bed net only) and distance to the nearest health facility (ITNs only). Logistic and Poisson regression models fitted to the rural cluster data indicated that, after controlling for measured covariates, ownership levels in the Bas-Congo province close to Kinshasa were much larger than that of other provinces. This was most noticeable when considering ITN coverage (odds ratio: 5.3, 95% CI: 3.67-7.70). This analysis provides key insights into the barriers of bed net ownership, which will help inform both LF and malaria bed net distribution campaigns as part of an integrated vector management strategy.	[Stanton, Michelle C.; Bockarie, Moses J.; Kelly-Hope, Louise A.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Stanton, MC (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.	michelle.stanton@liv.ac.uk	Bockarie, Moses/AAV-4578-2020; Bockarie, Moses/AAW-3130-2021	Kelly-Hope, Louise/0000-0002-3330-7629	Department for International Development (DFID); GlaxoSmithKline (GSK); GlaxoSmithKline	Department for International Development (DFID); GlaxoSmithKline (GSK)(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	The study was supported through a grant from the Department for International Development (DFID) and GlaxoSmithKline (GSK) for research on the elimination of lymphatic filariasis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported through a grant from the commercial funder GlaxoSmithKline. This does not alter the authors' adherence to all of the PLOS ONE policies on sharing data and materials.	African Programme for Onchocerciasis Control, 2010, WHO YEAR 2010 PROGR; Agresti A, 2007, INTRO CATEGORICAL DA; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P121; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], GLOB MAL ACT PLAN MA; Ashton RA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-134; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; Blackburn BG, 2006, AM J TROP MED HYG, V75, P650, DOI 10.4269/ajtmh.2006.75.650; Bockarie MJ, 2002, MED VET ENTOMOL, V16, P116, DOI 10.1046/j.0269-283x.2002.00352.x; Burkot T R, 2006, Filaria J, V5, P10, DOI 10.1186/1475-2883-5-10; Demographic and Health Survey, 2007, DEM REP CONG; Department for International Development, 2011, MAL COUNTR PROF; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Global Malaria Programme, 2007, INS TREAT MOSQ NETS; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; Hawking F, 1977, Trop Dis Bull, V74, P649; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Ichimori K, 2012, PROV STRAT INT LYMPH; Kelly-Hope LA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-178; Khan S, 2008, WHO USES INSECTICIDE; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Larson PS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-18; Macintyre K, 2006, TROP MED INT HEALTH, V11, P824, DOI 10.1111/j.1365-3156.2006.01637.x; Messina JP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-161; Ministere du Plan, 2007, ENQ DEM SANT REP DEM; Molyneux DH, 2006, ADV PARASIT, V61, P1, DOI 10.1016/S0065-308X(05)61001-9; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; O'Meara WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025949; Ouattara AF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-288; Pedersen EM, 2002, ANN TROP MED PARASIT, V96, pS91, DOI 10.1179/000349802125002437; President's Malaria Initiative, 2011, MAL OP PLAN FISC YEA; Rutstein SO, 2006, GUID DHS STAT; Sexton AR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-157; Socioeconomic Data and Application Center (SEDAC) Columbia University, GLOB RUR URB MAPP PR; Socioeconomic Data and Application Center (SEDAC) Columbia University, GRIDD POP WORLD VERS; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Taylor SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016420; United Nations' Children's Fund (UNICEF), 2011, MUULT IND CLUST SURV; Van den Berg H, 2012, LANCET INFECT DIS, V3099, P1; Wacira DG, 2007, TROP MED INT HEALTH, V12, P140, DOI 10.1111/j.1365-3156.2006.01759.x; World Bank Group, 2010, DEM REP CONG MULT TR; World Health Organization, 2009, LF PROGR REP STRAT P; Zoure HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001210	48	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53755	10.1371/journal.pone.0053755	http://dx.doi.org/10.1371/journal.pone.0053755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308281	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000313429100113
J	Svedruzic, ZM; Popovic, K; Sendula-Jengic, V				Svedruzic, Zeljko M.; Popovic, Katarina; Sendula-Jengic, Vesna			Modulators of gamma-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; APP LOCUS DUPLICATION; C-TERMINAL FRAGMENT; A-BETA; INTRAMEMBRANE CLEAVAGE; TRANSMEMBRANE DOMAIN; CEREBROSPINAL-FLUID; MOUSE MODEL; INHIBITOR; SITE	Background: Selective modulation of different A beta products of an intramembrane protease gamma-secretase, could be the most promising strategy for development of effective therapies for Alzheimer's disease. We describe how different drug-candidates can modulate gamma-secretase activity in cells, by studying how DAPT affects changes in gamma-secretase activity caused by gradual increase in A beta metabolism. Results: A beta 1-40 secretion in the presence of DAPT shows biphasic activation-inhibition dose-response curves. The biphasic mechanism is a result of modulation of gamma-secretase activity by multiple substrate and inhibitor molecules that can bind to the enzyme simultaneously. The activation is due to an increase in gamma-secretase's kinetic affinity for its substrate, which can make the enzyme increasingly more saturated with otherwise sub-saturating substrate. The noncompetitive inhibition that prevails at the saturating substrate can decrease the maximal activity. The synergistic activation-inhibition effects can drastically reduce gamma-secretase's capacity to process its physiological substrates. This reduction makes the biphasic inhibitors exceptionally prone to the toxic side-effects and potentially pathogenic. Without the modulation, gamma-secretase activity on it physiological substrate in cells is only 14% of its maximal activity, and far below the saturation. Significance: Presented mechanism can explain why moderate inhibition of gamma-secretase cannot lead to effective therapies, the pharmacodynamics of A beta-rebound phenomenon, and recent failures of the major drug-candidates such as semagacestat. Novel improved drug-candidates can be prepared from competitive inhibitors that can bind to different sites on gamma-secretase simultaneously. Our quantitative analysis of the catalytic capacity can facilitate the future studies of the therapeutic potential of gamma-secretase and the pathogenic changes in A beta metabolism.	[Svedruzic, Zeljko M.; Sendula-Jengic, Vesna] Univ Rijeka, Fac Med, PB Rab, Rab, Croatia; [Svedruzic, Zeljko M.] Univ Rijeka, Dept Biotechnol, Rijeka, Croatia	University of Rijeka; University of Rijeka	Svedruzic, ZM (corresponding author), Univ Rijeka, Fac Med, PB Rab, Rab, Croatia.	zsvedruz@biol.pmf.hr	Svedruzic, Zeljko M/R-3281-2018; Sendula Jengic, Vesna/U-2499-2018	Svedruzic, Zeljko M/0000-0002-0736-6182; Sendula Jengic, Vesna/0000-0003-2126-3793	Croatian Ministry of Health	Croatian Ministry of Health	The authors are funded by the Croatian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Benilova I, 2011, NAT NEUROSCI, V14, P949, DOI 10.1038/nn.2871; Berezovska O, 2003, J NEUROSCI, V23, P4560; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bulic B, 2011, CURR NEUROPHARMACOL, V9, P598, DOI 10.2174/157015911798376352; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Chau DM, 2012, J BIOL CHEM; Chavez-Gutierrez L, 2012, EMBO J; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Coric V., 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI [10.1001/archneurol.2012.2194, DOI 10.1001/ARCHNEUROL.2012.2194]; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Fersht A., 1999, STRUCTURE MECH PROTE; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; German DC, 2004, REV NEUROSCIENCE, V15, P353, DOI 10.1515/REVNEURO.2004.15.5.353; Guyant-Marechal L, 2007, NEUROLOGY, V68, P684, DOI 10.1212/01.wnl.0000255938.33739.46; Henley DB, 2009, EXPERT OPIN PHARMACO, V10, P1657, DOI 10.1517/14656560903044982; Henley DB, 2011, ALZHEIMERS DEMENT; Holsinger RMD, 2004, ANN NEUROL, V55, P898, DOI 10.1002/ana.20144; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kreft AF, 2009, J MED CHEM, V52, P6169, DOI 10.1021/jm900188z; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marlow L, 2003, BIOCHEM BIOPH RES CO, V305, P502, DOI 10.1016/S0006-291X(03)00797-6; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Nelson DL, 2008, LEHINGER PRINCIPLES; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Oehlrich D, 2010, J MED CHEM; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Refolo LM, 1999, J NEUROCHEM, V73, P2383, DOI 10.1046/j.1471-4159.1999.0732383.x; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Rovelet-Lecrux A, 2007, J NEUROL NEUROSUR PS, V78, P1158, DOI 10.1136/jnnp.2006.113514; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; SCHULZ AR, 1994, ENZYME KINETICS DIAS; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Suh YH, 2000, J NEURAL TRANSM-SUPP, P65; Sun AY, 2002, EXP NEUROL, V175, P10, DOI 10.1006/exnr.2002.7875; Svedruzic ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032293; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Tong G, 2012, CLIN THER, V34, P654, DOI 10.1016/j.clinthera.2012.01.022; Uemura K, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-15; Uemura K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1129; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200	76	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e50759	10.1371/journal.pone.0050759	http://dx.doi.org/10.1371/journal.pone.0050759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308095	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100003
J	Thombs, BD; Roseman, M; Coyne, JC; de Jonge, P; Delisle, VC; Arthurs, E; Levis, B; Ziegelstein, RC				Thombs, Brett D.; Roseman, Michelle; Coyne, James C.; de Jonge, Peter; Delisle, Vanessa C.; Arthurs, Erin; Levis, Brooke; Ziegelstein, Roy C.			Does Evidence Support the American Heart Association's Recommendation to Screen Patients for Depression in Cardiovascular Care? An Updated Systematic Review	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; SEROTONIN REUPTAKE INHIBITORS; MAJOR DEPRESSION; DIAGNOSTIC-ACCURACY; CARDIAC EVENTS; DOUBLE-BLIND; RISK; EFFICACY; ANTIDEPRESSANTS	Objectives: To systematically review evidence on depression screening in coronary heart disease (CHD) by assessing the (1) accuracy of screening tools; (2) effectiveness of treatment; and (3) effect of screening on depression outcomes. Background: A 2008 American Heart Association (AHA) Science Advisory recommended routine depression screening in CHD. Methods: CINAHL, Cochrane, EMBASE, ISI, MEDLINE, PsycINFO and SCOPUS databases searched through December 2, 2011; manual journal searches; reference lists; citation tracking; trial registries. Included articles (1) compared a depression screening instrument to a depression diagnosis; (2) compared depression treatment to placebo or usual care in a randomized controlled trial (RCT); or (3) assessed the effect of screening on depression outcomes in a RCT. Results: There were few examples of screening tools with good sensitivity and specificity using a priori-defined cutoffs in more than one patient sample among 15 screening accuracy studies. Depression treatment with antidepressants or psychotherapy generated modest symptom reductions among post-myocardial infarction (post-MI) and stable CHD patients (N = 6; effect size = 0.20-0.38), but antidepressants did not improve symptoms more than placebo in 2 heart failure (HF) trials. Depression treatment did not improve cardiac outcomes. No RCTs investigated the effects of screening on depression outcomes. Conclusions: There is evidence that treatment of depression results in modest improvement in depressive symptoms in post-MI and stable CHD patients, although not in HF patients. There is still no evidence that routine screening for depression improves depression or cardiac outcomes. The AHA Science Advisory on depression screening should be revised to reflect this lack of evidence.	[Thombs, Brett D.; Roseman, Michelle] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Thombs, Brett D.; Levis, Brooke] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.; Delisle, Vanessa C.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada; [Thombs, Brett D.; Roseman, Michelle; Delisle, Vanessa C.; Arthurs, Erin; Levis, Brooke] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Coyne, James C.] Univ Penn, Sch Med, Abramson Canc Ctr, Behav Oncol Program, Philadelphia, PA 19104 USA; [Coyne, James C.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Coyne, James C.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Hlth Psychol Sect, Groningen, Netherlands; [de Jonge, Peter] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychiat Epidemiol, Groningen, Netherlands; [Ziegelstein, Roy C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Groningen; University of Groningen; Johns Hopkins University	Thombs, BD (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	de Jonge, peter/L-6395-2013	de Jonge, peter/0000-0002-0866-6929; Thombs, Brett D./0000-0002-5644-8432	Canadian Institutes for Health Research [KRS 111754]; Canadian Institutes of Health Research; Fonds de la Recherche en Sante Quebec; McGill University; Johns Hopkins Center for Innovative Medicine	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); McGill University; Johns Hopkins Center for Innovative Medicine	This research was supported by a grant from the Canadian Institutes for Health Research (KRS 111754). Dr. Thombs is supported by a New Investigator Award from the Canadian Institutes of Health Research and an Etablissement de Jeunes Chercheurs award from the Fonds de la Recherche en Sante Quebec. Ms. Roseman is supported by a Master's Training Award from the Fonds de la recherche en sante Quebec, a McGill University Provost's Graduate Fellowship and a McGill University Principal's Graduate Fellowship. Ms. Delisle is supported by a Master's Training Award from the Fonds de la recherche en sante Quebec, and McGill University Graduate Studies Fellowship. Dr. Ziegelstein is supported by the Miller Family Scholar Program of the Johns Hopkins Center for Innovative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, 2009, J Am Coll Cardiol, V54, P2102, DOI 10.1016/j.jacc.2009.07.004; Annunziato RA, 2008, PSYCHOSOMATICS, V49, P386, DOI 10.1176/appi.psy.49.5.386; Benazon NR, 2005, PSYCHOSOM MED, V67, P916, DOI 10.1097/01.psy.0000188399.80167.aa; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Bunevicius A, 2012, J PSYCHOSOM RES, V72, P22, DOI 10.1016/j.jpsychores.2011.10.006; Burton C, PSYCHOL MED; Cruz LN, 2010, SOC PSYCH PSYCH EPID, V45, P953, DOI 10.1007/s00127-009-0141-2; Czarny MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027671; Denollet J, 2006, PSYCHOTHER PSYCHOSOM, V75, P346, DOI 10.1159/000095440; Dickens CM, 2004, PSYCHOL MED, V34, P1083, DOI 10.1017/S0033291704001965; Elderon L, 2011, CIRC-CARDIOVASC QUAL, V4, P533, DOI 10.1161/CIRCOUTCOMES.110.960302; Fraguas R, 2009, CONTEMP CLIN TRIALS, V30, P205, DOI 10.1016/j.cct.2009.01.007; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; Freedland KE, 2003, PSYCHOSOM MED, V65, P119, DOI 10.1097/01.PSY.0000038938.67401.85; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Goryachkina K, 2008, EUR J CLIN PHARMACOL, V64, P275, DOI 10.1007/s00228-007-0404-3; GUTIERREZ RC, 1999, CAN J CARDIOVASC NUR, V10, P29; Honig A, 2007, PSYCHOSOM MED, V69, P606, DOI 10.1097/PSY.0b013e31814b260d; Huffman JC, 2006, HEART, V92, P1656, DOI 10.1136/hrt.2005.087213; Huffman JC, 2010, INT J PSYCHIAT MED, V40, P187, DOI 10.2190/PM.40.2.e; Jacq F, 2009, GEN HOSP PSYCHIAT, V31, P266, DOI 10.1016/j.genhosppsych.2009.01.003; Krantz DS, 2009, HEART, V95, P1901, DOI 10.1136/hrt.2009.176040; Labos C, 2011, CAN MED ASSOC J, V183, P1835, DOI 10.1503/cmaj.100912; Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367; Licht CMM, 2010, BIOL PSYCHIAT, V68, P861, DOI 10.1016/j.biopsych.2010.06.032; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Low GD, 2007, SOC INDIC RES, V82, P527, DOI 10.1007/s11205-006-9049-3; Manea L., 2011, CMAJ; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; National Collaborating Center for Mental Health, 2010, NICE GUID MAN TREATM; O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068; Pinho MX, 2010, ARQ BRAS CARDIOL, V94, P570, DOI 10.1590/S0066-782X2010005000032; Roose SP, 1998, JAMA-J AM MED ASSOC, V279, P287, DOI 10.1001/jama.279.4.287; Schalekamp T, 2008, ARCH INTERN MED, V168, P180, DOI 10.1001/archinternmed.2007.32; Schelleman H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021447; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Smolderen KG, 2011, CIRC-CARDIOVASC QUAL, V4, P283, DOI 10.1161/CIRCOUTCOMES.110.960013; Smoller JW, 2009, ARCH INTERN MED, V169, P2128, DOI 10.1001/archinternmed.2009.436; Sowden G, 2010, AM HEART J, V159, P780, DOI 10.1016/j.ahj.2010.02.029; Spina E, 2008, CLIN THER, V30, P1206, DOI 10.1016/S0149-2918(08)80047-1; Stafford L, 2007, GEN HOSP PSYCHIAT, V29, P417, DOI 10.1016/j.genhosppsych.2007.06.005; Stahl SM, 2005, CNS SPECTRUMS, V10, P732, DOI 10.1017/S1092852900019726; Strik JJMH, 2001, PSYCHOSOMATICS, V42, P423, DOI 10.1176/appi.psy.42.5.423; Strik JTMH, 2000, PSYCHOSOM MED, V62, P783, DOI 10.1097/00006842-200011000-00007; Subramanian Deepak N, 2008, Qual Prim Care, V16, P341; Swardfager W, 2011, J CLIN PSYCHIAT, V72, P1181, DOI 10.4088/JCP.09m05810blu; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667; Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035; Thombs BD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4825; Thombs BD, 2009, AM HEART J, V158, P503, DOI 10.1016/j.ahj.2009.07.032; Thombs BD, 2008, J GEN INTERN MED, V23, P2014, DOI 10.1007/s11606-008-0802-y; Tiringer Istvan, 2008, Psychiatr Hung, V23, P430; U.S. Food and Drug Administration, 2012, CEL CIT HYDR DRUG SA; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; Van Melle JP, 2007, BRIT J PSYCHIAT, V190, P460, DOI 10.1192/bjp.bp.106.028647; Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060; Wilson JMG, 1968, PRINCIPLES PRACTICES; Xiong GL, 2006, AM J CARDIOL, V98, P42, DOI 10.1016/j.amjcard.2006.01.051; Ziegelstein RC, 2011, J PSYCHOSOM RES, V71, P3, DOI 10.1016/j.jpsychores.2011.03.007; Ziegelstein RC, 2009, J AM COLL CARDIOL, V54, P886, DOI 10.1016/j.jacc.2009.01.082	64	99	100	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52654	10.1371/journal.pone.0052654	http://dx.doi.org/10.1371/journal.pone.0052654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308116	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100013
J	Bucchi, A; Baruscotti, M; Nardini, M; Barbuti, A; Micheloni, S; Bolognesi, M; DiFrancesco, D				Bucchi, Annalisa; Baruscotti, Mirko; Nardini, Marco; Barbuti, Andrea; Micheloni, Stefano; Bolognesi, Martino; DiFrancesco, Dario			Identification of the Molecular Site of Ivabradine Binding to HCN4 Channels	PLOS ONE			English	Article							ACTIVATED CATION CHANNELS; POTASSIUM CHANNEL; STRUCTURAL BASIS; BLOCK; TOPOLOGY; MODEL; PREDICTION; CURRENTS	Ivabradine is a specific heart rate-reducing agent approved as a treatment of chronic stable angina. Its mode of action involves a selective and specific block of HCN channels, the molecular components of sinoatrial "funny" (f)-channels. Different studies suggest that the binding site of ivabradine is located in the inner vestibule of HCN channels, but the molecular details of ivabradine binding are unknown. We thus sought to investigate by mutagenesis and in silico analysis which residues of the HCN4 channel, the HCN isoform expressed in the sinoatrial node, are involved in the binding of ivabradine. Using homology modeling, we verified the presence of an inner cavity below the channel pore and identified residues lining the cavity; these residues were replaced with alanine (or valine) either alone or in combination, and WT and mutant channels were expressed in HEK293 cells. Comparison of the block efficiency of mutant vs WT channels, measured by patch-clamp, revealed that residues Y506, F509 and I510 are involved in ivabradine binding. For each mutant channel, docking simulations correctly explain the reduced block efficiency in terms of proportionally reduced affinity for ivabradine binding. In summary our study shows that ivabradine occupies a cavity below the channel pore, and identifies specific residues facing this cavity that interact and stabilize the ivabradine molecule. This study provides an interpretation of known properties of f/HCN4 channel block by ivabradine such as the "open channel block", the current-dependence of block and the property of "trapping" of drug molecules in the closed configuration.	[Bucchi, Annalisa; Baruscotti, Mirko; Barbuti, Andrea; Micheloni, Stefano; DiFrancesco, Dario] Univ Milan, Dept Life Sci, PaceLab, Milan, Italy; [Bucchi, Annalisa; Baruscotti, Mirko; Barbuti, Andrea; DiFrancesco, Dario] Univ Milan, Ctr Interuniv Med Mol & Biofis Appicata, Milan, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dept Life Sci, Lab Prot Biochem, Milan, Italy	University of Milan; University of Milan; University of Milan	DiFrancesco, D (corresponding author), Univ Milan, Dept Life Sci, PaceLab, Milan, Italy.	dario.difrancesco@unimi.it	Barbuti, Andrea/N-9805-2013; Nardini, Marco/B-7842-2017; Bucchi, Annalisa/B-1882-2017; DiFrancesco, Dario/G-8408-2017; Bolognesi, Martino/B-7924-2017; BARUSCOTTI, MIRKO/D-7017-2017	Barbuti, Andrea/0000-0002-4521-4913; Nardini, Marco/0000-0002-3718-2165; Bucchi, Annalisa/0000-0002-5303-4242; DiFrancesco, Dario/0000-0002-7322-1790; Bolognesi, Martino/0000-0002-9253-5170; BARUSCOTTI, MIRKO/0000-0002-6155-8388	Institut de Recherches Internationales Servier	Institut de Recherches Internationales Servier(Servier)	The authors thank the Institut de Recherches Internationales Servier for providing support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bois P, 1996, BRIT J PHARMACOL, V118, P1051, DOI 10.1111/j.1476-5381.1996.tb15505.x; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; Bucchi A, 2006, J PHYSIOL-LONDON, V572, P335, DOI 10.1113/jphysiol.2005.100776; Chan YC, 2009, PFLUG ARCH EUR J PHY, V459, P25, DOI 10.1007/s00424-009-0719-2; Cheng L, 2007, J PHARMACOL EXP THER, V322, P931, DOI 10.1124/jpet.107.121467; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Giorgetti A, 2005, BIOPHYS J, V89, P932, DOI 10.1529/biophysj.104.045286; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roncaglia P, 2002, BIOPHYS J, V83, P1953, DOI 10.1016/S0006-3495(02)73957-X; Rothberg BS, 2003, J GEN PHYSIOL, V122, P501, DOI 10.1085/jgp.200308928; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez-Chapula JA, 2003, MOL PHARMACOL, V63, P1051, DOI 10.1124/mol.63.5.1051; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Stansfeld PJ, 2007, PROTEINS, V68, P568, DOI 10.1002/prot.21400; Thollon C, 2010, ADV PHARMACOL, V59, P53, DOI 10.1016/S1054-3589(10)59003-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849	33	45	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53132	10.1371/journal.pone.0053132	http://dx.doi.org/10.1371/journal.pone.0053132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308150	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100020
J	Postnova, S; Robinson, PA; Postnov, DD				Postnova, Svetlana; Robinson, Peter A.; Postnov, Dmitry D.			Adaptation to Shift Work: Physiologically Based Modeling of the Effects of Lighting and Shifts' Start Time	PLOS ONE			English	Article							ASCENDING AROUSAL SYSTEM; QUANTITATIVE MODEL; SLEEP-DEPRIVATION; FATIGUE; ENTRAINMENT; SCHEDULES; EXPOSURE; DARKNESS; HUMANS; PERIOD	Shift work has become an integral part of our life with almost 20% of the population being involved in different shift schedules in developed countries. However, the atypical work times, especially the night shifts, are associated with reduced quality and quantity of sleep that leads to increase of sleepiness often culminating in accidents. It has been demonstrated that shift workers' sleepiness can be improved by a proper scheduling of light exposure and optimizing shifts timing. Here, an integrated physiologically-based model of sleep-wake cycles is used to predict adaptation to shift work in different light conditions and for different shift start times for a schedule of four consecutive days of work. The integrated model combines a model of the ascending arousal system in the brain that controls the sleep-wake switch and a human circadian pacemaker model. To validate the application of the integrated model and demonstrate its utility, its dynamics are adjusted to achieve a fit to published experimental results showing adaptation of night shift workers (n = 8) in conditions of either bright or regular lighting. Further, the model is used to predict the shift workers' adaptation to the same shift schedule, but for conditions not considered in the experiment. The model demonstrates that the intensity of shift light can be reduced fourfold from that used in the experiment and still produce good adaptation to night work. The model predicts that sleepiness of the workers during night shifts on a protocol with either bright or regular lighting can be significantly improved by starting the shift earlier in the night, e.g.; at 21:00 instead of 00:00. Finally, the study predicts that people of the same chronotype, i.e. with identical sleep times in normal conditions, can have drastically different responses to shift work depending on their intrinsic circadian and homeostatic parameters.	[Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, CIRUS, Sydney, NSW 2006, Australia; [Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, Brain Dynam Ctr, Sydney, NSW 2006, Australia; [Postnov, Dmitry D.] Saratov NG Chernyshevskii State Univ, Sch Phys, Saratov, Russia	University of Sydney; University of Sydney; University of Sydney; Saratov State University	Postnova, S (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	postnova@physics.usyd.edu.au	Postnov, Dmitry E/D-4316-2013	Postnova, Svetlana/0000-0002-1224-0779; Postnov, Dmitry D/0000-0002-9708-8453; Robinson, Peter/0000-0002-5050-9804	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC); Westmead Millennium Institute	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Westmead Millennium Institute	This work is supported by the Australian Research Council (ARC), the National Health and Medical Research Council (NHMRC), and Westmead Millennium Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 1995, J SLEEP RES, V4, P15, DOI 10.1111/j.1365-2869.1995.tb00221.x; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Boivin DB, 2002, J BIOL RHYTHM, V17, P556, DOI 10.1177/0748730402238238; Boivin DB, 2007, SLEEP MED, V8, P578, DOI 10.1016/j.sleep.2007.03.015; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1992, J SLEEP RES, V1, P63, DOI 10.1111/j.1365-2869.1992.tb00013.x; CZEISLER CA, 1990, NEW ENGL J MED, V322, P1253, DOI 10.1056/NEJM199005033221801; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Dinges DF, 1995, J SLEEP RES, V4, P4, DOI 10.1111/j.1365-2869.1995.tb00220.x; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Folkard S, 2005, IND HEALTH, V43, P20, DOI 10.2486/indhealth.43.20; Fulcher BD, 2010, J THEOR BIOL, V264, P407, DOI 10.1016/j.jtbi.2010.02.028; GLASS L, 1984, AM J PHYSIOL, V246, pR251, DOI 10.1152/ajpregu.1984.246.2.R251; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Hilaire MAS, 2007, J THEOR BIOL, V247, P583, DOI 10.1016/j.jtbi.2007.04.001; Hursh SR, 2004, AVIAT SPACE ENVIR MD, V75, pA44; Jewett ME, 1999, J BIOL RHYTHM, V14, P588, DOI 10.1177/074873099129000920; Landolt HP, 2008, BIOCHEM PHARMACOL, V75, P2070, DOI 10.1016/j.bcp.2008.02.024; Mallis MM, 2004, AVIAT SPACE ENVIR MD, V75, pA4; MINORS DS, 1991, NEUROSCI LETT, V133, P36, DOI 10.1016/0304-3940(91)90051-T; Moore RY, 2007, SLEEP MED, V8, pS27, DOI 10.1016/j.sleep.2007.10.003; Olofsen E., 2010, OPEN SLEEP J, V3, P24; Philip P, 2005, IND HEALTH, V43, P30, DOI 10.2486/indhealth.43.30; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2008, J THEOR BIOL, V255, P413, DOI 10.1016/j.jtbi.2008.08.022; Phillips AJK, 2011, J BIOL RHYTHM, V26, P441, DOI 10.1177/0748730411414163; Postnova S, 2012, J BIOL RHYTHM, V27, P91, DOI 10.1177/0748730411419934; Postnova S, 2009, J BIOL RHYTHM, V24, P523, DOI 10.1177/0748730409346655; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Tononi G., 2009, J CLIN SLEEP MED, V5, P16	34	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53379	10.1371/journal.pone.0053379	http://dx.doi.org/10.1371/journal.pone.0053379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308206	gold, Green Published			2022-12-27	WOS:000313670100034
J	Kempster, RM; Hart, NS; Collin, SP				Kempster, Ryan M.; Hart, Nathan S.; Collin, Shaun P.			Survival of the Stillest: Predator Avoidance in Shark Embryos	PLOS ONE			English	Article							ELECTROSENSORY SYSTEM; RESPONSE PROPERTIES; ELECTRORECEPTION; SENSE	Sharks use highly sensitive electroreceptors to detect the electric fields emitted by potential prey. However, it is not known whether prey animals are able to modulate their own bioelectrical signals to reduce predation risk. Here, we show that some shark (Chiloscyllium punctatum) embryos can detect predator-mimicking electric fields and respond by ceasing their respiratory gill movements. Despite being confined to the small space within the egg case, where they are vulnerable to predators, embryonic sharks are able to recognise dangerous stimuli and react with an innate avoidance response. Knowledge of such behaviours, may inform the development of effective shark repellents.	[Kempster, Ryan M.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Kempster, RM (corresponding author), Univ Western Australia, Oceans Inst, Crawley, WA, Australia.	ryankempster@supportoursharks.com	Collin, Shaun/K-8827-2012; Kempster, Ryan M/A-4910-2011; Hart, Nathan S/B-8564-2011	Collin, Shaun/0000-0001-6236-0771; Hart, Nathan S/0000-0002-7289-9399	WA State Government; University of Western Australia	WA State Government; University of Western Australia	This work was supported by funding from the WA State Government and The University of Western Australia (to SPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Bowers K, 2012, ZOOBIQUITY WHAT ANIM, P320; COX DL, 1993, ENVIRON BIOL FISH, V38, P117, DOI 10.1007/BF00842908; ESPMARK Y, 1985, J MAMMAL, V66, P702, DOI 10.2307/1380796; Fitzgerald TP, 2002, THESIS U HAWAII; Freitas R, 2006, EVOL DEV, V8, P74, DOI 10.1111/j.1525-142X.2006.05076.x; Harahush BK, 2007, J FISH BIOL, V71, P1007, DOI 10.1111/j.1095-8649.2007.01569.x; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; Huveneers C, 2012, SARDI RES REP SER, V632; Kajiura SM, 2002, J EXP BIOL, V205, P3609; Kajiura SM, 2009, ZOOLOGY, V112, P241, DOI 10.1016/j.zool.2008.07.001; Kalmijn A.J., 1988, P151; Kalmijn A.J., 1974, P147; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1982, SCIENCE, V218, P916, DOI 10.1126/science.7134985; Kempster RM, 2012, J FISH BIOL, V80, P2055, DOI 10.1111/j.1095-8649.2011.03214.x; MOEN AN, 1978, CAN J ZOOL, V56, P1207, DOI 10.1139/z78-165; Montgomery JC, 2001, ENVIRON BIOL FISH, V60, P109, DOI 10.1023/A:1007679005704; PAULIN MG, 1995, J THEOR BIOL, V174, P325, DOI 10.1006/jtbi.1995.0102; PETERS RC, 1985, J EXP BIOL, V118, P99; Rivera-Vicente AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016008; Sisneros JA, 2002, J PHYSIOL-PARIS, V96, P379, DOI 10.1016/S0928-4257(03)00016-0; Sisneros JA, 2002, BRAIN BEHAV EVOLUT, V59, P130, DOI 10.1159/000064160; Sisneros JA, 1998, J COMP PHYSIOL A, V183, P87, DOI 10.1007/s003590050237; SMITH EN, 1981, COMP BIOCHEM PHYS A, V70, P529, DOI 10.1016/0300-9629(81)92565-2; Smith EN, 2006, PASSIVE FEAR ALTERNA, P112; TRICAS TC, 1982, COPEIA, P948, DOI 10.2307/1444104; Tricas TC, 1995, NEUROSCI LETT, V202, P129, DOI 10.1016/0304-3940(95)12230-3; Wueringer BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041605	29	39	39	2	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52551	10.1371/journal.pone.0052551	http://dx.doi.org/10.1371/journal.pone.0052551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326342	gold, Green Submitted, Green Published			2022-12-27	WOS:000313551500019
J	Furukawa, H; Oka, S; Shimada, K; Sugii, S; Hashimoto, A; Komiya, A; Fukui, N; Nagai, T; Hirohata, S; Setoguchi, K; Okamoto, A; Chiba, N; Suematsu, E; Miyashita, T; Migita, K; Suda, A; Nagaoka, S; Tsuchiya, N; Tohma, S				Furukawa, Hiroshi; Oka, Shomi; Shimada, Kota; Sugii, Shoji; Hashimoto, Atsushi; Komiya, Akiko; Fukui, Naoshi; Nagai, Tatsuo; Hirohata, Shunsei; Setoguchi, Keigo; Okamoto, Akira; Chiba, Noriyuki; Suematsu, Eiichi; Miyashita, Taiichiro; Migita, Kiyoshi; Suda, Akiko; Nagaoka, Shouhei; Tsuchiya, Naoyuki; Tohma, Shigeto			Association of Increased Frequencies of HLA-DPB1*05:01 with the Presence of Anti-Ro/SS-A and Anti-La/SS-B Antibodies in Japanese Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients	PLOS ONE			English	Article							PRIMARY SJOGRENS-SYNDROME; HLA CLASS-II; RO SSA ANTIBODIES; AUTOANTIBODY PRODUCTION; CLINICAL-SIGNIFICANCE; REVISED CRITERIA; CLASSIFICATION; EPITOPES; MARKER	Introduction: Autoantibodies to ribonucleoprotein are associated with a variety of autoimmune diseases, including rheumatoid arthritis (RA). Many studies on associations between human leukocyte antigen (HLA) alleles and RA have been reported, but few have been validated in RA subpopulations with anti-La/SS-B or anti-Ro/SS-A antibodies. Here, we investigated associations of HLA class II alleles with the presence of anti-Ro/SS-A or anti-La/SS-B antibodies in RA. Methods: An association study was conducted for HLA-DRB1, DQB1, and DPB1 in Japanese RA and systemic lupus erythematosus (SLE) patients that were positive or negative for anti-Ro/SS-A and/or anti-La/SS-B antibodies. Results: An increased prevalence of certain class II alleles was associated with the presence of anti-Ro/SS-A antibodies as follows:DRB1*08:03 (Pc = 3.79x10(-5), odds ratio [OR] 3.06, 95% confidence interval [CI] 1.98-4.73), DQB1*06:01 (Pc = 0.0106, OR 1.70, 95% CI 1.26-2.31), and DPB1*05:01 (Pc = 0.0040, OR 1.55, 95% CI 1.23-1.96). On the other hand, DRB1*15:01 (Pc = 0.0470, OR 3.14, 95% CI 1.63-6.05), DQB1*06:02 (Pc = 0.0252,OR 3.14, 95% CI 1.63-6.05), and DPB1*05:01 (Pc = 0.0069, OR 2.27, 95% CI 1.44-3.57) were associated with anti-La/SS-B antibodies. The DPB1*05:01 allele was associated with anti-Ro/SS-A (Pc = 0.0408, OR 1.69, 95% CI 1.19-2.41) and anti-La/SS-B antibodies (Pc = 2.48x10(-5), OR 3.31, 95% CI 2.02-5.43) in SLE patients. Conclusion: HLA-DPB1*05:01 was the only allele associated with the presence of both anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese RA and SLE patients.	[Furukawa, Hiroshi; Oka, Shomi; Komiya, Akiko; Fukui, Naoshi; Tohma, Shigeto] Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Sugii, Shoji] Tokyo Metropolitan Tama Med Ctr, Dept Rheumatol, Fuchu, Tokyo, Japan; [Hashimoto, Atsushi] Natl Hosp Org, Sagamihara Hosp, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Nagai, Tatsuo; Hirohata, Shunsei] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Sagamihara, Kanagawa 228, Japan; [Setoguchi, Keigo] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Okamoto, Akira] Natl Hosp Org, Himeji Med Ctr, Dept Rheumatol, Himeji, Hyogo, Japan; [Chiba, Noriyuki] Natl Hosp Org, Morioka Hosp, Dept Rheumatol, Morioka, Iwate, Japan; [Suematsu, Eiichi] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Dept Internal Med & Rheumatol, Fukuoka, Japan; [Miyashita, Taiichiro; Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, Omura, Japan; [Suda, Akiko; Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Yokohama, Kanagawa, Japan; [Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan	Kitasato University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; University of Tsukuba	Furukawa, H (corresponding author), Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan.	h-furukawa@sagamihara-hosp.gr.jp	Tsuchiya, Naoyuki/CAA-4545-2022	Tsuchiya, Naoyuki/0000-0002-6776-5580	Japan Society for the Promotion of Science, Health and Labour Science Research [22390199, 22591090, 24791018]; Ministry of Health, Labour, and Welfare of Japan; National Hospital Organization; Daiwa Securities Health Foundation; Japan Research Foundation for Clinical Pharmacology; Nakatomi Foundation; Takeda Science Foundation; Abbott Japan Co., Ltd.; Astellas Pharma Inc.; Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.; Mitsubishi Tanabe Pharma Corporation; Merck Sharp and Dohme Inc.; Pfizer Japan Inc.; Takeda Pharmaceutical Company Limited; Teijin Pharma Limited; Takeda Pharmaceutical Company; Astellas Pharma Inc.,; Hisamitsu Pharmaceutical Co., Inc.	Japan Society for the Promotion of Science, Health and Labour Science Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Hospital Organization; Daiwa Securities Health Foundation; Japan Research Foundation for Clinical Pharmacology; Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Abbott Japan Co., Ltd.(Abbott Laboratories); Astellas Pharma Inc.(Astellas Pharmaceuticals); Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.(Eisai Co Ltd); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Merck Sharp and Dohme Inc.(Merck & Company); Pfizer Japan Inc.(Pfizer); Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); Teijin Pharma Limited(Teijin Pharma Limited); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Astellas Pharma Inc.,(Astellas Pharmaceuticals); Hisamitsu Pharmaceutical Co., Inc.	This work was supported by Grants-in-Aid for Scientific Research (B, C) (22390199, 22591090) and for Young Scientists (24791018) from the Japan Society for the Promotion of Science, Health and Labour Science Research, Grants from the Ministry of Health, Labour, and Welfare of Japan, Grants-in-Aid for Clinical Research from National Hospital Organization, Research Grants from Daiwa Securities Health Foundation, Research Grants from Japan Research Foundation for Clinical Pharmacology, Research Grants from The Nakatomi Foundation, Research Grants from the Takeda Science Foundation, and research grants from pharmaceutical companies: Abbott Japan Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp and Dohme Inc., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited and Teijin Pharma Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparing the manuscript.; HF has the following conflicts. The following funders are supported in whole or in part by the indicated pharmaceutical companies. The Japan Research Foundation for Clinical Pharmacology is run by Daiichi Sankyo, the Takeda Science Foundation is supported by an endowment from Takeda Pharmaceutical Company and the Nakatomi Foundation was established by Hisamitsu Pharmaceutical Co., Inc. The Daiwa Securities Health Foundation was established by Daiwa Securities Group Inc. ST was supported by research grants from nine pharmaceutical companies: Abbott Japan Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp and Dohme Inc., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited, and Teijin Pharma Limited. NT is supported by the Takeda Science Foundation, which is supported by an endowment from the Takeda Pharmaceutical Company. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The other authors declare no financial or commercial conflicts of interest.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BOIRE G, 1993, J RHEUMATOL, V20, P1654; BOIRE G, 1988, J RHEUMATOL, V15, P391; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Furukawa H, 2012, ANN RHEUM D IN PRESS; Furukawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033133; Gottenberg JE, 2003, ARTHRITIS RHEUM, V48, P2240, DOI 10.1002/art.11103; Hernandez-Molina G, 2011, AUTOIMMUN REV, V10, P123, DOI 10.1016/j.autrev.2010.09.001; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kamada N, 2006, J DERMATOL, V33, P616, DOI 10.1111/j.1346-8138.2006.00142.x; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kominami S, 2009, J HUM GENET, V54, P108, DOI 10.1038/jhg.2008.15; Lewis SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027175; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Miyagawa S, 1998, ARTHRITIS RHEUM-US, V41, P927, DOI 10.1002/1529-0131(199805)41:5<927::AID-ART21>3.0.CO;2-R; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Oka S, 2012, TISSUE ANTIGENS, V80, P386, DOI 10.1111/j.1399-0039.2012.01921.x; Perricone C, 2011, AUTOIMMUN REV, V10, P599, DOI 10.1016/j.autrev.2011.04.021; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; Rischmueller M, 1998, CLIN EXP IMMUNOL, V111, P365; Schneeberger E, 2008, CLIN RHEUMATOL, V27, P517, DOI 10.1007/s10067-007-0812-x; Scott IC, 2011, BEST PRACT RES CL RH, V25, P447, DOI 10.1016/j.berh.2011.10.010; Tishler M, 1997, RHEUMATOL INT, V17, P133, DOI 10.1007/s002960050023; TISHLER M, 1994, J RHEUMATOL, V21, P1040; TISHLER M, 1992, J RHEUMATOL, V19, P234; Tsuboi H, 2010, CLIN EXP IMMUNOL, V162, P53, DOI 10.1111/j.1365-2249.2010.04188.x; Tzioufas AG, 2002, ANN RHEUM DIS, V61, P398, DOI 10.1136/ard.61.5.398	30	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53910	10.1371/journal.pone.0053910	http://dx.doi.org/10.1371/journal.pone.0053910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320107	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800072
J	Iuso, D; Czernik, M; Di Egidio, F; Sampino, S; Zacchini, F; Bochenek, M; Smorag, Z; Modlinski, JA; Ptak, G; Loi, P				Iuso, Domenico; Czernik, Marta; Di Egidio, Fiorella; Sampino, Silvestre; Zacchini, Federica; Bochenek, Michal; Smorag, Zdzislaw; Modlinski, Jacek A.; Ptak, Grazyna; Loi, Pasqualino			Genomic Stability of Lyophilized Sheep Somatic Cells before and after Nuclear Transfer	PLOS ONE			English	Article							DESICCATION TOLERANCE; FREEZE TOLERANCE; DNA; SURVIVAL; EMBRYOS; REPAIR; DAMAGE	The unprecedented decline of biodiversity worldwide is urging scientists to collect and store biological material from seriously threatened animals, including large mammals. Lyophilization is being explored as a low-cost system for storage in bio-banks of cells that might be used to expand or restore endangered or extinct species through the procedure of Somatic Cell Nuclear Transfer (SCNT). Here we report that the genome is intact in about 60% of lyophylized sheep lymphocytes, whereas DNA damage occurs randomly in the remaining 40%. Remarkably, lyophilized nuclei injected into enucleated oocytes are repaired by a robust DNA repairing activity of the oocytes, and show normal developmental competence. Cloned embryos derived from lyophylized cells exhibited chromosome and cellular composition comparable to those of embryos derived from fresh donor cells. These findings support the feasibility of lyophylization as a storage procedure of mammalian cells to be used for SCNT.	[Iuso, Domenico; Czernik, Marta; Di Egidio, Fiorella; Sampino, Silvestre; Zacchini, Federica; Ptak, Grazyna; Loi, Pasqualino] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy; [Bochenek, Michal; Smorag, Zdzislaw] Natl Res Inst Anim Prod, Balice, Poland; [Modlinski, Jacek A.] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Expt Embryol, Jastrzebiec, Poland	University of Teramo; National Research Institute of Animal Production; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Ptak, G (corresponding author), Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy.	gptak@unite.it; ploi@unite.it	Zacchini, Federica/GQY-5276-2022; Sampino, Silvestre/K-5033-2012	Zacchini, Federica/0000-0001-7942-2625; Sampino, Silvestre/0000-0001-8266-5062; CZERNIK, Marta Teresa/0000-0002-4535-4932; Iuso, Domenico/0000-0001-5946-2793; Ptak, Grazyna/0000-0003-1437-4698	European Research Council under the European Community [210103]; GP: PRIN [2007MY2M92]; EU FP7-KBBE-2009-3 Programme [244356]; NextGen; PRIN MIUR [2009JE3CHM]; Bank Foundation Tercas (Teramo, Italy)	European Research Council under the European Community(European Research Council (ERC)); GP: PRIN; EU FP7-KBBE-2009-3 Programme; NextGen; PRIN MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Bank Foundation Tercas (Teramo, Italy)	The research leading to these results received funding from the European Research Council under the European Community Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 210103; GP: PRIN 2007, no 2007MY2M92 to GP. PL acknowledges the support of the EU FP7-KBBE-2009-3 Programme, project no 244356, NextGen, and PRIN MIUR funding (protocol no 2009JE3CHM). Funds from the Bank Foundation Tercas (Teramo, Italy) are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JP, 2004, LIFE IN THE FROZEN STATE, P563, DOI 10.1201/9780203647073.ch20; Baatout S, 2007, IN VIVO, V21, P571; BLACKMAN SA, 1991, PLANT PHYSIOL, V96, P868, DOI 10.1104/pp.96.3.868; Buchanan SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012518; Buitink J, 2004, CRYOBIOLOGY, V48, P215, DOI 10.1016/j.cryobiol.2004.02.011; COLLAS P, 1991, BIOL REPROD, V45, P455, DOI 10.1095/biolreprod45.3.455; COSTANZO JP, 1993, J EXP BIOL, V181, P245; Crowe JH, 2005, INTEGR COMP BIOL, V45, P810, DOI 10.1093/icb/45.5.810; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Dutta R, 2011, THERIOGENOLOGY, V76, P851, DOI 10.1016/j.theriogenology.2011.03.025; Franklin Rosalind E, 2003, Nature, V421, P400; Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; LEHMAN CW, 1993, MOL CELL BIOL, V13, P6897, DOI 10.1128/MCB.13.11.6897; Leibo SP, 2011, FERTIL STERIL, V96, P269, DOI 10.1016/j.fertnstert.2011.06.065; Loi P, 2011, THERIOGENOLOGY, V76, P217, DOI 10.1016/j.theriogenology.2011.01.016; Loi P, 2002, BIOL REPROD, V67, P126, DOI 10.1095/biolreprod67.1.126; Loi P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002978; Menezo Y, 2007, J ASSIST REPROD GEN, V24, P513, DOI 10.1007/s10815-007-9167-0; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; Muriel L, 2004, MOL HUM REPROD, V10, P203, DOI 10.1093/molehr/gah029; Natan D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005240; Ono T, 2008, J REPROD DEVELOP, V54, P486, DOI 10.1262/jrd.20112; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Resch GP, 2002, J STRUCT BIOL, V137, P305, DOI 10.1016/S1047-8477(02)00005-9; REY L, 1975, PROC R SOC SER B-BIO, V191, P9, DOI 10.1098/rspb.1975.0110; Ryder OA, 2000, SCIENCE, V288, P275, DOI 10.1126/science.288.5464.275; Sakkas D, 2010, FERTIL STERIL, V93, P1027, DOI 10.1016/j.fertnstert.2009.10.046; SCHMID WD, 1982, SCIENCE, V215, P697, DOI 10.1126/science.7058335; SMALL JV, 1994, J STRUCT BIOL, V113, P135, DOI 10.1006/jsbi.1994.1043; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; T'Joen V, 2012, STEM CELLS DEV, V21, P721, DOI 10.1089/scd.2011.0192; The Practice Committee of the American Society for reproduction Medicine, 2008, FERTIL STERIL, V86, P35; Turinetto V, 2012, STEM CELLS, V30, P1414, DOI 10.1002/stem.1133; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Weinstein R, 1995, TRANSFUS CLIN BIOL, V2, P427, DOI 10.1016/S1246-7820(05)80067-9; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; Wessman P, 2011, J SCI FOOD AGR, V91, P2518, DOI 10.1002/jsfa.4343; Whelan DR, 2001, NUCLEIC ACIDS RES, V39, P5439; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80	42	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e51317	10.1371/journal.pone.0051317	http://dx.doi.org/10.1371/journal.pone.0051317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308098	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800007
J	Gelman, JS; Sironi, J; Berezniuk, I; Dasgupta, S; Castro, LM; Gozzo, FC; Ferro, ES; Fricker, LD				Gelman, Julia S.; Sironi, Juan; Berezniuk, Iryna; Dasgupta, Sayani; Castro, Leandro M.; Gozzo, Fabio C.; Ferro, Emer S.; Fricker, Lloyd D.			Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib	PLOS ONE			English	Article							THIMET OLIGOPEPTIDASE; PROTEIN INTERACTIONS; NATURAL REGULATORS; MASS-SPECTROMETRY; MULTIPLE-MYELOMA; CELLS; SPECIFICITY; DEGRADATION; IDENTIFICATION; SELECTIVITY	Bortezomib is an antitumor drug that competitively inhibits proteasome beta-1 and beta-5 subunits. While the impact of bortezomib on protein stability is known, the effect of this drug on intracellular peptides has not been previously explored. A quantitative peptidomics technique was used to examine the effect of treating human embryonic kidney 293T (HEK293T) cells with 5-500 nM bortezomib for various lengths of time (30 minutes to 16 hours), and human neuroblastoma SH-SY5Y cells with 500 nM bortezomib for 1 hour. Although bortezomib treatment decreased the levels of some intracellular peptides, the majority of peptides were increased by 50-500 nM bortezomib. Peptides requiring cleavage at acidic and hydrophobic sites, which involve beta-1 and -5 proteasome subunits, were among those elevated by bortezomib. In contrast, the proteasome inhibitor epoxomicin caused a decrease in the levels of many of these peptides. Although bortezomib can induce autophagy under certain conditions, the rapid bortezomib-mediated increase in peptide levels did not correlate with the induction of autophagy. Taken together, the present data indicate that bortezomib alters the balance of intracellular peptides, which may contribute to the biological effects of this drug.	[Gelman, Julia S.; Sironi, Juan; Berezniuk, Iryna; Dasgupta, Sayani; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Gelman, Julia S.; Berezniuk, Iryna; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Castro, Leandro M.; Ferro, Emer S.] Univ Sao Paulo, Dept Cell Biol & Dev, Sao Paulo, Brazil; [Gozzo, Fabio C.] Univ Estadual Campinas, Inst Chem, Sao Paulo, Brazil	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Universidade de Sao Paulo; Universidade Estadual de Campinas	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	Lloyd.fricker@einstein.yu.edu	Castro, Leandro M/E-5654-2014; Castro, Leandro/ABI-5520-2020; Gozzo, Fabio/F-8123-2010; Castro, Leandro/O-6762-2019; Ferro, Emer S/D-3908-2012	Castro, Leandro/0000-0002-7156-2006; Castro, Leandro/0000-0002-7156-2006; Ferro, Emer S/0000-0003-1651-9192; Dasgupta, Sayani/0000-0003-4782-7956	National Institutes of Health [R01 DA-004494]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [559698/2009-7]; University of Sao Paulo [2011.1.9333.1.3]; CNPq; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Sao Paulo; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was primarily supported by National Institutes of Health grant R01 DA-004494 (L. D. F.), and by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant 559698/2009-7, Rede GENOPROT) and partially supported by the University of Sao Paulo (grants 2011.1.9333.1.3, NAPNA). LMC, FCG and ESF are fellowship recipients from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2002, CURR OPIN CHEM BIOL, V6, P493, DOI 10.1016/S1367-5931(02)00343-5; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Berti DA, 2012, PROTEOMICS, V12, P2668, DOI 10.1002/pmic.201200051; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2005, J MASS SPECTROM, V40, P238, DOI 10.1002/jms.743; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; DENAULT JB, 2002, CURR PROTOC PROTEIN, pCH21; Ferro ES, 2004, J NEUROCHEM, V91, P769, DOI 10.1111/j.1471-4159.2004.02757.x; Fontanini A, 2009, J BIOL CHEM, V284, P8369, DOI 10.1074/jbc.M806113200; Fricker LD, 2006, MASS SPECTROM REV, V25, P327, DOI 10.1002/mas.20079; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Gass J, 2007, CELL MOL LIFE SCI, V64, P345, DOI 10.1007/s00018-006-6317-y; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grasso G, 2009, JMASS SPECTROM; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Gucinski AC, 2010, METHODS MOL BIOL, V604, P73, DOI 10.1007/978-1-60761-444-9_6; Harada M, 2008, HEPATOLOGY, V47, P2026, DOI 10.1002/hep.22294; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Lightcap ES, 2000, CLIN CHEM, V46, P673; Lioni M, 2008, MOL CANCER THER, V7, P2866, DOI 10.1158/1535-7163.MCT-08-0391; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Moore HE, 2009, MOL CANCER THER, V8, P762, DOI 10.1158/1535-7163.MCT-08-0735; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; ORLOWSKI M, 1989, BIOCHEM J, V261, P951, DOI 10.1042/bj2610951; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; Rubakhin SS, 2006, ANAL CHEM, V78, P7267, DOI 10.1021/ac0607010; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Russo LC, 2012, PROTEOMICS, V12, P2641, DOI 10.1002/pmic.201200032; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Schulz-Knappe P, 2001, COMB CHEM HIGH T SCR, V4, P207; Svensson M, 2003, J PROTEOME RES, V2, P213, DOI 10.1021/pr020010u; Terpos E, 2008, EXPERT OPIN DRUG MET, V4, P639, DOI [10.1517/17425255.4.5.639, 10.1517/17425255.4.5.639 ]; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Utecht KN, 2008, AM J HEALTH-SYST PH, V65, P1221, DOI 10.2146/ajhp070272; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	58	59	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53263	10.1371/journal.pone.0053263	http://dx.doi.org/10.1371/journal.pone.0053263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308178	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100047
J	Yeoh, CC; Balcerowicz, M; Zhang, LL; Jaudal, M; Brocard, L; Ratet, P; Putterill, J				Yeoh, Chin Chin; Balcerowicz, Martin; Zhang, Lulu; Jaudal, Mauren; Brocard, Lysiane; Ratet, Pascal; Putterill, Joanna			Fine Mapping Links the FTa1 Flowering Time Regulator to the Dominant Spring1 Locus in Medicago	PLOS ONE			English	Article							GENETIC-CONTROL; T HOMOLOG; ARABIDOPSIS; TRUNCATULA; PEA; GENOME; FLORIGEN; ROLES	To extend our understanding of flowering time control in eudicots, we screened for mutants in the model legume Medicago truncatula (Medicago). We identified an early flowering mutant, spring1, in a T-DNA mutant screen, but spring1 was not tagged and was deemed a somaclonal mutant. We backcrossed the mutant to wild type R108. The F1 plants and the majority of F2 plants were early flowering like spring1, strongly indicating that spring1 conferred monogenic, dominant early flowering. We hypothesized that the spring1 phenotype resulted from over expression of an activator of flowering. Previously, a major QTL for flowering time in different Medicago accessions was located to an interval on chromosome 7 with six candidate flowering-time activators, including a CONSTANS gene, MtCO, and three FLOWERING LOCUS T (FT) genes. Hence we embarked upon linkage mapping using 29 markers from the MtCO/FT region on chromosome 7 on two populations developed by crossing spring1 with Jester. Spring1 mapped to an interval of similar to 0.5 Mb on chromosome 7 that excluded MtCO, but contained 78 genes, including the three FT genes. Of these FT genes, only FTa1 was up-regulated in spring1 plants. We then investigated global gene expression in spring1 and R108 by microarray analysis. Overall, they had highly similar gene expression and apart from FTa1, no genes in the mapping interval were differentially expressed. Two MADS transcription factor genes, FRUITFULLb (FULb) and SUPPRESSOR OF OVER EXPRESSION OF CONSTANS1a (SOC1a), that were up-regulated in spring1, were also up-regulated in transgenic Medicago over-expressing FTa1. This suggested that their differential expression in spring1 resulted from the increased abundance of FTa1. A 6255 bp genomic FTa1 fragment, including the complete 5' region, was sequenced, but no changes were observed indicating that the spring1 mutation is not a DNA sequence difference in the FTa1 promoter or introns.	[Yeoh, Chin Chin; Balcerowicz, Martin; Zhang, Lulu; Jaudal, Mauren; Putterill, Joanna] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Brocard, Lysiane; Ratet, Pascal] CNRS, Inst Sci Vegetal, Gif Sur Yvette, France	University of Auckland; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Putterill, J (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	J.Putterill@auckland.ac.nz	Ratet, Pascal/GPP-3654-2022; Balcerowicz, Martin/AAF-9638-2020	Ratet, Pascal/0000-0002-8621-1495; Balcerowicz, Martin/0000-0001-9462-4436; Jaudal, Mauren/0000-0002-5760-2497; Brocard, Lysiane/0000-0002-9397-1660	New Zealand Foundation for Research Science and Technology [C10X0816 MeriNET, C10X0704]; New Zealand Marsden Fund [10-UOA-200]	New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	The research was funded by the New Zealand Foundation for Research Science and Technology (www.msi.govt.nz/) contract numbers C10X0816 MeriNET and C10X0704 and by the New Zealand Marsden Fund (www.royalsociety.org.nz/programmes/funds/marsden/) contract 10-UOA-200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Brocard L, 2006, CAB REV, P23; Chabaud M., 2008, HDB NEW TECHNOLOGIES, P45; Chabaud M., 2006, MEDICAGO TRUNCATULA; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Gibeaut DM, 1997, PLANT PHYSIOL, V115, P317, DOI 10.1104/pp.115.2.317; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Hecht V, 2007, PLANT PHYSIOL, V144, P648, DOI 10.1104/pp.107.096818; Hecht V, 2011, PLANT CELL, V23, P147, DOI 10.1105/tpc.110.081042; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hill J.R., 2000, PLANT VARIETIES J, V13, P40; Julier B, 2007, THEOR APPL GENET, V114, P1391, DOI 10.1007/s00122-007-0525-1; Espinoza LDL, 2012, THEOR APPL GENET, V124, P739, DOI 10.1007/s00122-011-1743-0; Laurie RE, 2011, PLANT PHYSIOL, V156, P2207, DOI 10.1104/pp.111.180182; Liew LC, 2009, PLANT CELL, V21, P3198, DOI 10.1105/tpc.109.067223; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; Ovchinnikova E, 2011, MOL PLANT MICROBE IN, V24, P1333, DOI 10.1094/MPMI-01-11-0013; Pierre JB, 2008, THEOR APPL GENET, V117, P609, DOI 10.1007/s00122-008-0805-4; Pierre JB, 2011, MOL BREEDING, V28, P25, DOI 10.1007/s11032-010-9457-6; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Rakocevic A, 2009, PLANT PHYSIOL, V151, P1250, DOI 10.1104/pp.109.138024; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Scholte M, 2002, MOL BREEDING, V10, P203, DOI 10.1023/A:1020564612093; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Simon R, 1996, SEMIN CELL DEV BIOL, V7, P419, DOI 10.1006/scdb.1996.0052; Smykal P, 2009, HEREDITY, V103, P157, DOI 10.1038/hdy.2009.45; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Tadege M, 2009, PLANT PHYSIOL, V151, P978, DOI 10.1104/pp.109.144097; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Trinh TH, 1998, PLANT CELL REP, V17, P345, DOI 10.1007/s002990050405; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turnbull C, 2011, J EXP BOT, V62, P4399, DOI 10.1093/jxb/err191; Weller JL, 2009, J EXP BOT, V60, P2493, DOI 10.1093/jxb/erp120; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yeoh CC, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-36; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	41	25	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53467	10.1371/journal.pone.0053467	http://dx.doi.org/10.1371/journal.pone.0053467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308229	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100072
J	Birky, CW				Birky, C. William, Jr.			Species Detection and Identification in Sexual Organisms Using Population Genetic Theory and DNA Sequences	PLOS ONE			English	Article							DELIMITATION; SELECTION; CORVUS	Phylogenetic trees of DNA sequences of a group of specimens may include clades of two kinds: those produced by stochastic processes (random genetic drift) within a species, and clades that represent different species. The ratio of the mean pairwise sequence difference between a pair of clades (K) to the mean pairwise sequence difference within a clade (theta) can be used to determine whether the clades are samples from different species (K/theta >= 4) or the same species (K/theta<4) with probability >= 0.95. Previously I applied this criterion to delimit species of asexual organisms. Here I use data from the literature to show how it can also be applied to delimit sexual species using four groups of sexual organisms as examples: ravens, spotted leopards, sea butterflies, and liverworts. Mitochondrial or chloroplast genes are used because these segregate earlier during speciation than most nuclear genes and hence detect earlier stages of speciation. In several cases the K/theta ratio was greater than 4, confirming the original authors' intuition that the clades were sufficiently different to be assigned to different species. But the K/theta ratio split each of two liverwort species into two evolutionary species, and showed that support for the distinction between the common and Chihuahuan raven species is weak. I also discuss some possible sources of error in using the K/theta ratio; the most significant one would be cases where males migrate between different populations but females do not, making the use of maternally inherited organelle genes problematic. The K/theta ratio must be used with some caution, like all other methods for species delimitation. Nevertheless, it is a simple theory-based quantitative method for using DNA sequences to make rigorous decisions about species delimitation in sexual as well as asexual eukaryotes.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Birky, CW (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	birky@u.arizona.edu						Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Avise John C., 1994, pi; Birky CW, 2008, CURR BIOL, V18, pR692, DOI 10.1016/j.cub.2008.06.049; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Birky CW, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P201, DOI 10.1007/978-90-481-2770-2_10; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; BIRKY CW, 1991, EVOLUTION AT THE MOLECULAR LEVEL, P112; Buckley-Beason VA, 2006, CURR BIOL, V16, P2371, DOI 10.1016/j.cub.2006.08.066; Carnargo A, 2012, EVOLUTION, V66-9, P2834; Cook LG, 2010, INVERTEBR SYST, V24, P322, DOI 10.1071/IS10011; Coyne J.A., 2004, SPECIATION; Darwin C., 1871, P423; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Feldman CR, 2005, ZOOL SCR, V34, P145, DOI 10.1111/j.1463-6409.2005.00182.x; Grassman LI, 2005, J MAMMAL, V86, P29, DOI 10.1644/1545-1542(2005)086&lt;0029:EOTSFI&gt;2.0.CO;2; Hausdorf B, 2010, SYST BIOL, V59, P491, DOI 10.1093/sysbio/syq039; Hedrick PW, 2007, EVOLUTION, V61, P2750, DOI 10.1111/j.1558-5646.2007.00250.x; HEINRICH B, 1994, CONDOR, V96, P545, DOI 10.2307/1369334; Heinrichs J, 2010, MOL PHYLOGENET EVOL, V56, P1105, DOI 10.1016/j.ympev.2010.05.004; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Hunt Brian, 2010, PLoS ONE, V5, P1, DOI 10.1371/journal.pone.0009835; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Maddison WP, 2001, MACCLADE 4 ANAL PHYL; Marrone F, 2010, HYDROBIOLOGIA, V644, P115, DOI 10.1007/s10750-010-0101-6; May RM, 2009, SCIENCE, V323, P687, DOI 10.1126/science.1170937; MYERS GS, 1952, SYST ZOOL, V1, P106, DOI 10.2307/2411812; Nei M., 2000, MOL EVOLUTION PHYLOG; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Omland KE, 2006, MOL ECOL, V15, P795, DOI 10.1111/j.1365-294X.2005.02827.x; Omland KE, 2000, P ROY SOC B-BIOL SCI, V267, P2475, DOI 10.1098/rspb.2000.1308; Osada N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025549; Pacak A, 2003, J MOL EVOL, V56, P11, DOI 10.1007/s00239-002-2375-4; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rodrigo A, 2008, PHILOS T R SOC B, V363, P3893, DOI 10.1098/rstb.2008.0173; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Schon I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039844; SIMPSON GEORGE GAYLORD, 1961; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109	45	53	54	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52544	10.1371/journal.pone.0052544	http://dx.doi.org/10.1371/journal.pone.0052544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308113	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100010
J	Friedrich, RM; Friederici, AD				Friedrich, Roland M.; Friederici, Angela D.			Mathematical Logic in the Human Brain: Semantics	PLOS ONE			English	Article							LATERAL PREFRONTAL CORTEX; COGNITIVE CONTROL; WORKING-MEMORY; PARIETAL CORTEX; ORGANIZATION; INFORMATION; REPRESENTATION; INTEGRATION; ACTIVATION; RETRIEVAL	As a higher cognitive function in humans, mathematics is supported by parietal and prefrontal brain regions. Here, we give an integrative account of the role of the different brain systems in processing the semantics of mathematical logic from the perspective of macroscopic polysynaptic networks. By comparing algebraic and arithmetic expressions of identical underlying structure, we show how the different subparts of a fronto-parietal network are modulated by the semantic domain, over which the mathematical formulae are interpreted. Within this network, the prefrontal cortex represents a system that hosts three major components, namely, control, arithmetic-logic, and short-term memory. This prefrontal system operates on data fed to it by two other systems: a premotor-parietal top-down system that updates and transforms (external) data into an internal format, and a hippocampal bottom-up system that either detects novel information or serves as an access device to memory for previously acquired knowledge.	[Friedrich, Roland M.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Friedrich, Roland M.; Friederici, Angela D.] Humboldt Univ, Inst Math, D-10099 Berlin, Germany	Max Planck Society; Humboldt University of Berlin	Friedrich, RM (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	rolandf@mathematik.hu-berlin.de	Nishihara, Greg/H-6808-2019; Manda, Atsuyoshi/AAH-1228-2021; Nishihara, Gregory N/GNM-5370-2022	Nishihara, Greg/0000-0003-2543-1301; Manda, Atsuyoshi/0000-0001-7065-7751; Nishihara, Gregory N/0000-0003-2543-1301	Max Planck Institute for Human Cognitive and Brain Sciences	Max Planck Institute for Human Cognitive and Brain Sciences	The work was funded by Max Planck Institute for Human Cognitive and Brain Sciences, www.cbs.mpg.de/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; Anderson JR, 2008, TRENDS COGN SCI, V12, P136, DOI 10.1016/j.tics.2008.01.006; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bledowski C, 2009, J NEUROSCI, V29, P13735, DOI 10.1523/JNEUROSCI.2547-09.2009; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Butterworth B, 2005, J CHILD PSYCHOL PSYC, V46, P3, DOI 10.1111/j.1469-7610.2004.00374.x; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cusack R, 2010, J COGNITIVE NEUROSCI, V22, P32, DOI 10.1162/jocn.2009.21194; De Pisapia N, 2007, CEREB CORTEX, V17, P993, DOI 10.1093/cercor/bhl010; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Desrochers TM, 2012, TRENDS COGN SCI, V16, P407, DOI 10.1016/j.tics.2012.06.009; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friedrich R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005599; Goel V, 2007, TRENDS COGN SCI, V11, P435, DOI 10.1016/j.tics.2007.09.003; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; Hanakawa T, 2002, CEREB CORTEX, V12, P1157, DOI 10.1093/cercor/12.11.1157; Jubault T, 2007, J NEUROSCI, V27, P11028, DOI 10.1523/JNEUROSCI.1986-07.2007; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Makuuchi M, 2009, P NATL ACAD SCI USA, V106, P8362, DOI 10.1073/pnas.0810928106; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Mestres-Misse A, 2012, NEUROIMAGE, V62, P41, DOI 10.1016/j.neuroimage.2012.05.021; Montojo CA, 2008, NEURON, V59, P173, DOI 10.1016/j.neuron.2008.05.012; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Verstynen TD, 2012, J NEUROPHYSIOL, V107, P2984, DOI 10.1152/jn.00995.2011; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wendelken C, 2008, NEUROPSYCHOLOGIA, V46, P665, DOI 10.1016/j.neuropsychologia.2007.09.015; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	50	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53699	10.1371/journal.pone.0053699	http://dx.doi.org/10.1371/journal.pone.0053699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070BE	23301101	Green Published, Green Submitted, gold			2022-12-27	WOS:000313480000076
J	Perez-Bercoff, A; Hudson, CM; Conant, GC				Perez-Bercoff, Asa; Hudson, Corey M.; Conant, Gavin C.			A Conserved Mammalian Protein Interaction Network	PLOS ONE			English	Article							EVOLUTIONARY RATE; INTERACTION PARTNERS; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; GENOME DUPLICATION; SIMPLE DEPENDENCE; YEAST; COEVOLUTION; GENE; CONSTRAINT	Physical interactions between proteins mediate a variety of biological functions, including signal transduction, physical structuring of the cell and regulation. While extensive catalogs of such interactions are known from model organisms, their evolutionary histories are difficult to study given the lack of interaction data from phylogenetic outgroups. Using phylogenomic approaches, we infer a upper bound on the time of origin for a large set of human protein-protein interactions, showing that most such interactions appear relatively ancient, dating no later than the radiation of placental mammals. By analyzing paired alignments of orthologous and putatively interacting protein-coding genes from eight mammals, we find evidence for weak but significant co-evolution, as measured by relative selective constraint, between pairs of genes with interacting proteins. However, we find no strong evidence for shared instances of directional selection within an interacting pair. Finally, we use a network approach to show that the distribution of selective constraint across the protein interaction network is non-random, with a clear tendency for interacting proteins to share similar selective constraints. Collectively, the results suggest that, on the whole, protein interactions in mammals are under selective constraint, presumably due to their functional roles.	[Perez-Bercoff, Asa] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland; [Hudson, Corey M.; Conant, Gavin C.] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Conant, Gavin C.] Univ Missouri, Div Anim Sci, Columbia, MO USA	Trinity College Dublin; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Conant, GC (corresponding author), Univ Missouri, Inst Informat, Columbia, MO 65211 USA.	conantg@missouri.edu	Hudson, Corey M./I-1283-2019; Conant, Gavin/R-7022-2019	Hudson, Corey M./0000-0003-4796-538X; Conant, Gavin/0000-0002-8677-4933	Galostiftelsen Stipendium for hogre utlandsstudier; National Library of Medicine Biomedical and Health Informatics Training Fellowship [LM007089-19]; Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri; NATIONAL LIBRARY OF MEDICINE [T15LM007089] Funding Source: NIH RePORTER	Galostiftelsen Stipendium for hogre utlandsstudier; National Library of Medicine Biomedical and Health Informatics Training Fellowship; Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	A.P.B. is supported by Galostiftelsen Stipendium for hogre utlandsstudier. C.M.H. is supported by a National Library of Medicine Biomedical and Health Informatics Training Fellowship [LM007089-19]. G.C.C. is supported by the Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Bloom JD, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-21; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Bustamante CD, 2000, MOL BIOL EVOL, V17, P301, DOI 10.1093/oxfordjournals.molbev.a026310; Campos PRA, 2004, J THEOR BIOL, V231, P197, DOI 10.1016/j.jtbi.2004.06.014; Choi SS, 2006, MOL BIOL EVOL, V23, P2131, DOI 10.1093/molbev/msl086; Clark NL, 2010, MOL BIOL EVOL, V27, P1152, DOI 10.1093/molbev/msp324; Conant GC, 2009, TRENDS GENET, V25, P377, DOI 10.1016/j.tig.2009.07.004; Conant GC, 2006, PLOS BIOL, V4, P545, DOI 10.1371/journal.pbio.0040109; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fares MA, 2006, BIOINFORMATICS, V22, P2821, DOI 10.1093/bioinformatics/btl493; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Hahn MW, 2004, J MOL EVOL, V58, P203, DOI 10.1007/s00239-003-2544-0; Hakes L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r209; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Hudson CM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-89; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Juan D, 2008, FEBS LETT, V582, P1225, DOI 10.1016/j.febslet.2008.02.017; Julenius K, 2006, MOL BIOL EVOL, V23, P2039, DOI 10.1093/molbev/msl081; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kunin V, 2004, MOL BIOL EVOL, V21, P1171, DOI 10.1093/molbev/msh085; Li L, 2006, MOL BIOL EVOL, V23, P2467, DOI 10.1093/molbev/msl121; Liang Z, 2010, FEBS LETT, V584, P4237, DOI 10.1016/j.febslet.2010.09.014; Liao BY, 2010, GENOME BIOL EVOL, V2, P39, DOI 10.1093/gbe/evp058; Lin YS, 2007, MOL BIOL EVOL, V24, P1005, DOI 10.1093/molbev/msm019; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pal C, 2001, GENETICS, V158, P927; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perez-Bercoff A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-160; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Qian WF, 2011, P NATL ACAD SCI USA, V108, P8725, DOI 10.1073/pnas.1104695108; Rambaut A., 2006, TREE FIGURE DRAWING; Saeed R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-128; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Travers SAA, 2007, MOL BIOL EVOL, V24, P2787, DOI 10.1093/molbev/msm213; Vinogradov AE, 2010, P ROY SOC B-BIOL SCI, V277, P1403, DOI 10.1098/rspb.2009.1865; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	59	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52581	10.1371/journal.pone.0052581	http://dx.doi.org/10.1371/journal.pone.0052581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23320073	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900032
J	Amieva, H; Meillon, C; Helmer, C; Barberger-Gateau, P; Dartigues, JF				Amieva, Helene; Meillon, Celine; Helmer, Catherine; Barberger-Gateau, Pascale; Dartigues, Jean Francois			Ginkgo Biloba Extract and Long-Term Cognitive Decline: A 20-Year Follow-Up Population-Based Study	PLOS ONE			English	Article							PRECLINICAL ALZHEIMERS-DISEASE; PLACEBO-CONTROLLED TRIAL; EGB 761(R); BENZODIAZEPINE USE; RANDOMIZED-TRIAL; VITAMIN-E; DEMENTIA; PREVENTION; SUPPLEMENTATION; IMPAIRMENT	Background: Numerous studies have looked at the potential benefits of various nootropic drugs such as Ginkgo biloba extract (EGb761 (R); Tanakan (R)) and piracetam (Nootropyl (R)) on age-related cognitive decline often leading to inconclusive results due to small sample sizes or insufficient follow-up duration. The present study assesses the association between intake of EGb761 (R) and cognitive function of elderly adults over a 20-year period. Methods and Findings: The data were gathered from the prospective community-based cohort study 'Paquid'. Within the study sample of 3612 non-demented participants aged 65 and over at baseline, three groups were compared: 589 subjects reporting use of EGb761 (R) at at least one of the ten assessment visits, 149 subjects reporting use of piracetam at one of the assessment visits and 2874 subjects not reporting use of either EGb761 (R) or piracetam. Decline on MMSE, verbal fluency and visual memory over the 20-year follow-up was analysed with a multivariate mixed linear effects model. A significant difference in MMSE decline over the 20-year follow-up was observed in the EGb761 (R) and piracetam treatment groups compared to the 'neither treatment' group. These effects were in opposite directions: the EGb761 (R) group declined less rapidly than the 'neither treatment' group, whereas the piracetam group declined more rapidly (beta = -0.6). Regarding verbal fluency and visual memory, no difference was observed between the EGb761 (R) group and the 'neither treatment' group (respectively, beta = 0.21 and beta = -0.03), whereas the piracetam group declined more rapidly (respectively, beta = -1.40 and beta = -0.44). When comparing the EGb761 (R) and piracetam groups directly, a different decline was observed for the three tests (respectively beta = -1.07, beta = -1.61 and beta = -0.41). Conclusion: Cognitive decline in a non-demented elderly population was lower in subjects who reported using EGb761 (R) than in those who did not. This effect may be a specific medication effect of EGb761 (R), since it was not observed for another nootropic medication, piracetam.	[Amieva, Helene; Meillon, Celine; Helmer, Catherine; Barberger-Gateau, Pascale; Dartigues, Jean Francois] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Amieva, Helene] Univ Bordeaux, Dept Psychol, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Amieva, H (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.	helene.amieva@isped.u-bordeaux2.fr	DARTIGUES, Jean François/T-4513-2019; HELMER, Catherine/AAG-5126-2021; HELMER, Catherine/I-6581-2015; Amieva, Helene/T-4170-2019; Meillon, Céline/T-4487-2019; Amieva, Helene/E-4850-2014	HELMER, Catherine/0000-0002-5169-7421; Amieva, Helene/0000-0002-0119-7242; 	ARMA (Bordeaux); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS); Conseil General de la Dordogne; Conseil General de la Gironde; Conseil Regional d'Aquitaine; Fondation de France; France Alzheimer (Paris); GIS Longevite; Institut National de la Sante et de la Recherche Medicale (INSERM); Mutuelle Generale de l'Education Nationale (MGEN); Mutualite Sociale Agricole (MSA); NOVARTIS Pharma (France); SCOR Insurance (France)	ARMA (Bordeaux); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS); Conseil General de la Dordogne(Region Nouvelle-Aquitaine); Conseil General de la Gironde(Region Nouvelle-Aquitaine); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Fondation de France(Fondation de France); France Alzheimer (Paris); GIS Longevite; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Mutuelle Generale de l'Education Nationale (MGEN); Mutualite Sociale Agricole (MSA); NOVARTIS Pharma (France); SCOR Insurance (France)	Funding: The PAQUID study was supported by ARMA (Bordeaux); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS); Conseil General de la Dordogne; Conseil General de la Gironde; Conseil Regional d'Aquitaine; Fondation de France; France Alzheimer (Paris); GIS Longevite; Institut National de la Sante et de la Recherche Medicale (INSERM); Mutuelle Generale de l'Education Nationale (MGEN); Mutualite Sociale Agricole (MSA); NOVARTIS Pharma (France); SCOR Insurance (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Kader R, 2007, PHARMACOL RES, V56, P493, DOI 10.1016/j.phrs.2007.09.011; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Andrieu S, 2003, J GERONTOL A-BIOL, V58, P372; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Benton A, 1965, MANUEL APPL TEST RET; Bierman EJM, 2007, INT J GERIATR PSYCH, V22, P1194, DOI 10.1002/gps.1811; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Chen PJ, 2001, ARCH GEN PSYCHIAT, V58, P853, DOI 10.1001/archpsyc.58.9.853; Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b; Dartigues JF, 2007, J AM GERIATR SOC, V55, P395, DOI 10.1111/j.1532-5415.2007.01084.x; Dartigues JF, 1997, THERAPIE, V52, P503; DARTIGUES JF, 1992, NEUROEPIDEMIOLOGY, V11, P14, DOI 10.1159/000110955; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Dodge HH, 2008, NEUROLOGY, V70, P1809, DOI 10.1212/01.wnl.0000303814.13509.db; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko DR, 2012, ARCH NEUROL; Grodstein F, 2007, ARCH INTERN MED, V167, P2184, DOI 10.1001/archinte.167.20.2184; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Herrschaft H, 2012, J PSYCHIATR RES, V46, P716, DOI 10.1016/j.jpsychires.2012.03.003; Howieson DB, 2008, J INT NEUROPSYCH SOC, V14, P192, DOI 10.1017/S1355617708080375; Ihl R, 2010, J NEUROL SCI, V299, P184, DOI 10.1016/j.jns.2010.08.033; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; Janssen IM, 2010, WIEN MED WOCHENSCHR, V160, P539, DOI 10.1007/s10354-010-0844-8; Jia X, 2008, J HUM NUTR DIET, V21, P317, DOI 10.1111/j.1365-277X.2008.00887.x; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Kehr J, 2012, INT PSYCHOGERIATR, V24, pS25, DOI 10.1017/S1041610212000567; Kesse-Guyot E, 2011, AM J CLIN NUTR, V94, P892, DOI 10.3945/ajcn.110.007815; KOLTRINGER P, 1995, CLIN HEMORHEOL, V15, P649; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Leoutsakos JMS, 2012, INT J GERIATR PSYCH, V27, P364, DOI 10.1002/gps.2723; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meinert CL, 2008, ALZHEIMERS DEMENT, V4, pS7, DOI 10.1016/j.jalz.2007.10.007; Paterniti S, 2002, J CLIN PSYCHOPHARM, V22, P285, DOI 10.1097/00004714-200206000-00009; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Rosler M, 1998, J NEURAL TRANSM-SUPP, P211; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Schneider Lon S., 2005, Current Alzheimer Research, V2, P541, DOI 10.2174/156720505774932287; Schneider LS, 2012, LANCET NEUROL, V11, P836, DOI 10.1016/S1474-4422(12)70212-0; Small BJ, 2007, CORTEX, V43, P826, DOI 10.1016/S0010-9452(08)70682-8; Tchantchou F, 2007, FASEB J, V21, P2400, DOI 10.1096/fj.06-7649com; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; van Vliet P, 2009, EXP GERONTOL, V44, P112, DOI 10.1016/j.exger.2008.05.004; Vellas B, 2012, LANCET NEUROL, V11, P851, DOI 10.1016/S1474-4422(12)70206-5; Weinmann S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-14; Williams B, 2004, NEUROBIOL AGING, V25, P955, DOI 10.1016/j.neurobiolaging.2003.10.008; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Yaffe K, 2004, NEUROLOGY, V63, P1705, DOI 10.1212/01.WNL.0000142969.19465.8F; Yoshitake T, 2010, BRIT J PHARMACOL, V159, P659, DOI 10.1111/j.1476-5381.2009.00580.x; Zandi PP, 2005, ARCH GEN PSYCHIAT, V62, P217, DOI 10.1001/archpsyc.62.2.217	55	48	59	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52755	10.1371/journal.pone.0052755	http://dx.doi.org/10.1371/journal.pone.0052755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326356	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800024
J	Migheli, F; Stoccoro, A; Coppede, F; Omar, WAW; Failli, A; Consolini, R; Seccia, M; Spisni, R; Miccoli, P; Mathers, JC; Migliore, L				Migheli, Francesca; Stoccoro, Andrea; Coppede, Fabio; Omar, Wan Adnan Wan; Failli, Alessandra; Consolini, Rita; Seccia, Massimo; Spisni, Roberto; Miccoli, Paolo; Mathers, John C.; Migliore, Lucia			Comparison Study of MS-HRM and Pyrosequencing Techniques for Quantification of APC and CDKN2A Gene Methylation	PLOS ONE			English	Article							COLORECTAL-CANCER; DNA; EPIGENETICS	There is increasing interest in the development of cost-effective techniques for the quantification of DNA methylation biomarkers. We analyzed 90 samples of surgically resected colorectal cancer tissues for APC and CDKN2A promoter methylation using methylation sensitive-high resolution melting (MS-HRM) and pyrosequencing. MS-HRM is a less expensive technique compared with pyrosequencing but is usually more limited because it gives a range of methylation estimates rather than a single value. Here, we developed a method for deriving single estimates, rather than a range, of methylation using MS-HRM and compared the values obtained in this way with those obtained using the gold standard quantitative method of pyrosequencing. We derived an interpolation curve using standards of known methylated/unmethylated ratio (0%, 12.5%, 25%, 50%, 75%, and 100% of methylation) to obtain the best estimate of the extent of methylation for each of our samples. We observed similar profiles of methylation and a high correlation coefficient between the two techniques. Overall, our new approach allows MS-HRM to be used as a quantitative assay which provides results which are comparable with those obtained by pyrosequencing.	[Migheli, Francesca; Stoccoro, Andrea; Migliore, Lucia] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Div Med Genet, Pisa, Italy; [Coppede, Fabio; Migliore, Lucia] Pisa Univ Hosp AOUP, Dept Lab Med, Pisa, Italy; [Omar, Wan Adnan Wan] Univ Sains Malaysia, Adv Med & Dent Inst, George Town, Malaysia; [Failli, Alessandra; Consolini, Rita] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Seccia, Massimo; Spisni, Roberto; Miccoli, Paolo] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy; [Omar, Wan Adnan Wan; Mathers, John C.] Newcastle Univ, Human Nutr Res Ctr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Migheli, Francesca; Coppede, Fabio; Migliore, Lucia] Ist Toscano Tumori, Florence, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Universiti Sains Malaysia; University of Pisa; University of Pisa; Newcastle University - UK; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Migliore, L (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Div Med Genet, Pisa, Italy.	l.migliore@geog.unipi.it	Stoccoro, Andrea/L-1644-2019; Coppedè, Fabio/X-6085-2019	Stoccoro, Andrea/0000-0002-6768-8466; Coppede, Fabio/0000-0002-3081-6647; Mathers, John/0000-0003-3406-3002	Istituto Toscano Tumori (ITT) [Prot.AOOGRT/325424/Q.80.110 16/12/2009]; Food Standards Agency UK [N12009]; Medical Research Council [G0700718B] Funding Source: researchfish	Istituto Toscano Tumori (ITT); Food Standards Agency UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: The study was funded by Istituto Toscano Tumori (ITT)(http://www.ittumori.it/IttSanitaSrty/jsp/start.jsp)(Prot.AOOGRT/325424/Q.80.110 16/12/2009) "Correlation among epigenetic, environmental and genetic factors in colorectal carcinoma" with additional funding for sample collection and archiving by the Food Standards Agency UK (Project No. N12009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belshaw NJ, 2004, CANCER EPIDEM BIOMAR, V13, P1495; Candiloro ILM, 2011, EPIGENETICS-US, V6, P501, DOI 10.4161/epi.6.4.14853; Chen WD, 2005, JNCI-J NATL CANCER I, V97, P1124, DOI 10.1093/jnci/dji204; Crea F, 2011, DRUG RESIST UPDATE, V14, P280, DOI 10.1016/j.drup.2011.08.001; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Huang KT, 2010, BREAST CANCER RES TR, V124, P555, DOI 10.1007/s10549-010-0970-4; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Liu M, 2010, J GENET GENOMICS, V37, P347, DOI 10.1016/S1673-8527(09)60053-9; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Migliore L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/792362; Newman MR, 2012, EPIGENETICS-US, V7, P92, DOI 10.4161/epi.7.1.18815; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Quillien V, 2012, CANCER IN PRESS; Schnekenburger M, 2012, CURR COLORECT CANC R, V8, P66, DOI 10.1007/s11888-011-0116-z; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Wang Z, 2011, PATHOL ONCO IN PRESS; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Wojdacz TK, 2009, EPIGENETICS-US, V4, P231, DOI 10.4161/epi.9020	21	73	75	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52501	10.1371/journal.pone.0052501	http://dx.doi.org/10.1371/journal.pone.0052501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326336	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800020
J	Strambi, A; Mori, M; Rossi, M; Colecchia, D; Manetti, F; Carlomagno, F; Botta, M; Chiariello, M				Strambi, Angela; Mori, Mattia; Rossi, Matteo; Colecchia, David; Manetti, Fabrizio; Carlomagno, Francesca; Botta, Maurizio; Chiariello, Mario			Structure Prediction and Validation of the ERK8 Kinase Domain	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; MOLECULAR-DYNAMICS; MAP KINASE; INHIBITORS; ATP; RECEPTOR; DOCKING; PHOSPHORYLATION; SENSITIVITY; REVEALS	Extracellular signal-regulated kinase 8 (ERK8) has been already implicated in cell transformation and in the protection of genomic integrity and, therefore, proposed as a novel potential therapeutic target for cancer. In the absence of a crystal structure, we developed a three-dimensional model for its kinase domain. To validate our model we applied a structure-based virtual screening protocol consisting of pharmacophore screening and molecular docking. Experimental characterization of the hit compounds confirmed that a high percentage of the identified scaffolds was able to inhibit ERK8. We also confirmed an ATP competitive mechanism of action for the two best-performing molecules. Ultimately, we identified an ERK8 drug-resistant "gatekeeper" mutant that corroborated the predicted molecular binding mode, confirming the reliability of the generated structure. We expect that our model will be a valuable tool for the development of specific ERK8 kinase inhibitors.	[Strambi, Angela; Rossi, Matteo; Colecchia, David; Chiariello, Mario] AOU Senese, Signal Transduct Unit, Ist Toscano Tumori Core Res Lab, Siena, Italy; [Strambi, Angela; Chiariello, Mario] CNR, Ist Fisiol Clin, Siena, Italy; [Mori, Mattia; Manetti, Fabrizio; Botta, Maurizio] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy; [Rossi, Matteo; Colecchia, David] Univ Siena, I-53100 Siena, Italy; [Carlomagno, Francesca] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Siena; University Hospital of Siena; Consiglio Nazionale delle Ricerche (CNR); University of Siena; University of Siena; University of Naples Federico II	Chiariello, M (corresponding author), AOU Senese, Signal Transduct Unit, Ist Toscano Tumori Core Res Lab, Siena, Italy.	mario.chiariello@ittumori.it	Manetti, Fabrizio/Q-9412-2019; Chiariello, Mario/O-3642-2014; Colecchia, David/J-8361-2016; Colecchia, David/AAS-8110-2021	Manetti, Fabrizio/0000-0002-9598-2339; Chiariello, Mario/0000-0001-8434-5177; Colecchia, David/0000-0002-0364-8924; Mori, Mattia/0000-0003-2398-1254	Regione Toscana; Ministero della Salute; ASINEX	Regione Toscana(Regione Toscana); Ministero della Salute(Ministry of Health, Italy); ASINEX	Funding: This work was supported by a Start-up grant from Regione Toscana and by a grant to Regione Toscana from Ministero della Salute, in the context of the "Programma per la Ricerca Sanitaria 2008: Bando Cellule Staminali". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Federica Sasdelli for critical reading of this manuscript; Mark Abe for ERK8 kinase-dead plasmid; ASINEX for support.	Abe MK, 2002, J BIOL CHEM, V277, P16733, DOI 10.1074/jbc.M112483200; Alaimo PJ, 2005, BIOORGAN MED CHEM, V13, P2825, DOI 10.1016/j.bmc.2005.02.021; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Baxter CA, 1998, PROTEINS, V33, P367, DOI 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.3.CO;2-N; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Caballero J, 2012, CURR PHARM DESIGN, V18, P2946, DOI 10.2174/138161212800672705; Case D. A., 2010, AMBER 10; Cerone MA, 2011, CANCER RES, V71, P3328, DOI 10.1158/0008-5472.CAN-10-2734; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Cohen P, 2010, BIOCHEM J, V425, P53, DOI 10.1042/BJ20091428; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; DAVIS PD, 1989, FEBS LETT, V259, P61, DOI 10.1016/0014-5793(89)81494-2; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Elphick LM, 2007, ACS CHEM BIOL, V2, P299, DOI 10.1021/cb700027u; Elphick LM, 2009, CHEMBIOCHEM, V10, P1519, DOI 10.1002/cbic.200900052; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Groehler AL, 2010, J CELL BIOL, V190, P575, DOI 10.1083/jcb.201002124; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Jarvis DL, 2009, METHOD ENZYMOL, V463, P191, DOI 10.1016/S0076-6879(09)63014-7; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Klevernic IV, 2006, BIOCHEM J, V394, P365, DOI 10.1042/BJ20051288; Klevernic IV, 2009, FEBS LETT, V583, P680, DOI 10.1016/j.febslet.2009.01.011; Kraybill BC, 2002, J AM CHEM SOC, V124, P12118, DOI 10.1021/ja0264798; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Marco E, 2007, CHEMMEDCHEM, V2, P1388, DOI 10.1002/cmdc.200700087; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Mori M, 2012, VIRUS RES, V169, P377, DOI 10.1016/j.virusres.2012.05.011; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ortuso F, 2006, BIOINFORMATICS, V22, P1449, DOI 10.1093/bioinformatics/btl115; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Rossi M, 2011, J BIOL CHEM, V286, P8507, DOI 10.1074/jbc.M110.179523; Saelzler MP, 2006, J BIOL CHEM, V281, P16821, DOI 10.1074/jbc.M512418200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; SchulzeGahmen U, 1996, J MED CHEM, V39, P4540, DOI 10.1021/jm960402a; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsigelny I, 1999, BIOPOLYMERS, V50, P513, DOI 10.1002/(SICI)1097-0282(19991015)50:5<513::AID-BIP5>3.0.CO;2-I; Tuccinardi T, 2007, J CHEM INF MODEL, V47, P644, DOI 10.1021/ci6004383; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306; Yong HY, 2009, EXPERT OPIN INV DRUG, V18, P1893, DOI 10.1517/13543780903321490; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0	55	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52011	10.1371/journal.pone.0052011	http://dx.doi.org/10.1371/journal.pone.0052011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326322	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800012
J	Yap, L; Butler, T; Richters, J; Malacova, E; Wand, H; Smith, AMA; Grant, L; Richards, A; Donovan, B				Yap, Lorraine; Butler, Tony; Richters, Juliet; Malacova, Eva; Wand, Handan; Smith, Anthony M. A.; Grant, Luke; Richards, Alun; Donovan, Basil			Penile Implants among Prisoners-A Cause for Concern?	PLOS ONE			English	Article							ARTIFICIAL-NODULES; SEX; HIV; MEN; HEALTH; SKIN	Background: We report the prevalence of penile implants among prisoners and determine the independent predictors for having penile implants. Questions on penile implants were included in the Sexual Health and Attitudes of Australian Prisoners (SHAAP) survey following concerns raised by prison health staff that increasing numbers of prisoners reported having penile implants while in prison. Methods: Computer-Assisted Telephone Interviewing (CATI) of a random sample of prisoners was carried out in 41 prisons in New South Wales and Queensland (Australia). Men were asked, "Have you ever inserted or implanted an object under the skin of your penis?'' If they responded Yes: "Have you ever done so while you were in prison?'' Univariate logistic regression and logistic regression were used to determine the factors associated with penile implants. Results: A total of 2,018 male prisoners were surveyed, aged between 18 and 65 years, and 118 (5.8%) reported that they had inserted or implanted an object under the skin of their penis. Of these men, 87 (73%) had this done while they were in prison. In the multivariate analysis, a younger age, birth in an Asian country, and prior incarceration were all significantly associated with penile implants (p<0.001). Men with penile implants were also more likely to report being paid for sex (p<0.001), to have had body piercings (p<0.001) or tattoos in prison (p<0.001), and to have taken non-prescription drugs while in prison (p< 0.05). Conclusions: Penile implants appear to be fairly common among prisoners and are associated with risky sexual and drug use practices. As most of these penile implants are inserted in prison, these men are at risk of blood borne viruses and wound infection. Harm reduction and infection control strategies need to be developed to address this potential risk.	[Yap, Lorraine; Butler, Tony; Wand, Handan; Donovan, Basil] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Richters, Juliet] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Malacova, Eva] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Smith, Anthony M. A.] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Bundoora, Vic, Australia; [Grant, Luke] New S Wales Dept Correct Serv, Offender Serv & Programs, Sydney, NSW, Australia; [Richards, Alun] Queensland Hlth, Chief Hlth Officer Branch, Communicable Dis Unit, Brisbane, Qld, Australia; [Donovan, Basil] Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of Western Australia; La Trobe University; Queensland Health	Yap, L (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	l.yap@unsw.edu.au	Donovan, Basil J/K-1246-2012; Richters, Juliet/AAD-2402-2019	Donovan, Basil J/0000-0001-8851-4126; Butler, Tony/0000-0002-2679-2769; Richters, Juliet/0000-0003-0469-5762	National Health and Medical Research Council Project Grant [350860]; New South Wales Department of Health; New South Wales Justice Health; New South Wales Department of Corrective Services; Queensland Corrective Services; Faculty of Medicine, University of New South Wales; National Health and Medical Research Council Practitioner Fellowship [568613]; Australian Research Council Future Fellowship [FT0991864]	National Health and Medical Research Council Project Grant(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Department of Health; New South Wales Justice Health; New South Wales Department of Corrective Services; Queensland Corrective Services; Faculty of Medicine, University of New South Wales; National Health and Medical Research Council Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	The Sexual Health and Attitudes of Australian Prisoners Project (SHAAP) was funded by the National Health and Medical Research Council Project Grant No. 350860. Additional funding was provided by the New South Wales Department of Health, New South Wales Justice Health, New South Wales Department of Corrective Services, Queensland Corrective Services and the Faculty of Medicine, University of New South Wales. Basil Donovan is supported by the National Health and Medical Research Council Practitioner Fellowship (No. 568613). Tony Butler is supported by an Australian Research Council Future Fellowship (No. FT0991864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MG, 2003, J SEX RES, V40, P27, DOI 10.1080/00224490309552164; Beyrer C, 2005, AIDS, V19, P1535, DOI 10.1097/01.aids.0000183122.01583.c7; Brown D, 1988, PENIS INSERTS SE ASI; Butler T., 2010, SEXUAL HLTH BEHAV QU; Butler T, 2012, SEXUAL HLTH IN PRESS; Butler T., 2008, NATL PRISON ENTRANTS; Catania JA, 1996, PUBLIC OPIN QUART, V60, P345, DOI 10.1086/297758; Djajakusumah TS, 2000, SEX TRANSM DIS, V27, P152, DOI 10.1097/00007435-200003000-00006; Fischer N, 2010, J SEX MED, V7, P3565, DOI 10.1111/j.1743-6109.2009.01659.x; Fisher TD, 2007, ARCH SEX BEHAV, V36, P89, DOI 10.1007/s10508-006-9094-7; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Hudak SJ, 2012, J SEX MED, V9, P632, DOI 10.1111/j.1743-6109.2011.02551.x; Hull TH, 2001, REPROD HEALTH MATTER, V9, P60, DOI 10.1016/S0968-8080(01)90091-6; Kelly A, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-10; Lee R, 2001, THIGHS PENILE UNPUB; LIM KB, 1986, GENITOURIN MED, V62, P123; Loue Sana, 2002, J Immigr Health, V4, P117, DOI 10.1023/A:1014506811197; MARZOUK E, 1990, SCAND J UROL NEPHROL, V24, P167, DOI 10.3109/00365599009180852; NITIDANDHAPRABHAS P, 1975, BRIT J UROL, V47, P463, DOI 10.1111/j.1464-410X.1975.tb04009.x; NORTON SA, 1993, CUTIS, V51, P295; Primus Lake M, 2004, 15 INT AIDS C BANGK; Richters J., 2008, SEXUAL HLTH BEHAV NE; Rothschild MA, 1997, INT J LEGAL MED, V110, P88, DOI 10.1007/s004140050037; Rutty G, 2001, ESSENTIALS AUTOPSY P; SEROUR F, 1993, SEX TRANSM DIS, V20, P192, DOI 10.1097/00007435-199307000-00002; Setiawan IM, 2008, THESIS U ILLINOIS CH; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P106, DOI 10.1111/j.1467-842X.2003.tb00797.x; *SPSS INC, 2006, SPSS VERS 15; Thomson N, 2008, SEX TRANSM INFECT, V84, P195, DOI 10.1136/sti.2007.028530; THORBURN KM, 1982, AM J FOREN MED PATH, V3, P287, DOI 10.1097/00000433-198209000-00021; Tsunenari S, 1984, Ann Acad Med Singap, V13, P25; TSUNENARI S, 1981, AM J FOREN MED PATH, V2, P203, DOI 10.1097/00000433-198109000-00003; Wardi N, 2011, THESIS I SOCIAL STUD; Ware J., 1998, SF 12 SCORE SF 12 PH; Weeks MF, 1992, J OFF STAT, V8, P445; Wilcher G, 2006, MED SCI LAW, V46, P349, DOI 10.1258/rsmmsl.46.4.349; WOLF P, 1991, GENITOURIN MED, V67, P247	37	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53065	10.1371/journal.pone.0053065	http://dx.doi.org/10.1371/journal.pone.0053065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326383	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800029
J	Chenevert, J; Pruliere, G; Ishii, H; Sardet, C; Nishikata, T				Chenevert, Janet; Pruliere, Gerard; Ishii, Hirokazu; Sardet, Christian; Nishikata, Takahito			Purification of Mitochondrial Proteins HSP60 and ATP Synthase from Ascidian Eggs: Implications for Antibody Specificity	PLOS ONE			English	Article							CHORDATE CIONA-INTESTINALIS; CENTROSOME-ATTRACTING BODY; MATERNAL MESSENGER-RNAS; HALOCYNTHIA-RORETZI; CORTICAL REORGANIZATIONS; MONOCLONAL-ANTIBODIES; EMBRYONIC-DEVELOPMENT; POSTPLASMIC/PEM RNAS; CYTOSKELETAL DOMAIN; MUSCLE DEVELOPMENT	Use of antibodies is a cornerstone of biological studies and it is important to identify the recognized protein with certainty. Generally an antibody is considered specific if it labels a single band of the expected size in the tissue of interest, or has a strong affinity for the antigen produced in a heterologous system. The identity of the antibody target protein is rarely confirmed by purification and sequencing, however in many cases this may be necessary. In this study we sought to characterize the myoplasm, a mitochondria-rich domain present in eggs and segregated into tadpole muscle cells of ascidians (urochordates). The targeted proteins of two antibodies that label the myoplasm were purified using both classic immunoaffinity methods and a novel protein purification scheme based on sequential ion exchange chromatography followed by two-dimensional gel electrophoresis. Surprisingly, mass spectrometry sequencing revealed that in both cases the proteins recognized are unrelated to the original antigens. NN18, a monoclonal antibody which was raised against porcine spinal cord and recognizes the NF-M neurofilament subunit in vertebrates, in fact labels mitochondrial ATP synthase in the ascidian embryo. PMF-C13, an antibody we raised to and purified against PmMRF, which is the MyoD homolog of the ascidian Phallusia mammillata, in fact recognizes mitochondrial HSP60. High resolution immunolabeling on whole embryos and isolated cortices demonstrates localization to the inner mitochondrial membrane for both ATP synthase and HSP60. We discuss the general implications of our results for antibody specificity and the verification methods which can be used to determine unequivocally an antibody's target.	[Chenevert, Janet; Pruliere, Gerard; Sardet, Christian] Univ Paris 06, Villefranche Sur Mer, France; [Chenevert, Janet; Pruliere, Gerard; Sardet, Christian] CNRS, Dev Biol Unit UMR7009, Villefranche Sur Mer, France; [Ishii, Hirokazu; Nishikata, Takahito] Konan Univ, FIRST, Kobe, Hyogo, Japan; [Nishikata, Takahito] Konan Univ, FIBER, Kobe, Hyogo, Japan	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Konan University; Konan University	Chenevert, J (corresponding author), Univ Paris 06, Villefranche Sur Mer, France.	chenevert@obs-vlfr.fr		Ishii, Hirokazu/0000-0001-8391-194X	French Foundations for Research on Muscle (AFM); Cancer (ARC); French National Research Agency (ANR); MEXT; Japan Science Society	French Foundations for Research on Muscle (AFM); Cancer (ARC); French National Research Agency (ANR)(French National Research Agency (ANR)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Society	This work was funded by grants to CS from the French Foundations for Research on Muscle (AFM), and Cancer (ARC) and the French National Research Agency (ANR), a grant to TN from MEXT, and a grant to HI from the Japan Science Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda D, 2011, CELL MOL NEUROBIOL, V31, P1113, DOI 10.1007/s10571-011-9712-3; Balaratnasingam C, 2011, NEUROSCIENCE, V177, P269, DOI 10.1016/j.neuroscience.2010.12.053; Bates WR, 1996, DEV GROWTH DIFFER, V38, P307; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Burry RW, 2011, J HISTOCHEM CYTOCHEM, V59, P6, DOI 10.1369/jhc.2010.956920; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chiba S, 1999, DEV GROWTH DIFFER, V41, P265; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Correa C, 2004, CELL TISSUE RES, V318, P609, DOI 10.1007/s00441-004-0992-5; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Deutsch EW, 2008, NAT BIOTECHNOL, V26, P305, DOI 10.1038/nbt1391; Dumollard R, 2006, SEMIN CELL DEV BIOL, V17, P314, DOI 10.1016/j.semcdb.2006.02.009; Endo T, 2011, NUCLEIC ACIDS RES, V39, pD807, DOI 10.1093/nar/gkq1144; FRANKE FE, 1991, AM J PATHOL, V139, P67; Gilbert SF, 2010, DEV BIOL, P237; Goh YC, 2011, CELL MOL LIFE SCI, V68, P1581, DOI 10.1007/s00018-010-0534-0; Hughes Alis, 2011, PLoS Curr, V3, pRRN1211, DOI 10.1371/currents.RRN1211; Ishii H, 2012, DEV GROWTH DIFFER, V54, P753, DOI 10.1111/dgd.12003; Jeffery WR, 1995, CURR TOP DEV BIOL, V31, P243; JEFFERY WR, 1983, DEV BIOL, V96, P125, DOI 10.1016/0012-1606(83)90317-2; JEFFERY WR, 1985, J EMBRYOL EXP MORPH, V89, P275; JEFFERY WR, 1992, DEV BIOL, V153, P194, DOI 10.1016/0012-1606(92)90105-P; Karabinos A, 2004, GENE, V326, P123, DOI 10.1016/j.gene.2003.10.019; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kubo A, 2010, DEVELOPMENT, V137, P1613, DOI 10.1242/dev.046789; Kugler JE, 2010, J CELL SCI, V123, P2453, DOI 10.1242/jcs.066910; Lemaire P, 2008, CURR BIOL, V18, pR620, DOI 10.1016/j.cub.2008.05.039; Marikawa, 1995, J EXP ZOOL, V271, P348; Meedel TH, 2002, DEV BIOL, V241, P238, DOI 10.1006/dbio.2001.0511; Meedel TH, 2007, DEV BIOL, V302, P333, DOI 10.1016/j.ydbio.2006.09.043; MELAN MA, 1992, J CELL SCI, V101, P731; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; MIRANDE M, 1985, EXP CELL RES, V156, P91, DOI 10.1016/0014-4827(85)90264-2; MIYA T, 1994, DEV GROWTH DIFFER, V36, P39; Negishi T, 2007, CURR BIOL, V17, P1014, DOI 10.1016/j.cub.2007.05.047; NISHIDA H, 1992, DEVELOPMENT, V116, P521; Nishida H, 2001, NATURE, V409, P724, DOI 10.1038/35055568; Nishikata T, 1999, DEV BIOL, V209, P72, DOI 10.1006/dbio.1999.9244; NISHIKATA T, 1987, DEVELOPMENT, V100, P577; Nishikata T, 1996, DEV GENES EVOL, V206, P72, DOI 10.1007/s004270050032; Nomura M, 2009, DEV BIOL, V325, P468, DOI 10.1016/j.ydbio.2008.10.038; Ohashi S, 2009, BIOCHEM BIOPH RES CO, V385, P545, DOI 10.1016/j.bbrc.2009.05.094; Oka T, 1999, DEV GROWTH DIFFER, V41, P1; Paix A, 2011, DEV BIOL, V357, P211, DOI 10.1016/j.ydbio.2011.06.019; Paix A, 2009, DEV BIOL, V336, P96, DOI 10.1016/j.ydbio.2009.09.001; Patalano S, 2006, J CELL SCI, V119, P1592, DOI 10.1242/jcs.02873; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Prodon F, 2006, DEV BIOL, V290, P297, DOI 10.1016/j.ydbio.2005.11.025; Prodon F, 2007, DEV DYNAM, V236, P1698, DOI 10.1002/dvdy.21109; Prodon F, 2010, DEVELOPMENT, V137, P2011, DOI 10.1242/dev.047845; REVERBERI G, 1956, EXPERIENTIA, V12, P55, DOI 10.1007/BF02164674; Roegiers F, 1999, DEVELOPMENT, V126, P3101; ROEGIERS F, 1995, DEVELOPMENT, V121, P3457; Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770; SARDET C, 1992, DEVELOPMENT, V115, P221; Sardet C, 2002, DEV BIOL, V241, P1, DOI 10.1006/dbio.2001.0474; Sardet C, 2003, DEVELOPMENT, V130, P5839, DOI 10.1242/dev.00805; Sardet C, 2007, DEV DYNAM, V236, P1716, DOI 10.1002/dvdy.21136; Sardet C, 2011, METHODS MOL BIOL, V770, P365, DOI 10.1007/978-1-61779-210-6_14; Sasakura Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S3; Satoh N, 1996, P NATL ACAD SCI USA, V93, P9315, DOI 10.1073/pnas.93.18.9315; Satoh N, 2003, NAT REV GENET, V4, P285, DOI 10.1038/nrg1042; Satoh N, 1994, DEV BIOL; Sawada K, 2005, GENE EXPR PATTERNS, V5, P429, DOI 10.1016/j.modgep.2004.09.003; SAWADA T, 1989, DEV BIOL, V132, P331, DOI 10.1016/0012-1606(89)90230-3; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Stolfi A, 2012, GENETICS, V192, P55, DOI 10.1534/genetics.112.140590; SWALLA BJ, 1991, DEVELOPMENT, V111, P425; Tanaka KJ, 2004, DEV BIOL, V272, P217, DOI 10.1016/j.ydbio.2004.04.032; True LD, 2008, HISTOCHEM CELL BIOL, V130, P473, DOI 10.1007/s00418-008-0481-0; Vierra DA, 2012, DEV GENES EVOL, V222, P55, DOI 10.1007/s00427-011-0386-0; Willingham MC, 1999, J HISTOCHEM CYTOCHEM, V47, P1233, DOI 10.1177/002215549904701002; ZALOKAR M, 1984, DEV BIOL, V102, P195, DOI 10.1016/0012-1606(84)90184-2; Zhou RR, 2010, CURR GENET, V56, P101, DOI 10.1007/s00294-010-0291-5	78	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52996	10.1371/journal.pone.0052996	http://dx.doi.org/10.1371/journal.pone.0052996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326373	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400012
J	Pyritz, LW; Fichtel, C; Huchard, E; Kappeler, PM				Pyritz, Lennart W.; Fichtel, Claudia; Huchard, Elise; Kappeler, Peter M.			Determinants and Outcomes of Decision-Making, Group Coordination and Social Interactions during a Foraging Experiment in a Wild Primate	PLOS ONE			English	Article							EULEMUR-FULVUS-RUFUS; CAPUCHIN MONKEYS; CONSENSUS DECISION; REDFRONTED LEMURS; GROUP MOVEMENTS; FEMALE DOMINANCE; LIFE-HISTORY; PATTERNS; LEADERSHIP; MODEL	Social animals have to coordinate joint movements to maintain group cohesion, but the latter is often compromised by diverging individual interests. A widespread behavioral mechanism to achieve coordination relies on shared or unshared consensus decision-making. If consensus costs are high, group fission represents an alternative tactic. Exploring determinants and outcomes of spontaneous group decisions and coordination of free-ranging animals is methodologically challenging. We therefore conducted a foraging experiment with a group of wild redfronted lemurs (Eulemur rufifrons) to study decision outcomes, coordination of movements, individual foraging benefits and social interactions in response to the presentation of drinking platforms with varying baiting patterns. Behavioral observations were complemented with data from recordings of motion detector cameras installed at the platforms. The animal's behavior in the experimental conditions was compared to natural group movements. We could not determine the type of consensus decision-making because the group visited platforms randomly. The group fissioned during 23.3% of platform visits, and fissioning resulted in more individuals drinking simultaneously. As under natural conditions, adult females initiated most group movements, but overtaking by individuals of different age and sex classes occurred in 67% of movements to platforms, compared to only 18% during other movements. As a result, individual resource intake at the platforms did not depend on departure position, age or sex, but on arrival order. Aggression at the platforms did not affect resource intake, presumably due to low supplanting rates. Our findings highlight the diversity of coordination processes and related consequences for individual foraging benefits in a primate group living under natural conditions.	[Pyritz, Lennart W.; Fichtel, Claudia; Huchard, Elise; Kappeler, Peter M.] German Primate Ctr, Behav Ecol & Sociobiol Unit, Gottingen, Germany; [Pyritz, Lennart W.; Fichtel, Claudia; Huchard, Elise; Kappeler, Peter M.] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen	Pyritz, LW (corresponding author), German Primate Ctr, Behav Ecol & Sociobiol Unit, Gottingen, Germany.	LennartPyritz@gmx.net	Huchard, Elise/G-9072-2011; Kappeler, Peter/B-6825-2012	Huchard, Elise/0000-0002-6944-449X; 	The German Research Foundation (DFG) [KA 1082/16-1]	The German Research Foundation (DFG)(German Research Foundation (DFG))	The German Research Foundation (DFG: KA 1082/16-1; http://www.dfg.de/index.jsp) provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barthold J, 2009, AM J PHYS ANTHROPOL, V138, P1, DOI 10.1002/ajpa.20868; Bertram B.C.R., 1978, P64; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bourjade M, 2010, BEHAV PROCESS, V84, P648, DOI 10.1016/j.beproc.2010.02.027; Bousquet CAH, 2011, ANIM BEHAV, V81, P1101, DOI 10.1016/j.anbehav.2011.02.030; Bousquet CAH, 2011, P ROY SOC B-BIOL SCI, V278, P1482, DOI 10.1098/rspb.2010.1739; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Erhart EM, 1999, INT J PRIMATOL, V20, P927, DOI 10.1023/A:1020830703012; Erwin N, 1976, APPL ANIM ETHOL, V2, P265, DOI [DOI 10.1016/0304-3762(76)90059-6, 10.1016/0304-3762(76)90059-6]; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fichtel Claudia, 2012, P169; Fichtel C, 2011, COORDINATION IN HUMAN AND PRIMATE GROUPS, P37, DOI 10.1007/978-3-642-15355-6_3; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Gautrais J, 2010, BEHAV PROCESS, V84, P664, DOI 10.1016/j.beproc.2010.03.002; Gompper ME, 1996, BEHAV ECOL, V7, P254, DOI 10.1093/beheco/7.3.254; Harcourt JL, 2010, CURR BIOL, V20, P156, DOI 10.1016/j.cub.2009.11.045; Hawkins CE, 2008, J MAMMAL, V89, P64, DOI 10.1644/06-MAMM-A-366.1; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; JANSON CH, 1995, BEHAV ECOL, V6, P326, DOI 10.1093/beheco/6.3.326; Janson CH, 1997, BEHAV ECOL SOCIOBIOL, V41, P17, DOI 10.1007/s002650050359; Janson CH, 1998, ANIM BEHAV, V55, P1229, DOI 10.1006/anbe.1997.0688; Janson CH, 2007, ANIM COGN, V10, P341, DOI 10.1007/s10071-007-0079-2; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kappeler PM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1477, DOI 10.1007/s00265-008-0577-5; Kappeler Peter M., 2012, P101; KAPPELER PM, 1991, FOLIA PRIMATOL, V57, P132, DOI 10.1159/000156575; Kerth G, 2006, P ROY SOC B-BIOL SCI, V273, P2785, DOI 10.1098/rspb.2006.3647; Kerth G, 2010, BEHAV PROCESS, V84, P662, DOI 10.1016/j.beproc.2010.02.023; King AJ, 2011, BIOL LETTERS, V7, P237, DOI 10.1098/rsbl.2010.0808; King AJ, 2010, BEHAV PROCESS, V84, P671, DOI 10.1016/j.beproc.2010.03.006; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Koenig A, 2002, INT J PRIMATOL, V23, P759, DOI 10.1023/A:1015524931226; Krause J, 2002, LIVING GROUPS; Meunier H, 2006, BEHAVIOUR, V143, P1511, DOI 10.1163/156853906779366982; Moody AL, 1996, BEHAV ECOL SOCIOBIOL, V38, P131, DOI 10.1007/s002650050225; Ostner J, 2004, ANIM BEHAV, V67, P249, DOI 10.1016/j.anbehav.2003.05.012; OVERDORFF DJ, 1993, INT J PRIMATOL, V14, P721, DOI 10.1007/BF02192188; PEREIRA ME, 1988, ETHOLOGY, V79, P195, DOI 10.1111/j.1439-0310.1988.tb00711.x; PEREIRA ME, 1990, FOLIA PRIMATOL, V55, P96, DOI 10.1159/000156505; Pereira ME, 1997, AM J PRIMATOL, V43, P239, DOI 10.1002/(SICI)1098-2345(1997)43:3<239::AID-AJP4>3.0.CO;2-Y; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pyritz L, 2010, LEMUR NEWS, V15, P15; Pyritz L, 2010, BEHAV PROCESS, V84, P681, DOI 10.1016/j.beproc.2010.02.025; Pyritz LW, 2011, INT J PRIMATOL, V32, P1325, DOI 10.1007/s10764-011-9549-0; Pyritz LW, 2011, INT J PRIMATOL, V32, P1268, DOI 10.1007/s10764-011-9524-9; Ramseyer A, 2009, ETHOLOGY, V115, P948, DOI 10.1111/j.1439-0310.2009.01686.x; Ramseyer A, 2009, J ETHOL, V27, P369, DOI 10.1007/s10164-008-0128-6; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; RASA OAE, 1987, ADV STUD BEHAV, V17, P121, DOI 10.1016/S0065-3454(08)60178-3; Rasoloarison Rodin M., 1995, Ecotropica, V1, P59; Rubenstein RI, 1994, INDIVIDUALS INTERACT, P13; Scholz F, 2004, INT J PRIMATOL, V25, P599, DOI 10.1023/B:IJOP.0000023577.32587.0b; Seeley TD, 2006, AM SCI, V94, P220, DOI 10.1511/2006.59.220; Sorg JP, 1996, PRIMATE REPORT, P57; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sussman R.W., 1974, P75; Trillmich J, 2004, BEHAVIOUR, V141, P1103, DOI 10.1163/1568539042664579; VANSCHAIK CP, 1985, FOLIA PRIMATOL, V44, P138, DOI 10.1159/000156208; Vogel ER, 2005, BEHAV ECOL SOCIOBIOL, V58, P333, DOI 10.1007/s00265-005-0960-4; Wheeler BC, 2009, P ROY SOC B-BIOL SCI, V276, P3013, DOI 10.1098/rspb.2009.0544; Wimmer B, 2002, ANIM BEHAV, V64, P557, DOI 10.1006/anbe.2002.4003; Zuur Alain F., 2009, P1	70	8	8	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53144	10.1371/journal.pone.0053144	http://dx.doi.org/10.1371/journal.pone.0053144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326392	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400014
J	Hu, Q; Chen, BH; Zhu, ZO; Tian, JH; Zhou, Y; Zhang, XY; Zheng, X				Hu, Quan; Chen, Banghua; Zhu, Zerong; Tian, Junhua; Zhou, Yu; Zhang, Xiaoyong; Zheng, Xin			Recurrence of Japanese Encephalitis Epidemic in Wuhan, China, 2009-2010	PLOS ONE			English	Article							SOUTHEAST-ASIA; VIRUS; OUTBREAK; IMMUNIZATION; AUSTRALIA; SA14-14-2; VACCINE	Background: Japanese encephalitis (JE) was once epidemic in most areas of China, including Wuhan, a city located in the central part of China. The incidence of JE dramatically decreased due to nationwide immunization with the live attenuated JE virus (JEV) vaccine, and no JE cases were reported during 2005-2008 in Wuhan. In 2009 and 2010, 31 JE cases reoccurred in this area. In this study, we investigated the causes of JE recurrence. Methods and Findings: All JE cases were laboratory-confirmed by detecting the JEV-specific IgM antibody with an IgM-capture enzyme-linked immunosorbent assay (ELISA). All patients were children between 2 months and 9 years of age with a median age of 2 years. Of the 31 cases, 9 had received one or two doses of the JEV vaccine, 11 had not been immunized previously with the JEV vaccine, and 11 had an unclear immunization history. Through reverse transcription polymerase chain reaction (RT-PCR), sequencing, and phylogenetic analysis, two new strains of JEV were isolated from Culex tritaeniorhynchus and identified as genotype 1 JEV, rather than genotype 3, which circulated in this area previously. Conclusions: Vaccine failure or missed vaccination may have caused JE recurrence. Local centers for disease control and prevention need to improve immunization coverage, and the efficacy of the JE vaccine needs to be reevaluated in a population at risk for disease.	[Hu, Quan; Chen, Banghua; Zhu, Zerong; Tian, Junhua] Wuhan Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Zhou, Yu] Childrens Hosp Philadelphia, Dept Pediat, Joseph Stokes Jr Res Inst, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Zhang, Xiaoyong] Univ Hosp Essen, Inst Virol, Essen, Germany; [Zheng, Xin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Duisburg Essen; Huazhong University of Science & Technology	Hu, Q (corresponding author), Wuhan Ctr Dis Control & Prevent, Wuhan, Peoples R China.	powerhu21@yahoo.com; Xin11@hotmail.com		Hu, Quan/0000-0002-2483-5008	Technology & Science Youth Talent Foundation from Hubei Health Department [QJX2008-47]	Technology & Science Youth Talent Foundation from Hubei Health Department	This study was supported by the Technology & Science Youth Talent Foundation from Hubei Health Department (No. QJX2008-47). [http://dns2.yymc.edu.cn/gljg/kcy/file/zxjlzl/cgzt/08n(wst)xdqnrcjjxm(48 h).pdf] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba T, 2001, EPIDEMIOL INFECT, V126, P81, DOI 10.1017/S0950268801004769; BUESCHER EL, 1959, AM J TROP MED HYG, V8, P719, DOI 10.4269/ajtmh.1959.8.719; Campbell Grant L, 2011, B WORLD HEALTH ORGAN, V89, P766; Chen BH, 2007, J PUBLIC HLTH PREVEN, V18, P25; Chotpitayasunondh Tawee, 2011, J Med Assoc Thai, V94 Suppl 3, pS195; Endy TP, 2002, CURR TOP MICROBIOL, V267, P11; Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; GRESSER I, 1958, AM J TROP MED HYG, V7, P365, DOI 10.4269/ajtmh.1958.7.365; Halstead SB, 1996, LANCET, V348, P341, DOI 10.1016/S0140-6736(05)64516-3; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2; [王环宇 Wang Huanyu], 2004, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V24, P843; Johansen CA, 2000, AM J TROP MED HYG, V62, P631, DOI 10.4269/ajtmh.2000.62.631; Keiser J, 2005, ACTA TROP, V95, P40, DOI 10.1016/j.actatropica.2005.04.012; Liu XY, 2011, VACCINE, V29, P2127, DOI 10.1016/j.vaccine.2010.12.108; Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0; PAUL WS, 1993, J INFECT DIS, V167, P1053, DOI 10.1093/infdis/167.5.1053; Ritchie SA, 1997, AM J TROP MED HYG, V56, P80, DOI 10.4269/ajtmh.1997.56.80; ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143; Sohn YM, 2000, EMERG INFECT DIS, V6, P17; Sohn YM, 2008, VACCINE, V26, P1638, DOI 10.1016/j.vaccine.2008.01.021; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Wang HY, 2009, JPN J INFECT DIS, V62, P331; Wang LH, 2007, EMERG INFECT DIS, V13, P1123, DOI 10.3201/eid1307.070010; World Health Organization, 2006, WHO REC STAND SURV S; Wu SC, 2001, VIRUS RES, V76, P59, DOI 10.1016/S0168-1702(01)00246-5; Wu YC, 1999, AM J TROP MED HYG, V61, P78, DOI 10.4269/ajtmh.1999.61.78; Zhang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016418; Zhang S, 2011, PUBLIC HEALTH, V125, P79, DOI 10.1016/j.puhe.2010.10.011	33	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52687	10.1371/journal.pone.0052687	http://dx.doi.org/10.1371/journal.pone.0052687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326348	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500025
J	Sheard, JM; Ash, S; Mellick, GD; Silburn, PA; Kerr, GK				Sheard, Jamie M.; Ash, Susan; Mellick, George D.; Silburn, Peter A.; Kerr, Graham K.			Malnutrition in a Sample of Community-Dwelling People with Parkinson's Disease	PLOS ONE			English	Article							SUBJECTIVE GLOBAL ASSESSMENT; NUTRITIONAL-STATUS; WEIGHT CHANGE; BODY-COMPOSITION; OLDER-ADULTS; HOME; ASSOCIATION; PREVALENCE; PREDICTION; MORTALITY	Objective: Malnutrition results in poor health outcomes, and people with Parkinson's disease may be more at risk of malnutrition. However, the prevalence of malnutrition in Parkinson's disease is not yet well defined. The aim of this study is to provide an estimate of the extent of malnutrition in community-dwelling people with Parkinson's disease. Methods: This is a cross-sectional study of people with Parkinson's disease residing within a 2 hour driving radius of Brisbane, Australia. The Subjective Global Assessment (SGA) and scored Patient Generated Subjective Global Assessment (PG-SGA) were used to assess nutritional status. Body weight, standing or knee height, mid-arm circumference and waist circumference were measured. Results: Nineteen (15%) of the participants were moderately malnourished (SGA-B). The median PG-SGA score of the SGA-B group was 8 (4-15), significantly higher than the SGA-A group, U = 1860.5, p<.05. The symptoms most influencing intake were loss of appetite, constipation, early satiety and problems swallowing. Conclusions: As with other populations, malnutrition remains under-recognised and undiagnosed in people with Parkinson's disease. Regular screening of nutritional status in people with Parkinson's disease by health professionals with whom they have regular contact should occur to identify those who may benefit from further nutrition assessment and intervention.	Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; [Sheard, Jamie M.; Ash, Susan; Kerr, Graham K.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; [Sheard, Jamie M.; Kerr, Graham K.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Movement Neurosci Program, Brisbane, Qld 4001, Australia; [Mellick, George D.] Griffith Univ, Australia Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Silburn, Peter A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); Griffith University; University of Queensland	Sheard, JM (corresponding author), Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia.	jamie.sheard@qut.edu.au	Mellick, George D./A-7650-2010; Sheard, Jamie M/C-3184-2012; Kerr, Graham/I-9705-2012; Ash, Susan/I-9664-2012	Mellick, George D./0000-0002-7211-4651; Sheard, Jamie M/0000-0002-1730-4831; Kerr, Graham/0000-0002-1008-256X; Ash, Susan/0000-0003-2078-7560	Parkinson's Queensland, Inc	Parkinson's Queensland, Inc	Parkinson's Queensland, Inc (http://parkinsons-qld.org.au/) provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders did advertise the study in their newsletter and on their website for the purpose of recruiting participants.	Alho Letra Martins Catia Patricia, 2005, Journal of Nutrition for the Elderly, V25, P5, DOI 10.1300/J052v25n02_02; [Anonymous], 2009, NUTR DIET, V66, pS1; Banks M, 2010, NUTRITION, V26, P896, DOI 10.1016/j.nut.2009.09.024; Barbosa-Silva MCG, 2006, CURR OPIN CLIN NUTR, V9, P263, DOI 10.1097/01.mco.0000222109.53665.ed; Barichella M, 2008, NUTR NEUROSCI, V11, P128, DOI 10.1179/147683008X301441; BEYER PL, 1995, J AM DIET ASSOC, V95, P979, DOI 10.1016/S0002-8223(95)00269-3; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chen HL, 2003, ANN NEUROL, V53, P676, DOI 10.1002/ana.10577; Chumlea WC, 1998, J AM DIET ASSOC, V98, P137, DOI 10.1016/S0002-8223(98)00036-4; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Crogan NL, 2003, J GERONTOL A-BIOL, V58, P159; DAVIDSON J, 2008, TLS TIMES LIT S 0613, P24; Deloitte Access Economics, 2011, LIV PARK DIS UPD; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Donini LM, 2012, J NUTR HEALTH AGING, V16, P89, DOI 10.1007/s12603-011-0073-x; Gibson R, 2005, PRINCIPLES NUTR ASSE; Jaafar AF, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-124; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Johansson Y, 2009, J CLIN NURS, V18, P1354, DOI 10.1111/j.1365-2702.2008.02552.x; Lee JS, 2005, AM J CLIN NUTR, V82, P644, DOI 10.1093/ajcn/82.3.644; Leggo M, 2008, NUTR DIET, V65, P162, DOI 10.1111/j.1747-0080.2008.00239.x; Mamhidir AG, 2006, J NUTR HEALTH AGING, V10, P255; Martorell R, 1988, ANTHROPOMETRIC STAND, V24, P425; Morley JE, 1997, AM J CLIN NUTR, V66, P760, DOI 10.1093/ajcn/66.4.760; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Ottery F, 2000, CLIN GUIDE ONCOLOGY, P11; Pai MK, 2011, BIOMED RES-INDIA, V22, P120; Pfeiffer RF, 2003, LANCET NEUROL, V2, P107, DOI 10.1016/S1474-4422(03)00307-7; Sheard JM, 2011, NUTR REV, V69, P520, DOI 10.1111/j.1753-4887.2011.00413.x; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837; Visvanathan R, 2003, J AM GERIATR SOC, V51, P1007, DOI 10.1046/j.1365-2389.2003.51317.x; Wang G, 2010, PARKINSONISM RELAT D, V16, P119, DOI 10.1016/j.parkreldis.2009.08.009; Wikby K, 2006, J NUTR HEALTH AGING, V10, P232	33	46	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53290	10.1371/journal.pone.0053290	http://dx.doi.org/10.1371/journal.pone.0053290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326408	Green Published, gold			2022-12-27	WOS:000313551500060
J	Caballero, I; Al Ghareeb, S; Basatvat, S; Sanchez-Lopez, JA; Montazeri, M; Maslehat, N; Elliott, S; Chapman, NR; Fazeli, A				Caballero, Ignacio; Al Ghareeb, Sumiah; Basatvat, Shaghayegh; Sanchez-Lopez, Javier A.; Montazeri, Mehrnaz; Maslehat, Nasim; Elliott, Sarah; Chapman, Neil R.; Fazeli, Alireza			Human Trophoblast Cells Modulate Endometrial Cells Nuclear Factor kappa B Response to Flagellin In Vitro	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; UTERINE RECEPTIVITY; ENDOGENOUS LIGANDS; IMPLANTATION; ACTIVATION; PREGNANCY; TRANSCRIPTION; ATTACHMENT; EXPRESSION; EPITHELIUM	Background: Implantation is a complex process that requires a delicate cooperation between the immune and reproductive system. Any interference in the fine balance could result in embryo loss and infertility. We have recently shown that Toll-like receptor 5 activation results in a decrease of trophoblast cells binding to endometrial cells in an in vitro model of human implantation. However, little is known about the downstream signalling leading to the observed failure in implantation and the factors that modulate this immune response. Methods and Principal Findings: An in vitro model of embryo implantation was used to evaluate the effect of trophoblasts and flagellin on the activation of NF-kappa B in endometrial cells and whether TLR5-related in vitro implantation failure is signalled through NF-kappa B. We generated two different NF-kappa B reporting cell lines by transfecting either an immortalized endometrial epithelial cell line (hTERT-EECs) or a human endometrial carcinoma cell line (Ishikawa 3-H-12) with a plasmid containing the secreted alkaline phosphatase (SEAP) under the control of five NF-kappa B sites. The presence of trophoblast cells as well as flagellin increased NF-kappa B activity when compared to controls. The NF-kappa B activation induced by flagellin was further increased by the addition of trophoblast cells. Moreover, blocking NF-kappa B signalling with a specific inhibitor (BAY11-7082) was able to restore the binding ability of our trophoblast cell line to the endometrial monolayer. Conclusions: These are the first results showing a local effect of the trophoblasts on the innate immune response of the endometrial epithelium. Moreover, we show that implantation failure caused by intrauterine infections could be associated with abnormal levels of NF-kappa B activation. Further studies are needed to evaluate the target genes through which NF-kappa B activation after TLR5 stimulation lead to failure in implantation and the effect of the embryo on those genes. Understanding these pathways could help in the diagnosis and treatment of implantation failure cases.	[Caballero, Ignacio; Al Ghareeb, Sumiah; Basatvat, Shaghayegh; Sanchez-Lopez, Javier A.; Montazeri, Mehrnaz; Maslehat, Nasim; Elliott, Sarah; Chapman, Neil R.; Fazeli, Alireza] Univ Sheffield, Sch Med, Dept Human Metab, Acad Unit Reprod & Dev Med, Sheffield, S Yorkshire, England	University of Sheffield	Fazeli, A (corresponding author), Univ Sheffield, Sch Med, Dept Human Metab, Acad Unit Reprod & Dev Med, Sheffield, S Yorkshire, England.	A.Fazeli@Sheffield.ac.uk	Fazeli, Alireza/G-3679-2010	Fazeli, Alireza/0000-0003-0870-9914; Basatvat, Shaghayegh/0000-0001-6201-4588; Chapman, Neil/0000-0002-4853-2909; Sanchez-Lopez, Javier Arturo/0000-0003-4684-1238; Caballero, Ignacio/0000-0002-0628-4134	Marie Curie [IIF-253948]	Marie Curie(European Commission)	This research was supported by Marie Curie IIF-253948. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussahoud W, 2010, HUM REPROD, V25, P2217, DOI 10.1093/humrep/deq185; Aboussahoud W, 2010, J REPROD IMMUNOL, V84, P41, DOI 10.1016/j.jri.2009.09.008; Aflatoonian R, 2007, HUM REPROD, V22, P586, DOI 10.1093/humrep/del388; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Carvalho FA, 2011, MUCOSAL IMMUNOL, V4, P102, DOI 10.1038/mi.2010.57; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fazleabas AT, 2004, PLACENTA, V25, pS26, DOI 10.1016/j.placenta.2004.01.014; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; GRUMMER R, 1994, PLACENTA, V15, P411, DOI 10.1016/0143-4004(94)90008-6; Guimond MJ, 1998, J EXP MED, V187, P217, DOI 10.1084/jem.187.2.217; Hohn HP, 2000, MOL REPROD DEV, V57, P135; Hombach-Klonisch S, 2005, J MOL ENDOCRINOL, V34, P517, DOI 10.1677/jme.1.01550; Jarvis JN, 1998, PEDIATR RES, V43, P509, DOI 10.1203/00006450-199804000-00012; JOHN NJ, 1993, IN VITRO CELL DEV-AN, V29A, P461, DOI 10.1007/BF02639380; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Klein C, 2006, BIOL REPROD, V74, P253, DOI 10.1095/biolreprod.105.046748; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Kwak-Kim J, 2010, AM J REPROD IMMUNOL, V63, P611, DOI 10.1111/j.1600-0897.2010.00847.x; Ledee-Bataille N, 2002, HUM REPROD, V17, P213, DOI 10.1093/humrep/17.1.213; Lessey BA, 1996, FERTIL STERIL, V65, P477, DOI 10.1016/S0015-0282(16)58140-0; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; Meter RA, 2007, FERTIL STERIL, V88, pS40, DOI 10.1016/j.fertnstert.2007.07.144; Nakamura H, 2004, BIOCHEM BIOPH RES CO, V321, P886, DOI 10.1016/j.bbrc.2004.07.045; Nakamura H, 2004, AM J REPROD IMMUNOL, V51, P16, DOI 10.1046/j.8755-8920.2003.00116.x; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Robertson SA, 2011, AM J REPROD IMMUNOL, V66, P2, DOI 10.1111/j.1600-0897.2011.01039.x; Ross JW, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-39; Ross JW, 2003, BIOL REPROD, V69, P1251, DOI 10.1095/biolreprod.103.015842; SHYAMALA G, 1992, P NATL ACAD SCI USA, V89, P10628, DOI 10.1073/pnas.89.22.10628; Simon C, 1998, FERTIL STERIL, V70, P896, DOI 10.1016/S0015-0282(98)00275-1; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; SMITH MF, 1994, J IMMUNOL, V153, P3584; Staun-Ram E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-56; Teklenburg G, 2010, MOL HUM REPROD, V16, P886, DOI 10.1093/molehr/gaq079; Thie M, 1998, HUM REPROD, V13, P3211, DOI 10.1093/humrep/13.11.3211; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Walker CG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-474; Zhang JH, 2007, J REPROD IMMUNOL, V74, P61, DOI 10.1016/j.jri.2006.10.005	45	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e39441	10.1371/journal.pone.0039441	http://dx.doi.org/10.1371/journal.pone.0039441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320062	Green Published, gold			2022-12-27	WOS:000313429800001
J	Makarov, V; Rakitina, D; Protopopova, A; Yaminsky, I; Arutiunian, A; Love, AJ; Taliansky, M; Kalinina, N				Makarov, Valentine; Rakitina, Daria; Protopopova, Anna; Yaminsky, Igor; Arutiunian, Alexander; Love, Andrew J.; Taliansky, Michael; Kalinina, Natalia			Plant Coilin: Structural Characteristics and RNA-Binding Properties	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; CAJAL BODIES; SECONDARY STRUCTURE; BODY FORMATION; PROTEIN; PHOSPHORYLATION; SNRNPS; DOMAIN; SMN; INTERMEDIATE	Cajal bodies (CBs) are dynamic subnuclear compartments involved in the biogenesis of ribonucleoproteins. Coilin is a major structural scaffolding protein necessary for CB formation, composition and activity. The predicted secondary structure of Arabidopsis thaliana coilin (Atcoilin) suggests that the protein is composed of three main domains. Analysis of the physical properties of deletion mutants indicates that Atcoilin might consist of an N-terminal globular domain, a central highly disordered domain and a C-terminal domain containing a presumable Tudor-like structure adjacent to a disordered C terminus. Despite the low homology in amino acid sequences, a similar type of domain organization is likely shared by human and animal coilin proteins and coilin-like proteins of various plant species. Atcoilin is able to bind RNA effectively and in a non-specific manner. This activity is provided by three RNA-binding sites: two sets of basic amino acids in the N-terminal domain and one set in the central domain. Interaction with RNA induces the multimerization of the Atcoilin molecule, a consequence of the structural alterations in the N-terminal domain. The interaction with RNA and subsequent multimerization may facilitate coilin's function as a scaffolding protein. A model of the N-terminal domain is also proposed.	[Makarov, Valentine; Arutiunian, Alexander; Kalinina, Natalia] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Makarov, Valentine; Rakitina, Daria] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Protopopova, Anna; Yaminsky, Igor] Moscow MV Lomonosov State Univ, Fac Phys, Moscow, Russia; [Love, Andrew J.; Taliansky, Michael] James Hutton Inst, Dundee, Scotland	Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University; James Hutton Institute	Rakitina, D (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia.	rakitina@genebee.msu.ru; kalinina@genebee.msu.ru	Protopopova, Anna D/J-4764-2013; Taliansky, Michael/H-8483-2013; Yaminsky, Igor/H-7857-2013	Protopopova, Anna D/0000-0003-3729-4922; Yaminsky, Igor/0000-0001-8731-3947; Rakitina, Daria/0000-0003-3554-7690	RFBR [10-04-0522a]; Scottish Government Rural and Environmental Science and Analytical Services Division	RFBR(Russian Foundation for Basic Research (RFBR)); Scottish Government Rural and Environmental Science and Analytical Services Division	This work was supported by RFBR grant 10-04-0522a. The work of A.J.L. and M. T. was supported by funding from Scottish Government Rural and Environmental Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; [Anonymous], [No title captured]; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Bellini M, 1998, MOL BIOL CELL, V9, P2987, DOI 10.1091/mbc.9.10.2987; Broome HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036300; CARMOFONSECA M, 1993, J CELL BIOL, V120, P841, DOI 10.1083/jcb.120.4.841; Carrero ZI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025743; Collier S, 2006, MOL BIOL CELL, V17, P2942, DOI 10.1091/mbc.E05-12-1157; Hearst SM, 2009, J CELL SCI, V122, P1872, DOI 10.1242/jcs.044040; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Hebert MD, 2010, ARCH BIOCHEM BIOPHYS, V496, P69, DOI 10.1016/j.abb.2010.02.012; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Matera AG, 1998, J CELL BIOCHEM, V70, P181; Nizami Z, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000653; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rea AM, 2008, BIOCHEMISTRY-US, V47, P8225, DOI 10.1021/bi800722d; Roy S, 1995, Subcell Biochem, V24, P101; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Shanbhag R, 2010, FEBS LETT, V584, P4351, DOI 10.1016/j.febslet.2010.09.034; Shpargel KB, 2003, J CELL SCI, V116, P303, DOI 10.1242/jcs.00211; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Strzelecka M, 2010, NUCLEUS-PHILA, V1, P96, DOI 10.4161/nucl.1.1.10680; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2000, J STRUCT BIOL, V129, P269, DOI 10.1006/jsbi.2000.4234; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; TUMA RS, 1993, J CELL BIOL, V122, P767, DOI 10.1083/jcb.122.4.767; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vallee-Belisle A, 2007, J MOL BIOL, V374, P791, DOI 10.1016/j.jmb.2007.09.018; Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004; Walker MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006171; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Whittom AA, 2008, CELL MOL LIFE SCI, V65, P1256, DOI 10.1007/s00018-008-7587-3; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu HZ, 2005, CHROMOSOMA, V114, P155, DOI 10.1007/s00412-005-0003-y; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	46	22	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53571	10.1371/journal.pone.0053571	http://dx.doi.org/10.1371/journal.pone.0053571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320094	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429800059
J	Schumacher, J; Gautier, A; Morgant, G; Studt, L; Ducrot, PH; Le Pecheur, P; Azeddine, S; Fillinger, S; Leroux, P; Tudzynski, B; Viaud, M				Schumacher, Julia; Gautier, Angelique; Morgant, Guillaume; Studt, Lena; Ducrot, Paul-Henri; Le Pecheur, Pascal; Azeddine, Saad; Fillinger, Sabine; Leroux, Pierre; Tudzynski, Bettina; Viaud, Muriel			A Functional Bikaverin Biosynthesis Gene Cluster in Rare Strains of Botrytis cinerea Is Positively Controlled by VELVET	PLOS ONE			English	Article							BOTRYOTINIA-FUCKELIANA; SECONDARY METABOLISM; MOLECULAR PHYLOGENY; HORIZONTAL TRANSFER; GRAY MOLD; FUNGAL; ACID; EVOLUTION; MELANIN; IDENTIFICATION	The gene cluster responsible for the biosynthesis of the red polyketidic pigment bikaverin has only been characterized in Fusarium ssp. so far. Recently, a highly homologous but incomplete and nonfunctional bikaverin cluster has been found in the genome of the unrelated phytopathogenic fungus Botrytis cinerea. In this study, we provided evidence that rare B. cinerea strains such as 1750 have a complete and functional cluster comprising the six genes orthologous to Fusarium fujikuroi ffbik1-ffbik6 and do produce bikaverin. Phylogenetic analysis confirmed that the whole cluster was acquired from Fusarium through a horizontal gene transfer (HGT). In the bikaverin-nonproducing strain B05.10, the genes encoding bikaverin biosynthesis enzymes are nonfunctional due to deleterious mutations (bcbik2-3) or missing (bcbik1) but interestingly, the genes encoding the regulatory proteins BcBIK4 and BcBIK5 do not harbor deleterious mutations which suggests that they may still be functional. Heterologous complementation of the F. fujikuroi Delta ffbik4 mutant confirmed that bcbik4 of strain B05.10 is indeed fully functional. Deletion of bcvel1 in the pink strain 1750 resulted in loss of bikaverin and overproduction of melanin indicating that the VELVET protein BcVEL1 regulates the biosynthesis of the two pigments in an opposite manner. Although strain 1750 itself expresses a truncated BcVEL1 protein (100 instead of 575 aa) that is nonfunctional with regard to sclerotia formation, virulence and oxalic acid formation, it is sufficient to regulate pigment biosynthesis (bikaverin and melanin) and fenhexamid HydR2 type of resistance. Finally, a genetic cross between strain 1750 and a bikaverin-nonproducing strain sensitive to fenhexamid revealed that the functional bikaverin cluster is genetically linked to the HydR2 locus.	[Schumacher, Julia; Studt, Lena; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Plants, D-48149 Munster, Germany; [Gautier, Angelique; Morgant, Guillaume; Le Pecheur, Pascal; Azeddine, Saad; Fillinger, Sabine; Leroux, Pierre; Viaud, Muriel] INRA, UR BIOGER CPP, F-78850 Thiverval Grignon, France; [Studt, Lena] Univ Munster, Inst Food Chem, D-48149 Munster, Germany; [Ducrot, Paul-Henri] INRA, IJPB, F-78026 Versailles, France	University of Munster; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Munster; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Tudzynski, B (corresponding author), Univ Munster, Inst Biol & Biotechnol Plants, D-48149 Munster, Germany.	bettina.tudzynski@uni-muenster.de; viaud@versailles.inra.fr	Schumacher, Julia/B-9142-2019; Studt, Lena/AAE-3991-2021	Schumacher, Julia/0000-0001-9120-9675; Studt-Reinhold, Lena/0000-0002-8738-2106; Fillinger, Sabine/0000-0003-4683-0803				Albertini C, 2004, EUR J PLANT PATHOL, V110, P723, DOI 10.1023/B:EJPP.0000041567.94140.05; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; BALAN J, 1970, Folia Microbiologica, V15, P479, DOI 10.1007/BF02880192; Barnes B, 1930, ANN BOT-LONDON, V44, P825, DOI 10.1093/oxfordjournals.aob.a090252; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Campbell MA, 2012, GENOME BIOL EVOL, V4, P289, DOI 10.1093/gbe/evs011; Limon MC, 2010, APPL MICROBIOL BIOT, V87, P21, DOI 10.1007/s00253-010-2551-1; Choi YE, 2008, MYCOLOGIA, V100, P701, DOI 10.3852/08-015; Choi YE, 2011, APPL ENVIRON MICROB, V77, P942, DOI 10.1128/AEM.01830-10; CORNFORTH JW, 1971, J CHEM SOC C, P2786, DOI 10.1039/j39710002786; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; Debieu D, 2001, PEST MANAG SCI, V57, P1060, DOI 10.1002/ps.394; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doss RP, 2003, PHYTOCHEMISTRY, V63, P687, DOI 10.1016/S0031-9422(03)00323-6; FARETRA F, 1988, J GEN MICROBIOL, V134, P2543; Fillinger S, 2008, ANTIMICROB AGENTS CH, V52, P3933, DOI 10.1128/AAC.00615-08; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Gao Q, 2011, NAT REV MICROBIOL, V9, P791, DOI 10.1038/nrmicro2649; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; GRINDLE M, 1979, J GEN MICROBIOL, V111, P109, DOI 10.1099/00221287-111-1-109; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; Hearld FD, 1926, PHYTOPATHOLOGY, V16, P485; HEWITT TG, 1971, J CHEM SOC A, P817, DOI 10.1039/j19710000817; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Kohut G, 2010, J BASIC MICROB, V50, P59, DOI 10.1002/jobm.200900113; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Lawrence DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028231; Leroux P, 2002, PEST MANAG SCI, V58, P876, DOI 10.1002/ps.566; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Malz S, 2005, FUNGAL GENET BIOL, V42, P420, DOI 10.1016/j.fgb.2005.01.010; Merhej J, 2012, MOL PLANT PATHOL, V13, P363, DOI 10.1111/j.1364-3703.2011.00755.x; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Musavi M., 1991, APPL BIOCH MICROBIOL, V27, P255; Osbourn A, 2010, TRENDS GENET, V26, P449, DOI 10.1016/j.tig.2010.07.001; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Quidde T, 1999, EUR J PLANT PATHOL, V105, P273, DOI 10.1023/A:1008796006051; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schumacher J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047840; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Son SW, 2008, J APPL MICROBIOL, V104, P692, DOI 10.1111/j.1365-2672.2007.03581.x; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Walker AS, 2011, PHYTOPATHOLOGY, V101, P1433, DOI 10.1094/PHYTO-04-11-0104; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224; Watanabe M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-322; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Wu DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002542; ZEUN R, 1985, PHYTOPATHOL Z, V112, P259	59	51	51	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53729	10.1371/journal.pone.0053729	http://dx.doi.org/10.1371/journal.pone.0053729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308280	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100112
J	Siddique, HR; Parray, A; Zhong, WX; Karnes, RJ; Bergstralh, EJ; Koochekpour, S; Rhim, JS; Konety, BR; Saleem, M				Siddique, Hifzur Rahman; Parray, Aijaz; Zhong, Weixiong; Karnes, R. Jeffery; Bergstralh, Eric J.; Koochekpour, Shahriar; Rhim, Johng S.; Konety, Badrinath R.; Saleem, Mohammad			BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer	PLOS ONE			English	Article							ANTIGEN; MEN; TRANSFORMATION; EXPRESSION; ESTABLISHMENT; MANAGEMENT; SURROGACY; INHIBITOR; PROGNOSIS; CARCINOMA	Background: Lack of reliable predictive biomarkers is a stumbling block in the management of prostate cancer (CaP). Prostate-specific antigen (PSA) widely used in clinics has several caveats as a CaP biomarker. African-American CaP patients have poor prognosis than Caucasians, and notably the serum-PSA does not perform well in this group. Further, some men with low serum-PSA remain unnoticed for CaP until they develop disease. Thus, there is a need to identify a reliable diagnostic and predictive biomarker of CaP. Here, we show that BMI1 stem-cell protein is secretory and could be explored for biomarker use in CaP patients. Methodology/Principal Findings: Semi-quantitative analysis of BMI1 was performed in prostatic tissues of TRAMP (autochthonous transgenic mouse model), human CaP patients, and in cell-based models representing normal and different CaP phenotypes in African-American and Caucasian men, by employing immunohistochemistry, immunoblotting and Slot-blotting. Quantitative analysis of BMI1 and PSA were performed in blood and culture-media of siRNA-transfected and non-transfected cells by employing ELISA. BMI1 protein is (i) secreted by CaP cells, (ii) increased in the apical region of epithelial cells and stromal region in prostatic tumors, and (iii) detected in human blood. BMI1 is detectable in blood of CaP patients in an order of increasing tumor stage, exhibit a positive correlation with serum-PSA and importantly is detectable in patients which exhibit low serum-PSA. The clinical significance of BMI1 as a biomarker could be ascertained from observation that CaP cells secrete this protein in higher levels than cells representative of benign prostatic hyperplasia (BPH). Conclusions/Significance: BMI1 could be developed as a dual bio-marker (serum and biopsy) for the diagnosis and prognosis of CaP in Caucasian and African-American men. Though compelling these data warrant further investigation in a cohort of African-American patients.	[Siddique, Hifzur Rahman; Parray, Aijaz; Saleem, Mohammad] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Zhong, Weixiong] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Karnes, R. Jeffery] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Urol, Rochester, MN 55905 USA; [Karnes, R. Jeffery; Bergstralh, Eric J.] Mayo Clin, Rochester, MN USA; [Bergstralh, Eric J.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Koochekpour, Shahriar] Roswell Pk Canc Inst, Ctr Genet & Pharmacol, Buffalo, NY 14263 USA; [Rhim, Johng S.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Konety, Badrinath R.; Saleem, Mohammad] Univ Minnesota, Dept Urol, Minneapolis, MN USA; [Saleem, Mohammad] Univ Minnesota, Dept Lab Med Pathol, Minneapolis, MN USA	University of Minnesota System; University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; Mayo Clinic; Mayo Clinic; Roswell Park Cancer Institute; Uniformed Services University of the Health Sciences - USA; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Saleem, M (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	msbhat@umn.edu	Saleem, Mohammad/GVS-9221-2022; Siddique, Hifzur R/H-4049-2019	Saleem, Mohammad/0000-0002-7422-7967; Siddique, Hifzur R/0000-0001-8736-0487	Department of Defense CDMRP [W81XWH-08-1-0605]	Department of Defense CDMRP(United States Department of Defense)	This work was in part supported by the Department of Defense CDMRP grant W81XWH-08-1-0605 to the corresponding author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AJ, 2007, J CLIN ONCOL, V25, P3965, DOI 10.1200/JCO.2007.11.4769; Armstrong AJ, 2012, EUR UROL, V61, P549, DOI 10.1016/j.eururo.2011.11.009; Asbell SO, 2000, J NATL MED ASSOC, V92, P445; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Bickers B, 2009, ANTICANCER RES, V29, P3289; Bigler SA, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/239460; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Casanova-Salas I, 2012, CLIN TRANSL ONCOL; Cenci T, 2012, AM J CLIN PATHOL, V138, P390, DOI 10.1309/AJCPRXHNJQLO09QA; Fowler JE, 2002, CANCER, V94, P1661, DOI 10.1002/cncr.10446; Fradet Y, 2009, CURR OPIN UROL, V19, P243, DOI 10.1097/MOU.0b013e32832a08b5; Gaston KE, 2003, J UROLOGY, V170, P990, DOI 10.1097/01.ju.0000079761.56154.e5; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hayward SW, 2001, CANCER RES, V61, P8135; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Koochekpour S, 2004, PROSTATE, V60, P141, DOI 10.1002/pros.20053; Levy David A, 2011, Curr Urol Rep, V12, P197, DOI 10.1007/s11934-011-0177-1; Madu CO, 2010, J CANCER, V1, P150; Meulenbeld HJ, 2013, BJU INT, V111, P44, DOI 10.1111/j.1464-410X.2012.11404.x; Parray A, 2012, BIOL-TARGETS THER, V6, P267, DOI 10.2147/BTT.S23954; Petrylak DP, 2006, J NATL CANCER I, V98, P516, DOI 10.1093/jnci/djj129; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sasaki T, 2005, EUR UROL, V48, P224, DOI 10.1016/j.eururo.2005.03.017; Shariat SF, 2011, ACTA ONCOL, V50, P61, DOI 10.3109/0284186X.2010.542174; Siddique HR, 2012, INT J CANCER, V131, P1720, DOI 10.1002/ijc.27409; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Siddique HR, 2011, CLIN CANCER RES, V17, P5379, DOI 10.1158/1078-0432.CCR-11-0916; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith DS, 1998, J UROLOGY, V160, P1734, DOI 10.1016/S0022-5347(01)62395-4; Spiess PE, 2007, CANCER-AM CANCER SOC, V110, P1729, DOI 10.1002/cncr.22971; Taplin ME, 2005, UROLOGY, V66, P386, DOI 10.1016/j.urology.2005.03.040; Theodore S, 2010, INT J ONCOL, V37, P1477, DOI 10.3892/ijo_00000800; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918	34	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52993	10.1371/journal.pone.0052993	http://dx.doi.org/10.1371/journal.pone.0052993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308129	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100022
J	Condren, AB; Kumar, A; Mettu, P; Liang, KJ; Zhao, L; Tsai, JY; Fariss, RN; Wong, WT				Condren, Audrey B.; Kumar, Anil; Mettu, Pradeep; Liang, Katharine J.; Zhao, Lian; Tsai, Jen-yue; Fariss, Robert N.; Wong, Wai T.			Perivascular Mural Cells of the Mouse Choroid Demonstrate Morphological Diversity That Is Correlated to Vasoregulatory Function	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; SMOOTH-MUSCLE-CELLS; MACULAR DEGENERATION; BLOOD-FLOW; HUMAN EYE; MORPHOMETRIC-ANALYSIS; CILIARY GANGLION; BRUCHS MEMBRANE; NITRIC-OXIDE; PERICYTES	Objective: Perivascular mural cells of the choroid have been implicated in physiological functioning as well as in retinal disease pathogenesis. However details regarding their form and function are not well understood. We aim to characterize choroidal mural cells in the adult mouse choroid in terms of their distribution and morphology, and correlate these to their contractile behavior. Methods: Sclerochoroidal flat-mounted explants were prepared from albino transgenic mice in which the a-smooth muscle actin (alpha-SMA) promoter drives the expression of green fluorescent protein (GFP). alpha-SMA-expressing smooth muscle cells and pericytes in the living choroid were thereby rendered fluorescent and imaged with confocal microscopy and live-cell imaging in situ. Results: Choroidal perivascular mural cells demonstrate significant diversity in terms of their distribution and morphology at different levels of the vasculature. They range from densely-packed circumferentially-oriented cells that provide complete vascular coverage in primary arteries to widely-spaced stellate-shaped cells that are distributed sparsely over terminal arterioles. Mural cells at each level are immunopositive for contractile proteins alpha-SMA and desmin and demonstrate vasoconstrictory contractile movements in response to endothelin-1 and the calcium ionophore, A23187, and vasodilation in response to the calcium chelator, BAPTA. The prominence of vasoregulatory contractile responses varies with mural cell morphology and density, and is greater in vessels with dense coverage of mural cells with circumferential cellular morphologies. In the choriocapillaris, pericytes demonstrate a sparse, horizontal distribution and are selectively distributed only to the scleral surface of the choriocapillaris. Conclusions: Diversity and regional specialization of perivascular mural cells may subserve varying requirements for vasoregulation in the choroid. The model of the alpha-SMA-GFP transgenic albino mouse provides a useful and intact system for the morphological and functional study of choroidal mural cells.	[Condren, Audrey B.; Kumar, Anil; Mettu, Pradeep; Liang, Katharine J.; Zhao, Lian; Wong, Wai T.] NEI, Unit Neuron Glia Interact Retinal Dis, NIH, Bethesda, MD 20892 USA; [Tsai, Jen-yue; Fariss, Robert N.] NEI, Biol Imaging Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Wong, WT (corresponding author), NEI, Unit Neuron Glia Interact Retinal Dis, NIH, Bethesda, MD 20892 USA.	wongw@nei.nih.gov	Fariss, Robert/ABI-1771-2020; Wong, Wai/B-6118-2017	Wong, Wai/0000-0003-0681-4016; Fariss, Robert/0000-0003-3227-7170	National Eye Institute Intramural Research Program; NATIONAL EYE INSTITUTE [ZICEY000459] Funding Source: NIH RePORTER	National Eye Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Eye Institute Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Berenberg TL, 2012, RETINA-J RET VIT DIS, V32, P25, DOI 10.1097/IAE.0b013e3182150483; Boltz A, 2010, INVEST OPHTH VIS SCI, V51, P4220, DOI 10.1167/iovs.09-4968; Chan-Ling T, 2011, INVEST OPHTH VIS SCI, V52, P399, DOI 10.1167/iovs.10-5403; Ciulla TA, 2002, BRIT J OPHTHALMOL, V86, P209, DOI 10.1136/bjo.86.2.209; Ciulla TA, 2001, ACTA OPHTHALMOL SCAN, V79, P108, DOI 10.1034/j.1600-0420.2001.079002108.x; COGAN DG, 1967, ARCH OPHTHALMOL-CHIC, V78, P133; Curtis TM, 2001, J PHYSIOL-LONDON, V532, P609, DOI 10.1111/j.1469-7793.2001.0609e.x; DAS A, 1988, EXP EYE RES, V46, P349, DOI 10.1016/S0014-4835(88)80025-3; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; Dimitrova G, 2001, EYE, V15, P602, DOI 10.1038/eye.2001.193; EPSTEIN ML, 1988, NEUROSCIENCE, V25, P1053, DOI 10.1016/0306-4522(88)90058-9; FERRARIDILEO G, 1989, INVEST OPHTH VIS SCI, V30, P473; FLUGEL C, 1994, INVEST OPHTH VIS SCI, V35, P592; Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P385; Grunwald JE, 2005, INVEST OPHTH VIS SCI, V46, P1033, DOI 10.1167/iovs.04-1050; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hlushchuk R, 2007, MICROCIRCULATION, V14, P813, DOI 10.1080/10739680701370021; ISHIBASHI T, 1995, ARCH OPHTHALMOL-CHIC, V113, P227, DOI 10.1001/archopht.1995.01100020111041; Jo N, 2006, AM J PATHOL, V168, P2036, DOI 10.2353/ajpath.2006.050588; KELLEY C, 1987, J CELL BIOL, V104, P483, DOI 10.1083/jcb.104.3.483; KILLINGSWORTH MC, 1995, GRAEF ARCH CLIN EXP, V233, P313, DOI 10.1007/BF00200479; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Ladewig MS, 2005, PROSTAG LEUKOTR ESS, V72, P251, DOI 10.1016/j.plefa.2004.11.006; LATIES AM, 1967, ARCH OPHTHALMOL-CHIC, V77, P405, DOI 10.1001/archopht.1967.00980020407021; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; MANCHE EE, 1990, ACTA ANAT, V138, P89; Mata NL, 2010, CURR OPIN OPHTHALMOL, V21, P190, DOI 10.1097/ICU.0b013e32833866c8; May CA, 2004, INVEST OPHTH VIS SCI, V45, P361, DOI 10.1167/iovs.03-0624; MERINEY SD, 1987, J NEUROSCI, V7, P3840; Metelitsina TI, 2008, INVEST OPHTH VIS SCI, V49, P358, DOI 10.1167/iovs.07-0526; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Muir ER, 2012, INVEST OPHTHALMOL VI; Nagaoka T, 2004, BRIT J OPHTHALMOL, V88, P1060, DOI 10.1136/bjo.2003.035345; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Nilsson SFE, 1996, INVEST OPHTH VIS SCI, V37, P2110; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Sarks JP, 1997, EYE, V11, P515, DOI 10.1038/eye.1997.137; Schmetterer L, 1998, GRAEF ARCH CLIN EXP, V236, P160, DOI 10.1007/s004170050058; Schocket Lisa S., 2004, International Ophthalmology, V25, P89, DOI 10.1023/B:INTE.0000031744.93778.60; Scholfield CN, 2007, MICROCIRCULATION, V14, P11, DOI 10.1080/10739680601072115; Schrodl F, 2003, INVEST OPHTH VIS SCI, V44, P3705, DOI 10.1167/iovs.03-0232; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Sims DE, 2000, CLIN EXP PHARMACOL P, V27, P842, DOI 10.1046/j.1440-1681.2000.03343.x; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; Spraul CW, 1999, SURV OPHTHALMOL, V44, pS10, DOI 10.1016/S0039-6257(99)00086-7; Spraul CW, 1996, INVEST OPHTH VIS SCI, V37, P2724; Wu DM, 2003, AM J PHYSIOL-HEART C, V284, pH2083, DOI 10.1152/ajpheart.01007.2002; YAMAMOTO R, 1993, NEUROSCIENCE, V54, P189, DOI 10.1016/0306-4522(93)90393-T; YE XO, 1990, INVEST OPHTH VIS SCI, V31, P1731; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346	51	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53386	10.1371/journal.pone.0053386	http://dx.doi.org/10.1371/journal.pone.0053386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308209	gold, Green Submitted, Green Published			2022-12-27	WOS:000313670100035
J	Somekh, J; Choder, M; Dori, D				Somekh, Judith; Choder, Mordechai; Dori, Dov			Conceptual Model-Based Systems Biology: Mapping Knowledge and Discovering Gaps in the mRNA Transcription Cycle	PLOS ONE			English	Article							TERMINAL DOMAIN PHOSPHATASE; SIMULATION; INITIATION; MEDIATOR; EXECUTION; NETWORK; TFIIB	We propose a Conceptual Model-based Systems Biology framework for qualitative modeling, executing, and eliciting knowledge gaps in molecular biology systems. The framework is an adaptation of Object-Process Methodology (OPM), a graphical and textual executable modeling language. OPM enables concurrent representation of the system's structure-the objects that comprise the system, and behavior-how processes transform objects over time. Applying a top-down approach of recursively zooming into processes, we model a case in point-the mRNA transcription cycle. Starting with this high level cell function, we model increasingly detailed processes along with participating objects. Our modeling approach is capable of modeling molecular processes such as complex formation, localization and trafficking, molecular binding, enzymatic stimulation, and environmental intervention. At the lowest level, similar to the Gene Ontology, all biological processes boil down to three basic molecular functions: catalysis, binding/dissociation, and transporting. During modeling and execution of the mRNA transcription model, we discovered knowledge gaps, which we present and classify into various types. We also show how model execution enhances a coherent model construction. Identification and pinpointing knowledge gaps is an important feature of the framework, as it suggests where research should focus and whether conjectures about uncertain mechanisms fit into the already verified model.	[Somekh, Judith; Dori, Dov] Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel; [Dori, Dov] MIT, Engn Syst Div, Cambridge, MA 02139 USA; [Choder, Mordechai] Technion Israel Inst Technol, Fac Med, Haifa, Israel	Technion Israel Institute of Technology; Massachusetts Institute of Technology (MIT); Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Somekh, J (corresponding author), Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel.	yuditol@technion.ac.il		Dori, Dov/0000-0002-2393-3124	Israeli Ministry of Science [38221]; European Union [262044 - VISIONAIR]; Gordon Center for Systems Engineering at the Technion; Israel Science Foundation	Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); European Union(European Commission); Gordon Center for Systems Engineering at the Technion; Israel Science Foundation(Israel Science Foundation)	This work was funded in part by a grant agreement No. 38221 for Promoting Women in Science by the Israeli Ministry of Science to JS. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 262044 - VISIONAIR and from Gordon Center for Systems Engineering at the Technion. This work was partially supported by a grant from Israel Science Foundation to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; [Anonymous], 2011, ENCY KNOWLEDGE MANAG; Calzone L, 2006, BIOINFORMATICS, V22, P1805, DOI 10.1093/bioinformatics/btl172; Cannata N, 2005, LECT NOTES COMPUT SC, V3737, P105; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Dori D, 2004, VLDB J, V13, P120, DOI 10.1007/s00778-004-0120-x; Dori D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000872; Efroni S, 2003, GENOME RES, V13, P2485, DOI 10.1101/gr.1215303; Faeder JR, 2005, COMPLEXITY, V10, P22, DOI 10.1002/cplx.20074; Fisher J, 2005, P NATL ACAD SCI USA, V102, P1951, DOI 10.1073/pnas.0409433102; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Friedl EM, 2003, P NATL ACAD SCI USA, V100, P2328, DOI 10.1073/pnas.2628049100; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Harel D, 2008, ELECTRON NOTES THEOR, V194, P119, DOI 10.1016/j.entcs.2007.12.009; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Jansson A, 2010, DRUG DISCOV TODAY, V15, P365, DOI 10.1016/j.drudis.2010.02.012; Kam N, 2003, LECT NOTES COMPUT SC, V2602, P4; Kielbassa J, 2009, COMPUT BIOL CHEM, V33, P46, DOI 10.1016/j.compbiolchem.2008.07.022; Kobor MS, 2000, MOL CELL BIOL, V20, P7438, DOI 10.1128/MCB.20.20.7438-7449.2000; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Machado D, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-45; MELTON J, 2006, QUERYING XML XQUERY; Moraru II, 2008, IET SYST BIOL, V2, P352, DOI 10.1049/iet-syb:20080102; Peleg M, 2002, BIOINFORMATICS, V18, P825, DOI 10.1093/bioinformatics/18.6.825; Peleg M, 2000, IEEE T SOFTWARE ENG, V26, P742, DOI 10.1109/32.879812; Perelman L, 2011, THESIS TECHNION ISRA; Perelman V, 2011, SIMUL SERIES, V43, P140; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Rani PG, 2004, MOL CELL BIOL, V24, P1709, DOI 10.1128/MCB.24.4.1709-1720.2004; Reddy VN, 1993, P INT C INTELL SYST, V1; Regev A, 2001, Pac Symp Biocomput, P459; Sadot A, 2008, IEEE ACM T COMPUT BI, V5, P223, DOI 10.1109/TCBB.2007.1076; Shmulevich I, 2003, P NATL ACAD SCI USA, V100, P10734, DOI 10.1073/pnas.1534782100; Smith Barry, 2003, AMIA Annu Symp Proc, P609; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Webb K, 2004, LECT NOTES COMPUT SC, V3029, P128; Yaroker Y, 2012, SYSTEMS ENG IN PRESS; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	45	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51430	10.1371/journal.pone.0051430	http://dx.doi.org/10.1371/journal.pone.0051430			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23308089	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500029
J	Firnhaber, C; Mayisela, N; Mao, L; Williams, S; Swarts, A; Faesen, M; Levin, S; Michelow, P; Omar, T; Hudgens, MG; Williamson, AL; Allan, B; Lewis, DA; Smith, JS				Firnhaber, Cynthia; Mayisela, Nomtha; Mao, Lu; Williams, Sophie; Swarts, Avril; Faesen, Mark; Levin, Simon; Michelow, Pam; Omar, Tanvier; Hudgens, Michael G.; Williamson, Anna-Lise; Allan, Bruce; Lewis, David A.; Smith, Jennifer S.			Validation of Cervical Cancer Screening Methods in HIV Positive Women from Johannesburg South Africa	PLOS ONE			English	Article							VIRUS-INFECTED WOMEN; HUMAN-PAPILLOMAVIRUS; VISUAL INSPECTION; ACETIC-ACID; ACCURACY; CYTOLOGY; DYSPLASIA; TESTS	Background: HIV-infected women are at increased risk for developing cervical cancer. Women living in resource-limited countries are especially at risk due to poor access to cervical cancer screening and treatment. We evaluated three cervical cancer screening methods to detect cervical intraepithelial neoplasia grade 2 and above (CIN 2+) in HIV-infected women in South Africa; Pap smear, visual inspection with 5% acetic acid (VIA) and human papillomavirus detection (HPV). Methods: HIV-infected women aged 18-65 were recruited in Johannesburg. A cross-sectional study evaluating three screening methods for the detection of the histologically-defined gold standard CIN-2 + was performed. Women were screened for cervical abnormalities with the Digene HC2 assay (HPV), Pap smear and VIA. VIA was performed by clinic nurses, digital photographs taken and then later reviewed by specialist physicians. The sensitivity, specificity and predictive valves for CIN-2 + were calculated using maximum likelihood estimators. Results: 1,202 HIV-infected women participated, with a median age of 38 years and CD4 counts of 394 cells/mm(3). One third of women had a high grade lesion on cytology. VIA and HPV were positive in 45% and 61% of women respectively. Estimated sensitivity/specificity for HPV, Pap smear and VIA for CIN 2+ was 92%/51.4%, 75.8%/83.4% and 65.4/68.5% (nurse reading), respectively. Sensitivities were similar, and specificities appeared significantly lower for the HPV test, cytology and VIA among women with CD4 counts <= 200 cells/mm(3) as compared to CD4 counts >350 cells/mm(3). Conclusions: Although HPV was the most sensitive screening method for detecting CIN 2+, it was less specific than conventional cytology and VIA with digital imaging review. Screening programs may need to be individualized in context of the resources and capacity in each area.	[Firnhaber, Cynthia; Swarts, Avril; Lewis, David A.] Univ Witwatersrand, Dept Med, Fac Hlth Sci Ctr, ZA-2001 Johannesburg, South Africa; [Firnhaber, Cynthia; Mayisela, Nomtha; Williams, Sophie; Faesen, Mark; Levin, Simon] Right Care, Johannesburg, South Africa; [Mao, Lu; Hudgens, Michael G.] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Levin, Simon] Univ Witwatersrand, Dept OB GYN, Coronat Hosp, ZA-2001 Johannesburg, South Africa; [Michelow, Pam; Omar, Tanvier] Univ Witwatersrand, Fac Hlth Sci, Dept Anat Pathol, Cytol Unit, ZA-2001 Johannesburg, South Africa; [Michelow, Pam; Omar, Tanvier] Natl Hlth Lab Serv, Johannesburg, South Africa; [Michelow, Pam; Omar, Tanvier] Dept Pathol, Johannesburg, South Africa; [Williamson, Anna-Lise; Allan, Bruce] Univ Cape Town, Inst Infect Dis, ZA-7925 Cape Town, South Africa; [Williamson, Anna-Lise; Allan, Bruce] Univ Cape Town, Div Med Virol, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Williamson, Anna-Lise] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Lewis, David A.] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr HIV & Sexually Transmitted Infect, Johannesburg, South Africa; [Smith, Jennifer S.] Univ N Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Smith, Jennifer S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Cape Town; University of Cape Town; University of Cape Town; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Firnhaber, C (corresponding author), Univ Witwatersrand, Dept Med, Fac Hlth Sci Ctr, ZA-2001 Johannesburg, South Africa.	cindy.firnhaber@righttocare.org	Mao, Lu/H-9998-2019	Mao, Lu/0000-0002-8626-9822; Williamson, Anna-Lise/0000-0002-5467-1200; Lewis, David/0000-0002-5534-8392	University of North Carolina Center for AIDS Research [P30-AI50410]; USAID PEPFAR [674-A-00-08-00007-00]; South African Research Chairs Initiative of the Department of Science and Technology [PHE ZA.09.0265]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	University of North Carolina Center for AIDS Research; USAID PEPFAR(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); South African Research Chairs Initiative of the Department of Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding Source: University of North Carolina Center for AIDS Research (P30-AI50410), USAID PEPFAR (674-A-00-08-00007-00), PHE ZA.09.0265 South African Research Chairs Initiative of the Department of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DH, 2012, AIDS; Akinwuntan AL, 2008, J OBSTET GYNAECOL, V28, P638, DOI 10.1080/01443610802259977; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; CUELLO C, 1983, JNCI-J NATL CANCER I, V70, P635; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; Eholie S P, 2009, Med Trop (Mars), V69, P520; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; Firnhaber C, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17382; Firnhaber C, 2010, CANCER CAUSE CONTROL, V21, P433, DOI 10.1007/s10552-009-9475-z; Firnhaber C, 2009, ACTA CYTOL, V53, P10, DOI 10.1159/000325079; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Kuhn L, 2012, AIDS, V24, P2553; Mabeya H, 2012, J LOW GENIT TRACT DI, V16, P92, DOI 10.1097/LGT.0b013e3182320f0c; Mannino J. Robert, 1998, Journal of the American Osteopathic Association, V98, P542; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Sahasrabuddhe VV, 2012, INT J CANCER, V130, P234, DOI 10.1002/ijc.25971; Sankaranarayanan R, 2003, PRACTICAL MANUAL VIS; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Sepulveda C, 2005, CANCER DETECT PREV, V29, P405, DOI 10.1016/j.cdp.2005.07.001; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Suba EJ, 2012, DIAGN CYTOPATHOL, V40, P355, DOI 10.1002/dc.21655; Tshabalala-Msimang ME, 2003, OPERATIONAL PLAN COM; Zhao FH, 2012, INT J CANCER, V131, P2929, DOI 10.1002/ijc.27571; ZHOU XH, 1993, COMMUN STAT THEORY, V22, P3177, DOI 10.1080/03610929308831209; Zhou XH, 2000, STAT MED, V19, P1697, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1697::AID-SIM455>3.0.CO;2-Q	29	85	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53494	10.1371/journal.pone.0053494	http://dx.doi.org/10.1371/journal.pone.0053494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326441	gold, Green Submitted, Green Published			2022-12-27	WOS:000314705800050
J	Mallick, A; Barik, S; Goswami, KK; Banerjee, S; Ghosh, S; Sarkar, K; Bose, A; Baral, R				Mallick, Atanu; Barik, Subhasis; Goswami, Kuntal Kanti; Banerjee, Saptak; Ghosh, Sarbari; Sarkar, Koustav; Bose, Anamika; Baral, Rathindranath			Neem Leaf Glycoprotein Activates CD8(+) T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse Sarcoma	PLOS ONE			English	Article							MURINE EHRLICH CARCINOMA; ADOPTIVE IMMUNOTHERAPY; SUPPRESSOR-CELLS; DENDRITIC CELLS; TUMOR-IMMUNITY; IFN-GAMMA; NK CELLS; INDUCTION; RESTORATION; CYTOKINES	In spite of sufficient data on Neem Leaf Glycoprotein (NLGP) as a prophylactic vaccine, little knowledge currently exists to support the use of NLGP as a therapeutic vaccine. Treatment of mice bearing established sarcomas with NLGP (25 mu g/mice/week subcutaneously for 4 weeks) resulted in tumor regression or dormancy (Tumor free/Regressor, 13/24 (NLGP), 4/24 (PBS)). Evaluation of CD8(+) T cell status in blood, spleen, TDLN, VDLN and tumor revealed increase in cellular number. Elevated expression of CD69, CD44 and Ki67 on CD8(+) T cells revealed their state of activation and proliferation by NLGP. Depletion of CD8(+) T cells in mice at the time of NLGP treatment resulted in partial termination of tumor regression. An expansion of CXCR3(+) and CCR5(+) T cells was observed in the TDLN and tumor, along with their corresponding ligands. NLGP treatment enhances type 1 polarized T-bet expressing T cells with downregulation of GATA3. Treg cell population was almost unchanged. However, T: Treg ratios significantly increased with NLGP. Enhanced secretion/expression of IFN gamma was noted after NLGP therapy. In vitro culture of T cells with IL-2 and sarcoma antigen resulted in significant enhancement in cytotoxic efficacy. Consistently higher expression of CD107a was also observed in CD8(+) T cells from tumors. Reinoculation of sarcoma cells in tumor regressed NLGP-treated mice maintained tumor free status in majority. This is correlated with the increment of CD44(hi)CD62L(hi) central memory T cells. Collectively, these findings support a paradigm in which NLGP dynamically orchestrates the activation, expansion, and recruitment of CD8(+) T cells into established tumors to operate significant tumor cell lysis.	[Mallick, Atanu; Barik, Subhasis; Goswami, Kuntal Kanti; Banerjee, Saptak; Ghosh, Sarbari; Sarkar, Koustav; Bose, Anamika; Baral, Rathindranath] CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India		Baral, R (corresponding author), CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India.	baralrathin@hotmail.com	Sarkar, Koustav/ABE-6071-2021; Banerjee, Dr Saptak/HDO-6987-2022	Banerjee, Dr Saptak/0000-0001-9211-2074; SARKAR, KOUSTAV/0000-0002-0696-6688; Barik, Subhasis/0000-0002-0488-0434	Indian Council of Medical Research, New Delhi [Immuno/18/11/08/2006-ECD-I, 3/2/2/188/2009/NCD-III]; Council of Scientific and Industrial Research, New Delhi [8463A, 09/030(0063)/2011-EMR-I, 09/030(0050)/2008-EMR-I]; University Grant Commission, New Delhi [F.2-3/2000 (SA-1)]; Department of Science and Technology, New Delhi (INSPIRE Fellowship) [2011/188]	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, New Delhi(University Grants Commission, India); Department of Science and Technology, New Delhi (INSPIRE Fellowship)(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	Funding: The work was partially supported by Indian Council of Medical Research, New Delhi (grant Immuno/18/11/08/2006-ECD-I; 3/2/2/188/2009/NCD-III to AM), Council of Scientific and Industrial Research, New Delhi (grants SRA (Scientists's Pool Scheme No: 8463A to AB); 09/030(0063)/2011-EMR-I to SB); 09/030(0050)/2008-EMR-I to SB), from University Grant Commission, New Delhi (grant F.2-3/2000 (SA-1) to KKG) and from Department of Science and Technology, New Delhi (INSPIRE Fellowship number 2011/188 to SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angevin E, 1997, INT J CANCER, V72, P431, DOI 10.1002/(SICI)1097-0215(19970729)72:3<431::AID-IJC10>3.3.CO;2-3; Apetoh L, 2011, CURR MOL MED, V11, P365, DOI 10.2174/156652411795976574; Bailey JL, 1967, TECHNIQUES PROTEIN C, P340; Baitsch L, 2012, TRENDS IMMUNOL, V33, P364, DOI 10.1016/j.it.2012.02.006; Baral R, 2005, INT IMMUNOPHARMACOL, V5, P1343, DOI 10.1016/j.intimp.2005.03.008; Baral R, 2004, INT IMMUNOPHARMACOL, V4, P355, DOI 10.1016/j.intimp.2003.09.006; Ben-Baruch A, 2012, CANCER MICROENVIRON, V5, P151, DOI 10.1007/s12307-011-0094-3; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bose A, 2009, HUM IMMUNOL, V70, P6, DOI 10.1016/j.humimm.2008.09.004; Bose A, 2007, HUM IMMUNOL, V68, P823, DOI 10.1016/j.humimm.2007.08.002; Bose A, 2007, PHYTOTHER RES, V21, P914, DOI 10.1002/ptr.2185; Bose A, 2009, J IMMUNOTHER, V32, P42, DOI 10.1097/CJI.0b013e31818e997d; Bourgeois C, 2003, EUR J IMMUNOL, V33, P3225, DOI 10.1002/eji.200324576; Butterfield LH, 2004, GASTROENTEROLOGY, V127, pS232, DOI 10.1053/j.gastro.2004.09.038; Chakraborty K, 2008, INT IMMUNOPHARMACOL, V8, P330, DOI 10.1016/j.intimp.2007.10.015; Chakraborty K, 2012, HUM IMMUNOL, V73, P38, DOI 10.1016/j.humimm.2011.10.015; Chakraborty K, 2010, CELL MOL IMMUNOL, V7, P396, DOI 10.1038/cmi.2010.29; Chakraborty T, 2011, IMMUNOTHERAPY-UK, V3, P949, DOI [10.2217/IMT.11.81, 10.2217/imt.11.81]; Chakroborty D, 2011, P NATL ACAD SCI USA, V108, P20730, DOI 10.1073/pnas.1108696108; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Goswami S, 2010, VACCINE, V28, P1241, DOI 10.1016/j.vaccine.2009.11.018; Haque E, 2006, IMMUNOPHARM IMMUNOT, V28, P33, DOI 10.1080/08923970600623632; Haque E, 2006, IMMUNOBIOLOGY, V211, P721, DOI 10.1016/j.imbio.2006.02.005; Higham EM, 2010, J IMMUNOL, V184, P5954, DOI 10.4049/jimmunol.1000265; Kemp RA, 2001, J IMMUNOL, V167, P6497, DOI 10.4049/jimmunol.167.11.6497; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Kurosaki M, 2011, CANCER IMMUNOL IMMUN, V60, P207, DOI 10.1007/s00262-010-0932-z; Le XD, 2005, P NATL ACAD SCI USA, V102, P8758, DOI 10.1073/pnas.0409581102; MacGregor JN, 2006, CANCER RES, V66, P4913, DOI 10.1158/0008-5472.CAN-05-3507; Mandal-Ghosh Ishita, 2007, Cancer Immun, V7, P8; Nishimura F, 2006, CANCER RES, V66, P4478, DOI 10.1158/0008-5472.CAN-05-3825; Pan PY, 2010, CANCER RES, V70, P99, DOI 10.1158/0008-5472.CAN-09-1882; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Redmond WL, 2009, EUR J IMMUNOL, V39, P2184, DOI 10.1002/eji.200939348; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Roy S, 2011, CLIN VACCINE IMMUNOL, V18, P571, DOI 10.1128/CVI.00499-10; Sampson JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031046; Sarkar K, 2008, VACCINE, V26, P4352, DOI 10.1016/j.vaccine.2008.06.048; Sarkar K, 2010, INT IMMUNOPHARMACOL, V10, P865, DOI 10.1016/j.intimp.2010.04.024; Sarkar K, 2009, INT IMMUNOPHARMACOL, V9, P753, DOI 10.1016/j.intimp.2009.02.016; Uekusa Y, 2002, CANCER RES, V62, P3751; Wang E, 2002, CANCER RES, V62, P3581; Wang Li-Xin, 2004, J Transl Med, V2, P41, DOI 10.1186/1479-5876-2-41; Wolkers MC, 2012, BLOOD, V119, P798, DOI 10.1182/blood-2011-08-373910; Wu R, 2012, CANCER J, V18, P160, DOI 10.1097/PPO.0b013e31824d4465; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang PS, 2007, CANCER RES, V67, P6468, DOI 10.1158/0008-5472.CAN-07-1264; Zhao X, 2011, MOL THER, V19, P805, DOI 10.1038/mt.2010.295; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	51	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e47434	10.1371/journal.pone.0047434	http://dx.doi.org/10.1371/journal.pone.0047434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326300	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800002
J	Chhabra, R; Kolli, S; Bauer, JH				Chhabra, Ria; Kolli, Santharam; Bauer, Johannes H.			Organically Grown Food Provides Health Benefits to Drosophila melanogaster	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; INSULIN-RESISTANCE; OBESITY; MODEL; FLY; LONGEVITY; EXTENSION; PATHWAY; SYSTEMS; BRAIN	The "organic food'' market is the fastest growing food sector, yet it is unclear whether organically raised food is nutritionally superior to conventionally grown food and whether consuming organic food bestows health benefits. In order to evaluate potential health benefits of organic foods, we used the well-characterized fruit fly Drosophila melanogaster as a model system. Fruit flies were raised on a diets consisting of extracts of either conventionally or organically raised produce (bananas, potatoes, raisins, soy beans). Flies were then subjected to a variety of tests designed to assess overall fly health. Flies raised on diets made from organically grown produce had greater fertility and longevity. On certain food sources, greater activity and greater stress resistance was additionally observed, suggesting that organic food bestows positive effects on fly health. Our data show that Drosophila can be used as a convenient model system to experimentally test potential health effects of dietary components. Using this system, we provide evidence that organically raised food may provide animals with tangible benefits to overall health.	[Chhabra, Ria] Clark High Sch, Plano, TX USA; [Kolli, Santharam; Bauer, Johannes H.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; [Kolli, Santharam; Bauer, Johannes H.] So Methodist Univ, Dedman Coll, Ctr Drug Discovery Design & Delivery, Dallas, TX 75275 USA	Southern Methodist University; Southern Methodist University	Bauer, JH (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	jbauer@smu.edu		Bauer, Johannes/0000-0001-5539-2601	Ralph E. Powe Junior Faculty Enhancement Award	Ralph E. Powe Junior Faculty Enhancement Award	The authors thank Chris Thephachanh, Claire Coogan, Babita Jain and Sarah Morris for technical assistance and helpful discussions. JHB is a recipient of the Ralph E. Powe Junior Faculty Enhancement Award.	Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bauer JH, 2011, GENETICS DIETARY MOD; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Bauer JH, 2009, AGING-US, V1, P38; BENDINER E, 1987, HOSP PRACT, V22, P116; Bendiner E., 1987, HOSP PRACT OFF ED, V22; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Dangour AD, 2010, AM J CLIN NUTR, V92, P203, DOI 10.3945/ajcn.2010.29269; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Gilden RC, 2010, JOGNN-J OBST GYN NEO, V39, P103, DOI 10.1111/j.1552-6909.2009.01092.x; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hallmann E, 2012, J SCI FOOD AGR, V92, P2840, DOI 10.1002/jsfa.5617; Hallmann E, 2012, J SCI FOOD AGR, V92, P2409, DOI 10.1002/jsfa.5624; Haselton AT, 2010, AGING-US, V2, P523, DOI 10.18632/aging.100185; Helfand SL, 2003, ADV GENET, V49, P67, DOI 10.1016/S0065-2660(03)01002-2; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Huber M, 2011, NJAS-WAGEN J LIFE SC, V58, P103, DOI 10.1016/j.njas.2011.01.004; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kim T, 2005, J BIOCHEM MOL BIOL, V38, P121; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Koh E, 2012, J AGR FOOD CHEM, V60, P3144, DOI 10.1021/jf300051f; Lester GE, 2011, J AGR FOOD CHEM, V59, P10401, DOI 10.1021/jf202385x; Lu CS, 2006, ENVIRON HEALTH PERSP, V114, P260, DOI 10.1289/ehp.8418; Morris SNS, 2012, BBA-MOL BASIS DIS, V1822, P1230, DOI 10.1016/j.bbadis.2012.04.012; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Palupi E, 2012, J SCI FOOD AGR, V92, P2774, DOI 10.1002/jsfa.5639; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Shepherd R, 2011, FORESIGHT GOVT OF SR, VSR12, P1; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030	36	22	24	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52988	10.1371/journal.pone.0052988	http://dx.doi.org/10.1371/journal.pone.0052988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326371	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500040
J	Freeth, M; Foulsham, T; Kingstone, A				Freeth, Megan; Foulsham, Tom; Kingstone, Alan			What Affects Social Attention? Social Presence, Eye Contact and Autistic Traits	PLOS ONE			English	Article							SPECTRUM DISORDERS; FUNCTIONING AUTISM; VISUAL INFORMATION; GAZE ALLOCATION; PATTERNS; CONVERSATION; ENVIRONMENT; PERCEPTION; MOVEMENTS; COGNITION	Social understanding is facilitated by effectively attending to other people and the subtle social cues they generate. In order to more fully appreciate the nature of social attention and what drives people to attend to social aspects of the world, one must investigate the factors that influence social attention. This is especially important when attempting to create models of disordered social attention, e.g. a model of social attention in autism. Here we analysed participants' viewing behaviour during one-to-one social interactions with an experimenter. Interactions were conducted either live or via video (social presence manipulation). The participant was asked and then required to answer questions. Experimenter eye-contact was either direct or averted. Additionally, the influence of participant self-reported autistic traits was also investigated. We found that regardless of whether the interaction was conducted live or via a video, participants frequently looked at the experimenter's face, and they did this more often when being asked a question than when answering. Critical differences in social attention between the live and video interactions were also observed. Modifications of experimenter eye contact influenced participants' eye movements in the live interaction only; and increased autistic traits were associated with less looking at the experimenter for video interactions only. We conclude that analysing patterns of eye-movements in response to strictly controlled video stimuli and natural real-world stimuli furthers the field's understanding of the factors that influence social attention.	[Freeth, Megan] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Foulsham, Tom] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England; [Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC V5Z 1M9, Canada	University of Sheffield; University of Essex; University of British Columbia	Freeth, M (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England.	m.freeth@sheffield.ac.uk	Freeth, Megan/L-4512-2016	Freeth, Megan/0000-0003-0534-9095; Foulsham, Tom/0000-0002-8444-7269	Economic and Social Research Council [PTA-026-27-2283]; Wellcome Trust VIP award; Leverhulme Early Career Fellowship [ECF/2010/0592]; Commonwealth Fellowship from the Government of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) operating grant; Economic and Social Research Council [ES/G046417/1] Funding Source: researchfish; ESRC [ES/G046417/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust VIP award(Wellcome Trust); Leverhulme Early Career Fellowship(Leverhulme Trust); Commonwealth Fellowship from the Government of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) operating grant; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	MF was supported by Economic and Social Research Council (PTA-026-27-2283), a Wellcome Trust VIP award and a Leverhulme Early Career Fellowship (ECF/2010/0592). TF was supported by a Commonwealth Fellowship from the Government of Canada. AK was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) operating grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranek GT, 1999, J AUTISM DEV DISORD, V29, P213, DOI 10.1023/A:1023080005650; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bird G, 2011, J AUTISM DEV DISORD, V41, P1556, DOI 10.1007/s10803-011-1183-3; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Brown-Schmidt S, 2008, COGNITIVE SCI, V32, P643, DOI 10.1080/03640210802066816; Chen FS, 2011, J AUTISM DEV DISORD, V41, P1131, DOI 10.1007/s10803-010-1136-2; Csibra G, 2006, ATTENTION PERFORM, P249; Doherty-Sneddon G, 2005, MEM COGNITION, V33, P727, DOI 10.3758/BF03195338; Doherty-Sneddon G, 2002, DEV PSYCHOL, V38, P438, DOI 10.1037//0012-1649.38.3.438; Droll JA, 2009, VIS COGN, V17, P1159, DOI 10.1080/13506280902797125; ELLSWORTH PC, 1972, J PERS SOC PSYCHOL, V21, P302, DOI 10.1037/h0032323; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Fletcher-Watson S, 2009, NEUROPSYCHOLOGIA, V47, P248, DOI 10.1016/j.neuropsychologia.2008.07.016; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Freeth M, 2010, J AUTISM DEV DISORD, V40, P534, DOI 10.1007/s10803-009-0893-2; Freeth M, 2010, J EXP CHILD PSYCHOL, V105, P20, DOI 10.1016/j.jecp.2009.10.001; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Gallup AC, 2012, BIOL LETTERS, V8, P520, DOI 10.1098/rsbl.2012.0160; Glenberg AM, 1998, MEM COGNITION, V26, P651, DOI 10.3758/BF03211385; GUERIN B, 1986, J EXP SOC PSYCHOL, V22, P38, DOI 10.1016/0022-1031(86)90040-5; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Kingstone A, 2008, BRIT J PSYCHOL, V99, P317, DOI 10.1348/000712607X251243; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Laidlaw K, J VISION IN PRESS, V11, P620; Laidlaw KEW, 2011, P NATL ACAD SCI USA, V108, P5548, DOI 10.1073/pnas.1017022108; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Nadig A, 2010, NEUROPSYCHOLOGIA, V48, P2730, DOI 10.1016/j.neuropsychologia.2010.05.020; Nakano T, 2010, P ROY SOC B-BIOL SCI, V277, P2935, DOI 10.1098/rspb.2010.0587; Norbury CF, 2009, J CHILD PSYCHOL PSYC, V50, P834, DOI 10.1111/j.1469-7610.2009.02073.x; Noris B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044144; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Ponkanen LM, 2011, SOC COGN AFFECT NEUR, V6, P486, DOI 10.1093/scan/nsq068; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Risko EF, CAMBRIDGE H IN PRESS; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Risko EF, 2011, ATTEN PERCEPT PSYCHO, V73, P291, DOI 10.3758/s13414-010-0042-1; Rutherford MD, 2008, J AUTISM DEV DISORD, V38, P1371, DOI 10.1007/s10803-007-0525-7; Schilbach L., BEHAV BRAIN IN PRESS; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Spezio ML, 2007, J NEUROSCI, V27, P3994, DOI 10.1523/JNEUROSCI.3789-06.2007; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Vatikiotis-Bateson E, 1998, PERCEPT PSYCHOPHYS, V60, P926, DOI 10.3758/BF03211929; von Hofsten C, 2009, RES AUTISM SPECT DIS, V3, P556, DOI 10.1016/j.rasd.2008.12.003	47	117	118	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53286	10.1371/journal.pone.0053286	http://dx.doi.org/10.1371/journal.pone.0053286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326407	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000313551500058
J	Gonzalez, A; Manosalva, I; Liu, TX; Kageyama, R				Gonzalez, Aitor; Manosalva, Iris; Liu, Tianxiao; Kageyama, Ryoichiro			Control of Hes7 Expression by Tbx6, the Wnt Pathway and the Chemical Gsk3 Inhibitor LiCl in the Mouse Segmentation Clock	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PRESOMITIC MESODERM; VERTEBRATE SEGMENTATION; SOMITE; NOTCH; OSCILLATION; INITIATION; MECHANISM; ENHANCER; PROTEIN	The mouse segmentation is established from somites, which are iteratively induced every two hours from the presomitic mesoderm (PSM) by a system known as the segmentation clock. A crucial component of the segmentation clock is the gene Hes7, which is regulated by the Notch and Fgf/Mapk pathways, but its relation to other pathways is unknown. In addition, chemical alteration of the Wnt pathway changes the segmentation clock period but the mechanism is unclear. To clarify these questions, we have carried out Hes7 promoter analysis in transgenic mouse embryos and have identified an essential 400 bp region, which contains binding sites of Tbx6 and the Wnt signaling effector Lef1. We have found that the Hes7 promoter is activated by Tbx6, and normal activity of the Hes7 promoter in the mouse PSM requires Tbx6 binding sites. Our results demonstrate that Wnt pathway molecules activate the Hes7 promoter cooperatively with Tbx6 in cell culture and are necessary for its proper expression in the mouse PSM. Furthermore, it is shown that the chemical Gsk3 inhibitor LiCl lengthens the oscillatory period of Hes7 promoter activity. Our data suggest that Tbx6 and the Wnt pathway cooperatively regulate proper Hes7 expression. Furthermore, proper Hes7 promoter activity and expression is important for the normal pace of oscillation.	[Gonzalez, Aitor; Manosalva, Iris; Liu, Tianxiao; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Gonzalez, Aitor; Manosalva, Iris; Liu, Tianxiao; Kageyama, Ryoichiro] Japan Sci & Technol Agcy, CREST, Kyoto, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Gonzalez, A (corresponding author), Univ Strasbourg, INSERM, U964, IGBMC,CNRS,UMR 7104, Illkirch Graffenstaden, France.	agonzale@igbmc.fr; rkageyam@virus.kyoto-u.ac.jp	Manosalva, Iris/A-5019-2017; Manosalva, Iris/G-6316-2014; González, Aitor/A-4275-2011	González, Aitor/0000-0002-8402-1655; , Manosalva/0000-0001-5756-2109	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [P06237]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. AG was partly supported by postdoctoral grant P06237 awarded by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Bialecka M, 2010, DEV BIOL, V347, P228, DOI 10.1016/j.ydbio.2010.08.032; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Dubchak Inna, 2007, V395, P3; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Gibb S, 2009, DEV BIOL, V330, P21, DOI 10.1016/j.ydbio.2009.02.035; Gonzalez A, 2009, J THEOR BIOL, V259, P176, DOI 10.1016/j.jtbi.2009.02.007; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Kim W, 2011, MOL BIOL CELL, V22, P3541, DOI 10.1091/mbc.E11-02-0139; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Masui O, 2002, INT J MOL MED, V9, P489; Niwa Y, 2011, GENES DEV; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Oginuma M, 2010, DEVELOPMENT, V137, P1515, DOI 10.1242/dev.044545; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Schroter C, 2010, CURR BIOL, V20, P1254, DOI 10.1016/j.cub.2010.05.071; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Takashima Y, 2011, P NATL ACAD SCI USA, V108, P3300, DOI 10.1073/pnas.1014418108; Uriu K, 2009, J THEOR BIOL, V257, P385, DOI 10.1016/j.jtbi.2009.01.003; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Yasuhiko Y, 2008, DEVELOPMENT, V135, P3511, DOI 10.1242/dev.027144; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	33	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53323	10.1371/journal.pone.0053323	http://dx.doi.org/10.1371/journal.pone.0053323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326414	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500065
J	Lama, G; Papi, M; Angelucci, C; Maulucci, G; Sica, G; De Spirito, M				Lama, Gina; Papi, Massimiliano; Angelucci, Cristiana; Maulucci, Giuseppe; Sica, Gigliola; De Spirito, Marco			Leuprorelin Acetate Long-Lasting Effects on GnRH Receptors of Prostate Cancer Cells: An Atomic Force Microscopy Study of Agonist/Receptor Interaction	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; MESSENGER-RIBONUCLEIC-ACID; ANTIGEN GENE-EXPRESSION; HUMAN-BREAST; MEDROXYPROGESTERONE ACETATE; ANTAGONIST CETRORELIX; HUMAN ENDOMETRIAL; MOLECULAR-SIZE; IN-VITRO; LH-RH	High cell-surface GnRH receptor (GnRH-R) levels have been shown to have a major influence on the extent of GnRH agonist-mediated tumor growth inhibition. The ability of the GnRH agonist leuprorelin acetate (LA) to induce a post-transcriptional upregulation of GnRH-R at the plasma membrane of androgen-sensitive (LNCaP) and -insensitive (PC-3) prostate cancer (PCa) cells has been previously demonstrated by Western blotting. Here we performed single molecule force spectroscopy by using Atomic Force Microscopy (AFM), which has proven to be a powerful tool allowing for investigation of living cell surface biological features, such as the so far unclear GnRH agonist/receptor interaction. Thus, in the hormone-insensitive PC-3 cells, we characterized the strength of the LA-receptor binding, and the amount and distribution of the functional receptor molecules on the cell surface. The effect of a long and continuous treatment (up to 30 days) with the agonist (10(-11) and 10(-6) M) on the same parameters was also investigated. A GnRH-R increase was observed, reaching the maximum (similar to 80%) after 30 days of treatment with the highest dose of LA (10(-6) M). The analogue-induced increase in GnRH-R was also demonstrated by Western blotting. In addition, two different receptor bound strengths were detected by AFM, which suggests the existence of two GnRH-R classes. A homogeneous distribution of the unbinding events has been found on untreated and treated PC-3 cell surfaces. The persistence of high receptor levels at the membrane of these living cells may warrant the maintenance of the response to LA also in androgen-unresponsive PCa. Moreover, the determination of ligand/receptor bond strength could shed light on the poorly understood event of LA/GnRH-R interaction and/or address structural/chemical agonist optimizations.	[Lama, Gina; Angelucci, Cristiana; Sica, Gigliola] Univ Cattolica Sacro Cuore, Fac Med & Chirurg A Gemelli, Ist Istol & Embriol, Rome, Italy; [Papi, Massimiliano; Maulucci, Giuseppe; De Spirito, Marco] Univ Cattolica Sacro Cuore, Fac Med & Chirurg A Gemelli, Ist Fis, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Sica, G (corresponding author), Univ Cattolica Sacro Cuore, Fac Med & Chirurg A Gemelli, Ist Istol & Embriol, Rome, Italy.	gigliola@rm.unicatt.it	De Spirito, Marco/U-3817-2019; De Spirito, Marco/C-5386-2008; Papi, Massimiliano/AAC-3657-2022; Maulucci, Giuseppe/C-7400-2009	De Spirito, Marco/0000-0003-4260-5107; De Spirito, Marco/0000-0003-4260-5107; Papi, Massimiliano/0000-0002-0029-1309; Maulucci, Giuseppe/0000-0002-2154-319X	Takeda Italia Farmaceutici SpA	Takeda Italia Farmaceutici SpA	Takeda Italia Farmaceutici SpA partially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON L, 1995, ENDOCRINOLOGY, V136, P5228, DOI 10.1210/en.136.11.5228; Angelucci C, 2004, ANTICANCER RES, V24, P2729; Angelucci C, 2011, INT J ONCOL, V38, P1501, DOI 10.3892/ijo.2011.998; Angelucci C, 2009, ENDOCRINE, V36, P87, DOI 10.1007/s12020-009-9195-x; Bono AV, 2002, ANAL QUANT CYTOL, V24, P221; Brunelli R, 2007, FASEB J, V21, P3872, DOI 10.1096/fj.07-8189com; Castellon E, 2006, CANCER INVEST, V24, P261, DOI 10.1080/07357900600629591; d'Onofrio A, 2005, PHYSICA D, V208, P220, DOI 10.1016/j.physd.2005.06.032; De Spirito M, 2006, BIOPHYS J, V90, P4239, DOI 10.1529/biophysj.105.075788; De Spirito M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041801; Dobkin-Bekman M, 2006, MOL CELL ENDOCRINOL, V252, P184, DOI 10.1016/j.mce.2006.03.035; DONDI D, 1994, CANCER RES, V54, P4091; EMONS G, 1993, J CLIN ENDOCR METAB, V77, P1458, DOI 10.1210/jc.77.6.1458; Fost C, 2011, ONCOL REP, V25, P1481, DOI 10.3892/or.2011.1188; Green S, 1999, ENDOCR-RELAT CANCER, V6, P349, DOI 10.1677/erc.0.0060349; Grundker C, 2004, EUR J ENDOCRINOL, V151, P141, DOI 10.1530/eje.0.1510141; Iacopino F, 2006, INT J ONCOL, V29, P237; Kahan Z, 1999, J CLIN ENDOCR METAB, V84, P582, DOI 10.1210/jc.84.2.582; KAIGHN ME, 1979, INVEST UROL, V17, P16; KAISER UB, 1993, ENDOCRINOLOGY, V133, P931, DOI 10.1210/en.133.2.931; Kakar SS, 1995, CANCER LETT, V98, P57, DOI 10.1016/0304-3835(95)90203-1; KAKAR SS, 1994, MOL CELL ENDOCRINOL, V106, P145, DOI 10.1016/0303-7207(94)90196-1; LABRIE F, 1995, J CLIN ENDOCR METAB, V80, P1066, DOI 10.1210/jcem.80.4.7714068; Lamharzi N, 1998, INT J ONCOL, V13, P429; LIMONTA P, 1992, J CLIN ENDOCR METAB, V75, P207, DOI 10.1210/jcem.75.1.1320049; Limonta P, 1999, ENDOCRINOLOGY, V140, P5250, DOI 10.1210/en.140.11.5250; Lin XW, 1998, MOL CELL ENDOCRINOL, V146, P27, DOI 10.1016/S0303-7207(98)00204-4; Manni A, 1999, ENDOCR-RELAT CANCER, V6, P483, DOI 10.1677/erc.0.0060483; MARINI L, 1994, ANTICANCER RES, V14, P1881; McArdle CA, 2002, J ENDOCRINOL, V173, P1, DOI 10.1677/joe.0.1730001; MILLER WR, 1985, NATURE, V313, P231, DOI 10.1038/313231a0; Moretti RM, 2003, ENDOCR-RELAT CANCER, V10, P161, DOI 10.1677/erc.0.0100161; Morgan K, 2008, CANCER RES, V68, P6331, DOI 10.1158/0008-5472.CAN-08-0197; Papi M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2200588; Papi M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2970963; Papi M, 2010, EUR BIOPHYS J BIOPHY, V39, P987, DOI 10.1007/s00249-009-0468-3; Papi M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3107265; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; PLOSKER GL, 1994, DRUGS, V48, P930, DOI 10.2165/00003495-199448060-00008; QAYUM A, 1990, BRIT J CANCER, V62, P96, DOI 10.1038/bjc.1990.236; Ravenna L, 2000, J ANDROL, V21, P549; Sica G, 1999, EUR UROL, V35, P2, DOI 10.1159/000052300; Sica G, 2003, ANTICANCER RES, V23, P1283; Sica G, 2001, MOL CELL ENDOCRINOL, V176, P121, DOI 10.1016/S0303-7207(01)00429-4; SICA G, 1994, J CANCER RES CLIN, V120, P605, DOI 10.1007/BF01212815; SICA G, 1992, CLIN THER, V14, P87; Soumetz FC, 2010, ULTRAMICROSCOPY, V110, P330, DOI 10.1016/j.ultramic.2010.01.005; Tieva A, 2003, BJU INT, V91, P227, DOI 10.1046/j.1464-410X.2003.03054.x; White CD, 2008, NEUROENDOCRINOLOGY, V88, P67, DOI 10.1159/000119093; WORMALD PJ, 1985, J CLIN ENDOCR METAB, V61, P1190, DOI 10.1210/jcem-61-6-1190; YASIN M, 1995, ENDOCRINOLOGY, V136, P1559, DOI 10.1210/en.136.4.1559; Zhang X, 2006, TRENDS PHARMACOL SCI, V27, P324, DOI 10.1016/j.tips.2006.04.005	52	12	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52530	10.1371/journal.pone.0052530	http://dx.doi.org/10.1371/journal.pone.0052530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326338	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500015
J	Pirozhkova, I; Barat, A; Dmitriev, P; Kim, E; Robert, T; Guegan, J; Bilhou-Nabera, C; Busato, F; Tost, J; Carnac, G; Laoudj-Chenivesse, D; Lipinski, M; Vassetzky, Y				Pirozhkova, Iryna; Barat, Ana; Dmitriev, Petr; Kim, Elena; Robert, Thomas; Guegan, Justine; Bilhou-Nabera, Chrystele; Busato, Florence; Tost, Joerg; Carnac, Gilles; Laoudj-Chenivesse, Dalila; Lipinski, Marc; Vassetzky, Yegor			Differences in Transcription Patterns between Induced Pluripotent Stem Cells Produced from the Same Germ Layer Are Erased upon Differentiation	PLOS ONE			English	Article							HUMAN FIBROBLASTS; INDUCTION; GENERATION; ALPHA	Little is known about differences between induced pluripotent stem cells produced from tissues originating from the same germ layer. We have generated human myoblast-derived iPS cells by retroviral transduction of human primary myoblasts with the OCT3/4, SOX2, KLF4 and MYC coding sequences and compared them to iPS produced from human primary fibroblasts. When cultivated in vitro, these iPS cells proved similar to human embryonic stem cells in terms of morphology, expression of embryonic stemness markers and gene promoter methylation patterns. Embryonic bodies were derived that expressed endodermal, mesodermal as well as ectodermal markers. A comparative analysis of transcription patterns revealed significant differences in the gene expression pattern between myoblast- and fibroblast-derived iPS cells. However, these differences were reduced in the mesenchymal stem cells derived from the two iPS cell types were compared.	[Pirozhkova, Iryna; Barat, Ana; Dmitriev, Petr; Kim, Elena; Bilhou-Nabera, Chrystele; Lipinski, Marc; Vassetzky, Yegor] Univ Paris 11, Inst Cancerol Gustave Roussy, UMR 8126, CNRS, Villejuif, France; [Busato, Florence; Tost, Joerg] CEA Inst Genom, Ctr Natl Genotypage, Lab Epigenet, Evry, France; [Tost, Joerg] Fdn Jean Dausset CEPH, Lab Funct Genom, Paris, France; [Dmitriev, Petr; Carnac, Gilles; Laoudj-Chenivesse, Dalila] Univ Montpellier 2, Univ Montpellier 1, INSERM U1046, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Vassetzky, Y (corresponding author), Univ Paris 11, Inst Cancerol Gustave Roussy, UMR 8126, CNRS, Villejuif, France.	vassetzky@igr.fr	Vassetzky, Yegor S/C-6447-2008; Tost, Joerg/H-7129-2019; Vassetzky, Yegor/M-3383-2019; Laoudj-Chenivesse, dalila/N-7097-2018; Carnac, Gilles/N-6744-2018	Vassetzky, Yegor S/0000-0003-3101-7043; Tost, Joerg/0000-0002-2683-0817; Vassetzky, Yegor/0000-0003-3101-7043; Laoudj-Chenivesse, dalila/0000-0003-4356-9187; Pirozhkova, Iryna/0000-0001-8196-7069; Carnac, Gilles/0000-0002-3518-8774	Association Francaise contre les Myopathies (AFM); FSHD Facioscapulohumeral Mulcular Dystrophy Stitching (The Netherlands)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); FSHD Facioscapulohumeral Mulcular Dystrophy Stitching (The Netherlands)	This research was supported by grants to YSV and DL from the Association Francaise contre les Myopathies (AFM). EK was a recipient of a postdoctoral fellowship from the FSHD Facioscapulohumeral Mulcular Dystrophy Stitching (The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ball SG, 2007, INT J BIOCHEM CELL B, V39, P379, DOI 10.1016/j.biocel.2006.09.005; Barrero MJ, 2011, NAT CELL BIOL, V13, P523, DOI 10.1038/ncb0511-523; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eisenstein M, 2010, NAT METHODS, V7, P81, DOI 10.1038/nmeth0110-81; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Klaavuniemi T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-22; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Mangeot PE, 2011, MOL THER, V19, P1656, DOI 10.1038/mt.2011.138; Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394; Oda Y, 2010, J BIOL CHEM, V285, P29270, DOI 10.1074/jbc.M109.055889; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026406; TONIN PN, 1991, CANCER RES, V51, P5100; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Trokovic R, 2012, STEM CELLS DEV; Watanabe S, 2011, STEM CELLS, V29, P505, DOI 10.1002/stem.598; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53033	10.1371/journal.pone.0053033	http://dx.doi.org/10.1371/journal.pone.0053033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326377	gold, Green Published			2022-12-27	WOS:000313551500043
J	Sandfort, TGM; Baumann, LRM; Matebeni, Z; Reddy, V; Southey-Swartz, I				Sandfort, Theo G. M.; Baumann, Linda R. M.; Matebeni, Zethu; Reddy, Vasu; Southey-Swartz, Ian			Forced Sexual Experiences as Risk Factor for Self-Reported HIV Infection among Southern African Lesbian and Bisexual Women	PLOS ONE			English	Article							GENITAL HUMAN-PAPILLOMAVIRUS; TO-FEMALE TRANSMISSION; TRANSMITTED INFECTIONS; PREVALENCE; BEHAVIORS; MEN; SEROPREVALENCE; RELIABILITY; EPIDEMIC	Even though women who have sex with women are usually understood to be at no or very low risk for HIV infection, we explored whether lesbian and bisexual women in a geographical area with high HIV prevalence (Southern Africa) get tested for HIV and whether, among those women who get tested, there are women who live with HIV/AIDS. The study was conducted in collaboration with community-based organizations in Botswana, Namibia, South Africa and Zimbabwe. Data were collected via written surveys of women who in the preceding year had had sex with a woman (18 years and older; N = 591). Most participating women identified as lesbian and black. Almost half of the women (47.2%) reported ever having had consensual heterosexual sex. Engagement in transactional sex (lifetime) was reported by 18.6% of all women. Forced sex by men or women was reported by 31.1% of all women. A large proportion of the women reported to ever have been tested for HIV (78.3%); number of lifetime female and male partners was independently associated with having been tested; women who had engaged in transactional sex with women only or with women and men were less likely to have been tested. Self-reported HIV prevalence among tested women who knew their serostatus was 9.6%. Besides age, the sole independent predictor of a positive serostatus was having experienced forced sex by men, by women, or by both men and women. Study findings indicate that despite the image of invulnerability, HIV/AIDS is a reality for lesbian and bisexual women in Southern Africa. Surprisingly, it is not sex with men per se, but rather forced sex that is the important risk factor for self-reported HIV infection among the participating women. HIV/AIDS policy should also address the needs of lesbian, bisexual and other women who have sex with women.	[Sandfort, Theo G. M.] New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA; [Sandfort, Theo G. M.] Columbia Univ, New York, NY USA; [Baumann, Linda R. M.] Out Right Namibia, Windhoek, Namibia; [Matebeni, Zethu] Univ Cape Town, Inst Humanities Africa, ZA-7925 Cape Town, South Africa; [Reddy, Vasu] Human Sci Res Council, Human & Social Dev Programme, Pretoria, South Africa; [Reddy, Vasu] Univ KwaZulu Natal, Durban, South Africa; [Southey-Swartz, Ian] Open Soc Initiat So Africa, Johannesburg, South Africa	New York State Psychiatry Institute; Columbia University; University of Cape Town; Human Sciences Research Council-South Africa; University of Kwazulu Natal	Sandfort, TGM (corresponding author), New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA.	tgs2001@columbia.edu	Sandfort, Theo/D-1796-2011	Sandfort, Theo/0000-0002-4986-1739; MATEBENI, Zintombizethu/0000-0002-8202-8431	Open Society Initiative for Southern Africa; United Nations Development Programme; Open Society Foundations; NIMH-center grant [P30-MH43520]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	Open Society Initiative for Southern Africa; United Nations Development Programme; Open Society Foundations; NIMH-center grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project was funded by the Open Society Initiative for Southern Africa (PI: Vasu Reddy, Ph.D.), with additional support from the United Nations Development Programme, and Open Society Foundations; these organizations also participated in the study. Additional support came from a NIMH-center grant (P30-MH43520; PI: Anke A. Ehrhardt, Ph.D.). Representatives of Open Society Initiative for Southern Africa contributed to the study design, interpretation of the study findings, and preparation of the manuscript. Other funders, United Nations Development Programme and Open Society Foundations, reviewed data collection tools and supported interpretation of the study findings.	[Anonymous], SOCIAL SILENCE SOCIA, DOI DOI 10.1186/s12889-016-2980-6; Arend ED, 2005, J HOMOSEXUAL, V49, P97, DOI 10.1300/J082v49n01_05; Arend Elizabeth D, 2003, J Assoc Nurses AIDS Care, V14, P37; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Bailey JV, 2003, SEX TRANSM INFECT, V79, P147, DOI 10.1136/sti.79.2.147; BEVIER PJ, 1995, AM J PUBLIC HEALTH, V85, P1366, DOI 10.2105/AJPH.85.10.1366; CHU SY, 1990, AM J PUBLIC HEALTH, V80, P1380, DOI 10.2105/AJPH.80.11.1380; Cloete A., 2011, J AIDS HIV RES, V3, P1, DOI DOI 10.5897/JAHR.9000007; COHEN H, 1993, J ACQ IMMUN DEF SYND, V6, P1173; Deren S, 1996, DRUGS SOC, V9, P97; Diamant AL, 1999, ARCH INTERN MED, V159, P2730, DOI 10.1001/archinte.159.22.2730; Diaz T, 2001, J WOMEN HEALTH GEN-B, V10, P371, DOI 10.1089/152460901750269698; Dolan KA, 2003, SOC SCI MED, V57, P25, DOI 10.1016/S0277-9536(02)00305-2; Dolcini MM, 2003, JAIDS-J ACQ IMM DEF, V33, pS115, DOI 10.1097/00126334-200306012-00008; Dworkin SL, 2005, CULT HEALTH SEX, V7, P615, DOI 10.1080/13691050500100385; Fethers K, 2000, SEX TRANSM INFECT, V76, P345, DOI 10.1136/sti.76.5.345; Fisher DG, 2007, AIDS CARE, V19, P692, DOI 10.1080/09540120601087004; Fishman Seja Joyce, 2003, J Assoc Nurses AIDS Care, V14, P48, DOI 10.1177/1055329003255591; Friedman SR, 2003, AM J PUBLIC HEALTH, V93, P902, DOI 10.2105/AJPH.93.6.902; Gorgos LM, 2011, CLIN INFECT DIS, V53, pS84, DOI 10.1093/cid/cir697; Harris A, 2003, PSYCHOTHERAPY GAY ME, p[231, xiii]; Kennedy M B, 1995, J Am Med Womens Assoc (1972), V50, P103; Knox J, 2011, INT J STD AIDS, V22, P709, DOI 10.1258/ijsa.2011.010350; Kral AH, 1997, J ACQ IMMUN DEF SYND, V16, P211, DOI 10.1097/00042560-199711010-00011; Kwakwa HA, 2003, CLIN INFECT DIS, V36, pE40, DOI 10.1086/345462; Lewis RJ, 2012, AGGRESS VIOLENT BEH, V17, P247, DOI 10.1016/j.avb.2012.02.004; Marrazzo JM, 2012, CURR INFECT DIS REP, V14, P204, DOI 10.1007/s11908-012-0244-x; Marrazzo JM, 1998, J INFECT DIS, V178, P1604, DOI 10.1086/314494; Marrazzo JM, 2005, SEX TRANSM DIS, V32, P570, DOI 10.1097/01.olq.0000175368.82940.61; Marrazzo JM, 2001, AM J PUBLIC HEALTH, V91, P947, DOI 10.2105/AJPH.91.6.947; Marrazzo JM, 2008, SEXUALLY TRANSMITTED, P219; Mercer CH, 2007, AM J PUBLIC HEALTH, V97, P1126, DOI 10.2105/AJPH.2006.086439; Montcalm D. M., 2000, J LESBIAN STUDIES, V4, P131, DOI [10.1300/J155v04n02_09., DOI 10.1300/J155V04N02_09]; MONZON OT, 1987, LANCET, V2, P40; Naughton MJ, 2009, HDB HLTH BEHAV CHANG, P253; OHanlan KA, 1996, OBSTET GYNECOL, V88, P702, DOI 10.1016/0029-7844(96)00206-2; PETERSEN LR, 1992, J ACQ IMMUN DEF SYND, V5, P853; Pinto VM, 2005, AIDS, V19, pS64, DOI 10.1097/01.aids.0000191493.43865.2a; Raiteri R, 1998, AIDS, V12, P450; REYNOLDS G, 1994, LANCET, V344, P544, DOI 10.1016/S0140-6736(94)91934-8; Richardson D., 2000, Culture, Health & Sexuality, V2, P33, DOI 10.1080/136910500300859; Richters J, 2010, SEX HEALTH, V7, P165, DOI 10.1071/SH09072; Rosario M, 1999, HEALTH PSYCHOL, V18, P272, DOI 10.1037/0278-6133.18.3.272; Mota RMS, 2011, JAIDS-J ACQ IMM DEF, V57, pS153, DOI 10.1097/QAI.0b013e31821e9c10; Shotsky WJ, 1996, WOMEN HEALTH, V24, P1, DOI 10.1300/J013v24n02_01; Singh D, 2011, AM J PUBLIC HEALTH, V101, P1284, DOI 10.2105/AJPH.2009.169631; STORMS MD, 1979, J PERS SOC PSYCHOL, V37, P1779, DOI 10.1037/0022-3514.37.10.1779; Tallis V, 2009, SOCIAL SILENCE SOCIA; Teti M, 2011, J GAY LESBIAN SOC E, V23, P69, DOI 10.1080/10538720.2010.538009; UNAIDS, 2010, REP GLOB AIDS EP; Xu FJ, 2010, SEX TRANSM DIS, V37, P407, DOI 10.1097/OLQ.0b013e3181db2e18	51	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53552	10.1371/journal.pone.0053552	http://dx.doi.org/10.1371/journal.pone.0053552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326452	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500080
J	Chau, LH; Liang, WF; Cheung, FWK; Liu, WK; Li, WJ; Chen, SC; Lee, GB				Chau, Long-Ho; Liang, Wenfeng; Cheung, Florence Wing Ki; Liu, Wing Keung; Li, Wen Jung; Chen, Shih-Chi; Lee, Gwo-Bin			Self-Rotation of Cells in an Irrotational AC E-Field in an Opto-Electrokinetics Chip	PLOS ONE			English	Article							DIELECTROPHORESIS; MANIPULATION	The use of optical dielectrophoresis (ODEP) to manipulate microparticles and biological cells has become increasingly popular due to its tremendous flexibility in providing reconfigurable electrode patterns and flow channels. ODEP enables the parallel and free manipulation of small particles on a photoconductive surface on which light is projected, thus eliminating the need for complex electrode design and fabrication processes. In this paper, we demonstrate that mouse cells comprising melan-a cells, RAW 267.4 macrophage cells, peripheral white blood cells and lymphocytes, can be manipulated in an opto-electrokinetics (OEK) device with appropriate DEP parameters. Our OEK device generates a non-rotating electric field and exerts a localized DEP force on optical electrodes. Hitherto, we are the first group to report that among all the cells investigated, melan-a cells, lymphocytes and white blood cells were found to undergo self-rotation in the device in the presence of a DEP force. The rotational speed of the cells depended on the voltage and frequency applied and the cells' distance from the optical center. We discuss a possible mechanism for explaining this new observation of induced self-rotation based on the physical properties of cells. We believe that this rotation phenomenon can be used to identify cell type and to elucidate the dielectric and physical properties of cells.	[Chau, Long-Ho; Li, Wen Jung; Chen, Shih-Chi] Chinese Univ Hong Kong, Ctr Micro & Nano Syst, Hong Kong, Hong Kong, Peoples R China; [Liang, Wenfeng; Li, Wen Jung] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China; [Cheung, Florence Wing Ki; Liu, Wing Keung] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Wen Jung] City Univ Hong Kong, Dept Mech & Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Lee, Gwo-Bin] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan	Chinese University of Hong Kong; Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Chinese University of Hong Kong; City University of Hong Kong; National Tsing Hua University	Liu, WK (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	ken-liu@cuhk.edu.hk; wenjli@cityu.edu.hk	Li, Wen Jung/A-6153-2010; Chen, Shih-Chi/T-2988-2019; Lee, Gwo-Bin Vincent/D-3032-2012; Li, Wen Jung/M-9995-2013; Chen, Shih-Chi/C-7537-2011	Li, Wen Jung/0000-0001-9616-6213; Chen, Shih-Chi/0000-0002-4935-8412; Lee, Gwo-Bin Vincent/0000-0001-6910-9133; Li, Wen Jung/0000-0001-9616-6213; Liang, Wenfeng/0000-0002-6605-2511	City University of Hong Kong [9610216]; Chinese University of Hong Kong	City University of Hong Kong(City University of Hong Kong); Chinese University of Hong Kong(Chinese University of Hong Kong)	This project was funded by a start-up fund from the City University of Hong Kong (project no. 9610216). The project was also partially supported by The Chinese University of Hong Kong's graduate assistantship to Mr. Long-Ho Chau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami K, 2000, YEAST, V16, P1359, DOI 10.1002/1097-0061(200011)16:15<1359::AID-YEA631>3.0.CO;2-E; Bang HW, 2006, MICROSYST TECHNOL, V12, P746, DOI 10.1007/s00542-005-0076-9; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Chiou PY, 2004, PROC IEEE MICR ELECT, P21; Chrimes AF, 2012, ANAL CHEM, V84, P4029, DOI 10.1021/ac203381n; Davis JA, 2006, P NATL ACAD SCI USA, V103, P14779, DOI 10.1073/pnas.0605967103; GIMSA J, 1991, BIOPHYS J, V60, P749, DOI 10.1016/S0006-3495(91)82109-9; HOLZAPFEL C, 1982, J MEMBRANE BIOL, V67, P13, DOI 10.1007/BF01868644; Kim U, 2007, P NATL ACAD SCI USA, V104, P20708, DOI 10.1073/pnas.0708760104; Li ML, 2008, IEEE T NANOTECHNOL, V7, P477, DOI 10.1109/TNANO.2008.926351; Liang YL, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3496357; Lin YH, 2009, IEEE NANOTECHNOL MAG, V3, P6, DOI 10.1109/MNANO.2009.934211; Lin YH, 2010, SENSOR ACTUAT B-CHEM, V145, P854, DOI 10.1016/j.snb.2010.01.019; Loiko VA, 2007, 10 INT C EL LIGHT SC, P105; Long-Ho Chau, 2012, 2012 7th IEEE International Conference on Nano/Micro Engineered and Molecular Systems (NEMS), P195, DOI 10.1109/NEMS.2012.6196755; Mengxing Ouyang, 2011, 2011 IEEE International Conference on Robotics and Biomimetics (ROBIO), P1397, DOI 10.1109/ROBIO.2011.6181485; Minerick AR, 2002, ELECTROPHORESIS, V23, P2165, DOI 10.1002/1522-2683(200207)23:14<2165::AID-ELPS2165>3.0.CO;2-#; Morgan H., 2002, AC ELECTROKINETICS C; Park K, 2009, LAB CHIP, V9, P2224, DOI 10.1039/b904328d; Roman GT, 2007, ANAL BIOANAL CHEM, V387, P9, DOI 10.1007/s00216-006-0670-4; Vahey MD, 2009, ANAL CHEM, V81, P2446, DOI 10.1021/ac8019575; Wenfeng Liang, 2011, Proceedings of the 2011 6th IEEE International Conference on Nano/Micro Engineered and Molecular Systems (NEMS 2011), P825, DOI 10.1109/NEMS.2011.6017481; Wu HW, 2009, BIOMED MICRODEVICES, V11, P1297, DOI 10.1007/s10544-009-9349-x; Wu J, 2005, IND ENG CHEM RES, V44, P2815, DOI 10.1021/ie049417u; Wu ZG, 2008, BIOMED MICRODEVICES, V10, P631, DOI 10.1007/s10544-008-9174-7; YING H, 1992, PHYS MED BIOL, V37, P1499, DOI 10.1088/0031-9155/37/7/003	26	43	43	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e51577	10.1371/journal.pone.0051577	http://dx.doi.org/10.1371/journal.pone.0051577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320067	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429800009
J	Hamlin, AS; Windels, F; Boskovic, Z; Sah, P; Coulson, EJ				Hamlin, Adam S.; Windels, Francois; Boskovic, Zoran; Sah, Pankaj; Coulson, Elizabeth J.			Lesions of the Basal Forebrain Cholinergic System in Mice Disrupt Idiothetic Navigation	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; HIPPOCAMPAL THETA; SPATIAL MEMORY; NEURONS; ACETYLCHOLINE; DEMENTIA; RATS; NEUROTRANSMITTER; INVOLVEMENT	Loss of integrity of the basal forebrain cholinergic neurons is a consistent feature of Alzheimer's disease, and measurement of basal forebrain degeneration by magnetic resonance imaging is emerging as a sensitive diagnostic marker for prodromal disease. It is also known that Alzheimer's disease patients perform poorly on both real space and computerized cued (allothetic) or uncued (idiothetic) recall navigation tasks. Although the hippocampus is required for allothetic navigation, lesions of this region only mildly affect idiothetic navigation. Here we tested the hypothesis that the cholinergic medial septo-hippocampal circuit is important for idiothetic navigation. Basal forebrain cholinergic neurons were selectively lesioned in mice using the toxin saporin conjugated to a basal forebrain cholinergic neuronal marker, the p75 neurotrophin receptor. Control animals were able to learn and remember spatial information when tested on a modified version of the passive place avoidance test where all extramaze cues were removed, and animals had to rely on idiothetic signals. However, the exploratory behaviour of mice with cholinergic basal forebrain lesions was highly disorganized during this test. By contrast, the lesioned animals performed no differently from controls in tasks involving contextual fear conditioning and spatial working memory (Y maze), and displayed no deficits in potentially confounding behaviours such as motor performance, anxiety, or disturbed sleep/wake cycles. These data suggest that the basal forebrain cholinergic system plays a specific role in idiothetic navigation, a modality that is impaired early in Alzheimer's disease.	[Hamlin, Adam S.; Windels, Francois; Boskovic, Zoran; Sah, Pankaj; Coulson, Elizabeth J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Hamlin, Adam S.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia	University of Queensland; Charles Sturt University	Coulson, EJ (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	e.coulson@uq.edu.au	Windels, Francois/G-5432-2010; Sah, Pankaj/C-8175-2009; Boskovic, Zoran/Y-2764-2018; Coulson, Elizabeth J./C-8766-2009	Boskovic, Zoran/0000-0002-9867-1827; Coulson, Elizabeth J./0000-0003-3783-6197; Sah, Pankaj/0000-0001-5063-1589; Windels, Francois/0000-0001-5341-2197; Hamlin, Adam/0000-0003-0495-1973	National Health and Medical Research Council of Australia [569507, 569886, 569601]; Mason Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Mason Foundation	This work was supported by the National Health and Medical Research Council of Australia (Project Grant 569507; Postdoctoral Fellowship 569886 to A. S. H.; Career Development Fellowship 569601 to E.J.C.) and a Mason Foundation grant [http://www.nhmrc.gov.au/, http://www.anz.com/personal/private-bank-trustees/trustees/granting/granting-programs/health-medical/#NMP] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger-Sweeney J, 2001, J NEUROSCI, V21, P8164, DOI 10.1523/JNEUROSCI.21-20-08164.2001; Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Cimadevilla JM, 2000, J NEUROSCI METH, V102, P155, DOI 10.1016/S0165-0270(00)00288-0; Craig LA, 2011, NEUROSCI BIOBEHAV R, V35, P1397, DOI 10.1016/j.neubiorev.2011.03.001; Czeh B, 2001, NEUROBIOL LEARN MEM, V75, P190, DOI 10.1006/nlme.2000.3975; Feigenbaum JD, 2004, NEUROPSYCHOLOGY, V18, P462, DOI 10.1037/0894-4105.18.3.462; FOSTER TC, 1989, SCIENCE, V244, P1580, DOI 10.1126/science.2740902; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gallistel C. R., 1990, ORG LEARNING; Gorny JH, 2002, LEARN MEMORY, V9, P387, DOI 10.1101/lm.53002; Grothe M, 2012, BIOL PSYCHIAT, V71, P805, DOI 10.1016/j.biopsych.2011.06.019; Grothe M, 2010, CEREB CORTEX, V20, P1685, DOI 10.1093/cercor/bhp232; Hall JR, 2008, INT J GERIATR PSYCH, V23, P314, DOI 10.1002/gps.1881; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Henny P, 2008, EUR J NEUROSCI, V27, P654, DOI 10.1111/j.1460-9568.2008.06029.x; Hort J, 2007, P NATL ACAD SCI USA, V104, P4042, DOI 10.1073/pnas.0611314104; Hunter CL, 2004, EUR J NEUROSCI, V19, P3305, DOI 10.1111/j.0953-816X.2004.03439.x; Laczo J, 2010, NEURODEGENER DIS, V7, P148, DOI 10.1159/000289226; Laczo J, 2011, NEURODEGENER DIS, V8, P169, DOI 10.1159/000321581; Laczo J, 2009, BEHAV BRAIN RES, V202, P252, DOI 10.1016/j.bbr.2009.03.041; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541; Mapstone M, 2003, NEUROLOGY, V60, P802, DOI 10.1212/01.WNL.0000049471.76799.DE; Martin MM, 2007, PHYSIOL BEHAV, V90, P412, DOI 10.1016/j.physbeh.2006.10.007; Mesulam M, 2004, LEARN MEMORY, V11, P43, DOI 10.1101/lm.69204; Monacelli AM, 2003, NEUROLOGY, V61, P1491, DOI 10.1212/WNL.61.11.1491; Moreau PH, 2008, HIPPOCAMPUS, V18, P610, DOI 10.1002/hipo.20422; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muth K, 2010, BIOL PSYCHIAT, V67, P588, DOI 10.1016/j.biopsych.2009.02.026; Nag N, 2009, NEUROSCI LETT, V452, P247, DOI 10.1016/j.neulet.2009.01.006; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; PERRY EK, 1981, LANCET, V2, P149, DOI 10.1016/S0140-6736(81)90327-5; Pinto T, 2011, AGEING RES REV, V10, P404, DOI 10.1016/j.arr.2011.01.003; Schliebs R, 2006, J NEURAL TRANSM, V113, P1625, DOI 10.1007/s00702-006-0579-2; Tai SK, 2012, HIPPOCAMPUS, V22, P914, DOI 10.1002/hipo.20955; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vanderwolf CH, 1977, CIBA F SYMP, P199; Whishaw IQ, 2001, BEHAV BRAIN RES, V127, P49, DOI 10.1016/S0166-4328(01)00359-X; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	42	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53472	10.1371/journal.pone.0053472	http://dx.doi.org/10.1371/journal.pone.0053472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320088	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429800052
J	Buades, JM; Rodriguez, V; Terrasa, B; Perez-Mellado, V; Brown, RP; Castro, JA; Picornell, A; Ramon, MM				Buades, Joana M.; Rodriguez, Virginia; Terrasa, Barbara; Perez-Mellado, Valentin; Brown, Richard P.; Castro, Jose A.; Picornell, Antonia; Ramon, M. M.			Variability of the mc1r Gene in Melanic and Non-Melanic Podarcis lilfordi and Podarcis pityusensis from the Balearic Archipelago	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; PHENOTYPIC ASSOCIATIONS; STATISTICAL-METHOD; CLADISTIC-ANALYSIS; SEQUENCE VARIATION; DNA POLYMORPHISM; PLUMAGE COLOR; LIZARDS; MUTATIONS; CONSERVATION	The association between polymorphism at the mc1r locus and colour variation was studied in two wall lizard species (Podarcis lilfordi and P. pityusensis) from the Balearic archipelago. Podarcis lilfordi comprises several deep mitochondrial lineages, the oldest of which originated in the Pliocene, while much shallower mitochondrial lineages are found in P. pityusensis. Here, we examined whether specific substitutions were associated with the melanic colouration found in islet populations of these species. Homologous nuclear sequences covering most of the mc1r gene were obtained from 73 individuals from melanic and non-melanic Podarcis from different populations (the entire gene was also sequenced in six selected individuals). MtDNA gene trees were also constructed and used as a framework to assess mc1r diversity. Mc1r showed greater polymorphism in P. lilfordi than in P. pityusensis. However, we observed no substitutions that were common to all melanic individuals across the two species. Only one significant association was detected in the mc1r partial sequence, but this was a synonymous A/G mutation with A alleles being more abundant in melanic populations. In addition, there were no associations between the main dominant phenotypes (green and brown, blue and yellow spots and ventral colour) and synonymous or non-synonymous substitutions in the mc1r gene. There was no statistical evidence of selection on mc1r. This study suggests no relationship between mc1r polymorphism and colour variation in Balearic Podarcis.	[Buades, Joana M.; Rodriguez, Virginia; Terrasa, Barbara; Castro, Jose A.; Picornell, Antonia; Ramon, M. M.] Univ Illes Balears, Genet Lab, Palma De Mallorca, Spain; [Perez-Mellado, Valentin] Univ Salamanca, Dept Biol Anim, E-37008 Salamanca, Spain; [Brown, Richard P.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England	Universitat de les Illes Balears; University of Salamanca; Liverpool John Moores University	Ramon, MM (corresponding author), Univ Illes Balears, Genet Lab, Palma De Mallorca, Spain.	cori.ramon@uib.es	Pont, Barbara Terrasa/AAA-7194-2019; Picornell, Antonia/H-5072-2017; Castro, Jose A./J-9192-2014; RAMON, M MISERICORDIA/Y-2497-2018; Perez-Mellado, Valentin/G-3476-2015	Picornell, Antonia/0000-0003-4454-5304; Castro, Jose A./0000-0001-8262-560X; RAMON, M MISERICORDIA/0000-0003-1234-3337; Perez-Mellado, Valentin/0000-0002-7137-4945; Brown, Richard P./0000-0003-2401-6077	Spanish Ministerio de Ciencia e Innovacion and European Union FEDER funds [CGL2006-10893, CGL2009-12926]; Direccio General URT (Govern de les Illes Balears); European Union FSE	Spanish Ministerio de Ciencia e Innovacion and European Union FEDER funds; Direccio General URT (Govern de les Illes Balears); European Union FSE(European Social Fund (ESF))	This work has been financed by the research funds CGL2006-10893 and CGL2009-12926 of the Spanish Ministerio de Ciencia e Innovacion and European Union FEDER funds. VR is supported by a grant from Direccio General URT (Govern de les Illes Balears) and European Union FSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Arnold EN, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1430.1.1; Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x; Brown RP, 2008, MOL PHYLOGENET EVOL, V48, P350, DOI 10.1016/j.ympev.2008.04.013; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corso J, 2012, GENET MOL BIOL, V35, P81, DOI 10.1590/S1415-47572012005000015; Daniels SR, 2004, J ZOOL, V263, P373, DOI 10.1017/S0952836904005424; Eisentraut M., 1954, Zoologischer Anzeiger, V152, P317; Eisentraut M., 1949, Mitt zool Mus Berlin1949, V26, P1; FU YX, 1993, GENETICS, V133, P693; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Guo XL, 2010, BRIT POULTRY SCI, V51, P734, DOI 10.1080/00071668.2010.518408; Harris DJ, 1999, COPEIA, P749; HARTMANN M., 1953, ZOOL JAHRB ABT ALLG ZOOL U PHYSIOL TIERE, V64, P86; Herczeg G, 2010, ANN ZOOL FENN, V47, P37, DOI 10.5735/086.047.0104; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kerje S, 2003, ANIM GENET, V34, P241, DOI 10.1046/j.1365-2052.2003.00991.x; Kijas JMH, 1998, GENETICS, V150, P1177; KRAMER G, 1949, Z INDUKT ABSTAMM VER, V83, P157, DOI 10.1007/BF00309280; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McRobie H, 2009, J HERED, V100, P709, DOI 10.1093/jhered/esp059; Micheletti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047694; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nunes VL, 2011, J EVOLUTION BIOL, V24, P2289, DOI 10.1111/j.1420-9101.2011.02359.x; Parker AR, 1998, J EXP BIOL, V201, P2343; Perez-Mellado V, 1988, BALEARIC LIZARD PODA, V1; Pinho C, 2010, CONSERV GENET RESOUR, V2, P181, DOI 10.1007/s12686-009-9126-4; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Salvador A, 1984, BIOGEOGRAPHY ECOLOGY, P429; Schioth HB, 2005, PEPTIDES, V26, P1886, DOI 10.1016/j.peptides.2004.11.034; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1306, P122, DOI 10.1016/0167-4781(96)00026-7; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 1993, GENETICS, V134, P659; Terrasa B, 2009, DIVERS DISTRIB, V15, P207, DOI 10.1111/j.1472-4642.2008.00520.x	43	20	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53088	10.1371/journal.pone.0053088	http://dx.doi.org/10.1371/journal.pone.0053088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308144	gold, Green Published			2022-12-27	WOS:000313429100028
J	Desel, C; Werninghaus, K; Ritter, M; Jozefowski, K; Wenzel, J; Russkamp, N; Schleicher, U; Christensen, D; Wirtz, S; Kirschning, C; Agger, EM; da Costa, CP; Lang, R				Desel, Christiane; Werninghaus, Kerstin; Ritter, Manuel; Jozefowski, Katrin; Wenzel, Jens; Russkamp, Norman; Schleicher, Ulrike; Christensen, Dennis; Wirtz, Stefan; Kirschning, Carsten; Agger, Else Marie; da Costa, Clarissa Prazeres; Lang, Roland			The Mincle-Activating Adjuvant TDB Induces MyD88-Dependent Th1 and Th17 Responses through IL-1R Signaling	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; T-CELLS; INFLAMMASOME ACTIVATION; ANTIBODY-RESPONSES; CRUCIAL ROLE; CASPASE-1; CYTOKINE; MYD88; IL-1-BETA; INDUCTION	Successful vaccination against intracellular pathogens requires the generation of cellular immune responses. Trehalose-6,6-dibehenate (TDB), the synthetic analog of the mycobacterial cord factor trehalose-6,6-dimycolate (TDM), is a potent adjuvant inducing strong Th1 and Th17 immune responses. We previously identified the C-type lectin Mincle as receptor for these glycolipids that triggers the FcR gamma-Syk-Card9 pathway for APC activation and adjuvanticity. Interestingly, in vivo data revealed that the adjuvant effect was not solely Mincle-dependent but also required MyD88. Therefore, we dissected which MyD88-dependent pathways are essential for successful immunization with a tuberculosis subunit vaccine. We show here that antigen-specific Th1/Th17 immune responses required IL-1 receptor-mediated signals independent of IL-18 and IL-33-signaling. ASC-deficient mice had impaired IL-17 but intact IFN gamma responses, indicating partial independence of TDB adjuvanticity from inflammasome activation. Our data suggest that the glycolipid adjuvant TDB triggers Mincle-dependent IL-1 production to induce MyD88-dependent Th1/Th17 responses in vivo.	[Desel, Christiane; Werninghaus, Kerstin; Jozefowski, Katrin; Wenzel, Jens; Russkamp, Norman; Schleicher, Ulrike; Lang, Roland] Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany; [Ritter, Manuel; da Costa, Clarissa Prazeres] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Christensen, Dennis; Agger, Else Marie] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Wirtz, Stefan] Univ Hosp Erlangen, Med Clin 1, Erlangen, Germany; [Kirschning, Carsten] Inst Med Mikrobiol, Essen, Germany	University of Erlangen Nuremberg; Technical University of Munich; Statens Serum Institut; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Desel, C (corresponding author), Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany.	christiane.desel@uk-erlangen.de; roland.lang@uk-erlangen.de	Ritter, Manuel/ABE-7747-2020; Christensen, Dennis/C-6378-2008	Ritter, Manuel/0000-0001-8667-2067; Christensen, Dennis/0000-0003-2382-8639; Desel, Christiane/0000-0003-2029-3851; Lang, Roland/0000-0003-0502-3677; Wirtz, Stefan/0000-0001-6936-7431	Deutsche Forschungsgemeinschaft [SFB796, SFB/TR22]; European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB796 to RL and SFB/TR22 to CPdP) and the European Union (FP6 NEWTBVAC to EMA, DC and RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Ippagunta SK, 2012, NAT IMMUNOL, V13, P701, DOI 10.1038/ni.2389; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lindenstrom T, 2012, INFECT IMMUN, V80, P3533, DOI 10.1128/IAI.00550-12; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto M, 1999, J IMMUNOL, V163, P5039; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ottenhoff TH, 2010, HUM VACCINES, V6, P1007, DOI 10.4161/hv.6.12.13143; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Schweneker K, 2012, IMMUNOBIOLOGY, DOI [10.1016/j.imbio.2012.07.029, DOI 10.1016/J.IM-BI0.2012.07.029]; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Wenzel J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00071; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1	37	98	100	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53531	10.1371/journal.pone.0053531	http://dx.doi.org/10.1371/journal.pone.0053531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308247	Green Published, gold			2022-12-27	WOS:000313429100085
J	Hou, DJ; Li, GH; Fang, L; Li, B				Hou, Dianju; Li, Gehong; Fang, Lin; Li, Bing			Frontalis Muscle Flap Suspension for the Correction of Congenital Blepharoptosis in Early Age Children	PLOS ONE			English	Article							AUTOGENOUS FASCIA-LATA; SEVERE PTOSIS	Background: We aimed to report our successful use of frontalis muscle flap suspension for the correction of congenital blepharoptosis in early age children. Methods: This retrospective study included 61 early age children (41 boys, 20 girls) with an average age of 6 years (range, 3-10 years) with congenital blepharoptosis who received surgery during the period from March 2007 to January 2011. There were 39 cases of unilateral blepharoptosis and 22 cases of bilateral blepharoptosis, thus a total of 83 eyes were affected. If patient had bilateral blepharoptosis, both eyes were operated on in the same surgery. Patients were followed for 3 months to 5 years. The procedure was performed without complications in all cases. Results: The postoperative healing grade was good in 81 eyes (97.6%); the correction of blepharoptosis was satisfactory, the double eyelid folds were natural and aesthetic, the eyelid position and the curvature were ideal, and the eyes were bilaterally symmetrical. The postoperative healing grade was fair in 2 eyes (2.4%); blepharoptosis was improved compared with that before surgery. At discharge, lagophthalmos was noted in 10 eyes of which 4 cases resolved by the last follow-up. The remaining 6 cases were mild. Eleven eyes received reoperation for residual ptosis after the first surgery. The curvature of the palpebral margin was not natural in 4 eyes. These unnatural curvature possibly was caused by an excessively low lateral fixation point or postoperative avulsion. Conclusion: Frontalis muscle flap suspension under general anesthesia for the correction of congenital blepharoptosis in early age children can achieve good surgical results.	[Hou, Dianju; Fang, Lin; Li, Bing] Peking Union Med Coll, Plast Surg Hosp, Dept Microinvas Plasit Surg Ctr, Beijing 100021, Peoples R China; [Hou, Dianju; Li, Gehong; Fang, Lin; Li, Bing] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Li, Gehong] Peking Union Med Coll, Plast Surg Hosp, Dept Hosp Infect Control, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Plastic Surgery Hospital - CAMS	Li, GH (corresponding author), Peking Union Med Coll, Plast Surg Hosp, Dept Hosp Infect Control, Beijing 100021, Peoples R China.	hglabcde@163.com						Allard FD, 2010, MIDDLE EAST AFR J OP, V17, P129, DOI 10.4103/0974-9233.63073; Allen RC, 2012, BRIT J OPHTHALMOL, V96, P841, DOI 10.1136/bjophthalmol-2011-300667; Arajy ZY, 2012, J CRANIO MAXILL SURG, V40, P129, DOI 10.1016/j.jcms.2011.03.002; Baroody Michael, 2005, Curr Opin Ophthalmol, V16, P351, DOI 10.1097/01.icu.0000186647.00413.21; Beard C, 1981, PTOSIS, V3rd, P39; Berry-Brincat A, 2009, EYE, V23, P1554, DOI 10.1038/eye.2008.311; Bhiromekraibhak Keerapat, 2010, J Med Assoc Thai, V93 Suppl 2, pS15; Bleyen I, 2009, OPHTHAL PLAST RECONS, V25, P359, DOI 10.1097/IOP.0b013e3181b1e67a; Cetinkaya A, 2008, CURR OPIN OPHTHALMOL, V19, P428, DOI 10.1097/ICU.0b013e32830b88eb; Deenstra W, 1996, ANN PLAS SURG, V36, P348, DOI 10.1097/00000637-199604000-00004; Evereklioglu C, 2012, BRIT J OPHTHALMOL, V96, P570, DOI 10.1136/bjophthalmol-2011-300400; Friedhofer H, 2012, PLAST RECONSTR SURG, V129, p453E, DOI 10.1097/PRS.0b013e3182402deb; Han X, 2007, CHIN COSMETIC MED, V16, P522; Kim CY, 2012, AM J OPHTHALMOL, V153, P334, DOI 10.1016/j.ajo.2011.07.023; Leibovitch I, 2003, AM J OPHTHALMOL, V136, P866, DOI 10.1016/S0002-9394(03)00466-5; Lin MC, 2006, CHIN COSMETIC MED, V15, P46; Luo J, 1994, CHIN J PLAST SURG, V10, P466; Pan Y, 2008, AESTHET PLAST SURG, V32, P604, DOI 10.1007/s00266-008-9125-y; Philandrianos C, 2010, J PLAST RECONSTR AES, V63, P782, DOI 10.1016/j.bjps.2009.01.083; Qiu SS, 2011, ANN PLAS SURG, V67, P129, DOI 10.1097/SAP.0b013e3181f3e5eb; Ramirez OM, 2004, PLAST RECONSTR SURG, V113, P1841, DOI 10.1097/01.PRS.0000117664.07831.48; Sakol P J, 1999, Curr Opin Ophthalmol, V10, P335, DOI 10.1097/00055735-199910000-00010; Small RG, 2000, OPHTHALMIC PLAST REC, V16, P81, DOI 10.1097/00002341-200003000-00001; Sokol JA, 2011, OPHTHAL PLAST RECONS, V27, P211, DOI 10.1097/IOP.0b013e3181ef72cd; Tong JT, 2000, J AAPOS, V4, P186, DOI 10.1067/mpa.2000.105275; Zhang HM, 1999, BRIT J PLAST SURG, V52, P524, DOI 10.1054/bjps.1999.3149	26	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53185	10.1371/journal.pone.0053185	http://dx.doi.org/10.1371/journal.pone.0053185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308158	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100034
J	Liu, ZJ; Chen, LJ; Liu, KW; Li, LQ; Rao, WH; Zhang, YT; Tang, GD; Huang, LQ				Liu, Zhong-Jian; Chen, Li-Jun; Liu, Ke-Wei; Li, Li-Qiang; Rao, Wen-Hui; Zhang, Yu-Ting; Tang, Guang-Da; Huang, Lai-Qiang			Adding Perches for Cross-Pollination Ensures the Reproduction of a Self-Incompatible Orchid	PLOS ONE			English	Article							FERTILIZATION; EVOLUTION	Background: Outcrossing is known to carry genetic advantages in comparison with inbreeding. In many cases, flowering plants develop a self-incompatibility mechanism, along with a floral component adaptation mechanism, to avoid self-pollination and to promote outbreeding. Orchids commonly have a lip in their flower that functions as the a visiting plate for insect pollinators. Aside from the lip, however, many species (including Coelogyne rigida) have sheaths around the axis of inflorescence. The function of these sheaths remains unknown, and has long been a puzzle to researchers. Methodology/Principal Findings: We investigated the function of these sheaths in relation to the lip and the pollinators, as well as their role in the modes of pollination and reproduction of Coelogyne rigida in 30 flowering populations of orchids in the limestone area of Southeast Yunnan, China. We found that self-incompatible C. rigida developed specialized bird perches around the basal axis of inflorescence to attract sunbirds and to complement their behavioral tendency to change foraging locations frequently. This self-incompatibility mechanism operates separately from the floral component adaptation mechanism. This mechanism thus prevents bees from repeatedly visiting the floral lip of the same plant which, in turn, results in autogamy. In this way, instead of preventing autogamy, C. rigida responds to these negative effects through a highly efficient cross-pollination method that successfully transfers pollen to different plants. Conclusions: The proposed method ensures reproductive success, while offsetting the infertile self-pollination by insects, thereby reducing mating costs and addressing the lack of cross-pollination. The adaptation provides a novel and striking example of structural adaptation that promotes cross-pollination in angiosperms.	[Liu, Zhong-Jian; Chen, Li-Jun; Liu, Ke-Wei; Li, Li-Qiang; Rao, Wen-Hui; Zhang, Yu-Ting] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Liu, Zhong-Jian; Chen, Li-Jun; Liu, Ke-Wei; Li, Li-Qiang; Rao, Wen-Hui; Zhang, Yu-Ting] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Liu, Zhong-Jian; Liu, Ke-Wei; Huang, Lai-Qiang] Tsinghua Univ, Grad Sch Shenzhen, Ctr Biotechnol & BioMed, Shenzhen 518057, Peoples R China; [Liu, Zhong-Jian; Tang, Guang-Da; Huang, Lai-Qiang] S China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; South China Agricultural University	Liu, ZJ (corresponding author), Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China.	liuzj@sinicaorchid.org; huanglq@mail.tsinghua.edu.cn		Liu, Zhong-Jian/0000-0003-4390-3878	State Forestry Administration, China [2011-4-53]; State Forestry Administration of China [2010-240]; Forestry Construction Program of Guangdong Province, China [2010-317]	State Forestry Administration, China; State Forestry Administration of China; Forestry Construction Program of Guangdong Province, China	This work was supported by fellowships from the 948 Program of State Forestry Administration, China (No. 2011-4-53), the Forestry Construction Program of State Forestry Administration of China (No. 2010-240), and the Forestry Construction Program of Guangdong Province, China (No. 2010-317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2005, NATURE, V435, P41, DOI 10.1038/435041a; Anderson B, 2010, EVOLUTION, V64, P960, DOI 10.1111/j.1558-5646.2009.00880.x; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett SCH, 1996, PHILOS T R SOC B, V351, P1271, DOI 10.1098/rstb.1996.0110; Chen LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037478; Chen S.C., 2009, FLORA CHINA, VVol. 25, P315; Cheng J, 2009, ANN BOT-LONDON, V104, P565, DOI 10.1093/aob/mcp029; CONNER JK, 1995, OECOLOGIA, V104, P234, DOI 10.1007/BF00328588; Darwin C, 1916, EFFECTS CROSS AND SE; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Fleming PA, 2002, OECOLOGIA, V132, P361, DOI 10.1007/s00442-002-0921-9; Herlihy CR, 2002, NATURE, V416, P320, DOI 10.1038/416320a; HOLSINGER KE, 1991, TRENDS ECOL EVOL, V6, P307, DOI 10.1016/0169-5347(91)90033-T; Johnson SD, 2004, PLANT SYST EVOL, V244, P181, DOI 10.1007/s00606-003-0106-y; [刘仲健 LIU ZhongJian], 2008, [生态学报, Acta Ecologica Sinica], V28, P111; Ollerton J, 1998, NATURE, V394, P726, DOI 10.1038/29409; Richards RJ, 1997, PLANT BREEDING SYSTE; Sahli HF, 2011, EVOLUTION, V65, P1457, DOI 10.1111/j.1558-5646.2011.01229.x; SMITH R M, 1990, Edinburgh Journal of Botany, V47, P1; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Takebayashi N, 2001, AM J BOT, V88, P1143, DOI 10.2307/3558325; WESTERKAMP C, 1990, BOT ACTA, V103, P366, DOI 10.1111/j.1438-8677.1990.tb00176.x; Zhang DY, 2004, HIST EVOLUTION REPRO	24	6	6	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53695	10.1371/journal.pone.0053695	http://dx.doi.org/10.1371/journal.pone.0053695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308277	Green Published, gold			2022-12-27	WOS:000313429100109
J	Nagarajan, R; Jonkman, JN				Nagarajan, Radhakrishnan; Jonkman, Jeffrey N.			A Neural Network Model to Translate Brain Developmental Events across Mammalian Species	PLOS ONE			English	Article								Translating the timing of brain developmental events across mammalian species using suitable models has provided unprecedented insights into neural development and evolution. More importantly, these models can prove to be useful abstractions and predict unknown events across species from known empirical event timing data retrieved from published literature. Such predictions can be especially useful since the distribution of the event timing data is skewed with a majority of events documented only across a few selected species. The present study investigates the choice of single hidden layer feed-forward neural networks (FFNN) for predicting the unknown events from the empirical data. A leave-one-out cross-validation approach is used to determine the optimal number of units in the hidden layer and the decay parameter for the FFNN. It is shown that unlike the present Finlay-Darlington (FD) model, FFNN does not impose any constraints on the functional form of the model and falls under the class of semiparametric regression models that can approximate any continuous function. The results from FFNN as well as FD model also indicate that a majority of events with large absolute prediction errors correspond to those of primates and late events comprising the tail of event timing data distribution with minimal representation in the empirical data. These results also indicate that accurate prediction of primate events may be challenging.	[Nagarajan, Radhakrishnan] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Div Biomed Informat, Lexington, KY 40506 USA; [Jonkman, Jeffrey N.] Grinnell Coll, Dept Math & Stat, Grinnell, IA 50112 USA	University of Kentucky	Nagarajan, R (corresponding author), Univ Kentucky, Coll Publ Hlth, Dept Biostat, Div Biomed Informat, Lexington, KY 40506 USA.	rnagarajan@uky.edu			National Science Foundation [NSF DBI-0849684]	National Science Foundation(National Science Foundation (NSF))	RK acknowledges funding from the National Science Foundation (NSF DBI-0849684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M, 2006, PATTERN RECOGNITION; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Clancy B, 2000, DEVELOPMENTAL SCI, V3, P57, DOI 10.1111/1467-7687.00100; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Efron B., 1994, INTRO BOOTSTRAP; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Gybenko G, 1989, MATH CONTROL SIGNAL, V2, P303, DOI DOI 10.1007/BF02551274; Harrell FE, 2001, REGRESSION MODELING; Hassoun MH., 1995, FUNDAMENTALS ARTIFIC, DOI 10.1109/JPROC.1996.503146; Hastie T., 2003, ELEMENTS STAT LEARNI; HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T; Ingrassia S, 2005, TECHNOMETRICS, V47, P297, DOI 10.1198/004017005000000058; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Nagarajan R, 2008, NEUROINFORMATICS, V6, P71, DOI 10.1007/s12021-008-9013-2; Nagarajan R, 2010, NEUROINFORMATICS, V8, P201, DOI 10.1007/s12021-010-9081-y; Ripley B. D., 1996, PATTERN RECOGNITION; Rojas R., 1996, NEURAL NETWORKS SYST, DOI [10.1007/978-3-642-61068-4{\_}7, DOI 10.1007/978-3-642-61068-4]; Venables WN., 2002, MODERN APPL STAT S 4	19	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53225	10.1371/journal.pone.0053225	http://dx.doi.org/10.1371/journal.pone.0053225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308165	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100040
J	Zhou, ZH; Zhu, HM; Chen, L				Zhou, Zhenhe; Zhu, Hongmei; Chen, Lin			Effect of Aripiprazole on Mismatch Negativity (MMN) in Schizophrenia	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SPECTRUM DISORDERS; COGNITIVE DEFICITS; HEALTHY-VOLUNTEERS; PARTIAL AGONIST; ATTENTION; MEMORY; 1ST-EPISODE; RISPERIDONE; GENERATION	Background: Cognitive deficits are considered core symptoms of the schizophrenia. Cognitive function has been found to be a better predictor of functional outcome than symptom levels. Changed mismatch negativity (MMN) reflects abnormalities of early auditory processing in schizophrenia. Up to now, no studies for the effects of aripiprazole on MMN in schizophrenia have been reported. Methodology/Principal Findings: Subjects included 26 patients with schizophrenia, and 26 controls. Psychopathology was rated in patients with the Positive and Negative Syndrome Scale (PANSS) at baseline, after 4- and 8-week treatments with aripiprazole. Auditory stimuli for ERP consisted of 100 millisecond/1000 Hz standards, intermixed with 100 millisecond/1500 Hz frequency deviants and 250 millisecond/1000 Hz duration deviants. EEG was recorded at Fz. BESA 5.1.8 was used to perform data analysis. MMN waveforms were obtained by subtracting waveforms elicited by standards from waveforms elicited by frequency-or duration-deviant stimuli. Aripiprazole decreased all PANSS. Patients showed smaller mean amplitudes of frequency and duration MMN at baseline than did controls. A repeated measure ANOVA with sessions (i.e., baseline, 4- and 8-week treatments) and MMN type (frequency vs. duration) as within-subject factors revealed no significant MMN type or MMN type x session main effect for MMN amplitudes. Session main effect was significant. LSD tests demonstrated significant differences between MMN amplitudes at 8 weeks and those at both baseline and 4 weeks. There was significant negative correlation between changes in amplitudes of frequency and duration MMN and changes in PANSS total scores at baseline and follow-up periods. Conclusions: Aripiprazole improved the amplitudes of MMN. MMN offers objective evidence that treatment with the aripiprazole may ameliorate preattentive deficits in schizophrenia.	[Zhou, Zhenhe; Zhu, Hongmei; Chen, Lin] Nanjing Med Univ, Wuxi Mental Hlth Ctr, Dept Psychiat, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, ZH (corresponding author), Nanjing Med Univ, Wuxi Mental Hlth Ctr, Dept Psychiat, Wuxi, Jiangsu, Peoples R China.	wuxich102@sohu.com			Medical Research Foundation of Department of Public Health, Jiangsu Province, China [H201043]	Medical Research Foundation of Department of Public Health, Jiangsu Province, China	This study was supported by the Medical Research Foundation of Department of Public Health, Jiangsu Province, China (No.H201043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdede BBK, 2005, PROG NEURO-PSYCHOPH, V29, P233, DOI 10.1016/j.pnpbp.2004.11.005; Alain C, 1997, PSYCHOPHYSIOLOGY, V34, P534, DOI 10.1111/j.1469-8986.1997.tb01740.x; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Bramon E, 2004, SCHIZOPHR RES, V67, P1, DOI 10.1016/S0920-9964(03)00132-4; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Dittmann BA, 2001, NEUROSCI LETT, V308, P119; Dittmann-Balcar A, 1999, NEUROREPORT, V10, P3749, DOI 10.1097/00001756-199912160-00005; Domjan N, 2012, SCHIZOPHR RES, V139, P253, DOI 10.1016/j.schres.2012.06.002; Evans JD, 2004, SCHIZOPHR RES, V70, P331, DOI 10.1016/j.schres.2004.01.011; GOLD JM, 1993, PSYCHIAT CLIN N AM, V16, P295; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hori H, 2012, J PSYCHIATR RES, V46, P757, DOI 10.1016/j.jpsychires.2012.02.013; Javitt DC, 2000, ARCH GEN PSYCHIAT, V57, P1131, DOI 10.1001/archpsyc.57.12.1131; Jordan S, 2002, EUR J PHARMACOL, V441, P137, DOI 10.1016/S0014-2999(02)01532-7; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kern RS, 2006, PSYCHOPHARMACOLOGY, V187, P312, DOI 10.1007/s00213-006-0428-x; Kishi T, 2010, NEUROSCI RES, V66, P340, DOI 10.1016/j.neures.2009.12.007; Korostenskaja M, 2005, PROG NEURO-PSYCHOPH, V29, P543, DOI 10.1016/j.pnpbp.2005.01.019; Lavoie AS, 2007, PROGR NEUROPSYCHOPHA, V11, P1; LAVOIE S, 2007, NEUROPSYCHOPHARMACOL, V33, P1; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Malhi GS, 2008, ACTA PSYCHIAT SCAND, V117, P100, DOI 10.1111/j.1600-0447.2007.01111.x; Michie PT, 2002, BIOL PSYCHIAT, V52, P749, DOI 10.1016/S0006-3223(02)01379-3; Murphy A, 2009, EUR NEUROPSYCHOPHARM, V19, pS188, DOI 10.1016/S0924-977X(09)70226-3; NAATANEN R, 1995, EAR HEARING, V16, P6; Riedel M, 2010, PHARMACOPSYCHIATRY, V43, P50, DOI 10.1055/s-0029-1239539; Salisbury DF, 2002, ARCH GEN PSYCHIAT, V59, P686, DOI 10.1001/archpsyc.59.8.686; Sato Y, 2000, NEUROREPORT, V11, P3703, DOI 10.1097/00001756-200011270-00023; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Stip E, 2010, CLIN THER, V32, pS3, DOI 10.1016/j.clinthera.2010.01.021; Tamo N, 2011, FRONTIERS PSYCHOL, V2, P367; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Umbricht D, 1998, BIOL PSYCHIAT, V44, P716, DOI 10.1016/S0006-3223(97)00524-6; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Umbricht D, 2003, BIOL PSYCHIAT, V53, P1120, DOI 10.1016/S0006-3223(02)01642-6; Umbricht D, 1999, INT J NEUROPSYCHOP, V2, P299, DOI 10.1017/S1461145799001595; Umbricht DSG, 2006, BIOL PSYCHIAT, V59, P762, DOI 10.1016/j.biopsych.2005.08.030; Velligan DI, 1997, SCHIZOPHR RES, V25, P21, DOI 10.1016/S0920-9964(97)00010-8; Woldorff MG, 1998, PSYCHOPHYSIOLOGY, V35, P283, DOI 10.1017/S0048577298961601; Yago E, 2001, NEUROREPORT, V12, P2583, DOI 10.1097/00001756-200108080-00058; Yiting L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034454, DOI 10.1371/JOURNAL.PONE.0034454]; Zhang MY, 1998, MANUAL RATING SCALE, P150	43	25	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52186	10.1371/journal.pone.0052186	http://dx.doi.org/10.1371/journal.pone.0052186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308105	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100008
J	Jaafari, N; Konopacki, FA; Owen, TF; Kantamneni, S; Rubin, P; Craig, TJ; Wilkinson, KA; Henley, JM				Jaafari, Nadia; Konopacki, Filip A.; Owen, Thomas F.; Kantamneni, Sriharsha; Rubin, Philip; Craig, Tim J.; Wilkinson, Kevin A.; Henley, Jeremy M.			SUMOylation Is Required for Glycine-Induced Increases in AMPA Receptor Surface Expression (ChemLTP) in Hippocampal Neurons	PLOS ONE			English	Article							PROTEIN SUMOYLATION; MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; SYNAPTIC PLASTICITY; PHOSPHORYLATION; TRAFFICKING; LOCALIZATION; TRANSLATION; MECHANISMS; GROWTH	Multiple pathways participate in the AMPA receptor trafficking that underlies long-term potentiation (LTP) of synaptic transmission. Here we demonstrate that protein SUMOylation is required for insertion of the GluA1 AMPAR subunit following transient glycine-evoked increase in AMPA receptor surface expression (ChemLTP) in dispersed neuronal cultures. ChemLTP increases co-localisation of SUMO-1 and the SUMO conjugating enzyme Ubc9 and with PSD95 consistent with the recruitment of SUMOylated proteins to dendritic spines. In addition, we show that ChemLTP increases dendritic levels of SUMO-1 and Ubc9 mRNA. Consistent with activity dependent translocation of these mRNAs to sites near synapses, levels of the mRNA binding and dendritic transport protein CPEB are also increased by ChemLTP. Importantly, reducing the extent of substrate protein SUMOylation by overexpressing the deSUMOylating enzyme SENP-1 or inhibiting SUMOylation by expressing dominant negative Ubc9 prevent the ChemLTP-induced increase in both AMPAR surface expression and dendritic SUMO-1 mRNA. Taken together these data demonstrate that SUMOylation of synaptic protein(s) involved in AMPA receptor trafficking is necessary for activity-dependent increases in AMPAR surface expression.	[Jaafari, Nadia; Konopacki, Filip A.; Owen, Thomas F.; Kantamneni, Sriharsha; Rubin, Philip; Craig, Tim J.; Wilkinson, Kevin A.; Henley, Jeremy M.] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Bristol	Henley, JM (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	j.m.henley@bristol.ac.uk	Kantamneni, Sriharsha/G-6504-2012; Wilkinson, Kevin/AAM-2888-2020	Kantamneni, Sriharsha/0000-0002-3750-9447; Wilkinson, Kevin/0000-0002-8115-8592; Henley, Jeremy/0000-0003-3589-8335; Konopacki, Filip/0000-0001-6679-1966	Medical Research Council; European Research Council; Wellcome Trust; BBSRC [BB/K014358/1, BB/K014366/1, BB/F00723X/1] Funding Source: UKRI; MRC [G9629038, G0601810] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K014358/1, BB/K014366/1, BB/F00723X/1] Funding Source: researchfish; Medical Research Council [G0601810, G9629038] Funding Source: researchfish; Alzheimer&quot;s Society [170] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Alzheimer&quot;s Society	Funding: The authors are grateful to the Medical Research Council, the European Research Council and the Wellcome Trust for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DB, 2009, DRUG NEWS PERSPECT, V22, P255, DOI 10.1358/dnp.2009.22.5.1378636; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Atkins CM, 2005, J NEUROSCI, V25, P5604, DOI 10.1523/JNEUROSCI.5051-04.2005; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Cimarosti H, 2012, J CEREBR BLOOD F MET, V32, P17, DOI 10.1038/jcbfm.2011.146; Costa-Mattioli M, 2009, PROG MOL BIOL TRANSL, V90, P293, DOI 10.1016/S1877-1173(09)90008-4; Craig TJ, 2012, CURR OPIN NEUROBIOL, V22, P480, DOI 10.1016/j.conb.2011.10.017; Craig TJ, 2012, J BIOL CHEM, V287, P22781, DOI 10.1074/jbc.M112.356337; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kantamneni S, 2011, BIOCHEM BIOPH RES CO, V409, P657, DOI 10.1016/j.bbrc.2011.05.060; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Konopacki FA, 2007, NEUROSCIENCE, V150, P31, DOI 10.1016/j.neuroscience.2007.08.026; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; SCHUMANN MA, 1993, J BIOL CHEM, V268, P2134; Wilkinson Kevin A, 2012, Commun Integr Biol, V5, P223, DOI 10.4161/cib.19195; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	31	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52345	10.1371/journal.pone.0052345	http://dx.doi.org/10.1371/journal.pone.0052345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326329	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800015
J	Kesel, S; Mader, A; Hofler, C; Mascher, T; Leisner, M				Kesel, Sara; Mader, Andreas; Hoefler, Carolin; Mascher, Thorsten; Leisner, Madeleine			Immediate and Heterogeneous Response of the LiaFSR Two-Component System of Bacillus subtilis to the Peptide Antibiotic Bacitracin	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEM; GREEN FLUORESCENT PROTEIN; DEPENDENT GENE-EXPRESSION; BACTERIA; LIARS; STATE; VIRULENCE; BINDING; TARGET	Background: Two-component signal transduction systems are one means of bacteria to respond to external stimuli. The LiaFSR two-component system of Bacillus subtilis consists of a regular two-component system LiaRS comprising the core Histidine Kinase (HK) LiaS and the Response Regulator (RR) LiaR and additionally the accessory protein LiaF, which acts as a negative regulator of LiaRS-dependent signal transduction. The complete LiaFSR system was shown to respond to various peptide antibiotics interfering with cell wall biosynthesis, including bacitracin. Methodology and Principal Findings: Here we study the response of the LiaFSR system to various concentrations of the peptide antibiotic bacitracin. Using quantitative fluorescence microscopy, we performed a whole population study analyzed on the single cell level. We investigated switching from the non-induced 'OFF' state into the bacitracin-induced 'ON' state by monitoring gene expression of a fluorescent reporter from the RR-regulated liaI promoter. We found that switching into the 'ON' state occurred within less than 20 min in a well-defined switching window, independent of the bacitracin concentration. The switching rate and the basal expression rate decreased at low bacitracin concentrations, establishing clear heterogeneity 60 min after bacitracin induction. Finally, we performed time-lapse microscopy of single cells confirming the quantitative response as obtained in the whole population analysis for high bacitracin concentrations. Conclusion: The LiaFSR system exhibits an immediate, heterogeneous and graded response to the inducer bacitracin in the exponential growth phase.	[Kesel, Sara; Mader, Andreas; Leisner, Madeleine] Univ Munich, Fak Phys, Ctr NanoSci, Munich, Germany; [Hoefler, Carolin; Mascher, Thorsten] Ludwig Maximilians Univ Munchen, Dept Biol 1, Planegg Martinsried, Germany	University of Munich; University of Munich	Leisner, M (corresponding author), Univ Munich, Fak Phys, Ctr NanoSci, Munich, Germany.	madeleine.leisner@physik.uni-muenchen.de	Mascher, Thorsten/G-2074-2011	Mascher, Thorsten/0000-0002-6300-5541	excellence cluster Nano Initiative Munich; Center for Nanoscience; Deutsche Forschungsgemeinschaft [MA2873/3-1]	excellence cluster Nano Initiative Munich; Center for Nanoscience; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding to ML, the authors thank excellence cluster Nano Initiative Munich and the Center for Nanoscience for funding. Funding to TM, funding is gratefully acknowledged by the Deutsche Forschungsgemeinschaft (MA2873/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisicchia P, 2010, PLASMID, V64, P143, DOI 10.1016/j.plasmid.2010.06.002; Botella E, 2011, MICROBIOL-SGM, V157, P2470, DOI 10.1099/mic.0.049205-0; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elsen S, 2003, J BACTERIOL, V185, P7111, DOI 10.1128/JB.185.24.7111-7119.2003; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; Gebhard S, 2011, MOL MICROBIOL, V81, P581, DOI 10.1111/j.1365-2958.2011.07747.x; Ghosh S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-18; Groban ES, 2009, J MOL BIOL, V390, P380, DOI 10.1016/j.jmb.2009.05.007; Hauser K, 2000, EUR J CELL BIOL, V79, P144, DOI 10.1078/S0171-9335(04)70016-3; Hoch J.A., 1995, 2 COMPONENT SIGNAL T, DOI [10.1128/9781555818319, DOI 10.1128/9781555818319]; Izuka R, 2011, ANAL CHEM, V414, P173; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Jordan S, 2007, MICROBIOL-SGM, V153, P2530, DOI 10.1099/mic.0.2007/006817-0; Jordan S, 2006, J BACTERIOL, V188, P5153, DOI 10.1128/JB.00310-06; Kato A, 2007, P NATL ACAD SCI USA, V104, P12063, DOI 10.1073/pnas.0704462104; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; Leisner M, 2009, BIOPHYS J, V96, P1178, DOI 10.1016/j.bpj.2008.10.034; LI JY, 1995, BIOCHEMISTRY-US, V34, P14626, DOI 10.1021/bi00045a003; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Marmaar H, 2007, SCIENCE, V317, P525; Mascher T, 2004, ANTIMICROB AGENTS CH, V48, P2888, DOI 10.1128/AAC.48.8.2888-2896.2004; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Mitrophanov AY, 2007, J THEOR BIOL, V246, P113, DOI 10.1016/j.jtbi.2006.11.009; Nagasawa S, 1997, DNA RES, V4, P161; Pratt L., 1995, 2 COMPONENT SIGNAL T, P105; Ray JCJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000676; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; Scharf BE, 2010, CURR OPIN MICROBIOL, V13, P246, DOI 10.1016/j.mib.2010.01.006; Schrecke K, 2012, MOL MICROBI IN PRESS; Schrecke K, 2012, 2 COMPONENT SIGNALIN; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Staron A, 2011, ANTIMICROB AGENTS CH, V55, P515, DOI 10.1128/AAC.00352-10; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Szurmant H, 2008, P NATL ACAD SCI USA, V105, P5891, DOI 10.1073/pnas.0800247105; Toymentseva AA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-143; Wolf D, 2012, ANTIMICROB AGENTS CH, DOI 10.1128; Wolf D, 2010, J BACTERIOL, V192, P4680, DOI 10.1128/JB.00543-10; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200	44	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53457	10.1371/journal.pone.0053457	http://dx.doi.org/10.1371/journal.pone.0053457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326432	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800046
J	Langendam, MW; Tiemersma, EW; van der Werf, MJ; Sandgren, A				Langendam, Miranda W.; Tiemersma, Edine W.; van der Werf, Marieke J.; Sandgren, Andreas			Adverse Events in Healthy Individuals and MDR-TB Contacts Treated with Anti-Tuberculosis Drugs Potentially Effective for Preventing Development of MDR-TB: A Systematic Review	PLOS ONE			English	Review							MULTIDRUG-RESISTANT TUBERCULOSIS; HOUSEHOLD CONTACTS; CLOSE CONTACTS; PHARMACOKINETICS; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; SAFETY; OUTBREAK; FLUOROQUINOLONES	A recent systematic review concluded that there is insufficient evidence on the effectiveness to support or reject preventive therapy for treatment of contacts of patients with multidrug resistant tuberculosis (MDR-TB). Whether preventive therapy is favorable depends both on the effectiveness and the adverse events of the drugs used. We performed a systematic review to assess adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB. We searched MEDLINE, EMBASE, and other databases (August 2011). Record selection, data extraction, and study quality assessment were done in duplicate. The quality of evidence was assessed using the GRADE approach. Of 6,901 identified references, 20 studies were eligible. Among the 16 studies in healthy volunteers (a total of 87 persons on either levofloxacin, moxifloxacin, ofloxacin, or rifabutin, mostly for 1 week), serious adverse events and treatment discontinuation due to adverse events were rare (<1 and <5%, respectively), but mild adverse events frequently occurred. Due to small sample sizes of the levofloxacin and ofloxacin studies an increased frequency of mild adverse events compared to placebo could not be demonstrated or excluded. For moxifloxacin the comparative results were inconsistent. In four studies describing preventive therapy of MDR-TB contacts, therapy was stopped for 58-100% of the included persons because of the occurrence of adverse events ranging from mild adverse events such as nausea and dizziness to serious events requiring treatment. The quality of the evidence was very low. Although the number of publications and quality of evidence are low, the available evidence suggests that shortly after starting treatment the occurrence of serious adverse events is rare. Mild adverse events occur more frequently and may be of importance because these may provoke treatment interruption.	[Langendam, Miranda W.] Univ Amsterdam, Acad Med Ctr, Dutch Cochrane Ctr, NL-1105 AZ Amsterdam, Netherlands; [Tiemersma, Edine W.; van der Werf, Marieke J.] KNCV TB Fdn, The Hague, Netherlands; [Tiemersma, Edine W.; van der Werf, Marieke J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Sandgren, Andreas] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden	University of Amsterdam; Academic Medical Center Amsterdam; KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam; European Centre for Disease Prevention & Control	Sandgren, A (corresponding author), European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.	andreas.sandgren@ecdc.europa.eu		van der Werf, Marieke J./0000-0001-8021-1358; Langendam, Miranda/0000-0001-9038-3209; Sandgren, Andreas/0000-0001-7358-0809				Amsden GW, 1999, CHEST, V116, P115, DOI 10.1378/chest.116.1.115; [Anonymous], 1992, MMWR Recomm Rep, V41, P61; Attamna A, 2009, THORAX, V64, P271, DOI 10.1136/thx.2008.100974; Ayalasomayajula S, 2008, J CLIN PHARMACOL, V48, P799, DOI 10.1177/0091270008319330; Barry PM, 2012, EMERG INFECT DIS, V18, P113, DOI 10.3201/eid1801.110671; Bayona J, 2003, INT J TUBERC LUNG D, V7, pS501; Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1; Burkhardt O, 2002, SCAND J INFECT DIS, V34, P898, DOI 10.1080/0036554021000026963; Chien SC, 1997, ANTIMICROB AGENTS CH, V41, P2256, DOI 10.1128/AAC.41.10.2256; Chien SC, 1998, ANTIMICROB AGENTS CH, V42, P885, DOI 10.1128/AAC.42.4.885; Chow AT, 2001, ANTIMICROB AGENTS CH, V45, P2122, DOI 10.1128/AAC.45.7.2122-2125.2001; DANAN G, 1981, LANCET, V2, P1056; European Centre for Disease Prevention and Control (ECDC), 2012, ECDC GUID MAN CONT M; Ford SL, 2008, ANTIMICROB AGENTS CH, V52, P534, DOI 10.1128/AAC.00724-07; Golder S, 2006, HEALTH INFO LIBR J, V23, P3, DOI 10.1111/j.1471-1842.2006.00634.x; Grandjean L, 2011, INT J TUBERC LUNG D, V15, P1164, DOI 10.5588/ijtld.11.0030; GUAY DRP, 1992, ANTIMICROB AGENTS CH, V36, P308, DOI 10.1128/AAC.36.2.308; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; HORN DL, 1994, NEW ENGL J MED, V330, P1241, DOI 10.1056/NEJM199404283301718; Kraft WK, 2004, J CLIN PHARMACOL, V44, P305, DOI 10.1177/0091270003262807; Kritski AL, 1996, AM J RESP CRIT CARE, V153, P331, DOI 10.1164/ajrccm.153.1.8542139; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Marier JF, 2006, CLIN THER, V28, P2070, DOI 10.1016/j.clinthera.2006.12.018; Migliori GB, 2012, EUR RESPIR J, V39, P807, DOI 10.1183/09031936.00203811; Mohammadi A, 2008, East Mediterr Health J, V14, P1240; National Institute for Health and Clinical Excellence (NICE), 2011, NICE CLIN GUID 117 C; Oeltmann JE, 2008, EMERG INFECT DIS, V14, P1715, DOI 10.3201/eid1411.071629; Palmero D, 2005, INT J TUBERC LUNG D, V9, P1168; Papastavros T, 2002, CAN MED ASSOC J, V167, P131; Peeters M, 2008, ANN PHARMACOTHER, V42, P757, DOI 10.1345/aph.1K681; Ridzon R, 1997, CLIN INFECT DIS, V24, P1264, DOI 10.1093/clinids/24.6.1264; Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765; Single N, 2011, INT J TUBERC LUNG D, V15, P1326, DOI 10.5588/ijtld.10.0564; Society AT, 2000, MMWR RECOMM REP, V49, P1; STEIN GE, 1991, DRUG EXP CLIN RES, V17, P525; Sullivan JT, 1999, ANTIMICROB AGENTS CH, V43, P2793, DOI 10.1128/AAC.43.11.2793; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Teixeira L, 2001, INT J TUBERC LUNG D, V5, P321; Tsikouris JP, 2006, ANN NONINVAS ELECTRO, V11, P52, DOI 10.1111/j.1542-474X.2006.00082.x; van der Werf MJ, 2012, INT J TUBERC LUNG D, V16, P288, DOI 10.5588/ijtld.11.0437; VANSAENE HKF, 1988, J ANTIMICROB CHEMOTH, V22, P127; Vella V, 2011, INT J TUBERC LUNG D, V15, P1170, DOI 10.5588/ijtld.10.0781; Wells GA, 2011, LANCET; WHO, 2011, WHO TECH REP SER, V959, P1; WHO, 2010, MULT EXT DRUG RES TB; World Health Organization, 2008, WHOHTMTB2008402; Younossian AB, 2005, EUR RESPIR J, V26, P462, DOI 10.1183/09031936.05.00006205; Zhang L, 2002, ACTA PHARMACOL SIN, V23, P381	49	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53599	10.1371/journal.pone.0053599	http://dx.doi.org/10.1371/journal.pone.0053599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326464	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800058
J	Singh, N; Bajpai, S; Kumar, V; Gour, JK; Singh, RK				Singh, Nisha; Bajpai, Surabhi; Kumar, Vinod; Gour, Jalaj K.; Singh, Rakesh K.			Identification and Functional Characterization of Leishmania donovani Secretory Peroxidase: Delineating Its Role in NRAMP1 Regulation	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; IMMUNE-RESPONSE; MACROPHAGE; IRON; TRANSPORTER; CYTOKINES; CHAGASI; CLONING; LIPOPOLYSACCHARIDE; MECHANISMS	Leishmania silently evades host immune system and establish in the hostile environment of host macrophage phagolysosomes. For differentiation, growth and division parasite acquires divalent cations especially iron from the host nutritive pool. Natural resistance associated with macrophage protein1 (NRAMP1), a cation transporter that effluxes out divalent cations specifically iron from phagosomal milieu to the cytosol, to create ions deprived status for pathogenic microorganisms. The mechanisms of NRAMP1 regulation are largely unknown in leishmanial infections. In the present study, we identified a secretory Leishmania donovani peroxidase (Prx) that showed peroxidoxin like peroxidase activity and significantly reduced H2O2, O-2(-) and NO levels in LPS activated macrophages. Further, we also observed down regulated Nramp1 expression and concomitantly declined labile iron pool in activated macrophages treated with identified peroxidase. Prx also decreased levels of TNF-alpha, IFN-gamma and IL-12 in LPS activated macrophages. These observations indicate a bifunctional protective role of secretory Prx; first it reduces redox activation of macrophages, and secondly it allows iron access to Leishmania by down regulating NRAMP1 expression.	[Singh, Nisha; Bajpai, Surabhi; Kumar, Vinod; Gour, Jalaj K.; Singh, Rakesh K.] Banaras Hindu Univ, Fac Sci, Dept Biochem, Mol Immunol Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Singh, RK (corresponding author), Banaras Hindu Univ, Fac Sci, Dept Biochem, Mol Immunol Lab, Varanasi 221005, Uttar Pradesh, India.	rakesh_bc@bhu.ac.in	Singh, Nisha/B-4760-2013; Singh, Nisha/ABF-6782-2020; Singh, Rakesh K./AAX-9528-2021	Singh, Nisha/0000-0003-4897-8123; Singh, Nisha/0000-0003-4897-8123; Bajpai, Surabhi/0000-0002-2093-7437	Department of Biotechnology, New Delhi [BT/PR11177/MED/29/99/2008]; DBT; CSIR; UGC; UP-CST	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India); UP-CST	The financial support received from Department of Biotechnology, New Delhi (BT/PR11177/MED/29/99/2008) is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors sincerely acknowledge Dr. Arvind Mishra and Dr. Monika, Department of Chemistry, BHU for their support in fluorescent studies. The authors NS, SB, VK and JKG are thankful to DBT, CSIR, UGC and UP-CST, respectively for their research fellowships.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Bacellar O, 2000, CYTOKINE, V12, P1228, DOI 10.1006/cyto.2000.0694; Balanco JMF, 1998, PARASITOLOGY, V116, P103, DOI 10.1017/S003118209700214X; Barnett PG, 2005, AM J TROP MED HYG, V73, P720, DOI 10.4269/ajtmh.2005.73.720; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; Barr SD, 2001, J BIOL CHEM, V276, P34279, DOI 10.1074/jbc.M104406200; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0; Cabantchik ZI, 1996, ANAL BIOCHEM, V233, P221, DOI 10.1006/abio.1996.0032; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Castro H, 2008, EXP PARASITOL, V120, P421, DOI 10.1016/j.exppara.2008.09.002; Chakraborty R, 1996, MOL CELL BIOCHEM, V154, P23, DOI 10.1007/BF00248457; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; Das NK, 2009, CELL MICROBIOL, V11, P83, DOI 10.1111/j.1462-5822.2008.01241.x; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DING AH, 1988, J IMMUNOL, V141, P2407; Ferret PJ, 2002, BMC IMMUNOL, V12, P17; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Gomez MA, 2007, J BIOL CHEM, V282, P36190, DOI 10.1074/jbc.M703140200; HECHT D, 1992, BIOCHEM BIOPH RES CO, V188, P773, DOI 10.1016/0006-291X(92)91123-8; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Iles KE, 2002, IMMUNOL RES, V26, P95, DOI 10.1385/IR:26:1-3:095; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; JOHNSTON RB, 1978, J EXP MED, V148, P115; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Kima PE, 2007, INT J PARASITOL, V37, P1087, DOI 10.1016/j.ijpara.2007.04.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafuse WP, 2000, BIOCHEM J, V351, P687, DOI 10.1042/0264-6021:3510687; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994; Murray HW, 1997, J EXP MED, V185, P867, DOI 10.1084/jem.185.5.867; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Paramchuk WJ, 1997, MOL BIOCHEM PARASIT, V90, P203, DOI 10.1016/S0166-6851(97)00141-2; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Romao S, 2009, INT J PARASITOL, V39, P703, DOI 10.1016/j.ijpara.2008.11.009; Saha S, 2006, INDIAN J MED RES, V123, P245; Singh RK, 2012, MICROBIOL RES, V167, P445, DOI 10.1016/j.micres.2012.01.002; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Soe-Lin S, 2008, EXP HEMATOL, V36, P929, DOI 10.1016/j.exphem.2008.02.013; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Srivastava A, 2012, MOL CELL BIOCHEM, V359, P359, DOI 10.1007/s11010-011-1029-5; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; World Health Organization, 2008, The global burden of disease: 2004 update; Yeung IYL, 2004, BIOCHEM SOC T, V32, P1008, DOI 10.1042/BST0321008; Zhang GL, 2000, INFECT IMMUN, V68, P1086, DOI 10.1128/IAI.68.3.1086-1093.2000	53	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53442	10.1371/journal.pone.0053442	http://dx.doi.org/10.1371/journal.pone.0053442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326430	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800044
J	Meng, R; Zhu, DL; Bi, Y; Yang, DH; Wang, YP				Meng, Ran; Zhu, Dalong; Bi, Yan; Yang, Donghui; Wang, Yaping			Erythropoietin Inhibits Gluconeogenesis and Inflammation in the Liver and Improves Glucose Intolerance in High-Fat Diet-Fed Mice	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; INDUCED INSULIN-RESISTANCE; ISCHEMIA-REPERFUSION INJURY; SIGNALING PATHWAYS; HEMODIALYSIS-PATIENTS; GENE-EXPRESSION; INDUCED OBESITY; IKK-BETA; PROTECTS; METABOLISM	Erythropoietin (EPO) has multiple biological functions, including the modulation of glucose metabolism. However, the mechanisms underlying the action of EPO are still obscure. This study is aimed at investigating the potential mechanisms by which EPO improves glucose tolerance in an animal model of type 2 diabetes. Male C57BL/6 mice were fed with high-fat diet (HFD) for 12 weeks and then treated with EPO (HFD-EPO) or vehicle saline (HFD-Con) for two week. The levels of fasting blood glucose, serum insulin and glucose tolerance were measured and the relative levels of insulin-related phosphatidylinositol 3-kinase (PI3K)/Akt, insulin receptor (IR) and IR substrate 1 (IRS1) phosphorylation were determined. The levels of phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase (G6Pase), toll like receptor 4 (TLR4), tumor necrosis factor (TNF)-alpha and IL-6 expression and nuclear factor-kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK), extracellular-signal-regulated kinase (ERK) and p38 MAPK activation in the liver were examined. EPO treatment significantly reduced the body weights and the levels of fasting blood glucose and serum insulin and improved the HFD-induced glucose intolerance in mice. EPO treatment significantly enhanced the levels of Akt, but not IR and IRS1, phosphorylation, accompanied by inhibiting the PEPCK and G6Pase expression in the liver. Furthermore, EPO treatment mitigated the HFD-induced inflammatory TNF-alpha and IL-6 production, TLR4 expression, NF-kappa B and JNK, but not ERK and p38 MAPK, phosphorylation in the liver. Therefore, our data indicated that EPO treatment improved glucose intolerance by inhibiting gluconeogenesis and inflammation in the livers of HFD-fed mice.	[Meng, Ran; Zhu, Dalong; Bi, Yan; Yang, Donghui] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Endocrinol, Nanjing 210008, Jiangsu, Peoples R China; [Meng, Ran; Wang, Yaping] Nanjing Univ, Sch Med, Dept Med Genet, Nanjing 210008, Jiangsu, Peoples R China; [Meng, Ran; Wang, Yaping] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Zhu, DL (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Endocrinol, Nanjing 210008, Jiangsu, Peoples R China.	zhudldr@gmail.com; wangyap@nju.edu.cn	Bi, Yan/O-5153-2015		National Natural Science Foundation of China [81070636]; Natural Science Foundation of Jiangsu Province of China [BK2010110]; Jiangsu Province's Key Discipline/Laboratory of Medicine [XK201105]; Program for the Talents in science and education of Jiangsu Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Key Discipline/Laboratory of Medicine; Program for the Talents in science and education of Jiangsu Province, China	This study was supported by National Natural Science Foundation of China (81070636), Natural Science Foundation of Jiangsu Province of China (BK2010110), Jiangsu Province's Key Discipline/Laboratory of Medicine (XK201105) and Program for the Talents in science and education of Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ben-Ari Z, 2011, TRANSPLANTATION, V92, P18, DOI 10.1097/TP.0b013e31821cdea5; Buchner DA, 2011, OBESITY, V19, P917, DOI 10.1038/oby.2010.214; Burger D, 2009, Curr Mol Pharmacol, V2, P56; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cassis P, 2012, KIDNEY INT, V81, P903, DOI 10.1038/ki.2011.473; Cho GW, 2010, BRAIN RES, V1353, P1, DOI 10.1016/j.brainres.2010.06.013; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Eipel C, 2012, J SURG RES, V173, P171, DOI 10.1016/j.jss.2010.09.008; HE TC, 1993, BLOOD, V82, P3530; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hochhauser E, 2008, APOPTOSIS, V13, P77, DOI 10.1007/s10495-007-0155-8; Hojman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005894; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Katz O, 2010, J ENDOCRINOL, V205, P87, DOI 10.1677/JOE-09-0425; Khedr E, 2009, HEMODIAL INT, V13, P340, DOI 10.1111/j.1542-4758.2009.00367.x; Kim JJ, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/212563; Kleemann R, 2003, BLOOD, V101, P545, DOI 10.1182/blood-2002-06-1762; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Mudalagiri NR, 2008, BRIT J PHARMACOL, V153, P50, DOI 10.1038/sj.bjp.0707461; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Pappo O, 2010, CAN J PHYSIOL PHARM, V88, P1130, DOI 10.1139/Y10-091; Rodrigues CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029893; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmeding M, 2010, TRANSPLANTATION, V89, P161, DOI 10.1097/TP.0b013e3181c425fd; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Summers SA, 1999, ANN NY ACAD SCI, V892, P169, DOI 10.1111/j.1749-6632.1999.tb07795.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Tuzcu A, 2004, HORM METAB RES, V36, P716, DOI 10.1055/s-2004-826021; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	39	36	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53557	10.1371/journal.pone.0053557	http://dx.doi.org/10.1371/journal.pone.0053557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326455	Green Submitted, gold, Green Published			2022-12-27	WOS:000313552400028
J	Rodriguez, A; Falcon, A; Cuevas, MT; Pozo, F; Guerra, S; Garcia-Barreno, B; Martinez-Orellana, P; Perez-Brena, P; Montoya, M; Melero, JA; Pizarro, M; Ortin, J; Casas, I; Nieto, A				Rodriguez, Ariel; Falcon, Ana; Teresa Cuevas, Maria; Pozo, Francisco; Guerra, Susana; Garcia-Barreno, Blanca; Martinez-Orellana, Pamela; Perez-Brena, Pilar; Montoya, Maria; Antonio Melero, Jose; Pizarro, Manuel; Ortin, Juan; Casas, Inmaculada; Nieto, Amelia			Characterization In Vitro and In Vivo of a Pandemic H1N1 Influenza Virus from a Fatal Case	PLOS ONE			English	Article							A H1N1; FULMINANT MYOCARDITIS; MUTATIONAL ANALYSIS; PA PROTEIN; INFECTION; CCR5; HEMAGGLUTININ; PATHOGENICITY; ENDONUCLEASE; SUBSTITUTION	Pandemic 2009 H1N1 (pH1N1) influenza viruses caused mild symptoms in most infected patients. However, a greater rate of severe disease was observed in healthy young adults and children without co-morbid conditions. Here we tested whether influenza strains displaying differential virulence could be present among circulating pH1N1 viruses. The biological properties and the genotype of viruses isolated from a patient showing mild disease (M) or from a fatal case (F), both without known co-morbid conditions were compared in vitro and in vivo. The F virus presented faster growth kinetics and stronger induction of cytokines than M virus in human alveolar lung epithelial cells. In the murine model in vivo, the F virus showed a stronger morbidity and mortality than M virus. Remarkably, a higher proportion of mice presenting infectious virus in the hearts, was found in F virus-infected animals. Altogether, the data indicate that strains of pH1N1 virus with enhanced pathogenicity circulated during the 2009 pandemic. In addition, examination of chemokine receptor 5 (CCR5) genotype, recently reported as involved in severe influenza virus disease, revealed that the F virus-infected patient was homozygous for the deleted form of CCR5 receptor (CCR5 Delta 32).	[Rodriguez, Ariel; Falcon, Ana; Ortin, Juan; Nieto, Amelia] CSIC Darwin 3, Ctr Nacl Biotecnol, Madrid, Spain; [Rodriguez, Ariel; Falcon, Ana; Garcia-Barreno, Blanca; Antonio Melero, Jose; Ortin, Juan; Nieto, Amelia] Ciber Enfermedades Resp, Mallorca, Illes Balears, Spain; [Teresa Cuevas, Maria; Pozo, Francisco; Garcia-Barreno, Blanca; Perez-Brena, Pilar; Antonio Melero, Jose; Casas, Inmaculada] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dpto Med Prevent Salud Publ & Microbiol, Madrid, Spain; [Martinez-Orellana, Pamela; Montoya, Maria] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Montoya, Maria] IRTA, Barcelona, Spain; [Pizarro, Manuel] Univ Complutense Madrid, Fac Vet, Hosp Clin Vet, Serv Anat Patol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Autonomous University of Madrid; IRTA; IRTA; Complutense University of Madrid	Nieto, A (corresponding author), CSIC Darwin 3, Ctr Nacl Biotecnol, Madrid, Spain.	anieto@cnb.csic.es	Falcon, Ana/L-8304-2018; Montoya, Maria/G-3430-2015; Garcia-Barreno, Blanca/AAF-5554-2019; Rodriguez, Ariel/B-3908-2013; Rodriguez Frandsen, Ariel/HDM-7270-2022; Casas, Inmaculada/H-9442-2015; gonzalez-nico, maria teresa cuevas/E-2001-2014; guerra, susana/K-5972-2014; Pozo, Francisco/F-4426-2012; Ortin, Juan/L-3622-2013; Casas, Inmaculada/X-7579-2019	Montoya, Maria/0000-0002-5703-7360; Rodriguez, Ariel/0000-0001-6850-5003; Rodriguez Frandsen, Ariel/0000-0001-6850-5003; Casas, Inmaculada/0000-0003-1840-1198; gonzalez-nico, maria teresa cuevas/0000-0002-4195-1975; guerra, susana/0000-0001-9067-2991; Pozo, Francisco/0000-0003-1828-733X; Casas, Inmaculada/0000-0003-1840-1198; Martinez-Orellana, Pamela/0000-0002-2025-9445; Ortin, Juan/0000-0002-6200-4678; Melero, Jose A./0000-0001-8148-6521	Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica) [GR09/0023, GR09/0040, GR09/0039]; Ciber de Enfermedades Respiratorias	Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica); Ciber de Enfermedades Respiratorias	This work was supported by Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica GR09/0023, GR09/0040, GR09/0039) and Ciber de Enfermedades Respiratorias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2002, DIABETES, V51, P2489, DOI 10.2337/diabetes.51.8.2489; Almansa R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-232; [Anonymous], 2010, VOP VIRUSOL; Antonopoulou A, 2012, INT J INFECT DIS IJI; Baumeister E, 2010, MEDICINA-BUENOS AIRE, V70, P518; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Bratincsak A, 2010, J AM COLL CARDIOL, V55, P928, DOI 10.1016/j.jacc.2010.01.004; Brown SM, 2011, EUR RESPIR J, V37, P112, DOI 10.1183/09031936.00008210; Carmona F, 2011, AM J CLIN PATHOL, V136, P416, DOI 10.1309/AJCP1Y6LLHWSKYHW; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Cheng XW, 2011, RESP PHYSIOL NEUROBI, V175, P185, DOI 10.1016/j.resp.2010.11.004; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estella A, 2011, J INFECT DEV COUNTR, V5, P540, DOI 10.3855/jidc.1618; Everitt AR, 2012, NATURE; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Falagas ME, 2010, EUR J CLIN MICROBIOL, V29, P1327, DOI 10.1007/s10096-010-1002-3; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gokhroo R K, 2011, J Assoc Physicians India, V59, P51; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ison MG, 2005, CLIN INFECT DIS, V40, P415, DOI 10.1086/427282; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Keynan Y, 2010, EMERG INFECT DIS, V16, P1621, DOI 10.3201/eid1610.100108; Kilander A, 2010, EUROSURVEILLANCE, V4, P15; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kwon D, 2010, J MICROBIOL, V48, P657, DOI 10.1007/s12275-010-0120-z; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Liao YC, 2011, J CHIN MED ASSOC, V74, P130, DOI 10.1016/j.jcma.2011.01.028; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Meunier I, 2012, VIROLOGY, V422, P125, DOI 10.1016/j.virol.2011.10.018; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Mok CKP, 2011, J VIROL, V85, P9641, DOI 10.1128/JVI.00702-11; Nakajima N, 2011, MODERN PATHOLOGY OFF; Nakajima N, 2010, JPN J INFECT DIS, V63, P67; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nin N, 2011, INTENS CARE MED, V37, P880, DOI 10.1007/s00134-011-2183-7; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Perales B, 1996, J VIROL, V70, P1678, DOI 10.1128/JVI.70.3.1678-1686.1996; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Phung TT, 2011, MICROBIOLOGY IMMUNOL; Prasad H B, 2011, J Assoc Physicians India, V59, P498; Ru YX, 2011, ULTRASTRUCT PATHOL, V35, P155, DOI 10.3109/01913123.2011.574249; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Sambhara S, 2010, ANNU REV MED, V61, P187, DOI 10.1146/annurev.med.050908.132031; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Singanayagam A, 2011, J INFECTION, V63, P243, DOI 10.1016/j.jinf.2011.07.014; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Sun RQ, 2009, INTEGR ZOOL, V4, P402, DOI 10.1111/j.1749-4877.2009.00178.x; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; Wasilenko JL, 2011, ARCH VIROL, V156, P37, DOI 10.1007/s00705-010-0813-y; Wiegand JA, 2011, WIEN KLIN WOCHENSCHR, V123, P120, DOI 10.1007/s00508-010-1520-0; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020698; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Yu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020575, 10.1371/journal.pone.0028680]; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zachary JF., 2012, PATHOLOGICAL BASIS V, V5; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Zuniga J, 2011, AUTOIMMUNITY, V44, P562, DOI 10.3109/08916934.2011.592885; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	74	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53515	10.1371/journal.pone.0053515	http://dx.doi.org/10.1371/journal.pone.0053515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326447	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400027
J	Greene, MJ; Pinter-Wollman, N; Gordon, DM				Greene, Michael J.; Pinter-Wollman, Noa; Gordon, Deborah M.			Interactions with Combined Chemical Cues Inform Harvester Ant Foragers' Decisions to Leave the Nest in Search of Food	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; GEOGRAPHIC VARIATIONS; FORAGING ACTIVITY; FATTY-ACIDS; HYMENOPTERA; ACTIVATION; DISPERSAL; PLANT	Social insect colonies operate without central control or any global assessment of what needs to be done by workers. Colony organization arises from the responses of individuals to local cues. Red harvester ants (Pogonomyrmex barbatus) regulate foraging using interactions between returning and outgoing foragers. The rate at which foragers return with seeds, a measure of food availability, sets the rate at which outgoing foragers leave the nest on foraging trips. We used mimics to test whether outgoing foragers inside the nest respond to the odor of food, oleic acid, the odor of the forager itself, cuticular hydrocarbons, or a combination of both with increased foraging activity. We compared foraging activity, the rate at which foragers passed a line on a trail, before and after the addition of mimics. The combination of both odors, those of food and of foragers, is required to stimulate foraging. The addition of blank mimics, mimics coated with food odor alone, or mimics coated with forager odor alone did not increase foraging activity. We compared the rates at which foragers inside the nest interacted with other ants, blank mimics, and mimics coated with a combination of food and forager odor. Foragers inside the nest interacted more with mimics coated with combined forager/seed odors than with blank mimics, and these interactions had the same effect as those with other foragers. Outgoing foragers inside the nest entrance are stimulated to leave the nest in search of food by interacting with foragers returning with seeds. By using the combined odors of forager cuticular hydrocarbons and of seeds, the colony captures precise information, on the timescale of seconds, about the current availability of food.	[Greene, Michael J.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Pinter-Wollman, Noa; Gordon, Deborah M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Colorado System; University of Colorado Denver; Stanford University	Greene, MJ (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	michael.greene@ucdenver.edu			NSF [IOS-0718631]	NSF(National Science Foundation (NSF))	NSF grant IOS-0718631 to DMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; Biesmeijer JC, 1998, BEHAV ECOL SOCIOBIOL, V42, P107, DOI 10.1007/s002650050418; Bollazzi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017667; Boulay R, 2007, NATURWISSENSCHAFTEN, V94, P242, DOI 10.1007/s00114-006-0185-z; Boulay R, 2006, CHEMOECOLOGY, V16, P1, DOI 10.1007/s00049-005-0322-8; CAMAZINE S, 1993, BEHAV ECOL SOCIOBIOL, V32, P265, DOI 10.1007/BF00166516; Copeland LO, 2001, PRINCIPLES SEED SCI, P48; Fernandez PC, 2003, BEHAV ECOL SOCIOBIOL, V54, P80, DOI 10.1007/s00265-003-0607-2; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Gordon DM, 2007, NATURE, V446, P143, DOI 10.1038/446143a; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; GORDON DM, 1983, J CHEM ECOL, V9, P105, DOI 10.1007/BF00987774; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; GORDON DM, 1995, ANIM BEHAV, V49, P649, DOI 10.1016/0003-3472(95)80198-7; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; Gordon DM, 2002, AM NAT, V159, P509, DOI 10.1086/339461; GORDON DM, 1993, OECOLOGIA, V95, P479, DOI 10.1007/BF00317431; Greene MJ, 2007, AM NAT, V170, P943, DOI 10.1086/522843; Greene MJ, 2007, J EXP BIOL, V210, P897, DOI 10.1242/jeb.02706; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Gruter C, 2008, P R SOC B, V275, P1321, DOI 10.1098/rspb.2008.0186; Helmy O, 2003, INSECT SOC, V50, P32, DOI 10.1007/s000400300005; Ichinose K, 2005, INSECT SOC, V57, P453; Kanchanamayoon Wanna, 2007, Chiang Mai Journal of Science, V34, P249; Laffargue A, 2007, PLANT PHYSIOL BIOCH, V45, P250, DOI 10.1016/j.plaphy.2007.01.012; Martin SJ, 2009, BIOL J LINN SOC, V96, P732, DOI 10.1111/j.1095-8312.2008.01158.x; Nelson D.R., 1995, WAXES CHEM MOL BIOL, P1; Nelson DR, 2001, COMP BIOCHEM PHYS B, V128, P575, DOI 10.1016/S1096-4959(00)00354-7; O'Donnell S, 2001, BEHAV ECOL, V12, P353, DOI 10.1093/beheco/12.3.353; Pinter-Wollman N, 2011, J R SOC INTERFACE, V8, P1562, DOI 10.1098/rsif.2011.0059; Schafer RJ, 2006, ANIM BEHAV, V71, P815, DOI 10.1016/j.anbehav.2005.05.024; Steck K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-5; Sturgis SJ, 2011, J CHEM ECOL, V37, P514, DOI 10.1007/s10886-011-9947-y; Vioque J, 2003, J CHEM ECOL, V70, P1157; Wagner D, 2000, J CHEM ECOL, V26, P2245, DOI 10.1023/A:1005529224856; Wagner D, 1998, J CHEM ECOL, V24, P2021, DOI 10.1023/A:1020781508889; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391	39	37	38	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52219	10.1371/journal.pone.0052219	http://dx.doi.org/10.1371/journal.pone.0052219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308106	Green Published, gold			2022-12-27	WOS:000313429800013
J	Swidsinski, A; Verstraelen, H; Loening-Baucke, V; Swidsinski, S; Mendling, W; Halwani, Z				Swidsinski, Alexander; Verstraelen, Hans; Loening-Baucke, Vera; Swidsinski, Sonja; Mendling, Werner; Halwani, Zaher			Presence of a Polymicrobial Endometrial Biofilm in Patients with Bacterial Vaginosis	PLOS ONE			English	Article							VAGINAL MICROFLORA; ASSOCIATION; WOMEN; COLONIZATION; MISCARRIAGE; STERILITY	Objective: To assess whether the bacterial vaginosis biofilm extends into the upper female genital tract. Study Design: Endometrial samples obtained during curettage and fallopian tube samples obtained during salpingectomy were collected. Endometrial and fallopian tube samples were analyzed for the presence of bacteria with fluorescence-in-situ-hybridisation (FISH) analysis with probes targeting bacterial vaginosis-associated and other bacteria. Results: A structured polymicrobial Gardnerella vaginalis biofilm could be detected in part of the endometrial and fallopian tube specimens. Women with bacterial vaginosis had a 50.0% (95% CI 24.0-76.0) risk of presenting with an endometrial Gardnerella vaginalis biofilm. Pregnancy (AOR = 41.5, 95% CI 5.0-341.9, p<0.001) and the presence of bacterial vaginosis (AOR = 23.2, 95% CI 2.6-205.9, p<0.001) were highly predictive of the presence of uterine or fallopian bacterial colonisation when compared to non-pregnant women without bacterial vaginosis. Conclusion: Bacterial vaginosis is frequently associated with the presence of a structured polymicrobial Gardnerella vaginalis biofilm attached to the endometrium. This may have major implications for our understanding of the pathogenesis of adverse pregnancy outcome in association with bacterial vaginosis.	[Swidsinski, Alexander; Loening-Baucke, Vera] Univ Med Berlin, Lab Mol Genet Polymicrobial Infect & Bacterial Bi, Charite Hosp, CCM, Berlin, Germany; [Swidsinski, Alexander; Loening-Baucke, Vera] Univ Med Berlin, Dept Med, Berlin, Germany; [Verstraelen, Hans] Univ Ghent, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium; [Swidsinski, Sonja] Lab Berlin, Dept Microbiol, Berlin, Germany; [Mendling, Werner] German Ctr Infect Obstet & Gynaecol, Wuppertal, Germany; [Halwani, Zaher] DRK Kliniken Berlin Westend, Klin Gynakol & Geburtshilfe, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ghent University	Verstraelen, H (corresponding author), Univ Ghent, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium.	hans.verstraelen@ugent.be	Verstraelen, Hans/AAA-8694-2019; Verstraelen, Hans/A-5602-2008; Mendling, Werner/ABF-9498-2021	Verstraelen, Hans/0000-0002-4070-1587; Swidsinski, Alexander/0000-0002-7071-0417				Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P1611, DOI 10.1016/j.ajog.2006.04.010; ANSBACHE.R, 1967, AM J OBSTET GYNECOL, V99, P394, DOI 10.1016/S0002-9378(16)34549-5; COWLING P, 1992, EUR J CLIN MICROBIOL, V11, P204, DOI 10.1007/BF01967084; DUFF P, 1983, OBSTET GYNECOL, V61, P217; El Aila NA, 2011, RES MICROBIOL, V162, P506, DOI 10.1016/j.resmic.2011.04.004; Espinoza J, 2006, AM J OBSTET GYNECOL, V194, P630, DOI 10.1016/j.ajog.2005.11.050; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Leitich H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/j.bpobgyn.2006.12.005; MOLLER BR, 1995, ACTA OBSTET GYN SCAN, V74, P216, DOI 10.3109/00016349509008942; NELSON LH, 1986, J REPROD MED, V31, P473; Oakeshott P, 2002, BRIT MED J, V325, P1334, DOI 10.1136/bmj.325.7376.1334; Ralph SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/bmj.319.7204.220; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; Swidsinski A, 2010, ANAEROBE, V16, P478, DOI 10.1016/j.anaerobe.2010.06.011; Tita ATN, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.028; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Verstraelen H, 2004, AM J OBSTET GYNECOL, V191, P1130, DOI 10.1016/j.ajog.2004.04.013; Verstraelen H, 2009, EXPERT REV ANTI-INFE, V7, P1109, DOI [10.1586/eri.09.87, 10.1586/ERI.09.87]; Wilson JD, 2002, BJOG-INT J OBSTET GY, V109, P714, DOI 10.1016/S1470-0328(02)01297-1	21	96	115	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53997	10.1371/journal.pone.0053997	http://dx.doi.org/10.1371/journal.pone.0053997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320114	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429800080
J	Takamatsu, S; Onoguchi, K; Onomoto, K; Narita, R; Takahasi, K; Ishidate, F; Fujiwara, TK; Yoneyama, M; Kato, H; Fujita, T				Takamatsu, Shiori; Onoguchi, Kazuhide; Onomoto, Koji; Narita, Ryo; Takahasi, Kiyohiro; Ishidate, Fumiyoshi; Fujiwara, Takahiro K.; Yoneyama, Mitsutoshi; Kato, Hiroki; Fujita, Takashi			Functional Characterization of Domains of IPS-1 Using an Inducible Oligomerization System	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; ANTIVIRAL SIGNALING PROTEIN; HEPATITIS-C-VIRUS; NF-KAPPA-B; RIG-I; INNATE IMMUNITY; ADAPTER PROTEIN; IFN-BETA; MAVS; RESPONSES	The innate immune system recognizes viral nucleic acids and stimulates cellular antiviral responses. Intracellular detection of viral RNA is mediated by the Retinoic acid inducible gene (RIG)-I Like Receptor (RLR), leading to production of type I interferon (IFN) and pro-inflammatory cytokines. Once cells are infected with a virus, RIG-I and MDA5 bind to viral RNA and undergo conformational change to transmit a signal through direct interaction with downstream CARD-containing adaptor protein, IFN-beta promoter stimulator-1 (IPS-1, also referred as MAVS/VISA/Cardif). IPS-1 is composed of N-terminal Caspase Activation and Recruitment Domain (CARD), proline-rich domain, intermediate domain, and C-terminal transmembrane (TM) domain. The TM domain of IPS-1 anchors it to the mitochondrial outer membrane. It has been hypothesized that activated RLR triggers the accumulation of IPS-1, which forms oligomer as a scaffold for downstream signal proteins. However, the exact mechanisms of IPS-1-mediated signaling remain controversial. In this study, to reveal the details of IPS-1 signaling, we used an artificial oligomerization system to induce oligomerization of IPS-1 in cells. Artificial oligomerization of IPS-1 activated antiviral signaling without a viral infection. Using this system, we investigated the domain-requirement of IPS-1 for its signaling. We discovered that artificial oligomerization of IPS-1 could overcome the requirement of CARD and the TM domain. Moreover, from deletion- and point-mutant analyses, the C-terminal Tumor necrosis factor Receptor-Associated Factor (TRAF) binding motif of IPS-1 (aa. 453-460) present in the intermediate domain is critical for downstream signal transduction. Our results suggest that IPS-1 oligomerization is essential for the formation of a multiprotein signaling complex and enables downstream activation of transcription factors, Interferon Regulatory Factor 3 (IRF3) and Nuclear Factor-kappa B (NF-kappa B), leading to type I IFN and pro-inflammatory cytokine production.	[Takamatsu, Shiori; Onoguchi, Kazuhide; Narita, Ryo; Takahasi, Kiyohiro; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan; [Takamatsu, Shiori; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Mol Cell Biol Lab, Kyoto, Japan; [Onomoto, Koji; Yoneyama, Mitsutoshi] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chuo Ku, Chiba, Japan; [Takahasi, Kiyohiro] Kyoto Univ, Grad Sch Pharmaceut Sci, Inst Innovat NanoBio Drug Discovery & Dev, Kyoto, Japan; [Ishidate, Fumiyoshi; Fujiwara, Takahiro K.] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Ctr Meso Bio Single Mol Imaging CeMI, Kyoto, Japan	Kyoto University; Kyoto University; Chiba University; Kyoto University; Kyoto University	Fujita, T (corresponding author), Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan.	tfujita@virus.kyoto-u.ac.jp	Yoneyama, Mitsutoshi/D-8244-2017; Fujiwara, Takahiro/G-2755-2012	Yoneyama, Mitsutoshi/0000-0001-9512-0408; Fujiwara, Takahiro/0000-0001-5576-759X	Ministry of Education, Culture, Sports, Science and Technology in Japan [24115004, 23249023]; Ministry of Health, Labor and Welfare of Japan; PRESTO Japan Science and Technology Agency; Uehara Memorial Foundation; Takaeda Science Foundation; Naito Foundation; Nippon Boehringer Ingelheim; Grants-in-Aid for Scientific Research [23249023, 24115004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); PRESTO Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takaeda Science Foundation; Naito Foundation(Naito Memorial Foundation); Nippon Boehringer Ingelheim(Boehringer Ingelheim); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Ministry of Education, Culture, Sports, Science and Technology in Japan (Innovative Areas "Infection competency" (No.24115004), Scientific Research "A"(23249023) (http://www.mext.go.jp/english/), the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/index.html), the PRESTO Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/presto/index_e.html), the Uehara Memorial Foundation (http://www.ueharazaidan.com/), the Takaeda Science Foundation (http://www.takeda-sci.or.jp/index.html), the Naito Foundation (http://www.naito-f.or.jp/), and Nippon Boehringer Ingelheim (http://www.boehringer-ingelheim.co.jp/com/Home/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; DALY C, 1993, MOL CELL BIOL, V13, P3756, DOI 10.1128/MCB.13.6.3756; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Koshiba T, 2012, BIOCH BIOPHYS ACTA; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Ouda R, 2011, J BIOL CHEM, V286, P26210, DOI 10.1074/jbc.M111.229856; Paz S, 2011, CELL RES, V21, P895, DOI 10.1038/cr.2011.2; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sambhara S, 2012, NUCL ACID SENSORS AN; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Tang ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009172; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200	35	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53578	10.1371/journal.pone.0053578	http://dx.doi.org/10.1371/journal.pone.0053578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308256	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100092
J	Tarradas, A; Selga, E; Beltran-Alvarez, P; Perez-Serra, A; Riuro, H; Pico, F; Iglesias, A; Campuzano, O; Castro-Urda, V; Fernandez-Lozano, I; Perez, GJ; Scornik, FS; Brugada, R				Tarradas, Anna; Selga, Elisabet; Beltran-Alvarez, Pedro; Perez-Serra, Alexandra; Riuro, Helena; Pico, Ferran; Iglesias, Anna; Campuzano, Oscar; Castro-Urda, Victor; Fernandez-Lozano, Ignacio; Perez, Guillermo J.; Scornik, Fabiana S.; Brugada, Ramon			A Novel Missense Mutation, I890T, in the Pore Region of Cardiac Sodium Channel Causes Brugada Syndrome	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SCN5A MUTATIONS; GENETIC-BASIS; CHANNELOPATHIES; POLYMORPHISM; MODULATION; EXPRESSION; DISEASE	Brugada syndrome (BrS) is a life-threatening, inherited arrhythmogenic syndrome associated with autosomal dominant mutations in SCN5A, the gene encoding the cardiac Na+ channel alpha subunit (Na(v)1.5). The aim of this work was to characterize the functional alterations caused by a novel SCN5A mutation, I890T, and thus establish whether this mutation is associated with BrS. The mutation was identified by direct sequencing of SCN5A from the proband's DNA. Wild-type (WT) or I890T Na(v)1.5 channels were heterologously expressed in human embryonic kidney cells. Sodium currents were studied using standard whole cell patch-clamp protocols and immunodetection experiments were performed using an antibody against human Na(v)1.5 channel. A marked decrease in current density was observed in cells expressing the I890T channel (from -52.0 +/- 6.5 pA/pF, n=15 to -35.9 +/- 3.4 pA/pF, n = 22, at -20 mV, WT and I890T, respectively). Moreover, a positive shift of the activation curve was identified (V-1/2 = -32.0 +/- 0.3 mV, n = 18, and -27.3 +/- 0.3 mV, n = 22, WT and I890T, respectively). No changes between WT and I890T currents were observed in steady-state inactivation, time course of inactivation, slow inactivation or recovery from inactivation parameters. Cell surface protein biotinylation analyses confirmed that Na(v)1.5 channel membrane expression levels were similar in WT and I890T cells. In summary, our data reveal that the I890T mutation, located within the pore of Na(v)1.5, causes an evident loss-of-function of the channel. Thus, the BrS phenotype observed in the proband is most likely due to this mutation.	[Tarradas, Anna; Selga, Elisabet; Beltran-Alvarez, Pedro; Perez-Serra, Alexandra; Riuro, Helena; Pico, Ferran; Iglesias, Anna; Campuzano, Oscar; Perez, Guillermo J.; Scornik, Fabiana S.; Brugada, Ramon] Inst Invest Biomed Girona IDIBGi, Cardiovasc Genet Ctr, Girona, Spain; [Tarradas, Anna; Selga, Elisabet; Beltran-Alvarez, Pedro; Perez-Serra, Alexandra; Riuro, Helena; Pico, Ferran; Iglesias, Anna; Campuzano, Oscar; Perez, Guillermo J.; Scornik, Fabiana S.; Brugada, Ramon] Univ Girona UdG, Sch Med, Girona, Spain; [Castro-Urda, Victor; Fernandez-Lozano, Ignacio] Hosp Puerta de Hierro, Arrhythmia Unit, Madrid, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Hospital Puerta de Hierro-Majadahonda	Brugada, R (corresponding author), Inst Invest Biomed Girona IDIBGi, Cardiovasc Genet Ctr, Girona, Spain.	rbrugada@idibgi.org	campuzano, oscar/J-1968-2014; Selga, Elisabet/H-9007-2015; Perez, Guillermo J/D-5932-2013; Beltran-Alvarez, Pedro/AAU-5826-2021; Scornik, Fabiana S/I-1516-2014	campuzano, oscar/0000-0001-5298-5276; Selga, Elisabet/0000-0002-4290-8370; Perez, Guillermo J/0000-0003-0237-2150; Scornik, Fabiana S/0000-0002-0477-1924; Beltran-Alvarez, Pedro/0000-0001-8136-8963; Fernandez Lozano, Ignacio/0000-0002-3092-8761; Castro, Victor/0000-0002-8325-1379	Fundacio Obra social "La Caixa", Centro Nacional de Investigaciones Cardiovasculares [CNIC-03-2008]; Instituto de Salud Carlos III [FIS-PI08/1800]	Fundacio Obra social "La Caixa", Centro Nacional de Investigaciones Cardiovasculares; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Fundacio Obra social "La Caixa", Centro Nacional de Investigaciones Cardiovasculares [CNIC-03-2008] and Instituto de Salud Carlos III [FIS-PI08/1800]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Antzelevitch C, 2002, CIRC RES, V91, P1114, DOI 10.1161/01.RES.0000046046.53721.90; Antzelevitch Charles, 2008, Curr Cardiol Rep, V10, P376, DOI 10.1007/s11886-008-0060-y; Brugada J, 1998, CIRCULATION, V97, P457; Campuzano O, 2009, REV ESP CARDIOL, V62, P422, DOI 10.1016/S0300-8932(09)70899-1; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hilber K, 2001, J BIOL CHEM, V276, P27831, DOI 10.1074/jbc.M101933200; Itoh H, 2005, J CARDIOVASC ELECTR, V16, P378, DOI 10.1046/j.1540-8167.2005.40606.x; Jung C, 2011, CARDIOVASC RES, V91, P465, DOI 10.1093/cvr/cvr083; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Keller DI, 2005, CARDIOVASC RES, V67, P510, DOI 10.1016/j.cardiores.2005.03.024; Lizotte E, 2009, J CARDIOVASC ELECTR, V20, P1137, DOI 10.1111/j.1540-8167.2009.01508.x; Makita N, 2008, J CLIN INVEST, V118, P2219, DOI [10.1172/JCl34057, 10.1172/JCI34057]; Marangoni S, 2011, CARDIOVASC RES, V91, P606, DOI 10.1093/cvr/cvr142; Meregalli PG, 2009, HEART RHYTHM, V6, P341, DOI 10.1016/j.hrthm.2008.11.009; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Shirai N, 2002, CARDIOVASC RES, V53, P348, DOI 10.1016/S0008-6363(01)00494-1; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tan BH, 2006, AM J PHYSIOL-HEART C, V291, pH1822, DOI 10.1152/ajpheart.00101.2006; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Wilde AAM, 2011, CIRC RES, V108, P884, DOI 10.1161/CIRCRESAHA.110.238469; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	27	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53220	10.1371/journal.pone.0053220	http://dx.doi.org/10.1371/journal.pone.0053220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308164	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100039
J	Fung, C; De Marchis, GM; Katan, M; Seiler, M; Arnold, M; Gralla, J; Raabe, A; Beck, J				Fung, Christian; De Marchis, Gian Marco; Katan, Mira; Seiler, Marleen; Arnold, Marcel; Gralla, Jan; Raabe, Andreas; Beck, Juergen			Copeptin as a Marker for Severity and Prognosis of Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							VASOPRESSIN PRECURSOR; CEREBRAL VASOSPASM; STABLE PEPTIDE; STROKE	Background: Grading of patients with aneurysmal subarachnoid hemorrhage (aSAH) is often confounded by seizure, hydrocephalus or sedation and the prediction of prognosis remains difficult. Recently, copeptin has been identified as a serum marker for outcomes in acute ischemic stroke and intracerebral hemorrhage (ICH). We investigated whether copeptin might serve as a marker for severity and prognosis in aSAH. Methods: Eighteen consecutive patients with aSAH had plasma copeptin levels measured with a validated chemiluminescence sandwich immunoassay. The primary endpoint was the association of copeptin levels at admission with the World Federation of Neurological Surgeons (WFNS) grade score after resuscitation. Levels of copeptin were compared across clinical and radiological scores as well as between patients with ICH, intraventricular hemorrhage, hydrocephalus, vasospasm and ischemia. Results: Copeptin levels were significantly associated with the severity of aSAH measured by WFNS grade (P = 0.006), the amount of subarachnoid blood (P = 0.03) and the occurrence of ICH (P = 0.02). There was also a trend between copeptin levels and functional clinical outcome at 6-months (P = 0.054). No other clinical outcomes showed any statistically significant association. Conclusions: Copeptin may indicate clinical severity of the initial bleeding and may therefore help in guiding treatment decisions in the setting of aSAH. These initial results show that copeptin might also have prognostic value for clinical outcome in aSAH.	[Fung, Christian; Raabe, Andreas; Beck, Juergen] Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; [De Marchis, Gian Marco; Arnold, Marcel] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Katan, Mira] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Seiler, Marleen] Thermo Fisher Sci, Thermo Sci Biomarkers, Clin Diagnost, Hennigsdorf, Germany; [Gralla, Jan] Univ Hosp Bern, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Columbia University; Thermo Fisher Scientific; University of Bern; University Hospital of Bern	Beck, J (corresponding author), Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland.	Juergen.beck@insel.ch	De Marchis, Gian Marco/J-5414-2019	De Marchis, Gian Marco/0000-0002-0342-9780; Beck, Jurgen/0000-0002-7687-6098; Katan, Mira/0000-0002-9265-8066	Bern University Hospital	Bern University Hospital	Bern University Hospital sponsored the study. Thermo Scientific B. R. A. H. M. S., Henningsdorf, Germany provided all copeptin assays. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; DRAKE CG, 1988, J NEUROSURG, V68, P985; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Khan SQ, 2007, CIRCULATION, V115, P2103, DOI 10.1161/CIRCULATIONAHA.106.685503; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lackner P, 2010, STROKE, V41, P2353, DOI 10.1161/STROKEAHA.110.584995; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Macdonald RL, 2010, NEUROCRIT CARE, V13, P416, DOI 10.1007/s12028-010-9433-3; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Muller B, 2007, EUR J CLIN INVEST, V37, P145, DOI 10.1111/j.1365-2362.2007.01762.x; Stoiser B, 2006, EUR J CLIN INVEST, V36, P771, DOI 10.1111/j.1365-2362.2006.01724.x; Volpi S, 2004, STRESS, V7, P75, DOI 10.1080/10253890410001733535; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-34	17	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53191	10.1371/journal.pone.0053191	http://dx.doi.org/10.1371/journal.pone.0053191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326397	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000314705800036
J	Lopez, C; Falconer, CJ; Mast, FW				Lopez, Christophe; Falconer, Caroline J.; Mast, Fred W.			Being Moved by the Self and Others: Influence of Empathy on Self-Motion Perception	PLOS ONE			English	Article							GALVANIC VESTIBULAR STIMULATION; TACTILE PERCEPTION; PERIPHERAL-VISION; NEURAL RESPONSES; OWN FACE; MIRROR; SIMON; TOUCH; NEUROSCIENCE; INFORMATION	Background: The observation of conspecifics influences our bodily perceptions and actions: Contagious yawning, contagious itching, or empathy for pain, are all examples of mechanisms based on resonance between our own body and others. While there is evidence for the involvement of the mirror neuron system in the processing of motor, auditory and tactile information, it has not yet been associated with the perception of self-motion. Methodology/Principal Findings: We investigated whether viewing our own body, the body of another, and an object in motion influences self-motion perception. We found a visual-vestibular congruency effect for self-motion perception when observing self and object motion, and a reduction in this effect when observing someone else's body motion. The congruency effect was correlated with empathy scores, revealing the importance of empathy in mirroring mechanisms. Conclusions/Significance: The data show that vestibular perception is modulated by agent-specific mirroring mechanisms. The observation of conspecifics in motion is an essential component of social life, and self-motion perception is crucial for the distinction between the self and the other. Finally, our results hint at the presence of a "vestibular mirror neuron system".	[Lopez, Christophe; Falconer, Caroline J.; Mast, Fred W.] Univ Bern, Dept Psychol, Bern, Switzerland; [Lopez, Christophe] Aix Marseille Univ, CNRS, Lab Neurosci Integrat & Adaptat, Marseille, France; [Mast, Fred W.] Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland	University of Bern; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Bern	Lopez, C (corresponding author), Univ Bern, Dept Psychol, Bern, Switzerland.	christophe.lopez@univ-amu.fr	Lopez, Christophe/ABG-6263-2020; Mast, Fred/B-5058-2013; Lopez, Christophe/AAJ-6155-2020	Mast, Fred/0000-0002-0665-4457; Lopez, Christophe/0000-0001-9298-2969; Falconer, Caroline/0000-0002-6707-5184	Swiss National Science Foundation (SINERGIA project) [CRSII1-125135]; Volkswagen Stiftung's European Platform for Life Sciences, Mind Sciences, and the Humanities	Swiss National Science Foundation (SINERGIA project); Volkswagen Stiftung's European Platform for Life Sciences, Mind Sciences, and the Humanities	Funding: This research was supported by the Swiss National Science Foundation (SINERGIA project "Balancing Self and Body": CRSII1-125135). CL is supported by the Volkswagen Stiftung's European Platform for Life Sciences, Mind Sciences, and the Humanities ("The (Un)bound Body Project. Exploring the constraints of embodiment & the limits of body representation"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Angelaki DE, 2009, NEURON, V64, P448, DOI 10.1016/j.neuron.2009.11.010; Aspell JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006488; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Banissy MJ, 2007, NAT NEUROSCI, V10, P815, DOI 10.1038/nn1926; Banissy MJ, 2009, EXP BRAIN RES, V198, P261, DOI 10.1007/s00221-009-1810-9; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BERTHOZ A, 1975, EXP BRAIN RES, V23, P471; BERTHOZ A, 1995, SCIENCE, V269, P95, DOI 10.1126/science.7604286; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Bosbach S, 2005, Q J EXP PSYCHOL-A, V58, P467, DOI 10.1080/02724980443000016; Bosbach S, 2004, J EXP PSYCHOL HUMAN, V30, P39, DOI 10.1037/0096-1523.30.1.39; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Brass M, 2001, NEUROIMAGE, V14, P1416, DOI 10.1006/nimg.2001.0944; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Brooks A, 2007, NEUROPSYCHOLOGIA, V45, P523, DOI 10.1016/j.neuropsychologia.2005.12.012; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Cardini F, 2011, J COGNITIVE NEUROSCI, V23, P503, DOI 10.1162/jocn.2010.21484; Costantini M, 2008, EUR J NEUROSCI, V28, P1222, DOI 10.1111/j.1460-9568.2008.06406.x; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2003, CONSCIOUS COGN, V12, P577, DOI 10.1016/S1053-8100(03)00076-X; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Dichgans J, 1978, HDB SENSORY PHYSL, P755, DOI DOI 10.1007/978-3-642-46354-9_25; EHRENSTEIN WH, 1994, PSYCHOL RES-PSYCH FO, V56, P163, DOI 10.1007/BF00419703; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Figliozzi F, 2010, NEUROPSYCHOLOGIA, V48, P1011, DOI 10.1016/j.neuropsychologia.2009.11.025; Fitzpatrick RC, 2002, NEUROREPORT, V13, P2379, DOI 10.1097/00001756-200212200-00001; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Han SH, 2009, HUM BRAIN MAPP, V30, P3227, DOI 10.1002/hbm.20742; Heed T, 2010, CURR BIOL, V20, P1345, DOI 10.1016/j.cub.2010.05.068; Holle H, 2011, CONSCIOUS COGN, V20, P720, DOI 10.1016/j.concog.2010.12.002; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Ishida H, 2010, J COGNITIVE NEUROSCI, V22, P83, DOI 10.1162/jocn.2009.21185; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kerzel D, 2001, PERCEPT PSYCHOPHYS, V63, P862, DOI 10.3758/BF03194443; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Kleinschmidt A, 2002, NEUROIMAGE, V16, P873, DOI 10.1006/nimg.2002.1181; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lenggenhager B, 2008, EXP BRAIN RES, V184, P211, DOI 10.1007/s00221-007-1095-9; Longo MR, 2011, NEUROSCI LETT, V489, P159, DOI 10.1016/j.neulet.2010.12.007; Lopez C, 2008, NEUROPHYSIOL CLIN, V38, P149, DOI 10.1016/j.neucli.2007.12.006; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; Mast Fred W., 2007, P353, DOI 10.1007/978-0-387-71978-8_18; Mohr C, 2010, BRIT J PSYCHOL, V101, P277, DOI 10.1348/000712609X457450; MONK TH, 1982, ACTA PSYCHOL, V51, P207, DOI 10.1016/0001-6918(82)90035-X; NAVON D, 1983, Q J EXP PSYCHOL-A, V35, P497, DOI 10.1080/14640748308402484; O'Brien E, 2012, PSYCHOL SCI, V23, P391, DOI 10.1177/0956797611432179; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Papoiu A D P, 2011, Br J Dermatol, V164, P1299, DOI 10.1111/j.1365-2133.2011.10318.x; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Peruch P, 2011, NEUROPSYCHOLOGIA, V49, P3136, DOI 10.1016/j.neuropsychologia.2011.07.026; Press C, 2005, COGNITIVE BRAIN RES, V25, P632, DOI 10.1016/j.cogbrainres.2005.08.020; Putnam KM, 2007, PSYCHIAT RES, V151, P67, DOI 10.1016/j.psychres.2006.09.010; REMINGTON RW, 1992, PERCEPT PSYCHOPHYS, V51, P279, DOI 10.3758/BF03212254; Riecke B. E., 2005, P APGV 2005 2 S APPL, P111, DOI [10.1145/1080402.1080422, DOI 10.1145/1080402.1080422]; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; ROLL JP, 1989, PROG BRAIN RES, V80, P113; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048; Serino A, 2008, PSYCHOL SCI, V19, P434, DOI 10.1111/j.1467-9280.2008.02105.x; Serino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004930; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; SIMON JR, 1969, J APPL PSYCHOL, V53, P433, DOI 10.1037/h0028034; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Thomas R, 2006, ACTA PSYCHOL, V121, P317, DOI 10.1016/j.actpsy.2005.08.002; TOWNSEND JT, 1971, PERCEPT PSYCHOPHYS, V10, P375, DOI 10.3758/BF03207464; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Vaillant J, 2004, ARCH PHYS MED REHAB, V85, P1962, DOI 10.1016/j.apmr.2004.02.019; Valjamae A, 2008, PRESENCE-TELEOP VIRT, V17, P43, DOI 10.1162/pres.17.1.43; Valjamae A, 2009, BRAIN RES REV, V61, P240, DOI 10.1016/j.brainresrev.2009.07.001; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; vonBrevern M, 1997, AM J OTOL, V18, P484; Watanabe K, 2001, VISION RES, V41, P801, DOI 10.1016/S0042-6989(00)00301-1; WEISZ J, 1988, PSYCHOPHYSIOLOGY, V25, P193, DOI 10.1111/j.1469-8986.1988.tb00987.x; Zupan LH, 2008, EXP BRAIN RES, V191, P505, DOI 10.1007/s00221-008-1540-4	89	16	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e48293	10.1371/journal.pone.0048293	http://dx.doi.org/10.1371/journal.pone.0048293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326302	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800004
J	Nigam, P; Bhatt, SP; Misra, A; Vaidya, M; Dasgupta, J; Chadha, DS				Nigam, Priyanka; Bhatt, Surya P.; Misra, Anoop; Vaidya, Meera; Dasgupta, Jharna; Chadha, Davinder Singh			Non-Alcoholic Fatty Liver Disease Is Closely Associated with Sub-Clinical Inflammation: A Case-Control Study on Asian Indians in North India	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; CARDIOVASCULAR-DISEASE; BODY-FAT; OBESITY; STEATOHEPATITIS; MARKERS	Objectives: Association between sub-clinical inflammation and non-alcoholic fatty liver disease (NAFLD) has not been studied in Asian Indians. In this case-control study, we aimed to analyse association of NAFLD with the sub-clinical inflammation and metabolic profile in Asian Indians in north India. Methods: Ultrasound diagnosed 120 cases of NAFLD were compared to 152 healthy controls without NAFLD. Anthropometric profile [body mass index (BMI), waist circumference (WC), hip circumference (HC)], high-sensitivity Creactive protein (hs-CRP), metabolic profile [fasting blood glucose (FBG), lipid profile] and hepatic function tests [alanine aminotransferase (ALT) and aspartate aminotransferase (AST)] were recorded. Results: Metabolic parameters [FBG, total cholesterol (TC), serum triglycerides (TG), low-density lipoprotein (LDL-c)], hs-CRP and prevalence of the metabolic syndrome were higher in cases as compared to controls (p-value, 0.05 for all). The median (range) of hs-CRP (mg/L) for cases [2.6 (0.2-13.4)] were significantly higher than in controls [1.4 (0.03-11.4), p = 0.01]. Similarly, higher values of hs-CRP were obtained when subgroups of cases with obesity, abdominal obesity and the metabolic syndrome were compared to controls [2.75 (0.03-14.3) vs. 1.52 (0.04-14.3), p = 0.0010; 2.8 (0.03-14.3) vs. 1.5 (0.06-14.3), p = 0.0014 and 2.7 (0.5-14.3) vs. 1.6 (0.06-8.5), p = 0.0013, respectively. On multivariate logistic regression analysis BMI (p = 0.001), WC (p = 0.001), FBG (p = 0.002), TC (p = 0.008), TG (p = 0.002), blood pressure (p = 0.005), metabolic syndrome (p = 0.001) and hs-CRP (p = 0.003) were significantly and independently associated with NAFLD. After adjusting for significant variables, the association between high hs-CRP and NAFLD remained large and statistically significant [adjusted OR = 1.17, 95% confidence interval (CI) = 1.05-1.29]. An increase in 1 mg/dl of hs-CRP level calculated to increase the risk of developing NAFLD by 1.7 times as compared to controls after adjusting for significant variables associated with NAFLD. Conclusions: In this cohort of Asian Indians in North India, presence of NAFLD showed independent relationships with subclinical inflammation.	[Nigam, Priyanka; Misra, Anoop; Dasgupta, Jharna] SDA, Natl Diabet Obes & Cholesterol Fdn N DOC, New Delhi, India; [Nigam, Priyanka; Vaidya, Meera] Govt MH Coll Home Sci & Sci Woman, Dept Food & Nutr, Jabalpur, India; [Bhatt, Surya P.] All India Inst Med Sci, Dept Med, New Delhi 110029, India; [Misra, Anoop] Fortis CDOC Ctr Excellence Diabet Metab Dis & End, New Delhi, India; [Chadha, Davinder Singh] AFMC, MH CTC, Dept Cardiol, Pune, Maharashtra, India; [Nigam, Priyanka; Misra, Anoop; Dasgupta, Jharna] Diabet Fdn India, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Armed Forces Medical College	Misra, A (corresponding author), SDA, Natl Diabet Obes & Cholesterol Fdn N DOC, New Delhi, India.	anoopmisra@metabolicresearchindia.com	Bhatt, Surya/K-5263-2019; Bhatt, Surya Prakash/X-5941-2018	Bhatt, Surya/0000-0001-9489-9747; Bhatt, Surya Prakash/0000-0001-9489-9747	Indian Council of Medical Research Government of India [5/9/70/2008-RHM]	Indian Council of Medical Research Government of India(Indian Council of Medical Research (ICMR))	Funding: This study was fully supported by a grant from the Indian Council of Medical Research (No. 5/9/70/2008-RHM) Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj S, 2009, INDIAN J MED RES, V129, P285; Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Chambers JC, 2001, CIRCULATION, V104, P145, DOI 10.1161/01.CIR.104.2.145; Chandalia M, 2003, J CLIN ENDOCR METAB, V88, P3773, DOI 10.1210/jc.2003-030301; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Duvnjak M, 2007, WORLD J GASTROENTERO, V13, P4539, DOI 10.3748/wjg.v13.i34.4539; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Gavin JR, 1999, DIABETES CARE, V22, pS5; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamer OW, 2006, RADIOGRAPHICS, V26, P1637, DOI 10.1148/rg.266065004; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hsiao PJ, 2007, J GASTROEN HEPATOL, V22, P2118, DOI 10.1111/j.1440-1746.2006.04698.x; Kao PC, 2006, ANN CLIN LAB SCI, V36, P163; Kaser S, 2005, GUT, V54, P117, DOI 10.1136/gut.2003.037010; Kogiso T, 2009, J GASTROENTEROL, V44, P313, DOI 10.1007/s00535-009-0002-5; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; Misra A, 2004, INT J OBESITY, V28, P1217, DOI 10.1038/sj.ijo.0802704; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Park SH, 2004, J GASTROEN HEPATOL, V19, P694, DOI 10.1111/j.1440-1746.2004.03362.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Riquelme A, 2009, LIVER INT, V29, P82, DOI 10.1111/j.1478-3231.2008.01823.x; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sinha S, 2009, MAGN RESON IMAGING, V27, P94, DOI 10.1016/j.mri.2008.06.001; Socha Piotr, 2007, Rocz Panstw Zakl Hig, V58, P129; Uchihara Masakatsu, 2006, Nihon Rinsho, V64, P1133; Vikram NK, 2006, INDIAN J MED RES, V124, P677; Vikram NK, 2003, ATHEROSCLEROSIS, V168, P305, DOI 10.1016/S0021-9150(03)00096-0; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Yoneda M, 2007, J GASTROENTEROL, V42, P573, DOI 10.1007/s00535-007-2060-x	37	46	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e49286	10.1371/journal.pone.0049286	http://dx.doi.org/10.1371/journal.pone.0049286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326306	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800007
J	Nunes, MJ; Moutinho, M; Gama, MJ; Rodrigues, CMP; Rodrigues, E				Nunes, Maria Joao; Moutinho, Miguel; Gama, Maria Joao; Rodrigues, Cecilia M. P.; Rodrigues, Elsa			Histone Deacetylase Inhibition Decreases Cholesterol Levels in Neuronal Cells by Modulating Key Genes in Cholesterol Synthesis, Uptake and Efflux	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SP TRANSCRIPTION FACTORS; SPINAL MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; HUNTINGTONS-DISEASE; SODIUM-BUTYRATE; HUMAN BRAIN; C DISEASE; CYP46A1; MICE	Cholesterol is an essential component of the central nervous system and increasing evidence suggests an association between brain cholesterol metabolism dysfunction and the onset of neurodegenerative disorders. Interestingly, histone deacetylase inhibitors (HDACi) such as trichostatin A (TSA) are emerging as promising therapeutic approaches in neurodegenerative diseases, but their effect on brain cholesterol metabolism is poorly understood. We have previously demonstrated that HDACi up-regulate CYP46A1 gene transcription, a key enzyme in neuronal cholesterol homeostasis. In this study, TSA was shown to modulate the transcription of other genes involved in cholesterol metabolism in human neuroblastoma cells, namely by up-regulating genes that control cholesterol efflux and down-regulating genes involved in cholesterol synthesis and uptake, thus leading to an overall decrease in total cholesterol content. Furthermore, co-treatment with the amphipathic drug U18666A that can mimic the intracellular cholesterol accumulation observed in cells of Niemman-Pick type C patients, revealed that TSA can ameliorate the phenotype induced by pathological cholesterol accumulation, by restoring the expression of key genes involved in cholesterol synthesis, uptake and efflux and promoting lysosomal cholesterol redistribution. These results clarify the role of TSA in the modulation of neuronal cholesterol metabolism at the transcriptional level, and emphasize the idea of HDAC inhibition as a promising therapeutic tool in neurodegenerative disorders with impaired cholesterol metabolism.	[Nunes, Maria Joao; Moutinho, Miguel; Gama, Maria Joao; Rodrigues, Cecilia M. P.; Rodrigues, Elsa] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal; [Gama, Maria Joao; Rodrigues, Cecilia M. P.; Rodrigues, Elsa] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Rodrigues, E (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal.	Elsa.Rodrigues@ff.ul.pt	iMed.ULisboa, CellFun/A-4244-2014; Moutinho, Miguel/AFR-5130-2022; Gama, Maria Joao/AAC-3089-2021; Nunes, Maria João/AAB-5062-2022; Gama, Maria João/M-7617-2013; Rodrigues, Cecilia MP/M-3572-2013; Rodrigues, Elsa/J-3100-2012; Nunes, Maria João/F-6766-2015; Moutinho, Miguel/I-4683-2015	Moutinho, Miguel/0000-0003-0525-9145; Nunes, Maria João/0000-0002-4922-633X; Gama, Maria João/0000-0002-4943-0349; Rodrigues, Cecilia MP/0000-0002-4829-754X; Rodrigues, Elsa/0000-0003-1669-365X; Nunes, Maria João/0000-0002-4922-633X; Moutinho, Miguel/0000-0003-0525-9145	FEDER (COMPETE Programme); FCT - Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-NMC/110809/2009, PEst-OE/SAU/UI4013/2011, SFRH/BD/41848/2007, SFRH/BD/78041/2011]	FEDER (COMPETE Programme); FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by FEDER (COMPETE Programme) and by national funds (FCT - Fundacao para a Ciencia e a Tecnologia - projects PTDC/SAU-NMC/110809/2009 and PEst-OE/SAU/UI4013/2011, and PhD grants SFRH/BD/41848/2007 to MJN and SFRH/BD/78041/2011 to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Castro-Caldas M, 2009, NEUROSCI LETT, V451, P241, DOI 10.1016/j.neulet.2009.01.017; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Corcoran LJ, 2004, CURR BIOL, V14, P488, DOI 10.1016/j.cub.2004.03.003; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Fan QW, 2002, J NEUROCHEM, V80, P178, DOI 10.1046/j.0022-3042.2001.00686.x; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haggarty SJ, 2011, NEUROBIOL LEARN MEM, V96, P41, DOI 10.1016/j.nlm.2011.04.009; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kim SJ, 2007, BIOCHEM BIOPH RES CO, V360, P593, DOI 10.1016/j.bbrc.2007.06.116; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Milagre I, 2008, J NEUROCHEM, V106, P835, DOI 10.1111/j.1471-4159.2008.05442.x; Milagre I, 2012, NEUROCHEM INT, V60, P192, DOI 10.1016/j.neuint.2011.12.003; Milagre I, 2012, J NEUROCHEM, V120, P220, DOI 10.1111/j.1471-4159.2011.07577.x; Milagre I, 2010, J ALZHEIMERS DIS, V22, P1209, DOI 10.3233/JAD-2010-100651; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; Petri S, 2006, NEUROBIOL DIS, V22, P40, DOI 10.1016/j.nbd.2005.09.013; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Subramanian C, 2007, NEOPLASIA, V9, P495, DOI 10.1593/neo.07262; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Villagra A, 2007, J BIOL CHEM, V282, P35457, DOI 10.1074/jbc.M701719200; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200; Xu Y, 2011, MOLECULES, V16, P7183, DOI 10.3390/molecules16097183; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	48	21	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53394	10.1371/journal.pone.0053394	http://dx.doi.org/10.1371/journal.pone.0053394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326422	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400022
J	Wu, HY; Chen, LH; Zhang, X; Zhou, QL; Li, JM; Berger, S; Borok, Z; Zhou, BY; Xiao, Z; Yin, HL; Liu, MY; Wang, Y; Jin, JP; Blackburn, MR; Xia, Y; Zhang, WZ				Wu, Hongyu; Chen, Lihe; Zhang, Xi; Zhou, Qiaoling; Li, Ju-Mei; Berger, Stefan; Borok, Zea; Zhou, Beiyun; Xiao, Zhou; Yin, Hongling; Liu, Mingyao; Wang, Ying; Jin, Jianping; Blackburn, Michael R.; Xia, Yang; Zhang, Wenzheng			Aqp5 Is a New Transcriptional Target of Dot1a and a Regulator of Aqp2	PLOS ONE			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; AQUAPORIN-2 TRAFFICKING; DOWN-REGULATION; WATER CHANNELS; ENAC-ALPHA; SET DOMAIN; METHYLTRANSFERASE; MICE; METHYLATION; EXPRESSION	Dot1l encodes histone H3 K79 methyltransferase Dot1a. Mice with Dot1l deficiency in renal Aqp2-expressing cells (Dot1l (AC)) develop polyuria by unknown mechanisms. Here, we report that Aqp5 links Dot1l deletion to polyuria through Aqp2. cDNA array analysis revealed and real-time RT-qPCR validated Aqp5 as the most upregulated gene in Dot1l(AC) vs. control mice. Aqp5 protein is barely detectable in controls, but robustly expressed in the Dot1l(AC) kidneys, where it colocalizes with Aqp2. The upregulation of Aqp5 is coupled with reduced association of Dot1a and H3 dimethyl K79 with specific subregions in Aqp5 5' flanking region in Dot1l(AC) vs. control mice. In vitro studies in IMCD3, MLE-15 and 293Tcells using multiple approaches including real-time RT-qPCR, luciferase reporter assay, cell surface biotinylation assay, colocalization, and co-immunoprecipitation uncovered that Dot1a represses Aqp5. Human AQP5 interacts with AQP2 and impairs its cell surface localization. The AQP5/AQP2 complex partially resides in the ER/Golgi. Consistently, AQP5 is expressed in none of 15 normal controls, but in all of 17 kidney biopsies from patients with diabetic nephropathy. In the patients with diabetic nephropathy, AQP5 colocalizes with AQP2 in the perinuclear region and AQP5 expression is associated with impaired cellular H3 dimethyl K79. Taken together, these data for the first time identify Aqp5 as a Dot1a potential transcriptional target, and an Aqp2 binding partner and regulator, and suggest that the upregulated Aqp5 may contribute to polyuria, possibly by impairing Aqp2 membrane localization, in Dot1l(AC) mice and in patients with diabetic nephropathy.	[Wu, Hongyu; Zhang, Xi; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA; [Chen, Lihe; Liu, Mingyao; Jin, Jianping; Blackburn, Michael R.; Xia, Yang; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX USA; [Zhou, Qiaoling; Xiao, Zhou; Yin, Hongling] Cent S Univ, Xiangya Hosp, Dept Internal Med, Changsha, Hunan, Peoples R China; [Li, Ju-Mei; Jin, Jianping; Blackburn, Michael R.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Berger, Stefan] German Canc Res Ctr, Div Mol Biol Cell 1, Heidelberg, Germany; [Borok, Zea; Zhou, Beiyun] Univ So Calif, Dept Med, Will Rogers Inst, Pulm Res Ctr,Div Pulm & Crit Care Med, Los Angeles, CA USA; [Liu, Mingyao; Wang, Ying] Texas A&M Univ Syst, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Liu, Mingyao; Wang, Ying] Texas A&M Univ Syst, Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Central South University; University of Texas System; University of Texas Health Science Center Houston; Helmholtz Association; German Cancer Research Center (DKFZ); University of Southern California; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Zhang, WZ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA.	wenzheng.zhang@uth.tmc.edu	Jin, Jianping/K-5002-2018; Chen, Lihe/N-3186-2018; Borok, Zea/J-9015-2013	Jin, Jianping/0000-0003-4175-9104; Chen, Lihe/0000-0002-6207-6364; Blackburn, Michael/0000-0002-1394-9966; Liu, Mingyao/0000-0001-7339-5048; Borok, Zea/0000-0001-8673-8177	National Institutes of Health [R01 DK080236, GM102529]; American Heart Association [0865271F]; The National Natural Science Foundation of China (NSFC) [81070552]; Welch Foundation [AU-1711]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148, TL1RR024147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); The National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants: National Institutes of Health Grants R01 DK080236 (to W.Z.Z.), American Heart Association Grant (0865271F to W.Z.Z.), and The National Natural Science Foundation of China (NSFC) grant 81070552 (to Q.L.Z.). Z. Borok is the Ralph Edgington Chair in Medicine. J.J. is supported by a grant (AU-1711) from the Welch Foundation and a grant (GM102529) from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardoux P, 2001, DIABETOLOGIA, V44, P637, DOI 10.1007/s001250051671; Barok Z, 2000, J BIOL CHEM, V275, P26507, DOI 10.1074/jbc.M910007199; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bichet DG, 2006, ADV CHRONIC KIDNEY D, V13, P96, DOI 10.1053/j.ackd.2006.01.006; BRODSKY WA, 1950, J CLIN INVEST, V29, P1021, DOI 10.1172/JCI102333; Chang MJ, 2010, CANCER RES, V70, P10234, DOI 10.1158/0008-5472.CAN-10-3294; Chen LH, 2011, J AM SOC NEPHROL, V22, P1076, DOI 10.1681/ASN.2010121270; de Seigneux S, 2007, AM J PHYSIOL-RENAL, V293, pF87, DOI 10.1152/ajprenal.00431.2006; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kamsteeg EJ, 2000, J CELL BIOL, V151, P919, DOI 10.1083/jcb.151.4.919; Kamsteeg EJ, 2007, P NATL ACAD SCI USA, V104, P16696, DOI 10.1073/pnas.0708023104; Kim D, 2003, AM J PHYSIOL-RENAL, V285, pF303, DOI 10.1152/ajprenal.00438.2002; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Krane CM, 2007, MAMM GENOME, V18, P452, DOI 10.1007/s00335-007-9041-5; Krane CM, 1999, MAMM GENOME, V10, P498, DOI 10.1007/s003359901030; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; McKenna K, 2000, AM J PHYSIOL-ENDOC M, V279, pE155, DOI 10.1152/ajpendo.2000.279.1.E155; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Molitoris BA, 2009, J AM SOC NEPHROL, V20, P1754, DOI 10.1681/ASN.2008111204; Muller C, 2006, J EXP BIOL, V209, P4067, DOI 10.1242/jeb.02491; Nejsum LN, 2001, AM J PHYSIOL-RENAL, V280, pF715, DOI 10.1152/ajprenal.2001.280.4.F715; Nguyen AT, 2011, GENE DEV, V25, P263, DOI 10.1101/gad.2018511; Nielsen J, 2006, AM J PHYSIOL-RENAL, V290, pF438, DOI 10.1152/ajprenal.00158.2005; Noda Y, 2004, BIOCHEM BIOPH RES CO, V322, P740, DOI 10.1016/j.bbrc.2004.07.195; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Noda Y, 2008, J CELL BIOL, V182, P587, DOI 10.1083/jcb.200709177; Noda Y, 2010, NAT REV NEPHROL, V6, P168, DOI 10.1038/nrneph.2009.231; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okutsu R, 2008, KIDNEY INT, V74, P1429, DOI 10.1038/ki.2008.402; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Reisenauer MR, 2010, AM J PHYSIOL-RENAL, V299, pF63, DOI 10.1152/ajprenal.00105.2010; Reisenauer MR, 2009, J BIOL CHEM, V284, P35659, DOI 10.1074/jbc.M109.038448; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; Singer MS, 1998, GENETICS, V150, P613; Tamma G, 2008, PFLUG ARCH EUR J PHY, V456, P729, DOI 10.1007/s00424-008-0453-1; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Vernimmen D, 2011, GENE DEV, V25, P1583, DOI 10.1101/gad.16985411; Wang S, 2008, NEPHROL DIAL TRANSPL, V23, P2167, DOI 10.1093/ndt/gfn115; Wu H, 2012, JASN IN PRESS; Wu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027429; Yamamura Y, 2012, J CELL MOL MED, V16, P1766, DOI 10.1111/j.1582-4934.2011.01456.x; Yao CJ, 2010, AM J PATHOL, V177, P724, DOI 10.2353/ajpath.2010.090282; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Zhou QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047360; Zwang NA, 2009, J PROTEOME RES, V8, P1540, DOI 10.1021/pr800894p	58	36	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53342	10.1371/journal.pone.0053342	http://dx.doi.org/10.1371/journal.pone.0053342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326416	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400018
J	Hou, WG; Wang, S; Dong, HL; Jiang, HC; Briggs, BR; Peacock, JP; Huang, QY; Huang, LQ; Wu, G; Zhi, XY; Li, WJ; Dodsworth, JA; Hedlund, BP; Zhang, CL; Hartnett, HE; Dijkstra, P; Hungate, BA				Hou, Weiguo; Wang, Shang; Dong, Hailiang; Jiang, Hongchen; Briggs, Brandon R.; Peacock, Joseph P.; Huang, Qiuyuan; Huang, Liuqin; Wu, Geng; Zhi, Xiaoyang; Li, Wenjun; Dodsworth, Jeremy A.; Hedlund, Brian P.; Zhang, Chuanlun; Hartnett, Hilairy E.; Dijkstra, Paul; Hungate, Bruce A.			A Comprehensive Census of Microbial Diversity in Hot Springs of Tengchong, Yunnan Province China Using 16S rRNA Gene Pyrosequencing	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; ACIDIC GEOTHERMAL SPRINGS; COMMUNITY STRUCTURE; WEST-YUNNAN; SP NOV.; GEOCHEMISTRY; ARCHAEAL; REHAI; FIELD; BACTERIAL	The Rehai and Ruidian geothermal fields, located in Tengchong County, Yunnan Province, China, host a variety of geochemically distinct hot springs. In this study, we report a comprehensive, cultivation-independent census of microbial communities in 37 samples collected from these geothermal fields, encompassing sites ranging in temperature from 55.1 to 93.6 degrees C, in pH from 2.5 to 9.4, and in mineralogy from silicates in Rehai to carbonates in Ruidian. Richness was low in all samples, with 21-123 species-level OTUs detected. The bacterial phylum Aquificae or archaeal phylum Crenarchaeota were dominant in Rehai samples, yet the dominant taxa within those phyla depended on temperature, pH, and geochemistry. Rehai springs with low pH (2.5-2.6), high temperature (85.1-89.1 degrees C), and high sulfur contents favored the crenarchaeal order Sulfolobales, whereas those with low pH (2.6-4.8) and cooler temperature (55.1-64.5 degrees C) favored the Aquificae genus Hydrogenobaculum. Rehai springs with neutral-alkaline pH (7.2-9.4) and high temperature (>80 degrees C) with high concentrations of silica and salt ions (Na, K, and Cl) favored the Aquificae genus Hydrogenobacter and crenarchaeal orders Desulfurococcales and Thermoproteales. Desulfurococcales and Thermoproteales became predominant in springs with pH much higher than the optimum and even the maximum pH known for these orders. Ruidian water samples harbored a single Aquificae genus Hydrogenobacter, whereas microbial communities in Ruidian sediment samples were more diverse at the phylum level and distinctly different from those in Rehai and Ruidian water samples, with a higher abundance of uncultivated lineages, close relatives of the ammonia-oxidizing archaeon "Candidatus Nitrosocaldus yellowstonii'', and candidate division O1aA90 and OP1. These differences between Ruidian sediments and Rehai samples were likely caused by temperature, pH, and sediment mineralogy. The results of this study significantly expand the current understanding of the microbiology in Tengchong hot springs and provide a basis for comparison with other geothermal systems around the world.	[Hou, Weiguo; Wang, Shang; Dong, Hailiang; Jiang, Hongchen; Huang, Liuqin] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China; [Hou, Weiguo; Wang, Shang; Dong, Hailiang; Jiang, Hongchen; Huang, Liuqin] China Univ Geosci, Inst Earth Sci, Beijing, Peoples R China; [Dong, Hailiang; Briggs, Brandon R.; Huang, Qiuyuan] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Peacock, Joseph P.; Dodsworth, Jeremy A.; Hedlund, Brian P.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Wu, Geng] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Hubei Province, Peoples R China; [Zhi, Xiaoyang; Li, Wenjun] Yunnan Univ, Yunnan Inst Microbiol, Minist Educ, Key Lab Microbial Divers SW China, Kunming, Yunnan Province, Peoples R China; [Zhi, Xiaoyang; Li, Wenjun] Yunnan Univ, Yunnan Inst Microbiol, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan Province, Peoples R China; [Zhang, Chuanlun] Tongji Univ, Sch Ocean Earth Sci, State Key Lab Marine Geol, Shanghai 200092, Peoples R China; [Zhang, Chuanlun] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Hartnett, Hilairy E.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Hartnett, Hilairy E.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA; [Dijkstra, Paul; Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	China University of Geosciences; China University of Geosciences; University System of Ohio; Miami University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; China University of Geosciences; Yunnan University; Yunnan University; Tongji University; University System of Georgia; University of Georgia; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Northern Arizona University	Dong, HL (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China.	dongh@cugb.edu.cn	Wu, Geng/G-9740-2018; Hungate, Bruce/F-8991-2011; WU, Geng/F-8840-2010; Jiang, Hongchen/Y-9471-2018; hou, wei/GWM-4800-2022; Jiang, Hongchen/I-5838-2016	Hungate, Bruce/0000-0002-7337-1887; WU, Geng/0000-0002-7259-1044; Jiang, Hongchen/0000-0003-1271-7028; Briggs, Brandon/0000-0002-3808-8269; Hartnett, Hilairy/0000-0003-0736-7844; Dong, Hailiang/0000-0002-7468-1350; Dodsworth, Jeremy/0000-0003-2014-5488; Hedlund, Brian/0000-0001-8530-0448	National Natural Science Foundation of China [41030211, 41002123, 40972211]; Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing; National Science Foundation [OISE-0968421, ETBC-1024614, DBI REU 1005223]; Div Of Biological Infrastructure [1005223] Funding Source: National Science Foundation; Office Of The Director [0968421] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing; National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Natural Science Foundation of China grants (41030211, 41002123, 40972211), the Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing, National Science Foundation grants (OISE-0968421, ETBC-1024614 and DBI REU 1005223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bershaw J, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016132; Boyd ES, 2009, APPL ENVIRON MICROB, V75, P4289, DOI 10.1128/AEM.02751-08; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brock T.D., 1978, THERMOPHILIC MICROOR; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; Cox A, 2011, CHEM GEOL, V280, P344, DOI 10.1016/j.chemgeo.2010.11.022; da Costa M.S., 2006, PROKARYOTES, VVolume 7, P797; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Dodsworth JA, 2011, ENVIRON MICROBIOL, V13, P2371, DOI 10.1111/j.1462-2920.2011.02508.x; Dodsworth JA, 2011, METHOD ENZYMOL, V486, P171, DOI [10.1016/S0076-6879(11)86008-8, 10.1016/B978-0-12-381294-0.00008-0]; Du JG, 2005, J VOLCANOL GEOTH RES, V142, P243, DOI 10.1016/j.jvolgeores.2004.11.009; Eder W, 2002, EXTREMOPHILES, V6, P309, DOI 10.1007/s00792-001-0259-y; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FOURNIER RO, 1989, ANNU REV EARTH PL SC, V17, P13, DOI 10.1146/annurev.ea.17.050189.000305; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hall JR, 2008, APPL ENVIRON MICROB, V74, P4910, DOI 10.1128/AEM.00233-08; Hedlund BP, 2012, GEOSCI FRONT, V3, P273, DOI 10.1016/j.gsf.2011.12.006; Huang QY, 2011, EXTREMOPHILES, V15, P549, DOI 10.1007/s00792-011-0386-z; Huber H, 2001, BERGEYS MANUAL SYSTE, P169; Huber H., 2001, BERGEYS MANUAL SYSTE, V1, P198; Inskeep W. P., 2005, GEOTHERMAL BIOL GEOC, P143; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Jiang HC, 2010, APPL ENVIRON MICROB, V76, P4538, DOI 10.1128/AEM.00143-10; Kan JJ, 2011, ISME J, V5, P1784, DOI 10.1038/ismej.2011.56; KEMPNER ES, 1963, SCIENCE, V142, P1318, DOI 10.1126/science.142.3597.1318; Kozubal M, 2008, APPL ENVIRON MICROB, V74, P942, DOI 10.1128/AEM.01200-07; Kozubal MA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00109; Kyle JE, 2007, GEOMICROBIOL J, V24, P627, DOI 10.1080/01490450701672158; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LIAO ZJ, 1986, GEOTHERMICS, V15, P339; [刘文杰 LIU WenJie], 2006, [生态学报, Acta Ecologica Sinica], V26, P1303, DOI 10.1016/S1872-2032(06)60022-X; Macur RE, 2004, GEOBIOLOGY, V2, P163, DOI 10.1111/j.1472-4677.2004.00032.x; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Meyer-Dombard DR, 2011, ENVIRON MICROBIOL, V13, P2216, DOI 10.1111/j.1462-2920.2011.02476.x; Nakagawa S, 2005, INT J SYST EVOL MICR, V55, P2263, DOI 10.1099/ijs.0.63708-0; Oksanen J., 2007, VEGAN COMMUNITY ECOL, V1, P8; Pagaling E, 2012, EXTREMOPHILES, V16, P607, DOI 10.1007/s00792-012-0460-1; Pearson A, 2008, APPL ENVIRON MICROB, V74, P3523, DOI 10.1128/AEM.02450-07; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reysenbach A.L., 2005, GEOTHERMAL BIOL GEOC, P129; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharp JH, 2004, MAR CHEM, V84, P181, DOI 10.1016/j.marchem.2003.07.003; SHARP JH, 1993, LIMNOL OCEANOGR, V38, P1774, DOI 10.4319/lo.1993.38.8.1774; Shen M, 1982, RECORDS GEOL RES, P187; Song ZQ, 2010, EXTREMOPHILES, V14, P287, DOI 10.1007/s00792-010-0307-6; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Swingley WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038108; Tong W., 1989, TENGCHONG GEOTHERMIC; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Vick TJ, 2010, GEOBIOLOGY, V8, P140, DOI 10.1111/j.1472-4669.2009.00228.x; Wang F, 2000, CHINESE SCI BULL, V45, P83, DOI 10.1007/BF02884910; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Xiang XY, 2003, EXTREMOPHILES, V7, P493, DOI 10.1007/s00792-003-0355-2; Yang TT, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00130; YOSHIDA Y, 1991, GEOCHEM J, V25, P203, DOI 10.2343/geochemj.25.203; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08; Zhang G, 2008, GEOTHERMICS, V37, P73, DOI 10.1016/j.geothermics.2007.09.002; ZHANG ZF, 1987, GEOTHERMICS, V16, P169; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	64	139	151	7	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53350	10.1371/journal.pone.0053350	http://dx.doi.org/10.1371/journal.pone.0053350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326417	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500066
J	Woods, CW; McClain, MT; Chen, MH; Zaas, AK; Nicholson, BP; Varkey, J; Veldman, T; Kingsmore, SF; Huang, YS; Lambkin-Williams, R; Gilbert, AG; Hero, AO; Ramsburg, E; Glickman, S; Lucas, JE; Carin, L; Ginsburg, GS				Woods, Christopher W.; McClain, Micah T.; Chen, Minhua; Zaas, Aimee K.; Nicholson, Bradly P.; Varkey, Jay; Veldman, Timothy; Kingsmore, Stephen F.; Huang, Yongsheng; Lambkin-Williams, Robert; Gilbert, Anthony G.; Hero, Alfred O., III; Ramsburg, Elizabeth; Glickman, Seth; Lucas, Joseph E.; Carin, Lawrence; Ginsburg, Geoffrey S.			A Host Transcriptional Signature for Presymptomatic Detection of Infection in Humans Exposed to Influenza H1N1 or H3N2	PLOS ONE			English	Article							GENE-EXPRESSION; VIRUS-INFECTION; A VIRUS; CHILDREN; PREVENTION; CHALLENGE; DIAGNOSIS; DISEASE; OSELTAMIVIR; MODULATION	There is great potential for host-based gene expression analysis to impact the early diagnosis of infectious diseases. In particular, the influenza pandemic of 2009 highlighted the challenges and limitations of traditional pathogen-based testing for suspected upper respiratory viral infection. We inoculated human volunteers with either influenza A (A/Brisbane/59/2007 (H1N1) or A/Wisconsin/67/2005 (H3N2)), and assayed the peripheral blood transcriptome every 8 hours for 7 days. Of 41 inoculated volunteers, 18 (44%) developed symptomatic infection. Using unbiased sparse latent factor regression analysis, we generated a gene signature (or factor) for symptomatic influenza capable of detecting 94% of infected cases. This gene signature is detectable as early as 29 hours post-exposure and achieves maximal accuracy on average 43 hours (p = 0.003, H1N1) and 38 hours (p-value = 0.005, H3N2) before peak clinical symptoms. In order to test the relevance of these findings in naturally acquired disease, a composite influenza A signature built from these challenge studies was applied to Emergency Department patients where it discriminates between swine-origin influenza A/H1N1 (2009) infected and non-infected individuals with 92% accuracy. The host genomic response to Influenza infection is robust and may provide the means for detection before typical clinical symptoms are apparent.	[Woods, Christopher W.; Zaas, Aimee K.; Veldman, Timothy; Lucas, Joseph E.; Ginsburg, Geoffrey S.] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27706 USA; [Woods, Christopher W.; McClain, Micah T.; Zaas, Aimee K.; Varkey, Jay] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC USA; [Woods, Christopher W.; McClain, Micah T.; Nicholson, Bradly P.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Chen, Minhua; Carin, Lawrence] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Kingsmore, Stephen F.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Huang, Yongsheng; Hero, Alfred O., III] Univ Michigan, Ctr Computat Biol & Bioinformat, Ann Arobor, MI USA; [Lambkin-Williams, Robert; Gilbert, Anthony G.] Retroscreen Virol, London, England; [Ramsburg, Elizabeth] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Glickman, Seth] Univ N Carolina Chapel Hill, Dept Emergency Med, Chapel Hill, NC USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; National Center for Genome Resources (NCGR); University of Michigan System; University of Michigan; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Woods, CW (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27706 USA.	chris.woods@duke.edu; geoffrey.ginsburg@duke.edu	Lambkin-Williams, Rob/L-2397-2019; Lambkin-Williams, Robert/P-5963-2016	Lambkin-Williams, Rob/0000-0003-2107-0174; Lambkin-Williams, Robert/0000-0003-2107-0174; Carin, Lawrence/0000-0001-6277-7948; Gilbert, Anthony Saul/0000-0002-6582-3820; Hero, Alfred/0000-0002-2531-9670; kingsmore, stephen/0000-0002-3758-4631; Kingsmore, Stephen/0000-0001-7180-2527	US Defense Advanced Research Projects Agency (DARPA) [N66001-07-C-2024]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066569] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000611] Funding Source: NIH RePORTER	US Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	Funding for this study was provided by the US Defense Advanced Research Projects Agency (DARPA) through contract N66001-07-C-2024 (P.I., Ginsburg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett B, 2006, EUR RESPIR J, V28, P358, DOI 10.1183/09031936.06.00002606; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boggild AK, 2010, CRIT CARE MED, V38, pE38, DOI 10.1097/CCM.0b013e3181cd7bb2; Calpin C, 1997, J ALLERGY CLIN IMMUN, V100, P452, DOI 10.1016/S0091-6749(97)70134-9; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-552; Chiarini A, 2008, J CLIN MICROBIOL; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Garvalho C, 2008, J AM STAT ASS; Gharabaghi F, 2008, J CLIN VIROL, V42, P190, DOI 10.1016/j.jcv.2008.01.013; Goldstein E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-211; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Katze MG, 2008, NAT REV IMMUNOL, V8, P644, DOI 10.1038/nri2377; Kawada J, 2006, J GEN VIROL, V87, P1677, DOI 10.1099/vir.0.81670-0; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; Lucas JE, 2008, BAYESIAN MODELING BI; Lucas J, 2006, BAYESIAN INFERENCE FOR GENE EXPRESSION AND PROTEOMICS, P155; Memoli MJ, 2008, DRUG DISCOV TODAY, V13, P590, DOI 10.1016/j.drudis.2008.03.024; Nakaya HI, 2011, NAT IMMUNOL; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ramilo O, 2009, CELL HOST MICROBE, V6, P199, DOI 10.1016/j.chom.2009.08.007; Robinson JL, 2008, CLIN INFECT DIS, V46, pE61, DOI 10.1086/529386; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Turner RB, 2001, CLIN INFECT DIS, V33, P1865, DOI 10.1086/324347; Walker FDL, 2000, CLIN OTOLARYNGOL, V25, P482, DOI 10.1046/j.1365-2273.2000.00349.x; WANG Q, 2007, B INT SOC BAYESIAN A, V14, P4; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zaas AK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000715; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zhu W, 2010, VACCINE, V28, P2865, DOI 10.1016/j.vaccine.2010.01.060	41	121	121	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52198	10.1371/journal.pone.0052198	http://dx.doi.org/10.1371/journal.pone.0052198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326326	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500010
J	Mesquita, FS; Holden, DW; Rolhion, N				Mesquita, Francisco S.; Holden, David W.; Rolhion, Nathalie			Lack of Effect of the Salmonella Deubiquitinase SseL on the NF-kappa B Pathway	PLOS ONE			English	Article							AVRA; TYPHIMURIUM; INNATE; REPLICATION; IMMUNE; MAPK	Intracellular replication of Salmonella enterica requires effector proteins translocated across the Salmonella-containing vacuolar membrane by Salmonella pathogenicity island-2 (SPI-2) encoded type III secretion system (T3SS). The SPI-2 T3SS effector SseL is a deubiquitinase that contributes to virulence in mice. Previous work has produced conflicting evidence as to the involvement of SseL in interference with the NF-kappa B pathway. To attempt to clarify these discrepancies, we compared mRNA levels in mouse primary bone marrow-derived macrophages infected with wild-type or sseL mutant strains using a genome-wide microarray. There was no detectable effect of loss of SseL on mRNA levels corresponding to any known NF-kappa B-regulated gene. In addition, there was no effect of SseL on (i) the activation or levels of both the canonical inhibitor of the NF-kappa B pathway (I kappa B alpha and phospho-I kappa B alpha), and the non-canonical NF-kappa B precursor p100/p52, (ii) the translocation of the NF-kappa B transcription factor p65 to the nucleus of infected macrophages and (iii) pro-inflammatory cytokines secretion. Furthermore, ectopic expression of SseL did not affect NF-kappa B activation in reporter cell lines. These results fail to support a role for SseL in the down-regulation of the host immune response and in particular the NF-kappa B pathway.	[Mesquita, Francisco S.; Holden, David W.; Rolhion, Nathalie] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, MRC Ctr Mol Bacteriol & Infect, London, England	Imperial College London	Rolhion, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, MRC Ctr Mol Bacteriol & Infect, London, England.	n.rolhion@imperial.ac.uk	Mesquita, Francisco/AAF-7557-2019; Mesquita, Francisco/K-5869-2013	Mesquita, Francisco/0000-0002-3777-825X; Mesquita, Francisco/0000-0002-3777-825X; ROLHION, nathalie/0000-0002-2946-4808	European Union Marie Curie Actions [MEST-CT-2005-020311]; Medical Research Council [G0800148]; European Molecular Biology Organization [ALTF 1177-2007]; Wellcome Trust (UK) [092686/Z/10/Z]; MRC [MR/J006874/1, G0800148] Funding Source: UKRI	European Union Marie Curie Actions(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust (UK)(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the European Union Marie Curie Actions (MEST-CT-2005-020311) (http://www.eimid.org/), the Medical Research Council (G0800148) (http://www.mrc.ac.uk/), the European Molecular Biology Organization (ALTF 1177-2007) and the Wellcome Trust (UK) (092686/Z/10/Z) (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena ET, 2011, INFECT IMMUN, V79, P4392, DOI 10.1128/IAI.05478-11; Auweter SD, 2012, MICROBES INFECT, V14, P148, DOI 10.1016/j.micinf.2011.09.003; Auweter SD, 2011, J BIOL CHEM, V286, P24023, DOI 10.1074/jbc.M111.224600; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Coombes BK, 2007, INFECT IMMUN, V75, P574, DOI 10.1128/IAI.00985-06; Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gotoh Y, 2004, BIOCHEM BIOPH RES CO, V314, P688, DOI 10.1016/j.bbrc.2003.12.148; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Kato T, 2008, GENES CELLS, V13, P509, DOI 10.1111/j.1365-2443.2008.01182.x; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Le Negrate G, 2012, CELL MICROBIOL, V14, P155, DOI 10.1111/j.1462-5822.2011.01719.x; Mesquita FS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002743; Mukherjee S, 2008, METHOD ENZYMOL, V438, P343, DOI 10.1016/S0076-6879(07)38024-5; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Schesser K, 2000, MICROB PATHOGENESIS, V28, P59, DOI 10.1006/mpat.1999.0324; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220	40	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53064	10.1371/journal.pone.0053064	http://dx.doi.org/10.1371/journal.pone.0053064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308136	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800026
J	Ouedraogo, A; Tiono, AB; Diarra, A; Sanon, S; Yaro, JB; Ouedraogo, E; Bougouma, EC; Soulama, I; Gansane, A; Ouedraogo, A; Konate, AT; Nebie, I; Watson, NL; Sanza, M; Dube, TJT; Sirima, SB				Ouedraogo, Alphonse; Tiono, Alfred B.; Diarra, Amidou; Sanon, Souleymane; Yaro, Jean Baptiste; Ouedraogo, Esperance; Bougouma, Edith C.; Soulama, Issiaka; Gansane, Adama; Ouedraogo, Amathe; Konate, Amadou T.; Nebie, Issa; Watson, Nora L.; Sanza, Megan; Dube, Tina J. T.; Sirima, Sodiomon Bienvenu			Malaria Morbidity in High and Seasonal Malaria Transmission Area of Burkina Faso	PLOS ONE			English	Article							CLINICAL MALARIA; CASE DEFINITIONS; WEST-AFRICA; CHILDREN; EFFICACY; VACCINES	Background: Malariometric parameters are often primary endpoints of efficacy trials of malaria vaccine candidates. This study aims to describe the epidemiology of malaria prior to the conduct of a series of drug and vaccine trials in a rural area of Burkina Faso. Methods: Malaria incidence was prospectively evaluated over one year follow-up among two cohorts of children aged 0-5 years living in the Sapone health district. The parents of 1089 children comprising a passive case detection cohort were encouraged to seek care from the local health clinic at any time their child felt sick. Among this cohort, 555 children were randomly selected for inclusion in an active surveillance sub-cohort evaluated for clinical malaria during twice weekly home visits. Malaria prevalence was evaluated by cross-sectional survey during the low and high transmission seasons. Results: Number of episodes per child ranged from 0 to 6 per year. Cumulative incidence was 67.4% in the passive and 86.2% in the active cohort and was highest among children 0-1 years. Clinical malaria prevalence was 9.8% in the low and 13.0% in the high season (p>0.05). Median days to first malaria episode ranged from 187 (95% CI 180-193) among children 0-1 years to 228 (95% CI 212, 242) among children 4-5 years. The alternative parasite thresholds for the malaria case definition that achieved optimal sensitivity and specificity (70-80%) were 3150 parasites/mu l in the high and 1350 parasites/mu l in the low season. Conclusion: Clinical malaria burden was highest among the youngest age group children, who may represent the most appropriate target population for malaria vaccine candidate development. The pyrogenic threshold of parasitaemia varied markedly by season, suggesting a value for alternative parasitaemia levels in the malaria case defintion. Regional epidemiology of malaria described, Sapone area field centers are positioned for future conduct of malaria vaccine trials.	[Ouedraogo, Alphonse; Tiono, Alfred B.; Diarra, Amidou; Sanon, Souleymane; Yaro, Jean Baptiste; Ouedraogo, Esperance; Bougouma, Edith C.; Soulama, Issiaka; Gansane, Adama; Ouedraogo, Amathe; Konate, Amadou T.; Nebie, Issa; Sirima, Sodiomon Bienvenu] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Watson, Nora L.; Sanza, Megan; Dube, Tina J. T.] EMMES Corp, Rockville, MD USA; [Sirima, Sodiomon Bienvenu] Grp Act & Rech Sante, Ouagadougou, Burkina Faso	Emmes Corporation	Sirima, SB (corresponding author), Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.	s.sirima.cnlp@fasonet.bf	OUEDRAOGO, Alphonse/F-7859-2019; SOULAMA, Issiaka/Z-1254-2019	SOULAMA, Issiaka/0000-0002-0993-0525; Tiono, B. Alfred/0000-0002-5104-3946; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Ouedraogo, Alphonse/0000-0002-3520-6637; Nebie, Issa/0000-0003-3051-3600	NIAID/DMID [HHSN266200416C]	NIAID/DMID	Sources of funding NIAID/DMID (subcontract No HHSN266200416C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDON D, 1985, T ROY SOC TROP MED H, V79, P283, DOI 10.1016/0035-9203(85)90361-X; Breman JG, 2007, AM J TROP MED HYG, V77, P36; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Dicko A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023390; Greenwood B, 2005, ACTA TROP, V95, P298, DOI 10.1016/j.actatropica.2005.04.017; Indepth N, 2006, SIT D; Konate AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023391; Ministere de la sante DGISS, 2009, ANN STAT 2009 ANN ST, P178; Moorthy VS, 2009, VACCINE, V27, P624, DOI 10.1016/j.vaccine.2008.11.034; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Olotu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015569; Ouedraogo A, 2010, TROP MED INT HEALTH, V15, P1315, DOI 10.1111/j.1365-3156.2010.02618.x; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Rogers WO, 2006, J INFECT DIS, V193, P467, DOI 10.1086/499314; Sabatinelli G, 1986, Parassitologia, V28, P17; SANTE MDL, 2008, ANN STAT 2008; Saute F, 2003, T ROY SOC TROP MED H, V97, P655, DOI 10.1016/S0035-9203(03)80097-4; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; SCHELLENBERG JRMA, 1994, T ROY SOC TROP MED H, V88, P429, DOI 10.1016/0035-9203(94)90416-2; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; WHO, 2009, WHO MAL REP MALARIA; YE Y, 2009, GLOB HLTH ACTION, V2; [No title captured]	23	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e50036	10.1371/journal.pone.0050036	http://dx.doi.org/10.1371/journal.pone.0050036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320064	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800003
J	Turner, C; Turner, P; Carrara, V; Burgoine, K; Htoo, STL; Watthanaworawit, W; Day, NP; White, NJ; Goldblatt, D; Nosten, F				Turner, Claudia; Turner, Paul; Carrara, Verena; Burgoine, Kathy; Htoo, Saw Tha Ler; Watthanaworawit, Wanitda; Day, Nicholas P.; White, Nicholas J.; Goldblatt, David; Nosten, Francois			High Rates of Pneumonia in Children under Two Years of Age in a South East Asian Refugee Population	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; ETIOLOGY; EPIDEMIOLOGY; INFANTS	Background: There are an estimated 150 million episodes of childhood pneumonia per year, with 11-20 million hospital admissions and 1.575 million deaths. Refugee children are particularly vulnerable, with poorly defined pneumonia epidemiology. Methods: We followed a birth cohort of 955 refugee infants, born over a one-year period, until two years of age. Clinical and radiographic pneumonia were diagnosed according to WHO criteria. Detailed characteristics were collected to determine risk factors for clinical, radiological and multiple episodes of pneumonia. Investigations were taken during a pneumonia episode to help determine or to infer an aetiological diagnosis. Findings: The incidence of clinical pneumonia was 0.73 (95% CI 0.70-0.75) episodes per child year (/CY) and of radiological primary endpoint pneumonia (PEP) was 0.22/CY (95% CI 0.20-0.24). The incidence of pneumonia without severe signs was 0.50/CY (95% CI 0.48-0.53), severe pneumonia 0.15/CY (95% CI 0.13-0.17) and very severe pneumonia 0.06/CY (0.05-0.07). Virus was detected, from a nasopharyngeal aspirate, in 61.3% of episodes. A reduced volume of living space per person (IRR 0.99, 95% CI 0.99-1.0, p = 0.003) and young maternal age (IRR 1.59, 95% CI 1.12-2.27, p = 0.01) were risk factors for developing pneumonia. The risk of a child having >1 episode of pneumonia was increased by having a shorter distance to the next house (IRR 0.86, 95% CI 0.74-1.00, p = 0.04). Infants were at risk of having an episode of PEP if there was a shorter distance from stove to bed (IRR 0.89, 95% CI 0.80-0.99, p = 0.03). Raised CRP and neutrophil values were associated with PEP. Conclusions: There was a high incidence of pneumonia in young children in this SE Asian refugee population. Viral infections were important, however CXR and non-specific marker findings suggested that bacteria may be involved in up to a third of cases.	[Turner, Claudia; Turner, Paul; Carrara, Verena; Burgoine, Kathy; Htoo, Saw Tha Ler; Watthanaworawit, Wanitda; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Turner, Claudia; Turner, Paul; Watthanaworawit, Wanitda; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Turner, Claudia; Turner, Paul; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois] Univ Oxford, Ctr Trop Med, Oxford, England; [Goldblatt, David] UCL, Inst Child Hlth, Immunobiol Unit, London, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; University of London; University College London	Turner, C (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Thailand.	claudia@tropmedres.ac	Nosten, Francois/AAC-5509-2019; White, Nick/AAC-6527-2019; Goldblatt, David/C-5972-2008; Carrara, Verena/R-6492-2019	Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; Goldblatt, David/0000-0002-0769-5242; Carrara, Verena/0000-0002-2758-0872; Turner, Paul/0000-0002-1013-7815; Burgoine, Kathy/0000-0001-7975-745X	Wellcome Trust of Great Britain [077166/Z/05]; Wellcome Trust [083735]; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish	Wellcome Trust of Great Britain(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	CT and FN are supported by the Wellcome Trust of Great Britain (Grant No. 077166/Z/05). PT is also supported by the Wellcome Trust (Grant 083735). SMRU is part of the Mahidol-Oxford University Tropical Medicine Research Program and is supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Bellos Anna, 2010, Confl Health, V4, P3, DOI 10.1186/1752-1505-4-3; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cashat-Cruz Miguel, 2005, Semin Pediatr Infect Dis, V16, P84, DOI 10.1053/j.spid.2005.12.005; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; CRUZ JR, 1990, REV INFECT DIS, V12, pS1029; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Ferrero F, 2010, PEDIATR PULM, V45, P1009, DOI 10.1002/ppul.21287; HORTAL M, 1990, REV INFECT DIS, V12, pS966; Korppi M, 2004, PEDIATR INT, V46, P545, DOI 10.1111/j.1442-200x.2004.01947.x; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Madhi SA, 2006, PEDIATR INFECT DIS J, V25, P30, DOI 10.1097/01.inf.0000195787.99199.4a; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Neil McIntosh PH, 2008, FORFAR ARNEILS TXB P; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Scott JAG, 2008, B WORLD HEALTH ORGAN, V86, P494, DOI 10.2471/BLT.08.052753; Thorn LKAM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-180; Turner P, 2010, EMERG INFECT DIS, V16, P1366, DOI 10.3201/eid1609.100220; UNHCR, 2011, UNHCR 2011 GLOB TREN; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; WHO, 2007, INT MAN CHILDH ILL; WHO, 2005, PCK BOOK HOSP CAR CH; WHO U, 2006, PNEUM FORG KILL CHIL; World Health Organization, 2001, WHOVB0135	28	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54026	10.1371/journal.pone.0054026	http://dx.doi.org/10.1371/journal.pone.0054026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320118	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800085
J	Golec, DP; Dower, NA; Stone, JC; Baldwin, TA				Golec, Dominic P.; Dower, Nancy A.; Stone, James C.; Baldwin, Troy A.			RasGRP1, but Not RasGRP3, Is Required for Efficient Thymic beta-Selection and ERK Activation Downstream of CXCR4	PLOS ONE			English	Article							T-CELL DEVELOPMENT; ADAPTER PROTEIN SLP-76; GAMMA-DELTA; RAS ACTIVATION; THYMOCYTE DIFFERENTIATION; TCR SIGNALS; IN-VIVO; RECEPTOR; PROLIFERATION; MEMBRANE	T cell development is a highly dynamic process that is driven by interactions between developing thymocytes and the thymic microenvironment. Upon entering the thymus, the earliest thymic progenitors, called CD4(-) CD8(-) 'double negative' (DN) thymocytes, pass through a checkpoint termed "beta-selection" before maturing into CD4(+) CD8(+) 'double positive' (DP) thymocytes. beta-selection is an important developmental checkpoint during thymopoiesis where developing DN thymocytes that successfully express the pre-T cell receptor (TCR) undergo extensive proliferation and differentiation towards the DP stage. Signals transduced through the pre-TCR, chemokine receptor CXCR4 and Notch are thought to drive beta-selection. Additionally, it has long been known that ERK is activated during beta-selection; however the pathways regulating ERK activation remain unknown. Here, we performed a detailed analysis of the beta-selection events in mice lacking RasGRP1, RasGRP3 and RasGRP1 and 3. We report that RasGRP1 KO and RasGRP1/3 DKO deficient thymi show a partial developmental block at the early DN3 stage of development. Furthermore, DN3 thymocytes from RasGRP1 and RasGRP1/3 double knockout thymi show significantly reduced proliferation, despite expression of the TCR beta chain. As a result of impaired beta-selection, the pool of TCR beta(+) DN4 is significantly diminished, resulting in inefficient DN to DP development. Also, we report that RasGRP1 is required for ERK activation downstream of CXCR4 signaling, which we hypothesize represents a potential mechanism of RasGRP1 regulation of beta-selection. Our results demonstrate that RasGRP1 is an important regulator of proliferation and differentiation at the beta-selection checkpoint and functions downstream of CXCR4 to activate the Ras/MAPK pathway.	[Golec, Dominic P.; Baldwin, Troy A.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Stone, James C.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Dower, Nancy A.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Baldwin, TA (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	tbaldwin@ualberta.ca		Golec, Dominic/0000-0002-2741-3302	Canadian Institutes of Health Research (CIHR) grant [MOP-86595]; National Sciences and Engineering Research Council of Canada CGS M; Alberta Innovates [201300120] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR) grant(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada CGS M; Alberta Innovates	This work was supported by Canadian Institutes of Health Research (CIHR) grant MOP-86595 (to TAB). TAB is an Alberta Innovates - Health Solutions Scholar and CIHR New Investigator. A National Sciences and Engineering Research Council of Canada CGS M scholarship award supports DPG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Beaulieu N, 2007, MOL BIOL CELL, V18, P3156, DOI 10.1091/mbc.E06-10-0932; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Chen Y, 2012, J IMMUNOL, V189, P61, DOI 10.4049/jimmunol.1103272; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; Ciofani M, 2010, NAT REV IMMUNOL, V10, P657, DOI 10.1038/nri2820; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Dose M, 2006, BLOOD, V108, P2669, DOI 10.1182/blood-2006-02-005900; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Fuller DM, 2012, J IMMUNOL, V189, P4005, DOI 10.4049/jimmunol.1201380; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Holmes R., 2009, COLD SPRING HARB PRO; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Janas ML, 2011, J IMMUNOL, V187, P4667, DOI 10.4049/jimmunol.1101949; Janas ML, 2010, TRENDS IMMUNOL, V31, P370, DOI 10.1016/j.it.2010.07.002; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Kortum RL, 2012, MOL CELL BIOL, V32, P2748, DOI 10.1128/MCB.00317-12; Kortum RL, 2011, P NATL ACAD SCI USA, V108, P12407, DOI 10.1073/pnas.1104295108; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Michie AM, 1999, J EXP MED, V190, P1647, DOI 10.1084/jem.190.11.1647; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Rincon M, 2001, ONCOGENE, V20, P2490, DOI 10.1038/sj.onc.1204382; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Shen SD, 2011, J IMMUNOL, V187, P4467, DOI 10.4049/jimmunol.1003798; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Sugawara T, 1998, J IMMUNOL, V161, P2888; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Thompson PK, 2011, SEMIN IMMUNOL, V23, P350, DOI 10.1016/j.smim.2011.08.007; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Zahedi B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.189605; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916; Zhu MH, 2012, J BIOL CHEM, V287, P8135, DOI 10.1074/jbc.M111.320580	48	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53300	10.1371/journal.pone.0053300	http://dx.doi.org/10.1371/journal.pone.0053300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308188	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100052
J	Hansen, BH; Holme, I; Anderssen, SA; Kolle, E				Hansen, Bjorge Herman; Holme, Ingar; Anderssen, Sigmund Alfred; Kolle, Elin			Patterns of Objectively Measured Physical Activity in Normal Weight, Overweight, and Obese Individuals (20-85 Years): A Cross-Sectional Study	PLOS ONE			English	Article							MIDDLE-AGED WOMEN; BODY-MASS INDEX; SELF-REPORT; UNITED-STATES; ADULTS; MEN; ACCELEROMETER; POPULATION; DIET; ASSOCIATIONS	Background: The magnitude of the association between physical activity (PA) and obesity has been difficult to establish using questionnaires. The aim of the study was to evaluate patterns of PA across BMI-defined weight categories and to examine the independent contribution of PA on weight status, using accelerometers. Methods: The study was a cross-sectional population-based study of 3,867 adults and older people aged 20-85 years, living in Norway. PA was assessed for seven consecutive days using the ActiGraph GT1M accelerometer. Anthropometrical data was self-reported and overweight and obesity was defined as having a body mass index (BMI) of 25-<30 and >= 30 kg/m(2), respectively. Results: Overweight and obese participants performed less overall PA and PA of at least moderate intensity and took fewer steps, compared to normal weight participants. Although overall PA did not differ between weekdays and weekends, an interaction between BMI category and type of day was present, indicating a larger difference in overall PA between BMI categories on weekends compared to weekdays. Obese participants displayed 19% and 25% lower overall physical activity compared to normal weight participants, on weekdays and weekends, respectively. Participants in the most active quintile of overall PA had a 53% lower risk (OR 0.47, 95% CI: 0.37 to 0.60) for having a BMI above or below 25 kg/m(2), and a 71% lower risk (OR: 0.29, 95% CI: 0.20 to 0.44) for having a BMI above or below 30 kg/m(2). Conclusions: Overweight and obese participants engaged in less overall PA and moderate and vigorous PA compared with normal weight individuals. The weight related differences in overall PA were most pronounced on the weekend and the risk of being overweight or obese decreases across quintiles of PA.	[Hansen, Bjorge Herman; Holme, Ingar; Anderssen, Sigmund Alfred; Kolle, Elin] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway	Norwegian School of Sport Sciences	Hansen, BH (corresponding author), Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway.	bjorge.herman.hansen@nih.no			Norwegian Directorate of Health; Norwegian School of Sport Sciences	Norwegian Directorate of Health; Norwegian School of Sport Sciences	The study was funded by the Norwegian Directorate of Health and the Norwegian School of Sport Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderssen SA, 2008, SCAND J MED SCI SPOR, V18, P309, DOI 10.1111/j.1600-0838.2007.00645.x; Anderssen SA, 2004, NORDIC NUTR RECOMMEN; Ball K, 2001, INT J OBESITY, V25, P914, DOI 10.1038/sj.ijo.0801622; Bernstein MS, 2004, PREV MED, V38, P94, DOI 10.1016/j.ypmed.2003.09.032; Cooper AR, 2000, EUR J CLIN NUTR, V54, P887, DOI 10.1038/sj.ejcn.1601116; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Corder K, 2010, AM J EPIDEMIOL, V171, P1065, DOI 10.1093/aje/kwq068; Davis JN, 2006, OBESITY, V14, P2259, DOI 10.1038/oby.2006.265; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Droyvold WB, 2004, INT J OBESITY, V28, P410, DOI 10.1038/sj.ijo.0802569; FORBES GB, 1993, NUTR REV, V51, P296, DOI 10.1111/j.1753-4887.1993.tb03058.x; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Haapanen N, 1997, INT J OBESITY, V21, P288, DOI 10.1038/sj.ijo.0800403; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; JACOBSEN BK, 1988, SCAND J SOC MED, V16, P101, DOI 10.1177/140349488801600207; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Katzmarzyk PT, 2009, J PHYS ACT HEALTH, V6, P269, DOI 10.1123/jpah.6.3.269; Lopes VP, 2009, J PHYS ACT HEALTH, V6, pS133, DOI 10.1123/jpah.6.s1.s133; Meyer HE, 2005, PROSTAG LEUKOTR ESS, V73, P3, DOI 10.1016/j.plefa.2005.04.003; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Norum KR, 2005, PREVENTITIVE NUTR CO; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sogaard Anne Johanne, 2004, Int J Equity Health, V3, P3; SONNEHOLM S, 1989, J EPIDEMIOL COMMUN H, V43, P369, DOI 10.1136/jech.43.4.369; Strandhagen E, 2010, EUR J EPIDEMIOL, V25, P163, DOI 10.1007/s10654-010-9427-7; Strath Scott J, 2008, Prev Chronic Dis, V5, pA131; Thompson DL, 2004, MED SCI SPORT EXER, V36, P911, DOI 10.1249/01.MSS.0000126787.14165.B3; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tucker LA, 2003, OBES RES, V11, P1581, DOI 10.1038/oby.2003.210; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; Tudor-Locke C, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-39; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; Wareham NJ, 1998, INT J OBESITY, V22, pS30; Weinsier RL, 1998, AM J MED, V105, P145, DOI 10.1016/S0002-9343(98)00190-9; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; WHO, 2000, OB PREV MAN GLOB EP; Wyatt HR, 2005, MED SCI SPORT EXER, V37, P724, DOI 10.1249/01.MSS.0000161750.84096.D4; Yoshioka M, 2005, INT J OBESITY, V29, P502, DOI 10.1038/sj.ijo.0802891	43	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53044	10.1371/journal.pone.0053044	http://dx.doi.org/10.1371/journal.pone.0053044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308135	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100025
J	Knowlton, AE; Fowler, LJ; Patel, RK; Wallet, SM; Grieshaber, SS				Knowlton, Andrea E.; Fowler, Larry J.; Patel, Rahul K.; Wallet, Shannon M.; Grieshaber, Scott S.			Chlamydia Induces Anchorage Independence in 3T3 Cells and Detrimental Cytological Defects in an Infection Model	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; TRACHOMATIS INFECTION; INTRAEPITHELIAL NEOPLASIA; CELL-TRANSFORMATION; RISK; MICE; VITRO; DNA; INSTABILITY; SEGREGATION	Chlamydia are Gram negative, obligate intracellular bacterial organisms with different species causing a multitude of infections in both humans and animals. Chlamydia trachomatis is the causative agent of the sexually transmitted infection (STI) Chlamydia, the most commonly acquired bacterial STI in the United States. Chlamydial infections have also been epidemiologically linked to cervical cancer in women co-infected with the human papillomavirus (HPV). We have previously shown chlamydial infection results in centrosome amplification and multipolar spindle formation leading to chromosomal instability. Many studies indicate that centrosome abnormalities, spindle defects, and chromosome segregation errors can lead to cell transformation. We hypothesize that the presence of these defects within infected dividing cells identifies a possible mechanism for Chlamydia as a cofactor in cervical cancer formation. Here we demonstrate that infection with Chlamydia trachomatis is able to transform 3T3 cells in soft agar resulting in anchorage independence and increased colony formation. Additionally, we show for the first time Chlamydia infects actively replicating cells in vivo. Infection of mice with Chlamydia results in significantly increased cell proliferation within the cervix, and in evidence of cervical dysplasia. Confocal examination of these infected tissues also revealed elements of chlamydial induced chromosome instability. These results contribute to a growing body of data implicating a role for Chlamydia in cervical cancer development and suggest a possible molecular mechanism for this effect.	[Knowlton, Andrea E.; Patel, Rahul K.; Grieshaber, Scott S.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Wallet, Shannon M.] Univ Florida, Coll Dent, Dept Periodontol Biol, Gainesville, FL USA; [Fowler, Larry J.] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Grieshaber, SS (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	sgriesha@ufl.edu			National Institutes of Allergy and Infectious Disease, National Institutes of Health [R01 AI077583]; NIDCR, National Institutes of Health [5 T32 DE007200, T90 DE021990]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007200] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research presented here was funded by the National Institutes of Allergy and Infectious Disease, National Institutes of Health R01 AI077583. AEK was supported by fellowships from the NIDCR, National Institutes of Health, 5 T32 DE007200 and T90 DE021990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila T, 2001, JAMA-J AM MED ASSOC, V285, P47, DOI 10.1001/jama.285.1.47; Autier P, 1996, BRIT J CANCER, V74, P488, DOI 10.1038/bjc.1996.388; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; BERWALD Y, 1963, NATURE, V200, P1182, DOI 10.1038/2001182a0; Brake T, 2005, P NATL ACAD SCI USA, V102, P2490, DOI 10.1073/pnas.0409883102; Brown HM, 2012, CELL MICROBIOL, V14, P1554, DOI 10.1111/j.1462-5822.2012.01820.x; CAMPBELL S, 1989, J GEN MICROBIOL, V135, P2379; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; COTTER TW, 1995, INFECT IMMUN, V63, P4704, DOI 10.1128/IAI.63.12.4704-4714.1995; Datta SD, 2012, SEX TRANSM DIS, V39, P92, DOI 10.1097/OLQ.0b013e31823e2ff7; DIPAOLO JA, 1969, SCIENCE, V165, P917, DOI 10.1126/science.165.3896.917; Duensing S, 2002, ONCOGENE, V21, P6241, DOI 10.1038/sj.onc.1205709; Duensing S, 2001, CANCER RES, V61, P2356; Elson DA, 2000, CANCER RES, V60, P1267; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Fenech M, 2011, MUTAGENESIS, V26, P43, DOI 10.1093/mutage/geq050; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gisselsson D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001871; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Greene W, 2003, J INFECTION, V47, P45, DOI 10.1016/S0163-4453(03)00039-2; Grieshaber SS, 2006, TRAFFIC, V7, P940, DOI 10.1111/j.1600-0854.2006.00439.x; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Hinkula M, 2004, BRIT J CANCER, V90, P1025, DOI 10.1038/sj.bjc.6601650; HOWARD L, 1974, APPL MICROBIOL, V27, P102, DOI 10.1128/AEM.27.1.102-106.1974; Johnson KA, 2009, CELL MICROBIOL, V11, P1064, DOI 10.1111/j.1462-5822.2009.01307.x; KirschVolders M, 1997, MUTAT RES-GEN TOX EN, V392, P19, DOI 10.1016/S0165-1218(97)00042-6; Knowlton AE, 2011, TRAFFIC, V12, P854, DOI 10.1111/j.1600-0854.2011.01204.x; Koskela P, 2000, INT J CANCER, V85, P35, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;35::AID-IJC6&gt;3.0.CO;2-A; LASNE C, 1974, NATURE, V247, P490, DOI 10.1038/247490a0; Leppert PC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099283; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Madeleine MM, 2007, INT J CANCER, V120, P650, DOI 10.1002/ijc.22325; Matsumoto K, 2003, BRIT J CANCER, V89, P831, DOI 10.1038/sj.bjc.6601220; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Ohman H, 2009, J INFECT DIS, V199, P1353, DOI 10.1086/597620; PATTON DL, 1989, J INFECT DIS, V159, P1105, DOI 10.1093/infdis/159.6.1105; Pihan G, 2003, CANCER CELL, V4, P89, DOI 10.1016/S1535-6108(03)00195-8; Pihan GA, 1998, CANCER RES, V58, P3974; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Riley RR, 2003, CANCER RES, V63, P4862; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sasaki K, 2012, MUTAT RES-GEN TOX EN, V744, P30, DOI 10.1016/j.mrgentox.2011.12.014; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Smith JS, 2002, J INFECT DIS, V185, P324, DOI 10.1086/338569; Steenbergen RDM, 2005, J CLIN VIROL, V32, pS25, DOI 10.1016/j.jcv.2004.11.019; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Walboomers JM, 1999, AID PATH431 3 0 CO 2; Wallin KL, 2002, INT J CANCER, V101, P371, DOI 10.1002/ijc.10639; WHO, 2001, GUIDELINES STANDARDS, P1; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	61	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e54022	10.1371/journal.pone.0054022	http://dx.doi.org/10.1371/journal.pone.0054022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308295	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100126
J	Salazar, CR; Sun, JH; Li, YH; Francois, F; Corby, P; Perez-Perez, G; Dasanayake, A; Pei, ZH; Chen, Y				Salazar, Christian R.; Sun, Jinghua; Li, Yihong; Francois, Fritz; Corby, Patricia; Perez-Perez, Guillermo; Dasanayake, Ananda; Pei, Zhiheng; Chen, Yu			Association between Selected Oral Pathogens and Gastric Precancerous Lesions	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CHRONIC ATROPHIC GASTRITIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; STREPTOCOCCUS-MUTANS; PERIODONTAL-DISEASE; TOOTH LOSS; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; INTESTINAL METAPLASIA; SUBGINGIVAL PLAQUE	We examined whether colonization of selected oral pathogens is associated with gastric precancerous lesions in a cross-sectional study. A total of 119 participants were included, of which 37 were cases of chronic atrophic gastritis, intestinal metaplasia, or dysplasia. An oral examination was performed to measure periodontal indices. Plaque and saliva samples were tested with real-time quantitative PCR for DNA levels of pathogens related to periodontal disease (Porphyromonas gingivalis, Tannerella forsythensis, Treponema denticola, Actinobacillus actinomycetemcomitans) and dental caries (Streptococcus mutans and S. sobrinus). There were no consistent associations between DNA levels of selected bacterial species and gastric precancerous lesions, although an elevated but non-significant odds ratio (OR) for gastric precancerous lesions was observed in relation to increasing colonization of A. actinomycetemcomitans (OR = 1.36 for one standard deviation increase, 95% Confidence Interval = 0.87-2.12), P. gingivalis (OR = 1.12, 0.67-1.88) and T. denticola (OR = 1.34, 0.83-2.12) measured in plaque. To assess the influence of specific long-term infection, stratified analyses by levels of periodontal indices were conducted. A. actinomycetemcomitans was significantly associated with gastric precancerous lesions (OR = 2.51, 1.13-5.56) among those with >= median of percent tooth sites with PD >= 3 mm, compared with no association among those below the median (OR = 0.86, 0.43-1.72). A significantly stronger relationship was observed between the cumulative bacterial burden score of periodontal disease-related pathogens and gastric precancerous lesions among those with higher versus lower levels of periodontal disease indices (p-values for interactions: 0.03-0.06). Among individuals with periodontal disease, high levels of colonization of periodontal pathogens are associated with an increased risk of gastric precancerous lesions.	[Salazar, Christian R.; Dasanayake, Ananda] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY USA; [Salazar, Christian R.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Sun, Jinghua; Li, Yihong] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA; [Francois, Fritz; Pei, Zhiheng; Chen, Yu] NYU, Sch Med, Dept Med, New York, NY USA; [Francois, Fritz; Chen, Yu] NYU, Sch Med, Inst Canc, New York, NY USA; [Corby, Patricia] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA; [Chen, Yu] NYU, Sch Med, Div Epidemiol, Dept Environm Med, New York, NY USA; [Perez-Perez, Guillermo] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Pei, Zhiheng] NYU, Sch Med, Dept Pathol, New York, NY USA	New York University; Columbia University; New York University; New York University; New York University; New York University; New York University; New York University; New York University	Li, YH (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA.	yihong.li@hyu.edu; yu.chen@nyumc.org	Perez, Guillermo Perez/AAJ-3761-2020; Salazar, Christian/I-1096-2013	Li, Yihong/0000-0002-5476-1943; Perez Perez, Guillermo/0000-0002-0131-5798; Chen, Yu/0000-0002-1519-4894; Salazar, Christian/0000-0003-3755-275X; Francois, Fritz/0000-0003-4491-2637; Pei, Zhiheng/0000-0001-8570-6747	U.S. National Institute [R21DE018438, P30CA016087, ES000260, K23CA107123, T32-DE007255]; NATIONAL CANCER INSTITUTE [P30CA016087, K23CA107123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018438, T32DE007255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	U.S. National Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by U.S. National Institute grants R21DE018438, P30CA016087, ES000260, K23CA107123, and T32-DE007255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2005, SCAND J GASTROENTERO, V40, P681, DOI 10.1080/00365520510015430; Abnet CC, 2001, CANCER CAUSE CONTROL, V12, P847, DOI 10.1023/A:1012290009545; [Anonymous], 1996, Ann Periodontol, V1, P926; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaser MJ, 2010, P NATL ACAD SCI USA, V107, P6125, DOI 10.1073/pnas.1002112107; BLASER MJ, 1995, CANCER RES, V55, P2111; Breslow N, 1980, IARC SCI PUBL, V32, P227; Buchmann R, 2000, J PERIODONTOL, V71, P444, DOI 10.1902/jop.2000.71.3.444; Casarin RCV, 2010, J PERIODONTAL RES, V45, P635, DOI 10.1111/j.1600-0765.2010.01278.x; CORREA P, 1975, LANCET, V2, P58; CORREA P, 1988, CANCER RES, V48, P3554; Correa Pelayo, 2004, Gastric Cancer, V7, P9, DOI 10.1007/s10120-003-0265-0; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; da Silva-Boghossian CM, 2011, ARCH ORAL BIOL, V56, P899, DOI 10.1016/j.archoralbio.2011.02.009; DEMIRER T, 1990, CANCER, V65, P2344, DOI 10.1002/1097-0142(19900515)65:10&lt;2344::AID-CNCR2820651030&gt;3.0.CO;2-H; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dye BA, 2005, J CLIN PERIODONTOL, V32, P1189, DOI 10.1111/j.1600-051X.2005.00856.x; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; FARINATI F, 1995, EUR J CANCER PREV, V4, P181, DOI 10.1097/00008469-199504000-00009; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fives-Taylor PM, 1999, PERIODONTOL 2000, V20, P136, DOI 10.1111/j.1600-0757.1999.tb00161.x; FONTHAM E, 1986, JNCI-J NATL CANCER I, V76, P621, DOI 10.1093/jnci/76.4.621; FONTHAM ETH, 1995, AM J GASTROENTEROL, V90, P1094; FOXMAN B, 2008, INTERDISCIP PERSPECT, P1; Francois F, 2008, GUT, V57, P16, DOI 10.1136/gut.2007.131672; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Kato I, 2004, CANCER EPIDEM BIOMAR, V13, P468; KIGURE T, 1995, J PERIODONTAL RES, V30, P332, DOI 10.1111/j.1600-0765.1995.tb01284.x; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Li Y, 2006, ORAL MICROBIOL IMMUN, V21, P333, DOI 10.1111/j.1399-302X.2006.00301.x; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; National Institute of Dental Research, 1987, EP OR DIS PREV PROGR; Nibali L, 2007, J DENT RES, V86, P416, DOI 10.1177/154405910708600505; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peleteiro B, 2007, CANCER EPIDEM BIOMAR, V16, P322, DOI 10.1158/1055-9965.EPI-06-0885; PEREZPEREZ GI, 1988, ANN INTERN MED, V109, P11, DOI 10.7326/0003-4819-109-1-11; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pritchard DM, 2006, CURR OPIN GASTROEN, V22, P620, DOI 10.1097/01.mog.0000245539.50765.f6; Psoter WJ, 2011, CLIN ORAL INVEST, V15, P461, DOI 10.1007/s00784-010-0413-y; Salazar CR, 2012, CARCINOGENESIS, V33, P399, DOI 10.1093/carcin/bgr284; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; TALLEY NJ, 1991, J NATL CANCER I, V83, P1734, DOI 10.1093/jnci/83.23.1734; Terry MB, 2002, SEMIN RADIAT ONCOL, V12, P111, DOI 10.1053/srao.30814; Watabe K, 1998, ONCOL REP, V5, P1191; Weck MN, 2006, CANCER EPIDEM BIOMAR, V15, P1083, DOI 10.1158/1055-9965.EPI-05-0931; Whiley RA, 1998, ORAL MICROBIOL IMMUN, V13, P195, DOI 10.1111/j.1399-302X.1998.tb00698.x; Yano A, 2002, FEMS MICROBIOL LETT, V217, P23, DOI 10.1111/j.1574-6968.2002.tb11451.x; Zadeh HH, 1999, PERIODONTOL 2000, V20, P239, DOI 10.1111/j.1600-0757.1999.tb00163.x	52	39	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e51604	10.1371/journal.pone.0051604	http://dx.doi.org/10.1371/journal.pone.0051604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308100	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100005
J	Zimmer, F; Zollner, FG; Hoeger, S; Klotz, S; Tsagogiorgas, C; Kramer, BK; Schad, LR				Zimmer, Fabian; Zoellner, Frank G.; Hoeger, Simone; Klotz, Sarah; Tsagogiorgas, Charalambos; Kraemer, Bernhard K.; Schad, Lothar R.			Quantitative Renal Perfusion Measurements in a Rat Model of Acute Kidney Injury at 3T: Testing Inter- and Intramethodical Significance of ASL and DCE-MRI	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; GLOMERULAR-FILTRATION; COMPARTMENT MODEL; FAIR TECHNIQUE; QUANTIFICATION; INVERSION; FEASIBILITY; TRANSPLANTATION; DOPAMINE; PULSES	Objectives: To establish arterial spin labelling (ASL) for quantitative renal perfusion measurements in a rat model at 3 Tesla and to test the diagnostic significance of ASL and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in a model of acute kidney injury (AKI). Material and Methods: ASL and DCE-MRI were consecutively employed on six Lewis rats, five of which had a unilateral ischaemic AKI. All measurements in this study were performed on a 3 Tesla MR scanner using a FAIR True-FISP approach and a TWIST sequence for ASL and DCE-MRI, respectively. Perfusion maps were calculated for both methods and the cortical perfusion of healthy and diseased kidneys was inter-and intramethodically compared using a region-of-interest based analysis. Results/Significance: Both methods produce significantly different values for the healthy and the diseased kidneys (P<0.01). The mean difference was 147+/-47 ml/100 g/min and 141+/-46 ml/100 g/min for ASL and DCE-MRI, respectively. ASL measurements yielded a mean cortical perfusion of 416+/-124 ml/100 g/min for the healthy and 316+/-102 ml/100 g/min for the diseased kidneys. The DCE-MRI values were systematically higher and the mean cortical renal blood flow (RBF) was found to be 542+/-85 ml/100 g/min (healthy) and 407+/-119 ml/100 g/min (AKI). Conclusion: Both methods are equally able to detect abnormal perfusion in diseased (AKI) kidneys. This shows that ASL is a capable alternative to DCE-MRI regarding the detection of abnormal renal blood flow. Regarding absolute perfusion values, nontrivial differences and variations remain when comparing the two methods.	[Zimmer, Fabian; Zoellner, Frank G.; Schad, Lothar R.] Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany; [Hoeger, Simone; Klotz, Sarah; Kraemer, Bernhard K.] Heidelberg Univ, Dept Med 5, Univ Med Ctr Mannheim, Mannheim, Germany; [Tsagogiorgas, Charalambos] Heidelberg Univ, Clin Anaesthesiol & Intens Care, Univ Med Ctr Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Zollner, FG (corresponding author), Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany.	frank.zoellner@medma.uni-heidelberg.de	Zimmer, Fabian/M-4765-2014; Zöllner, Frank G/A-2725-2012	Zöllner, Frank G/0000-0003-3405-1394	Bayer HealthCare	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	This work was supported by Bayer HealthCare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annet L, 2004, J MAGN RESON IMAGING, V20, P843, DOI 10.1002/jmri.20173; Artz NS, 2011, MAGN RESON IMAGING, V29, P74, DOI 10.1016/j.mri.2010.07.018; Artz NS, 2011, INVEST RADIOL, V46, P124, DOI 10.1097/RLI.0b013e3181f5e101; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bokacheva L, 2008, MAGN RESON IMAGING C, V16, P597, DOI 10.1016/j.mric.2008.07.001; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Broome DR, 2008, EUR J RADIOL, V66, P230, DOI 10.1016/j.ejrad.2008.02.011; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Calamante F, 2005, J MAGN RESON IMAGING, V22, P718, DOI 10.1002/jmri.20454; Calamante F, 1996, NMR BIOMED, V9, P79, DOI 10.1002/(SICI)1099-1492(199604)9:2<79::AID-NBM399>3.0.CO;2-4; CONOLLY S, 1988, J MAGN RESON, V78, P440, DOI 10.1016/0022-2364(88)90131-X; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Dujardin M, 2005, MAGNET RESON MED, V54, P841, DOI 10.1002/mrm.20608; Gardener AG, 2010, MAGN RESON MED, V63, P1627, DOI 10.1002/mrm.22387; GARWOOD M, 1989, MAGNET RESON MED, V9, P25, DOI 10.1002/mrm.1910090105; Gunther M, 2001, MAGNET RESON MED, V46, P974, DOI 10.1002/mrm.1284; Hoeger S, 2008, TRANSPL INT, V21, P1072, DOI 10.1111/j.1432-2277.2008.00725.x; Hsu H, 2007, WILEY ENC Y CLIN TRI; Karger N, 2000, MAGN RESON IMAGING, V18, P641, DOI 10.1016/S0730-725X(00)00155-7; Kiefer C, 2009, ACAD RADIOL, V16, P79, DOI 10.1016/j.acra.2008.04.024; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; Kinsey GR, 2011, AM J KIDNEY DIS, V58, P291, DOI 10.1053/j.ajkd.2011.02.385; Konstandin S, 2011, Z MED PHYS, V21, P26, DOI 10.1016/j.zemedi.2010.06.003; KWONG KK, 1995, MAGNET RESON MED, V34, P878, DOI 10.1002/mrm.1910340613; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; Lietzmann F, 2012, J MAGN RESON IMAGING, V35, P868, DOI 10.1002/jmri.23509; Mani S, 1997, MAGN RESON MED, V37, P898, DOI 10.1002/mrm.1910370615; Martirosian P, 2004, MAGNET RESON MED, V51, P353, DOI 10.1002/mrm.10709; Mendichovszky IA, 2009, EUR J RADIOL, V71, P576, DOI 10.1016/j.ejrad.2008.09.025; Michaely HJ, 2007, ABDOM IMAGING, V32, P1, DOI 10.1007/s00261-005-8004-0; Michaely HJ, 2008, INVEST RADIOL, V43, P120, DOI 10.1097/RLI.0b013e3181583b0c; Notohamiprodjo M, 2010, EUR J RADIOL, V76, P337, DOI 10.1016/j.ejrad.2010.05.033; OPPELT A, 1986, Electromedica (English Edition), V54, P15; Pedersen M, 2010, Z MED PHYS, V20, P134, DOI 10.1016/j.zemedi.2010.02.002; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Rieg T, 2004, N-S ARCH PHARMACOL, V370, P320, DOI 10.1007/s00210-004-0982-x; Schnuelle P, 2009, JAMA-J AM MED ASSOC, V302, P1067, DOI 10.1001/jama.2009.1310; Schwarzbauer C, 1996, MAGNET RESON MED, V35, P540, DOI 10.1002/mrm.1910350413; Song RT, 2010, MAGN RESON MED, V64, P1352, DOI 10.1002/mrm.22532; Song T, 2009, MAGN RESON MED, V61, P1242, DOI 10.1002/mrm.21901; Sourbron SP, 2008, INVEST RADIOL, V43, P40, DOI 10.1097/RLI.0b013e31815597c5; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Tsagogiorgas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043525; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Winter JD, 2011, J MAGN RESON IMAGING, V34, P608, DOI 10.1002/jmri.22660; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Wu WC, 2011, RADIOLOGY, V261, P845, DOI 10.1148/radiol.11110668; Zollner FG, 2009, COMPUT MED IMAG GRAP, V33, P171, DOI 10.1016/j.compmedimag.2008.11.004; Zollner FG, 2012, J DIGIT IMAGING	52	54	57	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53849	10.1371/journal.pone.0053849	http://dx.doi.org/10.1371/journal.pone.0053849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308289	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100121
J	Cullen, JA; Maie, T; Schoenfuss, HL; Blob, RW				Cullen, Joshua A.; Maie, Takashi; Schoenfuss, Heiko L.; Blob, Richard W.			Evolutionary Novelty versus Exaptation: Oral Kinematics in Feeding versus Climbing in the Waterfall-Climbing Hawaiian Goby Sicyopterus stimpsoni	PLOS ONE			English	Article							EXTREME ENVIRONMENTS; GOBIID FISHES; PERFORMANCE; SUCTION; RECRUITMENT; SIMULATION; CHALLENGES; MORPHOLOGY; PROPULSION; DIVERSITY	Species exposed to extreme environments often exhibit distinctive traits that help meet the demands of such habitats. Such traits could evolve independently, but under intense selective pressures of extreme environments some existing structures or behaviors might be coopted to meet specialized demands, evolving via the process of exaptation. We evaluated the potential for exaptation to have operated in the evolution of novel behaviors of the waterfall-climbing gobiid fish genus Sicyopterus. These fish use an "inching'' behavior to climb waterfalls, in which an oral sucker is cyclically protruded and attached to the climbing surface. They also exhibit a distinctive feeding behavior, in which the premaxilla is cyclically protruded to scrape diatoms from the substrate. Given the similarity of these patterns, we hypothesized that one might have been coopted from the other. To evaluate this, we filmed climbing and feeding in Sicyopterus stimpsoni from Hawai'i, and measured oral kinematics for two comparisons. First, we compared feeding kinematics of S. stimpsoni with those for two suction feeding gobiids (Awaous guamensis and Lentipes concolor), assessing what novel jaw movements were required for algal grazing. Second, we quantified the similarity of oral kinematics between feeding and climbing in S. stimpsoni, evaluating the potential for either to represent an exaptation from the other. Premaxillary movements showed the greatest differences between scraping and suction feeding taxa. Between feeding and climbing, overall profiles of oral kinematics matched closely for most variables in S. stimpsoni, with only a few showing significant differences in maximum values. Although current data cannot resolve whether oral movements for climbing were coopted from feeding, or feeding movements coopted from climbing, similarities between feeding and climbing kinematics in S. stimpsoni are consistent with evidence of exaptation, with modifications, between these behaviors. Such comparisons can provide insight into the evolutionary mechanisms facilitating exploitation of extreme habitats.	[Cullen, Joshua A.; Maie, Takashi; Blob, Richard W.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Schoenfuss, Heiko L.] St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA	Clemson University; Minnesota State Colleges & Universities; Saint Cloud State University	Blob, RW (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	rblob@clemson.edu		Schoenfuss, Heiko/0000-0001-5464-992X; Cullen, Joshua/0000-0002-6935-9340; Blob, Richard/0000-0001-5026-343X	US National Science foundation [IOS-0817911, IOS-0817794]; St. Cloud State University Faculty Research Grant; Clemson University Creative Inquiry Grant [479]; Direct For Biological Sciences [0817794, 0817911] Funding Source: National Science Foundation	US National Science foundation(National Science Foundation (NSF)); St. Cloud State University Faculty Research Grant; Clemson University Creative Inquiry Grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by the US National Science foundation (http://www.nsf.gov) IOS-0817911 (HLS) and IOS-0817794 (RWB), a St. Cloud State University Faculty Research Grant (HLS), and Clemson University Creative Inquiry Grant #479 (RWB, JAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blob RW, 2007, J ZOOL, V273, P200, DOI 10.1111/j.1469-7998.2007.00315.x; Blob RW, 2010, INTEGR COMP BIOL, V50, P1185, DOI 10.1093/icb/icq070; Blob RW, 2008, INTEGR COMP BIOL, V48, P734, DOI 10.1093/icb/icn086; Blob RW, 2006, J ZOOL, V268, P315, DOI 10.1111/j.1469-7998.2005.00034.x; FITZSIMONS JM, 1995, ENVIRON BIOL FISH, V43, P39, DOI 10.1007/BF00001816; FUKUI S, 1979, JPN J ICHTHYOL, V26, P84; GERARD JF, 1993, REV ECOL-TERRE VIE, V48, P239; Gerstner CL, 2007, CAN J ZOOL, V85, P133, DOI 10.1139/Z06-199; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Hamilton AG, 1989, LINEAR ALGEBRA; Hankison SJ, 2006, J FISH BIOL, V68, P1610, DOI 10.1111/j.0022-1112.2006.001051.x; Julius ML, 2005, AQUAT ECOL, V39, P473, DOI 10.1007/s10452-005-9007-1; Keith P, 2008, MAR FRESHWATER RES, V59, P876, DOI 10.1071/MF08116; Keith P, 2011, MAR BIOL, V158, P311, DOI 10.1007/s00227-010-1560-z; Keith P, 2003, J FISH BIOL, V63, P831, DOI 10.1046/j.1095-8649.2003.00197.x; Kido Michael H., 1996, Pacific Science, V50, P184; Lauder George V., 1996, P55; LAUDER GV, 1980, J EXP BIOL, V88, P49; Legreneur P, 2012, ADAPT BEHAV, V20, P67, DOI 10.1177/1059712311426797; Maie T, 2012, J EXP BIOL, V215, P3925, DOI 10.1242/jeb.072967; Maie T, 2009, J MORPHOL, V270, P976, DOI 10.1002/jmor.10737; Maie T, 2009, J MORPHOL, V270, P344, DOI 10.1002/jmor.10695; McDowall RM, 2004, FISH FISH, V5, P75, DOI 10.1111/j.1467-2960.2004.00138.x; McDowall RM, 2003, J BIOGEOGR, V30, P703, DOI 10.1046/j.1365-2699.2003.00851.x; Nishimoto Robert T., 1997, Micronesica, V30, P41; Patek SN, 2006, P NATL ACAD SCI USA, V103, P12787, DOI 10.1073/pnas.0604290103; RADTKE RL, 1988, ENVIRON BIOL FISH, V23, P205, DOI 10.1007/BF00004911; Rivera ARV, 2013, J EXP BIOL, V216, P668, DOI 10.1242/jeb.079715; SCHAEFER SA, 1986, SYST ZOOL, V35, P489, DOI 10.2307/2413111; Schoenfuss Heiko L., 2007, Bishop Museum Bulletin in Cultural and Environmental Studies, V3, P125; Schoenfuss HL, 2011, CYBIUM, V35, P361; Schoenfuss Heiko L., 1997, Micronesica, V30, P93; Schoenfuss HL, 2003, J ZOOL, V261, P191, DOI 10.1017/S0952836903004102; Sokal RR, 1995, BIOMETRY; Tobalske BW, 2007, J EXP BIOL, V210, P1742, DOI 10.1242/jeb.001701; Van Wassenbergh S, 2009, J EXP BIOL, V212, P116, DOI 10.1242/jeb.023929; Voegtle B., 2002, B FRANCAIS PECHE PIS, V364, P109, DOI DOI 10.1051/KMAE:2002006; Vogel S., 2003, COMP BIOMECHANICS LI; Walker JA, 1998, J EXP BIOL, V201, P981; Waterman TH, 1999, J EXP ZOOL, V285, P326, DOI 10.1002/(SICI)1097-010X(19991215)285:4<326::AID-JEZ3>3.3.CO;2-K; Waterman TH, 2001, J EXP ZOOL, V291, P130, DOI 10.1002/jez.1065	41	15	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53274	10.1371/journal.pone.0053274	http://dx.doi.org/10.1371/journal.pone.0053274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308184	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100030
J	Fujikura, K; Setsu, T; Tanigaki, K; Abe, T; Kiyonari, H; Terashima, T; Sakisaka, T				Fujikura, Kohei; Setsu, Tomiyoshi; Tanigaki, Kenji; Abe, Takaya; Kiyonari, Hiroshi; Terashima, Toshio; Sakisaka, Toshiaki			Kif14 Mutation Causes Severe Brain Malformation and Hypomyelination	PLOS ONE			English	Article							MUTANT MICE; MOUSE GENOME; NEURAL-TUBE; OLIGODENDROCYTE; PROTEINS; MYELIN; NEUROGENESIS; CYTOKINESIS; MECHANISMS; DEFECTS	We describe a novel spontaneous mouse mutant, laggard (lag), characterized by a flat head, motor impairment and growth retardation. The mutation is inherited as an autosomal recessive trait, and lag/lag mice suffer from cerebellar ataxia and die before weaning. lag/lag mice exhibit a dramatic reduction in brain size and slender optic nerves. By positional cloning, we identify a splice site mutation in Kif14. Transgenic complementation with wild-type Kif14-cDNA alleviates ataxic phenotype in lag/lag mice. To further confirm that the causative gene is Kif14, we generate Kif14 knockout mice and find that all of the phenotypes of Kif14 knockout mice are similar to those of lag/lag mice. The main morphological abnormality of lag/lag mouse is severe hypomyelination in central nervous system. The lag/lag mice express an array of myelin-related genes at significantly reduced levels. The disrupted cytoarchitecture of the cerebellar and cerebral cortices appears to result from apoptotic cell death. Thus, we conclude that Kif14 is essential for the generation and maturation of late-developing structures such as the myelin sheath, cerebellar and cerebral cortices. So far, no Kif14-deficient mice or mutation in Kif14 has ever been reported and we firstly define the biological function of Kif14 in vivo. The discovery of mammalian models, laggard, has opened up horizons for researchers to add more knowledge regarding the etiology and pathology of brain malformation.	[Fujikura, Kohei; Sakisaka, Toshiaki] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 657, Japan; [Setsu, Tomiyoshi; Terashima, Toshio] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Dev Neurobiol, Kobe, Hyogo 657, Japan; [Tanigaki, Kenji] Shiga Med Ctr, Res Inst, Moriyama, Shiga, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan	Kobe University; Kobe University; RIKEN	Sakisaka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 657, Japan.	sakisaka@med.kobe-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015		Ministry of Education, Culture, Sports, Science and Technology, Japan [22500334]; Japan Epilepsy Research Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Epilepsy Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (number 22500334), by a grant provided by The Japan Epilepsy Research Foundation, and by the grant provided by Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Goldowitz D, 1997, J NEUROSCI, V17, P8767; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; GUNTHER T, 1994, DEVELOPMENT, V120, P3119; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; HERRUP K, 1979, BRAIN RES, V178, P443, DOI 10.1016/0006-8993(79)90705-4; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Jejeli M, 2003, NEUROSCI RES, V47, P309, DOI 10.1016/S0168-0102(03)00224-4; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lyons DA, 2009, NAT GENET, V41, P854, DOI 10.1038/ng.376; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; Rhodes M, 1998, GENOME RES, V8, P531, DOI 10.1101/gr.8.5.531; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	33	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53490	10.1371/journal.pone.0053490	http://dx.doi.org/10.1371/journal.pone.0053490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308235	gold, Green Published, Green Submitted			2022-12-27	WOS:000313670100045
J	Kamtekar, N; Pandey, A; Agrawal, N; Pissurlenkar, RRS; Borana, M; Ahmad, B				Kamtekar, Nayana; Pandey, Anita; Agrawal, Neeraj; Pissurlenkar, Raghuvir R. S.; Borana, Mohanish; Ahmad, Basir			Interaction of Multimicrobial Synthetic Inhibitor 1,2-Bis(2-Benzimidazolyl)-1,2-Ethanediol with Serum Albumin: Spectroscopic and Computational Studies	PLOS ONE			English	Article							TARGET RESIDENCE TIME; ACCURATE DOCKING; LIGAND-BINDING; BOVINE; FLUORESCENCE; GLIDE; BENZIMIDAZOLE; AGGREGATION; SPECIFICITY; DERIVATIVES	The molecule, 1,2-Bis(2-benzimidazolyl)-1,2-ethanediol (BBE) is known to act as a selective inhibitor of poliovirus, rhinovirus, Candida albicans, several bacterial species, and is easily synthesized by Phillips reaction. The interaction of BBE with BSA and the effects of its binding on the conformation and unfolding/refolding pathways of the protein were investigated using multispectroscopic techniques and molecular modeling. The binding studies indicate that BSA has one high affinity BBE binding site with association constant 6.02 +/- 0.05x10(4) M-1 at 298 K. By measuring binding at different temperatures, we determined the changes in enthalpy (Delta H = -15.13 +/- 2.15 kJ mol(-1)), entropy (Delta S = 40.87 +/- 7.25 J mol(-1) K-1) and free energy (Delta G = 26.78 +/- 1.02) of interaction, which indicate that the binding was spontaneous and both enthalpically and entropically driven. Based on molecular modeling and thermodynamic parameters, we proposed that the complex formation involved mainly hydrophilic interaction such as hydrogen bonding between hydroxyl groups of ethane-1,2-diol fragment with Tyr410 and benzimidazole sp(2) nitrogen atom with Ser488 and hydrophobic interaction between phenyl ring of one benzimidazole of the ligand and hydrophobic residues namely, Ile387, Cys391, Phe402, Val432 and Cys437. The sequential unfolding mechanism of BSA, site-specific marker displacement experiments and molecular modeling showed that the molecule preferably binds in subdomain IIIA. The BBE binding to BSA was found to cause both secondary and tertiary structural alterations in the protein as studied by intrinsic fluorescence, near-UV and far-UV circular dichroism results. The unfolding/refolding study showed that BBE stabilized native to intermediate states (N reversible arrow I) transition of the protein by similar to 2 kJ mol(-1) without affecting the intermediate to unfolded states (I reversible arrow U) transition and general mechanism of unfolding of BSA.	[Kamtekar, Nayana; Pandey, Anita; Agrawal, Neeraj; Borana, Mohanish; Ahmad, Basir] Univ Mumbai, UM DAE Ctr Excellence Basic Sci, Mumbai, Maharashtra, India; [Pissurlenkar, Raghuvir R. S.] Bombay Coll Pharm, Pharmaceut Chem Div, Mumbai, Maharashtra, India	UM-DAE Centre for Excellence in Basic Sciences; University of Mumbai	Ahmad, B (corresponding author), Univ Mumbai, UM DAE Ctr Excellence Basic Sci, Kalina Campus, Mumbai, Maharashtra, India.	basir.ahmad@cbs.ac.in	Ahmad, Basir/O-9344-2017; Pissurlenkar, Raghuvir R/H-7621-2017	Ahmad, Basir/0000-0002-0120-5097; Pissurlenkar, Raghuvir R/0000-0002-1983-1336	UM-DAE Centre for Excellence in Basic Sciences	UM-DAE Centre for Excellence in Basic Sciences	Financial Support was provided by UM-DAE Centre for Excellence in Basic Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043814; Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad B, 2004, BIOCHEM BIOPH RES CO, V314, P166, DOI 10.1016/j.bbrc.2003.12.069; Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Ahmad E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038372; AKIHAMA S, 1968, NATURE, V217, P562, DOI 10.1038/217562a0; Bagatolli LA, 1996, J PHARM SCI, V85, P1131, DOI 10.1021/js960142k; Bourassa P, 2010, J PHYS CHEM B, V114, P3348, DOI 10.1021/jp9115996; Charbonneau DM, 2010, J PHYS CHEM B, V114, P1148, DOI 10.1021/jp910077h; Coan KED, 2008, J AM CHEM SOC, V130, P9606, DOI 10.1021/ja802977h; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Copeland RA, 2010, EXPERT OPIN DRUG DIS, V5, P305, DOI 10.1517/17460441003677725; Creighton T. E., 1993, PROTEINS STRUCTURE M; de Azevedo WF, 2008, CURR DRUG TARGETS, V9, P1071, DOI 10.2174/138945008786949441; Dubeau S, 2010, BIOMACROMOLECULES, V11, P1507, DOI 10.1021/bm100144v; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Han XL, 2012, J PHOTOCH PHOTOBIO B, V109, P1, DOI 10.1016/j.jphotobiol.2011.12.010; Hung HC, 2012, ANAL CHEM, V84, P6391, DOI 10.1021/ac2022426; Isele K, 2002, J CHEM SOC DALTON, P3899, DOI 10.1039/b203229e; Kang J, 2004, BBA-GEN SUBJECTS, V1674, P205, DOI 10.1016/j.bbagen.2004.06.021; Kume S, 2012, BIOCHEM J, V446, P279, DOI 10.1042/BJ20120324; Lakowicz J.R., 2004, PRINCIPLES FLUORESCE, V2nd ed.; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011; Narazaki R, 1997, BBA-PROTEIN STRUCT M, V1338, P275, DOI 10.1016/S0167-4838(96)00221-X; OSULLIVAN DG, 1963, NATURE, V198, P1270, DOI 10.1038/1981270a0; Owen SC, 2012, ACS CHEM BIOL, V7, P1429, DOI 10.1021/cb300189b; Patel AB, 1999, J BIOL CHEM, V274, P21755, DOI 10.1074/jbc.274.31.21755; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Peters T., 1996, ALL ALBUMIN BIOCH GE; Ryan CW, 2004, CLIN CANCER RES, V10, P4406, DOI 10.1158/1078-0432.CCR-04-0083; Schmidt S, 2008, ANTIMICROB AGENTS CH, V52, P3994, DOI 10.1128/AAC.00427-08; Seeliger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000634; SHIPKOWITZ NL, 1972, APPL MICROBIOL, V23, P117, DOI 10.1128/AEM.23.1.117-122.1972; SJOHOLM I, 1979, MOL PHARMACOL, V16, P767; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; TANFORD C, 1968, ADVANCES PROTEIN CHE, V23, P122; Tavman A, 2005, FOLIA MICROBIOL, V50, P467, DOI 10.1007/BF02931431; Tayyab S, 2002, INT J BIOL MACROMOL, V30, P17, DOI 10.1016/S0141-8130(01)00185-4; Thomas GL, 2011, CURR OPIN CHEM BIOL, V15, P516, DOI 10.1016/j.cbpa.2011.05.022; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; WALLEVIK K, 1973, J BIOL CHEM, V248, P2650; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Zhang R, 2009, CURR OPIN DRUG DISC, V12, P488	50	21	21	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53499	10.1371/journal.pone.0053499	http://dx.doi.org/10.1371/journal.pone.0053499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308237	Green Submitted, Green Published, gold			2022-12-27	WOS:000313670100046
J	Hilbers, F; Junge, W; Sielaff, H				Hilbers, Florian; Junge, Wolfgang; Sielaff, Hendrik			The Torque of Rotary F-ATPase Can Unfold Subunit Gamma If Rotor and Stator Are Cross-Linked	PLOS ONE			English	Article							ELASTIC POWER TRANSMISSION; ESCHERICHIA-COLI; F-1-ATPASE; SYNTHASE; ROTATION; DYNAMICS; ENERGY; F0F1-ATPASE; REGION; ASSAY	During ATP hydrolysis by F-1-ATPase subunit gamma rotates in a hydrophobic bearing, formed by the N-terminal ends of the stator subunits (alpha beta)(3). If the penultimate residue at the alpha-helical C-terminal end of subunit gamma is artificially cross-linked (via an engineered disulfide bridge) with the bearing, the rotary function of F-1 persists. This observation has been tentatively interpreted by the unfolding of the alpha-helix and swiveling rotation in some dihedral angles between lower residues. Here, we screened the domain between rotor and bearing where an artificial disulfide bridge did not impair the rotary ATPase activity. We newly engineered three mutants with double cysteines farther away from the C-terminus of subunit gamma, while the results of three further mutants were published before. We found ATPase and rotary activity for mutants with cross-links in the single alpha-helical, C-terminal portion of subunit gamma (from gamma 285 to gamma 276 in E. coli), and virtually no activity when the cross-link was placed farther down, where the C-terminal alpha-helix meets its N-terminal counterpart to form a supposedly stable coiled coil. In conclusion, only the C-terminal singular alpha-helix is prone to unwinding and can form a swivel joint, whereas the coiled coil portion seems to resist the enzyme's torque.	[Hilbers, Florian] MPI Biophys, Dept Mol Membrane Biol, Frankfurt, Germany; [Junge, Wolfgang] Univ Osnabruck, Div Biophys, Osnabruck, Germany; [Sielaff, Hendrik] Jena Univ Hosp, Single Mol Microscopy Grp, Jena, Germany	Max Planck Society; University Osnabruck; Friedrich Schiller University of Jena	Sielaff, H (corresponding author), Jena Univ Hosp, Single Mol Microscopy Grp, Jena, Germany.	hendrik.sielaff@med.uni-jena.de		Sielaff, Hendrik/0000-0001-5231-7286	DFG [SFB 431]; Volkswagen-Stiftung; Fonds der Chemischen Industrie	DFG(German Research Foundation (DFG)); Volkswagen-Stiftung(Volkswagen); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	The project was funded by DFG (SFB 431), Volkswagen-Stiftung, and Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cherepanov DA, 1999, FEBS LETT, V449, P1, DOI 10.1016/S0014-5793(99)00386-5; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Czub J, 2011, P NATL ACAD SCI USA, V108, P7408, DOI 10.1073/pnas.1018686108; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Gumbiowski K, 2001, J BIOL CHEM, V276, P42287, DOI 10.1074/jbc.M106884200; Hossain MD, 2008, BIOPHYS J, V95, P4837, DOI 10.1529/biophysj.108.140061; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; LEBEL D, 1978, ANAL BIOCHEM, V85, P86, DOI 10.1016/0003-2697(78)90277-4; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P26519, DOI 10.1074/jbc.M109.030528; Muller M, 2004, EUR J BIOCHEM, V271, P3914, DOI 10.1111/j.1432-1033.2004.04328.x; Muller M, 2002, J BIOL CHEM, V277, P23308, DOI 10.1074/jbc.M201998200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Panke O, 1999, BBA-BIOENERGETICS, V1412, P118, DOI 10.1016/S0005-2728(99)00059-6; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sabbert D, 1997, P NATL ACAD SCI USA, V94, P4401, DOI 10.1073/pnas.94.9.4401; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Sokolov M, 1999, J BIOL CHEM, V274, P13824, DOI 10.1074/jbc.274.20.13824; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; WISE JG, 1990, J BIOL CHEM, V265, P10403	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53754	10.1371/journal.pone.0053754	http://dx.doi.org/10.1371/journal.pone.0053754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301103	Green Published, gold			2022-12-27	WOS:000313480000078
J	Millet, B; Dondaine, T; Reymann, JM; Bourguignon, A; Naudet, F; Jaafari, N; Drapier, D; Turmel, V; Mesbah, H; Verin, M; Le Jeune, F				Millet, Bruno; Dondaine, Thibaut; Reymann, Jean-Michel; Bourguignon, Aurelie; Naudet, Florian; Jaafari, Nematollah; Drapier, Dominique; Turmel, Valerie; Mesbah, Habiba; Verin, Marc; Le Jeune, Florence			Obsessive Compulsive Disorder Networks: Positron Emission Tomography and Neuropsychology Provide New Insights	PLOS ONE			English	Article							GLUCOSE METABOLIC RATES; PREFRONTAL CORTEX; DECISION-MAKING; STIMULATION; RELIABILITY; DYSFUNCTIONS; METAANALYSIS; PERFORMANCE; INTERRATER; INTERVIEW	Background: Deep brain stimulation has shed new light on the central role of the prefrontal cortex (PFC) in obsessive compulsive disorder (OCD). We explored this structure from a functional perspective, synchronizing neuroimaging and cognitive measures. Methods and Findings: This case-control cross-sectional study compared 15 OCD patients without comorbidities and not currently on serotonin reuptake inhibitors or cognitive behavioural therapy with 15 healthy controls (matched for age, sex and education level) on resting-state (18)FDG-PET scans and a neuropsychological battery assessing executive functions. We looked for correlations between metabolic modifications and impaired neuropsychological scores. Modifications in glucose metabolism were found in frontal regions (orbitofrontal cortex and dorsolateral cortices), the cingulate gyrus, insula and parietal gyrus. Neuropsychological differences between patients and controls, which were subtle, were correlated with the metabolism of the prefrontal, parietal, and temporal cortices. Conclusion: As expected, we confirmed previous reports of a PFC dysfunction in OCD patients, and established a correlation with cognitive deficits. Other regions outside the prefrontal cortex, including the dorsoparietal cortex and the insula, also appeared to be implicated in the pathophysiology of OCD, providing fresh insights on the complexity of OCD syndromes.	[Millet, Bruno; Dondaine, Thibaut; Bourguignon, Aurelie; Naudet, Florian; Drapier, Dominique] Guillaume Regnier Hosp, Univ Dept Adult Psychiat, Rennes, France; [Millet, Bruno; Dondaine, Thibaut; Naudet, Florian; Drapier, Dominique; Verin, Marc; Le Jeune, Florence] Univ Hosp, Behav & Basal Ganglia Res Unit, EA 4712, Rennes, France; [Millet, Bruno; Dondaine, Thibaut; Reymann, Jean-Michel; Naudet, Florian; Drapier, Dominique; Turmel, Valerie; Verin, Marc; Le Jeune, Florence] Univ Rennes 1, Rennes, France; [Reymann, Jean-Michel; Naudet, Florian; Turmel, Valerie] Univ Hosp, Clin Pharmacol Unit, INSERM 0203, Clin Invest Ctr, Rennes, France; [Jaafari, Nematollah] Team Psychobiol Compuls Disorders, Expt & Clin Neurosci Lab, INSERM, Poitiers, France; [Jaafari, Nematollah] Univ Hosp Poitiers, INSERM, CIC U802, Poitiers, France; [Jaafari, Nematollah] Univ Poitiers, Poitiers, France; [Dondaine, Thibaut; Jaafari, Nematollah] Ctr Hosp Henri Laborit, Unite Rech Clin Intersectorielle Psychiat, Poitiers, France; [Mesbah, Habiba] Eugene Marquis Ctr, Dept Med Informat, Rennes, France; [Verin, Marc] Rennes Univ Hosp, Pontchaillou Hosp, Dept Neurol, Rennes, France; [Le Jeune, Florence] Eugene Marquis Ctr, Dept Nucl Med, Rennes, France	CHU Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; UNICANCER; Centre Eugene Marquis; CHU Rennes; Universite de Rennes; UNICANCER; Centre Eugene Marquis	Naudet, F (corresponding author), Guillaume Regnier Hosp, Univ Dept Adult Psychiat, Rennes, France.	floriannaudet@gmail.com	Naudet, Florian/H-5644-2019; Le Jeune, Florence/ABC-6983-2020; Verin, Marc/ABC-6924-2020	Naudet, Florian/0000-0003-3760-3801; Dondaine, Thibaut/0000-0002-8778-5079; MESBAH, Habiba/0000-0003-1540-6321	French "Programme Hospitalier de Recherche Clinique" (PHRC); Fondation Pierre Deniker; "Unite de Recherche Clinique Intersectorielle en Psychiatrie" du Centre Hospitalier Henri Laborit; Agence Regionale de la Sante de Poitou-Charentes; "bourse chercheur invite", of the Region Poitou-Charentes	French "Programme Hospitalier de Recherche Clinique" (PHRC); Fondation Pierre Deniker; "Unite de Recherche Clinique Intersectorielle en Psychiatrie" du Centre Hospitalier Henri Laborit; Agence Regionale de la Sante de Poitou-Charentes(Region Nouvelle-Aquitaine); "bourse chercheur invite", of the Region Poitou-Charentes(Region Nouvelle-Aquitaine)	This study was supported by a grant from the French "Programme Hospitalier de Recherche Clinique" (PHRC) and by a grant from the "Fondation Pierre Deniker". This study was partially supported by the "Unite de Recherche Clinique Intersectorielle en Psychiatrie" du Centre Hospitalier Henri Laborit, which received financial support from the Agence Regionale de la Sante de Poitou-Charentes. N. Jaafari was supported by the financial support, "bourse chercheur invite", of the Region Poitou-Charentes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aouizerate B, 2004, PROG NEUROBIOL, V72, P195, DOI 10.1016/j.pneurobio.2004.02.004; Aycicegi A, 2003, EUR PSYCHIAT, V18, P241, DOI 10.1016/S0924-9338(03)00065-8; Banich MT, 2009, NEUROSCI BIOBEHAV R, V33, P613, DOI 10.1016/j.neubiorev.2008.09.010; BAXTER LR, 1988, AM J PSYCHIAT, V145, P1560; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Eisen JL, 1998, AM J PSYCHIAT, V155, P102, DOI 10.1176/ajp.155.1.102; First M.B., 2014, STRUCTURED CLIN INTE; FREEDMAN M, 1990, BRAIN COGNITION, V14, P134, DOI 10.1016/0278-2626(90)90025-J; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Goodman W., 1989, ARCH GEN PSYCHIAT, V48, P1006; Guy W, 1976, ECDEU ASSESSMENT MAN; Hesse S, 2011, INT J NEUROPSYCHOPH, V14, P606, DOI 10.1017/S1461145710001604; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kunde W, 2012, ADV COGN PSYCHOL, V8, P9, DOI [10.2478/v10053-008-0097-x, 10.5709/acp-0097-x]; Kwon JS, 2003, PSYCHIAT RES-NEUROIM, V122, P37, DOI 10.1016/S0925-4927(02)00104-X; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Le Jeune F, 2010, BIOL PSYCHIAT, V68, P1016, DOI 10.1016/j.biopsych.2010.06.033; Maffei C, 1997, J PERS DISORD, V11, P279, DOI 10.1521/pedi.1997.11.3.279; Mallet L, 2008, NEW ENGL J MED, V359, P2121, DOI 10.1056/NEJMoa0708514; MARTINOT JL, 1990, ACTA PSYCHIAT SCAND, V82, P233, DOI 10.1111/j.1600-0447.1990.tb03059.x; Mattis S, 1988, DEMENTIA RATING SCAL; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Moncrieff J, 2002, BRIT J PSYCHIAT, V180, P193, DOI 10.1192/bjp.180.3.193; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NORDAHL TE, 1989, NEUROPSYCHOPHARMACOL, V2, P23, DOI 10.1016/0893-133X(89)90003-1; Osterrieth P, 1944, ARCH PSYCHOL, P205; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; PERANI D, 1995, BRIT J PSYCHIAT, V166, P244, DOI 10.1192/bjp.166.2.244; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Reitan R, 1958, PERCEPT MOTOR SKILL, P271; Rey A, 1942, ARCH PSYCHOL, P286; Rieu D, 2006, REV NEUROL-FRANCE, V162, P721, DOI 10.1016/S0035-3787(06)75069-X; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Russell A, 2003, J CHILD ADOL PSYCHOP, V13, pS31, DOI 10.1089/104454603322126322; Sachdev PS, 2005, AUST NZ J PSYCHIAT, V39, P757, DOI 10.1080/j.1440-1614.2005.01680.x; Schwartz JM, 1996, ARCH GEN PSYCHIAT, V53, P109; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P518; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; Wagner S, 2012, ACTA PSYCHIAT SCAND, V125, P281, DOI 10.1111/j.1600-0447.2011.01762.x; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001	49	29	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53241	10.1371/journal.pone.0053241	http://dx.doi.org/10.1371/journal.pone.0053241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326403	gold, Green Submitted, Green Published			2022-12-27	WOS:000314705800039
J	Bhatnagar, A; Unal, H; Jagannathan, R; Kaveti, S; Duan, ZH; Yong, S; Vasanji, A; Kinter, M; Desnoyer, R; Karnik, SS				Bhatnagar, Anushree; Unal, Hamiyet; Jagannathan, Rajaganapathi; Kaveti, Suma; Duan, Zhong-Hui; Yong, Sandro; Vasanji, Amit; Kinter, Michael; Desnoyer, Russell; Karnik, Sadashiva S.			Interaction of G-Protein beta gamma Complex with Chromatin Modulates GPCR-Dependent Gene Regulation	PLOS ONE			English	Article							5-HT2A SEROTONIN RECEPTORS; ANGIOTENSIN-II; STRUCTURAL BASIS; INDUCED HYPERTROPHY; CARDIAC MYOCYTES; SUBUNIT; RECOGNITION; NUCLEUS	Heterotrimeric G-protein signal transduction initiated by G-protein-coupled receptors (GPCRs) in the plasma membrane is thought to propagate through protein-protein interactions of subunits, G alpha and G beta gamma in the cytosol. In this study, we show novel nuclear functions of G beta gamma through demonstrating interaction of G beta(2) with integral components of chromatin and effects of G beta(2) depletion on global gene expression. Agonist activation of several GPCRs including the angiotensin II type 1 receptor specifically augmented G beta(2) levels in the nucleus and G beta(2) interacted with specific nucleosome core histones and transcriptional modulators. Depletion of G beta(2) repressed the basal and angiotensin II-dependent transcriptional activities of myocyte enhancer factor 2. G beta(2) interacted with a sequence motif that was present in several transcription factors, whose genome-wide binding accounted for the G beta(2)-dependent regulation of approximately 2% genes. These findings suggest a wide-ranging mechanism by which direct interaction of G beta gamma with specific chromatin bound transcription factors regulates functional gene networks in response to GPCR activation in cells.	[Bhatnagar, Anushree; Unal, Hamiyet; Jagannathan, Rajaganapathi; Duan, Zhong-Hui; Yong, Sandro; Desnoyer, Russell; Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Kaveti, Suma; Kinter, Michael] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [Vasanji, Amit] Cleveland Clin, Lerner Res Inst, Biomed Imaging & Anal Core, Cleveland, OH 44106 USA; [Duan, Zhong-Hui] Univ Akron, Dept Comp Sci, Akron, OH 44325 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Akron	Karnik, SS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753; Kinter, Michael/0000-0001-7409-8918	National Institutes of Health grants [R01 HL-057470, R01 HL-083243, R21 HL110043, F32 HL088893, T32 HL007914]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL088893, R01HL083243, R01HL057470, T32HL007914, R21HL110043] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants R01 HL-057470, R01 HL-083243, R21 HL110043 (to S.S.K.); F32 HL088893 (to A.B.) and T32 HL007914 (H.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1999, J BIOL CHEM, V274, P16646, DOI 10.1074/jbc.274.23.16646; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bhatnagar A, 2004, J BIOL CHEM, V279, P34614, DOI 10.1074/jbc.M404673200; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Billet S, 2008, KIDNEY INT, V74, P1379, DOI 10.1038/ki.2008.358; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; DeSilva H, 1998, GENETICS, V148, P657; DORING HJ, 1990, PHYSIOL BOHEMOSLOV, V39, P481; DYNLACHT BD, 1993, NATURE, V363, P176, DOI 10.1038/363176a0; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hepler John R, 2005, Sci STKE, V2005, ppe38, DOI 10.1126/stke.2942005pe38; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; KANAYA N, 1998, ANESTHESIOLOGY, V84, P397; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kino T, 2005, J CELL BIOL, V169, P885, DOI 10.1083/jcb.200409150; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lambert NA, 2008, SCI SIGNAL, V1, P1; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Park JG, 1999, EMBO J, V18, P4004, DOI 10.1093/emboj/18.14.4004; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Robitaille M, 2010, CELL SIGNAL, V22, P1254, DOI 10.1016/j.cellsig.2010.04.005; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Spiegelberg BD, 2005, J BIOL CHEM, V280, P41769, DOI 10.1074/jbc.M504066200; Suka N, 2006, NUCLEIC ACIDS RES, V34, P3555, DOI 10.1093/nar/gkl487; Tang WY, 2007, REV ENDOCR METAB DIS, V8, P173, DOI 10.1007/s11154-007-9042-4; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Yong Sandro L., 2006, V129, P127; Zakynthinos E, 2005, ANGIOLOGY, V56, P439, DOI 10.1177/000331970505600412; Zhang QH, 2000, MOL CELL BIOL, V20, P4970, DOI 10.1128/MCB.20.14.4970-4978.2000; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	46	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52689	10.1371/journal.pone.0052689	http://dx.doi.org/10.1371/journal.pone.0052689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326349	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500026
J	Chuang, LC; Kao, CF; Shih, WL; Kuo, PH				Chuang, Li-Chung; Kao, Chung-Feng; Shih, Wei-Liang; Kuo, Po-Hsiu			Pathway Analysis Using Information from Allele-Specific Gene Methylation in Genome-Wide Association Studies for Bipolar Disorder	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; DNA METHYLATION; NEUROTROPHIC-FACTOR; SCHIZOPHRENIA; POLYMORPHISMS; HERITABILITY; VARIANTS; COMPLEX	Bipolar disorder (BPD) is a complex psychiatric trait with high heritability. Despite efforts through conducting genome-wide association (GWA) studies, the success of identifying susceptibility loci for BPD has been limited, which is partially attributed to the complex nature of its pathogenesis. Pathway-based analytic strategy is a powerful tool to explore joint effects of gene sets within specific biological pathways. Additionally, to incorporate other aspects of genomic data into pathway analysis may further enhance our understanding for the underlying mechanisms for BPD. Patterns of DNA methylation play important roles in regulating gene expression and function. A commonly observed phenomenon, allele-specific methylation (ASM) describes the associations between genetic variants and DNA methylation patterns. The present study aimed to identify biological pathways that are involve in the pathogenesis of BPD while incorporating brain specific ASM information in pathway analysis using two large-scale GWA datasets in Caucasian populations. A weighting scheme was adopted to take ASM information into consideration for each pathway. After multiple testing corrections, we identified 88 and 15 enriched pathways for their biological relevance for BPD in the Genetic Association Information Network (GAIN) and the Wellcome Trust Case Control Consortium dataset, respectively. Many of these pathways were significant only when applying the weighting scheme. Three ion channel related pathways were consistently identified in both datasets. Results in the GAIN dataset also suggest for the roles of extracellular matrix in brain for BPD. Findings from Gene Ontology (GO) analysis exhibited functional enrichment among genes of non-GO pathways in activity of gated channel, transporter, and neurotransmitter receptor. We demonstrated that integrating different data sources with pathway analysis provides an avenue to identify promising and novel biological pathways for exploring the underlying molecular mechanisms for bipolar disorder. Further basic research can be conducted to target the biological mechanisms for the identified genes and pathways.	[Chuang, Li-Chung; Kao, Chung-Feng; Shih, Wei-Liang; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Chuang, Li-Chung; Kao, Chung-Feng; Shih, Wei-Liang; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chuang, Li-Chung] Cardinal Tien Coll Healthcare & Management, Dept Nursing, Ilan, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Kuo, PH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan.	phkuo@ntu.edu.tw	Kuo, Po-Hsiu/H-9882-2013	SHIH, WEI-LIANG/0000-0002-4160-7541; Kuo, Po-Hsiu/0000-0003-0365-3587	National Science Council [NSC 99-2314-B-002-140-MY3]; National Health Research Institute [NHRI-EX99-9918NC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This research was supported by National Science Council (NSC 99-2314-B-002-140-MY3) and National Health Research Institute (NHRI-EX99-9918NC) grants to Dr. P-H Kuo (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askland K, 2009, HUM GENET, V125, P63, DOI 10.1007/s00439-008-0600-y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Deng GF, 2011, J MOL NEUROSCI, V44, P115, DOI 10.1007/s12031-011-9492-8; Drago A, 2011, AM J MED GENET B, V156B, P975, DOI 10.1002/ajmg.b.31245; Edvardsen J, 2008, J AFFECT DISORDERS, V106, P229, DOI 10.1016/j.jad.2007.07.001; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grube S, 2011, EMBO MOL MED, V3, P309, DOI 10.1002/emmm.201100135; Hartz SM, 2011, PSYCHIAT GENET, V21, P77, DOI 10.1097/YPG.0b013e32834135eb; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kao CF, 2012, INT J NEUROPSYCHOPH, P1; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lydall GJ, 2011, PSYCHIAT GENET, V21, P294, DOI 10.1097/YPG.0b013e32834915c2; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Saito A, 2007, NEUROSCI LETT, V411, P168, DOI 10.1016/j.neulet.2006.08.042; SANES JR, 1983, ANNU REV PHYSIOL, V45, P581, DOI 10.1146/annurev.ph.45.030183.003053; Sarras H, 2010, SCHIZOPHR RES, V120, P236, DOI 10.1016/j.schres.2010.03.002; Saus E, 2010, J PSYCHIATR RES, V44, P971, DOI 10.1016/j.jpsychires.2010.03.007; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Squassina A, 2011, PHARMACOGENOMICS, V12, P1559, DOI [10.2217/PGS.11.102, 10.2217/pgs.11.102]; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui L, 2012, NEUROBIOL LEARN MEM, V97, P425, DOI 10.1016/j.nlm.2012.03.007; Tintle Nathan L, 2009, BMC Proc, V3 Suppl 7, pS96; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Xu Z, 2012, J PSYCHOPHARMACOL, V26, P349, DOI 10.1177/0269881111414452; Yang W, 2011, EUR J HUM GENET, V19, P893, DOI 10.1038/ejhg.2011.46; Zaykin DV, 2007, PHARM STAT, V6, P217, DOI 10.1002/pst.304; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	50	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53092	10.1371/journal.pone.0053092	http://dx.doi.org/10.1371/journal.pone.0053092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326387	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500049
J	Glaumann, S; Nopp, A; Johansson, SGO; Borres, MP; Nilsson, C				Glaumann, Susanne; Nopp, Anna; Johansson, S. G. O.; Borres, Magnus P.; Nilsson, Caroline			Oral Peanut Challenge Identifies an Allergy but the Peanut Allergen Threshold Sensitivity Is Not Reproducible	PLOS ONE			English	Article							CONTROLLED FOOD CHALLENGES; QUALITY-OF-LIFE; DOUBLE-BLIND; RECOMBINANT ALLERGENS; BASOPHIL ACTIVATION; IGE-SENSITIZATION; COWS MILK; CD-SENS; CHILDREN; DIAGNOSIS	Background: Double-blind placebo-controlled food challenge, DBPCFC, the gold standard for diagnosing food allergy, is time-consuming and potentially dangerous. A basophil allergen threshold sensitivity test, CD-sens, has shown promising results as a diagnostic tool in food allergy. Objectives: To evaluate the reproducibility of oral peanut challenge and compare the outcome to CD-sens in peanut-sensitized children. Methods: Twenty-seven children (4-19 years) underwent a DBPCFC followed by a single-blind oral food-challenge. The peanut challenges (1 mg to 5 g) were evaluated by severity scoring. Blood samples were drawn for CD-sens before the two first challenges. Results: Thirteen children (48%) did not react at any of the challenges. Fourteen reacted at both peanut challenges but not to placebo. Only two of these children reacted at the same threshold dose and with the same severity score. All other children scored differently or reacted at different doses. For children with a positive challenge the geometric mean of the ratio of the doses was 1.834 (p = 0.307) and the arithmetic mean of the difference between the severity scores was 0.143 (p = 0.952). No association was obtained between the two peanut challenges regarding severity score (r(s) = 0.11, p = 0.71) or threshold dose (r(s) = 0.35, p = 0.22). Among the children positive in peanut challenge, 12 were positive in CD-sens. Two were low-responders and could not be evaluated. Geometric mean of the ratio of CD-sens values in children with a positive challenge was 1.035 (p = 0.505) but unlike for the severity score and the threshold dose the association between the two CD-sens values was strong (r(s) = 0.94, P<0.001). Conclusions: For a positive/negative test the reproducibility is 100% for both peanut challenge and CD-sens. However, a comparison of the degree of allergen threshold sensitivity between the two tests is not possible since the threshold dose and severity scoring is not reproducible.	[Glaumann, Susanne; Nilsson, Caroline] Karolinska Inst, Ctr Allergy Res, Dept Clin Sci & Educ, Stockholm, Sweden; [Glaumann, Susanne; Nilsson, Caroline] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden; [Nopp, Anna; Johansson, S. G. O.] Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden; [Borres, Magnus P.] Thermo Fisher Sci, Uppsala, Sweden; [Borres, Magnus P.] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Thermo Fisher Scientific; University of Gothenburg	Glaumann, S (corresponding author), Karolinska Inst, Ctr Allergy Res, Dept Clin Sci & Educ, Stockholm, Sweden.	susanne.glaumann@sodersjukhuset.se	Nilsson, Caroline/AFK-2402-2022; Nilsson, Caroline/AAF-9663-2022	Nopp, Anna/0000-0003-1389-8676	Foundation ''Mjolkdroppen'', Sweden; Swedish Asthma and Allergy Associations Research Foundation, Sweden; Centre for Allergy Research, Karolinska Institutet, Sweden; Hesselman Foundation, Sweden; Foundation "Samariten'', Sweden; Princess Lovisa's Association for Childrens Medical Care, Sweden	Foundation ''Mjolkdroppen'', Sweden; Swedish Asthma and Allergy Associations Research Foundation, Sweden; Centre for Allergy Research, Karolinska Institutet, Sweden; Hesselman Foundation, Sweden; Foundation "Samariten'', Sweden; Princess Lovisa's Association for Childrens Medical Care, Sweden	This work was supported in part by the Foundation ''Mjolkdroppen'', Sweden; Swedish Asthma and Allergy Associations Research Foundation, Sweden; Centre for Allergy Research, Karolinska Institutet, Sweden; Hesselman Foundation, Sweden; Foundation "Samariten'', Sweden and Princess Lovisa's Association for Childrens Medical Care, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assa'ad AH, 2012, ANN ALLERG ASTHMA IM, V108, P289, DOI 10.1016/j.anai.2012.03.014; Astier C, 2006, J ALLERGY CLIN IMMUN, V118, P250, DOI 10.1016/j.jaci.2006.04.053; BOCK SA, 1988, J ALLERGY CLIN IMMUN, V82, P986; Bock SA, 2000, J PEDIATR GASTR NUTR, V30, pS20, DOI 10.1097/00005176-200001001-00004; Chafen JJS, 2010, JAMA-J AM MED ASSOC, V303, P1848, DOI 10.1001/jama.2010.582; Codreanu F, 2011, INT ARCH ALLERGY IMM, V154, P216, DOI 10.1159/000321108; Cummings AJ, 2010, PEDIAT ALLERG IMM-UK, V21, P586, DOI 10.1111/j.1399-3038.2009.00975.x; Dahlen B, 2011, CLIN EXP ALLERGY, V41, P1091, DOI 10.1111/j.1365-2222.2011.03763.x; Eller E, 2012, ANN ALLERG ASTHMA IM, V108, P332, DOI 10.1016/j.anai.2012.03.010; Flinterman AE, 2006, J ALLERGY CLIN IMMUN, V117, P448, DOI 10.1016/j.jaci.2005.11.035; Gellerstedt M, 2007, J INVEST ALLERG CLIN, V17, P350; Glaumann S, 2012, ALLERGY, V67, P242, DOI 10.1111/j.1398-9995.2011.02754.x; Hourihane JO, 2005, CLIN EXP ALLERGY, V35, P1227, DOI 10.1111/j.1365-2222.2005.02312.x; Johansson SGO, 2005, ALLERGY, V60, P1192, DOI 10.1111/j.1398-9995.2005.00870.x; Lieberman JA, 2011, CURR ALLERGY ASTHM R, V11, P58, DOI 10.1007/s11882-010-0149-4; Niggemann B, 2010, ALLERGY, V65, P2, DOI 10.1111/j.1398-9995.2009.02170.x; Nopp A, 2006, ALLERGY, V61, P298, DOI 10.1111/j.1398-9995.2006.00987.x; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Ostblom E, 2008, ALLERGY, V63, P211, DOI 10.1111/j.1398-9995.2007.01559.x; Rubio A, 2011, ALLERGY, V66, P92, DOI 10.1111/j.1398-9995.2010.02432.x; Sabato V, 2011, J INVEST ALLERG CLIN, V21, P179; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Shreffler WG, 2006, CURR OPIN ALLERGY CL, V6, P226, DOI 10.1097/01.all.0000225165.83144.2f; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; van der Zee T, 2011, J ALLERGY CLIN IMMUN, V128, P1031, DOI 10.1016/j.jaci.2011.07.050; van Odijk J, 2005, ALLERGY, V60, P602, DOI 10.1111/j.1398-9995.2005.00666.x; Vlieg-Boerstra BJ, 2007, ALLERGY, V62, P905, DOI 10.1111/j.1398-9995.2007.01430.x	28	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53465	10.1371/journal.pone.0053465	http://dx.doi.org/10.1371/journal.pone.0053465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326435	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500075
J	Staines, K; Young, JR; Butter, C				Staines, Karen; Young, John R.; Butter, Colin			Expression of Chicken DEC205 Reflects the Unique Structure and Function of the Avian Immune System	PLOS ONE			English	Article							ANTIVIMENTIN MONOCLONAL-ANTIBODY; MACROPHAGE MANNOSE RECEPTOR; SOMATIC MAMMALIAN CELLS; DENDRITIC CELLS; T-CELLS; EPITHELIAL-CELLS; B-CELLS; FABRICIUS; DEC-205; BURSA	The generation of appropriate adaptive immune responses relies critically on dendritic cells, about which relatively little is known in chickens, a vital livestock species, in comparison with man and mouse. We cloned and sequenced chicken DEC205 cDNA and used this knowledge to produce quantitative PCR assays and monoclonal antibodies to study expression of DEC205 as well as CD83. The gene structure of DEC205 was identical to those of other species. Transcripts of both genes were found at higher levels in lymphoid tissues and the expression of DEC205 in normal birds had a characteristic distribution in the primary lymphoid organs. In spleen, DEC205 was seen on cells ideally located to trap antigen. In thymus it was found on cells thought to participate in the education of T cells, and in the bursa on cells that may be involved in presentation of antigen to B cells and regulation of B cell migration. The expression of DEC205 on cells other than antigen presenting cells (APC) is also described. Isolated splenocytes strongly expressing DEC205 but not the KUL01 antigen have morphology similar to mammalian dendritic cells and the distinct expression of DEC205 within the avian-specific Bursa of Fabricius alludes to a unique function in this organ of B cell diversification.	[Staines, Karen; Young, John R.; Butter, Colin] Pirbright Inst, Compton Lab, Avian Viral Dis Programme, Newbury, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Butter, C (corresponding author), Pirbright Inst, Compton Lab, Avian Viral Dis Programme, Newbury, Berks, England.	colin.butter@avianimmunology.org			BBSRC (Biotechnology and Biological Sciences Research Council) as part of the Institute Strategic Programme Grant [BBS/E/I/00001423]; BBSRC [BBS/E/I/00001423] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001423] Funding Source: researchfish	BBSRC (Biotechnology and Biological Sciences Research Council) as part of the Institute Strategic Programme Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC (Biotechnology and Biological Sciences Research Council) under grant number BBS/E/I/00001423 as part of the Institute Strategic Programme Grant to the Avian Viral Diseases Programme at the IAH (Institute for Animal Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Baaten BJG, 2009, VIRAL IMMUNOL, V22, P431, DOI 10.1089/vim.2009.0047; Balfour B M, 1981, Ciba Found Symp, V84, P281; Betts M. J., 2003, BIOINFORMATICS GENET, DOI 10.1002/0470867302.ch14; BIGGS P. M., 1957, ACTA ANAT, V29, P36; Butter C, 2007, AVIAN PATHOL, V36, P93, DOI 10.1080/03079450601156075; Cheong C, 2010, BLOOD, V116, P3828, DOI 10.1182/blood-2010-06-288068; DELCACHO E, 1995, ANAT REC, V241, P105, DOI 10.1002/ar.1092410114; Flores-Mendoza L, 2010, DEV COMP IMMUNOL, V34, P715, DOI 10.1016/j.dci.2010.02.010; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; GLICK B, 1993, POULTRY SCI, V72, P1262, DOI 10.3382/ps.0721262; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gross GM, 1988, AVIAN LYMPHATIC SYST; Hansell C, 2007, J IMMUNOL, V179, P5117, DOI 10.4049/jimmunol.179.8.5117; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; JEURISSEN SHM, 1991, RES IMMUNOL, V142, P352, DOI 10.1016/0923-2494(91)90090-6; JEURISSEN SHM, 1992, IMMUNOLOGY, V77, P75; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; KAO FT, 1968, P NATL ACAD SCI USA, V60, P1275, DOI 10.1073/pnas.60.4.1275; Kaspers B, 2008, AVIAN IMMUNOLOGY, P183, DOI 10.1016/B978-012370634-8.50012-3; Kato M, 2006, INT IMMUNOL, V18, P857, DOI 10.1093/intimm/dxl022; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; KRUISBEEK AM, 1984, J EXP MED, V160, P839, DOI 10.1084/jem.160.3.839; LASSILA O, 1989, EUR J IMMUNOL, V19, P955, DOI 10.1002/eji.1830190527; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Mahnke K, 2003, TRENDS IMMUNOL, V24, P646, DOI 10.1016/j.it.2003.09.012; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; MOTYKA B, 1991, EUR J IMMUNOL, V21, P1951, DOI 10.1002/eji.1830210825; OLAH I, 1982, AM J ANAT, V165, P445, DOI 10.1002/aja.1001650408; OLAH I, 1979, DEV COMP IMMUNOL, V3, P101, DOI 10.1016/S0145-305X(79)80010-5; OLAH I, 1992, ANAT RECORD, V232, P121, DOI 10.1002/ar.1092320113; OLAH I, 1978, EXPERIENTIA, V34, P1642, DOI 10.1007/BF02034727; OLAH I, 1992, ANAT RECORD, V233, P111, DOI 10.1002/ar.1092330115; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Small M, 2003, INT IMMUNOL, V15, P197, DOI 10.1093/intimm/dxg024; Snell D, 2000, CELL SURFACE MOL DEV; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; SWIGGARD WJ, 1995, CELL IMMUNOL, V165, P302, DOI 10.1006/cimm.1995.1218; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Tregaskes CA, 1996, IMMUNOGENETICS, V44, P212, DOI 10.1007/BF02602587; Tregaskes CA, 2005, DEV COMP IMMUNOL, V29, P361, DOI 10.1016/j.dci.2004.09.001; VANDEWATER J, 1990, CLIN IMMUNOL IMMUNOP, V56, P169, DOI 10.1016/0090-1229(90)90139-H; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; White R. G., 1981, Avian immunology. Proceedings of the 16th Poultry Science Symposium, P21; Wu ZG, 2011, IMMUNOBIOLOGY, V216, P1177, DOI 10.1016/j.imbio.2011.05.012; Wu ZG, 2011, DEV COMP IMMUNOL, V35, P563, DOI 10.1016/j.dci.2010.12.015; Wu ZG, 2010, DEV COMP IMMUNOL, V34, P183, DOI 10.1016/j.dci.2009.09.007; Wu ZG, 2010, IMMUNOLOGY, V129, P133, DOI 10.1111/j.1365-2567.2009.03129.x; YOUNG JR, 1994, J IMMUNOL, V152, P3848; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	54	30	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e51799	10.1371/journal.pone.0051799	http://dx.doi.org/10.1371/journal.pone.0051799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326318	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000313551500008
J	Vainio, L; Schulman, M; Tiippana, K; Vainio, M				Vainio, Lari; Schulman, Mirjam; Tiippana, Kaisa; Vainio, Martti			Effect of Syllable Articulation on Precision and Power Grip Performance	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; ACTION RECOGNITION; VISUAL OBJECT; AREA F5; LANGUAGE; MONKEY; GRASP; FMRI; REPRESENTATION; MOVEMENTS	The present study was motivated by a theory, which proposes that speech includes articulatory gestures that are connected to particular hand actions. We hypothesized that certain articulatory gestures would be more associated with the precision grip than with the power grip, and vice versa. In the study, the participants pronounced a syllable and performed simultaneously a precision or power grip that was theorized to be either congruent or incongruent with the syllable. Relatively fast precision grip responses were associated with articulatory gestures in which the tip of the tongue contacted the alveolar ridge ([te]) or the aperture of the vocal tract remained small ([hi]), as well as gestures that required lip protrusion ([pu]). In contrast, relatively fast power grip responses were associated with gestures that were produced by moving the back of the tongue against the velum ([ke]) or in which the aperture of the vocal tract remained large ([h alpha]). In addition to demonstrating that certain articulatory gestures are systematically connected to different grip types, the study may shed some light on discussion concerning sound symbolism and evolution of speech.	[Vainio, Lari; Schulman, Mirjam; Tiippana, Kaisa] Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland; [Vainio, Martti] Univ Helsinki, Inst Behav Sci, Phonet & Speech Synth Res Grp, Helsinki, Finland	University of Helsinki; University of Helsinki	Vainio, L (corresponding author), Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland.	lari.vainio@helsinki.fi	Tiippana, Kaisa/AFQ-7636-2022	Tiippana, Kaisa/0000-0002-2305-8104; Vainio, Martti/0000-0003-2570-0196; Vainio, Lari/0000-0001-7754-9745				Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Armstrong AC, 1995, GESTURE AND THE NATU; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Corballis MC, 2002, HAND MOUTH ORIGINS L; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; de Saussure F., 1916, COURS LINGUISTIQUE G; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Ellis R, 2007, J EXP PSYCHOL HUMAN, V33, P670, DOI 10.1037/0096-1523.33.3.670; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gentilucci M, 2003, EUR J NEUROSCI, V17, P179, DOI 10.1046/j.1460-9568.2003.02438.x; Gentilucci M, 1998, EUR J NEUROSCI, V10, P752, DOI 10.1046/j.1460-9568.1998.00060.x; Gentilucci M, 2001, J NEUROPHYSIOLOGY, V86, P1885; Gentilucci M., 1990, VISION ACTION CONTRO, P147; Gentilucci M, 2008, J PHYSIOL-PARIS, V102, P21, DOI 10.1016/j.jphysparis.2008.03.002; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Gentilucci M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019793; Glover S, 2002, EXP BRAIN RES, V146, P383, DOI 10.1007/s00221-002-1222-6; Graziano MSA, 2007, NEURON, V56, P239, DOI 10.1016/j.neuron.2007.09.013; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Halverson HM, 1931, GENET PSYCHOL MONOGR, V10, P107; Hamzei F, 2003, NEUROIMAGE, V19, P637, DOI 10.1016/S1053-8119(03)00087-9; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Higginbotham DR, 2008, EXP BRAIN RES, V186, P603, DOI 10.1007/s00221-007-1265-9; JOHANNESSON A, 1950, NATURE, V166, P60, DOI 10.1038/166060a0; Kohler W., 1929, GESTALT PSYCHOL; Kroliczak G, 2011, NEUROPSYCHOLOGIA, V49, P1698, DOI 10.1016/j.neuropsychologia.2011.02.044; Ku┬hler W., 1947, GESTALT PSYCHOL; Lindemann O, 2007, J EXP PSYCHOL HUMAN, V33, P1400, DOI 10.1037/0096-1523.33.6.1400; Maestripieri D, 1996, INT J PRIMATOL, V17, P785, DOI 10.1007/BF02735264; McNeill D., 1992, HAND MIND WHAT HANDS; Moretto G, 2008, EXP BRAIN RES, V188, P505, DOI 10.1007/s00221-008-1386-9; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Paget R, 1930, HUMAN SPEECH; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791; Peters R. A, 1968, LINGUISTIC HIST ENGL; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Rizzolatti G., 1988, NEUROBIOLOGY NEOCORT, P269; Sapir E, 1929, J EXP PSYCHOL, V12, P239; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Tanaka S, 2002, NEUROREPORT, V13, P1599, DOI 10.1097/00001756-200209160-00005; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Vainio L, 2007, BRAIN COGNITION, V65, P195, DOI 10.1016/j.bandc.2007.07.004; van Hooff J.A.R.A.M., 1967, PRIMATE ETHOLOGY, P1; Vingerhoets G., CORTEX IN PRESS; Wallace AR, 1881, NATURE, V24, P242; Waters GS, 2002, NEUROL RES, V24, P174, DOI 10.1179/016164102101199585; Westbury C, 2005, BRAIN LANG, V93, P10, DOI 10.1016/j.bandl.2004.07.006	61	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53061	10.1371/journal.pone.0053061	http://dx.doi.org/10.1371/journal.pone.0053061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326381	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500047
J	Dumurgier, J; Mouton-Liger, F; Lapalus, P; Prevot, M; Laplanche, JL; Hugon, J; Paquet, C				Dumurgier, Julien; Mouton-Liger, Francois; Lapalus, Pauline; Prevot, Magali; Laplanche, Jean-Louis; Hugon, Jacques; Paquet, Claire		Grp Invest Liquide Cephalorachidie	Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer's Disease	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CSF BIOMARKERS PREDICT; PHOSPHORYLATION; ASSOCIATION; PROGRESSION; ACTIVATION	The cerebrospinal fluid (CSF) levels of the proapoptotic kinase R (PKR) and its phosphorylated PKR (pPKR) are increased in Alzheimer's disease (AD), but whether CSF PKR concentrations are associated with cognitive decline in AD patients remain unknown. In this study, 41 consecutive patients with AD and 11 patients with amnestic mild cognitive impairment (aMCI) from our Memory Clinic were included. A lumbar puncture was performed during the following month of the clinical diagnosis and Mini-Mental State Examination (MMSE) evaluations were repeated every 6 months during a mean follow-up of 2 years. In AD patients, linear mixed models adjusted for age and sex were used to assess the cross-sectional and longitudinal associations between MMSE scores and baseline CSF levels of A beta peptide (A beta 1-42), Tau, phosphorylated Tau (p-Tau 181), PKR and pPKR. The mean (SD) MMSE at baseline was 20.5 (6.1) and MMSE scores declined over the follow-up (-0.12 point/month, standard error [SE] = 0.03). A lower MMSE at baseline was associated with lower levels of CSF A beta 1-42 and p-Tau 181/Tau ratio. pPKR level was associated with longitudinal MMSE changes over the follow-up, higher pPKR levels being related with an exacerbated cognitive deterioration. Other CSF biomarkers were not associated with MMSE changes over time. In aMCI patients, mean CSF biomarker levels were not different in patients who converted to AD from those who did not convert. These results suggest that at the time of AD diagnosis, a higher level of CSF pPKR can predict a faster rate of cognitive decline.	[Dumurgier, Julien; Lapalus, Pauline; Prevot, Magali; Hugon, Jacques; Paquet, Claire] Univ Paris Diderot, Paris Nord Ile France St Louis Lariboisiere Ferna, AP HP, Clin & Res Memory Ctr, Paris, France; [Dumurgier, Julien; Mouton-Liger, Francois; Hugon, Jacques; Paquet, Claire] Inserm, UMR S 839, Inst Fer Moulin, Paris, France; [Laplanche, Jean-Louis] Univ Paris Diderot, St Louis Lariboisiere Fernand Hosp, AP HP, Dept Biochem, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Hugon, J (corresponding author), Univ Paris Diderot, Paris Nord Ile France St Louis Lariboisiere Ferna, AP HP, Clin & Res Memory Ctr, Paris, France.	jacques.hugon@lrb.aphp.fr	LAPLANCHE, Jean-Louis/S-8707-2016; Dumurgier, Julien/G-2400-2017; Peoc'h, Katell/V-1604-2017; Mouton-Liger, Francois/A-3234-2016	Dumurgier, Julien/0000-0003-2070-9706; Peoc'h, Katell/0000-0002-8203-1243; Mouton-Liger, Francois/0000-0001-8172-6548; LAPLANCHE, Jean-Louis/0000-0003-2836-2903	Assistance publique hopitaux de Paris and Inserm	Assistance publique hopitaux de Paris and Inserm	This study was supported by Assistance publique hopitaux de Paris and Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bose A, 2011, BRAIN PATHOL, V21, P189, DOI 10.1111/j.1750-3639.2010.00437.x; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158; Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x; Chui HC, 2006, ANN NEUROL, V60, P677, DOI 10.1002/ana.21009; Dumurgier J, 2010, NEUROBIOL DIS, V40, P456, DOI 10.1016/j.nbd.2010.07.007; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Fjell AM, 2010, J NEUROSCI, V30, P2088, DOI 10.1523/JNEUROSCI.3785-09.2010; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Henneman WJP, 2009, NEUROLOGY, V73, P935, DOI 10.1212/WNL.0b013e3181b879ac; Hugon J, 2009, EXPERT REV NEUROTHER, V9, P1455, DOI [10.1586/ern.09.92, 10.1586/ERN.09.92]; Ill-Raga G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021456; Ito K, 2010, ALZHEIMERS DEMENT, V6, P39, DOI 10.1016/j.jalz.2009.05.665; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Kester MI, 2009, NEUROLOGY, V73, P1353, DOI 10.1212/WNL.0b013e3181bd8271; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; Mouton-Liger F, 2012, BIOL PSYCHIAT, V71, P829, DOI 10.1016/j.biopsych.2011.11.031; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Seppala TT, 2012, NEUROLOGY, V78, P1568, DOI 10.1212/WNL.0b013e3182563bd0; Tapiola T, 2000, NEUROBIOL AGING, V21, P735, DOI 10.1016/S0197-4580(00)00164-0; Tarawneh R, 2012, NEUROLOGY, V78, P709, DOI 10.1212/WNL.0b013e318248e568; Tarawneh R, 2011, ANN NEUROL, V70, P274, DOI 10.1002/ana.22448; Vemuri P, 2010, ANN NEUROL, V67, P308, DOI 10.1002/ana.21953; Wallin AK, 2010, NEUROLOGY, V74, P1531, DOI 10.1212/WNL.0b013e3181dd4dd8; Wang L, 2011, ALZHEIMER DIS ASS DI; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000	27	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53587	10.1371/journal.pone.0053587	http://dx.doi.org/10.1371/journal.pone.0053587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320095	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800060
J	Teixido, C; Mares, R; Aracil, M; Cajal, SRY; Hernandez-Losa, J				Teixido, Cristina; Mares, Roso; Aracil, Miguel; Ramon y Cajal, Santiago; Hernandez-Losa, Javier			Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines	PLOS ONE			English	Article							KAHALALIDE-F; E-CADHERIN; TUMOR PROGRESSION; STRUCTURAL BASIS; PROSTATE-CANCER; ERBB3; ADHESION; MECHANISM; COMPOUND; PM02734	Elisidepsin (elisidepsin trifluoroacetate, Irvalec(R), PM02734) is a new synthetic depsipeptide, a result of the PharmaMar Development Program that seeks synthetic products of marine origin-derived compounds. Elisidepsin is a drug with antiproliferative activity in a wide range of tumors. In the present work we studied and characterized the mechanisms associated with sensitivity and resistance to elisidepsin treatment in a broad panel of tumor cell lines from breast and pancreas carcinomas, focusing on different factors involved in epithelial-mesenchymal transition (EMT) and the use of HER family receptors in predicting the in vitro drug response. Interestingly, we observed that the basal protein expression levels of EMT markers show a significant correlation with cell viability in response to elisidepsin treatment in a panel of 12 different breast and pancreatic cancer cell lines. In addition, we generated three elisidepsin treatment-resistant cell lines (MCF-7, HPAC and AsPC-1) and analyzed the pattern of expression of different EMT markers in these cells, confirming that acquired resistance to elisidepsin is associated with a switch to the EMT state. Furthermore, a direct correlation between basal HER3 expression and sensitivity to elisidepsin was observed; moreover, modulation of HER3 expression levels in different cancer cell lines alter their sensitivities to the drug, making them more resistant when HER3 expression is downregulated by a HER3-specific short hairpin RNA and more sensitive when the receptor is overexpressed. These results show that HER3 expression is an important marker of sensitivity to elisidepsin treatment.	[Teixido, Cristina; Mares, Roso] Univ Autonoma Barcelona, Vall Hebron Univ Inst, Mol Pathol Grp, E-08193 Barcelona, Spain; [Aracil, Miguel] Pharmamar, Madrid, Spain; [Ramon y Cajal, Santiago; Hernandez-Losa, Javier] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Dept Pathol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; PharmaMar; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Hernandez-Losa, J (corresponding author), Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Dept Pathol, E-08193 Barcelona, Spain.	jahernan@vhebron.net	Javier, Hernandez Losa/C-1173-2008; Ramon y Cajal, Santiago/H-4955-2016; Teixido, Cristina/I-4505-2019	Javier, Hernandez Losa/0000-0003-1526-3201; Ramon y Cajal, Santiago/0000-0002-3867-1390; Teixido, Cristina/0000-0002-7226-6567; mares, Roso/0000-0002-7339-0172	Pharmamar Company; CENIT [CEN-2009-1016]	Pharmamar Company; CENIT	This work has been partially funded by Pharmamar Company and by CENIT grant (CEN-2009-1016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; CIARDIELLO F, 1991, P NATL ACAD SCI USA, V88, P7792, DOI 10.1073/pnas.88.17.7792; Friess H, 1995, CLIN CANCER RES, V1, P1413; GarciaRocha M, 1996, CANCER LETT, V99, P43, DOI 10.1016/0304-3835(95)04036-6; Gomez SG, 2003, EXP HEMATOL, V31, P1104, DOI 10.1016/j.exphem.2003.07.004; Hama H, 2000, FEBS LETT, V478, P26, DOI 10.1016/S0014-5793(00)01821-4; Hamann MT, 1996, J ORG CHEM, V61, P6594, DOI 10.1021/jo960877+; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Herrero AB, 2008, CANCER RES, V68, P9779, DOI 10.1158/0008-5472.CAN-08-1981; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Janmaat ML, 2005, MOL PHARMACOL, V68, P502, DOI 10.1124/mol.105.011361; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; Kountourakis P, 2006, CANCER J, V12, P229, DOI 10.1097/00130404-200605000-00012; LEMOINE NR, 1992, BRIT J CANCER, V66, P1116, DOI 10.1038/bjc.1992.420; Ling YH, 2009, EUR J CANCER, V45, P1855, DOI 10.1016/j.ejca.2009.03.003; Lozano JJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-109; Molina-Guijarro JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019042; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Naidu R, 1998, BRIT J CANCER, V78, P1385, DOI 10.1038/bjc.1998.689; NYHOLM PG, 1990, CHEM PHYS LIPIDS, V52, P1, DOI 10.1016/0009-3084(90)90002-9; PATEL DJ, 1995, NATURE, V374, P306, DOI 10.1038/374306a0; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Sewell JM, 2005, EUR J CANCER, V41, P1637, DOI 10.1016/j.ejca.2005.04.015; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shilabin AG, 2007, J MED CHEM, V50, P4340, DOI 10.1021/jm061288r; Suarez Y, 2003, MOL CANCER THER, V2, P863; Tanner B, 2006, J CLIN ONCOL, V24, P4317, DOI 10.1200/JCO.2005.04.8397; Teixido C, 2012, INT J ONCOL; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Varadi T, 2011, EUR J PHARMACOL, V667, P91, DOI 10.1016/j.ejphar.2011.05.064; Wosikowski K, 1997, JNCI-J NATL CANCER I, V89, P1505, DOI 10.1093/jnci/89.20.1505; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545	41	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53645	10.1371/journal.pone.0053645	http://dx.doi.org/10.1371/journal.pone.0053645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320098	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800063
J	Zhou, D; Li, ST; Zhang, XH; Cai, D				Zhou, Douglas; Li, Songting; Zhang, Xiao-hui; Cai, David			Phenomenological Incorporation of Nonlinear Dendritic Integration Using Integrate-and-Fire Neuronal Frameworks	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; SHUNTING INHIBITION; SUPRALINEAR SUMMATION; SPIKING NEURONS; MODEL; CORTEX; CELLS; OSCILLATIONS; POTENTIALS; EXCITATION	It has been discovered recently in experiments that the dendritic integration of excitatory glutamatergic inputs and inhibitory GABAergic inputs in hippocampus CA1 pyramidal neurons obeys a simple arithmetic rule as V-S(Exp) approximate to V-E(Exp) + V-I(Exp) + kV(E)(Exp) V-I(Exp), where V-S(Exp), V-E(Exp) and V-I(Exp) are the respective voltage values of the summed somatic potential, the excitatory postsynaptic potential (EPSP) and the inhibitory postsynaptic potential measured at the time when the EPSP reaches its peak value. Moreover, the shunting coefficient k in this rule only depends on the spatial location but not the amplitude of the excitatory or inhibitory input on the dendrite. In this work, we address the theoretical issue of how much the above dendritic integration rule can be accounted for using subthreshold membrane potential dynamics in the soma as characterized by the conductance-based integrate-and-fire (I&F) model. Then, we propose a simple I&F neuron model that incorporates the spatial dependence of the shunting coefficient k by a phenomenological parametrization. Our analytical and numerical results show that this dendritic-integration-rule-based I&F (DIF) model is able to capture many experimental observations and it also yields predictions that can be used to verify the validity of the DIF model experimentally. In addition, the DIF model incorporates the dendritic integration effects dynamically and is applicable to more general situations than those in experiments in which excitatory and inhibitory inputs occur simultaneously in time. Finally, we generalize the DIF neuronal model to incorporate multiple inputs and obtain a similar dendritic integration rule that is consistent with the results obtained by using a realistic neuronal model with multiple compartments. This generalized DIF model can potentially be used to study network dynamics that may involve effects arising from dendritic integrations.	[Zhou, Douglas; Li, Songting; Cai, David] Shanghai Jiao Tong Univ, Dept Math, MOE LSC, Shanghai 200030, Peoples R China; [Zhou, Douglas; Li, Songting; Cai, David] Shanghai Jiao Tong Univ, Inst Nat Sci, Shanghai 200030, Peoples R China; [Zhang, Xiao-hui] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Zhang, Xiao-hui] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China; [Cai, David] NYU, Courant Inst Math Sci, New York, NY USA; [Cai, David] NYU, Ctr Neural Sci, New York, NY 10003 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; New York University; New York University	Cai, D (corresponding author), Shanghai Jiao Tong Univ, Dept Math, MOE LSC, Shanghai 200030, Peoples R China.	sdcai@sjtu.edu.cn	Zhou, Douglas/E-5428-2019	Zhou, Douglas/0000-0001-6631-2961	Shanghai Pujiang Program [10PJ1406300]; NSFC [11101275]; 973 Program [2011CBA00403]; SA-SIBS Scholarship Program; NSF [DMS-1009575]; Shanghai Jiao Tong University	Shanghai Pujiang Program(Shanghai Pujiang Program); NSFC(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); SA-SIBS Scholarship Program; NSF(National Science Foundation (NSF)); Shanghai Jiao Tong University	This work was supported by Shanghai Pujiang Program (Grant No. 10PJ1406300), NSFC (Grant No. 11101275), 973 Program (2011CBA00403) and the SA-SIBS Scholarship Program, NSF grant DMS-1009575, an R&D Grant from Shanghai Jiao Tong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel M, 2005, J NEUROPHYSIOL, V93, P1959, DOI 10.1152/jn.00214.2004; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Badel L, 2008, BIOL CYBERN, V99, P361, DOI 10.1007/s00422-008-0259-4; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BURKE RE, 1967, J NEUROPHYSIOL, V30, P1114, DOI 10.1152/jn.1967.30.5.1114; Carandini M, 1996, J NEUROPHYSIOL, V76, P3425, DOI 10.1152/jn.1996.76.5.3425; Carnevale NT, 2006, NEURON BOOK; Cash S, 1998, J NEUROSCI, V18, P10; Chacron MJ, 2006, J NEUROPHYSIOL, V95, P2933, DOI 10.1152/jn.01296.2005; David F, 2008, J COMPUT NEUROSCI, V25, P25, DOI 10.1007/s10827-007-0063-5; Dayan P, 2001, COMPUTATIONAL NEUROS; Feng HF, 2001, NEURAL NETWORKS, V14, P955, DOI 10.1016/S0893-6080(01)00074-0; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Hao J, 2009, P NATL ACAD SCI USA, V106, P21906, DOI 10.1073/pnas.0912022106; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Koch C, 2005, BIOPHYSICS COMPUTATI; KUNO M, 1969, J PHYSIOL-LONDON, V201, P465, DOI 10.1113/jphysiol.1969.sp008767; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Rall W., 1995, THEORETICAL FDN DEND; Rall W, 1964, NEURAL THEORY MODELI, P122; ROSE RM, 1989, PROC R SOC SER B-BIO, V237, P267, DOI 10.1098/rspb.1989.0049; Schwindt PC, 1998, J NEUROPHYSIOL, V79, P2432, DOI 10.1152/jn.1998.79.5.2432; Smith GD, 2000, J NEUROPHYSIOL, V83, P588, DOI 10.1152/jn.2000.83.1.588; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilson HR, 1999, J THEOR BIOL, V200, P375, DOI 10.1006/jtbi.1999.1002	41	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53508	10.1371/journal.pone.0053508	http://dx.doi.org/10.1371/journal.pone.0053508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308241	Green Published, gold			2022-12-27	WOS:000313429100079
J	Zou, ZW; Ishida, M; Li, F; Kakizaki, T; Suzuki, S; Kitashiba, H; Nishio, T				Zou, Zhongwei; Ishida, Masahiko; Li, Feng; Kakizaki, Tomohiro; Suzuki, Sho; Kitashiba, Hiroyasu; Nishio, Takeshi			QTL Analysis Using SNP Markers Developed by Next-Generation Sequencing for Identification of Candidate Genes Controlling 4-Methylthio-3-Butenyl Glucosinolate Contents in Roots of Radish, Raphanus sativus L	PLOS ONE			English	Article							CHAIN ELONGATION; BRASSICA-JUNCEA; LINKAGE MAP; BIOSYNTHESIS; TRAIT; LOCI; BIOAVAILABILITY; RESISTANCE; CATALYZES; DENSITY	SNP markers for QTL analysis of 4-MTB-GSL contents in radish roots were developed by determining nucleotide sequences of bulked PCR products using a next-generation sequencer. DNA fragments were amplified from two radish lines by multiplex PCR with six primer pairs, and those amplified by 2,880 primer pairs were mixed and sequenced. By assembling sequence data, 1,953 SNPs in 750 DNA fragments, 437 of which have been previously mapped in a linkage map, were identified. A linkage map of nine linkage groups was constructed with 188 markers, and five QTLs were detected in two F-2 populations, three of them accounting for more than 50% of the total phenotypic variance being repeatedly detected. In the identified QTL regions, nine SNP markers were newly produced. By synteny analysis of the QTLs regions with Arabidopsis thaliana and Brassica rapa genome sequences, three candidate genes were selected, i.e., RsMAM3 for production of aliphatic glucosinolates linked to GSL-QTL-4, RsIPMDH1 for leucine biosynthesis showing strong co-expression with glucosinolate biosynthesis genes linked to GSL-QTL-2, and RsBCAT4 for branched-chain amino acid aminotransferase linked to GSL-QTL-1. Nucleotide sequences and expression of these genes suggested their possible function in 4MTB-GSL biosynthesis in radish roots.	[Zou, Zhongwei; Li, Feng; Suzuki, Sho; Kitashiba, Hiroyasu; Nishio, Takeshi] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Ishida, Masahiko; Kakizaki, Tomohiro] NARO Inst Vegetable & Tea Sci, Tsu, Mie, Japan	Tohoku University	Nishio, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan.	nishio@bios.tohoku.ac.jp	Zou, Zhongwei/AAE-9108-2020; KAKIZAKI, Tomohiro/E-6304-2011	KAKIZAKI, Tomohiro/0000-0002-3636-6616; Zou, Zhongwei/0000-0002-8955-1153	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN), Japan	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN), Japan	This work was supported by the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bett KE, 2003, GENOME, V46, P423, DOI [10.1139/g03-026, 10.1139/G03-026]; Bisht NC, 2009, THEOR APPL GENET, V118, P413, DOI 10.1007/s00122-008-0907-z; Bjerg B, 1987, GLUCOSINOLATES RAPES, P125; Brader G, 2006, PLANT J, V46, P758, DOI 10.1111/j.1365-313X.2006.02743.x; Brautigam A, 2010, PLANT BIOLOGY, V12, P831, DOI 10.1111/j.1438-8677.2010.00373.x; Budahn H, 2009, THEOR APPL GENET, V118, P775, DOI 10.1007/s00122-008-0937-6; CARLSON DG, 1985, J AM SOC HORTIC SCI, V110, P634; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Field B, 2004, PLANT PHYSIOL, V135, P828, DOI 10.1104/pp.104.039347; Gigolashvili T, 2009, PLANT CELL, V21, P1813, DOI 10.1105/tpc.109.066399; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen CH, 2001, J BIOL CHEM, V276, P11078, DOI 10.1074/jbc.M010123200; He Y, 2009, PLANT J, V60, P679, DOI 10.1111/j.1365-313X.2009.03990.x; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; Ishida M, 2012, BREEDING SCI, V62, P63, DOI 10.1270/jsbbs.62.63; Ishida M, 2011, BREEDING SCI, V61, P208, DOI 10.1270/jsbbs.61.208; ISHII G, 1987, J JPN SOC HORTIC SCI, V56, P313, DOI 10.2503/jjshs.56.313; Kamei A, 2010, THEOR APPL GENET, V120, P1021, DOI 10.1007/s00122-009-1230-z; Kaplinski L, 2005, BIOINFORMATICS, V21, P1701, DOI 10.1093/bioinformatics/bti219; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Li F, 2011, DNA RES, V18, P401, DOI 10.1093/dnares/dsr027; Lou P, 2008, NEW PHYTOL, V179, P1017, DOI 10.1111/j.1469-8137.2008.02530.x; Mithen RF, 2000, J SCI FOOD AGR, V80, P967, DOI [10.1002/(SICI)1097-0010(20000515)80:7<967::AID-JSFA597>3.0.CO;2-V, 10.1002/(SICI)1097-0010(20000515)80:7&lt;967::AID-JSFA597&gt;3.0.CO;2-V]; Naur P, 2003, PLANT PHYSIOL, V133, P63, DOI 10.1104/pp.102.019240; Ramchiary N, 2007, THEOR APPL GENET, V116, P77, DOI 10.1007/s00122-007-0648-4; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P1181, DOI 10.1093/pcp/pcp079; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Shiokai S, 2010, PLANT CELL REP, V29, P829, DOI 10.1007/s00299-010-0867-z; Shiokai S, 2010, MOL BREEDING, V25, P179, DOI 10.1007/s11032-009-9315-6; Shirasawa K, 2011, DNA RES, V18, P221, DOI 10.1093/dnares/dsr013; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Tsuro M, 2005, BREEDING SCI, V55, P107, DOI 10.1270/jsbbs.55.107; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Wang S., 2007, WINDOWS QTL CARTOGRA; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Zang YX, 2009, FEBS J, V276, P3559, DOI 10.1111/j.1742-4658.2009.07076.x	46	31	35	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53541	10.1371/journal.pone.0053541	http://dx.doi.org/10.1371/journal.pone.0053541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308250	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100087
J	Auburn, S; Marfurt, J; Maslen, G; Campino, S; Rubio, VR; Manske, M; MacHunter, B; Kenangalem, E; Noviyanti, R; Trianty, L; Sebayang, B; Wirjanata, G; Sriprawat, K; Alcock, D; MacInnis, B; Miotto, O; Clark, TG; Russell, B; Anstey, NM; Nosten, F; Kwiatkowski, DP; Price, RN				Auburn, Sarah; Marfurt, Jutta; Maslen, Gareth; Campino, Susana; Rubio, Valentin Ruano; Manske, Magnus; MacHunter, Barbara; Kenangalem, Enny; Noviyanti, Rintis; Trianty, Leily; Sebayang, Boni; Wirjanata, Grennady; Sriprawat, Kanlaya; Alcock, Daniel; MacInnis, Bronwyn; Miotto, Olivo; Clark, Taane G.; Russell, Bruce; Anstey, Nicholas M.; Nosten, Francois; Kwiatkowski, Dominic P.; Price, Ric N.			Effective Preparation of Plasmodium vivax Field Isolates for High-Throughput Whole Genome Sequencing	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; CHLOROQUINE RESISTANCE; FALCIPARUM; AMPLIFICATION; SAMPLES; BLOOD; INFECTIONS; SELECTION; DISEASE; BENIGN	Whole genome sequencing (WGS) of Plasmodium vivax is problematic due to the reliance on clinical isolates which are generally low in parasitaemia and sample volume. Furthermore, clinical isolates contain a significant contaminating background of host DNA which confounds efforts to map short read sequence of the target P. vivax DNA. Here, we discuss a methodology to significantly improve the success of P. vivax WGS on natural (non-adapted) patient isolates. Using 37 patient isolates from Indonesia, Thailand, and travellers, we assessed the application of CF11-based white blood cell filtration alone and in combination with short term ex vivo schizont maturation. Although CF11 filtration reduced human DNA contamination in 8 Indonesian isolates tested, additional short-term culture increased the P. vivax DNA yield from a median of 0.15 to 6.2 ng mu l(-1) packed red blood cells (pRBCs) (p = 0.001) and reduced the human DNA percentage from a median of 33.9% to 6.22% (p = 0.008). Furthermore, post-CF11 and culture samples from Thailand gave a median P. vivax DNA yield of 2.34 ng mu l(-1) pRBCs, and 2.65% human DNA. In 22 P. vivax patient isolates prepared with the 2-step method, we demonstrate high depth (median 654X coverage) and breadth (>= 89%) of coverage on the Illumina GAII and HiSeq platforms. In contrast to the A+T-rich P. falciparum genome, negligible bias was observed in coverage depth between coding and non-coding regions of the P. vivax genome. This uniform coverage will greatly facilitate the detection of SNPs and copy number variants across the genome, enabling unbiased exploration of the natural diversity in P. vivax populations.	[Auburn, Sarah; Marfurt, Jutta; MacHunter, Barbara; Wirjanata, Grennady; Anstey, Nicholas M.; Price, Ric N.] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0909, Australia; [Maslen, Gareth; Campino, Susana; Rubio, Valentin Ruano; Manske, Magnus; Alcock, Daniel; MacInnis, Bronwyn; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, England; [Maslen, Gareth; Campino, Susana; Rubio, Valentin Ruano; Manske, Magnus; Alcock, Daniel; MacInnis, Bronwyn; Miotto, Olivo; Kwiatkowski, Dominic P.] Univ Oxford, Ctr Genom & Global Hlth, MRC, Oxford, England; [Kenangalem, Enny; Noviyanti, Rintis; Trianty, Leily; Sebayang, Boni] Papuan Hlth & Community Dev Fdn, Timika Malaria Res Programme, Timika, Papua, Indonesia; [Noviyanti, Rintis; Trianty, Leily; Sebayang, Boni] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Sriprawat, Kanlaya; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Tak Province, Thailand; [Miotto, Olivo; Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok, Thailand; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Russell, Bruce] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Anstey, Nicholas M.; Price, Ric N.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Nosten, Francois; Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Charles Darwin University; Menzies School of Health Research; Wellcome Trust Sanger Institute; University of Oxford; Eijkman Institute; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; National University of Singapore; University of Oxford	Auburn, S (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0909, Australia.	sarah.auburn@menzies.edu.au	Russell, Bruce/A-9240-2011; Miotto, Olivo/AAE-7124-2019; Campino, Susana/AAM-2577-2020; Nosten, Francois/AAC-5509-2019; Mead, Daniel/AAE-6629-2019; Clark, Taane G./AAM-2570-2020; Auburn, Sarah/N-2266-2013	Russell, Bruce/0000-0003-2333-4348; Miotto, Olivo/0000-0001-8060-6771; Campino, Susana/0000-0003-1403-6138; Nosten, Francois/0000-0002-7951-0745; Mead, Daniel/0000-0001-7717-4330; Clark, Taane G./0000-0001-8985-9265; Price, Richard/0000-0003-2000-2874; Sebayang, Boni/0000-0002-7264-2366; Kwiatkowski, Dominic/0000-0002-5023-0176; Manske, Magnus/0000-0001-5916-0947; Maslen, Gareth/0000-0001-7318-3678; Auburn, Sarah/0000-0002-4638-536X; Wirjanata, Grennady/0000-0002-6858-8547; Noviyanti, Rintis/0000-0003-1383-3274; Trianty, Leily/0000-0002-4368-476X	Wellcome Trust Senior Research Fellowship in Clinical Science; Asia Pacific Malaria Elimination Network; Wellcome Trust; Bill and Melinda Gates Foundation; Medical Research Council United Kingdom; National Health and Medical Research Council, Australia; Swiss National Science Foundation Career Development Fellowship; Wellcome Trust of Great Britain; Medical Research Council [G19/9, G0600718B] Funding Source: researchfish; MRC [G19/9] Funding Source: UKRI	Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); Asia Pacific Malaria Elimination Network; Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation Career Development Fellowship(Swiss National Science Foundation (SNSF)); Wellcome Trust of Great Britain(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in part by a Wellcome Trust Senior Research Fellowship in Clinical Science awarded RP (RP, SA) and part by the Asia Pacific Malaria Elimination Network (RP, SA), the Wellcome Trust (DK, GM, SC, VRR, MM, DA, B. MacInnis, OM), the Bill and Melinda Gates Foundation (DK, GM, SC, VRR, MM, DA, B. MacInnis, OM), the Medical Research Council United Kingdom (DK, GM, SC, VRR, MM, DA, B. MacInnis, OM), the National Health and Medical Research Council, Australia (NA, JM), and a Swiss National Science Foundation Career Development Fellowship (JM). The Shoklo Malaria Research Unit (KS, FN) is part of the Mahidol-Oxford-University Research Unit, supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisue N, 2012, MOL BIOL EVOL, V29, P2095, DOI 10.1093/molbev/mss082; Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Baird JK, 2009, ANN TROP PAEDIATR, V29, P251, DOI 10.1179/027249309X12547917868808; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; BARNES DA, 1992, EMBO J, V11, P3067, DOI 10.1002/j.1460-2075.1992.tb05378.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boissiere A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-163; Bright AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-262; Carlton J, 2003, TRENDS PARASITOL, V19, P227, DOI 10.1016/S1471-4922(03)00066-7; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001160; Dharia NV, 2010, P NATL ACAD SCI USA, V107, P20045, DOI 10.1073/pnas.1003776107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; KEMP DJ, 1992, MEM I OSWALDO CRUZ, V87, P85, DOI 10.1590/S0074-02761992000700011; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mason DP, 1999, AM J TROP MED HYG, V61, P367, DOI 10.4269/ajtmh.1999.61.367; Mayxay M, 2004, TROP MED INT HEALTH, V9, P325, DOI 10.1111/j.1365-3156.2004.01199.x; Melnikov A, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2011-12-8-R73, 10.1186/gb-2011-12-8-r73]; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Russell B, 2012, INT J PARASITOL; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Tao ZY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-115; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Venkatesan M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-41; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061	38	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53160	10.1371/journal.pone.0053160	http://dx.doi.org/10.1371/journal.pone.0053160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308154	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000313670100023
J	Gao, WJ; Peng, Y; Liang, GY; Liang, AJ; Ye, W; Zhang, LM; Sharma, S; Su, PQ; Huang, DS				Gao, Wenjie; Peng, Yan; Liang, Guoyan; Liang, Anjing; Ye, Wei; Zhang, Liangming; Sharma, Swarkar; Su, Peiqiang; Huang, Dongsheng			Association between Common Variants near LBX1 and Adolescent Idiopathic Scoliosis Replicated in the Chinese Han Population	PLOS ONE			English	Article							RECEPTOR GENE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; DORSAL SPINAL-CORD; CURVE SEVERITY; TRANSMITTER PHENOTYPES; EVOKED-POTENTIALS; SUSCEPTIBILITY; LOCUS; ASSIGNMENT; OSTEOPENIA	Background: Adolescent idiopathic scoliosis (AIS) is one of the most common spinal deformities found in adolescent populations. Recently, a genome-wide association study (GWAS) in a Japanese population indicated that three single nucleotide polymorphisms (SNPs), rs11190870, rs625039 and rs11598564, all located near the LBX1 gene, may be associated with AIS susceptibility [1]. This study suggests a novel AIS predisposition candidate gene and supports the hypothesis that somatosensory functional disorders could contribute to the pathogenesis of AIS. These findings warrant replication in other populations. Methodology/Principal Findings: First, we conducted a case-control study consisting of 953 Chinese Han individuals from southern China (513 patients and 440 healthy controls), and the three SNPs were all found to be associated with AIS predisposition. The ORs were observed as 1.49 (95% CI 1.23-1.80, P = 5.09E-5), 1.70 (95% CI 1.42-2.04, P = 1.17E-8) and 1.52 (95% CI 1.27-1.83, P = 5.54E-6) for rs625039, rs11190870 and rs11598564, respectively. Second, a case-only study including a subgroup of AIS patients (N = 234) was performed to determine the effects of these variants on the severity of the condition. However, we did not find any association between these variants and the severity of curvature. Conclusion: This study shows that the genetic variants near the LBX1 gene are associated with AIS susceptibility in Chinese Han population. It successfully replicates the results of the GWAS, which was performed in a Japanese population.	[Gao, Wenjie; Su, Peiqiang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped Surg, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Wenjie; Peng, Yan; Liang, Guoyan; Liang, Anjing; Ye, Wei; Zhang, Liangming; Huang, Dongsheng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped Surg, Guangzhou 510275, Guangdong, Peoples R China; [Sharma, Swarkar] Texas Scottish Rite Hosp Children, Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Sharma, Swarkar] Shri Mata Vaishno Devi Univ, Sch Biol & Chem, Katra, India	Sun Yat Sen University; Sun Yat Sen University; Texas Scottish Rite Hospital for Children; Shri Mata Vaishno Devi University	Su, PQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped Surg, Guangzhou 510275, Guangdong, Peoples R China.	spq88007@yahoo.com.cn; huangdongshen18@hotmail.com	Liang, Guoyan/AEL-4482-2022; SHARMA, SWARKAR/B-8096-2008; zhang, liangming/Q-9967-2016	SHARMA, SWARKAR/0000-0001-8857-5906; zhang, liangming/0000-0003-2282-4687	National Natural Science Foundation of China [81171674, 81071703]; Research Fund of Social Development of Guangdong Province [2010B031900023]; Research Fund of Popular Science of Guangzhou City [2011KP012]; Fundamental Research Funds for the Central Universities [11ykzd10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of Social Development of Guangdong Province; Research Fund of Popular Science of Guangzhou City; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 81171674 and No. 81071703), Research Fund of Social Development of Guangdong Province (No. 2010B031900023), Research Fund of Popular Science of Guangzhou City (No. 2011KP012) and the Fundamental Research Funds for the Central Universities (No. 11ykzd10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden KJ, 2006, SPINE, V31, P1815, DOI 10.1097/01.brs.0000227264.23603.dc; Asher MA, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-2; Aulisa L, 2007, SPINE, V32, P2700, DOI 10.1097/BRS.0b013e31815a5943; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BARRIOS C, 1987, SPINE, V12, P433, DOI 10.1097/00007632-198706000-00003; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Chan V, 2002, AM J HUM GENET, V71, P401, DOI 10.1086/341607; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen ZJ, 2009, EUR J HUM GENET, V17, P525, DOI 10.1038/ejhg.2008.203; Cheng JCY, 2007, CLIN ORTHOP RELAT R, P38, DOI 10.1097/BLO.0b013e3180d09dcc; Cheng JCY, 1998, SPINE, V23, P332, DOI 10.1097/00007632-199802010-00009; Cheng JCY, 1999, SPINE, V24, P1679, DOI 10.1097/00007632-199908150-00009; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Fan YH, 2012, J HUM GENET, V57, P244, DOI 10.1038/jhg.2012.11; Gao XC, 2007, AM J HUM GENET, V80, P957, DOI 10.1086/513571; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Guo X, 2006, SPINE, V31, pE437, DOI 10.1097/01.brs.0000222048.47010.bf; Gurnett CA, 2009, SPINE, V34, pE94, DOI 10.1097/BRS.0b013e31818b88a5; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; Hung VWY, 2005, J BONE JOINT SURG AM, V87A, P2709, DOI 10.2106/JBJS.D.02782; Inoue M, 2002, SPINE, V27, P2357, DOI 10.1097/00007632-200211010-00009; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; Jiang H, 2012, EUR SPINE J; Jiang J, 1976, SPINE PHILA PA 1976; Justice CM, 2003, SPINE, V28, P589, DOI 10.1097/00007632-200303150-00014; Karachalios T, 1999, SPINE, V24, P2318, DOI 10.1097/00007632-199911150-00006; Kim H, 2010, RADIOGRAPHICS, V30, P1823, DOI 10.1148/rg.307105061; Kouwenhoven JWM, 2008, SPINE, V33, P2898, DOI 10.1097/BRS.0b013e3181891751; LONSTEIN JE, 1994, J BONE JOINT SURG AM, V76A, P1207, DOI 10.2106/00004623-199408000-00011; Mao SH, 2011, EUR SPINE J, V20, P260, DOI 10.1007/s00586-010-1649-6; Miller MR, 2010, OBESITY, V18, P555, DOI 10.1038/oby.2009.303; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nelson LM, 2011, SPINE, V36, P37, DOI 10.1097/BRS.0b013e3181e8755b; Ocaka L, 2008, J MED GENET, V45, P87, DOI 10.1136/jmg.2007.051896; Oestreich AE, 1998, SKELETAL RADIOL, V27, P591, DOI 10.1007/s002560050445; Ott J, 2004, NEUROLOGY, V63, P955, DOI 10.1212/WNL.63.6.955; PINCOTT JR, 1984, J BONE JOINT SURG BR, V66, P27; PINCOTT JR, 1982, J BONE JOINT SURG BR, V64, P503; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu XS, 2007, SPINE, V32, P1748, DOI 10.1097/BRS.0b013e3180b9f0ff; Qiu Y, 2011, SPINE PHILA PA 1976; Reamy BV, 2001, AM FAM PHYSICIAN, V64, P111; RISSER J C, 1958, Clin Orthop, V11, P111; Risser JC, 1936, J BONE JOINT SURG, V18, P667; Salehi LB, 2002, HUM GENET, V111, P401, DOI 10.1007/s00439-002-0785-4; Sharma S, 2011, HUM MOL GENET, V20, P1456, DOI 10.1093/hmg/ddq571; Sieber MA, 2007, J NEUROSCI, V27, P4902, DOI 10.1523/JNEUROSCI.0717-07.2007; SUK SI, 1989, SPINE, V14, P692, DOI 10.1097/00007632-198907000-00008; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Takahashi Y, 2011, J ORTHOP RES, V29, P1055, DOI 10.1002/jor.21347; Takahashi Y, 2011, J ORTHOP RES, V29, P834, DOI 10.1002/jor.21322; Tang NLS, 2006, SPINE, V31, P2463, DOI 10.1097/01.brs.0000239179.81596.2b; Wang H, 2008, SPINE, V33, P2199, DOI 10.1097/BRS.0b013e31817c03f9; Weinstein SL, 1999, SPINE, V24, P2592, DOI 10.1097/00007632-199912150-00006; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Wise CA, 2000, SPINE, V25, P2372, DOI 10.1097/00007632-200009150-00017; Wu J, 2006, SPINE, V31, P1131, DOI 10.1097/01.brs.0000216603.91330.6f; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yeung HY, 2006, STUD HEALTH TECHNOL, V123, P18; Zhang HQ, 2009, SPINE, V34, P760, DOI 10.1097/BRS.0b013e31818ad5ac	66	38	42	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53234	10.1371/journal.pone.0053234	http://dx.doi.org/10.1371/journal.pone.0053234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308168	Green Submitted, gold, Green Published			2022-12-27	WOS:000313670100025
J	Colbert, CL; Agar, NYR; Kumar, P; Chakko, MN; Sinha, SC; Powlowski, JB; Eltis, LD; Bolin, JT				Colbert, Christopher L.; Agar, Nathalie Y. R.; Kumar, Pravindra; Chakko, Mathew N.; Sinha, Sangita C.; Powlowski, Justin B.; Eltis, Lindsay D.; Bolin, Jeffrey T.			Structural Characterization of Pandoraea pnomenusa B-356 Biphenyl Dioxygenase Reveals Features of Potent Polychlorinated Biphenyl-Degrading Enzymes	PLOS ONE			English	Article							TERMINAL OXYGENASE COMPONENT; CRYSTAL-STRUCTURE; NAPHTHALENE DIOXYGENASE; 3-DIMENSIONAL STRUCTURE; CLASSIFICATION-SYSTEM; FUNCTIONAL-ANALYSIS; ENCODING BIPHENYL; GENE-CLUSTER; DEGRADATION; CRYSTALLIZATION	The oxidative degradation of biphenyl and polychlorinated biphenyls (PCBs) is initiated in Pandoraea pnomenusa B-356 by biphenyl dioxygenase (BPDOB356). BPDOB356, a heterohexameric (alpha beta)(3) Rieske oxygenase (RO), catalyzes the insertion of dioxygen with stereo- and regioselectivity at the 2,3-carbons of biphenyl, and can transform a broad spectrum of PCB congeners. Here we present the X-ray crystal structures of BPDOB356 with and without its substrate biphenyl 1.6-angstrom resolution for both structures. In both cases, the Fe(II) has five ligands in a square pyramidal configuration: H233 N epsilon 2, H239 N epsilon 2, D386 O delta 1 and O delta 2, and a single water molecule. Analysis of the active sites of BPDOB356 and related ROs revealed structural features that likely contribute to the superior PCB-degrading ability of certain BPDOs. First, the active site cavity readily accommodates biphenyl with minimal conformational rearrangement. Second, M231 was predicted to sterically interfere with binding of some PCBs, and substitution of this residue yielded variants that transform 2,2'-dichlorobiphenyl more effectively. Third, in addition to the volume and shape of the active site, residues at the active site entrance also apparently influence substrate preference. Finally, comparison of the conformation of the active site entrance loop among ROs provides a basis for a structure-based classification consistent with a phylogeny derived from amino acid sequence alignments.	[Colbert, Christopher L.; Sinha, Sangita C.] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58105 USA; [Agar, Nathalie Y. R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg & Radiol, Boston, MA 02115 USA; [Kumar, Pravindra] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttarakhand, India; [Chakko, Mathew N.] Providence Hosp & Med Ctr, Dept Diagnost Radiol, Southfield, MI USA; [Agar, Nathalie Y. R.; Powlowski, Justin B.] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada; [Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Microbiol, Vancouver, BC, Canada; [Eltis, Lindsay D.] Univ British Columbia, Dept Biochem, Inst Life Sci, Vancouver, BC, Canada; [Colbert, Christopher L.; Kumar, Pravindra; Chakko, Mathew N.; Bolin, Jeffrey T.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Colbert, Christopher L.; Kumar, Pravindra; Chakko, Mathew N.; Bolin, Jeffrey T.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	North Dakota State University Fargo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Concordia University - Canada; University of British Columbia; University of British Columbia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Colbert, CL (corresponding author), N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58105 USA.	christopher.colbert@ndsu.edu	KUMAR, PRAVINDRA/AAF-2859-2020; Eltis, Lindsay D/J-8272-2015	KUMAR, PRAVINDRA/0000-0003-2128-7736; Eltis, Lindsay D/0000-0002-6774-8158	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Discovery grant; National Institutes of Health (NIH) [R01-GM52381]; NIH award [P20 RR015566]; NSF ND EPSCoR [EPS-0814442]; NIH training grant [T32-GM008296]; NSERC; Fonds FCAR postgraduate scholarships; National Center for Research Resources [5P41RR007707]; National Institute of General Medical Sciences from the National Institutes of Health [8P41GM103543]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Office Of The Director [0814442] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566, P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103332, P41GM103543, R01GM052381, T32GM008296] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF ND EPSCoR; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds FCAR postgraduate scholarships; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Discovery and Strategic grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to LDE, a NSERC Discovery grant to JP, and National Institutes of Health (NIH) award R01-GM52381 to JTB. CLC and SCS were supported by NIH award P20 RR015566 and NSF ND EPSCoR EPS-0814442. CLC was supported in part by an NIH training grant, T32-GM008296. NYRA was the recipient of NSERC and Fonds FCAR postgraduate scholarships. Use of the BioCARS Sector 14 was supported by grants from the National Center for Research Resources (5P41RR007707) and the National Institute of General Medical Sciences (8P41GM103543) from the National Institutes of Health. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 1996, J FERMENT BIOENG, V81, P187, DOI 10.1016/0922-338X(96)82207-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barriault D, 2002, J BACTERIOL, V184, P3794, DOI 10.1128/JB.184.14.3794-3800.2002; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Chebrou H, 1999, J BACTERIOL, V181, P4805, DOI 10.1128/JB.181.16.4805-4811.1999; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dai SD, 2002, NAT STRUCT BIOL, V9, P934, DOI 10.1038/nsb866; Dodson E, 1996, REF PROT STRUCT P DA; Dong XS, 2005, J BACTERIOL, V187, P2483, DOI 10.1128/JB.187.7.2483-2490.2005; ERICKSON BD, 1993, APPL ENVIRON MICROB, V59, P3858, DOI 10.1128/AEM.59.11.3858-3862.1993; ERICKSON BD, 1992, J BACTERIOL, V174, P2903, DOI 10.1128/JB.174.9.2903-2912.1992; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferraro DJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-10; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; FURUKAWA K, 1986, J BACTERIOL, V166, P392, DOI 10.1128/jb.166.2.392-398.1986; Furukawa K, 2004, J BACTERIOL, V186, P5189, DOI 10.1128/JB.186.16.5189-5196.2004; Furukawa K, 2000, J GEN APPL MICROBIOL, V46, P283, DOI 10.2323/jgam.46.283; Furusawa Y, 2004, J MOL BIOL, V342, P1041, DOI 10.1016/j.jmb.2004.07.062; GIBSON DT, 1993, J BACTERIOL, V175, P4561, DOI 10.1128/JB.175.14.4561-4564.1993; Gomez-Gil L, 2007, J BACTERIOL, V189, P5705, DOI 10.1128/JB.01476-06; Goodwill KE, 1997, NAT STRUCT BIOL, V4, P578, DOI 10.1038/nsb0797-578; Habe H, 2003, APPL MICROBIOL BIOT, V61, P44, DOI 10.1007/s00253-002-1166-6; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; HIROSE J, 1994, GENE, V138, P27; HOWELLS ER, 1950, ACTA CRYSTALLOGR, V3, P210, DOI 10.1107/S0365110X50000513; Hurtubise Y, 1998, J BACTERIOL, V180, P5828, DOI 10.1128/JB.180.22.5828-5835.1998; Imbeault NYR, 2000, J BIOL CHEM, V275, P12430, DOI 10.1074/jbc.275.17.12430; Iwasaki T, 2007, BIOSCI BIOTECH BIOCH, V71, P993, DOI 10.1271/bbb.60663; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kim E, 1999, J IND MICROBIOL BIOT, V23, P294, DOI 10.1038/sj.jim.2900724; Kimura N, 1997, J BACTERIOL, V179, P3936, DOI 10.1128/jb.179.12.3936-3943.1997; Kweon Ohgew, 2008, BMC Biochemistry, V9, P11, DOI 10.1186/1471-2091-9-11; Martins BM, 2005, STRUCTURE, V13, P817, DOI 10.1016/j.str.2005.03.008; Mondello FJ, 1997, APPL ENVIRON MICROB, V63, P3096, DOI 10.1128/AEM.63.8.3096-3103.1997; Nam JW, 2001, BIOSCI BIOTECH BIOCH, V65, P254, DOI 10.1271/bbb.65.254; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parales RE, 2005, APPL ENVIRON MICROB, V71, P3806, DOI 10.1128/AEM.71.7.3806-3814.2005; Parales RE, 1998, J BACTERIOL, V180, P2337, DOI 10.1128/JB.180.9.2337-2344.1998; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; REES DC, 1980, ACTA CRYSTALLOGR A, V36, P578, DOI 10.1107/S0567739480001234; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Suenaga H, 2002, J BACTERIOL, V184, P3682, DOI 10.1128/JB.184.13.3682-3688.2002; Suenaga H, 2001, J BACTERIOL, V183, P5441, DOI 10.1128/JB.183.18.5441-5444.2001; SUGIYAMA K, 1995, P JPN ACAD B-PHYS, V71, P32, DOI 10.2183/pjab.71.32; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vezina J, 2008, J MOL MICROB BIOTECH, V15, P139, DOI 10.1159/000121326; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Zielinski M, 2003, J BACTERIOL, V185, P6976, DOI 10.1128/JB.185.23.6976-6980.2003	54	24	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52550	10.1371/journal.pone.0052550	http://dx.doi.org/10.1371/journal.pone.0052550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23308114	Green Published, gold, Green Accepted			2022-12-27	WOS:000313480000010
J	Frana, TS; Beahm, AR; Hanson, BM; Kinyon, JM; Layman, LL; Karriker, LA; Ramirez, A; Smith, TC				Frana, Timothy S.; Beahm, Aleigh R.; Hanson, Blake M.; Kinyon, Joann M.; Layman, Lori L.; Karriker, Locke A.; Ramirez, Alejandro; Smith, Tara C.			Isolation and Characterization of Methicillin-Resistant Staphylococcus aureus from Pork Farms and Visiting Veterinary Students	PLOS ONE			English	Article							SLAUGHTER PIGS; UNITED-STATES; ANTIBIOTIC-RESISTANCE; NASAL COLONIZATION; PORCINE ORIGIN; HIGH-RISK; ST398; PREVALENCE; MRSA; SWINE	In the last decade livestock-associated methicillin-resistant S. aureus (LA-MRSA) has become a public health concern in many parts of the world. Sequence type 398 (ST398) has been the most commonly reported type of LA-MRSA. While many studies have focused on long-term exposure experienced by swine workers, this study focuses on short-term exposures experienced by veterinary students conducting diagnostic investigations. The objectives were to assess the rate of MRSA acquisition and longevity of carriage in students exposed to pork farms and characterize the recovered MRSA isolates. Student nasal swabs were collected immediately before and after farm visits. Pig nasal swabs and environmental sponge samples were also collected. MRSA isolates were identified biochemically and molecularly including spa typing and antimicrobial susceptibility testing. Thirty (30) veterinary students were enrolled and 40 pork farms were visited. MRSA was detected in 30% of the pork farms and in 22% of the students following an exposure to a MRSA-positive pork farm. All students found to be MRSA-positive initially following farm visit were negative for MRSA within 24 hours post visit. Most common spa types recovered were t002 (79%), t034 (16%) and t548 (4%). Spa types found in pork farms closely matched those recovered from students with few exceptions. Resistance levels to antimicrobials varied, but resistance was most commonly seen for spectinomycin, tetracyclines and neomycin. Non-ST398 MRSA isolates were more likely to be resistant to florfenicol and neomycin as well as more likely to be multidrug resistant compared to ST398 MRSA isolates. These findings indicate that MRSA can be recovered from persons visiting contaminated farms. However, the duration of carriage was very brief and most likely represents contamination of nasal passages rather than biological colonization. The most common spa types found in this study were associated with ST5 and expands the range of livestock-associated MRSA types.	[Frana, Timothy S.; Beahm, Aleigh R.; Kinyon, Joann M.; Layman, Lori L.; Karriker, Locke A.; Ramirez, Alejandro] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Hanson, Blake M.; Smith, Tara C.] Univ Iowa, Coll Publ Hlth, Ctr Emerging Infect Dis, Dept Epidemiol, Iowa City, IA USA	Iowa State University; University of Iowa	Frana, TS (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	tfrana@iastate.edu	Hanson, Blake/AAL-8522-2021	Hanson, Blake/0000-0003-2949-7818; Smith, Tara C./0000-0003-3747-1116	National Institute for Occupational Safety and Health [K01OH009793]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [K01OH009793] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	TCS is partially supported through research funding from The National Institute for Occupational Safety and Health K01OH009793 (http://www.cdc.gov/niosh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; CLSI, 2008, PERFORMANCE STANDARD; Crombe F, 2012, MICROB DRUG RESIST, V18, P125, DOI 10.1089/mdr.2011.0138; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652; Dressler AE, 2012, VET REC, V170, P495, DOI 10.1136/vr.100570; EFSA, 2009, AN BAS SURV PREV M B; Garcia-Graells C, 2012, EPIDEMIOL INFECT, V140, P383, DOI 10.1017/S0950268811002263; Gordoncillo MJ, 2012, ZOONOSES PUBLIC HLTH, V59, P212, DOI 10.1111/j.1863-2378.2011.01437.x; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Hanson B M, 2011, J Infect Public Health, V4, P169, DOI 10.1016/j.jiph.2011.06.001; Horgan M, 2011, VET J, V190, P255, DOI 10.1016/j.tvjl.2010.10.025; Huber H, 2010, EURO SURVEILL, V15; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Jamrozy DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040458; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Kehrenberg C, 2009, ANTIMICROB AGENTS CH, V53, P779, DOI 10.1128/AAC.01376-08; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Louie L, 2002, J CLIN MICROBIOL, V40, P2786, DOI 10.1128/JCM.40.8.2786-2790.2002; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Meeniken D, 2008, DEUT TIERARZTL WOCH, V115, P132, DOI 10.2377/0341-6593-115-132; Mendes RE, 2011, DIAGN MICR INFEC DIS, V71, P177, DOI 10.1016/j.diagmicrobio.2011.06.009; Molla B, 2012, J CLIN MICROBIOL, V50, P3687, DOI 10.1128/JCM.01971-12; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219; Morcillo A, 2012, FOODBORNE PATHOG DIS, V9, P207, DOI 10.1089/fpd.2011.0982; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; O'Brien AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030092; Overesch G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-30; Pomba CA, 2009, INT J ANTIMICROB AG, V34, P193, DOI 10.1016/j.ijantimicag.2009.02.019; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Riesen A, 2009, SCHWEIZ ARCH TIERH, V151, P425, DOI 10.1024/0036-7281.151.9.425; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Smith TC, 2010, EMERGENCE STAPHYLOCO; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; Van Hoecke H, 2009, LARYNGOSCOPE, V119, P137, DOI 10.1002/lary.20030; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Weese JS, 2011, ZOONOSES PUBLIC HLTH, V58, P238, DOI 10.1111/j.1863-2378.2010.01340.x; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf M, 2006, EMERG INFECT DIS, V12, P1939	61	105	108	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53738	10.1371/journal.pone.0053738	http://dx.doi.org/10.1371/journal.pone.0053738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301102	Green Published, gold			2022-12-27	WOS:000313480000077
J	Chang, SH; Chen, CC; Hsieh, MJ; Wang, CY; Lee, CH; Hsieh, IC				Chang, Shang-Hung; Chen, Chun-Chi; Hsieh, Ming-Jer; Wang, Chao-Yung; Lee, Cheng-Hung; Hsieh, I-Chang			Lesion Length Impacts Long Term Outcomes of Drug-Eluting Stents and Bare Metal Stents Differently	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY LESIONS; 3-YEAR FOLLOW-UP; RANDOMIZED-TRIAL; CLINICAL-OUTCOMES; MULTILINK STENT; RESTENOSIS; SIROLIMUS; IMPLANTATION; MULTICENTER	Background: Long lesions have been associated with adverse outcomes in percutaneous coronary interventions with bare metal stents (BMS). However, the exact impact of lesion length on the short-and long-term outcomes of drug-eluting stent (DES) implantations is not as clear. Methods and Results: This study compared the impact of lesion length on angiographic and clinical outcomes of BMS and DES in a single-center prospective registry. Lesion length was divided into tertiles. The primary endpoints were angiographically defined binary in-stent restenosis (ISR) rate and major adverse cardiac event (MACE). Of the 4,312 de novo lesions in 3,447 consecutive patients in the CAPTAIN registry, 2,791 lesions (of 2,246 patients) received BMS, and the remaining 1,521 lesions (of 1,201 patients) received DES. The mean follow-up duration was 4.5 years. The longer the lesion, the higher the ISR rate (14%, 18%, and 29%, p < 0.001) and the lower the MACE-free survivals (p = 0.007) in the BMS group. However, lesion length showed no such correlation with ISR rates (4.7%, 3.3%, and 7.8%, p = 0.67) or MACE-free survivals (p = 0.19) in the DES group. Conclusions: In our single-center prospective registry, lesion length defined in tertiles has no impact on the short-term (ISR) or long-term (MACE) outcomes of patients implanted with DES. In contrast, longer lesion correlates with higher ISR and MACE rates in BMS group.	[Hsieh, I-Chang] Chang Gung Mem Hosp, Sect Cardiol 2, Taipei 10591, Taiwan; Chang Gung Mem Hosp, Percutaneous Coronary Intervent Ctr, Dept Med, Taipei 10591, Taiwan; Chang Gung Univ, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Hsieh, IC (corresponding author), Chang Gung Mem Hosp, Sect Cardiol 2, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	hsiehic@ms28.hinet.net	Wang, Chao-Yung/ABA-6757-2021; Hsieh, Ming-Jer/M-1340-2013	Wang, Chao-Yung/0000-0003-1546-7298; Hsieh, Ming-Jer/0000-0002-0148-8357; Chang, Shang-hung/0000-0003-0462-2344	Chang Gung Memorial Hospital [CMRPG350214]; Taiwan National Science Council [98-2314-B-182-060]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	Shang-Hung Chang was supported by a grant from Chang Gung Memorial Hospital (CMRPG350214). I-Chang Hsieh was supported by a grant from the Taiwan National Science Council (98-2314-B-182-060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden WE, 2007, AM J CARDIOL, V99, P208, DOI 10.1016/j.amjcard.2006.07.082; Caputo RP, 2012, AM J CARDIOL, V110, P350, DOI 10.1016/j.amjcard.2012.03.031; Cutlip DE, 2002, J AM COLL CARDIOL, V40, P2082, DOI 10.1016/S0735-1097(02)02597-4; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Dawkins KD, 2005, CIRCULATION, V112, P3306, DOI 10.1161/CIRCULATIONAHA.105.552190; de Feyter PJ, 1999, CIRCULATION, V100, P1777, DOI 10.1161/01.CIR.100.17.1777; Dibra A, 2007, J AM COLL CARDIOL, V49, P616, DOI 10.1016/j.jacc.2006.10.049; Foley DP, 2001, EUR HEART J, V22, P1585, DOI 10.1053/euhj.2001.2752; Grube E, 2009, EUROINTERVENTION, V4, P572, DOI 10.4244/EIJV4I5A97; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Hsieh IC, 2006, INT J CARDIOL, V111, P209, DOI 10.1016/j.ijcard.2005.07.005; Hsieh IC, 2004, CATHETER CARDIO INTE, V62, P453, DOI 10.1002/ccd.20116; Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P9, DOI 10.1161/CIRCINTERVENTIONS.110.940320; Kastrati A, 1999, AM J CARDIOL, V83, P1617, DOI 10.1016/S0002-9149(99)00165-4; Kereiakes D, 2000, AM J CARDIOL, V86, P336, DOI 10.1016/S0002-9149(00)00928-0; Kim YH, 2006, CIRCULATION, V114, P2148, DOI 10.1161/CIRCULATIONAHA.106.666396; Kimura T, 2002, CIRCULATION, V105, P2986, DOI 10.1161/01.CIR.0000019743.11941.3B; Kimura T, 1996, NEW ENGL J MED, V334, P561, DOI 10.1056/NEJM199602293340903; Kobayashi Y, 1999, J AM COLL CARDIOL, V34, P651, DOI 10.1016/S0735-1097(99)00303-4; Koh AS, 2011, CORONARY ARTERY DIS, V22, P96, DOI 10.1097/MCA.0b013e32834236d0; Liistro F, 2002, CIRCULATION, V105, P1883, DOI 10.1161/01.CIR.0000016042.69606.61; Mauri L, 2005, AM J CARDIOL, V95, P1140, DOI 10.1016/j.amjcard.2005.01.039; Mauri L, 2004, AM J CARDIOL, V93, P1340, DOI 10.1016/j.amjcard.2004.02.027; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Menichelli M, 2007, J AM COLL CARDIOL, V49, P1924, DOI 10.1016/j.jacc.2007.01.081; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Park KW, 2010, AM HEART J, V159, P446, DOI 10.1016/j.ahj.2010.01.001; Raber L, 2010, J AM COLL CARDIOL, V55, P1178, DOI 10.1016/j.jacc.2009.11.052; Rathore S, 2009, EUROINTERVENTION, V5, P349, DOI 10.4244/V5I3A55; Rozenman Y, 2009, EUROINTERVENTION, V5, P219, DOI 10.4244/EIJV5I2A34; Shirai S, 2010, JACC-CARDIOVASC INTE, V3, P180, DOI 10.1016/j.jcin.2009.11.009; Tcheng JE, 2009, CIRC-CARDIOVASC INTE, V2, P43, DOI 10.1161/CIRCINTERVENTIONS.108.809285; Teirstein PS, 2010, CIRCULATION, V122, P5, DOI 10.1161/CIRCULATIONAHA.110.962423; Violini R, 2010, J AM COLL CARDIOL, V55, P810, DOI 10.1016/j.jacc.2009.09.046	34	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53207	10.1371/journal.pone.0053207	http://dx.doi.org/10.1371/journal.pone.0053207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326399	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800038
J	Decelle, J; Martin, P; Paborstava, K; Pond, DW; Tarling, G; Mahe, F; de Vargas, C; Lampitt, R; Not, F				Decelle, Johan; Martin, Patrick; Paborstava, Katsiaryna; Pond, David W.; Tarling, Geraint; Mahe, Frederic; de Vargas, Colomban; Lampitt, Richard; Not, Fabrice			Diversity, Ecology and Biogeochemistry of Cyst-Forming Acantharia (Radiolaria) in the Oceans	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; COMMUNITY STRUCTURE; SEAWATER STRONTIUM; SURFACE WATERS; PARTICLE-FLUX; ABUNDANCE; PATTERNS; SEDIMENTATION; ENCYSTMENT; ATLANTIC	Marine planktonic organisms that undertake active vertical migrations over their life cycle are important contributors to downward particle flux in the oceans. Acantharia, globally distributed heterotrophic protists that are unique in building skeletons of celestite (strontium sulfate), can produce reproductive cysts covered by a heavy mineral shell that sink rapidly from surface to deep waters. We combined phylogenetic and biogeochemical analyses to explore the ecological and biogeochemical significance of this reproductive strategy. Phylogenetic analysis of the 18S and 28S rRNA genes of different cyst morphotypes collected in different oceans indicated that cyst-forming Acantharia belong to three early diverging and essentially non symbiotic clades from the orders Chaunacanthida and Holacanthida. Environmental high-throughput V9 tag sequences and clone libraries of the 18S rRNA showed that the three clades are widely distributed in the Indian, Atlantic and Pacific Oceans at different latitudes, but appear prominent in regions of higher primary productivity. Moreover, sequences of cyst-forming Acantharia were distributed evenly in both the photic and mesopelagic zone, a vertical distribution that we attribute to their life cycle where flagellated swarmers are released in deep waters from sinking cysts. Bathypelagic sediment traps in the subantarctic and oligotrophic subtropical Atlantic Ocean showed that downward flux of Acantharia was only large at high-latitudes and during a phytoplankton bloom. Their contribution to the total monthly particulate organic matter flux can represent up to 3%. High organic carbon export in cold waters would be a putative nutritional source for juveniles ascending in the water column. This study improves our understanding of the life cycle and biogeochemical contribution of Acantharia, and brings new insights into a remarkable reproductive strategy in marine protists.	[Decelle, Johan; Mahe, Frederic; de Vargas, Colomban; Not, Fabrice] Univ Paris 06, Stn Biol Roscoff, EPPO, CNRS,UMR 7144, Roscoff, France; [Martin, Patrick; Paborstava, Katsiaryna; Lampitt, Richard] Natl Oceanog Ctr, Southampton, Hants, England; [Pond, David W.; Tarling, Geraint] British Antarctic Survey, Cambridge CB3 0ET, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; NERC National Oceanography Centre; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Decelle, J (corresponding author), Univ Paris 06, Stn Biol Roscoff, EPPO, CNRS,UMR 7144, Pl Georges Teissier, Roscoff, France.	decelle@sb-roscoff.fr	Martin, Patrick/F-6263-2017; Mahé, Frédéric/AAR-8568-2021	Martin, Patrick/0000-0001-8008-5558; Mahé, Frédéric/0000-0002-2808-0984; Decelle, Johan/0000-0002-4343-8358; de Vargas, Colomban/0000-0002-6476-6019	PhD fellowship DIPHOPE from the Region Bretagne [044763]; SYMFORAD project from the Region Bretagne; EGIDE program; French ANR [POSEIDON 09-BLAN-0348]; NERC [bas0100025, noc010009] Funding Source: UKRI; Natural Environment Research Council [bas0100025, noc010009] Funding Source: researchfish	PhD fellowship DIPHOPE from the Region Bretagne; SYMFORAD project from the Region Bretagne; EGIDE program; French ANR(French National Research Agency (ANR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the PhD fellowship DIPHOPE (044763) and SYMFORAD project from the Region Bretagne, as well as, the EGIDE program and the French ANR (POSEIDON 09-BLAN-0348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher J, 2009, DEEP-SEA RES PT I, V56, P2206, DOI 10.1016/j.dsr.2009.08.007; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; ANDERSON OR, 1990, PHILOS T ROY SOC B, V329, P81, DOI 10.1098/rstb.1990.0152; ANTIA AN, 1993, J PLANKTON RES, V15, P99, DOI 10.1093/plankt/15.1.99; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; BEERS JR, 1970, LIMNOL OCEANOGR, V15, P825, DOI 10.4319/lo.1970.15.5.0825; BERNSTEIN RE, 1992, GEOCHIM COSMOCHIM AC, V56, P3273, DOI 10.1016/0016-7037(92)90304-2; BERNSTEIN RE, 1987, SCIENCE, V237, P1490, DOI 10.1126/science.237.4821.1490; BIDWELL JP, 1986, BIOL BULL, V170, P75, DOI 10.2307/1541382; Bottazzi E.M., 1973, Rendiconti Ist Lomb Sci Lett (B), V107, P3; Countway PD, 2007, ENVIRON MICROBIOL, V9, P1219, DOI 10.1111/j.1462-2920.2007.01243.x; De Deckker P, 2004, HYDROBIOLOGIA, V517, P1, DOI 10.1023/B:HYDR.0000027333.02017.50; de Villiers S, 1999, EARTH PLANET SC LETT, V171, P623, DOI 10.1016/S0012-821X(99)00174-0; Decelle J, 2012, SYMBIOSIS, V58, P233, DOI 10.1007/s13199-012-0195-x; Decelle J, 2012, P NATL ACAD SCI USA, V109, P18000, DOI 10.1073/pnas.1212303109; Decelle J, 2012, PROTIST, V163, P435, DOI 10.1016/j.protis.2011.10.002; Dennett MR, 2002, J PLANKTON RES, V24, P797, DOI 10.1093/plankt/24.8.797; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; Febvre Colette, 2002, P783; Febvre J, 2001, ACANTHARIA, DOI DOI 10.1038/NPG.ELS.0002102; Gilg IC, 2010, PROTIST, V161, P197, DOI 10.1016/j.protis.2009.09.002; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haeckel E, 1888, MONOGRAPHIE DRITTER, P33; HANLON RT, 1989, J EXP BIOL, V141, P187; Hewson I, 2006, LIMNOL OCEANOGR, V51, P1274, DOI 10.4319/lo.2006.51.3.1274; HOLLANDE A, 1957, CR HEBD ACAD SCI, V244, P508; Hollande A ., 1965, Protistologica, V1, P91; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kremp A, 2009, LIMNOL OCEANOGR, V54, P1125, DOI 10.4319/lo.2009.54.4.1125; Kwon EY, 2009, NAT GEOSCI, V2, P630, DOI 10.1038/NGEO612; Lamborg CH, 2008, DEEP-SEA RES PT II, V55, P1540, DOI 10.1016/j.dsr2.2008.04.011; Lampitt RS, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003221; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Martin P, 2011, DEEP-SEA RES PT I, V58, P338, DOI 10.1016/j.dsr.2011.01.006; Martin P, 2010, LIMNOL OCEANOGR, V55, P604, DOI 10.4319/lo.2009.55.2.0604; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; MICHAELS AF, 1995, J PLANKTON RES, V17, P131, DOI 10.1093/plankt/17.1.131; MICHAELS AF, 1988, MAR BIOL, V97, P559, DOI 10.1007/BF00391052; Muller H, 1999, AQUAT MICROB ECOL, V17, P37, DOI 10.3354/ame017037; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Popofsky A, 1908, ZOOLOGIE 2, V10, P183; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; REID PC, 1987, MAR BIOL, V95, P221, DOI 10.1007/BF00409009; Richardson TL, 1998, J PLANKTON RES, V20, P219, DOI 10.1093/plankt/20.2.219; Salani FS, 2012, ISME J, V6, P713, DOI 10.1038/ismej.2011.138; Salter I, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003977; SCHEWIAKOFF W., 1926, FAUNA E FLORA DEL GOLFO NAPOLI MONOGR, V37, P1; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Schiebel Ralf, 2005, Palaeontologische Zeitschrift, V79, P135; Schnetzer A, 2011, DEEP-SEA RES PT I, V58, P16, DOI 10.1016/j.dsr.2010.10.003; Shaked Y, 2006, MAR ECOL PROG SER, V325, P59, DOI 10.3354/meps325059; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; SPINDLER M, 1990, MAR MICROPALEONTOL, V15, P209, DOI 10.1016/0377-8398(90)90011-A; Suzuki Noritoshi, 2009, Bulletin of the National Museum of Nature and Science Series B-Botany, V35, P169; SWANBERG NR, 1991, J PLANKTON RES, V13, P287, DOI 10.1093/plankt/13.2.287; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan Z., 1989, Studia Marina Sinica, P127; Vaidya G, CLADISTICS IN PRESS; VILLAREAL TA, 1993, NATURE, V363, P709, DOI 10.1038/363709a0; von Dassow P, 2011, J PLANKTON RES, V33, P3, DOI 10.1093/plankt/fbq137; Whitehouse MJ, 2012, DEEP-SEA RES PT II, V59, P47, DOI 10.1016/j.dsr2.2011.05.010	70	41	43	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53598	10.1371/journal.pone.0053598	http://dx.doi.org/10.1371/journal.pone.0053598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326463	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000314705800057
J	Hou, L; Zhao, XH; Wang, P; Ning, Q; Meng, M; Liu, CG				Hou, Lei; Zhao, Xinhan; Wang, Pei; Ning, Qian; Meng, Min; Liu, Caigang			Antitumor Activity of Antimicrobial Peptides Containing CisoDGRC in CD13 Negative Breast Cancer Cells	PLOS ONE			English	Article							TUMOR PROGRESSION; NGR; ISOASPARTATE; MEMBRANE; INTEGRIN; BINDING; ISODGR; ALPHA(V)BETA(3); ANGIOGENESIS	Backgroud: isoAsp-Gly-Arg (isoDGR) is a derivative of the Asn-Gly-Arg (NGR) motif, which is used as a targeted delivery tool to aminopeptidase N (CD13) positive cells. Recent studies have shown that cyclic isoDGR (CisoDGRC) has a more efficient affinity with alpha(v)beta(3), a type of integrin that overexpresses in tumor cells. Antimicrobial peptides (AMPs) are an efficient antitumor peptide that specifically kills tumor cells. In the present study, we designed antimicrobial peptides containing the CisoDGRC motif (CDAK) and assessed its antitumor activity for CD13(-)/alpha(v)beta(+)(3) breast cancer cells (MCF-7 and MDA-MB-231) in vitro and in vivo. Methods: In vitro: We assessed the cytotoxicity of CDAK for MCF-7 and MDA-MB-231 breast cancer cells, the human umbilical vein endothelial cell (HUVEC), and human foreskin fibroblasts (HFF). We performed an apoptosis assay using Annexin-V/PI, DNA ladder, mitochondrial membrane potential, and Caspase-3 and Bcl-2. The effect on cell cycles and affinity with cell were tested using flow cytometry and fluorescent microscopy and the effect on invasion was analyzed using an invasion assay. CDAK was injected intravenously into tumor-bearing athymic nude mice in vivo experiment. Results: CDAK showed cytotoxic activity in MCF-7 and MDA-MB-231 cells, whereas HUVEC and HFF were less sensitive to the peptides. CDAK induced apoptosis, reduced mitochondrial membrane potential, promoted Caspase-3, and inhibited Bcl-2 expression in the two breast cancer cell lines. In addition, CDAK inhibited proliferation of cancer cell through S phase arrest, and own selective affinity with MCF-7 and MDA-MB-231cells, inhibited the invasion of MDA-MB-231 cells. In vivo, CDAK significant inhibited the progression of the tumor and the generation of neovascularization. Conclusion: Antimicrobial peptides containing the CisoDGRC (CDAK) motif could efficiently exhibit the antitumor activity for CD13(-)/alpha(v)beta(+)(3) breast cancer cells.	[Hou, Lei; Zhao, Xinhan; Wang, Pei; Ning, Qian; Meng, Min] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Xian 710049, Shaanxi Provinc, Peoples R China; [Liu, Caigang] China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Liaoning Provin, Peoples R China	Xi'an Jiaotong University; China Medical University	Zhao, XH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Xian 710049, Shaanxi Provinc, Peoples R China.	zhaoxinhanprof@163.com	Liu, Caigang/C-7179-2018; meng, meng/GWZ-7461-2022	Liu, Caigang/0000-0003-2083-235X; 	national natural science foundation of China [30772112.]	national natural science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant of the national natural science foundation of China (30772112.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun K, 2010, INT J MED SCI, V7, P326; Carraway KL, 2007, CURR TOP DEV BIOL, V78, P1, DOI 10.1016/S0070-2153(06)78001-2; Chen YC, 2010, MOL THER, V18, P828, DOI 10.1038/mt.2009.291; Colombo G, 2002, J BIOL CHEM, V277, P47891, DOI 10.1074/jbc.M207500200; Corti A, 2010, J ONCOL, V2010, DOI 10.1155/2010/732680; Corti A, 2011, J CELL SCI, V124, P515, DOI 10.1242/jcs.077172; Curnis F, 2008, CANCER RES, V68, P7073, DOI 10.1158/0008-5472.CAN-08-1272; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Curnis F, 2010, J BIOL CHEM, V285, P9114, DOI 10.1074/jbc.M109.044297; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Gasparini G, 1998, CLIN CANCER RES, V4, P2625; Gregorc V, 2011, CLIN CANCER RES, V17, P1964, DOI 10.1158/1078-0432.CCR-10-1376; Haier J, 2002, CLIN EXP METASTAS, V19, P665, DOI 10.1023/A:1021316531912; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Kawamoto M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-359; Law B, 2006, MOL CANCER THER, V5, P1944, DOI 10.1158/1535-7163.MCT-05-0509; Mai JC, 2001, CANCER RES, V61, P7709; Ranogajec I, 2012, MED ONCOL, V29, P561, DOI 10.1007/s12032-011-9984-y; Rizzardi GP, 2009, BLOOD, V113, P5366, DOI 10.1182/blood-2009-02-207068; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Spitaleri A, 2008, J BIOL CHEM, V283, P19757, DOI 10.1074/jbc.M710273200; Sulochana KN, 2007, CURR PHARM DESIGN, V13, P2074; van Wijngaarden P, 2005, JAMA-J AM MED ASSOC, V293, P1509, DOI 10.1001/jama.293.12.1509; von Wallbrunn A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839046; Wu JH, 2012, BIOCONJUGATE CHEM, V23, P796, DOI 10.1021/bc2006576; Zhang Z, 2005, PHARM RES-DORDR, V22, P381, DOI 10.1007/s11095-004-1875-x; Zhou TY, 2011, INT J NANOMED, V6, P1527, DOI 10.2147/IJN.S15239	28	11	14	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53491	10.1371/journal.pone.0053491	http://dx.doi.org/10.1371/journal.pone.0053491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326440	gold, Green Submitted, Green Published			2022-12-27	WOS:000314705800049
J	Welsh, AH; Lindenmayer, DB; Donnelly, CF				Welsh, Alan H.; Lindenmayer, David B.; Donnelly, Christine F.			Fitting and Interpreting Occupancy Models	PLOS ONE			English	Article							SPECIES OCCURRENCE; ABUNDANCE	We show that occupancy models are more difficult to fit than is generally appreciated because the estimating equations often have multiple solutions, including boundary estimates which produce fitted probabilities of zero or one. The estimates are unstable when the data are sparse, making them difficult to interpret, and, even in ideal situations, highly variable. As a consequence, making accurate inference is difficult. When abundance varies over sites (which is the general rule in ecology because we expect spatial variance in abundance) and detection depends on abundance, the standard analysis suffers bias (attenuation in detection, biased estimates of occupancy and potentially finding misleading relationships between occupancy and other covariates), asymmetric sampling distributions, and slow convergence of the sampling distributions to normality. The key result of this paper is that the biases are of similar magnitude to those obtained when we ignore non-detection entirely. The fact that abundance is subject to detection error and hence is not directly observable, means that we cannot tell when bias is present (or, equivalently, how large it is) and we cannot adjust for it. This implies that we cannot tell which fit is better: the fit from the occupancy model or the fit ignoring the possibility of detection error. Therefore trying to adjust occupancy models for non-detection can be as misleading as ignoring non-detection completely. Ignoring non-detection can actually be better than trying to adjust for it.	[Welsh, Alan H.] Australian Natl Univ, Ctr Math & Its Applicat, Canberra, ACT, Australia; [Lindenmayer, David B.; Donnelly, Christine F.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University; Australian National University	Welsh, AH (corresponding author), Australian Natl Univ, Ctr Math & Its Applicat, Canberra, ACT, Australia.	Alan.Welsh@anu.edu.au	Lindenmayer, David B/P-7183-2017	Lindenmayer, David B/0000-0002-4766-4088; Welsh, Alan/0000-0002-3165-9559	Australian Research Council	Australian Research Council(Australian Research Council)	Funding was received from the Australian Research Council to support this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL HL, 1980, EMU, V80, P227, DOI 10.1071/MU9800227; Carroll R., 1995, MEASUREMENT ERROR NO; Chambers RL, 2012, MONOGR STAT APPL PRO, V125, P1; Lindenmayer DB, 2008, ECOL MONOGR, V78, P567, DOI 10.1890/07-0945.1; Lindenmayer DB, 2001, BIOL CONSERV, V101, P157, DOI 10.1016/S0006-3207(01)00061-1; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McCullagh P, 1989, GEN LINEAR MODELS; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; Royle JA, 2005, ECOLOGY, V86, P2505, DOI 10.1890/04-1802; Royle JA, 2004, CONSERV BIOL, V18, P1378, DOI 10.1111/j.1523-1739.2004.00147.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Schieck J, 1997, CONDOR, V99, P179, DOI 10.2307/1370236; Simons TR, 2007, AUK, V124, P986, DOI 10.1642/0004-8038(2007)124[986:EAOTAD]2.0.CO;2; Welsh A.H., 1996, ASPECTS STAT INFEREN; Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1; Yee TW, 2008, R NEWS, V8, P28	20	122	122	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52015	10.1371/journal.pone.0052015	http://dx.doi.org/10.1371/journal.pone.0052015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326323	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400006
J	Battivelli, E; Lecossier, D; Clavel, F; Hance, AJ				Battivelli, Emilie; Lecossier, Denise; Clavel, Francois; Hance, Allan J.			Delaying Reverse Transcription Does Not Increase Sensitivity of HIV-1 to Human TRIM5 alpha	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYCLOPHILIN-A; HUMAN-CELLS; RETROVIRAL RESTRICTION; PREINTEGRATION COMPLEX; RHESUS TRIM5-ALPHA; ANTIVIRAL ACTIVITY; TRIM5 PROTEINS; RING DOMAIN; DNA FLAP	Background: Because uncoating of the capsid is linked to reverse transcription, modifications that delay this process lead to the persistence in the cytoplasm of capsids susceptible to recognition by the human restriction factor TRIM5 alpha (hTRIM5 alpha). It is unknown, however, if increasing the time available for capsid-hTRIM5 alpha interactions would actually render viruses more sensitive to hTRIM5 alpha. Results: Viral sensitivity to hTRIM5 alpha was evaluated by comparing their replication in human U373-X4 cells in which hTRIM5 alpha activity had or had not been inhibited by overexpression of human TRIM5 gamma. No differences were observed comparing wildtype HIV-1 and variants carrying mutations in reverse transcriptase or the central polypurine tract that delayed the completion of reverse transcription. In addition, the effect of delaying the onset of reverse transcription for several hours by treating target cells with nevirapine was evaluated using viral isolates with different sensitivities to hTRIM5 alpha. Delaying reverse transcription led to a time-dependent loss in viral infectivity that was increased by inhibiting capsid-cyclophilin A interactions, but did not result in increased viral sensitivity to hTRIM5 alpha, regardless of their intrinsic sensitivity to this restriction factor. Conclusions: Consistent with prior studies, the HIV-1 capsid can be targeted for destruction by hTRIM5 alpha, but different strains display considerable variability in their sensitivity to this restriction factor. Capsids can also be lost more slowly through a TRIM5 alpha-independent process that is accelerated when capsid-cyclophilin A interactions are inhibited, an effect that may reflect changes in the intrinsic stability of the capsid. Blocking the onset or delaying reverse transcription does not, however, increase viral sensitivity to hTRIM5 alpha, indicating that the recognition of the capsids by hTRIM5 alpha is completed rapidly following entry into the cytoplasm, as previously observed for the simian restriction factors TRIM-Cyp and rhesus TRIM5 alpha.	[Battivelli, Emilie; Lecossier, Denise; Clavel, Francois; Hance, Allan J.] INSERM, U941, Paris, France; [Battivelli, Emilie; Lecossier, Denise; Clavel, Francois; Hance, Allan J.] Univ Paris Diderot, Inst Univ Hematol, Hop St Louis, Paris, France; [Hance, Allan J.] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Serv Malad Infect & Trop, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Hance, AJ (corresponding author), INSERM, U941, Paris, France.	allan.hance@inserm.fr			INSERM, Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS), Sidaction	INSERM, Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS), Sidaction	INSERM, Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS), Sidaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Arhel N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-96; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Battivelli E, 2011, J VIROL, V85, P11846, DOI 10.1128/JVI.05201-11; Battivelli E, 2011, J VIROL, V85, P7828, DOI 10.1128/JVI.00648-11; Battivelli E, 2010, J VIROL, V84, P11010, DOI 10.1128/JVI.00758-10; Berube J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-68; BILLICH A, 1995, J VIROL, V69, P2451, DOI 10.1128/JVI.69.4.2451-2461.1995; Bouchonnet F, 2005, J VIROL, V79, P812, DOI 10.1128/JVI.79.2.812-822.2005; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; CHARNEAU P, 1992, J VIROL, V66, P2814, DOI 10.1128/JVI.66.5.2814-2820.1992; Diaz-Griffero F, 2007, VIROLOGY, V369, P400, DOI 10.1016/j.virol.2007.08.032; Diaz-Griffero F, 2007, J VIROL, V81, P10362, DOI 10.1128/JVI.00703-07; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Hulme AE, 2011, P NATL ACAD SCI USA, V108, P9975, DOI 10.1073/pnas.1014522108; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Kim J, 2011, J VIROL, V85, P8116, DOI 10.1128/JVI.00341-11; Kratovac Z, 2008, J VIROL, V82, P6772, DOI 10.1128/JVI.00410-08; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Leschonsky B, 2007, J GEN VIROL, V88, P207, DOI 10.1099/vir.0.81894-0; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Luban J., 2012, MOL BIOL INT, V2012; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Maegawa H, 2008, J VIROL METHODS, V151, P249, DOI 10.1016/j.jviromet.2008.04.012; Maegawa H, 2010, VIROLOGY, V399, P212, DOI 10.1016/j.virol.2010.01.003; Matsuoka S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-21; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Passerini LD, 2006, J VIROL, V80, P2100, DOI 10.1128/JVI.80.5.2100-2105.2006; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stremlau M, 2006, VIROLOGY, V351, P112, DOI 10.1016/j.virol.2006.03.015; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Thomas DC, 2007, J VIROL, V81, P4798, DOI 10.1128/JVI.02471-06; Towers GJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-40; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yap MW, 2006, J VIROL, V80, P4061, DOI 10.1128/JVI.80.8.4061-4067.2006; Yin L, 1998, J VIROL, V72, P6430, DOI 10.1128/JVI.72.8.6430-6436.1998; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhao GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002009	53	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52434	10.1371/journal.pone.0052434	http://dx.doi.org/10.1371/journal.pone.0052434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320071	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429800014
J	Chisti, MJ; Salam, MA; Ashraf, H; Faruque, ASG; Bardhan, PK; Shahid, ASMSB; Shahunja, KM; Das, SK; Ahmed, T				Chisti, Mohammod Jobayer; Salam, Mohammed Abdus; Ashraf, Hasan; Faruque, Abu S. G.; Bardhan, Pradip Kumar; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Das, Sumon Kumar; Ahmed, Tahmeed			Predictors and Outcome of Hypoxemia in Severely Malnourished Children under Five with Pneumonia: A Case Control Design	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; LOWER RESPIRATORY-INFECTION; DEVELOPING-COUNTRIES; UNDER-5 CHILDREN; OXYGEN PROGRAM; DIARRHEA; BANGLADESH; HYPERNATREMIA; EPIDEMIOLOGY; HOSPITALS	Background: There is lack of information in the medical literature on predictors of hypoxemia in severely malnourished children with pneumonia, although hypoxemia is common and is often associated with fatal outcome in this population. We explored the predictors of hypoxemia in under-five children who were hospitalized for the management of pneumonia and severe acute malnutrition (SAM). Methods: In this unmatched case-control design, SAM children of both sexes, aged 0-59 months, admitted to the Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b) with radiological pneumonia and hypoxemia during April 2011 to April 2012 were studied. SAM children with pneumonia and hypoxemia (SpO(2)<90%) constituted the cases (n = 37), and randomly selected SAM children with pneumonia but without hypoxemia constituted controls (n = 111). Results: The case-fatality was significantly higher among the cases than the controls (30% vs. 4%; p<0.001). In logistic regression analysis, after adjusting for potential confounders such as nasal flaring, head nodding, inability to drink, and crackles in lungs, fast breathing (95% CI = 1.09-13.55), lower chest wall in-drawing (95% CI = 2.48-43.41), and convulsion at admission (95% CI = 3.14-234.01) were identified as independent predictors of hypoxemia in this population. The sensitivity of fast breathing, lower chest wall in-drawing and convulsion at admission and their 95% confidence intervals (CI) to predict hypoxemia were 84 (67-93)%, 89 (74-96)%, and 19 (9-36)% respectively, and their specificity were 53 (43-63)%, 60 (51-69)% and 98 (93-100)% respectively. Conclusion and Significance: Fast breathing and lower chest wall in-drawing were the best predictors of hypoxemia in SAM children with pneumonia. There thus, in resources poor settings where pulse oximetry is not available, identification of these simple clinical predictors of hypoxemia in such children could be reliably used for early O-2 supplementation in addition to other appropriate management to reduce morbidity and deaths.	[Chisti, Mohammod Jobayer; Ashraf, Hasan; Faruque, Abu S. G.; Bardhan, Pradip Kumar; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Das, Sumon Kumar; Ahmed, Tahmeed] Int Ctr Diarhoeal Dis Res, Ctr Nutr & Food Secur, Icddr B, Dhaka, Bangladesh; [Chisti, Mohammod Jobayer; Ashraf, Hasan; Bardhan, Pradip Kumar] Icddr B, Clin Serv, Dhaka, Bangladesh; [Salam, Mohammed Abdus] Icddr B, Res Adm Serv, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Chisti, MJ (corresponding author), Int Ctr Diarhoeal Dis Res, Ctr Nutr & Food Secur, Icddr B, Dhaka, Bangladesh.	chisti@icddrb.org	Shahunja, K M/AAR-6229-2020; Das, Sumon Kumar/AAD-1551-2019; Chisti, Mohammod J/A-7216-2018; Das, Sumon Kumar/T-6384-2019	Shahunja, K M/0000-0002-9345-206X; 	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B) [Gr-00233]; Australian Agency for International Development; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperation Agency; Department for International Development, United Kingdom	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B); Australian Agency for International Development; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperation Agency; Department for International Development, United Kingdom	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B; grant no Gr-00233) and its donors, which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Alam Nure H, 2003, Paediatr Drugs, V5, P151, DOI 10.2165/00128072-200305030-00002; Chisti MJ, 2011, TROP MED INT HLTH; Chisti MJ, 2007, ACTA PAEDIATR, V96, P693, DOI 10.1111/j.1651-2227.2007.00192.x; Chisti MJ, 2011, ACTA PAEDIATR, V100, pE275, DOI 10.1111/j.1651-2227.2011.02368.x; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Duke T, 2002, ARCH DIS CHILD, V86, P108, DOI 10.1136/adc.86.2.108; DYKE T, 1995, J TROP PEDIATRICS, V41, P196, DOI 10.1093/tropej/41.4.196; Lodha Rakesh, 2004, Indian Pediatr, V41, P129; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; Matai S, 2008, ANN TROP PAEDIATR, V28, P71, DOI 10.1179/146532808X270716; Morgan G, 1997, LANCET, V349, P1693, DOI 10.1016/S0140-6736(96)12038-9; ONYANGO FE, 1993, BRIT MED J, V306, P612, DOI 10.1136/bmj.306.6878.612; Rahman M M, 1997, Bangladesh Med Res Counc Bull, V23, P47; REDD SC, 1994, T ROY SOC TROP MED H, V88, P307, DOI 10.1016/0035-9203(94)90092-2; SAMADI AR, 1983, BRIT MED J, V286, P671, DOI 10.1136/bmj.286.6366.671; Smyth A, 1998, ANN TROP PAEDIATR, V18, P31, DOI 10.1080/02724936.1998.11747923; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Suskind DMK, 1990, MALNOURISHED CHILD; Terborg C, MED KLIN INTENSIVMED; Wandi F, 2006, ANN TROP PAEDIATR, V26, P277, DOI 10.1179/146532806X152791; Weber MW, 1997, ARCH DIS CHILD, V76, P310, DOI 10.1136/adc.76.4.310; West JB., 2008, WESTS RESP PHYSL ESS, V9th; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	27	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e51376	10.1371/journal.pone.0051376	http://dx.doi.org/10.1371/journal.pone.0051376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320066	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800008
J	Gustafsson, E; Almonte-Becerril, M; Bloch, W; Costell, M				Gustafsson, Erika; Almonte-Becerril, Maylin; Bloch, Wilhelm; Costell, Mercedes			Perlecan Maintains Microvessel Integrity In Vivo and Modulates Their Formation In Vitro	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; FIBROBLAST-GROWTH-FACTOR; SCHWARTZ-JAMPEL-SYNDROME; HEPARAN-SULFATE; BASEMENT-MEMBRANES; ALPHA-2-BETA-1 INTEGRIN; ENDOTHELIAL-CELLS; DEFICIENT MICE; TUMOR-GROWTH; ANGIOGENESIS	Perlecan is a heparan sulfate proteoglycan assembled into the vascular basement membranes (BMs) during vasculogenesis. In the present study we have investigated vessel formation in mice, teratomas and embryoid bodies (EBs) in the absence of perlecan. We found that perlecan was dispensable for blood vessel formation and maturation until embryonic day (E) 12.5. At later stages of development 40% of mutant embryos showed dilated microvessels in brain and skin, which ruptured and led to severe bleedings. Surprisingly, teratomas derived from perlecan-null ES cells showed efficient contribution of perlecan-deficient endothelial cells to an apparently normal tumor vasculature. However, in perlecan-deficient EBs the area occupied by an endothelial network and the number of vessel branches were significantly diminished. Addition of FGF-2 but not VEGF(165) rescued the in vitro deficiency of the mutant ES cells. Furthermore, in the absence of perlecan in the EB matrix lower levels of FGFs are bound, stored and available for cell surface presentation. Altogether these findings suggest that perlecan supports the maintenance of brain and skin subendothelial BMs and promotes vasculo- and angiogenesis by modulating FGF-2 function.	[Gustafsson, Erika] Lund Univ, Dept Expt Pathol, Lund, Sweden; [Almonte-Becerril, Maylin; Costell, Mercedes] Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain; [Almonte-Becerril, Maylin] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Infect & Patogenesis Mol, Mexico City, DF, Mexico; [Bloch, Wilhelm] Dept Mol & Cellular Sport Med, Cologne, Germany	Lund University; University of Valencia; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Costell, M (corresponding author), Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain.	Mercedes.Costell@uv.es	ALMONTE-BECERRIL, MAYLIN/F-2830-2019; Costell, Mercedes/H-7850-2015	Costell, Mercedes/0000-0001-6146-996X; ALMONTE-BECERRIL, MAYLIN/0000-0003-1552-5961	Universitat de Valencia; University of Lund; Deutsche Forschungsgemeinschaft [DFG419/2]	Universitat de Valencia; University of Lund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Universitat de Valencia (to M. C.) and the University of Lund (to E. G.). W. B. was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG419/2). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adatia R, 1997, ANN ONCOL, V8, P1257, DOI 10.1023/A:1008243115385; Arikawa-Hirasawa E, 2002, AM J HUM GENET, V70, P1368, DOI 10.1086/340390; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2008, MICROSC RES TECHNIQ, V71, P339, DOI 10.1002/jemt.20562; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chadderton NS, 2003, INT J BIOCHEM CELL B, V35, P1052, DOI 10.1016/S1357-2725(02)00299-6; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Eberhard A, 2000, CANCER RES, V60, P1388; Eklund L, 2001, P NATL ACAD SCI USA, V98, P1194, DOI 10.1073/pnas.031444798; Feitsma K, 2000, J BIOL CHEM, V275, P9396, DOI 10.1074/jbc.275.13.9396; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Garl PJ, 2004, CIRC RES, V94, P175, DOI 10.1161/01.RES.0000109791.69181.B6; Giros A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-29; Gohring W, 1998, EUR J BIOCHEM, V255, P60, DOI 10.1046/j.1432-1327.1998.2550060.x; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Handler M, 1997, AIDAJA630CO2H; Henry MD, 2001, J CELL SCI, V114, P1137; Ishijima M, 2012, MATRIX BIOL, V31, P234, DOI 10.1016/j.matbio.2012.02.006; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kazemi S, 2002, CELL PHYSIOL BIOCHEM, V12, P55, DOI 10.1159/000063781; Kinsella MG, 2003, ARTERIOSCL THROM VAS, V23, P608, DOI 10.1161/01.ATV.0000063109.94810.EE; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Mathiak M, 1997, CANCER RES, V57, P2130; Miosge N, 2003, J HISTOCHEM CYTOCHEM, V51, P285, DOI 10.1177/002215540305100303; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Montanez E, 2007, METHOD ENZYMOL, V426, P239, DOI 10.1016/S0076-6879(07)26012-4; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; RISAU W, 1988, DEVELOPMENT, V102, P471; RISAU W, 1988, DEV BIOL, V125, P441, DOI 10.1016/0012-1606(88)90225-4; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Sakai K, 2009, J BIOL CHEM, V284, P22491, DOI 10.1074/jbc.M109.025148; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Segev A, 2004, CARDIOVASC RES, V63, P603, DOI 10.1016/j.cardiores.2004.03.028; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Tran PK, 2004, CIRC RES, V94, P550, DOI 10.1161/01.RES.0000117772.86853.34; Wickstrom SA, 2003, CANCER CELL, V3, P513, DOI 10.1016/S1535-6108(03)00143-0; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810; Zhu JW, 2002, DEVELOPMENT, V129, P2891; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010	56	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53715	10.1371/journal.pone.0053715	http://dx.doi.org/10.1371/journal.pone.0053715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320101	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800066
J	Haselhorst, DS; Moreno, JE; Punyasena, SW				Haselhorst, Derek S.; Enrique Moreno, J.; Punyasena, Surangi W.			Variability within the 10-Year Pollen Rain of a Seasonal Neotropical Forest and Its Implications for Paleoenvironmental and Phenological Research	PLOS ONE			English	Article							EL-NINO; TROPICAL TREES; CLIMATE; VEGETATION; DISPERSAL; PATTERNS; SPECTRA; RECORD; DIFFERENTIATION; REPRESENTATION	Tropical paleoecologists use a combination of mud-water interface and modern pollen rain samples (local samples of airborne pollen) to interpret compositional changes within fossil pollen records. Taxonomic similarities between the composition of modern assemblages and fossil samples are the basis of reconstructing paleoclimates and paleoenvironments. Surface sediment samples reflect a time-averaged accumulation of pollen spanning several years or more. Due to experimental constraints, modern pollen rain samples are generally collected over shorter timeframes (1-3 years) and are therefore less likely to capture the full range of natural variability in pollen rain composition and abundance. This potentially biases paleoenvironmental interpretations based on modern pollen rain transfer functions. To determine the degree to which short-term environmental change affects the composition of the aerial pollen flux of Neotropical forests, we sampled ten years of the seasonal pollen rain from Barro Colorado Island, Panama and compared it to climatic and environmental data over the same ten-year span. We establish that the pollen rain effectively captured the strong seasonality and stratification of pollen flow within the forest canopy and that individual taxa had variable sensitivity to seasonal and annual changes in environmental conditions, manifested as changes in pollen productivity. We conclude that modern pollen rain samples capture the reproductive response of moist tropical plants to short-term environmental change, but that consequently, pollen rain-based calibrations need to include longer sampling periods (>= 7 years) to reflect the full range of natural variability in the pollen output of a forest and simulate the time-averaging present in sediment samples. Our results also demonstrate that over the long-term, pollen traps placed in the forest understory are representative samples of the pollen output of both canopy and understory vegetation. Aerial pollen traps, therefore, also represent an underutilized means of monitoring the pollen productivity and reproductive behavior of moist tropical forests.	[Haselhorst, Derek S.; Punyasena, Surangi W.] Univ Illinois, Program Ecol Evolut & Conservat Biol, Urbana, IL 61801 USA; [Enrique Moreno, J.] Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archaeol, Panama City, Panama; [Punyasena, Surangi W.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Illinois System; University of Illinois Urbana-Champaign	Punyasena, SW (corresponding author), Univ Illinois, Program Ecol Evolut & Conservat Biol, Urbana, IL 61801 USA.	punyasena@life.illinois.edu	Punyasena, Surangi/C-9134-2011	Punyasena, Surangi/0000-0003-2110-5840	University of Illinois Campus Research Board [09236, 11239]; University of Illinois Center for Latin American and Caribbean Studies Tinker Travel Grant; U.S. National Science Foundation [NSF EF-1137396]; Direct For Biological Sciences [1137396] Funding Source: National Science Foundation	University of Illinois Campus Research Board; University of Illinois Center for Latin American and Caribbean Studies Tinker Travel Grant; U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the University of Illinois Campus Research Board (Grants #09236 and #11239) to SWP and a University of Illinois Center for Latin American and Caribbean Studies Tinker Travel Grant to DSH. SWP acknowledges additional support from the U.S. National Science Foundation (NSF EF-1137396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler GH, 2000, BIOTROPICA, V32, P686, DOI 10.1646/0006-3606(2000)032[0686:RPOATC]2.0.CO;2; [Anonymous], 1976, J BIOGEOGR, DOI DOI 10.2307/3038013; Behling H, 1998, REV PALAEOBOT PALYNO, V99, P143, DOI 10.1016/S0034-6667(97)00044-4; Behling H, 1997, REV PALAEOBOT PALYNO, V97, P287, DOI 10.1016/S0034-6667(96)00073-5; BORCHERT R, 1980, ECOLOGY, V61, P1065, DOI 10.2307/1936825; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Burn MJ, 2010, PALAEOGEOGR PALAEOCL, V295, P1, DOI 10.1016/j.palaeo.2010.05.009; Bush M.B., 1991, HOLOCENE, V1, P162, DOI DOI 10.1177/095968369100100209; Bush MB, 1998, GLOBAL ECOL BIOGEOGR, V7, P379, DOI 10.2307/2997685; BUSH MB, 1992, J VEG SCI, V3, P275, DOI 10.2307/3235691; Bush MB, 2000, QUATERNARY RES, V54, P132, DOI 10.1006/qres.2000.2138; BUSH MB, 1995, AM NAT, V145, P594, DOI 10.1086/285757; Bush MB, 2001, GLOBAL ECOL BIOGEOGR, V10, P359, DOI 10.1046/j.1466-822X.2001.00247.x; Bush NB, 2001, J TROP ECOL, V17, P729, DOI 10.1017/S0266467401001547; Colinvaux P., 1999, AMAZON POLLEN MANUAL; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Colinvaux PA, 2001, PALAEOGEOGR PALAEOCL, V166, P51, DOI 10.1016/S0031-0182(00)00201-7; Condit R, 1998, CLIMATIC CHANGE, V39, P413, DOI 10.1023/A:1005395806800; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; Correa-Metrio A, 2011, HOLOCENE, V21, P681, DOI 10.1177/0959683610391321; Croat T.B., 1978, FLORA BARRO COLORADO; DAVIS MB, 1960, ECOLOGY, V41, P346, DOI 10.2307/1930226; FRANKIE GW, 1974, J ECOL, V62, P881, DOI 10.2307/2258961; Gonzalez C, 2006, PALAEOGEOGR PALAEOCL, V234, P62, DOI 10.1016/j.palaeo.2005.10.019; Gosling WD, 2005, QUATERNARY RES, V64, P284, DOI 10.1016/j.yqres.2005.08.008; Gosling WD, 2003, HOLOCENE, V13, P613, DOI 10.1191/0959683603hl649rr; Gosling WD, 2009, REV PALAEOBOT PALYNO, V153, P70, DOI 10.1016/j.revpalbo.2008.06.007; GRANT PR, 1987, OIKOS, V49, P55, DOI 10.2307/3565554; Iversen J, 1989, J BIOGEOGR; Jackson ST, 1999, BOT REV, V65, P39, DOI 10.1007/BF02856557; Jones HT, 2011, REV PALAEOBOT PALYNO, V164, P223, DOI 10.1016/j.revpalbo.2011.01.001; KERSHAW AP, 1990, REV PALAEOBOT PALYNO, V64, P281, DOI 10.1016/0034-6667(90)90143-7; KERSHAW AP, 1994, REV PALAEOBOT PALYNO, V83, P83, DOI 10.1016/0034-6667(94)90060-4; Leigh EG, 1999, TROPICAL FOREST ECOL; Lobo JA, 2003, AM J BOT, V90, P1054, DOI 10.3732/ajb.90.7.1054; MACHADO JL, 1994, TREE PHYSIOL, V14, P219, DOI 10.1093/treephys/14.3.219; MORI S A, 1976, Biotropica, V8, P184, DOI 10.2307/2989684; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; OPLER P A, 1975, Biotropica, V7, P234, DOI 10.2307/2989736; Paton S, METEOROLOGICAL HYDRO; PUTZ FE, 1984, ECOLOGY, V65, P1713, DOI 10.2307/1937767; Rodgers JC, 1996, PALAEOGEOGR PALAEOCL, V124, P53, DOI 10.1016/0031-0182(96)00004-1; Roubik D.W., 1991, POLLEN SPORES BARRO; Seppa H, 2004, J BIOGEOGR, V31, P251, DOI 10.1111/j.1365-2699.2004.00923.x; STOCKMARR J, 1971, Pollen et Spores, V13, P615; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; Travers SE, 1999, BIOTROPICA, V31, P159; Valderrama MJ, 2010, BIOMETRICS, V66, P578, DOI 10.1111/j.1541-0420.2009.01293.x; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; WRIGHT SJ, 1994, AM NAT, V143, P192, DOI 10.1086/285600; WRIGHT SJ, 1991, ECOLOGY, V72, P1643, DOI 10.2307/1940964; Wright SJ, 2004, ECOLOGY, V85, P484, DOI 10.1890/02-0757; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890	53	21	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53485	10.1371/journal.pone.0053485	http://dx.doi.org/10.1371/journal.pone.0053485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320089	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800054
J	Nielsen, R; Norrelund, H; Kampmann, U; Botker, HE; Moller, N; Wiggers, H				Nielsen, Roni; Norrelund, Helene; Kampmann, Ulla; Botker, Hans Erik; Moller, Niels; Wiggers, Henrik			Effect of Acute Hyperglycemia on Left Ventricular Contractile Function in Diabetic Patients with and without Heart Failure: Two Randomized Cross-Over Studies	PLOS ONE			English	Article							TISSUE DOPPLER-ECHOCARDIOGRAPHY; FREE FATTY-ACIDS; GLUCOSE-UPTAKE; C-PEPTIDE; INSULIN; METABOLISM; EXERCISE; DISEASE; CYCLE	Background: It is unknown whether changes in circulating glucose levels due to short-term insulin discontinuation affect left ventricular contractile function in type 2 diabetic patients with (T2D-HF) and without (T2D-nonHF) heart failure. Materials and Methods: In two randomized cross-over-designed trials, 18 insulin-treated type 2 diabetic patients with (Ejection Fraction (EF) 36 +/- 6%, n = 10) (trial 2) and without systolic heart failure (EF 60 +/- 3%, n = 8) (trial 1) were subjected to hyper- and normoglycemia for 9-12 hours on two different occasions. Advanced echocardiography, bicycle exercise tests and 6-minute hall walk distance were applied. Results: Plasma glucose levels differed between study arms (6.5 +/- 0.8 mM vs 14.1 +/- 2.6 mM (T2D-HF), 5.8 +/- 0.4 mM vs 9.9 +/- 2.1 mM (T2D-nonHF), p<0.001). Hyperglycemia was associated with an increase in several parameters: maximal global systolic tissue velocity (Vmax) (p<0.001), maximal mitral annulus velocity (S'max) (p<0.001), strain rate (p = 0.02) and strain (p = 0.05). Indices of increased myocardial systolic contractile function were significant in both T2D-HF (Vmax: 14%, p = 0.02; S'max: 10%, p = 0.04), T2D-nonHF (Vmax: 12%, p<0.01; S'max: 9%, p<0.001) and in post exercise S'max (7%, p = 0.049) during hyperglycemia as opposed to normoglycemia. LVEF did not differ between normo- and hyperglycemia (p = 0.17), and neither did peak exercise capacity nor catecholamine levels. Type 2 diabetic heart failure patients' 6-minute hall walk distance improved by 7% (p = 0.02) during hyperglycemia as compared with normoglycemia. Conclusions: Short-term hyperglycemia by insulin discontinuation is associated with an increase in myocardial systolic contractile function in type 2 diabetic patients with and without heart failure and with a slightly prolonged walking distance in type 2 diabetic heart failure patients. (Clinicaltrials.gov identifier NCT00653510)	[Nielsen, Roni; Botker, Hans Erik; Wiggers, Henrik] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Norrelund, Helene] Viborg Hosp, Dept Med, Viborg, Denmark; [Kampmann, Ulla; Moller, Niels] Aarhus Univ Hosp, Dept Endocrinol & Metab, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Nielsen, R (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark.	roni.r.nielsen@gmail.com	Moller, Niels/E-5091-2011	Moller, Niels/0000-0001-5627-7322; Botker, Hans Erik/0000-0001-6358-8962; Wiggers, Henrik/0000-0002-9753-4142; Kampmann, Ulla/0000-0002-2234-7780	Danish Heart Foundation [R68-A2122-B983]; Food, Obesity, and Overt Cardiovascular Disease - The FOOD study group [3304-FSE-06-0505-4]; Aarhus University; Novo Nordisk Fonden [NNF13OC0007447] Funding Source: researchfish	Danish Heart Foundation; Food, Obesity, and Overt Cardiovascular Disease - The FOOD study group; Aarhus University; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study is supported by grants from the Danish Heart Foundation (R68-A2122-B983), by a grant from Food, Obesity, and Overt Cardiovascular Disease - The FOOD study group (jr. nr. 3304-FSE-06-0505-4) and Aarhus University. The authors have no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardehali H, 2012, EUR J HEART FAIL, V14, P120, DOI 10.1093/eurjhf/hfr173; Botker HE, 1997, J NUCL CARDIOL, V4, P125, DOI 10.1016/S1071-3581(97)90061-1; Cittadini A, 2012, DIABETES, V61, P944, DOI 10.2337/db11-1132; Cook SA, 2010, EUR HEART J, V31, P100, DOI 10.1093/eurheartj/ehp396; FRATI AC, 1987, CLIN CARDIOL, V10, P594, DOI 10.1002/clc.4960101017; Fugmann A, 2003, CLIN SCI, V105, P715, DOI 10.1042/CS20030036; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Ha JW, 2006, J AM SOC ECHOCARDIOG, V19, P1314, DOI 10.1016/j.echo.2006.05.022; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Halbirk M, 2010, AM J PHYSIOL-HEART C, V299, pH1220, DOI 10.1152/ajpheart.00475.2010; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Johansson BL, 2004, AM J PHYSIOL-ENDOC M, V286, pE14, DOI 10.1152/ajpendo.00236.2003; Khoury VK, 2003, HEART, V89, P61, DOI 10.1136/heart.89.1.61; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mogelvang R, 2009, EUR HEART J, V30, P731, DOI 10.1093/eurheartj/ehn596; MONTI LD, 1995, DIABETES, V44, P537, DOI 10.2337/diabetes.44.5.537; Murarka S, 2010, J CARD FAIL, V16, P971, DOI 10.1016/j.cardfail.2010.07.249; Nielsen TS, 2012, J CLIN ENDOCR METAB, V97, pE1348, DOI 10.1210/jc.2012-1159; Nikitin NP, 2006, HEART, V92, P775, DOI 10.1136/hrt.2005.067140; Nikitin NP, 2003, J AM SOC ECHOCARDIOG, V16, P906, DOI 10.1016/S0894-7317(03)00279-7; Norrelund H, 2006, J INTERN MED, V260, P11, DOI 10.1111/j.1365-2796.2006.01663.x; Olsson LG, 2005, EUR HEART J, V26, P778, DOI 10.1093/eurheartj/ehi162; Opie LH, 2004, LANCET, V364, P1733, DOI 10.1016/S0140-6736(04)17412-6; Parsonage WA, 2001, HEART, V85, P508, DOI 10.1136/heart.85.5.508; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Quintard H, 2012, J CLIN ULTRASOUND; Rassam AG, 1998, DIABETES CARE, V21, P1369, DOI 10.2337/diacare.21.8.1369; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; Smogorzewski M, 1998, KIDNEY INT, V53, P1237, DOI 10.1046/j.1523-1755.1998.00868.x; Sondergaard HM, 2006, J CLIN ENDOCR METAB, V91, P4854, DOI 10.1210/jc.2006-1416; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Swan JW, 1997, J AM COLL CARDIOL, V30, P527, DOI 10.1016/S0735-1097(97)00185-X; Taegtmeyer H, 2000, J AM COLL CARDIOL, V36, P1386, DOI 10.1016/S0735-1097(00)00870-6; Tsujita-Kuroda K, 2000, J AM SOC ECHOCARDIOG, V13, P300, DOI 10.1067/mje.2000.103962; Tuunanen H, 2006, CIRCULATION, V114, P2130, DOI 10.1161/CIRCULATIONAHA.106.645184; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; VANBEAUMONT W, 1972, J APPL PHYSIOL, V33, P55, DOI 10.1152/jappl.1972.33.1.55; Wiggers H, 2005, AM J PHYSIOL-HEART C, V289, pH938, DOI 10.1152/ajpheart.00150.2005; Wu WH, 2012, J DIABETES COMPLICAT, V26, P83, DOI 10.1016/j.jdiacomp.2012.02.010; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87	41	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53247	10.1371/journal.pone.0053247	http://dx.doi.org/10.1371/journal.pone.0053247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308171	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800032
J	Sawicka, M; Pawlikowski, J; Wilson, S; Ferdinando, D; Wu, H; Adams, PD; Gunn, DA; Parish, W				Sawicka, Magdalena; Pawlikowski, Jeffrey; Wilson, Stephen; Ferdinando, Dudley; Wu, Hong; Adams, Peter David; Gunn, David Andrew; Parish, William			The Specificity and Patterns of Staining in Human Cells and Tissues of p16INK4a Antibodies Demonstrate Variant Antigen Binding	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; LUNG-CANCER; CERVICAL BIOPSIES; EPITHELIAL-CELLS; P16; P16(INK4A); EXPRESSION; MARKER; INHIBITION; MUTATIONS	The validity of the identification and classification of human cancer using antibodies to detect biomarker proteins depends upon antibody specificity. Antibodies that bind to the tumour-suppressor protein p16INK4a are widely used for cancer diagnosis and research. In this study we examined the specificity of four commercially available anti-p16INK4a antibodies in four immunological applications. The antibodies H-156 and JC8 detected the same 16 kDa protein in western blot and immunoprecipitation tests, whereas the antibody F-12 did not detect any protein in western blot analysis or capture a protein that could be recognised by the H-156 antibody. In immunocytochemistry tests, the antibodies JC8 and H-156 detected a predominately cytoplasmic localised antigen, whose signal was depleted in p16INK4a siRNA experiments. F-12, in contrast, detected a predominately nuclear located antigen and there was no noticeable reduction in this signal after siRNA knockdown. Furthermore in immunohistochemistry tests, F-12 generated a different pattern of staining compared to the JC8 and E6H4 antibodies. These results demonstrate that three out of four commercially available p16INK4a antibodies are specific to, and indicate a mainly cytoplasmic localisation for, the p16INK4a protein. The F-12 antibody, which has been widely used in previous studies, gave different results to the other antibodies and did not demonstrate specificity to human p16INK4a. This work emphasizes the importance of the validation of commercial antibodies, aside to the previously reported use, for the full verification of immunoreaction specificity.	[Sawicka, Magdalena; Wilson, Stephen; Ferdinando, Dudley; Gunn, David Andrew; Parish, William] Unilever Discover, Sharnbrook, Beds, England; [Pawlikowski, Jeffrey; Adams, Peter David] Univ Glasgow, Inst Canc Sci, CR UK Beatson Labs, Glasgow, Lanark, Scotland; [Wu, Hong] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Unilever; University of Glasgow; Fox Chase Cancer Center	Sawicka, M (corresponding author), Unilever Discover, Colworth Sci Pk, Sharnbrook, Beds, England.	Magdalena.Sawicka@unilever.com; David.Gunn@unilever.com		Adams, Peter/0000-0002-0684-1770; Gunn, David/0000-0001-9866-3221	Unilever PLC; CRUK program [C10652/A10250]; Biotechnology and Biological Sciences Research Council [BB/H021019/1] Funding Source: researchfish; BBSRC [BB/H021019/1] Funding Source: UKRI	Unilever PLC(Unilever); CRUK program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by Unilever PLC and work in the lab of PDA was funded by CRUK program grant C10652/A10250. Authors MS, SW, DF, DG and WP were employees of Unilever at the time of the study and were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Chen JT, 2001, LUNG CANCER, V31, P163, DOI 10.1016/S0169-5002(00)00191-4; Cheng YL, 2003, EUR J CARDIO-THORAC, V23, P221, DOI 10.1016/S1010-7940(02)00749-2; Cuschieri K, 2008, CANCER EPIDEM BIOMAR, V17, P2536, DOI 10.1158/1055-9965.EPI-08-0306; Dray M, 2005, PATHOLOGY, V37, P112, DOI 10.1080/00313020500058607; Groeger AM, 1999, J THORAC CARDIOV SUR, V118, P529, DOI 10.1016/S0022-5223(99)70192-3; Haller F, 2008, J PATHOL, V215, P253, DOI 10.1002/path.2352; Haller F, 2010, HISTOPATHOLOGY, V56, P305, DOI 10.1111/j.1365-2559.2010.03478.x; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lin H, 2006, WORLD J SURG ONCOL, V7, P1; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Marra DE, 2000, CIRCULATION, V102, P2124, DOI 10.1161/01.CIR.102.17.2124; McKenzie HA, 2010, HUM MUTAT, V31, P692, DOI 10.1002/humu.21245; Melck A, 2007, ANN SURG ONCOL, V14, P3403, DOI 10.1245/s10434-007-9572-8; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nilsson K, 2006, INT J CANCER, V118, P1120, DOI 10.1002/ijc.21466; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11045, DOI 10.1073/pnas.91.23.11045; Pavey S, 1999, CANCER RES, V59, P4185; Pilon C, 1999, J CLIN ENDOCR METAB, V84, P2776, DOI 10.1210/jc.84.8.2776; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Schutte M, 1997, CANCER RES, V57, P3126; de Sa BCS, 2009, MELANOMA RES, V19, P135, DOI 10.1097/CMR.0b013e32831993f3; Volgareva G, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-58; Wang SS, 2004, CANCER EPIDEM BIOMAR, V13, P1355; Zhu CQ, 2006, J CLIN PATHOL, V59, P790, DOI 10.1136/jcp.2005.031351	26	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53313	10.1371/journal.pone.0053313	http://dx.doi.org/10.1371/journal.pone.0053313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308192	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000313429800037
J	Borgeaud, S; Blokesch, M				Borgeaud, Sandrine; Blokesch, Melanie			Overexpression of the tcp Gene Cluster Using the T7 RNA Polymerase/Promoter System and Natural Transformation-Mediated Genetic Engineering of Vibrio cholerae	PLOS ONE			English	Article							TOXIN-COREGULATED PILUS; MANNOSE-SENSITIVE HEMAGGLUTININ; GRAM-NEGATIVE BACTERIA; EL-TOR; MICROCOLONY FORMATION; CULTURE-CONDITIONS; ESCHERICHIA-COLI; CLONED GENES; DNA-SEQUENCE; BACTERIOPHAGE-T7	The human pathogen and aquatic bacterium Vibrio cholerae belongs to the group of naturally competent bacteria. This developmental program allows the bacterium to take up free DNA from its surrounding followed by a homologous recombination event, which allows integration of the transforming DNA into the chromosome. Taking advantage of this phenomenon we genetically engineered V. cholerae using natural transformation and FLP recombination. More precisely, we adapted the T7 RNA polymerase/promoter system in this organism allowing expression of genes in a T7 RNA polymerase-dependent manner. We naturally transformed V. cholerae by adding a T7-specific promoter sequence upstream the toxin-coregulated pilus (tcp) gene cluster. In a V. cholerae strain, which concomitantly produced the T7 RNA polymerase, this genetic manipulation resulted in the overexpression of downstream genes. The phenotypes of the strain were also in line with the successful production of TCP pili. This provides a proof-of-principle that the T7 RNA polymerase/promoter system is functional in V. cholerae and that genetic engineering of this organism by natural transformation is a straightforward and efficient approach.	[Borgeaud, Sandrine; Blokesch, Melanie] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Blokesch, M (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland.	melanie.blokesch@epfl.ch	Blokesch, Melanie/A-4057-2013	Blokesch, Melanie/0000-0002-7024-1489	Swiss National Science Foundation [31003A_127029]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation grant 31003A_127029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, MOL CLONING LAB MANU; BAO Y, 1991, GENE, V109, P167, DOI 10.1016/0378-1119(91)90604-A; Beyhan S, 2006, J BACTERIOL, V188, P3600, DOI 10.1128/JB.188.10.3600-3613.2006; Blokesch M, 2012, MOB GENET ELEMENTS, V2, P5; Blokesch M, 2007, PLOS PATHOG, V3, P733, DOI 10.1371/journal.ppat.0030081; Blokesch M, 2012, JOVE-J VIS EXP, DOI 10.3791/3761; Blokesch M, 2012, ENVIRON MICROBIOL, V14, P1898, DOI 10.1111/j.1462-2920.2011.02689.x; BROWN RC, 1995, MOL MICROBIOL, V16, P425, DOI 10.1111/j.1365-2958.1995.tb02408.x; CHAMBERL.M, 1970, NATURE, V228, P227, DOI 10.1038/228227a0; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; De Souza Silva O, 2010, PLASMID, V64, P186, DOI 10.1016/j.plasmid.2010.08.001; DiRita VJ, 1996, P NATL ACAD SCI USA, V93, P7991, DOI 10.1073/pnas.93.15.7991; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Faruque SM, 2003, INFECT IMMUN, V71, P2993, DOI 10.1128/IAI.71.6.2993-2999.2003; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; IKEDA RA, 1992, NUCLEIC ACIDS RES, V20, P2517, DOI 10.1093/nar/20.10.2517; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Jude BA, 2011, J STRUCT BIOL, V175, P1, DOI 10.1016/j.jsb.2011.04.008; Judson N, 2000, NAT BIOTECHNOL, V18, P740, DOI 10.1038/77305; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Krebs SJ, 2011, J BACTERIOL, V193, P5260, DOI 10.1128/JB.00378-11; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; Li J, 2012, J MOL BIOL, V418, P47, DOI 10.1016/j.jmb.2012.02.017; Lim MS, 2010, MOL MICROBIOL, V77, P755, DOI 10.1111/j.1365-2958.2010.07244.x; Lo Scrudato M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002778; Marvig RL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-155; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Medrano AI, 1999, INFECT IMMUN, V67, P2178, DOI 10.1128/IAI.67.5.2178-2183.1999; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Nielsen AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001102; OAKLEY JL, 1977, P NATL ACAD SCI USA, V74, P4266, DOI 10.1073/pnas.74.10.4266; PANAYOTATOS N, 1979, NATURE, V280, P35, DOI 10.1038/280035a0; ROSA MD, 1979, CELL, V16, P815, DOI 10.1016/0092-8674(79)90097-7; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; Seitz P, 2013, FEMS MICROBIOL REV, V37, P336, DOI 10.1111/j.1574-6976.2012.00353.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Suckow G, 2011, J BACTERIOL, V193, P4914, DOI 10.1128/JB.05396-11; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998	47	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53952	10.1371/journal.pone.0053952	http://dx.doi.org/10.1371/journal.pone.0053952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308292	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100124
J	Mehtala, ML; Lensink, MF; Pietikainen, LP; Hiltunen, JK; Glumoff, T				Mehtala, Maija L.; Lensink, Marc F.; Pietikainen, Laura P.; Hiltunen, J. Kalervo; Glumoff, Tuomo			On the Molecular Basis of D-Bifunctional Protein Deficiency Type III	PLOS ONE			English	Article							PEROXISOMAL MULTIFUNCTIONAL ENZYME; CRYSTAL-STRUCTURE; BETA-OXIDATION; DEHYDROGENASE; YEAST; RESOLUTION; SIMULATIONS; RESIDUES; DYNAMICS; SPECTRUM	Molecular basis of D-bifunctional protein (D-BP) deficiency was studied with wild type and five disease-causing variants of 3R-hydroxyacyl-CoA dehydrogenase fragment of the human MFE-2 (multifunctional enzyme type 2) protein. Complementation analysis in vivo in yeast and in vitro enzyme kinetic and stability determinants as well as in silico stability and structural fluctuation calculations were correlated with clinical data of known patients. Despite variations not affecting the catalytic residues, enzyme kinetic performance (K-m, V-max and k(cat)) of the recombinant protein variants were compromised to a varying extent and this can be judged as the direct molecular cause for D-BP deficiency. Protein stability plays an additional role in producing non-functionality of MFE-2 in case structural variations affect cofactor or substrate binding sites. Structure-function considerations of the variant proteins matched well with the available data of the patients.	[Mehtala, Maija L.; Pietikainen, Laura P.; Hiltunen, J. Kalervo; Glumoff, Tuomo] Univ Oulu, Dept Biochem, Oulu, Finland; [Mehtala, Maija L.; Pietikainen, Laura P.; Hiltunen, J. Kalervo; Glumoff, Tuomo] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Lensink, Marc F.] Univ Lille 1, Ctr Hyperfrequences & Semicond, CNRS, Interdisciplinary Res Inst, F-59655 Villeneuve Dascq, France	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Glumoff, T (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	tuomo.glumoff@oulu.fi	Lensink, Marc F/A-1678-2008	Lensink, Marc F/0000-0003-3957-9470; Hiltunen, Kalervo/0000-0002-3073-9602	Academy of Finland [1122531, 138690]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by the Academy of Finland (grant number 1122531 (to T.G.)); and the Sigrid Juselius Foundation and the Academy of Finland (grant number 138690 (to K.H.)). URL of funders: www.aka.fi and www.sigridjuselius.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; CHANDRASEKHAR J, 1984, J AM CHEM SOC, V106, P903, DOI 10.1021/ja00316a012; Churchill CDM, 2009, J PHYS CHEM B, V113, P16046, DOI 10.1021/jp907887y; Copeland KL, 2008, J PHYS CHEM B, V112, P14291, DOI 10.1021/jp805528v; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Ferdinandusse S, 2006, ANN NEUROL, V59, P92, DOI 10.1002/ana.20702; Ferdinandusse S, 2006, AM J HUM GENET, V78, P112, DOI 10.1086/498880; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; FILPPULA SA, 1995, J BIOL CHEM, V270, P27453, DOI 10.1074/jbc.270.46.27453; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gronborg S, 2010, AM J MED GENET A, V152A, P2845, DOI 10.1002/ajmg.a.33677; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Haapalainen AM, 2003, STRUCTURE, V11, P87, DOI 10.1016/S0969-2126(02)00931-0; Haapalainen AM, 2001, J MOL BIOL, V313, P1127, DOI 10.1006/jmbi.2001.5084; Haataja TJK, 2011, BIOCHEM J, V435, P771, DOI 10.1042/BJ20101661; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HILTUNEN JK, 1989, J BIOL CHEM, V264, P13536; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kashiwayama Y, 2010, J BIOL CHEM, V285, P26315, DOI 10.1074/jbc.M110.104547; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lukacik P, 2005, PDB ID 1ZBQ CRYSTAL; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Qin YM, 1999, J BIOL CHEM, V274, P28619, DOI 10.1074/jbc.274.40.28619; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Schulz G. E., 1979, PRINCIPLES PROTEIN S; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Grunsven EG, 1998, P NATL ACAD SCI USA, V95, P2128, DOI 10.1073/pnas.95.5.2128; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wanders R.J., 2001, METABOLIC MOL BASES, P3219; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001; Ylianttila MS, 2006, J MOL BIOL, V358, P1286, DOI 10.1016/j.jmb.2006.03.001	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53688	10.1371/journal.pone.0053688	http://dx.doi.org/10.1371/journal.pone.0053688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308274	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100106
J	Pham, LL; Lemaire, P; Harroche, A; Souberbielle, JC; Brauner, R				Pham, Luu-Ly; Lemaire, Pierre; Harroche, Annie; Souberbielle, Jean-Claude; Brauner, Raja			Pituitary Stalk Interruption Syndrome in 53 Postpubertal Patients: Factors Influencing the Heterogeneity of Its Presentation	PLOS ONE			English	Article							GROWTH-HORMONE DEFICIENCY; MAGNETIC-RESONANCE; CHILDREN; HYPOPITUITARISM; MUTATIONS; MORTALITY	Background: Pituitary stalk interruption syndrome (PSIS) may induce an isolated growth hormone (GH) deficiency or multiple hypothalamic-pituitary (HP) deficiencies. Patients with multiple HP deficiencies, primarily those with adrenocorticotropin (ACTH) deficiency, are at increased risk of morbidity and mortality. Our objective was to identify the factors influencing each symptom and the MRI features of the syndrome to enhance its diagnosis and genetic analysis. Methods: This study was a retrospective, single-center, case-cohort study of 53 patients with PSIS who had reached pubertal age. Results: Patients were classified as having an isolated GH deficiency (n = 24, Group 1) or HP deficiencies (n = 29, Group 2); of these, 19 had complete HP deficiency, and 10 had GH deficiency associated with TSH (n = 4), TSH and ACTH (n = 3), TSH and gonadotropin (n = 1) deficiencies or amenorrhea (n = 2). The following features were less frequent in Group 1 than in Group 2: breech presentation (4% vs 35%, P = 0.008), hypoglycemia (0% vs 59%, P<0.00001), micropenis (13% vs 69%, P<0.003), hypothalamic origin (0% vs 52%, P<0.000001), ophthalmic malformation (8% vs 38%, P<0.02) and psychomotor delay (0% vs 31%, P<0.004). The frequencies of all other malformations were similar in both groups (37% vs 59%). A visible pituitary stalk was characteristic of patients belonging to Group 1 (P<0.0002). The GH peak was greater in Group 1 than in Group 2 (P<0.0003), as was the anterior pituitary height (P = 0.01). Conclusion: The factors that best discriminate patients with multiple HP deficiencies from those with an isolated GH deficiency are breech presentation, hypoglycemia, and micropenis. No patient with an isolated GH deficiency had psychomotor delay, but associated malformations and/or syndromes, with the exception of ophthalmic disorders, occurred with similar frequencies in both groups. We have also shown that each of the above characteristics is associated with a given HP deficiency and/or malformation/syndrome in the majority of cases.	[Pham, Luu-Ly; Harroche, Annie; Brauner, Raja] Univ Paris 05, Paris, France; [Pham, Luu-Ly; Harroche, Annie; Brauner, Raja] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Lemaire, Pierre] UJF Grenoble 1, G SCOP UMR5272, Grenoble INP, CNRS, Grenoble, France; [Souberbielle, Jean-Claude] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Fondation Adolphe de Rothschild; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Brauner, R (corresponding author), Univ Paris 05, Paris, France.	raja.brauner@wanadoo.fr						Albertsson-Wikland K, 1990, ACTA PAEDIATR SC   S, V370, P121; ALBERTSSONWIKLAND K, 1990, ACTA PAEDIATR SCAND, P115; ARGYROPOULOU M, 1991, PEDIATR RADIOL, V21, P247, DOI 10.1007/BF02018614; ARGYROPOULOU M, 1992, J PEDIATR-US, V120, P886, DOI 10.1016/S0022-3476(05)81955-9; Beukhof CM, 2007, CLASSIC TRIAD VARIAN, P69; Carayol M, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, pS37; CRAFT WH, 1980, J PEDIATR-US, V96, P397, DOI 10.1016/S0022-3476(80)80680-9; Dupuis-Girod S, 2001, J PEDIATR-US, V138, P129, DOI 10.1067/mpd.2001.109200; Gascoin-Lachambre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016367; Groisne C, 2002, HORM RES, V58, P94, DOI 10.1159/000064660; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Le Ray C, 2006, OBSTET GYNECOL, V107, P1269; Leblanc T, 2003, J PEDIATR-US, V142, P358, DOI 10.1067/mpd.2003.57; Leroy B, 1971, Rev Fr Gynecol Obstet, V66, P391; Pham LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026516; Machinis K, 2001, AM J HUM GENET, V69, P961, DOI 10.1086/323764; Mcnay DEG, 2007, J CLIN ENDOCR METAB, V92, P691, DOI 10.1210/jc.2006-1609; Melo ME, 2007, CLIN ENDOCRINOL, V66, P95, DOI 10.1111/j.1365-2265.2006.02692.x; Mills JL, 2004, J PEDIATR-US, V144, P430, DOI 10.1016/j.jpeds.2003.12.036; Murray PG, 2008, CLIN ENDOCRINOL, V69, P597, DOI 10.1111/j.1365-2265.2008.03236.x; Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450; Rayl J, 1996, AM J OBSTET GYNECOL, V174, P28, DOI 10.1016/S0002-9378(96)70368-X; Reynaud R, 2011, EUR J ENDOCRINOL, V164, P457, DOI 10.1530/EJE-10-0892; Reynaud R, 2012, J CLIN ENDOCR METAB, V97, pE1068, DOI 10.1210/jc.2011-3056; RONA RJ, 1977, ARCH DIS CHILD, V52, P197, DOI 10.1136/adc.52.3.197; ROOT AW, 1989, AM J DIS CHILD, V143, P366, DOI 10.1001/archpedi.1989.02150150124031; Rottembourg D, 2008, CLIN ENDOCRINOL, V69, P105, DOI 10.1111/j.1365-2265.2007.03155.x; Simon D, 2006, CLIN ENDOCRINOL, V64, P416, DOI 10.1111/j.1365-2265.2006.02484.x; Baquedano MS, 2010, J CLIN ENDOCR METAB, V95, pE98, DOI 10.1210/jc.2010-0223; STEENDIJK R, 1980, HELV PAEDIATR ACTA, V35, P129; Taback SP, 1996, J CLIN ENDOCR METAB, V81, P1693, DOI 10.1210/jc.81.5.1693; TRIULZI F, 1994, PEDIATRICS, V93, P409; Trivin C, 2007, GROWTH HORM IGF RES, V17, P122, DOI 10.1016/j.ghir.2006.12.007; Woods KS, 2005, AM J HUM GENET, V76, P833, DOI 10.1086/430134	34	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53189	10.1371/journal.pone.0053189	http://dx.doi.org/10.1371/journal.pone.0053189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308160	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100036
J	Zhang, X; Reinhardt, JD; Gosney, JE; Li, JN				Zhang, Xia; Reinhardt, Jan D.; Gosney, James E.; Li, Jianan			The NHV Rehabilitation Services Program Improves Long-Term Physical Functioning in Survivors of the 2008 Sichuan Earthquake: A Longitudinal Quasi Experiment	PLOS ONE			English	Article							WENCHUAN EARTHQUAKE; DISASTER RELIEF; RESCUE EFFORTS; HEALTH; INJURY; CHINA; DISABILITY; EMERGENCY; OUTCOMES; VICTIMS	Background: Long-term disability following natural disasters significantly burdens survivors and the impacted society. Nevertheless, medical rehabilitation programming has been historically neglected in disaster relief planning. 'NHV' is a rehabilitation services program comprised of non-governmental organizations (NGOs) (N), local health departments (H), and professional rehabilitation volunteers (V) which aims to improve long-term physical functioning in survivors of the 2008 Sichuan earthquake. We aimed to evaluate the effectiveness of the NHV program. Methods/Findings: 510 of 591 enrolled earthquake survivors participated in this longitudinal quasi-experimental study (86.3%). The early intervention group (NHV-E) consisted of 298 survivors who received institutional-based rehabilitation (IBR) followed by community-based rehabilitation (CBR); the late intervention group (NHV-L) was comprised of 101 survivors who began rehabilitation one year later. The control group of 111 earthquake survivors did not receive IBR/CBR. Physical functioning was assessed using the Barthel Index (BI). Data were analyzed with a mixed-effects Tobit regression model. Physical functioning was significantly increased in the NHV-E and NHV-L groups at follow-up but not in the control group after adjustment for gender, age, type of injury, and time to measurement. We found significant effects of both NHV (11.14, 95% CI 9.0-13.3) and sponaneaous recovery (5.03; 95% CI 1.73-8.34). The effect of NHV-E (11.3, 95% CI 9.0-13.7) was marginally greater than that of NHV-L (10.7, 95% CI 7.9-13.6). It could, however, not be determined whether specific IBR or CBR program components were effective since individual component exposures were not evaluated. Conclusion: Our analysis shows that the NHV improved the long-term physical functioning of Sichuan earthquake survivors with disabling injuries. The comprehensive rehabilitation program benefitted the individual and society, rehabilitation services in China, and international rehabilitation disaster relief planning. Similar IBR/CBR programs should therefore be considered for future large-scale rehabilitation disaster relief efforts.	[Zhang, Xia; Li, Jianan] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Xia; Reinhardt, Jan D.; Gosney, James E.; Li, Jianan] WHO, Liaison Subcomm Rehabil Disaster Relief, Int Soc Phys & Rehabil Med, CH-1211 Geneva, Switzerland; [Reinhardt, Jan D.] Swiss Parapleg Res, Nottwil, Switzerland; [Reinhardt, Jan D.] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland	Nanjing Medical University; World Health Organization; Swiss Paraplegic Research; University of Lucerne	Li, JN (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	lijianan@carm.org.cn			Hong Kong Caring for Children Foundation; Chinese Association of Rehabilitation Medicine; Nanjing Medical University; Handicap International; Sichuan Province and Mianzhu County Government; Mianzhu County People's Hospital; Anxian Traditional Chinese Medicine Hospital; Hong Kong Rehabilitation Society	Hong Kong Caring for Children Foundation; Chinese Association of Rehabilitation Medicine; Nanjing Medical University; Handicap International; Sichuan Province and Mianzhu County Government; Mianzhu County People's Hospital; Anxian Traditional Chinese Medicine Hospital; Hong Kong Rehabilitation Society	This study was funded by the Hong Kong Caring for Children Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of the Hong Kong Caring For Children Foundation, the Chinese Association of Rehabilitation Medicine, the Nanjing Medical University, Handicap International, the Sichuan Province and Mianzhu County Government, the Mianzhu County People's Hospital, the Anxian Traditional Chinese Medicine Hospital, and the Hong Kong Rehabilitation Society. We deeply thank the rehabilitation volunteers who participated in this study. The investigation would not have been possible without the significant contributions of Xiaorong Hu, Sijing Chen, and Shouguo Liu, who were intimately involved in NHV design and data collection. Carolina Ballert, Nandini Devi, Bernd Fellinghauer, Per von Groote, Andrew Pennycott, and Sheng Cai are kindly acknowledged as well for their technical contributions.	Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Burns AS, 2012, J REHABIL MED, V44, P414, DOI 10.2340/16501977-0974; Chan EYY, 2011, EUR J EMERG MED, V18, P111, DOI 10.1097/MEJ.0b013e32833dba19; Chen Jin, 2009, J Evid Based Med, V2, P270, DOI 10.1111/j.1756-5391.2009.01053.x; CRED, 2012, EM DAT INT DIS DAT; Dong ZH, 2009, NEW ENGL J MED, V361, P636, DOI 10.1056/NEJMc0903047; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gosney J, 2011, J REHABIL MED, V43, P965, DOI 10.2340/16501977-0890; Gu JW, 2010, EMERG MED J, V27, P216, DOI 10.1136/emj.2008.065342; Kett M, 2009, LANCET, V374, P1801, DOI 10.1016/S0140-6736(09)62024-9; Knowlton LM, 2011, PREHOSP DISASTER MED, V26, P438, DOI 10.1017/S1049023X12000076; Landry MD, 2010, DISABIL REHABIL, V32, P1616, DOI 10.3109/09638288.2010.500345; Leung SOC, 2007, CLIN REHABIL, V21, P912, DOI 10.1177/0269215507077286; Li YQ, 2012, J REHABIL MED, V44, P534, DOI 10.2340/16501977-1005; Li Yuanfeng, 2009, J Evid Based Med, V2, P258, DOI 10.1111/j.1756-5391.2009.01045.x; [宁宁 NING Ning], 2008, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V8, P496; Rabe-Hesketh S, 2004, TOBIT GLLAMM; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Rathore FA, 2012, ARCH PHYS MED REHABI; Rathore FA, 2012, ARCH PHYS MED REHAB, V93, P1875, DOI 10.1016/j.apmr.2012.05.018; Redmond AD, 2011, EMERG MED J, V28, P516, DOI 10.1136/emj.2009.089920; Redmond AD, 2011, PREHOSP DISASTER MED, V26, P449, DOI 10.1017/S1049023X12000088; Redmond AD, 2011, LANCET, V377, P1054, DOI 10.1016/S0140-6736(11)60319-X; Reinhardt JD, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7191; Roy N, 2011, DISASTER MED PUBLIC, V5, P112, DOI 10.1001/dmp.2011.35; Twisk J, 2009, J CLIN EPIDEMIOL, V62, P953, DOI 10.1016/j.jclinepi.2008.10.003; WAECKERLE JF, 1991, NEW ENGL J MED, V324, P815; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2001, WHO INT CLASS FUNCT; Wong CNC, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-43; World Health Organisation (WHO), 2005, DIS DIS REH; World Health Organization, 2010, COMM BAS REH CBR GUI; Xiao MY, 2011, J REHABIL MED, V43, P515, DOI 10.2340/16501977-0813; You CM, 2009, J PUBLIC HEALTH POL, V30, P379, DOI 10.1057/jphp.2009.30; Zhang LL, 2012, LANCET, V379, P853, DOI 10.1016/S0140-6736(11)61876-X; Zhang LL, 2011, EMERG MED J, V28, P618, DOI 10.1136/emj.2009.087296; Zhang X, 2012, J REHABIL MED, V44, P206, DOI 10.2340/16501977-0945	38	23	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53995	10.1371/journal.pone.0053995	http://dx.doi.org/10.1371/journal.pone.0053995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308293	Green Published, gold			2022-12-27	WOS:000313429100125
J	Etich, J; Bergmeier, V; Frie, C; Kreft, S; Bengestrate, L; Eming, S; Mauch, C; Eckes, B; Ulus, H; Lund, FE; Rappl, G; Abken, H; Paulsson, M; Brachvogel, B				Etich, Julia; Bergmeier, Vera; Frie, Christian; Kreft, Sandra; Bengestrate, Lena; Eming, Sabine; Mauch, Cornelia; Eckes, Beate; Ulus, Hikmet; Lund, Frances E.; Rappl, Gunter; Abken, Hinrich; Paulsson, Mats; Brachvogel, Bent			PECAM1(+)/Sca1(+)/CD38(+) Vascular Cells Transform into Myofibroblast-Like Cells in Skin Wound Repair	PLOS ONE			English	Article							SURFACE ANTIGEN CD38; ENDOTHELIAL PRECURSORS; PERIVASCULAR CELLS; PROGENITOR CELLS; POPULATION; ACTIVATION; EXPRESSION; CONTRIBUTE; TISSUE; LIVER	Skin injury induces the formation of new blood vessels by activating the vasculature in order to restore tissue homeostasis. Vascular cells may also differentiate into matrix-secreting contractile myofibroblasts to promote wound closure. Here, we characterize a PECAM1(+)/Sca1(+) vascular cell population in mouse skin, which is highly enriched in wounds at the peak of neoangiogenesis and myofibroblast formation. These cells express endothelial and perivascular markers and present the receptor CD38 on their surface. PECAM1(+)/Sca1(+)/CD38(+) cells proliferate upon wounding and could give rise to alpha-SMA(+) myofibroblast-like cells. CD38 stimulation in immunodeficient mice reduced the wound size at the peak of neoangiogenesis and myofibroblast formation. In humans a corresponding cell population was identified, which was enriched in sprouting vessels of basal cell carcinoma biopsies. The results indicate that PECAM1(+)/Sca1(+)/CD38(+) vascular cells could proliferate and differentiate into myofibroblast-like cells in wound repair. Moreover, CD38 signaling modulates PECAM1(+)/Sca1(+)/CD38(+) cell activation in the healing process implying CD38 as a target for anti-angiogenic therapies in human basal cell carcinoma.	[Etich, Julia; Bergmeier, Vera; Frie, Christian; Kreft, Sandra; Bengestrate, Lena; Paulsson, Mats; Brachvogel, Bent] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, North Rhine Wes, Germany; [Eming, Sabine; Rappl, Gunter; Abken, Hinrich; Paulsson, Mats; Brachvogel, Bent] Univ Cologne, Fac Med, Ctr Mol Med Cologne, D-50931 Cologne, North Rhine Wes, Germany; [Eming, Sabine; Mauch, Cornelia; Eckes, Beate] Univ Cologne, Dept Dermatol, D-50931 Cologne, North Rhine Wes, Germany; [Ulus, Hikmet] Clin Paediat Surg, D-50931 Cologne, North Rhine Wes, Germany; [Lund, Frances E.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Rappl, Gunter; Abken, Hinrich] Univ Cologne, Fac Med, Dept Internal Med 1, D-50931 Cologne, North Rhine Wes, Germany; [Paulsson, Mats] Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, North Rhine Wes, Germany	University of Cologne; University of Cologne; University of Cologne; University of Rochester; University of Cologne; University of Cologne	Brachvogel, B (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, North Rhine Wes, Germany.	bent.brachvogel@uni-koeln.de		Etich, Julia/0000-0003-3238-6692; Brachvogel, Bent/0000-0002-3923-0554	DFG [SFB829-B04]; BMBF [01-GN-0823]; Wilhelm Sander-Stiftung; Deutsche Krebshilfe	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Wilhelm Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe)	This project was supported by the DFG (SFB829-B04), BMBF (01-GN-0823); Wilhelm Sander-Stiftung and the Deutsche Krebshilfe to H.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; Brachvogel B, 2007, EXP CELL RES, V313, P2730, DOI 10.1016/j.yexcr.2007.04.031; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Deaglio S, 2010, MOL MED, V16, P87, DOI 10.2119/molmed.2009.00146; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Gerharz M, 2007, WOUND REPAIR REGEN, V15, P105, DOI 10.1111/j.1524-475X.2006.00191.x; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grenier G, 2007, STEM CELLS, V25, P3101, DOI 10.1634/stemcells.2006-0795; Hara-Yokoyama M, 2008, INT IMMUNOPHARMACOL, V8, P59, DOI 10.1016/j.intimp.2007.10.010; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hoofnagle MH, 2004, J CLIN INVEST, V113, P1249, DOI 10.1172/JCI200421761; Luna G, 2004, STEM CELLS DEV, V13, P528, DOI 10.1089/scd.2004.13.528; Mack JA, 2003, FASEB J, V17, P1352, DOI 10.1096/fj.02-0959fje; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; NISHINA H, 1994, BIOCHEM BIOPH RES CO, V203, P1318, DOI 10.1006/bbrc.1994.2326; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Petroll WM, 1997, EXP EYE RES, V64, P257, DOI 10.1006/exer.1996.0211; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Rasband W., 2006, IMAGEJ; Sundberg C, 1996, LAB INVEST, V74, P452; Torsney E, 2011, J MOL CELL CARDIOL, V50, P304, DOI 10.1016/j.yjmcc.2010.09.006; Tsuchiya A, 2008, BIOCHEM BIOPH RES CO, V365, P595, DOI 10.1016/j.bbrc.2007.10.150; WATSON JV, 1987, CYTOMETRY, V8, P1, DOI 10.1002/cyto.990080101; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	25	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53262	10.1371/journal.pone.0053262	http://dx.doi.org/10.1371/journal.pone.0053262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308177	gold, Green Published, Green Submitted			2022-12-27	WOS:000313670100028
J	Joers, P; Jacobs, HT				Joers, Priit; Jacobs, Howard T.			Analysis of Replication Intermediates Indicates That Drosophila melanogaster Mitochondrial DNA Replicates by a Strand-Coupled Theta Mechanism	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; SACCHAROMYCES-CEREVISIAE; LAGGING-STRAND; FORK MOVEMENT; ORIGINS; MUTATIONS; MOLECULES; DIRECTION; PLASMID; DISEASE	Mitochondrial DNA synthesis is necessary for the normal function of the organelle and for the eukaryotic organism as a whole. Here we demonstrate, using two-dimensional agarose gel electrophoresis to analyse replication intermediates, that unidirectional, strand-coupled DNA synthesis is the prevalent mode of mtDNA replication in Drosophila melanogaster. Commencing within the single, extended non-coding region (NCR), replication proceeds around the circular genome, manifesting an irregular rate of elongation, and pausing frequently in specific regions. Evidence for a limited contribution of strand-asynchronous DNA synthesis was found in a subset of mtDNA molecules, but confined to the ribosomal RNA gene region, just downstream of the NCR. Our findings imply that strand-coupled replication is widespread amongst metazoans, and should inform future research on mtDNA metabolism in D. melanogaster.	[Jacobs, Howard T.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital	Jacobs, HT (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	Howard.T.Jacobs@uta.fi	Jacobs, Howard T/G-2434-2011	Jacobs, Howard/0000-0003-1895-6003; Joers, Priit/0000-0002-9248-1774	Academy of Finland; Sigrid Juselius Foundation; Tampere University Hospital Medical Research Fund	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital Medical Research Fund	Funding for this work was provided by Academy of Finland, Sigrid Juselius Foundation and Tampere University Hospital Medical Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Belanger KG, 1996, NUCLEIC ACIDS RES, V24, P2166, DOI 10.1093/nar/24.11.2166; BELL L, 1983, ANAL BIOCHEM, V130, P527, DOI 10.1016/0003-2697(83)90628-0; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Ermakova OV, 1996, J BIOL CHEM, V271, P33009, DOI 10.1074/jbc.271.51.33009; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GARESSE R, 1988, GENETICS, V118, P649; GODDARD JM, 1980, NUCLEIC ACIDS RES, V8, P741; GODDARD JM, 1978, P NATL ACAD SCI USA, V75, P3886, DOI 10.1073/pnas.75.8.3886; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Huberman JA, 1997, METHODS, V13, P247, DOI 10.1006/meth.1997.0524; Krasilnikova Maria M., 2004, V277, P19; KRYSAN PJ, 1991, MOL CELL BIOL, V11, P1464, DOI 10.1128/MCB.11.3.1464; Kuzminov A, 1997, J MOL BIOL, V268, P1, DOI 10.1006/jmbi.1997.0955; LINDSEY JC, 1989, J MOL BIOL, V206, P779, DOI 10.1016/0022-2836(89)90584-6; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; MATSUMOTO L, 1974, J CELL BIOL, V63, P146, DOI 10.1083/jcb.63.1.146; Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Pohlhaus JR, 2006, METHOD ENZYMOL, V409, P477, DOI 10.1016/S0076-6879(05)09028-2; RAO BS, 1994, GENE, V140, P233, DOI 10.1016/0378-1119(94)90549-5; Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2; RUBENSTEIN JLR, 1977, CELL, V12, P471, DOI 10.1016/0092-8674(77)90123-4; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schvartzman JB, 2010, PLASMID, V63, P1, DOI 10.1016/j.plasmid.2009.11.001; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; WEISMANSHOMER P, 1989, BIOCHEM BIOPH RES CO, V164, P1149, DOI 10.1016/0006-291X(89)91789-0; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392	35	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53249	10.1371/journal.pone.0053249	http://dx.doi.org/10.1371/journal.pone.0053249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308172	gold, Green Published, Green Submitted			2022-12-27	WOS:000313670100026
J	Hong, Y; Ge, ZJ; Jing, CR; Shi, J; Dong, X; Zhou, FY; Wang, ML; Zhang, ZD; Gong, WD				Hong, Yan; Ge, Zhijun; Jing, Changrui; Shi, Jun; Dong, Xiao; Zhou, Fengying; Wang, Meilin; Zhang, Zhengdong; Gong, Weida			Functional Promoter-308G > A Variant in Tumor Necrosis Factor alpha Gene Is Associated with Risk and Progression of Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; SQUAMOUS-CELL CARCINOMA; TNF-ALPHA; PROMOTER POLYMORPHISM; SUSCEPTIBILITY; ADENOCARCINOMA; TRANSCRIPTION; METAANALYSIS	Background: Tumor necrosis factor-alpha (TNF-alpha) plays a crucial role in the development and progression of gastric cancer. A functional polymorphism, -308 G>A (rs1800629), which is located in the promoter of TNFA gene, has been suggested to alter the production of TNF-alpha and influence cancer risk. In the present study, we sought to investigate whether this polymorphism has effects on the risk and progression of gastric cancer in a Chinese population. Methods: We genotyped the TNFA -308 G>A polymorphism using the TaqMan method in a two-stage case-control study comprising a total of 1686 gastric cancer patients and 1895 cancer-free subjects. The logistic regression was used to assess the genetic associations with occurrence and progression of gastric cancer. Results: We found a significant association between the variant genotypes and increased risk of gastric cancer [P = 0.034, odds ratio (OR) = 1.39, 95% confidence interval (CI) = 1.01-1.67, GA/AA vs. GG]. Similar results were observed in the follow-up replication study. When combined the data from the two studies, we found a more significant association (P = 0.001, OR = 1.34, 95%CI = 1.13-1.59), especially for older subjects (>65 years). Furthermore, the patients carrying the variant genotypes had a significantly greater prevalence of T4 stage of disease (P = 0.001, OR = 2.19, 95%CI = 1.39-3.47) and distant metastasis (P = 0.013, OR = 1.61, 95%CI = 1.10-2.35). Conclusions: Our results suggest that the functional promoter -308 G>A polymorphism in TNFA influence the susceptibility and progression of gastric cancer in the Chinese population.	[Hong, Yan; Ge, Zhijun; Shi, Jun; Gong, Weida] Yixing Peoples Hosp, Dept Surg, Yixing, Peoples R China; [Jing, Changrui] Wuxi 2 Peoples Hosp, Dept Plast Surg, Wuxi, Peoples R China; [Dong, Xiao; Gong, Weida] Yixing Canc Hosp, Dept Surg, Yixing, Peoples R China; [Zhou, Fengying] Wuxi Maternal & Child Hlth Hosp, Dept Breast Surg, Wuxi, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Mol & Genet Toxicol, Nanjing, Jiangsu, Peoples R China; [Gong, Weida] Nanjing Med Univ, Ctr Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Gong, WD (corresponding author), Yixing Peoples Hosp, Dept Surg, Yixing, Peoples R China.	gongweida2010@gmail.com	zhang, zheng/HCH-9684-2022		"the Six Talent Summit" Project of Jiangsu Province [SWYY-71-028]; National Natural Science Foundation of Jiangsu [BK2011194]; National Natural Science Foundation of China [30872084, 30972444, 81001274]	"the Six Talent Summit" Project of Jiangsu Province; National Natural Science Foundation of Jiangsu; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by "the Six Talent Summit" Project of Jiangsu Province (SWYY-71-028), the National Natural Science Foundation of Jiangsu (BK2011194) and the National Natural Science Foundation of China (30872084, 30972444, and 81001274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Correa GTB, 2011, ORAL ONCOL, V47, P888, DOI 10.1016/j.oraloncology.2011.07.001; Crew KD, 2004, SEMIN ONCOL, V31, P450, DOI 10.1053/j.seminoncol.2004.04.021; Fei BY, 2004, WORLD J GASTROENTERO, V10, P1256; FUJIKI H, 1994, CANCER DETECT PREV, V18, P1; Fujiki H, 2011, ANTI-CANCER AGENT ME, V11, P4, DOI 10.2174/187152011794941163; Ginaldi L, 1999, IMMUNOL RES, V20, P109, DOI 10.1007/BF02786467; Gorouhi F, 2008, BRIT J CANCER, V98, P1443, DOI 10.1038/sj.bjc.6604277; Grimm M, 2010, ANAL CELL PATHOL, V33, P151, DOI [10.1155/2010/891869, 10.3233/ACP-CLO-2010-0539]; Guo W, 2005, CHINESE MED J-PEKING, V118, P1870; Harris PR, 1996, GASTROENTEROLOGY, V111, P419, DOI 10.1053/gast.1996.v111.pm8690207; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; KOMORI A, 1993, CANCER RES, V53, P1982; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Li C, 2005, AM J GASTROENTEROL, V100, P290, DOI 10.1111/j.1572-0241.2005.40806.x; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pawelec G, 2002, FRONT BIOSCI-LANDMRK, V7, pD1056; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Senthilkumar C, 2011, J CANCER RES CLIN, V137, P577, DOI 10.1007/s00432-010-0921-9; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Thalmaier U, 2002, INFECT IMMUN, V70, P3149, DOI 10.1128/IAI.70.6.3149-3155.2002; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Wu MS, 2002, J INFECT DIS, V185, P106, DOI 10.1086/324771; Yea SS, 2001, J CLIN PATHOL, V54, P703, DOI 10.1136/jcp.54.9.703; Yoshida T, 2010, CANCER SCI, V101, P1582, DOI 10.1111/j.1349-7006.2010.01590.x; You WC, 2000, J NATL CANCER I, V92, P1607, DOI 10.1093/jnci/92.19.1607; Zhang JY, 2008, J HUM GENET, V53, P479, DOI 10.1007/s10038-008-0273-3; Zhou F, 2012, DNA CELL BIOL	31	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e50856	10.1371/journal.pone.0050856	http://dx.doi.org/10.1371/journal.pone.0050856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326309	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400002
J	Keren-Shaul, H; Lev-Maor, G; Ast, G				Keren-Shaul, Hadas; Lev-Maor, Galit; Ast, Gil			Pre-mRNA Splicing Is a Determinant of Nucleosome Organization	PLOS ONE			English	Article							POLYMERASE-II; MICROCOCCAL NUCLEASE; PLASMID DNA; CROSS-TALK; U1 SNRNP; TRANSCRIPTION; CHROMATIN; RECRUITMENT; ELONGATION; METHYLATION	Chromatin organization affects alternative splicing and previous studies have shown that exons have increased nucleosome occupancy compared with their flanking introns. To determine whether alternative splicing affects chromatin organization we developed a system in which the alternative splicing pattern switched from inclusion to skipping as a function of time. Changes in nucleosome occupancy were correlated with the change in the splicing pattern. Surprisingly, strengthening of the 5' splice site or strengthening the base pairing of U1 snRNA with an internal exon abrogated the skipping of the internal exons and also affected chromatin organization. Over-expression of splicing regulatory proteins also affected the splicing pattern and changed nucleosome occupancy. A specific splicing inhibitor was used to show that splicing impacts nucleosome organization endogenously. The effect of splicing on the chromatin required a functional U1 snRNA base pairing with the 5' splice site, but U1 pairing was not essential for U1 snRNA enhancement of transcription. Overall, these results suggest that splicing can affect chromatin organization.	[Keren-Shaul, Hadas; Lev-Maor, Galit; Ast, Gil] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Ast, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	gilast@post.tau.ac.il			Israel Science Foundation [ISF 61/09, ISF bikura 838/10]; Joint Germany-Israeli Research Program [ca-139]; Deutsche-Israel Project [DIP MI-1317]; Israel Cancer Research Foundation	Israel Science Foundation(Israel Science Foundation); Joint Germany-Israeli Research Program; Deutsche-Israel Project; Israel Cancer Research Foundation	This work was supported by a grant from the Israel Science Foundation (ISF 61/09; ISF bikura 838/10); Joint Germany-Israeli Research Program (ca-139); Deutsche-Israel Project (DIP MI-1317); and Israel Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert BJ, 2007, J AM CHEM SOC, V129, P2648, DOI 10.1021/ja067870m; Albert BJ, 2009, MOL CANCER THER, V8, P2308, DOI 10.1158/1535-7163.MCT-09-0051; Alexander R, 2010, BIOCHEM SOC T, V38, P1251, DOI 10.1042/BST0381251; Allan J, 2012, J MOL BIOL, V417, P152, DOI 10.1016/j.jmb.2012.01.043; Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; BARSOUM J, 1985, J BIOL CHEM, V260, P7688; Baserga SJ, 1993, RNA WORLD, P359; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Capranico G, 2010, BBA-REV CANCER, V1806, P240, DOI 10.1016/j.bbcan.2010.06.003; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; de Almeida SF, 2012, TRENDS BIOCH SCI; de la Mata M, 2011, GENET RES INT, V2011, DOI 10.4061/2011/309865; de la Mata M, 2010, RNA, V16, P904, DOI 10.1261/rna.1993510; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Hnilicova J, 2011, NUCLEUS-PHILA, V2, P182, DOI 10.4161/nucl.2.3.15876; Hnilicova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016727; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; JEONG SW, 1994, NUCLEIC ACIDS RES, V22, P370, DOI 10.1093/nar/22.3.370; Jobert L, 2009, EMBO REP, V10, P494, DOI 10.1038/embor.2009.24; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; KESSEL D, 1971, CANCER RES, V31, P1883; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim S, 2011, N KOREAN REV, V7, P3; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kulaeva OI, 2007, MUTAT RES-FUND MOL M, V618, P116, DOI 10.1016/j.mrfmmm.2006.05.040; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Luco RF, 2011, CURR OPIN GENET DEV, V21, P366, DOI 10.1016/j.gde.2011.03.004; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Martins SB, 2011, NAT STRUCT MOL BIOL, V18, P1115, DOI 10.1038/nsmb.2124; Mladenova V, 2009, BIOTECHNOL BIOTEC EQ, V23, P1044, DOI 10.1080/13102818.2009.10817609; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; REEVES R, 1985, NUCLEIC ACIDS RES, V13, P3599, DOI 10.1093/nar/13.10.3599; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Spiluttini B, 2010, J CELL SCI, V123, P2084, DOI 10.1242/jcs.061358; Subtil-Rodriguez A, 2011, RNA BIOL, V8, P389, DOI 10.4161/rna.8.3.14334; Subtil-Rodriguez A, 2010, EMBO REP, V11, P751, DOI 10.1038/embor.2010.131; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	72	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53506	10.1371/journal.pone.0053506	http://dx.doi.org/10.1371/journal.pone.0053506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326444	gold, Green Published			2022-12-27	WOS:000313552400025
J	Mithu, VS; Bakthavatsalam, S; Madhu, PK				Mithu, Venus Singh; Bakthavatsalam, Subha; Madhu, Perunthiruthy K.			C-13-C-13 Homonuclear Recoupling in Solid-State Nuclear Magnetic Resonance at a Moderately High Magic-Angle-Spinning Frequency	PLOS ONE			English	Article							NMR-SPECTROSCOPY; ROTATIONAL RESONANCE; CROSS-POLARIZATION; DIFFUSION; FIELD	Two-dimensional C-13-C-13 correlation experiments are widely employed in structure determination of protein assemblies using solid-state nuclear magnetic resonance. Here, we investigate the process of C-13-C-13 magnetisation transfer at a moderate magic-angle-spinning frequency of 30 kHz using some of the prominent second-order dipolar recoupling schemes. The effect of isotropic chemical-shift difference and spatial distance between two carbons and amplitude of radio frequency on H-1 channel on the magnetisation transfer efficiency of these schemes is discussed in detail.	[Mithu, Venus Singh; Bakthavatsalam, Subha; Madhu, Perunthiruthy K.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Madhu, PK (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	madhu@tifr.res.in	Bakthavatsalam, Subha/N-2577-2018	Bakthavatsalam, Subha/0000-0002-1347-1480; Mithu, Venus Singh/0000-0003-2869-9776	Department of Science and Technology, India under SERC scheme [SR/S1/PC/27/2009]	Department of Science and Technology, India under SERC scheme(Department of Science & Technology (India))	PKM acknowledges assistance from Department of Science and Technology, India, for funding under SERC scheme, SR/S1/PC/27/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayro MJ, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3089370; Bennett AE, 1998, J CHEM PHYS, V108, P9463, DOI 10.1063/1.476420; de Lacaillerie JBD, 2005, SOLID STATE NUCL MAG, V28, P225, DOI 10.1016/j.ssnmr.2005.09.005; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Grommek A, 2006, CHEM PHYS LETT, V427, P404, DOI 10.1016/j.cplett.2006.07.005; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Hou GJ, 2011, J AM CHEM SOC, V133, P3943, DOI 10.1021/ja108650x; Hu BW, 2011, J MAGN RESON, V212, P320, DOI 10.1016/j.jmr.2011.07.011; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Ladizhansky V, 2009, SOLID STATE NUCL MAG, V36, P119, DOI 10.1016/j.ssnmr.2009.07.003; Lafon O, 2011, CHEM COMMUN, V47, P6930, DOI 10.1039/c1cc11705j; Lalli D, 2011, J BIOMOL NMR, V51, P477, DOI 10.1007/s10858-011-9578-1; LEVITT MH, 1990, J CHEM PHYS, V92, P6347, DOI 10.1063/1.458314; Linser R, 2011, ANGEW CHEM INT EDIT, V50, P4508, DOI 10.1002/anie.201008244; Manolikas T, 2008, J AM CHEM SOC, V130, P3959, DOI 10.1021/ja078039s; Marin-Montesinos I, 2006, CHEM PHYS LETT, V432, P572, DOI 10.1016/j.cplett.2006.10.101; McDermott A, 2009, ANNU REV BIOPHYS, V38, P385, DOI 10.1146/annurev.biophys.050708.133719; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Mithu VS, 2011, BIOPHYS J, V101, P2825, DOI 10.1016/j.bpj.2011.10.023; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Paepe GD, 2008, J CHEM PHYS, V128; Paravastu AK, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2192516; Ramachandran R, 2003, J AM CHEM SOC, V125, P15623, DOI 10.1021/ja037761x; Renault M, 2010, ANGEW CHEM INT EDIT, V49, P8346, DOI 10.1002/anie.201002823; Scholz I, 2008, CHEM PHYS LETT, V460, P278, DOI 10.1016/j.cplett.2008.05.058; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Sun SJ, 2012, METHODS MOL BIOL, V831, P303, DOI 10.1007/978-1-61779-480-3_17; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Thakur RS, 2006, CHEM PHYS LETT, V426, P459, DOI 10.1016/j.cplett.2006.06.007; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Verel R, 1998, CHEM PHYS LETT, V287, P421, DOI 10.1016/S0009-2614(98)00172-9; Weingarth M, 2010, CHEM PHYS LETT, V488, P10, DOI 10.1016/j.cplett.2010.01.072; Weingarth M, 2009, J AM CHEM SOC, V131, P13937, DOI 10.1021/ja9036143; Weingarth M, 2009, CHEM PHYS LETT, V469, P342, DOI 10.1016/j.cplett.2008.12.084; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Yang J, 2008, J AM CHEM SOC, V130, P5798, DOI 10.1021/ja711304e; Zhao X, 2001, CHEM PHYS LETT, V342, P353, DOI 10.1016/S0009-2614(01)00593-0	38	7	7	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e50504	10.1371/journal.pone.0050504	http://dx.doi.org/10.1371/journal.pone.0050504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326308	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400001
J	Boyda, HN; Procyshyn, RM; Pang, CCY; Hawkes, E; Wong, D; Jin, CH; Honer, WG; Barr, AM				Boyda, Heidi N.; Procyshyn, Ric M.; Pang, Catherine C. Y.; Hawkes, Erin; Wong, Daniel; Jin, Chen Helen; Honer, William G.; Barr, Alasdair M.			Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; ATYPICAL ANTIPSYCHOTICS; IN-VIVO; PREPULSE INHIBITION; INSULIN-RESISTANCE; ANIMAL-MODEL; DOUBLE-BLIND; GLUCOSE-TOLERANCE; CONTROLLED TRIAL; BODY-WEIGHT	Background: The second generation antipsychotic (SGA) drugs are widely used in psychiatry due to their clinical efficacy and low incidence of neurological side-effects. However, many drugs in this class cause deleterious metabolic side-effects. Animal models accurately predict metabolic side-effects for SGAs with known clinical metabolic liability. We therefore used preclinical models to evaluate the metabolic side-effects of glucose intolerance and insulin resistance with the novel SGAs asenapine and iloperidone for the first time. Olanzapine was used as a comparator. Methods: Adults female rats were treated with asenapine (0.01, 0.05, 0.1, 0.5, 1.0 mg/kg), iloperidone (0.03, 0.5, 1.0, 5.0, 10.0 mg/kg) or olanzapine (0.1, 0.5, 1.5, 5.0, 10.0 mg/kg) and subjected to the glucose tolerance test (GTT). Separate groups of rats were treated with asenapine (0.1 and 1.0 mg/kg), iloperidone (1.0 and 10 mg/kg) or olanzapine (1.5 and 15 mg/kg) and tested for insulin resistance with the hyperinsulinemic-euglycemic clamp (HIEC). Results: Asenapine showed no metabolic effects at any dose in either test. Iloperidone caused large and significant glucose intolerance with the three highest doses in the GTT, and insulin resistance with both doses in the HIEC. Olanzapine caused significant glucose intolerance with the three highest doses in the GTT, and insulin resistance with the higher dose in the HIEC. Conclusions: In preclinical models, asenapine shows negligible metabolic liability. By contrast, iloperidone exhibits substantial metabolic liability, comparable to olanzapine. These results emphasize the need for appropriate metabolic testing in patients treated with novel SGAs where current clinical data do not exist.	[Boyda, Heidi N.; Pang, Catherine C. Y.; Hawkes, Erin; Wong, Daniel; Jin, Chen Helen; Barr, Alasdair M.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Procyshyn, Ric M.; Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Procyshyn, Ric M.; Honer, William G.; Barr, Alasdair M.] British Columbia Mental Hlth & Addict Res Inst, British Columbia Mental Hlth & Addict Serv, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Barr, AM (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	albarr@interchange.ubc.ca	Procyshyn, Ric/AAE-5499-2019	Barr, Alasdair/0000-0002-3407-1574; Procyshyn, Ric/0000-0002-4348-0855	British Columbia Provincial Health Services Authority; NSERC [356069-09, 355912-11]; AstraZeneca; Bristol-Myers Squibb; Janssen; Sunovion; Pfizer; Otsuka; Novartis; Roche Canada; Canadian Agency for Drugs and Technology in Health; Eli Lilly Canada; BMS Canada	British Columbia Provincial Health Services Authority; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Sunovion; Pfizer(Pfizer); Otsuka(Otsuka Pharmaceutical); Novartis(Novartis); Roche Canada(Roche Holding); Canadian Agency for Drugs and Technology in Health; Eli Lilly Canada(Eli Lilly); BMS Canada	The current research was supported by grants from the British Columbia Provincial Health Services Authority and NSERC grant 356069-09 to AMB, and NSERC grant 355912-11 to CCYP. AMB is a CIHR New Investigator and HNB is a CIHR Banting scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Procyshyn has received consulting and lectures fees from AstraZeneca, Bristol-Myers Squibb, Janssen, Sunovion, Pfizer, Otsuka. Dr. Honer has received consulting fees or sat on paid advisory boards for Novartis, Roche Canada and the Canadian Agency for Drugs and Technology in Health; and has received royalties for the licenses of antibody manufacturers from the University of British Columbia. Dr. Barr is on the advisory board or received consulting fees from Roche Canada and Eli Lilly Canada; and received educational grant support from BMS Canada. All other authors reported no biomedical financial interests or potential conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Albaugh VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022662; BAKSHI VP, 1995, PSYCHOPHARMACOLOGY, V122, P198, DOI 10.1007/BF02246096; Baptista T, 2002, BRAIN RES, V957, P144, DOI 10.1016/S0006-8993(02)03616-8; Baptista T, 2009, PHARMACOPSYCHIATRY, V42, P14, DOI 10.1055/s-0028-1085438; Baptista T, 2008, CNS DRUGS, V22, P477, DOI 10.2165/00023210-200822060-00003; Barr AM, 2008, EUR J NEUROSCI, V27, P2568, DOI 10.1111/j.1460-9568.2008.06233.x; Barr AM, 2008, SCHIZOPHR RES, V100, P252, DOI 10.1016/j.schres.2007.11.027; Barr AM, 2006, NEUROPHARMACOLOGY, V51, P457, DOI 10.1016/j.neuropharm.2006.04.004; Barr AM, 2011, PSYCHIAT SERV, V62, P682, DOI 10.1176/ps.62.6.pss6206_0682a; Barr AM, 2010, J CLIN PSYCHOPHARM, V30, P741, DOI 10.1097/JCP.0b013e3181fab7ca; Barr AM, 2004, EUR J NEUROSCI, V20, P303, DOI 10.1111/j.0953-816X.2004.03457.x; Boyda HN, 2012, NEUROPHARMACOLOGY, V62, P1391, DOI 10.1016/j.neuropharm.2011.02.019; Boyda HN, 2010, TRENDS PHARMACOL SCI, V31, P484, DOI 10.1016/j.tips.2010.07.002; Boyda HN, 2010, PROG NEURO-PSYCHOPH, V34, P945, DOI 10.1016/j.pnpbp.2010.04.024; Boyda HN, J PSYCHIAT IN PRESS, V37; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Buchanan RW, 2012, J CLIN PSYCHOPHARM, V32, P36, DOI 10.1097/JCP.0b013e31823f880a; Carrizo E, 2009, SCHIZOPHR RES, V113, P19, DOI 10.1016/j.schres.2009.05.007; Chaggar PS, 2011, J CLIN PHARMACOL, V51, P631, DOI 10.1177/0091270010368678; Chintoh AF, 2008, J CLIN PSYCHOPHARM, V28, P494, DOI 10.1097/JCP.0b013e318184b4c5; Chintoh AF, 2009, SCHIZOPHR RES, V108, P127, DOI 10.1016/j.schres.2008.12.012; Citrome L., 2007, PSYCHIAT TIMES, V1, P27; Citrome L, 2011, POSTGRAD MED, V123, P153, DOI 10.3810/pgm.2011.03.2273; Cooper GD, 2005, PSYCHOPHARMACOLOGY, V181, P80, DOI 10.1007/s00213-005-2224-4; Cutler AJ, 2008, J CLIN PSYCHOPHARM, V28, pS20, DOI 10.1097/JCP.0b013e318169d4ce; Davey KJ, 2012, PSYCHOPHARMACOLOGY, V221, P155, DOI 10.1007/s00213-011-2555-2; Dubovsky SL, 2011, INT J GERIATR PSYCHI; Ferno J, 2009, PSYCHOPHARMACOLOGY, V203, P73, DOI 10.1007/s00213-008-1370-x; Franberg O, 2008, PSYCHOPHARMACOLOGY, V196, P417, DOI 10.1007/s00213-007-0973-y; Gallego JA, 2012, EXPERT OPIN DRUG SAF, V11, P527, DOI 10.1517/14740338.2012.683523; Gohlke Julia M, 2012, Front Psychiatry, V3, P62, DOI 10.3389/fpsyt.2012.00062; Hahn M, 2011, SCHIZOPHR RES, V131, P90, DOI 10.1016/j.schres.2011.06.004; Henderson DC, 2008, J CLIN PSYCHIAT, V69, P32, DOI 10.4088/JCP.0208e04; Houseknecht KL, 2007, NEUROPSYCHOPHARMACOL, V32, P289, DOI 10.1038/sj.npp.1301209; Jassim G, 2011, PSYCHOPHARMACOLOGY B; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; Kane JM, 2008, J CLIN PSYCHOPHARM, V28, pS29, DOI 10.1097/JCP.0b013e318169cca7; Kane JM, 2010, J CLIN PSYCHOPHARM, V30, P106, DOI 10.1097/JCP.0b013e3181d35d6b; Kapur S, 2003, J PHARMACOL EXP THER, V305, P625, DOI 10.1124/jpet.102.046987; Leung JYT, 2012, PHARMACOL THERAPEUT, V135, P113, DOI 10.1016/j.pharmthera.2012.04.003; Liao CH, 2011, SCHIZOPHR RES, V126, P110, DOI 10.1016/j.schres.2010.12.007; Marston HM, 2009, PSYCHOPHARMACOLOGY, V206, P699, DOI 10.1007/s00213-009-1570-z; Martins PJF, 2010, DIABETES, V59, P2418, DOI 10.2337/db10-0449; Mather K, 2009, AM J PHYSIOL-ENDOC M, V296, pE398, DOI 10.1152/ajpendo.90889.2008; McEvoy JP, 2005, SCHIZOPHR RES, V80, P19, DOI 10.1016/j.schres.2005.07.014; McIntyre RS, 2010, J AFFECT DISORDERS, V126, P358, DOI 10.1016/j.jad.2010.04.005; McIntyre RS, 2009, BIPOLAR DISORD, V11, P673, DOI 10.1111/j.1399-5618.2009.00748.x; Mitchell M, 2006, CLIN THER, V28, P881, DOI 10.1016/j.clinthera.2006.06.008; Monzillo LU, 2003, NUTR REV, V61, P397, DOI 10.1301/nr.2003.dec.397-412; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; National Research Council (US), 2011, COMM GUID CAR US LAB; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8; Newcomer JW, 2002, ARCH GEN PSYCHIAT, V59, P337, DOI 10.1001/archpsyc.59.4.337; Newcomer JW, 2005, CNS DRUGS, V19, P1; Patil BM, 2006, EUR J PHARMACOL, V551, P112, DOI 10.1016/j.ejphar.2006.09.009; Procyshyn RM, 2007, J PSYCHIATR NEUROSCI, V32, P331; Procyshyn RM, 2010, J CLIN PSYCHIAT, V71, P566, DOI 10.4088/JCP.08m04912gre; Rummel-Kluge G, 2010, SCHIZOPHR RES; Sacher J, 2008, NEUROPSYCHOPHARMACOL, V33, P1633, DOI 10.1038/sj.npp.1301541; Simon V, 2009, J CLIN PSYCHIAT, V70, P1041, DOI 10.4088/JCP.08r04392; Skrede S, 2012, INT J NEUROPSYCHOPH, V15, P163, DOI 10.1017/S1461145711001271; Smith GC, 2008, DIABETOLOGIA, V51, P2309, DOI 10.1007/s00125-008-1152-3; Smith GC, 2011, ARCH PHYSL BIOCH; Snigdha S, 2011, PSYCHOPHARMACOLOGY, V214, P843, DOI 10.1007/s00213-010-2091-5; STRUPCZEWSKI JT, 1995, J MED CHEM, V38, P1119, DOI 10.1021/jm00007a009; Victoriano M, 2009, PSYCHOPHARMACOLOGY, V206, P167, DOI 10.1007/s00213-009-1593-5; Vidarsdottir S, 2010, J CLIN ENDOCR METAB, V95, P118, DOI 10.1210/jc.2008-1815; Weiden PJ, 2008, J CLIN PSYCHOPHARM, V28, pS12, DOI 10.1097/JCP.0b013e3181694f5a; Weston-Green K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033548; Weston-Green K, 2011, BEHAV BRAIN RES, V217, P337, DOI 10.1016/j.bbr.2010.10.039; Weston-Green K, 2010, SCHIZOPHR RES, V116, P299, DOI 10.1016/j.schres.2009.09.034	72	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53459	10.1371/journal.pone.0053459	http://dx.doi.org/10.1371/journal.pone.0053459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326434	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500074
J	Bryson, RW; Riddle, BR; Graham, MR; Smith, BT; Prendini, L				Bryson, Robert W., Jr.; Riddle, Brett R.; Graham, Matthew R.; Smith, Brian Tilston; Prendini, Lorenzo			As Old as the Hills: Montane Scorpions in Southwestern North America Reveal Ancient Associations between Biotic Diversification and Landscape History	PLOS ONE			English	Article							SPECIATION; GULF; PHYLOGEOGRAPHY; BIOGEOGRAPHY; SYSTEMATICS; CHELICERATA; POPULATIONS; EVOLUTION; EXPANSION; ALIGNMENT	Background:The age of lineages has become a fundamental datum in studies exploring the interaction between geological transformation and biotic diversification. However, phylogeographical studies are often biased towards lineages that are younger than the geological features of the landscapes they inhabit. A temporally deeper historical biogeography framework may be required to address episodes of biotic diversification associated with geologically older landscape changes. Signatures of such associations may be retained in the genomes of ecologically specialized (stenotopic) taxa with limited vagility. In the study presented here, genetic data from montane scorpions in the Vaejovis vorhiesi group, restricted to humid rocky habitats in mountains across southwestern North America, were used to explore the relationship between scorpion diversification and regional geological history. Results: Strong phylogeographical signal was evident within the vorhiesi group, with 27 geographically cohesive lineages inferred from a mitochondrial phylogeny. A time-calibrated multilocus species tree revealed a pattern of Miocene and Pliocene (the Neogene period) lineage diversification. An estimated 21 out of 26 cladogenetic events probably occurred prior to the onset of the Pleistocene, 2.6 million years ago. The best-fit density-dependent model suggested diversification rate in the vorhiesi group gradually decreased through time. Conclusions: Scorpions of the vorhiesi group have had a long history in the highlands of southwestern North America. Diversification among these stenotopic scorpions appears to have occurred almost entirely within the Neogene period, and is temporally consistent with the dynamic geological history of the Basin and Range, and Colorado Plateau physiographical provinces. The persistence of separate lineages at small spatial scales suggests that a combination of ecological stenotopy and limited vagility may make these scorpions particularly valuable indicators of geomorphological evolution.	[Bryson, Robert W., Jr.; Riddle, Brett R.; Graham, Matthew R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Bryson, Robert W., Jr.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Bryson, Robert W., Jr.] Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Smith, Brian Tilston] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Prendini, Lorenzo] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Louisiana State University System; Louisiana State University; American Museum of Natural History (AMNH)	Bryson, RW (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	brysonjr@uw.edu	Prendini, Lorenzo/AAY-6611-2021	Prendini, Lorenzo/0000-0001-8727-7106	University of Nevada, Las Vegas Graduate and Professional Student Association; National Science Foundation [DEB 0413453]; Richard Lounsbery Foundation	University of Nevada, Las Vegas Graduate and Professional Student Association; National Science Foundation(National Science Foundation (NSF)); Richard Lounsbery Foundation	Funding for the first author was provided in part by the University of Nevada, Las Vegas Graduate and Professional Student Association. Aspects of the work conducted at the AMNH were funded by National Science Foundation grant DEB 0413453, and by a grant from the Richard Lounsbery Foundation to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Ayoub NA, 2004, MOL ECOL, V13, P3453, DOI 10.1111/j.1365-294X.2004.02335.x; Badgley C, 2010, ECOGRAPHY, V33, P220, DOI 10.1111/j.1600-0587.2010.06282.x; Bertheau C, 2011, MOL ECOL RESOUR, V11, P1056, DOI 10.1111/j.1755-0998.2011.03050.x; Borges A, 2010, TOXICON, V55, P436, DOI 10.1016/j.toxicon.2009.09.011; Brand P., 2011, TERTIARY EXTENSION F; Bryson RW, 2011, J BIOGEOGR, V38, P2299, DOI 10.1111/j.1365-2699.2011.02565.x; Bryson RW, 2012, MOL PHYLOGENET EVOL, V62, P447, DOI 10.1016/j.ympev.2011.10.014; Burbrink FT, 2010, EVOLUTION, V64, P934, DOI 10.1111/j.1558-5646.2009.00888.x; Coddington JA, 2004, ASSEMBLING THE TREE OF LIFE, P296; Cody S, 2010, ECOGRAPHY, V33, P326, DOI 10.1111/j.1600-0587.2010.06327.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FERRARI L, 1995, GEOLOGY, V23, P751, DOI 10.1130/0091-7613(1995)023<0751:MSATNB>2.3.CO;2; Gantenbein B, 2003, MOL PHYLOGENET EVOL, V28, P119, DOI 10.1016/S1055-7903(03)00031-9; Graham MR, 2012, J ARACHNOL, V40, P281, DOI 10.1636/Ha11-78.1; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Henry CD, 2000, TECTONOPHYSICS, V318, P1, DOI 10.1016/S0040-1951(99)00304-2; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Knowles LL, 2001, P ROY SOC B-BIOL SCI, V268, P319, DOI 10.1098/rspb.2000.1364; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lourenco W. R., 2000, BIODIVERSIDAD TAXONO, V2, P115; McCormack JE, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-28; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Menges C. M., 1989, GEOLOGIC EVOLUTION A, V17, P649; Morrone J.J., 2009, EVOLUTIONARY BIOGEOG; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Mulcahy DG, 2009, MOL PHYLOGENET EVOL, V53, P537, DOI 10.1016/j.ympev.2009.05.037; Nylander J. A. A., 2004, MRMODELTEST V2; Oskin M, 2003, GEOLOGY, V31, P23, DOI 10.1130/0091-7613(2003)031<0023:MISWPB>2.0.CO;2; Parmakelis A, 2006, MOL ECOL, V15, P2883, DOI 10.1111/j.1365-294X.2006.02982.x; Parmakelis A, 2006, J BIOGEOGR, V33, P251, DOI 10.1111/j.1365-2699.2005.01386.x; Pigot AL, 2010, SYST BIOL, V59, P660, DOI 10.1093/sysbio/syq058; Prendini L, 2005, AFRICAN BIODIVERSITY: MOLECULES, ORGANISMS, ECOSYSTEMS, P25, DOI 10.1007/0-387-24320-8_2; Prendini L, 2005, ORG DIVERS EVOL, V5, P203, DOI 10.1016/j.ode.2004.12.004; Prendini L, 2003, INVERTEBR SYST, V17, P185, DOI 10.1071/IS02016; Prendini Lorenzo, 2001, P113; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A., 2012, TRACER V1 5; Retallack GJ, 1997, PALAIOS, V12, P380, DOI 10.2307/3515337; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sabels BE, 1962, GUIDEBOOK MOGOLLON R, P100; SEAGER WR, 1984, GEOL SOC AM BULL, V95, P87, DOI 10.1130/0016-7606(1984)95<87:NKDFBA>2.0.CO;2; Shafiqullah M., 1980, ARIZONA GEOLOGICAL S, VXII, P201; Sissom W. David, 2005, P122; Sissom WD, 2012, AM MUS NOVIT, P1, DOI 10.1206/3742.2; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Sousa P, 2010, J ARACHNOL, V38, P206, DOI 10.1636/H08-98.1; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stockwell SA, 1989, THESIS; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thomas GH, 2008, GLOBAL ECOL BIOGEOGR, V17, P340, DOI 10.1111/j.1466-8238.2008.00384.x; Tully T, 2006, PEDOBIOLOGIA, V50, P95, DOI 10.1016/j.pedobi.2005.11.003; Van Devender T.R., 1990, PACKRAT MIDDENS LAST; Wiens JJ, 2007, P ROY SOC B-BIOL SCI, V274, P919, DOI 10.1098/rspb.2006.0301; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Wilson JS, 2010, PROG PHYS GEOG, V34, P419, DOI 10.1177/0309133310363991; Wood DA, 2011, MOL ECOL, V20, P3856, DOI 10.1111/j.1365-294X.2011.05211.x	69	52	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52822	10.1371/journal.pone.0052822	http://dx.doi.org/10.1371/journal.pone.0052822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326361	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500032
J	Heathcote, AJ; Filstrup, CT; Downing, JA				Heathcote, Adam J.; Filstrup, Christopher T.; Downing, John A.			Watershed Sediment Losses to Lakes Accelerating Despite Agricultural Soil Conservation Efforts	PLOS ONE			English	Article							LAND-USE; SURFACE WATERS; PHOSPHORUS; BIOMASS; RATES	Agricultural soil loss and deposition in aquatic ecosystems is a problem that impairs water quality worldwide and is costly to agriculture and food supplies. In the US, for example, billions of dollars have subsidized soil and water conservation practices in agricultural landscapes over the past decades. We used paleolimnological methods to reconstruct trends in sedimentation related to human-induced landscape change in 32 lakes in the intensively agricultural region of the Midwestern United States. Despite erosion control efforts, we found accelerating increases in sediment deposition from erosion; median erosion loss since 1800 has been 15.4 tons ha(-1). Sediment deposition from erosion increased >6-fold, from 149 g m(-2) yr(-1) in 1850 to 986 g m(-2) yr(-1) by 2010. Average time to accumulate one mm of sediment decreased from 631 days before European settlement (ca. 1850) to 59 days mm(-1) at present. Most of this sediment was deposited in the last 50 years and is related to agricultural intensification rather than land clearance or predominance of agricultural lands. In the face of these intensive agricultural practices, traditional soil conservation programs have not decelerated downstream losses. Despite large erosion control subsidies, erosion and declining water quality continue, thus new approaches are needed to mitigate erosion and water degradation.	[Heathcote, Adam J.; Filstrup, Christopher T.; Downing, John A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA	Iowa State University	Heathcote, AJ (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	aheathco@iastate.edu	Heathcote, Adam J./I-9253-2019	Heathcote, Adam J./0000-0002-9633-9548; Downing, John/0000-0001-8547-0789	Iowa Department of Natural Resources [08-39HA-18-05]	Iowa Department of Natural Resources	This work was funded by a research grant from the Iowa Department of Natural Resources (Contract #: 08-39HA-18-05) (http://www.iowadnr.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach T., 1994, ANN ASSOC AM GEOGR, V8, P5; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cleveland W.S., 1992, LOCAL REGRESSION MOD, P309; DAVIS M B, 1976, Environmental Conservation, V3, P139, DOI 10.1017/S0376892900018269; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; ENGSTROM DR, 1999, TRENDS ATMOSPHERIC M; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Heathcote AJ, 2012, ECOSYSTEMS, V15, P60, DOI 10.1007/s10021-011-9488-9; JONES JR, 1978, HYDROBIOLOGIA, V57, P267, DOI 10.1007/BF00014580; MCCAULEY E, 1981, CAN J FISH AQUAT SCI, V38, P458, DOI 10.1139/f81-063; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Pavelis G., 2011, SOIL WATER CONSERVAT; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Renwick WH, 2006, IAHS-AISH P, V306, P341; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Trimble S., 1982, 1234 GEOL SURV; TRIMBLE SW, 1981, SCIENCE, V214, P181, DOI 10.1126/science.214.4517.181; Trimble SW, 2000, SCIENCE, V289, P248, DOI 10.1126/science.289.5477.248; WATSON S, 1988, CAN J FISH AQUAT SCI, V45, P915, DOI 10.1139/f88-112; Winsten JR, 2011, J SOIL WATER CONSERV, V66, p111A, DOI 10.2489/jswc.66.4.111A; Wren DG, 2008, J SOIL WATER CONSERV, V63, P129, DOI 10.2489/63.3.129; Wren DG, 2011, J SOIL WATER CONSERV, V66, P313, DOI 10.2489/jswc.66.5.313	23	52	55	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53554	10.1371/journal.pone.0053554	http://dx.doi.org/10.1371/journal.pone.0053554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326454	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500082
J	Thompson, B; Tjan, BS; Liu, ZL				Thompson, Benjamin; Tjan, Bosco S.; Liu, Zili			Perceptual Learning of Motion Direction Discrimination with Suppressed and Unsuppressed MT in Humans: An fMRI Study	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; AREA MT; ORIENTATION DISCRIMINATION; CORTICAL AREA; V1 NEURONS; TEXTURE-DISCRIMINATION; TRANSPARENT MOTION; BRAIN ACTIVITY; MONKEY; PERFORMANCE	The middle temporal area of the extrastriate visual cortex (area MT) is integral to motion perception and is thought to play a key role in the perceptual learning of motion tasks. We have previously found, however, that perceptual learning of a motion discrimination task is possible even when the training stimulus contains locally balanced, motion opponent signals that putatively suppress the response of MT. Assuming at least partial suppression of MT, possible explanations for this learning are that 1) training made MT more responsive by reducing motion opponency, 2) MT remained suppressed and alternative visual areas such as V1 enabled learning and/or 3) suppression of MT increased with training, possibly to reduce noise. Here we used fMRI to test these possibilities. We first confirmed that the motion opponent stimulus did indeed suppress the BOLD response within hMT+ compared to an almost identical stimulus without locally balanced motion signals. We then trained participants on motion opponent or non-opponent stimuli. Training with the motion opponent stimulus reduced the BOLD response within hMT+ and greater reductions in BOLD response were correlated with greater amounts of learning. The opposite relationship between BOLD and behaviour was found at V1 for the group trained on the motion-opponent stimulus and at both V1 and hMT+ for the group trained on the non-opponent motion stimulus. As the average response of many cells within MT to motion opponent stimuli is the same as their response to non-directional flickering noise, the reduced activation of hMT+ after training may reflect noise reduction.	[Thompson, Benjamin] Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand; [Tjan, Bosco S.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Tjan, Bosco S.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA USA; [Liu, Zili] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	University of Auckland; University of Southern California; University of Southern California; University of California System; University of California Los Angeles	Thompson, B (corresponding author), Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand.	b.thompson@auckland.ac.nz		Thompson, Benjamin/0000-0002-3902-2712	US NSF grant [BCS 0617628]; NEI grant [RO1 EY01 7707]; NATIONAL EYE INSTITUTE [R01EY017707] Funding Source: NIH RePORTER	US NSF grant(National Science Foundation (NSF)); NEI grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a US NSF grant to Z.L. (BCS 0617628) and an NEI grant to B.S.T. (RO1 EY01 7707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adab HZ, 2011, CURR BIOL, V21, P1661, DOI 10.1016/j.cub.2011.08.037; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Bao M, 2010, J NEUROSCI, V30, P15080, DOI 10.1523/JNEUROSCI.5703-09.2010; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen N, 2012, VSS 2012; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Epstein W., 1967, VARIETIES PERCEPTUAL; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gibson E. J., 1991, ODYSSEY LEARNING PER; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; GILBERT CD, 1994, P NATL ACAD SCI USA, V91, P1195, DOI 10.1073/pnas.91.4.1195; GLASS L, 1969, NATURE, V223, P578, DOI 10.1038/223578a0; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Hotson JR, 1999, NEUROPSYCHOLOGIA, V37, P169; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Li W, 2008, NEURON, V57, P442, DOI 10.1016/j.neuron.2007.12.011; Lu HJ, 2004, VISION RES, V44, P1817, DOI 10.1016/j.visres.2004.03.002; MISHKIN M, 1954, J COMP PHYSIOL PSYCH, V47, P187, DOI 10.1037/h0057551; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; QIAN N, 1994, J NEUROSCI, V14, P7367; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; Rainer G, 2004, PLOS BIOL, V2, P275, DOI 10.1371/journal.pbio.0020044; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; Schiltz C, 2001, CORTEX, V37, P243, DOI 10.1016/S0010-9452(08)70571-9; Schiltz C, 1999, NEUROIMAGE, V9, P46, DOI 10.1006/nimg.1998.0394; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Seitz AR, 2011, CURR BIOL, V21, pR814, DOI 10.1016/j.cub.2011.08.042; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Thompson B, 2006, VISION RES, V46, P2110, DOI 10.1016/j.visres.2006.01.005; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; Villeneuve MY, 2012, EUR J NEUROSCI; Walker MP, 2005, CEREB CORTEX, V15, P1666, DOI 10.1093/cercor/bhi043; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; Zhang JX, 2010, J NEUROSCI, V30, P14127, DOI 10.1523/JNEUROSCI.2204-10.2010; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	54	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53458	10.1371/journal.pone.0053458	http://dx.doi.org/10.1371/journal.pone.0053458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326433	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500073
J	Balakrishnan, B; Sen, D; Hareendran, S; Roshini, V; David, S; Srivastava, A; Jayandharan, GR				Balakrishnan, Balaji; Sen, Dwaipayan; Hareendran, Sangeetha; Roshini, Vaani; David, Sachin; Srivastava, Alok; Jayandharan, Giridhara R.			Activation of the Cellular Unfolded Protein Response by Recombinant Adeno-Associated Virus Vectors	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INNATE IMMUNE-RESPONSES; KAPPA-B PATHWAY; VIRAL VECTORS; GENE-THERAPY; INTRACELLULAR TRAFFICKING; TRANSCRIPTION FACTOR; METABOLIC DISEASE; AIRWAY EPITHELIA; MESSENGER-RNA	The unfolded protein response (UPR) is a stress-induced cyto-protective mechanism elicited towards an influx of large amount of proteins in the endoplasmic reticulum (ER). In the present study, we evaluated if AAV manipulates the UPR pathways during its infection. We first examined the role of the three major UPR axes, namely, endoribonuclease inositol-requiring enzyme-1 (IRE1 alpha), activating transcription factor 6 (ATF6) and PKR-like ER kinase (PERK) in AAV infected cells. Total RNA from mock or AAV infected HeLa cells were used to determine the levels of 8 different ER-stress responsive transcripts from these pathways. We observed a significant up-regulation of IRE1 alpha (up to 11 fold) and PERK (up to 8 fold) genes 12-48 hours after infection with self-complementary (sc)AAV2 but less prominent with single-stranded (ss) AAV2 vectors. Further studies demonstrated that scAAV1 and scAAV6 also induce cellular UPR in vitro, with AAV1 vectors activating the PERK pathway (3 fold) while AAV6 vectors induced a significant increase on all the three major UPR pathways [6-16 fold]. These data suggest that the type and strength of UPR activation is dependent on the viral capsid. We then examined if transient inhibition of UPR pathways by RNA interference has an effect on AAV transduction. siRNA mediated silencing of PERK and IRE1 alpha had a modest effect on AAV2 and AAV6 mediated gene expression (similar to 1.5-2 fold) in vitro. Furthermore, hepatic gene transfer of scAAV2 vectors in vivo, strongly elevated IRE1 alpha and PERK pathways (2 and 3.5 fold, respectively). However, when animals were pre-treated with a pharmacological UPR inhibitor (metformin) during scAAV2 gene transfer, the UPR signalling and its subsequent inflammatory response was attenuated concomitant to a modest 2.8 fold increase in transgene expression. Collectively, these data suggest that AAV vectors activate the cellular UPR pathways and their selective inhibition may be beneficial during AAV mediated gene transfer.	[Balakrishnan, Balaji; Sen, Dwaipayan; Roshini, Vaani; David, Sachin; Srivastava, Alok; Jayandharan, Giridhara R.] Christian Med Coll & Hosp, Dept Hematol, Vellore, Tamil Nadu, India; [Hareendran, Sangeetha; Srivastava, Alok; Jayandharan, Giridhara R.] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Jayandharan, GR (corresponding author), Christian Med Coll & Hosp, Dept Hematol, Vellore, Tamil Nadu, India.	jay@cmcvellore.ac.in	Hareendran, Sangeetha/AAE-6392-2019; Balakrishnan, Balaji/AAW-7251-2020	Balakrishnan, Balaji/0000-0003-4852-3022; Sen, Dwaipayan/0000-0002-3485-494X; Hareendran, Sangeetha/0000-0002-9070-8023	Department of Science of Technology, Government of India; Department of Biotechnology (DBT), Government of India [BT/03/IYBA/2010, BT/PR14748/MED/12/491/2010, BT/01/COE/08/03]; Bayer Inc, USA; University Grants Commission, New Delhi, India	Department of Science of Technology, Government of India; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Bayer Inc, USA; University Grants Commission, New Delhi, India(University Grants Commission, India)	GRJ is supported by research grants from Department of Science of Technology, Government of India (Swarnajayanti Fellowship 2011), Department of Biotechnology (DBT), Government of India (Innovative Young Biotechnologist award 2010: BT/03/IYBA/2010; Grant: BT/PR14748/MED/12/491/2010; Grant: BT/01/COE/08/03) and an early career investigator award-2010 from Bayer Hemophilia Awards program, Bayer Inc, USA. BB is supported by a junior research fellowship from University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNS KI, 1995, BIOESSAYS, V17, P237, DOI 10.1002/bies.950170310; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Clavarino G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002708; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Ding W, 2003, J VIROL, V77, P7361, DOI 10.1128/JVI.77.13.7361-7366.2003; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Duan DS, 1999, J VIROL, V73, P10371, DOI 10.1128/JVI.73.12.10371-10376.1999; Engel A, 2010, NAT IMMUNOL, V11, P365, DOI 10.1038/ni0510-365; Erles K, 1999, J MED VIROL, V59, P406, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;406::AID-JMV22&gt;3.0.CO;2-N; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; Hauck B, 2004, J VIROL, V78, P13678, DOI 10.1128/JVI.78.24.13678-13686.2004; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hiramatsu N, 2011, METHOD ENZYMOL, V491, P183, DOI 10.1016/B978-0-12-385928-0.00011-0; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Jayandharan GR, 2011, P NATL ACAD SCI USA, V108, P3743, DOI 10.1073/pnas.1012753108; Johnson JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002053; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Kube DM, 1997, NUCLEIC ACIDS RES, V25, P3375, DOI 10.1093/nar/25.16.3375; Lazar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034169; Lee DY, 2009, J VIROL, V83, P1168, DOI 10.1128/JVI.01358-08; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Martino AT, 2011, BLOOD, V117, P6459, DOI 10.1182/blood-2010-10-314518; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Nonnenmacher M, 2012, GENE THER, V19, P649, DOI 10.1038/gt.2012.6; Nonnenmacher M, 2012, GENE THER; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pien GC, 2009, J CLIN INVEST, V119, P1688, DOI 10.1172/JCI36891; Rogers GL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00194; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sanlioglu S., 2001, Current Gene Therapy, V1, P137, DOI 10.2174/1566523013348788; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Theriault JR, 2011, BIOCHEM BIOPH RES CO, V409, P500, DOI 10.1016/j.bbrc.2011.05.034; Trujillo-Alonso V, 2011, J VIROL, V85, P12594, DOI 10.1128/JVI.05620-11; Xia LM, 2012, J IMMUNOL, V188, P753, DOI 10.4049/jimmunol.1101652; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	56	29	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53845	10.1371/journal.pone.0053845	http://dx.doi.org/10.1371/journal.pone.0053845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320106	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429800071
J	Pinne, M; Haake, DA				Pinne, Marija; Haake, David A.			LipL32 Is a Subsurface Lipoprotein of Leptospira interrogans: Presentation of New Data and Reevaluation of Previous Studies	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; SURFACE-EXPOSED LIPOPROTEIN; PATHOGENIC LEPTOSPIRA; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; EPIDEMIC; ANTIGEN; BINDS; OMPL1	The agents of leptospirosis, a zoonosis with worldwide distribution, are pathogenic spirochetes belonging to the genus Leptospira. The leptospiral life cycle involves transmission via fresh water and colonization of the renal tubules of their reservoir hosts. Infection of accidental hosts, including humans, may result in life-threatening sequelae. Bacterial outer membrane proteins (OMPs), particularly those with surface-exposed regions, play crucial roles in pathogen virulence mechanisms and adaptation to environmental conditions, including those found in the mammalian host. Therefore, elucidation and characterization of the surface-exposed OMPs of Leptospira spp. is of great interest in the leptospirosis field. A thorough, multi-pronged approach for assessing surface exposure of leptospiral OMPs is essential. Herein, we present evidence for a sub-surface location for most or all of the major leptospiral lipoprotein, LipL32, based on surface immunofluorescence utilizing three different types of antibodies and four different permeabilization methods, as well as surface proteolysis of intact and lysed leptospires. We reevaluate prior evidence presented in support of LipL32 surface-exposure and present a novel perspective on a protein whose location has been misleading researchers, due in large part to its extraordinary abundance in leptospiral cells.	[Pinne, Marija] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA; [Haake, David A.] Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA; [Pinne, Marija; Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Haake, David A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Pinne, M (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA.	mpinne@ucla.edu			VA Medical Research Funds; National Institute of Allergy and Infectious Diseases [AI-034431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034431] Funding Source: NIH RePORTER	VA Medical Research Funds(US Department of Veterans Affairs); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by VA Medical Research Funds (to D. A. H.) and grant AI-034431 (to D. A. H.) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Cao XJ, 2010, CELL RES, V20, P197, DOI 10.1038/cr.2009.127; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; Domingos RF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-50; Eshghi A, 2011, MICROBIOLOGY, V158, P622; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fernandes CPH, 2007, HYBRIDOMA, V26, P35, DOI 10.1089/hyb.2006.033; Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612; Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991; Habarta A, 2011, CURR MICROBIOL, V62, P526, DOI 10.1007/s00284-010-9739-6; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; ITO K, 1991, MOL MICROBIOL, V5, P2243, DOI 10.1111/j.1365-2958.1991.tb02154.x; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lucas DSD, 2011, VACCINE, V29, P3413, DOI 10.1016/j.vaccine.2011.02.084; Ludtke CB, 2003, BRAZ J MICROBIOL, V34, P1, DOI 10.1590/S1517-83822003000500001; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Matsunaga J, 2002, INFECT IMMUN, V70, P323, DOI 10.1128/IAI.70.1.323-334.2002; Matsunaga J, 2006, MICROBIOL-SGM, V152, P3777, DOI 10.1099/mic.0.29162-0; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Mendes RS, 2011, INFECT IMMUN, V79, P4657, DOI 10.1128/IAI.05583-11; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nally JE, 2005, PROTEOMICS, V5, P144, DOI 10.1002/pmic.200400880; Nally JE, 2001, INFECT IMMUN, V69, P7616, DOI 10.1128/IAI.69.12.7616-7624.2001; Oliveira R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021962; Pinne M, 2011, JOVE-J VIS EXP, DOI 10.3791/2805; Pinne M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006071; Seixas FK, 2007, VACCINE, V26, P88, DOI 10.1016/j.vaccine.2007.10.052; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; SHANG ES, 1995, INFECT IMMUN, V63, P3174, DOI 10.1128/IAI.63.8.3174-3181.1995; Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996; STADER J, 1988, J BACTERIOL, V170, P1973, DOI 10.1128/jb.170.4.1973-1974.1988; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; ZUERNER RL, 1991, MICROB PATHOGENESIS, V10, P311, DOI 10.1016/0882-4010(91)90014-2	50	48	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e51025	10.1371/journal.pone.0051025	http://dx.doi.org/10.1371/journal.pone.0051025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23323152	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429800006
J	Bai, Y; Wang, MY; Han, YH; Dou, SW; Lin, Q; Guo, Y; Li, W; Ding, DG; Dai, JP; Qin, W; Shi, DP; Tian, J; Dai, YM				Bai, Yan; Wang, Mei-Yun; Han, Yan-Hong; Dou, She-Wei; Lin, Qing; Guo, Ying; Li, Wei; Ding, De-Gang; Dai, Jian-Ping; Qin, Wei; Shi, Da-Peng; Tian, Jie; Dai, Yong-Ming			Susceptibility Weighted Imaging: A New Tool in the Diagnosis of Prostate Cancer and Detection of Prostatic Calcification	PLOS ONE			English	Article							GROWTH-FACTOR VEGF; CEREBRAL MICROBLEEDS; MR; BRAIN; INJURY; TUMOR; CT	Background: Susceptibility weighted imaging (SWI) is a new MRI technique which has been proved very useful in the diagnosis of brain diseases, but few study was performed on its value in prostatic diseases. The aim of the present study was to investigate the value of SWI in distinguishing prostate cancer from benign prostatic hyperplasia and detecting prostatic calcification. Methodology/Principal Findings: 23 patients with prostate cancer and 53 patients with benign prostatic hyperplasia proved by prostate biopsy were scanned on a 3.0T MR and a 16-row CT scanner. High-resolution SWI, conventional MRI and CT were performed on all patients. The MRI and CT findings, especially SWI, were analyzed and compared. The analyses revealed that 19 out of 23 patients with prostate cancer presented hemorrhage within tumor area on SWI. However, in 53 patients with benign prostatic hyperplasia, hemorrhage was detected only in 1 patient in prostate by SWI. When comparing SWI, conventional MRI and CT in detecting prostate cancer hemorrhage, out of the 19 patients with prostate cancer who had prostatic hemorrhage detected by SWI, the prostatic hemorrhage was detected in only 7 patients by using conventional MRI, and none was detected by CT. In addition, CT demonstrated calcifications in 22 patients which were all detected by SWI whereas only 3 were detected by conventional MRI. Compared to CT, SWI showed 100% in the diagnostic sensitivity, specificity, accuracy, positive predictive value(PPV) and negative predictive value(NPV) in detecting calcifications in prostate but conventional MRI demonstrated 13.6% in sensitivity, 100% in specificity, 75% in accuracy, 100% in PPV and 74% in NPV. Conclusions: More apparent prostate hemorrhages were detected on SWI than on conventional MRI or CT. SWI may provide valuable information for the differential diagnosis between prostate cancer and prostatic hyperplasia. Filtered phase images can identify prostatic calcifications as well as CT.	[Bai, Yan; Wang, Mei-Yun; Han, Yan-Hong; Dou, She-Wei; Lin, Qing; Guo, Ying; Li, Wei; Dai, Jian-Ping; Shi, Da-Peng] Henan Prov Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China; [Ding, De-Gang] Henan Prov Peoples Hosp, Dept Urinary Surg, Zhengzhou, Henan, Peoples R China; [Dai, Yong-Ming] Siemens Healthcare, MRI, Shanghai, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Li, Wei] Xidian Univ, Sch Sci & Technol, Life Sci Res Ctr, Xian, Shanxi, Peoples R China	Zhengzhou University; Zhengzhou University; Siemens AG; Chinese Academy of Sciences; Institute of Automation, CAS; Xidian University	Wang, MY (corresponding author), Henan Prov Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China.	meiyun9999@gmail.com; cjr.shidapeng@vip.163.com; tian@ieee.org	Tian, Jie/H-1190-2011; tian, jie/M-6336-2013	Tian, Jie/0000-0003-0498-0432; 	National Natural Science Foundation of China [81271565]; Distinguished Young Scholar in Scientific and Technical Innovation Foundation of Henan Province [124100510016]; Science and Technology Foundation of Public Health of Henan Province [201202018, 201003095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Distinguished Young Scholar in Scientific and Technical Innovation Foundation of Henan Province; Science and Technology Foundation of Public Health of Henan Province	This study was supported by the National Natural Science Foundation of China under Grant Nos. 81271565, the Distinguished Young Scholar in Scientific and Technical Innovation Foundation of Henan Province under Grant No. 124100510016, and the Science and Technology Foundation of Public Health of Henan Province under Grant Nos. 201202018 and 201003095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter M, 2007, ACAD RADIOL, V14, P1011, DOI 10.1016/j.acra.2007.05.013; Al Sayyari A, 2010, AM J NEURORADIOL, V31, P1049, DOI 10.3174/ajnr.A2011; AVRAHAMI E, 1994, J NEUROL, V241, P381, DOI 10.1007/BF02033355; Barth PJ, 1996, HUM PATHOL, V27, P1306, DOI 10.1016/S0046-8177(96)90342-1; CARTER HB, 1991, RADIOLOGY, V178, P523, DOI 10.1148/radiology.178.2.1987620; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao TL, 2008, NEUROL RES, V30, P272, DOI 10.1179/016164107X251556; Geramoutsos L, 2004, EUR UROL, V45, P333; Haacke EM, 2011, J MAGN RESON IMAGING, V33, P1527, DOI 10.1002/jmri.22578; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Ikonen S, 2001, ACTA RADIOL, V42, P348, DOI 10.1034/j.1600-0455.2001.420402.x; INABA T, 1992, J UROLOGY, V148, P1457, DOI 10.1016/S0022-5347(17)36939-2; Kim JK, 2009, KOREAN J RADIOL, V10, P535, DOI 10.3348/kjr.2009.10.6.535; Kim WB, 2011, UROLOGY, V78, P447, DOI 10.1016/j.urology.2010.12.056; KUCHARCZYK W, 1994, AM J NEURORADIOL, V15, P1145; Li H, 2006, AM J ROENTGENOL, V186, P729, DOI 10.2214/AJR.04.0775; Ling MT, 2005, CARCINOGENESIS, V26, P1668, DOI 10.1093/carcin/bgi128; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Park MJ, 2009, AM J NEURORADIOL, V30, P1402, DOI 10.3174/ajnr.A1593; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Santhosh K, 2009, CLIN RADIOL, V64, P74, DOI 10.1016/j.crad.2008.04.022; Stefanou D, 2004, IN VIVO, V18, P155; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; Tempany C, 2008, J MAGN RESON IMAGING, V27, P356, DOI 10.1002/jmri.21259; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; TSUCHIYA K, 1993, NEURORADIOLOGY, V35, P341, DOI 10.1007/BF00588364; Wang MY, 2011, MAGN RESON IMAGING, V29, P365, DOI 10.1016/j.mri.2010.10.016; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Yang J, 2006, ASIAN J ANDROL, V8, P169, DOI 10.1111/j.1745-7262.2006.00120.x; Zhu WZ, 2008, CHINESE MED J-PEKING, V121, P2021, DOI 10.1097/00029330-200810020-00014	31	34	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53237	10.1371/journal.pone.0053237	http://dx.doi.org/10.1371/journal.pone.0053237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308170	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100044
J	Cui, XL; Witalison, EE; Chumanevich, AP; Chumanevich, AA; Poudyal, D; Subramanian, V; Schetter, AJ; Harris, CC; Thompson, PR; Hofseth, LJ				Cui, Xiangli; Witalison, Erin E.; Chumanevich, Alena P.; Chumanevich, Alexander A.; Poudyal, Deepak; Subramanian, Venkataraman; Schetter, Aaron J.; Harris, Curtis C.; Thompson, Paul R.; Hofseth, Lorne J.			The Induction of microRNA-16 in Colon Cancer Cells by Protein Arginine Deiminase Inhibition Causes a p53-Dependent Cell Cycle Arrest	PLOS ONE			English	Article							PEPTIDYLARGININE DEIMINASE; GENE-EXPRESSION; DOWN-REGULATION; MIR-16 FAMILY; ULCERATIVE-COLITIS; PAD4; P53; SUPPRESSION; CITRULLINATION; INACTIVATORS	Protein Arginine Deiminases (PADs) catalyze the post-translational conversion of peptidyl-Arginine to peptidyl-Citrulline in a calcium-dependent, irreversible reaction. Evidence is emerging that PADs play a role in carcinogenesis. To determine the cancer-associated functional implications of PADs, we designed a small molecule PAD inhibitor (called Chor-amidine or Cl-amidine), and tested the impact of this drug on the cell cycle. Data derived from experiments in colon cancer cells indicate that Cl-amidine causes a G1 arrest, and that this was p53-dependent. In a separate set of experiments, we found that Cl-amidine caused a significant increase in microRNA-16 (miRNA-16), and that this increase was also p53-dependent. Because miRNA-16 is a putative tumor suppressor miRNA, and others have found that miRNA-16 suppresses proliferation, we hypothesized that the p53-dependent G1 arrest associated with PAD inhibition was, in turn, dependent on miRNA-16 expression. Results are consistent with this hypothesis. As well, we found the G1 arrest is at least in part due to the ability of Cl-amidine-mediated expression of miRNA-16 to suppress its' G1-associated targets: cyclins D1, D2, D3, E1, and cdk6. Our study sheds light into the mechanisms by which PAD inhibition can protect against or treat colon cancer.	[Cui, Xiangli; Witalison, Erin E.; Chumanevich, Alena P.; Chumanevich, Alexander A.; Poudyal, Deepak; Hofseth, Lorne J.] Univ S Carolina, S Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA; [Subramanian, Venkataraman; Thompson, Paul R.] Scripps Florida, Scripps Res Inst, Dept Chem, Jupiter, FL USA; [Schetter, Aaron J.; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Scripps Research Institute; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hofseth, LJ (corresponding author), Univ S Carolina, S Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA.	hofseth@cop.sc.edu			National Institutes of Health [5R01CA151304]; NATIONAL CANCER INSTITUTE [R01CA151304, ZIABC011496] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following grants: National Institutes of Health grant 5R01CA151304 to LJH and PRT (http://projectreporter.nih.gov/reporter_searchresults.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan A, 2010, EXP CELL RES, V316, P3512, DOI 10.1016/j.yexcr.2010.07.007; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Biggar KK, 2012, CELL CYCLE, V11, P1705, DOI 10.4161/cc.19790; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Cai CK, 2012, ONCOL REP, V28, P1764, DOI 10.3892/or.2012.1995; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Causey CP, 2008, TETRAHEDRON LETT, V49, P4383, DOI 10.1016/j.tetlet.2008.05.021; Chang XT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-40; Chang XT, 2006, MOL CARCINOGEN, V45, P183, DOI 10.1002/mc.20169; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Cherrington BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041242; Chumanevich AA, 2011, AM J PHYSIOL-GASTR L, V300, pG929, DOI 10.1152/ajpgi.00435.2010; Chumanevich AA, 2010, CARCINOGENESIS, V31, P1787, DOI 10.1093/carcin/bgq158; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; FUJISAKI M, 1981, J BIOCHEM, V89, P257, DOI 10.1093/oxfordjournals.jbchem.a133189; Guo CJ, 2009, APOPTOSIS, V14, P1331, DOI 10.1007/s10495-009-0401-3; Guo Q, 2011, J BIOL CHEM, V286, P17069, DOI 10.1074/jbc.M111.230961; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Katsanos KH, 2007, DIGESTION, V75, P113, DOI 10.1159/000104731; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Knuckley B, 2010, BIOCHEMISTRY-US, V49, P4852, DOI 10.1021/bi100363t; LENNARDJONES JE, 1983, LANCET, V2, P149, DOI 10.1016/S0140-6736(83)90129-0; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Mohanan S, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/895343; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Porkka KP, 2011, GENE CHROMOSOME CANC, V50, P499, DOI 10.1002/gcc.20873; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; RANSOHOFF DF, 1988, GASTROENTEROLOGY, V94, P1089, DOI 10.1016/0016-5085(88)90573-2; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Rivas MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3187; Slack JL, 2011, CELL MOL LIFE SCI, V68, P709, DOI 10.1007/s00018-010-0480-x; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang F, 2009, BMB REP, V42, P725, DOI 10.5483/BMBRep.2009.42.11.725; Wang KH, 2011, J BIOL CHEM, V286, P9468, DOI 10.1074/jbc.M110.178335; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wu G, 2011, BRIT J CANCER, V105, P146, DOI 10.1038/bjc.2011.190; Wu WKK, 2011, CARCINOGENESIS, V32, P247, DOI 10.1093/carcin/bgq243; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Ying L, 2007, CANCER RES, V67, P9286, DOI 10.1158/0008-5472.CAN-07-2238; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337	52	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53791	10.1371/journal.pone.0053791	http://dx.doi.org/10.1371/journal.pone.0053791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308284	Green Published, gold			2022-12-27	WOS:000313429100116
J	Lefebvre, R; Legrand, C; Groom, L; Dirksen, RT; Jacquemond, V				Lefebvre, Romain; Legrand, Claude; Groom, Linda; Dirksen, Robert T.; Jacquemond, Vincent			Ca2+ Release in Muscle Fibers Expressing R4892W and G4896V Type 1 Ryanodine Receptor Disease Mutants	PLOS ONE			English	Article							CENTRAL CORE DISEASE; PORE-FORMING SEGMENT; SKELETAL-MUSCLE; MALIGNANT HYPERTHERMIA; CALCIUM HOMEOSTASIS; CHANNEL FUNCTION; ION PERMEATION; MUTATIONS; MOUSE; RYR1	The large and rapidly increasing number of potentially pathological mutants in the type 1 ryanodine receptor (RyR1) prompts the need to characterize their effects on voltage-activated sarcoplasmic reticulum (SR) Ca2+ release in skeletal muscle. Here we evaluated the function of the R4892W and G4896V RyR1 mutants, both associated with central core disease (CCD) in humans, in myotubes and in adult muscle fibers. For both mutants expressed in RyR1-null (dyspedic) myotubes, voltage-gated Ca2+ release was absent following homotypic expression and only partially restored following heterotypic expression with wild-type (WT) RyR1. In muscle fibers from adult WT mice, both mutants were expressed in restricted regions of the fibers with a pattern consistent with triadic localization. Voltage-clamp-activated confocal Ca2+ signals showed that fiber regions endowed with G4896V-RyR1s exhibited an similar to 30% reduction in the peak rate of SR Ca2+ release, with no significant change in SR Ca2+ content. Immunostaining revealed no associated change in the expression of either alpha 1S subunit (Cav1.1) of the dihydropyridine receptor (DHPR) or type 1 sarco(endo) plasmic reticulum Ca2+ ATPase (SERCA1), indicating that the reduced Ca2+ release resulted from defective RyR1 function. Interestingly, in spite of robust localized junctional expression, the R4892W mutant did not affect SR Ca2+ release in adult muscle fibers, consistent with a low functional penetrance of this particular CCD-associated mutant.	[Lefebvre, Romain; Legrand, Claude; Jacquemond, Vincent] Univ Lyon 1, CNRS UMR 5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France; [Groom, Linda; Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Rochester	Jacquemond, V (corresponding author), Univ Lyon 1, CNRS UMR 5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France.	vincent.jacquemond@univ-lyon1.fr		Jacquemond, Vincent/0000-0003-4944-270X	Centre National de la Recherche Scientifique (CNRS), Universite Lyon 1; Association Francaise contre les Myopathies (AFM); NIH [AR055349]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053349] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS), Universite Lyon 1; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from Centre National de la Recherche Scientifique (CNRS), Universite Lyon 1, Association Francaise contre les Myopathies (AFM) and NIH (AR055349 to R. T. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila G, 2003, J GEN PHYSIOL, V121, P277, DOI 10.1085/jgp.200308791; Avila G, 2001, P NATL ACAD SCI USA, V98, P4215, DOI 10.1073/pnas.071048198; Avila G, 2001, J GEN PHYSIOL, V118, P277, DOI 10.1085/jgp.118.3.277; Balshaw D, 1999, P NATL ACAD SCI USA, V96, P3345, DOI 10.1073/pnas.96.7.3345; Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Collet C, 2004, CELL BIOCHEM BIOPHYS, V40, P225, DOI 10.1385/CBB:40:2:225; Dirksen RT, 2004, BIOPHYS J, V87, P3193, DOI 10.1529/biophysj.104.049447; Du GG, 2004, BIOCHEM J, V382, P557, DOI 10.1042/BJ20040580; Ducreux S, 2004, J BIOL CHEM, V279, P43838, DOI 10.1074/jbc.M403612200; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; Jungbluth H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-25; Kimura T, 2009, CELL CALCIUM, V45, P264, DOI 10.1016/j.ceca.2008.11.005; Kossugue PM, 2007, MUSCLE NERVE, V35, P670, DOI 10.1002/mus.20715; Lefebvre R, 2011, J PHYSIOL-LONDON, V589, P5361, DOI 10.1113/jphysiol.2011.216408; Legrand C, 2008, J PHYSIOL-LONDON, V586, P441, DOI 10.1113/jphysiol.2007.145862; Loy RE, 2011, J GEN PHYSIOL, V137, P43, DOI 10.1085/jgp.201010523; Lyfenko AD, 2004, BIOCHEM BIOPH RES CO, V322, P1256, DOI 10.1016/j.bbrc.2004.08.031; Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164; Monnier N, 2001, HUM MOL GENET, V10, P2581, DOI 10.1093/hmg/10.22.2581; Muntoni F, 2003, BRAIN, V126, P2339, DOI 10.1093/brain/awg288; Pouvreau S, 2006, BIOPHYS J, V91, P2206, DOI 10.1529/biophysj.105.078089; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rosenberg H, 2010, GENE REV; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005; Vega AV, 2011, J PHYSIOL-LONDON, V589, P4649, DOI 10.1113/jphysiol.2011.210765; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Weiss N, 2010, J PHYSIOL-LONDON, V588, P2945, DOI 10.1113/jphysiol.2010.191593; Xu L, 2008, J BIOL CHEM, V283, P6321, DOI 10.1074/jbc.M707353200; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zvaritch E, 2007, P NATL ACAD SCI USA, V104, P18537, DOI 10.1073/pnas.0709312104; Zvaritch E, 2009, P NATL ACAD SCI USA, V106, P21813, DOI 10.1073/pnas.0912126106	37	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e54042	10.1371/journal.pone.0054042	http://dx.doi.org/10.1371/journal.pone.0054042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308296	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100127
J	Mizrahi-Man, O; Davenport, ER; Gilad, Y				Mizrahi-Man, Orna; Davenport, Emily R.; Gilad, Yoav			Taxonomic Classification of Bacterial 16S rRNA Genes Using Short Sequencing Reads: Evaluation of Effective Study Designs	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; SPECIES LIVING TREE; PAIRED-END; COMMUNITY; DIVERSITY; PROJECT; TOOLS; GENERATION; PRIMERS; SEARCH	Massively parallel high throughput sequencing technologies allow us to interrogate the microbial composition of biological samples at unprecedented resolution. The typical approach is to perform high-throughout sequencing of 16S rRNA genes, which are then taxonomically classified based on similarity to known sequences in existing databases. Current technologies cause a predicament though, because although they enable deep coverage of samples, they are limited in the length of sequence they can produce. As a result, high-throughout studies of microbial communities often do not sequence the entire 16S rRNA gene. The challenge is to obtain reliable representation of bacterial communities through taxonomic classification of short 16S rRNA gene sequences. In this study we explored properties of different study designs and developed specific recommendations for effective use of short-read sequencing technologies for the purpose of interrogating bacterial communities, with a focus on classification using naive Bayesian classifiers. To assess precision and coverage of each design, we used a collection of similar to 8,500 manually curated 16S rRNA gene sequences from cultured bacteria and a set of over one million bacterial 16S rRNA gene sequences retrieved from environmental samples, respectively. We also tested different configurations of taxonomic classification approaches using short read sequencing data, and provide recommendations for optimal choice of the relevant parameters. We conclude that with a judicious selection of the sequenced region and the corresponding choice of a suitable training set for taxonomic classification, it is possible to explore bacterial communities at great depth using current technologies, with only a minimal loss of taxonomic resolution.	[Mizrahi-Man, Orna; Davenport, Emily R.; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Gilad, Y (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	gilad@uchicago.edu		Davenport, Emily R./0000-0002-6938-4933	NIH [HL092206]; DDRC grant (Digestive Diseases Research Core Center); DDRCC;  [P30DK42086]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DDRC grant (Digestive Diseases Research Core Center); DDRCC; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant HL092206 to YG, and by a pilot and feasibility DDRC grant (Digestive Diseases Research Core Center) to YG, funded by P30DK42086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Gilad lab for helpful discussions and C. Ober and Z. Gauhar for comments on the manuscript. This work was supported by NIH grant HL092206 to YG, and by a pilot and feasibility DDRCC grant to YG, funded by P30DK42086.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Charlson ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042786; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; DeSantis Todd Z., 2011, BMC Ecology, V11, P11, DOI 10.1186/1472-6785-11-11; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fagen Jennie R, 2012, Open Microbiol J, V6, P29, DOI 10.2174/1874285801206010029; Finkel OM, 2011, APPL ENVIRON MICROB, V77, P7647, DOI 10.1128/AEM.05565-11; Garrity GM, 2007, TAXONOMIC OUTLINE BA; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Hackl E, 2004, APPL ENVIRON MICROB, V70, P5057, DOI 10.1128/AEM.70.9.5057-5065.2004; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hummelen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026602; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Munoz R, 2011, SYST APPL MICROBIOL, V34, P169, DOI 10.1016/j.syapm.2011.03.001; Nakayama J, 2011, FEMS IMMUNOL MED MIC, V63, P397, DOI 10.1111/j.1574-695X.2011.00872.x; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Soergel DAW, 2012, ISME J; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhang XJ, 2011, APPL MICROBIOL BIOT, V91, P425, DOI 10.1007/s00253-011-3296-1	52	193	200	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53608	10.1371/journal.pone.0053608	http://dx.doi.org/10.1371/journal.pone.0053608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308262	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100095
J	Zhang, J; Yang, JM; Wang, HJ; Ru, GQ; Fan, DM				Zhang, Jun; Yang, Jian-min; Wang, Hui-ju; Ru, Guo-qing; Fan, Dai-ming			Synthesized Multiple Antigenic Polypeptide Vaccine Based on B-Cell Epitopes of Human Heparanase Could Elicit a Potent Antimetastatic Effect on Human Hepatocellular Carcinoma In Vivo (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							CANCER METASTASIS; GROWTH-FACTOR; SULFATE; ANGIOGENESIS; IDENTIFICATION; MIMETICS; INVASION; TRENDS; LINE	Aims: The aim of this study was to investigate the antimetastatic effect of multiple antigenic polypeptide (MAP) vaccine based on B-cell epitopes of heparanase (HPSE) on human hepatocellular carcinoma (HCC) in vivo. Methods: The antiserum against B-cell epitopes of HPSE was isolated, purified and characterized after immunizing white-hair-black-eye (WHBY) rabbit with freshly synthesized MAP vaccine. Tumor-bearing murine models of orthotopic implants using HCC-97H cell line were built in BALB/c nude mice. Anti-MAP polyclonal antibodies induced by MAP vaccine were administrated to the models. The impact on metastasis was assessed, the expressions of VEGF/bFGF in hepatoma tissues and in murine sera were evaluated, and the micro-vessel density (MVD) was counted as well. In addition, the possible impairments of the HPSE MAP vaccine on certain HPSE positive normal organs and blood cells were investigated. Results: The antiserum was harvested, purified and identified. The antibodies induced by MAP vaccine could specifically react with the dominant epitopes of both precursor protein and large subunit monomer of HPSE, markedly decrease HPSE activity, suppress the expressions of both VEGF and bFGF, and reduce the MVD. Pulmonary metastasis was also attenuated significantly by the anti-MAP polyclonal antibodies. In addition, no obvious impairment could be observed in certain HPSE positive organs and cells. Conclusion: MAP vaccine based on B-cell epitopes of HPSE is capable of alleviating HCC metastasis in vivo, mainly through inhibiting the HPSE activity and tumor associated angiogenesis, by virtue of the specific anti-MAP polyclonal antibodies. Furthermore, these HPSE-specific antibodies do not cause obvious abnormalities on certain HPSE positive blood cells and organs. Our study provides theoretical evidences for the clinical use of the synthesized MAP vaccine based on B-cell epitopes of HPSE in preventing HCC metastasis.	[Zhang, Jun; Fan, Dai-ming] Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp Digest Dis, Xian 710032, Shanxi Province, Peoples R China; [Zhang, Jun; Fan, Dai-ming] Fourth Mil Med Univ, Inst Digest Dis, Xijing Hosp Digest Dis, Xian 710032, Shanxi Province, Peoples R China; [Zhang, Jun; Yang, Jian-min] Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Wang, Hui-ju] Key Lab Gastroenterol Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Ru, Guo-qing] Zhejiang Prov Peoples Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Fan, DM (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp Digest Dis, Xian 710032, Shanxi Province, Peoples R China.	fandaim@fmmu.edu.cn			National Natural Science Foundation of China [30570816]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30570816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FQ, 2000, J CANCER RES CLIN, V126, P153, DOI 10.1007/s004320050025; Chan A, 2007, ANN ONCOL, V18, P1152, DOI 10.1093/annonc/mdl476; Du Ling, 2008, Zhonghua Weishengwuxue He Mianyixue Zazhi, V28, P869; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; Han Xiao-mei, 2009, Zhonghua Zhongliu Zazhi, V31, P10, DOI 10.3760/cma.j.issn.0253-3766.2009.01.003; Hao XS, 2003, EUR J CANCER PREV, V12, P273, DOI 10.1097/00008469-200308000-00006; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; KATZ M, 1981, INFECT IMMUN, V31, P1125, DOI 10.1128/IAI.31.3.1125-1131.1981; Levy-Adam F, 2005, J BIOL CHEM, V280, P20457, DOI 10.1074/jbc.M414546200; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Liu Xiaobo, 1999, Journal of West China University of Medical Sciences, V30, P455; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Nasser NJ, 2009, P NATL ACAD SCI USA, V106, P2253, DOI 10.1073/pnas.0812846106; Poon RT, 2011, ANN SURG, V233, P227; Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005; Sawai H, 2008, J SURG RES, V144, P117, DOI 10.1016/j.jss.2007.03.023; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Shen FG, 2011, J ANHUI AGR SCI, V20, P12264; Shen KK, 2011, J BIOCHEM, V150, P189, DOI 10.1093/jb/mvr060; Sommerfeldt N, 2006, CANCER RES, V66, P7716, DOI 10.1158/0008-5472.CAN-05-2363; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Uchino K, 2011, CANCER-AM CANCER SOC, V117, P4475, DOI 10.1002/cncr.25960; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; WEIDNER N, 1995, AM J PATHOL, V147, P9; Xu YZ, 2011, ENDOCRINE, V40, P445, DOI 10.1007/s12020-011-9502-1; Yang JM, 2009, CANCER IMMUNOL IMMUN, V58, P1387, DOI 10.1007/s00262-008-0651-x; Zarour HM, 2011, EUR J IMMUNOL, V41, P1510, DOI 10.1002/eji.201190035; Zhao HJ, 2006, CANCER RES, V66, P8779, DOI 10.1158/0008-5472.CAN-06-1382	37	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52940	10.1371/journal.pone.0052940	http://dx.doi.org/10.1371/journal.pone.0052940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308126	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100021
J	Egli, A; Schafer, J; Osthoff, M; Thiel, S; Mikkelsen, C; Rauch, A; Hirsch, HH; Bucher, HC; Young, J; Jensenius, JC; Battegay, M; Trendelenburg, M				Egli, Adrian; Schaefer, Juliane; Osthoff, Michael; Thiel, Steffen; Mikkelsen, Christina; Rauch, Andri; Hirsch, Hans H.; Bucher, Heiner C.; Young, James; Jensenius, Jens C.; Battegay, Manuel; Trendelenburg, Marten		Swiss HIV Cohort Study	Low Levels of Mannan-Binding Lectin or Ficolins Are Not Associated with an Increased Risk of Cytomegalovirus Disease in HIV-Infected Patients	PLOS ONE			English	Article							GENE POLYMORPHISMS; COMPLEMENT PATHWAY; IMMUNE REGULATION; CMV DISEASE; VIRUS; PROTEIN; DEFICIENCY; TRANSPLANT; RETINITIS; MBL2	Background: In HIV-infected patients, prediction of Cytomegalovirus (CMV) disease remains difficult. A protective role of mannan-binding lectin (MBL) and ficolins against CMV disease has been reported after transplantation, but the impact in HIV-infected patients is unclear. Methods: In a case-control study nested within the Swiss HIV Cohort Study, we investigated associations between plasma levels of MBL/ficolins and CMV disease. We compared HIV-infected patients with CMV disease (cases) to CMV-seropositive patients without CMV disease (controls) matched for CD4 T-cells, sampling time, and use of combination antiretroviral therapy. MBL and M-ficolin, L-ficolin, and H-ficolin were quantified using ELISA. Results: We analysed 105 cases and 105 matched controls. CMV disease was neither associated with MBL (odds ratio [OR] 1.03 per log(10) ng/mL increase (95% CI 0.73-1.45)) nor with ficolins (OR per log(10) ng/mL increase 0.66 (95% CI 0.28-1.52), 2.34 (95% CI 0.44-12.36), and 0.89 (95% CI 0.26-3.03) for M-ficolin, L-ficolin, and H-ficolin, respectively). We found no evidence of a greater association between MBL and CMV disease in patients with low CD4 counts; however in the multivariable analysis, CMV disease was more likely in patients with an increased HIV RNA (OR 1.53 per log(10) copies/mL; 95% CI 1.08-2.16), or a shorter duration of HIV-infection (OR 0.91 per year; 95% CI 0.84-0.98). Conclusions: CMV disease is not associated with low levels of MBL/ficolins, suggesting a lack of a protective role in HIV-infected patients.	[Egli, Adrian; Hirsch, Hans H.; Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Egli, Adrian; Osthoff, Michael; Trendelenburg, Marten] Univ Basel, Dept Biomed, Clin Immunol Lab, Basel, Switzerland; [Schaefer, Juliane; Bucher, Heiner C.; Young, James] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Thiel, Steffen; Mikkelsen, Christina; Jensenius, Jens C.] Univ Aarhus, Dept Biomed, Aarhus, Denmark; [Rauch, Andri] Univ Hosp Bern, Div Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [Hirsch, Hans H.] Univ Basel, Inst Med Microbiol, Dept Biomed, Basel, Switzerland; [Trendelenburg, Marten] Univ Basel Hosp, Clin Internal Med, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel; Aarhus University; University of Bern; University Hospital of Bern; University of Bern; University of Basel; University of Basel	Egli, A (corresponding author), Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland.	aegli@ualberta.ca	Trendelenburg, Marten/AAM-1626-2020; Rauch, Andri/E-9948-2017; Pantaleo, Giuseppe/K-6163-2016	Trendelenburg, Marten/0000-0001-7036-8386; Rauch, Andri/0000-0001-5297-6062; Hirsch, Hans H./0000-0003-0883-0423; Thiel, Steffen/0000-0002-4817-155X; Young, Jim/0000-0002-4314-3007; Osthoff, Michael/0000-0001-5439-957X; Mikkelsen, Christina/0000-0002-2945-6197	framework of the Swiss HIV Cohort Study [637]; Swiss National Science Foundation [33CS30_134277]; Swiss National Foundation [3200B0-110040/1]; Astellas Foundation University Hospital of Basel; Novartis Jubilaumsstiftung; Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	framework of the Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Astellas Foundation University Hospital of Basel; Novartis Jubilaumsstiftung(Novartis); Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	This study was supported by the framework of the Swiss HIV Cohort Study (project # 637), the Swiss National Science Foundation (grant # 33CS30_134277), and through grants from the Swiss National Foundation (grant # 3200B0-110040/1), from the Astellas Foundation University Hospital of Basel, and from the Novartis Jubilaumsstiftung to AE and MT. The Basel Institute for Clinical Epidemiology and Biostatistics is supported by grants from Santesuisse and from the Gottfried and Julia Bangerter-Rhyner-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; BENKO DM, 1986, J VIROL, V59, P703, DOI 10.1128/JVI.59.3.703-713.1986; Bouwman LH, 2005, GASTROENTEROLOGY, V129, P408, DOI 10.1053/j.gastro.2005.06.049; Brantsaeter AB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-127; BRESLOW N, 1982, BIOMETRICS, V38, P661, DOI 10.2307/2530047; Bronke C, 2005, J INFECT DIS, V191, P873, DOI 10.1086/427828; Brown KS, 2010, PROTEIN CELL, V1, P664, DOI 10.1007/s13238-010-0088-9; Cervera C, 2009, TRANSPL P, V41, P2259, DOI 10.1016/j.transproceed.2009.06.056; Cervera C, 2007, TRANSPLANTATION, V83, P1493, DOI 10.1097/01.tp.0000264999.71318.2b; Chow SP, 2011, CLIN EXP OPHTHALMOL, V39, P871, DOI 10.1111/j.1442-9071.2011.02572.x; Cummings KL, 2007, VIRAL IMMUNOL, V20, P505, DOI 10.1089/vim.2007.0061; Cunha AA, 2011, REV INST MED TROP SP, V53, P83, DOI 10.1590/S0036-46652011000100005; de Rooij BJF, 2011, J HEPATOL, V55, P800, DOI 10.1016/j.jhep.2011.01.039; Deayton JR, 2000, SEX TRANSM INFECT, V76, P342, DOI 10.1136/sti.76.5.342; Egli A, 2008, TRANSPL INFECT DIS, V10, P27, DOI 10.1111/j.1399-3062.2007.00285.x; Egli A, 2012, CLIN INFECT DIS, V55, P1678, DOI 10.1093/cid/cis818; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; Fiane AE, 2005, EUR HEART J, V26, P1660, DOI 10.1093/eurheartj/ehi198; Gadjeva M, 2004, CLIN EXP IMMUNOL, V138, P304, DOI 10.1111/j.1365-2249.2004.02616.x; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517; Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005; Henckaerts L, 2009, CRIT CARE MED, V37, P192, DOI 10.1097/CCM.0b013e31819263d8; Herpers BL, 2009, CLIN EXP IMMUNOL, V156, P488, DOI 10.1111/j.1365-2249.2009.03929.x; Hu YZ, 2010, VIRAL IMMUNOL, V23, P443, DOI 10.1089/vim.2009.0109; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; Jabs DA, 2011, AM J OPHTHALMOL, V151, P198, DOI 10.1016/j.ajo.2010.10.018; Jacobson MA, 2008, CLIN INFECT DIS, V46, P458, DOI 10.1086/525853; Jeon S, 2012, OPHTHALMOLOGY, V119, P1892, DOI 10.1016/j.ophtha.2012.03.032; Kase T, 1999, IMMUNOLOGY, V97, P385; Kwakkel-van Erp JM, 2011, CLIN EXP IMMUNOL, V165, P410, DOI 10.1111/j.1365-2249.2011.04436.x; Lachin JM, 2008, STAT MED, V27, P2509, DOI 10.1002/sim.3057; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Manuel O, 2007, TRANSPLANTATION, V83, P359, DOI 10.1097/01.tp.0000251721.90688.c2; O'Brien KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017377; Osthoff M, 2010, HAEMATOL-HEMATOL J, V95, P1389, DOI 10.3324/haematol.2009.017863; Perez-Castellano M, 2006, CLIN EXP IMMUNOL, V145, P228, DOI 10.1111/j.1365-2249.2006.03140.x; Sagedal S, 2008, NEPHROL DIAL TRANSPL, V23, P4054, DOI 10.1093/ndt/gfn355; Sarkar N, 2008, LATTICE MULTIVARIATE; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Seppanen M, 2009, HUM IMMUNOL, V70, P218, DOI 10.1016/j.humimm.2009.01.022; Singh KP, 2007, CLIN IMMUNOL, V124, P200, DOI 10.1016/j.clim.2007.04.018; Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022; Spiller OB, 1998, J INFECT DIS, V178, P1597, DOI 10.1086/314499; Stoermer KA, 2011, VIROLOGY, V411, P362, DOI 10.1016/j.virol.2010.12.045; SUPER M, 1992, NAT GENET, V2, P50, DOI 10.1038/ng0992-50; Szala A, 2011, MOL IMMUNOL, V48, P2203, DOI 10.1016/j.molimm.2011.06.220; TayKearney ML, 1997, J INFECT DIS, V176, P790, DOI 10.1086/517303; Thielens NM, 2002, IMMUNOBIOLOGY, V205, P563, DOI 10.1078/0171-2985-00155; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; Worthley DL, 2009, CLIN INFECT DIS, V48, P410, DOI 10.1086/596313; Wu W, 2012, APMIS, V120, P675, DOI 10.1111/j.1600-0463.2012.02880.x	55	8	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e51983	10.1371/journal.pone.0051983	http://dx.doi.org/10.1371/journal.pone.0051983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308103	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100005
J	Fordyce, SL; Avila-Arcos, MC; Rasmussen, M; Cappellini, E; Romero-Navarro, JA; Wales, N; Alquezar-Planas, DE; Penfield, S; Brown, TA; Vielle-Calzada, JP; Montiel, R; Jorgensen, T; Odegaard, N; Jacobs, M; Arriaza, B; Higham, TFG; Ramsey, CB; Willersiev, E; Gilbert, MTP				Fordyce, Sarah L.; Avila-Arcos, Maria C.; Rasmussen, Morten; Cappellini, Enrico; Romero-Navarro, J. Alberto; Wales, Nathan; Alquezar-Planas, David E.; Penfield, Steven; Brown, Terence A.; Vielle-Calzada, Jean-Philippe; Montiel, Rafael; Jorgensen, Tina; Odegaard, Nancy; Jacobs, Michael; Arriaza, Bernardo; Higham, Thomas F. G.; Ramsey, Christopher Bronk; Willersiev, Eske; Gilbert, M. Thomas P.			Deep Sequencing of RNA from Ancient Maize Kernels	PLOS ONE			English	Article							MESSENGER-RNA; ARTIFICIAL SELECTION; SEED-GERMINATION; DNA-SEQUENCES; GENOME; DOMESTICATION; TRANSCRIPTOME; ALIGNMENT; TOOL; NEANDERTHAL	The characterization of biomolecules from ancient samples can shed otherwise unobtainable insights into the past. Despite the fundamental role of transcriptomal change in evolution, the potential of ancient RNA remains unexploited - perhaps due to dogma associated with the fragility of RNA. We hypothesize that seeds offer a plausible refuge for long-term RNA survival, due to the fundamental role of RNA during seed germination. Using RNA-Seq on cDNA synthesized from nucleic acid extracts, we validate this hypothesis through demonstration of partial transcriptomal recovery from two sources of ancient maize kernels. The results suggest that ancient seed transcriptomics may offer a powerful new tool with which to study plant domestication.	[Fordyce, Sarah L.; Avila-Arcos, Maria C.; Rasmussen, Morten; Cappellini, Enrico; Romero-Navarro, J. Alberto; Wales, Nathan; Alquezar-Planas, David E.; Jorgensen, Tina; Willersiev, Eske; Gilbert, M. Thomas P.] Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Romero-Navarro, J. Alberto] Univ Nacl Autonoma Mexico, Cuernavaca 62191, Morelos, Mexico; [Wales, Nathan] Univ Connecticut, Dept Anthropol, Storrs, CT USA; [Penfield, Steven] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England; [Brown, Terence A.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Vielle-Calzada, Jean-Philippe; Montiel, Rafael] CINVESTAV IPN, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Odegaard, Nancy; Jacobs, Michael] Univ Arizona, Arizona State Museum, Tucson, AZ 85721 USA; [Arriaza, Bernardo] Univ Tarapaca, Ctr Invest Hombre Desierto, Dept Antropol, Inst Alta Invest, Arica, Chile; [Higham, Thomas F. G.; Ramsey, Christopher Bronk] Univ Oxford Archaeol & Hist Art Res Lab, Oxford, England	Universidad Nacional Autonoma de Mexico; University of Connecticut; University of York - UK; University of Manchester; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Arizona State University; University of Arizona; Universidad de Tarapaca; University of Oxford	Gilbert, MTP (corresponding author), Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	mtpgilbert@gmail.com	Ramsey, Christopher Bronk/A-3277-2012; Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011; Ávila-Arcos, Maria C./AGZ-3897-2022; Martin, Sarah Louise/AAE-7701-2021; Vielle-Calzada, Jean-Philippe/AAG-4036-2019; Higham, Tom/Y-2707-2019; Montiel, Rafael/A-6774-2008; Wales, Nathan/B-4263-2015; Ramsey, Christopher Bronk/AAQ-2227-2021; Cappellini, Enrico/F-9346-2013; Gilbert, Marcus/A-8936-2013	Ramsey, Christopher Bronk/0000-0002-8641-9309; Willerslev, Eske/0000-0002-7081-6748; Ávila-Arcos, Maria C./0000-0003-1691-1696; Martin, Sarah Louise/0000-0002-1741-4387; Higham, Tom/0000-0002-5949-598X; Montiel, Rafael/0000-0001-8052-0679; Wales, Nathan/0000-0003-0359-8450; Ramsey, Christopher Bronk/0000-0002-8641-9309; Cappellini, Enrico/0000-0001-7885-7811; Vielle-Calzada, Jean-Philippe/0000-0002-3017-2490; Penfield, Steven/0000-0001-6340-1731; Gilbert, Marcus/0000-0002-5805-7195	Danish Natural Science Research Council; Danish National Research Foundations; Natural Environment Research Council [NRCF010002] Funding Source: researchfish; NERC [NRCF010002] Funding Source: UKRI	Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundations; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding: The authors thank the Danish Natural Science Research Council and Danish National Research Foundations for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOGUERA C, 1992, PLANT MOL BIOL, V19, P781, DOI 10.1007/BF00027074; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], REPEATMODELER OP 1 0; Avila-Arcos MC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00074; Bannister Bryant, 1968, TREE RING DATES ARIZ; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; BUESCHER PJ, 1984, BIOCHEM GENET, V22, P923, DOI 10.1007/BF00499483; Buitink J, 2006, PLANT J, V47, P735, DOI 10.1111/j.1365-313X.2006.02822.x; DURE L, 1965, SCIENCE, V147, P410, DOI 10.1126/science.147.3656.410; Freitas FO, 2003, J ARCHAEOL SCI, V30, P901, DOI 10.1016/S0305-4403(02)00269-8; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; HAMMETT JR, 1975, BIOCHEMISTRY-US, V14, P4375, DOI 10.1021/bi00691a005; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jaenicke-Despres V, 2003, SCIENCE, V302, P1206, DOI 10.1126/science.1089056; Kan YC, 2006, J CEREAL SCI, V44, P75, DOI 10.1016/j.jcs.2006.04.004; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Masaki S, 2008, BIOTECHNOL LETT, V30, P955, DOI 10.1007/s10529-007-9619-8; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; ODonoghue K, 1996, P ROY SOC B-BIOL SCI, V263, P541, DOI 10.1098/rspb.1996.0082; Prioul JL, 2008, PLANT BIOTECHNOL J, V6, P855, DOI 10.1111/j.1467-7652.2008.00368.x; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; ROLLO F, 1991, GENET RES, V58, P193, DOI 10.1017/S0016672300029943; Rollo F, 1985, THEOR APPL GENET, V41, P330; Sallon S, 2008, SCIENCE, V320, P1464, DOI 10.1126/science.1153600; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; VENANZI FM, 1990, NATURE, V343, P25, DOI 10.1038/343025b0; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242	39	29	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e50961	10.1371/journal.pone.0050961	http://dx.doi.org/10.1371/journal.pone.0050961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326310	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800008
J	Lamb, LS; Bowersock, J; Dasgupta, A; Gillespie, GY; Su, Y; Johnson, A; Spencer, HT				Lamb, Lawrence S., Jr.; Bowersock, Joscelyn; Dasgupta, Anindya; Gillespie, G. Yancey; Su, Yun; Johnson, Austin; Spencer, H. Trent			Engineered Drug Resistant gamma delta T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy	PLOS ONE			English	Article							MALIGNANT GLIOMA; RECOMBINANT INTERLEUKIN-2; ADOPTIVE IMMUNOTHERAPY; RECURRENT GLIOBLASTOMA; IMMUNOGENE THERAPY; IMMUNE-RESPONSE; LAK CELLS; LYMPHOCYTES; CANCER; RECEPTOR	Classical approaches to immunotherapy that show promise in some malignancies have generally been disappointing when applied to high-grade brain tumors such as glioblastoma multiforme (GBM). We recently showed that ex vivo expanded/activated gamma delta T cells recognize NKG2D ligands expressed on malignant glioma and are cytotoxic to glioma cell lines and primary GBM explants. In addition, gamma delta T cells extend survival and slow tumor progression when administered to immunodeficient mice with intracranial human glioma xenografts. We now show that temozolomide (TMZ), a principal chemotherapeutic agent used to treat GBM, increases the expression of stress-associated NKG2D ligands on TMZ-resistant glioma cells, potentially rendering them vulnerable to gamma delta T cell recognition and lysis. TMZ is also highly toxic to gamma delta T cells, however, and to overcome this cytotoxic effect gamma delta T cells were genetically modified using a lentiviral vector encoding the DNA repair enzyme O(6)-alkylguanine DNA alkyltransferase (AGT) from the O(6)-methylguanine methyltransferase (MGMT) cDNA, which confers resistance to TMZ. Genetic modification of gamma delta T cells did not alter their phenotype or their cytotoxicity against GBM target cells. Importantly, gene modified gamma delta T cells showed greater cytotoxicity to two TMZ resistant GBM cell lines, U373(TMZ-R) and SNB-19(TMZ-R) cells, in the presence of TMZ than unmodified cells, suggesting that TMZ exposed more receptors for gamma delta T cell-targeted lysis. Therefore, TMZ resistant gamma delta T cells can be generated without impairing their anti-tumor functions in the presence of high concentrations of TMZ. These results provide a mechanistic basis for combining chemotherapy and gamma delta T cell-based drug resistant cellular immunotherapy to treat GBM.	[Lamb, Lawrence S., Jr.; Bowersock, Joscelyn; Su, Yun; Johnson, Austin] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Lamb, Lawrence S., Jr.; Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Dasgupta, Anindya; Spencer, H. Trent] Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA USA; [Dasgupta, Anindya; Spencer, H. Trent] Blood Disorders Serv, Atlanta, GA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University	Lamb, LS (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	Lawrence.Lamb@ccc.uab.edu; hspence@emory.edu		Gillespie, George/0000-0001-6436-9542; Lamb, Lawrence/0000-0001-7180-0994	CURE Childhood Cancer; NATIONAL CANCER INSTITUTE [P20CA151129] Funding Source: NIH RePORTER	CURE Childhood Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported by grants from CURE Childhood Cancer to HTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonia SJ, 2006, CLIN CANCER RES, V12, P878, DOI 10.1158/1078-0432.CCR-05-2013; Arlen PM, 2006, CLIN CANCER RES, V12, P1260, DOI 10.1158/1078-0432.CCR-05-2059; Banissi C, 2009, CANCER IMMUNOL IMMUN, V58, P1627, DOI 10.1007/s00262-009-0671-1; BARBA D, 1989, J NEUROSURG, V70, P175, DOI 10.3171/jns.1989.70.2.0175; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BOIARDI A, 1994, CANCER IMMUNOL IMMUN, V39, P193, DOI 10.1007/BF01533386; Bryant N.A., 2010, VET MICROBIOL; Bryant NL, 2011, J NEURO-ONCOL, V101, P179, DOI 10.1007/s11060-010-0245-2; Bryant NL, 2009, NEURO-ONCOLOGY, V11, P357, DOI 10.1215/15228517-2008-111; Castro MG, 2003, PHARMACOL THERAPEUT, V98, P71, DOI 10.1016/S0163-7258(03)00014-7; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Dasgupta A, 2012, HUM GENE THER; Dasgupta A, 2010, BIOCHEM BIOPH RES CO, V391, P170, DOI 10.1016/j.bbrc.2009.11.026; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dillman RO, 2004, J IMMUNOTHER, V27, P398, DOI 10.1097/00002371-200409000-00009; Doering CB, 2009, MOL THER, V17, P1145, DOI 10.1038/mt.2009.35; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; FARKKILA M, 1994, BRIT J CANCER, V70, P138, DOI 10.1038/bjc.1994.263; Fridlender ZG, 2010, MOL THER, V18, P1947, DOI 10.1038/mt.2010.159; Friese MA, 2003, CANCER RES, V63, P8996; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; GROSS JL, 1988, CANCER RES, V48, P291; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Gulley JL, 2007, VACCINE, V25, pB89, DOI 10.1016/j.vaccine.2007.04.091; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; HAYES RL, 1995, CANCER-AM CANCER SOC, V76, P840, DOI 10.1002/1097-0142(19950901)76:5<840::AID-CNCR2820760519>3.0.CO;2-R; Kato Y, 2001, J IMMUNOL, V167, P5092, DOI 10.4049/jimmunol.167.9.5092; Komatsu F, 2000, ONCOL RES, V12, P17; Kruse CA, 1997, CANCER IMMUNOL IMMUN, V45, P77, DOI 10.1007/s002620050405; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lamb LS, 2009, IMMUNOL RES, V45, P85, DOI 10.1007/s12026-009-8114-9; Liseth K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/692097; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; MAHALEY MS, 1988, J NEUROSURG, V69, P826, DOI 10.3171/jns.1988.69.6.0826; McMillin DW, 2006, HUM GENE THER, V17, P798, DOI 10.1089/hum.2006.17.798; MERCHANT RE, 1990, J NEURO-ONCOL, V8, P173; Merchant RE, 1997, NEUROL RES, V19, P145; Mitchell MS, 2003, CANCER IMMUNOL IMMUN, V52, P686, DOI 10.1007/s00262-003-0427-2; Plautz GE, 1998, J NEUROSURG, V89, P42, DOI 10.3171/jns.1998.89.1.0042; Poggi A, 2004, BLOOD, V103, P2205, DOI 10.1182/blood-2003-08-2928; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Rainov NG, 2000, GENE THER, V7, P1853, DOI 10.1038/sj.gt.3301311; Ramakrishnan R, 2008, CANCER IMMUNOL IMMUN, V57, P1523, DOI 10.1007/s00262-008-0531-4; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Read SB, 2003, J INTERF CYTOK RES, V23, P379, DOI 10.1089/107999003322226032; SARIS SC, 1989, J NEUROSURG, V71, P169, DOI 10.3171/jns.1989.71.2.0169; van der Most RG, 2008, CELL DEATH DIFFER, V15, P13, DOI 10.1038/sj.cdd.4402255; van der Most Robbert G, 2005, Discov Med, V5, P265; WELCH WC, 1995, IN VITRO CELL DEV-AN, V31, P610; Wischhusen J, 2005, J NEUROPATH EXP NEUR, V64, P523, DOI 10.1093/jnen/64.6.523; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Zhang JH, 2010, ONCOLOGY-BASEL, V78, P103, DOI 10.1159/000306139; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	54	51	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e51805	10.1371/journal.pone.0051805	http://dx.doi.org/10.1371/journal.pone.0051805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326319	gold, Green Published			2022-12-27	WOS:000314705800011
J	Hanke, A				Hanke, Andreas			Non-Equilibrium Casimir Force between Vibrating Plates	PLOS ONE			English	Article							RENORMALIZATION-GROUP TREATMENT; CRITICAL-DYNAMICS; SPHERE; FLUID	We study the fluctuation-induced, time-dependent force between two plates confining a correlated fluid which is driven out of equilibrium mechanically by harmonic vibrations of one of the plates. For a purely relaxational dynamics of the fluid we calculate the fluctuation-induced force generated by the vibrating plate on the plate at rest. The time-dependence of this force is characterized by a positive lag time with respect to the driving. We obtain two distinctive contributions to the force, one generated by diffusion of stress in the fluid and another related to resonant dissipation in the cavity. The relation to the dynamic Casimir effect of the electromagnetic field and possible experiments to measure the time-dependent Casimir force are discussed.	Univ Texas Brownsville, Dept Phys, Brownsville, TX 78520 USA	University of Texas System; University of Texas Rio Grande Valley	Hanke, A (corresponding author), Univ Texas Brownsville, Dept Phys, Brownsville, TX 78520 USA.	hanke@phys.utb.edu			Air Force Office of Scientific Research [FA9550-10-1-0408]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the Air Force Office of Scientific Research under Grant No. FA9550-10-1-0408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolo D, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061112; Bialynicki-Birula I, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.042109; Bitbol AF, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061107; Bordag M, 2009, INT J MOD PHYS A, V24, P1743, DOI 10.1142/S0217751X09045315; Bordag M., 2009, ADV CASIMIR EFFECT, DOI [10.1093/acprof:oso/9780199238743.001.0001, DOI 10.1093/ACPROF:OSO/9780199238743.001.0001]; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; Brito R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011113; Buenzli PR, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.020102; Canaguier-Durand A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230404; Capasso F, 2007, IEEE J SEL TOP QUANT, V13, P400, DOI 10.1109/JSTQE.2007.893082; Casimir H. B. G., 1948, P KON NED AKAD WET, V51, P793; Cattuto C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.178001; Chadwick RS, 2008, SIAM REV, V50, P313, DOI 10.1137/06067763X; Chan HB, 2001, SCIENCE, V291, P1941, DOI 10.1126/science.1057984; Chan HB, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.211801; Chandler D., 1987, INTRO MODERN STAT ME; Clarke RJ, 2005, J FLUID MECH, V545, P397, DOI 10.1017/S0022112005006907; Collins Harry, 2004, GRAVITYS SHADOW SEAR; Davies P, 1996, NATURE, V382, P761, DOI 10.1038/382761a0; Dean DS, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041126; Dean DS, 2009, J STAT MECH-THEORY E, V81; Demery V, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.010103; Demery V, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.080601; Emig T, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.022114; Emig T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.160801; Emig T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.260402; Emig T, 2009, NONLINEAR DYNAMICS N; FISHER ME, 1978, CR ACAD SCI B PHYS, V287, P207; Folk R, 2006, J PHYS A-MATH GEN, V39, pR207, DOI 10.1088/0305-4470/39/24/R01; Gambassi A, 2006, J STAT PHYS, V123, P929, DOI 10.1007/s10955-006-9089-8; Gies H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220405; Golestanian R, 1997, PHYS REV LETT, V78, P3421, DOI 10.1103/PhysRevLett.78.3421; Golestanian R, 1998, PHYS REV A, V58, P1713, DOI 10.1103/PhysRevA.58.1713; HALPERIN BI, 1976, PHYS REV B, V13, P1299, DOI 10.1103/PhysRevB.13.1299; Hanke A, 1998, PHYS REV LETT, V81, P1885, DOI 10.1103/PhysRevLett.81.1885; Hanke A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046121; Hanke A, 2001, PHYS REV LETT, V86, P4596, DOI 10.1103/PhysRevLett.86.4596; Hertlein C, 2008, NATURE, V451, P172, DOI 10.1038/nature06443; Kardar M, 1999, REV MOD PHYS, V71, P1233, DOI 10.1103/RevModPhys.71.1233; Krech M., 1994, CASIMIR EFFECT CRITI; Kruger M, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/21002; Kruger M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.210404; Lambrecht A, 1996, PHYS REV LETT, V77, P615, DOI 10.1103/PhysRevLett.77.615; Lamoreaux SK, 1997, PHYS REV LETT, V78, P5, DOI 10.1103/PhysRevLett.78.5; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; LI H, 1992, PHYS REV A, V46, P6490, DOI 10.1103/PhysRevA.46.6490; McMullin E, 2002, PHYS PERSPECT, V4, P13, DOI 10.1007/s00016-002-8357-5; Milonni P. W., 1993, QUANTUM VACUUM INTRO; Milton K. A., 2001, CASIMIR EFFECT; Mohideen U, 1998, PHYS REV LETT, V81, P4549, DOI 10.1103/PhysRevLett.81.4549; Najafi A, 2004, EUROPHYS LETT, V68, P776, DOI 10.1209/epl/i2004-10275-5; Reid MTH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.040401; Rodriguez AW, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.012115; Rodriguez-Lopez P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031102; Rousseau E, 2009, NAT PHOTONICS, V3, P514, DOI 10.1038/NPHOTON.2009.144; Scheel S, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.042902; Schlesener F, 2003, J STAT PHYS, V110, P981, DOI 10.1023/A:1022184508016; Shen S, 2009, NANO LETT, V9, P2909, DOI 10.1021/nl901208v; SIGGIA ED, 1976, PHYS REV B, V13, P2110, DOI 10.1103/PhysRevB.13.2110; Sushkov AO, 2011, NAT PHYS, V7, P230, DOI [10.1038/nphys1909, 10.1038/NPHYS1909]; Vasilyev O, 2009, REV REV E, V79	61	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53228	10.1371/journal.pone.0053228	http://dx.doi.org/10.1371/journal.pone.0053228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326401	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400017
J	Shao, HY; Hsu, HY; Wu, KS; Hee, SW; Chuang, LM; Yeh, JI				Shao, Hsiao-Yun; Hsu, Hsue-Yin; Wu, Kuan-Sju; Hee, Siow-Wey; Chuang, Lee-Ming; Yeh, Jih-I			Prolonged Induction Activates Cebp alpha Independent Adipogenesis in NIH/3T3 Cells	PLOS ONE			English	Article							C/EBP-ALPHA; INSULIN SENSITIVITY; ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; BLOOD-PRESSURE; EXPRESSION; THIAZOLIDINEDIONE; PATHWAY; CULTURE; LINE	Background: 3T3-L1 cells are widely used to study adipogenesis and insulin response. Their adipogenic potential decreases with time in the culture. Expressing exogenous genes in 3T3-L1 cells can be challenging. This work tries to establish and characterize an alternative model of cultured adipocytes that is easier to work with than the 3T3-L1 cells. Methodology/Principal Findings: Induced cells were identified as adipocytes based on the following three characteristics: (1) Accumulation of triglyceride droplets as demonstrated by oil red O stain. (2) Transport rate of 2-deoxyglucose increased after insulin stimulation. (3) Expression of fat specific genes such as Fabp4 (aP2), Slc2a4 (Glut4) and Pparg (PPAR gamma). Among the cell lines induced under different conditions in this study, only NIH/3T3 cells differentiated into adipocytes after prolonged incubation in 3T3-L1 induction medium containing 20% instead of 10% fetal bovine serum. Rosiglitazone added to the induction medium shortened the incubation period from 14 to 7 days. The PI3K/AKT pathway showed similar changes upon insulin stimulation in these two adipocytes. C/EBP alpha mRNA was barely detectable in NIH/3T3 adipocytes. NIH/3T3 adipocytes induced in the presence of rosiglitazone showed higher 2-deoxyglucose transport rate after insulin stimulation, expressed less Agt (angiotensinogen) and more PPAR gamma. Knockdown of C/EBP alpha using shRNA blocked 3T3-L1 but not NIH/3T3 cell differentiation. Mouse adipose tissues from various anatomical locations showed comparable levels of C/EBPa mRNA. Conclusions/Significance: NIH/3T3 cells were capable of differentiating into adipocytes without genetic engineering. They were an adipocyte model that did not require the reciprocal activation between C/EBP alpha and PPAR gamma to differentiate. Future studies in the C/EBP alpha independent pathways leading to insulin responsiveness may reveal new targets to diabetes treatment.	[Shao, Hsiao-Yun; Yeh, Jih-I] Tzu Chi Univ, Grad Inst Mol & Cell Biol, Hualien, Taiwan; [Hsu, Hsue-Yin] Tzu Chi Univ, Dept & Grad Inst Life Sci, Hualien, Taiwan; [Wu, Kuan-Sju] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Hee, Siow-Wey; Chuang, Lee-Ming] Natl Taiwan Univ, Inst Mol Med, Taipei 10764, Taiwan; [Yeh, Jih-I] Tzu Chi Univ, Dept Family Med, Hualien, Taiwan; [Yeh, Jih-I] Buddhist Tzu Chi Gen Hosp, Dept Family Med, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; Tzu Chi University; National Taiwan University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Yeh, JI (corresponding author), Tzu Chi Univ, Grad Inst Mol & Cell Biol, Hualien, Taiwan.	jihiyeh@mail.tcu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019	CHUANG, LEE-MING/0000-0003-0978-2662	Tzu Chi University [TCIRP 96005-04Y1]; Buddhist Tzu Chi General Hospital [TCRD 101-20]; National Research Program for Genomic Medicine Grants of NSC [NSC97-3112-B-001-016]	Tzu Chi University; Buddhist Tzu Chi General Hospital; National Research Program for Genomic Medicine Grants of NSC	Part of this work was funded by Tzu Chi University (TCIRP 96005-04Y1) and Buddhist Tzu Chi General Hospital (TCRD 101-20). The RNAi reagents obtained from Academia Sinica was supported by the National Research Program for Genomic Medicine Grants of NSC (NSC97-3112-B-001-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bakris G, 2003, J HUM HYPERTENS, V17, P7, DOI 10.1038/sj.jhh.1001444; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; El-Jack AK, 1999, J BIOL CHEM, V274, P7946, DOI 10.1074/jbc.274.12.7946; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guo W, 2009, CELL RES, V19, P216, DOI 10.1038/cr.2008.319; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; KANEKO T, 1978, CANCER RES, V38, P2084; Lambe KG, 1996, EUR J BIOCHEM, V239, P1, DOI 10.1111/j.1432-1033.1996.0001u.x; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Payne VA, 2007, J BIOL CHEM, V282, P21005, DOI 10.1074/jbc.M702871200; Raji A, 2003, DIABETES CARE, V26, P172, DOI 10.2337/diacare.26.1.172; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Sarafidis PA, 2004, J HYPERTENS, V22, P1769, DOI 10.1097/00004872-200409000-00022; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; WANG M, 1995, J IMMUNOL, V154, P4685; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	24	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e51459	10.1371/journal.pone.0051459	http://dx.doi.org/10.1371/journal.pone.0051459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326314	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400004
J	Granmo, M; Jensen, T; Schouenborg, J				Granmo, Marcus; Jensen, Tanja; Schouenborg, Jens			Nociceptive Transmission to Rat Primary Somatosensory Cortex - Comparison of Sedative and Analgesic Effects	PLOS ONE			English	Article							POWER SPECTRUM ANALYSIS; TOOTH-PULP STIMULATION; C-FIBER INPUT; SPINAL-CORD; EXPERIMENTAL PAIN; FIELD POTENTIALS; AWAKE RATS; MIDAZOLAM; MORPHINE; RESPONSES	CO2-laser C-fibre evoked cortical potentials (LCEPs) is a potentially useful animal model for studies of pain mechanisms. A potential confounding factor when assessing analgesic effects of systemically administered drugs using LCEP is sedation. This study aims to clarify: 1) the relation between level of anaesthesia and magnitude of LCEP, 2) the effects of a sedative and an analgesic on LCEP and dominant EEG frequency 3) the effects of a sedative and analgesic on LCEP when dominant EEG frequency is kept stable. LCEP and EEG were recorded in isoflurane/nitrous-oxide anaesthetized rats. Increasing isoflurane level gradually reduced LCEPs and lowered dominant EEG frequencies. Systemic midazolam (10 mu mol/kg) profoundly reduced LCEP (19% of control) and lowered dominant EEG frequency. Similarly, morphine 1 and 3 mg/kg reduced LCEP (39%, 12% of control, respectively) and decreased EEG frequency. When keeping the dominant EEG frequency stable, midazolam caused no significant change of LCEP. Under these premises, morphine at 3 mg/kg, but not 1 mg/kg, caused a significant LCEP reduction (26% of control). In conclusion, the present data indicate that the sedative effects should be accounted for when assessing the analgesic effects of drug. Furthermore, it is suggested that LCEP, given that changes in EEG induced by sedation are compensated for, can provide information about the analgesic properties of systemically administrated drugs.	[Granmo, Marcus; Jensen, Tanja; Schouenborg, Jens] Lund Univ, Neuronano Res Ctr, Dept Expt Med Sci, Lund, Sweden	Lund University	Granmo, M (corresponding author), Lund Univ, Neuronano Res Ctr, Dept Expt Med Sci, Lund, Sweden.	marcus.granmo@med.lu.se		Schouenborg, Jens/0000-0002-2815-6918	Schering-Plough; Swedish Research Council [60012701]; Knut and Alice Wallenberg Foundation [KAW 2004.0119]	Schering-Plough(Merck & CompanySchering Plough Corporation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This project was sponsored by Organon Inc (now Schering-Plough), a Linnaeus grant (project number: 60012701) from the Swedish Research Council and The Knut and Alice Wallenberg Foundation (project number: KAW 2004.0119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop T, 2007, PAIN, V131, P70, DOI 10.1016/j.pain.2006.12.014; CLARKE RW, 1990, NEUROSCIENCE, V36, P105, DOI 10.1016/0306-4522(90)90354-7; CLAVIER N, 1992, PAIN, V48, P61, DOI 10.1016/0304-3959(92)90132-U; DANNEMAN PJ, 1994, J PHARMACOL EXP THER, V269, P1100; Davies SL, 2005, J NEUROSCI METH, V148, P161, DOI 10.1016/j.jneumeth.2005.04.020; Drummond GB, 2009, J PHYSIOL-LONDON, V587, P713, DOI 10.1113/jphysiol.2008.167387; Gall O, 1999, ANESTHESIOLOGY, V90, P1129, DOI 10.1097/00000542-199904000-00028; Glass PS, 1997, ANESTHESIOLOGY, V86, P836, DOI 10.1097/00000542-199704000-00014; HAIMICOHEN R, 1983, J NEUROSCI METH, V8, P127, DOI 10.1016/0165-0270(83)90113-9; Huffman JC, 2003, J EMERG MED, V25, P427, DOI 10.1016/j.jemermed.2003.01.001; JAGOX A, 1994, NEW ENGL J MED, V330, P651, DOI 10.1056/NEJM199403033300926; Jensen T, 2011, EUR J PAIN, V15, P368, DOI 10.1016/j.ejpain.2010.09.009; Jensen TS, 1997, ACTA ANAESTH SCAND, V41, P123, DOI 10.1111/j.1399-6576.1997.tb04626.x; Jugovac I, 2006, ANESTHESIOLOGY, V105, P764, DOI 10.1097/00000542-200610000-00023; Kalliomaki J, 2003, PAIN, V104, P195, DOI 10.1016/S0304-3959(03)00002-2; KALLIOMAKI J, 1993, BRAIN RES, V622, P271, DOI 10.1016/0006-8993(93)90828-B; Kalliomaki J, 1998, PAIN, V77, P323, DOI 10.1016/S0304-3959(98)00115-8; KOLTZENBURG M, 1994, BRAIN, V117, P579, DOI 10.1093/brain/117.3.579; LEVY WJ, 1980, ANESTHESIOLOGY, V53, P223, DOI 10.1097/00000542-198009000-00009; MCMAHON SB, 1991, PAIN, V44, P301, DOI 10.1016/0304-3959(91)90101-3; Munro G, 2008, NEUROPHARMACOLOGY, V54, P331, DOI 10.1016/j.neuropharm.2007.10.005; Nishiyama T, 2006, CAN J ANAESTH, V53, P1004, DOI 10.1007/BF03022529; Olkkola K. T., 2008, V182, P335, DOI 10.1007/978-3-540-74806-9_16; Otto KA, 2008, LAB ANIM-UK, V42, P45, DOI 10.1258/la.2007.006025; Palecek J, 2002, PAIN, V96, P297, DOI 10.1016/S0304-3959(01)00459-6; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Qiao ZM, 2008, CELL MOL NEUROBIOL, V28, P671, DOI 10.1007/s10571-007-9216-3; Rampil I J, 2001, Curr Opin Anaesthesiol, V14, P649, DOI 10.1097/00001503-200112000-00009; RANDICH A, 1992, J NEUROPHYSIOL, V68, P1027, DOI 10.1152/jn.1992.68.4.1027; REVES JG, 1985, ANESTHESIOLOGY, V62, P310, DOI 10.1097/00000542-198503000-00017; Rosow CE, 1997, J CLIN ANESTH, V9, pS27, DOI 10.1016/S0952-8180(97)00124-4; Saade NE, 2008, BRAIN BEHAV IMMUN, V22, P245, DOI 10.1016/j.bbi.2007.08.002; SANDKUHLER J, 1984, BRAIN RES, V305, P67, DOI 10.1016/0006-8993(84)91120-X; Schomburg ED, 2001, J PHYSIOL-LONDON, V536, P605, DOI 10.1111/j.1469-7793.2001.0605c.xd; SCHOUENBORG J, 1986, BRAIN RES, V397, P86, DOI 10.1016/0006-8993(86)91371-5; SISSON DF, 1989, NEUROTOXICOL TERATOL, V11, P51, DOI 10.1016/0892-0362(89)90085-8; Sun JJ, 2006, NEUROSCIENCE, V140, P1321, DOI 10.1016/j.neuroscience.2006.03.018; Tsai ML, 2004, PAIN, V110, P665, DOI 10.1016/j.pain.2004.05.016; Valle M, 2000, J PHARMACOL EXP THER, V293, P646; Weng HR, 1996, J PHYSIOL-LONDON, V493, P253, DOI 10.1113/jphysiol.1996.sp021380; YAKSH TL, 1981, PAIN, V11, P293, DOI 10.1016/0304-3959(81)90633-3; YANEZ A, 1990, NEUROPHARMACOLOGY, V29, P359, DOI 10.1016/0028-3908(90)90094-8; Yeomans DC, 1996, PAIN, V68, P133, DOI 10.1016/S0304-3959(96)03176-4; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zollner C, 2007, Handb Exp Pharmacol, P31	45	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53966	10.1371/journal.pone.0053966	http://dx.doi.org/10.1371/journal.pone.0053966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320109	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429800074
J	Krycer, JR; Brown, AJ				Krycer, James Robert; Brown, Andrew John			Does Changing Androgen Receptor Status during Prostate Cancer Development Impact upon Cholesterol Homeostasis?	PLOS ONE			English	Article							CELL-LINE; DEPRIVATION THERAPY; PROLONGED TREATMENT; GENE AMPLIFICATION; TUMOR PROGRESSION; EXPRESSION; LNCAP; BICALUTAMIDE; CARCINOMA; CASTRATION	Background: Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an important raw material for cell-growth. Within the cell, cholesterol homeostasis is maintained by two master transcription factors: sterol-regulatory element-binding protein 2 (SREBP-2) and liver X receptor (LXR). We previously showed that the androgen receptor, a major player in prostate cell physiology, toggles these transcription factors to promote cholesterol accumulation. Given that prostate cancer therapy targets the androgen receptor, selecting for cells with altered androgen receptor activity, how would this affect SREBP-2 and LXR activity? Using a novel prostate cancer progression model, we explored how this crosstalk between the androgen receptor and cholesterol homeostasis changes during prostate cancer development. Methodology/Principal Findings: Firstly, we characterised our progression model, which involved 1) culturing LNCaP cells at physiological testosterone levels to generate androgen-tolerant LNCaP-305 cells, and 2) culturing LNCaP-305 with the anti-androgen casodex to generate castration-resistant LNCaP-364 cells. This progression was accompanied by upregulated androgen receptor expression, typically seen clinically, and a reduction in androgen receptor activity. Although this influenced how SREBP-2 and LXR target genes responded to androgen treatment, cellular cholesterol levels and their response to changing sterol status was similar in all LNCaP sub-lines. Conclusion/Significance: Overall cholesterol homeostasis is unaffected by changing androgen receptor activity in prostate cancer cells. This does not negate the relationship between androgens and cholesterol homeostasis, but rather suggests that other factors compensate for altered androgen receptor activity. Given that cholesterol regulation is maintained during progression, this supports the growing idea that cholesterol metabolism is a suitable target for prostate cancer.	[Krycer, James Robert; Brown, Andrew John] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	aj.brown@unsw.edu.au		Krycer, James/0000-0003-1536-7270; Migliaccio, Antimo/0000-0002-4197-2055	Prostate Cancer Foundation of Australia [PG2710]; Petre Foundation	Prostate Cancer Foundation of Australia; Petre Foundation	AJB's research is supported by a grant from the Prostate Cancer Foundation of Australia (PG2710, http://www.prostate.org.au). JRK is the recipient of the Petre Foundation scholarship (http://www.petrefoundation.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaza H, 2011, CANCER SCI, V102, P51, DOI 10.1111/j.1349-7006.2010.01774.x; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Dai JL, 1996, MOL ENDOCRINOL, V10, P1582, DOI 10.1210/me.10.12.1582; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Ford OH, 2003, J UROLOGY, V170, P1817, DOI 10.1097/01.ju.0000091873.09677.f4; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Fuse H, 2007, PROSTATE, V67, P630, DOI 10.1002/pros.20269; Galea AM, 2009, FREE RADICAL BIO MED, V47, P880, DOI 10.1016/j.freeradbiomed.2009.06.027; Hara T, 2003, CANCER RES, V63, P149; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Hobisch A, 2006, PROSTATE, V66, P413, DOI 10.1002/pros.20365; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huggins C, 1941, CANCER RES, V1, P293; Ishikura N, 2010, PROSTATE, V70, P457, DOI 10.1002/pros.21079; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kawata H, 2010, PROSTATE, V70, P745, DOI 10.1002/pros.21107; Koivisto P, 1997, CANCER RES, V57, P314; KOKONTIS J, 1994, CANCER RES, V54, P1566; Kokontis JM, 2005, PROSTATE, V65, P287, DOI 10.1002/pros.20285; Krycer JR, 2012, BIOCHEM J, V446, P191, DOI 10.1042/BJ20120545; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Krycer JR, 2011, J BIOL CHEM, V286, P20637, DOI 10.1074/jbc.M111.227082; Krycer JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008496; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Malerod L, 2002, BIOCHEM BIOPH RES CO, V299, P916, DOI 10.1016/S0006-291X(02)02760-2; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Olsson M, 2011, PROSTATE, V71, P909, DOI 10.1002/pros.21307; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; RAGO R, 1990, ANAL BIOCHEM, V191, P31; Rudolfsson SH, 2009, EXPERT OPIN THER TAR, V13, P219, DOI [10.1517/14728220802626249 , 10.1517/14728220802626249]; Schaffner C P, 1981, Prog Clin Biol Res, V75A, P279; Schrijvers Dirk, 2007, Recent Results Cancer Res, V175, P239; Sedelaar JPM, 2009, PROSTATE, V69, P1724, DOI 10.1002/pros.21028; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Soto AM, 1995, ONCOL RES, V7, P545; Swinnen JV, 1996, ENDOCRINOLOGY, V137, P4468, DOI 10.1210/en.137.10.4468; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Twiddy AL, 2011, PHARM RES-DORDR, V28, P423, DOI 10.1007/s11095-010-0210-y; Vander Griend DJ, 2007, CELL CYCLE, V6, P647, DOI 10.4161/cc.6.6.4028; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906	50	13	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54007	10.1371/journal.pone.0054007	http://dx.doi.org/10.1371/journal.pone.0054007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320115	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800081
J	Mandel, Y; Malki, G; Adawi, E; Glassberg, E; Afek, A; Zagetzki, M; Barnea, O				Mandel, Yossi; Malki, Guy; Adawi, Eid; Glassberg, Elon; Afek, Arnon; Zagetzki, Michael; Barnea, Ofer			Hemorrhage Control of Liver Injury by Short Electrical Pulses	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; THERMAL COAGULATION; ARTERIAL THROMBOSIS; TISSUE ABLATION; HEPATIC-ARTERY; SMOOTH-MUSCLE; PORTAL-VEIN; RESUSCITATION; STIMULATION; MODEL	Trauma is a leading cause of death among young individuals globally and uncontrolled hemorrhage is the leading cause of preventable death. Controlling hemorrhage from a solid organ is often very challenging in military as well as civilian setting. Recent studies demonstrated reversible vasoconstriction and irreversible thrombosis following application of microseconds-long electrical pulses. The current paper describes for the first time reduction in bleeding from the injured liver in rat and rabbit model in-vivo. We applied short (25 and 50 mu s) electrical pulses of 1250 V/cm to rats and rabbit liver following induction of standardized penetrating injury and measured the amount of bleeding into the abdominal cavity one hour post injury. We found a 60 and 36 percent reduction in blood volume in rats treated by 25 mu s and 50 mu s, respectively (P<0.001). Similar results were found for the rabbit model. Finite element simulation revealed that the effect was likely non-thermal. Histological evaluation found local cellular injury with intravascular thrombosis. Further research should be done to fully explore the mechanism of action and the potential use of short electric pulses for hemorrhage control.	[Mandel, Yossi; Glassberg, Elon] IDF Med Corps, Ramat Gan, Israel; [Mandel, Yossi; Malki, Guy; Adawi, Eid; Barnea, Ofer] Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel; [Afek, Arnon; Zagetzki, Michael] Chaim Sheba Med Ctr, Ramat Gan, Israel	Tel Aviv University; Chaim Sheba Medical Center	Mandel, Y (corresponding author), IDF Med Corps, Ramat Gan, Israel.	yossi.mandel@gmail.com			Israeli Ministry of defence; IDF (Israel Defense Forces) Medical Corps	Israeli Ministry of defence; IDF (Israel Defense Forces) Medical Corps	This study was supported by a grant from the Israeli Ministry of defence and the IDF (Israel Defense Forces) Medical Corps. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Noorbakhsh S, 2012, J SURG RES; Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; AYUSE T, 1994, AM J PHYSIOL-HEART C, V267, pH1233, DOI 10.1152/ajpheart.1994.267.4.H1233; Blackbourne LH, 2010, J TRAUMA, V69, pS1, DOI 10.1097/TA.0b013e3181e4206f; BOURGAIN RH, 1974, THROMB RES, V4, P599, DOI 10.1016/0049-3848(74)90234-5; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; EZZAT WR, 1987, AM J PHYSIOL, V252, pH836, DOI 10.1152/ajpheart.1987.252.4.H836; Gehl J, 2002, BBA-GEN SUBJECTS, V1569, P51, DOI 10.1016/S0304-4165(01)00233-1; Graham SJ, 1998, MAGNET RESON MED, V39, P198, DOI 10.1002/mrm.1910390206; Guarini S, 1996, J PHARMACOL TOXICOL, V35, P101, DOI 10.1016/1056-8719(96)00006-8; Haemmerich D, 2002, IEEE T BIO-MED ENG, V49, P836, DOI 10.1109/TBME.2002.800790; HLADOVEC J, 1973, THROMB DIATH HAEMOST, V29, P196, DOI 10.1055/s-0038-1647760; Holcomb JB, 2000, J TRAUMA, V49, P246, DOI 10.1097/00005373-200008000-00010; Ivorra A, 2007, BIOELECTROCHEMISTRY, V70, P287, DOI 10.1016/j.bioelechem.2006.10.005; Ivorra Antoni, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5056; Ivorra A, 2009, PHYS MED BIOL, V54, P5949, DOI 10.1088/0031-9155/54/19/019; Kanthou C, 2006, MOL CANCER THER, V5, P3145, DOI 10.1158/1535-7163.MCT-06-0410; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kragh JF, 2011, J EMERG MED, V41, P590, DOI 10.1016/j.jemermed.2009.07.022; Kragh John F Jr, 2011, US Army Med Dep J, P38; Mandel Y, J HEAT TRAN IN PRESS; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Maor E, 2010, J VASC INTERV RADIOL, V21, P1708, DOI 10.1016/j.jvir.2010.06.024; Matsuoka C, 2004, J MAGN MAGN MATER, V272, P2426, DOI 10.1016/j.j,,,.2003.12.848; Matsuoka T, 1996, J TRAUMA, V40, P915, DOI 10.1097/00005373-199606000-00009; Matsuoka T, 1996, J TRAUMA, V41, P439, DOI 10.1097/00005373-199609000-00009; MATSUOKA T, 1995, J TRAUMA, V39, P674, DOI 10.1097/00005373-199510000-00010; MATSUSHIMA Y, 1994, EUR J SURG, P59; McManus JG, 2007, J TRAUMA, V62, pS14, DOI 10.1097/TA.0b013e3180653b6d; MOUCHAWAR GA, 1992, MED BIOL ENG COMPUT, V30, P162, DOI 10.1007/BF02446126; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Palanker D, 2008, BIOELECTROMAGNETICS, V29, P100, DOI 10.1002/bem.20368; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Phillips M, 2011, J HEAT TRANS-T ASME, V133, DOI 10.1115/1.4002301; Poliachik SL, 2001, ULTRASOUND MED BIOL, V27, P1567, DOI 10.1016/S0301-5629(01)00444-6; Precup CG, 2010, CHIRURGIA-BUCHAREST, V105, P71; Pusateri AE, 2003, J TRAUMA, V55, P518, DOI 10.1097/01.TA.0000075336.92129.27; Ramirez LH, 1998, BRIT J CANCER, V77, P2104, DOI 10.1038/bjc.1998.354; Rossini PM, 2007, NEUROLOGY, V68, P484, DOI 10.1212/01.wnl.0000250268.13789.b2; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Rubinsky J, 2008, J UROLOGY, V180, P2668, DOI 10.1016/j.juro.2008.08.003; Scope A, 2001, INJURY, V32, P1, DOI 10.1016/S0020-1383(00)00101-7; Sersa G, 2008, BRIT J CANCER, V98, P388, DOI 10.1038/sj.bjc.6604168; SONG YQ, 1994, EUR J SURG, P41; Tangwongsan C, 2003, MEASUREMENT IN VIVO; Vaezy S, 2004, J ULTRAS MED, V23, P217, DOI 10.7863/jum.2004.23.2.217; Vaezy S, 1997, ULTRASOUND MED BIOL, V23, P1413, DOI 10.1016/S0301-5629(97)00143-9; Velmahos GC, 2007, J TRAUMA, V63, P285, DOI 10.1097/TA.0b013e3180d0a6ea; Xin YL, 1997, BIOELECTROMAGNETICS, V18, P8, DOI 10.1002/(SICI)1521-186X(1997)18:1<8::AID-BEM3>3.0.CO;2-6; YEAGER VL, 1985, EXPERIENTIA, V41, P262, DOI 10.1007/BF02002627	53	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e49852	10.1371/journal.pone.0049852	http://dx.doi.org/10.1371/journal.pone.0049852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320063	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429800002
J	Mestre, O; Hurtado-Ortiz, R; Dos Vultos, T; Namouchi, A; Cimino, M; Pimentel, M; Neyrolles, O; Gicquel, B				Mestre, Olga; Hurtado-Ortiz, Raquel; Dos Vultos, Tiago; Namouchi, Amine; Cimino, Mena; Pimentel, Madalena; Neyrolles, Olivier; Gicquel, Brigitte			High Throughput Phenotypic Selection of Mycobacterium tuberculosis Mutants with Impaired Resistance to Reactive Oxygen Species Identifies Genes Important for Intracellular Growth	PLOS ONE			English	Article							TAGGED TRANSPOSON MUTAGENESIS; PHAGOSOME MATURATION; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; DRUG-RESISTANCE; SURVIVAL; VIRULENCE; MACROPHAGES; REQUIREMENTS; COMPLEX	Mycobacterium tuberculosis has the remarkable capacity to survive within the hostile environment of the macrophage, and to resist potent antibacterial molecules such as reactive oxygen species (ROS). Thus, understanding mycobacterial resistance mechanisms against ROS may contribute to the development of new anti-tuberculosis therapies. Here we identified genes involved in such mechanisms by screening a high-density transposon mutant library, and we show that several of them are involved in the intracellular lifestyle of the pathogen. Many of these genes were found to play a part in cell envelope functions, further strengthening the important role of the mycobacterial cell envelope in protection against aggressions such as the ones caused by ROS inside host cells.	[Mestre, Olga; Hurtado-Ortiz, Raquel; Dos Vultos, Tiago; Namouchi, Amine; Cimino, Mena; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Pimentel, Madalena] Univ Lisbon, Fac Farm, Unidade Retrovirus & Infeccoes Associadas, Ctr Patogenese Mol, P-1699 Lisbon, Portugal; [Neyrolles, Olivier] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Neyrolles, Olivier] Univ Toulouse 3, Inst Pharmacol & Biol Struct, Toulouse, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Lisboa; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Mestre, O (corresponding author), Inst Pasteur, Unite Genet Mycobacterienne, Paris, France.	olga.mestre@pasteur.fr	Pimentel, Madalena/AAZ-5857-2021; iMed.ULisboa, M2B/B-5277-2014; Neyrolles, Olivier/AAG-3692-2019; Pimentel, Madalena/C-3582-2014; Mestre, Olga/D-7418-2013	Pimentel, Madalena/0000-0002-4598-1290; iMed.ULisboa, M2B/0000-0002-1245-3715; Neyrolles, Olivier/0000-0003-0047-5885; Pimentel, Madalena/0000-0002-4598-1290; Hurtado-Ortiz, Raquel/0000-0002-7650-2993; Mestre, Olga/0000-0002-0993-2248	European NEWTBVAC FP7 241745 Project; Fundacao para a Ciencia e Tecnologia [SFRH/BD/39079/2007]	European NEWTBVAC FP7 241745 Project; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the European NEWTBVAC FP7 241745 Project. OM is a recipient of a Fellowship from Fundacao para a Ciencia e Tecnologia (SFRH/BD/39079/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Bange F.-C., 1999, Tubercle and Lung Disease, V79, P171, DOI 10.1054/tuld.1998.0201; Baranov PV, 2001, NUCLEIC ACIDS RES, V29, P264, DOI 10.1093/nar/29.1.264; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Bustamante J, 2007, J ALLERGY CLIN IMMUN, V120, P32, DOI 10.1016/j.jaci.2007.04.034; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Ezraty B, 2005, J BACTERIOL, V187, P231, DOI 10.1128/JB.187.1.231-237.2005; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Malaga W, 2008, J BIOL CHEM, V283, P15177, DOI 10.1074/jbc.M710275200; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; McAdam RA, 2002, MICROBIOL-SGM, V148, P2975, DOI 10.1099/00221287-148-10-2975; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rosas-Magallanes V, 2007, INFECT IMMUN, V75, P504, DOI 10.1128/IAI.00058-06; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; WALKER L, 1981, NATURE, V293, P69, DOI 10.1038/293069a0; Williams MJ, 2011, J BACTERIOL, V193, P98, DOI 10.1128/JB.00774-10; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924	52	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53486	10.1371/journal.pone.0053486	http://dx.doi.org/10.1371/journal.pone.0053486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320090	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429800055
J	Armstrong, N; Ramamoorthy, M; Lyon, D; Jones, K; Duttaroy, A				Armstrong, Najealicka; Ramamoorthy, Malaisamy; Lyon, Delina; Jones, Kimberly; Duttaroy, Atanu			Mechanism of Silver Nanoparticles Action on Insect Pigmentation Reveals Intervention of Copper Homeostasis	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; IN-VITRO; OXIDE NANOPARTICLES; ZEBRAFISH EMBRYOS; NULL MUTATION; TOXICITY; CELLS; CYTOTOXICITY; TRANSPORTER; GOLD	Silver nanoparticles (AgNPs), like almost all nanoparticles, are potentially toxic beyond a certain concentration because the survival of the organism is compromised due to scores of pathophysiological abnormalities past that concentration. However, the mechanism of AgNP toxicity remains undetermined. Instead of applying a toxic dose, we attempted to monitor the effects of AgNPs at a nonlethal concentration on wild type Drosophila melanogaster by exposing them throughout their development. All adult flies raised in AgNP doped food showed that up to 50 mg/L concentration AgNP has no negative influence on median survival; however, these flies appeared uniformly lighter in body color due to the loss of melanin pigments in their cuticle. Additionally, fertility and vertical movement ability were compromised due to AgNP feeding. Determination of the amount of free ionic silver (Ag+) led us to claim that the observed biological effects have resulted from the AgNPs and not from Ag+. Biochemical analysis suggests that the activity of copper dependent enzymes, namely tyrosinase and Cu-Zn superoxide dismutase, are decreased significantly following the consumption of AgNPs, despite the constant level of copper present in the tissue. Consequently, we propose a mechanism whereby consumption of excess AgNPs in association with membrane bound copper transporter proteins cause sequestration of copper, thus creating a condition that resembles copper starvation. This model also explains the cuticular demelanization effect resulting from AgNP since tyrosinase activity is essential for melanin biosynthesis. Finally, we claim that Drosophila, an established genetic model system, can be well utilized for further understanding of the biological effects of nanoparticles.	[Armstrong, Najealicka; Duttaroy, Atanu] Howard Univ, Dept Biol, Washington, DC 20059 USA; [Ramamoorthy, Malaisamy; Lyon, Delina; Jones, Kimberly] Howard Univ, Dept Civil & Environm Engn, Washington, DC 20059 USA	Howard University; Howard University	Duttaroy, A (corresponding author), Howard Univ, Dept Biol, Washington, DC 20059 USA.	aduttaroy@howard.edu	Lyon, Delina/ABD-7121-2021	Lyon, Delina/0000-0002-2291-9048	Center for Environmental Implications of Nanotechnology (CEINT) at Duke University; Howard University; National Science Foundation	Center for Environmental Implications of Nanotechnology (CEINT) at Duke University; Howard University; National Science Foundation(National Science Foundation (NSF))	This work is supported by the Center for Environmental Implications of Nanotechnology (CEINT) at Duke University with Howard University as a partner. CEINT is funded by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716; Bertinato J, 2010, J TRACE ELEM MED BIO, V24, P178, DOI 10.1016/j.jtemb.2010.01.009; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Brisson JA, 2005, EVOLUTION, V59, P1046; Cha K, 2008, BIOTECHNOL LETT, V30, P1893, DOI 10.1007/s10529-008-9786-2; Demir ER, 2011, NANOTOXICOLOGY, V5, P417, DOI 10.3109/17435390.2010.529176; Di Stefano HS, 1943, AM NAT, V77, P94, DOI 10.1086/281108; Duttaroy A, 2003, GENETICS, V165, P2295; Falugi C, 2012, MAR ENVIRON RES, V76, P114, DOI 10.1016/j.marenvres.2011.10.003; Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009; Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Huang N, 2012, NANOTOXICOLOGY; Johnston HJ, 2010, CRIT REV TOXICOL, V40, P328, DOI 10.3109/10408440903453074; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee HY, 2007, CHEM COMMUN, P2959, DOI 10.1039/b703034g; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Li PW, 2010, TOXICOL LETT, V197, P82, DOI 10.1016/j.toxlet.2010.05.003; Nalabotu SK, 2011, INT J NANOMED, V6, P2327, DOI 10.2147/IJN.S25119; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Ostrowski AD, 2009, J NANOPART RES, V11, P251, DOI 10.1007/s11051-008-9579-5; Panacek A, 2011, ENVIRON SCI TECHNOL, V45, P4974, DOI 10.1021/es104216b; Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; Prohaska JR, 2004, J NUTR, V134, P1003, DOI 10.1093/jn/134.5.1003; Prota G., 1992, MELANINS MELANOGENES; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Song JE, 2011, ENVIRON SCI TECHNOL, V45, P5988, DOI 10.1021/es200547c; Srivastava M, 2012, ENVIRON HEALTH PERSP, V120, P56, DOI 10.1289/ehp.1103928; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Vanwinkle BA, 2009, NANOTOXICOLOGY, V3, P307, DOI 10.3109/17435390903121949; Vecchio G, 2012, NANOMED-NANOTECHNOL, V8, P1, DOI 10.1016/j.nano.2011.11.001; Vigneshwaran N, 2007, J NANOSCI NANOTECHNO, V7, P1893, DOI 10.1166/jnn.2007.737; WINDER AJ, 1991, EUR J BIOCHEM, V198, P317, DOI 10.1111/j.1432-1033.1991.tb16018.x; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200; Zhu SQ, 2006, MAR ENVIRON RES, V62, pS5, DOI 10.1016/j.marenvres.2006.04.059	48	84	85	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53186	10.1371/journal.pone.0053186	http://dx.doi.org/10.1371/journal.pone.0053186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308159	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100035
J	Bashir, MEH; Ward, JM; Cummings, M; Karrar, EE; Root, M; Mohamed, AA; Naclerio, RM; Preuss, D				Bashir, Mohamed Elfatih H.; Ward, Jason M.; Cummings, Matthew; Karrar, Eltayeb E.; Root, Michael; Mohamed, Abu Bekr A.; Naclerio, Robert M.; Preuss, Daphne			Dual Function of Novel Pollen Coat (Surface) Proteins: IgE-binding Capacity and Proteolytic Activity Disrupting the Airway Epithelial Barrier	PLOS ONE			English	Article							BERMUDA GRASS-POLLEN; GROUP-I ALLERGENS; CYNODON-DACTYLON POLLEN; MAJOR ALLERGEN; STRUCTURAL-CHARACTERIZATION; IDENTIFICATION; CLONING; PURIFICATION; ISOALLERGENS; EXPRESSION	Background: The pollen coat is the first structure of the pollen to encounter the mucosal immune system upon inhalation. Prior characterizations of pollen allergens have focused on water-soluble, cytoplasmic proteins, but have overlooked much of the extracellular pollen coat. Due to washing with organic solvents when prepared, these pollen coat proteins are typically absent from commercial standardized allergenic extracts (i.e., "de-fatted"), and, as a result, their involvement in allergy has not been explored. Methodology/Principal Findings: Using a unique approach to search for pollen allergenic proteins residing in the pollen coat, we employed transmission electron microscopy (TEM) to assess the impact of organic solvents on the structural integrity of the pollen coat. TEM results indicated that de-fatting of Cynodon dactylon (Bermuda grass) pollen (BGP) by use of organic solvents altered the structural integrity of the pollen coat. The novel IgE-binding proteins of the BGP coat include a cysteine protease (CP) and endoxylanase (EXY). The full-length cDNA that encodes the novel IgE-reactive CP was cloned from floral RNA. The EXY and CP were purified to homogeneity and tested for IgE reactivity. The CP from the BGP coat increased the permeability of human airway epithelial cells, caused a clear concentration-dependent detachment of cells, and damaged their barrier integrity. Conclusions/Significance: Using an immunoproteomics approach, novel allergenic proteins of the BGP coat were identified. These proteins represent a class of novel dual-function proteins residing on the coat of the pollen grain that have IgE-binding capacity and proteolytic activity, which disrupts the integrity of the airway epithelial barrier. The identification of pollen coat allergens might explain the IgE-negative response to available skin-prick-testing proteins in patients who have positive symptoms. Further study of the role of these pollen coat proteins in allergic responses is warranted and could potentially lead to the development of improved diagnostic and therapeutic tools.	[Bashir, Mohamed Elfatih H.; Karrar, Eltayeb E.; Mohamed, Abu Bekr A.; Naclerio, Robert M.] Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; [Bashir, Mohamed Elfatih H.; Ward, Jason M.; Cummings, Matthew; Root, Michael; Preuss, Daphne] Univ Chicago, Dept Mol Genet & Cell Biol, Div Biol Sci, Chicago, IL 60637 USA; [Ward, Jason M.] Monsanto Co, St Louis, MO USA; [Preuss, Daphne] Chromatin Inc, Chicago, IL USA	University of Chicago; University of Chicago; Monsanto	Bashir, MEH (corresponding author), Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mbashir@surgery.bsd.uchicago.edu		Bashir, Mohamed Elfatih/0000-0003-0125-1648	The Strategic Program for Asthma Research; National Science Foundation ""Arabidopsis 2010: Functional analysis of pollen exine assembly" [MCB-0520283]; Department of Energy "Cell-Cell Interaction during Pollen Tube Guidance in Arabidopsis" [DE-FG02-96ER20240]; The McHugh Otolaryngology Research Fund	The Strategic Program for Asthma Research; National Science Foundation ""Arabidopsis 2010: Functional analysis of pollen exine assembly"(National Science Foundation (NSF)); Department of Energy "Cell-Cell Interaction during Pollen Tube Guidance in Arabidopsis"(United States Department of Energy (DOE)); The McHugh Otolaryngology Research Fund	The Strategic Program for Asthma Research (www.spar-aaf.org); National Science Foundation, http://www.nsf.gov/ "Arabidopsis 2010: Functional analysis of pollen exine assembly," MCB-0520283; Department of Energy, http://energy.gov/ "Cell-Cell Interaction during Pollen Tube Guidance in Arabidopsis," DE-FG02-96ER20240; The McHugh Otolaryngology Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; Asturias JA, 1997, J ALLERGY CLIN IMMUN, V100, P365, DOI 10.1016/S0091-6749(97)70250-1; Bashir MEH, 2002, J IMMUNOL, V169, P3284, DOI 10.4049/jimmunol.169.6.3284; Bass DJ, 2000, ANN ALLERG ASTHMA IM, V85, P374, DOI 10.1016/S1081-1206(10)62549-5; Beers EP, 2004, PHYTOCHEMISTRY, V65, P43, DOI 10.1016/j.phytochem.2003.09.005; Burr ML, 2003, CLIN EXP ALLERGY, V33, P1675, DOI 10.1111/j.1365-2222.2003.01816.x; Cadot P, 2000, J ALLERGY CLIN IMMUN, V105, P286, DOI 10.1016/S0091-6749(00)90078-2; Chow LP, 2005, FEBS J, V272, P6218, DOI 10.1111/j.1742-4658.2005.05000.x; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Dedic A, 2009, MOL IMMUNOL, V46, P416, DOI 10.1016/j.molimm.2008.10.012; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Esch RE, 1997, METHODS, V13, P2, DOI 10.1006/meth.1997.0491; FORD SA, 1987, J ALLERGY CLIN IMMUN, V79, P711, DOI 10.1016/0091-6749(87)90201-6; Grobe K, 1999, EUR J BIOCHEM, V263, P33, DOI 10.1046/j.1432-1327.1999.00462.x; Grobe K, 2002, EUR J BIOCHEM, V269, P2083, DOI 10.1046/j.1432-1033.2002.02856.x; Grote M, 1999, INT ARCH ALLERGY IMM, V118, P1, DOI 10.1159/000024024; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Hurley BP, 2006, AM J PHYSIOL-LUNG C, V290, pL703, DOI 10.1152/ajplung.00390.2005; Johnson CC, 2002, CURR OPIN ALLERGY CL, V2, P133, DOI 10.1097/00130832-200204000-00009; Kao SH, 2005, PROTEOMICS, V5, P3805, DOI 10.1002/pmic.200401229; Li BL, 2001, ADV EXP MED BIOL, V495, P271; Liaw SH, 2001, BIOCHEM BIOPH RES CO, V280, P738, DOI 10.1006/bbrc.2000.4203; MATTHIESEN F, 1991, J ALLERGY CLIN IMMUN, V88, P763, DOI 10.1016/0091-6749(91)90184-P; Mayfield JA, 2000, NAT CELL BIOL, V2, P128, DOI 10.1038/35000084; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Minero FJG, 1998, ALLERGY, V53, P266, DOI 10.1111/j.1398-9995.1998.tb03886.x; Nathan RA, 2007, ALLERGY ASTHMA PROC, V28, P3, DOI 10.2500/aap.2007.28.2934; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; SHEN HD, 1988, CLIN ALLERGY, V18, P401, DOI 10.1111/j.1365-2222.1988.tb02888.x; Smith GL, 2002, NAT REV IMMUNOL, V2, P521, DOI 10.1038/nri845; SMITH PM, 1994, INT ARCH ALLERGY IMM, V104, P57, DOI 10.1159/000236709; Stingone JA, 2008, J ALLERGY CLIN IMMUN, V122, P748, DOI 10.1016/j.jaci.2008.08.001; Su SN, 1996, J ALLERGY CLIN IMMUN, V98, P486, DOI 10.1016/S0091-6749(96)70080-5; Suphioglu C, 1997, FEBS LETT, V402, P167, DOI 10.1016/S0014-5793(96)01520-7; Suvilehto J, 2007, RHINOLOGY, V45, P286; Swanson R, 2004, ANNU REV GENET, V38, P793, DOI 10.1146/annurev.genet.38.072902.092356; Tao AL, 2005, ACTA PHARMACOL SIN, V26, P1225, DOI 10.1111/j.1745-7254.2005.00194.x; Verdino P, 2006, CLIN REV ALLERG IMMU, V30, P73, DOI 10.1385/CRIAI:30:2:73; Vigh-Conrad KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010174; Vrtala S, 2007, J IMMUNOL, V179, P1730, DOI 10.4049/jimmunol.179.3.1730; Watkins DN, 1997, BRIT J PHARMACOL, V121, P1482; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilkesman JG, 2007, ELECTROPHORESIS, V28, P429, DOI 10.1002/elps.200600332; Wu WC, 2001, J BIOMED SCI, V8, P342, DOI 10.1007/BF02258376	47	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53337	10.1371/journal.pone.0053337	http://dx.doi.org/10.1371/journal.pone.0053337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308195	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100055
J	Cesani, MF; Garraza, M; Sanchis, MLB; Luis, MA; Torres, MF; Quintero, FA; Oyhenart, EE				Florencia Cesani, Maria; Garraza, Mariela; Bergel Sanchis, Maria Laura; Antonia Luis, Maria; Fernanda Torres, Maria; Anibal Quintero, Fabian; Edith Oyhenart, Evelia			A Comparative Study on Nutritional Status and Body Composition of Urban and Rural Schoolchildren from Brandsen District (Argentina)	PLOS ONE			English	Article							CHILDREN; ADOLESCENTS; OVERWEIGHT; CHILDHOOD; OBESITY; BURDEN; TRENDS; POOR	The purpose of this study was to analyze whether nutritional status and body composition varies according to the environment of residence (urban or rural) of children in the Brandsen district (Argentina). Weight, height, arm circumference and tricipital and subscapular skinfolds were performed in 1368 schoolchildren aged 3 to 14. NHANES III reference was used to estimate nutritional status -underweight, stunting, wasting, overweight, and obesity-and to evaluate body composition deficit and excess of adipose (DA, EA) and muscular (DM, EM) tissues of the arm-. Central fat distribution (CFD) was estimated using the subscapular-tricipital index. A structured questionnaire was implemented to evaluate socio-environmental characteristics. Nutritional categories based on body size and body composition were compared between urban and rural areas of residence using Chi-squared tests (chi 2). The results indicated for the total sample: 1.1% underweight, 6.9% stunting, 0.4% wasting, 12.1% overweight, 9.7% obesity, 22.0% DM, 2.5% EM, 0.1% DA, 17.6% EA, and 8.5% CFD. Significant differences between urban and rural areas were found only for CFD. The socio-environmental analysis showed that while access to public services and housing quality was significantly better in the urban area, a considerable number of city households lived under deficient conditions, lacked health insurance and had low socioeconomic level. Fifty-three percent of the undernourished children had DM without urban-rural significant differences, and none of them showed DA. In the overweight plus obesity group, 62.8% presented EA, 6.4% EM, 4.7% DM, and 22.8% CFD. The highest percentages of DM and CFD were recorded in rural areas (p = 0.00). We conclude that the child population shows the "double burden" of malnutrition. The environment of residence does not promote any differentiation in the nutritional status. Nevertheless, the increment of central adiposity and, in some cases of muscle deficit in rural children, suggests a consumption of unbalanced diet.	[Florencia Cesani, Maria; Garraza, Mariela; Fernanda Torres, Maria; Anibal Quintero, Fabian; Edith Oyhenart, Evelia] Univ Nacl La Plata, UNLP CONICET CCT La Plata, Fac Ciencias Vet, Inst Genet Vet, La Plata, Buenos Aires, Argentina; [Bergel Sanchis, Maria Laura; Antonia Luis, Maria; Anibal Quintero, Fabian; Edith Oyhenart, Evelia] Fac Ciencias Nat & Museo UNLP, La Plata, Buenos Aires, Argentina; [Fernanda Torres, Maria] Univ Buenos Aires, Fac Filosofia & Letras, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; University of Buenos Aires	Cesani, MF (corresponding author), Univ Nacl La Plata, UNLP CONICET CCT La Plata, Fac Ciencias Vet, Inst Genet Vet, La Plata, Buenos Aires, Argentina.	mfcesani@fcnym.unlp.edu.ar	Torres, Maria/GVU-3391-2022; Cesani, María Florencia/AAE-8475-2021; Oyhenart, Evelia/L-1616-2017	Quintero, Fabian Anibal/0000-0001-5605-759X; Oyhenart, Evelia/0000-0003-1331-7368; Cesani, Maria Florencia/0000-0003-1372-9231; Bergel Sanchis, Maria Laura/0000-0002-4293-9855	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica) [PICT 14095]; UNLP (Universidad Nacional de La Plata) [11/N428]	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica)(ANPCyT); UNLP (Universidad Nacional de La Plata)(National University of La Plata)	This work was supported by ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica, PICT 14095) and UNLP (Universidad Nacional de La Plata, 11/N428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre P., 2005, ESTRATEGIAS CONSUMO; Aguirre P, 2011, VOCES FENIX, V7, P52; [Anonymous], 2005, Arch. argent. pediatr., V103, P450; Barria RM, 2006, ARCH LATINOAM NUTR, V56, P3; Bejarano Ignacio, 2005, Arch. argent. pediatr., V103, P101; Bogin B., 1999, PATTERNS HUMAN GROWT, V2nd ed.; Bolzán Andrés, 2005, Arch. argent. pediatr., V103, P545; BOUCHARD C, 1988, INT J OBESITY, V12, P205; BOUCHARD C, 1993, ENDOCR REV, V14, P72, DOI 10.1210/er.14.1.72; Britos S, 2004, OBESIDAD ARGENTINA H; Cesani MF, 2010, ARCH ARGENT PEDIATR, V108, P294, DOI 10.1590/S0325-00752010000400002; Cesani MF, 2007, REV ARG ANTROP BIOL, V9, P105, DOI DOI 10.31134/AP.89.2.3; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; de Onis M, 2000, AM J CLIN NUTR, V72, P1032; DEURENBERG P, 1990, BRIT J NUTR, V63, P293, DOI 10.1079/BJN19900116; Diaz A, 2010, ARCH ARGENT PEDIATR, V108, P68, DOI 10.1590/S0325-00752010000100012; Food and Agriculture Organization, 2012, NUTR TRANS OB FOCUS; Fotso Jean-Christophe, 2006, Int J Equity Health, V5, P9, DOI 10.1186/1475-9276-5-9; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Frisancho R., 2008, ANTHROPOMETRIC STAND; Garrett James L., 2005, Food and Nutrition Bulletin, V26, P209; Haddad L, 1999, WORLD DEV, V27, P1891, DOI 10.1016/S0305-750X(99)00093-5; Heyward V.H., 2004, APPL BODY COMPOSITIO, V2nd ed.; Instituto Nacional de Estadistica y Censos (INDEC), 2004, CENS NAC POBL HOG VI; Instituto Nacional de Estadsticas y Censos (INDEC), 2013, CENS NAC POBL HOG VI; Katzmarzyk PT, 2009, J PHYS ACT HEALTH, V6, P269, DOI 10.1123/jpah.6.3.269; Khor GL, 2008, ASIA PAC J CLIN NUTR, V17, P111; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; Lamounier Joel Alves, 2009, Rev. paul. pediatr., V27, P124; Landaeta-Jimenez M, 2002, ARCH LATINOAM NUTR, V52, P128; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Luis MA, 2006, ESCENARIOS, V11, P35; Marrodan Serrano MD, 2007, NUTR CLIN DIET HOSP, V19, P11; MARTINEZ E, 1993, ARCH LATINOAM NUTR, V43, P199; Mendez MA, 2005, ELECT J AGR DEV EC, V1, P220; Menon Purnima, 2000, Food and Nutrition Bulletin, V21, P282; Ministerio de Salud de la Nacion, 2007, ENC NAC NUTR SAL; Oyhenart EE, 2008, REV ARG ANTROP BIOL, V10, P1; Oyhenart EE, 2005, REV ARG ANTROP BIOL, V7, P35; Oyhenart EE, 2007, REV PANAM SALUD PUBL, V22, P194, DOI 10.1590/S1020-49892007000800006; Popkin B. M., 2003, Development Policy Review, V21, P581, DOI 10.1111/j.1467-8659.2003.00225.x; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2005, PUBLIC HEALTH NUTR, V8, P724, DOI 10.1079/PHN2005776; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Ruel M, 1998, 51 FCND INT FOOD POL; Ruiz de La F Marcela, 2007, Rev. chil. nutr., V34, P251; Sahn DE, 2003, J AFR ECON, V12, P564, DOI 10.1093/jae/12.4.564; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Van de Poel L, 2009, URBANIZATION HLTH IN; Varela-Silva MI, 2012, COLLEGIUM ANTROPOL, V36, P39; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Wilcox S, 2000, J EPIDEMIOL COMMUN H, V54, P667, DOI 10.1136/jech.54.9.667; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x; Zonta ML, 2011, AM J HUM BIOL, V23, P592, DOI 10.1002/ajhb.21175	54	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52792	10.1371/journal.pone.0052792	http://dx.doi.org/10.1371/journal.pone.0052792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308120	Green Published, gold			2022-12-27	WOS:000313429100015
J	Gu, YJ; Wang, CF; Zheng, Y; Hou, XH; Mo, YF; Yu, WH; Zhang, L; Hu, C; Nan, HR; Chen, L; Li, J; Liu, YX; Huang, ZZ; Han, M; Bao, YQ; Zhong, WJ; Jia, WP				Gu, Yunjuan; Wang, Chunfang; Zheng, Ying; Hou, Xuhong; Mo, Yifei; Yu, Weihui; Zhang, Lei; Hu, Cheng; Nan, Hairong; Chen, Lei; Li, Jie; Liu, Yuxiang; Huang, Zhezhou; Han, Ming; Bao, Yuqian; Zhong, Weijian; Jia, Weiping			Cancer Incidence and Mortality in Patients with Type 2 Diabetes Treated with Human Insulin: A Cohort Study in Shanghai	PLOS ONE			English	Article							RISK; MALIGNANCIES; CARCINOMA; GLARGINE; MELLITUS; ANALOGS	Aim: The aim was to investigate the association between human insulin and cancer incidence and mortality in Chinese patients with type 2 diabetes. Methods: We recruited 8,774 insulin-naive diabetes patients from the Shanghai Diabetes Registry (SDR). The follow-up rate was 85.4%. All subjects were divided into the insulin use cohort (n = 3,639) and the non-insulin use cohort (n = 5,135). The primary outcome was the first diagnosis of any cancer. The secondary outcome was all-cause mortality. Cox proportional hazards model was used to estimate the relative risk (RR) of cancer and mortality. Results: We observed 98 cancer events in the insulin use cohort and 170 in the non-insulin use cohort. Cancer incidence rates were 78.6 and 74.3 per 10,000 patients per year in the insulin users and the non-insulin users, respectively. No significant difference in cancer risk was observed between the two cohorts (adjusted RR = 1.20, 95% CI 0.89-1.62, P = 0.228). Regarding site-specific cancers, only the risk of liver cancer was significantly higher in the insulin users compared to that in the non-insulin users (adjusted RR = 2.84, 95% CI 1.12-7.17, P = 0.028). The risks of overall mortality (adjusted RR = 1.89, 95% CI 1.47-2.43, P < 0.0001) and death from cancer (adjusted RR = 2.16, 95% CI 1.39-3.35, P = 0.001) were all significantly higher in the insulin users than in the non-insulin users. Conclusion: There was no excess risk of overall cancer in patients with type 2 diabetes who were treated with human insulin. However, a significantly higher risk of liver cancer was found in these patients. Moreover, insulin users showed higher risks of overall and cancer mortality. Considering that individuals treated with insulin were more likely to be advanced diabetic patients, caution should be used in interpreting these results.	[Gu, Yunjuan; Hou, Xuhong; Mo, Yifei; Yu, Weihui; Zhang, Lei; Hu, Cheng; Chen, Lei; Li, Jie; Liu, Yuxiang; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Gu, Yunjuan; Mo, Yifei; Yu, Weihui; Liu, Yuxiang] Shanghai Jiao Tong Univ, Sch Med, Dept Med, Shanghai 200030, Peoples R China; [Gu, Yunjuan; Hou, Xuhong; Mo, Yifei; Yu, Weihui; Zhang, Lei; Hu, Cheng; Chen, Lei; Li, Jie; Liu, Yuxiang; Bao, Yuqian; Jia, Weiping] Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China; [Gu, Yunjuan] Nantong Univ, Affiliated Hosp, Dept Endocrinol & Metab, Nantong, Jiangsu, Peoples R China; [Wang, Chunfang; Han, Ming] Shanghai Municipal Ctr Dis Control & Prevent, Dept Vital Stat, Shanghai, Peoples R China; [Zheng, Ying; Huang, Zhezhou] Shanghai Municipal Ctr Dis Control & Prevent, Dept Canc Prevent & Control, Shanghai, Peoples R China; [Nan, Hairong] Univ Hong Kong, Dept Community Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nantong University; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; University of Hong Kong	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Dept Endocrinol & Metab, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012; Hu, Cheng/C-3346-2008	Hu, Cheng/0000-0003-4314-2386; Chen, Lei/0000-0002-6581-0544; Gu, Yunjuan/0000-0002-5840-1494	National 973 Program [2011CB504001]; Shanghai municipal hospitals' project of chronic disease prevention and treatment [SHDC12007316]; Ministry of Health [201002002]	National 973 Program(National Basic Research Program of China); Shanghai municipal hospitals' project of chronic disease prevention and treatment; Ministry of Health	This work was funded by the National 973 Program (2011CB504001); Shanghai municipal hospitals' project of chronic disease prevention and treatment (SHDC12007316); Specific research fund from Ministry of Health (201002002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000433; Baur DM, 2011, METABOLISM, V60, P1363, DOI 10.1016/j.metabol.2010.09.012; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0021368]; Chang CH, 2012, J CLIN ENDOCR METAB, V97, pE1170, DOI 10.1210/jc.2012-1162; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Eurich DT, 2007, BMJ-BRIT MED J, V335, P497, DOI 10.1136/bmj.39314.620174.80; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; HEUSON JC, 1972, CANCER RES, V32, P233; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Nicolucci A, 2010, ACTA DIABETOL, V47, P87, DOI 10.1007/s00592-010-0187-3; Rosenstock J, 2009, DIABETOLOGIA, V52, P1971, DOI 10.1007/s00125-009-1452-2; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Tseng CH, 2012, WORLD J GASTROENTERO, V18, P4182, DOI 10.3748/wjg.v18.i31.4182; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Yamasaki K, 2010, CANCER SCI, V101, P65, DOI 10.1111/j.1349-7006.2009.01345.x; Yang XL, 2010, DIABETES, V59, P1254, DOI 10.2337/db09-1371	22	23	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53411	10.1371/journal.pone.0053411	http://dx.doi.org/10.1371/journal.pone.0053411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308218	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100064
J	Qin, W; Liu, Y; Jiang, TZ; Yu, CS				Qin, Wen; Liu, Yong; Jiang, Tianzi; Yu, Chunshui			The Development of Visual Areas Depends Differently on Visual Experience	PLOS ONE			English	Article							LATERAL OCCIPITAL COMPLEX; EARLY BLIND SUBJECTS; STATE FUNCTIONAL CONNECTIVITY; CROSS-MODAL PLASTICITY; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; MIDDLE TEMPORAL AREA; CONGENITALLY BLIND; AUDITORY SUBSTITUTION; CORTICAL SURFACE	Visual experience plays an important role in the development of the visual cortex; however, recent functional imaging studies have shown that the functional organization is preserved in several higher-tier visual areas in congenitally blind subjects, indicating that maturation of visual areas depend unequally on visual experience. In this study, we aim to validate this hypothesis using a multimodality MRI approach. We found increased cortical thickness in the congenitally blind was present in the early visual areas and absent in the higher-tier ones, suggesting that the structural development of the visual cortex depends hierarchically on visual experience. In congenitally blind subjects, the decreased resting-state functional connectivity with the primary somatosensory cortex was more prominent in the early visual areas than in the higher-tier ones and were more pronounced in the ventral stream than in the dorsal one, suggesting that the development of functional organization of the visual cortex also depends differently on visual experience. Moreover, congenitally blind subjects showed normal or increased functional connectivity between ipsilateral higher-tier and early visual areas, suggesting an indirect corticocortical pathway through which somatosenroy information can reach the early visual areas. These findings support our hypothesis that the development of visual areas depends differently on visual experience.	[Qin, Wen; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Liu, Yong; Jiang, Tianzi] Chinese Acad Sci, Natl Lab Pattern Recognit Inst Automat, LIAMA Ctr Computat Med, Beijing, Peoples R China; [Yu, Chunshui] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China	Tianjin Medical University; Chinese Academy of Sciences; Capital Medical University	Jiang, TZ (corresponding author), Chinese Acad Sci, Natl Lab Pattern Recognit Inst Automat, LIAMA Ctr Computat Med, Beijing, Peoples R China.	jiangtz@nlpr.ia.ac.cn; chunshuiyu@yahoo.cn	Liu, Yong/F-2682-2011; QIN, WEN/F-3783-2015; Jiang, Tianzi/I-4256-2012	Liu, Yong/0000-0002-1862-3121; QIN, WEN/0000-0002-9121-8296; Jiang, Tianzi/0000-0001-9531-291X; Yu, Chunshui/0000-0001-5648-5199	National Basic Research Program of China (973 program) [2011CB707800]; Natural Science Foundation of China [30870694, 30900476, 81270020]; Open Projects Program of National Laboratory of Pattern Recognition	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Projects Program of National Laboratory of Pattern Recognition	This work was supported by grants from the National Basic Research Program of China (973 program, No. 2011CB707800), Natural Science Foundation of China (Grant Nos. 30870694,30900476 and 81270020), and the Open Projects Program of National Laboratory of Pattern Recognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; Amedi A, 2010, RESTOR NEUROL NEUROS, V28, P143, DOI [10.3233/RNN-2010-0503, 10.3233/RNN-2010-0497]; Auvray M, 2007, PERCEPTION, V36, P416, DOI 10.1068/p5631; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bedny M, 2011, P NATL ACAD SCI USA, V108, P4429, DOI 10.1073/pnas.1014818108; Bedny M, 2010, CURR BIOL, V20, P1900, DOI 10.1016/j.cub.2010.09.044; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bock AS, 2011, J COMP NEUROL; BOURGEOIS JP, 1989, P NATL ACAD SCI USA, V86, P4297, DOI 10.1073/pnas.86.11.4297; Bourne JA, 2006, CEREB CORTEX, V16, P405, DOI 10.1093/cercor/bhi119; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; BRONCHTI G, 1991, DEV BRAIN RES, V58, P159, DOI 10.1016/0165-3806(91)90002-Z; Buchel C, 2003, NAT NEUROSCI, V6, P657, DOI 10.1038/nn0703-657; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; CALLAWAY EM, 1991, P NATL ACAD SCI USA, V88, P745, DOI 10.1073/pnas.88.3.745; Chechik G, 1999, NEURAL COMPUT, V11, P2061, DOI 10.1162/089976699300016089; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Collignon O, 2011, P NATL ACAD SCI USA, V108, P4435, DOI 10.1073/pnas.1013928108; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; den Ouden HEM, 2009, CEREB CORTEX, V19, P1175, DOI 10.1093/cercor/bhn161; DeVolder AG, 1997, BRAIN RES, V750, P235, DOI 10.1016/S0006-8993(96)01352-2; Distler C, 1996, CEREB CORTEX, V6, P184, DOI 10.1093/cercor/6.2.184; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Eckert MA, 2008, HUM BRAIN MAPP, V29, P848, DOI 10.1002/hbm.20560; Falchier A, 2002, J NEUROSCI, V22, P5749; Fiehler K, 2010, RESTOR NEUROL NEUROS, V28, P193, DOI 10.3233/RNN-2010-0500; Fiehler K, 2009, CEREB CORTEX, V19, P1, DOI 10.1093/cercor/bhn067; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fujii T, 2009, NEUROSCI RES, V65, P175, DOI 10.1016/j.neures.2009.06.014; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; INNOCENTI GM, 1995, TRENDS NEUROSCI, V18, P397, DOI 10.1016/0166-2236(95)93936-R; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; Kassuba T, 2011, NEUROIMAGE, V56, P1566, DOI 10.1016/j.neuroimage.2011.02.032; Kim JK, 2011, J NEUROSCI, V31, P7848, DOI 10.1523/JNEUROSCI.3399-10.2011; Kim JK, 2008, BRAIN RES, V1242, P263, DOI 10.1016/j.brainres.2008.06.038; Kiorpes L, 2003, VISUAL NEUROSCI, V20, P567, DOI 10.1017/S0952523803205101; Kiorpes L, 2012, VISION RES, V63, P34, DOI 10.1016/j.visres.2012.04.018; Klinge C, 2010, J NEUROSCI, V30, P12798, DOI 10.1523/JNEUROSCI.2384-10.2010; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; Kovacs I, 2000, VISION RES, V40, P1301, DOI 10.1016/S0042-6989(00)00055-9; Kupers R, 2006, P NATL ACAD SCI USA, V103, P13256, DOI 10.1073/pnas.0602925103; Kupers R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00019; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; Lepore N, 2010, NEUROIMAGE, V49, P134, DOI 10.1016/j.neuroimage.2009.07.048; Lewis TL, 2005, DEV PSYCHOBIOL, V46, P163, DOI 10.1002/dev.20055; Liu C, 2011, NEUROREPORT, V22, P190, DOI 10.1097/WNR.0b013e3283447c09; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Matsui T, 2011, CEREB CORTEX; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; Mishina M, 2003, NEUROIMAGE, V19, P125, DOI 10.1016/S1053-8119(03)00051-X; Noppeney U, 2005, CURR BIOL, V15, pR488, DOI 10.1016/j.cub.2005.06.053; Norman-Haignere SV, 2012, CEREB CORTEX, V22, P391, DOI 10.1093/cercor/bhr118; Pan WJ, 2007, NEUROIMAGE, V37, P212, DOI 10.1016/j.neuroimage.2007.05.014; Park HJ, 2009, NEUROIMAGE, V47, P98, DOI 10.1016/j.neuroimage.2009.03.076; Peltier S, 2007, NEUROPSYCHOLOGIA, V45, P476, DOI 10.1016/j.neuropsychologia.2006.03.003; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Poirier C, 2005, COGNITIVE BRAIN RES, V25, P650, DOI 10.1016/j.cogbrainres.2005.08.015; Proulx MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001840; Ptito M, 2008, EXP BRAIN RES, V184, P193, DOI 10.1007/s00221-007-1091-0; Ptito M, 2008, EXP BRAIN RES, V187, P41, DOI 10.1007/s00221-008-1273-4; Ptito M, 2009, NEUROREPORT, V20, P543, DOI 10.1097/WNR.0b013e3283279909; Raz N, 2005, CEREB CORTEX, V15, P1459, DOI 10.1093/cercor/bhi026; REHKAMPER G, 1994, J COMP NEUROL, V347, P570, DOI 10.1002/cne.903470408; Reich L, 2012, CURR OPIN NEUROL, V25, P86, DOI 10.1097/WCO.0b013e32834ed723; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Renier L, 2010, DISABIL REHABIL-ASSI, V5, P175, DOI 10.3109/17483100903253936; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Ricciardi E, 2007, CEREB CORTEX, V17, P2933, DOI 10.1093/cercor/bhm018; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; RODMAN HR, 1993, J NEUROPHYSIOL, V70, P1115, DOI 10.1152/jn.1993.70.3.1115; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Shu N, 2009, HUM BRAIN MAPP, V30, P220, DOI 10.1002/hbm.20507; Striem-Amit E, 2012, CEREB CORTEX, V22, P1698, DOI 10.1093/cercor/bhr253; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Talairach J., 1988, COPLANAR STEREOTAXIC; UHL F, 1993, NEUROSCI LETT, V150, P162, DOI 10.1016/0304-3940(93)90526-Q; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; VERAART C, 1990, BRAIN RES, V510, P115, DOI 10.1016/0006-8993(90)90735-T; Wattam-Bell J, 2010, CURR BIOL, V20, P411, DOI 10.1016/j.cub.2009.12.020; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Wittenberg GF, 2004, EUR J NEUROSCI, V20, P1923, DOI 10.1111/j.1460-9568.2004.03630.x; Wolbers T, 2011, NEUROIMAGE, V56, P681, DOI 10.1016/j.neuroimage.2010.04.266; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420	98	35	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53784	10.1371/journal.pone.0053784	http://dx.doi.org/10.1371/journal.pone.0053784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308283	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100115
J	Himeda, T; Hosomi, T; Okuwa, T; Muraki, Y; Ohara, Y				Himeda, Toshiki; Hosomi, Takushi; Okuwa, Takako; Muraki, Yasushi; Ohara, Yoshiro			Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells	PLOS ONE			English	Article							CHILDREN; CARDIOVIRUSES; INFECTIONS; GROWTH	Saffold virus (SAFV) was identified as a human cardiovirus in 2007. Although several epidemiological studies have been reported, they have failed to provide a clear picture of the relationship between SAFV and human diseases. SAFV genotype 3 has been isolated from the cerebrospinal fluid specimen of patient with aseptic meningitis. This finding is of interest since Theiler's murine encephalomyelitis virus (TMEV), which is the closely related virus, is known to cause a multiple sclerosis-like syndrome in mice. TMEV persistently infects in mouse macrophage cells in vivo and in vitro, and the viral persistence is essential in TMEV-induced demyelinating disease. The precise mechanism(s) of SAFV infection still remain unclear. In order to clarify the SAFV pathogenicity, in the present study, we studied the possibilities of the in vitro persistent infection of SAFV. The two distinct phenotypes of HeLa cells, HeLa-N and HeLa-R, were identified. In these cells, the type of SAFV-3 infection was clearly different. HeLa-N cells were lyticly infected with SAFV-3 and the host suitable for the efficient growth. On the other hand, HeLa-R cells were persistently infected with SAFV-3. In addition, the SAFV persistence in HeLa-R cells is independent of type HFN response of host cells although the TMEV persistence in mouse macrophage cells depends on the response. Furthermore, it was suggested that SAFV persistence may be influenced by the expression of receptor(s) for SAFV infection on the host cells. The present findings on SAFV persistence will provide the important information to encourage the research of SAFV pathogenicity.	[Himeda, Toshiki; Okuwa, Takako; Muraki, Yasushi; Ohara, Yoshiro] Kanazawa Med Univ, Sch Med, Dept Microbiol, Kanazawa, Ishikawa, Japan; [Hosomi, Takushi] Publ Hlth Inst Kochi Prefecture, Kochi, Japan	Kanazawa Medical University	Ohara, Y (corresponding author), Kanazawa Med Univ, Sch Med, Dept Microbiol, Kanazawa, Ishikawa, Japan.	ohara@kanazawa-med.ac.jp			Japan Society for the Promotion of Science [24790449]; Ministry of Education, Culture, Sports, Science and Technology [22590421]; Kanazawa Medical University [S2012-6]; Takeda Science Foundation; Neuroimmunological Research Committee of the Ministry of Health, Labor and Welfare; Ministry of Health, Labour and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kanazawa Medical University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Neuroimmunological Research Committee of the Ministry of Health, Labor and Welfare; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (24790449), Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology (22590421), a grant for promoted Research from Kanazawa Medical University (S2012-6), a grant from Takeda Science Foundation, a grant from the Neuroimmunological Research Committee of the Ministry of Health, Labor and Welfare, a Grant-in-Aid for Research on Emerging and Re-emerging Infectious Diseases and a Grant-in-Aid for the Promotion of Polio Eradication from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2008, EMERG INFECT DIS, V14, P834, DOI 10.3201/eid1405.071675; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Boldogh I, 1996, MED MICROBIOLOGY; Feuer R, 2002, J VIROL, V76, P4430, DOI 10.1128/JVI.76.9.4430-4440.2002; Hertzler S, 2011, J VIROL, V85, P7411, DOI 10.1128/JVI.00265-11; Himeda T, 2011, CLIN EXP NEUROIMMUNO, V2, P49; Himeda T, 2012, J VIROL, V86, P1292, DOI 10.1128/JVI.06087-11; Himeda T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-110; Himeda T, 2010, J NEUROVIROL, V16, P219, DOI 10.3109/13550284.2010.484040; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P7, DOI 10.3201/eid1801.110725; Pinkert S, 2011, J VIROL, V85, P13409, DOI 10.1128/JVI.00621-11; Sorgeloos F, 2010, EUR 2010, P104; YOSHITAKE Y, 1992, IN VITRO CELL DEV-AN, V28A, P419; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	17	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53194	10.1371/journal.pone.0053194	http://dx.doi.org/10.1371/journal.pone.0053194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308162	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100024
J	Jensen, MM; Erichsen, KD; Johnbeck, CB; Bjorkling, F; Madsen, J; Bzorek, M; Jensen, PB; Hojgaard, L; Sehested, M; Kjaer, A				Jensen, Mette Munk; Erichsen, Kamille Dumong; Johnbeck, Camilla Bardram; Bjorkling, Fredrik; Madsen, Jacob; Bzorek, Michael; Jensen, Peter Buhl; Hojgaard, Liselotte; Sehested, Maxwell; Kjaer, Andreas			[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; THYMIDINE KINASE-1; TUMOR RESPONSE; IMAGING PROLIFERATION; THERAPY; MICE; FDG; PHARMACOKINETICS; VALIDATION	Introduction: APO866 is a new anti-tumor compound inhibiting nicotinamide phosphoribosyltransferase (NAMPT). APO866 has an anti-tumor effect in several pre-clinical tumor models and is currently in several clinical phase II studies. 3'-deoxy-3'-[18F]fluorothymidine ([18F]FLT) is a tracer used to assess cell proliferation in vivo. The aim of this study was non-invasively to study effect of APO866 treatment on [18F]FLT and 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake. Methods: In vivo uptake of [18F]FLT and [18F]FDG in human ovary cancer xenografts in mice (A2780) was studied at various time points after APO866 treatment. Baseline [18F]FLT or [18F]FDG scans were made before treatment and repeated after 24 hours, 48 hours and 7 days. Tumor volume was followed with computed tomography (CT). Tracer uptake was quantified using small animal PET/CT. One hour after iv injection of tracer, static PET scans were performed. Imaging results were compared with Ki67 immunohistochemistry. Results: Tumors treated with APO866 had volumes that were 114% (24 h), 128% (48 h) and 130% (Day 7) relative to baseline volumes at Day 0. In the control group tumor volumes were 118% (24 h), 145% (48 h) and 339% (Day 7) relative to baseline volumes Day 0. Tumor volume between the treatment and control group was significantly different at Day 7 (P = 0.001). Compared to baseline, [18F]FLT SUVmax was significantly different at 24 h (P < 0.001), 48 h (P < 0.001) and Day 7 (P < 0.001) in the APO866 group. Compared to baseline, [18F]FDG SUVmax was significantly different at Day 7 (P = 0.005) in the APO866 group. Conclusions: APO866 treatment caused a significant decrease in [18F]FLT uptake 24 and 48 hours after treatment initiation. The early reductions in tumor cell proliferation preceded decrease in tumor volume. The results show the possibility to use [18F]FLT and [18F]FDG to image treatment effect early following treatment with APO866 in future clinical studies.	[Jensen, Mette Munk; Johnbeck, Camilla Bardram; Hojgaard, Liselotte; Kjaer, Andreas] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jensen, Mette Munk; Johnbeck, Camilla Bardram; Madsen, Jacob; Hojgaard, Liselotte; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Erichsen, Kamille Dumong; Bjorkling, Fredrik; Jensen, Peter Buhl; Sehested, Maxwell] TopoTarget AS, Copenhagen, Denmark; [Bzorek, Michael] Naestved Hosp, Dept Pathol, Naestved, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Naestved Hospital	Jensen, MM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.	mettemj@sund.ku.dk	Højgaard, Liselotte/AAK-8329-2020; Kjaer, Andreas/E-8932-2015	Bjorkling, Fredrik/0000-0001-7018-8334; Kjaer, Andreas/0000-0002-2706-5547	National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Medical Research Council; Rigshospitalets Research Foundation; Svend Andersen Foundation; AP Moller Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Danish Cancer Society	National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rigshospitalets Research Foundation; Svend Andersen Foundation; AP Moller Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society)	Funding came from the National Advanced Technology Foundation, The John and Birthe Meyer Foundation, Danish Medical Research Council, Rigshospitalets Research Foundation, Svend Andersen Foundation, AP Moller Foundation, Novo Nordisk Foundation, Lundbeck Foundation and Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Apisarnthanarax S, 2006, CLIN CANCER RES, V12, P4590, DOI 10.1158/1078-0432.CCR-05-2720; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0; Barthel H, 2003, CANCER RES, V63, P3791; Berghmans T, 2008, J THORAC ONCOL, V3, P6, DOI 10.1097/JTO.0b013e31815e6d6b; Borst GR, 2005, EUR J CANCER, V41, P1533, DOI 10.1016/j.ejca.2005.03.026; Brepoels L, 2009, J NUCL MED, V50, P1102, DOI 10.2967/jnumed.109.062208; Buck AK, 2003, J NUCL MED, V44, P1426; Deroose CM, 2007, J NUCL MED, V48, P295; Downey RJ, 2004, J CLIN ONCOL, V22, P3255, DOI 10.1200/JCO.2004.11.109; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602; Fueger BJ, 2006, J NUCL MED, V47, P999; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Ishimori T, 2005, ACAD RADIOL, V12, P776, DOI 10.1016/j.acra.2005.03.062; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; KONG XB, 1992, ANTIMICROB AGENTS CH, V36, P808, DOI 10.1128/AAC.36.4.808; Leyton J, 2005, CANCER RES, V65, P4202, DOI 10.1158/0008-5472.CAN-04-4008; Leyton J, 2008, MOL CANCER THER, V7, P3112, DOI 10.1158/1535-7163.MCT-08-0264; Leyton J, 2006, CANCER RES, V66, P7621, DOI 10.1158/0008-5472.CAN-05-3962; Molthoff CFM, 2007, MOL IMAGING BIOL, V9, P340, DOI 10.1007/s11307-007-0104-5; MUNCHPETERSEN B, 1995, ADV ENZYME REGUL, V35, P69, DOI 10.1016/0065-2571(94)00014-T; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; Oyama N, 2004, J NUCL MED, V45, P519; Rasey JS, 2002, J NUCL MED, V43, P1210; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Sohn HJ, 2008, CLIN CANCER RES, V14, P7423, DOI 10.1158/1078-0432.CCR-08-0312; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Waldherr C, 2005, J NUCL MED, V46, P114; Wosikowski K, 2002, CANCER RES, V62, P1057; Yang YJ, 2006, EUR J NUCL MED MOL I, V33, P412, DOI 10.1007/s00259-005-0011-4	36	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53410	10.1371/journal.pone.0053410	http://dx.doi.org/10.1371/journal.pone.0053410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308217	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100039
J	Correia, B; Valledor, L; Meijon, M; Rodriguez, JL; Dias, MC; Santos, C; Canal, MJ; Rodriguez, R; Pinto, G				Correia, Barbara; Valledor, Luis; Meijon, Monica; Rodriguez, Jose Luis; Dias, Maria Celeste; Santos, Conceicao; Canal, Maria Jesus; Rodriguez, Roberto; Pinto, Gloria			Is the Interplay between Epigenetic Markers Related to the Acclimation of Cork Oak Plants to High Temperatures?	PLOS ONE			English	Article							DNA METHYLATION; CLIMATIC ADAPTATION; HEAT-STRESS; HISTONE; PHOTOSYNTHESIS; DIFFERENTIATION; ACETYLATION; EXTRACTION; RESPONSES; DYNAMICS	Trees necessarily experience changes in temperature, requiring efficient short-term strategies that become crucial in environmental change adaptability. DNA methylation and histone posttranslational modifications have been shown to play a key role in both epigenetic control and plant functional status under stress by controlling the functional state of chromatin and gene expression. Cork oak (Quercus suber L.) is a key stone of the Mediterranean region, growing at temperatures of 45 degrees C. This species was subjected to a cumulative temperature increase from 25 degrees C to 55 degrees C under laboratory conditions in order to test the hypothesis that epigenetic code is related to heat stress tolerance. Electrolyte leakage increased after 35 degrees C, but all plants survived to 55 degrees C. DNA methylation and acetylated histone H3 (AcH3) levels were monitored by HPCE (high performance capillary electrophoresis), MS-RAPD (methylation-sensitive random-amplified polymorphic DNA) and Protein Gel Blot analysis and the spatial distribution of the modifications was assessed using a confocal microscope. DNA methylation analysed by HPCE revealed an increase at 55 degrees C, while MS-RAPD results pointed to dynamic methylation-demethylation patterns over stress. Protein Gel Blot showed the abundance index of AcH3 decreasing from 25 degrees C to 45 degrees C. The immunohistochemical detection of 5-mC (5-methyl-2'-deoxycytidine) and AcH3 came upon the previous results. These results indicate that epigenetic mechanisms such as DNA methylation and histone H3 acetylation have opposite and particular dynamics that can be crucial for the stepwise establishment of this species into such high stress (55 degrees C), allowing its acclimation and survival. This is the first report that assesses epigenetic regulation in order to investigate heat tolerance in forest trees.	[Correia, Barbara; Dias, Maria Celeste; Santos, Conceicao; Pinto, Gloria] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Correia, Barbara; Dias, Maria Celeste; Santos, Conceicao; Pinto, Gloria] Univ Aveiro, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal; [Valledor, Luis; Meijon, Monica; Rodriguez, Jose Luis; Canal, Maria Jesus; Rodriguez, Roberto] Univ Inst Biotechnol, Epiphysage Res Grp, Biol Organisms & Syst Dept, Oviedo, Spain; [Valledor, Luis; Meijon, Monica; Rodriguez, Jose Luis; Canal, Maria Jesus; Rodriguez, Roberto] Univ Oviedo, Oviedo, Spain; [Valledor, Luis] Univ Vienna, Mol Syst Biol Dept, Vienna, Austria; [Meijon, Monica] Austrian Acad Sci, Gregor Mendel Inst Plant Mol Biol, A-1010 Vienna, Austria	Universidade de Aveiro; Universidade de Aveiro; University of Oviedo; University of Vienna; Austrian Academy of Sciences	Pinto, G (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	gpinto@ua.pt	Cañal, María Jesús/L-1005-2014; Pinto, Glória Catarina/B-1271-2011; Santos, Conceição LV/A-8651-2008; Valledor, Luis/E-8881-2017; Meijón, Mónica/N-6285-2014; santos, conceição/GQQ-7378-2022; Lorenzo, José Luis Rodriguez/H-1907-2014; Meijón, Mónica/G-7366-2016; Dias, Maria Celeste/K-7622-2015; Correia, Barbara/I-2146-2014; Santos, Conceição/ABE-6172-2020; Valledor, Luis/B-4791-2010	Cañal, María Jesús/0000-0002-1639-9672; Pinto, Glória Catarina/0000-0001-7735-5131; Santos, Conceição LV/0000-0003-4129-6381; Meijón, Mónica/0000-0003-1563-5554; Lorenzo, José Luis Rodriguez/0000-0003-2566-3102; Meijón, Mónica/0000-0003-1563-5554; Dias, Maria Celeste/0000-0002-3083-6218; Correia, Barbara/0000-0002-8277-7061; Santos, Conceição/0000-0003-4129-6381; Valledor, Luis/0000-0002-0636-365X	FEDER through COMPETE (Programa Operacional Factores de Competitividade); FCT project [PTDC/AGR-CFL/112996/2009]; Human Potential Operational Programme (National Strategic Reference Framework); European Social Fund (EU); FCT [SFRH/BPD/41700/2007]; Marie Curie Action of the European Union (FP7-PEOPLE-IEF); Fundação para a Ciência e a Tecnologia [PTDC/AGR-CFL/112996/2009] Funding Source: FCT	FEDER through COMPETE (Programa Operacional Factores de Competitividade); FCT project(Portuguese Foundation for Science and Technology); Human Potential Operational Programme (National Strategic Reference Framework); European Social Fund (EU)(European Social Fund (ESF)European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Action of the European Union (FP7-PEOPLE-IEF); Fundação para a Ciência e a Tecnologia	This work is supported by FEDER through COMPETE (Programa Operacional Factores de Competitividade) and by the FCT project PTDC/AGR-CFL/112996/2009. G. Pinto is hired under the programme Ciencia 2008 (FCT, Portugal), co-funded by the Human Potential Operational Programme (National Strategic Reference Framework 2007-2013) and European Social Fund (EU). FCT supported the fellowship of M. C. Dias (SFRH/BPD/41700/2007). L. Valledor fellow was supported by a Marie Curie Action of the European Union (FP7-PEOPLE-IEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Ramirez-Valiente JA, 2011, TREE GENET GENOMES, V7, P285, DOI 10.1007/s11295-010-0331-9; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Chaves I, 2011, J PLANT PHYSIOL, V168, P1729, DOI 10.1016/j.jplph.2011.05.013; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; COCCONCELLI PS, 1995, LETT APPL MICROBIOL, V21, P376, DOI 10.1111/j.1472-765X.1995.tb01085.x; Daas C, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008002; Faria T, 1996, J EXP BOT, V47, P1755, DOI 10.1093/jxb/47.11.1755; Ghouil H, 2003, TREE PHYSIOL, V23, P1031, DOI 10.1093/treephys/23.15.1031; Haldimann P, 2004, PLANT CELL ENVIRON, V27, P1169, DOI 10.1111/j.1365-3040.2004.01222.x; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hasbun R, 2007, ACTA HORTIC, P563, DOI 10.17660/ActaHortic.2007.760.80; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Kovalchuk O, 2003, MUTAT RES-FUND MOL M, V529, P13, DOI 10.1016/S0027-5107(03)00103-9; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lauria M, 2011, BBA-GENE REGUL MECH, V1809, P369, DOI 10.1016/j.bbagrm.2011.03.002; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Meijon M, 2011, PHYSIOL PLANTARUM, V143, P82, DOI 10.1111/j.1399-3054.2011.01485.x; Meijon M, 2011, PHYSIOL PLANTARUM, V141, P276, DOI 10.1111/j.1399-3054.2010.01430.x; Meijon M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-10; Meijon M, 2009, J PLANT PHYSIOL, V166, P1624, DOI 10.1016/j.jplph.2009.04.014; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Mishkind M, 2009, PLANT J, V60, P10, DOI 10.1111/j.1365-313X.2009.03933.x; Monteuuis O, 2009, SILVAE GENET, V58, P287, DOI 10.1515/sg-2009-0037; Pecinka A, 2010, PLANT CELL, V22, P3118, DOI 10.1105/tpc.110.078493; Penuelas J, 2002, NEW PHYTOL, V155, P227, DOI 10.1046/j.1469-8137.2002.00457.x; Pinto G, 2010, ANT TURK 24 IUFRO C; Ramirez-Valiente JA, 2009, MOL ECOL, V18, P3803, DOI 10.1111/j.1365-294X.2009.04317.x; Ribeiro T, 2009, SEX PLANT REPROD, V22, P1, DOI 10.1007/s00497-008-0083-y; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Tetievsky A, 2010, J APPL PHYSIOL, V109, P1552, DOI 10.1152/japplphysiol.00469.2010; THOMAS MR, 1993, THEOR APPL GENET, V86, P173, DOI 10.1007/BF00222076; Tittel-Elmer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001175; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; Valledor L, 2009, J PLANT BIOCHEM BIOT, V18, P229, DOI 10.1007/BF03263325; Valledor L, 2012, PHYSL PLANTARUM; Valledor L, 2007, PLANT CELL TISS ORG, V91, P75, DOI 10.1007/s11240-007-9262-z; Valledor L, 2010, J PLANT PHYSIOL, V167, P351, DOI 10.1016/j.jplph.2009.09.018; Vanyushin BF, 2006, CURR TOP MICROBIOL, V301, P67; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Yakovlev IA, 2011, PLANT SCI, V180, P132, DOI 10.1016/j.plantsci.2010.07.004; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x	52	57	62	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53543	10.1371/journal.pone.0053543	http://dx.doi.org/10.1371/journal.pone.0053543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326451	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800054
J	Williams, C; Wilson, P; Morrison, J; McMahon, A; Andrew, W; Allan, L; McConnachie, A; McNeill, Y; Tansey, L				Williams, Christopher; Wilson, Philip; Morrison, Jill; McMahon, Alex; Andrew, Walker; Allan, Lesley; McConnachie, Alex; McNeill, Yvonne; Tansey, Louise			Guided Self-Help Cognitive Behavioural Therapy for Depression in Primary Care: A Randomised Controlled Trial	PLOS ONE			English	Article							CLINICAL EFFECTIVENESS	Background: Access to Cognitive behavioural therapy (CBT) for depression is limited. One solution is CBT self-help books. Trial Objectives: To assess the impact of a guided self-help CBT book (GSH-CBT) on mood, compared to treatment as usual (TAU). Hypotheses: 1. GSH-CBT will have improved mood and knowledge of the causes and treatment of depression compared to the control receiving TAU 2. Guided self-help will be acceptable to patients and staff. Methods and Findings: Participants: Adults attending seven general practices in Glasgow, UK with a BDI-II score of >= 14. 141 randomised to GSH-CBT and 140 to TAU. Interventions: RCT comparing 'Overcoming Depression: A Five Areas Approach' book plus 3-4 short face to face support appointments totalling up to 2 hours of guided support, compared with general practitioner TAU. Primary outcome: The BDI (II) score at 4 months. Numbers analysed: 281 at baseline, 203 at 4 months (primary outcome), 117 at 12 months. Outcome: Mean BDI-II scores were lower in the GSH-CBT group at 4 months by 5.3 points (2.6 to 7.9, p<0.001). At 4 and 12 months there were also significantly higher proportions of participants achieving a 50% reduction in BDI-II in the GSH-CBT arm. The mean support was 2 sessions with 42.7 minutes for session 1, 41.4 minutes for session 2 and 40.2 minutes of support for session 3. Adverse effects/Harms: Significantly less deterioration in mood in GSH-CBT (2.0% compared to 9.8% in the TAU group for BDI-II category change). Limitations: Weaknesses: Our follow-up rate of 72.2% at 4 months is better than predicted but is poorer at 12 months (41.6%). In the GSH-CBT arm, around 50% of people attended 2 or fewer sessions. 22% failed to take up treatment. Conclusions: GSH-CBT is substantially more effective than TAU.	[Williams, Christopher; Wilson, Philip; Morrison, Jill; Andrew, Walker; Allan, Lesley; McNeill, Yvonne; Tansey, Louise] Univ Glasgow, Inst Hlth & Wellbeing, Strathclyde, Scotland; [McMahon, Alex] Univ Glasgow, Sch Dent, Strathclyde, Scotland; [McConnachie, Alex] Univ Glasgow, Robertson Ctr, Strathclyde, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Williams, C (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Strathclyde, Scotland.	chris.williams@glasgow.ac.uk	Wilson, Philip/V-6519-2019	Wilson, Philip/0000-0002-4123-8248	Chief Scientist Office; National Health Service Greater Glasgow and Clyde [CZH/4/61]	Chief Scientist Office; National Health Service Greater Glasgow and Clyde	Funding: The authors acknowledge the Chief Scientist Office and National Health Service Greater Glasgow and Clyde for funding and supporting this study Ref CZH/4/61. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2005, BRIT J GEN PRACT, V55, P387; Barnhofer T, 2009, BEHAV RES THER, V47, P366, DOI 10.1016/j.brat.2009.01.019; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Carstairs V., 1991, DEPRIVATION HLTH SCO; de Graaf LE, 2009, BRIT J PSYCHIAT, V195, P73, DOI 10.1192/bjp.bp.108.054429; Evans C, 2002, BRIT J PSYCHIAT, V180, P51, DOI 10.1192/bjp.180.1.51; Gellatly J, 2007, PSYCHOL MED, V37, P1217, DOI 10.1017/S0033291707000062; Jorm AF, 2000, BRIT J PSYCHIAT, V177, P396, DOI 10.1192/bjp.177.5.396; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Martinez R, 2008, BEHAV COGN PSYCHOTH, V36, P89, DOI 10.1017/S1352465807004067; McLoone P., 1994, CARSTAIRS SCORES SCO; National Institute for Clinical Excellence, 2009, PART UPD CG23 DEPR M; Richards A, 2003, BRIT J GEN PRACT, V53, P764; Ward E, 2000, BRIT MED J, V321, P1383, DOI 10.1136/bmj.321.7273.1383; Whitfield GE, 2001, BEHAV COGN PSYCHOTH, V29, P333, DOI 10.1017/S135246580100306X; Williams C, 2001, BRIT MED BULL, V57, P133, DOI 10.1093/bmb/57.1.133; WILLIAMS C, 2001, OVERCOMING DEPRESSIO; Williams C, 2010, CLIN GUIDE USING 5 A, P179	18	37	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52735	10.1371/journal.pone.0052735	http://dx.doi.org/10.1371/journal.pone.0052735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326352	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000314705800023
J	Jensen, CB; Thorne-Lyman, AL; Hansen, LV; Strom, M; Nielsen, NO; Cohen, A; Olsen, SF				Jensen, Camilla Bjorn; Thorne-Lyman, Andrew L.; Hansen, Linda Vadgard; Strom, Marin; Nielsen, Nina Odgaard; Cohen, Arieh; Olsen, Sjurdur Frodi			Development and Validation of a Vitamin D Status Prediction Model in Danish Pregnant Women: A Study of the Danish National Birth Cohort	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; D INSUFFICIENCY; DETERMINANTS; POPULATION; RISK; DISPARITIES; DIETARY; FAT	Vitamin D has been hypothesized to reduce risk of pregnancy complications such as preeclampsia, gestational diabetes mellitus, and preterm delivery. However, many of these outcomes are rare and require a large sample size to study, representing a challenge for cohorts with a limited number of preserved samples. The aims of this study were to (1) identify predictors of serum 25-hydroxy-vitamin D (25(OH)D) among pregnant women in a subsample (N = 1494) of the Danish National Birth Cohort (DNBC) and (2) develop and validate a score predicting 25(OH)D-status in order to explore associations between vitamin D and maternal and offspring health outcomes in the DNBC. In our study sample, 42.3% of the population had deficient levels of vitamin D (<50 nmol/L 25(OH)D) and average levels of 25(OH)D-status were 56.7(s.d. 24.6) nmol/L. A prediction model consisting of intake of vitamin D from diet and supplements, outdoor physical activity, tanning bed use, smoking, and month of blood draw explained 40.1% of the variance in 25(OH)D and mean measured 25(OH)D-level increased linearly by decile of predicted 25(OH)D-score. In total 32.2% of the women were placed in the same quintile by both measured and predicted 25(OH)D-values and 69.9% were placed in the same or adjacent quintile by both methods. Cohen's weighted kappa coefficient (K = 0.3) reflected fair agreement between measured 25(OH)D-levels and predicted 25(OH)D-score. These results are comparable to other settings in which vitamin D scores have shown similar associations with disease outcomes as measured 25(OH)D-levels. Our findings suggest that predicted 25(OH)D-scores may be a useful alternative to measured 25(OH)D for examining associations between vitamin D and disease outcomes in the DNBC cohort, but cannot substitute for measured 25(OH)D-levels for estimates of prevalence.	[Jensen, Camilla Bjorn; Hansen, Linda Vadgard; Strom, Marin; Olsen, Sjurdur Frodi] Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark; [Thorne-Lyman, Andrew L.; Olsen, Sjurdur Frodi] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Nielsen, Nina Odgaard] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Cohen, Arieh] Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Harvard University; Harvard T.H. Chan School of Public Health; University of Southern Denmark; Statens Serum Institut	Strom, M (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark.	mrm@ssi.dk		Strom, Marin/0000-0003-1926-6610; Olsen, Sjurdur/0000-0003-3017-7096; Nielsen, Nina Odgaard/0000-0001-6127-5970	Danish National Research Foundation; March of Dimes Birth Defects Foundation; Pharmacy Foundation; Egmont Foundation; Augustinus Foundation; Health Foundation; European Union [QLK1-2000-00 083]; Lundbeck Foundation [R13-A907]; Danish Council [09-067124]; U.S. National Institutes of Health (NIH) [T32 DK 007703]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); March of Dimes Birth Defects Foundation(March of Dimes); Pharmacy Foundation; Egmont Foundation; Augustinus Foundation; Health Foundation; European Union(European Commission); Lundbeck Foundation(Lundbeckfonden); Danish Council(Danish Medical Research Council); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The DNBC was funded by the Danish National Research Foundation, March of Dimes Birth Defects Foundation, Pharmacy Foundation, Egmont Foundation, Augustinus Foundation, the Health Foundation and the European Union (QLK1-2000-00 083). We would like to acknowledge the Managerial Team of the Danish National Birth Cohort. The study was supported by the Lundbeck Foundation (R13-A907). The study is a part of the research program of the Centre for Fetal Programming (CFP). CFP is supported by the Danish Council for Strategic Research (grant 09-067124). Andrew Thorne-Lyman is supported by training grant T32 #DK 007703 from the U.S. National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2005, EUR J CLIN NUTR, V59, P533, DOI 10.1038/sj.ejcn.1602108; Bertrand KA, 2012, BR J NUTR, P1; Bodnar LM, 2010, OBSTET GYNECOL SURV, V65, P273, DOI 10.1097/OGX.0b013e3181dbc55b; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; Bodnar LM, 2009, BRIT J NUTR, V101, P278, DOI 10.1017/S0007114508981460; Brot C, 2001, BRJ NUTR S1, V86, pS97; BRUINSE HW, 1995, EUR J OBSTET GYN R B, V61, P31, DOI 10.1016/0028-2243(95)02150-Q; Chan J, 2010, CANCER CAUSE CONTROL, V21, P501, DOI 10.1007/s10552-009-9481-1; Davis LM, 2010, J PEDIATR ADOL GYNEC, V23, P45, DOI 10.1016/j.jpag.2009.05.005; Egan KM, 2008, CANCER CAUSE CONTROL, V19, P527, DOI 10.1007/s10552-008-9115-z; Gozdzik A, 2008, BMC PUBLIC HEALTH, V8, P1471; Hill TR, 2008, BRIT J NUTR, V99, P1061, DOI 10.1017/S0007114507842826; Hirani V, 2009, BRIT J NUTR, V101, P760, DOI 10.1017/S0007114508023416; Holick MF, 2011, JINVESTIGMED; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J INVEST MED, V59, P872, DOI 10.2310/JIM.0b013e318214ea2d; Holmes VA, 2009, BRIT J NUTR, V102, P876, DOI 10.1017/S0007114509297236; Husemoen LL, 2012, DIABETES CARE, P1935; Jacobs ET, 2008, AM J CLIN NUTR, V87, P608, DOI 10.1093/ajcn/87.3.608; Jacques PF, 1997, AM J CLIN NUTR, V66, P929, DOI 10.1093/ajcn/66.4.929; Kaludjerovic J, 2010, J MIDWIFERY WOM HEAL, V55, P550, DOI 10.1016/j.jmwh.2010.02.016; KUMAR R, 1994, SOC PSYCH PSYCH EPID, V29, P250, DOI 10.1007/BF00802048; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lappe JM, 2006, J AM COLL NUTR, V25, P395, DOI 10.1080/07315724.2006.10719551; Li WY, 2011, CAN J PUBLIC HEALTH, V102, P308, DOI 10.1007/BF03404056; McCullough ML, 2010, AM J EPIDEMIOL, V172, P21, DOI 10.1093/aje/kwq113; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; McKinney K, 2008, CLIN ENDOCRINOL, V69, P535, DOI 10.1111/j.1365-2265.2008.03233.x; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Olsen SF, 2007, PAEDIATR PERINAT EP, V21, P76, DOI 10.1111/j.1365-3016.2007.00777.x; Pazaitou-Panayiotou K, 2012, EXP CLIN ENDOCR DIAB, V120, P14, DOI 10.1055/s-0031-1285912; Rock CL, 1999, J NUTR, V129, P855, DOI 10.1093/jn/129.4.855; Roth DE, 2011, J PERINATOL, V31, P449, DOI 10.1038/jp.2010.203; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; van der Meer IM, 2008, CLIN ENDOCRINOL, V68, P466, DOI 10.1111/j.1365-2265.2007.03066.x; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038	39	42	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53059	10.1371/journal.pone.0053059	http://dx.doi.org/10.1371/journal.pone.0053059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326380	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500046
J	Li, WX; Zhou, M; Ren, HY; Hu, HM; Lu, LW; Cao, M; Wang, LX				Li, Weixia; Zhou, Meng; Ren, Hongyan; Hu, Hong-Ming; Lu, Liwei; Cao, Meng; Wang, Li-xin			Tumor-Derived Autophagosomes (DRibbles) Induce B Cell Activation in a TLR2-MyD88 Dependent Manner	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CROSS-PRESENTATION; IMMUNE-RESPONSES; DENDRITIC CELLS; T-CELLS; ANTIGENS; LYMPHOCYTES; DIFFERENTIATION; STIMULATION; LYMPHOMAS	Previously, we have documented that isolated autophagosomes from tumor cells could efficiently cross-prime tumor-reactive naive T cells and mediate tumor regression in preclinical mouse models. However, the effect of tumor-derived autophagosomes, here we refer as to DRibbles, on B cells has not been studied so far. At present study, we found that DRibbles generated from a murine hepatoma cell line Hep1-6, induced B-cell activation after intravenous injection into mice. B-cell populations were significantly expanded and the production of Hep1-6 tumor-specific antibodies was successfully induced. Moreover, in vitro studies showed that DRibbles could induce more efficient B-cell proliferation and activation, antibody production, and cytokine secretion than whole tumor cell lysates. Notably, we found that B-cell activation required proteins but not DNA in the DRibbles. We further showed that B cells could capture DRibbles and present antigens in the DRibbles to directly induce T cell activation. Furthermore, we found that B-cell activation, antibody production, cytokine secretion and antigen cross-presentation were TLR2-MyD88 pathway dependent. Taken together, the present studies demonstrated that tumor-derived autophagosomes (DRibbles) efficiently induced B cells activation, antibody production, cytokine secretion and antigen cross-presentation mainly depending on their protein component via TLR2/MyD88 dependent manner.	[Li, Weixia; Zhou, Meng; Ren, Hongyan; Cao, Meng; Wang, Li-xin] Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Ren, Hongyan; Hu, Hong-Ming; Wang, Li-xin] Southeast Univ, Affiliated Hosp 2, Canc Res & Biotherapy Ctr, Nanjing, Jiangsu, Peoples R China; [Hu, Hong-Ming] Providence Portland Med Ctr, Earle A Chiles Res Inst, Lab Canc Immunobiol, Portland, OR USA; [Lu, Liwei] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lu, Liwei] Univ Hong Kong, Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China	Southeast University - China; Southeast University - China; Providence Portland Medical Center; University of Hong Kong; University of Hong Kong	Cao, M (corresponding author), Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China.	mcao1979@yahoo.com.cn; wanglx66@yahoo.com.cn	Zhou, Meng/M-7954-2019; Lu, Liwei/C-4357-2009	Hu, Hong-Ming/0000-0002-2206-3470; Lu, Liwei/0000-0002-8634-0967	National Natural Science Foundation of China [31170857, 30972783, 300771999, 81001299]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is funded by National Natural Science Foundation of China (31170857, 30972783, 300771999, 81001299) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; Agrawal S, 2011, J CLIN IMMUNOL, V31, P472, DOI [10.1007/s10875-010-9456-8, 10.1007/s10875-010-9507-1]; Airoldi I, 2001, CANCER RES, V61, P1285; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barnes N, 2002, IMMUNITY, V16, P379, DOI 10.1016/S1074-7613(02)00287-X; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Bolhassani A, 2008, EXPERT REV VACCINES, V7, P1185, DOI 10.1586/14760584.7.8.1185; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Crampton SR, 2010, ANN NY ACAD SCI, V1183, P58, DOI 10.1111/j.1749-6632.2009.05123.x; de Wit J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013016; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Gantner F, 2003, EUR J IMMUNOL, V33, P1576, DOI 10.1002/eji.200323444; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; GOSSELIN EJ, 1988, J IMMUNOL, V140, P1408; Gray D, 2007, EUR J IMMUNOL, V37, P3304, DOI 10.1002/eji.200737728; Grivel J C, 1994, Immunomethods, V4, P223, DOI 10.1006/immu.1994.1024; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Ke Y, 1996, J EXP MED, V184, P1179, DOI 10.1084/jem.184.3.1179; KINDLER V, 1995, EUR J IMMUNOL, V25, P1239, DOI 10.1002/eji.1830250516; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; Li YH, 2011, CLIN CANCER RES, V17, P1; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Li YH, 2009, AUTOPHAGY, V5, P576, DOI 10.4161/auto.5.4.8366; Lu HT, 2011, TOXICOL APPL PHARM, V255, P251, DOI 10.1016/j.taap.2011.06.026; Menard LC, 2007, J IMMUNOL, V179, P4857, DOI 10.4049/jimmunol.179.7.4857; Neller MA, 2008, SEMIN IMMUNOL, V20, P286, DOI 10.1016/j.smim.2008.09.006; OGARRA A, 1990, INT IMMUNOL, V2, P821, DOI 10.1093/intimm/2.9.821; Ohnishi E, 1997, J INTERF CYTOK RES, V17, P597, DOI 10.1089/jir.1997.17.597; Peng SL, 2005, CURR OPIN IMMUNOL, V17, P230, DOI 10.1016/j.coi.2005.03.003; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Rozkova D, 2010, INT J CANCER, V126, P1132, DOI 10.1002/ijc.24832; Sartori A, 1997, METHODS, V11, P116, DOI 10.1006/meth.1996.0395; Serre K, 1998, J IMMUNOL, V161, P6059; SINGER DF, 1990, J CELL BIOL, V111, P55, DOI 10.1083/jcb.111.1.55; Skok J, 1999, J IMMUNOL, V163, P4284; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Twitty CG, 2011, CLIN CANCER RES, V17, P6467, DOI 10.1158/1078-0432.CCR-11-0812; Vidard L, 1996, J IMMUNOL, V156, P2809; Vos Q, 2000, IMMUNOL REV, V176, P154; Wagle NM, 1999, VACCINE, V18, P376, DOI 10.1016/S0264-410X(99)00207-8; Yang M, 2010, J IMMUNOL, V184, P3321, DOI 10.4049/jimmunol.0902551; Zhang P, 2007, MOL IMMUNOL, V44, P332, DOI 10.1016/j.molimm.2006.02.030; Zhao FS, 2010, VACCINE, V28, P2846, DOI 10.1016/j.vaccine.2010.01.057	45	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53564	10.1371/journal.pone.0053564	http://dx.doi.org/10.1371/journal.pone.0053564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326458	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500084
J	Lindsey, PA; Havemann, CP; Lines, R; Palazy, L; Price, AE; Retief, TA; Rhebergen, T; Van der Waal, C				Lindsey, Peter Andrew; Havemann, Carl Peter; Lines, Robin; Palazy, Lucille; Price, Aaron Ernest; Retief, Tarryn Anne; Rhebergen, Tiemen; Van der Waal, Cornelis			Determinants of Persistence and Tolerance of Carnivores on Namibian Ranches: Implications for Conservation on Southern African Private Lands	PLOS ONE			English	Article							DOG LYCAON-PICTUS; HUMAN-WILDLIFE CONFLICT; LIONS PANTHERA-LEO; LIVESTOCK PREDATION; HUMAN DENSITIES; ATTITUDES; POPULATION; MANAGEMENT; DEPREDATION; PATTERNS	Changing land use patterns in southern Africa have potential to dramatically alter the prospects for carnivore conservation. Understanding these influences is essential for conservation planning. We interviewed 250 ranchers in Namibia to assess human tolerance towards and the distribution of large carnivores. Cheetahs (Acinonyx jubatus), leopards (Panthera pardus) and brown hyaenas (Hyaena brunnea) were widely distributed on Namibian farmlands, spotted hyaenas (Crocuta crocuta) had a narrower distribution, and wild dogs (Lycaon pictus) and lions (Panthera leo) are largely limited to areas near source populations. Farmers were most tolerant of leopards and least tolerant of lions, wild dogs and spotted hyaenas. Several factors relating to land use correlated consistently with carnivore-presence and landowner tolerance. Carnivores were more commonly present and/or tolerated where; wildlife diversity and biomass were higher; income from wildlife was higher; income from livestock was lower; livestock biomass was lower; in conservancies; game fencing was absent; and financial losses from livestock depredation were lower. Efforts to create conditions whereby the costs associated with carnivores are lowest, and which confer financial value to them are likely to be the most effective means of promoting carnivore conservation. Such conditions are achieved where land owners pool land to create conservancies where livestock are replaced with wildlife (or where livestock husbandry is improved) and where wildlife generates a significant proportion of ranch income. Additional measures, such as promoting improved livestock husbandry and educational outreach efforts may also help achieve coexistence with carnivores. Our findings provide insights into conditions more conducive to the persistence of and tolerance towards large carnivores might be increased on private (and even communal) lands in Namibia, elsewhere in southern and East Africa and other parts of the world where carnivore conservation is being attempted on private lands.	[Lindsey, Peter Andrew; Havemann, Carl Peter; Retief, Tarryn Anne] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Lindsey, Peter Andrew] Panthera, New York, NY USA; [Lines, Robin] Namibian Nat Fdn, Windhoek, Namibia; [Price, Aaron Ernest] Nebraska Dept Environm Qual, Lincoln, NE USA; [Rhebergen, Tiemen] Wageningen Univ, Dept Plant Prod Syst, NL-6700 AP Wageningen, Netherlands; [Van der Waal, Cornelis] Vanderwaal & Associates Agriecol Serv, Omaruru, Namibia	University of Pretoria; Wageningen University & Research	Lindsey, PA (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	palindsey@gmail.com		Rhebergen, Tiemen/0000-0002-1175-8672	German Federal Ministry for Economic Cooperation and Development; African Wildlife Conservation Fund	German Federal Ministry for Economic Cooperation and Development; African Wildlife Conservation Fund	The authors thank TRAFFIC East/Southern Africa and Tom Milliken, and thank the German Federal Ministry for Economic Cooperation and Development and African Wildlife Conservation Fund for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beinart W, 1998, PAST PRESENT, P172; Casey Anne L., 2005, Human Dimensions of Wildlife, V10, P29, DOI 10.1080/10871200590904860; CHILDES SL, 1988, BIOL CONSERV, V44, P301, DOI 10.1016/0006-3207(88)90022-5; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Creel S., 2002, AFRICAN WILD DOG BEH; Davies-Mostert H, 2009, CRITICAL ASSESSMENT; Ericsson G, 2003, BIOL CONSERV, V111, P149, DOI 10.1016/S0006-3207(02)00258-6; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Gusset M, 2009, ORYX, V43, P67, DOI 10.1017/S0030605308990475; Hanks J., 2003, Journal of Sustainable Forestry, V17, P127, DOI 10.1300/J091v17n01_08; Hayward MW, 2007, ORYX, V41, P205, DOI 10.1017/S0030605307001767; Hemson G, 2009, BIOL CONSERV, V142, P2718, DOI 10.1016/j.biocon.2009.06.024; Hofer Heribert, 1996, P117; Holmern T, 2007, BIOL CONSERV, V135, P518, DOI 10.1016/j.biocon.2006.10.049; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; IUCN, 2007, REG CONS STRAT CHEET; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Kelly MJ, 1988, J ZOOL, V244, P473; Lagendijk DDG, 2008, ENVIRON MANAGE, V42, P971, DOI 10.1007/s00267-008-9204-5; Lindner J. R., 2002, J INT AGR EXTENSION, V9, P55; Lindsey P, 2011, ORYX, V45, P587, DOI 10.1017/S003060531000150X; Lindsey P., 2008, EVOLUTION INNOVATION, P163; Lindsey P, ORYX IN PRESS; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2005, BIOL CONSERV, V125, P113, DOI 10.1016/j.biocon.2005.03.015; Lindsey PA, 2005, BIOL CONSERV, V123, P339, DOI 10.1016/j.biocon.2004.12.002; Lindsey Peter A., 2007, Journal of Ecotourism, V6, P19, DOI 10.2167/joe133.0; Lindsey Peter A., 2009, P321, DOI 10.1002/9781444312034.ch15; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Marker Laurie, 2007, Cat News, P4; Marker Laurie, 2004, Human Dimensions of Wildlife, V9, P297, DOI 10.1080/10871200490505729; Marker LL, 2003, CONSERV BIOL, V17, P1290, DOI 10.1046/j.1523-1739.2003.02077.x; Marker LL, 2003, BIOL CONSERV, V114, P401, DOI 10.1016/S0006-3207(03)00068-5; Marnewick K., 2007, CAT NEWS, V3, P27; Marnewick Kelly, 2009, P282, DOI 10.1002/9781444312034.ch13; Mendelsohn J., 2006, FARMING SYSTEMS NAMI; Mills M.G.L., 1998, STATUS SURVEY CONSER; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Purchase G, 2007, CAT NEWS SI, VSI3, P44; Rasmussen GSA, 1999, BIOL CONSERV, V88, P133, DOI 10.1016/S0006-3207(98)00006-8; Ray J, 2005, SETTING CONSERVATION, P24; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Romanach SS, 2007, ORYX, V41, P185, DOI 10.1017/S0030605307001779; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; SAS Institute, 2000, JMPIN 4 0 2; Schumann M, 2008, S AFR J WILDL RES, V38, P123, DOI 10.3957/0379-4369-38.2.123; Stander F, 2005, REV CONFLICT HUMANS, P33; Stein AB, 2010, ANIM CONSERV, V13, P419, DOI 10.1111/j.1469-1795.2010.00364.x; Stein AB, 2011, AFR J ECOL, V49, P383, DOI 10.1111/j.1365-2028.2011.01267.x; Swanepoel LH, 2008, ECOLOGY CONSERVATION; Tempest K, 2011, STATUS CONSERVATION; Thorn M, 2012, BIOL CONSERV, V150, P23, DOI 10.1016/j.biocon.2012.02.017; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	59	37	37	2	194	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52458	10.1371/journal.pone.0052458	http://dx.doi.org/10.1371/journal.pone.0052458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326333	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500014
J	Thom, JM; Clayton, NS				Thom, James M.; Clayton, Nicola S.			Re-caching by Western Scrub-Jays (Aphelocoma californica) Cannot Be Attributed to Stress	PLOS ONE			English	Article							STRATEGIES; EVOLUTION; BEHAVIOR	Western scrub-jays (Aphelocoma californica) live double lives, storing food for the future while raiding the stores of other birds. One tactic scrub-jays employ to protect stores is "re-caching"-relocating caches out of sight of would-be thieves. Recent computational modelling work suggests that re-caching might be mediated not by complex cognition, but by a combination of memory failure and stress. The "Stress Model" asserts that re-caching is a manifestation of a general drive to cache, rather than a desire to protect existing stores. Here, we present evidence strongly contradicting the central assumption of these models: that stress drives caching, irrespective of social context. In Experiment (i), we replicate the finding that scrub-jays preferentially relocate food they were watched hiding. In Experiment (ii) we find no evidence that stress increases caching. In light of our results, we argue that the Stress Model cannot account for scrub-jay re-caching.	[Thom, James M.; Clayton, Nicola S.] Univ Cambridge, Dept Psychol, Cambridge, England	University of Cambridge	Clayton, NS (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	nsc22@cam.ac.uk		Clayton, Nicola/0000-0003-1835-423X	University of Cambridge; MRC doctoral training grant; BBSRC [BB/I000690/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000690/1] Funding Source: researchfish	University of Cambridge(University of Cambridge); MRC doctoral training grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Research was financially supported by the University of Cambridge. J. M. Thom was funded by an MRC doctoral training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Dally JM, 2006, ANIM BEHAV, V72, P13, DOI 10.1016/j.anbehav.2005.08.020; Dally JM, 2006, SCIENCE, V312, P1662, DOI 10.1126/science.1126539; de Kort SR, 2007, J EXP PSYCHOL ANIM B, V33, P361, DOI 10.1037/0097-7403.33.4.361; Emery NJ, 2009, ANNU REV PSYCHOL, V60, P87, DOI 10.1146/annurev.psych.60.110707.163526; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Emery NJ, 2004, ANIM COGN, V7, P37, DOI 10.1007/s10071-003-0178-7; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; van der Vaart E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032904; van der Vaart E, 2011, J EXP PSYCHOL-ANIM B, V37, P330, DOI 10.1037/a0022988; Watanabe S, 2007, J ETHOL, V25, P271, DOI 10.1007/s10164-006-0023-y	11	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52936	10.1371/journal.pone.0052936	http://dx.doi.org/10.1371/journal.pone.0052936			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326366	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500036
J	Sarabhai, S; Sharma, P; Capalash, N				Sarabhai, Sajal; Sharma, Prince; Capalash, Neena			Ellagic Acid Derivatives from Terminalia chebula Retz. Downregulate the Expression of Quorum Sensing Genes to Attenuate Pseudomonas aeruginosa PAO1 Virulence	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; BIOFILM FORMATION; MEDICINAL-PLANTS; CYSTIC-FIBROSIS; INHIBITORS; FRUITS; TRANSCRIPTION; STRAINS; TANNINS; GROWTH	Background: Burgeoning antibiotic resistance in Pseudomonas aeruginosa has necessitated the development of anti pathogenic agents that can quench acylhomoserine lactone (AHL) mediated QS with least risk of resistance. This study explores the anti quorum sensing potential of T. chebula Retz. and identification of probable compounds(s) showing anti QS activity and the mechanism of attenuation of P. aeruginosa PAO1 virulence factors. Methods and Results: Methanol extract of T. chebula Retz. fruit showed anti QS activity using Agrobacterium tumefaciens A136. Bioactive fraction (F7), obtained by fractionation of methanol extract using Sephadex LH20, showed significant reduction (p<0.001) in QS regulated production of extracellular virulence factors in P. aeruginosa PAO1. Biofilm formation and alginate were significantly (p<0.05) reduced with enhanced (20%) susceptibility to tobramycin. Real Time PCR of F7 treated P. aeruginosa showed down regulation of autoinducer synthase (lasI and rhlI) and their cognate receptor (lasR and rhlR) genes by 89, 90, 90 and 93%, respectively. Electrospray Ionization Mass Spectrometry also showed 90 and 64% reduction in the production of 3-oxo-C12HSL and C4HSL after treatment. Decrease in AHLs as one of the mechanisms of quorum quenching by F7 was supported by the reversal of inhibited swarming motility in F7-treated P. aeruginosa PAO1 on addition of C4HSL. F7 also showed antagonistic activity against 3-oxo-C12HSL-dependent QS in E. coli bioreporter. C. elegans fed on F7-treated P. aeruginosa showed enhanced survival with LT50 increasing from 24 to 72 h. LC-ESI-MS of F7 revealed the presence of ellagic acid derivatives responsible for anti QS activity in T. chebula extract. Conclusions: This is the first report on anti QS activity of T. chebula fruit linked to EADs which down regulate the expression of lasIR and rhlIR genes with concomitant decrease in AHLs in P. aeruginosa PAO1 causing attenuation of its virulence factors and enhanced sensitivity of its biofilm towards tobramycin.	[Sarabhai, Sajal; Sharma, Prince] Panjab Univ, Dept Microbiol, Chandigarh 160014, India; [Capalash, Neena] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India	Panjab University; Panjab University	Capalash, N (corresponding author), Panjab Univ, Dept Biotechnol, Chandigarh 160014, India.	caplash@pu.ac.in		Capalash, Neena/0000-0002-0197-8428	Council of Scientific and Industrial Research (CSIR) [09/135(0544)/2008-EMR-I]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Funding in the form of a fellowship to Sajal Sarabhai from the Council of Scientific and Industrial Research (CSIR) is acknowledged [Grant no: 09/135(0544)/2008-EMR-I]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonizio A, 2008, ANTIMICROB AGENTS CH, V52, P198, DOI 10.1128/AAC.00612-07; Adonizio AL, 2006, J ETHNOPHARMACOL, V105, P427, DOI 10.1016/j.jep.2005.11.025; Agarwal V, 2008, MYCOPATHOLOGIA, V165, P13, DOI 10.1007/s11046-007-9077-9; Amara N, 2009, J AM CHEM SOC, V131, P10610, DOI 10.1021/ja903292v; Anwesa Bag, 2009, African Journal of Plant Science, V3, P25; Babic F, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-148; Balasubramanian D, 2011, J MED MICROBIOL, V60, P147, DOI 10.1099/jmm.0.021600-0; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P3873, DOI 10.1099/mic.0.27955-0; Chalise JP, 2010, INT J FOOD SCI NUTR, V61, P425, DOI 10.3109/09637481003591590; Cheng HY, 2002, ANTIVIR RES, V55, P447, DOI 10.1016/S0166-3542(02)00077-3; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057, DOI 10.1128/JB.175.16.5057-5065.1993; Fuqua C, 1996, J BACTERIOL, V178, P435, DOI 10.1128/jb.178.2.435-440.1996; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gao H, 2008, BIOSCI BIOTECH BIOCH, V72, P601, DOI 10.1271/bbb.70591; Haagensen JAJ, 2007, J BACTERIOL, V189, P28, DOI 10.1128/JB.00720-06; Harborne J, 1973, PHYTOCHEMICALS METHO; Hentzer M, 2003, BIODRUGS, V17, P241, DOI 10.2165/00063030-200317040-00003; Hoang TT, 1999, MOL MICROBIOL, V45, P1655; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Huber B, 2003, Z NATURFORSCH C, V58, P879; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Jakobsen TH, 2012, APPL ENVIRON MICROB, V78, P2410, DOI 10.1128/AEM.05992-11; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Juang LJ, 2004, J SEP SCI, V27, P718, DOI 10.1002/jssc.200401741; Kannan P, 2009, AFR J MICROBIOL RES, V3, P180; Kaur Kamaljit, 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P45; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kociolek Martin G., 2009, Anti-Infective Agents in Medicinal Chemistry, V8, P315; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lee JH, 2006, MOL MICROBIOL, V59, P602, DOI 10.1111/j.1365-2958.2005.04960.x; Makemson J, 2006, LUMINESCENCE, V21, P1, DOI 10.1002/bio.873; Manefield M, 2002, MICROBIOL-SGM, V148, P1119, DOI 10.1099/00221287-148-4-1119; May CO, 2011, APPL ENVIRON MICROB, V77, P3061; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; MCCLURE CD, 1992, J LEUKOCYTE BIOL, V51, P97, DOI 10.1002/jlb.51.2.97; Miller JH., 1972, EXPT MOL GENETICS; Ni NT, 2009, MED RES REV, V29, P65, DOI 10.1002/med.20145; O'Donovan L, 2001, MICROBIOL-SGM, V147, P1025, DOI 10.1099/00221287-147-4-1025; Oncul O, 2009, INDIAN J MED RES, V130, P758; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Pfundstein B, 2010, PHYTOCHEMISTRY, V71, P1132, DOI 10.1016/j.phytochem.2010.03.018; Quave CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028737; Rambaugh KP, 2006, APPL ENVIRON MICROB, V72, P5135; Rasmussen TB, 2006, MICROBIOL-SGM, V152, P895, DOI 10.1099/mic.0.28601-0; Reddy DB, 2009, J ETHNOPHARMACOL, V124, P506, DOI 10.1016/j.jep.2009.05.022; Rudrappa T, 2008, J AGR FOOD CHEM, V56, P1955, DOI 10.1021/jf072591j; Sadlon AE, 2010, ALTERN MED REV, V15, P33; Saleem A, 2002, J ETHNOPHARMACOL, V81, P327, DOI 10.1016/S0378-8741(02)00099-5; Senturk S, 2012, J INFECT DEV COUNTR, V6, P501; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Shin TY, 2001, J ETHNOPHARMACOL, V74, P133, DOI 10.1016/S0378-8741(00)00360-3; Srikumar R, 2005, BIOL PHARM BULL, V28, P1398, DOI 10.1248/bpb.28.1398; Stehling EG, 2008, BRAZ J INFECT DIS, V12, P86, DOI 10.1590/S1413-86702008000100018; Suguna L, 2002, PHYTOTHER RES, V16, P227, DOI 10.1002/ptr.827; Taganna JC, 2011, J ETHNOPHARMACOL, V134, P865, DOI 10.1016/j.jep.2011.01.028; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Vattem DA, 2005, ASIA PAC J CLIN NUTR, V14, P120; Wang EW, 2005, ARCH OTOLARYNGOL, V131, P983, DOI 10.1001/archotol.131.11.983; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002; Zahin M, 2010, INDIAN J EXP BIOL, V48, P1219; Zhu H, 2002, J MED MICROBIOL, V51, P1063, DOI 10.1099/0022-1317-51-12-1063	66	139	148	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53441	10.1371/journal.pone.0053441	http://dx.doi.org/10.1371/journal.pone.0053441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320085	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429800050
J	Vecile, E; Dobrina, A; Salloum, FN; Van Tassell, BW; Falcione, A; Gustini, E; Secchiero, S; Crovella, S; Sinagra, G; Finato, N; Nicklin, MJ; Abbate, A				Vecile, Elena; Dobrina, Aldo; Salloum, Fadi N.; Van Tassell, Benjamin W.; Falcione, Antonella; Gustini, Edoardo; Secchiero, Samuele; Crovella, Sergio; Sinagra, Gianfranco; Finato, Nicoletta; Nicklin, Martin J.; Abbate, Antonio			Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CYTOCHROME-C RELEASE; IN-VIVO; AUTOINFLAMMATORY DISEASE; CASPASE ACTIVATION; GENE-EXPRESSION; IAP PROTEINS; APOPTOSIS; INHIBITION; CELLS	Background: Loss of cardiac myocytes due to apoptosis is a relevant feature of ischemic heart disease. It has been described in infarct and peri-infarct regions of the myocardium in coronary syndromes and in ischemia-linked heart remodeling. Previous studies have provided protection against ischemia-induced cardiomyocyte apoptosis by the anti-inflammatory cytokine interleukin-1 receptor-antagonist (IL-1Ra). Mitochondria triggering of caspases plays a central role in ischemia-induced apoptosis. We examined the production of IL-1Ra in the ischemic heart and, based on dual intra/extracellular function of some other interleukins, we hypothesized that IL-1Ra may also directly inhibit mitochondria-activated caspases and cardiomyocyte apoptosis. Methodology/Principal Findings: Synthesis of IL-1Ra was evidenced in the hearts explanted from patients with ischemic heart disease. In the mouse ischemic heart and in a mouse cardiomyocyte cell line exposed to long-lasting hypoxia, IL-1Ra bound and inhibited mitochondria-activated caspases, whereas inhibition of caspase activation was not observed in the heart of mice lacking IL-1Ra (Il-1ra-/-) or in siRNA to IL-1Ra-interfered cells. An impressive 6-fold increase of hypoxia-induced apoptosis was observed in cells lacking IL-1Ra. IL-1Ra down-regulated cells were not protected against caspase activation and apoptosis by knocking down of the IL-1 receptor, confirming the intracellular, receptor-independent, antiapoptotic function of IL-1Ra. Notably, the inhibitory effect of IL-1Ra was not influenced by enduring ischemic conditions in which previously described physiologic inhibitors of apoptosis are neutralized. Conclusions/Significance: These observations point to intracellular IL-1Ra as a critical mechanism of the cell self-protection against ischemia-induced apoptosis and suggest that this cytokine plays an important role in the remodeling of heart by promoting survival of cardiomyocytes in the ischemic regions.	[Vecile, Elena; Dobrina, Aldo; Falcione, Antonella; Gustini, Edoardo; Secchiero, Samuele] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy; [Salloum, Fadi N.; Van Tassell, Benjamin W.; Abbate, Antonio] Virginia Commonwealth Univ, Victoria Johnson Res Lab, Richmond, VA USA; [Salloum, Fadi N.; Van Tassell, Benjamin W.; Abbate, Antonio] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA; [Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Sinagra, Gianfranco] Univ Trieste, Cardiovasc Dept, I-34127 Trieste, Italy; [Finato, Nicoletta] Univ Udine, Dept Med & Morphol Res, I-33100 Udine, Italy; [Nicklin, Martin J.] Univ Sheffield, Sir Henry Wellcome Labs Med Res, Div Genom Med, Sheffield S10 2TN, S Yorkshire, England	University of Trieste; Virginia Commonwealth University; Virginia Commonwealth University; IRCCS Burlo Garofolo; University of Trieste; University of Udine; University of Sheffield	Dobrina, A (corresponding author), Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.	dobrina@units.it	Crovella, Sergio/K-5050-2016; Sinagra, Gianfranco/AAE-3943-2020; sinagra, gianfranco gs/P-7643-2014; Abbate, Antonio/G-8805-2016; Salloum, Fadi N/C-2391-2008; Abbate, Antonio/E-3405-2014	Crovella, Sergio/0000-0001-8493-1168; Abbate, Antonio/0000-0002-1930-785X; Salloum, Fadi N/0000-0002-8947-9315; SINAGRA, GIANFRANCO/0000-0003-2700-8478; Nicklin, Martin/0000-0002-0127-1131; Dobrina, Aldo/0000-0002-8393-1796	Italian Ministero dell'Universita e della Ricerca; American Heart Association;  [KL2RR031989-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031989] Funding Source: NIH RePORTER	Italian Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); American Heart Association(American Heart Association); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funds of the Italian Ministero dell'Universita e della Ricerca and by an American Heart Association Beginning Grant-in-Aid (Mid-Atlantic Affiliate) to AA. FNS is supported by an American Heart Association Scientist Development Grant. BWVT is supported by an institutional KL2RR031989-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2005, EUR HEART J, V26, P2039, DOI 10.1093/eurheartj/ehi419; Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Abbate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027923; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; AREND WP, 1991, J CLIN INVEST, V88, P1445, DOI 10.1172/JCI115453; Banda NK, 2005, J IMMUNOL, V174, P3608, DOI 10.4049/jimmunol.174.6.3608; Biasucci LM, 1999, CIRCULATION, V99, P2079, DOI 10.1161/01.CIR.99.16.2079; Boniotto M, 2003, EUR J HISTOCHEM, V47, P177; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cortes A, 2001, BIOCHEM J, V357, P263, DOI 10.1042/0264-6021:3570263; de Moissac D, 2000, J MOL CELL CARDIOL, V32, P53, DOI 10.1006/jmcc.1999.1057; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Ekhterae D, 1999, CIRC RES, V85, pE70; Gabay C, 1997, J IMMUNOL, V159, P5905; Gabay C, 1999, CYTOKINE, V11, P561, DOI 10.1006/cyto.1998.0451; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Patti G, 2004, J AM COLL CARDIOL, V43, P35, DOI 10.1016/j.jacc.2003.07.032; Recchia AG, 2009, J MOL CELL CARDIOL, V46, P352, DOI 10.1016/j.yjmcc.2008.11.017; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Suzuki K, 2001, CIRCULATION, V104, pI308; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	39	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53265	10.1371/journal.pone.0053265	http://dx.doi.org/10.1371/journal.pone.0053265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308180	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000313429800035
J	Verdurand, M; Fillman, SG; Weickert, CS; Zavitsanou, K				Verdurand, Mathieu; Fillman, Stu G.; Weickert, Cynthia Shannon; Zavitsanou, Katerina			Increases in [H-3]Muscimol and [H-3]Flumazenil Binding in the Dorsolateral Prefrontal Cortex in Schizophrenia Are Linked to alpha 4 and gamma 2S mRNA Levels Respectively	PLOS ONE			English	Article							BENZODIAZEPINE-RECEPTOR-BINDING; AMINOBUTYRIC ACID(A) RECEPTORS; GABA(A) RECEPTOR; A RECEPTOR; GENE-EXPRESSION; HIPPOCAMPAL-FORMATION; NEUROTROPHIC FACTOR; CORTICAL GABA(A); POSTMORTEM-BRAIN; CINGULATE CORTEX	Background: GABA(A) receptors (GABA(A)R) are composed of several subunits that determine sensitivity to drugs, synaptic localisation and function. Recent studies suggest that agonists targeting selective GABA(A)R subunits may have therapeutic value against the cognitive impairments observed in schizophrenia. In this study, we determined whether GABA(A)R binding deficits exist in the dorsolateral prefrontal cortex (DLPFC) of people with schizophrenia and tested if changes in GABA(A)R binding are related to the changes in subunit mRNAs. The GABA orthosteric and the benzodiazepine allosteric binding sites were assessed autoradiographically using [H-3]Muscimol and [H-3]Flumazenil, respectively, in a large cohort of individuals with schizophrenia (n = 37) and their matched controls (n = 37). We measured, using qPCR, mRNA of beta (beta 1, beta 2, beta 3), gamma (gamma 1, gamma 2, gamma 2S for short and gamma 2L for long isoform, gamma 3) and delta subunits and used our previous measurements of GABA(A)R alpha subunit mRNAs in order to relate mRNAs and binding through correlation and regression analysis. Results: Significant increases in both [H-3]Muscimol (p = 0.016) and [H-3]Flumazenil (p = 0.012) binding were found in the DLPFC of schizophrenia patients. Expression levels of mRNA subunits measured did not show any significant difference in schizophrenia compared to controls. Regression analysis revealed that in schizophrenia, the [H-3]Muscimol binding variance was most related to alpha 4 mRNA levels and the [H-3]Flumazenil binding variance was most related to gamma 2S subunit mRNA levels. [H-3]Muscimol and [H-3]Flumazenil binding were not affected by the lifetime anti-psychotics dose (chlorpromazine equivalent). Conclusions: We report parallel increases in orthosteric and allosteric GABA(A)R binding sites in the DLPFC in schizophrenia that may be related to a "shift" in subunit composition towards alpha 4 and gamma 2S respectively, which may compromise normal GABAergic modulation and function. Our results may have implications for the development of treatment strategies that target specific GABA(A)R receptor subunits.	[Verdurand, Mathieu; Fillman, Stu G.; Weickert, Cynthia Shannon; Zavitsanou, Katerina] Schizophrenia Res Inst, Sydney, NSW, Australia; [Fillman, Stu G.; Weickert, Cynthia Shannon; Zavitsanou, Katerina] Neurosci Res Australia, Sydney, NSW, Australia; [Fillman, Stu G.; Weickert, Cynthia Shannon; Zavitsanou, Katerina] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Verdurand, Mathieu] Australian Nucl Sci & Technol Org, ANSTO LifeSci, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Australian Nuclear Science & Technology Organisation	Zavitsanou, K (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	k.zavitsanou@neura.edu.au	Zavitsanou, Katerina/G-5936-2012	Shannon Weickert, Cynthia/0000-0002-4560-0259; Verdurand, Mathieu/0000-0003-2619-3907	Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales, and Neuroscience Research Australia; National Health and Medical Research Council of Australia; National Institute of Alcohol Abuse and Alcoholism [R24AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725, R28AA012725] Funding Source: NIH RePORTER	Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales, and Neuroscience Research Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Schizophrenia Research Institute (utilising infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. The New South Wales Tissue Resource Centre at the University of Sydney is supported by the National Health and Medical Research Council of Australia, Schizophrenia Research Institute, and National Institute of Alcohol Abuse and Alcoholism (grant number R24AA012725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1999, NEUROPSYCHOPHARMACOL, V20, P650, DOI 10.1016/S0893-133X(98)00107-9; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Baer K, 2000, EUR J NEUROSCI, V12, P2639, DOI 10.1046/j.1460-9568.2000.00159.x; Ball S, 1998, BIOL PSYCHIAT, V43, P107, DOI 10.1016/S0006-3223(97)00300-4; Benes FM, 1996, NEUROSCIENCE, V75, P1021, DOI 10.1016/0306-4522(96)00328-4; BENES FM, 1992, J NEUROSCI, V12, P924; Benes FM, 1996, SYNAPSE, V22, P338; Benes FM, 1997, BRAIN RES, V755, P121, DOI 10.1016/S0006-8993(97)00113-3; Beneyto M, 2011, CEREB CORTEX, V21, P999, DOI 10.1093/cercor/bhq169; Boileau AJ, 2010, J NEUROSCI, V30, P4895, DOI 10.1523/JNEUROSCI.5039-09.2010; Busatto GF, 1997, AM J PSYCHIAT, V154, P56; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Daskalakis ZJ, 2007, BRAIN RES REV, V56, P427, DOI 10.1016/j.brainresrev.2007.09.006; Dean B, 1999, J NEUROCHEM, V72, P1593, DOI 10.1046/j.1471-4159.1999.721593.x; Deng C, 2006, EXP BRAIN RES, V168, P587, DOI 10.1007/s00221-005-0290-9; Duncan CE, 2010, J PSYCHIATR RES, V44, P673, DOI 10.1016/j.jpsychires.2009.12.007; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fatemi SH, 2010, J AUTISM DEV DISORD, V40, P743, DOI 10.1007/s10803-009-0924-z; Fillman SG, 2010, INT J DEV NEUROSCI, V28, P513, DOI 10.1016/j.ijdevneu.2010.05.004; Flynn G, 2008, SCHIZOPHR RES, V105, P262, DOI 10.1016/j.schres.2008.05.029; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; HANADA S, 1987, LIFE SCI, V40, P259, DOI 10.1016/0024-3205(87)90341-9; Hand KSP, 1997, BRIT J PHARMACOL, V122, P358, DOI 10.1038/sj.bjp.0701365; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; HARPER CG, 1988, J NEUROL NEUROSUR PS, V51, P124, DOI 10.1136/jnnp.51.1.124; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; Haw C, 2007, J PSYCHOPHARMACOL, V21, P645, DOI 10.1177/0269881106072386; HERB A, 1992, P NATL ACAD SCI USA, V89, P1433, DOI 10.1073/pnas.89.4.1433; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Huntsman MM, 1998, P NATL ACAD SCI USA, V95, P15066, DOI 10.1073/pnas.95.25.15066; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Kellendonk C, 2009, TRENDS NEUROSCI, V32, P347, DOI 10.1016/j.tins.2009.02.003; KIUCHI Y, 1989, EUR ARCH PSY CLIN N, V239, P71, DOI 10.1007/BF01759578; Knoflach F, 1996, MOL PHARMACOL, V50, P1253; Lewis DA, 2008, NEUROTOX RES, V14, P237, DOI 10.1007/BF03033813; LUDDENS H, 1994, MOL PHARMACOL, V45, P810; McLeod MC, 2010, PSYCHIAT RES, V179, P139, DOI 10.1016/j.psychres.2009.03.034; Newell KA, 2007, PROG NEURO-PSYCHOPH, V31, P225, DOI 10.1016/j.pnpbp.2006.07.004; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; OWEN F, 1981, ACTA PSYCHIAT SCAND, V63, P20, DOI 10.1111/j.1600-0447.1981.tb02455.x; Pandey GN, 1997, PSYCHIAT RES, V71, P137, DOI 10.1016/S0165-1781(97)00060-7; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; SANNA E, 1995, J PHARMACOL EXP THER, V274, P353; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Strous RD, 2007, PSYCHONEUROENDOCRINO, V32, P96, DOI 10.1016/j.psyneuen.2006.11.002; Vinkers CH, 2010, EXPERT OPIN INV DRUG, V19, P1217, DOI 10.1517/13543784.2010.513382; Volk DW, 2002, CEREB CORTEX, V12, P1063, DOI 10.1093/cercor/12.10.1063; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; WOLKOWITZ OM, 1991, AM J PSYCHIAT, V148, P714; Wong J, 2010, NEUROSCIENCE, V169, P1071, DOI 10.1016/j.neuroscience.2010.05.037; Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341; YMER S, 1990, EMBO J, V9, P3261, DOI 10.1002/j.1460-2075.1990.tb07525.x	58	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52724	10.1371/journal.pone.0052724	http://dx.doi.org/10.1371/journal.pone.0052724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320076	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429800018
J	Dillen, S; Zels, S; Verlinden, H; Spit, J; Van Wielendaele, P; Vanden Broeck, J				Dillen, Senne; Zels, Sven; Verlinden, Heleen; Spit, Jornt; Van Wielendaele, Pieter; Vanden Broeck, Jozef			Functional Characterization of the Short Neuropeptide F Receptor in the Desert Locust, Schistocerca gregaria	PLOS ONE			English	Article							PROTEIN COUPLED RECEPTORS; FOOD-INTAKE; NEUROHORMONE GPCRS; GENE-EXPRESSION; BEHAVIOR; PEPTIDES; MOSQUITO; DEPENDS; NEURONS; GENOME	Whereas short neuropeptide F (sNPF) has already been reported to stimulate feeding behaviour in a variety of insect species, the opposite effect was observed in the desert locust. In the present study, we cloned a G protein-coupled receptor (GPCR) cDNA from the desert locust, Schistocerca gregaria. Cell-based functional analysis of this receptor indicated that it is activated by both known isoforms of Schgr-sNPF in a concentration dependent manner, with EC50 values in the nanomolar range. This Schgr-sNPF receptor constitutes the first functionally characterized peptide GPCR in locusts. The in vivo effects of the sNPF signalling pathway on the regulation of feeding in locusts were further studied by knocking down the newly identified Schgr-sNPF receptor by means of RNA interference, as well as by means of peptide injection studies. While injection of sNPF caused an inhibitory effect on food uptake in the desert locust, knocking down the corresponding peptide receptor resulted in an increase of total food uptake when compared to control animals. This is the first comprehensive study in which a clearly negative correlation is described between the sNPF signalling pathway and feeding, prompting a reconsideration of the diverse roles of sNPFs in the physiology of insects.	[Dillen, Senne; Zels, Sven; Verlinden, Heleen; Spit, Jornt; Van Wielendaele, Pieter; Vanden Broeck, Jozef] Katholieke Univ Leuven, Dept Biol, Louvain, Belgium	KU Leuven	Vanden Broeck, J (corresponding author), Katholieke Univ Leuven, Dept Biol, Louvain, Belgium.	jozef.vandenbroeck@bio.kuleuven.be	Verlinden, Heleen/D-1033-2011	Verlinden, Heleen/0000-0001-6721-3973; Van Wielendaele, Pieter/0000-0003-1492-6165; Vanden Broeck, Jozef/0000-0001-7653-0516	KU Leuven Research Foundation [GOA/11/02]; Research Foundation of Flanders (FWO-Flanders); Interuniversity Attraction Poles program (Belgian Science Policy) [IAP P6/14]; Agency for Innovation by Science and Technology (IWT)	KU Leuven Research Foundation; Research Foundation of Flanders (FWO-Flanders)(FWO); Interuniversity Attraction Poles program (Belgian Science Policy)(Belgian Federal Science Policy Office); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the KU Leuven Research Foundation (Grant GOA/11/02, www.kuleuven.be/bof), the Research Foundation of Flanders (FWO-Flanders, www.fwo.be) and the Interuniversity Attraction Poles program (Belgian Science Policy, Grant IAP P6/14, www.belspo.be). SZ and JS were supported by a scholarship from the Agency for Innovation by Science and Technology (IWT, www.iwt.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; Badisco L, 2011, PLOS ONE, V6, pe17274; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; BROWN MR, 1994, J INSECT PHYSIOL, V40, P399, DOI 10.1016/0022-1910(94)90158-9; Chen ME, 2006, ARCH INSECT BIOCHEM, V61, P195, DOI 10.1002/arch.20103; Clynen E, 2009, INSECT BIOCHEM MOLEC, V39, P491, DOI 10.1016/j.ibmb.2009.06.001; Clynen E, 2009, ANN NY ACAD SCI, V1163, P60, DOI 10.1111/j.1749-6632.2008.03624.x; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Garczynski SF, 2007, PEPTIDES, V28, P109, DOI 10.1016/j.peptides.2006.09.019; Gazi L, 1999, BRIT J PHARMACOL, V128, P613, DOI 10.1038/sj.bjp.0702849; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huang YQ, 2011, PEPTIDES, V32, P483, DOI 10.1016/j.peptides.2010.09.014; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Huybrechts J, 2004, BIOCHEM BIOPH RES CO, V317, P909, DOI 10.1016/j.bbrc.2004.03.136; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Kahsai L, 2010, J EXP BIOL, V213, P2256, DOI 10.1242/jeb.043190; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HL, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-57; McDonald J, 2003, BRIT J PHARMACOL, V140, P61, DOI 10.1038/sj.bjp.0705401; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Mikani A, 2012, PEPTIDES, V34, P135, DOI 10.1016/j.peptides.2011.10.028; Nagata Shinji, 2012, Front Endocrinol (Lausanne), V3, P3, DOI 10.3389/fendo.2012.00003; Nagata S, 2011, GEN COMP ENDOCR, V172, P90, DOI 10.1016/j.ygcen.2011.03.004; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Ons S, 2011, INSECT MOL BIOL, V20, P29, DOI 10.1111/j.1365-2583.2010.01050.x; Poels J, 2005, PEPTIDES, V26, P109, DOI 10.1016/j.peptides.2004.07.015; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Schoofs L, 2001, PEPTIDES, V22, P219, DOI 10.1016/S0196-9781(00)00385-5; Spit J, 2012, CAN J ZOOL, V90, P489, DOI 10.1139/Z2012-014; Spit J, 2012, PEPTIDES, V34, P251, DOI 10.1016/j.peptides.2011.06.019; Van Wielendaele P, 2013, INSECT BIOCHEM MOLEC, V43, P102, DOI 10.1016/j.ibmb.2012.10.002; Van Wielendaele P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031425; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Wei Z, 2000, J INSECT PHYSIOL, V46, P1259, DOI 10.1016/S0022-1910(00)00046-9; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048	42	42	43	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53604	10.1371/journal.pone.0053604	http://dx.doi.org/10.1371/journal.pone.0053604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308260	Green Published, gold			2022-12-27	WOS:000313670100050
J	Zhang, F; Gao, B; Xu, LD; Li, CQ; Hao, DP; Zhang, SJ; Zhou, M; Su, F; Chen, X; Zhi, H; Li, X				Zhang, Fan; Gao, Bo; Xu, Liangde; Li, Chunquan; Hao, Dapeng; Zhang, Shaojun; Zhou, Meng; Su, Fei; Chen, Xi; Zhi, Hui; Li, Xia			Allele-Specific Behavior of Molecular Networks: Understanding Small-Molecule Drug Response in Yeast	PLOS ONE			English	Article							LARGE GENE LISTS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; GENOME ORGANIZATION; EXPRESSION NETWORKS; PLASMA-MEMBRANE; COMPLEX TRAITS; DISEASE; ARABIDOPSIS; DISCOVERY	The study of systems genetics is changing the way the genetic and molecular basis of phenotypic variation, such as disease susceptibility and drug response, is being analyzed. Moreover, systems genetics aids in the translation of insights from systems biology into genetics. The use of systems genetics enables greater attention to be focused on the potential impact of genetic perturbations on the molecular states of networks that in turn affects complex traits. In this study, we developed models to detect allele-specific perturbations on interactions, in which a genetic locus with alternative alleles exerted a differing influence on an interaction. We utilized the models to investigate the dynamic behavior of an integrated molecular network undergoing genetic perturbations in yeast. Our results revealed the complexity of regulatory relationships between genetic loci and networks, in which different genetic loci perturb specific network modules. In addition, significant within-module functional coherence was found. We then used the network perturbation model to elucidate the underlying molecular mechanisms of individual differences in response to 100 diverse small molecule drugs. As a result, we identified sub-networks in the integrated network that responded to variations in DNA associated with response to diverse compounds and were significantly enriched for known drug targets. Literature mining results provided strong independent evidence for the effectiveness of these genetic perturbing networks in the elucidation of small-molecule responses in yeast.	[Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Li, X (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	lixia@hrbmu.edu.cn	Li, Chunquan/AAI-1072-2020; li, xia/HHZ-7468-2022; Zhou, Meng/G-7674-2011	Li, Chunquan/0000-0002-4700-5496; Zhou, Meng/0000-0001-9987-9024	National Natural Science Foundation of China [31200998, 61170154, 61073136]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307110022, 20102307120027]; Science Foundation of Heilongjiang Province [ZD200816-01]; Science Foundation of Heilongjiang Province Education Department [11541137, 12511273]; Science Foundation of Heilongjiang Provincial Health Department [2011-249]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Foundation of Heilongjiang Province; Science Foundation of Heilongjiang Province Education Department; Science Foundation of Heilongjiang Provincial Health Department	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 31200998, 61170154 and 61073136), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant Nos. 20102307110022 and 20102307120027), the Science Foundation of Heilongjiang Province (Grant Nos. ZD200816-01), the Science Foundation of Heilongjiang Province Education Department (Grant Nos. 11541137 and 12511273), and the Science Foundation of Heilongjiang Provincial Health Department (Grant Nos. 2011-249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Amoroso F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.105; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker KG, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-61; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyer A, 2006, PLOS COMPUT BIOL, V2, P615, DOI 10.1371/journal.pcbi.0020070; Bon C, 2007, ANN BIOL CLIN-PARIS, V65, P609, DOI 10.1684/abc.2007.0168; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chan EKF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001198; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; del Sol A, 2010, CURR OPIN BIOTECH, V21, P566, DOI 10.1016/j.copbio.2010.07.010; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Ertekin-Taner N, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-31; Folmer V, 2008, BBA-BIOMEMBRANES, V1778, P1141, DOI 10.1016/j.bbamem.2007.12.008; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Gelis S, 2012, MICROBIOLOGYOPEN, V1, P182, DOI 10.1002/mbo3.23; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ito A, 2011, J RADIAT RES, V52, P342, DOI 10.1269/jrr.10151; Kamolrat T, 2012, EUR J NUTR; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Kawahata M, 2006, FEMS YEAST RES, V6, P924, DOI 10.1111/j.1567-1364.2006.00089.x; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Kim HS, 2007, P NATL ACAD SCI USA, V104, P19387, DOI 10.1073/pnas.0708194104; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000587; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Kliebenstein DJ, 2009, METHODS MOL BIOL, V553, P227, DOI 10.1007/978-1-60327-563-7_11; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Lan H, 2006, PLOS GENET, V2, P51, DOI 10.1371/journal.pgen.0020006; Law BK, 2005, CRIT REV ONCOL HEMAT, V56, P47, DOI 10.1016/j.critrevonc.2004.09.009; Le Morvan V, 2006, PHARMACOGENOMICS, V7, P843, DOI 10.2217/14622416.7.6.843; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Maynard ND, 2008, NAT METHODS, V5, P307, DOI [10.1038/NMETH.1194, 10.1038/nmeth.1194]; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Owsianik G, 2002, MOL MICROBIOL, V43, P1295, DOI 10.1046/j.1365-2958.2002.02823.x; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pedroso N, 2009, FREE RADICAL BIO MED, V46, P289, DOI 10.1016/j.freeradbiomed.2008.10.039; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Rachlin J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100103; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Ruderfer DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006907; Saez-Vasquez J, 2010, MOL PLANT, V3, P678, DOI 10.1093/mp/ssq034; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Sharifpoor S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r39; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Tamura KI, 2004, J BIOSCI BIOENG, V98, P159, DOI 10.1016/S1389-1723(04)00260-9; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058; Zou F, 2010, NEUROLOGY, V74, P480, DOI 10.1212/WNL.0b013e3181d07654; Zunino SJ, 2007, CANCER LETT, V254, P119, DOI 10.1016/j.canlet.2007.03.002	73	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53581	10.1371/journal.pone.0053581	http://dx.doi.org/10.1371/journal.pone.0053581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308257	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100049
J	Suzuki, M; Yoshimine, H; Harada, Y; Tsuchiya, N; Shimada, I; Ariyoshi, K; Inoue, K				Suzuki, Motoi; Yoshimine, Hiroyuki; Harada, Yoshitaka; Tsuchiya, Naho; Shimada, Ikumi; Ariyoshi, Koya; Inoue, Kenichiro			Estimating the Influenza Vaccine Effectiveness against Medically Attended Influenza in Clinical Settings: A Hospital-Based Case-Control Study with a Rapid Diagnostic Test in Japan	PLOS ONE			English	Article							AUSTRALIA; EFFICACY; DESIGNS; VIRUS	Background: Influenza vaccine effectiveness (VE) studies are usually conducted by specialized agencies and require time and resources. The objective of this study was to estimate the influenza VE against medically attended influenza using a test-negative case-control design with rapid influenza diagnostic tests (RIDT) in a clinical setting. Methods: A prospective study was conducted at a community hospital in Nagasaki, western Japan during the 2010/11 influenza season. All outpatients aged 15 years and older with influenza-like illnesses (ILI) who had undergone RIDT were enrolled. A test-negative case-control design was applied to estimate the VEs: the cases were ILI patients with positive RIDT results and the controls were ILI patients with negative RIDT results. Information on patient characteristics, including vaccination histories, was collected using questionnaires and medical records. Results: Between December 2010 and April 2011, 526 ILI patients were tested with RIDT, and 476 were eligible for the analysis. The overall VE estimate against medically attended influenza was 47.6%, after adjusting for the patients' age groups, presence of chronic conditions, month of visit, and smoking and alcohol use. The seasonal influenza vaccine reduced the risk of medically attended influenza by 60.9% for patients less than 50 years of age, but a significant reduction was not observed for patients 50 years of age and older. A sensitivity analysis provided similar figures. Conclusion: The test-negative case-control study using RIDT provided moderate influenza VE consistent with other reports. Utilizing the commonly used RIDT to estimate VE provides rapid assessment of VE; however, it may require validation with more specific endpoint.	[Suzuki, Motoi; Harada, Yoshitaka; Tsuchiya, Naho; Shimada, Ikumi; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Yoshimine, Hiroyuki; Harada, Yoshitaka; Inoue, Kenichiro] Inoue Hosp, Nagasaki, Japan	Nagasaki University	Ariyoshi, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan.	kari@nagasaki-u.ac.jp		Suzuki, Motoi/0000-0002-8340-0880	"Improvement of Research Environment for Young Researchers" program	"Improvement of Research Environment for Young Researchers" program	Funding: This work was supported by the "Improvement of Research Environment for Young Researchers" program organized by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Castilla J, 2011, EURO SURVEILL, V16; Center IDS, 2011, 2010 11 INFL SEAS; Cheng AC, 2011, VACCINE, V29, P7320, DOI 10.1016/j.vaccine.2011.07.087; Chu H, 2011, INFLUENZA OTHER RESP; Diseases NESoV-P, 2010, AGE DISTRIBUTION INF; Ferdinands JM, 2011, CLIN INFECT DIS; Fielding JE, 2011, EMERG INFECT DIS, V17, P1181, DOI 10.3201/eid1707.101959; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Katayose M, 2011, VACCINE, V29, P1844, DOI 10.1016/j.vaccine.2010.12.049; Mahmud S, 2011, VACCINE, V29, P7975, DOI 10.1016/j.vaccine.2011.08.068; Michiels B, 2011, VACCINE, V29, P9159, DOI 10.1016/j.vaccine.2011.08.008; Ministry of Health LaW Japan, 2010, VACC PAND INFL A H1N; Mori M, 2008, VACCINE, V26, P6459, DOI 10.1016/j.vaccine.2008.06.040; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; NESVPD, 2011, AG DISTR INFL VACC H; Nishiura H, 2011, EMERG INFECT DIS, V17, P746, DOI [10.3201/eid1704.100525, 10.3201/eid1706.100525]; Ochiai H, 2009, VACCINE, V27, P7031, DOI 10.1016/j.vaccine.2009.09.067; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Osterholm MT, 2011, LANCET INFECT DIS; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Steens A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-196; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Valenciano M, 2010, VACCINE, V28, P7381, DOI 10.1016/j.vaccine.2010.09.010	35	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52103	10.1371/journal.pone.0052103	http://dx.doi.org/10.1371/journal.pone.0052103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326324	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800013
J	Duarte, M; Wang, LL; Calderwood, MA; Adelmant, G; Ohashi, M; Roecklein-Canfield, J; Marto, JA; Hill, DE; Deng, HY; Johannsen, E				Duarte, Melissa; Wang, Lili; Calderwood, Michael A.; Adelmant, Guillaume; Ohashi, Makoto; Roecklein-Canfield, Jennifer; Marto, Jarrod A.; Hill, David E.; Deng, Hongyu; Johannsen, Eric			An RS Motif within the Epstein-Barr Virus BLRF2 Tegument Protein Is Phosphorylated by SRPK2 and Is Important for Viral Replication	PLOS ONE			English	Article							MURINE GAMMAHERPESVIRUS-68; GENE-EXPRESSION; SM PROTEIN; KINASES; SEQUENCE; ORF52; IDENTIFICATION; HERPESVIRUS; ENRICHMENT; INHIBITION	Epstein-Barr virus (EBV) is a gammaherpesvirus that causes infectious mononucleosis, B cell lymphomas, and nasopharyngeal carcinoma. Many of the genes required for EBV virion morphogenesis are found in all herpesviruses, but some are specific to gammaherpesviruses. One of these gamma-specific genes, BLRF2, encodes a tegument protein that has been shown to be essential for replication in other gammaherpesviruses. In this study, we identify BLRF2 interacting proteins using binary and co-complex protein assays. Serine/Arginine-rich Protein Kinase 2 (SRPK2) was identified by both assays and was further shown to phosphorylate an RS motif in the BLRF2 C-terminus. Mutation of this RS motif (S148A+S150A) abrogated the ability of BLRF2 to support replication of a murine gammaherpesvirus 68 genome lacking the BLRF2 homolog (ORF52). We conclude that the BLRF2 RS motif is phosphorylated by SRPK2 and is important for viral replication.	[Duarte, Melissa; Calderwood, Michael A.; Johannsen, Eric] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; [Duarte, Melissa; Calderwood, Michael A.; Roecklein-Canfield, Jennifer; Hill, David E.] Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; [Duarte, Melissa; Calderwood, Michael A.; Roecklein-Canfield, Jennifer; Hill, David E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Wang, Lili; Deng, Hongyu] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Calderwood, Michael A.; Hill, David E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Adelmant, Guillaume; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Dept Canc Biol, Boston, MA 02115 USA; [Adelmant, Guillaume; Marto, Jarrod A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ohashi, Makoto; Johannsen, Eric] Univ Wisconsin, Dept Med, Madison, WI USA; [Roecklein-Canfield, Jennifer] Simmons Coll, Dept Chem & Phys, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Chinese Academy of Sciences; Institute of Biophysics, CAS; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Simmons University	Johannsen, E (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.	ejohannsen@medicine.wisc.edu	Calderwood, Mike/B-2475-2014; Wang, Lili/AAJ-8511-2020; Hill, David E/B-6617-2011	Calderwood, Mike/0000-0001-6475-1418; Wang, Lili/0000-0002-8315-531X; 	Center of Excellence in Genomic Science (CEGS) grant from the National Human Genome Research Institute (NHGRI) [P50HG004233]; Howard Hughes Medical Institute Physician-Scientist Early Career Award; National Natural Science Foundation of China [30930007, 81171582]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233] Funding Source: NIH RePORTER	Center of Excellence in Genomic Science (CEGS) grant from the National Human Genome Research Institute (NHGRI); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Melissa Duarte was post-baccalaureate trainee as part of a Center of Excellence in Genomic Science (CEGS) grant P50HG004233 from the National Human Genome Research Institute (NHGRI) awarded to Marc Vidal (PI). Eric Johannsen is the recipient of a Howard Hughes Medical Institute Physician-Scientist Early Career Award. Part of the research was supported by grants No. 30930007 and 81171582 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askenazi M, 2010, PROTEOMICS, V10, P1880, DOI 10.1002/pmic.200900723; Benach J, 2007, J BIOL CHEM, V282, P31534, DOI 10.1074/jbc.M705637200; Bortz E, 2007, J VIROL, V81, P10137, DOI 10.1128/JVI.01233-06; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Ficarro SB, 2009, ANAL CHEM, V81, P4566, DOI 10.1021/ac9004452; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Gore M, 2009, VIROLOGY, V383, P162, DOI 10.1016/j.virol.2008.10.010; Hatzivassiliou E, 1997, BIOCHEMISTRY-US, V36, P9221, DOI 10.1021/bi963145k; Hinderer W, 1999, J CLIN MICROBIOL, V37, P3239, DOI 10.1128/JCM.37.10.3239-3244.1999; Hong Y, 2011, J BIOL CHEM, V286, P777, DOI 10.1074/jbc.M110.193441; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jang SW, 2009, J BIOL CHEM, V284, P24512, DOI 10.1074/jbc.M109.026237; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Karakama Y, 2010, ANTIMICROB AGENTS CH, V54, P3179, DOI 10.1128/AAC.00113-10; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002297; Loesing JB, 2009, J GEN VIROL, V90, P1440, DOI 10.1099/vir.0.009571-0; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Parikh JR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-364; Rickinson AB, 2007, FIELDS VIROLOGY, V2, P2655; Rivailler P, 2002, J VIROL, V76, P12055, DOI 10.1128/JVI.76.23.12055-12068.2002; Rivailler P, 2002, J VIROL, V76, P421, DOI 10.1128/JVI.76.1.421-426.2002; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Sathish N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000332; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Song MJ, 2005, P NATL ACAD SCI USA, V102, P3805, DOI 10.1073/pnas.0404521102; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002376; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Verma D, 2010, J VIROL, V84, P11781, DOI 10.1128/JVI.01359-10; Verma D, 2009, J VIROL, V83, P8041, DOI 10.1128/JVI.00382-09; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wang LL, 2012, J VIROL, V86, P1348, DOI 10.1128/JVI.05497-11; Young LS, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P461	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53512	10.1371/journal.pone.0053512	http://dx.doi.org/10.1371/journal.pone.0053512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326445	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500079
J	Yang, GH; Dong, YB; Li, YL; Wang, QL; Shi, QL; Zhou, Q				Yang, Guohu; Dong, Yongbin; Li, Yuling; Wang, Qilei; Shi, Qingling; Zhou, Qiang			Verification of QTL for Grain Starch Content and Its Genetic Correlation with Oil Content Using Two Connected RIL Populations in High-Oil Maize	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ILLINOIS HIGH OIL; KERNEL OIL; PROTEIN; SELECTION; ASSOCIATIONS; CROSS; F-23; IDENTIFICATION; YIELD	Grain oil content is negatively correlated with starch content in maize in general. In this study, 282 and 263 recombinant inbred lines (RIL) developed from two crosses between one high-oil maize inbred and two normal dent maize inbreds were evaluated for grain starch content and its correlation with oil content under four environments. Single-trait QTL for starch content in single-population and joint-population analysis, and multiple-trait QTL for both starch and oil content were detected, and compared with the result obtained in the two related F-2:3 populations. Totally, 20 single-population QTL for grain starch content were detected. No QTL was simultaneously detected across all ten cases. QTL at bins 5.03 and 9.03 were all detected in both populations and in 4 and 5 cases, respectively. Only 2 of the 16 joint-population QTL had significant effects in both populations. Three single-population QTL and 8 joint-population QTL at bins 1.03, 1.04-1.05, 3.05, 8.04-8.05, 9.03, and 9.05 could be considered as fine-mapped. Common QTL across F-2:3 and RIL generations were observed at bins 5.04, 8.04 and 8.05 in population 1 (Pop. 1), and at bin 5.03 in population 2 (Pop. 2). QTL at bins 3.02-3.03, 3.05, 8.04-8.05 and 9.03 should be focused in high-starch maize breeding. In multiple-trait QTL analysis, 17 starch-oil QTL were detected, 10 in Pop. 1 and 7 in Pop. 2. And 22 single-trait QTL failed to show significance in multiple-trait analysis, 13 QTL for starch content and 9 QTL for oil content. However, QTL at bins 1.03, 6.03-6.04 and 8.03-8.04 might increase grain starch content and/or grain oil content without reduction in another trait. Further research should be conducted to validate the effect of these QTL in the simultaneous improvement of grain starch and oil content in maize.	[Yang, Guohu; Dong, Yongbin; Li, Yuling; Wang, Qilei; Shi, Qingling; Zhou, Qiang] Henan Agr Univ, Coll Agr, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Li, YL (corresponding author), Henan Agr Univ, Coll Agr, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	yuling_li@126.com			Henan Innovation Project for University Prominent Research Talents [2005HANCET-12]; Henan Scientific Technology Research Project [0623011700]	Henan Innovation Project for University Prominent Research Talents; Henan Scientific Technology Research Project	This study was supported by Henan Innovation Project for University Prominent Research Talents (2005HANCET-12), Henan Scientific Technology Research Project (0623011700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS KL, 1987, ANIM FEED SCI TECH, V17, P201, DOI 10.1016/0377-8401(87)90003-4; ALEXANDER DE, 1968, CROP SCI, V8, P273, DOI 10.2135/cropsci1968.0011183X000800030002x; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Austin DF, 1996, THEOR APPL GENET, V92, P817, DOI 10.1007/BF00221893; BERKE TG, 1995, CROP SCI, V35, P1542, DOI 10.2135/cropsci1995.0011183X003500060004x; CHURCHILL GA, 1994, GENETICS, V138, P963; Dudley, 1974, 70 GENERATIONS SELEC, P181; DUDLEY JW, 1992, MAYDICA, V37, P81; Dudley JW, 2004, CROP SCI, V44, P1419, DOI 10.2135/cropsci2004.1419; GOLDMAN IL, 1994, CROP SCI, V34, P908, DOI 10.2135/cropsci1994.0011183X003400040013x; Goss J, 1992, P 47 ANN CORN SORGH, P82; HAN Y, 1987, POULTRY SCI, V66, P103, DOI 10.3382/ps.0660103; HENDERSON CR, 1953, BIOMETRICS, V9, P226, DOI 10.2307/3001853; Hopkins C.G., 1899, ILL AGR EXP STN B, V55, P205; JIANG CJ, 1995, GENETICS, V140, P1111; Jiang HaiYing, 2005, Acta Agronomica Sinica, V31, P361; Kao CH, 1999, GENETICS, V152, P1203; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Lambert R.J., 2001, SPECIALTY CORNS, P131, DOI DOI 10.1201/9781420038569.CH5; Lambert RJ, 1997, MAYDICA, V42, P39; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Li HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017573; Li YL, 2009, J GENET, V88, P61, DOI 10.1007/s12041-009-0008-z; Liu YY, 2008, J CEREAL SCI, V48, P625, DOI 10.1016/j.jcs.2008.02.003; Lynch M, 1998, GENETICS ANAL QUANTI, P448; Mangolin CA, 2004, EUPHYTICA, V137, P251, DOI 10.1023/B:EUPH.0000041588.95689.47; Miranda JB., 1981, QUANTITATIVE GENETIC; MISEVIC D, 1989, CROP SCI, V29, P320, DOI 10.2135/cropsci1989.0011183X002900020018x; Piepho HP, 2001, GENETICS, V157, P425; Prioul JL, 1997, J EXP BOT, V48, P1151, DOI 10.1093/jxb/48.6.1151; PRIOUL JL, 1994, PLANT PHYSIOL, V104, P179, DOI 10.1104/pp.104.1.179; PRIOUL JL, 1990, PLANT PHYSIOL BIOCH, V28, P485; Slattery CJ, 2000, TRENDS PLANT SCI, V5, P291, DOI 10.1016/S1360-1385(00)01657-5; Song XF, 2004, MAYDICA, V49, P41; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang YZ, 2010, EUPHYTICA, V174, P239, DOI 10.1007/s10681-010-0123-1; Wassom JJ, 2008, CROP SCI, V48, P243, DOI 10.2135/cropsci2007.04.0205; Watson S. A., 1987, Corn: chemistry and technology., P53; Willmot DB, 2006, MAYDICA, V51, P187; WOODWORTH CM, 1952, AGRON J, V44, P60, DOI 10.2134/agronj1952.00021962004400020002x; Yang GH, 2012, MOL BREEDING, V29, P313, DOI 10.1007/s11032-011-9548-z; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang J, 2008, EUPHYTICA, V162, P335, DOI 10.1007/s10681-007-9500-9; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	45	13	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53770	10.1371/journal.pone.0053770	http://dx.doi.org/10.1371/journal.pone.0053770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320103	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800068
J	Abbas, A; Kong, XB; Liu, Z; Jing, BY; Gao, X				Abbas, Ahmed; Kong, Xin-Bing; Liu, Zhi; Jing, Bing-Yi; Gao, Xin			Automatic Peak Selection by a Benjamini-Hochberg-Based Algorithm	PLOS ONE			English	Article							NMR; PICKING; DISCOVERY; MUNIN	A common issue in bioinformatics is that computational methods often generate a large number of predictions sorted according to certain confidence scores. A key problem is then determining how many predictions must be selected to include most of the true predictions while maintaining reasonably high precision. In nuclear magnetic resonance (NMR)-based protein structure determination, for instance, computational peak picking methods are becoming more and more common, although expert-knowledge remains the method of choice to determine how many peaks among thousands of candidate peaks should be taken into consideration to capture the true peaks. Here, we propose a Benjamini-Hochberg (BH)-based approach that automatically selects the number of peaks. We formulate the peak selection problem as a multiple testing problem. Given a candidate peak list sorted by either volumes or intensities, we first convert the peaks into p-values and then apply the B-H-based algorithm to automatically select the number of peaks. The proposed approach is tested on the state-of-the-art peak picking methods, including WaVPeak [1] and PICKY [2]. Compared with the traditional fixed number-based approach, our approach returns significantly more true peaks. For instance, by combining WaVPeak or PICKY with the proposed method, the missing peak rates are on average reduced by 20% and 26%, respectively, in a benchmark set of 32 spectra extracted from eight proteins. The consensus of the B-H-selected peaks from both WaVPeak and PICKY achieves 88% recall and 83% precision, which significantly outperforms each individual method and the consensus method without using the B-H algorithm. The proposed method can be used as a standard procedure for any peak picking method and straightforwardly applied to some other prediction selection problems in bioinformatics. The source code, documentation and example data of the proposed method is available at http://sfb.kaust.edu.sa/pages/software.aspx.	[Abbas, Ahmed; Gao, Xin] King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal, Saudi Arabia; [Kong, Xin-Bing] Fudan Univ, Dept Stat, Shanghai 200433, Peoples R China; [Liu, Zhi] Univ Macau, Fac Sci & Technol, Dept Math, Taipa, Peoples R China; [Jing, Bing-Yi] Hong Kong Univ Sci & Technol, Dept Math, Kowloon, Hong Kong, Peoples R China	King Abdullah University of Science & Technology; Fudan University; University of Macau; Hong Kong University of Science & Technology	Jing, BY (corresponding author), Hong Kong Univ Sci & Technol, Dept Math, Kowloon, Hong Kong, Peoples R China.	majing@ust.hk; xin.gao@kaust.edu.sa	Gao, Xin/D-5487-2013	Gao, Xin/0000-0002-7108-3574; Jing, Bing-yi/0000-0002-8876-1570	GMSV-OCRF award from King Abdullah University of Science and Technology; Hong Kong Research Grants Council [HKUST6019/10P, HKUST6019/12P];  [GRP-CF-2011-19-P-Gao-Huang]	GMSV-OCRF award from King Abdullah University of Science and Technology; Hong Kong Research Grants Council(Hong Kong Research Grants Council); 	This work was supported by Award No. GRP-CF-2011-19-P-Gao-Huang, a GMSV-OCRF award from King Abdullah University of Science and Technology, and Hong Kong Research Grants Council grants HKUST6019/10P and HKUST6019/12P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipanahi B, 2011, J BIOINF COMPUT BIOL, V9, P15, DOI 10.1142/S0219720011005276; Alipanahi B, 2009, BIOINFORMATICS, V25, pI268, DOI 10.1093/bioinformatics/btp225; Altieri AS, 2004, CURR OPIN STRUC BIOL, V14, P547, DOI 10.1016/j.sbi.2004.09.003; ANTZ C, 1995, J BIOMOL NMR, V5, P287, DOI 10.1007/BF00211755; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; CARRARA EA, 1993, NEURAL NETWORKS, V6, P1023, DOI 10.1016/S0893-6080(09)80012-9; Coin L, 2003, P NATL ACAD SCI USA, V100, P4516, DOI 10.1073/pnas.0737502100; CORNE SA, 1992, J MAGN RESON, V100, P256, DOI 10.1016/0022-2364(92)90260-E; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; Efron B., 2010, LARGE SCALE INFERENC; Forslund K, 2008, BIOINFORMATICS, V24, P1681, DOI 10.1093/bioinformatics/btn312; Gao X, 2009, THESIS U WATERLOO; Gao X., 2012, J APPL COMPUT MATH, V1, P1; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gronwald W, 2004, PROG NUCL MAG RES SP, V44, P33, DOI 10.1016/j.pnmrs.2003.12.002; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kleywegt G., 1990, J MAGN RESON, V135, P288; Koradi R, 1998, J MAGN RESON, V135, P288, DOI 10.1006/jmre.1998.1570; Korzhnev DM, 2001, J BIOMOL NMR, V21, P263, DOI 10.1023/A:1012982830367; Liu Z, 2012, BIOINFORMATICS, V28, P914, DOI 10.1093/bioinformatics/bts078; Messih MA, 2012, BIOINFORMATICS, V28, pI444, DOI 10.1093/bioinformatics/bts398; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Orekhov VY, 2001, J BIOMOL NMR, V20, P49, DOI 10.1023/A:1011234126930; ROUH A, 1994, J BIOMOL NMR, V4, P505, DOI 10.1007/BF00156617; Silvescu A., 2004, INTERELEMENT DEPENDE; Wuthrich K, 1986, NMR PROTEINS NUCL AC	29	23	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53112	10.1371/journal.pone.0053112	http://dx.doi.org/10.1371/journal.pone.0053112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308147	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100030
J	Hozumi, H; Tada, R; Murakami, T; Adachi, Y; Ohno, N				Hozumi, Hiroyasu; Tada, Rui; Murakami, Taisuke; Adachi, Yoshiyuki; Ohno, Naohito			Comparative Analysis of Hepatic CD14 Expression between Two Different Endotoxin Shock Model Mice: Relation between Hepatic Injury and CD14 Expression	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SOLUBLE CD14; RETICULOENDOTHELIAL SYSTEM; BACTERIAL-ENDOTOXIN; SEPTIC SHOCK; LIPOPOLYSACCHARIDE; GALACTOSAMINE; HEPATOCYTES; SEPSIS; ALPHA	CD14 is a glycoprotein that recognizes gram-negative bacterial lipopolysaccharide (LPS) and exists in both membrane-bound and soluble forms. Infectious and/or inflammatory diseases induce CD14 expression, which may be involved in the pathology of endotoxin shock. We previously found that the expression of CD14 protein differs among the endotoxin shock models used, although the reasons for these differences are unclear. We hypothesized that the differences in CD14 expression might be due to liver injury, because the hepatic tissue produces CD14 protein. We investigated CD14 expression in the plasma and liver in the carrageenan (CAR)-primed and D-galN-primed mouse models of endotoxin shock. Our results showed that severe liver injury was not induced in CAR-primed endotoxin shock model mice. In this CAR-primed model, the higher mRNA and protein expression of CD14 was observed in the liver, especially in the interlobular bile duct in contrast to D-galN-primed-endotoxin shock model mice. Our findings indicated that the molecular mechanism(s) underlying septic shock in CAR-primed and D-galN-primed endotoxin shock models are quite different. Because CD14 expression is correlated with clinical observations, the CAR-primed endotoxin shock model might be useful for studying the functions of CD14 during septic shock in vivo.	[Hozumi, Hiroyasu; Tada, Rui; Murakami, Taisuke; Adachi, Yoshiyuki; Ohno, Naohito] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Hachioji, Tokyo 19203, Japan	Tokyo University of Pharmacy & Life Sciences	Adachi, Y (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, 1432-1 Horinouchi, Hachioji, Tokyo 19203, Japan.	adachiyo@toyaku.ac.jp	Tada, Rui/M-3278-2019	Tada, Rui/0000-0003-0098-9587	Ministry of Education, Culture, Sports, Science, and Technology; Japan Private School Promotion Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Private School Promotion Foundation	This work was supported by a grant for private universities provided by the Ministry of Education, Culture, Sports, Science, and Technology and Japan Private School Promotion Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto H, 2007, SCAND J INFECT DIS, V39, P596, DOI 10.1080/00365540701199808; Antal-Szalmas P, 2000, EUR J CLIN INVEST, V30, P167; BAAS J, 1995, EUR SURG RES, V27, P137, DOI 10.1159/000129392; Bahjat FR, 2000, J IMMUNOL, V165, P6559, DOI 10.4049/jimmunol.165.11.6559; BAHRAMI S, 1994, INFECT IMMUN, V62, P99, DOI 10.1128/IAI.62.1.99-105.1994; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; Chou MH, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-138; de Aguiar BB, 2008, IMMUNOL INVEST, V37, P752, DOI 10.1080/08820130802403242; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Harada K, 2003, LAB INVEST, V83, P1657, DOI 10.1097/01.LAB.0000097190.56734.FE; HOUSTON MC, 1984, ARCH INTERN MED, V144, P1433, DOI 10.1001/archinte.144.7.1433; Hozumi H, 2006, BIOL PHARM BULL, V29, P1015, DOI 10.1248/bpb.29.1015; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Liu SB, 1998, INFECT IMMUN, V66, P5089, DOI 10.1128/IAI.66.11.5089-5098.1998; Miyake Kensuke, 2004, Current Drug Targets - Inflammation and Allergy, V3, P291, DOI 10.2174/1568010043343633; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Nishio A, 2011, PANCREAS, V40, P95, DOI 10.1097/MPA.0b013e3181f3a5d4; OGATA M, 1991, INFECT IMMUN, V59, P679, DOI 10.1128/IAI.59.2.679-683.1991; Ogata M, 1999, INFECT IMMUN, V67, P3284, DOI 10.1128/IAI.67.7.3284-3289.1999; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pan Z, 2000, J BIOL CHEM, V275, P36430, DOI 10.1074/jbc.M003192200; Prigent H, 2004, CRIT CARE, V8, P122, DOI [10.1186/cc2374), 10.1186/cc2374]; READ MA, 1993, P NATL ACAD SCI USA, V90, P9887, DOI 10.1073/pnas.90.21.9887; REGAN MC, 1994, BRIT J SURG, V81, P271, DOI 10.1002/bjs.1800810239; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Schleicher C, 2001, ANN SURG, V233, P528, DOI 10.1097/00000658-200104000-00008; Shoji H, 1998, Ther Apher, V2, P3, DOI 10.1111/j.1744-9987.1998.tb00066.x; Shozushima T, 2011, J INFECT CHEMOTHER, V17, P764, DOI 10.1007/s10156-011-0254-x; Su GL, 1999, J HEPATOL, V31, P435, DOI 10.1016/S0168-8278(99)80034-8; Tada R, 2006, BIOL PHARM BULL, V29, P240, DOI 10.1248/bpb.29.240; Tada R, 2007, CHEM PHARM BULL, V55, P992, DOI 10.1248/cpb.55.992; Triantafilou M, 2005, J ENDOTOXIN RES, V11, P5, DOI 10.1179/096805105225006641; Tsutsui S, 1997, J VET MED SCI, V59, P785, DOI 10.1292/jvms.59.785; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Yaegashi Yasunori, 2005, Journal of Infection and Chemotherapy, V11, P234, DOI 10.1007/s10156-005-0400-4	39	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53692	10.1371/journal.pone.0053692	http://dx.doi.org/10.1371/journal.pone.0053692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308276	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100108
J	Liaw, C; Tung, CW; Ho, SY				Liaw, Chyn; Tung, Chun-Wei; Ho, Shinn-Ying			Prediction and Analysis of Antibody Amyloidogenesis from Sequences	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; PROTEIN; AGGREGATION; PEPTIDES; IDENTIFICATION; HUMANIZATION; SERVER; IMMUNOGENICITY; DETERMINANTS; CONFORMATION	Antibody amyloidogenesis is the aggregation of soluble proteins into amyloid fibrils that is one of major causes of the failures of humanized antibodies. The prediction and prevention of antibody amyloidogenesis are helpful for restoring and enhancing therapeutic effects. Due to a large number of possible germlines, the existing method is not practical to predict sequences of novel germlines, which establishes individual models for each known germline. This study proposes a first automatic and across-germline prediction method (named AbAmyloid) capable of predicting antibody amyloidogenesis from sequences. Since the amyloidogenesis is determined by a whole sequence of an antibody rather than germline-dependent properties such as mutated residues, this study assess three types of germline-independent sequence features (amino acid composition, dipeptide composition and physicochemical properties). AbAmyloid using a Random Forests classifier with dipeptide composition performs well on a data set of 12 germlines. The within-and across-germline prediction accuracies are 83.10% and 83.33% using Jackknife tests, respectively, and the novel-germline prediction accuracy using a leave-one-germline-out test is 72.22%. A thorough analysis of sequence features is conducted to identify informative properties for further providing insights to antibody amyloidogenesis. Some identified informative physicochemical properties are amphiphilicity, hydrophobicity, reverse turn, helical structure, isoelectric point, net charge, mutability, coil, turn, linker, nuclear protein, etc. Additionally, the numbers of ubiquitylation sites in amyloidogenic and nonamyloidogenic antibodies are found to be significantly different. It reveals that antibodies less likely to be ubiquitylated tend to be amyloidogenic. The method AbAmyloid capable of automatically predicting antibody amyloidogenesis of novel germlines is implemented as a publicly available web server at http://iclab.life.nctu.edu.tw/abamyloid.	[Liaw, Chyn; Ho, Shinn-Ying] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Tung, Chun-Wei] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Ho, Shinn-Ying] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Kaohsiung Medical University; National Yang Ming Chiao Tung University	Ho, SY (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	syho@mail.nctu.edu.tw	Ho, Shinn-Ying/AFD-8402-2022; Ho, Shinn-Ying/AAE-9394-2022; Tung, Chun-Wei/B-3749-2008	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353; Tung, Chun-Wei/0000-0003-3011-8440	National Science Council of Taiwan [NSC-101-2627-B-009-003-]; "Center for Bioinformatics Research of Aiming for the Top University Program'' of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C [101W962]; UST-UCSD International Center of Excellence in Advanced Bioengineering; Taiwan National Science Council I-RiCE Program [NSC-101-2911-I-009-101]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program'' of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C(Ministry of Education, Taiwan); UST-UCSD International Center of Excellence in Advanced Bioengineering; Taiwan National Science Council I-RiCE Program	This work was supported by National Science Council of Taiwan under the contract number NSC-101-2627-B-009-003-, and "Center for Bioinformatics Research of Aiming for the Top University Program'' of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C for the project 101W962. This work was also supported in part by the UST-UCSD International Center of Excellence in Advanced Bioengineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC-101-2911-I-009-101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaratunga D, 2008, BIOINFORMATICS, V24, P2010, DOI 10.1093/bioinformatics/btn356; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bond JP, 2003, J STRUCT BIOL, V141, P156, DOI 10.1016/S1047-8477(02)00625-1; BRACK A, 1975, NATURE, V256, P383, DOI 10.1038/256383a0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Broome BM, 2000, J MOL BIOL, V296, P961, DOI 10.1006/jmbi.2000.3514; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Calle M Luz, 2011, Brief Bioinform, V12, P86, DOI 10.1093/bib/bbq011; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Clark M, 2000, IMMUNOL TODAY, V21, P397, DOI 10.1016/S0167-5699(00)01680-7; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; David MPC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-79; de Groot NS, 2012, METHODS MOL BIOL, V819, P199, DOI 10.1007/978-1-61779-465-0_14; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Es-haghi A, 2012, BBA-PROTEINS PROTEOM, V1824, P468, DOI 10.1016/j.bbapap.2011.12.010; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gordon DJ, 2004, BIOPHYS J, V86, P428, DOI 10.1016/S0006-3495(04)74119-3; Huang WL, 2007, BIOSYSTEMS, V90, P573, DOI 10.1016/j.biosystems.2007.01.001; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Krebs MRH, 2009, BIOPHYS J, V96, P5013, DOI 10.1016/j.bpj.2009.03.028; Kryszkiewicz MRH, 2011, 19 INT S ISMIS 2011; Lim A, 1998, PROTEIN SCI, V7, P1545, DOI 10.1002/pro.5560070708; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; Maji SK, 2004, TETRAHEDRON, V60, P3251, DOI 10.1016/j.tet.2004.02.019; Mateo C, 1997, IMMUNOTECHNOLOGY, V3, P71, DOI 10.1016/S1380-2933(97)00065-1; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; ROGUSKA MA, 1994, P NATL ACAD SCI USA, V91, P969, DOI 10.1073/pnas.91.3.969; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Srisailam S, 2002, J BIOL CHEM, V277, P19027, DOI 10.1074/jbc.M110762200; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Topilina NI, 2010, BIOMACROMOLECULES, V11, P1721, DOI 10.1021/bm901467a; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; Tung CW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-446; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Vidal R, 1999, AM J PATHOL, V155, P2009, DOI 10.1016/S0002-9440(10)65520-4; Villegas V, 2000, PROTEIN SCI, V9, P1700, DOI 10.1110/ps.9.9.1700; Waldmann H, 2005, PHILOS T ROY SOC B, V360, P1707, DOI 10.1098/rstb.2005.1702; Wang LJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S2; Zavaljevski N, 2002, BIOINFORMATICS, V18, P689, DOI 10.1093/bioinformatics/18.5.689; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508	58	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53235	10.1371/journal.pone.0053235	http://dx.doi.org/10.1371/journal.pone.0053235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308169	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100043
J	Nguyen, J; Tang, SY; Nguyen, D; Alliston, T				Nguyen, Jacqueline; Tang, Simon Y.; Nguyen, Daniel; Alliston, Tamara			Load Regulates Bone Formation and Sclerostin Expression through a TGF beta-Dependent Mechanism	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; CANCELLOUS BONE; GENE; INCREASES; SOST; TRANSCRIPTION; RECEPTOR; SMAD3; MASS	Bone continually adapts to meet changing physical and biological demands. Osteoblasts, osteoclasts, and osteocytes cooperate to integrate these physical and biochemical cues to maintain bone homeostasis. Although TGF beta acts on all three of these cell types to maintain bone homeostasis, the extent to which it participates in the adaptation of bone to mechanical load is unknown. Here, we investigated the role of the TGF beta pathway in load-induced bone formation and the regulation of Sclerostin, a mechanosensitive antagonist of bone anabolism. We found that mechanical load rapidly represses the net activity of the TGF beta pathway in osteocytes, resulting in reduced phosphorylation and activity of key downstream effectors, Smad2 and Smad3. Loss of TGF beta sensitivity compromises the anabolic response of bone to mechanical load, demonstrating that the mechanosensitive regulation of TGF beta signaling is essential for load-induced bone formation. Furthermore, sensitivity to TGF beta is required for the mechanosensitive regulation of Sclerostin, which is induced by TGF beta in a Smad3-dependent manner. Together, our results show that physical cues maintain bone homeostasis through the TGF beta pathway to regulate Sclerostin expression and the deposition of new bone.	[Nguyen, Jacqueline; Alliston, Tamara] Univ Calif San Francisco, Grad Program Oral & Craniofacial Sci, San Francisco, CA 94143 USA; [Tang, Simon Y.; Nguyen, Daniel; Alliston, Tamara] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Alliston, Tamara] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Alliston, Tamara] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA USA; [Alliston, Tamara] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alliston, T (corresponding author), Univ Calif San Francisco, Grad Program Oral & Craniofacial Sci, San Francisco, CA 94143 USA.	tamara.alliston@ucsf.edu	Tang, Simon/AAZ-1179-2021	Tang, Simon/0000-0002-5570-3921; Alliston, Tamara/0000-0001-9992-2897	National Institutes of Health [F30DE022680, F32AR059497, R01DE019284]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR059497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019284, F30DE022680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by the National Institutes of Health F30DE022680, F32AR059497, and R01DE019284 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131; Alford AI, 2012, CALCIFIED TISSUE INT, V90, P420, DOI 10.1007/s00223-012-9580-y; Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Fox SW, 2005, MOL CELL ENDOCRINOL, V243, P19, DOI 10.1016/j.mce.2005.09.008; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Galea GL, 2011, FEBS LETT, V585, P2450, DOI 10.1016/j.febslet.2011.06.019; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Loots GG, 2012, BONE, V50, P663, DOI 10.1016/j.bone.2011.11.016; Moester MJC, 2010, CALCIFIED TISSUE INT, V87, P99, DOI 10.1007/s00223-010-9372-1; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Price Joanna S, 2011, Curr Osteoporos Rep, V9, P76, DOI 10.1007/s11914-011-0050-7; Qiu T, 2010, NAT CELL BIOL, V12, P224, DOI 10.1038/ncb2022; RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Reijnders CMA, 2007, J ENDOCRINOL, V192, P131, DOI 10.1677/joe.1.06880; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sakai K, 1998, CALCIFIED TISSUE INT, V63, P515, DOI 10.1007/s002239900567; SALVESEN H, 1994, CALCIFIED TISSUE INT, V54, P256, DOI 10.1007/BF00295947; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; Tian XY, 2011, BONE, V48, P197, DOI 10.1016/j.bone.2010.09.009; van der Meulen MCH, 2006, BONE, V38, P871, DOI 10.1016/j.bone.2005.11.026; van der Meulen MCH, 2009, CLIN ORTHOP RELAT R, V467, P2000, DOI 10.1007/s11999-009-0897-4; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	45	57	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53813	10.1371/journal.pone.0053813	http://dx.doi.org/10.1371/journal.pone.0053813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308287	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100119
J	Wang, ZY; Chai, WD; Burwinkel, M; Twardziok, S; Wrede, P; Palissa, C; Esch, B; Schmidt, MFG				Wang, Zhenya; Chai, Weidong; Burwinkel, Michael; Twardziok, Sven; Wrede, Paul; Palissa, Christiane; Esch, Bettina; Schmidt, Michael F. G.			Inhibitory Influence of Enterococcus faecium on the Propagation of Swine Influenza A Virus In Vitro	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; NITRIC-OXIDE; ROTAVIRUS INFECTION; MACROPHAGES; PROBIOTICS; RESPONSES; CELLS; MODEL; SOWS	The control of infectious diseases such as swine influenza viruses (SwIV) plays an important role in food production both from the animal health and from the public health point of view. Probiotic microorganisms and other health improving food supplements have been given increasing attention in recent years, but, no information on the effects of probiotics on swine influenza virus is available. Here we address this question by assessing the inhibitory potential of the probiotic Enterococcus faecium NCIMB 10415 (E. faecium) on the replication of two porcine strains of influenza virus (H1N1 and H3N2 strain) in a continuous porcine macrophage cell line (3D4/21) and in MDBK cells. Cell cultures were treated with E. faecium at the nontoxic concentration of 1x10(6) CFU/ml in growth medium for 60 to 90 min before, during and after SwIV infection. After further incubation of cultures in probiotic-free growth medium, cell viability and virus propagation were determined at 48 h or 96 h post infection. The results obtained reveal an almost complete recovery of viability of SwIV infected cells and an inhibition of virus multiplication by up to four log units in the E. faecium treated cells. In both 3D4/21- and MDBK-cells a 60 min treatment with E. faecium stimulated nitric oxide (NO) release which is in line with published evidence for an antiviral function of NO. Furthermore, E. faecium caused a modified cellular expression of selected mediators of defence in 3D4-cells: while the expression of TNF-alpha, TLR-3 and IL-6 were decreased in the SwIV-infected and probiotic treated cells, IL-10 was found to be increased. Since we obtained experimental evidence for the direct adsorptive trapping of SwIV through E. faecium, this probiotic microorganism inhibits influenza viruses by at least two mechanisms, direct physical interaction and strengthening of innate defence at the cellular level.	[Wang, Zhenya; Chai, Weidong; Burwinkel, Michael; Palissa, Christiane; Esch, Bettina; Schmidt, Michael F. G.] Free Univ Berlin, Inst Immunol, Berlin, Germany; [Twardziok, Sven; Wrede, Paul] Charite Univ Med Berlin, Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt, MFG (corresponding author), Free Univ Berlin, Inst Immunol, Berlin, Germany.	michael.schmidt3@fu-berlin.de		Twardziok, Sven/0000-0002-0326-5704; Burwinkel, Michael/0000-0003-4811-7323	DFG (German Research Council) [SFB 852]	DFG (German Research Council)(German Research Foundation (DFG))	SFB 852 sub-project A5 funded by the DFG (German Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Breen EC, 2002, PHARMACOL THERAPEUT, V95, P295, DOI 10.1016/S0163-7258(02)00263-2; Chae SY, 2004, BIOMATERIALS, V25, P843, DOI 10.1016/S0142-9612(03)00605-7; Clancy R, 2003, FEMS IMMUNOL MED MIC, V38, P9, DOI 10.1016/S0928-8244(03)00147-0; de Vrese M, 2002, BRIT J NUTR, V88, pS59, DOI 10.1079/BJN2002630; Ducatez MF, 2008, VACCINE, V26, pD67, DOI 10.1016/j.vaccine.2008.07.064; Fineberg HV, 2008, J INFECT DIS, V197, pS14, DOI 10.1086/524989; Hatakka K, 2001, BMJ-BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; Ivec M, 2007, ANTIVIR RES, V75, P266, DOI 10.1016/j.antiviral.2007.03.013; KRAH DL, 1991, BIOLOGICALS, V19, P223, DOI 10.1016/1045-1056(91)90039-M; Kritas SK, 2007, VET MICROBIOL, V119, P248, DOI 10.1016/j.vetmic.2006.09.012; Kumar VJR, 2010, TROP ANIM HEALTH PRO, V42, P1855, DOI 10.1007/s11250-010-9648-5; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; MARKWELL MAK, 1984, BIOCHIM BIOPHYS ACTA, V775, P7, DOI 10.1016/0005-2736(84)90228-1; Meyerhoff RR, 2012, COMP IMMUNOL MICROB, V35, P63, DOI [10.1016/j.cimid.2011.10.002, 10.1016/j.cimid.2011.10.001]; Miettinen M, 1996, INFECT IMMUN, V64, P5403, DOI 10.1128/IAI.64.12.5403-5405.1996; Rimmelzwaan GF, 1999, J VIROL, V73, P8880, DOI 10.1128/JVI.73.10.8880-8883.1999; Scharek L, 2005, VET IMMUNOL IMMUNOP, V105, P151, DOI 10.1016/j.vetimm.2004.12.022; Schierack P, 2009, VET IMMUNOL IMMUNOP, V127, P26, DOI 10.1016/j.vetimm.2008.09.002; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Simon O, 2010, J ANIM FEED SCI, V19, P230, DOI 10.22358/jafs/66284/2010; Weingartl HM, 2002, J VIROL METHODS, V104, P203, DOI 10.1016/S0166-0934(02)00085-X; Yasui H, 1999, ANTON LEEUW INT J G, V76, P383, DOI 10.1023/A:1002041616085; Zhang W, 2008, VET IMMUNOL IMMUNOP, V122, P175, DOI 10.1016/j.vetimm.2007.10.003	25	39	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53043	10.1371/journal.pone.0053043	http://dx.doi.org/10.1371/journal.pone.0053043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308134	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100024
J	Zopf, R; Williams, MA				Zopf, Regine; Williams, Mark A.			Preference for Orientations Commonly Viewed for One's Own Hand in the Anterior Intraparietal Cortex	PLOS ONE			English	Article							EXTRASTRIATE BODY AREA; LATERAL OCCIPITOTEMPORAL CORTEX; FMRI ADAPTATION REVEALS; PARIETAL CORTEX; RESPONSE PROPERTIES; PERIPERSONAL SPACE; POSTERIOR PARIETAL; VISUAL-CORTEX; REPRESENTATION; PERCEPTION	Brain regions in the intraparietal and the premotor cortices selectively process visual and multisensory events near the hands (peri-hand space). Visual information from the hand itself modulates this processing potentially because it is used to estimate the location of one's own body and the surrounding space. In humans specific occipitotemporal areas process visual information of specific body parts such as hands. Here we used an fMRI block-design to investigate if anterior intraparietal and ventral premotor 'peri-hand areas' exhibit selective responses to viewing images of hands and viewing specific hand orientations. Furthermore, we investigated if the occipitotemporal 'hand area' is sensitive to viewed hand orientation. Our findings demonstrate increased BOLD responses in the left anterior intraparietal area when participants viewed hands and feet as compared to faces and objects. Anterior intraparietal and also occipitotemporal areas in the left hemisphere exhibited response preferences for viewing right hands with orientations commonly viewed for one's own hand as compared to uncommon own hand orientations. Our results indicate that both anterior intraparietal and occipitotemporal areas encode visual limb-specific shape and orientation information.	[Zopf, Regine; Williams, Mark A.] Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia	Macquarie University	Zopf, R (corresponding author), Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia.	regine.zopf@mq.edu.au		Williams, Mark/0000-0002-3897-5167; Zopf, Regine/0000-0002-1375-3832	Macquarie University; Australian Research Council [DP 0984919]; Queen Elizabeth II Fellowship from the Australian Research Council	Macquarie University; Australian Research Council(Australian Research Council); Queen Elizabeth II Fellowship from the Australian Research Council(Australian Research Council)	R.Z. was supported by a Macquarie University Research Excellence Scholarship and M. A. W. by a Queen Elizabeth II Fellowship from the Australian Research Council. This work was supported by the Australian Research Council (DP 0984919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Bracci S, 2012, J NEUROPHYSIOL, V107, P1443, DOI 10.1152/jn.00619.2011; Bracci S, 2010, J NEUROPHYSIOL, V103, P3389, DOI 10.1152/jn.00215.2010; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Dinstein I, 2008, J NEUROSCI, V28, P11231, DOI 10.1523/JNEUROSCI.3585-08.2008; Dinstein I, 2007, J NEUROPHYSIOL, V98, P1415, DOI 10.1152/jn.00238.2007; Downing PE, 2011, COGN NEUROSCI-UK, V2, P186, DOI 10.1080/17588928.2011.582945; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Ehrsson H. H., 2012, NEW HDB MULTISENSORY; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Heed T, 2011, J NEUROSCI, V31, P3066, DOI 10.1523/JNEUROSCI.4370-10.2011; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Longo MR, 2009, J NEUROSCI, V29, P12125, DOI 10.1523/JNEUROSCI.3072-09.2009; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Moseley GL, 2008, CURR BIOL, V18, pR1047, DOI 10.1016/j.cub.2008.09.031; O'Toole AJ, 2011, VISION RES, V51, P74, DOI 10.1016/j.visres.2010.09.035; Orlov T, 2010, NEURON, V68, P586, DOI 10.1016/j.neuron.2010.09.032; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Shmuelof L, 2008, NAT NEUROSCI, V11, P1267, DOI 10.1038/nn.2196; Weiner KS, 2011, NEUROIMAGE, V56, P2183, DOI 10.1016/j.neuroimage.2011.03.041; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Whiteley L, 2004, PERCEPTION, V33, P307, DOI 10.1068/p5053; Zopf R, 2011, COGN NEUROSCI-UK, V2, P147, DOI 10.1080/17588928.2011.578208; Zopf R, 2010, NEUROPSYCHOLOGIA, V48, P713, DOI 10.1016/j.neuropsychologia.2009.10.028	50	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53812	10.1371/journal.pone.0053812	http://dx.doi.org/10.1371/journal.pone.0053812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308286	gold, Green Published			2022-12-27	WOS:000313429100118
J	Naruse, M; Shibasaki, K; Yokoyama, S; Kurachi, M; Ishizaki, Y				Naruse, Masae; Shibasaki, Koji; Yokoyama, Shuichi; Kurachi, Masashi; Ishizaki, Yasuki			Dynamic Changes of CD44 Expression from Progenitors to Subpopulations of Astrocytes and Neurons in Developing Cerebellum	PLOS ONE			English	Article							NEURAL STEM-CELLS; RADIAL GLIA; OLIGODENDROCYTE; IDENTIFICATION; HYALURONAN; PROLIFERATION; MULTIPOTENT; PROGRESSION; MIGRATION; LINEAGE	We previously reported that CD44-positive cells were candidates for astrocyte precursor cells in the developing cerebellum, because cells expressing high levels of CD44 selected by fluorescence-activated cell sorting (FACS) gave rise only to astrocytes in vitro. However, whether CD44 is a specific cell marker for cerebellar astrocyte precursor cells in vivo is unknown. In this study, we used immunohistochemistry, in situ hybridization, and FACS to analyze the spatial and temporal expression of CD44 and characterize the CD44-positive cells in the mouse cerebellum during development. CD44 expression was observed not only in astrocyte precursor cells but also in neural stem cells and oligodendrocyte precursor cells (OPCs) at early postnatal stages. CD44 expression in OPCs was shut off during oligodendrocyte differentiation. Interestingly, during development, CD44 expression was limited specifically to Bergmann glia and fibrous astrocytes among three types of astrocytes in cerebellum, and expression in astrocytes was shut off during postnatal development. CD44 expression was also detected in developing Purkinje and granule neurons but was limited to granule neurons in the adult cerebellum. Thus, at early developmental stages of the cerebellum, CD44 was widely expressed in several types of precursor cells, and over the course of development, the expression of CD44 became restricted to granule neurons in the adult.	[Naruse, Masae; Shibasaki, Koji; Yokoyama, Shuichi; Kurachi, Masashi; Ishizaki, Yasuki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma 371, Japan	Gunma University	Shibasaki, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma 371, Japan.	shibasaki@gunma-u.ac.jp; yasukiishizaki@gunma-u.ac.jp	Ishizaki, Yasuki/AAB-1209-2020; Shibasaki, Koji/U-8674-2018	Shibasaki, Koji/0000-0003-2330-1749	Uehara Memorial Foundation; Takeda Science Foundation, Tokyo, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan [23650159, 21200012, 20399554, 24111507]; Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation [12C2]	Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation, Tokyo, Japan(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation	This research was supported by a grant from Uehara Memorial Foundation (to K.S., Y.I.), by a grant from Takeda Science Foundation, Tokyo, Japan (to K.S., Y.I.) and by a grant from Grants-in-Aid for Scientific Research (Project No. 23650159 to Y.I., 21200012, 20399554, 24111507, Brain Environment. to K.S.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by a grant from the Sumitomo Foundation (to K.S.), by a grant from the Brain Science Foundation (to K.S.), by a grant from Narishige Neuroscience Research Foundation (to K.S.), by a grant from Salt Science Research Foundation No. 12C2 (to K.S.). The all funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1993, BRAIN RES, V632, P249, DOI 10.1016/0006-8993(93)91160-T; Alfei L, 1999, EUR J HISTOCHEM, V43, P29; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Baier C, 2007, MATRIX BIOL, V26, P348, DOI 10.1016/j.matbio.2007.02.002; Bausch SB, 2006, NEUROSCIENCE, V143, P339, DOI 10.1016/j.neuroscience.2006.07.037; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bouvier-Labit C, 2002, J NEURO-ONCOL, V60, P127, DOI 10.1023/A:1020630732625; Cai N, 2012, CEREBELLUM, V11, P181, DOI 10.1007/s12311-011-0294-x; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; De Falco V, 2012, CANCER RES, V72, P1449, DOI 10.1158/0008-5472.CAN-11-3320; GHANDOUR MS, 1979, J HISTOCHEM CYTOCHEM, V27, P1634, DOI 10.1177/27.12.118210; GIRGRAH N, 1991, J NEUROPATH EXP NEUR, V50, P779, DOI 10.1097/00005072-199111000-00009; Glezer I, 2009, J COMP NEUROL, V517, P906, DOI 10.1002/cne.22185; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; KUPPNER MC, 1992, INT J CANCER, V50, P572, DOI 10.1002/ijc.2910500414; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Liu Y, 2002, GLIA, V40, P25, DOI 10.1002/glia.10111; Matsumoto T, 2012, NEUROSCI LETT, V520, P115, DOI 10.1016/j.neulet.2012.05.048; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Morales D, 2006, J NEUROSCI, V26, P12226, DOI 10.1523/JNEUROSCI.3493-06.2006; MORETTO G, 1993, J NEUROPATH EXP NEUR, V52, P419, DOI 10.1097/00005072-199307000-00009; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Negi LM, 2012, J DRUG TARGET, V20, P561, DOI 10.3109/1061186X.2012.702767; Oishi K, 2006, BIOCHEM BIOPH RES CO, V349, P1065, DOI 10.1016/j.bbrc.2006.08.135; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shinoe T, 2010, J NEUROCHEM, V115, P1633, DOI 10.1111/j.1471-4159.2010.07072.x; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suzuki DE, 2011, IN VITRO CELL DEV-AN, V47, P492, DOI 10.1007/s11626-011-9426-3; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Yoshida T, 2012, PATHOL INT, V62, P463, DOI 10.1111/j.1440-1827.2012.02823.x; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7	42	50	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53109	10.1371/journal.pone.0053109	http://dx.doi.org/10.1371/journal.pone.0053109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308146	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100018
J	Vogel, H; Montag, D; Kanzleiter, T; Jonas, W; Matzke, D; Scherneck, S; Chadt, A; Tole, J; Kluge, R; Joost, HG; Schurmann, A				Vogel, Heike; Montag, Dirk; Kanzleiter, Timo; Jonas, Wenke; Matzke, Daniela; Scherneck, Stephan; Chadt, Alexandra; Toele, Jonas; Kluge, Reinhart; Joost, Hans-Georg; Schuermann, Annette			An Interval of the Obesity QTL Nob3.38 within a QTL Hotspot on Chromosome 1 Modulates Behavioral Phenotypes	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENE-EXPRESSION; SUSCEPTIBILITY LOCUS; INSULIN-RESISTANCE; WEIGHT STATUS; DEPRESSION; MOUSE; MICE; MICRODELETION; HYPERGLYCEMIA	A region on mouse distal chromosome 1 (Chr. 1) that is highly enriched in quantitative trait loci (QTLs) controlling neural and behavioral phenotypes overlaps with the peak region of a major obesity QTL (Nob3.38), which we identified in an intercross of New Zealand Obese (NZO) mice with C57BL/6J (B6). By positional cloning we recently identified a microdeletion within this locus causing the disruption of Ifi202b that protects from adiposity by suppressing expression of 11 beta-Hsd1. Here we show that the Nob3.38 segment also corresponds with the QTL rich region (Qrr1) on Chr. 1 and associates with increased voluntary running wheel activity, Rota-rod performance, decreased grip strength, and anxiety-related traits. The characterization of a subcongenic line carrying 14.2 Mbp of Nob3.38 with a polymorphic region of 4.4 Mbp indicates that the microdeletion and/or other polymorphisms in its proximity alter body weight, voluntary activity, and exploration. Since 27 out of 32 QTL were identified in crosses with B6, we hypothesized that the microdeletion and or adjacent SNPs are unique for B6 mice and responsible for some of the complex Qrr1-mediated effects. Indeed, a phylogenic study of 28 mouse strains revealed a NZO-like genotype for 22 and a B6-like genotype for NZW/LacJ and 4 other C57BL strains. Thus, we suggest that a Nob3.38 interval (173.0-177.4 Mbp) does not only modify adiposity but also neurobehavioral traits by a haplotype segregating with C57BL strains.	[Vogel, Heike; Kanzleiter, Timo; Jonas, Wenke; Matzke, Daniela; Scherneck, Stephan; Chadt, Alexandra; Kluge, Reinhart; Joost, Hans-Georg; Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany; [Vogel, Heike; Kanzleiter, Timo; Jonas, Wenke; Matzke, Daniela; Scherneck, Stephan; Chadt, Alexandra; Kluge, Reinhart; Joost, Hans-Georg; Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Dept Expt Diabetol, Nuthetal, Germany; [Montag, Dirk] Leibniz Inst Neurobiol, Res Grp Neurogenet, Magdeburg, Germany; [Chadt, Alexandra] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, D-40225 Dusseldorf, Germany; [Toele, Jonas] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Leibniz Institut fur Neurobiologie (LIN); Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schurmann, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany.	schuermann@dife.de	Montag, Dirk/D-3925-2014; Joost, Hans-Georg/J-4462-2013	Montag, Dirk/0000-0002-4964-1330; Joost, Hans-Georg/0000-0002-5860-606X; Scherneck, Stephan/0000-0002-2811-5040; Schurmann, Annette/0000-0002-4113-4377	German Ministry of Education and Research [NGFN2: 01GS0487, NGFNplus: 01GS0821, NEUROTARGET: 01GI0847, DZD: 01GI0922]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Ministry of Education and Research (NGFN2: 01GS0487; NGFNplus: 01GS0821; NEUROTARGET: 01GI0847; DZD: 01GI0922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean MK, 2008, J CLIN PSYCHOL MED S, V15, P214, DOI 10.1007/s10880-008-9124-9; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen AY, 2010, OBESITY, V18, P210, DOI 10.1038/oby.2009.185; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; Derry JMJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014319; Dong C, 2004, INT J OBESITY, V28, P790, DOI 10.1038/sj.ijo.0802626; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Faith MS, 2002, J PSYCHOSOM RES, V53, P935, DOI 10.1016/S0022-3999(02)00308-2; Gatti DM, 2009, MAMM GENOME, V20, P437, DOI 10.1007/s00335-009-9199-0; Giesen K, 2003, BIOCHEM BIOPH RES CO, V304, P812, DOI 10.1016/S0006-291X(03)00664-8; Goldfield GS, 2010, J SCHOOL HEALTH, V80, P186, DOI 10.1111/j.1746-1561.2009.00485.x; Gribaudo G, 1999, FEBS LETT, V456, P31, DOI 10.1016/S0014-5793(99)00916-3; Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122; Herva A, 2006, PSYCHOSOM MED, V68, P213, DOI 10.1097/01.psy.0000203172.02305.ea; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hillman JB, 2010, CLIN PEDIATR, V49, P671, DOI 10.1177/0009922810363155; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Johnston E, 2004, CAN J PUBLIC HEALTH, V95, P179, DOI 10.1007/BF03403643; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Kelly MA, 2003, MAMM GENOME, V14, P692, DOI 10.1007/s00335-003-2273-0; Kluge R, 2000, DIABETOLOGIA, V43, P1565, DOI 10.1007/s001250051570; Kubzansky LD, 2012, ANN BEHAV MED, V43, P219, DOI 10.1007/s12160-011-9323-8; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Milhaud JM, 2002, BEHAV GENET, V32, P69, DOI 10.1023/A:1014412029774; Montag-Sallaz M, 2003, LEARN MEMORY, V10, P99, DOI 10.1101/lm.53403; Montag-Sallaz M, 2003, GENES BRAIN BEHAV, V2, P20, DOI 10.1034/j.1601-183X.2003.00003.x; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Nadeau KJ, 2011, NAT REV CARDIOL, V8, P513, DOI 10.1038/nrcardio.2011.86; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Plum L, 2000, DIABETES, V49, P1590, DOI 10.2337/diabetes.49.9.1590; Plum L, 2002, DIABETOLOGIA, V45, P823, DOI 10.1007/s00125-002-0796-7; Rawana JS, 2010, CLIN CHILD FAM PSYCH, V13, P213, DOI 10.1007/s10567-010-0072-1; Reaven GM, 2011, MED CLIN N AM, V95, P875, DOI 10.1016/j.mcna.2011.06.002; Roberts RE, 2002, ANN BEHAV MED, V24, P169, DOI 10.1207/S15324796ABM2403_02; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Scherneck S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000541; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Turri MG, 1999, MAMM GENOME, V10, P1098, DOI 10.1007/s003359901169; Vogel H, 2012, HUM MOL GENET, V21, P3845, DOI 10.1093/hmg/dds213; Vogel H, 2009, PHYSIOL GENOMICS, V38, P226, DOI 10.1152/physiolgenomics.00011.2009; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Whishaw IQ, 1999, MODERN TECHNIQUES NE, P1243, DOI 10.1007/978-3-642-58552-4_44; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; Wyrwoll CS, 2011, FRONT NEUROENDOCRIN, V32, P265, DOI 10.1016/j.yfrne.2010.12.001; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53025	10.1371/journal.pone.0053025	http://dx.doi.org/10.1371/journal.pone.0053025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308133	gold, Green Published, Green Submitted			2022-12-27	WOS:000313670100015
J	Haugen, MH; Johansen, HT; Pettersen, SJ; Solberg, R; Brix, K; Flatmark, K; Maelandsmo, GM				Haugen, Mads H.; Johansen, Harald T.; Pettersen, Solveig J.; Solberg, Rigmor; Brix, Klaudia; Flatmark, Kjersti; Maelandsmo, Gunhild M.			Nuclear Legumain Activity in Colorectal Cancer	PLOS ONE			English	Article							CYSTEINE PROTEINASE-INHIBITOR; CATHEPSIN-L; MAMMALIAN LEGUMAIN; CYSTATIN-M/E; ENDOPEPTIDASE; ACTIVATION; EXPRESSION; IDENTIFICATION; LOCALIZATION; DEGRADATION	The cysteine protease legumain is involved in several biological and pathological processes, and the protease has been found over-expressed and associated with an invasive and metastatic phenotype in a number of solid tumors. Consequently, legumain has been proposed as a prognostic marker for certain cancers, and a potential therapeutic target. Nevertheless, details on how legumain advances malignant progression along with regulation of its proteolytic activity are unclear. In the present work, legumain expression was examined in colorectal cancer cell lines. Substantial differences in amounts of pro- and active legumain forms, along with distinct intracellular distribution patterns, were observed in HCT116 and SW620 cells and corresponding subcutaneous xenografts. Legumain is thought to be located and processed towards its active form primarily in the endo-lysosomes; however, the subcellular distribution remains largely unexplored. By analyzing subcellular fractions, a proteolytically active form of legumain was found in the nucleus of both cell lines, in addition to the canonical endo-lysosomal residency. In situ analyses of legumain expression and activity confirmed the endo-lysosomal and nuclear localizations in cultured cells and, importantly, also in sections from xenografts and biopsies from colorectal cancer patients. In the HCT116 and SW620 cell lines nuclear legumain was found to make up approximately 13% and 17% of the total legumain, respectively. In similarity with previous studies on nuclear variants of related cysteine proteases, legumain was shown to process histone H3.1. The discovery of nuclear localized legumain launches an entirely novel arena of legumain biology and functions in cancer.	[Haugen, Mads H.; Pettersen, Solveig J.; Flatmark, Kjersti; Maelandsmo, Gunhild M.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Haugen, Mads H.; Brix, Klaudia] Jacobs Univ Bremen, Sch Sci & Engn, Res Ctr MOLIFE Mol Life Sci, Bremen, Germany; [Johansen, Harald T.; Solberg, Rigmor] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Flatmark, Kjersti] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Gastrointestinal Surg, Oslo, Norway; [Maelandsmo, Gunhild M.] Univ Tromso, Fac Hlth Sci, Dept Pharm, Tromso, Norway	University of Oslo; Jacobs University; University of Oslo; University of Oslo; UiT The Arctic University of Tromso	Haugen, MH (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.	mads.haugen@rr-research.no	Brix, Klaudia/F-5072-2013; Mælandsmo, Gunhild Mari/AFV-4446-2022	Brix, Klaudia/0000-0002-4476-0357; Johansen, Harald Thidemann/0000-0001-6617-1732; Solberg, Rigmor/0000-0001-7205-4401	South-East regional health authorities [HSO] [2011142]; Norwegian Research Council under the Functional Genomics Program [FUGE] [158954/S10]; Soren and Jeanette Bothners legacy; Norwegian Cancer Society [PR-2006-0272]; University of Oslo; Anders Jahres foundation for the Promotion of Science; Astrid and Birger Torsteds Foundation; Nansen Foundation	South-East regional health authorities [HSO]; Norwegian Research Council under the Functional Genomics Program [FUGE]; Soren and Jeanette Bothners legacy; Norwegian Cancer Society(Norwegian Cancer Society); University of Oslo; Anders Jahres foundation for the Promotion of Science; Astrid and Birger Torsteds Foundation; Nansen Foundation	This work has been generously supported by grants from South-East regional health authorities [HSO, #2011142], www.helse-sorost.no; The Norwegian Research Council under the Functional Genomics Program [FUGE, #158954/S10], www.forskningsradet.no/fuge; Soren and Jeanette Bothners legacy and the Norwegian Cancer Society [#PR-2006-0272], www.kreftforeningen.no; The University of Oslo; Anders Jahres foundation for the Promotion of Science; Astrid and Birger Torsteds Foundation; and the Nansen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Andrade V, 2011, J HEPATOL, V55, P626, DOI 10.1016/j.jhep.2010.12.022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs JJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-17; Brix K, 1996, ENDOCRINOLOGY, V137, P1963, DOI 10.1210/en.137.5.1963; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Chan CB, 2009, P NATL ACAD SCI USA, V106, P468, DOI 10.1073/pnas.0809824105; CHANTRET I, 1994, J CELL SCI, V107, P213; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Chen JM, 2000, BIOCHEM J, V352, P327, DOI 10.1042/0264-6021:3520327; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Dall E, 2012, ACTA CRYSTALLOGR F, V68, P24, DOI 10.1107/S1744309111048020; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Flatmark K, 2004, EUR J CANCER, V40, P1593, DOI 10.1016/j.ejca.2004.02.023; Flatmark K, 2003, J PATHOL, V200, P589, DOI 10.1002/path.1381; Gawenda J, 2007, BREAST CANCER RES TR, V102, P1, DOI 10.1007/s10549-006-9311-z; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; HARANISHIMURA I, 1993, PLANT CELL, V5, P1651, DOI 10.1105/tpc.5.11.1651; Herskowitz JH, 2012, PROTEOMICS, V12, P2455, DOI 10.1002/pmic.201200006; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Jedeszko C., 2008, CURR PROTOC CELL BIO; Johansen HT, 1999, ANAL BIOCHEM, V273, P278, DOI 10.1006/abio.1999.4221; Jordans S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-23; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; KEMBHAVI AA, 1993, ARCH BIOCHEM BIOPHYS, V303, P208, DOI 10.1006/abbi.1993.1274; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lecaille F, 2004, BIOL CHEM, V385, P511, DOI 10.1515/BC.2004.060; Liao D, 2011, NANOMED-NANOTECHNOL, V7, P665, DOI 10.1016/j.nano.2011.03.001; Liu C, 2003, CANCER RES, V63, P2957; Liu YH, 2011, LOCATION, LOCALIZATION, AND LOCALIZABILITY: LOCATION-AWARENESS TECHNOLOGY FOR WIRELESS NETWORKS, P9, DOI 10.1007/978-1-4419-7371-9_2; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Miller G, 2011, FASEB J, V25, P1606, DOI 10.1096/fj.10-172312; Murthy RV, 2005, CLIN CANCER RES, V11, P2293, DOI 10.1158/1078-0432.CCR-04-1642; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Ni J, 1997, J BIOL CHEM, V272, P10853; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Overbye A, 2011, AUTOPHAGY, V7, P1011, DOI 10.4161/auto.7.9.16436; Patel N, 2009, J CLIN INVEST, V119, P1964, DOI 10.1172/JCI37977; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Smith R, 2012, BIOCHIMIE, V94, P2590, DOI 10.1016/j.biochi.2012.07.026; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Sullivan S, 2009, INT J CANCER, V125, P54, DOI 10.1002/ijc.24275; Tedelind S, 2010, BIOL CHEM, V391, P923, DOI 10.1515/BC.2010.109; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Wu BH, 2010, J BIOL CHEM, V285, P1790, DOI 10.1074/jbc.M109.049064; Yamane T, 2002, BBA-PROTEIN STRUCT M, V1596, P108, DOI 10.1016/S0167-4838(02)00209-1; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zeeuwen PLJM, 2004, HUM MOL GENET, V13, P1069, DOI 10.1093/hmg/ddh115; Zeeuwen PLJM, 2010, FASEB J, P10; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	58	57	58	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52980	10.1371/journal.pone.0052980	http://dx.doi.org/10.1371/journal.pone.0052980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326369	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400011
J	Sriyudthsak, K; Shiraishi, F; Hirai, MY				Sriyudthsak, Kansuporn; Shiraishi, Fumihide; Hirai, Masami Yokota			Identification of a Metabolic Reaction Network from Time-Series Data of Metabolite Concentrations	PLOS ONE			English	Article							BIOCHEMICAL SYSTEMS-ANALYSIS; LACTIC-ACID BACTERIA; IN-VIVO; LACTOCOCCUS-LACTIS; KINETICS; LAW; BOTTLENECK	Recent development of high-throughput analytical techniques has made it possible to qualitatively identify a number of metabolites simultaneously. Correlation and multivariate analyses such as principal component analysis have been widely used to analyse those data and evaluate correlations among the metabolic profiles. However, these analyses cannot simultaneously carry out identification of metabolic reaction networks and prediction of dynamic behaviour of metabolites in the networks. The present study, therefore, proposes a new approach consisting of a combination of statistical technique and mathematical modelling approach to identify and predict a probable metabolic reaction network from time-series data of metabolite concentrations and simultaneously construct its mathematical model. Firstly, regression functions are fitted to experimental data by the locally estimated scatter plot smoothing method. Secondly, the fitted result is analysed by the bivariate Granger causality test to determine which metabolites cause the change in other metabolite concentrations and remove less related metabolites. Thirdly, S-system equations are formed by using the remaining metabolites within the framework of biochemical systems theory. Finally, parameters including rate constants and kinetic orders are estimated by the Levenberg-Marquardt algorithm. The estimation is iterated by setting insignificant kinetic orders at zero, i.e., removing insignificant metabolites. Consequently, a reaction network structure is identified and its mathematical model is obtained. Our approach is validated using a generic inhibition and activation model and its practical application is tested using a simplified model of the glycolysis of Lactococcus lactis MG1363, for which actual time-series data of metabolite concentrations are available. The results indicate the usefulness of our approach and suggest a probable pathway for the production of lactate and acetate. The results also indicate that the approach pinpoints a probable strong inhibition of lactate on the glycolysis pathway.	[Sriyudthsak, Kansuporn; Hirai, Masami Yokota] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Sriyudthsak, Kansuporn; Hirai, Masami Yokota] CREST, JST, Kawaguchi, Saitama, Japan; [Shiraishi, Fumihide] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan	RIKEN; Japan Science & Technology Agency (JST); Kyushu University	Shiraishi, F (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan.	fumishira@brs.kyushu-u.ac.jp; myhirai@psc.riken.jp	Sriyudthsak, Kansuporn/C-3664-2017; Hirai, Masami Y/D-5319-2009	Sriyudthsak, Kansuporn/0000-0001-9070-4092; Hirai, Masami Y/0000-0003-0802-6208	Japan Science and Technology Agency, CREST	Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Japan Science and Technology Agency, CREST to MYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bujara M, 2011, NAT CHEM BIOL, V7, P271, DOI 10.1038/nchembio.541; Chou IC, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-25; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Gavin H, 2011, ENV ENG, P1; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hoefnagel MHN, 2002, MICROBIOL-SGM, V148, P1003, DOI 10.1099/00221287-148-4-1003; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kutalik Z, 2007, IET SYST BIOL, V1, P174, DOI 10.1049/iet-syb:20060064; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Marino Simeone, 2006, Journal of Bioinformatics and Computational Biology, V4, P665, DOI 10.1142/S0219720006002259; Marquardt D., 1963, INT J COMPUT VISION, V11, P431, DOI DOI 10.1137/0111030; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2002, APPL ENVIRON MICROB, V68, P6332, DOI 10.1128/AEM.68.12.6332-6342.2002; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Papagianni M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-16; Ramos A, 2002, ANTON LEEUW INT J G, V82, P249, DOI 10.1023/A:1020664422633; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; SAVAGEAU MA, 1970, J THEOR BIOL, V26, P215, DOI 10.1016/S0022-5193(70)80013-3; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P37, DOI 10.1093/pcp/pcn183; Shuler M. L., 2002, BIOPROCESS ENG BASIC; Sriyudthsak K, 2010, MATH BIOSCI, V228, P1, DOI 10.1016/j.mbs.2010.08.001; Sriyudthsak K, 2010, IND ENG CHEM RES, V49, P9738, DOI 10.1021/ie100911h; Vilela M, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-47; Voet D., 2010, BIOCHEMISTRY; Voit EO, 2006, IEE P SYST BIOL, V153, P286, DOI 10.1049/ip-syb:20050087; Voit E. O., 2000, COMPUTATIONAL ANAL B; Walther D, 2010, OMICS, V14, P261, DOI 10.1089/omi.2010.0010	31	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e51212	10.1371/journal.pone.0051212	http://dx.doi.org/10.1371/journal.pone.0051212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326311	gold, Green Submitted, Green Published			2022-12-27	WOS:000313552400003
J	Ahn, SH; Tsalik, EL; Cyr, DD; Zhang, YR; van Velkinburgh, JC; Langley, RJ; Glickman, SW; Cairns, CB; Zaas, AK; Rivers, EP; Otero, RM; Veldman, T; Kingsmore, SF; Lucas, J; Woods, CW; Ginsburg, GS; Fowler, VG				Ahn, Sun Hee; Tsalik, Ephraim L.; Cyr, Derek D.; Zhang, Yurong; van Velkinburgh, Jennifer C.; Langley, Raymond J.; Glickman, Seth W.; Cairns, Charles B.; Zaas, Aimee K.; Rivers, Emanuel P.; Otero, Ronny M.; Veldman, Tim; Kingsmore, Stephen F.; Lucas, Joseph; Woods, Christopher W.; Ginsburg, Geoffrey S.; Fowler, Vance G., Jr.			Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CRITICALLY-ILL PATIENTS; GRAM-NEGATIVE BACTERIA; CELL-WALL COMPONENTS; SEPTIC SHOCK; ANIMAL-MODELS; INFLAMMATORY RESPONSE; EMERGENCY-DEPARTMENT; POSITIVE SEPSIS; HUMAN MONOCYTES	Staphylococcus aureus causes a spectrum of human infection. Diagnostic delays and uncertainty lead to treatment delays and inappropriate antibiotic use. A growing literature suggests the host's inflammatory response to the pathogen represents a potential tool to improve upon current diagnostics. The hypothesis of this study is that the host responds differently to S. aureus than to E. coli infection in a quantifiable way, providing a new diagnostic avenue. This study uses Bayesian sparse factor modeling and penalized binary regression to define peripheral blood gene-expression classifiers of murine and human S. aureus infection. The murine-derived classifier distinguished S. aureus infection from healthy controls and Escherichia coli-infected mice across a range of conditions (mouse and bacterial strain, time post infection) and was validated in outbred mice (AUC>0.97). A S. aureus classifier derived from a cohort of 94 human subjects distinguished S. aureus blood stream infection (BSI) from healthy subjects (AUC 0.99) and E. coli BSI (AUC 0.84). Murine and human responses to S. aureus infection share common biological pathways, allowing the murine model to classify S. aureus BSI in humans (AUC 0.84). Both murine and human S. aureus classifiers were validated in an independent human cohort (AUC 0.95 and 0.92, respectively). The approach described here lends insight into the conserved and disparate pathways utilized by mice and humans in response to these infections. Furthermore, this study advances our understanding of S. aureus infection; the host response to it; and identifies new diagnostic and therapeutic avenues.	[Ahn, Sun Hee; Tsalik, Ephraim L.; Zhang, Yurong; Zaas, Aimee K.; Woods, Christopher W.; Fowler, Vance G., Jr.] Duke Univ, Dept Med, Div Infect Dis & Int Hlth, Durham, NC USA; [Tsalik, Ephraim L.; Woods, Christopher W.] Durham Vet Affairs Med Ctr, Infect Dis Sect, Durham, NC USA; [Cyr, Derek D.; Zaas, Aimee K.; Veldman, Tim; Woods, Christopher W.; Ginsburg, Geoffrey S.; Fowler, Vance G., Jr.] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27706 USA; [van Velkinburgh, Jennifer C.] van Velkinburgh Initiat Collaborat BioMed Res, Santa Fe, NM USA; [Langley, Raymond J.] Lovelace Resp Res Inst, Div Immunol, Albuquerque, NM USA; [Glickman, Seth W.; Cairns, Charles B.] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC USA; [Rivers, Emanuel P.; Otero, Ronny M.] Wayne State Univ, Henry Ford Hosp, Dept Emergency Med, Detroit, MI USA; [Kingsmore, Stephen F.] Childrens Mercy Hosp & Clin, Ctr Pediat Genom Med, Kansas City, MO USA; [Fowler, Vance G., Jr.] Duke Clin Res Inst, Durham, NC USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Lovelace Respiratory Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Henry Ford Health System; Henry Ford Hospital; Wayne State University; Children's Mercy Hospital; Duke University	Ginsburg, GS (corresponding author), Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27706 USA.	Geoffrey.ginsburg@duke.edu; vance.fowler@duke.edu	Ha, Dat Thinh/D-4995-2015; Fowler, Vance/AAW-2017-2021; van Velkinburgh, Jennifer/D-7205-2015	Ha, Dat Thinh/0000-0003-4260-4876; Kingsmore, Stephen/0000-0001-7180-2527; kingsmore, stephen/0000-0002-3758-4631; Tsalik, Ephraim/0000-0002-6417-2042; van Velkinburgh, Jennifer/0000-0002-4592-2397	National Institute of Allergy and Infectious Diseases [R01-AI068804, K24-AI093969, 5U01AI066569-05, 3U01AI066569-05S1]; Wallace H. Coulter Foundation; Novartis Vaccines and Diagnostics, Inc.; Cubist Pharmaceuticals; Novartis Pharmaceuticals; Roche Molecular Diagnostics; Veterans Affairs Career Development Award; Astellas Pharma US; Merck; Theravance; Cerexa; Pfizer; Novartis; MedImmune; Advance Liquid Logic; National Institutes of Health; Agennix AG; Alere Corporation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068804, U01AI066569, K24AI093969] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wallace H. Coulter Foundation; Novartis Vaccines and Diagnostics, Inc.; Cubist Pharmaceuticals; Novartis Pharmaceuticals(Novartis); Roche Molecular Diagnostics; Veterans Affairs Career Development Award; Astellas Pharma US(Astellas Pharmaceuticals); Merck(Merck & Company); Theravance; Cerexa; Pfizer(Pfizer); Novartis(Novartis); MedImmune(AstraZenecaMedimmune); Advance Liquid Logic; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agennix AG; Alere Corporation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R01-AI068804 and K24-AI093969 from the National Institute of Allergy and Infectious Diseases (VGF), 5U01AI066569-05 and 3U01AI066569-05S1 from the National Institute of Allergy and Infectious Diseases (SFK), and the Wallace H. Coulter Foundation (AKZ and GSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: CBC and CWW have served as consultants for bioMerieux Inc. ELT, CWW, and GSG received research funding from Novartis Vaccines and Diagnostics, Inc. In the past 12 months, CWW has served as a consultant to Becton, Dickinson and Company, and Gilead Sciences; and has received research or grant support from Cubist Pharmaceuticals, Novartis Pharmaceuticals, and Roche Molecular Diagnostics. ELT is supported by a Veterans Affairs Career Development Award. In the past 12 months, VGF has received grant or research support from Astellas Pharma US, Merck, Theravance, Cerexa, Pfizer, Novartis, MedImmune, Advance Liquid Logic, and the National Institutes of Health; has served as a consultant for Achaogen, Merck, Novartis, Pfizer, NovaDigm Therapeutics, The Medicines Company, Durata Therapeutics, Galderma, and Biosynexus; and is on the Advisory Committee for Cubist Pharmaceuticals. AKZ is a consultant for Covance. EPR receives research support from Agennix AG, Alere Corporation, and National Institutes of Health; and has previously served as a consultant for Agennix AG, Eisai Pharmaceuticals, Idaho Technology, AstraZeneca, Masimo, and Sangard. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Chang JT, 2009, MOL CELL, V34, P104, DOI 10.1016/j.molcel.2009.02.030; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen M, 2011, J AM STAT A IN PRESS; Chen MH, 2011, IEEE T BIO-MED ENG, V58, P468, DOI 10.1109/TBME.2010.2059702; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Cross ML, 2004, FEMS IMMUNOL MED MIC, V42, P173, DOI 10.1016/j.femsim.2004.04.001; Cyr DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021854; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Desai KV, 2002, ENDOCR-RELAT CANCER, V9, P207, DOI 10.1677/erc.0.0090207; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Dziarski R, 2001, J IMMUNOL, V166, P1938, DOI 10.4049/jimmunol.166.3.1938; Esmon CT, 2004, CRIT CARE MED, V32, pS219, DOI 10.1097/01.CCM.0000127036.27343.48; Feezor RJ, 2003, INFECT IMMUN, V71, P5803, DOI 10.1128/IAI.71.10.5803-5813.2003; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Glickman SW, 2010, ACAD EMERG MED, V17, P383, DOI 10.1111/j.1553-2712.2010.00664.x; Hans C, 2007, J AM STAT ASSOC, V102, P507, DOI 10.1198/016214507000000121; He M, 2010, CLIN CANCER RES, V16, P249, DOI 10.1158/1078-0432.CCR-09-1602; Hessle CC, 2005, CYTOKINE, V30, P311, DOI 10.1016/j.cyto.2004.05.008; Kawada J, 2006, J GEN VIROL, V87, P1677, DOI 10.1099/vir.0.81670-0; Kim HS, 2005, INFECT IMMUN, V73, P3714, DOI 10.1128/IAI.73.6.3714-3724.2005; KIM JH, 1989, AM J MED, V87, P201; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; LaBreche HG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-61; Larsson O, 2004, CANCER RES, V64, P482, DOI 10.1158/0008-5472.CAN-03-1872; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; Lucas J, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1436; Lucas JE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000920; Lytkin NI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020662; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McDunn JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001564; Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535; Merl D, 2009, OXFORD HDB APPL BAYE; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MILLER RL, 1972, BIOCHEMISTRY-US, V11, P4723, DOI 10.1021/bi00775a014; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699; Nau GJ, 2003, J IMMUNOL, V170, P5203, DOI 10.4049/jimmunol.170.10.5203; Ng HH, 2005, GENOMICS, V86, P657, DOI 10.1016/j.ygeno.2005.07.005; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Sriskandan S, 1999, INFECT DIS CLIN N AM, V13, P397, DOI 10.1016/S0891-5520(05)70082-9; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; Timofeeva AV, 2009, KARDIOLOGIYA, V49, P27; Tsalik EL, 2010, J CLIN MICROBIOL, V48, P26, DOI 10.1128/JCM.01447-09; Unsinger J, 2009, J LEUKOCYTE BIOL, V86, P219, DOI 10.1189/jlb.1008615; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Voora D, 2010, CIRCULATION, V122; WANG Q, 2007, B INT SOC BAYESIAN A, V14, P4; Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S; Wennmalm K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r109; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yu SL, 2004, AM J RESP CRIT CARE, V169, P1135, DOI 10.1164/rccm.200211-1278OC; Zaas AK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000715; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001; Zhang H, 2006, MICROBES INFECT, V8, P2172, DOI 10.1016/j.micinf.2006.04.018	73	39	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e48979	10.1371/journal.pone.0048979	http://dx.doi.org/10.1371/journal.pone.0048979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326304	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500002
J	Chen, F; Griffith, A; Cottrell, A; Wong, YL				Chen, Frederick; Griffith, Amanda; Cottrell, Allin; Wong, Yue-Ling			Behavioral Responses to Epidemics in an Online Experiment: Using Virtual Diseases to Study Human Behavior	PLOS ONE			English	Article							PUBLIC PERCEPTIONS; RISK; VACCINATION; POPULATION; PREVALENCE; AVOIDANCE; DYNAMICS; DECLINES; MODEL	We report the results of a study we conducted using a simple multiplayer online game that simulates the spread of an infectious disease through a population composed of the players. We use our virtual epidemics game to examine how people respond to epidemics. The analysis shows that people's behavior is responsive to the cost of self-protection, the reported prevalence of disease, and their experiences earlier in the epidemic. Specifically, decreasing the cost of self-protection increases the rate of safe behavior. Higher reported prevalence also raises the likelihood that individuals would engage in self-protection, where the magnitude of this effect depends on how much time has elapsed in the epidemic. Individuals' experiences in terms of how often an infection was acquired when they did not engage in self-protection are another factor that determines whether they will invest in preventive measures later on. All else being equal, individuals who were infected at a higher rate are more likely to engage in self-protective behavior compared to those with a lower rate of infection. Lastly, fixing everything else, people's willingness to engage in safe behavior waxes or wanes over time, depending on the severity of an epidemic: when prevalence is high, people are more likely to adopt self-protective measures as time goes by; when prevalence is low, a 'self-protection fatigue' effect sets in whereby individuals are less willing to engage in safe behavior over time.	[Chen, Frederick; Griffith, Amanda; Cottrell, Allin] Wake Forest Univ, Dept Econ, Winston Salem, NC 27109 USA; [Wong, Yue-Ling] Wake Forest Univ, Dept Comp Sci, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University	Chen, F (corresponding author), Wake Forest Univ, Dept Econ, Winston Salem, NC 27109 USA.	chenfh@wfu.edu		Chen, Frederick/0000-0003-4746-0752	Wake Forest University	Wake Forest University	This work was funded by Wake Forest University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2010, P NATL ACAD SCI USA, V107, P1696, DOI 10.1073/pnas.0906078107; ANDERSON R M, 1991; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Breban R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031127; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Chen FH, 2004, THEOR POPUL BIOL, V66, P307, DOI 10.1016/j.tpb.2004.07.004; Chen FH, 2006, J MATH BIOL, V53, P253, DOI 10.1007/s00285-006-0006-1; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Gordon R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S13; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Kagel J., 1997, HDB EXPT EC; Lau JTF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-139; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Plott C.R., 2008, HDB EXPT EC RESULTS, V1; Reluga TC, 2006, MATH BIOSCI, V204, P185, DOI 10.1016/j.mbs.2006.08.015; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Shim E, 2012, J THEOR BIOL, V295, P194, DOI 10.1016/j.jtbi.2011.11.005; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; UNAIDS, 2001, HIV PREVENTION NEEDS; UNAIDS, 2010, GLOBAL REPORT UNAIDS; Warner L, 2006, SEX TRANSM DIS, V33, P36, DOI 10.1097/01.olq.0000187908.42622.fd; Wells CR, 2012, EPIDEMICS-NETH, V4, P139, DOI 10.1016/j.epidem.2012.06.002; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2007, THE WORLD HEALTH REP	30	27	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52814	10.1371/journal.pone.0052814	http://dx.doi.org/10.1371/journal.pone.0052814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326360	Green Submitted, gold, Green Published			2022-12-27	WOS:000313551500031
J	Gomez-Valdes, J; Hunemeier, T; Quinto-Sanchez, M; Paschetta, C; de Azevedo, S; Gonzalez, MF; Martinez-Abadias, N; Esparza, M; Pucciarelli, HM; Salzano, FM; Bau, CHD; Bortolini, MC; Gonzalez-Jose, R				Gomez-Valdes, Jorge; Huenemeier, Tabita; Quinto-Sanchez, Mirsha; Paschetta, Carolina; de Azevedo, Soledad; Gonzalez, Marina F.; Martinez-Abadias, Neus; Esparza, Mireia; Pucciarelli, Hector M.; Salzano, Francisco M.; Bau, Claiton H. D.; Bortolini, Maria Catira; Gonzalez-Jose, Rolando			Lack of Support for the Association between Facial Shape and Aggression: A Reappraisal Based on a Worldwide Population Genetics Perspective	PLOS ONE			English	Article							WEST CRANIAL DIFFERENTIATION; STRUCTURE PREDICTS; CRANIOMETRIC VARIATION; SEXUAL SELECTION; FACE; TESTOSTERONE; COMPETITION; VIOLENCE; WIDTH; MEN	Antisocial and criminal behaviors are multifactorial traits whose interpretation relies on multiple disciplines. Since these interpretations may have social, moral and legal implications, a constant review of the evidence is necessary before any scientific claim is considered as truth. A recent study proposed that men with wider faces relative to facial height (fWHR) are more likely to develop unethical behaviour mediated by a psychological sense of power. This research was based on reports suggesting that sexual dimorphism and selection would be responsible for a correlation between fWHR and aggression. Here we show that 4,960 individuals from 94 modern human populations belonging to a vast array of genetic and cultural contexts do not display significant amounts of fWHR sexual dimorphism. Further analyses using populations with associated ethnographical records as well as samples of male prisoners of the Mexico City Federal Penitentiary condemned by crimes of variable level of inter-personal aggression (homicide, robbery, and minor faults) did not show significant evidence, suggesting that populations/individuals with higher levels of bellicosity, aggressive behaviour, or power-mediated behaviour display greater fWHR. Finally, a regression analysis of fWHR on individual's fitness showed no significant correlation between this facial trait and reproductive success. Overall, our results suggest that facial attributes are poor predictors of aggressive behaviour, or at least, that sexual selection was weak enough to leave a signal on patterns of between- and within-sex and population facial variation.	[Gomez-Valdes, Jorge] Univ Nacl Autonoma Mexico, Fac Med, Dept Anat, Mexico City 04510, DF, Mexico; [Huenemeier, Tabita; Salzano, Francisco M.; Bau, Claiton H. D.; Bortolini, Maria Catira] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Quinto-Sanchez, Mirsha; Paschetta, Carolina; de Azevedo, Soledad; Gonzalez, Marina F.; Gonzalez-Jose, Rolando] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Argentina; [Martinez-Abadias, Neus] Univ Pompeu Fabra, Ctr Genom Regulat, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Esparza, Mireia] Univ Barcelona, Dept Biol Anim, Seccio Antropol, Barcelona, Spain; [Pucciarelli, Hector M.] Consejo Nacl Invest Cient & Tecn, Div Antropol, Museo La Plata, La Plata, Buenos Aires, Argentina	Universidad Nacional Autonoma de Mexico; Universidade Federal do Rio Grande do Sul; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Barcelona; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata	Gonzalez-Jose, R (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Argentina.	rolando@cenpat.edu.ar	Esparza, Mireia/L-5059-2014; Bau, Claiton Henrique Dotto/C-9980-2013; Salzano, Francisco M/L-7916-2015; Hünemeier, Tábita/F-4181-2011; Martinez-Abadias, Neus/H-2029-2015	Esparza, Mireia/0000-0002-3925-4142; Bau, Claiton Henrique Dotto/0000-0001-5644-3845; Paschetta, Carolina/0000-0002-5869-3570; Hunemeier, Tabita/0000-0002-3156-2079; Martinez-Abadias, Neus/0000-0003-3061-2123; Gonzalez-Jose, Rolando/0000-0002-8128-9381				Abbink JG, 1999, ETHNOLOGY, V38, P227, DOI 10.2307/3773815; Andersson Malte, 1994; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Bautista J, 1998, CRANEOMETRIA DE REOS; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Cicchetti D., 2006, DEV PSYCHOPATHOL, V2, P1; de Azevedo S, 2011, AM J PHYS ANTHROPOL, V146, P539, DOI 10.1002/ajpa.21564; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; FOLEY RA, 1991, ORIGINS HUMAN BEHAV, P25; GALL FJ, 1835, ON THE FUNCTIONS OF; Gonzalez-Jose R, 2004, AM J PHYS ANTHROPOL, V123, P69, DOI 10.1002/ajpa.10302; Gonzalez-Jose R, 2001, AM J PHYS ANTHROPOL, V116, P154, DOI 10.1002/ajpa.1108; Gonzalez-Jose R, 2008, AM J PHYS ANTHR, V137; Gonzalez-Jose RG, 2003, NATURE, V425, P62, DOI 10.1038/nature01816; Gonzalez-Jose R, 2007, P ROY SOC B-BIOL SCI, V274, P681, DOI 10.1098/rspb.2006.0151; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Howells W.W., 1989, PAPERS PEABODY MUSEU; Howells WW, 1973, PAPERS OF THE PEABOD; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; Jones AG, 2005, INTEGR COMP BIOL, V45, P874, DOI 10.1093/icb/45.5.874; Jose RG, 2002, AM J HUM BIOL, V14, P308, DOI 10.1002/ajhb.10033; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Lefevre CE, 2012, EVOL HUM BEHAV IN PR; Lombroso C., 1876, LUOMO DELINQUENTE; Martinez-Abadias N, 2012, EVOLUTION, V66, P1010, DOI 10.1111/j.1558-5646.2011.01496.x; Martinez-Abadias N, 2009, J ANAT, V214, P19, DOI 10.1111/j.1469-7580.2008.01015.x; Murdoch GP, 1967, ETHNOGRAPHIC ATLAS A; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Paschetta C, 2010, AM J PHYS ANTHROPOL, V141, P297, DOI 10.1002/ajpa.21151; Peskin M, 2004, PERCEPTION, V33, P147, DOI 10.1068/p5028; PINKER S, 2011, THE BETTER ANGELS OF; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Price ME, 2012, EVOL HUM BEHAV, V33, P174, DOI 10.1016/j.evolhumbehav.2011.08.004; Pucciarelli HM, 2008, J HUM EVOL, V54, P296, DOI 10.1016/j.jhevol.2007.08.011; Pucciarelli HM, 2006, HOMO, V57, P133, DOI 10.1016/j.jchb.2005.12.003; Pucciarelli HM, 2003, QUATERN INT, V109, P123, DOI 10.1016/S1040-6182(02)00208-2; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Relethford JH, 1997, HUM BIOL, V69, P443; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P249; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2012, EVOL HUM BEHAV, V33, P551, DOI 10.1016/j.evolhumbehav.2012.02.002; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Travis CB, 2003, EVOLUTION GENDER AND; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Weston EM, 2004, P ROY SOC B-BIOL SCI, V271, pS416, DOI 10.1098/rsbl.2004.0203; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838	50	43	45	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52317	10.1371/journal.pone.0052317	http://dx.doi.org/10.1371/journal.pone.0052317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326328	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500012
J	Jing, SS; Yin, AT; Shi, LZ; Liu, JN				Jing, Shanshan; Yin, Aitian; Shi, Lizheng; Liu, Jinan			Whether New Cooperative Medical Schemes Reduce the Economic Burden of Chronic Disease in Rural China	PLOS ONE			English	Article							CATASTROPHIC HEALTH EXPENDITURE; IMPOVERISHMENT; CARE	Background: The New Cooperative Medical Scheme (NCMS) provides health insurance coverage for rural populations in China. This study aimed to evaluate changes in household catastrophic health expenditure (CHE) due to chronic disease before and after the reimbursement policies for services of chronic disease were implemented to provide additional financial support. Methods: The study used data from the household surveys conducted in Shandong Province and Ningxia Hui Autonomous Region in 2006 and 2008. The study sample in village-level units was divided into two groups: 36 villages which implemented the NCMS reimbursement policies for chronic diseases as the intervention group, and 72 villages which did not as the control group. Health care expenditure of more than 40% of household's non-food expenditure was defined as a household with CHE (i.e., impoverishment). The conceptual framework was established based on the Andersen socio-behavioral model of health care utilization to explore how the NCMS reimbursement policies impacted health expenditures. A difference-in-difference model was employed to compare the change in the proportion of households incurring CHE due to chronic disease between the two groups over time. Results: The households that participated in the NCMS were less likely to become impoverished (P<0.05). In addition, the households with both male household head and higher income level were protective factors to prevent CHE (P<0.05). Young households with preschool children suffered less from CHE (P<0.05). The effect of the NCMS reimbursement policies for chronic disease on the CHE was negative, yet not statistically significant (p = 0.814). Conclusions: The NCMS coverage showed financial protection for households with chronic disease. However, the NCMS reimbursement policies should be strengthened in the future.	[Jing, Shanshan; Yin, Aitian] Shandong Univ, Ctr Hlth Management & Policy, Jinan 250100, Shandong, Peoples R China; [Shi, Lizheng; Liu, Jinan] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA	Shandong University; Tulane University	Shi, LZ (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA.	lshi1@tulane.edu			European Commission (Specific Targeted Research Project); Liverpool School of Tropical Medicine [015305]; China Scholarship Council	European Commission (Specific Targeted Research Project); Liverpool School of Tropical Medicine; China Scholarship Council(China Scholarship Council)	The data used for the paper were derived from the study conducted as part of a project entitled "Bringing health care to the vulnerable: developing equitable and sustainable rural health insurance in China and Vietnam (RHINCAV)'' funded by the European Commission (Specific Targeted Research Project) and coordinated by the Liverpool School of Tropical Medicine (grant number 015305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the participants. The government scholarship support from China Scholarship Council and comments from Jacob E Kendall on an earlier draft of this paper are equally appreciated. We also thank the comments from four anonymous reviewers.	[Anonymous], 2005, PREV CHRON DIS VIT I; Carrin G, 1999, SOC SCI MED, V48, P961, DOI 10.1016/S0277-9536(98)00396-7; Carrin G, 2004, REACHING UNIVERSAL C; Carrin G, 2005, ACHIEVING UNIVERSAL; Center for health statistics and information MOH, 2009, AN REP NAT HLTH SERV, P8; Committee CGPG, 2002, DEC CENTR COMM COMM; FENG XS, 1995, SOC SCI MED, V41, P1111; Hu J, 2007, CHIN J PREVCONTRCHRO, V15, P189; Jing S, 2010, CHINESE HLTH SERVICE, V2, P76; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; Qian D, 2007, CHINESE HLTH MANAGEM, V225, P194; Sun Q, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-42; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang Y, 2011, J NANJING AGR U SOCI, V11, P33; WYSZEWIANSKI L, 1986, INQUIRY-J HEALTH CAR, V23, P382; WYSZEWIANSKI L, 1986, HEALTH SERV RES, V21, P617; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006; Yin A, 2010, CHINESE HLTH EC, V2, P38; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066; Yu BR, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-116; Zhang LY, 2010, TROP MED INT HEALTH, V15, P468, DOI 10.1111/j.1365-3156.2010.02469.x	24	39	44	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53062	10.1371/journal.pone.0053062	http://dx.doi.org/10.1371/journal.pone.0053062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326382	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500048
J	Lei, WB; Jiang, AY; Chai, LP; Zhu, XL; Wang, ZF; Wen, YH; Su, ZZ; Wen, WP				Lei, Wen-bin; Jiang, Ai-yun; Chai, Li-ping; Zhu, Xiao-lin; Wang, Zhang-feng; Wen, Yi-hui; Su, Zhen-zhong; Wen, Wei-ping			Middle Frontal Horizontal Partial Laryngectomy (MFHPL): A Treatment for Stage T1b Squamous Cell Carcinoma of the Glottic Larynx Involving Anterior Vocal Commissure	PLOS ONE			English	Article							CANCER; RADIOTHERAPY; SURGERY	Objective: The therapeutic effect of middle frontal horizontal partial laryngectomy (MFHPL) in treating stage T1b squamous cell carcinoma of the glottic larynx involving anterior vocal commissure (AVC) was compared with that of the anterior frontolateral vertical partial laryngectomy (AFVPL). The feasibility and practical significance of MFHPL in clinical application was discussed in the present study. Methods: From January 1996 to January 2010, a total of 65 patients diagnosed with stage T1bN0M0 glottic laryngeal cancer were treated with MFHPL or AFVPL. The postoperative complications, glottic reconstruction, recurrence rate, voice quality and survival rates were evaluated and compared between two treatments. Results: AFVPL and MFHPL were performed in 34 and 31 patients, respectively. Flexible fiberoptic laryngoscopy revealed that in the MFHPL-treated patients the reconstructed glottis was spacious and symmetric. In contrast, AFVPL treatment resulted in irregular glottic area with poor symmetry and tubular glottis. The incidence of postoperative laryngeal stenosis significantly differed between the MFHPL- and AFVPL-treated groups (P = 0.025). No significant difference was detected in the 3- and 5-year overall-or tumor-free survival rates between two treatments. The Voice Handicap Index (VHI) and maximum phonation time (MPT) after surgery were 51.0 +/- 12.99 and 12.42 +/- 3.44 sec in the AFVPL-treated group; while in the MFHPL-treated patients they were 31.81 +/- 7.48 and 7.65 +/- 1.98 sec, respectively. Both differences in VHI (P = 0.012) and MPT (P = 0.024) were significant between two treatments. Conclusions: MFHPL was comparable to AFVPL with respect to postoperative complications, recurrence rate and survival rates, but possessed advantages over AFVPL in terms of the incidence of laryngeal stenosis and voice quality. Our study indicated that MFHPL has a potential value in clinical practice of treating stage T1b squamous cell carcinoma of the glottic larynx involving AVC.	[Lei, Wen-bin; Jiang, Ai-yun; Chai, Li-ping; Zhu, Xiao-lin; Wang, Zhang-feng; Wen, Yi-hui; Su, Zhen-zhong; Wen, Wei-ping] Sun Yat Sen Univ, Affiliated Hosp 1, Natl Key Dept Otorhinolaryngol Peoples Republ Chi, Otorhinolaryngol Hosp,Otorhinolaryngol Inst, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Su, ZZ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Natl Key Dept Otorhinolaryngol Peoples Republ Chi, Otorhinolaryngol Hosp,Otorhinolaryngol Inst, Guangzhou 510275, Guangdong, Peoples R China.	szhzh@163.com; wwp1901@yahoo.com.cn	温, 家琦/GYV-3177-2022		National Natural Science Foundation of China [81072224]; Young Faculty Cultivation Project of Sun Yat-sen University [10ykpy10]; Science and Technology Planning Project of Guangdong Province [2009B030801109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Faculty Cultivation Project of Sun Yat-sen University; Science and Technology Planning Project of Guangdong Province	This study was supported by National Natural Science Foundation of China (81072224), Young Faculty Cultivation Project of Sun Yat-sen University (10ykpy10) and Science and Technology Planning Project of Guangdong Province (2009B030801109): 1) National Natural Science Foundation of China, http://www.nsfc.gov.cn/Portal0/default166.htm; 2) Science and Technology Planning Project of Guangdong Province, http://pro.gdstc.gov.cn/stms/main.jsp; 3) Young Faculty Cultivation Project of Sun Yat-sen University, http://mso.sysu.edu.cn/sysufund/Index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey BJ, 1985, SURGERY LARYNX, P257; Bradley PJ, 2006, EUR ARCH OTO-RHINO-L, V263, P879, DOI 10.1007/s00405-006-0138-3; Chone CT, 2007, ARCH OTOLARYNGOL, V133, P882, DOI 10.1001/archotol.133.9.882; Dong P, 2009, OTOLARYNG HEAD NECK, V141, P70, DOI 10.1016/j.otohns.2009.02.007; Ganly I, 2009, HEAD NECK-J SCI SPEC, V31, P338, DOI 10.1002/hed.20975; Herranz J, 2007, ACTA OTORRINOLAR ESP, V58, P367, DOI 10.1016/S0001-6519(07)74947-6; Jacobson BH, 1997, AM J SPEECH LANGUAGE, V6, P66, DOI DOI 10.1044/1058-0360.0603.66; Jaworowska E, 1998, Ann Acad Med Stetin, V44, P175; Kocaturk S, 2005, OTOLARYNG HEAD NECK, V132, P581, DOI 10.1016/j.otohns.2004.09.133; Laccourreye H, 1987, Ann Otolaryngol Chir Cervicofac, V104, P163; Lawson G, 2001, HEAD NECK-J SCI SPEC, V23, P871, DOI 10.1002/hed.1126; Batalla FN, 2008, EUR ARCH OTO-RHINO-L, V265, P543, DOI 10.1007/s00405-007-0512-9; OLSEN KD, 1990, AM J OTOLARYNG, V11, P153, DOI 10.1016/0196-0709(90)90030-Y; Rucci L, 2010, HEAD NECK-J SCI SPEC, V32, P392, DOI 10.1002/hed.21200; Silver CE, 2009, EUR ARCH OTO-RHINO-L, V266, P1333, DOI 10.1007/s00405-009-1028-2; Smee RI, 2010, HEAD NECK-J SCI SPEC, V32, P850, DOI 10.1002/hed.21262; Xu W, 2001, Zhonghua Er Bi Yan Hou Ke Za Zhi, V36, P454; Xu Wen, 2008, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V43, P670; Yu F, 2001, Zhonghua Er Bi Yan Hou Ke Za Zhi, V36, P213	19	6	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52723	10.1371/journal.pone.0052723	http://dx.doi.org/10.1371/journal.pone.0052723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326350	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500027
J	Minion, J; Gallant, V; Wolfe, J; Jamieson, F; Long, R				Minion, Jessica; Gallant, Victor; Wolfe, Joyce; Jamieson, Frances; Long, Richard			Multidrug and Extensively Drug-resistant Tuberculosis in Canada 1997-2008: Demographic and Disease Characteristics	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS	Setting: Nationwide Canadian public health surveillance. Objective: Description of demographic features and disease characteristics of drug-resistant tuberculosis (TB) in Canada over a 12 year period. Design: Continuous surveillance of all cases of culture-confirmed TB in Canada. Demographic and microbiologic features were analyzed and comparisons between drug-susceptible, multidrug-resistant (MDR), and drug-resistant not-MDR were made. Cases of extensively drug resistant TB are described. Results: 15,993 cases of culture-confirmed TB were reported during the study period. There were 5 cases of XDR-TB, 177 cases of MDR-TB, and 1,234 cases of first-line drug resistance not-MDR. The majority of drug-resistant cases were reported in foreign-born individuals, with drug-resistant cases diagnosed earlier post-arrival in Canada compared to drug-susceptible cases. In MDR-TB isolates, there was a high rate of drug-resistance to other first- and second-line drugs, making reliable empiric therapeutic recommendations for MDR-TB difficult. There was a statistically significant association between both MDR and drug-resistance not-MDR, and the risk of a negative treatment outcome (defined as treatment failure, absconded, or treatment ongoing >3 yrs). Conclusion: Drug-resistance complicates TB management even in developed nations with well-established TB control programs. The predominantly international origin of drug-resistant cases highlights the need for global strategies to combat TB.	[Minion, Jessica] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Gallant, Victor] Publ Hlth Agcy Canada, HIV AIDS & TB Core Surveillance, Ottawa, ON, Canada; [Wolfe, Joyce] Natl Reference Ctr Mycobacteriol, Natl Microbiol Lab, Winnipeg, MB, Canada; [Jamieson, Frances] Publ Hlth Ontario, Publ Hlth Labs, Toronto, ON, Canada; [Long, Richard] Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada	University of Alberta; Public Health Agency of Canada; University of Alberta	Long, R (corresponding author), Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada.	richard.long@ualberta.ca						Angeby K, 2012, B WORLD HEALTH ORGAN, V90, P693, DOI 10.2471/BLT.11.096644; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Avendano M, 2000, Can Respir J, V7, P383; CLSI, 2003, M24A CLSI; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Fay MP, 2010, BIOSTATISTICS, V11, P373, DOI 10.1093/biostatistics/kxp050; Hah NS, 2005, INT J TUBERC LUNG D, V9, pS77; Hersi A, 1999, Can Respir J, V6, P155; Long R, 1999, AM J RESP CRIT CARE, V159, P2014, DOI 10.1164/ajrccm.159.6.9809076; Long R, 2012, CAN J PUBLI IN PRESS; Long R., 2007, CANADIAN TUBERCULOSI, V6th; Marras TK, 2003, CHEST, V124, P915, DOI 10.1378/chest.124.3.915; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Seoudi N, 2012, THORAX, V67, P361, DOI 10.1136/thoraxjnl-2011-200610; Sharma M, 2011, J CLIN MICROBIOL, V49, P4112, DOI 10.1128/JCM.05195-11; World Health Organization, 2006, GLOB PLAN STOP TB 20; World Health organization, 2008, POL GUID DRUG SUSC T; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301	20	30	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53466	10.1371/journal.pone.0053466	http://dx.doi.org/10.1371/journal.pone.0053466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326436	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500076
J	Jefferson, JM; Dolstad, HA; Sivalingam, MD; Snow, JW				Jefferson, Jamal M.; Dolstad, Hilary A.; Sivalingam, Meera D.; Snow, Jonathan W.			Barrier Immune Effectors Are Maintained during Transition from Nurse to Forager in the Honey Bee	PLOS ONE			English	Article							DIVISION-OF-LABOR; APIS-MELLIFERA; ANTIMICROBIAL PEPTIDES; HOST-DEFENSE; DROSOPHILA; INFECTION; BACTERIAL; GENE; AGE; DYNAMICS	Foragers facilitate horizontal pathogen transmission in honey bee colonies, yet their systemic immune function wanes during transition to this life stage. In general, the insect immune system can be categorized into mechanisms operating at both the barrier epithelial surfaces and at the systemic level. As proposed by the intergenerational transfer theory of aging, such immunosenescence may result from changes in group resource allocation. Yet, the relative influence of pathogen transmission and resource allocation on immune function in bees from different stages has not been examined in the context of barrier immunity. We find that expression levels of antimicrobial peptides (AMPs) in honey bee barrier epithelia of the digestive tract do not follow a life stage-dependent decrease. In addition, correlation of AMP transcript abundance with microbe levels reveals a number of microbe-associated changes in AMPs levels that are equivalent between nurses and foragers. These results favor a model in which barrier effectors are maintained in foragers as a first line of defense, while systemic immune effectors are dismantled to optimize hive-level resources. These findings have important implications for our understanding of immunosenescence in honey bees and other social insects.	[Jefferson, Jamal M.; Dolstad, Hilary A.; Sivalingam, Meera D.; Snow, Jonathan W.] Williams Coll, Dept Biol, Williamstown, MA 01267 USA	Williams College	Snow, JW (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	jsnow@barnard.edu						Amdam GV, 2011, AGING CELL, V10, P18, DOI 10.1111/j.1474-9726.2010.00647.x; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Amdam GV, 2005, AGEING RES REV, V4, P398, DOI 10.1016/j.arr.2005.03.007; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Ament SA, 2010, WIRES SYST BIOL MED, V2, P566, DOI 10.1002/wsbm.73; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Bedick JC, 2001, COMP BIOCHEM PHYS C, V130, P107, DOI 10.1016/S1532-0456(01)00226-5; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Choi YJ, 2008, BBA-GEN SUBJECTS, V1780, P1093, DOI 10.1016/j.bbagen.2008.06.008; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; DeVeale B, 2004, AGING CELL, V3, P195, DOI 10.1111/j.1474-9728.2004.00106.x; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Fujihashi K, 2009, TRENDS IMMUNOL, V30, P334, DOI 10.1016/j.it.2009.04.004; Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Laughton AM, 2011, J INSECT PHYSIOL, V57, P1023, DOI 10.1016/j.jinsphys.2011.04.020; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li JL, 2011, J ECON ENTOMOL, V104, P732, DOI 10.1603/EC10355; Lindstrom A, 2008, APIDOLOGIE, V39, P515, DOI 10.1051/apido:2008032; Lourenco AP, 2009, ARCH INSECT BIOCHEM, V71, P70, DOI 10.1002/arch.20301; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Omholt Stig W, 2004, Sci Aging Knowledge Environ, V2004, ppe28, DOI 10.1126/sageke.2004.26.pe28; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Ramsden S, 2008, AGING CELL, V7, P225, DOI 10.1111/j.1474-9726.2008.00370.x; Real LA, 2007, CURR TOP MICROBIOL, V315, P33; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schmid-Hempel P., 1998, Parasites in social insects.; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Welch A, 2009, APPL ENVIRON MICROB, V75, P7862, DOI 10.1128/AEM.01319-09; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Youngman MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002082	65	24	25	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54097	10.1371/journal.pone.0054097	http://dx.doi.org/10.1371/journal.pone.0054097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320121	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800088
J	Notomi, S; Hisatomi, T; Murakami, Y; Terasaki, H; Sonoda, S; Asato, R; Takeda, A; Ikeda, Y; Enaida, H; Sakamoto, T; Ishibashi, T				Notomi, Shoji; Hisatomi, Toshio; Murakami, Yusuke; Terasaki, Hiroto; Sonoda, Shozo; Asato, Ryo; Takeda, Atsunobu; Ikeda, Yasuhiro; Enaida, Hiroshi; Sakamoto, Taiji; Ishibashi, Tatsuro			Dynamic Increase in Extracellular ATP Accelerates Photoreceptor Cell Apoptosis via Ligation of P2RX7 in Subretinal Hemorrhage	PLOS ONE			English	Article							BRILLIANT BLUE-G; RETINAL GANGLION-CELLS; MACULAR DEGENERATION; P2X(7) RECEPTORS; INTRACEREBRAL HEMORRHAGE; IN-VIVO; RAT MODEL; CHOROIDAL NEOVASCULARIZATION; MITOCHONDRIAL APOPTOSIS; VITREOUS HEMORRHAGE	Photoreceptor degeneration is the most critical cause of visual impairment in age-related macular degeneration (AMD). In neovascular form of AMD, severe photoreceptor loss develops with subretinal hemorrhage due to choroidal neovascularization (CNV), growth of abnormal blood vessels from choroidal circulation. However, the detailed mechanisms of this process remain elusive. Here we demonstrate that neovascular AMD with subretinal hemorrhage accompanies a significant increase in extracellular ATP, and that extracellular ATP initiates neurodegenerative processes through specific ligation of Purinergic receptor P2X, ligand-gated ion channel, 7 (P2RX7; P2X7 receptor). Increased extracellular ATP levels were found in the vitreous samples of AMD patients with subretinal hemorrhage compared to control vitreous samples. Extravascular blood induced a massive release of ATP and photoreceptor cell apoptosis in co-culture with primary retinal cells. Photoreceptor cell apoptosis accompanied mitochondrial apoptotic pathways, namely activation of caspase-9 and translocation of apoptosis-inducing factor (AIF) from mitochondria to nuclei, as well as TUNEL-detectable DNA fragmentation. These hallmarks of photoreceptor cell apoptosis were prevented by brilliant blue G (BBG), a selective P2RX7 antagonist, which is an approved adjuvant in ocular surgery. Finally, in a mouse model of subretinal hemorrhage, photoreceptor cells degenerated through BBG-inhibitable apoptosis, suggesting that ligation of P2RX7 by extracellular ATP may accelerate photoreceptor cell apoptosis in AMD with subretinal hemorrhage. Our results indicate a novel mechanism that could involve neuronal cell death not only in AMD but also in hemorrhagic disorders in the CNS and encourage the potential application of BBG as a neuroprotective therapy.	[Notomi, Shoji; Hisatomi, Toshio; Murakami, Yusuke; Asato, Ryo; Takeda, Atsunobu; Ikeda, Yasuhiro; Enaida, Hiroshi; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan; [Hisatomi, Toshio; Asato, Ryo] Natl Hosp Org, Clin Res Inst, Kyushu Med Ctr, Fukuoka, Japan; [Terasaki, Hiroto; Sonoda, Shozo; Sakamoto, Taiji] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med Sci, Kagoshima 890, Japan	Kyushu University; Kagoshima University	Hisatomi, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan.	hisatomi@med.kyushu-u.ac.jp		Hisatomi, Toshio/0000-0003-2552-9595	Ministry of Education, Culture, Sports, Science, and Technology, Japan [21791690]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-In-Aid for Scientific Research (number 21791690) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Bhisitkul RB, 2008, INVEST OPHTH VIS SCI, V49, P4071, DOI 10.1167/iovs.08-1892; Bressler NM, 2004, OPHTHALMOLOGY, V111, P1993, DOI 10.1016/j.ophtha.2004.07.023; Burnstock G, 2008, PHARMACOL REP, V60, P12; Chused TM, 1996, J IMMUNOL, V157, P1371; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P623, DOI 10.1097/00006982-200607000-00006; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007; Farah ME, 2009, AM J OPHTHALMOL, V148, P332, DOI 10.1016/j.ajo.2009.04.003; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; GLATT H, 1982, AM J OPHTHALMOL, V94, P762, DOI 10.1016/0002-9394(82)90301-4; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Hisatomi T, 2006, ARCH OPHTHALMOL-CHIC, V124, P514, DOI 10.1001/archopht.124.4.514; Hisatomi T, 2001, AM J PATHOL, V158, P1271, DOI 10.1016/S0002-9440(10)64078-3; Hisatomi T, 2008, J CLIN INVEST, V118, P2025, DOI 10.1172/JCI34267; Holladay JT, 1997, J REFRACT SURG, V13, P388; Hu HL, 2010, EXP EYE RES, V91, P425, DOI 10.1016/j.exer.2010.06.017; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jaremko KM, 2010, J NEUROCHEM, V114, P1063, DOI 10.1111/j.1471-4159.2010.06826.x; Ricatti MJ, 2009, SYNAPSE, V63, P291, DOI 10.1002/syn.20605; Jung JH, 2010, RETINA-J RET VIT DIS, V30, P865, DOI 10.1097/IAE.0b013e3181c969e9; KLEIN R, 1995, OPHTHALMOLOGY, V102, P371; Lee JE, 2003, RETINA-J RET VIT DIS, V23, P675, DOI 10.1097/00006982-200310000-00012; Liu HT, 2008, PURINERG SIGNAL, V4, P147, DOI 10.1007/s11302-007-9077-8; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McLarnon JG, 2006, J NEUROPATH EXP NEUR, V65, P1090, DOI 10.1097/01.jnen.0000240470.97295.d3; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Mitchell CH, 2009, PURINERG SIGNAL, V5, P241, DOI 10.1007/s11302-009-9142-6; Murakami Y, 2008, AM J PATHOL, V173, P1326, DOI 10.2353/ajpath.2008.080466; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Notomi S, 2011, AM J PATHOL, V179, P2798, DOI 10.1016/j.ajpath.2011.08.035; Oike M, 2000, AM J PHYSIOL-HEART C, V279, pH630, DOI 10.1152/ajpheart.2000.279.2.H630; Pannicke T, 2000, J NEUROSCI, V20, P5965, DOI 10.1523/JNEUROSCI.20-16-05965.2000; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Puthussery T, 2004, J COMP NEUROL, V472, P13, DOI 10.1002/cne.20045; Puthussery T, 2006, EUR J NEUROSCI, V24, P7, DOI 10.1111/j.1460-9568.2006.04895.x; Puthussery T, 2009, J COMP NEUROL, V513, P430, DOI 10.1002/cne.21964; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Ralevic V, 1998, PHARMACOL REV, V50, P413; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; Rodrigues EB, 2005, GRAEF ARCH CLIN EXP, V243, P291, DOI 10.1007/s00417-004-0992-x; Rodrigues EB, 2010, AM J OPHTHALMOL, V149, P265, DOI 10.1016/j.ajo.2009.08.020; Rosenfeld PJ, 2011, NEW ENGL J MED, V364, P1966, DOI 10.1056/NEJMe1103334; SACCO RL, 1984, NEUROLOGY, V34, P847, DOI 10.1212/WNL.34.7.847; Sakamoto T, 2010, RETINA-J RET VIT DIS, V30, P856, DOI 10.1097/IAE.0b013e3181c969cb; Schulze-Bonsel K, 2006, INVEST OPHTH VIS SCI, V47, P1236, DOI 10.1167/iovs.05-0981; Steel DHW, 2011, BRIT J OPHTHALMOL, V95, P1051, DOI 10.1136/bjo.2010.182253; Sugiyama T, 2010, INVEST OPHTH VIS SCI, V51, P3236, DOI 10.1167/iovs.09-4192; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Trichonas G, 2010, P NATL ACAD SCI US; Ueno A, 2007, RETINA-J RET VIT DIS, V27, P499, DOI 10.1097/IAE.0b013e318030a129; Vessey KA, 2012, PLOS ONE, V7, P290, DOI 10.1371/journal.pone.0029990; Wang QF, 2004, AM J PHYSIOL-CELL PH, V287, pC1349, DOI 10.1152/ajpcell.00256.2004; Wood Rachel E., 2009, BMC Physiology, V9, P24, DOI 10.1186/1472-6793-9-24; Yang DL, 2011, INVEST OPHTH VIS SCI, V52, P1522, DOI 10.1167/iovs.10-6172; Yang L, 2004, INVEST OPHTH VIS SCI, V45, P648, DOI 10.1167/iovs.03-0827; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zacks DN, 2003, INVEST OPHTH VIS SCI, V44, P1262, DOI 10.1167/iovs.02-0492; Zhang XL, 2005, INVEST OPHTH VIS SCI, V46, P2183, DOI 10.1167/iovs.05-0052	70	55	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53338	10.1371/journal.pone.0053338	http://dx.doi.org/10.1371/journal.pone.0053338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308196	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800040
J	Tsou, HK; Chen, HT; Hung, YH; Chang, CH; Li, TM; Fong, YC; Tang, CH				Tsou, Hsi-Kai; Chen, Hsien-Te; Hung, Ya-Huey; Chang, Chia-Hao; Li, Te-Mao; Fong, Yi-Chin; Tang, Chih-Hsin			HGF and c-Met Interaction Promotes Migration in Human Chondrosarcoma Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; BREAST-CANCER; MATRIX METALLOPROTEINASES; SIGNALING PATHWAY; PARTIAL-PURIFICATION; GENE-EXPRESSION; INVASION; METASTASIS; RECEPTOR; PROGRESSION	Chondrosarcoma is a type of highly malignant tumor with a potent capacity for local invasion and causing distant metastasis. Chondrosarcoma shows a predilection for metastasis to the lungs. Hepatocyte growth factor (HGF) has been demonstrated to stimulate cancer proliferation, migration, and metastasis. However, the effect of HGF on migration activity of human chondrosarcoma cells is not well known. Here, we found that human chondrosarcoma tissues demonstrated significant expression of HGF, which was higher than that in normal cartilage. We also found that HGF increased the migration and expression of matrix metalloproteinase (MMP)-2 in human chondrosarcoma cells. c-Met inhibitor and siRNA reduced HGF-increased cell migration and MMP-2 expression. HGF treatment resulted in activation of the phosphatidylinositol 3'-kinase (PI3K)/Akt/PKC delta/NF-kappa B pathway, and HGF-induced expression of MMP-2 and cell migration was inhibited by specific inhibitors or siRNA-knockdown of PI3K, Akt, PKC delta, and NF-kappa B cascades. Taken together, our results indicated that HGF enhances migration of chondrosarcoma cells by increasing MMP-2 expression through the c-Met receptor/PI3K/Akt/PKC delta/NF-kappa B signal transduction pathway.	[Tsou, Hsi-Kai] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Tsou, Hsi-Kai; Chen, Hsien-Te] Feng Chia Univ, Dept Mat Sci & Engn, Taichung 40724, Taiwan; [Tsou, Hsi-Kai] Jen Teh Jr Coll Med Nursing & Management, Dept Early Childhood Care & Educ, Miaoli Cty, Taiwan; [Chen, Hsien-Te; Li, Te-Mao; Fong, Yi-Chin] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Chen, Hsien-Te; Fong, Yi-Chin] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Hung, Ya-Huey; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Chia-Hao] Chang Hwa Hosp, Dept Orthoped Surg, Dept Hlth, Executive Yuan, Chang Hwa Count, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan	Taichung Veterans General Hospital; Feng Chia University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Tang, CH (corresponding author), China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3]; China Medical University Hospital [DMR-102-055]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	This study was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3 and NSC100-2320-B-039-028-MY3) and China Medical University Hospital (DMR-102-055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibollet-Bahena O, 2009, J NEUROCHEM, V109, P1440, DOI 10.1111/j.1471-4159.2009.06071.x; Cecchi F, 2010, EUR J CANCER, V46, P1260, DOI 10.1016/j.ejca.2010.02.028; Chen HT, 2010, J CELL PHYSIOL, V223, P737, DOI 10.1002/jcp.22083; Chen YJ, 2009, J CELL PHYSIOL, V221, P98, DOI 10.1002/jcp.21835; DIRENZO MF, 1995, CANCER RES, V55, P1129; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fong YC, 2007, J ORTHOP RES, V25, P1106, DOI 10.1002/jor.20364; Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Hahm ER, 2002, CANCER LETT, V184, P89, DOI 10.1016/S0304-3835(02)00170-2; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hou CH, 2011, BIOCHEM PHARMACOL, V81, P1286, DOI 10.1016/j.bcp.2011.03.016; Hou CH, 2009, BONE, V44, P233, DOI 10.1016/j.bone.2008.09.021; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Huang CY, 2009, BIOCHEM PHARMACOL, V77, P794, DOI 10.1016/j.bcp.2008.11.014; Huang HC, 2003, J BIOL CHEM, V278, P46750, DOI 10.1074/jbc.M305216200; Jiang WG, 2005, CRIT REV ONCOL HEMAT, V53, P35, DOI 10.1016/j.critrevonc.2004.09.004; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang JY, 2003, CANCER RES, V63, P1101; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; Koh YW, 2011, J NUTR BIOCHEM, V22, P1074, DOI 10.1016/j.jnutbio.2010.09.005; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; LUETTEKE NC, 1985, CANCER RES, V45, P6331; Maemura M, 1998, CANCER LETT, V126, P215, DOI 10.1016/S0304-3835(98)00014-7; Mahtouk K, 2010, BBA-REV CANCER, V1806, P208, DOI 10.1016/j.bbcan.2010.07.006; Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2, DOI 10.2174/1871520611009010002; Moriya C, 2011, J INVEST DERMATOL, V131, P655, DOI 10.1038/jid.2010.361; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Ocal IT, 2003, CANCER-AM CANCER SOC, V97, P1841, DOI 10.1002/cncr.11335; Park SK, 2009, CARCINOGENESIS, V30, P1225, DOI 10.1093/carcin/bgp111; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Scherer RL, 2008, CANCER METAST REV, V27, P679, DOI 10.1007/s10555-008-9152-9; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Tang CH, 2011, J BIOL CHEM, V286, P11056, DOI 10.1074/jbc.M110.204081; Terek RM, 1998, J ORTHOPAED RES, V16, P585, DOI 10.1002/jor.1100160510; Toi M, 1998, CLIN CANCER RES, V4, P659; Tsai YY, 2010, INVEST OPHTH VIS SCI, V51, P3462, DOI 10.1167/iovs.09-4921; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; Wang YC, 2003, ANAL BIOCHEM, V319, P206, DOI 10.1016/S0003-2697(03)00330-0; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Yuan J, 2005, J ORTHOP RES, V23, P1467, DOI 10.1016/j.orthres.2005.04.004	43	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53974	10.1371/journal.pone.0053974	http://dx.doi.org/10.1371/journal.pone.0053974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320110	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800075
J	Ahmed, MZ; De Barro, PJ; Ren, SX; Greeff, JM; Qiu, BL				Ahmed, Muhammad Z.; De Barro, Paul J.; Ren, Shun-Xiang; Greeff, Jaco M.; Qiu, Bao-Li			Evidence for Horizontal Transmission of Secondary Endosymbionts in the Bemisia tabaci Cryptic Species Complex	PLOS ONE			English	Article							2 WOLBACHIA STRAINS; HEMIPTERA ALEYRODIDAE; BACTERIAL SYMBIONT; REPRODUCTIVE ISOLATION; Q-BIOTYPE; HOST; EVOLUTION; RECOMBINATION; DIVERSITY; PHYLOGENY	Bemisia tabaci (Hemiptera: Aleyrodidae) is a globally distributed pest composed of at least 34 morphologically indistinguishable cryptic species. At least seven species of endosymbiont have been found infecting some or all members of the complex. The origin(s) of the associations between specific endosymbionts and their whitefly hosts is unknown. Infection is normally vertical, but horizontal transmission does occur and is one way for new infections to be introduced into individuals. The relationships between the different members of the cryptic species complex and the endosymbionts have not been well explored. In this study, the phylogenies of different cryptic species of the host with those of their endosymbionts were compared. Of particular interest was whether there was evidence for both coevolution and horizontal transmission. Congruence was observed for the primary endosymbiont, Portiera aleyrodidarum, and partial incongruence in the case of two secondary endosymbionts, Arsenophonus and Cardinium and incongruence for a third, Wolbachia. The patterns observed for the primary endosymbiont supported cospeciation with the host while the patterns for the secondary endosymbionts, and especially Wolbachia showed evidence of host shifts and extinctions through horizontal transmission rather than cospeciation. Of particular note is the observation of several very recent host shift events in China between exotic invader and indigenous members of the complex. These shifts were from indigenous members of the complex to the invader as well as from the invader to indigenous relatives.	[Ahmed, Muhammad Z.; Ren, Shun-Xiang; Qiu, Bao-Li] S China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Ahmed, Muhammad Z.; Greeff, Jaco M.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [De Barro, Paul J.] CSIRO, Ecosyst Sci, Brisbane, Qld, Australia	South China Agricultural University; University of Pretoria; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Qiu, BL (corresponding author), S China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China.	baileyqiu@yahoo.com.cn	Greeff, Jaco M/A-5582-2011; Ahmed, Muhammad Z/E-5735-2011; De Barro, Paul J/C-1724-2008	Ahmed, Muhammad Z/0000-0003-2486-157X; Greeff, Jaco/0000-0003-2951-6791	Program for New Century Excellent Talents in University; National Basic Research Program of China (973 Project) [2009CB119203]; China National Natural Science Foundation [31071732]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Basic Research Program of China (973 Project)(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was funded by the Program for New Century Excellent Talents in University 2011, National Basic Research Program of China (973 Project, 2009CB119203) and the China National Natural Science Foundation (31071732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2012, J APPL ENTOMOL, V136, P510, DOI 10.1111/j.1439-0418.2011.01673.x; Ahmed MZ, 2010, J ECON ENTOMOL, V103, P1848, DOI 10.1603/EC10033; Ahmed MZ, 2010, CURR MICROBIOL, V61, P322, DOI 10.1007/s00284-010-9614-5; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Baumann L, 2004, CURR MICROBIOL, V48, P77, DOI 10.1007/s00284-003-4132-3; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BAUMANN P, 2000, PROKARYOTES; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL, P332; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu Dong, 2005, Acta Entomologica Sinica, V48, P518; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; CLARK MA, 1992, CURR MICROBIOL, V25, P119, DOI 10.1007/BF01570970; Costa HS, 1995, PROTOPLASMA, V189, P194, DOI 10.1007/BF01280174; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025579; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Guo Xiaopeng, 2008, Weishengwu Xuebao, V48, P63; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Huelsenbeck JP, 2000, EVOLUTION, V54, P352, DOI 10.1111/j.0014-3820.2000.tb00039.x; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1423, DOI 10.1098/rspb.2001.1656; Johnson KP, 2001, ZOOL SCR, V30, P79, DOI 10.1046/j.1463-6409.2001.00057.x; Keller GP, 2004, MOL ECOL, V13, P2405, DOI 10.1111/j.1365-294X.2004.02213.x; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; LEGENDRE P., 2001, TEST HOST PARASITE C; Leikoski N, 2009, APPL ENVIRON MICROB, V75, P853, DOI 10.1128/AEM.02134-08; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Li ZX, 2007, CURR MICROBIOL, V54, P467, DOI 10.1007/s00284-007-0011-7; Light JE, 2005, THESIS U MICHIGAN; Light JE, 2008, SYST BIOL, V57, P449, DOI 10.1080/10635150802169610; Light JE, 2007, MOL PHYLOGENET EVOL, V45, P997, DOI 10.1016/j.ympev.2007.09.001; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; MUNSON MA, 1991, J BACTERIOL, V173, P6321, DOI 10.1128/jb.173.20.6321-6324.1991; Nirgianaki A, 2003, CURR MICROBIOL, V47, P93, DOI 10.1007/s00284-002-3969-1; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Paterson AM, 2001, INT J PARASITOL, V31, P1012, DOI 10.1016/S0020-7519(01)00199-0; Peek AS, 1998, P NATL ACAD SCI USA, V95, P9962, DOI 10.1073/pnas.95.17.9962; Ronquist F, 1995, CLADISTICS, V11, P73, DOI 10.1111/j.1096-0031.1995.tb00005.x; Ruan Yong-Ming, 2005, Acta Entomologica Sinica, V48, P859; Ruan YM, 2006, ENTOMOL EXP APPL, V121, P159, DOI 10.1111/j.1570-8703.2006.00466.x; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shoemaker DD, 2004, GENETICS, V168, P2049, DOI 10.1534/genetics.104.030890; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Stahlhut JK, 2010, MOL ECOL, V19, P4102, DOI 10.1111/j.1365-294X.2010.04776.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Telschow A, 2005, J THEOR BIOL, V235, P265, DOI 10.1016/j.jtbi.2005.01.008; Telschow A, 2002, INTEGR COMP BIOL, V42, P340, DOI 10.1093/icb/42.2.340; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Thierry M, 2011, MOL ECOL, V20, P2172, DOI 10.1111/j.1365-294X.2011.05087.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Von der Schulenburg JHG, 2000, MOL BIOL EVOL, V17, P584; Wang P, 2011, INSECT SCI, V18, P67, DOI 10.1111/j.1744-7917.2010.01381.x; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Werren JH, 2001, CURR BIOL, V11, P431, DOI 10.1016/S0960-9822(01)00101-4; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 1998, ENDLESS FORMS, P245; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	94	43	46	3	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53084	10.1371/journal.pone.0053084	http://dx.doi.org/10.1371/journal.pone.0053084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308142	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100027
J	Strauss, S; Neumeister, A; Barcikowski, S; Kracht, D; Kuhbier, JW; Radtke, C; Reimers, K; Vogt, PM				Strauss, Sarah; Neumeister, Anne; Barcikowski, Stephan; Kracht, Dietmar; Kuhbier, Joern W.; Radtke, Christine; Reimers, Kerstin; Vogt, Peter M.			Adhesion, Vitality and Osteogenic Differentiation Capacity of Adipose Derived Stem Cells Seeded on Nitinol Nanoparticle Coatings	PLOS ONE			English	Article							HUMAN BONE-MARROW; SHAPE-MEMORY; MEDICAL APPLICATIONS; TISSUE; PROLIFERATION; BIOMATERIALS; REGENERATION; ALLOYS	Autologous cells can be used for a bioactivation of osteoimplants to enhance osseointegration. In this regard, adipose derived stem cells (ASCs) offer interesting perspectives in implantology because they are fast and easy to isolate. However, not all materials licensed for bone implants are equally suited for cell adhesion. Surface modifications are under investigation to promote cytocompatibility and cell growth. The presented study focused on influences of a Nitinol-nanoparticle coating on ASCs. Possible toxic effects as well as influences on the osteogenic differentiation potential of ASCs were evaluated by viability assays, scanning electron microscopy, immunofluorescence and alizarin red staining. It was previously shown that Nitinol-nanoparticles exert no cell toxic effects to ASCs either in soluble form or as surface coating. Here we could demonstrate that a Nitinol-nanoparticle surface coating enhances cell adherence and growth on Nitinol-surfaces. No negative influence on the osteogenic differentiation was observed. Nitinol-nanoparticle coatings offer new possibilities in implantology research regarding bioactivation by autologous ASCs, respectively enhancement of surface attraction to cells.	[Strauss, Sarah; Kuhbier, Joern W.; Radtke, Christine; Reimers, Kerstin; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany; [Neumeister, Anne; Barcikowski, Stephan; Kracht, Dietmar] Laser Zentrum Hannover eV, Hannover, Germany; [Barcikowski, Stephan] Univ Duisburg Essen, Ctr Nanointegrat, Essen, Germany	Hannover Medical School; University of Duisburg Essen	Strauss, S (corresponding author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany.	strauss.sarah@mh-hannover.de	Vogt, Peter M./AAL-1332-2020; Radtke, Christine/M-2927-2013; Barcikowski, Stephan/I-4754-2012; Radtke, Christine/B-8491-2018	Barcikowski, Stephan/0000-0002-9739-7272; Radtke, Christine/0000-0001-6877-5038; Kracht, Dietmar/0000-0003-3473-4814	German Research Foundation within the Collaborative Research Centre TransRegio 'Micro- and Nanosystems in Medicine - Reconstruction of biologic Functions' [37]	German Research Foundation within the Collaborative Research Centre TransRegio 'Micro- and Nanosystems in Medicine - Reconstruction of biologic Functions'	The study has been funded by the German Research Foundation within the Collaborative Research Centre TransRegio 37 'Micro- and Nanosystems in Medicine - Reconstruction of biologic Functions'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Bahat O, 2010, CLIN IMPLANT DENT S1, V12, P2; Barcikowski S, 2010, J NANOPART RES, V12, P1733, DOI 10.1007/s11051-009-9834-4; Blackwood DJ, 2003, CORROS REV, V21, P97; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Gebert A, 1998, J MICROSC-OXFORD, V191, P297, DOI 10.1046/j.1365-2818.1998.00380.x; Habijan T, 2011, ACTA BIOMATER, V7, P2733, DOI 10.1016/j.actbio.2011.02.022; Habijan T, 2009, THESIS RUHR U BOCHUM; Hahn A, 2011, LASERGENERIERTE NANO; Hahn A, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-011-0686-3; Honda M, 2010, J BIOMED MATER RES A, V94A, P937, DOI 10.1002/jbm.a.32779; Jeswani S, 2011, J NEUROINTERV SURG, V3, P2, DOI 10.1136/jnis.2010.003657; Kang JW, 2008, STEM CELLS DEV, V17, P681, DOI 10.1089/scd.2007.0153; Keyser KA, 2007, CELL TRANSPLANT, V16, P555, DOI 10.3727/000000007783464939; Kohl M, 2009, ADV ENG MATER, V11, P959, DOI 10.1002/adem.200900168; Kuhbier JW, 2010, CHIRURG, V81, P826, DOI 10.1007/s00104-010-1962-y; Kuhbier JW, 2010, ADV BIOCHEM ENG BIOT, V123, P55, DOI 10.1007/10_2009_24; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012; Menendez-Manjon A, 2009, J LASER MICRO NANOEN, V4, P95, DOI 10.2961/jlmn.2009.02.0004; Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56; Morgan NB, 2004, MAT SCI ENG A-STRUCT, V378, P16, DOI 10.1016/j.msea.2003.10.326; Muhonen V, 2009, J BIOMED MATER RES A, V88A, P787, DOI 10.1002/jbm.a.31953; Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013; Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267; Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745; Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	36	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53309	10.1371/journal.pone.0053309	http://dx.doi.org/10.1371/journal.pone.0053309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308190	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100054
J	Wang, JX; Xu, JX; Wang, QW; Brainard, RE; Watson, LJ; Jones, SP; Epstein, PN				Wang, Jianxun; Xu, Jianxiang; Wang, Qianwen; Brainard, Robert E.; Watson, Lewis J.; Jones, Steven P.; Epstein, Paul N.			Reduced Cardiac Fructose 2,6 Bisphosphate Increases Hypertrophy and Decreases Glycolysis following Aortic Constriction	PLOS ONE			English	Article							SUPEROXIDE-PRODUCTION; PRESSURE-OVERLOAD; OXIDATIVE STRESS; GLUCOSE-UPTAKE; FATTY-ACID; EXPRESSION; INSULIN; OVEREXPRESSION; CARDIOMYOPATHY; METABOLISM	This study was designed to test whether reduced levels of cardiac fructose-2,6-bisphosphate (F-2,6-P-2) exacerbates cardiac damage in response to pressure overload. F-2,6-P-2 is a positive regulator of the glycolytic enzyme phosphofructokinase. Normal and Mb transgenic mice were subject to transverse aortic constriction (TAC) or sham surgery. Mb transgenic mice have reduced F-2,6-P-2 levels, due to cardiac expression of a transgene for a mutant, kinase deficient form of the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2) which controls the level of F-2,6-P-2. Thirteen weeks following TAC surgery, glycolysis was elevated in FVB, but not in Mb, hearts. Mb hearts were markedly more sensitive to TAC induced damage. Echocardiography revealed lower fractional shortening in Mb-TAC mice as well as larger left ventricular end diastolic and end systolic diameters. Cardiac hypertrophy and pulmonary congestion were more severe in Mb-TAC mice as indicated by the ratios of heart and lung weight to tibia length. Expression of alpha-MHC RNA was reduced more in Mb-TAC hearts than in FVB-TAC hearts. TAC produced a much greater increase in fibrosis of Mb hearts and this was accompanied by 5-fold more collagen 1 RNA expression in Mb-TAC versus FVB-TAC hearts. Mb-TAC hearts had the lowest phosphocreatine to ATP ratio and the most oxidative stress as indicated by higher cardiac content of 4-hydroxynonenal protein adducts. These results indicate that the heart's capacity to increase F-2,6-P-2 during pressure overload elevates glycolysis which is beneficial for reducing pressure overload induced cardiac hypertrophy, dysfunction and fibrosis.	[Wang, Jianxun] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Wang, Qianwen; Brainard, Robert E.; Watson, Lewis J.; Jones, Steven P.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA; [Brainard, Robert E.; Watson, Lewis J.; Jones, Steven P.] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; [Xu, Jianxiang; Epstein, Paul N.] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Epstein, PN (corresponding author), Univ Louisville, Dept Pediat, Louisville, KY 40292 USA.	paul.epstein@louisville.edu	Watson, Lewis J/F-3688-2011; Jones, Steven P./D-5092-2009	Watson, Lewis J/0000-0002-8273-7676; Jones, Steven P./0000-0001-5376-8089; Epstein, Paul/0000-0002-7006-8954	National Institutes of Health (NIH) [DK073586, HL083320, HL094419]; American Diabetes Association [7-11-BS-37]; American Heart Association [0715389B]; National Center for Research Resources at NIH [P20 RR024489]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083320, R01HL094419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073586] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); National Center for Research Resources at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health (NIH) grants DK073586, HL083320 and HL094419 (NIH.gov), American Diabetes Association grant 7-11-BS-37 (http://professional.diabetes.org), American Heart Association (http://www.heart.org/HEARTORG/predoctoral fellowship) 0715389B and National Center for Research Resources at NIH P20 RR024489 (NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES A, 1980, BIOCHEM J, V186, P799, DOI 10.1042/bj1860799; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; Domenighetti AA, 2010, J MOL CELL CARDIOL, V48, P663, DOI 10.1016/j.yjmcc.2009.11.017; Donthi RV, 2004, J BIOL CHEM, V279, P48085, DOI 10.1074/jbc.M405510200; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Gupte SA, 2006, J MOL CELL CARDIOL, V41, P340, DOI 10.1016/j.yjmcc.2006.05.003; HAMBY RI, 1974, JAMA-J AM MED ASSOC, V229, P1749, DOI 10.1001/jama.229.13.1749; Hue L, 2002, J MOL CELL CARDIOL, V34, P1091, DOI 10.1006/jmcc.2002.2063; KAGAYA Y, 1995, J CLIN INVEST, V95, P2766, DOI 10.1172/JCI117980; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kim M, 2012, J MOL CELL CARDIOL, V52, P1066, DOI 10.1016/j.yjmcc.2012.01.016; Kockskamper J, 2005, J PHYSIOL-LONDON, V564, P697, DOI 10.1113/jphysiol.2004.078782; Liang QR, 2002, CARDIOVASC RES, V53, P423, DOI 10.1016/S0008-6363(01)00495-3; Liang QR, 2002, DIABETES, V51, P174, DOI 10.2337/diabetes.51.1.174; Liao RL, 2002, CIRCULATION, V106, P2125, DOI 10.1161/01.CIR.0000034049.61181.F3; Lowry OH, 1993, FLEXIBLE SYSTEM ENZY; Lu ZB, 2010, CIRCULATION, V121, P1474, DOI 10.1161/CIRCULATIONAHA.109.906818; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c; NEUBAUER S, 1992, CIRCULATION, V86, P1810, DOI 10.1161/01.CIR.86.6.1810; Neubauer S, 1997, CIRCULATION, V96, P2190; NEWSHOLM EA, 1964, BIOCHEM J, V93, P641, DOI 10.1042/bj0930641; Ritchie RH, 2007, J MOL CELL CARDIOL, V42, P1119, DOI 10.1016/j.yjmcc.2007.03.900; SCHWARTZ K, 1992, AM J PHYSIOL, V262, pR364, DOI 10.1152/ajpregu.1992.262.3.R364; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Taylor M, 2001, J NUCL MED, V42, P55; Ussher JR, 2012, CIRC RES, V111, P628, DOI 10.1161/CIRCRESAHA.111.246371; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JX, 2006, CIRCULATION, V113, P544, DOI 10.1161/CIRCULATIONAHA.105.537894; Wang QW, 2008, AM J PHYSIOL-HEART C, V294, pH2889, DOI 10.1152/ajpheart.91501.2007; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wu CD, 2002, DIABETES, V51, pA319; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702	39	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53951	10.1371/journal.pone.0053951	http://dx.doi.org/10.1371/journal.pone.0053951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308291	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100123
J	Park, JK; Kim, HS; Uh, KJ; Choi, KH; Kim, HM; Lee, T; Yang, BC; Kim, HJ; Ka, HH; Kim, H; Lee, CK				Park, Jin-Kyu; Kim, Hye-Sun; Uh, Kyung-Jun; Choi, Kwang-Hwan; Kim, Hyeong-Min; Lee, Taeheon; Yang, Byung-Chul; Kim, Hyun-Jong; Ka, Hak-Hyun; Kim, Heebal; Lee, Chang-Kyu			Primed Pluripotent Cell Lines Derived from Various Embryonic Origins and Somatic Cells in Pig	PLOS ONE			English	Article							EPIBLAST STEM-CELLS; IN-VITRO; PORCINE EMBRYO; BLASTOCYSTS; DERIVATION; GENERATION; CULTURE; VIVO; EXPRESSION; ESTABLISHMENT	Since pluripotent embryonic stem cell (ESC) lines were first derived from the mouse, tremendous efforts have been made to establish ESC lines in several domestic species including the pig; however, authentic porcine ESCs have not yet been established. It has proven difficult to maintain an ESC-like state in pluripotent porcine cell lines due to the frequent occurrence of spontaneous differentiation into an epiblast stem cell (EpiSC)-like state during culture. We have been able to derive EpiSC-like porcine ESC (pESC) lines from blastocyst stage porcine embryos of various origins, including in vitro fertilized (IVF), in vivo derived, IVF aggregated, and parthenogenetic embryos. In addition, we have generated induced pluripotent stem cells (piPSCs) via plasmid transfection of reprogramming factors (Oct4, Sox2, Klf4, and c-Myc) into porcine fibroblast cells. In this study, we analyzed characteristics such as marker expression, pluripotency and the X chromosome inactivation status in female of our EpiSC-like pESC lines along with our piPSC line. Our results show that these cell lines demonstrate the expression of genes associated with the Activin/Nodal and FGF2 pathways along with the expression of pluripotent markers Oct4, Sox2, Nanog, SSEA4, TRA 1-60 and TRA 1-81. Furthermore all of these cell lines showed in vitro differentiation potential, the X chromosome inactivation in female and a normal karyotype. Here we suggest that the porcine species undergoes reprogramming into a primed state during the establishment of pluripotent stem cell lines.	[Park, Jin-Kyu; Kim, Hye-Sun; Uh, Kyung-Jun; Choi, Kwang-Hwan; Kim, Hyeong-Min; Lee, Taeheon; Kim, Heebal; Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Park, Jin-Kyu; Kim, Hye-Sun; Uh, Kyung-Jun; Choi, Kwang-Hwan; Kim, Hyeong-Min; Lee, Taeheon; Kim, Heebal; Lee, Chang-Kyu] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Yang, Byung-Chul; Kim, Hyun-Jong] RDA, Natl Inst Anim Sci, Suwon, South Korea; [Ka, Hak-Hyun] Yonsei Univ, Dept Biol Resources & Technol, Wonju, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Yonsei University	Lee, CK (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	leeck@snu.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Choi, Kwang-Hwan/0000-0003-3919-7413	Next BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ0081382011]	Next BioGreen 21 Program, Rural Development Administration, Republic of Korea	Funding: This work was supported by the Next BioGreen 21 Program (PJ0081382011), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Anderson GB, 1996, ANIM REPROD SCI, V45, P231, DOI 10.1016/S0378-4320(96)01581-3; Blomberg LA, 2008, MOL REPROD DEV, V75, P450, DOI 10.1002/mrd.20780; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brevini TAL, 2007, THERIOGENOLOGY, V68, pS206, DOI 10.1016/j.theriogenology.2007.05.043; Brevini TAL, 2007, THERIOGENOLOGY, V67, P54, DOI 10.1016/j.theriogenology.2006.09.019; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; du Puy L, 2011, THERIOGENOLOGY, V75, P513, DOI 10.1016/j.theriogenology.2010.09.019; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall V, 2008, STEM CELL REV, V4, P275, DOI 10.1007/s12015-008-9040-2; Hall VJ, 2009, DEV DYNAM, V238, P2014, DOI 10.1002/dvdy.22027; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Kim S, 2010, ZYGOTE, V18, P93, DOI 10.1017/S0967199409990372; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li M, 2004, ZYGOTE, V12, P43, DOI 10.1017/S0967199404002679; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montserrat N, 2012, CELL TRANSPLANT, V21, P815, DOI 10.3727/096368911X601019; Munoz M, 2009, STEM CELL REV REP, V5, P6, DOI 10.1007/s12015-009-9052-6; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Oestrup O, 2009, REPROD DOMEST ANIM, V44, P39, DOI 10.1111/j.1439-0531.2009.01482.x; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P865, DOI 10.1016/0093-691X(90)90558-B; SAITO S, 1992, ROUX ARCH DEV BIOL, V201, P134, DOI 10.1007/BF00188711; Son HY, 2009, ASIAN AUSTRAL J ANIM, V22, P26, DOI 10.5713/ajas.2009.80343; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talbot NC, 2008, STEM CELL REV, V4, P235, DOI 10.1007/s12015-008-9026-0; Tan G, 2011, ZYGOTE, P1; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Telugu BPVL, 2010, STEM CELL REV REP, V6, P31, DOI 10.1007/s12015-009-9101-1; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, CURR TOP DEV BIOL, V38, P133; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vackova I, 2007, J REPROD DEVELOP, V53, P1137, DOI 10.1262/jrd.19108; Vackova I, 2011, J REPROD DEVELOP, V57, P594, DOI 10.1262/jrd.10-184H; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vassiliev I, 2011, CELL REPROGRAM, V13, P205, DOI 10.1089/cell.2010.0102; Vassiliev I, 2010, J REPROD DEVELOP, V56, P546, DOI 10.1262/jrd.09-197A; Vassiliev I, 2010, CELL REPROGRAM, V12, P223, DOI 10.1089/cell.2009.0053; Warnes G, LUMLEY T GPLOTS VARI; West FD, 2011, STEM CELLS, V29, P1640, DOI 10.1002/stem.713; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003	57	58	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52481	10.1371/journal.pone.0052481	http://dx.doi.org/10.1371/journal.pone.0052481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326334	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800018
J	Balkenhol, T; Wallhausser-Franke, E; Delb, W				Balkenhol, Tobias; Wallhaeusser-Franke, Elisabeth; Delb, Wolfgang			Psychoacoustic Tinnitus Loudness and Tinnitus-Related Distress Show Different Associations with Oscillatory Brain Activity	PLOS ONE			English	Article							GAMMA OSCILLATIONS; NUCLEUS-ACCUMBENS; EEG; INHIBITION; POWER; PERCEPTION; MECHANISMS; DIAGNOSIS; INTENSITY; RELEVANCE	Background: The phantom auditory perception of subjective tinnitus is associated with aberrant brain activity as evidenced by magneto- and electroencephalographic studies. We tested the hypotheses (1) that psychoacoustically measured tinnitus loudness is related to gamma oscillatory band power, and (2) that tinnitus loudness and tinnitus-related distress are related to distinct brain activity patterns as suggested by the distinction between loudness and distress experienced by tinnitus patients. Furthermore, we explored (3) how hearing impairment, minimum masking level, and (4) psychological comorbidities are related to spontaneous oscillatory brain activity in tinnitus patients. Methods and Findings: Resting state oscillatory brain activity recorded electroencephalographically from 46 male tinnitus patients showed a positive correlation between gamma band oscillations and psychoacoustic tinnitus loudness determined with the reconstructed tinnitus sound, but not with the other psychoacoustic loudness measures that were used. Tinnitus-related distress did also correlate with delta band activity, but at electrode positions different from those associated with tinnitus loudness. Furthermore, highly distressed tinnitus patients exhibited a higher level of theta band activity. Moreover, mean hearing loss between 0.125 kHz and 16 kHz was associated with a decrease in gamma activity, whereas minimum masking levels correlated positively with delta band power. In contrast, psychological comorbidities did not express significant correlations with oscillatory brain activity. Conclusion: Different clinically relevant tinnitus characteristics show distinctive associations with spontaneous brain oscillatory power. Results support hypothesis (1), but exclusively for the tinnitus loudness derived from matching to the reconstructed tinnitus sound. This suggests to preferably use the reconstructed tinnitus spectrum to determine psychoacoustic tinnitus loudness. Results also support hypothesis (2). Moreover, hearing loss and minimum masking level correlate with oscillatory power in distinctive frequency bands. The lack of an association between psychological comorbidities and oscillatory power may be attributed to the overall low level of mental health problems in the present sample.	[Balkenhol, Tobias; Wallhaeusser-Franke, Elisabeth; Delb, Wolfgang] Heidelberg Univ, Med Fac Mannheim, Dept Phoniatr & Audiol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Delb, W (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Phoniatr & Audiol, Mannheim, Germany.	wolfgang.delb@medma.uni-heidelberg.de						Adjamian P, 2012, JARO-J ASSOC RES OTO, V13, P715, DOI 10.1007/s10162-012-0340-5; Andersson G, 1999, CLIN OTOLARYNGOL, V24, P404, DOI 10.1046/j.1365-2273.1999.00278.x; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buehlmann A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000934; CAUDARELLA M, 1987, BRAIN RES, V435, P202, DOI 10.1016/0006-8993(87)91602-7; CHANG AYW, 1995, SYNAPSE, V21, P149, DOI 10.1002/syn.890210208; D'Amelio R, 2004, HNO, V52, P599, DOI 10.1007/s00106-003-0944-5; De Ridder D., 2011, PLOS ONE, V6; Delb W, 1999, P 6 INT TINN SEM, P446; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Derogatis LR., 1994, SCL 90 R SYMPTOM CHE; DIEROFF HG, 1976, AUDIOLOGY, V15, P152; Dominguez-Borras J, 2012, BIOL PSYCHOL, V89, P545, DOI 10.1016/j.biopsycho.2011.12.014; Fastl H., 2007, PSYCHOACOUSTICS FACT, V3rd; FERGER B, 1994, PSYCHOPHARMACOLOGY, V114, P297, DOI 10.1007/BF02244852; Fontani G, 1997, ARCH ITAL BIOL, V135, P49; Fowler E. P., 1942, LARYNGOSCOPE, V52, P275; Fowler EP, 1940, ARCHIV OTOLARYNGOL, V32, P903; Franke G.H., 2002, SCL 90 R SYMPTOM CHE; Gibbons J. D., 2010, NONPARAMETRIC STAT I, DOI DOI 10.5005/JP/BOOKS/10313_14; Goebel G, 1998, TINNITUS FRAGEBOGEN; Gordon JA, 2005, J NEUROSCI, V25, P6509, DOI 10.1523/JNEUROSCI.1211-05.2005; Gourevitch B, 2011, EUR J NEUROSCI, V34, P1953, DOI 10.1111/j.1460-9568.2011.07905.x; GRACE AA, 1995, DRUG ALCOHOL DEPEN, V37, P111, DOI 10.1016/0376-8716(94)01066-T; Gray J. A., 2003, NEUROPSYCHOLOGY ANXI; Grin-Yatsenko VA, 2010, CLIN NEUROPHYSIOL, V121, P281, DOI 10.1016/j.clinph.2009.11.015; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Hiller W, 2006, ARCH OTOLARYNGOL, V132, P1323, DOI 10.1001/archotol.132.12.1323; Hoffman LD, 1998, BIOL PSYCHOL, V48, P139, DOI 10.1016/S0301-0511(98)00010-6; JASTREBOFF PJ, 1994, HEARING RES, V80, P216, DOI 10.1016/0378-5955(94)90113-9; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Kahlbrock N, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-4; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Kohler S, 2011, INT PSYCHOGERIATR, V23, P141, DOI 10.1017/S1041610210001250; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Kuo S. M., 1996, ACTIVE NOISE CONTROL; Langenbach M, 2005, GEN HOSP PSYCHIAT, V27, P73, DOI 10.1016/j.genhosppsych.2004.08.008; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Leaver AM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00021; Lehtela L, 1997, NEUROSCI LETT, V222, P111, DOI 10.1016/S0304-3940(97)13361-4; LEUNG LS, 1993, CAN J PHYSIOL PHARM, V71, P311, DOI 10.1139/y93-049; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lorenz I, 2009, NEUROSCI LETT, V453, P225, DOI 10.1016/j.neulet.2009.02.028; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; McNaughton N, 2007, BEHAV PHARMACOL, V18, P329, DOI 10.1097/FBP.0b013e3282ee82e3; Meikle MB, 2012, EAR HEARING, V33, P153, DOI 10.1097/AUD.0b013e31822f67c0; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mitra P., 2007, OBSERVED BRAIN DYNAM; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Ortmann M, 2011, EUR J NEUROSCI, V33, P568, DOI 10.1111/j.1460-9568.2010.07542.x; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rosenhall U, 2003, Noise Health, V5, P47; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Sindhusake D, 2003, EAR HEARING, V24, P501, DOI 10.1097/01.AUD.0000100204.08771.3D; Siok CJ, 2009, NEUROPHARMACOLOGY, V56, P379, DOI 10.1016/j.neuropharm.2008.09.013; Sukov W, 1998, J NEUROPHYSIOL, V79, P2875, DOI 10.1152/jn.1998.79.6.2875; Tang YY, 2011, IEEE ENG MED BIO, P1717, DOI 10.1109/IEMBS.2011.6090492; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; TYLER RS, 1983, J SPEECH HEAR RES, V26, P59, DOI 10.1044/jshr.2601.59; Tyler RS, 1989, J SPEECH LANG HEAR R, V42, P52; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; van Lier H, 2004, NEUROPHARMACOLOGY, V47, P163, DOI 10.1016/j.neuropharm.2004.03.017; Vanneste S, 2011, NEUROSCIENCE, V199, P481, DOI 10.1016/j.neuroscience.2011.07.067; Vanneste S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031182; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Wallhausser-Franke E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034583; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Weisz N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00073; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3	82	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53180	10.1371/journal.pone.0053180	http://dx.doi.org/10.1371/journal.pone.0053180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326394	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400015
J	Hager, SB; Cosentino, BJ; Mckay, KJ; Monson, C; Zuurdeeg, W; Blevins, B				Hager, Stephen B.; Cosentino, Bradley J.; McKay, Kelly J.; Monson, Cathleen; Zuurdeeg, Walt; Blevins, Brian			Window Area and Development Drive Spatial Variation in Bird-Window Collisions in an Urban Landscape	PLOS ONE			English	Article							RELATIVE IMPORTANCE; HABITAT; MORTALITY; SCALE; URBANIZATION; COMPLEXITY; DIVERSITY; LANDBIRDS; COMMUNITY	Collisions with windows are an important human-related threat to birds in urban landscapes. However, the proximate drivers of collisions are not well understood, and no study has examined spatial variation in mortality in an urban setting. We hypothesized that the number of fatalities at buildings varies with window area and habitat features that influence avian community structure. In 2010 we documented bird-window collisions (BWCs) and characterized avian community structure at 20 buildings in an urban landscape in northwestern Illinois, USA. For each building and season, we conducted 21 daily surveys for carcasses and nine point count surveys to estimate relative abundance, richness, and diversity. Our sampling design was informed by experimentally estimated carcass persistence times and detection probabilities. We used linear and generalized linear mixed models to evaluate how habitat features influenced community structure and how mortality was affected by window area and factors that correlated with community structure. The most-supported model was consistent for all community indices and included effects of season, development, and distance to vegetated lots. BWCs were related positively to window area and negatively to development. We documented mortalities for 16/72 (22%) species (34 total carcasses) recorded at buildings, and BWCs were greater for juveniles than adults. Based on the most-supported model of BWCs, the median number of annual predicted fatalities at study buildings was 3 (range = 0-52). These results suggest that patchily distributed environmental resources and levels of window area in buildings create spatial variation in BWCs within and among urban areas. Current mortality estimates place little emphasis on spatial variation, which precludes a fundamental understanding of the issue. To focus conservation efforts, we illustrate how knowledge of the structural and environmental factors that influence bird-window collisions can be used to predict fatalities in the broader landscape.	[Hager, Stephen B.] Augustana Coll, Dept Biol, Rock Isl, IL 61201 USA; [Cosentino, Bradley J.] Hobart & William Smith Coll, Dept Biol, Geneva, NY 14456 USA; [McKay, Kelly J.] BioEco Res & Monitoring Ctr, Hampton, IL USA		Hager, SB (corresponding author), Augustana Coll, Dept Biol, Rock Isl, IL 61201 USA.	stevehager@augustana.edu			Quad City Audubon Society; Augustana College	Quad City Audubon Society; Augustana College	The authors received $2,400 from the Quad City Audubon Society (www.quadcityaudubon.org/) for travel expenses for carcass surveys. There is no grant number. The lead author (SBH) was awarded $ 1,000 Presidential Scholarship from Augustana College (www.augustana.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024708; Ausprey IJ, 2011, AUK, V128, P293, DOI 10.1525/auk.2011.10158; Balogh AL, 2011, J ORNITHOL, V152, P717, DOI 10.1007/s10336-011-0648-7; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Blair R, 2004, ECOL SOC, V9; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Blair RB, 2008, LANDSCAPE ECOL, V23, P1157, DOI 10.1007/s10980-008-9267-y; Blair Robert B., 2001, P459; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; Bonter DN, 2009, CONSERV BIOL, V23, P440, DOI 10.1111/j.1523-1739.2008.01085.x; Borden W. Calvin, 2010, Ohio Journal of Science, V110, P44; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; DUNN EH, 1993, J FIELD ORNITHOL, V64, P302; Evans-Ogden LJ, 1996, COLLISION COURSE THE; Fair J.M., 2010, GUIDELINES USE WILD; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Gehring J, 2009, ECOL APPL, V19, P505, DOI 10.1890/07-1708.1; Hager SB, 2008, WILSON J ORNITHOL, V120, P550, DOI 10.1676/07-075.1; Hager SB, 2012, J FIELD ORNITHOL, V83, P203, DOI 10.1111/j.1557-9263.2012.00370.x; Hennings LA, 2003, CONDOR, V105, P288, DOI 10.1650/0010-5422(2003)105[0288:RBCSIP]2.0.CO;2; Illinois Department of Agriculture, 2009, LAND COVER DATA FOR; Jenkins AR, 2010, BIRD CONSERV INT, V20, P263, DOI 10.1017/S0959270910000122; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; Kalinowski RS, 2010, CONDOR, V112, P274, DOI 10.1525/cond.2010.090037; Klem D, 2004, WILSON BULL, V116, P69, DOI 10.1676/0043-5643(2004)116[0069:EOWAFP]2.0.CO;2; KLEM D, 1989, WILSON BULL, V101, P606; KLEM D, 1990, J FIELD ORNITHOL, V61, P120; Klem D, 2009, WILSON J ORNITHOL, V121, P126, DOI 10.1676/08-068.1; Lang RE, 2009, URBAN GEOGR, V30, P726, DOI 10.2747/0272-3638.30.7.726; Longcore T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034025; Loss SR, 2012, FRONT ECOL ENVIRON, V10, P357, DOI 10.1890/110251; Loss SR, 2009, BIOL CONSERV, V142, P2578, DOI 10.1016/j.biocon.2009.06.004; MacGregor-Fors I, 2011, BASIC APPL ECOL, V12, P372, DOI 10.1016/j.baae.2011.04.003; Maechler M., 2011, LME4 LINEAR MIXED EF; Mannan R. William, 2008, Urban Ecosystems, V11, P141, DOI 10.1007/s11252-008-0056-9; Martin GR, 2011, IBIS, V153, P239, DOI 10.1111/j.1474-919X.2011.01117.x; Matthews SN, 2010, LANDSCAPE ECOL, V25, P955, DOI 10.1007/s10980-010-9475-0; Melles S, 2003, CONSERV ECOL, V7; O'connell Timothy J., 2001, Raven, V72, P141; Pennington DN, 2008, BIOL CONSERV, V141, P1235, DOI 10.1016/j.biocon.2008.02.021; Pyle P, 1997, IDENTIFICATION GUIDE; Ralph CJ, 1995, FOREST SERVICE GENER; Ramalho CE, 2012, TRENDS ECOL EVOL, V27, P179, DOI 10.1016/j.tree.2011.10.008; Ruth JM, 2006, PARTNERS IN FLIGHT U; San Francisco Planning Department, 2012, STANDARDS FOR BIRD S; Schramm M, 2007, MEADOWLARK, V16, P122; Seewagen CL, 2011, CONDOR, V113, P284, DOI 10.1525/cond.2011.100136; Seto KC, 2010, ANNU REV ENV RESOUR, V35, P167, DOI 10.1146/annurev-environ-100809-125336; Shannon Claude E, 1963, MATH THEORY COMMUNIC; Shochat E, 2015, URBAN ECOSYSTEM ECOL, P75; Team RDC, 2012, R LANG ENV STAT COMP; Thompson C., 2009, P 4 INT PARTN FLIGHT, P244; Whittaker KA, 2009, AUK, V126, P288, DOI 10.1525/auk.2009.07136	58	51	56	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53371	10.1371/journal.pone.0053371	http://dx.doi.org/10.1371/journal.pone.0053371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326420	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500067
J	Leppanen, T; Korhonen, R; Laavola, M; Nieminen, R; Tuominen, RK; Moilanen, E				Leppanen, Tiina; Korhonen, Riku; Laavola, Mirka; Nieminen, Riina; Tuominen, Raimo K.; Moilanen, Eeva			Down-Regulation of Protein Kinase C delta Inhibits Inducible Nitric Oxide Synthase Expression through IRF1	PLOS ONE			English	Article							DESTABILIZING MESSENGER-RNA; TRANSCRIPTION FACTOR IRF-1; INDUCED LUNG INJURY; INTERFERON-GAMMA; ACTIVATED MACROPHAGES; TARGETED DISRUPTION; TREATED MACROPHAGES; INOS EXPRESSION; FACTOR-I; GENE	In inflammation, pro-inflammatory cytokines and bacterial products induce the production of high amounts of NO by inducible nitric oxide synthase (iNOS) in inflammatory and tissue cells. NO is an effector molecule in innate immunity, and it also has regulatory and pro-inflammatory/destructive effects in the inflammatory process. Protein kinase C delta (PKC delta) is an important signaling protein regulating B lymphocyte functions, but less is known about its effects in innate immunity and inflammatory gene expression. In the present study we investigated the role of PKC delta in the regulation of iNOS expression in inflammatory conditions. NO production and iNOS expression were induced by LPS or a combination of cytokines IFN gamma, IL-1b, and TNF alpha. Down-regulation of PKC delta by siRNA and inhibition of PKCd by rottlerin suppressed NO production and iNOS expression in activated macrophages and fibroblasts. PKC delta directed siRNA and inhibition of PKCd by rottlerin suppressed also the expression of transcription factor IRF1, possibly through inhibition of STAT1 activation. Accordingly, down-regulation of IRF1 by siRNA reduced iNOS expression in response to inflammatory stimuli. In addition, inhibition of PKC delta showed anti-inflammatory effects in carrageenan induced paw inflammation in mice as did iNOS inhibitor L-NIL. These results suggest that inhibitors of PKC delta have anti-inflammatory effects in disease states complicated by enhanced NO production through iNOS pathway.	[Leppanen, Tiina; Korhonen, Riku; Laavola, Mirka; Nieminen, Riina; Moilanen, Eeva] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland; [Leppanen, Tiina; Korhonen, Riku; Laavola, Mirka; Nieminen, Riina; Moilanen, Eeva] Tampere Univ Hosp, Tampere, Finland; [Tuominen, Raimo K.] Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki	Moilanen, E (corresponding author), Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland.	eeva.moilanen@uta.fi		Korhonen, Riku/0000-0002-7264-517X	Finnish Funding Agency for Technology and Innovation; Medical Research Fund of Tampere University Hospital; Finnish Cultural Foundation - Pirkanmaa Regional Fund; National Programme of Musculoskeletal Disorders and Biomaterials	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Medical Research Fund of Tampere University Hospital; Finnish Cultural Foundation - Pirkanmaa Regional Fund; National Programme of Musculoskeletal Disorders and Biomaterials	This study was supported by grants from The Finnish Funding Agency for Technology and Innovation, The Medical Research Fund of Tampere University Hospital, Finnish Cultural Foundation - Pirkanmaa Regional Fund and The National Programme of Musculoskeletal Disorders and Biomaterials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhatt KH, 2010, MOL IMMUNOL, V47, P861, DOI 10.1016/j.molimm.2009.10.029; Blair LA, 2002, J BIOL CHEM, V277, P359, DOI 10.1074/jbc.M109819200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delgado M, 1999, J IMMUNOL, V162, P4685; Dugo L, 2004, BRIT J PHARMACOL, V141, P979, DOI 10.1038/sj.bjp.0705683; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Faggioli L, 1997, EUR J IMMUNOL, V27, P3022, DOI 10.1002/eji.1830271140; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fujimura M, 1997, BRAIN RES, V759, P247, DOI 10.1016/S0006-8993(97)00264-3; Gao JJ, 1998, J IMMUNOL, V161, P4803; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Handy RLC, 1998, BRIT J PHARMACOL, V123, P1119, DOI 10.1038/sj.bjp.0701735; Harkin DW, 2004, J SURG RES, V120, P230, DOI 10.1016/j.jss.2004.03.011; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Korhonen R, 2002, MOL PHARMACOL, V62, P698, DOI 10.1124/mol.62.3.698; Korhonen R, 2007, MOL PHARMACOL, V71, P1427, DOI 10.1124/mol.106.033449; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Lahti A, 2003, MOL PHARMACOL, V64, P308, DOI 10.1124/mol.64.2.308; Lee MR, 2008, EXPERT OPIN THER TAR, V12, P535, DOI 10.1517/14728222.12.5.535 ; Leitges M, 2001, J CLIN INVEST, V108, P1505; Leppanen T, 2010, EUR J PHARMACOL, V628, P220, DOI 10.1016/j.ejphar.2009.11.014; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; LYONS CR, 1992, J BIOL CHEM, V267, P6370; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Paukkeri EL, 2007, BRIT J PHARMACOL, V152, P1081, DOI 10.1038/sj.bjp.0707477; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Peng XQ, 2005, AM J RESP CRIT CARE, V172, P470, DOI 10.1164/rccm.200411-1547OC; Romeo G, 2002, J INTERF CYTOK RES, V22, P39, DOI 10.1089/107999002753452647; Salonen T, 2006, BRIT J PHARMACOL, V147, P790, DOI 10.1038/sj.bjp.0706672; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shiraishi A, 1997, J IMMUNOL, V159, P3549; Sittipunt C, 2001, AM J RESP CRIT CARE, V163, P503, DOI 10.1164/ajrccm.163.2.2004187; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Tinker AC, 2006, CURR TOP MED CHEM, V6, P77, DOI 10.2174/156802606775270297; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Vuolteenaho K, 2007, SCAND J RHEUMATOL, V36, P247, DOI 10.1080/03009740701483014; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yamagishi S, 2011, PHARMACOL RES, V64, P187, DOI 10.1016/j.phrs.2011.05.009	56	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52741	10.1371/journal.pone.0052741	http://dx.doi.org/10.1371/journal.pone.0052741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326354	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500030
J	Witt, A; Puspitawati, I; Vinter, A				Witt, Arnaud; Puspitawati, Ira; Vinter, Annie			How Explicit and Implicit Test Instructions in an Implicit Learning Task Affect Performance	PLOS ONE			English	Article							PSYCHOMETRIC INTELLIGENCE; AGE-DIFFERENCES; CHILDREN; MEMORY; KNOWLEDGE; ACQUISITION; LANGUAGE; JUDGMENT; ADULTS; COLOR	Typically developing children aged 5 to 8 years were exposed to artificial grammar learning. Following an implicit exposure phase, half of the participants received neutral instructions at test while the other half received instructions making a direct, explicit reference to the training phase. We first aimed to assess whether implicit learning operated in the two test conditions. We then evaluated the differential impact of age on learning performances as a function of test instructions. The results showed that performance did not vary as a function of age in the implicit instructions condition, while age effects emerged when explicit instructions were employed at test. However, performance was affected differently by age and the instructions given at test, depending on whether the implicit learning of short or long units was assessed. These results suggest that the claim that the implicit learning process is independent of age needs to be revised.	[Witt, Arnaud; Vinter, Annie] Univ Bourgogne, LEAD CNRS, Dijon, France; [Puspitawati, Ira] Univ Gunadarma, Jakarta, Indonesia	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Gunadarma University	Witt, A (corresponding author), Univ Bourgogne, LEAD CNRS, Dijon, France.	arnaud.witt@u-bourgogne.fr	Puspitawati, Ira/GQB-3373-2022					Arciuli J, 2011, DEVELOPMENTAL SCI, V14, P464, DOI 10.1111/j.1467-7687.2009.00937.x; Atwell JA, 2003, AM J MENT RETARD, V108, P56, DOI 10.1352/0895-8017(2003)108<0056:IAELIY>2.0.CO;2; Bebko J. M., 1998, HDB MENTAL RETARDATI, P382; Bennett IJ, 2007, J GERONTOL B-PSYCHOL, V62, pP98, DOI 10.1093/geronb/62.2.P98; BENNETT WF, 1954, J EXP PSYCHOL, V48, P303, DOI 10.1037/h0053543; Bray JNW, 1979, HDB MENTAL DEFICIENC, P699; Bray NW, 1986, INT REV RES MENT RET, V14, P77; Carr T. H., 1994, STUD SECOND LANG ACQ, V16, P205, DOI DOI 10.1017/S0272263100012882; CHANDLER S, 1993, J PSYCHOLINGUIST RES, V22, P593; Cowan N, 2001, INTERPRETTING, V5, P117; Demont E., 2004, ENFANCE, V3, P245; DULANY DE, 1984, J EXP PSYCHOL GEN, V113, P541, DOI 10.1037/0096-3445.113.4.541; Eisenberg Daniel, 2015, J MENT HEALTH, V20, P222, DOI [10.3109/10673229.2012.712839, DOI 10.3109/09638237.2014.954693, 10.3109/08039481003777484]; ELLIS NR, 1970, INT REV RES MENT RET, V4, P1; Lopez-Ramon MF, 2007, AV PSICOL LATINOAM, V25, P126; Fischer JP, 1997, ANN PSYCHOL, V97; Fletcher J, 2000, J EXP PSYCHOL LEARN, V26, P246, DOI 10.1037/0278-7393.26.1.246; FRENSCH PA, 1994, MEM COGNITION, V22, P95, DOI 10.3758/BF03202765; FRITH U, 1970, J EXP CHILD PSYCHOL, V10, P120, DOI 10.1016/0022-0965(70)90049-4; FRITH U, 1972, J AUTISM CHILD SCHIZ, V2, P160, DOI 10.1007/BF01537569; Gardiner John M., 1993, P163; Gebauer GF, 2007, J EXP PSYCHOL LEARN, V33, P34, DOI 10.1037/0278-7393.33.1.34; Hoffmann J, 2005, EUR J COGN PSYCHOL, V17, P449, DOI 10.1080/09541440440000203; Howard DV, 2008, J GERONTOL B-PSYCHOL, V63, pP100, DOI 10.1093/geronb/63.2.P100; Howard JH, 1997, PSYCHOL AGING, V12, P634, DOI 10.1037/0882-7974.12.4.634; Karatekin C, 2007, J EXP CHILD PSYCHOL, V96, P107, DOI 10.1016/j.jecp.2006.05.005; Komatsu S, 1996, J EXP CHILD PSYCHOL, V62, P151, DOI 10.1006/jecp.1996.0026; Krebs HI, 2001, EXP BRAIN RES, V141, P425, DOI 10.1007/s002210100871; KRIST H, 1993, J EXP PSYCHOL LEARN, V19, P952, DOI 10.1037/0278-7393.19.4.952; Litke DR, 2001, DISS ABSTR INT SCI B, V6111, P6159; MAYBERY M, 1995, AUST J PSYCHOL, V47, P8, DOI 10.1080/00049539508258763; McGeorge P, 1997, J EXP PSYCHOL LEARN, V23, P239, DOI 10.1037/0278-7393.23.1.239; MEADOR DM, 1987, AM J MENT RETARD, V91, P613; Meulemans T, 1997, J EXP PSYCHOL LEARN, V23, P1007; Meulemans T, 1998, J EXP CHILD PSYCHOL, V69, P199, DOI 10.1006/jecp.1998.2442; Meulemans T, 1998, APPRENTISSAGE IMPLIC; Mittenecker E, 1958, Z EXPT ANGEWANDTE PS, V5, P45; Murphy K, 2003, J EXP CHILD PSYCHOL, V84, P124, DOI 10.1016/S0022-0965(03)00002-X; MYERS C, 1992, APPL COGNITIVE PSYCH, V6, P429, DOI 10.1002/acp.2350060507; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; Pacton S, 2001, J EXP PSYCHOL GEN, V130, P401, DOI 10.1037//0096-3445.130.3.401; Pacton S., 2006, COMPRENDRE APPRENTIS, V2, P59; Pavlidou EV, 2009, ANN DYSLEXIA, V59, P55, DOI 10.1007/s11881-009-0023-z; Perez LA, 1998, J EXP CHILD PSYCHOL, V70, P167, DOI 10.1006/jecp.1998.2449; Perruchet P, 2005, PSYCHOL RES-PSYCH FO, V69, P316, DOI 10.1007/s00426-004-0205-6; PERRUCHET P, 1990, J EXP PSYCHOL GEN, V119, P264, DOI 10.1037/0096-3445.119.3.264; PERRUCHET P, 1994, J EXP PSYCHOL LEARN, V20, P223, DOI 10.1037/0278-7393.20.1.223; PERRUCHET P, 1997, IMPLICIT IS IMPLICIT, P124; Perruchet P., 2008, LEARNING MEMORY COMP, V2, P597, DOI DOI 10.1016/B978-012370509-9.00149-2; Reber A.S., 1993, IMPLICIT LEARNING TA; Roter A, 1985, IMPLICIT LEARN UNPUB; Rowland LA, 2006, PSYCHON B REV, V13, P643, DOI 10.3758/BF03193975; SERVANSCHREIBER E, 1990, J EXP PSYCHOL LEARN, V16, P592, DOI 10.1037/0278-7393.16.4.592; Soetens E, 2004, PSYCHOL RES-PSYCH FO, V69, P124, DOI 10.1007/s00426-003-0163-4; Stadler M. A., 1998, HDB IMPLICIT LEARNIN, P323; STADLER MA, 1994, SCIENCE, V265, P1600, DOI 10.1126/science.8079176; STADLER MA, 1992, J EXP PSYCHOL LEARN, V18, P318, DOI 10.1037/0278-7393.18.2.318; Thomas KM, 2001, J EXP CHILD PSYCHOL, V79, P364, DOI 10.1006/jecp.2000.2613; Van Den Bos E, 2008, MEM COGNITION, V36, P1122, DOI 10.3758/MC.36.6.1122; Vinter A, 2003, AM J MENT RETARD, V108, P94, DOI 10.1352/0895-8017(2003)108<0094:ILICAA>2.0.CO;2; Vinter A, 2002, MEM COGNITION, V30, P256, DOI 10.3758/BF03195286; Vinter A, 1999, Q J EXP PSYCHOL-A, V52, P857, DOI 10.1080/027249899390846; Vinter A, 2000, CHILD DEV, V71, P1223, DOI 10.1111/1467-8624.00225; Vinter A, 2008, BRIT J DEV PSYCHOL, V26, P507, DOI 10.1348/026151007X267300; WIEGERSMA S, 1982, PSYCHOL RES-PSYCH FO, V44, P175, DOI 10.1007/BF00308449; Witt A, 2012, PSYCHOL RES-PSYCH FO, V76, P97, DOI 10.1007/s00426-011-0328-5; Witt A, 2011, Q J EXP PSYCHOL, V64, P1173, DOI 10.1080/17470218.2010.543283	68	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53296	10.1371/journal.pone.0053296	http://dx.doi.org/10.1371/journal.pone.0053296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326409	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500061
J	Coutu, S; Rossi, L; Barry, DA; Rudaz, S; Vernaz, N				Coutu, Sylvain; Rossi, Luca; Barry, D. A.; Rudaz, Serge; Vernaz, Nathalie			Temporal Variability of Antibiotics Fluxes in Wastewater and Contribution from Hospitals	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; HUMAN PHARMACEUTICALS; TREATMENT PLANTS; CONSUMPTION; FATE; EXPOSURE; CONTAMINANTS; EFFLUENTS; RESIDUES	Significant quantities of antibiotics are used in all parts of the globe to treat diseases with bacterial origins. After ingestion, antibiotics are excreted by the patient and transmitted in due course to the aquatic environment. This study examined temporal fluctuations (monthly time scale) in antibiotic sources (ambulatory sales and data from a hospital dispensary) for Lausanne, Switzerland. Source variability (i.e., antibiotic consumption, monthly data for 2006-2010) were examined in detail for nine antibiotics - azithromycin, ciprofloxacin, clarithromycin, clindamycin, metronidazole, norfloxacin, ofloxacin, sulfamethoxazole and trimethoprim, from which two main conclusions were reached. First, some substances - azithromycin, clarithromycin, ciprofloxacin - displayed high seasonality in their consumption, with the winter peak being up to three times higher than the summer minimum. This seasonality in consumption resulted in seasonality in Predicted Environmental Concentrations (PECs). In addition, the seasonality in PECs was also influenced by that in the base wastewater flow. Second, the contribution of hospitals to the total load of antibiotics reaching the Lausanne Wastewater Treatment Plant (WTP) fluctuated markedly on a monthly time scale, but with no seasonal pattern detected. That is, there was no connection between fluctuations in ambulatory and hospital consumption for the substances investigated.	[Coutu, Sylvain; Rossi, Luca; Barry, D. A.] Ecole Polytech Fed Lausanne, ENAC IIE ECOL, CH-1015 Lausanne, Switzerland; [Rudaz, Serge] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland; [Rudaz, Serge] Univ Geneva, Swiss Ctr Appl Human Toxicol, Geneva, Switzerland; [Vernaz, Nathalie] Univ Hosp Geneva, Dept Pharm, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Lausanne; University of Geneva; University of Geneva	Coutu, S (corresponding author), Ecole Polytech Fed Lausanne, ENAC IIE ECOL, CH-1015 Lausanne, Switzerland.	sylvain.coutu@epfl.ch	Barry, D. Andrew/C-6077-2008; Rudaz, Serge/AAB-2861-2021	Barry, D. Andrew/0000-0002-8621-0425; Rudaz, Serge/0000-0002-4180-5417; Vernaz, Nathalie/0000-0002-1371-5510	FNS [PDFMP2-123021]	FNS(Swiss National Science Foundation (SNSF))	The study was supported by FNS (http://www.snf.ch/) under Grant number: PDFMP2-123021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assainissement Lausanne, 2009, TECHNICAL REPORT; Beier S, 2011, WATER SCI TECHNOL, V63, P66, DOI 10.2166/wst.2011.010; Besse JP, 2008, TOXICOL LETT, V176, P104, DOI 10.1016/j.toxlet.2007.10.012; Bonvin F, 2011, ENVIRON SCI TECHNOL, V45, P4702, DOI 10.1021/es2003588; Calamari D, 2003, ENVIRON SCI TECHNOL, V37, P1241, DOI 10.1021/es020158e; Carballa M, 2008, CHEMOSPHERE, V72, P1118, DOI 10.1016/j.chemosphere.2008.04.034; Conley JM, 2008, CHEMOSPHERE, V73, P1178, DOI 10.1016/j.chemosphere.2008.07.062; Feldmann DF, 2008, CHEMOSPHERE, V71, P1754, DOI 10.1016/j.chemosphere.2007.11.032; Filippini M, 2006, HEALTH POLICY, V78, P77, DOI 10.1016/j.healthpol.2005.09.009; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Gromaire-Mertz MC, 2000, HOUILLE BLANCHE, P66, DOI 10.1051/lhb/2000018; Heberer T, 2005, J HAZARD MATER, V122, P211, DOI 10.1016/j.jhazmat.2005.03.007; Hirsch R, 1999, SCI TOTAL ENVIRON, V225, P109, DOI 10.1016/S0048-9697(98)00337-4; Huschek G, 2004, ENVIRON TOXICOL, V19, P226, DOI 10.1002/tox.20015; Isidori M, 2005, SCI TOTAL ENVIRON, V346, P87, DOI 10.1016/j.scitotenv.2004.11.017; Jones OAH, 2002, WATER RES, V36, P5013, DOI 10.1016/S0043-1354(02)00227-0; Kfimmerer K., 2001, PHARM ENV SOURCES FA; Kummerer K, 2000, CHEMOSPHERE, V40, P701, DOI 10.1016/S0045-6535(99)00439-7; Langford KH, 2009, ENVIRON INT, V35, P766, DOI 10.1016/j.envint.2009.02.007; Lapworth DJ, 2012, ENVIRON POLLUT, V163, P287, DOI 10.1016/j.envpol.2011.12.034; Le Corre KS, 2012, ENVIRON INT, V45, P99, DOI 10.1016/j.envint.2012.03.008; Lissemore L, 2006, CHEMOSPHERE, V64, P717, DOI 10.1016/j.chemosphere.2005.11.015; McArdell CS, 2003, ENVIRON SCI TECHNOL, V37, P5479, DOI 10.1021/es034368i; Musolff A, 2009, ENVIRON POLLUT, V157, P3069, DOI 10.1016/j.envpol.2009.05.037; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Oropesa AL, 2011, ECOTOXICOLOGY, V21, P1; Ort C, 2010, WATER RES, V44, P605, DOI 10.1016/j.watres.2009.08.002; Patrick DM, 2004, CLIN INFECT DIS, V39, P11, DOI 10.1086/420825; Perazzolo C, 2010, ENVIRON TOXICOL CHEM, V29, P1649, DOI 10.1002/etc.221; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Reinert KH, 2002, ENVIRON TOXICOL CHEM, V21, P1977, DOI [10.1897/1551-5028(2002)021&lt;1977:EAOTVO&gt;2.0.CO;2, 10.1002/etc.5620210928]; Roig B, 2010, PHARM ENV; Santos JL, 2009, J HAZARD MATER, V164, P1509, DOI 10.1016/j.jhazmat.2008.09.073; Stuer-Lauridsen F, 2000, CHEMOSPHERE, V41, P1509, DOI 10.1016/S0045-6535(00)00152-1; Ternes T., 2006, WATER INTELL ONLINE, V5, P1; Thomas KV, 2007, J ENVIRON MONITOR, V9, P1410, DOI 10.1039/b709745j; Tomicic B, 2001, URBAN DRAINAGE MODEL, V80, P180; Vallotton N, 2008, ENVIRON TOXICOL CHEM, V27, P1399, DOI 10.1897/07-197; VanderStichele RH, 2006, J ANTIMICROB CHEMOTH, V58, P159, DOI 10.1093/jac/dkl147; Verlicchi P, 2012, SCI TOTAL ENVIRON, V430, P109, DOI 10.1016/j.scitotenv.2012.04.055; Watanabe N, 2010, ENVIRON SCI TECHNOL, V44, P6591, DOI 10.1021/es100834s; Webb S, 2003, TOXICOL LETT, V142, P157, DOI 10.1016/S0378-4274(03)00071-7	42	37	37	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53592	10.1371/journal.pone.0053592	http://dx.doi.org/10.1371/journal.pone.0053592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320096	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800061
J	Rosen, DB; Harrington, KH; Cordeiro, JA; Leung, LY; Putta, S; Lacayo, N; Laszlo, GS; Gudgeon, CJ; Hogge, DE; Hawtin, RE; Cesano, A; Walter, RB				Rosen, David B.; Harrington, Kimberly H.; Cordeiro, James A.; Leung, Ling Y.; Putta, Santosh; Lacayo, Norman; Laszlo, George S.; Gudgeon, Chelsea J.; Hogge, Donna E.; Hawtin, Rachael E.; Cesano, Alessandra; Walter, Roland B.			AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; HUMAN CELL-LINE; INDUCED CYTOTOXICITY; ESTABLISHMENT; SURVIVAL; THERAPY; NETWORK; PATHWAY; CYTOGENETICS	Gemtuzumab ozogamicin (GO), an immunoconjugate between an anti-CD33 antibody and a calicheamicin-gamma(1) derivative, induces remissions and improves survival in a subset of patients with acute myeloid leukemia (AML). As the mechanisms underlying GO and calicheamicin-gamma(1) resistance are incompletely understood, we herein used flow cytometry-based single cell network profiling (SCNP) assays to study cellular responses of primary human AML cells to GO. Our data indicate that the extent of DNA damage is quantitatively impacted by CD33 expression and drug efflux activity. However, although DNA damage is required for GO-induced cytotoxicity, it is not sufficient for effective cell kill, suggesting that downstream antiapoptotic pathways may function as relevant resistance mechanisms. Supporting this notion, we found activated PI3K/AKT signaling to be associated with GO resistance in vitro in primary AML cells. Consistently, the investigational AKT inhibitor MK-2206 significantly sensitized various human AML cells to GO or free calicheamicin-gamma(1) with particularly pronounced effects in otherwise GO or free calicheamicin-gamma(1) -resistant cells. Likewise, MK-2206 also sensitized primary AML cells to calicheamicin-gamma(1). Together, our findings illustrate the capacity of SCNP assays to discover chemotherapy-related biological pathways and signaling networks relevant to GO-induced genotoxic stress. The identification of AKT signaling as being associated with GO resistance in vitro may provide a novel approach to improve the in vivo efficacy of GO/calicheamicin-gamma(1) and, by extrapolation, other DNA damage-based therapeutics.	[Rosen, David B.; Cordeiro, James A.; Leung, Ling Y.; Putta, Santosh; Hawtin, Rachael E.; Cesano, Alessandra] Nodality Inc, San Francisco, CA USA; [Harrington, Kimberly H.; Laszlo, George S.; Gudgeon, Chelsea J.; Walter, Roland B.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Lacayo, Norman] Stanford Univ, Sch Med, Div Pediat Hematol Oncol, Palo Alto, CA 94304 USA; [Hogge, Donna E.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Walter, Roland B.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Walter, Roland B.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Stanford University; British Columbia Cancer Agency; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cesano, A (corresponding author), Nodality Inc, San Francisco, CA USA.	alessandra.cesano@nodality.com	Cordeiro, James/AAE-5295-2019; Walter, Roland/C-1064-2008	Walter, Roland/0000-0002-9268-3341; Hogge, Donna/0000-0002-5205-9982	National Cancer Institute/National Institutes of Health [P30-CA015704-35S6, R21-CA159285]; Valvano Foundation; Seattle Genetics Inc.; NATIONAL CANCER INSTITUTE [P30CA015704, R21CA159285] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Valvano Foundation; Seattle Genetics Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute/National Institutes of Health (P30-CA015704-35S6 and R21-CA159285 [RBW]) and the Valvano Foundation (NL). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DBR, LL, JAC, SP, REH, and AC are employees and stock-holders of Nodality, Inc. Based on these data, two patents entitled METHODS FOR ANALYING DRUG RESPONSE were filed by Nodality Inc. on Oct 19th, 2009 (USPTO Application No: 2/581,536) and May 1st, 2012 (USPTO Application No: 61/640794). RBW is a consultant for and receives research funding from Seattle Genetics Inc. KHH, GSL, NL, and DEH declare no potential conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BENBASSAT H, 1982, LEUKEMIA RES, V6, P743, DOI 10.1016/0145-2126(82)90055-8; Bressanin D, 2012, ONCOTARGET, V3, P811; Burnett AK, 2012, J CLIN ONCOL; Burnett AK, 2011, J CLIN ONCOL, V29, P369, DOI 10.1200/JCO.2010.31.4310; Castaigne S, 2012, LANCET, V379, P1508, DOI 10.1016/S0140-6736(12)60485-1; Cesano A, 2012, CYTOM PART B-CLIN CY, V82B, P158, DOI 10.1002/cyto.b.21007; Cheng Y, 2012, MOL CANCER THER, V11, P154, DOI 10.1158/1535-7163.MCT-11-0606; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Delaunay J, 2011, BLOOD, V118, P37, DOI 10.1182/blood.V118.21.79.79; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dowell JA, 2001, J CLIN PHARMACOL, V41, P1206, DOI 10.1177/00912700122012751; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Goemans BF, 2008, LEUKEMIA, V22, P2284, DOI 10.1038/leu.2008.147; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jager E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024265; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; LANOTTE M, 1991, BLOOD, V77, P1080; Linenberger ML, 2005, LEUKEMIA, V19, P176, DOI 10.1038/sj.leu.2403598; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Martelli AM, 2010, ONCOTARGET, V1, P89, DOI 10.18632/oncotarget.114; Meng JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014124; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rosen DB, 2012, LEUKEMIA RES, V36, P900, DOI 10.1016/j.leukres.2012.02.022; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013543; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Stegeman H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-463; Stelzer GT, 2000, IMMUNOPHENOTYPING, P215; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tai HL, 2000, CURR OPIN MOL THER, V2, P459; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Walter RB, 2005, BLOOD, V106, P3584, DOI 10.1182/blood-2005-02-0711; Walter RB, 2005, BLOOD, V105, P1295, DOI 10.1182/blood-2004-07-2784; Walter RB, 2004, BLOOD, V103, P4276, DOI 10.1182/blood-2003-11-3825; Walter RB, 2003, BLOOD, V102, P1466, DOI 10.1182/blood-2003-02-0396; Walter RB, 2012, BLOOD, V119, P6198, DOI 10.1182/blood-2011-11-325050	43	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53518	10.1371/journal.pone.0053518	http://dx.doi.org/10.1371/journal.pone.0053518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320091	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800056
J	Song, Y; Wang, HJ; Ma, J; Wang, ZQ				Song, Yi; Wang, Hai-Jun; Ma, Jun; Wang, Zhiqiang			Secular Trends of Obesity Prevalence in Urban Chinese Children from 1985 to 2010: Gender Disparity	PLOS ONE			English	Article							CHILDHOOD OBESITY; NUTRITION TRANSITION; ENERGY-EXPENDITURE; SEX-DIFFERENCES; OVERWEIGHT; EPIDEMIC; FOOD; AGE	Based on the data from six Chinese National Surveys on Students Constitution and Health (CNSSCH) from 1985 to 2010, we explored the secular trend in the prevalence of obesity in urban Chinese children over a period of 25 years. The aim of this study was to examine the gender disparities in the prevalence of childhood obesity over time. The standardized prevalence of obesity in Chinese children increased rapidly during the past 25 years from 0.2% in 1985 to 8.1% in 2010. The increasing trend was significant in all age subgroups (p<0.01). Although the prevalence of obesity continuously increased in both boys and girls, the changing pace in boys was faster than that in girls. Age-specific prevalence odds ratios (PORs) of boys versus girls for obesity increased over time during the 25 year period. The prevalence of obesity in boys was significantly higher than in girls in all age-specific subgroups from 1991 and after. The gradually expanding gender disparity suggests the prevalence of obesity in boys contribute to a large and growing proportion of obese children. Therefore, it is critical for developing and implementing gender-specific preventive guidelines and public health policies in China.	[Song, Yi; Wang, Hai-Jun; Ma, Jun; Wang, Zhiqiang] Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing 100871, Peoples R China; [Wang, Zhiqiang] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Ctr Chron Dis, Herston, Qld, Australia	Peking University; Royal Brisbane & Women's Hospital; University of Queensland	Wang, HJ (corresponding author), Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing 100871, Peoples R China.	whjun1@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021; Wang, Zhiqiang/A-5835-2010	Wang, Haijun/0000-0003-0849-2903; Wang, Zhiqiang/0000-0002-5839-743X	National Natural Science Foundation of China [81172683]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The data analysis of the present study was supported by grant from National Natural Science Foundation of China (81172683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babey SH, 2010, AM J PUBLIC HEALTH, V100, P2149, DOI 10.2105/AJPH.2010.192641; BEYDOUN MA, 2008, OBESITY, V0017; Borders TF, 2006, J COMMUN HEALTH, V31, P57, DOI 10.1007/s10900-005-8189-8; Cheng TO, 2005, INT J CARDIOL, V98, P173, DOI 10.1016/j.ijcard.2004.08.019; CNSSCH, 1997, REP 1995 NAT SURV ST; CNSSCH Association, 2007, REP 2005 NAT SURV ST; CNSSCH Association, 1993, REP 1991 NAT SURV ST; CNSSCH Association, 1987, REP 1985 NAT SURV ST; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; DeLany JP, 2004, AM J CLIN NUTR, V79, P268; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Goyal Ramesh K, 2010, J Assoc Physicians India, V58, P151; Gupta DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017221; Ji CY, 2008, INT J CARDIOL, V131, P1, DOI 10.1016/j.ijcard.2008.05.078; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Ji CY., 2007, REPORT 2005 CHINESE; Kirkby J, 2004, AM J CLIN NUTR, V80, P430, DOI 10.1093/ajcn/80.2.430; Kocoglu G., 2003, Pakistan Journal of Nutrition, V2, P292; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Lovejoy JC, 2009, OBES REV, V10, P154, DOI 10.1111/j.1467-789X.2008.00529.x; Ma J, 2012, CHIN J PREV MED, V46, P781; Mahfouz AA, 2011, SAUDI J GASTROENTERO, V17, P318, DOI 10.4103/1319-3767.84486; Marsh HW, 2007, DEV PSYCHOL, V43, P647, DOI 10.1037/0012-1649.43.3.647; Martin KS, 2007, J NUTR EDUC BEHAV, V39, P31, DOI 10.1016/j.jneb.2006.08.021; National Bureau of Statistics of China, 2011, CHIN STAT YB 2011; National Obesity Observatory, 2011, INT COMP OB PREV; Song Yi, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P789; The Chinese Students' Physique and Health Research Group, 2002, RES REP CHIN STUD PH; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Unnithan AG, 2008, INT J NUTR WELLNESS, V6; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wisniewski AB, 2009, GENDER MED, V6, P76, DOI 10.1016/j.genm.2008.12.001; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x; Zhang Xin, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P781	37	85	97	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53069	10.1371/journal.pone.0053069	http://dx.doi.org/10.1371/journal.pone.0053069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IY	23308137	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800027
J	Abrahams, PW; Davies, TC; Solomon, AO; Trow, AJ; Wragg, J				Abrahams, Peter W.; Davies, Theo C.; Solomon, Abiye O.; Trow, Amanda J.; Wragg, Joanna			Human Geophagia, Calabash Chalk and Undongo: Mineral Element Nutritional Implications	PLOS ONE			English	Article							PREGNANT-WOMEN; TRACE-ELEMENTS; IRON STATUS; SOIL; LEAD; BIOACCESSIBILITY; BIOAVAILABILITY; SUPPLEMENTATION; EXPOSURE; CHILDREN	The prime aim of our work is to report and comment on the bioaccessible concentrations - i.e., the soluble content of chemical elements in the gastrointestinal environment that is available for absorption - of a number of essential mineral nutrients and potentially harmful elements (PHEs) associated with the deliberate ingestion of African geophagical materials, namely Calabash chalk and Undongo. The pseudo-total concentrations of 13 mineral nutrients/PHEs were quantified following a nitric-perchloric acid digestion of nine different Calabash chalk samples, and bioaccessible contents of eight of these chemical elements were determined in simulated saliva/gastric and intestinal solutions obtained via use of the Fed ORganic Estimation human Simulation Test (FOREhST) in vitro procedure. The Calabash chalk pseudo-total content of the chemical elements is often below what may be regarded as average for soils/shales, and no concentration is excessively high. The in vitro leachate solutions had concentrations that were often lower than those of the blanks used in our experimental procedure, indicative of effective adsorption: lead, a PHE about which concern has been previously raised in connection with the consumption of Calabash chalk, was one such chemical element where this was evident. However, some concentrations in the leachate solutions are suggestive that Calabash chalk can be a source of chemical elements to humans in bioaccessible form, although generally the materials appear to be only a modest supplier: this applies even to iron, a mineral nutrient that has often been linked to the benefits of geophagia in previous academic literature. Our investigations indicate that at the reported rates of ingestion, Calabash chalk on the whole is not an important source of mineral nutrients or PHEs to humans. Similarly, although Undongo contains elevated pseudo-total concentrations of chromium and nickel, this soil is not a significant source to humans for any of the bioaccessible elements investigated.	[Abrahams, Peter W.; Trow, Amanda J.] Aberystwyth Univ, Inst Geog & Earth Sci, Ceredigion, Wales; [Davies, Theo C.; Solomon, Abiye O.] Univ Jos, Dept Geol & Min, Jos, Nigeria; [Wragg, Joanna] British Geol Survey, Nottingham NG12 5GG, England	Aberystwyth University; University of Jos; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey	Abrahams, PW (corresponding author), Aberystwyth Univ, Inst Geog & Earth Sci, Ceredigion, Wales.	pwa@aber.ac.uk		Wragg, Joanna/0000-0003-0011-641X	NERC [bgs05010] Funding Source: UKRI; Natural Environment Research Council [bgs05010] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abrahams PW, 2012, APPL GEOCHEM, V27, P954, DOI 10.1016/j.apgeochem.2011.05.003; Abrahams PW, 2006, APPL GEOCHEM, V21, P98, DOI 10.1016/j.apgeochem.2005.09.015; Abrahams PW, 1996, GEOGR J, V162, P63, DOI 10.2307/3060216; Abrahams PW, 1997, TROP MED INT HEALTH, V2, P617, DOI 10.1046/j.1365-3156.1997.d01-348.x; Al-Rmalli SW, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-79; Bascomb CL, 1974, SOIL SURVEY LABORATO, P14; Basden GT, 1938, CRAVING EARTH UNDERS; Beckett WS, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P39, DOI 10.1016/B978-012369413-3/50058-6; Berrow M. L., 1980, Reference Book, Ministry of Agriculture, Fisheries and Food, P159; Casteel SW, 2006, ENVIRON HEALTH PERSP, V114, P1162, DOI 10.1289/ehp.8852; Cave MR, 2011, DEALING WITH CONTAMINATED SITES: FROM THEORY TOWARDS PRACTICAL APPLICATION, P287, DOI 10.1007/978-90-481-9757-6_7; Cave MR, 2010, ENVIRON SCI TECHNOL, V44, P2654, DOI 10.1021/es903258v; Dean JR, 2004, CHEMOSPHERE, V57, P21, DOI 10.1016/j.chemosphere.2004.05.023; Denys S, 2012, ENVIRON SCI TECHNOL, V46, P6252, DOI 10.1021/es3006942; Ellickson KM, 2001, ARCH ENVIRON CON TOX, V40, P128, DOI 10.1007/s002440010155; European Food Safety Authority, 2010, EFSA J, V8, P1570, DOI [10.2903/j.efsa.2010.1570, DOI 10.2903/J.EFSA.2010.1570]; EVM, 2003, SAF UPP LEV VIT MIN; Food Standards Agency, 2002, CAL CHALK YOUR QUEST; Food Standards Agency, 2003, CAL CHALK WARN; Food Standards Agency, 2006, FOOD STAND AG ANN RE; Geissler PW, 1998, TROP MED INT HEALTH, V3, P529, DOI 10.1046/j.1365-3156.1998.00272.x; Geissler PW, 1998, T ROY SOC TROP MED H, V92, P549, DOI 10.1016/S0035-9203(98)90910-5; Gron C, 2003, HUMAN BIOACCESSIBILI; Health Canada, 2007, CAL CHALK MAY POS HL; Hooda PS, 2004, SCI TOTAL ENVIRON, V333, P75, DOI 10.1016/j.scitotenv.2004.04.023; HUNTER JM, 1973, GEOGR REV, V63, P170, DOI 10.2307/213410; Intawongse M, 2006, TRAC-TREND ANAL CHEM, V25, P876, DOI 10.1016/j.trac.2006.03.010; JECFA, 2011, EV CERT FOOD ADD CON; Kutalek R, 2010, T ROY SOC TROP MED H, V104, P787, DOI 10.1016/j.trstmh.2010.09.002; Maddaloni M, 1998, ENVIRON HEALTH PERSP, V106, P1589, DOI 10.1289/ehp.98106s61589; Mascolo N, 2004, APPL CLAY SCI, V25, P23, DOI 10.1016/j.clay.2003.07.001; MIDDLETON JD, 1989, BRIT MED J, V298, P407; Munsell Color Company, 1954, MUNS SOIL COL CHARTS; New York City Department of Health and Mental Hygiene, CAL CHALK CONT LEAD; NIELSEN FH, 1984, B NEW YORK ACAD MED, V60, P177; NIELSEN GD, 1990, BRIT J DERMATOL, V122, P299, DOI 10.1111/j.1365-2133.1990.tb08277.x; Oomen AG, 2002, ENVIRON SCI TECHNOL, V36, P3326, DOI 10.1021/es010204v; Ponka P, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P577, DOI 10.1016/B978-012369413-3/50085-9; SCN, 2004, 5 SCN; SHELLSHEAR ID, 1975, NEW ZEAL MED J, V81, P382; Smith B, 2000, J GEOL SOC LONDON, V157, P885, DOI 10.1144/jgs.157.4.885; Sule S, 2001, OBSTET GYNECOL SURV, V66, P452; Thompson M., 1982, ATOMIC ABSORPTION SP, V5, P261; Trow AJ, 2008, THESIS ABERYSTWYTH U; Turekian KK, 1972, CHEM EARTH; Vermeer D., 1979, AFR NOTES, V8, P13; VERMEER DE, 1985, SCIENCE, V227, P634, DOI 10.1126/science.3969552; VERMEER DE, 1966, ANN ASSOC AM GEOGR, V56, P197, DOI 10.1111/j.1467-8306.1966.tb00553.x; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; WEDEEN RP, 1978, ENVIRON RES, V17, P409, DOI 10.1016/0013-9351(78)90044-0; WHO, 1996, TRAC EL HUM NUTR HLT; Wigle DT, 2005, PLOS MED, V2, P1232, DOI 10.1371/journal.pmed.0020350; Wragg J, 2011, SCI TOTAL ENVIRON, V409, P4016, DOI 10.1016/j.scitotenv.2011.05.019; Yanai J, 2009, SOIL SCI PLANT NUTR, V55, P215, DOI 10.1111/j.1747-0765.2008.00346.x	55	17	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53304	10.1371/journal.pone.0053304	http://dx.doi.org/10.1371/journal.pone.0053304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308189	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100053
J	Chowdhury, AH; Ramroop, JR; Upadhyay, G; Sengupta, A; Andrzejczyk, A; Saleque, S				Chowdhury, Asif H.; Ramroop, Johnny R.; Upadhyay, Ghanshyam; Sengupta, Ananya; Andrzejczyk, Anna; Saleque, Shireen			Differential Transcriptional Regulation of meis1 by Gfi1b and Its Co-Factors LSD1 and CoREST	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; GROWTH-FACTOR INDEPENDENCE-1; ACUTE MYELOID-LEUKEMIA; ZINC-FINGER PROTEIN; ERYTHROID-DIFFERENTIATION; FACTOR GFI-1; IN-VITRO; GENES; REPRESSOR; HOX	Gfi1b (growth factor independence 1b) is a zinc finger transcription factor essential for development of the erythroid and megakaryocytic lineages. To elucidate the mechanism underlying Gfi1b function, potential downstream transcriptional targets were identified by chromatin immunoprecipitation and expression profiling approaches. The combination of these approaches revealed the oncogene meis1, which encodes a homeobox protein, as a direct and prominent target of Gfi1b. Examination of the meis1 promoter sequence revealed multiple Gfi1/1b consensus binding motifs. Distinct regions of the promoter were occupied by Gfi1b and its cofactors LSD1 and CoREST/Rcor1, in erythroid cells but not in the closely related megakaryocyte lineage. Accordingly, Meis1 was significantly upregulated in LSD1 inhibited erythroid cells, but not in megakaryocytes. This lineage specific upregulation in Meis1 expression was accompanied by a parallel increase in di-methyl histone3 lysine4 levels in the Meis1 promoter in LSD1 inhibited, erythroid cells. Meis1 was also substantially upregulated in gfi1b-/- fetal liver cells along with its transcriptional partners Pbx1 and several Hox messages. Elevated Meis1 message levels persisted in gfi1b mutant fetal liver cells differentiated along the erythroid lineage, relative to wild type. However, cells differentiated along the megakaryocytic lineage, exhibited no difference in Meis1 levels between controls and mutants. Transfection experiments further demonstrated specific repression of meis1 promoter driven reporters by wild type Gfi1b but neither by a SNAG domain mutant nor by a DNA binding deficient one, thus confirming direct functional regulation of this promoter by the Gfi1b transcriptional complex. Overall, our results demonstrate direct yet differential regulation of meis1 transcription by Gfi1b in distinct hematopoietic lineages thus revealing it to be a common, albeit lineage specific, target of both Gfi1b and its paralog Gfi1.	[Saleque, Shireen] CUNY City Coll, Dept Biol, New York, NY 10031 USA; CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Saleque, S (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	ssaleque@ccny.cuny.edu			NIMHD [G12RR03060-26A1, 8G12MD007603-27]; NHLBI [5SC1HL104638]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL104638] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants G12RR03060-26A1 and 8G12MD007603-27 from NIMHD to CCNY and by grant 5SC1HL104638 from NHLBI to S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai M, 2012, BLOOD; Daga A, 2000, EXP HEMATOL, V28, P569, DOI 10.1016/S0301-472X(00)00135-1; Duan Zhijun, 2003, Hematology, V8, P339, DOI 10.1080/10245330310001612116; Dwivedi PP, 2005, ENDOCR-RELAT CANCER, V12, P351, DOI 10.1677/erc.1.00920; Elmaagacli AH, 2007, BRIT J HAEMATOL, V136, P212, DOI 10.1111/j.1365-2141.2006.06407.x; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hock H, 2006, CURR OPIN HEMATOL, V13, P1, DOI 10.1097/01.moh.0000190111.85284.8f; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Horman SR, 2009, BLOOD, V113, P5466, DOI 10.1182/blood-2008-09-179747; Huang M, 2010, ACTA HAEMATOL-BASEL, V123, P1, DOI 10.1159/000253856; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; ISHIDA Y, 1993, EXP HEMATOL, V21, P289; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kazanjian A, 2004, CANCER RES, V64, P6874, DOI 10.1158/0008-5472.CAN-04-0633; Khandanpour C., 2012, BLOOD; Khandanpour C, 2010, BLOOD, V116, P5149, DOI 10.1182/blood-2010-04-280305; Khandanpour C, 2010, BLOOD, V115, P2462, DOI 10.1182/blood-2009-08-239822; Laurent B, 2012, J CELL SCI, V125, P993, DOI 10.1242/jcs.095877; Li-Kroeger D, 2008, DEV CELL, V15, P298, DOI 10.1016/j.devcel.2008.06.001; McGhee L, 2003, J CELL BIOCHEM, V89, P1005, DOI 10.1002/jcb.10548; Moroy T, 2011, SEMIN IMMUNOL, V23, P368, DOI 10.1016/j.smim.2011.08.006; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; Sakai I, 2001, INT J HEMATOL, V73, P507, DOI 10.1007/BF02994015; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Shin MS, 2004, CANCER RES, V64, P4419, DOI 10.1158/0008-5472.CAN-03-3885; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Tong B, 1998, MOL CELL BIOL, V18, P2462, DOI 10.1128/MCB.18.5.2462; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Vassen L, 2005, NUCLEIC ACIDS RES, V33, P987, DOI 10.1093/nar/gki243; Vassen L, 2006, EMBO J, V25, P2409, DOI 10.1038/sj.emboj.7601124; Vassen L, 2009, INT J HEMATOL, V89, P422, DOI 10.1007/s12185-009-0286-5; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	47	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53666	10.1371/journal.pone.0053666	http://dx.doi.org/10.1371/journal.pone.0053666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308270	Green Published, gold			2022-12-27	WOS:000313429100103
J	Nieto-Estevez, V; Pignatelli, J; Arauzo-Bravo, MJ; Hurtado-Chong, A; Vicario-Abejon, C				Nieto-Estevez, Vanesa; Pignatelli, Jaime; Arauzo-Bravo, Marcos J.; Hurtado-Chong, Anahi; Vicario-Abejon, Carlos			A Global Transcriptome Analysis Reveals Molecular Hallmarks of Neural Stem Cell Death, Survival, and Differentiation in Response to Partial FGF-2 and EGF Deprivation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL-CELLS; OLFACTORY-BULB; IN-VIVO; SUBVENTRICULAR ZONE; PROGENITOR CELLS; CEREBRAL-CORTEX; SELF-RENEWAL; HIPPOCAMPAL NEUROGENESIS	Neurosphere cell culture is a commonly used model to study the properties and potential applications of neural stem cells (NSCs). However, standard protocols to culture NSCs have yet to be established, and the mechanisms underlying NSC survival and maintenance of their undifferentiated state, in response to the growth factors FGF-2 and EGF are not fully understood. Using cultures of embryonic and adult olfactory bulb stem cells (eOBSCs and aOBSCs), we analyzed the consequences of FGF-2 and EGF addition at different intervals on proliferation, cell cycle progression, cell death and differentiation, as well as on global gene expression. As opposed to cultures supplemented daily, addition of FGF-2 and EGF every 4 days significantly reduced the neurosphere volume and the total number of cells in the spheres, mainly due to increased cell death. Moreover, partial FGF-2 and EGF deprivation produced an increase in OBSC differentiation during the proliferative phase. These changes were more evident in aOBSC than eOBSC cultures. Remarkably, these effects were accompanied by a significant upregulation in the expression of endogenous Fgf-2 and genes involved in cell death and survival (Cryab), lipid catabolic processes (Pla2g7), cell adhesion (Dscaml1), cell differentiation (Dscaml1, Gpr17, S100b, Ndrg2) and signal transduction (Gpr17, Ndrg2). These findings support that a daily supply of FGF-2 and EGF is critical to maintain the viability and the undifferentiated state of NSCs in culture, and they reveal novel molecular hallmarks of NSC death, survival and the initiation of differentiation.	[Nieto-Estevez, Vanesa; Pignatelli, Jaime; Hurtado-Chong, Anahi; Vicario-Abejon, Carlos] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Nieto-Estevez, Vanesa; Pignatelli, Jaime; Vicario-Abejon, Carlos] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Arauzo-Bravo, Marcos J.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Lab Computat Biol & Bioinformat, D-48149 Munster, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED; Max Planck Society	Vicario-Abejon, C (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	cvicario@cajal.csic.es	pignatelli, jaime/AAY-8734-2021; Marcos, Arauzo-Bravo/A-1706-2011; Vicario-Abejón, Carlos/G-2814-2016; Pignatelli, Jaime/L-3122-2014	pignatelli, jaime/0000-0002-8431-2241; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Vicario-Abejón, Carlos/0000-0002-7060-0250; Pignatelli, Jaime/0000-0002-8431-2241; Nieto-Estevez, Vanesa/0000-0002-7265-0593	Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad (MICINN and MINECO) [BFU2007-61230, BFU2010-1963]; Comunidad de Madrid [S2011/BMD-2336]; Instituto de Salud Carlos III (ISCIII) [CIBERNED CB06/05/0065]; MICINN; MINECO	Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad (MICINN and MINECO); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); MINECO(Spanish Government)	This work was funded by grants from the Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad (MICINN and MINECO; BFU2007-61230 and BFU2010-1963), the Comunidad de Madrid (S2011/BMD-2336), and the Instituto de Salud Carlos III (ISCIII; CIBERNED CB06/05/0065) to C.V.-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank M.J. Roman for her technical support. V.N.-E and A.H.-C were supported by FPI Fellowships from the MICINN and MINECO.	Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Andersson O, 2001, GENOMICS, V78, P178, DOI 10.1006/geno.2001.6666; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bernal GM, 2011, AGING CELL, V10, P466, DOI 10.1111/j.1474-9726.2011.00694.x; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Bousette N, 2010, P NATL ACAD SCI USA, V107, P18481, DOI 10.1073/pnas.1013555107; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Ceruti S, 2011, GLIA, V59, P363, DOI 10.1002/glia.21107; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Demos C, 2008, MOL VIS, V14, P1639; Diaz B, 2000, DEVELOPMENT, V127, P1641; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doncel-Perez E, 2009, GLIA, V57, P1393, DOI 10.1002/glia.20858; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fuerst PG, 2009, CURR OPIN NEUROBIOL, V19, P389, DOI 10.1016/j.conb.2009.07.013; Fukushima N, 2002, NEUROSCI RES, V44, P467, DOI 10.1016/S0168-0102(02)00173-6; Gao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036516; Giachino C, 2009, EUR J NEUROSCI, V30, P9, DOI 10.1111/j.1460-9568.2009.06798.x; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Gritti A, 1996, J NEUROSCI, V16, P1091; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hurtado-Chong A, 2009, EUR J NEUROSCI, V30, P742, DOI 10.1111/j.1460-9568.2009.06870.x; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lai WT, 2011, STEM CELLS, V29, P1102, DOI 10.1002/stem.661; Larrayoz IM, 2012, INT REV CEL MOL BIO, V297, P175, DOI 10.1016/B978-0-12-394308-8.00005-4; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li Y, 2011, BRAIN RES, V1382, P252, DOI 10.1016/j.brainres.2011.01.023; Lillien L, 2000, DEVELOPMENT, V127, P4993; Liu LJ, 2012, J MOL HISTOL, V43, P27, DOI 10.1007/s10735-011-9378-7; Lo Sardo V, 2012, NAT NEUROSCI, V15, P713, DOI 10.1038/nn.3080; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lukaszewicz AS, 2002, J NEUROSCI, V22, P6610; Lyon L, 2008, SYNAPSE, V62, P842, DOI 10.1002/syn.20553; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; Martin I, 2009, BRAIN RES, V1284, P22, DOI 10.1016/j.brainres.2009.05.070; Masilamoni JG, 2006, BBA-MOL BASIS DIS, V1762, P284, DOI 10.1016/j.bbadis.2005.11.007; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; McIntyre JC, 2010, J NEUROSCI RES, V88, P3243, DOI 10.1002/jnr.22497; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Mishra M, 2011, J CELL MOL MED, V15, P1713, DOI 10.1111/j.1582-4934.2010.01134.x; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ogata H, 2000, NUCLEIC ACIDS RES, V28, P4021, DOI 10.1093/nar/28.20.4021; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pappas IS, 1997, EXP NEUROL, V144, P302, DOI 10.1006/exnr.1997.6411; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Raballo R, 2000, J NEUROSCI, V20, P5012; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Schmidt H, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00025; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Stefaniuk M, 2010, J NEUROCHEM, V115, P1183, DOI 10.1111/j.1471-4159.2010.07023.x; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Sun YR, 2011, J CELL SCI, V124, P1867, DOI 10.1242/jcs.085506; Taniguchi H, 2006, DEVELOPMENT, V133, P1923, DOI 10.1242/dev.02354; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Tepavcevic V, 2011, J CLIN INVEST, V121, P4722, DOI 10.1172/JCI59145; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Vergano-Vera E, 2009, NEUROSCIENCE, V162, P39, DOI 10.1016/j.neuroscience.2009.03.033; Vergano-Vera E, 2006, DEVELOPMENT, V133, P4367, DOI 10.1242/dev.02601; Vergano-Vera E, 2010, CELL TISSUE RES, V340, P1, DOI 10.1007/s00441-010-0934-3; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Vicario-Abejon C, 2003, J NEUROSCI, V23, P895; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; Wingerd KL, 2004, DEV DYNAM, V231, P359, DOI 10.1002/dvdy.20120; Young KM, 2010, GLIA, V58, P943, DOI 10.1002/glia.20976	88	26	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53594	10.1371/journal.pone.0053594	http://dx.doi.org/10.1371/journal.pone.0053594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308259	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100094
J	Wang, L; Chen, H; Liu, DH; Huo, XX; Gao, JM; Song, XR; Xu, XC; Huang, KQ; Liu, WQ; Wang, Y; Lu, FL; Lun, ZR; Luo, QL; Wang, XL; Shen, JL				Wang, Lin; Chen, He; Liu, Daohua; Huo, Xingxing; Gao, Jiangmei; Song, Xiaorong; Xu, Xiucai; Huang, Kaiquan; Liu, Wenqi; Wang, Yong; Lu, Fangli; Lun, Zhao-Rong; Luo, Qingli; Wang, Xuelong; Shen, Jilong			Genotypes and Mouse Virulence of Toxoplasma gondii Isolates from Animals and Humans in China	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; POPULATION-STRUCTURE; CONGENITAL TOXOPLASMOSIS; CLONAL LINEAGES; HIGH PREVALENCE; NORTH-AMERICA; SOUTH-AMERICA; STRAINS; IDENTIFICATION; CATS	Background: Recent population structure studies of T. gondii revealed that a few major clonal lineages predominated in different geographical regions. T. gondii in South America is genetically and biologically divergent, whereas this parasite is remarkably clonal in North America and Europe with a few major lineages including Types I, II and III. Information on genotypes and mouse virulence of T. gondii isolates from China is scarce and insufficient to investigate its population structure, evolution, and transmission. Methodology/Principal Findings: Genotyping of 23 T. gondii isolates from different hosts using 10 markers for PCR-restriction fragment length polymorphism analyses (SAG1, SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico) revealed five genotypes; among them three genotypes were atypical and two were archetypal. Fifteen strains belong to the Chinese 1 lineage, which has been previously reported as a widespread lineage from swine, cats, and humans in China. Two human isolates fall into the type I and II lineages and the remaining isolates belong to two new atypical genotypes (ToxoDB#204 and #205) which has never been reported in China. Our results show that these genotypes of T. gondii isolates are intermediately or highly virulent in mice except for the strain TgCtwh6, which maintained parasitemia in mice for 35 days post infection although it possesses the uniform genotype of Chinese 1. Additionally, phylogenetic network analyses of all isolates of genotype Chinese 1 are identical, and there is no variation based on the sequence data generated for four introns (EF1, HP2, UPRT1 and UPRT7) and two dense granule proteins (GRA6 and GRA7). Conclusion/Significance: A limited genetic diversity was found and genotype Chinese 1 (ToxoDB#9) is dominantly circulating in mainland China. The results will provide a useful profile for deep insight to the population structure, epidemiology and biological characteristics of T. gondii in China.	[Wang, Lin; Song, Xiaorong; Xu, Xiucai; Luo, Qingli; Wang, Xuelong; Shen, Jilong] Anhui Med Univ, Dept Parasitol, Prov Lab Microbiol & Parasitol, Hefei, Anhui, Peoples R China; [Wang, Lin; Song, Xiaorong; Xu, Xiucai; Luo, Qingli; Wang, Xuelong; Shen, Jilong] Anhui Med Univ, Key Lab Zoonoses Anhui, Hefei, Anhui, Peoples R China; [Chen, He; Huo, Xingxing] Anhui Med Univ, Affiliated Hosp 1, Clin Lab, Hefei, Anhui, Peoples R China; [Wang, Lin; Huang, Kaiquan] Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Clin Lab, Hefei, Peoples R China; [Liu, Daohua] Prov Inst Parasit Dis Control Anhui, Hefei, Anhui, Peoples R China; [Gao, Jiangmei; Lun, Zhao-Rong] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Key Lab Trop Dis Control,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Wenqi] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Parasitol, Wuhan 430074, Hubei, Peoples R China; [Wang, Yong] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Lu, Fangli] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Fangli] Sun Yat Sen Univ, Zhongshan Sch Med, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui University of Chinese Medicine; Sun Yat Sen University; Huazhong University of Science & Technology; Nanjing Medical University; Sun Yat Sen University; Sun Yat Sen University	Shen, JL (corresponding author), Anhui Med Univ, Dept Parasitol, Prov Lab Microbiol & Parasitol, Hefei, Anhui, Peoples R China.	shenjilong53@126.com			National Basic Research Program of China (973 Program) [2010CB530001]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program, No. 2010CB530001) (http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032489; Ajzenberg D, 2010, FUTURE MICROBIOL, V5, P841, DOI 10.2217/FMB.10.55; Berenreiterova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028925; Carruthers VB, 2007, SCHIZOPHRENIA BULL, V33, P745, DOI 10.1093/schbul/sbm008; Chen ZW, 2011, VET PARASITOL, V183, P166, DOI 10.1016/j.vetpar.2011.06.013; Coordinating Office of the National Survey on the Important Human Parasitic Diseases, 2005, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V23, P332; CORNELISSEN AWCA, 1981, PARASITOLOGY, V83, P103, DOI 10.1017/S0031182000050071; DEROUIN F, 1991, EXP PARASITOL, V73, P460, DOI 10.1016/0014-4894(91)90070-D; Dubey JP, 2008, INT J PARASITOL, V38, P999, DOI 10.1016/j.ijpara.2007.11.012; Dubey JP, 2007, VET PARASITOL, V146, P347, DOI 10.1016/j.vetpar.2007.03.008; Dubey JP, 2007, VET PARASITOL, V146, P341, DOI 10.1016/j.vetpar.2007.03.009; Dubey JP, 2007, VET PARASITOL, V145, P45, DOI 10.1016/j.vetpar.2006.12.001; Dubey JP, 2007, VET PARASITOL, V145, P352, DOI 10.1016/j.vetpar.2006.12.016; Dubey JP, 2011, INT J PARASITOL, V41, P1139, DOI 10.1016/j.ijpara.2011.06.005; Dubey J.P., 2010, TOXOPLASMOSIS ANIMAL, P313, DOI DOI 10.1186/1756-3305-3-112; Dubey J.P., 1988, TOXOPLASMOSIS ANIMAL; Dubey JP, 1998, VET PARASITOL, V74, P75, DOI 10.1016/S0304-4017(97)00135-0; Elbez-Rubinstein A, 2009, J INFECT DIS, V199, P280, DOI 10.1086/595793; Gao X., 2011, P IEEE VEH TECHN C V, P1; Herrmann DC, 2012, VET PARASITOL, V185, P78, DOI 10.1016/j.vetpar.2011.10.030; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; Huang SY, 2012, J PARASITOL; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jamieson SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002285; Khan A, 2007, P NATL ACAD SCI USA, V104, P14872, DOI 10.1073/pnas.0702356104; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lehmann T, 2006, P NATL ACAD SCI USA, V103, P11423, DOI 10.1073/pnas.0601438103; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; Mavin S, 2003, BRIT J BIOMED SCI, V60, P217, DOI 10.1080/09674845.2003.11783702; McLeod R, 2006, PEDIATR INFECT DIS J, V25, P270, DOI 10.1097/01.inf.0000202070.59190.9a; Mercier A, 2011, INFECT GENET EVOL, V11, P1378, DOI 10.1016/j.meegid.2011.05.003; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Qian WF, 2012, VET PARASITOL, V187, P408, DOI 10.1016/j.vetpar.2012.01.026; Rajendran C, 2012, INFECT GENET EVOL, V12, P359, DOI 10.1016/j.meegid.2011.12.010; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Stillwaggon E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001333; Su C, 2006, INT J PARASITOL, V36, P841, DOI 10.1016/j.ijpara.2006.03.003; Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Velmurugan GV, 2008, VET PARASITOL, V155, P314, DOI 10.1016/j.vetpar.2008.04.021; Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742; Zhou P, 2008, TRENDS PARASITOL, V24, P190, DOI 10.1016/j.pt.2008.01.001; Zhou P, 2011, J PARASITOL, V97, P1193, DOI 10.1645/GE-2851.1; Zhou P, 2010, J PARASITOL, V96, P1027, DOI 10.1645/GE-2465.1; Zhou P, 2009, PARASITOL INT, V58, P193, DOI 10.1016/j.parint.2009.01.006	51	87	110	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53483	10.1371/journal.pone.0053483	http://dx.doi.org/10.1371/journal.pone.0053483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308233	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100073
J	Xuan, WJ; Vatansever, F; Huang, LY; Wu, QH; Xuan, Y; Dai, TH; Ando, T; Xu, T; Huang, YY; Hamblin, MR				Xuan, Weijun; Vatansever, Fatma; Huang, Liyi; Wu, Qiuhe; Xuan, Yi; Dai, Tianhong; Ando, Takahiro; Xu, Tao; Huang, Ying-Ying; Hamblin, Michael R.			Transcranial Low-Level Laser Therapy Improves Neurological Performance in Traumatic Brain Injury in Mice: Effect of Treatment Repetition Regimen	PLOS ONE			English	Article							BIPHASIC DOSE-RESPONSE; ACUTE ISCHEMIC-STROKE; LIGHT THERAPY; FLUORO-JADE; ADULT BRAIN; NEURONAL DEGENERATION; SUBVENTRICULAR ZONE; STEM-CELLS; DEFICITS; NEUROGENESIS	Low-level laser (light) therapy (LLLT) has been clinically applied around the world for a spectrum of disorders requiring healing, regeneration and prevention of tissue death. One area that is attracting growing interest in this scope is the use of transcranial LLLT to treat stroke and traumatic brain injury (TBI). We developed a mouse model of severe TBI induced by controlled cortical impact and explored the effect of different treatment schedules. Adult male BALB/c mice were divided into 3 broad groups (a) sham-TBI sham-treatment, (b) real-TBI sham-treatment, and (c) real-TBI active-treatment. Mice received active-treatment (transcranial LLLT by continuous wave 810 nm laser, 25 mW/cm(2), 18 J/cm(2), spot diameter 1 cm) while sham-treatment was immobilization only, delivered either as a single treatment at 4 hours post TBI, as 3 daily treatments commencing at 4 hours post TBI or as 14 daily treatments. Mice were sacrificed at 0, 4, 7, 14 and 28 days post-TBI for histology or histomorphometry, and injected with bromodeoxyuridine (BrdU) at days 21-27 to allow identification of proliferating cells. Mice with severe TBI treated with 1-laser Tx (and to a greater extent 3-laser Tx) had significant improvements in neurological severity score (NSS), and wire-grip and motion test (WGMT). However 14-laser Tx provided no benefit over TBI-sham control. Mice receiving 1-and 3-laser Tx had smaller lesion size at 28-days (although the size increased over 4 weeks in all TBI-groups) and less Fluoro-Jade staining for degenerating neurons (at 14 days) than in TBI control and 14-laser Tx groups. There were more BrdU-positive cells in the lesion in 1-and 3-laser groups suggesting LLLT may increase neurogenesis. Transcranial NIR laser may provide benefit in cases of acute TBI provided the optimum treatment regimen is employed.	[Xuan, Weijun; Vatansever, Fatma; Huang, Liyi; Wu, Qiuhe; Xuan, Yi; Dai, Tianhong; Ando, Takahiro; Xu, Tao; Huang, Ying-Ying; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Xuan, Weijun; Vatansever, Fatma; Huang, Liyi; Wu, Qiuhe; Dai, Tianhong; Xu, Tao; Huang, Ying-Ying; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Xuan, Weijun] Tradit Chinese Med Univ Guangxi, Dept Otolaryngol, Nanning, Peoples R China; [Huang, Liyi] Guangxi Med Univ, Affiliated Coll & Hosp 1, Dept Infect Dis, Nanning, Peoples R China; [Wu, Qiuhe] Jinan Ctr Hosp, Dept Burn, Jinan, Peoples R China; [Xuan, Yi] Tufts Univ, Sch Engn, Medford, MA USA; [Ando, Takahiro] Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Xu, Tao] Shanghai Jiao Tong Univ, Lab Anesthesiol, Shanghai 200030, Peoples R China; [Huang, Ying-Ying] Guangxi Med Univ, Aesthet & Plast Ctr, Nanning, Peoples R China; [Hamblin, Michael R.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Guangxi Medical University; Tufts University; Keio University; Shanghai Jiao Tong University; Guangxi Medical University; Harvard University	Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	hamblin@helix.mgh.harvard.edu	Dai, Tianhong/P-5961-2018; Ando, Takahiro/H-5209-2019; Huang, Ying-ying/G-3153-2011; Huang, yingying/J-7329-2012; Ando, Takahiro/R-8374-2019; Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022	Dai, Tianhong/0000-0001-8960-8896; Huang, Ying-ying/0000-0003-3066-6981; Huang, yingying/0000-0002-4038-0277; Hamblin, Michael R/0000-0001-6431-4605; Xu, Tao/0000-0001-5868-4079	NIH [R01AI050875]; Center for Integration of Medicine and Innovative Technology [DAMD17-02-2-0006]; CDMRP Program in TBI [W81XWH-09-1-0514]; Air Force Office of Scientific Research Military Photomedicine Program [FA9550-11-1-0331]; Grants-in-Aid for Scientific Research [10J04881] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integration of Medicine and Innovative Technology; CDMRP Program in TBI; Air Force Office of Scientific Research Military Photomedicine Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant R01AI050875, Center for Integration of Medicine and Innovative Technology (DAMD17-02-2-0006), CDMRP Program in TBI (W81XWH-09-1-0514) and Air Force Office of Scientific Research Military Photomedicine Program (FA9550-11-1-0331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Barker JM, 2011, EUR J NEUROSCI, V34, P963, DOI 10.1111/j.1460-9568.2011.07823.x; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Davis PJ., 2007, METHODS NUMERICAL IN; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Heile Anna, 2011, Dialogues Clin Neurosci, V13, P279; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Karonen JO, 1999, STROKE, V30, P1583, DOI 10.1161/01.STR.30.8.1583; KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3; Karu TI, 2005, LASER SURG MED, V36, P307, DOI 10.1002/lsm.20148; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kokaia Z, 2006, CEREB CORTEX, V16, pI162, DOI 10.1093/cercor/bhj174; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lampl Yair, 2007, Expert Rev Neurother, V7, P961, DOI 10.1586/14737175.7.8.961; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Ling GSF, 2005, NEUROCRIT CARE, V2, P75, DOI 10.1385/NCC:2:1:075; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Nichol AD, 2011, LANCET NEUROL, V10, P405, DOI 10.1016/S1474-4422(11)70085-0; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Sharma SK, 2011, LASER SURG MED, V43, P851, DOI 10.1002/lsm.21100; Stemer Andrew B, 2010, Curr Cardiol Rep, V12, P29, DOI 10.1007/s11886-009-0071-3; Streeter J, 2004, MITOCHONDRION, V4, P569, DOI 10.1016/j.mito.2004.07.037; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xiong Y, 2010, DISCOV MED, V10, P434; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	55	88	103	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53454	10.1371/journal.pone.0053454	http://dx.doi.org/10.1371/journal.pone.0053454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308226	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100069
J	Zhang, LJ; Qi, RF; Zhong, JH; Ni, L; Zheng, G; Xu, J; Lu, GM				Zhang, Long Jiang; Qi, Rongfeng; Zhong, Jianhui; Ni, Ling; Zheng, Gang; Xu, Jian; Lu, Guang Ming			Disrupted Functional Connectivity of the Anterior Cingulate Cortex in Cirrhotic Patients without Overt Hepatic Encephalopathy: A Resting State fMRI Study	PLOS ONE			English	Article							HUMAN BRAIN; ATTENTION SYSTEM; NEURAL MECHANISM; IMPAIRMENT; COGNITION; NETWORKS; INSIGHT; DRIVE; GYRUS	Background: To evaluate the changes of functional connectivity of the anterior cingulate cortex (ACC) in patients with cirrhosis without overt hepatic encephalopathy (HE) using resting state functional MRI. Methodology/Principal Findings: Participants included 67 cirrhotic patients (27 minimal hepatic encephalopathy (MHE) and 40 cirrhotic patients without MHE (non-HE)), and 40 age-and gender-matched healthy controls. rsfMRI were performed on 3 Telsa scanners. The pregenual ACC resting-state networks (RSNs) were characterized by using a standard seed-based whole-brain correlation method and compared between cirrhotic patients and healthy controls. Pearson correlation analysis was performed between the ACC RSNs and venous blood ammonia levels, neuropsychological tests (number connection test type A [NCT-A] and digit symbol test [DST]) scores in cirrhotic patients. All thresholds were set at P<0.05, with false discovery rate corrected. Compared with controls, non-HE and MHE patients showed significantly decreased functional connectivity in the bilateral ACC, bilateral middle frontal cortex (MFC), bilateral middle cingulate cortex (MCC), bilateral superior temporal gyri (STG)/middle temporal gyri (MTG), bilateral thalami, bilateral putamen and bilateral insula, and increased functional connectivity of bilateral precuneus and left temporo-occipital lobe and bilateral lingual gyri. Compared with non-HE patients, MHE showed the decreased functional connectivity of right MCC, bilateral STG/MTG and right putamen. This indicates decreased ACC functional connectivity predominated with the increasing severity of HE. NCT-A scores negatively correlated with ACC functional connectivity in the bilateral MCC, right temporal lobe, and DST scores positively correlated with functional connectivity in the bilateral ACC and the right putamen. No correlation was found between venous blood ammonia levels and functional connectivity in ACC in cirrhotic patients. Conclusions/Significance: Disrupted functional connectivity in ACC was found in cirrhotic patients which further deteriorated with the increasing severity of HE and correlated cognitive dysfunction in cirrhotic patients.	[Zhang, Long Jiang; Qi, Rongfeng; Ni, Ling; Zheng, Gang; Xu, Jian; Lu, Guang Ming] Nanjing Univ, Jinling Hosp, Clin Sch Med Coll, Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China; [Zhong, Jianhui] Zhejiang Univ, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China	Nanjing University; Zhejiang University	Xu, J (corresponding author), Nanjing Univ, Jinling Hosp, Clin Sch Med Coll, Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China.	13851656307@163.com; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020		Natural Scientific Foundation of China [30700194, 81230032, 81101039]; Chinese Key Program [BWS11J063, 10z026]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Program	This work was supported by the grants from the Natural Scientific Foundation of China [Grant Nos. 30700194 and 81230032 for Long Jiang Zhang, Grant No. 81101039 for Gang Zheng], and Chinese Key Program (Grant Nos BWS11J063 and 10z026 for Guangming Lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio P, 2005, METAB BRAIN DIS, V20, P115, DOI 10.1007/s11011-005-4149-3; Bajaj JS, 2008, CLIN GASTROENTEROL H, V6, P1135, DOI 10.1016/j.cgh.2008.05.025; Bajaj JS, 2008, WORLD J GASTROENTERO, V14, P3609, DOI 10.3748/wjg.14.3609; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Ciecko-Michalska I, 2006, Adv Med Sci, V51, P273; Durieux PF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00040; Dziobek I, 2011, NEUROIMAGE, V57, P539, DOI 10.1016/j.neuroimage.2011.05.005; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Iwasa M, 2005, METAB BRAIN DIS, V20, P7, DOI 10.1007/s11011-005-2472-3; Kato A, 2000, HEPATOL RES, V17, P237, DOI 10.1016/S1386-6346(99)00080-7; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036986; Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069; Luo Q, 2007, NEUROIMAGE, V38, P631, DOI 10.1016/j.neuroimage.2007.07.051; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Montoliu C, 2012, NEUROIMAGE, V61, P1165, DOI 10.1016/j.neuroimage.2012.03.041; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pourtois G, 2010, NEUROPSYCHOLOGIA, V48, P1144, DOI 10.1016/j.neuropsychologia.2009.12.020; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Roman E, 2011, AM J GASTROENTEROL, V106, P476, DOI 10.1038/ajg.2010.413; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Wein C, 2004, HEPATOLOGY, V39, P739, DOI 10.1002/hep.20095; Weissenborn K, 2001, METAB BRAIN DIS, V16, P13, DOI 10.1023/A:1011654210096; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zhang LJ, 2012, AJNR AM J NEURORADIO; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang LJ, 2010, HEPATOL RES, V40, P777, DOI 10.1111/j.1872-034X.2010.00681.x; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295	41	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53206	10.1371/journal.pone.0053206	http://dx.doi.org/10.1371/journal.pone.0053206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308163	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100038
J	Bigler, J; Rand, HA; Kerkof, K; Timour, M; Russell, CB				Bigler, Jeannette; Rand, Hugh A.; Kerkof, Keith; Timour, Martin; Russell, Christopher B.			Cross-Study Homogeneity of Psoriasis Gene Expression in Skin across a Large Expression Range	PLOS ONE			English	Article							T-CELL; TNF INHIBITION; MICROARRAY; REPRODUCIBILITY; CYCLOSPORINE; DISCOVERIES; ACTIVATION; PROFILES; PLAQUES; LISTS	Background: In psoriasis, only limited overlap between sets of genes identified as differentially expressed (psoriatic lesional vs. psoriatic non-lesional) was found using statistical and fold-change cut-offs. To provide a framework for utilizing prior psoriasis data sets we sought to understand the consistency of those sets. Methodology/Principal Findings: Microarray expression profiling and qRT-PCR were used to characterize gene expression in PP and PN skin from psoriasis patients. cDNA (three new data sets) and cRNA hybridization (four existing data sets) data were compared using a common analysis pipeline. Agreement between data sets was assessed using varying qualitative and quantitative cut-offs to generate a DEG list in a source data set and then using other data sets to validate the list. Concordance increased from 67% across all probe sets to over 99% across more than 10,000 probe sets when statistical filters were employed. The fold-change behavior of individual genes tended to be consistent across the multiple data sets. We found that genes with <2-fold change values were quantitatively reproducible between pairs of data-sets. In a subset of transcripts with a role in inflammation changes detected by microarray were confirmed by qRT-PCR with high concordance. For transcripts with both PN and PP levels within the microarray dynamic range, microarray and qRT-PCR were quantitatively reproducible, including minimal fold-changes in IL13, TNFSF11, and TNFRSF11B and genes with >10-fold changes in either direction such as CHRM3, IL12B and IFNG. Conclusions/Significance: Gene expression changes in psoriatic lesions were consistent across different studies, despite differences in patient selection, sample handling, and microarray platforms but between-study comparisons showed stronger agreement within than between platforms. We could use cut-offs as low as log10(ratio) = 0.1 (fold-change = 1.26), generating larger gene lists that validate on independent data sets. The reproducibility of PP signatures across data sets suggests that different sample sets can be productively compared.	[Bigler, Jeannette; Rand, Hugh A.; Kerkof, Keith; Timour, Martin; Russell, Christopher B.] Amgen Inc, Med Sci, Seattle, WA USA	Amgen	Bigler, J (corresponding author), Amgen Inc, Med Sci, Seattle, WA USA.	jbigler@amgen.com			Amgen	Amgen(Amgen)	All the authors are employees of Amgen Inc. and own stock. Amgen funded this research. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BACHA P, 1988, J EXP MED, V167, P612, DOI 10.1084/jem.167.2.612; Boulesteix AL, 2009, BRIEF BIOINFORM, V10, P556, DOI 10.1093/bib/bbp034; Bustin SA, 2004, A Z QUANTITATIVE PCR; Carr D., 2011, HEXBIN HEXAGONAL BIN; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Eklund AC, 2006, NAT BIOTECHNOL, V24, P1071, DOI 10.1038/nbt0906-1071; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; GOTTLIEB AB, 1992, J INVEST DERMATOL, V98, P302, DOI 10.1111/1523-1747.ep12499782; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; JENKINS MK, 1988, SCIENCE, V241, P1655, DOI 10.1126/science.3262237; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Papp KA, 2012, J INVEST DERMATOL, V132, P2466, DOI 10.1038/jid.2012.163; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Sarkar D, 2008, USE R, P1; Shi J, 2007, CURR BIOINFORM, V2, P133, DOI 10.2174/157489307780618231; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Suarez-Farinas M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-99; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhang M, 2009, BIOINFORMATICS, V25, P1662, DOI 10.1093/bioinformatics/btp295; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	28	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52242	10.1371/journal.pone.0052242	http://dx.doi.org/10.1371/journal.pone.0052242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308107	gold, Green Submitted, Green Published			2022-12-27	WOS:000313670100007
J	Carvalho, JG; Leite, AD; Peres-Buzalaf, C; Salvato, F; Labate, CA; Everett, ET; Whitford, GM; Buzalaf, MAR				Carvalho, Juliane Guimaraes; Leite, Aline de Lima; Peres-Buzalaf, Camila; Salvato, Fernanda; Labate, Carlos Alberto; Everett, Eric T.; Whitford, Gary Milton; Rabelo Buzalaf, Marilia Afonso			Renal Proteome in Mice with Different Susceptibilities to Fluorosis	PLOS ONE			English	Article							CYSTATHIONINE GAMMA-LYASE; QUANTITATIVE TRAIT LOCI; DENTAL FLUOROSIS; FLUORIDE METABOLISM; CELLS; PHOSPHATASE; KIDNEY; PHOSPHORYLATION; EXPRESSION; AQUAPORIN-2	A/J and 129P3/J mouse strains have different susceptibilities to dental fluorosis due to their genetic backgrounds. They also differ with respect to several features of fluoride (F) metabolism and metabolic handling of water. This study was done to determine whether differences in F metabolism could be explained by diversities in the profile of protein expression in kidneys. Weanling, male A/J mice (susceptible to dental fluorosis, n = 18) and 129P3/J mice (resistant, n = 18) were housed in pairs and assigned to three groups given low-F food and drinking water containing 0, 10 or 50 ppm [F] for 7 weeks. Renal proteome profiles were examined using 2D-PAGE and LC-MS/MS. Quantitative intensity analysis detected between A/J and 129P3/J strains 122, 126 and 134 spots differentially expressed in the groups receiving 0, 10 and 50 ppmF, respectively. From these, 25, 30 and 32, respectively, were successfully identified. Most of the proteins were related to metabolic and cellular processes, followed by response to stimuli, development and regulation of cellular processes. In F-treated groups, PDZK-1, a protein involved in the regulation of renal tubular reabsorption capacity was down-modulated in the kidney of 129P3/J mice. A/J and 129P3/J mice exhibited 11 and 3 exclusive proteins, respectively, regardless of F exposure. In conclusion, proteomic analysis was able to identify proteins potentially involved in metabolic handling of F and water that are differentially expressed or even not expressed in the strains evaluated. This can contribute to understanding the molecular mechanisms underlying genetic susceptibility to dental fluorosis, by indicating key-proteins that should be better addressed in future studies.	[Carvalho, Juliane Guimaraes; Leite, Aline de Lima; Peres-Buzalaf, Camila; Rabelo Buzalaf, Marilia Afonso] Univ Sao Paulo, Bauru Dent Sch, Dept Biol Sci, Bauru, SP, Brazil; [Salvato, Fernanda; Labate, Carlos Alberto] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiros, Piracicaba, SP, Brazil; [Everett, Eric T.] Univ N Carolina, Sch Dent, Dept Pediat Dent, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Whitford, Gary Milton] Med Coll Georgia, Sch Dent, Dept Oral Biol, Augusta, GA 30912 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Augusta University	Buzalaf, MAR (corresponding author), Univ Sao Paulo, Bauru Dent Sch, Dept Biol Sci, Bauru, SP, Brazil.	mbuzalaf@fob.usp.br	Leite, Aline/J-9748-2012; Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Labate, Carlos Alberto/L-2183-2015; Salvato, Fernanda/AAR-4373-2020; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021; Peres-Buzalaf, Camila/C-5109-2012; Everett, Eric/AAP-4459-2021; Salvato, Fernanda/J-6560-2014	Leite, Aline/0000-0002-2112-1309; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Labate, Carlos Alberto/0000-0001-7309-1300; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Salvato, Fernanda/0000-0003-1650-5399	Sao Paulo State Research Support Foundation (FAPESP) [2005/04671-0]; CNPq [471485/2007-1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018104] Funding Source: NIH RePORTER	Sao Paulo State Research Support Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Sao Paulo State Research Support Foundation (FAPESP) (grant 2005/04671-0) and CNPq (grant 471485/2007-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Becchetti A, 2002, AM J PHYSIOL-RENAL, V283, pF1030, DOI 10.1152/ajprenal.00011.2002; Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1; Blaszczyk I, 2010, BIOL TRACE ELEM RES, V133, P60, DOI 10.1007/s12011-009-8412-z; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Bronckers ALJJ, 2009, J DENT RES, V88, P877, DOI 10.1177/0022034509343280; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carvalho JG, 2009, J DENT RES, V88, P1054, DOI 10.1177/0022034509347249; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; Dynia DW, 2010, AM J PHYSIOL-RENAL, V298, pF745, DOI 10.1152/ajprenal.00182.2009; Everett ET, 2011, J DENT RES, V90, P552, DOI 10.1177/0022034510384626; Everett ET, 2011, EUR J ORAL SCI, V119, P8, DOI 10.1111/j.1600-0722.2011.00868.x; Everett ET, 2009, CELLS TISSUES ORGANS, V189, P212, DOI 10.1159/000151383; Everett ET, 2002, J DENT RES, V81, P794, DOI 10.1177/0810794; Gillmore JD, 1999, THORAX, V54, P444, DOI 10.1136/thx.54.5.444; Huang H, 2008, COMMUNITY DENT ORAL, V36, P517, DOI 10.1111/j.1600-0528.2007.00424.x; Khan A, 2005, SADJ, V60, P418; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Levonen AL, 2000, BIOCHEM J, V347, P291, DOI 10.1042/0264-6021:3470291; LI DL, 1995, AM J PHYSIOL-RENAL, V269, pF673, DOI 10.1152/ajprenal.1995.269.5.F673; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Mori Y, 2001, JPN J PHYSIOL, V51, P371, DOI 10.2170/jjphysiol.51.371; Mousny M, 2008, BONE, V43, P1067, DOI 10.1016/j.bone.2008.07.248; Mousny M, 2006, BONE, V39, P1283, DOI 10.1016/j.bone.2006.06.006; Peraza MA, 2003, CELL BIOL TOXICOL, V19, P253, DOI 10.1023/B:CBTO.0000003970.60896.49; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Buzalaf MAR, 2011, MONOGR ORAL SCI, V22, P1, DOI 10.1159/000325101; Buzalaf MAR, 2011, MONOGR ORAL SCI, V22, P20, DOI 10.1159/000325107; Rison Stuart C. G., 2000, Functional and Integrative Genomics, V1, P56; Roberts MF, 2000, FRONT BIOSCI-LANDMRK, V5, pD796, DOI 10.2741/roberts; SCHIFFL HH, 1980, NEPHRON, V26, P69, DOI 10.1159/000181954; TAVES DR, 1968, TALANTA, V15, P1015, DOI 10.1016/0039-9140(68)80109-2; Thomson RB, 2005, P NATL ACAD SCI USA, V102, P13331, DOI 10.1073/pnas.0506578102; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; Valenti G, 2000, J CELL SCI, V113, P1985; Whitford GM, 1996, MONOGR ORAL SCI, V16, P1; WHITFORD GM, 1976, AM J PHYSIOL, V230, P527, DOI 10.1152/ajplegacy.1976.230.2.527; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Zhang DJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE287, DOI 10.1152/ajpendo.00308.2010	41	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53261	10.1371/journal.pone.0053261	http://dx.doi.org/10.1371/journal.pone.0053261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308176	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100027
J	Mayan, MD				Mayan, Maria D.			RNAP-II Molecules Participate in the Anchoring of the ORC to rDNA Replication Origins	PLOS ONE			English	Article							BETA-GLOBIN LOCUS; C-TERMINAL DOMAIN; CTD KINASE-I; POLYMERASE-II; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; RECOGNITION COMPLEX; ALPHA-AMANITIN; GENOME-WIDE; FUNCTIONAL ELEMENTS	The replication of genomic DNA is limited to a single round per cell cycle. The first component, which recognises and remains bound to origins from recognition until activation and replication elongation, is the origin recognition complex. How origin recognition complex (ORC) proteins remain associated with chromatin throughout the cell cycle is not yet completely understood. Several genome-wide studies have undoubtedly demonstrated that RNA polymerase II (RNAP-II) binding sites overlap with replication origins and with the binding sites of the replication components. RNAP-II is no longer merely associated with transcription elongation. Several reports have demonstrated that RNAP-II molecules affect chromatin structure, transcription, mRNA processing, recombination and DNA repair, among others. Most of these activities have been reported to directly depend on the interaction of proteins with the C-terminal domain (CTD) of RNAP-II. Two-dimensional gels results and ChIP analysis presented herein suggest that stalled RNAP-II molecules bound to the rDNA chromatin participate in the anchoring of ORC proteins to origins during the G1 and S-phases. The results show that in the absence of RNAP-II, Orc1p, Orc2p and Cdc6p do not bind to origins. Moreover, co-immunoprecipitation experiments suggest that Ser2P-CTD and hypophosphorylated RNAP-II interact with Orc1p. In the context of rDNA, cryptic transcription by RNAP-II did not negatively interfere with DNA replication. However, the results indicate that RNAP-II is not necessary to maintain the binding of ORCs to the origins during metaphase. These findings highlight for the first time the potential importance of stalled RNAP-II in the regulation of DNA replication.	[Mayan, Maria D.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, London, England	Imperial College London	Mayan, MD (corresponding author), CHUAC, Biomed Res Ctr INIBIC, Div Rheumatol, La Coruna, Spain.	MA.Dolores.Mayan.Santos@sergas.es	Mayán, María D./AAR-9227-2021; Mayan, Maria D./C-8813-2012	Mayán, María D./0000-0002-5809-9440; Mayan, Maria D./0000-0002-5809-9440	Medical Research Council of the United Kingdom; Xunta de Galicia	Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by the Medical Research Council of the United Kingdom. Maria D. Mayan is currently funded by the Xunta de Galicia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; ALADJEM MI, 1995, SCIENCE, V270, P815, DOI 10.1126/science.270.5237.815; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bodmer-Glavas M, 2001, NUCLEIC ACIDS RES, V29, P4570, DOI 10.1093/nar/29.22.4570; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Bouchoux C, 2004, NUCLEIC ACIDS RES, V32, P5851, DOI 10.1093/nar/gkh927; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; Burkhalter MD, 2004, MOL CELL, V15, P409, DOI 10.1016/j.molcel.2004.06.024; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Calvi BR, 2007, GENETICS, V177, P1291, DOI 10.1534/genetics.107.070862; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; CHAFIN DR, 1995, J BIOL CHEM, V270, P19114, DOI 10.1074/jbc.270.32.19114; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Clemente-Blanco A, 2011, NAT CELL BIOL, V13, P1450, DOI 10.1038/ncb2365; Danis E, 2004, NAT CELL BIOL, V6, P721, DOI 10.1038/ncb1149; DePamphilis ML, 2005, CELL CYCLE, V4, P70, DOI 10.4161/cc.4.1.1333; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Dirks RW, 1999, HISTOCHEM CELL BIOL, V111, P405, DOI 10.1007/s004180050374; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Ganley ARD, 2005, P NATL ACAD SCI USA, V102, P11787, DOI 10.1073/pnas.0504905102; Gauthier L, 2002, GENETICS, V162, P1117; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; Gong XQ, 2004, J BIOL CHEM, V279, P27422, DOI 10.1074/jbc.M402163200; GOODENOUGH DA, 1980, J CELL BIOL, V86, P576, DOI 10.1083/jcb.86.2.576; Grenetier S, 2006, NUCLEIC ACIDS RES, V34, P4996, DOI 10.1093/nar/gkl493; Guillou E, GENES DEV, V24, P2812; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kanaporis G, 2008, J GEN PHYSIOL, V131, P293, DOI 10.1085/jgp.200709934; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Knott SR, CELL, V148, P99; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kohzaki H, 2005, BIOESSAYS, V27, P1107, DOI 10.1002/bies.20316; Li CH, 2006, MOL BIOL CELL, V17, P3848, DOI 10.1091/mbc.E06-03-0205; Lin HB, 2005, EXP CELL RES, V308, P53, DOI 10.1016/j.yexcr.2005.04.012; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; MARTIN C, 1989, MOL CELL BIOL, V9, P2341, DOI 10.1128/MCB.9.6.2341; MATSUI S, 1979, J CELL BIOL, V80, P451, DOI 10.1083/jcb.80.2.451; Mayan M, 2010, CELL CYCLE, V9, P4328, DOI 10.4161/cc.9.21.13591; Mayan MD, 2010, CURR PROTOC MOL BIOL, p2B; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Minami H, 2006, MOL CELL BIOL, V26, P8770, DOI 10.1128/MCB.00949-06; Muller M, 2000, MOL CELL, V5, P767, DOI 10.1016/S1097-2765(00)80317-2; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Parsons GG, 1997, MOL CELL BIOL, V17, P5791, DOI 10.1128/MCB.17.10.5791; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Prioleau MN, 2003, MOL CELL BIOL, V23, P3536, DOI 10.1128/MCB.23.10.3536-3549.2003; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rytkonen AK, 2006, FEBS J, V273, P5535, DOI 10.1111/j.1742-4658.2006.05544.x; SAFFER LD, 1986, MOL CELL BIOL, V6, P1148, DOI 10.1128/MCB.6.4.1148; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Shukla A, 2009, CURR ISSUES MOL BIOL, V11, pI65; Stagljar I, 1999, BIOL CHEM, V380, P525, DOI 10.1515/BC.1999.067; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Van Slyke C, 2003, NUCLEIC ACIDS RES, V31, P4597, DOI 10.1093/nar/gkg638; Vujcic M, 1999, MOL CELL BIOL, V19, P6098; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Yankulov K, 1999, MOL CELL BIOL, V19, P6154	89	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53405	10.1371/journal.pone.0053405	http://dx.doi.org/10.1371/journal.pone.0053405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308214	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100038
J	Vermeulen, JF; Kornegoor, R; van der Wall, E; van der Groep, P; van Diest, PJ				Vermeulen, Jeroen F.; Kornegoor, Robert; van der Wall, Elsken; van der Groep, Petra; van Diest, Paul J.			Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; CARCINOMA; EXPERIENCE; HYPOXIA; MEN	Introduction: Male breast cancer accounts for 0.5-1% of all breast cancers and is generally diagnosed at higher stage than female breast cancers and therefore might benefit from earlier detection and targeted therapy. Except for HER2 and EGFR, little is known about expression of growth factor receptors in male breast cancer. We therefore investigated expression profiles of growth factor receptors and membrane-bound tumor markers in male breast cancer and gynecomastia, in comparison with female breast cancer. Methods: Tissue microarrays containing 133 male breast cancer and 32 gynecomastia cases were stained by immunohistochemistry for a panel of membrane-bound targets and compared with data on 266 female breast cancers. Results: Growth factor receptors were variably expressed in 4.5% (MET) up to 38.5% (IGF1-R) of male breast cancers. Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer. Expression of EGFR, HER2, CAIX, and GLUT1 was not significantly different between male and female breast cancer. Further, 48.1% of male breast cancers expressed at least one and 18.0% expressed multiple growth factor receptors. Since individual membrane receptors are expressed in only half of male breast cancers, a panel of membrane markers will be required for molecular imaging strategies to reach sensitivity. A potential panel of markers for molecular imaging, consisting of EGFR, IGF1-R, FGFR2, CD44v6, CAXII, GLUT1, and CD44v6 was positive in 77% of male breast cancers, comparable to female breast cancers. Conclusions: Expression patterns of growth factor receptors and hypoxia membrane proteins in male breast cancer are different from female breast cancer. For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.	[Vermeulen, Jeroen F.; Kornegoor, Robert; van der Groep, Petra; van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Wall, Elsken; van der Groep, Petra] Univ Med Ctr Utrecht, Div Internal Med & Dermatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Diest, PJ (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	p.j.vandiest@umcutrecht.nl			AEGON Inc.; MAMmary carcinoma MOlecular imaging for diagnostics and THerapeutics (MAMMOTH) project of the Dutch Center for Translational Molecular Medicine	AEGON Inc.; MAMmary carcinoma MOlecular imaging for diagnostics and THerapeutics (MAMMOTH) project of the Dutch Center for Translational Molecular Medicine	This work was supported by an unrestricted research grant of AEGON Inc. and by the MAMmary carcinoma MOlecular imaging for diagnostics and THerapeutics (MAMMOTH) project of the Dutch Center for Translational Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 2010, J CLIN ONCOL, V28, P232, DOI 10.1200/JCO.2009.23.8162; Bane AL, 2009, BREAST CANCER RES TR, V117, P183, DOI 10.1007/s10549-008-0087-1; Barnett DH, 2008, CANCER RES, V68, P3505, DOI 10.1158/0008-5472.CAN-07-6151; Brockstein BE, 2011, DRUGS, V71, P1551, DOI 10.2165/11592540-000000000-00000; CCMO, CENTR COMM RES INV H; Ciocca V, 2006, HISTOPATHOLOGY, V49, P365, DOI 10.1111/j.1365-2559.2006.02519.x; Crane LMA, 2011, GYNECOL ONCOL, V120, P291, DOI 10.1016/j.ygyno.2010.10.009; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Evans DGR, 2010, J MED GENET, V47, P710, DOI 10.1136/jmg.2009.075176; Fentiman IS, 2006, LANCET, V367, P595, DOI 10.1016/S0140-6736(06)68226-3; Foerster R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-335; FOX SB, 1992, J PATHOL, V166, P13, DOI 10.1002/path.1711660104; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Garrett CR, 2011, EXPERT OPIN BIOL TH, V11, P937, DOI 10.1517/14712598.2011.582464; Ge YM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2258; Gee MS, 2008, RADIOLOGY, V248, P925, DOI 10.1148/radiol.2482071496; Gethins M, 2012, J NATL CANCER I, V104, P436, DOI 10.1093/jnci/djs172; Giordano SH, 2004, CANCER, V101, P51, DOI 10.1002/cncr.20312; Hirche C, 2010, BREAST CANCER RES TR, V121, P373, DOI 10.1007/s10549-010-0760-z; Kornegoor R, 2012, MODERN PATHOL, V25, P1397, DOI 10.1038/modpathol.2012.101; Kornegoor R, 2012, AM J SURG PATHOL, V36, P762, DOI 10.1097/PAS.0b013e31824324e6; Kornegoor R, 2012, MODERN PATHOL, V25, P398, DOI 10.1038/modpathol.2011.174; Lee SB, 2008, CLIN CANCER RES, V14, P3840, DOI 10.1158/1078-0432.CCR-07-4076; Miao H, 2011, J CLIN ONCOL, V29, P4381, DOI 10.1200/JCO.2011.36.8902; Moore J, 1998, Breast J, V4, P261, DOI 10.1046/j.1524-4741.1998.440261.x; PEYRAT JP, 1988, CANCER RES, V48, P6429; Pivot X, 2011, ANTI-CANCER DRUG, V22, P701, DOI 10.1097/CAD.0b013e328345ffa4; Pleijhuis RG, 2011, EJSO-EUR J SURG ONC, V37, P32, DOI 10.1016/j.ejso.2010.10.006; Pleijhuis RG, 2009, ANN SURG ONCOL, V16, P2717, DOI 10.1245/s10434-009-0609-z; Sampath L, 2007, J NUCL MED, V48, P1501, DOI 10.2967/jnumed.107.042234; Shaaban AM, 2012, BREAST CANCER RES TR, V133, P949, DOI 10.1007/s10549-011-1856-9; Stoll BA, 2002, ANN ONCOL, V13, P191, DOI 10.1093/annonc/mdf059; Valachis A, 2011, BREAST, V20, P485, DOI 10.1016/j.breast.2011.06.009; van der Groep P, 2006, J CLIN PATHOL, V59, P611, DOI 10.1136/jcp.2005.032151; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; Vermeulen JF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-240; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Willsher PC, 1997, ANTICANCER RES, V17, P2335; Wykoff CC, 2001, AM J PATHOL, V158, P1011, DOI 10.1016/S0002-9440(10)64048-5	39	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53353	10.1371/journal.pone.0053353	http://dx.doi.org/10.1371/journal.pone.0053353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308200	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100033
J	Ohno, Y; Yasunaga, S; Janmohamed, S; Ohtsubo, M; Saeki, K; Kurogi, T; Mihara, K; Iscove, NN; Takihara, Y				Ohno, Yoshinori; Yasunaga, Shin'ichiro; Janmohamed, Salima; Ohtsubo, Motoaki; Saeki, Keita; Kurogi, Toshiaki; Mihara, Keichiro; Iscove, Norman N.; Takihara, Yoshihiro			Hoxa9 Transduction Induces Hematopoietic Stem and Progenitor Cell Activity through Direct Down-Regulation of Geminin Protein	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; POLYCOMB-GROUP GENES; DNA-REPLICATION; MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR; PLURIPOTENT CELLS; MICE; IDENTIFICATION; PROLIFERATION; NUP98-HOXA9	Hoxb4, a 3'-located Hox gene, enhances hematopoietic stem cell (HSC) activity, while a subset of 5'-located Hox genes is involved in hematopoiesis and leukemogenesis, and some of them are common translocation partners for Nucleoporin 98 (Nup98) in patients with leukemia. Although these Hox gene derivatives are believed to act as transcription regulators, the molecular involvement of the Hox gene derivatives in hematopoiesis and leukemogenesis remains largely elusive. Since we previously showed that Hoxb4 forms a complex with a Roc1-Ddb1-Cul4a ubiquitin ligase core component and functions as an E3 ubiquitin ligase activator for Geminin, we here examined the E3 ubiquitin ligase activities of the 5'-located Hox genes, Hoxa9 and Hoxc13, and Nup98-Hoxa9. Hoxa9 formed a similar complex with the Roc1-Ddb1-Cul4a component to induce ubiquitination of Geminin, but the others did not. Retroviral transduction-mediated overexpression or siRNA-mediated knock-down of Hoxa9 respectively down-regulated or up-regulated Geminin in hematopoietic cells. And Hoxa9 transduction-induced repopulating and clonogenic activities were suppressed by Geminin supertransduction. These findings suggest that Hoxa9 and Hoxb4 differ from Hoxc13 and Nup98-Hoxa9 in their molecular role in hematopoiesis, and that Hoxa9 induces the activity of HSCs and hematopoietic progenitors at least in part through direct down-regulation of Geminin.	[Ohno, Yoshinori; Yasunaga, Shin'ichiro; Ohtsubo, Motoaki; Saeki, Keita; Kurogi, Toshiaki; Takihara, Yoshihiro] Hiroshima Univ, Dept Stem Cell Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Janmohamed, Salima; Iscove, Norman N.] Univ Toronto, Ontario Canc Inst, McEwen Ctr Regenerat Med, Dept Med Biophys, Toronto, ON, Canada; [Janmohamed, Salima; Iscove, Norman N.] Univ Toronto, Ontario Canc Inst, McEwen Ctr Regenerat Med, Dept Immunol, Toronto, ON, Canada; [Ohtsubo, Motoaki] Beppu Univ, Fac Food Sci & Nutr, Dept Food & Fermentat Sci, Beppu, Oita, Japan; [Mihara, Keichiro] Hiroshima Univ, Dept Hematol & Oncol, Res Inst Radiat Biol & Med, Hiroshima, Japan	Hiroshima University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Hiroshima University	Takihara, Y (corresponding author), Hiroshima Univ, Dept Stem Cell Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan.	takihara@hiroshima-u.ac.jp	Mihara, Keichiro/L-5167-2019	ohtsubo, motoaki/0000-0002-2479-3178	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science Summer program; Ube Foundation; Takeda Science Foundation; Tsuchiya Medical Foundation; Children's Cancer Foundation of Japan; Mitsubishi Pharma Research Foundation; Daiwa Securities Health Foundation; Novartis Pharma Japan; Okinaka Memorial Institute for Medical Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Summer program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ube Foundation(UBE Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tsuchiya Medical Foundation; Children's Cancer Foundation of Japan; Mitsubishi Pharma Research Foundation; Daiwa Securities Health Foundation; Novartis Pharma Japan; Okinaka Memorial Institute for Medical Research	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society for the Promotion of Science Summer program, the Ube Foundation, the Takeda Science Foundation, the Tsuchiya Medical Foundation, the Children's Cancer Foundation of Japan, the Mitsubishi Pharma Research Foundation and the Daiwa Securities Health Foundation, Novartis Pharma Japan and Okinaka Memorial Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bijl J, 2006, BLOOD, V108, P116, DOI 10.1182/blood-2005-06-2245; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Chen HX, 2005, J BIOL CHEM, V280, P19373, DOI 10.1074/jbc.M413528200; Chung KY, 2006, CANC RES, V66, P11781; Comelli L, 2009, CELL CYCLE, V8, P454, DOI 10.4161/cc.8.3.7649; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Di-Poi N, 2010, DEV BIOL, V341, P488, DOI 10.1016/j.ydbio.2010.03.006; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Iwasaki M, 2005, BLOOD, V105, P784, DOI 10.1182/blood-2004-04-1508; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lebert-Ghali CE, 2010, EXP HEMATOL, V38, P1074, DOI 10.1016/j.exphem.2010.07.006; Lei HY, 2005, P NATL ACAD SCI USA, V102, P2420, DOI 10.1073/pnas.0409700102; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Moore MAS, 2005, EXP HEMATOL, V33, P719, DOI 10.1016/j.exphem.2005.04.011; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P21529, DOI 10.1073/pnas.1011054107; Ohta H, 2002, J EXP MED, V195, P759, DOI 10.1084/jem.20011911; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Ohtsubo M, 2008, P NATL ACAD SCI USA, V105, P10396, DOI 10.1073/pnas.0800672105; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Oshima M, 2011, BLOOD, V117, pE142, DOI 10.1182/blood-2010-12-323212; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Shinnick KM, 2010, J CLIN INVEST, V120, P4303, DOI 10.1172/JCI43556; Takihara Y, 2000, INT J HEMATOL, V72, P165; Takihara Y, 2008, INT J HEMATOL, V87, P25, DOI 10.1007/s12185-007-0006-y; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yamada T, 2008, EXP CELL RES, V314, P847, DOI 10.1016/j.yexcr.2007.11.005; Yang VS, 2011, CURR BIOL, V21, P692, DOI 10.1016/j.cub.2011.03.026; Zhang Y, 2003, EMBO J, V22, P6057, DOI 10.1093/emboj/cdg577	52	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53161	10.1371/journal.pone.0053161	http://dx.doi.org/10.1371/journal.pone.0053161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326393	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800034
J	Valva, P; Casciato, P; Lezama, C; Galoppo, M; Gadano, A; Galdame, O; Galoppo, MC; Mullen, E; De Matteo, E; Preciado, MV				Valva, Pamela; Casciato, Paola; Lezama, Carol; Galoppo, Marcela; Gadano, Adrian; Galdame, Omar; Cristina Galoppo, Maria; Mullen, Eduardo; De Matteo, Elena; Victoria Preciado, Maria			Serum Apoptosis Markers Related to Liver Damage in Chronic Hepatitis C: sFas as a Marker of Advanced Fibrosis in Children and Adults While M30 of Severe Steatosis Only in Children	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; SOLUBLE FAS LEVELS; VIRUS-INFECTION; CELL-DEATH; CASPASE ACTIVATION; BIOPSY; EXPRESSION; DIAGNOSIS; DISEASE; BIOMARKERS	Background: Liver biopsy represents the gold standard for evaluating damage and progression in patients with chronic hepatitis C (CHC); however, developing noninvasive tests that can predict liver injury represents a growing medical need. Considering that hepatocyte apoptosis plays a role in CHC pathogenesis; the aim of our study was to evaluate the presence of different apoptosis markers that correlate with liver injury in a cohort of pediatric and adult patients with CHC. Methods: Liver biopsies and concomitant serum samples from 22 pediatric and 22 adult patients with CHC were analyzed. Histological parameters were evaluated. In serum samples soluble Fas (sFas), caspase activity and caspase-generated neoepitope of the CK-18 proteolytic fragment (M30) were measured. Results: sFas was associated with fibrosis severity in pediatric (significant fibrosis p = 0.03, advanced fibrosis p = 0.01) and adult patients (advanced fibrosis p = 0.02). M30 levels were elevated in pediatric patients with severe steatosis (p = 0.01) while in adults no relation with any histological variable was observed. Caspase activity levels were higher in pediatric samples with significant fibrosis (p = 0.03) and they were associated with hepatitis severity (p = 0.04) in adult patients. The diagnostic accuracy evaluation demonstrated only a good performance for sFas to evaluate advanced fibrosis both in children (AUROC: 0.812) and adults (AUROC: 0.800) as well as for M30 to determine steatosis severity in children (AUROC: 0.833). Conclusions: Serum sFas could be considered a possible marker of advanced fibrosis both in pediatric and adult patient with CHC as well as M30 might be a good predictor of steatosis severity in children.	[Valva, Pamela; De Matteo, Elena; Victoria Preciado, Maria] Hosp Ninos Dr Ricardo Gutierrez, Div Pathol, Mol Biol Lab, Buenos Aires, DF, Argentina; [Casciato, Paola; Gadano, Adrian; Galdame, Omar] Hosp Italiano Buenos Aires, Liver Unit, Buenos Aires, DF, Argentina; [Lezama, Carol; Galoppo, Marcela; Cristina Galoppo, Maria] Univ Buenos Aires, Liver Unit, Hosp Ninos Ricardo Gutierrez, Buenos Aires, DF, Argentina; [Mullen, Eduardo] Hosp Italiano Buenos Aires, Div Pathol, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires	Valva, P (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Div Pathol, Mol Biol Lab, Buenos Aires, DF, Argentina.	valvapamela@yahoo.com		Preciado, Maria Victoria/0000-0003-4082-0698	International Society for Infectious Diseases; National Agency for Scientific and Technology Promotion (PICT) [25344]; National Research Council (CONICET) [PIP2010 1392/11]	International Society for Infectious Diseases; National Agency for Scientific and Technology Promotion (PICT); National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was funded by grants from the International Society for Infectious Diseases, the National Agency for Scientific and Technology Promotion (PICT 2004 No25344) National Research Council (CONICET) (PIP2010 1392/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Ahmad W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-53; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Bantel H, 2001, HEPATOLOGY, V34, P758, DOI 10.1053/jhep.2001.28229; Bortolami M, 2008, J VIRAL HEPATITIS, V15, P515, DOI 10.1111/j.1365-2893.2008.00974.x; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Consenso Argentino de Hepatitis C, 2007, DOC FIN CONS ARG HEP; El Bassiouny A.E., 2008, MEDSCAPE J MED, V10, P130; El Sayed Zaki M, 2008, IMMUNOL INVEST, V37, P163, DOI 10.1080/08820130801897352; El-Bassiouni A, 2006, APMIS, V114, P420, DOI 10.1111/j.1600-0463.2006.apm_323.x; El-Shabrawi MH, 2010, EUR J GASTROEN HEPAT, V22, P946, DOI 10.1097/MEG.0b013e328336ec84; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Fitzpatrick E, 2010, J PEDIATR GASTR NUTR, V51, P500, DOI 10.1097/MPG.0b013e3181e376be; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Gebo KA, 2002, HEPATOLOGY, V36, pS161, DOI 10.1053/jhep.2002.36989; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Ghavami S, 2005, MED SCI MONITOR, V11, pRA337; Hermeziu B, 2010, GASTROEN CLIN BIOL, V34, P16, DOI 10.1016/j.gcb.2009.06.007; Joka D, 2012, HEPATOLOGY, V55, P455, DOI 10.1002/hep.24734; Kakiuchi Y, 2004, J GASTROENTEROL, V39, P1189, DOI 10.1007/s00535-004-1470-2; Kanto T, 2006, INTERNAL MED, V45, P183, DOI 10.2169/internalmedicine.45.1530; KERR JFR, 1979, LANCET, V2, P827; Kershenobich D, 2011, LIVER INT, V31, P18, DOI 10.1111/j.1478-3231.2011.02538.x; Kiyici M, 2003, EUR J GASTROEN HEPAT, V15, P1079, DOI 10.1097/00042737-200310000-00003; Lapinski TW, 2004, WORLD J GASTROENTERO, V10, P3650, DOI 10.3748/wjg.v10.i24.3650; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lebensztejn DM, 2011, ACTA BIOCHIM POL, V58, P563; Macias J, 2011, HIV MED, V12, P14, DOI 10.1111/j.1468-1293.2010.00836.x; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Mengshol JA, 2007, NAT CLIN PRACT GASTR, V4, P622, DOI 10.1038/ncpgasthep0961; Mohan N, 2010, J PEDIATR GASTR NUTR, V50, P123, DOI 10.1097/MPG.0b013e3181c61995; Moreno S, 2009, J VIRAL HEPATITIS, V16, P249, DOI 10.1111/j.1365-2893.2009.01088.x; Ozaslan E, 2003, J INT MED RES, V31, P384; Panasiuk A, 2010, LIVER INT, V30, P472, DOI 10.1111/j.1478-3231.2009.02159.x; Papatheodoridis GV, 2010, J CLIN GASTROENTEROL, V44, pE87, DOI 10.1097/MCG.0b013e3181c0945a; PATEL T, 1995, HEPATOLOGY, V21, P1725, DOI 10.1002/hep.1840210635; Poynard T, 2007, ALIMENT PHARM THER, V25, P733, DOI 10.1111/j.1365-2036.2007.03252.x; Poynard T, 2005, GASTROENTEROLOGY, V128, P1146, DOI 10.1053/j.gastro.2005.02.056; Que FG, 1996, GASTROENTEROLOGY, V110, P1238, DOI 10.1053/gast.1996.v110.pm8613014; Raghuraman S, 2005, J CLIN VIROL, V34, P63, DOI 10.1016/j.jcv.2005.01.009; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rust C, 2000, AM J MED, V108, P567, DOI 10.1016/S0002-9343(00)00370-3; Sebastiani G, 2011, ALIMENT PHARM THER, V34, P1202, DOI 10.1111/j.1365-2036.2011.04861.x; Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682; Seidel N, 2005, HEPATOLOGY, V42, P113, DOI 10.1002/hep.20747; Tamimi TIAR, 2011, J HEPATOL, V54, P1224, DOI 10.1016/j.jhep.2010.08.023; Thampanitchawong P, 1999, WORLD J GASTROENTERO, V5, P301; THEISE N, 2007, MACSWEENS PATHOLOGY, P418; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Toyoda M, 2000, LIVER, V20, P305, DOI 10.1034/j.1600-0676.2000.020004305.x; Valva P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023218; Valva P, 2010, J MED VIROL, V82, P949, DOI 10.1002/jmv.21699; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yilmaz Y, 2007, WORLD J GASTROENTERO, V13, P837, DOI 10.3748/wjg.v13.i6.837; Zekri Abdel-Rahman N, 2011, Comp Hepatol, V10, P4, DOI 10.1186/1476-5926-10-4; Zekri Abdel-Rahman N, 2010, Comp Hepatol, V9, P1, DOI 10.1186/1476-5926-9-1	64	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53519	10.1371/journal.pone.0053519	http://dx.doi.org/10.1371/journal.pone.0053519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326448	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800051
J	Janssens, E; Gaublomme, D; De Groef, L; Darras, VM; Arckens, L; Delorme, N; Claes, F; Van Hove, I; Moons, L				Janssens, Els; Gaublomme, Djoere; De Groef, Lies; Darras, Veerle M.; Arckens, Lut; Delorme, Nathalie; Claes, Filip; Van Hove, Inge; Moons, Lieve			Matrix Metalloproteinase 14 in the Zebrafish: An Eye on Retinal and Retinotectal Development	PLOS ONE			English	Article							VISUAL-SYSTEM; CRANIOFACIAL DEVELOPMENT; EMBRYONIC-DEVELOPMENT; VERTEBRATE RETINA; CELL-MIGRATION; HOMEOBOX GENE; OPTIC TECTUM; DANIO-RERIO; EXPRESSION; NEUROGENESIS	Background: Matrix metalloproteinases (MMPs) are members of the metzincin superfamily of proteinases that cleave structural elements of the extracellular matrix and many molecules involved in signal transduction. Although there is evidence that MMPs promote the proper development of retinotectal projections, the nature and working mechanisms of specific MMPs in retinal development remain to be elucidated. Here, we report a role for zebrafish Mmp14a, one of the two zebrafish paralogs of human MMP14, in retinal neurogenesis and retinotectal development. Results: Whole mount in situ hybridization and immunohistochemical stainings for Mmp14a in developing zebrafish embryos reveal expression in the optic tectum, in the optic nerve and in defined retinal cell populations, including retinal ganglion cells (RGCs). Furthermore, Mmp14a loss-of-function results in perturbed retinoblast cell cycle kinetics and consequently, in a delayed retinal neurogenesis, differentiation and lamination. These Mmp14a-dependent retinal defects lead to microphthalmia and a significantly reduced innervation of the optic tectum (OT) by RGC axons. Mmp14b, on the contrary, does not appear to alter retinal neurogenesis or OT innervation. As mammalian MMP14 is known to act as an efficient MMP2-activator, we also explored and found a functional link and a possible co-involvement of Mmp2 and Mmp14a in zebrafish retinotectal development. Conclusion: Both the Mmp14a expression in the developing visual system and the Mmp14a loss-of-function phenotype illustrate a critical role for Mmp14a activity in retinal and retinotectal development.	[Janssens, Els; Gaublomme, Djoere; De Groef, Lies; Delorme, Nathalie; Claes, Filip; Van Hove, Inge; Moons, Lieve] Katholieke Univ Leuven, Dept Biol, Res Grp Neural Circuit Dev & Regenerat, Louvain, Belgium; [Darras, Veerle M.] Katholieke Univ Leuven, Dept Biol, Lab Comparat Endocrinol, Louvain, Belgium; [Arckens, Lut] Katholieke Univ Leuven, Dept Biol, Lab Neuroplast & Neuroprote, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven	Moons, L (corresponding author), Katholieke Univ Leuven, Dept Biol, Res Grp Neural Circuit Dev & Regenerat, Louvain, Belgium.	lieve.moons@bio.kuleuven.be	Arckens, Lutgarde/C-3822-2016; De Groef, Lies/K-3296-2015	Arckens, Lutgarde/0000-0002-2909-8449; Van Hove, Inge/0000-0002-3125-0438; Moons, Lieve (Godelieve)/0000-0003-0186-1411; De Groef, Lies/0000-0002-3329-3474	National Institutes of Health-National Center for Research Resources [P40 RR012546]; Research Council of KU Leuven [KU Leuven BOF-OT/10/033]; Research Foundation Flanders (FWO) [FWO G.0369.09N]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER	National Institutes of Health-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Council of KU Leuven(KU Leuven); Research Foundation Flanders (FWO)(FWO); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The antisera were obtained from ZIRC, supported by grant P40 RR012546 from the National Institutes of Health-National Center for Research Resources. This work was supported by national grants from the Research Council of KU Leuven [KU Leuven BOF-OT/10/033] and the Research Foundation Flanders (FWO) [FWO G.0369.09N]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova OA, 2003, BRAIN RES, V967, P132, DOI 10.1016/S0006-8993(02)04234-8; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Avanesov A, 2004, METHODS CELL BIOL, V76, P333; Bai S, 2005, MATRIX BIOL, V24, P247, DOI 10.1016/j.matbio.2005.03.007; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Coyle RC, 2008, EXP CELL RES, V314, P2150, DOI 10.1016/j.yexcr.2008.03.010; Detry B, 2012, BLOOD; Diekmann H, 2009, J COMP NEUROL, V513, P38, DOI 10.1002/cne.21928; Easter SS, 2002, RES PRO CEL, V40, P346; Erickson T, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-22; Gariano RF, 2006, GENE EXPR PATTERNS, V6, P187, DOI 10.1016/j.modgep.2005.06.008; Glass AS, 2004, OPHTHALMIC RES, V36, P4, DOI 10.1159/000076105; Haupt C, 2008, FRONT BIOSCI-LANDMRK, V13, P3136, DOI 10.2741/2915; Hehr CL, 2005, DEVELOPMENT, V132, P3371, DOI 10.1242/dev.01908; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; Hillegass JM, 2008, TOXICOL SCI, V102, P413, DOI 10.1093/toxsci/kfn010; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hughes David P., 2011, BMC Ecology, V11, P13, DOI 10.1186/1472-6785-11-13; Huh MI, 2007, J CELL BIOCHEM, V101, P1222, DOI 10.1002/jcb.21246; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Keow JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043434; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; Liu YH, 2001, INVEST OPHTH VIS SCI, V42, P481; Llano E, 2002, J BIOL CHEM, V277, P23321, DOI 10.1074/jbc.M200121200; Malicki J, 2002, METHODS, V28, P427, DOI 10.1016/S1046-2023(02)00262-1; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Nakada C, 2006, MOL CELL BIOL, V26, P7246, DOI 10.1128/MCB.00429-06; Nakayama Y, 2008, DEV BIOL, V313, P752, DOI 10.1016/j.ydbio.2007.11.013; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Paridaen JTML, 2011, DEV BIOL, V355, P286, DOI 10.1016/j.ydbio.2011.04.028; Renninger SL, 2011, NEUROGENETICS, V12, P97, DOI 10.1007/s10048-011-0273-x; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Smine A, 1997, CURR EYE RES, V16, P925, DOI 10.1076/ceyr.16.9.925.5044; Stenkamp DL, 2007, INT REV CYTOL, V259, P173, DOI 10.1016/S0074-7696(06)59005-9; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tucker B, 2008, INVEST OPHTH VIS SCI, V49, P1686, DOI 10.1167/iovs.07-1058; Uribe RA, 2007, CSH PROTOC; Uribe RA, 2010, DEVELOPMENT, V137, P3763, DOI 10.1242/dev.050484; Van Hove I, 2012, MOL NEUROBIOL, V45, P17, DOI 10.1007/s12035-011-8215-z; Vinothkumar S, 2008, DEV BIOL, V314, P200, DOI 10.1016/j.ydbio.2007.11.034; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457; Webber CA, 2002, J NEUROSCI, V22, P8091; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang JS, 2003, DEV GENES EVOL, V213, P382, DOI 10.1007/s00427-003-0333-9; Zhang JS, 2003, MATRIX BIOL, V22, P279, DOI 10.1016/S0945-053X(03)00020-9; Zhang JS, 2003, DEV GENES EVOL, V213, P456, DOI 10.1007/s00427-003-0346-4; Zhao XPC, 2006, INVEST OPHTH VIS SCI, V47, P4341, DOI 10.1167/iovs.05-1611; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	67	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52915	10.1371/journal.pone.0052915	http://dx.doi.org/10.1371/journal.pone.0052915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326364	gold, Green Submitted, Green Published			2022-12-27	WOS:000313551500035
J	Zhou, WH; Suntharalingam, K; Brand, NJ; Barton, PJR; Vilar, R; Ying, LM				Zhou, Wenhua; Suntharalingam, Kogularamanan; Brand, Nigel J.; Barton, Paul J. R.; Vilar, Ramon; Ying, Liming			Possible Regulatory Roles of Promoter G-Quadruplexes in Cardiac Function-Related Genes - Human Tnlc as a Model	PLOS ONE			English	Article							TELOMERIC G-QUADRUPLEX; I-MOTIF STRUCTURES; SUSCEPTIBILITY LOCUS IDDM2; POLYMORPHIC REGION ADOPTS; C-MYC; METAL-COMPLEXES; FORMING REGION; DNA-STRUCTURE; GENOME; EXPRESSION	G-quadruplexes (G4s) are four-stranded DNA secondary structures, which are involved in a diverse range of biological processes. Although the anti-cancer potential of G4s in oncogene promoters has been thoroughly investigated, the functions of promoter G4s in non-cancer-related genes are not well understood. We have explored the possible regulatory roles of promoter G4s in cardiac function-related genes using both computational and a wide range of experimental approaches. According to our bioinformatics results, it was found that potential G4-forming sequences are particularly enriched in the transcription regulatory regions (TRRs) of cardiac function-related genes. Subsequently, the promoter of human cardiac troponin I (Tnlc) was chosen as a model, and G4s found in this region were subjected to biophysical characterisations. The chromosome 19 specific minisatellite G4 sequence (MNSG4) and near transcription start site (TSS) G4 sequence (-80 G4) adopt anti-parallel and parallel structures respectively in 100 mM KCl, with stabilities comparable to those of oncogene G4s. It was also found that Tnlc G4s act cooperatively as enhancers in gene expression regulation in HEK293 cells, when stabilised by a synthetic G4-binding ligand. This study provides the first evidence of the biological significance of promoter G4s in cardiac function-related genes. The feasibility of using a single ligand to target multiple G4s in a particular gene has also been discussed.	[Zhou, Wenhua; Ying, Liming] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Suntharalingam, Kogularamanan; Vilar, Ramon] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; [Brand, Nigel J.; Barton, Paul J. R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, Middlesex, England; [Barton, Paul J. R.] Royal Brompton & Harefield NHS Trust, NIHR Cardiovasc Biomed Res Unit, London, England	Imperial College London; Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital	Ying, LM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	l.ying@imperial.ac.uk	Vilar, Ramon/U-3746-2019; Ying, Liming/G-7999-2011	Vilar, Ramon/0000-0003-2992-199X; Ying, Liming/0000-0001-9752-6292; Barton, Paul/0000-0002-1165-7767	National Heart and Lung Institute Foundation PhD studentship; British Heart Foundation [PG/11/81/29130]; UK's Engineering and Physical Sciences Research Council (EPSRC) [EP/H005285/1]; National Institutes of Health Research (NIHR) Cardiovascular Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College London; Engineering and Physical Sciences Research Council [EP/H005285/1] Funding Source: researchfish; EPSRC [EP/H005285/1] Funding Source: UKRI	National Heart and Lung Institute Foundation PhD studentship; British Heart Foundation(British Heart Foundation); UK's Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institutes of Health Research (NIHR) Cardiovascular Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College London(General Electric); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by a National Heart and Lung Institute Foundation PhD studentship (to WZ) and the British Heart Foundation (grant No.PG/11/81/29130). KS and RV thank the UK's Engineering and Physical Sciences Research Council (EPSRC) for funding (grant number: EP/H005285/1). PB is supported by the National Institutes of Health Research (NIHR) Cardiovascular Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Barton PJR, 1999, GENOMICS, V57, P102, DOI 10.1006/geno.1998.5702; Baumann P., 2009, G QUADRUPLEX DNA MET; Bhavsar PK, 1996, GENOMICS, V35, P11, DOI 10.1006/geno.1996.0317; Bhavsar PK, 2000, J MOL CELL CARDIOL, V32, P95, DOI 10.1006/jmcc.1999.1058; BHAVSAR PK, 1991, FEBS LETT, V292, P5, DOI 10.1016/0014-5793(91)80820-S; Brooks Tracy A, 2010, Genes Cancer, V1, P641; Bryan TM, 2011, MOL BIOTECHNOL, V49, P198, DOI 10.1007/s12033-011-9395-5; Chaires JB, 2010, FEBS J, V277, P1098, DOI 10.1111/j.1742-4658.2009.07462.x; Cogoi S, 2008, NUCLEIC ACIDS RES, V36, P3765, DOI 10.1093/nar/gkn120; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Dapic V, 2003, NUCLEIC ACIDS RES, V31, P2097, DOI 10.1093/nar/gkg316; DAS HK, 1987, J BIOL CHEM, V262, P4787; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; Dixon IM, 2007, J AM CHEM SOC, V129, P1502, DOI 10.1021/ja065591t; DROGE P, 1994, BIOESSAYS, V16, P91, DOI 10.1002/bies.950160205; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Du Z, 2007, BIOCHEM BIOPH RES CO, V354, P1067, DOI 10.1016/j.bbrc.2007.01.093; Du Z, 2009, NUCLEIC ACIDS RES, V37, P6784, DOI 10.1093/nar/gkp710; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Fegan A, 2010, CHEM COMMUN, V46, P946, DOI 10.1039/b920680a; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Gallo P, 2008, GENE THER, V15, P161, DOI 10.1038/sj.gt.3303017; Georgiades SN, 2010, ANGEW CHEM INT EDIT, V49, P4020, DOI 10.1002/anie.200906363; Gomez D, 2004, NUCLEIC ACIDS RES, V32, P371, DOI 10.1093/nar/gkh181; Gomez D, 2002, CANCER RES, V62, P3365; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Grand CL, 2002, MOL CANCER THER, V1, P565; Green JJ, 2003, J AM CHEM SOC, V125, P3763, DOI 10.1021/ja029149w; Gunaratnam M, 2009, J MED CHEM, V52, P3774, DOI 10.1021/jm900424a; Guo K, 2007, J AM CHEM SOC, V129, P10220, DOI 10.1021/ja072185g; HAMMONDKOSACK MCU, 1993, J MOL ENDOCRINOL, V10, P121, DOI 10.1677/jme.0.0100121; HAMMONDKOSACK MCU, 1992, FEBS LETT, V301, P79, DOI 10.1016/0014-5793(92)80214-2; HAMMONDKOSACK MCU, 1992, NUCLEIC ACIDS RES, V20, P231, DOI 10.1093/nar/20.2.231; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Kojima T, 2001, BIOCHEM BIOPH RES CO, V284, P1039, DOI 10.1006/bbrc.2001.5080; Kumar N, 2004, BIOCHEM BIOPH RES CO, V319, P759, DOI 10.1016/j.bbrc.2004.05.052; Kumar N, 2008, NUCLEIC ACIDS RES, V36, P5610, DOI 10.1093/nar/gkn543; Kumar P, 2011, NUCLEIC ACIDS RES, V39, P8005, DOI 10.1093/nar/gkr536; Kuryavyi V, 2010, NUCLEIC ACIDS RES, V38, P6757, DOI 10.1093/nar/gkq558; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lee JY, 2005, P NATL ACAD SCI USA, V102, P18938, DOI 10.1073/pnas.0506144102; Leem SH, 2004, GENOME RES, V14, P239, DOI 10.1101/gr.1929904; Lew A, 2000, P NATL ACAD SCI USA, V97, P12508, DOI 10.1073/pnas.97.23.12508; Li W, 2002, FEBS LETT, V526, P77, DOI 10.1016/S0014-5793(02)03118-6; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; MCCARTHY JG, 1987, NUCLEIC ACIDS RES, V15, P8069, DOI 10.1093/nar/15.19.8069; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; MURCHIE AIH, 1992, NUCLEIC ACIDS RES, V20, P49, DOI 10.1093/nar/20.1.49; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Park GH, 1998, BLOOD, V92, P4138, DOI 10.1182/blood.V92.11.4138.423k44_4138_4149; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Phan AT, 2002, NUCLEIC ACIDS RES, V30, P4618, DOI 10.1093/nar/gkf597; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; RAGHURAMAN MK, 1990, NUCLEIC ACIDS RES, V18, P4543, DOI 10.1093/nar/18.15.4543; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Riou JF, 2002, P NATL ACAD SCI USA, V99, P2672, DOI 10.1073/pnas.052698099; Risebro CA, 2006, DEVELOPMENT, V133, P4595, DOI 10.1242/dev.02625; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Shklover J, 2010, NUCLEIC ACIDS RES, V38, P2369, DOI 10.1093/nar/gkp1208; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Sun D, 2008, MOL CANCER THER, V7, P880, DOI 10.1158/1535-7163.MCT-07-2119; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Sun D, 2010, METHODS MOL BIOL, V613, P223, DOI 10.1007/978-1-60327-418-0_14; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Suntharalingam K, 2010, INORG CHEM, V49, P8371, DOI 10.1021/ic100884p; Suntharalingam K, 2009, INORG CHEM, V48, P9427, DOI 10.1021/ic901319n; Thygesen K, 2007, EUR HEART J, V28, P2525; Todd AK, 2008, NUCLEIC ACIDS RES, V36, P2700, DOI 10.1093/nar/gkn078; Todd AK, 2007, NUCLEIC ACIDS RES, V35, P5799, DOI 10.1093/nar/gkm609; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485; Xu Yan, 2005, Nucleic Acids Symp Ser (Oxf), P177, DOI 10.1093/nass/49.1.177; Ying LM, 2003, P NATL ACAD SCI USA, V100, P14629, DOI 10.1073/pnas.2433350100; Zhao YQ, 2007, FEBS LETT, V581, P1951, DOI 10.1016/j.febslet.2007.04.017; Zhou WH, 2011, J CARDIOVASC TRANSL, V4, P256, DOI 10.1007/s12265-011-9258-2	95	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53137	10.1371/journal.pone.0053137	http://dx.doi.org/10.1371/journal.pone.0053137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326389	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500051
J	Cardenas-Aguayo, MD; Kazim, SF; Grundke-Iqbal, I; Iqbal, K				Cardenas-Aguayo, Maria del Carmen; Kazim, Syed Faraz; Grundke-Iqbal, Inge; Iqbal, Khalid			Neurogenic and Neurotrophic Effects of BDNF Peptides in Mouse Hippocampal Primary Neuronal Cell Cultures	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PARTIAL AGONISTS; SMALL-MOLECULE; ADULT NEUROGENESIS; DENTATE GYRUS; SPINAL-CORD; IN-VITRO; BRAIN	The level of brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, is down regulated in Alzheimer's disease (AD), Parkinson's disease (PD), depression, stress, and anxiety; conversely the level of this neurotrophin is increased in autism spectrum disorders. Thus, modulating the level of BDNF can be a potential therapeutic approach for nervous system pathologies. In the present study, we designed five different tetra peptides (peptides B-1 to B-5) corresponding to different active regions of BDNF. These tetra peptides were found to be non-toxic, and they induced the expression of neuronal markers in mouse embryonic day 18 (E18) primary hippocampal neuronal cultures. Additionally, peptide B-5 induced the expression of BDNF and its receptor, TrkB, suggesting a positive feedback mechanism. The BDNF peptides induced only a moderate activation (phosphorylation at Tyr 706) of the TrkB receptor, which could be blocked by the Trk's inhibitor, K252a. Peptide B-3, when combined with BDNF, potentiated the survival effect of this neurotrophin on H2O2-treated E18 hippocampal cells. Peptides B-3 and B-5 were found to work as partial agonists and as partial antagonists competing with BDNF to activate the TrkB receptor in a dose-dependent manner. Taken together, these results suggest that the described BDNF tetra peptides are neurotrophic, can modulate BDNF signaling in a partial agonist/antagonist way, and offer a novel therapeutic approach to neural pathologies where BDNF levels are dysregulated.	[Cardenas-Aguayo, Maria del Carmen; Kazim, Syed Faraz; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Kazim, Syed Faraz] Suny Downstate Med Ctr, Neural & Behav Sci Grad Program, Brooklyn, NY 11203 USA	Institute for Basic Research in Developmental Disabilities; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com	del Carmen Cardenas-Aguayo, Maria/AAH-5073-2020	del Carmen Cardenas-Aguayo, Maria/0000-0001-9156-2161	New York State Office of People with Developmental Disabilities; EVER NeuroPharma GmbH, Unterach, Austria	New York State Office of People with Developmental Disabilities; EVER NeuroPharma GmbH, Unterach, Austria	Studies described in this article were supported in part by the New York State Office of People with Developmental Disabilities, and a research grant from EVER NeuroPharma GmbH, Unterach, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Ankeny DP, 2001, EXP NEUROL, V170, P85, DOI 10.1006/exnr.2001.7699; Barkats M, 1998, PROG NEUROBIOL, V55, P333, DOI 10.1016/S0301-0082(98)00028-8; Barrett GL, 2000, PROG NEUROBIOL, V61, P205, DOI 10.1016/S0301-0082(99)00056-8; Beck M, 2005, AMYOTROPH LATERAL SC, V6, P100, DOI 10.1080/14660820510028412; Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blanchard J, 2011, J NEUROPATH EXP NEUR, V70, P1070, DOI 10.1097/NEN.0b013e318236e9ad; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Blanchard J, 2010, J ALZHEIMERS DIS, V21, P1185, DOI [10.3233/JAD-2010-100069, 10.3233/JAD-2010-1000069]; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Cardenas-Aguayo MD, 2003, J HEMATOTH STEM CELL, V12, P735; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; Correia CT, 2010, GENES BRAIN BEHAV, V9, P841, DOI 10.1111/j.1601-183X.2010.00627.x; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Counts SE, 2005, J NEUROPATH EXP NEUR, V64, P263, DOI 10.1093/jnen/64.4.263; Eglen R, 2011, PHARMACOL THERAPEUT, V130, P144, DOI 10.1016/j.pharmthera.2011.01.007; Fletcher JM, 2009, BIOORGAN MED CHEM, V17, P2695, DOI 10.1016/j.bmc.2009.02.053; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P95, DOI 10.1038/sj.tpj.6500360; GRUNDKEIQBAL I, 1988, MOL BRAIN RES, V4, P43, DOI 10.1016/0169-328X(88)90017-4; Haase G, 1998, J NEUROL SCI, V160, pS97, DOI 10.1016/S0022-510X(98)00207-X; Harper MM, 2009, EXP EYE RES, V89, P538, DOI 10.1016/j.exer.2009.05.013; HOYER D, 1993, TRENDS PHARMACOL SCI, V14, P270, DOI 10.1016/0165-6147(93)90129-8; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Li B, 2010, FEBS LETT, V584, P3359, DOI 10.1016/j.febslet.2010.06.025; Li N, 2010, ACTA PHARMACOL SIN, V31, P265, DOI 10.1038/aps.2010.3; Lieberman JA, 2004, CNS DRUGS, V18, P251, DOI 10.2165/00023210-200418040-00005; Longo FM, 2004, J ALZHEIMERS DIS, V6, pS13; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Manfredsson FP, 2012, NEUROBIOL DIS; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Massa F, 2011, P NATL ACAD SCI USA, V108, P6644, DOI 10.1073/pnas.1016928108; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Molina-Holgado F, 2008, CNS NEUROL DISORD-DR, V7, P110; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Price RD, 2007, PHARMACOL THERAPEUT, V115, P292, DOI 10.1016/j.pharmthera.2007.03.005; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tatebayashi Y, 1999, J NEUROSCI, V19, P5245; Tsai SJ, 2007, MED HYPOTHESES, V68, P674, DOI 10.1016/j.mehy.2006.06.019; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Whitty A, 1999, CHEM BIOL, V6, pR107, DOI 10.1016/S1074-5521(99)80034-9; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Zhang W, 2008, NEUROSCIENCE, V152, P502, DOI 10.1016/j.neuroscience.2007.12.037	61	47	47	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53596	10.1371/journal.pone.0053596	http://dx.doi.org/10.1371/journal.pone.0053596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320097	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800062
J	Mastroeni, D; Chouliaras, L; Grover, A; Liang, WS; Hauns, K; Rogers, J; Coleman, PD				Mastroeni, Diego; Chouliaras, Leonidas; Grover, Andrew; Liang, Winnie S.; Hauns, Kevin; Rogers, Joseph; Coleman, Paul D.			Reduced RAN Expression and Disrupted Transport between Cytoplasm and Nucleus; A Key Event in Alzheimer's Disease Pathophysiology	PLOS ONE			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; MECHANISMS; CASPASE-3; REGIONS; COMPLEX; IMPORT; EXPORT; HDAC1	Transcription of DNA is essential for cell maintenance and survival; inappropriate localization of proteins that are involved in transcription would be catastrophic. In Alzheimer's disease brains, and in vitro studies, we have found qualitative and quantitative deficits in transport into the nucleus of DNA methyltransferase 1 (DNMT1) and RNA polymerase II (RNA pol II), accompanied by their abnormal sequestration in the cytoplasm. RAN (RAs-related Nuclear protein) knockdown, by siRNA and oligomeric A beta 42 treatment in neurons, replicate human data which indicate that transport disruption in AD may be mechanistically linked to reduced expression of RAN, a pivotal molecule in nucleocytoplasmic transport. In vitro studies also indicate a significant role for oligomeric A beta 42 in the observed phenomena. We propose a model in which reduced transcription regulators in the nucleus and their increased presence in the cytoplasm may lead to many of the cellular manifestations of Alzheimer's disease.	[Mastroeni, Diego; Grover, Andrew; Hauns, Kevin; Rogers, Joseph; Coleman, Paul D.] Banner Sun Hlth Res Inst, LJ Roberts Alzheimers Dis Ctr, Sun City, AZ USA; [Mastroeni, Diego; Chouliaras, Leonidas] Maastricht Univ, Med Ctr, European Grad Sch Neurosci EURON,Sch Mental Hlth, Dept Psychiat & Neuropsychol,Fac Hlth Med & Life, Maastricht, Netherlands; [Liang, Winnie S.] Translat Genom Res Inst, Collaborat Sequencing Ctr, Phoenix, AZ USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Maastricht University; Translational Genomics Research Institute	Coleman, PD (corresponding author), Banner Sun Hlth Res Inst, LJ Roberts Alzheimers Dis Ctr, Sun City, AZ USA.	paul.coleman@bannerhealth.com	Chouliaras, Leonidas/W-8711-2019	Chouliaras, Leonidas/0000-0002-3052-3879	National Institutes of Health (NIH) [RO1 AG036400]; Arizona Alzheimer's Research Center DHS; National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services, Arizona Alzheimer's Research Center [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036400, P30AG019610] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Alzheimer's Research Center DHS; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services, Arizona Alzheimer's Research Center; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) RO1 AG036400 and Arizona Alzheimer's Research Center DHS Award FY 2012 to PDC. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carre C, 2011, MOL CELL BIOL, V31, P3953, DOI 10.1128/MCB.05442-11; Cotman CW, 2005, J NEUROPATH EXP NEUR, V64, P104, DOI 10.1093/jnen/64.2.104; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Czeko E, 2011, MOL CELL, V42, P261, DOI 10.1016/j.molcel.2011.02.033; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Desplats P, 2011, J BIOL CHEM, V286, P9031, DOI 10.1074/jbc.C110.212589; Husseman JW, 2001, J NEUROPATH EXP NEUR, V60, P1219, DOI 10.1093/jnen/60.12.1219; Irier HA, 2012, DNA CELL BIOL; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Liang WS, 2010, NEUROBIOL AGING, V31, P549, DOI 10.1016/j.neurobiolaging.2008.05.013; Mastroeni D, 2011, NEUROBIOL AGING, V32, P1161, DOI 10.1016/j.neurobiolaging.2010.08.017; Mastroeni D, 2010, NEUROBIOL AGING, V31, P2025, DOI 10.1016/j.neurobiolaging.2008.12.005; Mastroeni D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006617; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Sheffield LG, 2006, J NEUROPATH EXP NEUR, V65, P45, DOI 10.1097/01.jnen.0000195939.40410.08; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012	29	44	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53349	10.1371/journal.pone.0053349	http://dx.doi.org/10.1371/journal.pone.0053349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308199	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800041
J	Silva, G; Cardoso, BA; Belo, H; Almeida, AM				Silva, Gabriela; Cardoso, Bruno A.; Belo, Helio; Almeida, Antonio Medina			Vorinostat Induces Apoptosis and Differentiation in Myeloid Malignancies: Genetic and Molecular Mechanisms	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; SUBEROYLANILIDE HYDROXAMIC ACID; MYELODYSPLASTIC SYNDROMES; DOWN-REGULATION; CD34(+) CELLS; CANCER-CELLS; SP FAMILY; EXPRESSION; SP1; TRANSCRIPTION	Background: Aberrant epigenetic patterns are central in the pathogenesis of haematopoietic diseases such as myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). Vorinostat is a HDACi which has produced responses in these disorders. The purpose of this study was to address the functional effects of vorinostat in leukemic cell lines and primary AML and MDS myeloid cells and to dissect the genetic and molecular mechanisms by which it exerts its action. Methodology/Principal Findings: Functional assays showed vorinostat promoted cell cycle arrest, inhibited growth, and induced apoptosis and differentiation of K562, HL60 and THP-1 and of CD33(+) cells from AML and MDS patients. To explore the genetic mechanism for these effects, we quantified gene expression modulation by vorinostat in these cells. Vorinostat increased expression of genes down-regulated in MDS and/or AML (cFOS, COX2, IER3, p15, RAI3) and suppressed expression of genes over-expressed in these malignancies (AXL, c-MYC, Cyclin D1) and modulated cell cycle and apoptosis genes in a manner which would favor cell cycle arrest, differentiation, and apoptosis of neoplastic cells, consistent with the functional assays. Reporter assays showed transcriptional effect of vorinostat on some of these genes was mediated by proximal promoter elements in GC-rich regions. Vorinostat-modulated expression of some genes was potentiated by mithramycin A, a compound that interferes with SP1 binding to GC-rich DNA sequences, and siRNA-mediated SP1 reduction. ChIP assays revealed vorinostat inhibited DNA binding of SP1 to the proximal promoter regions of these genes. These results suggest vorinostat transcriptional action in some genes is regulated by proximal promoter GC-rich DNA sequences and by SP1. Conclusion: This study sheds light on the effects of vorinostat in AML and MDS and supports the implementation of clinical trials to explore the use of vorinostat in the treatment of these diseases.	[Silva, Gabriela; Cardoso, Bruno A.; Belo, Helio; Almeida, Antonio Medina] EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Unidade Invest Patobiol Mol, Lisbon, Portugal; [Silva, Gabriela; Cardoso, Bruno A.; Belo, Helio; Almeida, Antonio Medina] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal	Universidade Nova de Lisboa	Almeida, AM (corresponding author), EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Unidade Invest Patobiol Mol, Lisbon, Portugal.	amalmeida@ipolisboa.min-saude.pt		Silva, Gabriela/0000-0002-4004-9904; Cardoso, Bruno/0000-0002-6521-7257; Almeida, Antonio/0000-0003-4361-0928	Portuguese Association Against Leukemia; IPOLFG Oncology Research Fund; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/46494/2008]; Celgene; Novartis	Portuguese Association Against Leukemia; IPOLFG Oncology Research Fund; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Celgene(Bristol-Myers SquibbCelgene Corporation); Novartis(Novartis)	This study was funded by a research grant from the Portuguese Association Against Leukemia, from the IPOLFG Oncology Research Fund, and a post-doctoral fellowship from "Fundacao para a Ciencia e Tecnologia" (SFRH/BPD/46494/2008) for GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr AMA receives consulting fees from Celgene and Novartis and is on the board of speakers for Bristol-Meyer Squibb, Shire and Amgen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agirre X, 2006, ONCOGENE, V25, P1862, DOI 10.1038/sj.onc.1209236; Almeida AM, 2007, NEW ENGL J MED, V356, P1641, DOI 10.1056/NEJMoa063369; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Arinze IJ, 2003, J BIOL CHEM, V278, P17785, DOI 10.1074/jbc.M209430200; Blundell R.A., 2006, AM J BIOCH BIOTECHNO, V2, P33, DOI DOI 10.3844/AJBBSP.2006.33.40; Breen EC, 2006, TUMOR BIOL, V27, P187, DOI 10.1159/000093022; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Cheng YC, 2007, LEUKEMIA RES, V31, P1403, DOI 10.1016/j.leukres.2007.03.012; Chou CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018087; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Griffiths EA, 2008, SEMIN HEMATOL, V45, P23, DOI 10.1053/j.seminhematol.2007.11.007; Griffiths EA, 2010, EPIGENETICS-US, V5, P590, DOI 10.4161/epi.5.7.12558; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hofmann WK, 2002, BLOOD, V100, P3553, DOI 10.1182/blood.V100.10.3553; Jain N, 2009, INT J BIOCHEM CELL B, V41, P72, DOI 10.1016/j.biocel.2008.10.006; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lieberman HB, 2011, J MOL CELL BIOL, V3, P39, DOI 10.1093/jmcb/mjq039; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Long XH, 2007, INT J MOL MED, V19, P607; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Mano H, 2006, LEUKEMIA LYMPHOMA, V47, P9, DOI 10.1080/10428190500264231; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Marsee DK, 2010, AM J CLIN PATHOL, V134, P429, DOI 10.1309/AJCPCRK3MOAOJ6AT; Martin V, 2010, CANCER SCI, V101, P425, DOI 10.1111/j.1349-7006.2009.01413.x; Matarraz S, 2010, CYTOM PART B-CLIN CY, V78B, P154, DOI 10.1002/cyto.b.20513; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Neubauer A, 1997, LEUKEMIA LYMPHOMA, V25, P91, DOI 10.3109/10428199709042499; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pellagatti A, 2005, HEMATOLOGY, V10, P281, DOI 10.1080/10245330500065680; Pellagatti A, 2004, BRIT J HAEMATOL, V125, P576, DOI 10.1111/j.1365-2141.2004.04958.x; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Lima PSP, 2008, GENET MOL BIOL, V31, P632, DOI 10.1590/S1415-47572008000400005; Petruccelli LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020987; Plass C, 2008, SEMIN ONCOL, V35, P378, DOI 10.1053/j.seminoncol.2008.04.008; Richon VM, 2009, CANCER LETT, V280, P201, DOI 10.1016/j.canlet.2009.01.002; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Silva G, 2009, J BIOL CHEM, V284, P29582, DOI 10.1074/jbc.M109.045344; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Stintzing S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/214143; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Suzuki A, 2010, J BIOL CHEM, V285, P13444, DOI 10.1074/jbc.M109.062430; Suzuki E, 2010, INT J ONCOL, V36, P1299, DOI 10.3892/ijo_00000615; Tsiftsoglou AS, 2009, PHARMACOL THERAPEUT, V122, P264, DOI 10.1016/j.pharmthera.2009.03.001; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Witt O, 2003, BLOOD, V101, P2001, DOI 10.1182/blood-2002-08-2617; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Yoshima T, 1998, J BIOL CHEM, V273, P25466, DOI 10.1074/jbc.273.39.25466; Yu DCW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-276; Zeuner A, 2011, CELL DEATH DIFFER, V18, P371, DOI 10.1038/cdd.2010.110	63	53	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53766	10.1371/journal.pone.0053766	http://dx.doi.org/10.1371/journal.pone.0053766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320102	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800067
J	Subramanyam, MA; Diez-Roux, AV; Pilsner, JR; Villamor, E; Donohue, KM; Liu, YM; Jenny, NS				Subramanyam, Malavika A.; Diez-Roux, Ana V.; Pilsner, J. Richard; Villamor, Eduardo; Donohue, Kathleen M.; Liu, Yongmei; Jenny, Nancy S.			Social Factors and Leukocyte DNA Methylation of Repetitive Sequences: The Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; EPIGENETIC DIFFERENCES; PARTICULATE MATTER; GLOBAL METHYLATION; PRENATAL EXPOSURE; PHYSICAL-ACTIVITY; AFRICAN-AMERICAN; SEX-DIFFERENCES; HEALTH; BLOOD	Epigenetic changes are a potential mechanism contributing to race/ethnic and socioeconomic disparities in health. However, there is scant evidence of the race/ethnic and socioeconomic patterning of epigenetic marks. We used data from the Multi-Ethnic Study of Atherosclerosis Stress Study (N = 988) to describe age-and gender-independent associations of race/ethnicity and socioeconomic status (SES) with methylation of Alu and LINE-1 repetitive elements in leukocyte DNA. Mean Alu and Line 1 methylation in the full sample were 24% and 81% respectively. In multivariable linear regression models, African-Americans had 0.27% (p<0.01) and Hispanics 0.20% (p<0.05) lower Alu methylation than whites. In contrast, African-Americans had 0.41% (p<0.01) and Hispanics 0.39% (p<0.01) higher LINE-1 methylation than whites. These associations remained after adjustment for SES. In addition, a one standard deviation higher wealth was associated with 0.09% (p<0.01) higher Alu and 0.15% (p<0.01) lower LINE-1 methylation in age-and gender-adjusted models. Additional adjustment for race/ethnicity did not alter this pattern. No associations were observed with income, education or childhood SES. Our findings, from a large community-based sample, suggest that DNA methylation is socially patterned. Future research, including studies of gene-specific methylation, is needed to understand better the opposing associations of Alu and LINE-1 methylation with race/ethnicity and wealth as well as the extent to which small methylation changes in these sequences may influence disparities in health.	[Subramanyam, Malavika A.] Indian Inst Technol Gandhinagar, Ahmadabad, Gujarat, India; [Diez-Roux, Ana V.; Villamor, Eduardo] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Pilsner, J. Richard] Univ Massachusetts, Div Environm Hlth Sci, Amherst, MA 01003 USA; [Donohue, Kathleen M.] Columbia Univ, Med Ctr, New York, NY USA; [Liu, Yongmei] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Jenny, Nancy S.] Univ Vermont, Lab Clin Biochem Res, Colchester, VT USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Gandhinagar; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Amherst; Columbia University; Wake Forest University; University of Vermont	Subramanyam, MA (corresponding author), Indian Inst Technol Gandhinagar, Ahmadabad, Gujarat, India.	Malavika@iitgn.ac.in			National Heart, Lung, and Blood Institute (NHLBI);  [N01 HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169];  [RR-024156];  [RO1 HL076831];  [R01 HL101161]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095169, N01HC095163, N01HC095166, N01HC095168, N01HC095160, N01HC095162, N01HC095161, N01HC095164, N01HC095165, N01HC095167] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101161, R01HL076831] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MESA is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support is provided by grants and contracts N01 HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169 and RR-024156. MESA Stress Study was supported by RO1 HL076831 and R01 HL101161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	August KJ, 2011, J GEN INTERN MED, V26, P245, DOI 10.1007/s11606-010-1514-7; Axume J, 2007, EPIGENETICS-US, V2, P66, DOI 10.4161/epi.2.1.4066; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Bernabe E, 2012, COMMUNITY DENT ORAL, V40, P46, DOI 10.1111/j.1600-0528.2011.00633.x; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Cleland VJ, 2009, AM J EPIDEMIOL, V170, P1069, DOI 10.1093/aje/kwp271; Coogan PF, 2012, ETHNIC DIS, V22, P198; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Guerrero-Preston R, 2009, P R HEALTH SCI J, V28, P24; Hajat A, 2010, PSYCHONEUROENDOCRINO, V35, P932, DOI 10.1016/j.psyneuen.2009.12.009; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Janicki-Deverts D, 2012, PSYCHOSOM MED, V74, P728, DOI 10.1097/PSY.0b013e31825e32e8; Kant AK, 2007, PUBLIC HEALTH NUTR, V10, P158, DOI 10.1017/S1368980007246749; Kant AK, 2007, AM J PREV MED, V32, P264, DOI 10.1016/j.amepre.2006.12.011; Keister LA, 2000, ANNU REV SOCIOL, V26, P63, DOI 10.1146/annurev.soc.26.1.63; Kim KY, 2010, ENVIRON HEALTH PERSP, V118, P370, DOI 10.1289/ehp.0901131; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Madrigano J, 2011, ENVIRON HEALTH PERSP, V119, P977, DOI 10.1289/ehp.1002773; McGuinness D, 2012, INT J EPIDEMIOL, V41, P151, DOI 10.1093/ije/dyr215; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Niculescu MD, 2011, CURR OPIN CLIN NUTR, V14, P35, DOI 10.1097/MCO.0b013e328340ff7c; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Peters JL, 2011, AM J EPIDEMIOL, V174, P1345, DOI 10.1093/aje/kwr269; Pilsner JR, 2007, AM J CLIN NUTR, V86, P1179, DOI 10.1093/ajcn/86.4.1179; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Pollack CE, 2007, AM J PREV MED, V33, P250, DOI 10.1016/j.amepre.2007.04.033; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Tamashiro KLK, 2010, PHYSIOL BEHAV, V100, P560, DOI 10.1016/j.physbeh.2010.04.008; Tao MH, 2011, ALCOHOL, V45, P689, DOI 10.1016/j.alcohol.2010.11.006; Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Villamor E, 2008, J NUTR, V138, P1391, DOI 10.1093/jn/138.7.1391; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Wright RO, 2010, ENVIRON HEALTH PERSP, V118, P790, DOI 10.1289/ehp.0901429; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhang FF, 2011, EPIGENETICS-US, V6, P293, DOI 10.4161/epi.6.3.14378; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	58	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54018	10.1371/journal.pone.0054018	http://dx.doi.org/10.1371/journal.pone.0054018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IY	23320117	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429800084
J	Tibolla, G; Pineiro, R; Chiozzotto, D; Mavrommati, I; Wheeler, AP; Norata, GD; Catapano, AL; Maffucci, T; Falasca, M				Tibolla, Gianpaolo; Pineiro, Roberto; Chiozzotto, Daniela; Mavrommati, Ioanna; Wheeler, Ann P.; Norata, Giuseppe Danilo; Catapano, Alberico Luigi; Maffucci, Tania; Falasca, Marco			Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SPHINGOSINE 1-PHOSPHATE; GROWTH-FACTOR; MIGRATION; SPHINGOSINE-1-PHOSPHATE; ANGIOGENESIS; CHOLESTEROL; MECHANISM; DISTINCT; PATHWAY	The question of whether the distinct isoforms of the family of enzymes phosphoinositide 3-kinases (PI3Ks) play redundant roles within a cell or whether they control distinct cellular processes or distinct steps within the same cellular process has gained considerable importance in the recent years due to the development of inhibitors able to selectively target individual isoforms. It is important to understand whether inhibition of one PI3K can result in compensatory effect from other isoform(s) and therefore whether strategies aimed at simultaneously blocking more than one PI3K may be needed. In this study we investigated the relative contribution of distinct PI3K isoforms to endothelial cells (EC) functions specifically regulated by the sphingolipid sphingosine-1-phosphate (S1P) and by high density lipoproteins (HDL), the major carrier of S1P in human plasma. Here we show that a co-ordinated action of different PI3Ks is required to tightly regulate remodelling of EC on Matrigel, a process dependent on cell proliferation, apoptosis and migration. The contribution of each isoform to this process appears to be distinct, with the class II enzyme PI3K-C2 beta and the class IB isoform p110 gamma mainly regulating the S1P- and HDL-dependent EC migration and PI3K-C2 alpha primarily controlling EC survival. Data further indicate that PI3K-C2 beta and p110 gamma control distinct steps involved in cell migration supporting the hypothesis that different PI3Ks regulate distinct cellular processes.	[Tibolla, Gianpaolo; Pineiro, Roberto; Chiozzotto, Daniela; Mavrommati, Ioanna; Norata, Giuseppe Danilo; Maffucci, Tania; Falasca, Marco] Queen Mary Univ London, Inositide Signalling Grp, Ctr Diabet, Barts & London Sch Med & Dent,Blizard Inst, London, England; [Tibolla, Gianpaolo; Norata, Giuseppe Danilo; Catapano, Alberico Luigi] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Tibolla, Gianpaolo; Norata, Giuseppe Danilo] Bassini Hosp, Societa Italiana Studio Aterosclerosi, Ctr Study Atherosclerosis, Cinisello Balsamo, Italy; [Wheeler, Ann P.] Queen Mary Univ London, Blizard Adv Light Microscopy Core Facil, Barts & London Sch Med & Dent, London, England; [Catapano, Alberico Luigi] Ist Ric & Cura Carattere Sci MultiMed, Milan, Italy	University of London; Queen Mary University London; University of Milan; University of London; Queen Mary University London	Falasca, M (corresponding author), Queen Mary Univ London, Inositide Signalling Grp, Ctr Diabet, Barts & London Sch Med & Dent,Blizard Inst, London, England.	m.falasca@qmul.ac.uk	Catapano, alberico/AAC-2827-2019; Norata, Giuseppe Danilo/AAC-2863-2019; Piñeiro, Roberto/AAN-5561-2020; Falasca, Marco/S-4020-2016	Catapano, alberico/0000-0002-7593-2094; Piñeiro, Roberto/0000-0001-9479-139X; Wheeler, Ann/0000-0001-8617-827X; Norata, Giuseppe Danilo/0000-0002-6081-1257; Falasca, Marco/0000-0002-9801-7235	British Heart Foundation [PG/04/033/16906, PG/06/022/20348]; SISA Lombardia; Diabetes UK [BDA:09/0003971]; "Dote Ricerca FSE" Regione Lombardia; University of Milan; Diabetes UK [09/0003971] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); SISA Lombardia; Diabetes UK(Diabetes UK); "Dote Ricerca FSE" Regione Lombardia(Regione Lombardia); University of Milan; Diabetes UK(Diabetes UK)	This work was supported by British Heart Foundation [grant PG/04/033/16906 and grant PG/06/022/20348 to MF] and by SISA Lombardia. D. Chiozzotto was supported by British Heart Foundation [grant PG/04/033/16906 to MF]. T. Maffucci was supported by grant from Diabetes UK [( grant BDA:09/0003971], G. Tibolla was supported by "Dote Ricerca FSE" Regione Lombardia, G. D. Norata and A. L. Catapano were recipients of PUR grant from the University of Milan.	Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Arcaro A, 2002, EMBO J, V21, P5097, DOI 10.1093/emboj/cdf512; Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; Calabresi L, 2003, ARTERIOSCL THROM VAS, V23, P1724, DOI 10.1161/01.ATV.0000094961.74697.54; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Elis W, 2008, MOL CANCER RES, V6, P614, DOI 10.1158/1541-7786.MCR-07-0262; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Falasca M, 2009, BBA-MOL CELL RES, V1793, P1795, DOI 10.1016/j.bbamcr.2009.10.003; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Harada K, 2005, MOL CELL BIOL, V25, P11122, DOI 10.1128/MCB.25.24.11122-11130.2005; Heller R, 2008, CARDIOVASC RES, V80, P96, DOI 10.1093/cvr/cvn159; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Kimura T, 2003, ARTERIOSCL THROM VAS, V23, P1283, DOI 10.1161/01.ATV.0000079011.67194.5A; Kontush A, 2007, ARTERIOSCL THROM VAS, V27, P1843, DOI 10.1161/ATVBAHA.107.145672; Kwiterovich PO, 1998, AM J CARDIOL, V82, p13Q; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lucke S, 2010, CELL PHYSIOL BIOCHEM, V26, P87, DOI 10.1159/000315109; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Madeddu P, 2008, ARTERIOSCL THROM VAS, V28, P68, DOI 10.1161/ATVBAHA.107.145573; Maffucci T, 2005, CANCER RES, V65, P8339, DOI 10.1158/0008-5472.CAN-05-0121; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Matsuo Y, 2007, ATHEROSCLEROSIS, V194, P159, DOI 10.1016/j.atherosclerosis.2006.10.020; Mazza Simona, 2011, Int J Biochem Mol Biol, V2, P168; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Morello F, 2009, CARDIOVASC RES, V82, P261, DOI 10.1093/cvr/cvn325; MURUGESAN G, 1994, CIRC RES, V74, P1149, DOI 10.1161/01.RES.74.6.1149; Nofer JR, 2005, TRENDS CARDIOVAS MED, V15, P265, DOI 10.1016/j.tcm.2005.08.005; Norata GD, 2006, J CLIN ENDOCR METAB, V91, P546, DOI 10.1210/jc.2005-1664; Norata GD, 2004, ARTERIOSCL THROM VAS, V24, P871, DOI 10.1161/01.ATV.zhq0504.1403; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; Yatomi Y, 2008, BBA-GEN SUBJECTS, V1780, P606, DOI 10.1016/j.bbagen.2007.10.006; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zhan B, 2005, ATHEROSCLEROSIS, V178, P199, DOI 10.1016/j.atherosclerosis.2004.08.024	42	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53808	10.1371/journal.pone.0053808	http://dx.doi.org/10.1371/journal.pone.0053808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320105	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800070
J	Ettwig, JF; Bronkhorst, AW				Ettwig, Janne F.; Bronkhorst, Adelbert W.			Attentional Requirements on Feature Search Are Modulated by Stimulus Properties	PLOS ONE			English	Article							VISUAL-SEARCH; GUIDED SEARCH; ORIENTATION; DISCRIMINATION; CONTRAST; CAPTURE; VISION; MODEL; TASK	We report a series of dual-task experiments, in which a rapid serial visual presentation (RSVP) task was combined with a visual search task. Orientation, motion, and color were used as the defining target features in the search task. Lag between target onsets was manipulated and interference between the two tasks was quantified by measuring detection scores for the search task as a function of lag. While simultaneous performance of an orientation detection task with an RSVP letter identification task resulted in a performance decrease for lags up to 320 ms, no such decrease was detected for highly salient motion- and color-defined targets. Subsequently, detectability of the motion and color feature was matched to that of the orientation-feature resulting in the reintroduction of a (smaller) performance decrease, but only during simultaneous performance (lag 0 ms). The results suggest that there are two causes for the impaired search performance occurring when a feature search task is combined with an RSVP task. The first is short-lasting interference probably due to attentional competition; the second, which plays a role only when targets for both tasks share features, is interference that may be attributed to a central processing bottleneck.	[Ettwig, Janne F.; Bronkhorst, Adelbert W.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Ettwig, Janne F.; Bronkhorst, Adelbert W.] TNO, Soesterberg, Netherlands	Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research	Ettwig, JF (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	J.F.Ettwig@vu.nl			Netherlands Ministry of Defense	Netherlands Ministry of Defense	This research was supported by funding from the Netherlands Ministry of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLPORT DA, 1971, PERCEPT PSYCHOPHYS, V10, P104; [Anonymous], 1999, IEC 61966-2-1; BRAUN J, 1994, J NEUROSCI, V14, P554; Braun J, 1998, NATURE, V393, P424, DOI 10.1038/30875; Braun J, 1998, PERCEPT PSYCHOPHYS, V60, P1, DOI 10.3758/BF03211915; BRAUN J, 1991, PERCEPTION, V20, P483, DOI 10.1068/p200483; Broadbent D. E., 1958, SELECTIVE NATURE LEA, P244; Chua FK, 2005, PERCEPT PSYCHOPHYS, V67, P770, DOI 10.3758/BF03193532; DUNCAN J, 1993, PERCEPT PSYCHOPHYS, V54, P425, DOI 10.3758/BF03211764; Duncan J, 1996, PERCEPT PSYCHOPHYS, V58, P1076, DOI 10.3758/BF03206834; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; ENNS JT, 1990, SCIENCE, V247, P721, DOI 10.1126/science.2300824; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Gibson, 2001, ATTRACTION DISTRACTI, P77, DOI [DOI 10.1016/S0166-4115(01)80006-6, 10.1016/S0166-4115(01)80006-6]; HILLSTROM AP, 1994, PERCEPT PSYCHOPHYS, V55, P399, DOI 10.3758/BF03205298; Ho CE, 1998, P NATL ACAD SCI USA, V95, P400, DOI 10.1073/pnas.95.1.400; Jolic&OELIG;ur P., 2001, LIMITS ATTENTION, P82; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; JULESZ B, 1984, DYNAMIC ASPECTS NEOC, P585; Kawahara J, 1999, INVEST OPHTHALMOL, V40, pS259; KELLY DH, 1977, OPT ACTA, V24, P107, DOI 10.1080/713819495; Kinsbourne M, 1989, HUMAN SKILLS, P65; LANDY MS, 1991, VISION RES, V31, P679, DOI 10.1016/0042-6989(91)90009-T; Lee DK, 1999, PERCEPT PSYCHOPHYS, V61, P1241, DOI 10.3758/BF03206177; Leonard CJ, 2008, VIS COGN, V16, P1078, DOI 10.1080/13506280701580698; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Neisser U., 1967, COGNITIVE PSYCHOL; NOTHDURFT HC, 1991, VISION RES, V31, P1073, DOI 10.1016/0042-6989(91)90211-M; Nothdurft HC, 1999, VISION RES, V39, P2305, DOI 10.1016/S0042-6989(99)00006-1; Pashler H., 1997, PSYCHOL ATTENTION; POTTER MC, 1969, J EXP PSYCHOL, V81, P10, DOI 10.1037/h0027470; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; SAGI D, 1990, VISION RES, V30, P1377, DOI 10.1016/0042-6989(90)90011-9; Sharma G, 2003, EL EN AP SI, P1; Shih SI, 2007, SPATIAL VISION, V20, P301, DOI 10.1163/156856807780919019; Sperling G., 1986, HDB PERCEPTION PERFO, V1, P1; Theeuwes J, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P105; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; THEEUWES J, 1990, ACTA PSYCHOL, V74, P81, DOI 10.1016/0001-6918(90)90036-F; Theeuwes J, 2008, PSYCHON B REV, V15, P555, DOI 10.3758/PBR.15.3.555; Theeuwes J, 2006, VIS COGN, V14, P466, DOI 10.1080/13506280500195110; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Ward R, 1996, COGNITIVE PSYCHOL, V30, P79, DOI 10.1006/cogp.1996.0003; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 1999, VISION RES, V39, P2075, DOI 10.1016/S0042-6989(98)00260-0	52	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53093	10.1371/journal.pone.0053093	http://dx.doi.org/10.1371/journal.pone.0053093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308145	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100029
J	Holmquist, JG; Schmidt-Gengenbach, J; Haultain, SA				Holmquist, Jeffrey G.; Schmidt-Gengenbach, Jutta; Haultain, Sylvia A.			Effects of a Long-Term Disturbance on Arthropods and Vegetation in Subalpine Wetlands: Manifestations of Pack Stock Grazing in Early versus Mid-Season	PLOS ONE			English	Article							GRASSLAND INVERTEBRATES; SPECIES-DIVERSITY; MANAGEMENT; PLANT; TERRESTRIAL; ABUNDANCE; RESPONSES; PATCH; CONSERVATION; ASSEMBLAGES	Conclusions regarding disturbance effects in high elevation or high latitude ecosystems based solely on infrequent, long-term sampling may be misleading, because the long winters may erase severe, short-term impacts at the height of the abbreviated growing season. We separated a) long-term effects of pack stock grazing, manifested in early season prior to stock arrival, from b) additional pack stock grazing effects that might become apparent during annual stock grazing, by use of paired grazed and control wet meadows that we sampled at the beginning and end of subalpine growing seasons. Control meadows had been closed to grazing for at least two decades, and meadow pairs were distributed across Sequoia National Park, California, USA. The study was thus effectively a landscape-scale, long-term manipulation of wetland grazing. We sampled arthropods at these remote sites and collected data on associated vegetation structure. Litter cover and depth, percent bare ground, and soil strength had negative responses to grazing. In contrast, fauna showed little response to grazing, and there were overall negative effects for only three arthropod families. Mid-season and long-term results were generally congruent, and the only indications of lower faunal diversity on mid-season grazed wetlands were trends of lower abundance across morphospecies and lower diversity for canopy fauna across assemblage metrics. Treatment x Season interactions almost absent. Thus impacts on vegetation structure only minimally cascaded into the arthropod assemblage and were not greatly intensified during the annual growing season. Differences between years, which were likely a response to divergent snowfall patterns, were more important than differences between early and mid-season. Reliance on either vegetation or faunal metrics exclusively would have yielded different conclusions; using both flora and fauna served to provide a more integrative view of ecosystem response.	[Holmquist, Jeffrey G.; Schmidt-Gengenbach, Jutta] Univ Calif San Diego, White Mt Res Stn, Bishop, CA USA; [Haultain, Sylvia A.] Sequoia & Kings Canyon Natl Pk, Three Rivers, CA USA	University of California System; University of California San Diego	Holmquist, JG (corresponding author), Univ Calif Los Angeles, Inst Environm & Sustainabil, White Mt Res Ctr, Bishop, CA USA.	jholmquist@ucla.edu	Holmquist, Jeffrey G./H-3188-2011	Holmquist, Jeffrey G./0000-0003-3198-6338	National Park Service [J8R07080005]; NPS [J8C07100004, J8R07070006, J8R07030011]	National Park Service; NPS	This project was supported by the National Park Service (J8R07080005), and the current study built upon earlier work funded by the NPS (J8C07100004, J8R07070006, and J8R07030011); http://www.nps.gov/seki/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDRESEN H, 1990, VEGETATIO, V89, P137, DOI 10.1007/BF00032166; Baines M, 1998, ECOGRAPHY, V21, P74, DOI 10.1111/j.1600-0587.1998.tb00395.x; Bausell R.Barker., 2002, POWER ANAL EXPT RES; Bell JR, 2001, J ZOOL, V255, P377, DOI 10.1017/S0952836901001479; Bestelmeyer Brandon T., 2000, P122; Bestelmeyer BT, 1996, ECOL APPL, V6, P1225, DOI 10.2307/2269603; Bestelmeyer BT, 2001, ECOL APPL, V11, P1123, DOI 10.1890/1051-0761(2001)011[1123:ABISLM]2.0.CO;2; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Buckley R, 2004, ENV IMPACTS ECOTOURI, P383; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; Cole D. N., 2004, Environmental impacts of ecotourism, P41, DOI 10.1079/9780851998107.0041; Cole DN, 2004, J RANGE MANAGE, V57, P153, DOI 10.2307/4003913; Cole DN, 1998, J ENVIRON MANAGE, V53, P61, DOI 10.1006/jema.1998.0192; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; Cuffney TE, 2007, J N AM BENTHOL SOC, V26, P286, DOI 10.1899/0887-3593(2007)26[286:ATEOTC]2.0.CO;2; DAY TA, 1990, ECOLOGY, V71, P180, DOI 10.2307/1940258; Duffey E, 1974, GRASSLAND ECOLOGY WI; Elliott TL, 2011, ARCT ANTARCT ALP RES, V43, P198, DOI 10.1657/1938-4246-43.2.198; Fahrig L, 1998, ECOSYSTEMS, V1, P197, DOI 10.1007/s100219900015; Feber RE, 1996, J APPL ECOL, V33, P1191, DOI 10.2307/2404698; GIBSON CWD, 1992, ECOGRAPHY, V15, P166, DOI 10.1111/j.1600-0587.1992.tb00020.x; Hatfield RG, 2007, BIOL CONSERV, V139, P150, DOI 10.1016/j.biocon.2007.06.019; Hendricks HH, 2005, PLANT ECOL, V176, P19, DOI 10.1007/s11258-003-0009-6; Hoback WW, 1999, ENTOMOL EXP APPL, V91, P393, DOI 10.1023/A:1003667427454; HOLM S, 1979, SCAND J STAT, V6, P65; Holmquist JG, 2011, ARCT ANTARCT ALP RES, V43, P568, DOI 10.1657/1938-4246-43.4.568; Holmquist JG, 2011, BIOL CONSERV, V144, P518, DOI 10.1016/j.biocon.2010.10.007; Holmquist JG, 2010, WETLANDS, V30, P252, DOI 10.1007/s13157-010-0020-3; Holmquist JG, 1998, OIKOS, V81, P558, DOI 10.2307/3546776; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jones WM, 2011, BIOL CONSERV, V144, P511, DOI 10.1016/j.biocon.2010.10.005; Kelly Caroline L., 2003, Ecological Management & Restoration, V4, P37, DOI 10.1046/j.1442-8903.2003.00136.x; Kirk R., 2014, EXPT DESIGN PROCEDUR, DOI [10.4135/9781483384733, DOI 10.4135/9781483384733]; Kitti H, 2009, POLAR BIOL, V32, P253, DOI 10.1007/s00300-008-0526-9; Kohler F, 2006, LANDSCAPE ECOL, V21, P281, DOI 10.1007/s10980-005-0144-7; Kohler F, 2004, J VEG SCI, V15, P143, DOI 10.1111/j.1654-1103.2004.tb02249.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Kruess A, 2002, BIOL CONSERV, V106, P293, DOI 10.1016/S0006-3207(01)00255-5; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; LIVINGSTON RJ, 1987, ESTUARIES, V10, P194, DOI 10.2307/1351848; Longino John T., 2000, P186; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Majer JD, 1996, CONSERV BIOL, V10, P65, DOI 10.1046/j.1523-1739.1996.10010065.x; Marty JT, 2005, CONSERV BIOL, V19, P1626, DOI 10.1111/j.1523-1739.2005.00198.x; Mashiri FE, 2008, RANGELAND ECOL MANAG, V61, P368, DOI 10.2111/07-109.1; Mayr S, 2007, TUTOR QUANT METHODS, V3, P51, DOI 10.20982/tqmp.03.2.p051; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; MCCLARAN MP, 1989, RANGELANDS, V11, P3; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MILCHUNAS DG, 1995, OECOLOGIA, V101, P366, DOI 10.1007/BF00328824; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Monz CA, 2010, ENVIRON MANAGE, V45, P551, DOI 10.1007/s00267-009-9406-5; MORRIS MG, 1979, J APPL ECOL, V16, P77, DOI 10.2307/2402730; MORRIS MG, 1979, J APPL ECOL, V16, P417, DOI 10.2307/2402519; New TR, 1998, INVERTEBRATE SURVEYS; Newsome D., 2004, Environmental impacts of ecotourism, P61, DOI 10.1079/9780851998107.0061; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Oliver I, 1996, ECOL APPL, V6, P594, DOI 10.2307/2269394; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Olofsson J, 2006, J ECOL, V94, P431, DOI 10.1111/j.1365-2745.2006.01100.x; PASTOR J, 1993, ECOLOGY, V74, P467, DOI 10.2307/1939308; Peck J. E., 2010, MULTIVARIATE ANAL CO; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Pik AJ, 1999, AUST J ECOL, V24, P555, DOI 10.1046/j.1442-9993.1999.01003.x; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; Prieto-Benitez S, 2011, BIOL CONSERV, V144, P683, DOI 10.1016/j.biocon.2010.11.024; Ratkowsky David A., 2008, Australasian Mycologist, V27, P66; RICHARDS IR, 1975, J BRIT GRASSLAND SOC, V30, P187; Savage J, 2011, WETLANDS, V31, P125, DOI 10.1007/s13157-010-0133-8; Seymour CL, 1999, J ARID ENVIRON, V43, P267, DOI 10.1006/jare.1999.0552; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Southwood TRE, 2000, ECOLOGICAL METHODS; STOHLGREN TJ, 1989, ENVIRON MANAGE, V13, P485, DOI 10.1007/BF01867682; Strayer D, 1986, OCCAS PUBL I ECOSYST, V2; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Underwood AJ, 1997, EXPT ECOLOGY; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Waddle TJ, 2013, RIVER RES APPL, V29, P366, DOI 10.1002/rra.1607; WATSON AE, 1994, J LEISURE RES, V26, P372, DOI 10.1080/00222216.1994.11969968; Wettstein W, 1999, J APPL ECOL, V36, P363, DOI 10.1046/j.1365-2664.1999.00404.x; Wiens JA, 1997, OIKOS, V78, P257, DOI 10.2307/3546292; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; Williams DD., 2006, BIOL TEMPORARY WATER	87	16	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e54109	10.1371/journal.pone.0054109	http://dx.doi.org/10.1371/journal.pone.0054109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308297	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100128
J	Langridge, AT; Glasson, EJ; Nassar, N; Jacoby, P; Pennell, C; Hagan, R; Bourke, J; Leonard, H; Stanley, FJ				Langridge, Amanda T.; Glasson, Emma J.; Nassar, Natasha; Jacoby, Peter; Pennell, Craig; Hagan, Ronald; Bourke, Jenny; Leonard, Helen; Stanley, Fiona J.			Maternal Conditions and Perinatal Characteristics Associated with Autism Spectrum Disorder and Intellectual Disability	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; MENTAL-RETARDATION; RISK-FACTORS; WESTERN-AUSTRALIA; OBSTETRIC COMPLICATIONS; DEVELOPMENTAL-DISABILITIES; DIAGNOSTIC SUBSTITUTION; HEAD CIRCUMFERENCE; MEDICAL CONDITIONS; POPULATION COHORT	Background: As well as being highly comorbid conditions, autism spectrum disorders (ASD) and intellectual disability (ID) share a number of clinically-relevant phenomena. This raises questions about similarities and overlap in diagnosis and aetiological pathways that may exist for both conditions. Aims: To examine maternal conditions and perinatal factors for children diagnosed with an ASD, with or without ID, and children with ID of unknown cause, compared with unaffected children. Methods: The study population comprised all live singleton births in Western Australia (WA) between January 1984 and December 1999 (N = 383,153). Univariate and multivariate multinomial logistic regression models were applied using a blocked modelling approach to assess the effect of maternal conditions, sociodemographic factors, labour and delivery characteristics and neonatal outcomes. Results: In univariate analyses mild-moderate ID was associated with pregnancy hypertension, asthma, urinary tract infection, some types of ante-partum haemorrhage, any type of preterm birth, elective C-sections, breech presentation, poor fetal growth and need for resuscitation at birth, with all factors showing an increased risk. Severe ID was positively associated with poor fetal growth and need for resuscitation, as well as any labour or delivery complication. In the multivariate analysis no maternal conditions or perinatal factors were associated with an increased risk of ASD without ID. However, pregnancy hypertension and small head circumference were associated with a reduced risk (OR = 0.64, 95% CI: 0.43, 0.94; OR = 0.58, 95% CI: 0.34, 0.96, respectively). For ASD with ID, threatened abortion before 20 weeks gestation and poor fetal growth were associated with an increased risk. Conclusion: Findings show that indicators of a poor intrauterine environment are associated with an elevated risk of ID, while for ASD, and particularly ASD without ID, the associations are much weaker. As such, these findings highlight the importance of accounting for the absence or presence of ID when examining ASD, if we are to improve our understanding of the causal pathways associated with these conditions.	[Langridge, Amanda T.; Glasson, Emma J.; Nassar, Natasha; Jacoby, Peter; Bourke, Jenny; Leonard, Helen; Stanley, Fiona J.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Nassar, Natasha] Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2006, Australia; [Hagan, Ronald] Univ Western Australia, Sch Womens & Infants Hlth, Dept Neonatol, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia; University of Sydney; Kolling Institute of Medical Research; University of Western Australia	Langridge, AT (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	amandal@ichr.uwa.edu.au	Nassar, Natasha/K-3918-2019; Glasson, Emma/H-5339-2013; Pennell, Craig/ABD-6902-2020; Leonard, Helen/A-1010-2013	Glasson, Emma/0000-0003-3996-9049; Pennell, Craig/0000-0002-0937-6165; Leonard, Helen/0000-0001-6405-5834; , Emma/0000-0001-5547-8595; Nassar, Natasha/0000-0002-3720-9655	Australian National Health and Medical Research Council (NHMRC) [572742]; NHMRC [572568, 632955]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the Australian National Health and Medical Research Council (NHMRC, http://www.nhmrc.gov.au) Program Grant (572742), NHMRC Research Fellowship (572568 to HL) and NHMRC Career Development Fellowship (632955 to NN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baird G, 2000, J AM ACAD CHILD PSY, V39, P694, DOI 10.1097/00004583-200006000-00007; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Berger R, 2002, J SOC GYNECOL INVEST, V9, P319, DOI 10.1016/S1071-5576(02)00164-8; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bilder D, 2009, PEDIATRICS, V123, P1293, DOI 10.1542/peds.2008-0927; Blair E, 2005, BMC PEDIAT, V5; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Broman Sarah H, 1987, Public Health Rep, V102, P55; BRYSON SE, 1988, J AM ACAD CHILD PSY, V27, P418, DOI 10.1097/00004583-198807000-00006; Buchmayer S, 2009, PEDIATRICS, V124, pE817, DOI 10.1542/peds.2008-3582; Burstyn I, 2010, CHRONIC DIS CAN, V30, P125; Camp BW, 1998, EARLY HUM DEV, V50, P159, DOI 10.1016/S0378-3732(97)00034-9; Coo H, 2008, J AUTISM DEV DISORD, V38, P1036, DOI 10.1007/s10803-007-0478-x; Croen LA, 2002, J AUTISM DEV DISORD, V32, P217, DOI 10.1023/A:1015405914950; Croen LA, 2005, ARCH PEDIAT ADOL MED, V159, P151, DOI 10.1001/archpedi.159.2.151; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; Croen LA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e86; Croen LA, 2011, J NEURODEV DISORD, V3, P307, DOI 10.1007/s11689-011-9093-4; Crowther CA, 2003, JAMA-J AM MED ASSOC, V290, P2669, DOI 10.1001/jama.290.20.2669; Dammann O, 2002, MENT RETARD DEV D R, V8, P46, DOI 10.1002/mrdd.10005; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Department of Health and Aged Care, 2001, MEAS REM ACC REM IND; DEYKIN EY, 1980, AM J DIS CHILD, V134, P860, DOI 10.1001/archpedi.1980.02130210044012; Drews CD, 1996, PEDIATRICS, V97, P547; Eaton WW, 2001, J AUTISM DEV DISORD, V31, P279, DOI 10.1023/A:1010743203048; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Gardener H, 2011, PERINATAL NEONATAL R; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Gee V, 1994, VALIDATION STUDY W A; Gillberg C, 2002, DEV MED CHILD NEUROL, V44, P296; GILLBERG C, 1983, J AUTISM DEV DISORD, V13, P153, DOI 10.1007/BF01531816; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Glasson EJ, 2008, MED J AUSTRALIA, V188, P288, DOI 10.5694/j.1326-5377.2008.tb01623.x; HAGBERG B, 1983, BRAIN DEV-JPN, V5, P441, DOI 10.1016/S0387-7604(83)80072-2; Hallmayer J, 2011, ARCH GEN PSYCHIAT AR, V2011, P2076; Heber R, 1961, AM J MENTAL DEFICIEN, V64; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Hornig M, 2001, MENT RETARD DEV D R, V7, P200, DOI 10.1002/mrdd.1028; Hou JW, 1998, J INTELL DISABIL RES, V42, P137, DOI 10.1046/j.1365-2788.1998.00104.x; Huleihel Mahmoud, 2004, Reprod Biol Endocrinol, V2, P17, DOI 10.1186/1477-7827-2-17; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; JONAS O, 1989, EUR J EPIDEMIOL, V5, P322, DOI 10.1007/BF00144832; Juul-Dam N, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e63; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Leonard H, 2005, SOC SCI MED, V60, P1499, DOI 10.1016/j.socscimed.2004.08.014; Leonard H, 2008, AM J EPIDEMIOL, V167, P103, DOI 10.1093/aje/kwm245; Leonard H, 2006, ANN EPIDEMIOL, V16, P448, DOI 10.1016/j.annepidem.2005.05.002; Leonard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017875; Leonard H, 2010, RES AUTISM SPECT DIS, V4, P548, DOI 10.1016/j.rasd.2010.01.003; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Mann JR, 2010, J AUTISM DEV DISORD, V40, P548, DOI 10.1007/s10803-009-0903-4; McDermott S, 2000, OBSTET GYNECOL, V96, P113, DOI 10.1016/S0029-7844(00)00823-1; McDermott S, 2001, J FAM PRACTICE, V50, P433; McElrath TF, 2008, AM J EPIDEMIOL, V168, P980, DOI 10.1093/aje/kwn202; MERVIS CA, 1995, PAEDIATR PERINAT EP, V9, P455, DOI 10.1111/j.1365-3016.1995.tb00168.x; Murphy CC, 1998, MENT RETARD DEV D R, V4, P6, DOI 10.1002/(SICI)1098-2779(1998)4:1<6::AID-MRDD3>3.0.CO;2-P; Nassar N, 2009, INT J EPIDEMIOL, V38, P1245, DOI 10.1093/ije/dyp260; O'Roak BJ, 2008, AUTISM RES, V1, P4, DOI 10.1002/aur.3; Petterson B, 2005, ANN HUM BIOL, V32, P237, DOI 10.1080/03014460500075035; Pink B, 2008, SOCIOECONOMIC INDEXE; Pink B., 2006, INFORM PAPER INTRO S; Rapin I, 1997, NEW ENGL J MED, V337, P97, DOI 10.1056/NEJM199707103370206; ROELEVELD N, 1992, PREV MED, V21, P110, DOI 10.1016/0091-7435(92)90010-F; SALONEN JT, 1984, J MENT DEFIC RES, V28, P53; Schieve LA, 2012, RES DEV DISABIL, V33, P467, DOI 10.1016/j.ridd.2011.10.008; Shattuck PT, 2006, PEDIATRICS, V117, P1028, DOI 10.1542/peds.2005-1516; StataCorp, 2021, STATA STAT SOFTWARE; STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x; Stromme P, 2000, DEV MED CHILD NEUROL, V42, P76, DOI 10.1017/S0012162200000165; Sussmann JE, 2009, BRIT J PSYCHIAT, V194, P224, DOI 10.1192/bjp.bp.106.033134; TAYLOR DJ, 1985, LANCET, V1, P713; Tuovinen S, 2011, ANN MED, V15, P15; VanderWeele TJ, 2012, EPIDEMIOLOGY, V23, P1, DOI 10.1097/EDE.0b013e31823aca5d; Volkmar FR, 2009, J CHILD PSYCHOL PSYC, V50, P108, DOI 10.1111/j.1469-7610.2008.02010.x; Whitehouse AJO, 2011, J AUTISM DEV DISORD, V41, P122, DOI 10.1007/s10803-010-1019-6; Williams K, 2008, CHILD CARE HLTH DEV, V34, P249, DOI 10.1111/j.1365-2214.2007.00796.x; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; YearginAllsopp M, 1997, DEV MED CHILD NEUROL, V39, P142	84	82	86	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e50963	10.1371/journal.pone.0050963	http://dx.doi.org/10.1371/journal.pone.0050963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308096	Green Published, gold			2022-12-27	WOS:000313429100004
J	Vivo, M; Ranieri, M; Sansone, F; Santoriello, C; Calogero, RA; Calabro, V; Pollice, A; La Mantia, G				Vivo, Maria; Ranieri, Michela; Sansone, Federica; Santoriello, Cristina; Calogero, Raffaele A.; Calabro, Viola; Pollice, Alessandra; La Mantia, Girolama			Mimicking p14ARF Phosphorylation Influences Its Ability to Restrain Cell Proliferation	PLOS ONE			English	Article							PROTEIN-KINASE-C; ARF TUMOR-SUPPRESSOR; ONCOGENIC STRESS; PKC-ALPHA; P53; P14(ARF); APOPTOSIS; MDM2; STABILIZATION; DEGRADATION	The INK4a/ARF locus on the short arm of chromosome 9 is one of the most frequently altered loci in human cancer. It is generally accepted that ARF is involved in oncogenic checkpoint pathways by sensitizing incipient cancer cells to undergo growth arrest or apoptosis through both p53-dependent and independent pathways. While intensive studies have been focused on ARF activation at the transcriptional level, only recently mechanisms governing ARF turnover have been identified. Here, we show for the first time that p14ARF is a PKC target. Prediction analysis showed many potential phosphorylation sites in PKC consensus sequences within ARF protein, and, among them, the threonine at position 8 was the most conserved. Substitution of this threonine influences both ARF stability and localization. Furthermore, a phosphomimetic ARF mutation reduces the ability to arrest cell growth although the ability to bind MDM2 and stabilize p53 result unaffected. Thus we propose that phosphorylation of ARF in both immortalized and tumor cell lines could be a mechanism to escape ARF surveillance following proliferative and oncogenic stress.	[Vivo, Maria; Ranieri, Michela; Sansone, Federica; Calabro, Viola; Pollice, Alessandra; La Mantia, Girolama] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy; [Santoriello, Cristina] Harvard Univ, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Calogero, Raffaele A.] Univ Turin, Dept Comp Sci, Turin, Italy	University of Naples Federico II; Harvard University; University of Turin	Vivo, M (corresponding author), Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy.	maria.vivo@unina.it; lamantia@unina.it	Calabro, Viola/H-6156-2013; Calogero, Raffaele/K-9428-2019; Vivo, Maria/S-3390-2017	Calogero, Raffaele/0000-0002-2848-628X; Vivo, Maria/0000-0003-2458-4226; Calabro, Viola/0000-0002-6508-8889; Ranieri, Michela/0000-0002-3833-3594	PRIN (Programmi di ricerca di Rilevante Interesse Nazionale); AIRC (Associazione Italiana Ricerca sul Cancro)	PRIN (Programmi di ricerca di Rilevante Interesse Nazionale); AIRC (Associazione Italiana Ricerca sul Cancro)	This work was supported by grants awarded to GLM from PRIN (Programmi di ricerca di Rilevante Interesse Nazionale) and AIRC (Associazione Italiana Ricerca sul Cancro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bosco R, 2011, MINI-REV MED CHEM, V11, P185, DOI 10.2174/138955711795049899; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Calabro V, 1999, ONCOGENE, V18, P2157, DOI 10.1038/sj.onc.1202532; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; Colucci-D'Amato GL, 2000, J BIOL CHEM, V275, P19306, DOI 10.1074/jbc.275.25.19306; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; del Arroyo AG, 2007, CELL CYCLE, V6, P2697; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P149; Di Costanzo A, 2009, CELL CYCLE, V8, P1185, DOI 10.4161/cc.8.8.8202; di Tommaso A, 2009, EXP CELL RES, V315, P1326, DOI 10.1016/j.yexcr.2009.01.010; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Fagerstrom S, 1996, CELL GROWTH DIFFER, V7, P775; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hashemi J, 2002, CANCER LETT, V180, P211, DOI 10.1016/S0304-3835(02)00027-7; Herkert B, 2010, J CELL BIOL, V188, P905, DOI 10.1083/jcb.200908103; Inoue R, 2005, BIOCHEM BIOPH RES CO, V330, P1314, DOI 10.1016/j.bbrc.2005.03.117; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Jerome-Morais A, 2009, J INVEST DERMATOL, V129, P2365, DOI 10.1038/jid.2009.74; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Muniz VP, 2011, MOL CANCER RES, V9, P867, DOI 10.1158/1541-7786.MCR-10-0475; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pollice A, 2007, ONCOGENE, V26, P5154, DOI 10.1038/sj.onc.1210313; Pollice A, 2004, J BIOL CHEM, V279, P6345, DOI 10.1074/jbc.M310957200; Pollice A, 2008, FEBS LETT, V582, P3257, DOI 10.1016/j.febslet.2008.09.026; Popov N, 2010, EPIGENETICS-US, V5, P685, DOI 10.4161/epi.5.8.12996; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Rodriguez IP, 2004, REV ONCOL, V6, P7; Rodway H, 2004, ONCOGENE, V23, P6186, DOI 10.1038/sj.onc.1207854; Shen J, 2011, BIOCHEM J, V434, P275, DOI 10.1042/BJ20101163; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shimao Y, 1999, CLIN EXP METASTAS, V17, P351; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Taneja P, 2007, ONCOGENE, V26, P7457, DOI 10.1038/sj.onc.1210568; Vivo M, 2001, J BIOL CHEM, V276, P14161, DOI 10.1074/jbc.M006845200; Vivo M, 2009, CELL CYCLE, V8, P3545, DOI 10.4161/cc.8.21.9954; Wang S, 2010, FEBS LETT, V584, P3909, DOI 10.1016/j.febslet.2010.08.015; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Wheeler DL, 2005, AM J PATHOL, V166, P117, DOI 10.1016/S0002-9440(10)62237-7; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	55	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53631	10.1371/journal.pone.0053631	http://dx.doi.org/10.1371/journal.pone.0053631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308265	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100098
J	Fang, F; Sun, HY; Zhao, Q; Lin, CT; Sun, YF; Gao, W; Xu, JJ; Zhou, JY; Ge, F; Liu, NF				Fang, Fang; Sun, Hongying; Zhao, Qiang; Lin, Congtian; Sun, Yufang; Gao, Wei; Xu, Juanjuan; Zhou, Junying; Ge, Feng; Liu, Naifa			Patterns of Diversity, Areas of Endemism, and Multiple Glacial Refuges for Freshwater Crabs of the Genus Sinopotamon in China (Decapoda: Brachyura: Potamidae)	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; PARSIMONY ANALYSIS; HISTORICAL BIOGEOGRAPHY; SPECIES DISTRIBUTIONS; ENVIRONMENTAL NICHE; PLANT DIVERSITY; PHYLOGEOGRAPHY; CONSERVATION; BIODIVERSITY; REGION	Previous research has shown that the geographical distribution patterns of freshwater fishes and amphibians have been influenced by past climatic oscillations in China resulting from Pleistocene glacial activity. However, it remains unknown how these past changes have impacted the present-day distribution of Chinese freshwater crabs. This work describes the diversity and endemism of freshwater crabs belonging to Sinopotamon, a highly speciose genus endemic to China, and evaluates its distribution in terms of topography and past climatic fluctuations. Species diversity within Sinopotamon was found to be concentrated in an area from the northeastern edge of the Yunnan-Guizhou Plateau to the Jiangnan Hills, and three areas of endemism were identified. Multiple regression analysis between current climatic variables and Sinopotamon diversity suggested that regional annual precipitation, minimum temperature in the coldest month, and annual temperature range significantly influenced species diversity and may explain the diversity patterns of Sinopotamon. A comparison of ecological niche models (ENMs) between current conditions and the last glacial maximum (LGM) showed that suitable habitat for Sinopotamon in China severely contracted during the LGM. The coincidence of ENMs and the areas of endemism indicated that southeast of the Daba Mountains, and central and southeastern China, are potential Pleistocene refuges for Sinopotamon. The presence of multiple Pleistocene refuges within the range of this genus could further promote inter- and intraspecific differentiations, and may have led to high Sinopotamon species diversity, a high endemism rate and widespread distribution.	[Fang, Fang; Sun, Hongying; Sun, Yufang; Xu, Juanjuan] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Lin, Congtian] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhou, Junying; Ge, Feng] Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Liu, Naifa] Lanzou Univ, Sch Life Sci, Lanzhou, Peoples R China	Nanjing Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS	Sun, HY (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	sunhongying@njnu.edu.cn			National Natural Science Foundation of China [31071902]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Environmental Protection Public Welfare Science and Technology Research Program of China [201009033]; Nanjing Normal University Innovative Team Project [0319PM0902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; National Environmental Protection Public Welfare Science and Technology Research Program of China; Nanjing Normal University Innovative Team Project	This work was supported by grants from the National Natural Science Foundation of China (31071902) and the Priority Academic Program Development of Jiangsu Higher Education Institutions to SHY; the National Environmental Protection Public Welfare Science and Technology Research Program of China (201009033) to ZJY & GF; and Nanjing Normal University Innovative Team Project (0319PM0902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg M.R., 1973, CLUSTER ANAL APPL; [Anonymous], 2011, R LANG ENV STAT COMP; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; BIRNBAUM ZW, 1951, ANN MATH STAT, V22, P592, DOI 10.1214/aoms/1177729550; Brooks DR, 2003, J BIOGEOGR, V30, P819, DOI 10.1046/j.1365-2699.2003.00848.x; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Chambers J.M., 1992, LINEAR MODELS; Chang J, 1980, HENAN J PREVENTIVE M, V4, P41; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Chen G.-x., 1980, Acta Zootaxonomica Sinica, V5, P256; Chen L, 2008, PROG NAT SCI, V18, P833, DOI 10.1016/j.pnsc.2008.02.004; Chen Ling, 2004, Zoological Research, V25, P369; Chen YY, 2001, PROG NAT SCI, V11, P411; Cheng Youzhu, 1998, Wuyi Science Journal, V14, P21; Cheng Youzhu, 1998, Wuyi Science Journal, V14, P18; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; CRACRAFT J, 1991, Australian Systematic Botany, V4, P211, DOI 10.1071/SB9910211; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Cumberlidge N, 2011, INTEGR ZOOL, V6, P45, DOI 10.1111/j.1749-4877.2010.00228.x; Cumberlidge N, 2009, BIOL CONSERV, V142, P1665, DOI 10.1016/j.biocon.2009.02.038; DAI A, 1979, Acta Zoologica Sinica, V25, P243; Dai A.-y., 1979, Acta Zootaxonomica Sinica, V4, P122; Dai A.-y., 1986, Sinozoologia, V4, P55; DAI A-Y, 1975, Acta Zoologica Sinica, V21, P257; DAI A-Y, 1988, Acta Zootaxonomica Sinica, V13, P127; DAI AY, 1981, ACTA ZOOL SINICA, V27, P172; Dai AY., 1999, FAUNA SINICA ARTHROP; Dai AY, 1977, CHINESE J ZOOLOGY, V1, P29; Dai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029329; Debandi G, 2012, AUSTRAL ECOL, V37, P392, DOI 10.1111/j.1442-9993.2011.02295.x; Ding R., 1994, FISHES SICHUAN; Dobson M, 2007, FUND APPL LIMNOL, V168, P271, DOI 10.1127/1863-9135/2007/0168-0271; Dobson M, 2007, FRESHWATER BIOL, V52, P215, DOI 10.1111/j.1365-2427.2006.01648.x; Du Nanshan, 1981, Oceanologia et Limnologia Sinica, V12, P80; Du NS, 1979, J SHANGHAI NORMAL U, V1, P106; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fattorini S, 2002, J BIOGEOGR, V29, P49, DOI 10.1046/j.1365-2699.2002.00656.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Fox J., 2018, R COMPANION APPL REG, VThird; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; GHERARDI F, 1987, Investigacion Pesquera (Barcelona), V51, P389; Glasby CJ, 1999, J BIOGEOGR, V26, P507, DOI 10.1046/j.1365-2699.1999.00297.x; Gu XH, 1986, CHINESE J ZOOLOGY, V4, P22; HASUMI H, 2004, 1 U TOK CTR CLIM SYS; Hausdorf B, 2002, SYST BIOL, V51, P648, DOI 10.1080/10635150290102320; He PY, 1994, QUATERNARY SEDIMENTA; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Huang XL, 2008, J BIOGEOGR, V35, P230, DOI 10.1111/j.1365-2699.2007.01776.x; Huang XL, 2006, ECOL ENTOMOL, V31, P608, DOI 10.1111/j.1365-2311.2006.00819.x; Huang ZH, 2010, MOL PHYLOGENET EVOL, V56, P273, DOI 10.1016/j.ympev.2010.01.028; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; Institute oZiS, 1987, FISH QINL; IUCN (World Conservation Union), 2001, IUCN RED LIST CAT VE; Jesse R, 2011, MOL PHYLOGENET EVOL, V59, P23, DOI 10.1016/j.ympev.2010.12.011; Jezkova T, 2009, J MAMMAL, V90, P306, DOI 10.1644/08-MAMM-A-243.1; Kent M, 2006, PROG PHYS GEOG, V30, P399, DOI 10.1191/0309133306pp489pr; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Legendre L, 1983, NUMERICAL ECOLOGY; Lei FM, 2003, BIODIVERS CONSERV, V12, P239, DOI 10.1023/A:1021928801558; Lei FM, 2007, BIODIVERS CONSERV, V16, P1119, DOI 10.1007/s10531-006-9080-3; Li J. J., 1999, MAR GEOL Q GEOL, V19, P1; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Linder HP, 2001, SYST BIOL, V50, P892, DOI 10.1080/106351501753462867; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; Liu Huan-Zhang, 1998, Acta Zootaxonomica Sinica, V23, P10; Liu M.G., 2010, ATLAS PHYS GEOGRAPHY, V3rd ed.; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i18, DOI 10.18637/JSS.V008.I18]; McAllister Don E., 1994, P155; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Morrone JJ, 2005, J BIOGEOGR, V32, P1281, DOI 10.1111/j.1365-2699.2005.01279.x; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; Morrone JJ, 2002, J BIOGEOGR, V29, P1095, DOI 10.1046/j.1365-2699.2002.00753.x; MORRONE JJ, 1995, ANNU REV ECOL SYST, V26, P373, DOI 10.1146/annurev.es.26.110195.002105; Morrone Juan J., 2001, Diversity and Distributions, V7, P297, DOI 10.1046/j.1366-9516.2001.00116.x; Murtagh F., 1985, MULTIDIMENSIONAL CLU; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naruse T, 2008, ZOOTAXA, P49, DOI 10.11646/zootaxa.1812.1.3; Nelson G., 1981, SYSTEMATICS BIOGEOGR; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; Quijano-Abril MA, 2006, J BIOGEOGR, V33, P1266, DOI 10.1111/j.1365-2699.2006.01501.x; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Revenga C, 2005, PHILOS T ROY SOC B, V360, P397, DOI 10.1098/rstb.2004.1595; Rosen BR, 1988, FOSSILS EARTH HIST A, P437; Samyn Y, 2005, J BIOGEOGR, V32, P1523, DOI 10.1111/j.1365-2699.2005.01295.x; Santos CMD, 2005, J BIOGEOGR, V32, P1284, DOI 10.1111/j.1365-2699.2005.01269.x; Nihei SS, 2006, J BIOGEOGR, V33, P2099, DOI 10.1111/j.1365-2699.2006.01619.x; Shih HT, 2011, SYST BIODIVERS, V9, P1, DOI 10.1080/14772000.2011.554457; Smith B T, 1976, LECT NOTES COMPUTER; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Somers MJ, 1998, S AFR J ZOOL, V33, P31; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAI A-Y, 1975, Acta Zoologica Sinica, V21, P169; Tian B, 2009, J BIOGEOGR, V36, P2148, DOI 10.1111/j.1365-2699.2009.02157.x; Tribsch A, 2004, J BIOGEOGR, V31, P747, DOI 10.1111/j.1365-2699.2004.01065.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Wang JA, 2007, CHINESE GEOGRAPHY TU; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; WILKINSON GN, 1973, ROY STAT SOC C-APP, V22, P392; Wilkinson JH, 1965, ALGEBRAIC EIGENVALUE; WILLIAMS TR, 1962, ANN TROP MED PARASIT, V56, P362, DOI 10.1080/00034983.1962.11686133; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; Yang Yu-Hui, 2004, Acta Zoologica Sinica, V50, P193; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21; Zhang R. Z., 1999, ZOOGEOGRAPHY CHINA; Zhang Xiong-Fei, 2004, Acta Genetica Sinica, V31, P1232; ZHAO J, 1990, NATURAL HIST CHINA; Zhu C, 2003, GLOBAL CHANGE SCI; Zou JX, 2008, CRUSTACEANA, V81, P1381, DOI 10.1163/156854008X361076	121	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53143	10.1371/journal.pone.0053143	http://dx.doi.org/10.1371/journal.pone.0053143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308152	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100021
J	Lacourpaille, L; Hug, F; Nordez, A				Lacourpaille, Lilian; Hug, Francois; Nordez, Antoine			Influence of Passive Muscle Tension on Electromechanical Delay in Humans	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; HUMAN SKELETAL-MUSCLE; ELBOW FLEXOR MUSCLES; GASTROCNEMIUS-MUSCLE; ANKLE JOINT; FORCE TRANSMISSION; ELASTIC PROPERTIES; STIFFNESS; LENGTH	Background: Electromechanical delay is the time lag between onsets of muscle activation and muscle force production and reflects both electro-chemical processes and mechanical processes. The aims of the present study were two-fold: to experimentally determine the slack length of each head of the biceps brachii using elastography and to determine the influence of the length of biceps brachii on electromechanical delay and its electro-chemical/mechanical processes using very high frame rate ultrasound. Methods/Result: First, 12 participants performed two passive stretches to evaluate the change in passive tension for each head of the biceps brachii. Then, they underwent two electrically evoked contractions from 120 to 20 degrees of elbow flexion (0 degrees: full extension), with the echographic probe maintained over the muscle belly and the myotendinous junction of biceps brachii. The slack length was found to occur at 95.5 +/- 6.3 degrees and 95.3 +/- 8.2 degrees of the elbow joint angle for the long and short heads of the biceps brachii, respectively. The electromechanical delay was significantly longer at 120 degrees (16.9 +/- 3.1 ms; p<0.001), 110 degrees (15.0 +/- 3.1 ms; p<0.001) and 100 degrees (12.7 +/- 2.5 ms; p = 0.01) of elbow joint angle compared to 90 degrees (11.1 +/- 1.7 ms). However, the delay between the onset of electrical stimulation and the onset of both muscle fascicles (3.9 +/- 0.2 ms) and myotendinous junction (3.7 +/- 0.3 ms) motion was not significantly affected by the joint angle (p>0.95). Conclusion: In contrast to previous observations on gastrocnemius medialis, the onset of muscle motion and the onset of myotendinous junction motion occurred simultaneously regardless of the length of the biceps brachii. That suggests that the between-muscles differences reported in the literature cannot be explained by different muscle passive tension but instead may be attributable to muscle architectural differences.	[Lacourpaille, Lilian; Hug, Francois; Nordez, Antoine] Univ Nantes, Lab Motricite Interact Performance, EA 4334, Nantes, France	Nantes Universite	Hug, F (corresponding author), Univ Nantes, Lab Motricite Interact Performance, EA 4334, Nantes, France.	francois.hug@univ-nantes.fr	Hug, François/AAV-2415-2020	Hug, François/0000-0002-6432-558X; Lacourpaille, Lilian/0000-0002-9664-8121	European Regional Development Fund (ERDF) [37400]; Association Francaise contre les Myopathie (AFM) [14597]; Region des Pays de la Loire	European Regional Development Fund (ERDF)(European Commission); Association Francaise contre les Myopathie (AFM)(Association Francaise contre les Myopathies); Region des Pays de la Loire(Region Pays de la Loire)	This study was supported by grants from the European Regional Development Fund (ERDF, number 37400), the Association Francaise contre les Myopathie (AFM number 14597) and the Region des Pays de la Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland DC, 2012, J BIOMECH, V45, P1463, DOI 10.1016/j.jbiomech.2012.02.023; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Catheline S, 1999, J ACOUST SOC AM, V105, P2941, DOI 10.1121/1.426907; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; CAVANAGH PR, 1979, EUR J APPL PHYSIOL, V42, P159, DOI 10.1007/BF00431022; De Groote F, 2010, J BIOMECH, V43, P1876, DOI 10.1016/j.jbiomech.2010.03.022; Debernard L, 2011, CLIN BIOMECH, V26, P836, DOI 10.1016/j.clinbiomech.2011.04.004; Deffieux T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2378616; Deffieux T, 2008, IEEE T ULTRASON FERR, V55, P2177, DOI 10.1109/TUFFC.917; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T; Gajdosik RL, 2001, CLIN BIOMECH, V16, P87, DOI 10.1016/S0268-0033(00)00061-9; Hoang PD, 2005, J BIOMECH, V38, P1333, DOI 10.1016/j.jbiomech.2004.05.046; Hug F, 2011, MUSCLE NERVE, V43, P441, DOI 10.1002/mus.21948; Lacourpaille L, J ELECTROMY IN PRESS; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Maas H, 2001, J BIOMECH, V34, P927, DOI 10.1016/S0021-9290(01)00055-0; Maas H, 2008, J APPL PHYSIOL, V104, P1557, DOI 10.1152/japplphysiol.01208.2007; Magnusson SP, 1998, SCAND J MED SCI SPOR, V8, P65; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Martin A, 1996, EUR J APPL PHYSIOL, V73, P157, DOI 10.1007/BF00262825; McNair PJ, 2002, CLIN BIOMECH, V17, P536, DOI 10.1016/S0268-0033(02)00062-1; McNair PJ, 2001, MED SCI SPORT EXER, V33, P354, DOI 10.1097/00005768-200103000-00003; MORITANI T, 1987, EUR J APPL PHYSIOL O, V56, P30, DOI 10.1007/BF00696372; Muraoka T, 2004, J APPL PHYSIOL, V96, P540, DOI 10.1152/japplphysiol.01015.2002; Muro M., 1985, BIOMECHANICS A, P86; Murray WM, 2000, J BIOMECH, V33, P943, DOI 10.1016/S0021-9290(00)00051-8; Nordez A, 2008, J BIOMECH, V41, P2305, DOI 10.1016/j.jbiomech.2008.03.033; Nordez A, 2008, INT J SPORTS MED, V29, P414, DOI 10.1055/s-2007-964980; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Nordez A, 2009, J APPL PHYSIOL, V106, P1970, DOI 10.1152/japplphysiol.00221.2009; Riemann BL, 2001, J ATHL TRAINING, V36, P369; Sasaki K, 2011, MED SCI SPORT EXER, V43, P1200, DOI 10.1249/MSS.0b013e318209312c; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Tian M, J APPL PHYS IN PRESS; Valour D, 2003, PFLUG ARCH EUR J PHY, V445, P721, DOI 10.1007/s00424-002-0871-4	35	43	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53159	10.1371/journal.pone.0053159	http://dx.doi.org/10.1371/journal.pone.0053159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308153	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100022
J	Li, HR; Olson, M; Lin, GF; Hey, T; Tan, SY; Narva, KE				Li, Huarong; Olson, Monica; Lin, Gaofeng; Hey, Timothy; Tan, Sek Yee; Narva, Kenneth E.			Bacillus thuringiensis Cry34Ab1/Cry35Ab1 Interactions with Western Corn Rootworm Midgut Membrane Binding Sites	PLOS ONE			English	Article							LARVAL MIDGUT; AMINOPEPTIDASE N; DELTA-ENDOTOXIN; TOXIN; RESISTANCE; COLEOPTERA; CADHERIN; SUSCEPTIBILITY; IDENTIFICATION; CHRYSOMELIDAE	Background: Bacillus thuringiensis (Bt) Cry34Ab1/Cry35Ab1 are binary insecticidal proteins that are co-expressed in transgenic corn hybrids for control of western corn rootworm, Diabrotica virgifera virgifera LeConte. Bt crystal (Cry) proteins with limited potential for field-relevant cross-resistance are used in combination, along with non-transgenic corn refuges, as a strategy to delay development of resistant rootworm populations. Differences in insect midgut membrane binding site interactions are one line of evidence that Bt protein mechanisms of action differ and that the probability of receptor-mediated cross-resistance is low. Methodology/Principal Findings: Binding site interactions were investigated between Cry34Ab1/Cry35Ab1 and coleopteran active insecticidal proteins Cry3Aa, Cry6Aa, and Cry8Ba on western corn rootworm midgut brush border membrane vesicles (BBMV). Competitive binding of radio-labeled proteins to western corn rootworm BBMV was used as a measure of shared binding sites. Our work shows that I-125-Cry35Ab1 binds to rootworm BBMV, Cry34Ab1 enhances I-125-Cry35Ab1 specific binding, and that I-125-Cry35Ab1 with or without unlabeled Cry34Ab1 does not share binding sites with Cry3Aa, Cry6Aa, or Cry8Ba. Two primary lines of evidence presented here support the lack of shared binding sites between Cry34Ab1/Cry35Ab1 and the aforementioned proteins: 1) No competitive binding to rootworm BBMV was observed for competitor proteins when used in excess with I-125-Cry35Ab1 alone or combined with unlabeled Cry34Ab1, and 2) No competitive binding to rootworm BBMV was observed for unlabeled Cry34Ab1 and Cry35Ab1, or a combination of the two, when used in excess with I-125-Cry3Aa, or I-125-Cry8Ba. Conclusions/Significance: Combining two or more insecticidal proteins active against the same target pest is one tactic to delay the onset of resistance to either protein. We conclude that Cry34Ab1/Cry35Ab1 are compatible with Cry3Aa, Cry6Aa, or Cry8Ba for deployment as insect resistance management pyramids for in-plant control of western corn rootworm.	[Li, Huarong; Olson, Monica; Lin, Gaofeng; Hey, Timothy; Tan, Sek Yee; Narva, Kenneth E.] Dow AgroSci LLC, Indianapolis, IN USA	Dow Chemical Company	Narva, KE (corresponding author), Dow AgroSci LLC, Indianapolis, IN USA.	knarva@dow.com		Narva, Kenneth/0000-0001-8094-6418				Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; CARROLL J, 1989, BIOCHEM J, V261, P99, DOI 10.1042/bj2610099; Charles JF, 1997, FEMS MICROBIOL LETT, V156, P153, DOI 10.1016/S0378-1097(97)00419-9; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Drees BM, 1999, HDB CORN INSECTS, P66; Ellis RT, 2002, APPL ENVIRON MICROB, V68, P1137, DOI 10.1128/AEM.68.3.1137-1145.2002; Fabrick J, 2009, J BIOL CHEM, V284, P18401, DOI 10.1074/jbc.M109.001651; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Li HR, 2004, BIOCHEM BIOPH RES CO, V323, P52, DOI 10.1016/j.bbrc.2004.08.054; Li HR, 2004, INSECT BIOCHEM MOLEC, V34, P753, DOI 10.1016/j.ibmb.2004.03.010; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Masson L, 2004, BIOCHEMISTRY-US, V43, P12349, DOI 10.1021/bi048946z; Metcalf R. L., 1986, METHODS STUDY PEST D, pvii; Michaels T.E., 1996, U.S. Patent, Patent No. [5,554,534 A, 5554534, 5,554,534]; Moellenbeck DJ, 2001, NAT BIOTECHNOL, V19, P668, DOI 10.1038/90282; NARVA KE, 2002, Patent No. 6372480; Narva KE, 1993, US patent, Patent No. [5186934, 5,186,934]; O'Neal ME, 1999, J ECON ENTOMOL, V92, P1301, DOI 10.1093/jee/92.6.1301; Ochoa-Campuzano C, 2007, BIOCHEM BIOPH RES CO, V362, P437, DOI 10.1016/j.bbrc.2007.07.197; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Sayed A, 2007, INSECT MOL BIOL, V16, P591, DOI 10.1111/j.1365-2583.2007.00755.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schnepf H. E., 2007, US Patent, Patent No. [7,309,785, 7309785]; Schnepf HE, 2009, US patent, Patent No. 7524810; Siegfried BD, 2005, J ECON ENTOMOL, V98, P1320, DOI 10.1603/0022-0493-98.4.1320; Song P, 2012, J INVERTEBR PATHOL, V109, P318, DOI 10.1016/j.jip.2012.01.009; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Thomson M., 1999, U.S. Patent, Patent No. [5,874,288 A, 5874288]; United States Environmental Protection Agency, 2003, EPA PUBL; US Environmental Protection Agency, CURR PREV REG SECT 3; (US EPA) U. S. Environmental Protection Agency, 1998, ENV PROT AG WHIT PAP; US EPA (U.S. Environmental Protection Agency), 2001, BIOP REG ACT DOC BAC; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Walters FS, 2008, APPL ENVIRON MICROB, V74, P367, DOI 10.1128/AEM.02165-07; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Wright RJ, 2000, J ECON ENTOMOL, V93, P7, DOI 10.1603/0022-0493-93.1.7; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001	46	36	43	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53079	10.1371/journal.pone.0053079	http://dx.doi.org/10.1371/journal.pone.0053079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308139	gold, Green Published, Green Submitted			2022-12-27	WOS:000313670100016
J	Tam, JKV; Chow, BKC; Lee, LTO				Tam, Janice K. V.; Chow, Billy K. C.; Lee, Leo T. O.			Structural and Functional Divergence of Growth Hormone-Releasing Hormone Receptors in Early Sarcopterygians: Lungfish and Xenopus	PLOS ONE			English	Article							PEPTIDE HISTIDINE-ISOLEUCINE; MOLECULAR-CLONING; PITUITARY RECEPTOR; GENE-EXPRESSION; IDENTIFICATION; EVOLUTIONARY; COELACANTH; DISCOVERY; RNA	The evolutionary trajectories of growth hormone-releasing hormone (GHRH) receptor remain enigmatic since the discovery of physiologically functional GHRH-GHRH receptor (GHRHR) in non-mammalian vertebrates in 2007. Interestingly, subsequent studies have described the identification of a GHRHR(2) in chicken in addition to the GHRHR and the closely related paralogous receptor, PACAP-related peptide (PRP) receptor (PRPR). In this article, we provide information, for the first time, on the GHRHR in sarcopterygian fish and amphibians by the cloning and characterization of GHRHRs from lungfish (P. dolloi) and X. laevis. Sequence alignment and phylogenetic analyses demonstrated structural resemblance of lungfish GHRHR to their mammalian orthologs, while the X. laevis GHRHR showed the highest homology to GHRHR2 in zebrafish and chicken. Functionally, lungfish GHRHR displayed high affinity towards GHRH in triggering intracellular cAMP and calcium accumulation, while X. laevis GHRHR(2) was able to react with both endogenous GHRH and PRP. Tissue distribution analyses showed that both lungfish GHRHR and X. laevis GHRHR(2) had the highest expression in brain, and interestingly, X. laevis (GHRHR2) also had high abundance in the reproductive organs. These findings, together with previous reports, suggest that early in the Sarcopterygii lineage, GHRHR and PRPR have already established diverged and specific affinities towards their cognate ligands. GHRHR(2), which has only been found in xenopus, zebrafish and chicken hitherto, accommodates both GHRH and PRP.	[Tam, Janice K. V.; Chow, Billy K. C.; Lee, Leo T. O.] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Lee, LTO (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.	ltolee2@hku.hk	Chow, Billy/D-3064-2009; Lee, Leo T.O./AAB-1581-2021	Chow, Billy/0000-0003-3390-0307; 	Hong Kong Government RGC [7696/ 09M, CRFHKU6/CRF/11G]; Committee on Research [20101159013]	Hong Kong Government RGC; Committee on Research	The present study was supported by the Hong Kong Government RGC grant 7696/ 09M to LTOL, CRFHKU6/CRF/11G to BKCC and the Committee on Research 20101159013 to LTOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann H, 2004, P NATL ACAD SCI USA, V101, P4900, DOI 10.1073/pnas.0400609101; Cardoso JCR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-108; DIMALINE R, 1987, BIOCHIM BIOPHYS ACTA, V930, P97, DOI 10.1016/0167-4889(87)90160-1; GAYLINN BD, 1993, MOL ENDOCRINOL, V7, P77, DOI 10.1210/me.7.1.77; Hassan HA, 2001, ARCH BIOCHEM BIOPHYS, V387, P20, DOI 10.1006/abbi.2000.2208; Hoo RLC, 2001, J MOL ENDOCRINOL, V27, P229, DOI 10.1677/jme.0.0270229; Horikawa R, 2001, ENDOCRINOLOGY, V142, P2660, DOI 10.1210/en.142.6.2660; HSIUNG HM, 1993, NEUROPEPTIDES, V25, P1, DOI 10.1016/0143-4179(93)90062-F; Ji YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-263; Lee LTO, 2007, P NATL ACAD SCI USA, V104, P2133, DOI 10.1073/pnas.0611008104; Levy G, 2011, J MOL ENDOCRINOL, V46, P101, DOI 10.1530/JME-10-0065; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; MATSUBARA S, 1995, ENDOCRINOLOGY, V136, P4147, DOI 10.1210/en.136.9.4147; Mayden RL, 2007, J EXP ZOOL PART B, V308B, P642, DOI 10.1002/jez.b.21175; Mayo KE, 1996, ANN NY ACAD SCI, V805, P184, DOI 10.1111/j.1749-6632.1996.tb17483.x; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; Ogino Y, 2009, ENDOCRINOLOGY, V150, P5415, DOI 10.1210/en.2009-0523; Pollet N, 2006, GENOME DYN, V2, P138, DOI 10.1159/000095101; Porter TE, 2006, ENDOCRINOLOGY, V147, P2535, DOI 10.1210/en.2005-1534; Tam JKV, 2007, PEPTIDES, V28, P1920, DOI 10.1016/j.peptides.2007.07.011; Tam JKV, 2011, GEN COMP ENDOCR, V173, P405, DOI 10.1016/j.ygcen.2011.06.003; Tam JKV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019384; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toogood AA, 2006, ENDOCRINOLOGY, V147, P1838, DOI 10.1210/en.2005-0930; Tse DLY, 2002, ENDOCRINOLOGY, V143, P1327, DOI 10.1210/en.143.4.1327; Wang Y, 2010, DOMEST ANIM ENDOCRIN, V38, P13, DOI 10.1016/j.domaniend.2009.07.008; Wu S, 2008, J MOL ENDOCRINOL, V41, P343, DOI 10.1677/JME-08-0083; Zardoya R, 1997, NATURWISSENSCHAFTEN, V84, P389, DOI 10.1007/s001140050415; Zardoya R, 1996, P NATL ACAD SCI USA, V93, P5449, DOI 10.1073/pnas.93.11.5449	29	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53482	10.1371/journal.pone.0053482	http://dx.doi.org/10.1371/journal.pone.0053482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308232	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100044
J	Lamb, R; Ambler, CA				Lamb, Rebecca; Ambler, Carrie A.			Keratinocytes Propagated in Serum-Free, Feeder-Free Culture Conditions Fail to Form Stratified Epidermis in a Reconstituted Skin Model	PLOS ONE			English	Article							XENOBIOTIC-FREE CULTURE; TERMINAL DIFFERENTIATION; CLINICAL-USE; CELLS; CALCIUM; LAYER; FIBROBLASTS; COMMITMENT; EXPRESSION; INVOLUCRIN	Primary human epidermal stem cells isolated from skin tissues and subsequently expanded in tissue culture are used for human therapeutic use to reconstitute skin on patients and to generate artificial skin in culture for academic and commercial research. Classically, epidermal cells, known as keratinocytes, required fibroblast feeder support and serum-containing media for serial propagation. In alignment with global efforts to remove potential animal contaminants, many serum-free, feeder-free culture methods have been developed that support derivation and growth of these cells in 2-dimensional culture. Here we show that keratinocytes grown continually in serum-free and feeder-free conditions were unable to form into a stratified, mature epidermis in a skin equivalent model. This is not due to loss of cell potential as keratinocytes propagated in serum-free, feeder-free conditions retain their ability to form stratified epidermis when reintroduced to classic serum-containing media. Extracellular calcium supplementation failed to improve epidermis development. In contrast, the addition of serum to commercial, growth media developed for serum-free expansion of keratinocytes facilitated 3-dimensional stratification in our skin equivalent model. Moreover, the addition of heat-inactivated serum improved the epidermis structure and thickness, suggesting that serum contains factors that both aid and inhibit stratification.	[Lamb, Rebecca; Ambler, Carrie A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Ambler, Carrie A.] Univ Durham, Biophys Sci Inst, Durham, England	Durham University; Durham University	Ambler, CA (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham, England.	c.a.ambler@durham.ac.uk		Ambler, Carrie/0000-0002-2697-7376	British Skin Foundation [2010S]; BBSRC [BB/H02431X/1]; Durham University Faculty of Science; Biotechnology and Biological Sciences Research Council [BB/H02431X/1] Funding Source: researchfish	British Skin Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Durham University Faculty of Science; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding: This work was funded by the British Skin Foundation (2010S; www.britishskinfoundation.org.uk), BBSRC (BB/H02431X/1; www.bbsrc.ac.uk) and Durham University Faculty of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambler CA, 2010, DEVELOPMENT, V137, P3569, DOI 10.1242/dev.050310; Bullock AJ, 2006, TISSUE ENG, V12, P245, DOI 10.1089/ten.2006.12.245; CARROLL JM, 1993, P NATL ACAD SCI USA, V90, P10270, DOI 10.1073/pnas.90.21.10270; Coolen NA, 2007, CELL TRANSPLANT, V16, P649, DOI 10.3727/000000007783465046; De Corte P, 2012, CELL TISSUE BANK, V13, P175, DOI 10.1007/s10561-011-9247-3; Doupe DP, 2012, EXP DERMATOL, V21, P249, DOI 10.1111/j.1600-0625.2012.01447.x; El Ghalbzouri A, 2002, CELL TISSUE RES, V310, P189, DOI 10.1007/s00441-002-0621-0; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Ghadially R, 2012, J INVEST DERMATOL, V132, P797, DOI 10.1038/jid.2011.434; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Green H, 1977, Prog Clin Biol Res, V17, P493; Guo AH, 2009, EXP DERMATOL, V18, P720, DOI 10.1111/j.1600-0625.2009.00900.x; HAWLEYNELSON P, 1982, EXP CELL RES, V137, P155, DOI 10.1016/0014-4827(82)90017-9; HEFTON JM, 1983, LANCET, V2, P428; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; Higham MC, 2003, TISSUE ENG, V9, P919, DOI 10.1089/107632703322495565; IshidaYamamoto A, 1997, J INVEST DERMATOL, V108, P12, DOI 10.1111/1523-1747.ep12285611; Janes SM, 2009, CELL RES, V19, P328, DOI 10.1038/cr.2008.281; Jean J, 2011, TISSUE ENG PT A, V17, P877, DOI [10.1089/ten.tea.2010.0256, 10.1089/ten.TEA.2010.0256]; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; MacNeil S, 2011, METHODS MOL BIOL, V695, P129, DOI 10.1007/978-1-60761-984-0_9; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; PRUNEIRAS M, 1983, J INVEST DERMATOL, V81, P28; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROGUET R, 1994, TOXICOL IN VITRO, V8, P635, DOI 10.1016/0887-2333(94)90033-7; Shah G, 1999, Dev Biol Stand, V99, P17; Sun T, 2004, WOUND REPAIR REGEN, V12, P626, DOI 10.1111/j.1067-1927.2004.12609.x; TRINKAUSRANDALL V, 1984, J CELL BIOL, V98, P1565, DOI 10.1083/jcb.98.4.1565; VALNES K, 1985, J HISTOCHEM CYTOCHEM, V33, P755, DOI 10.1177/33.8.3926864; WATT FM, 1984, J CELL BIOL, V99, P2211, DOI 10.1083/jcb.99.6.2211; WATT FM, 1984, J CELL BIOL, V98, P16, DOI 10.1083/jcb.98.1.16; WATT FM, 1987, J CELL SCI, P313; Watt FM, 1983, J INVEST DERMATOL, V81, P100; WEISS L, 1959, EXP CELL RES, V17, P499, DOI 10.1016/0014-4827(59)90070-9	35	46	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52494	10.1371/journal.pone.0052494	http://dx.doi.org/10.1371/journal.pone.0052494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326335	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800019
J	Omumbo, JA; Noor, AM; Fall, IS; Snow, RW				Omumbo, Judy A.; Noor, Abdisalan M.; Fall, Ibrahima S.; Snow, Robert W.			How Well Are Malaria Maps Used to Design and Finance Malaria Control in Africa?0	PLOS ONE			English	Article							GEOGRAPHICAL PATTERNS; TRANSMISSION; RISK; PREVALENCE; PREDICTORS; PROGRESS; MODELS	Introduction: Rational decision making on malaria control depends on an understanding of the epidemiological risks and control measures. National Malaria Control Programmes across Africa have access to a range of state-of-the-art malaria risk mapping products that might serve their decision-making needs. The use of cartography in planning malaria control has never been methodically reviewed. Materials and Methods: An audit of the risk maps used by NMCPs in 47 malaria endemic countries in Africa was undertaken by examining the most recent national malaria strategies, monitoring and evaluation plans, malaria programme reviews and applications submitted to the Global Fund. The types of maps presented and how they have been used to define priorities for investment and control was investigated. Results: 91% of endemic countries in Africa have defined malaria risk at sub-national levels using at least one risk map. The range of risk maps varies from maps based on suitability of climate for transmission; predicted malaria seasons and temperature/altitude limitations, to representations of clinical data and modelled parasite prevalence. The choice of maps is influenced by the source of the information. Maps developed using national data through in-country research partnerships have greater utility than more readily accessible web-based options developed without inputs from national control programmes. Although almost all countries have stratification maps, only a few use them to guide decisions on the selection of interventions allocation of resources for malaria control. Conclusion: The way information on the epidemiology of malaria is presented and used needs to be addressed to ensure evidence-based added value in planning control. The science on modelled impact of interventions must be integrated into new mapping products to allow a translation of risk into rational decision making for malaria control. As overseas and domestic funding diminishes, strategic planning will be necessary to guide appropriate financing for malaria control.	[Omumbo, Judy A.; Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Wellcome Trust Res Programme, Kenya Med Res Inst, Malaria Publ Hlth Dept, Nairobi, Kenya; [Omumbo, Judy A.; Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Fall, Ibrahima S.] World Hlth Org, Reg Off Africa, Brazzaville, Rep Congo	Kenya Medical Research Institute; University of Oxford; World Health Organization	Omumbo, JA (corresponding author), Univ Oxford, Wellcome Trust Res Programme, Kenya Med Res Inst, Malaria Publ Hlth Dept, Nairobi, Kenya.	judyomumbo@gmail.com	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; Omumbo, Judy/0000-0002-9475-9346	Wellcome Trust [079080, 095127]	Wellcome Trust(Wellcome TrustEuropean Commission)	RWS is supported by the Wellcome Trust as a Principal Research Fellow (#079080). This fellowship also supports JAO. AMN is supported by the Wellcome Trust as an Intermediate Research Fellow (#095127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Craig MH, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-44; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gemperli A, 2006, AM J EPIDEMIOL, V163, P289, DOI 10.1093/aje/kwj026; Gething PW, 2008, GEOGR ANAL, V40, P167, DOI 10.1111/j.1538-4632.2008.00718.x; Giardina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032625; Gosoniu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0023966; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Griffin JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012618; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Le Sueur D, 1997, Afr Health, V19, P23; Lysenko A, 1968, GEOGRAPHY MALARIA ME; MARA/ARMA, 1999, ATL MAL RISK AFR 1 T; METSELAAR D., 1959, Tropical and Geographical Medicine, V11, P157; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Noor AM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-159; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Raso G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-160; Riedel N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-37; Roll Back Malaria (RBM)/World Health Organization (WHO), 2008, GLOB MAL ACT PLAN 2; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Snow R.W., 2010, ESTIMATING DISTRIBUT; Snow RW, 2012, ADV PARASIT, V78, P169, DOI 10.1016/B978-0-12-394303-3.00010-4; Snow RW, 2010, LANCET, V376, P1409, DOI 10.1016/S0140-6736(10)61340-2; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; Stensgaard AS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-298; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Taylor SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016420; Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214; UNICEF/RBM/Global Fund, 1999, MAL CHILDR PROGR INT; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; WHO, 2000, AB DECL PLAN ACT EXT; WHO Regional Office for Africa, 2011, MAN DEV NAT MAL STRA, P64; World Health Organization, 2010, MAN MAL PROGR PERF R	43	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53198	10.1371/journal.pone.0053198	http://dx.doi.org/10.1371/journal.pone.0053198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326398	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800037
J	Zhang, J; Zhang, BG; Zhang, XM; Sun, YG; Wei, XL; McNutt, MA; Lu, SJ; Liu, YQ; Zhang, DH; Wang, MY; Lin, ZJ; Niu, N				Zhang, Jie; Zhang, Baogang; Zhang, Xumei; Sun, Yingui; Wei, Xiaolong; McNutt, Michael A.; Lu, Shijun; Liu, Yuqing; Zhang, Donghong; Wang, Mingyu; Lin, Zhijuan; Niu, Na			SATB1 Expression Is Associated with Biologic Behavior in Colorectal Carcinoma In Vitro and In Vivo	PLOS ONE			English	Article							CLINICOPATHOLOGICAL FEATURES; CELL-PROLIFERATION; SERRATED POLYPS; DNA METHYLATION; GENE-EXPRESSION; MOLECULAR-BASIS; CANCER; GROWTH; MUTATIONS; PROTEIN	There is increasing evidence that Special AT-rich sequence-binding protein 1 (SATB1) is aberrantly expressed in several cancers and is correlated with clinicopathologic parameters in these tumors. In this study, we showed over-expression of SATB1 in 80 cases of colorectal cancer and in 3 colorectal cancer cell lines and found expression levels were strongly associated with tumor differentiation and stage. Expression levels of SATB1 protein were higher in poorly-differentiated as compared with well-differentiated cell lines, and both quantity and distribution patterns of SATB1 were associated with tumor differentiation and pTNM stage. Strikingly, we further investigated the effect of down regulation of SATB1 expression on malignant phenotypic features in colorectal cancer cells in vitro, and showed that SABT1 down-regulation negatively affected growth potential, anchorage-independent colony formation and cancer cell invasion, and resulted in increased apoptosis. SATB1 expression was positively associated with the expression of various biological and genetic markers, including Cyclin D1, MMP-2, NF-kappa B, and PCNA, and was associated with loss of APC and BRAF(V600E). These findings suggest that SATB1 is involved in the carcinogenesis, development and progression of colorectal cancer.	[Zhang, Jie] Weifang Med Univ, Dept Human Anat, Weifang, Peoples R China; [Zhang, Baogang; Lu, Shijun; Liu, Yuqing; Niu, Na] Weifang Med Univ, Dept Pathol, Weifang, Peoples R China; [Zhang, Xumei] Weifang Med Univ, Affiliated Hosp, Dept Pathol, Weifang, Peoples R China; [Sun, Yingui] Weifang Med Univ, Dept Anesthesia, Weifang, Peoples R China; [Wei, Xiaolong] Shantou Univ, Coll Med, Canc Hosp, Dept Pathol, Shantou, Peoples R China; [McNutt, Michael A.] Peking Univ, Sch Basic Med Sci, Dept Pathol, Beijing 100871, Peoples R China; [Zhang, Donghong] Beijing Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Zhang, Donghong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Mingyu] Weifang Med Univ, Dept Neurol, Weifang, Peoples R China; [Lin, Zhijuan] Weifang Med Univ, Univ Shandong Prov, Key Lab Immunol, Weifang, Peoples R China	Weifang Medical University; Weifang Medical University; Weifang Medical University; Weifang Medical University; Shantou University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Weifang Medical University; Weifang Medical University	Niu, N (corresponding author), Weifang Med Univ, Dept Pathol, Weifang, Peoples R China.	naniubjmu@gmail.com	Liu, LiuYuqing/GWZ-5665-2022; Niu, Na/A-2915-2016	Niu, Na/0000-0003-1016-7851	Young and Middle-Aged Scientists Research Awards Fundation of Shandong Province [BS2011SW051, 2010BSB14050]; National Natural Science Foundation of China [81100885, 81072068]	Young and Middle-Aged Scientists Research Awards Fundation of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by grants from the Young and Middle-Aged Scientists Research Awards Fundation of Shandong Province to Na Niu (No. BS2011SW051) and Baogang Zhang (No. 2010BSB14050), and National Natural Science Foundation of China to Na Niu (No. 81100885) and Baogang Zhang (No. 81072068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnen DJ, 2011, AM J GASTROENTEROL, V106, P190, DOI 10.1038/ajg.2010.423; Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Debska S, 2012, POSTEP HIG MED DOSW, V66, P311; Fernandez SV, 2012, INT J ONCOL, V41, P369, DOI 10.3892/ijo.2012.1444; Flatmark K, 2004, EUR J CANCER, V40, P1593, DOI 10.1016/j.ejca.2004.02.023; Forma E, 2012, GINEKOL POL, V83, P363; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Ioachim E, 2008, INT J CLIN PRACT, V62, P1736, DOI 10.1111/j.1742-1241.2006.01105.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Laulier C, 2012, MUTAT RES; Levidou G, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-47; Liu Chun-xiao, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1389; Maloney EK, 2003, CANCER RES, V63, P5073; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Markowitz SD, 2002, CANCER CELL, V1, P233, DOI 10.1016/S1535-6108(02)00053-3; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Nie H, 2008, MOL IMMUNOL, V46, P207, DOI 10.1016/j.molimm.2008.07.007; Niu N, 2011, INT J BIOCHEM CELL B, V43, P556, DOI 10.1016/j.biocel.2010.12.012; Niu N, 2011, CELL MOL LIFE SCI, V68, P2481, DOI 10.1007/s00018-010-0572-7; Niu N, 2009, LAB INVEST, V89, P636, DOI 10.1038/labinvest.2009.28; Parsons MT, 2012, J MED GENET, V49, P151, DOI 10.1136/jmedgenet-2011-100714; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Peng Zheng-kui, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1207; Qiu XY, 2003, CANCER RES, V63, P6488; Rigakos G, 2012, ONCOLOGIST, V17, P956, DOI 10.1634/theoncologist.2012-0028; Stecklein SR, 2012, TRANSL RES, V160, P178, DOI 10.1016/j.trsl.2012.01.022; Sun XF, 1996, INT J CANCER, V69, P5, DOI 10.1002/(SICI)1097-0215(19960220)69:1<5::AID-IJC2>3.0.CO;2-8; Tanikawa C, 2012, NEOPLASIA, V14, P141, DOI 10.1593/neo.111700; Turnbull CL, 2012, MUTAGENESIS, V27, P233, DOI 10.1093/mutage/ger069; Velho S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-255; Webber MM, 1995, CLIN CANCER RES, V1, P1089; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Zhao Xiao-lan, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P82; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777; Zheng H, 2007, CELL BIOL INT, V31, P82, DOI 10.1016/j.cellbi.2006.09.009; Zlobec I, 2008, J CLIN PATHOL, V61, P561, DOI 10.1136/jcp.2007.054858	42	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e47902	10.1371/journal.pone.0047902	http://dx.doi.org/10.1371/journal.pone.0047902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326301	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800003
J	Khatri, B; Fielder, M; Jones, G; Newell, W; Abu-Oun, M; Wheeler, PR				Khatri, Bhagwati; Fielder, Mark; Jones, Gareth; Newell, William; Abu-Oun, Manal; Wheeler, Paul R.			High Throughput Phenotypic Analysis of Mycobacterium tuberculosis and Mycobacterium bovis Strains' Metabolism Using Biolog Phenotype Microarrays	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; IN-VIVO GROWTH; LIPID-METABOLISM; ACID RESISTANCE; GENE; MUTANTS; ASSAY; BIOSYNTHESIS; TRANSPORT; VIRULENCE	Tuberculosis is a major human and animal disease of major importance worldwide. Genetically, the closely related strains within the Mycobacterium tuberculosis complex which cause disease are well-characterized but there is an urgent need better to understand their phenotypes. To search rapidly for metabolic differences, a working method using Biolog Phenotype MicroArray analysis was developed. Of 380 substrates surveyed, 71 permitted tetrazolium dye reduction, the readout over 7 days in the method. By looking for >= 5-fold differences in dye reduction, 12 substrates differentiated M. tuberculosis H37Rv and Mycobacterium bovis AF2122/97. H37Rv and a Beijing strain of M. tuberculosis could also be distinguished in this way, as could field strains of M. bovis; even pairs of strains within one spoligotype could be distinguished by 2 to 3 substrates. Cluster analysis gave three clear groups: H37Rv, Beijing, and all the M. bovis strains. The substrates used agreed well with prior knowledge, though an unexpected finding that AF2122/97 gave greater dye reduction than H37Rv with hexoses was investigated further, in culture flasks, revealing that hexoses and Tween 80 were synergistic for growth and used simultaneously rather than in a diauxic fashion. Potential new substrates for growth media were revealed, too, most promisingly N-acetyl glucosamine. Osmotic and pH arrays divided the mycobacteria into two groups with different salt tolerance, though in contrast to the substrate arrays the groups did not entirely correlate with taxonomic differences. More interestingly, these arrays suggested differences between the amines used by the M. tuberculosis complex and enteric bacteria in acid tolerance, with some hydrophobic amino acids being highly effective. In contrast, gamma-aminobutyrate, used in the enteric bacteria, had no effect in the mycobacteria. This study proved principle that Phenotype MicroArrays can be used with slow-growing pathogenic mycobacteria and already has generated interesting data worthy of further investigation.	[Khatri, Bhagwati; Wheeler, Paul R.] Anim Hlth Vet Labs Weybridge, Dept Bovine TB, New Haw, Surrey, England; [Fielder, Mark] Kingston Univ London, Sch Life Sci, Kingston Upon Thames, Surrey, England; [Jones, Gareth; Newell, William] Anim Hlth Vet Labs Weybridge, Specialist Sci Serv Dept, New Haw, Surrey, England; [Abu-Oun, Manal] Anim Hlth Vet Labs Weybridge, Dept Bacteriol, New Haw, Surrey, England	Kingston University	Wheeler, PR (corresponding author), Anim Hlth Vet Labs Weybridge, Dept Bovine TB, New Haw, Surrey, England.	Paul.Wheeler@ahvla.gsi.gov.uk			AHVLA's Seedcorn programme [SC0205]	AHVLA's Seedcorn programme	Funding for this work was provided though the AHVLA's (http://ahvlaintranet/) Seedcorn programme, SC0205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate G, 1998, INT J TUBERC LUNG D, V2, P1011; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Berney M, 2012, MOL MICROBIOL, V84, P664, DOI 10.1111/j.1365-2958.2012.08053.x; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Blomberg A, 2000, FEMS MICROBIOL LETT, V182, P1; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; CAMARGO EE, 1982, INT J LEPROSY, V50, P200; CAMARGO EE, 1987, NUCL MED BIOL, V14, P43; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; HARTMANN T, 1972, PHYTOCHEMISTRY, V11, P1327, DOI 10.1016/S0031-9422(00)90081-5; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Kairo SK, 1999, VACCINE, V17, P2423, DOI 10.1016/S0264-410X(99)00023-7; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Lee S, 2006, INFECT IMMUN, V74, P6491, DOI 10.1128/IAI.00531-06; Martinez-Gamboa A, 2008, ARCH MED RES, V39, P809, DOI 10.1016/j.arcmed.2008.08.006; Morita YS, 2010, J BIOL CHEM, V285, P16643, DOI 10.1074/jbc.M110.119263; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Parish T, 1999, MICROBIOL-SGM, V145, P3497, DOI 10.1099/00221287-145-12-3497; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Ratledge C., 1982, BIOL MYCOBACTERIA, P186; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; SIDDIQI SH, 1984, AM REV RESPIR DIS, V130, P634; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Smith NH, 2003, P NATL ACAD SCI USA, V100, P15271, DOI 10.1073/pnas.2036554100; SUTTON CR, 1962, ARCH BIOCHEM BIOPHYS, V96, P360, DOI 10.1016/0003-9861(62)90421-6; Titgemeyer F, 2007, J BACTERIOL, V189, P5903, DOI 10.1128/JB.00257-07; Vandal OH, 2009, J BACTERIOL, V191, P4714, DOI 10.1128/JB.00305-09; Wheeler PR, 2008, MICROBIOL-SGM, V154, P3731, DOI 10.1099/mic.0.2008/022269-0; Wheeler PR, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P309; Winder CL, 2006, MICROBIOL-SGM, V152, P2757, DOI 10.1099/mic.0.28986-0	43	28	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52673	10.1371/journal.pone.0052673	http://dx.doi.org/10.1371/journal.pone.0052673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326347	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000313552400008
J	Lee, RY; Reiner, D; Dekan, G; Moore, AE; Higgins, TJV; Epstein, MM				Lee, Rui-Yun; Reiner, Daniela; Dekan, Gerhard; Moore, Andrew E.; Higgins, T. J. V.; Epstein, Michelle M.			Genetically Modified alpha-Amylase Inhibitor Peas Are Not Specifically Allergenic in Mice	PLOS ONE			English	Article							PHASEOLUS-VULGARIS; TRANSGENIC EXPRESSION; SEEDS; IMMUNOGENICITY; ARCELIN; LEGUMES	Weevils can devastate food legumes in developing countries, but genetically modified peas (Pisum sativum), chickpeas and cowpeas expressing the gene for alpha-amylase inhibitor-1 (alpha AI) from the common bean (Phaseolus vulgaris) are completely protected from weevil destruction. alpha AI is seed-specific, accumulated at high levels and undergoes post-translational modification as it traverses the seed endomembrane system. This modification was thought to be responsible for the reported allergenicity in mice of the transgenic pea but not the bean. Here, we observed that transgenic alpha AI peas, chickpeas and cowpeas as well as non-transgenic beans were all allergenic in BALB/c mice. Even consuming non-transgenic peas lacking alpha AI led to an anti-alpha AI response due to a cross-reactive response to pea lectin. Our data demonstrate that alpha AI transgenic peas are not more allergenic than beans or non-transgenic peas in mice. This study illustrates the importance of repeat experiments in independent laboratories and the potential for unexpected cross-reactive allergic responses upon consumption of plant products in mice.	[Lee, Rui-Yun; Reiner, Daniela; Epstein, Michelle M.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Dekan, Gerhard] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Moore, Andrew E.; Higgins, T. J. V.] CSIRO, Plant Ind, Canberra, ACT, Australia	Medical University of Vienna; Medical University of Vienna; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Epstein, MM (corresponding author), Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria.	michelle.epstein@meduniwien.ac.at	Higgins, Thomas JV/F-8360-2010	Higgins, Thomas JV/0000-0002-4445-1327; Epstein, Michelle/0000-0002-4755-0224	GMSAFOOD project through the 7th Framework grant [211820]	GMSAFOOD project through the 7th Framework grant	Funding for this research was provided the GMSAFOOD project (grant nu,ber 211820), through the 7th Framework grant, administered by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, NAT BIOTECH, V24, P2; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Campbell PM, 2011, J AGR FOOD CHEM, V59, P6047, DOI 10.1021/jf200456j; GATEHOUSE JA, 1986, PHILOS T ROY SOC B, V314, P367, DOI 10.1098/rstb.1986.0059; Higgins T, 2012, INSECT PROT IN PRESS; HIGGINS TJV, 1983, J BIOL CHEM, V258, P9544; James C., 2004, GLOBAL STATUS COMMER; MARSHALL JJ, 1975, J BIOL CHEM, V250, P8030; MIRKOV TE, 1994, PLANT MOL BIOL, V26, P1103, DOI 10.1007/BF00040692; Mojtabavi N, 2002, J IMMUNOL, V169, P4788, DOI 10.4049/jimmunol.169.9.4788; Prescott VE, 2006, J LEUKOCYTE BIOL, V80, P258, DOI 10.1189/jlb.1105637; Prescott VE, 2005, J AGR FOOD CHEM, V53, P9023, DOI 10.1021/jf050594v; ROUGE P, 1993, BIOCHEM SYST ECOL, V21, P695, DOI 10.1016/0305-1978(93)90074-2; Sarmah BK, 2004, MOL BREEDING, V14, P73, DOI 10.1023/B:MOLB.0000037996.01494.12; SCHROEDER HE, 1995, PLANT PHYSIOL, V109, P1129; SHADE RE, 1994, BIO-TECHNOL, V12, P793, DOI 10.1038/nbt0894-793	16	20	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52972	10.1371/journal.pone.0052972	http://dx.doi.org/10.1371/journal.pone.0052972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326368	Green Published, gold			2022-12-27	WOS:000313551500038
J	Wang, L; Zheng, YB; Xu, HW; Yan, XF; Chang, XT				Wang, Lin; Zheng, Yabing; Xu, Hengwei; Yan, Xinfeng; Chang, Xiaotian			Investigate Pathogenic Mechanism of TXNDC5 in Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; T-CELLS; ADIPONECTIN; MICE; LYMPHOCYTES; EXPRESSION; INDUCER; RATIO; IL-1	Hypoxia stimulates synovial hypoperfusion in rheumatoid arthritis (RA). TXNDC5 stimulates cellular proliferation in hypoxic conditions. We previously detected increased TXNDC5 expression in synovial tissues and blood from RA patients and demonstrated that the gene encoding TXNDC5 increased RA risk. The present study investigated the pathogenic roles of TXNDC5 in RA. Transgenic mice that over-expressed TXNDC5 (TXNDC5-Tg) were generated using C57BL/6J mice and treated with bovine collagen II to induce arthritis (CIA). Synovial fibroblasts from RA patients (RASFs) were cultured and incubated with TXNDC5-siRNA or CoCl2, a chemical that induces hypoxia. CIA was observed in 80% of the TXNDC5-Tg, but only 20% of the wild-type mice (WT) developed CIA. The clinical arthritis scores reached 5 in the TXNDC5-Tg, but this index only reached 2 in the control mice. CIA TXNDC5-Tg exhibited clear pannus proliferation and bone erosion in joint tissues. A significant increase in CD4 T cells was observed in the thymus and spleen of TXNDC5-Tg during CIA. Serum levels of anti-collagen II IgG, IgG1 and IgG2a antibodies were significantly elevated in the mice. Increased cell proliferation, cell migration and TXNDC5 expression were observed in RASFs following incubation with 1 mu M CoCl2. However, this effect was diminished when TXNDC5 expression was inhibited with 100 nM siRNA. TNF-alpha, IL-1 alpha, IL-1 beta and IL-17 levels were significantly increased in the blood of TXNDC5-Tg mice, but the levels of these cytokines declined in the supernatant of RASFs that were treated with TXNDC5 siRNA. The expression of adiponectin, a cytokine-like mediator, decreased significantly in RASFs following TXNDC5 siRNA treatment. These results suggest that TXNDC5-over-expressing mice were susceptible to CIA. This study also suggests that hypoxia induced TXCNDC5 expression, which contributed to adiponectin expression, cytokine production and the cellular proliferation and migration of fibroblasts in RA.	[Wang, Lin] Shandong Acad Med Sci, Med Biotechnol Res Ctr, Jinan, Shandong, Peoples R China; [Wang, Lin] Shandong Univ, Dept Pathol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Zheng, Yabing; Yan, Xinfeng; Chang, Xiaotian] Shandong Univ, Shandong Prov Qianfoshan Hosp, Med Res Ctr, Jinan 250100, Shandong, Peoples R China; [Xu, Hengwei] Shandong Tumor Hosp, Dept Pharm, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Chang, XT (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Med Res Ctr, Jinan 250100, Shandong, Peoples R China.	changxt@126.com		Wang, Lin/0000-0002-0503-9727	National Basic Research Program of China [2010CB529105]; Shandong Taishan Scholarship	National Basic Research Program of China(National Basic Research Program of China); Shandong Taishan Scholarship	This study was supported by the National Basic Research Program of China (2010CB529105) and the Shandong Taishan Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3867; Brenner M, 2007, MOL MED, V13, P277, DOI 10.2119/2007-00003.Brenner; CANTAGREL A, 1988, J RHEUMATOL, V15, P899; Chabaud M, 2001, J IMMUNOL, V167, P6015, DOI 10.4049/jimmunol.167.10.6015; Chang XT, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3429; Chang XT, 2009, J RHEUMATOL, V36, P872, DOI 10.3899/jrheum.080939; Charlton HK, 2010, BIOCHEM BIOPH RES CO, V392, P234, DOI 10.1016/j.bbrc.2010.01.029; Chen LM, 2010, J IMMUNOL, V184, P4455, DOI 10.4049/jimmunol.0900525; Choi HM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2844; EMERY P, 1987, ARTHRITIS RHEUM, V30, P849, DOI 10.1002/art.1780300802; Evans DM, 2004, GENES IMMUN, V5, P548, DOI 10.1038/sj.gene.6364126; Frommer KW, 2010, ARTHRITIS RHEUM-US, V62, P2886, DOI 10.1002/art.27616; Huan J, 2008, J IMMUNOL, V180, P1249, DOI 10.4049/jimmunol.180.2.1249; KADOWAKI KM, 1994, CLIN EXP IMMUNOL, V97, P212; Kanda Hiroko, 2007, Mod Rheumatol, V17, P364, DOI 10.1007/s10165-007-0589-4; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kim KW, 2005, ARTHRITIS RES THER, V7, pR139, DOI 10.1186/ar1470; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Lee SW, 2012, BIOMATERIALS, V33, P1563, DOI 10.1016/j.biomaterials.2011.10.079; Li ZH, 2011, PROTEIN CELL, V2, P604, DOI 10.1007/s13238-011-1083-5; Lundy SK, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2107; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Muz B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2568; Nakamura H, 2004, ANTIOXID REDOX SIGN, V6, P15, DOI 10.1089/152308604771978309; Oh S, 2010, IMMUNOL REV, V233, P97, DOI 10.1111/j.0105-2896.2009.00848.x; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Ravlic-Gulan J, 2005, COLLEGIUM ANTROPOL, V29, P661; SEKI N, 1988, J IMMUNOL, V140, P1477; Senolt L, 2006, CYTOKINE, V35, P247, DOI 10.1016/j.cyto.2006.09.002; Sullivan DC, 2003, J BIOL CHEM, V278, P47079, DOI 10.1074/jbc.M308124200; TAYLOR PC, 1995, EUR J IMMUNOL, V25, P763, DOI 10.1002/eji.1830250321; WOOLEY PH, 1985, J IMMUNOL, V135, P2443; Zhang L, 2010, J CANCER RES CLIN, V136, P1497, DOI 10.1007/s00432-010-0807-x; Zwerina J, 2005, ANN NY ACAD SCI, V1051, P716, DOI 10.1196/annals.1361.116	35	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53301	10.1371/journal.pone.0053301	http://dx.doi.org/10.1371/journal.pone.0053301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326410	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500062
J	Banks, SC; Lindenmayer, DB; Wood, JT; McBurney, L; Blair, D; Blyton, MDJ				Banks, Sam C.; Lindenmayer, David B.; Wood, Jeff T.; McBurney, Lachlan; Blair, David; Blyton, Michaela D. J.			Can Individual and Social Patterns of Resource Use Buffer Animal Populations against Resource Decline?	PLOS ONE			English	Article							MOUNTAIN BRUSHTAIL POSSUM; DEER HABITAT SELECTION; SOUTHEASTERN AUSTRALIA; ARBOREAL MARSUPIALS; FUNCTIONAL-RESPONSES; BEHAVIORAL-RESPONSES; ENVIRONMENTAL-CHANGE; TERRITORY QUALITY; REGIME SHIFTS; FORESTS	Species in many ecosystems are facing declines of key resources. If we are to understand and predict the effects of resource loss on natural populations, we need to understand whether and how the way animals use resources changes under resource decline. We investigated how the abundance of arboreal marsupials varies in response to a critical resource, hollow-bearing trees. Principally, we asked what mechanisms mediate the relationship between resources and abundance? Do animals use a greater or smaller proportion of the remaining resource, and is there a change in cooperative resource use (den sharing), as the availability of hollow trees declines? Analyses of data from 160 sites surveyed from 1997 to 2007 showed that hollow tree availability was positively associated with abundance of the mountain brushtail possum, the agile antechinus and the greater glider. The abundance of Leadbeater's possum was primarily influenced by forest age. Notably, the relationship between abundance and hollow tree availability was significantly less than 1: 1 for all species. This was due primarily to a significant increase by all species in the proportional use of hollow-bearing trees where the abundance of this resource was low. The resource-sharing response was weaker and inconsistent among species. Two species, the mountain brushtail possum and the agile antechinus, showed significant but contrasting relationships between the number of animals per occupied tree and hollow tree abundance. The discrepancies between the species can be explained partly by differences in several aspects of the species' biology, including body size, types of hollows used and social behaviour as it relates to hollow use. Our results show that individual and social aspects of resource use are not always static in response to resource availability and support the need to account for dynamic resource use patterns in predictive models of animal distribution and abundance.	[Banks, Sam C.; Lindenmayer, David B.; Wood, Jeff T.; McBurney, Lachlan; Blair, David; Blyton, Michaela D. J.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University	Banks, SC (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	Banks@anu.edu.au	Blyton, Michaela/ABA-4463-2021; Lindenmayer, David B/P-7183-2017; Banks, Sam/K-4907-2012	Lindenmayer, David B/0000-0002-4766-4088; Banks, Sam/0000-0003-2415-0057	Hermon Slade Foundation [HSF 08-4]; Australian Research Council; APD fellowship [ARC DP 0984876]	Hermon Slade Foundation; Australian Research Council(Australian Research Council); APD fellowship	This research was supported by grants from the Hermon Slade Foundation (HSF 08-4; www.hermonslade.org.au) and the Australian Research Council (www.arc.gov.au), including an APD fellowship to Sam Banks (ARC DP 0984876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MA, 1984, AUST J BOT, V32, P205, DOI 10.1071/BT9840205; Aitken KEH, 2008, ECOLOGY, V89, P971, DOI 10.1890/07-0711.1; Banks SC, 2007, CAN J ZOOL, V85, P1065, DOI 10.1139/Z07-094; Banks SC, 2012, MOL ECOL, V21, P673, DOI 10.1111/j.1365-294X.2011.05282.x; Banks SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022952; Banks SC, 2011, P ROY SOC B-BIOL SCI, V278, P2768, DOI 10.1098/rspb.2010.2657; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bjorneraas K, 2012, OECOLOGIA, V168, P231, DOI 10.1007/s00442-011-2072-3; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Brown J. L., 1964, Wilson Bulletin, V76, P160; Dubois FD, 2005, ECOLOGY, V86, P3, DOI 10.1890/04-0566; Elton C., 1927, ANIMAL ECOLOGY; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fisher DO, 2011, BEHAV ECOL SOCIOBIOL, V65, P593, DOI 10.1007/s00265-010-1060-7; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Franklin JF, 2011, P NATL ACAD SCI USA, V108, P16863, DOI 10.1073/pnas.1114045108; Gibbons P, 2002, BIOL CONSERV, V103, P1, DOI 10.1016/S0006-3207(01)00109-4; Gibbons PL, 2011, AUSTR MAMMALOGY; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; HUGHES JJ, 1994, ECOLOGY, V75, P1397, DOI 10.2307/1937463; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Jones J, 2001, ECOLOGY, V82, P2628, DOI 10.1890/0012-9658(2001)082[2628:ATEOND]2.0.CO;2; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; Lindenmayer DB, 2011, ECOL MONOGR, V81, P557, DOI 10.1890/11-0279.1; Lindenmayer DB, 2006, BIODIVERS CONSERV, V15, P4079, DOI 10.1007/s10531-005-3367-7; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Lindenmayer DB, 2010, CAN J FOREST RES, V40, P48, DOI 10.1139/X09-185; Lindenmayer DB, 1997, J MAMMAL, V78, P1117, DOI 10.2307/1383054; Lindenmayer DB, 1996, WILDLIFE RES, V23, P343, DOI 10.1071/WR9960343; LINDENMAYER DB, 1990, AUST WILDLIFE RES, V17, P467, DOI 10.1071/WR9900467; Lindenmayer DB, 1997, ECOL APPL, V7, P625, DOI 10.1890/1051-0761(1997)007[0625:DACOTW]2.0.CO;2; LINDENMAYER DB, 1993, FOREST ECOL MANAG, V60, P77, DOI 10.1016/0378-1127(93)90024-H; Lindenmayer DB, 2000, FOREST ECOL MANAG, V134, P189, DOI 10.1016/S0378-1127(99)00257-1; Matthiopoulos J, 2011, ECOLOGY, V92, P583, DOI 10.1890/10-0751.1; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Morellet N, 2011, LANDSCAPE ECOL, V26, P999, DOI 10.1007/s10980-011-9624-0; Morris DW, 2011, P ROY SOC B-BIOL SCI, V278, P2401, DOI 10.1098/rspb.2011.0604; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Osko TJ, 2004, J WILDLIFE MANAGE, V68, P576, DOI 10.2193/0022-541X(2004)068[0576:MHPIRT]2.0.CO;2; Payne R.W., 2008, GENSTAT FOR WINDOWS; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; STACEY PB, 1991, AM NAT, V137, P831, DOI 10.1086/285196; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Wagner T, 2011, J WILDLIFE MANAGE, V75, P1788, DOI 10.1002/jwmg.212; Wauters LA, 2005, EVOL ECOL, V19, P375, DOI 10.1007/s10682-005-8311-5; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004	50	10	11	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53672	10.1371/journal.pone.0053672	http://dx.doi.org/10.1371/journal.pone.0053672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320100	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800065
J	Cesaro, S; Nesi, F; Tridello, G; Abate, M; Panizzolo, IS; Balter, R; Calore, E				Cesaro, Simone; Nesi, Francesca; Tridello, Gloria; Abate, Massimo; Panizzolo, Irene Sara; Balter, Rita; Calore, Elisabetta			A Randomized, Non-Inferiority Study Comparing Efficacy and Safety of a Single Dose of Pegfilgrastim versus Daily Filgrastim in Pediatric Patients after Autologous Peripheral Blood Stem Cell Transplant	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY; PHASE-II; SOLID TUMORS; ADMINISTRATION PEGFILGRASTIM; MULTIPLE-MYELOMA; BREAST-CANCER; EWING SARCOMA; STAGE-II; G-CSF	Purpose: To assess the non-inferiority of pegfilgrastim versus filgrastim in speeding the recovery of polymorphonuclear cells (PMN) in pediatric patients who underwent autologous peripheral blood stem cell transplant (PBSCT). Methods: The sample size of this randomized, multicenter, phase III study, was calculated assuming that a single dose of pegfilgrastim of 100 ug/kg was not inferior to 9 doses of filgrastim of 5 ug/kg/day. Randomization was performed by a computer-generated list and stored by sequentially numbered sealed envelopes. Results: Sixty-one patients, with a median age of 11.5 years, were recruited: 29 in the filgrastim arm and 32 in the pegfilgrastim arm. Twenty percent were affected by lymphoma/leukaemia and eighty percent by solid tumors. The mean time to PMN engraftment was 10.48 days (standard deviation [SD] 1.57) and 10.44 days (SD 2.44) in the filgrastim and pegfilgrastim arms, respectively. Having fixed a non-inferiority margin Delta of 3, the primary endpoint of non-inferiority was reached. No differences were observed for other secondary endpoints: platelet engraftment, mean time to platelet recovery (28 days vs. 33 days), fever of unknown origin (79% vs. 78%), proven infection (34% vs. 28%), mucositis (76% vs. 59%). After a median follow-up of 2.3 years (95% C.I.: 1.5, 3.3), 20 deaths were observed due to disease progression. Conclusions: We conclude that pegfilgrastim was not inferior to daily filgrastim in pediatric patients who underwent PBSCT. EU Clinical Trial Register Number: 2007-001430-14	[Cesaro, Simone; Tridello, Gloria; Panizzolo, Irene Sara; Balter, Rita] Azienda Osped Univ Integrata, Verona, Italy; [Nesi, Francesca] Osped Infantile Regina Margherita, Turin, Italy; [Abate, Massimo] Ist Ortoped Rizzoli, Bologna, Italy; [Calore, Elisabetta] Dept Pediat, Padua, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; A.O.U. Citta della Salute e della Scienza di Torino; IRCCS Istituto Ortopedico Rizzoli	Cesaro, S (corresponding author), Azienda Osped Univ Integrata, Verona, Italy.	simone.cesaro@ospedaleuniverona.it	Cesaro, Simone/F-8118-2019; Cesaro, Simone/I-3272-2019	Cesaro, Simone/0000-0002-8698-9547; Cesaro, Simone/0000-0002-8698-9547				Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Andre N, 2007, ANTI-CANCER DRUG, V18, P277, DOI 10.1097/CAD.0b013e328011a532; Ballestrero A, 2008, ANN HEMATOL, V87, P49, DOI 10.1007/s00277-007-0366-7; Borinstein SC, 2009, PEDIATR BLOOD CANCER, V53, P375, DOI 10.1002/pbc.22086; Castagna L, 2010, ANN ONCOL, V21, P1482, DOI 10.1093/annonc/mdp576; Cesaro S, 2011, TRANSFUSION, V51, P2480, DOI 10.1111/j.1537-2995.2011.03157.x; Dallorso S, 2008, BONE MARROW TRANSPL, V42, P507, DOI 10.1038/bmt.2008.206; Dallorso S, 2002, HAEMATOLOGICA, V87, P1274; Ferrara F, 2011, HEMATOL ONCOL, V29, P139, DOI 10.1002/hon.978; Fritsch P, 2010, PEDIATR BLOOD CANCER, V54, P134, DOI 10.1002/pbc.22304; Gerds A, 2010, BIOL BLOOD MARROW TR, V16, P678, DOI 10.1016/j.bbmt.2009.12.531; Green MD, 2003, ANN ONCOL, V14, P29, DOI 10.1093/annonc/mdg019; Holmes FA, 2002, J CLIN ONCOL, V20, P727, DOI 10.1200/JCO.20.3.727; Jagasia MH, 2005, BONE MARROW TRANSPL, V35, P1165, DOI 10.1038/sj.bmt.1704994; Martino M, 2006, EUR J HAEMATOL, V77, P410, DOI 10.1111/j.1600-0609.2006.00736.x; Mathew S, 2010, BONE MARROW TRANSPL, V45, P1522, DOI 10.1038/bmt.2009.373; Milano-Bausset E, 2009, CLIN THER, V31, P2388, DOI 10.1016/j.clinthera.2009.11.013; Musto P, 2007, LEUKEMIA RES, V31, P1487, DOI 10.1016/j.leukres.2007.01.008; Niederwieser D, 2011, EUR J HAEMATOL, V86, P277, DOI 10.1111/j.1600-0609.2010.01566.x; Passweg JR, 2012, BONE MARROW TRANSPL, V47, P906, DOI 10.1038/bmt.2012.66; Rifkin R, 2010, CL LYMPH MYELOM LEUK, V10, P186, DOI 10.3816/CLML.2010.n.029; Samaras P, 2011, ANN HEMATOL, V90, P89, DOI 10.1007/s00277-010-1036-8; Samaras P, 2010, ONCOLOGY-BASEL, V79, P93, DOI 10.1159/000320604; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Sebban C, 2012, EUR J CANCER, V48, P713, DOI 10.1016/j.ejca.2011.12.016; Siena S, 2003, ONCOL REP, V10, P715; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Spunt SL, 2010, J CLIN ONCOL, V28, P1329, DOI 10.1200/JCO.2009.24.8872; Staber PB, 2005, BONE MARROW TRANSPL, V35, P889, DOI 10.1038/sj.bmt.1704927; te Poele EM, 2005, J PEDIAT HEMATOL ONC, V27, P627, DOI 10.1097/01.mph.0000188631.41510.23; Trivedi M, 2009, BONE MARROW TRANSPL, V43, P895, DOI 10.1038/bmt.2009.75; Vanstraelen G, 2006, EXP HEMATOL, V34, P382, DOI 10.1016/j.exphem.2005.11.013; Wendelin G, 2005, J PEDIAT HEMATOL ONC, V27, P449, DOI 10.1097/01.mph.0000175711.73039.63; Ziakas PD, 2012, CLIN TRANSPLANT, V26, P16, DOI 10.1111/j.1399-0012.2011.01532.x; Zwick C, 2011, ANN ONCOL, V22, P1872, DOI 10.1093/annonc/mdq674	35	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53252	10.1371/journal.pone.0053252	http://dx.doi.org/10.1371/journal.pone.0053252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308174	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100045
J	Im, K; Lee, JM; Jeon, S; Kim, JH; Seo, SW; Na, DL; Grant, PE				Im, Kiho; Lee, Jong-Min; Jeon, Seun; Kim, Jong-Heon; Seo, Sang Won; Na, Duk L.; Grant, P. Ellen			Reliable Identification of Deep Sulcal Pits: The Effects of Scan Session, Scanner, and Surface Extraction Tool	PLOS ONE			English	Article							AUTOMATED 3-D EXTRACTION; CORTICAL SURFACE; GEOMETRICALLY ACCURATE; COORDINATE SYSTEM; CEREBRAL-CORTEX; MRI; RELIABILITY; VARIABILITY; THICKNESS; RECONSTRUCTION	Sulcal pit analysis has been providing novel insights into brain function and development. The purpose of this study was to evaluate the reliability of sulcal pit extraction with respect to the effects of scan session, scanner, and surface extraction tool. Five subjects were scanned 4 times at 3 MRI centers and other 5 subjects were scanned 3 times at 2 MRI centers, including 1 test-retest session. Sulcal pits were extracted on the white matter surfaces reconstructed with both Montreal Neurological Institute and Freesurfer pipelines. We estimated similarity of the presence of sulcal pits having a maximum value of 1 and their spatial difference within the same subject. The tests showed high similarity of the sulcal pit presence and low spatial difference. The similarity was more than 0.90 and the spatial difference was less than 1.7 mm in most cases according to different scan sessions or scanners, and more than 0.85 and about 2.0 mm across surface extraction tools. The reliability of sulcal pit extraction was more affected by the image processing-related factors than the scan session or scanner factors. Moreover, the similarity of sulcal pit distribution appeared to be largely influenced by the presence or absence of the sulcal pits on the shallow and small folds. We suggest that our sulcal pit extraction from MRI is highly reliable and could be useful for clinical applications as an imaging biomarker.	[Im, Kiho; Grant, P. Ellen] Harvard Univ, Sch Med, Div Newborn Med, Boston Childrens Hosp, Boston, MA USA; [Im, Kiho; Grant, P. Ellen] Harvard Univ, Sch Med, Ctr Fetal Neonatal Neuroimaging & Dev Sci, Boston Childrens Hosp, Boston, MA USA; [Lee, Jong-Min; Jeon, Seun] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Kim, Jong-Heon; Seo, Sang Won; Na, Duk L.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Grant, P. Ellen] Harvard Univ, Sch Med, Dept Radiol, Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Boston Children's Hospital; Harvard Medical School	Lee, JM (corresponding author), Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea.	ljm@hanyang.ac.kr	Jeon, Seun/AAK-3204-2020; Na, Duk Lyul/C-9598-2011; Grant, Peter/HIR-3733-2022	Jeon, Seun/0000-0003-2817-3352; Grant, Patricia/0000-0003-1005-4013	National Research Foundation of Korea [NRF-2009-352-D00344]; Korea Science and Engineering Foundation (KOSEF) NLRL program; Korean Government (MEST) [2011-0028333]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korea Science and Engineering Foundation (KOSEF) NLRL program(Korea Science and Engineering Foundation); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Research Foundation of Korea (grant NRF-2009-352-D00344) and the Korea Science and Engineering Foundation (KOSEF) NLRL program grant funded by the Korean Government (MEST) (2011-0028333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Coxeter H., 1969, INTRO GEOMETRY, V13, P216; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Derrfuss J, 2009, HUM BRAIN MAPP, V30, P299, DOI 10.1002/hbm.20501; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hasnain MK, 2006, HUM BRAIN MAPP, V27, P277, DOI 10.1002/hbm.20183; Hasnain MK, 2001, CEREB CORTEX, V11, P702, DOI 10.1093/cercor/11.8.702; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Im K, 2012, CEREB CORTE IN PRESS; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Im K, 2011, NEUROIMAGE, V57, P1077, DOI 10.1016/j.neuroimage.2011.04.062; Im K, 2011, NEUROIMAGE, V55, P1490, DOI 10.1016/j.neuroimage.2010.12.080; Im K, 2010, CEREB CORTEX, V20, P602, DOI 10.1093/cercor/bhp127; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Lanthier M, 2001, ALGORITHMICA, V30, P527, DOI 10.1007/s00453-001-0027-5; Lee JK, 2006, NEUROIMAGE, V31, P572, DOI 10.1016/j.neuroimage.2005.12.044; Lohmann G, 1999, CEREB CORTEX, V9, P754, DOI 10.1093/cercor/9.7.754; Lohmann G, 2008, CEREB CORTEX, V18, P1415, DOI 10.1093/cercor/bhm174; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Mangin J.-F., 1995, Journal of Mathematical Imaging and Vision, V5, P297, DOI 10.1007/BF01250286; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Regis J, 2005, NEUROL MED-CHIR, V45, P1, DOI 10.2176/nmc.45.1; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Walters RJL, 2001, NEPHRON, V87, P143, DOI 10.1159/000045903; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037; Zijdenbos A, 1996, LECT NOTES COMPUT SC, V1131, P439, DOI 10.1007/BFb0046984	39	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53678	10.1371/journal.pone.0053678	http://dx.doi.org/10.1371/journal.pone.0053678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308272	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100105
J	Kolaj-Robin, O; Noor, MR; O'Kane, SR; Baymann, F; Soulimane, T				Kolaj-Robin, Olga; Noor, Mohamed R.; O'Kane, Sarah R.; Baymann, Frauke; Soulimane, Tewfik			Atypical Features of Thermus thermophilus Succinate: Quinone Reductase	PLOS ONE			English	Article							BACILLUS-SUBTILIS SUCCINATE; FUMARATE REDUCTASE; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; MENAQUINONE OXIDOREDUCTASE; CRYSTAL-STRUCTURE; CYTOCHROME-B; DEHYDROGENASE; EXPRESSION; REPLACEMENT	The Thermus thermophilus succinate: quinone reductase (SQR), serving as the respiratory complex II, has been homologously produced under the control of a constitutive promoter and subsequently purified. The detailed biochemical characterization of the resulting wild type (wt-rcII) and His-tagged (rcII-His(8)-SdhB and rcII-SdhB-His(6)) complex II variants showed the same properties as the native enzyme with respect to the subunit composition, redox cofactor content and sensitivity to the inhibitors malonate, oxaloacetate, 3-nitropropionic acid and nonyl-4-hydroxyquinoline-N-oxide (NQNO). The position of the His-tag determined whether the enzyme retained its native trimeric conformation or whether it was present in a monomeric form. Only the trimer exhibited positive cooperativity at high temperatures. The EPR signal of the [2Fe-2S] cluster was sensitive to the presence of substrate and showed an increased rhombicity in the presence of succinate in the native and in all recombinant forms of the enzyme. The detailed analysis of the shape of this signal as a function of pH, substrate concentration and in the presence of various inhibitors and quinones is presented, leading to a model for the molecular mechanism that underlies the influence of succinate on the rhombicity of the EPR signal of the proximal iron-sulfur cluster.	[Kolaj-Robin, Olga; Noor, Mohamed R.; O'Kane, Sarah R.; Soulimane, Tewfik] Univ Limerick, Chem & Environm Sci Dept, Limerick, Ireland; [Kolaj-Robin, Olga; Noor, Mohamed R.; O'Kane, Sarah R.; Soulimane, Tewfik] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland; [Baymann, Frauke] Aix Marseille Univ, UMR7281, BIP CNRS, Lab Bioenerget & Ingn Prot, Marseille, France	University of Limerick; University of Limerick; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Baymann, F (corresponding author), Aix Marseille Univ, UMR7281, BIP CNRS, Lab Bioenerget & Ingn Prot, Marseille, France.	baymann@imm.cnrs.fr; tewfik.soulimane@ul.ie			Science Foundation Ireland [BICF685]; Irish Research Council for Science, Engineering and Technology; French National Center for Scientific Research (CNRS)	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Science Foundation Ireland (BICF685), by the Irish Research Council for Science, Engineering and Technology EMBARK Ulysses Research Visit to France 2009 grants (to TS) and PhD Scholarship (to MN) and by the French National Center for Scientific Research (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; Azarkina N, 2002, J BACTERIOL, V184, P5339, DOI 10.1128/JB.184.19.5339-5347.2002; BEINERT H, 1975, EUR J BIOCHEM, V54, P185, DOI 10.1111/j.1432-1033.1975.tb04128.x; Christenson A, 2008, BBA-BIOENERGETICS, V1777, P1203, DOI 10.1016/j.bbabio.2008.05.450; Darke PL, 1996, J BIOL CHEM, V271, P7445, DOI 10.1074/jbc.271.13.7445; Gambarelli S, 2004, INORG CHEM, V43, P1441, DOI 10.1021/ic0301167; Grisshammer Reinhard, 2005, Journal of Structural and Functional Genomics, V6, P159, DOI 10.1007/s10969-005-1917-6; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; HAGERHALL C, 1995, BIOCHEMISTRY-US, V34, P11080; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hederstedt L, 2002, BBA-BIOENERGETICS, V1553, P74, DOI 10.1016/S0005-2728(01)00231-6; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Kolaj-Robin O, 2011, BBA-BIOENERGETICS, V1807, P68, DOI 10.1016/j.bbabio.2010.10.009; KOTLYAR AB, 1984, BIOCHIM BIOPHYS ACTA, V784, P24, DOI 10.1016/0167-4838(84)90168-7; KROGER A, 1978, BIOCHIM BIOPHYS ACTA, V505, P129, DOI 10.1016/0304-4173(78)90010-1; KROGER A, 1992, ARCH MICROBIOL, V158, P311, DOI 10.1007/BF00245358; Kurokawa T, 2005, ARCH MICROBIOL, V183, P317, DOI 10.1007/s00203-005-0775-8; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; LAZAZZERA BA, 1993, GENE DEV, V7, P1993, DOI 10.1101/gad.7.10.1993; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Madej MG, 2006, EMBO J, V25, P4963, DOI 10.1038/sj.emboj.7601361; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Matsson M, 2000, BIOCHEMISTRY-US, V39, P8617, DOI 10.1021/bi000271m; Mohanty AK, 2004, PROTEIN EXPRES PURIF, V33, P311, DOI 10.1016/j.pep.2003.10.010; Mooser D, 2005, BBA-BIOENERGETICS, V1708, P262, DOI 10.1016/j.bbabio.2005.03.008; PETERSON J, 1992, J LIPID RES, V33, P1165; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shimizu H, 2012, J BIOCHEM, V151, P589, DOI 10.1093/jb/mvs051; SMIRNOVA IA, 1995, FEBS LETT, V359, P23, DOI 10.1016/0014-5793(94)01442-4; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Sytkowski AJ, 1998, P NATL ACAD SCI USA, V95, P1184, DOI 10.1073/pnas.95.3.1184; UNDEN G, 1980, BIOCHIM BIOPHYS ACTA, V591, P275, DOI 10.1016/0005-2728(80)90159-0; Wallace BA, 2003, PROTEIN SCI, V12, P875, DOI 10.1110/ps.0229603; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305	37	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53559	10.1371/journal.pone.0053559	http://dx.doi.org/10.1371/journal.pone.0053559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308253	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100090
J	Zayats, T; Yang, BZ; Xie, PX; Poling, J; Farrer, LA; Gelernter, J				Zayats, Tetyana; Yang, Bao-Zhu; Xie, Pingxing; Poling, James; Farrer, Lindsay A.; Gelernter, Joel			A Complex Interplay between Personality Domains, Marital Status and a Variant in CHRNA5 on the Risks of Cocaine, Nicotine Dependences and Cocaine-Induced Paranoia	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR GENES; MESSENGER-RNA EXPRESSION; UNITED-STATES; 5-FACTOR MODEL; SUBSTANCE USE; DRUG-USE; SEMISTRUCTURED ASSESSMENT; ADDICTIVE PERSONALITY; SMOKING INITIATION; COPING STYLES	Background: Personality correlates highly with both cocaine and nicotine dependencies (CD, ND), and their co-morbid psychopathologies. However, little is known about the nature of these relationships. This study examined if environment (marriage) or genetics (a single SNP, CHRNA5*rs16969968) would moderate the correlation of personality with CD, ND and cocaine-induced paranoia (CIP) in African and European Americans (AAs, EAs). Methods: 1432 EAs and 1513 AAs were examined using logistic regression. Personality was assessed by NEO-PI-R, while CD, ND and CIP were diagnosed according to DSM-IV. ND and CD were examined as binary traits and for the analysis of CIP, subjects were divided into 3 groups: (A) Controls with no CIP; (B) CD cases without CIP; and (C) CD cases with CIP. Multiple testing was Bonferroni-corrected. Results: For CD and ND in the EA population, marital status proved to be a significant moderator in their relationship with openness only (OR = 1.90, 95%CI = 1.36-2.64, p = 1.54e-04 and OR = 2.12, 95%CI = 1.52-2.90, p = 4.65e-06 respectively). For CIP, marriage was observed to moderate its correlation with openness and neuroticism (OR = 1.39, 95%CI = 1.18-1.63, p = 7.64e-04 and OR = 1.26, 95%CI = 1.12-1.42, p = 1.27e-03 respectively). The correlations moderated by rs16969968 were those of conscientiousness and CD (OR = 1.62, 95%CI: 1.23-2.12, p = 8.94e-04) as well as CIP (OR = 1.21, 95%CI: 1.11-1.32, p = 4.93e-04 when comparing group A versus group C). No significant interactions were observed in AA population. The Bonferroni-corrected significance threshold was set to be 1.67e-03. Conclusion: The role of personality in CD and CIP may be interceded by both environment and genetics, while in ND by environment only.	[Zayats, Tetyana; Yang, Bao-Zhu; Xie, Pingxing; Poling, James; Gelernter, Joel] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Poling, James; Gelernter, Joel] VACT Healthcare Ctr, West Haven, CT USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Biostat & Epidemiol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Med, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Ophthalmol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Genet & Genom, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Boston, MA USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Yale University; Yale University	Gelernter, J (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	joel.gelernter@yale.edu	Farrer, Lindsay/AAS-1035-2020; Xie, Pingxing/AAK-1965-2020	Poling, James/0000-0002-0133-3136; Farrer, Lindsay/0000-0001-5533-4225; Gelernter, Joel/0000-0002-4067-1859	National Institute on Drug Abuse (NIDA) [R01 DA12690, R01 DA12849, RC2 DA028909, K01 DA24758]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01 AA11330, R01 AA17535]; VA MERIT grant; VA Connecticut MIRECC Center; Brain and Behavior Research NARSAD Young Investigator award; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017535, R01AA011330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012690, K01DA024758, R01DA012849, RC2DA028909] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); VA MERIT grant; VA Connecticut MIRECC Center; Brain and Behavior Research NARSAD Young Investigator award; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by National Institute on Drug Abuse (NIDA) grants R01 DA12690, R01 DA12849, RC2 DA028909, and K01 DA24758, National Institute on Alcohol Abuse and Alcoholism (NIAAA) grants R01 AA11330 and R01 AA17535, a VA MERIT grant, and the VA Connecticut MIRECC Center, and a Brain and Behavior Research NARSAD Young Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 1998, DRUG ALCOHOL DEPEN, V50, P137, DOI 10.1016/S0376-8716(98)00023-4; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Bernstein E, 2005, J ADDICT DIS, V24, P43, DOI 10.1300/J069v24n04_04; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Botwin MD, 1997, J PERS, V65, P107, DOI 10.1111/j.1467-6494.1997.tb00531.x; BRADY KT, 1991, J CLIN PSYCHIAT, V52, P509; Broms U, 2004, NICOTINE TOB RES, V6, P447, DOI 10.1080/14622200410001696637; Brown JS, 2007, DEV PSYCHOL, V43, P1295, DOI 10.1037/0012-1649.43.6.1295; Budney A J, 1993, J Subst Abuse, V5, P117, DOI 10.1016/0899-3289(93)90056-H; Chen LS, 2009, ADDICTION, V104, P1731, DOI 10.1111/j.1360-0443.2009.02697.x; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; CHERRY N, 1976, BRIT J PREV SOC MED, V30, P123; Clemmey P, 1997, DRUG ALCOHOL DEPEN, V44, P123, DOI 10.1016/S0376-8716(96)01331-2; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Cromby J, 2009, THEOR PSYCHOL, V19, P335, DOI 10.1177/0959354309104158; Denissen JJA, 2008, J RES PERS, V42, P1285, DOI 10.1016/j.jrp.2008.04.002; DERBY CA, 1994, AM J PREV MED, V10, P327, DOI 10.1016/S0749-3797(18)30560-9; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Donnellan MB, 2004, J RES PERS, V38, P481, DOI 10.1016/j.jrp.2004.01.001; Epstein DH, 2010, ADDICT BEHAV, V35, P318, DOI 10.1016/j.addbeh.2009.11.003; Erlich PM, 2010, HUM GENET, V128, P491, DOI 10.1007/s00439-010-0876-6; Freathy RM, 2011, INT J EPIDEMIOL, V40, P1617, DOI 10.1093/ije/dyr077; FUNDER DC, 1995, PSYCHOL REV, V102, P652, DOI 10.1037/0033-295X.102.4.652; Garlow SJ, 2007, J PSYCHIATR RES, V41, P530, DOI 10.1016/j.jpsychires.2005.08.008; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grant BF, 1997, J STUD ALCOHOL, V58, P464, DOI 10.15288/jsa.1997.58.464; Grucza RA, 2010, ADDICT BIOL, V15, P346, DOI 10.1111/j.1369-1600.2010.00220.x; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Harwood HJ, 1999, ADDICTION, V94, P631; Heinz AJ, 2009, ADDICT BEHAV, V34, P258, DOI 10.1016/j.addbeh.2008.10.020; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Johnson EO, 2010, ADDICTION, V105, P2014, DOI 10.1111/j.1360-0443.2010.03074.x; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Kerr JS, 1996, HUM PSYCHOPHARM CLIN, V11, pS9; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lee CW, 2007, AM J PUBLIC HEALTH, V97, P1503, DOI 10.2105/AJPH.2005.083527; Lee-Baggley D, 2005, J PERS, V73, P1141, DOI 10.1111/j.1467-6494.2005.00345.x; LIPKUS IM, 1994, HEALTH PSYCHOL, V13, P149, DOI 10.1037/0278-6133.13.2.149; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; McCormick RA, 1998, ADDICT BEHAV, V23, P497, DOI 10.1016/S0306-4603(98)00005-7; McCrae R.R., 2002, 5 FACTOR MODEL PERSO; McGue M, 1999, J CONSULT CLIN PSYCH, V67, P394, DOI 10.1037/0022-006X.67.3.394; McKusick D, 1998, HEALTH AFFAIR, V17, P147, DOI 10.1377/hlthaff.17.5.147; Mello NK, 2011, EXP CLIN PSYCHOPHARM, V19, P203, DOI 10.1037/a0023373; Merline AC, 2004, AM J PUBLIC HEALTH, V94, P96, DOI 10.2105/AJPH.94.1.96; Moos RH, 2002, ADDICTION, V97, P75, DOI 10.1046/j.1360-0443.2002.00063.x; Muhuri PK, 2011, AM J DRUG ALCOHOL AB, V37, P155, DOI 10.3109/00952990.2011.553977; NATHAN PE, 1988, J CONSULT CLIN PSYCH, V56, P183, DOI 10.1037/0022-006X.56.2.183; O'Rourke N, 2011, AGING MENT HEALTH, V15, P344, DOI 10.1080/13607863.2010.519324; Orr N, 2008, ADV GENET, V62, P1, DOI 10.1016/S0065-2660(08)00601-9; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; Pierucci-Lagha A, 2005, DRUG ALCOHOL DEPEN, V80, P303, DOI 10.1016/j.drugalcdep.2005.04.005; Pierucci-Lagha A, 2007, DRUG ALCOHOL DEPEN, V91, P85, DOI 10.1016/j.drugalcdep.2007.04.014; Quirk SW, 1998, ASSESSMENT, V5, P157, DOI 10.1177/107319119800500206; REVELLE W, 1995, ANNU REV PSYCHOL, V46, P295, DOI 10.1146/annurev.ps.46.020195.001455; Roll JM, 1996, DRUG ALCOHOL DEPEN, V40, P195, DOI 10.1016/0376-8716(96)01219-7; Roll JM, 1997, EXP CLIN PSYCHOPHARM, V5, P263, DOI 10.1037/1064-1297.5.3.263; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; SATEL SL, 1991, AM J PSYCHIAT, V148, P495; Saucier G., 1996, 5 FACTOR MODEL PERSO; Sherva R, 2008, ADDICTION, V103, P1544, DOI 10.1111/j.1360-0443.2008.02279.x; Sherva R, 2010, NEUROPSYCHOPHARMACOL, V35, P1921, DOI 10.1038/npp.2010.64; Smith RM, 2011, EUR J HUM GENET, V19, P76, DOI 10.1038/ejhg.2010.120; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x; Terracciano A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-22; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; Trinidad DR, 2009, NICOTINE TOB RES, V11, P203, DOI 10.1093/ntr/ntn018; US Surgeon General, 1998, MMWR RECOMM REP, V47, pv; van Loon AJM, 2005, EUR J PUBLIC HEALTH, V15, P256, DOI 10.1093/eurpub/cki077; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; Wang JC, 2009, HUM MOL GENET, V18, P3125, DOI 10.1093/hmg/ddp231; Watson D, 1996, J PERS, V64, P737, DOI 10.1111/j.1467-6494.1996.tb00943.x; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; WHITE HR, 1995, ADDICTION, V90, P947, DOI 10.1046/j.1360-0443.1995.9079477.x; Williams DR, 1992, J HLTH SOCIAL BEHAV, V33; Williams PG, 2009, J RES PERS, V43, P777, DOI 10.1016/j.jrp.2009.06.003; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Yang BZ, 2005, GENET EPIDEMIOL, V28, P302, DOI 10.1002/gepi.20070; Zhang HP, 2010, NEUROPSYCHOPHARMACOL, V35, P2211, DOI 10.1038/npp.2010.95	87	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e49368	10.1371/journal.pone.0049368	http://dx.doi.org/10.1371/journal.pone.0049368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308091	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100001
J	Zhong, P; Agosto, LM; Ilinskaya, A; Dorjbal, B; Truong, R; Derse, D; Uchil, PD; Heidecker, G; Mothes, W				Zhong, Peng; Agosto, Luis M.; Ilinskaya, Anna; Dorjbal, Batsukh; Truong, Rosaline; Derse, David; Uchil, Pradeep D.; Heidecker, Gisela; Mothes, Walther			Cell-to-Cell Transmission Can Overcome Multiple Donor and Target Cell Barriers Imposed on Cell-Free HIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIROLOGICAL SYNAPSES; PERIPHERAL-BLOOD; IN-VIVO; NEUTRALIZING ANTIBODY; LYMPHOTROPIC-VIRUS; VACCINIA VIRUS; F-ACTIN; SPREAD; TYPE-1	Virus transmission can occur either by a cell-free mode through the extracellular space or by cell-to-cell transmission involving direct cell-to-cell contact. The factors that determine whether a virus spreads by either pathway are poorly understood. Here, we assessed the relative contribution of cell-free and cell-to-cell transmission to the spreading of the human immunodeficiency virus (HIV). We demonstrate that HIV can spread by a cell-free pathway if all the steps of the viral replication cycle are efficiently supported in highly permissive cells. However, when the cell-free path was systematically hindered at various steps, HIV transmission became contact-dependent. Cell-to-cell transmission overcame barriers introduced in the donor cell at the level of gene expression and surface retention by the restriction factor tetherin. Moreover, neutralizing antibodies that efficiently inhibit cell-free HIV were less effective against cell-to-cell transmitted virus. HIV cell-to-cell transmission also efficiently infected target T cells that were relatively poorly susceptible to cell-free HIV. Importantly, we demonstrate that the donor and target cell types influence critically the extent by which cell-to-cell transmission can overcome each barrier. Mechanistically, cell-to-cell transmission promoted HIV spread to more cells and infected target cells with a higher proviral content than observed for cell-free virus. Our data demonstrate that the frequently observed contact-dependent spread of HIV is the result of specific features in donor and target cell types, thus offering an explanation for conflicting reports on the extent of cell-to-cell transmission of HIV.	[Zhong, Peng; Agosto, Luis M.; Truong, Rosaline; Uchil, Pradeep D.; Mothes, Walther] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA; [Ilinskaya, Anna; Dorjbal, Batsukh; Derse, David; Heidecker, Gisela] Natl Canc Inst Frederick, HIV Drug Resistance Program, Frederick, MD USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mothes, W (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	walther.mothes@yale.edu	sourisseau, marion/M-7542-2014	Uchil, Pradeep/0000-0002-7236-858X	National Institutes of Health [R01s CA098727, AI084096]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA098727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the National Institutes of Health R01s CA098727 & AI084096 to WM, and a fellowship from the China Scholarship Council-Yale World Scholars in the Biomedical Sciences to PZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Alfsen A, 2005, MOL BIOL CELL, V16, P4267, DOI 10.1091/mbc.E05-03-0192; Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; BLACK FL, 1955, J IMMUNOL, V74, P236; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; BUBB MR, 1994, J BIOL CHEM, V269, P14869; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Casartelli N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000955; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Cordeiro JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008506; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Del Portillo A, 2011, J VIROL, V85, P7169, DOI 10.1128/JVI.00231-11; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Flint SJ, 2009, PRINCIPLES VIROLOGY, P40; Ganesh L, 2004, J VIROL, V78, P11980, DOI 10.1128/JVI.78.21.11980-11987.2004; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; GUPTA P, 1989, J VIROL, V63, P2361, DOI 10.1128/JVI.63.5.2361-2365.1989; Haller C, 2011, EUR J CELL BIOL, V90, P913, DOI 10.1016/j.ejcb.2010.09.010; Hatziioannou T, 2006, SCIENCE, V314, P95, DOI 10.1126/science.1130994; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; IWASAKI Y, 1975, LAB INVEST, V33, P391; Jin J, 2011, J VIROL, V85, P7672, DOI 10.1128/JVI.00409-11; Jin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006551; Jin J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000163; Johnson DC, 2002, J VIROL, V76, P1, DOI 10.1128/JVI.76.1.1-8.2002; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Jouvenet N, 2006, CELL MICROBIOL, V8, P1803, DOI 10.1111/j.1462-5822.2006.00750.x; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kuhl BD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-115; Lawrence DMP, 2000, J VIROL, V74, P1908, DOI 10.1128/JVI.74.4.1908-1918.2000; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Massanella M, 2009, AIDS, V23, P183, DOI 10.1097/QAD.0b013e32831ef1a3; Mazurov D, 2011, J VIROL, DOI [10.1128/JVI.06993-06911, DOI 10.1128/JVI.06993-06911]; Mazurov D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000788; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; MERZ DC, 1980, J EXP MED, V151, P275, DOI 10.1084/jem.151.2.275; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; PHILLIPS DM, 1994, AIDS, V8, P719, DOI 10.1097/00002030-199406000-00001; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Richardson MW, 2008, J VIROL, V82, P11117, DOI 10.1128/JVI.01046-08; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schindler M, 2005, J VIROL, V79, P5489, DOI 10.1128/JVI.79.9.5489-5498.2005; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09; Vogt VM, 1999, J VIROL, V73, P7050, DOI 10.1128/JVI.73.8.7050-7055.1999; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036	76	95	97	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53138	10.1371/journal.pone.0053138	http://dx.doi.org/10.1371/journal.pone.0053138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308151	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100031
J	Kumps, C; Fieuw, A; Mestdagh, P; Menten, B; Lefever, S; Pattyn, F; De Brouwer, S; Sante, T; Schulte, JH; Schramm, A; Van Roy, N; Van Maerken, T; Noguera, R; Combaret, V; Devalck, C; Westermann, F; Laureys, G; Eggert, A; Vandesompele, J; De Preter, K; Speleman, F				Kumps, Candy; Fieuw, Annelies; Mestdagh, Pieter; Menten, Bjorn; Lefever, Steve; Pattyn, Filip; De Brouwer, Sara; Sante, Tom; Schulte, Johannes Hubertus; Schramm, Alexander; Van Roy, Nadine; Van Maerken, Tom; Noguera, Rosa; Combaret, Valerie; Devalck, Christine; Westermann, Frank; Laureys, Genevieve; Eggert, Angelika; Vandesompele, Jo; De Preter, Katleen; Speleman, Frank			Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; N-MYC; TRANSCRIPTIONAL TARGET; ACTIVATING MUTATIONS; THERAPEUTIC TARGET; ALK KINASE; EXPRESSION; MICRORNA; RECEPTOR; REVEALS	Neuroblastoma is an embryonic tumor arising from immature sympathetic nervous system cells. Recurrent genomic alterations include MYCN and ALK amplification as well as recurrent patterns of gains and losses of whole or large partial chromosome segments. A recent whole genome sequencing effort yielded no frequently recurring mutations in genes other than those affecting ALK. However, the study further stresses the importance of DNA copy number alterations in this disease, in particular for genes implicated in neuritogenesis. Here we provide additional evidence for the importance of focal DNA copy number gains and losses, which are predominantly observed in MYCN amplified tumors. A focal 5 kb gain encompassing the MYCN regulated miR-17 similar to 92 cluster as sole gene was detected in a neuroblastoma cell line and further analyses of the array CGH data set demonstrated enrichment for other MYCN target genes in focal gains and amplifications. Next we applied an integrated genomics analysis to prioritize MYCN down regulated genes mediated by MYCN driven miRNAs within regions of focal heterozygous or homozygous deletion. We identified RGS5, a negative regulator of G-protein signaling implicated in vascular normalization, invasion and metastasis, targeted by a focal homozygous deletion, as a new MYCN target gene, down regulated through MYCN activated miRNAs. In addition, we expand the miR-17 similar to 92 regulatory network controlling TGF beta signaling in neuroblastoma with the ring finger protein 11 encoding gene RNF11, which was previously shown to be targeted by the miR-17 similar to 92 member miR-19b. Taken together, our data indicate that focal DNA copy number imbalances in neuroblastoma (1) target genes that are implicated in MYCN signaling, possibly selected to reinforce MYCN oncogene addiction and (2) serve as a resource for identifying new molecular targets for treatment.	[Kumps, Candy; Fieuw, Annelies; Mestdagh, Pieter; Menten, Bjorn; Lefever, Steve; Pattyn, Filip; De Brouwer, Sara; Sante, Tom; Van Roy, Nadine; Van Maerken, Tom; Vandesompele, Jo; De Preter, Katleen; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Schulte, Johannes Hubertus; Schramm, Alexander; Eggert, Angelika] Univ Childrens Hosp Essen, Dept Pediat Oncol & Haematol, Essen, Germany; [Noguera, Rosa] Univ Valencia, Sch Med, Dept Pathol, Valencia, Spain; [Combaret, Valerie] FNCLCC, Ctr Leon Berard, Lab Rech Translat, Lyon, France; [Devalck, Christine] Childrens Univ Hosp, Brussels, Belgium; [Westermann, Frank] German Canc Res Ctr, Dept Tumor Genet, Heidelberg, Germany; [Laureys, Genevieve] Ghent Univ Hosp, Dept Pediat Hematol Oncol, Ghent, Belgium	Ghent University; Ghent University Hospital; University of Duisburg Essen; University of Valencia; UNICANCER; Centre Leon Berard; Helmholtz Association; German Cancer Research Center (DKFZ); Ghent University; Ghent University Hospital	Speleman, F (corresponding author), Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium.	franki.speleman@ugent.be	laureys, genevieve/AAG-2390-2021; Schramm, Alexander/G-5688-2010; speleman, frank/AAR-5184-2020; Eggert, Angelika/AAE-6907-2022; Schulte, Johannes H/G-3981-2010; Vandesompele, Jo/W-3411-2018; Westermann, Frank/F-7509-2013; De Preter, Katleen/I-7135-2013; Schulte, Johannes H./V-2474-2018; Pattyn, Filip/Q-4003-2019; Menten, Björn/B-3072-2013; Pattyn, Filip/A-4164-2015	Schramm, Alexander/0000-0001-7670-7529; speleman, frank/0000-0002-6628-8559; Eggert, Angelika/0000-0003-3476-8184; Vandesompele, Jo/0000-0001-6274-0184; De Preter, Katleen/0000-0002-7726-5096; Pattyn, Filip/0000-0003-0858-6651; Pattyn, Filip/0000-0003-0858-6651; Mestdagh, Pieter/0000-0001-7821-9684; Menten, Bjorn/0000-0001-8182-659X; Schulte, Johannes Hubertus/0000-0003-0671-1201	Institute for the Promotion of Innovation by Science and Technology (IWT-Vlaanderen) [081373]; Fund for Scientific Research Flanders (FWO); "Emmanuel van der Schueren'' grant from the "Vlaamse Liga tegen Kanker''; European Union [037260, 259348]; FWO [G.0198.08]; Belgian program of Interuniversity Poles of Attraction (IUAP); GOA [01G01910]; FOD [NKP_29_014]; IWT [SBO60848]; department of Pathology, Medical School, University of Valencia, Valencia, Spain [RD06/0020/0102, PI10/0015, 396/2009]	Institute for the Promotion of Innovation by Science and Technology (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research Flanders (FWO)(FWO); "Emmanuel van der Schueren'' grant from the "Vlaamse Liga tegen Kanker''; European Union(European Commission); FWO(FWO); Belgian program of Interuniversity Poles of Attraction (IUAP); GOA; FOD; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); department of Pathology, Medical School, University of Valencia, Valencia, Spain	CK is indebted to the Institute for the Promotion of Innovation by Science and Technology (IWT-Vlaanderen; http://www.iwt.be/) for a predoctoral fellowship (grant number 081373), AF, KD, PM, and FP are supported by the Fund for Scientific Research Flanders (FWO; http://www.fwo.be/). SD is supported by an "Emmanuel van der Schueren'' grant from the "Vlaamse Liga tegen Kanker'' (http://www.tegenkanker.be/). This work was supported by the European Union (STREP-EET project, grant number 037260; http://ec.europa.eu/research/index.cfm), the FWO (grant number: G.0198.08), the Belgian program of Interuniversity Poles of Attraction (IUAP; http://www.belspo.be/belspo/iap/index_en.stm), initiated by the Belgian State, Prime Minister's Office, Science Policy Programming, by the GOA (http://www.ugent.be/nl/onderzoek/financiering/bof/GOA; grant number 01G01910), the FOD (http://www.health.belgium.be/eportal; grant number: NKP_29_014) and the IWT (grant number: SBO60848). This work was also funded by the department of Pathology, Medical School, University of Valencia, Valencia, Spain: RD06/0020/0102 and PI10/0015 (ISCIII & ERDF); 396/2009 (FAECC). The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no259348 (ASSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarova AM, 2011, SEMIN CANCER BIOL, V21, P267, DOI 10.1016/j.semcancer.2011.09.005; Azmi P, 2005, EUR J CANCER, V41, P2549, DOI 10.1016/j.ejca.2005.08.020; Azmi PB, 2009, ANTICANCER RES, V29, P2253; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brouwer S De, 2011, INT J CANC; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Caren H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-353; Chen LD, 2010, CANCER RES, V70, P1377, DOI 10.1158/0008-5472.CAN-09-2598; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chesler L, 2011, SEMIN CANCER BIOL, V21, P245, DOI 10.1016/j.semcancer.2011.09.011; Chiang MF, 2012, BIOMED PHARMACOTHER, V66, P433, DOI 10.1016/j.biopha.2012.03.003; Connor MK, 2004, ONCOGENE, V23, P2089, DOI 10.1038/sj.onc.1207380; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gantier MP, 2012, NUCL ACIDS RES; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gogada R, 2011, CELL CYCLE, V10, P4128, DOI 10.4161/cc.10.23.18292; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heukamp LC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003967; Hofer-Warbinek R, 2004, CELL DEATH DIFFER, V11, P1317, DOI 10.1038/sj.cdd.4401502; Hogarty MD, 2012, CANCER CELL, V21, P145, DOI 10.1016/j.ccr.2012.01.018; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Hu BS, 2012, WORLD J GASTROENTERO, V18, P3020, DOI 10.3748/wjg.v18.i23.3020; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang GC, 2012, J SURG ONCOL, V105, P420, DOI 10.1002/jso.22033; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kim M, 2009, CANCER GENET CYTOGEN, V195, P59, DOI 10.1016/j.cancergencyto.2009.06.013; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Li JN, 2011, BIOCHEMISTRY-US, V50, P5566, DOI 10.1021/bi200642e; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Lutz W, 1996, ONCOGENE, V13, P803; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mac SM, 2000, MOL CARCINOGEN, V29, P76, DOI 10.1002/1098-2744(200010)29:2<76::AID-MC4>3.0.CO;2-Y; Manzur M, 2009, TRENDS CARDIOVAS MED, V19, P26, DOI 10.1016/j.tcm.2009.04.002; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Meehan M, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-6; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Meyle KD, 2009, HUM GENET, V126, P499, DOI 10.1007/s00439-009-0715-9; Michels E, 2007, GENE CHROMOSOME CANC, V46, P1098, DOI 10.1002/gcc.20496; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Molenaar JJ, 2012, NAT GENET; Monti S, 2012, CANCER CELL, V22, P359, DOI 10.1016/j.ccr.2012.07.014; Mosse YP, 2008, NATURE; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Reiff T, 2011, DEVELOPMENT, V138, P4699, DOI 10.1242/dev.072157; Schonherr C., 2012, ONCOGENE; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Slack A, 2005, CANCER LETT, V228, P21, DOI 10.1016/j.canlet.2005.01.050; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Tzoneva G, 2012, CURR TOP MICROBIOL, V360, P163, DOI 10.1007/82_2012_232; van de Wiel MA, 2009, BIOINFORMATICS, V25, P1099, DOI 10.1093/bioinformatics/btp132; Van Maerken T, 2012, BMC RES NOTES UNPUB; Van Maerken T, 2006, CANCER RES, V66, P9646, DOI 10.1158/0008-5472.CAN-06-0792; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Yang HW, 2001, ONCOGENE, V20, P5075, DOI 10.1038/sj.onc.1204456; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	78	34	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52321	10.1371/journal.pone.0052321	http://dx.doi.org/10.1371/journal.pone.0052321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308108	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100008
J	Li, XJ; Ren, ZJ; Qin, JW; Zhao, JH; Tang, JH; Ji, MH; Wu, JZ				Li, Xiu Juan; Ren, Zhao Jun; Qin, Jian Wei; Zhao, Jian Hua; Tang, Jin Hai; Ji, Ming Hua; Wu, Jian Zhong			Coffee Consumption and Risk of Breast Cancer: An Up-To- Date Meta-Analysis	PLOS ONE			English	Article							CAFFEINE CONSUMPTION; DIETARY FACTORS; NO ASSOCIATION; GREEN TEA; COHORT; BRCA1; INHIBITION; DISEASE; MEN	Objectives: This updated meta-analysis was conducted to assess the association between coffee consumption and breast cancer risk. Methods: We conducted a systematic search updated July 2012 to identify observational studies providing quantitative estimates for breast cancer risk in relation to coffee consumption. Pooled relative risks (RRs) with 95% confidence intervals (CIs) were calculated using a random-effects model, and generalized least square trend estimation was used to assess dose-response relationships. Results: A total of 26 studies (16 cohort and 10 case-control studies) on coffee intake with 49497 breast cancer cases were included in the meta-analysis. The pooled RR showed a borderline significant influence of highest coffee consumption (RR = 0.96; 95% CI 0.93-1.00), low-to moderate coffee consumption (RR = 0.99; 95% CI 0.95-1.04), or an increment of 2 cups/day of coffee consumption (RR = 0.98; 95% CI 0.97-1.00) on the risk of breast cancer. In stratified analysis, a significant inverse association was observed in ER-negative subgroup. However, no significant association was noted in the others. Conclusions: Our findings suggest that increased coffee intake is not associated with a significantly reduced risk of breast cancer, but we observe an inverse association in ER-negative subgroup analysis. More large studies are needed to determine subgroups to obtain more valuable data on coffee drinking and breast cancer risk.	[Li, Xiu Juan] Xuzhou Med Coll, Dept Oncol, Xuzhou, Peoples R China; [Ren, Zhao Jun] Xuzhou Med Coll, Dept Pathol, Xuzhou, Peoples R China; [Qin, Jian Wei; Tang, Jin Hai] Jiangsu Canc Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Zhao, Jian Hua] Jiangsu Canc Hosp, Clin Lab Ctr, Nanjing, Jiangsu, Peoples R China; [Ji, Ming Hua] Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China; [Wu, Jian Zhong] Jiangsu Canc Hosp, Oncol Cent Lab, Nanjing, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhao, JH (corresponding author), Jiangsu Canc Hosp, Clin Lab Ctr, Nanjing, Jiangsu, Peoples R China.	jhzhao2838@sina.com; lxj221356@yahoo.cn	Wu, Jian/AAU-5221-2020; li, xiu/GXV-1745-2022; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China [81272470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81272470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001; Arab L, 2010, NUTR CANCER, V62, P271, DOI 10.1080/01635580903407122; Bageman E, 2008, CANCER EPIDEM BIOMAR, V17, P895, DOI 10.1158/1055-9965.EPI-07-0555; Baker JA, 2006, J NUTR, V136, P166, DOI 10.1093/jn/136.1.166; Boggs DA, 2010, CANCER CAUSE CONTROL, V21, P1941, DOI 10.1007/s10552-010-9622-6; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EWERTZ M, 1990, INT J CANCER, V46, P779, DOI 10.1002/ijc.2910460505; Fagherazzi G, 2011, PUBLIC HEALTH NUTR, V14, P1315, DOI 10.1017/S1368980011000371; FOLSOM AR, 1993, AM J EPIDEMIOL, V138, P380, DOI 10.1093/oxfordjournals.aje.a116870; Ganmaa D, 2008, INT J CANCER, V122, P2071, DOI 10.1002/ijc.23336; Gierach GL, 2012, INT J CANCER, V131, P452, DOI 10.1002/ijc.26372; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Gronwald J, 2006, BREAST CANCER RES TR, V95, P105, DOI 10.1007/s10549-005-9051-5; Hirvonen T, 2006, ANN EPIDEMIOL, V16, P503, DOI 10.1016/j.annepidem.2005.09.011; Horner NK, 2002, CANCER EPIDEM BIOMAR, V11, P121; HOYER AP, 1992, CANCER CAUSE CONTROL, V3, P403, DOI 10.1007/BF00051352; Hunter D. J., 1992, American Journal of Epidemiology, V136, P1000; Ishitani K, 2008, ARCH INTERN MED, V168, P2022, DOI 10.1001/archinte.168.18.2022; JACOBSEN BK, 1986, J NATL CANCER I, V76, P823; Johnson KC, 2002, EUR J CANCER PREV, V11, P253, DOI 10.1097/00008469-200206000-00009; KATSOUYANNI K, 1986, INT J CANCER, V38, P815, DOI 10.1002/ijc.2910380606; Key TJ, 1999, BRIT J CANCER, V81, P1248, DOI 10.1038/sj.bjc.6690837; Kotsopoulos J, 2007, CANCER EPIDEM BIOMAR, V16, P912, DOI 10.1158/1055-9965.EPI-06-1074; Larsson SC, 2009, CANCER CAUSE CONTROL, V20, P2039, DOI 10.1007/s10552-009-9396-x; LAVECCHIA C, 1986, SURGERY, V100, P477; LE MG, 1985, AM J EPIDEMIOL, V122, P721, DOI 10.1093/oxfordjournals.aje.a114152; Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206; LEVI F, 1993, NUTR CANCER, V19, P327, DOI 10.1080/01635589309514263; Li JM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2879; LUBIN F, 1985, J NATL CANCER I, V74, P569; Mannisto S, 1999, J CLIN EPIDEMIOL, V52, P429, DOI 10.1016/S0895-4356(99)00010-4; MCLAUGHLIN CC, 1992, CANCER CAUSE CONTROL, V3, P175, DOI 10.1007/BF00051658; Michels KB, 2002, ANN EPIDEMIOL, V12, P21, DOI 10.1016/S1047-2797(01)00238-1; Nilsson LM, 2010, CANCER CAUSE CONTROL, V21, P1533, DOI 10.1007/s10552-010-9582-x; Nkondjock A, 2006, INT J CANCER, V118, P103, DOI 10.1002/ijc.21296; Olsen A, 2004, CANCER EPIDEM BIOMAR, V13, P2084; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pathy NB, 2010, BREAST CANCER RES TR, V121, P461, DOI 10.1007/s10549-009-0583-y; ROSENBERG L, 1985, AM J EPIDEMIOL, V122, P391, DOI 10.1093/oxfordjournals.aje.a114120; Rosenblatt KA, 1999, CANCER CAUSE CONTROL, V10, P107, DOI 10.1023/A:1008808925665; SCALBERT A., 2000, J NUTR, V130, P2073; STENSVOLD I, 1994, CANCER CAUSE CONTROL, V5, P401, DOI 10.1007/BF01694753; Suzuki Y, 2004, BRIT J CANCER, V90, P1361, DOI 10.1038/sj.bjc.6601652; Tang NP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.019; Tavani A, 1998, EUR J CANCER PREV, V7, P77; VANDERPLOEG LC, 1991, CANCER LETT, V56, P245, DOI 10.1016/0304-3835(91)90009-7; VATTEN LJ, 1990, BRIT J CANCER, V62, P267, DOI 10.1038/bjc.1990.274; WELSCH CW, 1983, INT J CANCER, V32, P479, DOI 10.1002/ijc.2910320415; WOLFROM D, 1990, J MED, V21, P225; Wu AH, 2003, INT J CANCER, V106, P574, DOI 10.1002/ijc.11259	52	53	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52681	10.1371/journal.pone.0052681	http://dx.doi.org/10.1371/journal.pone.0052681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308117	gold, Green Published, Green Submitted			2022-12-27	WOS:000313670100011
J	Ishida, Y; Ishibashi, J; Leal, WS				Ishida, Yuko; Ishibashi, Jun; Leal, Walter S.			Fatty Acid Solubilizer from the Oral Disk of the Blowfly	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEIN; PHORMIA-REGINA; CRYSTAL-STRUCTURE; CORPUS ALLATUM; DROSOPHILA-MELANOGASTER; EXPRESSION PATTERNS; ANOPHELES-GAMBIAE; JUVENILE-HORMONE; SILKWORM MOTH; RELEASE	Background: Blowflies are economic pests of the wool industry and potential vectors for epidemics. The establishment of a pesticide-free, environmentally friendly blowfly control strategy is necessary. Blowflies must feed on meat in order to initiate the cascade of events that are involved in reproduction including juvenile hormone synthesis, vitellogenesis, and mating. During feeding blowflies regurgitate salivary lipase, which may play a role in releasing fatty acids from triglycerides that are found in food. However, long-chain fatty acids show low solubility in aqueous solutions. In order to solubilize and ingest the released hydrophobic fatty acids, the blowflies must use a solubilizer. Methodology: We applied native PAGE, Edman degradation, cDNA cloning, and RT-PCR to characterize a protein that accumulated in the oral disk of the black blowfly, Phormia regina. In situ hybridization was carried out to localize the expression at the cellular level. A fluorescence competitive binding assay was used to identify potential ligands of this protein. Conclusion: A protein newly identified from P. regina (PregOBP56a) belonged to the classic odorant-binding protein (OBP) family. This gene was expressed in a cluster of cells that was localized between pseudotracheae on the oral disk, which are not accessory cells of the taste peg chemosensory sensilla that normally synthesize OBPs. At pH 7 and pH 6, PregOBP56a bound palmitic, stearic, oleic, and linoleic acids, that are mainly found in chicken meat. The binding affinity of PregOBP56a decreased at pH 5. We propose that PregOBP56a is a protein that solubilizes fatty acids during feeding and subsequently helps to deliver the fatty acids to the midgut where it may help in the process of reproduction. As such, PregOBP56a is a potential molecular target for controlling the blowfly.	[Ishida, Yuko] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo 657, Japan; [Ishibashi, Jun] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Kobe University; National Institute of Agrobiological Sciences - Japan; University of California System; University of California Davis	Ishida, Y (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama, Japan.	y-ishida@pu-toyama.ac.jp	Leal, Walter/ABC-6940-2021	Leal, Walter/0000-0002-6800-1240; Leal Filho, Walter/0000-0002-1241-5225	Global COE program for Global Center for Education and Research in Integrative Membrane Biology; KAKENHI [23580070]; National Institutes of Health [1RO1AIO95514-01A1]	Global COE program for Global Center for Education and Research in Integrative Membrane Biology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was partly supported by the Global COE program for Global Center for Education and Research in Integrative Membrane Biology, Grant-in-Aid for Scientific Research (C) and KAKENHI (23580070) (to YI) and National Institutes of Health (1RO1AIO95514-01A1) to (WSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Almeida Jussara Carnevale de, 2006, Rev. Bras. Cienc. Farm., V42, P109, DOI 10.1590/S1516-93322006000100012; Coronado-Gonzalez PA, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.7301; Dethier VG, 1976, HUNGRY FLY; Galindo K, 2001, GENETICS, V159, P1059; Ghafouri B, 2003, PROTEOMICS, V3, P1003, DOI 10.1002/pmic.200300426; Graham-Smith GS, 1911, J HYG-CAMBRIDGE, V11, P390, DOI 10.1017/S0022172400016843; HANSENBAY CM, 1978, J EXP BIOL, V75, P189; Hayashi Toshihiko, 2012, Medical Entomology and Zoology, V63, P85; Hekmat-Scafe DS, 2000, GENETICS, V155, P117; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Ishida Y, 2011, NATURWISSENSCHAFTEN, V98, P635, DOI 10.1007/s00114-011-0806-z; KERLIN RL, 1992, MED VET ENTOMOL, V6, P121, DOI 10.1111/j.1365-2915.1992.tb00587.x; KNIPLING E. F., 1937, Journal of Parasitology, V23, P451, DOI 10.2307/3272391; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Leal Walter S., 2003, P447, DOI 10.1016/B978-012107151-6/50017-7; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; LEVOT GW, 1995, INT J PARASITOL, V25, P1355, DOI 10.1016/0020-7519(95)00070-I; LIU MA, 1988, PHYSIOL ENTOMOL, V13, P69, DOI 10.1111/j.1365-3032.1988.tb00910.x; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Nisimura T, 2005, J NEUROSCI, V25, P7507, DOI 10.1523/JNEUROSCI.1862-05.2005; ORR CWM, 1964, J INSECT PHYSIOL, V10, P53, DOI 10.1016/0022-1910(64)90093-9; ORR CWM, 1964, J INSECT PHYSIOL, V10, P103, DOI 10.1016/0022-1910(64)90099-X; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; Park SK, 2000, CELL TISSUE RES, V300, P181, DOI 10.1007/s004410050059; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; QIN WH, 1995, J INSECT PHYSIOL, V41, P617, DOI 10.1016/0022-1910(94)00135-4; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Savenije B, 2002, POULTRY SCI, V81, P699, DOI 10.1093/ps/81.5.699; Sawabe Kyoko, 2011, Influenza Res Treat, V2011, P652652, DOI 10.1155/2011/652652; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; STOFFOLANO JG, 1995, ANN ENTOMOL SOC AM, V88, P240, DOI 10.1093/aesa/88.2.240; Sukontason K, 2008, MICRON, V39, P190, DOI 10.1016/j.micron.2007.01.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR CW, 1985, AM J PHYSIOL, V249, pR209, DOI 10.1152/ajpregu.1985.249.2.R209; Tellam RL, 1997, INT J PARASITOL, V27, P261, DOI 10.1016/S0020-7519(96)00174-9; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; Vandermoten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023608; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; VORUM H, 1992, BIOCHIM BIOPHYS ACTA, V1126, P135, DOI 10.1016/0005-2760(92)90283-2; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015403; Yin CM, 1999, J INSECT PHYSIOL, V45, P815, DOI 10.1016/S0022-1910(99)00047-5; ZOU BX, 1989, PHYSIOL ENTOMOL, V14, P233, DOI 10.1111/j.1365-3032.1989.tb00956.x	54	37	41	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e51779	10.1371/journal.pone.0051779	http://dx.doi.org/10.1371/journal.pone.0051779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326317	gold, Green Submitted, Green Published			2022-12-27	WOS:000314705800010
J	Falter, JL; Lowe, RJ; Zhang, ZL; McCulloch, M				Falter, James L.; Lowe, Ryan J.; Zhang, Zhenlin; McCulloch, Malcolm			Physical and Biological Controls on the Carbonate Chemistry of Coral Reef Waters: Effects of Metabolism, Wave Forcing, Sea Level, and Geomorphology	PLOS ONE			English	Article							GREAT-BARRIER-REEF; OCEAN ACIDIFICATION; COMMUNITY METABOLISM; TUAMOTU ARCHIPELAGO; DRIVEN CIRCULATION; CO2 SYSTEM; BORA BAY; CALCIFICATION; DIOXIDE; LAGOON	We present a three-dimensional hydrodynamic-biogeochemical model of a wave-driven coral-reef lagoon system using the circulation model ROMS (Regional Ocean Modeling System) coupled with the wave transformation model SWAN (Simulating WAves Nearshore). Simulations were used to explore the sensitivity of water column carbonate chemistry across the reef system to variations in benthic reef metabolism, wave forcing, sea level, and system geomorphology. Our results show that changes in reef-water carbonate chemistry depend primarily on the ratio of benthic metabolism to the square root of the onshore wave energy flux as well as on the length and depth of the reef flat; however, they are only weakly dependent on channel geometry and the total frictional resistance of the reef system. Diurnal variations in pCO(2), pH, and aragonite saturation state (Omega(ar)) are primarily dependent on changes in net production and are relatively insensitive to changes in net calcification; however, net changes in pCO(2), pH, and Omega(ar) are more strongly influenced by net calcification when averaged over 24 hours. We also demonstrate that a relatively simple one-dimensional analytical model can provide a good description of the functional dependence of reef-water carbonate chemistry on benthic metabolism, wave forcing, sea level, reef flat morphology, and total system frictional resistance. Importantly, our results indicate that any long-term (weeks to months) net offsets in reef-water pCO(2) relative to offshore values should be modest for reef systems with narrow and/or deep lagoons. Thus, the long-term evolution of water column pCO(2) in many reef environments remains intimately connected to the regional-scale oceanography of offshore waters and hence directly influenced by rapid anthropogenically driven increases in pCO(2).	[Falter, James L.; Lowe, Ryan J.; Zhang, Zhenlin; McCulloch, Malcolm] Univ Western Australia, Sch Earth & Environm, Perth, WA 6009, Australia; [Falter, James L.; Zhang, Zhenlin; McCulloch, Malcolm] Univ Western Australia, ARC Ctr Excellence Coral Reef Studies, Perth, WA 6009, Australia; [Falter, James L.; Lowe, Ryan J.; Zhang, Zhenlin; McCulloch, Malcolm] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Falter, JL (corresponding author), Univ Western Australia, Sch Earth & Environm, Perth, WA 6009, Australia.	jim.falter@uwa.edu.au	Lowe, Ryan/A-5032-2012; McCulloch, Malcolm T/C-3651-2009	Lowe, Ryan/0000-0002-7080-8406; McCulloch, Malcolm T/0000-0003-1538-1558	Australian Research Council (ARC) Centre of Excellence for Coral Reef Studies; ARC Future Fellows program; ARC Super Science Fellowship program; iVEC	Australian Research Council (ARC) Centre of Excellence for Coral Reef Studies(Australian Research Council); ARC Future Fellows program(Australian Research Council); ARC Super Science Fellowship program(Australian Research Council); iVEC	Support for JLF and MM was provided by the Australian Research Council (ARC) Centre of Excellence for Coral Reef Studies. Support for RJL was provided by the ARC Future Fellows program. Support for ZZ was provided by the ARC Super Science Fellowship program. All use of supercomputing resources was supported through iVEC (http://www.ivec.org/about-ivec). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AJ, 2012, ANNU REV MAR SCI, V5; Andrefouet S, 2001, CORAL REEFS, V20, P399, DOI 10.1007/s00338-001-0190-9; Andrefouet S, 2001, CORAL REEFS, V19, P259; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Atkinson MJ, 2008, MAR ECOL PROG SER, V373, P249, DOI 10.3354/meps07867; ATKINSON MJ, 1984, CORAL REEFS, V3, P13, DOI 10.1007/BF00306136; BARNES DJ, 1984, J EXP MAR BIOL ECOL, V79, P213, DOI 10.1016/0022-0981(84)90196-5; Bates NR, 2010, BIOGEOSCIENCES, V7, P2509, DOI 10.5194/bg-7-2509-2010; Bonneton P, 2007, J COASTAL RES, P762; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Broecker W.S., 1982, TRACERS SEA; BROECKER WS, 1966, J GEOPHYS RES, V71, P1575, DOI 10.1029/JZ071i006p01575; Broecker WS, 2001, GLOBAL BIOGEOCHEM CY, V15, P589, DOI 10.1029/2000GB001350; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chan NCS, 2012, GLOBAL CHANGE BIOL, P1; Charpy L, 2012, MAR POLLUT BULL, V65, P471, DOI 10.1016/j.marpolbul.2011.12.026; Clavier J, 1999, MAR ECOL PROG SER, V191, P79, DOI 10.3354/meps191079; Dean R. G., 1991, WATER WAVE MECH ENG, V2; DELESALLE B, 1992, CONT SHELF RES, V12, P939, DOI 10.1016/0278-4343(92)90053-M; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dickson AG, 1990, DEEP-SEA RES, V40, P107; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dumas F, 2012, MAR POLLUT BULL, V65, P425, DOI 10.1016/j.marpolbul.2012.05.041; Falter JL, 2011, CORAL REEFS, V30, P53, DOI 10.1007/s00338-010-0671-9; Falter JL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007268; Falter JL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004663; Falter JL, 2004, LIMNOL OCEANOGR, V49, P1820, DOI 10.4319/lo.2004.49.5.1820; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Frankignoulle M, 1996, MAR ECOL PROG SER, V145, P123, DOI 10.3354/meps145123; FRANKIGNOULLE M, 1994, LIMNOL OCEANOGR, V39, P458, DOI 10.4319/lo.1994.39.2.0458; Friedrich T, 2012, NAT CLIM CHANGE, V2, P167, DOI [10.1038/NCLIMATE1372, 10.1038/nclimate1372]; Gattuso JP, 1996, MAR ECOL PROG SER, V145, P109, DOI 10.3354/meps145109; GATTUSO JP, 1993, MAR ECOL PROG SER, V96, P259, DOI 10.3354/meps096259; Gattuso JP, 1999, P NATL ACAD SCI USA, V96, P13017, DOI 10.1073/pnas.96.23.13017; Gledhill DK, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004629; Glud RN, 2008, LIMNOL OCEANOGR, V53, P1014, DOI 10.4319/lo.2008.53.3.1014; Gourlay MR, 2005, COAST ENG, V52, P353, DOI 10.1016/j.coastaleng.2004.11.007; Hearn CJ, 1999, J GEOPHYS RES, V104; Hearn GJ, 1988, HYDRODYNAMIC PROCESS, P497; Hench JL, 2008, LIMNOL OCEANOGR, V53, P2681, DOI 10.4319/lo.2008.53.6.2681; Hochberg EJ, 2008, CORAL REEFS, V27, P49, DOI 10.1007/s00338-007-0289-8; Hoegh-Guldberg O, 2007, SCIENCE, V318; Hoeke R, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006170; Jouon A, 2006, CONT SHELF RES, V26, P1395, DOI 10.1016/j.csr.2005.11.014; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; KAYANNE H, 1995, SCIENCE, V269, P214, DOI 10.1126/science.269.5221.214; Kinsey D.W., 1985, P 5 INT COR REEF S, V4, P505; Kinsey D.W., 1972, P 1 INT S COR COR RE, P13; Kinsey DW, 1974, EFFECTS FERTILIZATIO, P49; Kinsey DW, 1979, THESIS U HAWAII MANO; Kinsey DW, 1977, SEASONALITY ZONATION, P383; Kleypas J. A., 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; KOHN AJ, 1957, LIMNOL OCEANOGR, V2, P241, DOI 10.1002/lno.1957.2.3.0241; Kraines S, 1997, MAR ECOL PROG SER, V156, P1, DOI 10.3354/meps156001; Kraines S, 1996, LIMNOL OCEANOGR, V41, P1790, DOI 10.4319/lo.1996.41.8.1790; Kraines SB, 1999, J GEOPHYS RES-OCEANS, V104, P15635, DOI 10.1029/1999JC900065; Kraines SB, 1998, CORAL REEFS, V17, P133, DOI 10.1007/s003380050107; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; LIMER ET, 1976, SEARCH, V7, P463; Lowe RJ, 2009, J PHYS OCEANOGR, V39, P873, DOI 10.1175/2008JPO3958.1; Lowe RJ, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005753; Lowe RJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005081; Lowe RJ, 2008, LIMNOL OCEANOGR, V53, P2668, DOI 10.4319/lo.2008.53.6.2668; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Maragos J.E., 1978, Monographs on Oceanographic Methodology, P353; Marsh J.A. Jr., 1974, Proceedings int Coral Reef Symp, V2, P139; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Mass T, 2007, MAR ECOL PROG SER, V334, P93, DOI 10.3354/meps334093; McCulloch M, 2012, NATURE CLIMATE CHANG; McDonald CB, 2006, LIMNOL OCEANOGR, V51, P1294, DOI 10.4319/lo.2006.51.3.1294; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Mioche D, 2000, COMMUNITY METABOLISM; Mucci CN, 1971, AM J SCI, V283, P781; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; NUGENT LE, 1946, GEOL SOC AM BULL, V57, P735, DOI 10.1130/0016-7606(1946)57[735:CRITGM]2.0.CO;2; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; Ohde S, 1999, B MAR SCI, V65, P559; PICHON M, 1985, CR ACAD SCI III-VIE, V300, P99; Pichon M, 1985, ORGANIC PRODUCTION C, P173; QASIM S Z, 1972, Internationale Revue der Gesamten Hydrobiologie, V57, P207, DOI 10.1002/iroh.19720570203; Rosman JH, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006892; SARGENT M. C., 1949, TRANS AMER GEOPHYS UNION, V30, P245; Shamberger KEF, 2011, MAR CHEM, V127, P64, DOI 10.1016/j.marchem.2011.08.003; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Silverman J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003770; Silverman J, 2007, BIOGEOCHEMISTRY, V84, P67, DOI 10.1007/s10533-007-9075-5; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; SMITH SV, 1973, LIMNOL OCEANOGR, V18, P106, DOI 10.4319/lo.1973.18.1.0106; SMITH SV, 1973, LIMNOL OCEANOGR, V18, P953, DOI 10.4319/lo.1973.18.6.0953; Smith SV, 1995, REFLECTIONS MEASUREM; Smith SV, 1989, EST COAST SHELF SCI, V29; Soulsby RL, 1995, ADV COASTAL MORPHODY, P20; Suzuki A, 2001, GEOPHYS RES LETT, V28, P1243, DOI 10.1029/2000GL011875; Suzuki A, 1997, REEF WATER CO2 SYSTE, P971; SYMONDS G, 1995, J GEOPHYS RES-OCEANS, V100, P2639, DOI 10.1029/94JC02736; Taebi S, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006439; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Uthicke S, 1998, MAR ECOL PROG SER, V169, P1, DOI 10.3354/meps169001; WARE JR, 1992, CORAL REEFS, V11, P127, DOI 10.1007/BF00255465; Warner JC, 2008, COMPUT GEOSCI-UK, V34, P1284, DOI 10.1016/j.cageo.2008.02.012; Wiens Herald J., 1962, ATOLL ENV ECOLOGY; YOUNG IR, 1989, J GEOPHYS RES-OCEANS, V94, P9779, DOI 10.1029/JC094iC07p09779; Zhang Z, 2012, J GEOPHYS RES, V117; Zhang ZL, 2011, ECOL MODEL, V222, P1456, DOI 10.1016/j.ecolmodel.2011.01.014	111	87	87	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53303	10.1371/journal.pone.0053303	http://dx.doi.org/10.1371/journal.pone.0053303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326411	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500063
J	Sinniger, F; Ocana, OV; Baco, AR				Sinniger, Frederic; Ocana, Oscar V.; Baco, Amy R.			Diversity of Zoanthids (Anthozoa: Hexacorallia) on Hawaiian Seamounts: Description of the Hawaiian Gold Coral and Additional Zoanthids	PLOS ONE			English	Article							DEEP-WATER CORALS; MOLECULAR CHARACTERIZATION; REPRODUCTIVE-BIOLOGY; PRECIOUS CORALS; SEA CORALS; ZOANTHARIA; CNIDARIA; GENUS; ABYSSOANTHUS; GERARDIA	The Hawaiian gold coral has a history of exploitation from the deep slopes and seamounts of the Hawaiian Islands as one of the precious corals commercialised in the jewellery industry. Due to its peculiar characteristic of building a scleroproteic skeleton, this zoanthid has been referred as Gerardia sp. (a junior synonym of Savalia Nardo, 1844) but never formally described or examined by taxonomists despite its commercial interest. While collection of Hawaiian gold coral is now regulated, globally seamounts habitats are increasingly threatened by a variety of anthropogenic impacts. However, impact assessment studies and conservation measures cannot be taken without consistent knowledge of the biodiversity of such environments. Recently, multiple samples of octocoral-associated zoanthids were collected from the deep slopes of the islands and seamounts of the Hawaiian Archipelago. The molecular and morphological examination of these zoanthids revealed the presence of at least five different species including the gold coral. Among these only the gold coral appeared to create its own skeleton, two other species are simply using the octocoral as substrate, and the situation is not clear for the final two species. Phylogenetically, all these species appear related to zoanthids of the genus Savalia as well as to the octocoral-associated zoanthid Corallizoanthus tsukaharai, suggesting a common ancestor to all octocoral-associated zoanthids. The diversity of zoanthids described or observed during this study is comparable to levels of diversity found in shallow water tropical coral reefs. Such unexpected species diversity is symptomatic of the lack of biological exploration and taxonomic studies of the diversity of seamount hexacorals.	[Sinniger, Frederic] Japan Agcy Marine Earth Sci & Technol, Submarine Resources Project, Yokosuka, Kanagawa 2370061, Japan; [Sinniger, Frederic] Japan Agcy Marine Earth Sci & Technol, Global Oceanog Data Ctr, Nago, Okinawa, Japan; [Sinniger, Frederic] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Marine Biodivers Program, Yokosuka, Kanagawa 2370061, Japan; [Sinniger, Frederic] Univ Ryukyus, Trop Biosphere Res Ctr, Motobu, Okinawa, Japan; [Ocana, Oscar V.] Fdn Museo Mar, Dept Biol Marina, Ceuta, North Africa, Spain; [Baco, Amy R.] Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of the Ryukyus; State University System of Florida; Florida State University	Sinniger, F (corresponding author), Japan Agcy Marine Earth Sci & Technol, Submarine Resources Project, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	fredsinniger@hotmail.com		Sinniger, Frederic/0000-0002-4175-5931; Ocana Vicente, Oscar/0000-0002-4594-8642	Hawaii Undersea Research Laboratory and Hawaii SeaGrant; National Oceanic and Atmospheric Administration (NOAA) Office of Ocean Exploration Grant [NA04OAR4600071, NA0OAR4600108, NA03OAR4600110]	Hawaii Undersea Research Laboratory and Hawaii SeaGrant; National Oceanic and Atmospheric Administration (NOAA) Office of Ocean Exploration Grant	Specimens were collected by ARB through grants from the Hawaii Undersea Research Laboratory and Hawaii SeaGrant and by the National Oceanic and Atmospheric Administration (NOAA) Office of Ocean Exploration Grant numbers NA04OAR4600071, NA0OAR4600108, and NA03OAR4600110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Auster PJ, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P93; Baco AR, 2007, OCEANOGRAPHY, V20, P108, DOI 10.5670/oceanog.2007.11; Baco AR, 2005, ERLANGEN EARTH C SER, P663, DOI 10.1007/3-540-27673-4_33; Bertoloni A., 1819, AMOENITATES ITALICAE; Cairns SD, 2007, B MAR SCI, V81, P311; Carlgren Oskar, 1913, The Danish Ingolf Expedition, V5; Carreiro-Silva M, 2011, ICES J MAR SCI, V68, P408, DOI 10.1093/icesjms/fsq073; Clark MR, 2011, INT SEABED AUTHORITY; CUTRESS CHARLES E., 1960, PACIFIC SCI, V14, P89; den Hartog J.C., 1993, Zoologische Verhandelingen (Leiden), V282, P1; den Hartog J.C., 1984, Zoologische Verhandelingen (Leiden), P1; DENHARTOG JC, 1980, ZOOL VERH-LEIDEN, V176, P1; DRUFFEL ERM, 1995, GEOCHIM COSMOCHIM AC, V59, P5031, DOI 10.1016/0016-7037(95)00373-8; Etnoyer P, 2005, ERLANGEN EARTH C SER, P331, DOI 10.1007/3-540-27673-4_16; Fujii T, 2011, ZOOL SCR, V40, P418, DOI 10.1111/j.1463-6409.2011.00479.x; Goodfriend GA, 1997, GEOCHIM COSMOCHIM AC, V61, P1931, DOI 10.1016/S0016-7037(97)00067-7; Grigg R.W., 1974, Proceedings int Coral Reef Symp, V2, P235; Grigg R. W., 1976, UNIHISEAGRANTTR7703; Grigg Richard W., 1994, U S National Marine Fisheries Service Marine Fisheries Review, V55, P50; Grigg Richard W., 2002, U S National Marine Fisheries Service Marine Fisheries Review, V64, P13; GRIGG RW, 1976, PAC SCI, V30, P167; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haussermann V, 2003, MITTELMEER BESTIMMUN, P501; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Lwowsky Fritz F., 1913, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V34; Marschal C, 2004, CORAL REEFS, V23, P423, DOI 10.1007/s00338-004-0398-6; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Miller K, 2009, MAR ECOL PROG SER, V397, P1, DOI 10.3354/meps08452; MUIRHEAD A, 1986, J MAR BIOL ASSOC UK, V66, P131, DOI 10.1017/S0025315400039709; Ocana Oscar, 2007, Vieraea, V35, P163; Ocaû£a O., 2004, REV ACAD CANARIA CIE, V15, P159; Parrish FA, 2002, MAR MAMMAL SCI, V18, P244, DOI 10.1111/j.1748-7692.2002.tb01031.x; PARRISH FA, 2007, STATE DEEP CORAL ECO, P155; Parrish FA, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P185; Parrish FA, 2009, MAR ECOL PROG SER, V397, P163, DOI 10.3354/meps08299; Parrish Frank A., 2006, Atoll Research Bulletin, P425; Poche F., 1914, Archiv fuer Naturgeschichte Berlin for, V1914, P47; Previati M, 2010, MAR ECOL-EVOL PERSP, V31, P555, DOI 10.1111/j.1439-0485.2010.00390.x; Reimer JD, 2008, CORAL REEFS, V27, P641, DOI 10.1007/s00338-008-0376-5; Reimer JD, 2007, INVERTEBR SYST, V21, P255, DOI 10.1071/IS06008; Reimer JD, 2010, CAH BIOL MAR, V51, P451; Reimer JD, 2006, ZOOL SCI, V23, P261, DOI 10.2108/zsj.23.261; Reimer James Davis, 2010, Marine Biodiversity, V40, P249, DOI 10.1007/s12526-010-0045-0; Reimer JD, 2010, ZOOL SCI, V27, P729, DOI 10.2108/zsj.27.729; Ritt B, 2010, DEEP-SEA RES PT I, V57, P1120, DOI 10.1016/j.dsr.2010.05.011; Roark EB, 2006, MAR ECOL PROG SER, V327, P1, DOI 10.3354/meps327001; Roark EB, 2009, P NATL ACAD SCI USA, V106, P5204, DOI 10.1073/pnas.0810875106; Roberts J.M., 2009, COLD WATER CORALS BI; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryland JS, 2004, HYDROBIOLOGIA, V530, P179, DOI 10.1007/s10750-004-2685-1; Ryland JS, 2004, J NAT HIST, V38, P1193, DOI 10.1080/0022293031000155179; Sanamyan N.P., 2007, Zoologiya Bespozvonochnykh, V4, P83; SCHMIDT H, 1972, Zoologica (Stuttgart), V42, P1; Sinniger F, 2005, MAR BIOL, V147, P1121, DOI 10.1007/s00227-005-0016-3; Sinniger F, 2010, CAH BIOL MAR, V51, P475; Sinniger Frederic, 2010, Marine Biodiversity, V40, P57, DOI 10.1007/s12526-009-0034-3; Sinniger F, 2009, ORG DIVERS EVOL, V9, P23, DOI 10.1016/j.ode.2008.10.003; Sinniger F, 2008, ZOOL SCI, V25, P1253, DOI 10.2108/zsj.25.1253; Swain TD, 2010, MOL ECOL, V19, P2587, DOI 10.1111/j.1365-294X.2010.04672.x; Swain TD, 2009, ZOOTAXA, P41, DOI 10.11646/zootaxa.2051.1.3; Tracy DM, 2011, NZ AQUATIC ENV BIODI; Wagner D, 2011, P ROY SOC B-BIOL SCI, V278, P1323, DOI 10.1098/rspb.2010.1681; Waller RG, 2007, B MAR SCI, V81, P533; WALSH GE, 1971, ZOOL J LINN SOC-LOND, V50, P161, DOI 10.1111/j.1096-3642.1971.tb00757.x; WEILL ROBERT, 1934, TRAV STAT ZOOL WIMEREUX, V10, P1	67	46	49	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52607	10.1371/journal.pone.0052607	http://dx.doi.org/10.1371/journal.pone.0052607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326345	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500023
J	Woodcock, J; Givoni, M; Morgan, AS				Woodcock, James; Givoni, Moshe; Morgan, Andrei Scott			Health Impact Modelling of Active Travel Visions for England and Wales Using an Integrated Transport and Health Impact Modelling Tool (ITHIM)	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; LEISURE-TIME; MORTALITY; RISK; BENEFITS; METAANALYSIS; WALKING; DISEASE; CAR; PREVENTION	Background: Achieving health benefits while reducing greenhouse gas emissions from transport offers a potential policy win-win; the magnitude of potential benefits, however, is likely to vary. This study uses an Integrated Transport and Health Impact Modelling tool (ITHIM) to evaluate the health and environmental impacts of high walking and cycling transport scenarios for English and Welsh urban areas outside London. Methods: Three scenarios with increased walking and cycling and lower car use were generated based upon the Visions 2030 Walking and Cycling project. Changes to carbon dioxide emissions were estimated by environmental modelling. Health impact assessment modelling was used to estimate changes in Disability Adjusted Life Years (DALYs) resulting from changes in exposure to air pollution, road traffic injury risk, and physical activity. We compare the findings of the model with results generated using the World Health Organization's Health Economic Assessment of Transport (HEAT) tools. Results: This study found considerable reductions in disease burden under all three scenarios, with the largest health benefits attributed to reductions in ischemic heart disease. The pathways that produced the largest benefits were, in order, physical activity, road traffic injuries, and air pollution. The choice of dose response relationship for physical activity had a large impact on the size of the benefits. Modelling the impact on all-cause mortality rather than through individual diseases suggested larger benefits. Using the best available evidence we found fewer road traffic injuries for all scenarios compared with baseline but alternative assumptions suggested potential increases. Conclusions: Methods to estimate the health impacts from transport related physical activity and injury risk are in their infancy; this study has demonstrated an integration of transport and health impact modelling approaches. The findings add to the case for a move from car transport to walking and cycling, and have implications for empirical and modelling research.	[Woodcock, James] Univ Cambridge, Inst Publ Hlth, UKCRC Ctr Diet & Activ Res CEDAR, Cambridge, England; [Givoni, Moshe] Tel Aviv Univ, Dept Geog & Human Environm, IL-69978 Tel Aviv, Israel; [Morgan, Andrei Scott] UCL, Inst Womens Hlth, London, England	University of Cambridge; Tel Aviv University; University of London; University College London	Woodcock, J (corresponding author), Univ Cambridge, Inst Publ Hlth, UKCRC Ctr Diet & Activ Res CEDAR, Cambridge, England.	jw745@medschl.cam.ac.uk	Woodcock, James/AAH-6753-2021	Morgan, Andrei/0000-0003-4143-1977; Woodcock, James/0000-0003-4769-5375	British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust; UK Clinical Research Collaboration; UK Engineering and Physical Sciences Research Council on 'Visions of the Role of Walking and Cycling' [EP/G000468/1]; EPSRC [EP/G000468/1] Funding Source: UKRI; ESRC [ES/G007462/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G000468/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; UK Engineering and Physical Sciences Research Council on 'Visions of the Role of Walking and Cycling'(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The health impact modelling was undertaken at the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. This study was partly funded through the UK Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/Pages/default.aspx) on 'Visions of the Role of Walking and Cycling in 2030' (Grant reference:EP/G000468/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman F, 2011, ECONOMICS, V40, P2011; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, COMPENDIUM PHYS ACTI; Aldred J, 2006, LAND ECON, V82, P141, DOI 10.3368/le.82.2.141; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Besson H, 2008, MED SCI SPORT EXER, V40, P1909, DOI 10.1249/MSS.0b013e318180bcad; Bhalla K, 2007, RISK ANAL, V27, P125, DOI 10.1111/j.1539-6924.2006.00864.x; Bhatia R, 2011, ACCIDENT ANAL PREV, V43, P235, DOI 10.1016/j.aap.2010.08.015; Byberg L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b688; Cameron MH, 2010, ACCIDENT ANAL PREV, V42, P1908, DOI 10.1016/j.aap.2010.05.012; COMMITTEE ON THE MEDICAL EFFECTS OF AIR POLLUTANTS (COMEAP), 2010, MORT EFF LONG TERM E; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; DEFRA, 2010, NAT ATM EM INV DAT W; DEFRA, 2011, 2008 BAS BACKGR MAPS; Department for Transport, 2008, GUID APPR WALK CYCL; Department for Transport, 2009, NAT TRAV SURV 2008; Elvik R, 2009, ACCIDENT ANAL PREV, V41, P849, DOI 10.1016/j.aap.2009.04.009; Europe WHO, WHO EUR RAL RISK EST; Grabow ML, 2012, ENVIRON HEALTH PERSP, V120, P68, DOI 10.1289/ehp.1103440; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Holm AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001135; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Lindsay G, 2010, AUSTR NZ J PUBLIC HL, DOI [10.1111/j.1753-6405.2010.00621, DOI 10.1111/J.1753-6405.2010.00621]; Maizhsh N, 2013, AM J PUBLIC IN PRESS; Mathers C. D., 2002, SUMMARY MEASURES POP; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Metz D, 2008, TRANSPORT REV, V28, P321, DOI 10.1080/01441640701642348; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Morgan AS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-699; Office for National Statistics Rural and Urban Statistics in England, GUID NOT; Olabarria M, 2013, EUR J PUBLIC HEALTH, V23, P217, DOI 10.1093/eurpub/cks015; Organization WH, 2009, GLOB HLTH RISKS MORT; Ostro B, 2004, OUTDOOR AIR POLLUTIO; PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.x; Panis LI, 2010, ATMOS ENVIRON, V44, P2263, DOI 10.1016/j.atmosenv.2010.04.028; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Tight M, 2011, J TRANSP GEOGR, V19, P1580, DOI 10.1016/j.jtrangeo.2011.03.011; Transport for London, 2011, TRAV LOND SUPPL REP; Walker H, 2011, ROAD TRANSPORT EMISS; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Ward H, 2002, REPORTING ROAD TRAFF; WHO Europe, 2011, HLTH EC ASSESSMENT T; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	53	143	143	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e51462	10.1371/journal.pone.0051462	http://dx.doi.org/10.1371/journal.pone.0051462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326315	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500005
J	Ananthi, S; Prajna, NV; Lalitha, P; Valarnila, M; Dharmalingam, K				Ananthi, Sivagnanam; Prajna, Namperumalsamy Venkatesh; Lalitha, Prajna; Valarnila, Murugesan; Dharmalingam, Kuppamuthu			Pathogen Induced Changes in the Protein Profile of Human Tears from Fusarium Keratitis Patients	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; CORNEAL ULCERATION; SERUM ANTIPROTEASES; ETIOLOGIC DIAGNOSIS; PROTEOMIC ANALYSIS; ALPHA-1-ANTITRYPSIN; FLUID; IDENTIFICATION; EXPRESSION; CYSTATINS	Fusarium is the major causative agent of fungal infections leading to corneal ulcer (keratitis) in Southern India and other tropical countries. Keratitis caused by Fusarium is a difficult disease to treat unless antifungal therapy is initiated during the early stages of infection. In this study tear proteins were prepared from keratitis patients classified based on the duration of infection. Among the patients recruited, early infection (n = 35), intermediate (n = 20), late (n = 11), samples from five patients in each group were pooled for analysis. Control samples were a pool of samples from 20 patients. Proteins were separated on difference gel electrophoresis (DIGE) and the differentially expressed proteins were quantified using DeCyder software analysis. The following differentially expressed proteins namely alpha-1-antitrypsin, haptoglobin alpha 2 chain, zinc-alpha-2-glycoprotein, apolipoprotein, albumin, haptoglobin precursor - beta chain, lactoferrin, lacrimal lipocalin precursor, cystatin SA III precursor, lacritin precursor were identified using mass spectrometry. Variation in the expression level of some of the proteins was confirmed using western blot analysis. This is the first report to show stage specific tear protein profile in fungal keratitis patients. Validation of this data using a much larger sample set could lead to clinical application of these findings.	[Ananthi, Sivagnanam; Valarnila, Murugesan] Aravind Eye Care Syst, Aravind Med Res Fdn, Dr G Venkataswamy Eye Res Inst, Madurai, Tamil Nadu, India; [Prajna, Namperumalsamy Venkatesh] Aravind Eye Care Syst, Aravind Eye Hosp, Cornea Clin, Madurai, Tamil Nadu, India; [Lalitha, Prajna] Aravind Eye Care Syst, Aravind Eye Hosp, Dept Microbiol, Madurai, Tamil Nadu, India; [Dharmalingam, Kuppamuthu] Madurai Kamaraj Univ, Sch Biotechnol, Madurai 625021, Tamil Nadu, India	Madurai Kamaraj University	Dharmalingam, K (corresponding author), Madurai Kamaraj Univ, Sch Biotechnol, Madurai 625021, Tamil Nadu, India.	dharmalingam.k@gmail.com		Namperumalsamy, Venkatesh Prajna/0000-0003-2019-4044	Department of Biotechnology, Government of India, New Delhi, India [BT/INF/22/2/2007, BT/PR13879/MED/12/458/2010, BT/PR7592/MED/12/290/2006, BT/HRD/35/03/2010]	Department of Biotechnology, Government of India, New Delhi, India(Department of Biotechnology (DBT) India)	KD thanks the Department of Biotechnology, Government of India, New Delhi, India for grants no. BT/INF/22/2/2007, BT/PR13879/MED/12/458/2010 and BT/PR7592/MED/12/290/2006 for DBT Distinguished Biotechnology Research Professorship BT/HRD/35/03/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Ananthi S, 2008, MOL VIS, V14, P500; Ananthi S, 2011, EXP EYE RES, V92, P454, DOI 10.1016/j.exer.2011.03.002; ARORA PK, 1978, NATURE, V274, P589, DOI 10.1038/274589a0; Baker GRC, 2006, ARCH OPHTHALMOL-CHIC, V124, P1451, DOI 10.1001/archopht.124.10.1451; BARKA T, 1991, CURR EYE RES, V10, P25, DOI 10.3109/02713689109007608; BERMAN MB, 1973, INVEST OPHTH VISUAL, V12, P759; BIRGENS HS, 1985, SCAND J HAEMATOL, V34, P326; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREIT SN, 1985, CLIN IMMUNOL IMMUNOP, V35, P363, DOI 10.1016/0090-1229(85)90097-2; Brock JH, 2002, BIOCHEM CELL BIOL, V80, P1, DOI 10.1139/o01-212; CHEVANCE LG, 1976, ARCH OTOLARYNGOL, V102, P363; de Souza GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r72; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ERIE JC, 1993, ARCH OPHTHALMOL-CHIC, V111, P1665, DOI 10.1001/archopht.1993.01090120087027; FULLARD RJ, 1988, CURR EYE RES, V7, P163, DOI 10.3109/02713688808995746; GACHON AM, 1979, EXP EYE RES, V29, P539, DOI 10.1016/0014-4835(79)90154-4; Gachon AMF, 1998, BRIT J OPHTHALMOL, V82, P453, DOI 10.1136/bjo.82.4.453; Gonzales C A, 1996, Ophthalmic Epidemiol, V3, P159, DOI 10.3109/09286589609080122; Good DM, 2007, J PROTEOME RES, V6, P4549, DOI 10.1021/pr070529w; Green-Church KB, 2008, MOL VIS, V14, P456; GUPTA AK, 1988, BRIT J OPHTHALMOL, V72, P390, DOI 10.1136/bjo.72.5.390; Gupta N, 2007, J PROTEOME RES, V6, P3669, DOI 10.1021/pr070223p; Gupta N, 2010, J MED MICROBIOL, V59, P400, DOI 10.1099/jmm.0.016394-0; HAGAN M, 1995, BRIT J OPHTHALMOL, V79, P1024, DOI 10.1136/bjo.79.11.1024; Herber S, 2001, ELECTROPHORESIS, V22, P1838, DOI 10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7; Hirai K, 1998, CANCER RES, V58, P2359; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; ISEMURA S, 1991, J BIOCHEM, V110, P648, DOI 10.1093/oxfordjournals.jbchem.a123634; JONES BR, 1975, AM J OPHTHALMOL, V79, P719, DOI 10.1016/0002-9394(75)90730-8; Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110; Kawai S, 2002, ANN CLIN BIOCHEM, V39, P56, DOI 10.1258/0004563021901748; KIJLSTRA A, 1994, ADV EXP MED BIOL, V350, P299; Kolte Rajashri A, 2010, J Indian Soc Periodontol, V14, P227, DOI 10.4103/0972-124X.76923; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; Kuriakose T, 1991, Indian J Ophthalmol, V39, P118; KYAWMYINT TO, 1975, CLIN CHIM ACTA, V59, P51, DOI 10.1016/0009-8981(75)90217-X; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lescuyer P, 2007, J PROTEOME RES, V6, P3371, DOI 10.1021/pr0702060; Levin LA, 1996, SURV OPHTHALMOL, V41, P142, DOI 10.1016/S0039-6257(96)80004-X; Li N, 2005, J PROTEOME RES, V4, P2052, DOI 10.1021/pr0501970; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; METZBOUTIGUE MH, 1984, EUR J BIOCHEM, V145, P659, DOI 10.1111/j.1432-1033.1984.tb08607.x; MII S, 1992, ELECTROPHORESIS, V13, P379, DOI 10.1002/elps.1150130177; Molloy MP, 1997, ELECTROPHORESIS, V18, P2811, DOI 10.1002/elps.1150181516; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Nichols JJ, 2009, CORNEA, V28, P1109, DOI 10.1097/ICO.0b013e3181a2ad81; Poole TRG, 2002, BRIT J OPHTHALMOL, V86, P941, DOI 10.1136/bjo.86.8.941; PRAUSE JU, 1983, ACTA OPHTHALMOL, V61, P272; Ramachandran B, 2012, J BIOSCIENCES, V37, P617, DOI 10.1007/s12038-012-9245-z; Reitz C, 1998, GRAEF ARCH CLIN EXP, V236, P894, DOI 10.1007/s004170050177; Righetti PG, 2005, CLIN CHIM ACTA, V357, P123, DOI 10.1016/j.cccn.2005.03.018; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Saijyothi AV, 2010, ELECTROPHORESIS, V31, P3420, DOI 10.1002/elps.201000271; Samudre S, 2011, INVEST OPHTH VIS SCI, V52, P6265, DOI 10.1167/iovs.10-6220; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; Sen DK, 1986, PREOCULAR TEAR FILM, P192; SHARP HL, 1976, GASTROENTEROLOGY, V70, P611; Sharp HL, 1975, MODERN TRENDS GASTRO, P140; Sitaramamma T, 1998, Indian Journal of Ophthalmology, V46, P239; Srinivasan M, 2004, Curr Opin Ophthalmol, V15, P321, DOI 10.1097/00055735-200408000-00008; Srinivasan M, 1997, BRIT J OPHTHALMOL, V81, P965, DOI 10.1136/bjo.81.11.965; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940; TALAMO RC, 1975, PEDIATRICS, V56, P91; ter Rahe BSM, 1998, OPHTHALMOLOGICA, V212, P34, DOI 10.1159/000027256; Thomas PA, 2007, CURR OPIN INFECT DIS, V20, P129, DOI 10.1097/QCO.0b013e328017f878; Tomosugi N, 2005, J PROTEOME RES, V4, P820, DOI 10.1021/pr0497576; Tonge R, 2001, PROTEOMICS, V1, P377; Tseng CF, 2004, PROTEOMICS, V4, P2221, DOI 10.1002/pmic.200300787; TWINING SS, 1994, INVEST OPHTH VIS SCI, V35, P458; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; UPADHYAY MP, 1991, AM J OPHTHALMOL, V111, P92, DOI 10.1016/S0002-9394(14)76903-X; Vasanthi Mani, 2007, Indian Journal of Ophthalmology, V55, P27; Whitcher JP, 1997, BRIT J OPHTHALMOL, V81, P622, DOI 10.1136/bjo.81.8.622; YOHAI RA, 1994, SURV OPHTHALMOL, V39, P3, DOI 10.1016/S0039-6257(05)80041-4; Zhou L, 2004, J PROTEOME RES, V3, P410, DOI 10.1021/pr034065n; Zhou L, 2006, ANN ACAD MED SINGAP, V35, P400; Zolg W, 2006, MOL CELL PROTEOMICS, V5, P1720, DOI 10.1074/mcp.R600001-MCP200	80	43	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53018	10.1371/journal.pone.0053018	http://dx.doi.org/10.1371/journal.pone.0053018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308132	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800025
J	Nguemo, F; Fleischmann, BK; Gupta, MK; Saric, T; Malan, D; Liang, HM; Pfannkuche, K; Bloch, W; Schunkert, H; Hescheler, J; Reppel, M				Nguemo, Filomain; Fleischmann, Bernd K.; Gupta, Manoj K.; Saric, Tomo; Malan, Daniela; Liang, Huamin; Pfannkuche, Kurt; Bloch, Wilhelm; Schunkert, Heribert; Hescheler, Juergen; Reppel, Michael			The L-type Ca2+ Channels Blocker Nifedipine Represses Mesodermal Fate Determination in Murine Embryonic Stem Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CALCIUM-CHANNEL; CARDIAC MYOCYTES; FUNCTIONAL-PROPERTIES; VERTEBRATE HEART; IN-VITRO; CARDIOMYOCYTES; DIFFERENTIATION; EXPRESSION; CARDIOMYOGENESIS	Dihydropyridines (DHP), which nifedipine is a member of, preferentially block Ca2+ channels of different cell types. Moreover, influx of Ca2+ through L-type Ca2+ channels (LTCCs) activates Ca2+ signaling pathways, which in turn contribute to numerous cellular processes. Although LTCCs are expressed in undifferentiated cells, very little is known about its contributions to the transcriptional regulation of mesodermal and cardiac genes. This study aimed to examine the contribution of LTCCs and the effect of nifedipine on the commitment of pluripotent stem cells toward the cardiac lineage in vitro. The murine embryonic stem (ES, cell line D3) and induced pluripotent stem (iPS, cell clone 09) cells were differentiated into enhanced green fluorescence protein (EGFP) expressing spontaneously beating cardiomyocytes (CMs). Early treatment of differentiating cells with 10 mu M nifedipine led to a significant inhibition of the cardiac mesoderm formation and cardiac lineage commitment as revealed by gene regulation analysis. This was accompanied by the inhibition of spontaneously occurring Ca2+ transient and reduction of LTCCs current density (I-CaL) of differentiated CMs. In addition, nifedipine treatment instigated a pronounced delay of the spontaneous beating embryoid body (EB) and led to a poor surface localization of L-type Ca2+ channel alpha(1C) (Ca(V)1.2) subunits. Contrary late incubation of pluripotent stem cells with nifedipine was without any impact on the differentiation process and did not affect the derived CMs function. Our data indicate that nifedipine blocks the determined path of pluripotent stem cells to cardiomyogenesis by inhibition of mesodermal commitment at early stages of differentiation, thus the proper upkeep Ca2+ concentration and pathways are essentially required for cardiac gene expression, differentiation and function.	[Nguemo, Filomain; Gupta, Manoj K.; Saric, Tomo; Pfannkuche, Kurt; Hescheler, Juergen; Reppel, Michael] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany; [Fleischmann, Bernd K.; Malan, Daniela] Univ Bonn, Life & Brain Ctr, Inst Physiol 1, Bonn, Germany; [Liang, Huamin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Physiol, Wuhan 430074, Peoples R China; [Bloch, Wilhelm] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany; [Schunkert, Heribert; Reppel, Michael] Med Univ Lubeck, Dept Cardiol, D-23538 Lubeck, Germany	University of Cologne; University of Bonn; Huazhong University of Science & Technology; German Sport University Cologne; University of Lubeck	Nguemo, F (corresponding author), Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany.	b200028@uni-koeln.de	Saric, Tomo/B-3415-2015	Saric, Tomo/0000-0001-8344-1095; Nguemo, Filomain/0000-0002-2236-6797; Pfannkuche, Kurt Paul/0000-0002-4284-774X	Rosa-Luxemburg Foundation; Federal Ministry of Education and Research in Germany (BMBF) within the research consortium 'Human Heart Models' [01GG0708]	Rosa-Luxemburg Foundation; Federal Ministry of Education and Research in Germany (BMBF) within the research consortium 'Human Heart Models'	This work was supported by Rosa-Luxemburg Foundation through the scholarship offered to Filomain Nguemo and Federal Ministry of Education and Research in Germany (BMBF) within the research consortium 'Human Heart Models' (grant 01GG0708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2008, BASIC RES CARDIOL, V103, P514, DOI 10.1007/s00395-008-0729-9; Altomare C, 2010, BASIC RES CARDIOL, V105, P737, DOI 10.1007/s00395-010-0111-6; Best JM, 2012, J MOL CELL CARDIOL, V52, P376, DOI 10.1016/j.yjmcc.2011.08.014; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Ebert AM, 2005, P NATL ACAD SCI USA, V102, P17705, DOI 10.1073/pnas.0502683102; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gollasch M, 1998, FASEB J, V12, P593, DOI 10.1096/fasebj.12.7.593; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gupta MK, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-98; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Inagaki N, 2000, J BIOL CHEM, V275, P27165; Ji GJ, 1999, FASEB J, V13, P313, DOI 10.1096/fasebj.13.2.313; JOHNSON GJ, 1986, CIRCULATION, V73, P847, DOI 10.1161/01.CIR.73.4.847; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Kuryshev YA, 1999, CIRCULATION, V100, P675, DOI 10.1161/01.CIR.100.6.675; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Le Blanc C, 2004, CIRC RES, V95, P300, DOI 10.1161/01.RES.0000138017.76125.8b; Lin S, 2001, AM J PHYSIOL-HEART C, V280, pH1160, DOI 10.1152/ajpheart.2001.280.3.H1160; Linask KL, 2010, STEM CELLS DEV, V19, P1959, DOI 10.1089/scd.2010.0192; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Maruyama R, 2006, AM J PHYSIOL-HEART C, V290, pH1493, DOI 10.1152/ajpheart.00669.2005; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Muller-Borer BJ, 2007, P NATL ACAD SCI USA, V104, P3877, DOI 10.1073/pnas.0700416104; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Navedo MF, 2010, AM J PHYSIOL-CELL PH, V298, pC211, DOI 10.1152/ajpcell.00267.2009; Nguemo F, 2009, BASIC RES CARDIOL, V104, P295, DOI 10.1007/s00395-008-0755-7; Ohtani K, 2011, BASIC RES CARDIOL, V106, P5, DOI 10.1007/s00395-010-0139-7; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Porter GA, 2003, DEV DYNAM, V227, P280, DOI 10.1002/dvdy.10307; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; Puceat M, 2005, CELL CALCIUM, V38, P383, DOI 10.1016/j.ceca.2005.06.016; Rajala K, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/383709; Sachinidis A, 2006, CELL PHYSIOL BIOCHEM, V18, P303, DOI 10.1159/000097608; Sasse P, 2007, J GEN PHYSIOL, V130, P133, DOI 10.1085/jgp.200609575; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tsai CT, 2007, CIRC RES, V100, P1476, DOI 10.1161/01.RES.0000268497.93085.e1; Viatchenko-Karpinski S, 1999, P NATL ACAD SCI USA, V96, P8259, DOI 10.1073/pnas.96.14.8259; Wang Y, 2007, J MOL CELL CARDIOL, V42, P1045, DOI 10.1016/j.yjmcc.2007.03.905; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; YATANI A, 1988, AM J PHYSIOL, V254, pH140, DOI 10.1152/ajpheart.1988.254.1.H140; YONEMOCHI H, 1990, CIRCULATION, V81, P1401, DOI 10.1161/01.CIR.81.4.1401; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	55	18	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53407	10.1371/journal.pone.0053407	http://dx.doi.org/10.1371/journal.pone.0053407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320083	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429800047
J	Lieberman, OJ; DeStefano, JJ; Lee, VT				Lieberman, Ori J.; DeStefano, Jeffery J.; Lee, Vincent T.			Detection of Cyclic Diguanylate G-Octaplex Assembly and Interaction with Proteins	PLOS ONE			English	Article							C-DI-GMP; HUMAN-IMMUNODEFICIENCY-VIRUS; G-QUADRUPLEX; STRUCTURAL BASIS; REVERSE-TRANSCRIPTASE; ALLOSTERIC CONTROL; BINDING-PROTEIN; NUCLEIC-ACIDS; GUANOSINE-MONOPHOSPHATE; RESOLUTION STRUCTURE	Bacterial signaling networks control a wide variety of cellular processes including growth, metabolism, and pathogenesis. Bis-(3'-5')-cyclic dimeric guanosine monophosphate (cdiGMP) is a secondary signaling nucleotide that controls cellulose synthesis, biofilm formation, motility and virulence in a wide range of Gram-negative bacterial species. CdiGMP is a dynamic molecule that forms different tertiary structures in vitro, including a trans-monomer, cis-monomer, cis-dimer and G-octaplex (G8). Although the monomer and dimer have been shown to be physiologically relevant in modulating protein activity and transcription, the biological effects of the cdiGMP G8 has not yet been described. Here, we have developed a TLC-based assay to detect radiolabeled cdiGMP G8 formation. Utilizing the radiolabeled cdiGMP G8, we have also shown a novel inhibitory interaction between the cdiGMP G8 and HIV-1 reverse transcriptase and that the cdiGMP G8 does not interact with proteins from Pseudomonas aeruginosa known to bind monomeric and dimeric cdiGMP. These results suggest that the radiolabeled cdiGMP G8 can be used to measure interactions between the cdiGMP G8 and cellular proteins, providing an avenue through which the biological significance of this molecule could be investigated.	[Lieberman, Ori J.; DeStefano, Jeffery J.; Lee, Vincent T.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Lieberman, Ori J.; DeStefano, Jeffery J.; Lee, Vincent T.] Maryland Pathogen Res Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Lee, VT (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	vtlee@umd.edu		Lieberman, Ori/0000-0002-0467-0875; Lee, Vincent T./0000-0002-3593-0318	Maryland Summer Scholarship; University of Maryland-Howard Hughes Medical Institute; National Institute of Health [R21 R21AI096083]; Cystic Fibrosis Foundation; National Institute of General Medicine [GM051140]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051140, R29GM051140] Funding Source: NIH RePORTER	Maryland Summer Scholarship; University of Maryland-Howard Hughes Medical Institute; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a Maryland Summer Scholarship (OJL), University of Maryland-Howard Hughes Medical Institute Undergraduate Research Fellowship (OJL), National Institute of Health R21 R21AI096083 (VTL) and Cystic Fibrosis Foundation Grant (VTL), and National Institute of General Medicine grant GM051140 (JJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; DeStefano JJ, 2008, OLIGONUCLEOTIDES, V18, P133, DOI 10.1089/oli.2008.0103; DeStefano JJ, 2006, NUCLEIC ACIDS RES, V34, P130, DOI 10.1093/nar/gkj426; Donaldson GP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1299; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4336, DOI 10.2741/2391; Fukuda H, 2002, P NATL ACAD SCI USA, V99, P12685, DOI 10.1073/pnas.152456899; Gatto B, 2009, CURR MED CHEM, V16, P1248, DOI 10.2174/092986709787846640; Gentner M, 2012, J AM CHEM SOC; Habazettl J, 2011, J BIOL CHEM, V286, P14304, DOI 10.1074/jbc.M110.209007; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; Kelsey I, 2011, BIOORGANIC MED CHEM; Kendrick S, 2010, PURE APPL CHEM, V82, P1609, DOI 10.1351/PAC-CON-09-09-29; Keniry MA, 2001, BIOPOLYMERS, V56, P123, DOI 10.1002/1097-0282(2000/2001)56:3<123::AID-BIP10010>3.0.CO;2-3; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Lai YT, 2012, NUCL ACID THER; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; LIAW YC, 1990, FEBS LETT, V264, P223, DOI 10.1016/0014-5793(90)80253-F; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Michalowski D, 2008, NUCLEIC ACIDS RES, V36, P7124, DOI 10.1093/nar/gkn891; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200; Muniyappa K, 2000, MOL CELL BIOL, V20, P1361, DOI 10.1128/MCB.20.4.1361-1369.2000; Nakayama S, 2011, CHEM COMMUN, V47, P4766, DOI 10.1039/c0cc05432a; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Paeschke K, 2008, NAT STRUCT MOL BIOL, V15, P598, DOI 10.1038/nsmb.1422; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; RANDERATH K, 1964, EXPERIENTIA, V20, P406, DOI 10.1007/BF02147995; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2009, CONTRIB MICROBIOL, V16, P161, DOI 10.1159/000219379; ROSS P, 1985, FEBS LETT, V186, P191, DOI 10.1016/0014-5793(85)80706-7; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; SCHNEIDER DJ, 1995, BIOCHEMISTRY-US, V34, P9599, DOI 10.1021/bi00029a037; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Smith KD, 2011, P NATL ACAD SCI USA, V108, P7757, DOI 10.1073/pnas.1018857108; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Zhang ZY, 2006, J AM CHEM SOC, V128, P7015, DOI 10.1021/ja0613714; Zhang ZY, 2004, J AM CHEM SOC, V126, P16700, DOI 10.1021/ja0449832	70	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53689	10.1371/journal.pone.0053689	http://dx.doi.org/10.1371/journal.pone.0053689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308275	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100107
J	Sukhdeo, K; Paramban, RI; Vidal, JG; Elia, J; Martin, J; Rivera, M; Carrasco, DR; Jarrar, A; Kalady, MF; Carson, CT; Balderas, R; Hjelmeland, AB; Lathia, JD; Rich, JN				Sukhdeo, Kumar; Paramban, Rosanto I.; Vidal, Jason G.; Elia, Jeanne; Martin, Jody; Rivera, Maricruz; Carrasco, Daniel R.; Jarrar, Awad; Kalady, Matthew F.; Carson, Christian T.; Balderas, Robert; Hjelmeland, Anita B.; Lathia, Justin D.; Rich, Jeremy N.			Multiplex Flow Cytometry Barcoding and Antibody Arrays Identify Surface Antigen Profiles of Primary and Metastatic Colon Cancer Cell Lines	PLOS ONE			English	Article							STEM-CELLS; MESSENGER-RNA; PROTEIN; MICROARRAY; EXPRESSION	Colon cancer is a deadly disease affecting millions of people worldwide. Current treatment challenges include management of disease burden as well as improvements in detection and targeting of tumor cells. To identify disease state-specific surface antigen signatures, we combined fluorescent cell barcoding with high-throughput flow cytometric profiling of primary and metastatic colon cancer lines (SW480, SW620, and HCT116). Our multiplexed technique offers improvements over conventional methods by permitting the simultaneous and rapid screening of cancer cells with reduced effort and cost. The method uses a protein-level analysis with commercially available antibodies on live cells with intact epitopes to detect potential tumor-specific targets that can be further investigated for their clinical utility. Multiplexed antibody arrays can easily be applied to other tumor types or pathologies for discovery-based approaches to target identification.	[Sukhdeo, Kumar; Rivera, Maricruz; Hjelmeland, Anita B.; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Sukhdeo, Kumar] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Paramban, Rosanto I.; Vidal, Jason G.; Elia, Jeanne; Martin, Jody; Carson, Christian T.; Balderas, Robert] BD Biosci, San Diego, CA USA; [Carrasco, Daniel R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Jarrar, Awad; Kalady, Matthew F.] Cleveland Clin, Inst Digest Dis, Dept Colorectal Surg, Cleveland, OH 44106 USA; [Jarrar, Awad; Kalady, Matthew F.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Lathia, Justin D.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sukhdeo, K (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA.	kumar@case.edu; lathiaj@ccf.org; richj@ccf.org	Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022	Sukhdeo, Kumar/0000-0001-8725-6081	Pediatric Brain Tumor Foundation of the United States; Brain Tumor Society; Goldhirsh Foundation; James D. McDonnell Foundation; National Institutes of Health [CA112958, CA116659, CA154130]; Pathway to Independence Award [CA157948]; Case Western Reserve Medical Scientist Training Program [T32 GM007250]; National Research Service Award, National Cancer Institute [F30 CA165857]; NATIONAL CANCER INSTITUTE [R01CA116659, R00CA157948, K99CA157948, F30CA165857, R01CA154130] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088088, T32GM007250] Funding Source: NIH RePORTER	Pediatric Brain Tumor Foundation of the United States; Brain Tumor Society; Goldhirsh Foundation; James D. McDonnell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve Medical Scientist Training Program; National Research Service Award, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Pediatric Brain Tumor Foundation of the United States, Brain Tumor Society, Goldhirsh Foundation, and James D. McDonnell Foundation. This work was also funded by National Institutes of Health grants CA112958 (JNR), CA116659 (JNR), CA154130 (JNR), Pathway to Independence Award CA157948 (JDL), Case Western Reserve Medical Scientist Training Program T32 GM007250 (KS), and National Research Service Award, National Cancer Institute F30 CA165857 (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dydensborg AB, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-223; Ellmark P, 2006, PROTEOMICS, V6, P1791, DOI 10.1002/pmic.200500468; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Hewitt RE, 2000, J PATHOL, V192, P446; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Joyce T, 2007, EXPERT OPIN PHARMACO, V8, P895, DOI 10.1517/14656566.8.7.895; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Krutzik PO, 2011, CURRENT PROTOCOLS CY, V55, P63131; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sikaroodi M, 2010, CURR MOL MED, V10, P249, DOI 10.2174/156652410790963277; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Spizzo G, 2011, J CLIN PATHOL, V64, P415, DOI 10.1136/jcp.2011.090274; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Velazquez EF, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-2; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhou J, 2011, JOVE-J VIS EXP, DOI 10.3791/3322; Zhou J, 2010, J IMMUNOL METHODS, V355, P40, DOI 10.1016/j.jim.2010.01.015	32	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53015	10.1371/journal.pone.0053015	http://dx.doi.org/10.1371/journal.pone.0053015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308131	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100023
J	Xia, S; Zhang, Q; Zhu, H; Cheng, YY; Liu, GX; Hu, ZY				Xia, Shuang; Zhang, Qi; Zhu, Huan; Cheng, Yingyin; Liu, Guoxiang; Hu, Zhengyu			Systematics of a Kleptoplastidal Dinoflagellate, Gymnodinium eucyaneum Hu (Dinophyceae), and Its Cryptomonad Endosymbiont	PLOS ONE			English	Article							MARINE DINOFLAGELLATE; GREEN DINOFLAGELLATE; SEQUENCE ALIGNMENT; EVOLUTION; PHYLOGENY; ULTRASTRUCTURE; STRATEGIES; NUCLEAR; IDENTIFICATION; CRYPTOPHYCEAE	New specimens of the kleptoplastidal dinoflagellate Gymnodinium eucyaneum Hu were collected in China. We investigated the systematics of the dinoflagellate and the origin of its endosymbiont based on light morphology and phylogenetic analyses using multiple DNA sequences. Cells were dorsoventrally flattened with a sharply acute hypocone and a hemispherical epicone. The confusion between G. eucyaneum and G. acidotum Nygaard still needs to be resolved. We found that the hypocone was conspicuously larger than the epicone in most G. eucyaneum cells, which differed from G. acidotum, but there were a few cells whose hypocone and epicone were of nearly the same size. In addition, there was only one site difference in the partial nuclear LSU rDNA sequences of a sample from Japan given the name G. acidotum and G. eucyaneum in the present study, which suggest that G. eucyaneum may be a synonym of G. acidotum. Spectroscopic analyses and phylogenetic analyses based on nucleomorph SSU rDNA sequences and chloroplast 23 s rDNA sequences suggested that the endosymbiont of G. eucyaneum was derived from Chroomonas (Cryptophyta), and that it was most closely related to C. coerulea Skuja. Moreover, the newly reported kleptoplastidal dinoflagellates G. myriopyrenoides and G. eucyaneum in our study were very similar, and the taxonomy of kleptoplastidal dinoflagellates was discussed.	[Xia, Shuang; Zhang, Qi; Zhu, Huan; Liu, Guoxiang; Hu, Zhengyu] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China; [Xia, Shuang; Zhu, Huan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cheng, Yingyin] Chinese Acad Sci, Inst Hydrobiol, Ctr Water Environm & Human Hlth, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Liu, GX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China.	liugx@ihb.ac.cn	Liu, Guoxiang/L-7413-2019; González, Adela M Gómez/D-2863-2012; Pasanisi, Fabrizio/L-7437-2015; de Simone, Giovanni/D-1767-2011	Liu, Guoxiang/0000-0001-8565-2363; Pasanisi, Fabrizio/0000-0003-4224-7821; de Simone, Giovanni/0000-0001-8567-9881	National Natural Science Foundation of China [30970501, 31270252]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (Grant Nos 30970501 and 31270252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsanti L, 2009, J PHYCOL, V45, P1304, DOI 10.1111/j.1529-8817.2009.00751.x; BRETT SJ, 1994, PROTOPLASMA, V181, P106, DOI 10.1007/BF01666391; Chen B, 1990, J CHIN ELECT MICRO S, V3, P42; Chesnick JM, 1997, J EUKARYOT MICROBIOL, V44, P314, DOI 10.1111/j.1550-7408.1997.tb05672.x; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; de Salas MF, 2003, J PHYCOL, V39, P1233, DOI 10.1111/j.0022-3646.2003.03-019.x; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; FARMER MA, 1990, PROTOPLASMA, V153, P178, DOI 10.1007/BF01354002; FIELDS SD, 1991, J PHYCOL, V27, P525, DOI 10.1111/j.0022-3646.1991.00525.x; Garcia-Cuetos L, 2010, HARMFUL ALGAE, V9, P25, DOI 10.1016/j.hal.2009.07.002; GIBBS SP, 1981, ANN NY ACAD SCI, V361, P193; GILLOTT MA, 1980, J PHYCOL, V16, P558; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GREENWOOD A D, 1977, British Phycological Journal, V12, P119; Greenwood A. D., 1974, 8 INT C ELECT MICROS, P566; Hansen G, 2005, PHYCOL RES, V53, P169, DOI 10.1111/j.1440-183.2005.00383.x; Hansen G, 2000, J PHYCOL, V36, P394, DOI 10.1046/j.1529-8817.2000.99172.x; Hoef-Emden K, 2002, J MOL EVOL, V55, P161, DOI 10.1007/s00239-002-2313-5; Hoef-Emden K, 2008, J PHYCOL, V44, P985, DOI 10.1111/j.1529-8817.2008.00530.x; HORIGUCHI T, 1991, BOT MAR, V34, P123, DOI 10.1515/botm.1991.34.2.123; Horiguchi T, 2006, PHYCOL RES, V54, P193, DOI 10.1111/j.1440-1835.2006.00426.x; Horiguchi Takeo, 2006, Paleontological Research, V10, P299; HOSHAW RW, 1973, HDB PHYCOLOGICAL MET, P54; Hu H., 1980, KEXUE TONGBAO, V25, P882; Hu H.J., 1983, Chinese Journal of Oceanology and Limnology, V1, P198; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson MD, 2011, PHOTOSYNTH RES, V107, P117, DOI 10.1007/s11120-010-9546-8; Jorgensen MF, 2004, PHYCOL RES, V52, P284; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Kim E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-73; Kofoid C. A., 1921, Memoirs of the University of California, V5, P1; Kugrens P, 2003, FRESHWATER ALGAE N A, P740; Larsen Jacob, 1992, P427; Lewitus AJ, 1999, J PHYCOL, V35, P303, DOI 10.1046/j.1529-8817.1999.3520303.x; MAIER UG, 1992, BIOSYSTEMS, V28, P69, DOI 10.1016/0303-2647(92)90009-N; MAIER UG, 1994, ENDOCYTOBIOSIS CELL, V10, P129; Minnhagen S, 2008, ENVIRON MICROBIOL, V10, P2411, DOI 10.1111/j.1462-2920.2008.01666.x; Nagai S, 2008, J PHYCOL, V44, P909, DOI 10.1111/j.1529-8817.2008.00544.x; NICHOLS HW, 1965, J PHYCOL, V1, P34, DOI 10.1111/j.1529-8817.1965.tb04552.x; Novarino G, 2003, HYDROBIOLOGIA, V502, P225, DOI 10.1023/B:HYDR.0000004284.12535.25; Nygaard G, 1949, KONGEL DANSKE VIDENS, V7, P263; Park MG, 2008, J PHYCOL, V44, P1154, DOI 10.1111/j.1529-8817.2008.00579.x; Pochon X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029816; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; SCHNEPF E, 1989, PLANT SYST EVOL, V164, P75, DOI 10.1007/BF00940431; SCHNEPF E, 1992, EUR J PROTISTOL, V28, P3, DOI 10.1016/S0932-4739(11)80315-9; Schnepf Eberhard, 1992, P699; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Shi Z, 1983, HAIYANG YU HUZHAO, V14, P161; SITTE P, 1992, ENDOCYT CELL RES, V8, P223; Skovgaard A, 1998, AQUAT MICROB ECOL, V15, P293, DOI 10.3354/ame015293; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR F J R, 1974, Taxon, V23, P229, DOI 10.2307/1218702; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WHATLEY JM, 1981, NEW PHYTOL, V87, P233, DOI 10.1111/j.1469-8137.1981.tb03195.x; WILCOX LW, 1984, J PHYCOL, V20, P236, DOI 10.1111/j.0022-3646.1984.00236.x; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366; Yamaguchi H, 2011, PROTIST, V162, P650, DOI 10.1016/j.protis.2011.01.002; Yoon HS, 2005, MOL BIOL EVOL, V22, P1299, DOI 10.1093/molbev/msi118; Zhang S., 1989, Acta Hydrobiologica Sinica, V13, P289	62	14	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53820	10.1371/journal.pone.0053820	http://dx.doi.org/10.1371/journal.pone.0053820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308288	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100120
J	El Husseini, D; Boulanger, MC; Fournier, D; Mahmut, A; Bosse, Y; Pibarot, P; Mathieu, P				El Husseini, Diala; Boulanger, Marie-Chloe; Fournier, Dominique; Mahmut, Ablajan; Bosse, Yohan; Pibarot, Philippe; Mathieu, Patrick			High Expression of the Pi-Transporter SLC20A1/Pit1 in Calcific Aortic Valve Disease Promotes Mineralization through Regulation of Akt-1	PLOS ONE			English	Article							MUSCLE-CELL CALCIFICATION; VASCULAR CALCIFICATION; PHOSPHATE; STENOSIS; OSTEOPONTIN; SIGNAL; TRIAL	The regulation of phosphate (Pi) handling is crucial during calcification of the aortic valve. Gene profiling of Pi transporters revealed that VIC culture expresses SLC201A1/Pit1 and SLC20A2/Pit2. On exposure to a mineralizing medium (2 mM Pi), the expression of Pi transporters in VIC culture is increased several folds, with the highest magnitude for SLC20A1. By using siRNAs, we established that silencing SLC20A1 significantly reduced Pi-induced mineralization of VICs. In human pathological specimens, we found that the expression of SCL20A1 was increased in CAVD tissues compared to control non-mineralized aortic valves. Treatment of VIC culture with Pi promoted the loss of mitochondrial membrane potential (Delta psi m) and cytochrome c release within the cytosol, leading to apoptosis. Inhibition of Pi transporters with phosphonoformic acid (PFA) prevented Pi-mediated apoptosis of VICs. Moreover, we discovered that the level of the Akt-1 transcript is diminished in CAVD tissues compared with control valves. Accordingly, treatment with Pi caused a reduction of the Akt-1 transcript in VIC culture, and treatment with PFA or siRNA against SLC20A1 restored the level of Akt-1. Overexpression of Akt-1 (pCMVAkt-1) prevented both Pi-induced apoptosis and mineralization of VIC culture. These results strongly suggest that overexpression of SLC20A1 promotes apoptosis and mineralization by altering the level of Akt-1.	[El Husseini, Diala; Boulanger, Marie-Chloe; Fournier, Dominique; Mahmut, Ablajan; Mathieu, Patrick] Univ Laval, Dept Surg, Res Ctr, Quebec Heart & Lung Inst,GRV,LEMV, Quebec City, PQ, Canada; [Bosse, Yohan; Pibarot, Philippe] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Laval University; Quebec Heart & Lung Institute	Mathieu, P (corresponding author), Univ Laval, Dept Surg, Res Ctr, Quebec Heart & Lung Inst,GRV,LEMV, Quebec City, PQ, Canada.	patrick.mathieu@chg.ulaval.ca	Pibarot, Philippe/ABD-5300-2021		HSFC grant; CIHR grants [MOP114893]; Fonds de Recherche en Sante du Quebec (FRSQ)	HSFC grant; CIHR grants(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by HSFC grant and CIHR grants MOP114893. D. E.H. is supported by studentship grants from Fonds de Recherche en Sante du Quebec (FRSQ). Y.B. is a research scholar from the Heart and Stroke Foundation of Canada, Ottawa, Ontario, Canada. P.P. holds the Canada Research Chair in Valvular Heart Diseases, Ottawa, Ontario, Canada. P.M. is a research scholar from the Fonds de Recherche en Sante du Quebec, Montreal, Quebec, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Cote N, 2012, J MOL CELL CARDIOL, V52, P1191, DOI 10.1016/j.yjmcc.2012.02.003; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; Giachelli CM, 2001, AM J KIDNEY DIS, V38, pS34, DOI 10.1053/ajkd.2001.27394; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Lau WL, 2011, ADV CHRONIC KIDNEY D, V18, P105, DOI 10.1053/j.ackd.2010.12.002; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; LoghmanAdham M, 1996, GEN PHARMACOL-VASC S, V27, P305, DOI 10.1016/0306-3623(95)02017-9; Matheny RW, 2009, EXP BIOL MED, V234, P1264, DOI 10.3181/0904-MR-138; Mathieu P, 2007, CAN J CARDIOL, V23, p32B, DOI 10.1016/S0828-282X(07)71008-5; Mune S, 2009, CLIN EXP NEPHROL, V13, P571, DOI 10.1007/s10157-009-0208-0; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Pohjolainen V, 2012, ATHEROSCLEROSIS, V220, P66, DOI 10.1016/j.atherosclerosis.2011.10.003; Proudfoot D, 2001, Z Kardiol, V90 Suppl 3, P43; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Son BK, 2008, J ATHEROSCLER THROMB, V15, P63, DOI 10.5551/jat.E545; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Villa-Bellosta R, 2007, ARTERIOSCL THROM VAS, V27, P1030, DOI 10.1161/ATVBAHA.106.132266	20	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53393	10.1371/journal.pone.0053393	http://dx.doi.org/10.1371/journal.pone.0053393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308213	Green Published, gold			2022-12-27	WOS:000313670100037
J	Li, PF; Carter, G; Romero, J; Gower, KM; Watson, J; Patel, NA; Cooper, DR				Li, Pengfei; Carter, Gay; Romero, Jacqueline; Gower, Kathryn M.; Watson, James; Patel, Niketa A.; Cooper, Denise R.			Clk/STY (cdc2-Like Kinase 1) and Akt Regulate Alternative Splicing and Adipogenesis in 3T3-L1 Pre-Adipocytes	PLOS ONE			English	Article							C-BETA-II; SKELETAL-MUSCLE CELLS; PROTEIN-KINASE; ADIPOSE CONVERSION; INSULIN-RESISTANCE; DIFFERENTIATION; PHOSPHORYLATION; ALPHA; TRANSCRIPTION; ADIPONECTIN	The development of adipocytes from their progenitor cells requires the action of growth factors signaling to transcription factors to induce the expression of adipogenic proteins leading to the accumulation of lipid droplets, induction of glucose transport, and secretion of adipokines signaling metabolic events throughout the body. Murine 3T3-L1 pre-adipocytes sequentially express all the proteins necessary to become mature adipocytes throughout an 8-10 day process initiated by a cocktail of hormones. We examined the role of Clk/STY or Clk1, a cdc2-like kinase, in adipogenesis since it is known to be regulated by Akt, a pivotal kinase in development. Inhibition of Clk1 by a specific inhibitor, TG003, blocked alternative splicing of PKC beta II and expression of PPAR gamma 1 and PPAR gamma 2. SiRNA depletion of Clk1 resulted in early expression of PKC beta II and sustained PKC beta I expression. Since Clk1 is a preferred Akt substrate, required for phosphorylation of splicing factors, mutation of Clk1 Akt phosphorylation sites was undertaken. Akt sites on Clk1 are in the serine/arginine-rich domain and not the kinase domain. Mutation of single and multiple sites resulted in dysregulation of PKC beta II, PKC beta I, and PPAR gamma 1&2 expression. Additionally, adipogenesis was blocked as assessed by Oil Red O staining, adiponectin, and Glut1 and 4 expression. Immunofluorescence microscopy revealed that Clk1 triple mutant cDNA, transfected into pre-adipocytes, resulted in excluding SRp40 (SFSR6) from co-localizing to the nucleus with PFS, a perispeckle specific protein. This study demonstrates the role of Akt and Clk1 kinases in the early differentiation of 3T3-L1 cells to adipocytes.	[Li, Pengfei; Romero, Jacqueline; Gower, Kathryn M.; Patel, Niketa A.; Cooper, Denise R.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Carter, Gay; Watson, James; Patel, Niketa A.; Cooper, Denise R.] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Cooper, DR (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA.	dcooper@health.usf.edu		Patel, Niketa A./0000-0003-4811-8596	Department of Veterans Affairs Merit Review; National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [2RO1 054393, RO1 054393S2]; NIH NIDDK STEP-UP Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054393] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003689] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NIDDK STEP-UP Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs Merit Review (D.R.C., N.A.P.) and National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2RO1 054393 (D.R.C.), NIH NIDDK STEP-UP Award (J.A.R.), and NIH NIDDK RO1 054393S2 (D.R.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bullock AN, 2009, STRUCTURE, V17, P352, DOI 10.1016/j.str.2008.12.023; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; Chalfant CE, 1998, J BIOL CHEM, V273, P910, DOI 10.1074/jbc.273.2.910; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; DUNCAN PI, 1995, J BIOL CHEM, V270, P21524, DOI 10.1074/jbc.270.37.21524; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Garcia-Sacristan A, 2005, CELL RES, V15, P495, DOI 10.1038/sj.cr.7290319; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Heiker JT, 2010, BIOL CHEM, V391, P1005, DOI 10.1515/BC.2010.104; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; Huang H, 2008, J GASTROEN HEPATOL, V23, pS50, DOI 10.1111/j.1440-1746.2007.05284.x; Huang W, 2009, HEPATOLOGY, V49, P1525, DOI 10.1002/hep.22815; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Kleiman E, 2009, BIOCH BIOPH IN PRESS; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Mott BT, 2009, BIOORG MED CHEM LETT, V19, P6700, DOI 10.1016/j.bmcl.2009.09.121; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Nam SY, 2010, J BIOL CHEM, V285, P31157, DOI 10.1074/jbc.M110.122044; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patel NA, 2004, MOL ENDOCRINOL, V18, P899, DOI 10.1210/me.2003-0391; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Prasad J, 2003, MOL CELL BIOL, V23, P4139, DOI 10.1128/MCB.23.12.4139-4149.2003; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Stark JM, 1998, P NATL ACAD SCI USA, V95, P2163, DOI 10.1073/pnas.95.5.2163; Stark JM, 1999, J BIOL CHEM, V274, P29838, DOI 10.1074/jbc.274.42.29838; Stojdl DF, 1999, BIOCHEM CELL BIOL, V77, P293, DOI 10.1139/bcb-77-4-293; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; YUN B, 1994, GENE DEV, V8, P1160, DOI 10.1101/gad.8.10.1160; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029	39	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53268	10.1371/journal.pone.0053268	http://dx.doi.org/10.1371/journal.pone.0053268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308182	Green Submitted, Green Published, gold			2022-12-27	WOS:000313670100029
J	Laanto, E; Bamford, JKH; Laakso, J; Sundberg, LR				Laanto, Elina; Bamford, Jaana K. H.; Laakso, Jouni; Sundberg, Lotta-Riina			Phage-Driven Loss of Virulence in a Fish Pathogenic Bacterium	PLOS ONE			English	Article							FLAVOBACTERIUM-COLUMNARE; RESISTANT MUTANTS; MARINE VIRUSES; EVOLUTION; MOTILITY; DIVERSITY; ADHESION; DISEASE; BACTERIOPHAGES; SUSCEPTIBILITY	Parasites provide a selective pressure during the evolution of their hosts, and mediate a range of effects on ecological communities. Due to their short generation time, host-parasite interactions may also drive the virulence of opportunistic bacteria. This is especially relevant in systems where high densities of hosts and parasites on different trophic levels (e. g. vertebrate hosts, their bacterial pathogens, and virus parasitizing bacteria) co-exist. In farmed salmonid fingerlings, Flavobacterium columnare is an emerging pathogen, and phage that infect F. columnare have been isolated. However, the impact of these phage on their host bacterium is not well understood. To study this, four strains of F. columnare were exposed to three isolates of lytic phage and the development of phage resistance and changes in colony morphology were monitored. Using zebrafish (Danio rerio) as a model system, the ancestral rhizoid morphotypes were associated with a 25-100% mortality rate, whereas phage-resistant rough morphotypes that lost their virulence and gliding motility (which are key characteristics of the ancestral types), did not affect zebrafish survival. Both morphotypes maintained their colony morphologies over ten serial passages in liquid culture, except for the low-virulence strain, Os06, which changed morphology with each passage. To our knowledge, this is the first report of the effects of phage-host interactions in a commercially important fish pathogen where phage resistance directly correlates with a decline in bacterial virulence. These results suggest that phage can cause phenotypic changes in F. columnare outside the fish host, and antagonistic interactions between bacterial pathogens and their parasitic phage can favor low bacterial virulence under natural conditions. Furthermore, these results suggest that phage-based therapies can provide a disease management strategy for columnaris disease in aquaculture.	[Laanto, Elina; Bamford, Jaana K. H.; Laakso, Jouni; Sundberg, Lotta-Riina] Univ Jyvaskyla, Ctr Excellence Biol Interact, SF-40351 Jyvaskyla, Finland; [Laanto, Elina; Bamford, Jaana K. H.; Laakso, Jouni; Sundberg, Lotta-Riina] Univ Helsinki, Ctr Excellence Biol Interact, FIN-00014 Helsinki, Finland; [Laanto, Elina; Bamford, Jaana K. H.; Sundberg, Lotta-Riina] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Laanto, Elina; Bamford, Jaana K. H.] Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland; [Laakso, Jouni] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Jyvaskyla; University of Helsinki; University of Jyvaskyla; University of Jyvaskyla; University of Helsinki	Sundberg, LR (corresponding author), Univ Jyvaskyla, Ctr Excellence Biol Interact, SF-40351 Jyvaskyla, Finland.	lotta-riina.sundberg@jyu.fi	Sundberg, Lotta-Riina/AAW-3125-2020; Laanto, Elina/ABA-8049-2020; Sundberg, Lotta-Riina/N-1551-2014; Laakso, Jouni/I-7794-2013	Sundberg, Lotta-Riina/0000-0003-3510-4398; Sundberg, Lotta-Riina/0000-0003-3510-4398; Laakso, Jouni/0000-0001-8245-9912; Laanto, Elina/0000-0003-4172-3128	Finnish Centre of Excellence Program of the Academy of Finland [1129648, 252411]; Academy of Finland [127500, 125572]; Maj and Tor Nessling Foundation	Finnish Centre of Excellence Program of the Academy of Finland(Academy of Finland); Academy of Finland(Academy of Finland); Maj and Tor Nessling Foundation	This work was supported by Finnish Centre of Excellence Program of the Academy of Finland 2006-2011 CoE in Virus Research (#1129648), and CoE in Biological Interactions 2012-2017(#252411, Johanna Mappes), Academy of Finland grants 127500 (L. R. S.) and 125572 (J.L.), and a grant from the Maj and Tor Nessling Foundation (J.K.H.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon S.T, 2008, BACTERIOPHAGE ECOLOG; Abedon ST, 2005, EVOL BIOINFORM, V1, P97; ANACKER RL, 1959, J BACTERIOL, V78, P25, DOI 10.1128/JB.78.1.25-32.1959; Antonovics J, 2013, EVOLUTION, V67, P1, DOI 10.1111/j.1558-5646.2012.01793.x; Bader JA, 2005, LETT APPL MICROBIOL, V40, P123, DOI 10.1111/j.1472-765X.2004.01641.x; Bashey F, 2011, OIKOS, V120, P1539, DOI 10.1111/j.1600-0706.2011.19304.x; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Capparelli R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011720; Castillo D, 2012, J FISH DIS, V35, P193, DOI 10.1111/j.1365-2761.2011.01336.x; DARZINS A, 1993, J BACTERIOL, V175, P5934, DOI 10.1128/JB.175.18.5934-5944.1993; Decostere A, 1997, J CLIN MICROBIOL, V35, P322, DOI 10.1128/JCM.35.1.322-324.1997; Dumpala PR, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-26; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Friman VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017651; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; HEIERSON A, 1986, J BACTERIOL, V167, P18, DOI 10.1128/jb.167.1.18-24.1986; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Holmfeldt K, 2007, APPL ENVIRON MICROB, V73, P6730, DOI 10.1128/AEM.01399-07; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; King OD, 2007, THEOR POPUL BIOL, V72, P560, DOI 10.1016/j.tpb.2007.08.006; Kunttu HMT, 2011, J APPL MICROBIOL, V111, P1319, DOI 10.1111/j.1365-2672.2011.05149.x; Kunttu HMT, 2012, ENV MICROBIOL REP, V4, P398, DOI 10.1111/j.1758-2229.2012.00342.x; Kunttu HMT, 2009, EPIDEMICS-NETH, V1, P96, DOI 10.1016/j.epidem.2009.04.003; Kunttu HMT, 2009, MICROB PATHOGENESIS, V46, P21, DOI 10.1016/j.micpath.2008.10.001; Laanto E, 2011, APPL ENVIRON MICROB, V77, P7868, DOI 10.1128/AEM.05574-11; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; Mennerat A, 2010, EVOL BIOL, V37, P59, DOI 10.1007/s11692-010-9089-0; Moyer TR, 2007, DIS AQUAT ORGAN, V76, P39, DOI 10.3354/dao076039; Nakai T, 2002, RES MICROBIOL, V153, P13, DOI 10.1016/S0923-2508(01)01280-3; Olivares-Fuster O, 2011, J FISH DIS, V34, P385, DOI 10.1111/j.1365-2761.2011.01253.x; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Park SC, 2003, DIS AQUAT ORGAN, V53, P33, DOI 10.3354/dao053033; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Revetta Randy P., 2005, Journal of Water and Health, V3, P83; Rickard AH, 2003, FEMS MICROBIOL LETT, V220, P133, DOI 10.1016/S0378-1097(03)00094-6; Santander J, 2007, ELECTRON J BIOTECHN, V10, P627, DOI 10.2225/vol10-issue4-fulltext-14; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; SCHADE SYLVIA Z., 1967, J VIROL, V1, P599; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; SHIEH H S, 1980, Microbios Letters, V13, P129; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Suomalainen LR, 2006, DIS AQUAT ORGAN, V70, P55, DOI 10.3354/dao070055; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Zar JH., 2010, BIOSTAT ANAL, V5th	53	84	86	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53157	10.1371/journal.pone.0053157	http://dx.doi.org/10.1371/journal.pone.0053157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23308090	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600064
J	Hashemi, M; Fazaeli, A; Ghavami, S; Eskandari-Nasab, E; Arbabi, F; Mashhadi, MA; Taheri, M; Chaabane, W; Jain, MV; Los, MJ				Hashemi, Mohammad; Fazaeli, Aliakbar; Ghavami, Saeid; Eskandari-Nasab, Ebrahim; Arbabi, Farshid; Mashhadi, Mohammad Ali; Taheri, Mohsen; Chaabane, Wiem; Jain, Mayur V.; Los, Marek J.			Functional Polymorphisms of FAS and FASL Gene and Risk of Breast Cancer - Pilot Study of 134 Cases	PLOS ONE			English	Article							DEATH PATHWAY GENES; SQUAMOUS-CELL CARCINOMA; DRUG-INDUCED APOPTOSIS; LIGAND EXPRESSION; RHEUMATOID-ARTHRITIS; PROMOTER REGION; IMMUNE ESCAPE; ACTIVATION; CD95; MECHANISM	Fas/Fas ligand (FasL) system is one of the key apoptotic signaling entities in the extrinsic apoptotic pathway. De-regulation of this pathway, i.e. by mutations may prevent the immune system from the removal of newly-formed tumor cells, and thus lead to tumor formation. The present study investigated the association between -1377 G/A (rs2234767) and -670 A/G (rs1800682) polymorphisms in Fas as well as single nucleotide polymorphisms INV2nt -124 A/G (rs5030772) and -844 C/T (rs763110) in FasL in a sample of Iranian patients with breast cancer. This case-control study was done on 134 breast cancer patients and 152 normal women. Genomic DNA was extracted from whole blood samples. The polymorphisms were determined by using tetra-ARMS-PCR method. There was no significant difference in the genotype distribution of FAS rs2234767 polymorphism between cases and controls. FAS rs1800682, FASL rs5030772, and FASL rs763110 genotypes showed significant associations with an increasing risk of breast cancer (odds ratio OR = 3.18, P = 0.019; OR = 5.08, P = 0.012; OR = 2.40, P = 0.024, respectively). In conclusion, FAS rs2234767 was not associated with breast cancer risk. Though, FAS rs1800682, FASL rs5030772, and FASL rs763110 polymorphisms were associated with the risk of breast cancer in the examined population.	[Hashemi, Mohammad] Zahedan Univ Med Sci, Cellular & Mol Res Ctr, Zahedan, Iran; [Hashemi, Mohammad; Fazaeli, Aliakbar; Eskandari-Nasab, Ebrahim] Zahedan Univ Med Sci, Sch Med, Dept Clin Biochem, Zahedan, Iran; [Eskandari-Nasab, Ebrahim; Arbabi, Farshid; Mashhadi, Mohammad Ali] Zahedan Univ Med Sci, Sch Med, Dept Internal Med, Zahedan, Iran; [Ghavami, Saeid] Manitoba Inst Child Hlth, Biol Breathing Grp, Winnipeg, MB, Canada; [Ghavami, Saeid] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Taheri, Mohsen] Zahedan Univ Med Sci, Genet Non Communicable Dis Res Ctr, Zahedan, Iran; [Chaabane, Wiem; Jain, Mayur V.; Los, Marek J.] Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Integrat Regenerat Med Ctr IGEN, Linkoping, Sweden; [Chaabane, Wiem] Univ Tunis, Fac Sci, Dept Biol, Tunis, Tunisia; [Los, Marek J.] BioApplicat Enterprises, Winnipeg, MB, Canada	Zahedan University of Medical Sciences; Zahedan University of Medical Sciences; Zahedan University of Medical Sciences; University of Manitoba; Zahedan University of Medical Sciences; Linkoping University; Universite de Tunis; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST)	Los, MJ (corresponding author), Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Integrat Regenerat Med Ctr IGEN, Linkoping, Sweden.	marek.los@liu.se	fazaeli, aliakbar/B-1952-2019; Hashemi, Mohammad/H-2446-2016; Fazaeli, Aliakbar/AAL-7819-2020; Ghavami, Saeid/GLT-0606-2022; Ghavami, Saeid/Q-8918-2016; Mashhadi, Mohammad Ali/N-4579-2016; taheri, mohsen/I-2567-2016; Eskandari, Ebrahim/O-7398-2016	Hashemi, Mohammad/0000-0002-6074-7101; Fazaeli, Aliakbar/0000-0001-7860-3950; Ghavami, Saeid/0000-0001-5948-508X; Mashhadi, Mohammad Ali/0000-0002-7226-4633; taheri, mohsen/0000-0002-1110-4417; Eskandari, Ebrahim/0000-0001-7789-4194; Los, Marek/0000-0001-9518-1411	Parker B. Francis Fellowship in Respiratory Disease; Linkoping University; Integrative Regenerative Medicine Center (IGEN); Cancerfonden [CAN 2011/521]	Parker B. Francis Fellowship in Respiratory Disease; Linkoping University; Integrative Regenerative Medicine Center (IGEN); Cancerfonden(Swedish Cancer Society)	SG was supported by Parker B. Francis Fellowship in Respiratory Disease. ML, WC, and MVJ kindly acknowledge the core/startup support from Linkoping University, from Integrative Regenerative Medicine Center (IGEN), and from Cancerfonden (CAN 2011/521). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian SM, 2011, J VIRAL HEPATITIS, V18, P821, DOI 10.1111/j.1365-2893.2011.01530.x; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Babu GR, 2011, ASIAN PAC J CANCER P, V12, P1647; Bebenek M, 2008, ADV MED SCI-POLAND, V53, P49, DOI 10.2478/v10039-008-0015-y; Bebenek M, 2007, ANTICANCER RES, V27, P215; Brando C, 2005, J LEUKOCYTE BIOL, V78, P359, DOI 10.1189/jlb.0604360; Crew KD, 2007, CARCINOGENESIS, V28, P2548, DOI 10.1093/carcin/bgm211; Das H, 2000, BRIT J CANCER, V82, P1682; Dufournet C, 2006, J REPROD IMMUNOL, V70, P151, DOI 10.1016/j.jri.2005.11.003; Eberl LP, 1999, INT J CANCER, V81, P772, DOI 10.1002/(SICI)1097-0215(19990531)81:5<772::AID-IJC18>3.0.CO;2-S; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fulda S, 2010, PLANTA MED, V76, P1075, DOI 10.1055/s-0030-1249961; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Ghavami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016523; Ghavami S, 2009, BBA-MOL CELL RES, V1793, P546, DOI 10.1016/j.bbamcr.2009.01.002; Gurevich-Panigrahi T, 2009, CURR MED CHEM, V16, P506, DOI 10.2174/092986709787315568; Gutierrez LS, 1999, BREAST CANCER RES TR, V54, P245, DOI 10.1023/A:1006102601215; Hashemi M, 2010, GENET MOL RES, V9, P1735, DOI 10.4238/vol9-3gmr893; Hashemi M, 2010, GENET MOL RES, V9, P333, DOI 10.4238/vol9-1gmr728; Hashemi M, 2012, NUCLEOS NUCLEOT NUCL, V31, P55, DOI 10.1080/15257770.2011.643846; Huang QR, 1997, MOL IMMUNOL, V34, P577, DOI 10.1016/S0161-5890(97)00081-3; Koshkina NV, 2007, J PEDIAT HEMATOL ONC, V29, P815, DOI 10.1097/MPH.0b013e3181581506; Krippl P, 2004, J NATL CANCER I, V96, P1478, DOI 10.1093/jnci/djh289; Kurooka M, 2002, CANCER RES, V62, P1261; Lee SH, 2001, HUM PATHOL, V32, P250, DOI 10.1053/hupa.2001.22769; LEITHAUSER F, 1993, LAB INVEST, V69, P415; Liu KB, 2005, CANCER RES, V65, P4376, DOI 10.1158/0008-5472.CAN-04-4269; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; Los M, 1997, BLOOD, V90, P3118, DOI 10.1182/blood.V90.8.3118; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Mottolese M, 2000, INT J CANCER, V89, P127, DOI 10.1002/(SICI)1097-0215(20000320)89:2<127::AID-IJC5>3.0.CO;2-4; Mousavi SM, 2007, BREAST J, V13, P383, DOI 10.1111/j.1524-4741.2007.00446.x; Muschen M, 2000, IMMUNOLOGY, V99, P69, DOI 10.1046/j.1365-2567.2000.00921.x; Ni X, 2001, CLIN CANCER RES, V7, P2682; Nordgard SH, 2008, INT J CANCER, V123, P577, DOI 10.1002/ijc.23541; O'Brien DI, 2005, EXPERT OPIN THER TAR, V9, P1031, DOI 10.1517/14728222.9.5.1031; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; Rashedi I, 2007, CURR MED CHEM, V14, P3139, DOI 10.2174/092986707782793952; Reimer T, 2000, CANCER RES, V60, P822; Sibley K, 2003, CANCER RES, V63, P4327; Stecklein Shane R, 2012, Front Biosci (Elite Ed), V4, P934, DOI 10.2741/E431; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; TAKAHASHI T, 1994, INT IMMUNOL, V6, P1567, DOI 10.1093/intimm/6.10.1567; Villa-Morales M, 2012, EXPERT OPIN THER TAR; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Wiechec E, 2011, EXPERT REV MOL DIAGN, V11, P445, DOI [10.1586/erm.11.21, 10.1586/ERM.11.21]; Wiechec E, 2011, CANCER EPIDEM BIOMAR, V20, P397, DOI 10.1158/1055-9965.EPI-10-0514; Wiechec E, 2009, EUR J PHARMACOL, V625, P122, DOI 10.1016/j.ejphar.2009.08.045; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Wu JM, 2003, J IMMUNOL, V170, P132, DOI 10.4049/jimmunol.170.1.132; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Zhang BL, 2007, CARCINOGENESIS, V28, P1067, DOI 10.1093/carcin/bgl250; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhang ZZ, 2009, EUR J HUM GENET, V17, P1294, DOI 10.1038/ejhg.2009.45; Zhou RM, 2010, J GASTROEN HEPATOL, V25, P555, DOI 10.1111/j.1440-1746.2009.06116.x	58	60	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53075	10.1371/journal.pone.0053075	http://dx.doi.org/10.1371/journal.pone.0053075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326385	gold, Green Published			2022-12-27	WOS:000314705800031
J	Lancellotti, TES; Boarelli, PV; Romero, AA; Funes, AK; Cid-Barria, M; Cabrillana, ME; Monclus, MA; Simon, L; Vicenti, AE; Fornes, MW				Lancellotti, Tania E. Saez; Boarelli, Paola V.; Romero, Aida A.; Funes, Abi K.; Cid-Barria, Macarena; Cabrillana, Maria E.; Monclus, Maria A.; Simon, Layla; Vicenti, Amanda E.; Fornes, Miguel W.			Semen Quality and Sperm Function Loss by Hypercholesterolemic Diet Was Recovered by Addition of Olive Oil to Diet in Rabbit	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; BODY-MASS INDEX; MEDIATED SIGNAL-TRANSDUCTION; CHOLESTEROL CONTENT; ARTIFICIAL VAGINA; ACROSOME REACTION; MAMMALIAN SPERM; MALE OBESITY; IN-VITRO; MEMBRANE	Fat increment (0.05% cholesterol, chol) in standard diet promoted a significant increase in serum and sperm membrane chol, which ultimately altered membrane-coupled sperm specific functions: osmotic resistance, acrosomal reaction, and sperm capacitation in White New Zealand rabbits. These changes were also associated with a reduction in motility percentage and appearance of abnormal sperm morphology. The present study was carried out to evaluate the effect of dietary olive oil (OO, 7% v/w) administration to several male hypercholesterolemic rabbits (hypercholesterolemic rabbits, HCR) with altered fertility parameters. These HCR males were achieved by feeding normal rabbits with a high-fat diet (0.05% chol). HCR were associated with a modest non-significant increase in body weight (standard diet, 4.08 +/- 0.17 Kg, versus high-fat diet, 4.37 +/- 0.24 Kg). Hypercholesterolemic rabbits presented a marked decrease in semen volume, sperm cell count, and percentage of sperm motility, associated with a significant increase in sperm cell abnormalities. Moreover, sperm capacitation measured by the characteristic phosphorylated protein pattern in and induced acrosomal reaction were also altered suggesting sperm dysfunction. However, the administration of OO (for 16 weeks) to rabbits that were fed with 50% of the high-fat diet normalized serum chol. Curiously, OO supply succeeded to attenuate the seminal and sperm alterations observed in HCR group. Administration of OO alone did not cause any significant changes in above mentioned parameters. These data suggest that OO administration to HCR male rabbits recovers the loss of semen quality and sperm functionality.	[Lancellotti, Tania E. Saez; Boarelli, Paola V.; Romero, Aida A.; Funes, Abi K.; Cabrillana, Maria E.; Monclus, Maria A.; Simon, Layla; Vicenti, Amanda E.; Fornes, Miguel W.] Univ Nacl Cuyo, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Med, Inst Histol & Embriol IHEM,LIAM,CCT, RA-5500 Mendoza, Argentina; [Lancellotti, Tania E. Saez; Boarelli, Paola V.; Cid-Barria, Macarena; Cabrillana, Maria E.; Monclus, Maria A.; Fornes, Miguel W.] Univ Aconcagua, Fac Ciencias Med, Inst Invest, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Fornes, MW (corresponding author), Univ Nacl Cuyo, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Med, Inst Histol & Embriol IHEM,LIAM,CCT, RA-5500 Mendoza, Argentina.	mfornes@fcm.uncu.edu.ar	Lancellotti, T Estefania Saez/AAV-4007-2020	Lancellotti, T Estefania Saez/0000-0001-8830-6482; Funes, Abi/0000-0002-6540-3324; Cabrillana, Maria Eugenia/0000-0001-6794-8603	National University of Cuyo; Committee of Investigations of Aconcagua University (CIUDA), Aconcagua University	National University of Cuyo; Committee of Investigations of Aconcagua University (CIUDA), Aconcagua University	Funding: Funding provided by Program 2011-2014, Secretary of Science and Technology (SECyT), National University of Cuyo; and Projects 2011, 2012, 2013, Committee of Investigations of Aconcagua University (CIUDA), Aconcagua University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataineh HN, 2005, SAUDI MED J, V26, P398; Belmonte SA, 2005, DEV BIOL, V285, P393, DOI 10.1016/j.ydbio.2005.07.001; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Bolumar F, 2000, AM J EPIDEMIOL, V151, P1072, DOI 10.1093/oxfordjournals.aje.a010150; BREDDERMAN PJ, 1964, J REPROD FERTIL, V7, P401, DOI 10.1530/jrf.0.0070401; Buffone MG, 2009, J ANDROL, V30, P552, DOI 10.2164/jandrol.108.006551; Burgos MH, 1951, REV SOC ARG BIOL, P281; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; Chrysohoou C, 2010, QJM-INT J MED, V103, P413, DOI 10.1093/qjmed/hcq045; Comhaire FH, 2005, ASIAN J ANDROL, V7, P257, DOI 10.1111/j.1745-7262.2005.00047.x; Cross NL, 2004, BIOL REPROD, V71, P1367, DOI 10.1095/biolreprod.104.030502; DAVIS BK, 1974, P SOC EXP BIOL MED, V146, P11, DOI 10.3181/00379727-146-38033; DEBOER KF, 1991, LAB ANIM SCI, V41, P187; Diaz-Fontdevila M, 1998, ANDROLOGIA, V30, P15; DIAZFONTDEVILA M, 1993, MOL REPROD DEV, V35, P176, DOI 10.1002/mrd.1080350211; DIAZFONTDEVILA M, 1992, ANDROLOGIA, V24, P279; Fatma BA, 2009, ASIAN J ANDROL, V11, P393, DOI 10.1038/aja.2008.6; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; GRIZARD G, 1995, INT J ANDROL, V18, P151, DOI 10.1111/j.1365-2605.1995.tb00404.x; GUPTA RS, 1988, Z ERNAHRUNGSWISS, V27, P236, DOI 10.1007/BF02019512; HALLIWELL B, 1993, HAEMOSTASIS, V23, P118; Hammoud AO, 2008, FERTIL STERIL, V90, P897, DOI 10.1016/j.fertnstert.2008.08.026; Hammoud AO, 2006, J ANDROL, V27, P619, DOI 10.2164/jandrol.106.000125; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Hoefel AL, 2011, CELL BIOCHEM FUNCT, V29, P569, DOI 10.1002/cbf.1789; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219; Kamal R, 2003, PHYTOTHER RES, V17, P579, DOI 10.1002/ptr.1320; Katcher HI, 2009, ENDOCRIN METAB CLIN, V38, P45, DOI 10.1016/j.ecl.2008.11.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XD, 2011, PROTEIN CELL, V2, P189, DOI 10.1007/s13238-011-1016-3; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Nguyen RHN, 2007, HUM REPROD, V22, P2488, DOI 10.1093/humrep/dem139; Orgebin-Crist M. C., 1969, Biology of Reproduction Suppl, VNo.1, P155, DOI 10.1095/biolreprod1.Supplement_1.155; Osheroff JE, 1999, MOL HUM REPROD, V5, P1017, DOI 10.1093/molehr/5.11.1017; Ouvrier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026966; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V302, pE768, DOI 10.1152/ajpendo.00401.2011; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Pasquali R, 2006, MATURITAS, V54, P363, DOI 10.1016/j.maturitas.2006.04.018; Pasquali R, 2006, REPROD BIOMED ONLINE, V12, P542, DOI 10.1016/S1472-6483(10)61179-0; Perez-Lopez FR, 2009, MATURITAS, V64, P67, DOI 10.1016/j.maturitas.2009.07.013; Perona JS, 2006, J NUTR BIOCHEM, V17, P429, DOI 10.1016/j.jnutbio.2005.11.007; Pietrobon EO, 2001, J ANDROL, V22, P96; Piomboni P, 2008, ASIAN J ANDROL, V10, P201, DOI 10.1111/j.1745-7262.2008.00356.x; Rich-Edwards JW, 2002, EPIDEMIOLOGY, V13, P184, DOI 10.1097/00001648-200203000-00013; Saez F, 2011, ASIAN J ANDROL, V13, P11, DOI 10.1038/aja.2010.64; Lancellotti TES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013457; Sallmen M, 2006, EPIDEMIOLOGY, V17, P520, DOI 10.1097/01.ede.0000229953.76862.e5; Selvaraj V, 2007, J ANDROL, V28, P588, DOI 10.2164/jandrol.106.002279; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; TALBOT P, 1981, J EXP ZOOL, V215, P201, DOI 10.1002/jez.1402150210; Violante B, 2009, J ENDOCRINOL INVEST, V32, P794, DOI [10.1007/BF03345747, 10.3275/6103]; Visconti PE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3142pe35; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; Volle DH, 2007, MOL ENDOCRINOL, V21, P1014, DOI 10.1210/me.2006-0277; Yamamoto Y, 1999, HUM REPROD, V14, P1516, DOI 10.1093/humrep/14.6.1516; Yanagimachi R., 1994, P189; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G	60	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52386	10.1371/journal.pone.0052386	http://dx.doi.org/10.1371/journal.pone.0052386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326331	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800016
J	Mhlanga, P; Hassan, WAW; Hamerton, I; Howlin, BJ				Mhlanga, Phumzile; Hassan, Wan Aminah Wan; Hamerton, Ian; Howlin, Brendan J.			Using Combined Computational Techniques to Predict the Glass Transition Temperatures of Aromatic Polybenzoxazines	PLOS ONE			English	Article							MOLECULAR SIMULATION; NEURAL-NETWORK; FORCE-FIELD; POLYMERS; QSPR; POLYMERIZATION; BENZOXAZINES	The Molecular Operating Environment software (MOE) is used to construct a series of benzoxazine monomers for which a variety of parameters relating to the structures (e.g. water accessible surface area, negative van der Waals surface area, hydrophobic volume and the sum of atomic polarizabilities, etc.) are obtained and quantitative structure property relationships (QSPR) models are formulated. Three QSPR models (formulated using up to 5 descriptors) are first used to make predictions for the initiator data set (n = 9) and compared to published thermal data; in all of the QSPR models there is a high level of agreement between the actual data and the predicted data (within 0.63-1.86 K of the entire dataset). The water accessible surface area is found to be the most important descriptor in the prediction of T-g. Molecular modelling simulations of the benzoxazine polymer (minus initiator) carried out at the same time using the Materials Studio software suite provide an independent prediction of T-g. Predicted T-g values from molecular modelling fall in the middle of the range of the experimentally determined T-g values, indicating that the structure of the network is influenced by the nature of the initiator used. Hence both techniques can provide predictions of glass transition temperatures and provide complementary data for polymer design.	[Mhlanga, Phumzile; Hassan, Wan Aminah Wan; Hamerton, Ian; Howlin, Brendan J.] Univ Surrey, Dept Chem, Guildford GU2 5XH, Surrey, England	University of Surrey	Howlin, BJ (corresponding author), Univ Surrey, Dept Chem, Guildford GU2 5XH, Surrey, England.	b.howlin@surrey.ac.uk	Howlin, Brendan J/F-3343-2011; Hamerton, Ian/AAV-8918-2021	Howlin, Brendan J/0000-0002-9398-7152; Hamerton, Ian/0000-0003-3113-0345	Huntsman Corporation	Huntsman Corporation	PhD Studentship support for WAWH from Huntsman Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ACC MAT STUD VERS 5; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertinetto C, 2007, POLYMER, V48, P7121, DOI 10.1016/j.polymer.2007.09.043; Bicerano J, 1996, J MACROMOL SCI R M C, VC36, P161; Bicerano J, 2004, J MACROMOL SCI-POL R, VC44, P53, DOI 10.1081/MC-120027934; Bicerano J, 1993, ANTEC 93 BE NUMBER, V1-3, P292; Brostow W, 2008, MATER LETT, V62, P3152, DOI 10.1016/j.matlet.2008.02.008; Camelio P, 1997, J POLYM SCI POL CHEM, V35, P2579, DOI 10.1002/(SICI)1099-0518(19970930)35:13<2579::AID-POLA5>3.0.CO;2-M; Chutayothin P, 2010, MACROMOLECULES, V43, P4562, DOI 10.1021/ma901743h; Conolly ML, 1983, J APPL CRYSTALLOGR, V16, P548; Hall SA, 2012, THESIS U SURREY; Hall SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042928; Hamerton I, 2006, POLYMER, V47, P690, DOI 10.1016/j.polymer.2005.11.082; HAMERTON I, 1995, J MOL GRAPHICS, V13, P14, DOI 10.1016/0263-7855(94)00009-H; Hamerton I, 1996, MODEL SIMUL MATER SC, V4, P151, DOI 10.1088/0965-0393/4/2/003; Hamerton I, 1996, MACROMOL THEOR SIMUL, V5, P305, DOI 10.1002/mats.1996.040050211; Hamerton I, 2011, USING MOL SIMULATION, P127; Hamerton I, 2012, POLYM DEGRA IN PRESS; Hamerton I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038424; Heap K, 2012, EXAMINING EFFE UNPUB; Holly FW, 1944, J AM CHEM SOC, V66, P1875, DOI 10.1021/ja01239a022; Howlin BJ, 2012, PLOS IN PRESS; Ishida H, 2005, POLYMER, V46, P5588, DOI 10.1016/j.polymer.2005.04.080; Ishida H, 2011, HANDBOOK OF BENZOXAZINE RESINS, P1; ISHIDA H, 1995, POLYMER, V36, P3151, DOI 10.1016/0032-3861(95)97878-J; Ishida H, 2011, HANDBOOK OF BENZOXAZINE RESINS, P3, DOI 10.1016/B978-0-444-53790-4.00046-1; JOYCE SJ, 1995, J CHEM SOC FARADAY T, V91, P2491, DOI 10.1039/ft9959102491; Karelson M, 1996, CHEM REV, V96, P1027, DOI 10.1021/cr950202r; KATRITZKY AR, 1995, CHEM SOC REV, V24, P279, DOI 10.1039/cs9952400279; Katritzky AR, 1998, J CHEM INF COMP SCI, V38, P300, DOI 10.1021/ci9700687; Kim HJ, 1999, POLYMER, V40, P1815; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Molecular Operating Environment (MOE), 2011, MOL OP ENV MOE 2011; Sudo A, 2008, MACROMOLECULES, V41, P9030, DOI 10.1021/ma8013178; SUN H, 1994, J AM CHEM SOC, V116, P2978, DOI 10.1021/ja00086a030; VanKrevelen DW, 2009, PROPERTIES OF POLYMERS: THEIR CORRELATION WITH CHEMICAL STRUCTURE; THEIR NUMERICAL ESTIMATION AND PREDICTION FROM ADDITIVE GROUP CONTRIBUTIONS, P1; VAZ RJ, 1993, MAKROMOL CHEM-M SYMP, V65, P261, DOI 10.1002/masy.19930650129; Wang YX, 1999, POLYMER, V40, P4563, DOI 10.1016/S0032-3861(99)00074-9	38	12	12	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53367	10.1371/journal.pone.0053367	http://dx.doi.org/10.1371/journal.pone.0053367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326419	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400020
J	Lafargue, G; Noel, M; Luyat, M				Lafargue, Gilles; Noel, Myriam; Luyat, Marion			In the Elderly, Failure to Update Internal Models Leads to Over-Optimistic Predictions about Upcoming Actions	PLOS ONE			English	Article							REPRESENTED MOTOR ACTIONS; OLDER-ADULTS; HUNTINGTONS-DISEASE; POSTURAL LIMITS; RISK-FACTORS; FALLS; IMAGERY; AGE; MOVEMENTS; BRAIN	Before an action is performed, the brain simulates the body's dynamic behavior in relation to the environment, estimates the possible outcomes and assesses the feasibility of potential actions. Here, we tested a hypothesis whereby age-related changes in sensorimotor abilities result in failure to update internal models of action in the elderly. Young and older adults were required to judge in advance whether or not they could stand on an inclined plane (Experiment 1). Relative to young adults, elderly adults overestimated their postural capabilities: although the two groups made similar feasibility judgments, elderly participants showed significantly worse postural performance levels. This tendency to overestimate their own ability persisted when elderly adults had to not only estimate the feasibility of an action but also endanger themselves by walking towards an obstacle that was too high for them to clear (Experiment 2). An age-related failure to update internal models may prompt the elderly to make over-optimistic predictions about upcoming actions. In turn, this may favor risky motor decision-making and promote falls.	[Lafargue, Gilles; Luyat, Marion] Univ Lille 3, Dept Psychol, Villeneuve Dascq, France; [Lafargue, Gilles; Noel, Myriam; Luyat, Marion] Univ Lille N France, Lab Neurosci Fonct & Pathol, Lille, France; [Noel, Myriam] Hop Victor Provo, CHR Roubaix, Roubaix, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Lafargue, G (corresponding author), Univ Lille 3, Dept Psychol, Villeneuve Dascq, France.	gilles.lafargue@univ-lille3.fr; marion.luyat@univ-lille3.fr	Luyat, Marion/HIR-3502-2022	Luyat, Marion/0000-0002-5640-5002	Centre National pour la Recherche Scientifique (PIR "Longevite et Vieillissement'')	Centre National pour la Recherche Scientifique (PIR "Longevite et Vieillissement'')	This work was supported by the Centre National pour la Recherche Scientifique (PIR "Longevite et Vieillissement'') awarded to Marion Luyat and Gilles Lafargue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLARD B, 1980, PERCEPT MOTOR SKILL, V51, P903, DOI 10.2466/pms.1980.51.3.903; Bakker M, 2008, NEUROIMAGE, V41, P998, DOI 10.1016/j.neuroimage.2008.03.020; Cooper JW, 2009, J AM PHARM ASSOC, V49, pE70, DOI 10.1331/JAPhA.2009.09044; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; DECETY J, 1990, BRAIN RES, V535, P313, DOI 10.1016/0006-8993(90)91615-N; Desmurget M, 2009, TRENDS COGN SCI, V13, P411, DOI 10.1016/j.tics.2009.08.001; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Fabre JM, 2010, J GERIATR PHYS THER, V33, P184, DOI 10.1097/JPT.0b013e3181ff2a24; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frak V, 2001, EXP BRAIN RES, V136, P120, DOI 10.1007/s002210000583; Gabbard C, 2007, J MOTOR BEHAV, V39, P242, DOI 10.3200/JMBR.39.4.242-246; Gabbard C, 2011, BRAIN COGNITION, V77, P459, DOI 10.1016/j.bandc.2011.08.011; Gabbard C, 2011, ARCH GERONTOL GERIAT, V53, P206, DOI 10.1016/j.archger.2010.10.006; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Hogan M, 2005, INT J AGING HUM DEV, V60, P95, DOI 10.2190/PTG9-XDVM-YETA-MKXA; Hogan MJ, 2011, CORTEX, V47, P441, DOI 10.1016/j.cortex.2010.01.001; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kamata N, 2007, CLIN REHABIL, V21, P357, DOI 10.1177/0269215507073346; Luyat M, 2008, PSYCHOL NEUROPSYCHIA, V6, P287, DOI 10.1684/pnv.2008.0149; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mulder T, 2007, HUM MOVEMENT SCI, V26, P203, DOI 10.1016/j.humov.2007.01.001; Noel M, 2011, GERIATR PSYCHOL NEUR, V9, P287, DOI 10.1684/pnv.2011.0290; Personnier P, 2008, BEHAV BRAIN RES, V186, P273, DOI 10.1016/j.bbr.2007.08.018; Personnier P, 2010, BEHAV BRAIN RES, V206, P184, DOI 10.1016/j.bbr.2009.09.011; Porro CA, 1996, J NEUROSCI, V16, P7688; Raz N, 2003, AM J NEURORADIOL, V24, P1849; Resnick SM, 2003, J NEUROSCI, V23, P3295; Robinovitch SN, 1998, J MOTOR BEHAV, V30, P352, DOI 10.1080/00222899809601349; Rose DJ, 2008, J REHABIL RES DEV, V45, P1153, DOI 10.1682/JRRD.2008.03.0041; Roth R, 1996, NEUROREPORT, V7, P1280, DOI 10.1097/00001756-199605170-00012; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Saimpont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006714; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Skoura X, 2005, BEHAV BRAIN RES, V165, P229, DOI 10.1016/j.bbr.2005.07.023; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; Stelmach G., 1993, SENSORIMOTOR IMPAIRM, DOI [10.1007/978-94-011-1976-4, DOI 10.1007/978-94-011-1976-4]; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Takatori K, 2009, CLIN REHABIL, V23, P568, DOI 10.1177/0269215509102957; van Gelder BM, 2004, NEUROLOGY, V63, P2316, DOI 10.1212/01.WNL.0000147474.29994.35; Westerterp K R, 2000, Curr Opin Clin Nutr Metab Care, V3, P485, DOI 10.1097/00075197-200011000-00011; Wilson TM, 2000, AM J PHYSIOL-HEART C, V278, pH829, DOI 10.1152/ajpheart.2000.278.3.H829; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	49	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e51218	10.1371/journal.pone.0051218	http://dx.doi.org/10.1371/journal.pone.0051218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326312	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500004
J	Singhapol, C; Pal, D; Czapiewski, R; Porika, M; Nelson, G; Saretzki, GC				Singhapol, Chatchawan; Pal, Deepali; Czapiewski, Rafal; Porika, Mahendar; Nelson, Glyn; Saretzki, Gabriele C.			Mitochondrial Telomerase Protects Cancer Cells from Nuclear DNA Damage and Apoptosis	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; ASSOCIATION; EXPRESSION; GENES; RNA	Most cancer cells express high levels of telomerase and proliferate indefinitely. In addition to its telomere maintenance function, telomerase also has a pro-survival function resulting in an increased resistance against DNA damage and decreased apoptosis induction. However, the molecular mechanisms for this protective function remain elusive and it is unclear whether it is connected to telomere maintenance or is rather a non-telomeric function of the telomerase protein, TERT. It was shown recently that the protein subunit of telomerase can shuttle from the nucleus to the mitochondria upon oxidative stress where it protects mitochondrial function and decreases intracellular oxidative stress. Here we show that endogenous telomerase (TERT protein) shuttles from the nucleus into mitochondria upon oxidative stress in cancer cells and analyzed the nuclear exclusion patterns of endogenous telomerase after treatment with hydrogen peroxide in different cell lines. Cell populations excluded TERT from the nucleus upon oxidative stress in a heterogeneous fashion. We found a significant correlation between nuclear localization of telomerase and high DNA damage, while cells which excluded telomerase from the nucleus displayed no or very low DNA damage. We modeled nuclear and mitochondrial telomerase using organelle specific localization vectors and confirmed that mitochondrial localization of telomerase protects the nucleus from inflicted DNA damage and apoptosis while, in contrast, nuclear localization of telomerase correlated with higher amounts of DNA damage and apoptosis. It is known that nuclear DNA damage can be caused by mitochondrially generated reactive oxygen species (ROS). We demonstrate here that mitochondrial localization of telomerase specifically prevents nuclear DNA damage by decreasing levels of mitochondrial ROS. We suggest that this decrease of oxidative stress might be a possible cause for high stress resistance of cancer cells and could be especially important for cancer stem cells.	[Singhapol, Chatchawan; Pal, Deepali; Czapiewski, Rafal; Porika, Mahendar; Nelson, Glyn; Saretzki, Gabriele C.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Saretzki, GC (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Campus Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	gabriele.saretzki@ncl.ac.uk	nelson, glyn/A-6346-2009; Saretzki, Gabriele Christine/I-7175-2019	nelson, glyn/0000-0002-1895-4772; Saretzki, Gabriele Christine/0000-0003-2100-8223; Pal, Deepali/0000-0001-6326-5303; Czapiewski, Rafal/0000-0003-0211-8435	Thai government; BBSRC grant [BB/C008200/1(CISBAN)]; Biotechnology and Biological Sciences Research Council [BB/C008200/1] Funding Source: researchfish	Thai government; BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Chatchawan Singhapol was funded by a scholarship from Thai government. Glyn Nelson was supported by the BBSRC grant nr. BB/C008200/1(CISBAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Bagheri S, 2006, P NATL ACAD SCI USA, V103, P11306, DOI 10.1073/pnas.0510085103; Buchner N, 2010, EXP GERONTOL, V45, P558, DOI 10.1016/j.exger.2010.03.003; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; FLINT J, 1994, AM J HUM GENET, V55, P505; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Joseph I, 2010, CANCER RES, V70, P9494, DOI 10.1158/0008-5472.CAN-10-0233; Kovalenko OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010812; Kovalenko OA, 2010, AGING CELL, V9, P203, DOI 10.1111/j.1474-9726.2010.00551.x; Li S, 2005, J BIOL CHEM, V280, P23709, DOI 10.1074/jbc.M502782200; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Roth A, 2010, RECENT RESULTS CANC, V184, P221, DOI 10.1007/978-3-642-01222-8_16; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Sharma NK, 2012, NUCLEIC ACIDS RES, V40, P712, DOI 10.1093/nar/gkr758; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846	25	109	112	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52989	10.1371/journal.pone.0052989	http://dx.doi.org/10.1371/journal.pone.0052989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326372	Green Published, gold, Green Accepted			2022-12-27	WOS:000313551500041
J	Wierzbicki, R; Kobler, C; Jensen, MRB; Lopacinska, J; Schmidt, MS; Skolimowski, M; Abeille, F; Qvortrup, K; Molhave, K				Wierzbicki, Rafal; Kobler, Carsten; Jensen, Mikkel R. B.; Lopacinska, Joanna; Schmidt, Michael S.; Skolimowski, Maciej; Abeille, Fabien; Qvortrup, Klaus; Molhave, Kristian			Mapping the Complex Morphology of Cell Interactions with Nanowire Substrates Using FIB-SEM	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; SYNTHETIC NANOSTRUCTURES; FOCAL ADHESION; MOTILITY; SURFACE; ARRAYS; FORCE; PROLIFERATION; FABRICATION; BEHAVIOR	Using high resolution focused ion beam scanning electron microscopy (FIB-SEM) we study the details of cell-nanostructure interactions using serial block face imaging. 3T3 Fibroblast cellular monolayers are cultured on flat glass as a control surface and on two types of nanostructured scaffold substrates made from silicon black (Nanograss) with low- and high nanowire density. After culturing for 72 hours the cells were fixed, heavy metal stained, embedded in resin, and processed with FIB-SEM block face imaging without removing the substrate. The sample preparation procedure, image acquisition and image post-processing were specifically optimised for cellular monolayers cultured on nanostructured substrates. Cells display a wide range of interactions with the nanostructures depending on the surface morphology, but also greatly varying from one cell to another on the same substrate, illustrating a wide phenotypic variability. Depending on the substrate and cell, we observe that cells could for instance: break the nanowires and engulf them, flatten the nanowires or simply reside on top of them. Given the complexity of interactions, we have categorised our observations and created an overview map. The results demonstrate that detailed nanoscale resolution images are required to begin understanding the wide variety of individual cells' interactions with a structured substrate. The map will provide a framework for light microscopy studies of such interactions indicating what modes of interactions must be considered.	[Wierzbicki, Rafal; Kobler, Carsten; Jensen, Mikkel R. B.; Lopacinska, Joanna; Schmidt, Michael S.; Skolimowski, Maciej; Abeille, Fabien; Molhave, Kristian] Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark; [Kobler, Carsten] Tech Univ Denmark, DTU CEN, DK-2800 Lyngby, Denmark; [Qvortrup, Klaus] Univ Copenhagen, CFIM, Dept Biomed Sci, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen	Molhave, K (corresponding author), Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark.	kristian.molhave@nanotech.dtu.dk	Molhave, Kristian/B-9209-2008; Lopacinska-Jørgensen, Joanna/AGO-3187-2022; Schmidt, Michael S/F-1677-2010; Skolimowski, Maciej/G-6320-2011; Mølhave, Kristian/AAP-5837-2020	Molhave, Kristian/0000-0002-6493-2750; Lopacinska-Jørgensen, Joanna/0000-0001-7803-425X; Schmidt, Michael S/0000-0002-9673-3449; Mølhave, Kristian/0000-0002-6493-2750; Qvortrup, Klaus/0000-0001-8811-0260	FP7-Technotubes [CP-IP 228579-1]; FP7-Nanoscale [CP-FP 214566-2]; Technical University of Denmark; Institute: DTU CEN; Institute: DTU Nanotech	FP7-Technotubes; FP7-Nanoscale; Technical University of Denmark; Institute: DTU CEN; Institute: DTU Nanotech	This study was supported by FP7-Technotubes, CP-IP 228579-1; FP7-Nanoscale, CP-FP 214566-2 (http://www.nanoscale-fp7.eu/); Technical University of Denmark; Institutes: DTU CEN, DTU Nanotech (www.cen.dtu.dk and www.nanotech.dtu.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Berthing T, 2011, SMALL, V7, P640, DOI 10.1002/smll.201001642; Bittermann AG, 2009, ADV ENG MATER, V11, pB182, DOI 10.1002/adem.200900080; Canton I, 2012, CHEM SOC REV, V41, P2718, DOI 10.1039/c2cs15309b; Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]; Choi D, 2007, BIOMED MICRODEVICES, V9, P143, DOI 10.1007/s10544-006-9008-4; Cox G, 2004, MICROSC RES TECHNIQ, V63, P18, DOI 10.1002/jemt.10423; Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049; De Winter DAM, 2009, J MICROSC-OXFORD, V233, P372, DOI 10.1111/j.1365-2818.2009.03139.x; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Drobne D, 2008, ULTRAMICROSCOPY, V108, P663, DOI 10.1016/j.ultramic.2007.10.010; Edwards HK, 2009, J MICROSC-OXFORD, V234, P16, DOI 10.1111/j.1365-2818.2009.03152.x; Edwards RL, 2004, EXP MECH, V44, P49, DOI 10.1177/0014485104039749; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedmann A, 2011, ACTA BIOMATER, V7, P2499, DOI 10.1016/j.actbio.2011.02.024; Ghibaudo M, 2008, SOFT MATTER, V4, P1836, DOI 10.1039/b804103b; Gnauck P, 2005, MICROSC MICROANAL, V11, DOI [10.1017/S1431927605501843, DOI 10.1017/S1431927605501843]; Gradinaru C, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201207004; Greve F, 2007, BIOMATERIALS, V28, P5246, DOI 10.1016/j.biomaterials.2007.08.010; Hai A, 2009, J R SOC INTERFACE, V6, P1153, DOI 10.1098/rsif.2009.0087; Hallstrom W, 2007, NANO LETT, V7, P2960, DOI 10.1021/nl070728e; Hanson L, 2012, NANO LETT, V12, P5815, DOI 10.1021/nl303163y; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Hill JJ, 2010, ACS APPL MATER INTER, V2, P1992, DOI 10.1021/am100290z; Hoffmann S, 2006, NANO LETT, V6, P622, DOI 10.1021/nl052223z; JANSEN H, 1995, J MICROMECH MICROENG, V5, P115, DOI 10.1088/0960-1317/5/2/015; Jimenez N, 2010, J MICROSC-OXFORD, V237, P208, DOI 10.1111/j.1365-2818.2009.03329.x; Kim P, 2005, NANOTECHNOLOGY, V16, P2420, DOI 10.1088/0957-4484/16/10/072; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; KULKARNI GV, 1994, J CELL SCI, V107, P1169; Kwon NH, 2007, NANO LETT, V7, P2718, DOI 10.1021/nl071179f; Lamers E, 2011, TISSUE ENG PART C-ME, V17, P1, DOI [10.1089/ten.tec.2010.0251, 10.1089/ten.TEC.2010.0251]; Li Z, 2009, NANO LETT, V9, P3575, DOI 10.1021/nl901774m; Lopacinska JM, 2012, NANOSCALE, V4, P3739, DOI 10.1039/c2nr11455k; Marques MM, 2004, LASER SURG MED, V34, P260, DOI 10.1002/lsm.20008; Martinelli V, 2012, NANO LETT, V12, P1831, DOI 10.1021/nl204064s; Martinez E, 2008, MICRON, V39, P111, DOI 10.1016/j.micron.2006.12.003; McKnight TE, 2003, NANOTECHNOLOGY, V14, P551, DOI 10.1088/0957-4484/14/5/313; McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Murphy GE, 2011, J STRUCT BIOL, V176, P268, DOI 10.1016/j.jsb.2011.08.013; Obataya I, 2005, NANO LETT, V5, P27, DOI 10.1021/nl0485399; OKAMOTO K, 1980, REV SCI INSTRUM, V51, P302, DOI 10.1063/1.1136205; Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476; Persson H, 2012, NANO RES, V5, P190, DOI 10.1007/s12274-012-0199-0; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Robinson JT, 2012, NAT NANOTECHNOL, V7, P180, DOI [10.1038/nnano.2011.249, 10.1038/NNANO.2011.249]; Ryoo SR, 2010, ACS NANO, V4, P6587, DOI 10.1021/nn1018279; Safi M, 2011, ACS NANO, V5, P5354, DOI 10.1021/nn201121e; Schmidt MS, 2012, ADV MATER, V24, pOP11, DOI 10.1002/adma.201103496; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; Somosy Z, 2000, MICRON, V31, P165, DOI 10.1016/S0968-4328(99)00083-9; Stevenson PM, 2009, LANGMUIR, V25, P367, DOI 10.1021/la802859v; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Vitol EA, 2009, ACS NANO, V3, P3529, DOI 10.1021/nn9010768; Wrobel G, 2008, J R SOC INTERFACE, V5, P213, DOI 10.1098/rsif.2007.1094; Yang PD, 2010, NANO LETT, V10, P1529, DOI 10.1021/nl100665r; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yu Z, 2007, NANO LETT, V7, P2188, DOI 10.1021/nl070291a	61	50	50	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53307	10.1371/journal.pone.0053307	http://dx.doi.org/10.1371/journal.pone.0053307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326412	Green Submitted, gold, Green Published			2022-12-27	WOS:000313551500064
J	Zilioli, S; Watson, NV				Zilioli, Samuele; Watson, Neil V.			Winning Isn't Everything: Mood and Testosterone Regulate the Cortisol Response in Competition	PLOS ONE			English	Article							SALIVARY TESTOSTERONE; SOCIAL STRESS; NEUROENDOCRINE; BEHAVIOR; DOMINANCE; PERSONALITY; STEROIDS; STYLES; JUDO	Dominance contests are recurrent and widespread causes of stress among mammals. Studies of activation of the stress axis in social defeat - as reflected in levels of adrenal glucocorticoid, cortisol - have generated scattered and sometimes contradictory results, suggesting that biopsychological individual differences might play an important mediating role, at least in humans. In the context of a larger study of the regulation of endocrine responses to competition, we evaluated the notion that mood states, such as self-assurance and hostility, may influence cortisol reactivity to dominance cues via an interplay with baseline testosterone, considered as a potential marker of individual differences in dominance. Seventy healthy male university students (mean age 20.02, range 18-26) provided saliva samples before and after competing for fifteen minutes on a rigged computer task. After a winner was determined, all participants were assessed on their mood states through a standardized psychometric instrument (PANAS-X). Among winners of a rigged videogame competition, we found a significant interaction between testosterone and self-assurance in relation to post-competition cortisol. Specifically, self-assurance was associated with lower post-competition cortisol in subjects with high baseline testosterone levels, but no such relationship was observed in subjects with lower baseline testosterone levels. In losers of the competition no interaction effect between basal testosterone and hostility was observed. However, in this subgroup a significant negative relationship between basal testosterone and post-competition cortisol was evident. Overall, these findings provide initial support for the novel hypothesis that biological motivational predispositions (i.e. basal testosterone) and state (i.e. mood changes) may interact in regulating the hypothalamic-pituitary-adrenal axis activation after a social contest.	[Zilioli, Samuele; Watson, Neil V.] Simon Fraser Univ, Dept Psychol, Behav Endocrinol Lab, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Watson, NV (corresponding author), Simon Fraser Univ, Dept Psychol, Behav Endocrinol Lab, Burnaby, BC V5A 1S6, Canada.	nwatson@sfu.ca		Watson, Neil/0000-0002-1709-4889	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [00194522]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant 00194522 to NVW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; BERK LS, 1989, AM J MED SCI, V298, P390, DOI 10.1097/00000441-198912000-00006; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Bostock S, 2011, PSYCHONEUROENDOCRINO, V36, P1175, DOI 10.1016/j.psyneuen.2011.02.009; BREMNER WJ, 1983, J CLIN ENDOCR METAB, V56, P1278, DOI 10.1210/jcem-56-6-1278; CAMPBELL IT, 1982, CHRONOBIOLOGIA, V9, P389; Christensen AJ, 1996, PSYCHOSOM MED, V58, P150, DOI 10.1097/00006842-199603000-00009; Cohen J., 2003, APPL MULTIPLE REGRES; DABBS JM, 1990, PHYSIOL BEHAV, V48, P83, DOI 10.1016/0031-9384(90)90265-6; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; DIENER E, 1984, J PERS SOC PSYCHOL, V47, P1105, DOI 10.1037/0022-3514.47.5.1105; DIENSTBIER RA, 1989, PSYCHOL REV, V96, P84, DOI 10.1037/0033-295X.96.1.84; Flegr J, 2010, NEUROENDOCRINOL LETT, V31, P577; Geniole SN, 2011, BIOL PSYCHOL, V87, P137, DOI 10.1016/j.biopsycho.2011.02.020; Gonzalez-Bono E, 1999, HORM BEHAV, V35, P55, DOI 10.1006/hbeh.1998.1496; Gonzalez-Bono E, 2000, AGGRESSIVE BEHAV, V26, P235, DOI 10.1002/(SICI)1098-2337(2000)26:3<235::AID-AB3>3.0.CO;2-L; Hodge VJ, 2004, ARTIF INTELL REV, V22, P85, DOI 10.1023/B:AIRE.0000045502.10941.a9; HORROCKS PM, 1990, CLIN ENDOCRINOL, V32, P127, DOI 10.1111/j.1365-2265.1990.tb03758.x; Josephs RA, 2003, PSYCHOL SCI, V14, P158, DOI 10.1111/1467-9280.t01-1-01435; Keeney A, 2006, J NEUROENDOCRINOL, V18, P330, DOI 10.1111/j.1365-2826.2006.01422.x; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kramer M, 1999, NEUROSCI BIOBEHAV R, V23, P937, DOI 10.1016/S0149-7634(99)00027-5; Lazarus R.S., 1984, EMOTION ADAPTATION; LOUCH CD, 1967, GEN COMP ENDOCR, V8, P441, DOI 10.1016/S0016-6480(67)80006-6; MANOGUE K R, 1975, Primates, V16, P457, DOI 10.1007/BF02382742; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; MCCAUL KD, 1992, HORM BEHAV, V26, P486, DOI 10.1016/0018-506X(92)90016-O; McNair D., 1971, MANUAL PROFILE MOOD; Mehta PH, 2008, J PERS SOC PSYCHOL, V94, P1078, DOI 10.1037/0022-3514.94.6.1078; Miller GE, 1999, BRAIN BEHAV IMMUN, V13, P109, DOI 10.1006/brbi.1998.0545; Mills PJ, 1996, J PSYCHOSOM RES, V40, P417, DOI 10.1016/0022-3999(95)00614-1; Newman ML, 2005, HORM BEHAV, V47, P205, DOI 10.1016/j.yhbeh.2004.09.008; Parmigiani S, 2006, AGGRESSIVE BEHAV, V32, P481, DOI 10.1002/ab.20148; Polk DE, 2005, PSYCHONEUROENDOCRINO, V30, P261, DOI 10.1016/j.psyneuen.2004.08.004; POPE MK, 1991, PSYCHOSOM MED, V53, P386, DOI 10.1097/00006842-199107000-00004; Popma A, 2007, BIOL PSYCHIAT, V61, P405, DOI 10.1016/j.biopsych.2006.06.006; RIADFAHMY D, 1987, J REPROD MED, V32, P254; RIADFAHMY D, 1982, ENDOCR REV, V3, P367, DOI 10.1210/edrv-3-4-367; Salvador A, 2005, NEUROSCI BIOBEHAV R, V29, P195, DOI 10.1016/j.neubiorev.2004.07.004; Salvador A, 2003, PSYCHONEUROENDOCRINO, V28, P364, DOI 10.1016/S0306-4530(02)00028-8; Salvador A, 2009, NEUROSCI BIOBEHAV R, V33, P160, DOI 10.1016/j.neubiorev.2008.09.005; Schultheiss OC, 2005, J PERS SOC PSYCHOL, V88, P174, DOI 10.1037/0022-3514.88.1.174; Sellers JG, 2007, J RES PERS, V41, P126, DOI 10.1016/j.jrp.2006.02.004; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Suarez EC, 1998, PSYCHOSOM MED, V60, P78, DOI 10.1097/00006842-199801000-00017; SULS J, 1993, PSYCHOPHYSIOLOGY, V30, P615, DOI 10.1111/j.1469-8986.1993.tb02087.x; Takahashi T, 2005, BRAIN RES BULL, V67, P398, DOI 10.1016/j.brainresbull.2005.06.006; Van Anders SM, 2006, HUM NATURE-INT BIOS, V17, P212, DOI 10.1007/s12110-006-1018-7; Virgin CE, 1997, AM J PRIMATOL, V42, P25, DOI 10.1002/(SICI)1098-2345(1997)42:1<25::AID-AJP2>3.3.CO;2-T; Vogele C, 1998, INT J PSYCHOPHYSIOL, V28, P167, DOI 10.1016/S0167-8760(97)00094-9; Watson D., 1994, PANAS X MANUAL POSIT, DOI [10.17077/48vtm4t2, DOI 10.17077/48VTM4T2, DOI 10.13072/MIDSS.438]; Weiner H., 1992, PERTURBING ORGANISM; Wirth MM, 2006, HORM BEHAV, V49, P346, DOI 10.1016/j.yhbeh.2005.08.013; Zilioli S, 2012, PSYCHONEUROENDOCRINO, V37, P1855, DOI 10.1016/j.psyneuen.2012.03.022	56	30	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52582	10.1371/journal.pone.0052582	http://dx.doi.org/10.1371/journal.pone.0052582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326343	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500021
J	Zong, J; Deng, W; Zhou, H; Bian, ZY; Dai, J; Yuan, Y; Zhang, JY; Zhang, R; Zhang, Y; Wu, QQ; Guo, HP; Li, HL; Tang, QZ				Zong, Jing; Deng, Wei; Zhou, Heng; Bian, Zhou-yan; Dai, Jia; Yuan, Yuan; Zhang, Jie-yu; Zhang, Rui; Zhang, Yan; Wu, Qing-qing; Guo, Hai-peng; Li, Hong-liang; Tang, Qi-zhu			3,3 '-Diindolylmethane Protects against Cardiac Hypertrophy via 5 '-Adenosine Monophosphate-Activated Protein Kinase-alpha 2	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER CELLS; KINASE; AMPK; APOPTOSIS; MTOR; INDOLE-3-CARBINOL; DYSFUNCTION; INHIBITION; METABOLISM	Purpose: 3,3'-Diindolylmethane (DIM) is a natural component of cruciferous plants. It has strong antioxidant and anti-angiogenic effects and promotes the apoptosis of a variety of tumor cells. However, little is known about the critical role of DIM on cardiac hypertrophy. In the present study, we investigated the effects of DIM on cardiac hypertrophy. Methods: Multiple molecular techniques such as Western blot analysis, real-time PCR to determine RNA expression levels of hypertrophic, fibrotic and oxidative stress markers, and histological analysis including H&E for histopathology, PSR for collagen deposition, WGA for myocyte cross-sectional area, and immunohistochemical staining for protein expression were used. Results: In pre-treatment and reverse experiments, C57/BL6 mouse chow containing 0.05% DIM (dose 100 mg/kg/d DIM) was administered one week prior to surgery or one week after surgery, respectively, and continued for 8 weeks after surgery. In both experiments, DIM reduced to cardiac hypertrophy and fibrosis induced by aortic banding through the activation of 5'-adenosine monophosphate-activated protein kinase-alpha 2 (AMPK alpha 2) and inhibition of mammalian target of the rapamycin (mTOR) signaling pathway. Furthermore, DIM protected against cardiac oxidative stress by regulating expression of estrogen-related receptor-alpha (ERR alpha) and NRF2 etc. The cardioprotective effects of DIM were ablated in mice lacking functional AMPK alpha 2. Conclusion: DIM significantly improves left ventricular function via the activation of AMPK alpha 2 in a murine model of cardiac hypertrophy.	[Zong, Jing; Deng, Wei; Zhou, Heng; Bian, Zhou-yan; Dai, Jia; Yuan, Yuan; Zhang, Jie-yu; Zhang, Rui; Zhang, Yan; Wu, Qing-qing; Li, Hong-liang; Tang, Qi-zhu] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China; [Zong, Jing; Deng, Wei; Zhou, Heng; Bian, Zhou-yan; Dai, Jia; Yuan, Yuan; Zhang, Jie-yu; Zhang, Rui; Zhang, Yan; Wu, Qing-qing; Li, Hong-liang; Tang, Qi-zhu] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China; [Guo, Hai-peng] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China; [Guo, Hai-peng] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Peoples R China	Wuhan University; Wuhan University; Shandong University; Shandong University	Tang, QZ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China.	qztang@whu.edu.cn			National Nature Science Foundation of China [30901628, 30972954, 81000036, 81000095]; Fundamental Research Funds for the Central Universities of China [20103020201000193]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Nature Science Foundation of China [30901628, 30972954, 81000036 and 81000095]; and the Fundamental Research Funds for the Central Universities of China [20103020201000193]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi AS, 2008, PHARM RES-DORDR, V25, P2117, DOI 10.1007/s11095-008-9581-8; Balakumar Pitchai, 2007, Journal of Pharmacological and Toxicological Methods, V56, P1, DOI 10.1016/j.vascn.2007.01.003; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bian ZY, 2010, HYPERTENSION, V55, P257, DOI 10.1161/HYPERTENSIONAHA.109.135665; Chen DZ, 2001, J NUTR, V131, P3294, DOI 10.1093/jn/131.12.3294; Cho HJ, 2008, J NUTR, V138, P17, DOI 10.1093/jn/138.1.17; Ernst IMA, 2011, FREE RADICAL RES, V45, P941, DOI 10.3109/10715762.2011.571683; Finckenberg P, 2010, J HYPERTENS, V28, pS33, DOI 10.1097/01.hjh.0000388492.73954.0b; Gupta S, 2007, ANTIOXID REDOX SIGN, V9, P623, DOI 10.1089/ars.2007.1474; Heidrich F, 2010, CURR CARDIOL REV, V6, P337, DOI 10.2174/157340310793566073; Hu XL, 2011, HYPERTENSION, V58, P696, DOI 10.1161/HYPERTENSIONAHA.111.174128; Hwang JT, 2008, GENES NUTR, V2, P323, DOI 10.1007/s12263-007-0069-7; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jensen TE, 2009, ACTA PHYSIOL, V196, P155, DOI 10.1111/j.1748-1716.2009.01979.x; Khwaja FS, 2009, CANCER PREV RES, V2, P566, DOI 10.1158/1940-6207.CAPR-08-0202; Kunimasa K, 2010, J NUTR, V140, P1, DOI 10.3945/jn.109.112359; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Li YW, 2007, J BIOL CHEM, V282, P21542, DOI 10.1074/jbc.M701978200; Maulik SK, 2012, TOXICOL MECH METHOD, V22, P359, DOI 10.3109/15376516.2012.666650; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Ojamaa K, 2010, VASC PHARMACOL, V52, P113, DOI 10.1016/j.vph.2009.11.008; Proud CG, 2004, CARDIOVASC RES, V63, P403, DOI 10.1016/j.cardiores.2004.02.003; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Shirwany NA, 2010, ACTA PHARMACOL SIN, V31, P1075, DOI 10.1038/aps.2010.139; Soesanto W, 2009, HYPERTENSION, V54, P1321, DOI 10.1161/HYPERTENSIONAHA.109.138818; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Tian R, 2001, CIRCULATION, V104, P1664, DOI 10.1161/hc4001.097183; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Xue L, 2005, ONCOGENE, V24, P2343, DOI 10.1038/sj.onc.1208434; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0	34	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53427	10.1371/journal.pone.0053427	http://dx.doi.org/10.1371/journal.pone.0053427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326427	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500071
J	von der Lippe, M; Bullock, JM; Kowarik, I; Knopp, T; Wichmann, M				von der Lippe, Moritz; Bullock, James M.; Kowarik, Ingo; Knopp, Tatjana; Wichmann, Matthias			Human-Mediated Dispersal of Seeds by the Airflow of Vehicles	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; FERAL OILSEED RAPE; AMBROSIA-ARTEMISIIFOLIA; PLANT DISPERSAL; MOTOR-VEHICLES; WIND; MIGRATION; INVASION; BEHAVIOR; MODELS	Human-mediated dispersal is known as an important driver of long-distance dispersal for plants but underlying mechanisms have rarely been assessed. Road corridors function as routes of secondary dispersal for many plant species but the extent to which vehicles support this process remains unclear. In this paper we quantify dispersal distances and seed deposition of plant species moved over the ground by the slipstream of passing cars. We exposed marked seeds of four species on a section of road and drove a car along the road at a speed of 48 km/h. By tracking seeds we quantified movement parallel as well as lateral to the road, resulting dispersal kernels, and the effect of repeated vehicle passes. Median distances travelled by seeds along the road were about eight meters for species with wind dispersal morphologies and one meter for species without such adaptations. Airflow created by the car lifted seeds and resulted in longitudinal dispersal. Single seeds reached our maximum measuring distance of 45 m and for some species exceeded distances under primary dispersal. Mathematical models were fit to dispersal kernels. The incremental effect of passing vehicles on longitudinal dispersal decreased with increasing number of passes as seeds accumulated at road verges. We conclude that dispersal by vehicle airflow facilitates seed movement along roads and accumulation of seeds in roadside habitats. Dispersal by vehicle airflow can aid the spread of plant species and thus has wide implications for roadside ecology, invasion biology and nature conservation.	[von der Lippe, Moritz; Bullock, James M.; Knopp, Tatjana; Wichmann, Matthias] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [von der Lippe, Moritz; Kowarik, Ingo] Tech Univ Berlin, Dept Ecol, Berlin, Germany; [Knopp, Tatjana] Univ Potsdam, Dept Anim Ecol, Potsdam, Germany; [Wichmann, Matthias] Univ Potsdam, Potsdam, Germany	UK Centre for Ecology & Hydrology (UKCEH); Technical University of Berlin; University of Potsdam; University of Potsdam	von der Lippe, M (corresponding author), Ctr Ecol & Hydrol, Wallingford, Oxon, England.	moritz.vdlippe@tu-berlin.de	Bullock, James M/F-9997-2011; Wichmann, Matthias/F-8142-2013	von der Lippe, Moritz/0000-0003-4760-1420	German Academic Exchange Service (DAAD); NERC [NE/B503141/1]; Natural Environment Research Council [NE/B503141/1] Funding Source: researchfish	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	M. von der Lippe and T. Knopp were funded by research grants of the German Academic Exchange Service (DAAD, http://www.daad.de). M. Wichmann and J. Bullock were funded by the NERC research grant NE/B503141/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew AP, 1997, FUNCT ECOL, V11, P121, DOI 10.1046/j.1365-2435.1997.00049.x; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bullock JM, 2011, OIKOS, V120, P1201, DOI 10.1111/j.1600-0706.2010.19092.x; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; CLIFFORD HT, 1959, J ECOL, V47, P311, DOI 10.2307/2257368; Colbach N, 2001, AGR ECOSYST ENVIRON, V83, P255, DOI 10.1016/S0167-8809(00)00175-4; Crawley MJ, 2004, P ROY SOC B-BIOL SCI, V271, P1909, DOI 10.1098/rspb.2004.2814; Dark SJ, 2004, DIVERS DISTRIB, V10, P1, DOI 10.1111/j.1472-4642.2004.00054.x; ESKRIDGE RE, 1979, J APPL METEOROL, V18, P387, DOI 10.1175/1520-0450(1979)018<0387:HMPIPO>2.0.CO;2; Essl F, 2009, PRESLIA, V81, P119; Garnier A, 2008, BASIC APPL ECOL, V9, P533, DOI 10.1016/j.baae.2007.08.014; Greene DF, 2004, J ECOL, V92, P758, DOI 10.1111/j.0022-0477.2004.00921.x; Hodkinson DJ, 1997, J APPL ECOL, V34, P1484, DOI 10.2307/2405264; Hucho W-H, 2003, AERODYNAMICS ROAD VE; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Kawata M, 2009, ENVIRON SCI POLLUT R, V16, P120, DOI 10.1007/s11356-008-0074-4; Knispel AL, 2010, ENVIRON SCI POLLUT R, V17, P13, DOI 10.1007/s11356-009-0219-0; Kowarik I., 2011, NeoBiota, P49, DOI 10.3897/neobiota.9.1469; Kowarik I, 2007, PERSPECT PLANT ECOL, V8, P207, DOI 10.1016/j.ppees.2007.03.002; Lavoie C, 2007, J BIOGEOGR, V34, P1751, DOI 10.1111/j.1365-2699.2007.01730.x; Lemke A, 2009, J APPL ECOL, V46, P1122, DOI 10.1111/j.1365-2664.2009.01691.x; LONSDALE WM, 1994, BIOL CONSERV, V69, P277, DOI 10.1016/0006-3207(94)90427-8; MATLACK GR, 1987, AM J BOT, V74, P1150, DOI 10.2307/2444151; Morales JM, 2006, ECOLOGY, V87, P1489, DOI 10.1890/0012-9658(2006)87[1489:TEOPDA]2.0.CO;2; Myers JA, 2004, OECOLOGIA, V139, P35, DOI 10.1007/s00442-003-1474-2; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Niggemann M, 2009, ECOL MODEL, V220, P1339, DOI 10.1016/j.ecolmodel.2009.02.018; Ogle CC, 2000, AUSTRAL ECOL, V25, P539, DOI 10.1046/j.1442-9993.2000.01076.x; Pickering CM, 2011, BIOL INVASIONS, V13, P1869, DOI 10.1007/s10530-011-0006-y; R Core Team, 2020, R LANG ENV STAT COMP; Romermann C, 2005, OIKOS, V110, P219, DOI 10.1111/j.0030-1299.2005.13911.x; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; SCHMIDT W, 1989, VEGETATIO, V80, P147, DOI 10.1007/BF00048038; Schurr FM, 2005, J ECOL, V93, P1017, DOI 10.1111/j.1365-2745.2005.01018.x; Solazzo E, 2008, ATMOS ENVIRON, V42, P4918, DOI 10.1016/j.atmosenv.2008.02.032; Soons MB, 2004, ECOLOGY, V85, P3056, DOI 10.1890/03-0522; Soons MB, 2005, DIVERS DISTRIB, V11, P165, DOI 10.1111/j.1366-9516.2005.00148.x; Soons MB, 2008, J ECOL, V96, P581, DOI 10.1111/j.1365-2745.2008.01370.x; Tackenberg O, 2003, PLANT BIOLOGY, V5, P451, DOI 10.1055/s-2003-44789; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Taylor K, 2012, DIVERS DISTRIB, V18, P942, DOI 10.1111/j.1472-4642.2012.00926.x; Vila M, 2001, BIOL CONSERV, V100, P397, DOI 10.1016/S0006-3207(01)00047-7; Vitalos M, 2009, NEOBIOTA-SER, V8, P53; von der Lippe M, 2008, DIVERS DISTRIB, V14, P18, DOI 10.1111/j.1472-4642.2007.00401.x; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; von der Lippe M, 2007, ECOGRAPHY, V30, P483, DOI 10.1111/j.2007.0906-7590.05072.x; Wichmann MC, 2009, P ROY SOC B-BIOL SCI, V276, P523, DOI 10.1098/rspb.2008.1131; WILCOX DA, 1989, ENVIRON MANAGE, V13, P365, DOI 10.1007/BF01874916; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Zwaenepoel A, 2006, BASIC APPL ECOL, V7, P83, DOI 10.1016/j.baae.2005.04.003	51	85	93	0	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52733	10.1371/journal.pone.0052733	http://dx.doi.org/10.1371/journal.pone.0052733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320077	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429800019
J	Zinssmeister, C; Keupp, H; Tischendorf, G; Kaulbars, F; Gottschling, M				Zinssmeister, Carmen; Keupp, Helmut; Tischendorf, Gilbert; Kaulbars, Freya; Gottschling, Marc			Ultrastructure of Calcareous Dinophytes (Thoracosphaeraceae, Peridiniales) with a Focus on Vacuolar Crystal-Like Particles	PLOS ONE			English	Article							FRESH-WATER DINOFLAGELLATE; RDNA-BASED PHYLOGENY; FLAGELLAR APPARATUS; MARINE DINOFLAGELLATE; CYST FORMATION; FINE-STRUCTURE; SCRIPPSIELLA; GEN.; BIOMINERALIZATION; NOV	Biomineralization in calcareous dinophytes (Thoracosphaeracaea, Peridiniales) takes place in coccoid cells and is presently poorly understood. Vacuolar crystal-like particles as well as collection sites within the prospective calcareous shell may play a crucial role during this process at the ultrastructural level. Using transmission electron microscopy, we investigated the ultrastructure of coccoid cells at an early developmental stage in fourteen calcareous dinophyte strains (corresponding to at least ten species of Calciodinellum, Calcigonellum, Leonella, Pernambugia, Scrippsiella, and Thoracosphaera). The shell of the coccoid cells consisted either of one (Leonella, Thoracosphaera) or two matrices (Scrippsiella and its relatives) of unknown element composition, whereas calcite is deposited in the only or the outer layer, respectively. We observed crystal-like particles in cytoplasmic vacuoles in cells of nine of the strains investigated and assume that they are widespread among calcareous dinophytes. However, similar structures are also found outside the Thoracosphaeraceae, and we postulate an evolutionarily old physiological pathway (possibly involved in detoxification) that later was specialized for calcification. We aim to contribute to a deeper knowledge of the biomineralization process in calcareous dinophytes.	[Zinssmeister, Carmen; Gottschling, Marc] Univ Munich, Dept Biol Syst Bot & Mykol, Munich, Germany; [Zinssmeister, Carmen; Keupp, Helmut] Free Univ Berlin, Fachrichtung Palaontol, Fachbereich Geol Wissensch, Berlin, Germany; [Tischendorf, Gilbert; Kaulbars, Freya] Free Univ Berlin, Fachbereich Biol, Inst Biol Mikrobiol, Berlin, Germany	University of Munich; Free University of Berlin; Free University of Berlin	Gottschling, M (corresponding author), Univ Munich, Dept Biol Syst Bot & Mykol, Munich, Germany.	gottschling@bio.lmu.de	Gottschling, Marc/K-2186-2014		Deutsche Forschungsgemeinschaft [KE 322/30, KE 322/36, WI 725/18, WI 725/25]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Financial support was provided by the Deutsche Forschungsgemeinschaft (grants KE 322/30, KE 322/36, WI 725/18 and WI 725/25), and the Munchener Universitatsgesellschaft for equipment support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUERLEIN E, 2004, PROGR BIOL MOL BIOL; Bibby B.T., 1972, British phycol J, V7, P85; BIBBY BT, 1974, J ULTRA MOL STRUCT R, V48, P153, DOI 10.1016/S0022-5320(74)80051-1; Bolli H.M., 1974, Initial Rep Deep Sea Drilling Project, V27, P843; Calado AJ, 2006, J PHYCOL, V42, P434, DOI 10.1111/j.1529-8817.2006.00195.x; Calado AJ, 2005, PHYCOLOGIA, V44, P112, DOI 10.2216/0031-8884(2005)44[112:OTFDPI]2.0.CO;2; Calado AJ, 2002, PHYCOLOGIA, V41, P567, DOI 10.2216/i0031-8884-41-6-567.1; Calado AJ, 1999, EUR J PHYCOL, V34, P179, DOI 10.1080/09670269910001736232; Calado AJ, 2011, PHYCOLOGIA, V50, P641, DOI 10.2216/11-21.1; Carney CK, 2007, TOP CURR CHEM, V270, P155, DOI 10.1007/128_050; CHAPMAN DV, 1982, J PHYCOL, V18, P121, DOI 10.1111/j.1529-8817.1982.tb03165.x; COX R L, 1971, Palaeontology (Oxford), V14, P22; Craveiro SC, 2011, PROTIST, V162, P590, DOI 10.1016/j.protis.2011.03.003; Craveiro SC, 2010, J EUKARYOT MICROBIOL, V57, P568, DOI 10.1111/j.1550-7408.2010.00512.x; de Nooijer LJ, 2009, P NATL ACAD SCI USA, V106, P15374, DOI 10.1073/pnas.0904306106; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Deflandre G., 1949, BOTANISTE, V34, P191; DESA R, 1968, J GEN PHYSIOL, V51, P105, DOI 10.1085/jgp.51.1.105; DODGE J D, 1975, Phycologia, V14, P253, DOI 10.2216/i0031-8884-14-4-253.1; DODGE JD, 1983, BIOSYSTEMS, V16, P259, DOI 10.1016/0303-2647(83)90009-6; DODGE JD, 1971, BOT REV, V37, P481, DOI 10.1007/BF02868686; DOUCETTE GJ, 1989, J PHYCOL, V25, P721, DOI 10.1111/j.0022-3646.1989.00721.x; Eaton G.L., 1984, Journal of Micropalaeontology, V3, P53; Elbrachter M, 2008, TAXON, V57, P1289, DOI 10.1002/tax.574019; Evitt WR, 1968, DINOFLAGELLATE STUDI; GAO XP, 1989, BRIT PHYCOL J, V24, P153; Gottschling M, 2005, MOL PHYLOGENET EVOL, V36, P444, DOI 10.1016/j.ympev.2005.03.036; Gottschling M, 2012, PROTIST, V163, P15, DOI 10.1016/j.protis.2011.06.003; Gussone N, 2010, EARTH PLANET SC LETT, V289, P180, DOI 10.1016/j.epsl.2009.11.006; Hansen G, 2005, PHYCOL RES, V53, P169, DOI 10.1111/j.1440-183.2005.00383.x; Henriksen K, 2004, AM MINERAL, V89, P1709, DOI 10.2138/am-2004-11-1217; Hesse KJ, 1995, OLSEN INT S, P11; Horiguchi Takeo, 1998, Phycological Research, V46, P205; Horiguchi Takeo, 1994, Japanese Journal of Phycology, V42, P21; INOUYE I, 1983, S AFR J BOT, V2, P63, DOI 10.1016/S0022-4618(16)30147-4; Janofske Dorothea, 1996, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P295; KELLER MD, 1987, J PHYCOL, V23, P633; Keupp H., 1981, Facies, V5, P1, DOI 10.1007/BF02536655; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Kohring Rolf, 2005, Palaeontologische Zeitschrift, V79, P79; Kreimer G, 1999, PROTIST, V150, P311, DOI 10.1016/S1434-4610(99)70032-5; Kremp A, 2005, J PHYCOL, V41, P629, DOI 10.1111/j.1529-8817.2005.00070.x; LEADBEATER B, 1967, ARCH MIKROBIOL, V57, P239, DOI 10.1007/BF00405950; LEWIS J, 1988, J MAR BIOL ASSOC UK, V68, P701, DOI 10.1017/S0025315400028812; LEWIS J, 1988, BRIT PHYCOL J, V23, P49, DOI 10.1080/00071618800650071; Mann S., 2001, BIOMINERALIZATION PR; Meier K.J. Sebastian, 2009, Berliner Palaeobiologische Abhandlungen, V10, P245; Moestrup O, 2009, PHYCOL RES, V57, P203, DOI 10.1111/j.1440-1835.2009.00540.x; Moestrup Ojvind, 2007, Systematics Association Special Volume Series, V75, P215; Monnet Birgit, 1993, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V7, P1; Montresor M, 1998, J PLANKTON RES, V20, P2291, DOI 10.1093/plankt/20.12.2291; Murdock DJE, 2011, CELLS TISSUES ORGANS, V194, P98, DOI 10.1159/000324245; NEHRING S, 1994, NETH J SEA RES, V33, P57, DOI 10.1016/0077-7579(94)90051-5; POKORNY KS, 1973, J PHYCOL, V9, P218, DOI 10.1111/j.0022-3646.1973.00218.x; Raven JA, 2009, GEOBIOLOGY, V7, P140, DOI 10.1111/j.1472-4669.2008.00181.x; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROBERTS KR, 1989, J PHYCOL, V25, P270, DOI 10.1111/j.1529-8817.1989.tb00123.x; Sgrosso S, 2001, MAR ECOL PROG SER, V211, P77, DOI 10.3354/meps211077; Siano R, 2010, PROTIST, V161, P385, DOI 10.1016/j.protis.2010.01.002; SIMKISS K, 1977, CALC TISS RES, V24, P199, DOI 10.1007/BF02223316; Simkiss K., 1989, BIOMINERALIZATION; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Tamura M, 2005, J PHYCOL, V41, P658, DOI 10.1111/j.1529-8817.2005.00085.x; TANGEN K, 1982, MAR MICROPALEONTOL, V7, P193, DOI 10.1016/0377-8398(82)90002-0; TAYLOR DL, 1968, J MAR BIOL ASSOC UK, V48, P349, DOI 10.1017/S0025315400034548; WALL D, 1970, Phycologia, V9, P151, DOI 10.2216/i0031-8884-9-2-151.1; WALL D, 1968, Micropaleontology (New York), V14, P265, DOI 10.2307/1484690; WEDEMAYER GJ, 1984, J PROTOZOOL, V31, P444, DOI 10.1111/j.1550-7408.1984.tb02992.x; Young JR, 2003, REV MINERAL GEOCHEM, V54, P189, DOI 10.2113/0540189; Young JR, 1999, J STRUCT BIOL, V126, P195, DOI 10.1006/jsbi.1999.4132; Zinssmeister C, 2011, SYST BIODIVERS, V9, P145, DOI 10.1080/14772000.2011.586071	71	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54038	10.1371/journal.pone.0054038	http://dx.doi.org/10.1371/journal.pone.0054038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320120	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429800087
J	Guirao-Rico, S; Aguade, M				Guirao-Rico, Sara; Aguade, Montserrat			Patterns of Nucleotide Diversity at the Regions Encompassing the Drosophila Insulin-Like Peptide (dilp) Genes: Demography vs. Positive Selection in Drosophila melanogaster	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; NATURAL-POPULATIONS; MORPHOMETRICAL TRAITS; MOLECULAR EVOLUTION; LATITUDINAL CLINES; DNA; POLYMORPHISM; GROWTH; SIZE; VARIABILITY	In Drosophila, the insulin-signaling pathway controls some life history traits, such as fertility and lifespan, and it is considered to be the main metabolic pathway involved in establishing adult body size. Several observations concerning variation in body size in the Drosophila genus are suggestive of its adaptive character. Genes encoding proteins in this pathway are, therefore, good candidates to have experienced adaptive changes and to reveal the footprint of positive selection. The Drosophila insulin-like peptides (DILPs) are the ligands that trigger the insulin-signaling cascade. In Drosophila melanogaster, there are several peptides that are structurally similar to the single mammalian insulin peptide. The footprint of recent adaptive changes on nucleotide variation can be unveiled through the analysis of polymorphism and divergence. With this aim, we have surveyed nucleotide sequence variation at the dilp1-7 genes in a natural population of D. melanogaster. The comparison of polymorphism in D. melanogaster and divergence from D. simulans at different functional classes of the dilp genes provided no evidence of adaptive protein evolution after the split of the D. melanogaster and D. simulans lineages. However, our survey of polymorphism at the dilp gene regions of D. melanogaster has provided some evidence for the action of positive selection at or near these genes. The regions encompassing the dilp1-4 genes and the dilp6 gene stand out as likely affected by recent adaptive events.	[Guirao-Rico, Sara; Aguade, Montserrat] Univ Barcelona, Dept Genet, Inst Recerca Biodiversitat, Barcelona, Spain	University of Barcelona	Aguade, M (corresponding author), Univ Barcelona, Dept Genet, Inst Recerca Biodiversitat, Barcelona, Spain.	maguade@ub.edu	Guirao-Rico, Sara/F-4145-2016	Guirao-Rico, Sara/0000-0001-9896-4665; Aguade, Montserrat/0000-0002-3884-7800	Ministerio de Educacion y Ciencia (Spain); Comissio Interdepartamental de Ciencia i Tecnologia, Spain [BFU 2004-02253, BFU 2007-63229]; Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain [2005 SGR/00166, 2009 SGR/1287]	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Comissio Interdepartamental de Ciencia i Tecnologia, Spain; Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain(Generalitat de Catalunya)	SG-R was supported by a predoctoral fellowship from Ministerio de Educacion y Ciencia (Spain). This work was supported by grants BFU 2004-02253 and BFU 2007-63229 from Comissio Interdepartamental de Ciencia i Tecnologia, Spain, and grants 2005 SGR/00166 and 2009 SGR/1287 from Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain, to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Ashburner M., 1989, DROSOPHILA LAB HDB; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Begun DJ, 2000, P NATL ACAD SCI USA, V97, P5960, DOI 10.1073/pnas.97.11.5960; Beisswanger S, 2006, GENETICS, V172, P265, DOI 10.1534/genetics.105.049346; Beisswanger S, 2008, P NATL ACAD SCI USA, V105, P5447, DOI 10.1073/pnas.0710892105; Betancourt AJ, 2002, P NATL ACAD SCI USA, V99, P13616, DOI 10.1073/pnas.212277199; Braverman JM, 2005, GENETICS, V170, P1153, DOI 10.1534/genetics.104.033456; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; CAPY P, 1993, GENET SEL EVOL, V25, P517, DOI 10.1051/gse:19930602; COYNE JA, 1987, GENETICS, V117, P727; DAVID JR, 1975, EXPERIENTIA, V31, P164, DOI 10.1007/BF01990682; DAVID JR, 1982, JPN J GENET, V57, P89, DOI 10.1266/jjg.57.89; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Fay JC, 2000, GENETICS, V155, P1405; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gibert P, 2004, GENETICA, V120, P165, DOI 10.1023/B:GENE.0000017639.62427.8b; Gilchrist AS, 1999, GENETICS, V153, P1775; Glinka S, 2003, GENETICS, V165, P1269; Glinka S, 2006, MOL BIOL EVOL, V23, P1869, DOI 10.1093/molbev/msl069; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Guirao-Rico S, 2009, MOL BIOL EVOL, V26, P1723, DOI 10.1093/molbev/msp088; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; HASSON E, 1993, GENETICA, V92, P61, DOI 10.1007/BF00057508; Hipfner DR, 1999, BIOESSAYS, V21, P718, DOI 10.1002/(SICI)1521-1878(199909)21:9<718::AID-BIES2>3.0.CO;2-Z; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1990, OXFORD SURVEYS EVOLU; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; JAMES AC, 1995, GENETICS, V140, P659; James AC, 1997, GENETICS, V146, P881; Jensen JD, 2005, GENETICS, V170, P1401, DOI 10.1534/genetics.104.038224; Jukes T.H., 1969, MAMMALIAN PROTEIN ME; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Karan D, 1998, GENET RES, V71, P31, DOI 10.1017/S0016672397003054; Kim Y, 2002, GENETICS, V160, P765; Kim Y, 2010, GENETICS, V184, P571, DOI 10.1534/genetics.109.109447; LACHAISE D, 1988, EVOL BIOL, V22, P159; Larracuente AM, 2008, TRENDS GENET, V24, P114, DOI 10.1016/j.tig.2007.12.001; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; Noor MAF, 2007, GENETICS, V177, P1417, DOI 10.1534/genetics.107.070672; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Orengo DJ, 2004, GENETICS, V167, P1759, DOI 10.1534/genetics.104.028969; Orengo DJ, 2007, MOL BIOL EVOL, V24, P1122, DOI 10.1093/molbev/msm032; Orengo DJ, 2010, MOL BIOL EVOL, V27, P153, DOI 10.1093/molbev/msp220; Paaby AB, 2010, MOL ECOL, V19, P760, DOI 10.1111/j.1365-294X.2009.04508.x; PARTRIDGE L, 1987, ANIM BEHAV, V35, P468, DOI 10.1016/S0003-3472(87)80272-5; PREVOSTI A, 1988, P NATL ACAD SCI USA, V85, P5597, DOI 10.1073/pnas.85.15.5597; PREVOSTI A, 1955, COLD SPRING HARB SYM, V20, P294, DOI 10.1101/SQB.1955.020.01.028; Ramos-Onsins SE, 2007, EVOL BIOINFORM, V3, P41; Robertson FW., 1957, J GENET, V55, P428, DOI [10.1007/BF02984061, DOI 10.1007/BF02984061]; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Rychlik W, 1992, OLIGO 4 06 PRIMER AN; Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6; Singh ND, 2005, GENETICS, V169, P709, DOI 10.1534/genetics.104.032250; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; STALKER HD, 1947, EVOLUTION, V1, P237, DOI 10.2307/2405325; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; TAJIMA F, 1989, GENETICS, V123, P585; Tavare S, 1997, GENETICS, V145, P505; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton K, 2006, GENETICS, V172, P1607, DOI 10.1534/genetics.105.048223; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van't Land J, 1999, J EVOLUTION BIOL, V12, P222, DOI 10.1046/j.1420-9101.1999.00029.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432	77	0	0	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53593	10.1371/journal.pone.0053593	http://dx.doi.org/10.1371/journal.pone.0053593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308258	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100093
J	Perrault, I; Estrada-Cuzcano, A; Lopez, I; Kohl, S; Li, SQ; Testa, F; Zekveld-Vroon, R; Wang, X; Pomares, E; Andorf, J; Aboussair, N; Banfi, S; Delphin, N; den Hollander, AI; Edelson, C; Florijn, R; Jean-Pierre, M; Leowski, C; Megarbane, A; Villanueva, C; Flores, B; Munnich, A; Ren, HN; Zobor, D; Bergen, A; Chen, R; Cremers, FPM; Gonzalez-Duarte, R; Koenekoop, RK; Simonelli, F; Stone, E; Wissinger, B; Zhang, QJ; Kaplan, J; Rozet, JM				Perrault, Isabelle; Estrada-Cuzcano, Alejandro; Lopez, Irma; Kohl, Susanne; Li, Shiqiang; Testa, Francesco; Zekveld-Vroon, Renate; Wang, Xia; Pomares, Esther; Andorf, Jean; Aboussair, Nisrine; Banfi, Sandro; Delphin, Nathalie; den Hollander, Anneke I.; Edelson, Catherine; Florijn, Ralph; Jean-Pierre, Marc; Leowski, Corinne; Megarbane, Andre; Villanueva, Cristina; Flores, Blanca; Munnich, Arnold; Ren, Huanan; Zobor, Ditta; Bergen, Arthur; Chen, Rui; Cremers, Frans P. M.; Gonzalez-Duarte, Roser; Koenekoop, Robert K.; Simonelli, Francesca; Stone, Edwin; Wissinger, Bernd; Zhang, Qingjiong; Kaplan, Josseline; Rozet, Jean-Michel			Union Makes Strength: A Worldwide Collaborative Genetic and Clinical Study to Provide a Comprehensive Survey of RD3 Mutations and Delineate the Associated Phenotype	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; SEVERE RETINAL DYSTROPHY; SENIOR-LOKEN SYNDROME; ROD-CONE DYSPLASIA; RETINITIS-PIGMENTOSA; PHOTORECEPTOR CELLS; NMNAT1 MUTATIONS; PROTEIN; DEGENERATION; CRX	Leber congenital amaurosis (LCA) is the earliest and most severe retinal degeneration (RD), and the most common cause of incurable blindness diagnosed in children. It is occasionally the presenting symptom of multisystemic ciliopathies which diagnosis will require a specific care of patients. Nineteen LCA genes are currently identified and three of them account for both non-syndromic and syndromic forms of the disease. RD3 (LCA12) was implicated as a LCA gene based on the identification of homozygous truncating mutations in two LCA families despite the screening of large cohorts of patients. Here we provide a comprehensive survey of RD3 mutations and of their clinical expression through the screening of a cohort of 852 patients originating worldwide affected with LCA or early-onset and severe RD. We identified three RD3 mutations in seven unrelated consanguineous LCA families - i.e., a 2 bp deletion and two nonsense mutations - predicted to cause complete loss of function. Five families originating from the Southern Shores of the Mediterranean segregated a similar mutation (c.112C>T, p.R38*) suggesting that this change may have resulted from an ancient founder effect. Considering the low frequency of RD3 carriers, the recurrence risk for LCA in non-consanguineous unions is negligible for both heterozygote and homozygote RD3 individuals. The LCA12 phenotype in our patients is highly similar to those of patients with mutant photoreceptor-specific guanylate cyclase (GUCY2D/LCA1). This observation is consistent with the report of the role of RD3 in trafficking of GUCYs and gives further support to a common mechanism of photoreceptor degeneration in LCA12 and LCA1, i.e., inability to increase cytoplasmic cGMP concentration in outer segments and thus to recover the dark-state. Similar to LCA1, LCA12 patients have no extraocular symptoms despite complete inactivation of both RD3 alleles, supporting the view that extraocular investigations in LCA infants with RD3 mutations should be avoided.	[Perrault, Isabelle; Delphin, Nathalie; Munnich, Arnold; Kaplan, Josseline; Rozet, Jean-Michel] Univ Paris 05, Fdn IMAGINE, INSERM,U781, Unite Rech Genet & Epigenet Malad Metab Neurosens, Paris, France; [Estrada-Cuzcano, Alejandro; den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Lopez, Irma; Ren, Huanan; Koenekoop, Robert K.] McGill Univ, Montreal Childrens Hosp, McGill Ocular Genet Lab, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Kohl, Susanne; Zobor, Ditta; Wissinger, Bernd] Univ Tubingen, Inst Ophthalm Res, Univ Eye Hosp, Tubingen, Germany; [Li, Shiqiang; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Testa, Francesco; Simonelli, Francesca] Univ Naples 2, Dept Ophthalmol, Naples, Italy; [Zekveld-Vroon, Renate; Florijn, Ralph; Bergen, Arthur] Netherlands Inst Neurosci NIN KNAW, Amsterdam, Netherlands; [Wang, Xia; Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pomares, Esther; Gonzalez-Duarte, Roser] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Andorf, Jean; Stone, Edwin] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA; [Aboussair, Nisrine] Univ Caddi Ayyed, Fac Med & Pharm, Serv Genet CHU Mohammed 6, Marrakech, Morocco; [Banfi, Sandro] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Banfi, Sandro] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Edelson, Catherine] Fdn Adolphe De Rothschild, Paris, France; [Jean-Pierre, Marc] Univ Paris 05, Inst Cochin, Paris, France; [Leowski, Corinne] Inst Natl Jeunes Aveugles, Paris, France; [Megarbane, Andre] Univ St Joseph, Serv Genet Med, Beirut, Lebanon; [Villanueva, Cristina; Flores, Blanca] Asociac Evitar La Ceguera Mexico, Serv Genet, Mexico City, DF, Mexico	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; McGill University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Sun Yat Sen University; Universita della Campania Vanvitelli; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Baylor College of Medicine; University of Barcelona; University of Iowa; Cadi Ayyad University of Marrakech; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Marrakech; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint Joseph University Beirut	Rozet, JM (corresponding author), Univ Paris 05, Fdn IMAGINE, INSERM,U781, Unite Rech Genet & Epigenet Malad Metab Neurosens, Paris, France.	jean-michel.rozet@inserm.fr	Cremers, Frans/A-5625-2014; Estrada-Cuzcano, Alejandro/J-4365-2019; Koenekoop, Robert/AAT-6676-2021; Wang, Xia/O-4036-2014; Banfi, Sandro/K-3963-2018; Hollander, Anneke den/N-4911-2014; Zhang, Qingjiong/AAR-6331-2021; ROZET, Jean-Michel/E-5737-2016; Simonelli, Francesca/AHE-7571-2022; Megarbane, Andre/ABD-5574-2021; KAPLAN, Josseline/I-2622-2017; perrault, isabelle/H-3047-2017	Cremers, Frans/0000-0002-4954-5592; Estrada-Cuzcano, Alejandro/0000-0001-9868-2465; Wang, Xia/0000-0002-7750-1167; Banfi, Sandro/0000-0002-6541-8833; Zhang, Qingjiong/0000-0001-7508-848X; ROZET, Jean-Michel/0000-0001-7951-7886; Simonelli, Francesca/0000-0001-8520-6769; Pomares, Esther/0000-0002-3818-3303; Kohl, Susanne/0000-0002-6438-6331; Bergen, Arthur/0000-0002-6333-9576; KAPLAN, Josseline/0000-0002-1849-8658; Testa, Francesco/0000-0002-1482-1577; Stone, Edwin M./0000-0003-3343-4414; perrault, isabelle/0000-0002-8560-1379	Association Retina France; Telethon Foundation; Italian Ministry of Health; Fondazione Retina Italia; Ministerio de Ciencia e Innovacion [SAF2009-08079]; CIBERER, Instituto de Salud Carlos III, Barcelona, Spain; National Science Fund for Distinguished Young Scholars [30725044]; Foundation Fighting Blindness Canada; Canadian Institutes for Health Research; National Eye Institute; Radboud University Nijmegen Medical Centre	Association Retina France; Telethon Foundation(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Retina Italia; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBERER, Instituto de Salud Carlos III, Barcelona, Spain; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Foundation Fighting Blindness Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Radboud University Nijmegen Medical Centre	This work was funded by Association Retina France, Telethon Foundation, Italian Ministry of Health, Fondazione Retina Italia, SAF2009-08079 Ministerio de Ciencia e Innovacion and CIBERER, Instituto de Salud Carlos III, Barcelona, Spain. This study was also supported by the National Science Fund for Distinguished Young Scholars (30725044 to QZ) and funding was received from the Foundation Fighting Blindness Canada, The Canadian Institutes for Health Research and the National Eye Institute (to RKK). These studies were supported by the Radboud University Nijmegen Medical Centre (to FC and AIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussair N, 2010, J FR OPHTALMOL, V33, p117e1; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; CHANG B, 1993, GENOMICS, V16, P45, DOI 10.1006/geno.1993.1138; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Chung DC, 2009, J AAPOS, V13, P587, DOI 10.1016/j.jaapos.2009.10.004; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; den Hollander AI, 2001, AM J HUM GENET, V69, P198; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gerber S, 2001, EUR J HUM GENET, V9, P561, DOI 10.1038/sj.ejhg.5200689; Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Hanein S, 2008, EUR J HUM GENET, V16, P115, DOI 10.1038/sj.ejhg.5201905; Hanein Sylvain, 2002, Hum Mutat, V20, P322, DOI 10.1002/humu.9067; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; Kaplan J, 2008, OPHTHALMIC GENET, V29, P92, DOI 10.1080/13816810802232768; Keen TJ, 2003, EUR J HUM GENET, V11, P420, DOI 10.1038/sj.ejhg.5200981; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; Kukekova AV, 2009, MAMM GENOME, V20, P109, DOI 10.1007/s00335-008-9163-4; Lavorgna G, 2003, BIOCHEM BIOPH RES CO, V308, P414, DOI 10.1016/S0006-291X(03)01410-4; Linberg KA, 2005, VISUAL NEUROSCI, V22, P721, DOI 10.1017/S0952523805226044; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; Perrault I, 1999, AM J HUM GENET, V64, P1225, DOI 10.1086/302335; Perrault I, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e90; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Perrault I, 2012, NAT GENET, V44, P975, DOI 10.1038/ng.2357; Preising MN, 2012, INVEST OPHTH VIS SCI, V53, P3463, DOI 10.1167/iovs.12-9519; SANTOSANDERSON RM, 1980, INVEST OPHTH VIS SCI, V19, P1281; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Stone EM, 2011, ARCH OPHTHALMOL-CHIC, V129, P81, DOI 10.1001/archophthalmol.2010.330; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Wang H, 2009, AM J HUM GENET, V84, P380, DOI 10.1016/j.ajhg.2009.02.005; WOLF ED, 1978, J AM VET MED ASSOC, V173, P1331	50	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e51622	10.1371/journal.pone.0051622	http://dx.doi.org/10.1371/journal.pone.0051622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308101	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100006
J	Scheffler, M; Zander, T; Nogova, L; Kobe, C; Kahraman, D; Dietlein, M; Papachristou, I; Heukamp, L; Buttner, R; Boellaard, R; Lammertsma, AA; Querings, S; Stoelben, E; Engel-Riedel, W; Neumaier, B; Wolf, J				Scheffler, Matthias; Zander, Thomas; Nogova, Lucia; Kobe, Carsten; Kahraman, Deniz; Dietlein, Markus; Papachristou, Irini; Heukamp, Lukas; Buettner, Reinhard; Boellaard, Ron; Lammertsma, Adriaan A.; Querings, Silvia; Stoelben, Erich; Engel-Riedel, Walburga; Neumaier, Bernd; Wolf, Juergen			Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients with Lung Cancer Treated First-Line with Erlotinib	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; FLUORODEOXYGLUCOSE UPTAKE; IMAGING PROLIFERATION; FLT-PET; KI-67; GEFITINIB; MUTATIONS; F-18-FLT; SURVIVAL	3'-deoxy-3'-[F-18]fluoro-L-thymidine (FLT) and 2'-deoxy-2'-[F-18]fluoro-D-glucose (FDG) are used to visualize proliferative and metabolic activity of tumors. In this study we aimed at evaluating the prognostic value of FLT and FDG uptake measured by positron emission tomography (PET) in patients with metastatic non-small cell lung cancer (NSCLC) prior to systemic therapy with erlotinib. FLT and FDG maximum standardized uptake (SUVmax) values per patient were analyzed in 40 chemotherapy naive patients with advanced NSCLC (stage IV) before treatment with erlotinib. Prior therapy median SUVmax was 6.6 for FDG and 3.0 for FLT, respectively. In univariate analysis, patients with an FDG SUVmax <6.6 had a significantly better overall survival (16.3 months [95% confidence interval [CI] 7.1-25.4 months]) compared to patients with an FDG SUVmax >= 6.6 (3.1 months [95% CI 0.6-5.5 months]) (p<0.001, log rank). Similarly, low FLT uptake (SUVmax <3.0) was associated with significantly longer survival (10.3 months (0-23.3 months, 95% CI) compared to high FLT uptake (3.4 months (0-8.1 months, 95% CI) (p = 0.027). The independent prognostic value of baseline FDG uptake was demonstrated in multivariate analysis (p = 0.05, Cox regression). These data suggest that baseline SUVmax values for both FDG and FLT PET might be further developed as markers for prognostic stratification of patients in advanced NSCLC treated with tyrosine kinase inhibitors (TKI) directed against the epidermal growth factor receptor (EGFR).	[Scheffler, Matthias; Zander, Thomas; Nogova, Lucia; Papachristou, Irini; Wolf, Juergen] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Scheffler, Matthias; Zander, Thomas; Nogova, Lucia; Papachristou, Irini; Heukamp, Lukas; Buettner, Reinhard; Wolf, Juergen] Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Kobe, Carsten; Kahraman, Deniz; Dietlein, Markus] Univ Hosp Cologne, Clin Nucl Med, Cologne, Germany; [Heukamp, Lukas; Buettner, Reinhard] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Boellaard, Ron; Lammertsma, Adriaan A.] Vrije Univ Amsterdam, Med Ctr, Dept Nucl Med, Amsterdam, Netherlands; [Boellaard, Ron; Lammertsma, Adriaan A.] Vrije Univ Amsterdam, Med Ctr, PET Res, Amsterdam, Netherlands; [Querings, Silvia; Neumaier, Bernd] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Stoelben, Erich; Engel-Riedel, Walburga] Hosp Cologne, Lung Clin Merheim, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Max Planck Society	Wolf, J (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany.	juergen.wolf@uk-koeln.de	Scheffler, Matthias/AAC-1656-2019; Heukamp, Lukas C/A-8338-2013; Heukamp, Lukas/G-9967-2012; Neumaier, Bernd/G-7058-2019	Boellaard, Ronald/0000-0002-0313-5686; Heukamp, Lukas/0000-0002-3388-3482; Neumaier, Bernd/0000-0001-5425-3116; Scheffler, Matthias/0000-0002-9031-1368; Lammertsma, Adriaan/0000-0003-1237-2891	German Cancer Aid, Interdisciplinary Oncology Centers of Excellence program; Federal German Ministry of Science and Education (BMBF), National Genome Research Network program (NGFNplus) [01GS08100, 01GS08101]; German Federal Ministry of Research and Education (BMBF) [01KN0706]	German Cancer Aid, Interdisciplinary Oncology Centers of Excellence program; Federal German Ministry of Science and Education (BMBF), National Genome Research Network program (NGFNplus)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Cancer Aid as part of the Interdisciplinary Oncology Centers of Excellence program to the Center for Integrated Oncology Koln Bonn and by the Federal German Ministry of Science and Education (BMBF) as part of the National Genome Research Network program (NGFNplus, grants 01GS08100 and 01GS08101) to JW and RT. MS was partly supported by the German Federal Ministry of Research and Education (BMBF grant 01KN0706). Erlotinib was supplied by Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarntzen EHJG, 2011, P NATL ACAD SCI USA, V108, P18396, DOI 10.1073/pnas.1113045108; Agarwal M, 2010, EUR J NUCL MED MOL I, V37, P691, DOI 10.1007/s00259-009-1291-x; Bats AS, 2012, EUR J NUCL MED MOL I, V39, P474, DOI 10.1007/s00259-011-1984-9; Buck AK, 2003, J NUCL MED, V44, P1426; Chalkidou A, 2012, EUROPEAN J CANC; Dosaka-Akita H, 2001, CANCER RES, V61, P2500; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gaertner J, 2011, SUPPORT CARE CANCER, V19, P1037, DOI 10.1007/s00520-011-1131-y; HAMACHER K, 1986, J NUCL MED, V27, P235; Hatt M, 2011, EUR J NUCL MED MOL I, V38, P1595, DOI 10.1007/s00259-011-1834-9; Herrmann K, 2011, J NUCL MED, V52, P690, DOI 10.2967/jnumed.110.084566; Hoang JK, 2008, J CLIN ONCOL, V26, P1459, DOI 10.1200/JCO.2007.14.3628; Hommura F, 2000, CLIN CANCER RES, V6, P4073; Huang W, 2011, EUR J NUCL MED MOL I, V38, P1628, DOI 10.1007/s00259-011-1838-5; Kahraman D, 2011, J NUCL MED, V52, P1871, DOI 10.2967/jnumed.111.094458; Lara-Guerra H, 2012, LUNG CANCER, V76, P235, DOI 10.1016/j.lungcan.2011.10.020; Li ZL, 2012, CANCER RES, V72, P5014, DOI 10.1158/0008-5472.CAN-12-0635; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Martin B, 2004, BRIT J CANCER, V91, P2018, DOI 10.1038/sj.bjc.6602233; Martoni AA, 2011, ANN ONCOL, V22, P650, DOI 10.1093/annonc/mdq433; McArthur GA, 2012, J CLIN ONCOL, V30, P1628, DOI 10.1200/JCO.2011.39.1938; Mileshkin L, 2011, CLIN CANCER RES, V17, P3304, DOI 10.1158/1078-0432.CCR-10-2763; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Querings S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019601; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sasaki R, 2005, J CLIN ONCOL, V23, P1136, DOI 10.1200/JCO.2005.06.129; Scheffler M, 2012, LUNG CANCER, V77, P617, DOI 10.1016/j.lungcan.2012.05.110; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shiba M, 2000, CANCER, V89, P1457, DOI 10.1002/1097-0142(20001001)89:7<1457::AID-CNCR7>3.0.CO;2-L; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Sohn HJ, 2008, CLIN CANCER RES, V14, P7423, DOI 10.1158/1078-0432.CCR-08-0312; Takigawa N, 1996, LUNG CANCER, V15, P67, DOI 10.1016/0169-5002(96)00571-5; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tsubochi H, 2006, ANN THORAC SURG, V82, P1198, DOI 10.1016/j.athoracsur.2006.04.069; Ullrich RT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003908; van Westreenen HL, 2005, J NUCL MED, V46, P400; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Vesselle H, 2007, CLIN CANCER RES, V13, P3255, DOI 10.1158/1078-0432.CCR-06-1128; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Yang J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-203; Yap CS, 2006, CHEST, V129, P393, DOI 10.1378/chest.129.2.393; Zander T, 2011, J CLIN ONCOL, V29, P1701, DOI 10.1200/JCO.2010.32.4939; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	46	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53081	10.1371/journal.pone.0053081	http://dx.doi.org/10.1371/journal.pone.0053081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308140	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100017
J	Mavros, MN; Alexiou, VG; Vardakas, KZ; Falagas, ME				Mavros, Michael N.; Alexiou, Vangelis G.; Vardakas, Konstantinos Z.; Falagas, Matthew E.			Understanding of Statistical Terms Routinely Used in Meta-Analyses: An International Survey among Researchers	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; PUBLISHED RESEARCH; RISK	Objective: Biomedical literature is increasingly enriched with literature reviews and meta-analyses. We sought to assess the understanding of statistical terms routinely used in such studies, among researchers. Methods: An online survey posing 4 clinically-oriented multiple-choice questions was conducted in an international sample of randomly selected corresponding authors of articles indexed by PubMed. Results: A total of 315 unique complete forms were analyzed (participation rate 39.4%), mostly from Europe (48%), North America (31%), and Asia/Pacific (17%). Only 10.5% of the participants answered correctly all 4 "interpretation" questions while 9.2% answered all questions incorrectly. Regarding each question, 51.1%, 71.4%, and 40.6% of the participants correctly interpreted statistical significance of a given odds ratio, risk ratio, and weighted mean difference with 95% confidence intervals respectively, while 43.5% correctly replied that no statistical model can adjust for clinical heterogeneity. Clinicians had more correct answers than non-clinicians (mean score 6 standard deviation: 2.27 +/- 1.06 versus 1.83 +/- 1.14, p<0.001); among clinicians, there was a trend towards a higher score in medical specialists (2.37 +/- 1.07 versus 2.04 +/- 1.04, p = 0.06) and a lower score in clinical laboratory specialists (1.7 +/- 0.95 versus 2.3 +/- 1.06, p = 0.08). No association was observed between the respondents' region or questionnaire completion time and participants' score. Conclusion: A considerable proportion of researchers, randomly selected from a diverse international sample of biomedical scientists, misinterpreted statistical terms commonly reported in meta-analyses. Authors could be prompted to explicitly interpret their findings to prevent misunderstandings and readers are encouraged to keep up with basic biostatistics.	[Mavros, Michael N.; Alexiou, Vangelis G.; Vardakas, Konstantinos Z.; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Alexiou, Vangelis G.] Univ Hosp Leicester, Dept Surg, Leicester, Leics, England; [Vardakas, Konstantinos Z.; Falagas, Matthew E.] Mitera Hosp, Dept Med, Hygeia Grp, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; University Hospitals of Leicester NHS Trust; University of Leicester; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Mavros, M/AAS-3154-2020; Alexiou, Vangelis/GLR-9050-2022; Vardakas, Konstantinos/M-5253-2019	Alexiou, Vangelis/0000-0003-1388-4880				Alexiou VG, 2010, SURG INFECT, V11, P343, DOI 10.1089/sur.2009.023; BENZER A, 1993, LANCET, V341, P247, DOI 10.1016/0140-6736(93)90116-X; Bero LA, 1997, ANN INTERN MED, V127, P37, DOI 10.7326/0003-4819-127-1-199707010-00007; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Falagas ME, 2009, CLIN MICROBIOL INFEC, V15, P684, DOI 10.1111/j.1469-0691.2009.02784.x; Falagas ME, 2009, EPIDEMIOLOGY, V20, P930, DOI 10.1097/EDE.0b013e3181ba40eb; Falagas ME, 2006, CAN MED ASSOC J, V175, P1389, DOI 10.1503/cmaj.060361; FORROW L, 1992, AM J MED, V92, P121, DOI 10.1016/0002-9343(92)90100-P; Holcomb WL, 2001, OBSTET GYNECOL, V98, P685, DOI 10.1016/S0029-7844(01)01488-0; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Katz KA, 2006, ARCH DERMATOL, V142, P761, DOI 10.1001/archderm.142.6.761; Mavros MN, 2012, EUR J CLIN MICROBIOL, V31, P2439, DOI 10.1007/s10096-012-1587-9; Mulrow CD, 1997, ANN INTERN MED, V126, P389, DOI 10.7326/0003-4819-126-5-199703010-00008; National Resident Matching Program, 2011, RES DAT 2011 MAIN RE; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; Rahman M, 2003, PUBLIC HEALTH, V117, P274, DOI 10.1016/S0033-3506(03)00068-4; Schmidt WC, 1997, BEHAV RES METH INS C, V29, P274, DOI 10.3758/BF03204826; Shojania K G, 2001, Eff Clin Pract, V4, P157; Soteriades ES, 2005, BRIT MED J, V331, P192, DOI 10.1136/bmj.331.7510.192; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10	21	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e47229	10.1371/journal.pone.0047229	http://dx.doi.org/10.1371/journal.pone.0047229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326299	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800001
J	O'Neill, SC; DeFrank, JT; Vegella, P; Richman, AR; Henry, LR; Carey, LA; Brewer, NT				O'Neill, Suzanne C.; DeFrank, Jessica T.; Vegella, Patti; Richman, Alice R.; Henry, Leonard R.; Carey, Lisa A.; Brewer, Noel T.			Engaging in Health Behaviors to Lower Risk for Breast Cancer Recurrence	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; BLACK-WOMEN; WEIGHT-LOSS; SURVIVORS; ASSOCIATIONS; INTERVENTION; NUTRITION; ADHERENCE; OUTCOMES	Purpose: While post-treatment breast cancer survivors face up to twice the cancer risk of the general population, modifiable health behaviors may somewhat reduce this risk. We sought to better understand health behaviors that early stage breast cancer survivors engage in to reduce recurrence risk. Methods: Data came from a cross-sectional multi-site survey of 186 early-stage breast cancer survivors who received genomic testing for breast cancer recurrence risk (Oncotype DX) during their clinical care. Study outcomes were meeting health behavior recommendations (daily fruit and vegetable intake, regular physical activity, and having a healthy body mass index (BMI)). Results: Approximately three-quarters of survivors we surveyed believed the 3 behaviors might reduce their cancer risk but many did not engage in these behaviors for this purpose: 62% for BMI, 36% for fruit and vegetable consumption, and 37% for physical activity. Survivors with higher recurrence risk, as indicated by their genomic test results, were no more likely to meet any of the three health behavior recommendations. Adherence to health behavior recommendations was higher for women who were white, college-educated, and had higher incomes. Conclusions: Many nonadherent breast cancer survivors wish to use these behavioral strategies to reduce their risk for recurrence, suggesting an important opportunity for intervention. Improving BMI, which has the largest association with cancer risk, is an especially promising target.	[O'Neill, Suzanne C.; Vegella, Patti] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [DeFrank, Jessica T.; Brewer, Noel T.] Univ N Carolina, Dept Hlth Behav, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Richman, Alice R.] E Carolina Univ, Coll Hlth & Human Performance, Dept Hlth Educ & Promot, Greenville, NC USA; [Henry, Leonard R.] Indiana Univ Hlth, Goshen Ctr Canc Care, Goshen, IN USA; [Carey, Lisa A.; Brewer, Noel T.] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA	Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; East Carolina University; Indiana University System; University of North Carolina; University of North Carolina Chapel Hill	O'Neill, SC (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA.	sco4@georgetown.edu	Brewer, Noel T/C-4375-2008	Brewer, Noel T/0000-0003-2241-7002	American Cancer Society [MSRG-06-259-01-CPPB, MSRG-10-110-01-CPPB, 97-152-04]; National Cancer Institute [P30CA051008]; UNC Cancer Care and Quality Training Program (NCI R25 Grant) [CA116339]; NATIONAL CANCER INSTITUTE [P30CA016086, R25CA116339] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UNC Cancer Care and Quality Training Program (NCI R25 Grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support was provided by grants MSRG-06-259-01-CPPB (NTB), MSRG-10-110-01-CPPB (SCO), and 97-152-04 (Georgetown University) from the American Cancer Society. The project was also supported, in part, by Award Number P30CA051008 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. At the time of this research, Jessica T. DeFrank was funded by the UNC Cancer Care and Quality Training Program (NCI R25 Grant, CA116339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; American Cancer Society, 2012, CANC FACTS FIG 2012; Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Befort CA, 2012, BREAST CANCER RES TR, V132, P631, DOI 10.1007/s10549-011-1922-3; Blackburn GL, 2007, AM J CLIN NUTR, V86, p878S, DOI 10.1093/ajcn/86.3.878S; Blanchard CM, 2008, J CLIN ONCOL, V26, P2198, DOI 10.1200/JCO.2007.14.6217; Bloom Joan R, 2008, J Cancer Surviv, V2, P190, DOI 10.1007/s11764-008-0058-x; Brewster AM, 2008, JNCI-J NATL CANCER I, V100, P1179, DOI 10.1093/jnci/djn233; CHLEBOWSKI RT, 1992, BREAST CANCER RES TR, V20, P73; Christy SM, 2011, J AM DIET ASSOC, V111, P1844, DOI 10.1016/j.jada.2011.09.013; Chuang SC, 2012, AM J CLIN NUTR, V96, P164, DOI 10.3945/ajcn.111.028415; Costanza ME, 2005, PREV MED, V41, P707, DOI 10.1016/j.ypmed.2004.12.013; Darga LL, 2007, ONCOL NURS FORUM, V34, P86, DOI 10.1188/07.ONF.86-92; Davies NJ, 2011, BRIT J CANCER, V105, pS52, DOI 10.1038/bjc.2011.423; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dillard AJ, 2012, HEALTH PSYCHOL, V31, P106, DOI 10.1037/a0024787; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Fairley TL, 2010, PREV CHRONIC DIS, V7; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gao X, 2003, INT J RADIAT ONCOL, V56, P1038, DOI 10.1016/S0360-3016(03)00203-7; George SM, 2011, CANCER CAUSE CONTROL, V22, P589, DOI 10.1007/s10552-011-9732-9; Green L. W., 1999, HLTH PROMOTION PLANN; Greenlee HA, 2013, OBESITY, V21, P65, DOI 10.1002/oby.20245; Hansen-Krone IJ, 2012, THROMB HAEMOSTASIS, V108, P554, DOI 10.1160/TH11-11-0818; Irwin ML, 2008, J CLIN ONCOL, V26, P3958, DOI 10.1200/JCO.2007.15.9822; Key TJ, 2011, BRIT J CANCER, V104, P6, DOI 10.1038/sj.bjc.6606032; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Latka RN, 2009, J CANCER SURVIV, V3, P148, DOI 10.1007/s11764-009-0088-z; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; Levy AG, 2006, CANCER EPIDEM BIOMAR, V15, P1893, DOI 10.1158/1055-9965.EPI-05-0482; Lu YN, 2011, J CLIN ONCOL, V29, P3358, DOI 10.1200/JCO.2010.34.2048; McQueen A, 2008, HEALTH PSYCHOL, V27, P68, DOI 10.1037/0278-6133.27.1.68; Meeske KA, 2009, BREAST CANCER RES TR, V113, P383, DOI 10.1007/s10549-008-9940-5; Morimoto LM, 2002, CANCER CAUSE CONTROL, V13, P741, DOI 10.1023/A:1020239211145; Mosher CE, 2008, J HEALTH PSYCHOL, V13, P1105, DOI 10.1177/1359105308095964; National Comprehensive Cancer Network, 2012, NCCN CLIN PRACT GUID; Nelson DE, 2004, J HEALTH COMMUN, V9, P443, DOI 10.1080/10810730490504233; Newman VA, 2005, J AM DIET ASSOC, V105, P382, DOI 10.1016/j.jada.2004.12.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Partridge AH, 2003, J CLIN ONCOL, V21, P602, DOI 10.1200/JCO.2003.07.071; Partridge AH, 2008, J CLIN ONCOL, V26, P556, DOI 10.1200/JCO.2007.11.5451; Patterson RE, 2010, MATURITAS, V66, P5, DOI 10.1016/j.maturitas.2010.01.004; Paxton RJ, 2012, CANCER-AM CANCER SOC, V118, P4024, DOI 10.1002/cncr.27389; Pekmezi DW, 2011, ACTA ONCOL, V50, P167, DOI 10.3109/0284186X.2010.529822; Pierce JP, 2007, JAMA-J AM MED ASSOC, V298, P289, DOI 10.1001/jama.298.3.289; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Schootman M, 2010, CANCER CAUSE CONTROL, V21, P1387, DOI 10.1007/s10552-010-9566-x; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Stolley MR, 2009, CANCER-AM CANCER SOC, V115, P4385, DOI 10.1002/cncr.24585; Sulayman N, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/728290; Tzeng JP, 2010, CANCER-AM CANCER SOC, V116, P1992, DOI 10.1002/cncr.24990; Winzer BM, 2011, CANCER CAUSE CONTROL, V22, P811, DOI 10.1007/s10552-011-9761-4	52	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53607	10.1371/journal.pone.0053607	http://dx.doi.org/10.1371/journal.pone.0053607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326466	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800060
J	West, LC; Grotzke, JE; Cresswell, P				West, Laura Ciaccia; Grotzke, Jeff E.; Cresswell, Peter			MHC Class II-Restricted Presentation of the Major House Dust Mite Allergen Der p 1 Is GILT-Dependent: Implications for Allergic Asthma	PLOS ONE			English	Article							LYSOSOMAL THIOL REDUCTASE; ANTIGEN PRESENTATION; DISULFIDE BONDS; FREE MICE; RECOGNITION; CYTOKINES; DISEASE; CELLS	Gamma-interferon-inducible lysosomal thiol reductase (GILT) is known to reduce disulfide bonds present in proteins internalized by antigen presenting cells, facilitating optimal processing and presentation of peptides on Major Histocompatibility Complex class II molecules, as well as the subsequent activation of CD4-positive T lymphocytes. Here, we show that GILT is required for class II-restricted processing and presentation of immunodominant epitopes from the major house dust mite allergen Der p 1. In the absence of GILT, CD4-positive T cell responses to Der p 1 are significantly reduced, resulting in mitigated allergic airway inflammation in response to Der p 1 and house dust mite extracts in a murine model of asthma.	[West, Laura Ciaccia; Grotzke, Jeff E.; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA.	peter.cresswell@yale.edu			American Asthma Foundation; Howard Hughes Medical Institute; National Institutes of Health [T32AI07019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019] Funding Source: NIH RePORTER	American Asthma Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by the American Asthma Foundation, the Howard Hughes Medical Institute, and the National Institutes of Health Training Grant from T32AI07019, Yale Immunobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Bogunovic B, 2008, J BIOL CHEM, V283, P8855, DOI 10.1074/jbc.M708998200; Chruszcz M, 2009, J MOL BIOL, V386, P520, DOI 10.1016/j.jmb.2008.12.049; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P1604, DOI 10.1016/j.jaci.2011.03.031; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; Hastings KT, 2011, ANTIOXID REDOX SIGN, V15, P657, DOI 10.1089/ars.2010.3684; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Kaiser L, 2007, J MOL BIOL, V370, P714, DOI 10.1016/j.jmb.2007.04.074; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; Lackman RL, 2007, TRAFFIC, V8, P1179, DOI 10.1111/j.1600-0854.2007.00600.x; Lackman RL, 2006, J IMMUNOL, V177, P4833, DOI 10.4049/jimmunol.177.7.4833; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Li P, 2002, J IMMUNOL, V169, P2444, DOI 10.4049/jimmunol.169.5.2444; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; O'Donnell PW, 2004, J IMMUNOL, V173, P731, DOI 10.4049/jimmunol.173.2.731; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Rausch MP, 2010, J IMMUNOL, V185, P2828, DOI 10.4049/jimmunol.1000945; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Singh R, 2010, SCIENCE, V328, P1394, DOI 10.1126/science.1189176; Tan YW, 2009, J BIOL CHEM, V284, P3148, DOI 10.1074/jbc.M807209200; TOPHAM CM, 1994, PROTEIN ENG, V7, P869, DOI 10.1093/protein/7.7.869; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175	30	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e51343	10.1371/journal.pone.0051343	http://dx.doi.org/10.1371/journal.pone.0051343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326313	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800009
J	Lu, Y; Li, YJ; Zhang, JC; Xiao, YT; Yue, YS; Duan, LS; Zhang, MC; Li, ZH				Lu, Yao; Li, Yajun; Zhang, Jiachang; Xiao, Yitao; Yue, Yuesen; Duan, Liusheng; Zhang, Mingcai; Li, Zhaohu			Overexpression of Arabidopsis Molybdenum Cofactor Sulfurase Gene Confers Drought Tolerance in Maize (Zea mays L.)	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; 9-CIS-EPOXYCAROTENOID DIOXYGENASE GENE; ALDEHYDE OXIDASE; HYDROGEN-PEROXIDE; GLYCINEBETAINE SYNTHESIS; HYDRAULIC CONDUCTIVITY; SALT TOLERANCE; LOCUS ENCODES; WATER-STRESS; EXPRESSION	Abscisic acid (ABA) is a key component of the signaling system that integrates plant adaptive responses to abiotic stress. Overexpression of Arabidopsis molybdenum cofactor sulfurase gene (LOS5) in maize markedly enhanced the expression of ZmAO and aldehyde oxidase (AO) activity, leading to ABA accumulation and increased drought tolerance. Transgenic maize (Zea mays L.) exhibited the expected reductions in stomatal aperture, which led to decreased water loss and maintenance of higher relative water content (RWC) and leaf water potential. Also, transgenic maize subjected to drought treatment exhibited lower leaf wilting, electrolyte leakage, malondialdehyde (MDA) and H2O2 content, and higher activities of antioxidative enzymes and proline content compared to wild-type (WT) maize. Moreover, overexpression of LOS5 enhanced the expression of stress-regulated genes such as Rad 17, NCED1, CAT1, and ZmP5CS1 under drought stress conditions, and increased root system development and biomass yield after re-watering. The increased drought tolerance in transgenic plants was associated with ABA accumulation via activated AO and expression of stress-related gene via ABA induction, which sequentially induced a set of favorable stress-related physiological and biochemical responses.	[Lu, Yao; Li, Yajun; Zhang, Jiachang; Xiao, Yitao; Yue, Yuesen; Duan, Liusheng; Zhang, Mingcai; Li, Zhaohu] China Agr Univ, Coll Agron & Biotechnol, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Zhang, MC (corresponding author), China Agr Univ, Coll Agron & Biotechnol, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	zmc1214@163.com	li, zh/HII-5698-2022; Duan, Liusheng/F-8954-2011	Duan, Liusheng/0000-0003-0323-9378; Lu, Yao/0000-0001-9258-8224	National Natural Science Foundation of China [30825028]; Ministry of Agricultural of China for transgenic research [2008ZX08004-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agricultural of China for transgenic research	This work was supported by National Natural Science Foundation of China (grant 30825028) and the Ministry of Agricultural of China for transgenic research (2008ZX08004-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aswath CR, 2005, PLANT GROWTH REGUL, V47, P129, DOI 10.1007/s10725-005-3380-6; Baisakh N, 2012, PLANT BIOTECHNOL J, V10, P453, DOI 10.1111/j.1467-7652.2012.00678.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN T, 1977, PLANT PHYSIOL, V59, P411, DOI 10.1104/pp.59.3.411; Chen ZZ, 2006, MOL CELL BIOL, V26, P6902, DOI 10.1128/MCB.00433-06; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Cohen A, 1999, PLANT CELL ENVIRON, V22, P989, DOI 10.1046/j.1365-3040.1999.00474.x; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gong ZZ, 1997, PLANT MOL BIOL, V35, P915, DOI 10.1023/A:1005959203396; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; He CM, 2010, PLANT CELL TISS ORG, V101, P65, DOI 10.1007/s11240-009-9665-0; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Kizis D, 2002, PLANT J, V30, P679, DOI 10.1046/j.1365-313X.2002.01325.x; Laboski CAM, 1998, PLANT SOIL, V203, P239, DOI 10.1023/A:1004391104778; Lv S, 2007, MOL BREEDING, V20, P233, DOI 10.1007/s11032-007-9086-x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Park EJ, 2004, PLANT J, V40, P474, DOI 10.1111/j.1365-313X.2004.02237.x; Park HY, 2008, BIOCHEM BIOPH RES CO, V375, P80, DOI 10.1016/j.bbrc.2008.07.128; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Porch TG, 2006, PLANT J, V45, P250, DOI 10.1111/j.1365-313X.2005.02621.x; Qin XQ, 2002, PLANT PHYSIOL, V128, P544, DOI 10.1104/pp.010663; Quan RD, 2004, PLANT SCI, V166, P141, DOI 10.1016/j.plantsci.2003.08.018; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Seo M, 2004, PLANT CELL PHYSIOL, V45, P1694, DOI 10.1093/pcp/pch198; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shou HX, 2004, P NATL ACAD SCI USA, V101, P3298, DOI 10.1073/pnas.0308095100; Strizhov N, 1997, PLANT J, V12, P557, DOI 10.1046/j.1365-313X.1997.00557.x; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Thompson AJ, 2007, PLANT PHYSIOL, V143, P1905, DOI 10.1104/pp.106.093559; Tung SA, 2008, PLANT CELL ENVIRON, V31, P968, DOI 10.1111/j.1365-3040.2008.01812.x; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wei AY, 2011, PLANT BIOTECHNOL J, V9, P216, DOI 10.1111/j.1467-7652.2010.00548.x; Xiao BZ, 2009, MOL PLANT, V2, P73, DOI 10.1093/mp/ssn068; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang Q, 2009, MOL PLANT, V2, P22, DOI 10.1093/mp/ssn058; Yue YS, 2011, PLANT SCI, V181, P405, DOI 10.1016/j.plantsci.2011.06.010; Zdunek E, 2001, J EXP BOT, V52, P1269, DOI 10.1093/jexbot/52.359.1269; Zhang AY, 2007, NEW PHYTOL, V175, P36, DOI 10.1111/j.1469-8137.2007.02071.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	59	110	120	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52126	10.1371/journal.pone.0052126	http://dx.doi.org/10.1371/journal.pone.0052126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326325	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400007
J	Bull-Otterson, L; Feng, WK; Kirpich, I; Wang, YH; Qin, X; Liu, YL; Gobejishvili, L; Joshi-Barve, S; Ayvaz, T; Petrosino, J; Kong, MY; Barker, D; McClain, C; Barve, S				Bull-Otterson, Lara; Feng, Wenke; Kirpich, Irina; Wang, Yuhua; Qin, Xiang; Liu, Yanlong; Gobejishvili, Leila; Joshi-Barve, Swati; Ayvaz, Tulin; Petrosino, Joseph; Kong, Maiying; Barker, David; McClain, Craig; Barve, Shirish			Metagenomic Analyses of Alcohol Induced Pathogenic Alterations in the Intestinal Microbiome and the Effect of Lactobacillus rhamnosus GG Treatment	PLOS ONE			English	Article							INDUCED LIVER-INJURY; GUT LEAKINESS; DISEASE; ENDOTOXEMIA; RATS; PERMEABILITY; PROBIOTICS; ETHANOL; STEATOHEPATITIS; MICROFLORA	Enteric dysbiosis plays an essential role in the pathogenesis of alcoholic liver disease (ALD). Detailed characterization of the alterations in the gut microbiome is needed for understanding their pathogenic role in ALD and developing effective therapeutic approaches using probiotic supplementation. Mice were fed liquid Lieber-DeCarli diet without or with alcohol (5% v/v) for 6 weeks. A subset of mice were administered the probiotic Lactobacillus rhamnosus GG (LGG) from 6 to 8 weeks. Indicators of intestinal permeability, hepatic steatosis, inflammation and injury were evaluated. Metagenomic analysis of the gut microbiome was performed by analyzing the fecal DNA by amplification of the V3-V5 regions of the 16S rRNA gene and large-scale parallel pyrosequencing on the 454 FLX Titanium platform. Chronic ethanol feeding caused a decline in the abundance of both Bacteriodetes and Firmicutes phyla, with a proportional increase in the gram negative Proteobacteria and gram positive Actinobacteria phyla; the bacterial genera that showed the biggest expansion were the gram negative alkaline tolerant Alcaligenes and gram positive Corynebacterium. Commensurate with the qualitative and quantitative alterations in the microbiome, ethanol caused an increase in plasma endotoxin, fecal pH, hepatic inflammation and injury. Notably, the ethanol-induced pathogenic changes in the microbiome and the liver were prevented by LGG supplementation. Overall, significant alterations in the gut microbiome over time occur in response to chronic alcohol exposure and correspond to increases in intestinal barrier dysfunction and development of ALD. Moreover, the altered bacterial communities of the gut may serve as significant therapeutic target for the prevention/treatment of chronic alcohol intake induced intestinal barrier dysfunction and liver disease.	[Bull-Otterson, Lara; Ayvaz, Tulin; Petrosino, Joseph] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Bull-Otterson, Lara; Ayvaz, Tulin; Petrosino, Joseph] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Feng, Wenke; Kirpich, Irina; Wang, Yuhua; Liu, Yanlong; Gobejishvili, Leila; Joshi-Barve, Swati; Barker, David; McClain, Craig; Barve, Shirish] Univ Louisville, Sch Med, Dept Med, Alcohol Res Ctr, Louisville, KY 40292 USA; [Qin, Xiang] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Kong, Maiying] Univ Louisville, Sch Med, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [McClain, Craig; Barve, Shirish] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [McClain, Craig] Robley Rex VAMC, Louisville, KY USA	Baylor College of Medicine; Baylor College of Medicine; University of Louisville; Baylor College of Medicine; University of Louisville; University of Louisville	Barve, S (corresponding author), Univ Louisville, Sch Med, Dept Med, Alcohol Res Ctr, Louisville, KY 40292 USA.	shirishbarve@gmail.com	Petrosino, Joseph F./AAF-1621-2019; Barker, David/HHZ-0471-2022	Barker, David/0000-0002-1438-4100	National Institutes of Health (NIH) [AAO14371, P01 AA017103, R01 AA0015970, R01 AA018016, R01 DK071765, R37 AA010762, R01 AA018869, P30 AA019360, RC2AA019385]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018869, R01AA015970, P30AA019360, RC2AA019385, R21AA020849, P01AA017103, R37AA010762, R01AA018016, U01AA021901] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institutes of Health (NIH) grants R01 AAO14371 (SB), P01 AA017103 (CM), R01 AA0015970 (CM), R01 AA018016 (CM, SB), R01 DK071765 (CM), R37 AA010762 (CM), R01 AA018869 (CM), P30 AA019360 (CM), RC2AA019385 (CM), and the Department of Veterans Affairs (CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P1415, DOI 10.1080/15287390802328630; ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; [Anonymous], 2012, PLOS ONE; [Anonymous], 2006, BROCK BIOL MICROORGA; Bezkorovainy A, 2001, AM J CLIN NUTR, V73, p399S, DOI 10.1093/ajcn/73.2.399s; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Brandt K, 2003, INT J FOOD MICROBIOL, V84, P189, DOI 10.1016/S0168-1605(02)00419-1; Cericco M, 1996, GASTROEN CLIN BIOL, V20, P514; Dommels YEM, 2009, APPL ENVIRON MICROB, V75, P6198, DOI 10.1128/AEM.01054-09; Drisko Jeanne A, 2003, Altern Med Rev, V8, P143; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Fooks LJ, 2002, BRIT J NUTR, V88, pS39, DOI [10.1079/BJN2002628, 10.1079/BJNBJN2002591]; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Fouts DE, 2012, J HEPATOLOGY; FUKUI H, 1991, J HEPATOL, V12, P162, DOI 10.1016/0168-8278(91)90933-3; Gobejishvili L, 2008, AM J PHYSIOL-GASTR L, V295, pG718, DOI 10.1152/ajpgi.90232.2008; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HARNISCH JP, 1989, ANN INTERN MED, V111, P71, DOI 10.7326/0003-4819-111-1-71; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Keshavarzian A, 2001, J PHARMACOL EXP THER, V299, P442; Kirpich IA, 2008, ALCOHOL, V42, P675, DOI 10.1016/j.alcohol.2008.08.006; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; NANJI AA, 1994, P SOC EXP BIOL MED, V205, P243; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Saxelin M, 2002, LACTOBACILLUS GG ITS; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang YH, 2011, AM J PATHOL, V179, P2866, DOI 10.1016/j.ajpath.2011.08.039; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Zhao Hai Ying, 2004, Chin J Dig Dis, V5, P64, DOI 10.1111/j.1443-9573.2004.00157.x	41	335	355	6	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53028	10.1371/journal.pone.0053028	http://dx.doi.org/10.1371/journal.pone.0053028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326376	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500042
J	Kaspar, K; Hloucal, TM; Kriz, J; Canzler, S; Gameiro, RR; Krapp, V; Konig, P				Kaspar, Kai; Hloucal, Teresa-Maria; Kriz, Juergen; Canzler, Sonja; Gameiro, Ricardo Ramos; Krapp, Vanessa; Koenig, Peter			Emotions' Impact on Viewing Behavior under Natural Conditions	PLOS ONE			English	Article							EYE-MOVEMENTS; LUMINANCE-CONTRAST; VISUAL-SEARCH; FIXATION BEHAVIOR; BRAIN POTENTIALS; SALIENCY MAP; ATTENTION; PERCEPTION; AROUSAL; REAL	Human overt attention under natural conditions is guided by stimulus features as well as by higher cognitive components, such as task and emotional context. In contrast to the considerable progress regarding the former, insight into the interaction of emotions and attention is limited. Here we investigate the influence of the current emotional context on viewing behavior under natural conditions. In two eye-tracking studies participants freely viewed complex scenes embedded in sequences of emotion-laden images. The latter primes constituted specific emotional contexts for neutral target images. Viewing behavior toward target images embedded into sets of primes was affected by the current emotional context, revealing the intensity of the emotional context as a significant moderator. The primes themselves were not scanned in different ways when presented within a block (Study 1), but when presented individually, negative primes were more actively scanned than positive primes (Study 2). These divergent results suggest an interaction between emotional priming and further context factors. Additionally, in most cases primes were scanned more actively than target images. Interestingly, the mere presence of emotion-laden stimuli in a set of images of different categories slowed down viewing activity overall, but the known effect of image category was not affected. Finally, viewing behavior remained largely constant on single images as well as across the targets' post-prime positions (Study 2). We conclude that the emotional context significantly influences the exploration of complex scenes and the emotional context has to be considered in predictions of eye-movement patterns.	[Kaspar, Kai; Hloucal, Teresa-Maria; Kriz, Juergen] Univ Osnabruck, Inst Psychol, Osnabruck, Germany; [Kaspar, Kai; Canzler, Sonja; Gameiro, Ricardo Ramos; Krapp, Vanessa; Koenig, Peter] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany; [Koenig, Peter] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University Osnabruck; University Osnabruck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kaspar, K (corresponding author), Univ Osnabruck, Inst Psychol, Osnabruck, Germany.	kkaspar@uos.de	König, Peter/ABB-2380-2020; Kriz, Juergen/ABD-5435-2021	König, Peter/0000-0003-3654-5267; 	Community Research and Development Information Service [FP7-ICT-270212]	Community Research and Development Information Service	The work was supported by grant FP7-ICT-270212 Extending Sensorimotor Contingencies to Cognition (Peter Konig); Community Research and Development Information Service. URL: http://cordis.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acik A, 2010, FRONT PERCEPT SCI, V1; Acik A, 2009, VISION RES, V49, P1541, DOI 10.1016/j.visres.2009.03.011; Baddeley RJ, 2006, VISION RES, V46, P2824, DOI 10.1016/j.visres.2006.02.024; Ballard DH, 2009, VIS COGN, V17, P1185, DOI 10.1080/13506280902978477; Bradley M. M., 2007, HDB EMOTION ELICITAT, P29; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Calvo MG, 2005, J EXP PSYCHOL HUMAN, V31, P502, DOI 10.1037/0096-1523.31.3.502; Calvo MG, 2004, MOTIV EMOTION, V28, P221, DOI 10.1023/B:MOEM.0000040153.26156.ed; Carmi R, 2006, VISION RES, V46, P4333, DOI 10.1016/j.visres.2006.08.019; Cerf M, 2008, ADV NEUR IN, V20; Chen X, 2006, VISION RES, V46, P4118, DOI 10.1016/j.visres.2006.08.008; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; DeAngelus M, 2009, VIS COGN, V17, P790, DOI 10.1080/13506280902793843; Einhauser W, 2006, J VISION, V6, P1148, DOI 10.1167/6.11.1; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Einhauser W, 2010, CURR OPIN NEUROBIOL, V20, P389, DOI 10.1016/j.conb.2010.03.010; Einhauser W, 2003, EUR J NEUROSCI, V17, P1089, DOI 10.1046/j.1460-9568.2003.02508.x; Flaisch T, 2008, BRAIN TOPOGR, V20, P183, DOI 10.1007/s10548-008-0045-6; Frey HP, 2008, J VISION, V8, DOI 10.1167/8.14.6; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Hamborg KC, 2012, COMPUT HUM BEHAV, V28, P576, DOI 10.1016/j.chb.2011.11.003; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Henderson J, 2005, EYE MOVEMENT RES INS, P2; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Isaacowitz DM, 2006, EMOTION, V6, P511, DOI 10.1037/1528-3542.6.3.511; Ishihara S., 2005, ISHIHARAS TESTS COLO; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Joormann J, 2007, J ABNORM PSYCHOL, V116, P80, DOI 10.1037/0021-843X.116.1.80; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Kaspar K, PARADOXICAL EF UNPUB; Kaspar K, 2011, J EYE MOVEMENT RES, V4; Kaspar K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00321; Kaspar K, 2011, J VISION, V11, DOI 10.1167/11.13.26; Kaspar K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021719; Kayser C, 2006, VISION RES, V46, P2535, DOI 10.1016/j.visres.2006.02.003; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Kensinger EA, 2004, REV NEUROSCIENCE, V15, P241, DOI 10.1515/REVNEURO.2004.15.4.241; Krieger G, 2000, SPATIAL VISION, V13, P201, DOI 10.1163/156856800741216; Lang P.J., 2008, INT AFFECTIVE PICTUR; Lang P.J., 2005, INT AFFECTIVE PICTUR; Lykins AD, 2006, ARCH SEX BEHAV, V35, P569, DOI 10.1007/s10508-006-9065-z; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; Miller GA., 1955, INF THEORY PSYCHOL P, V2, P95; Most SB, 2005, PSYCHON B REV, V12, P654, DOI 10.3758/BF03196754; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Navalpakkam V, 2006, J VISION, V6, P1180, DOI 10.1167/6.11.4; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Olmos A., 2004, MCGILL CALIBRATED CO; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Peira N, 2010, EXP PSYCHOL, V57, P470, DOI 10.1027/1618-3169/a000058; Peters R.J., 2007, 2007 IEEE C COMP VIS; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Pomplun M, 2006, VISION RES, V46, P1886, DOI 10.1016/j.visres.2005.12.003; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; REINAGEL P., 1999, NETWORK COMPUTATION, V10, P1; Schubo A, 2006, EMOTION, V6, P246, DOI 10.1037/1528-3542.6.2.246; Segerstrom SC, 2001, PERS SOC PSYCHOL B, V27, P1334, DOI 10.1177/01461672012710009; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Underwood G, 2006, EUR J COGN PSYCHOL, V18, P321, DOI 10.1080/09541440500236661; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; Velichkovsky B, 1997, GEM FACHT GERM CHAPT, P317; Wilming N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024038	67	19	19	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52737	10.1371/journal.pone.0052737	http://dx.doi.org/10.1371/journal.pone.0052737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326353	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500029
J	Woznica, A; Nowak, A; Ziemski, P; Kwasniewski, M; Bernas, T				Woznica, Andrzej; Nowak, Agnieszka; Ziemski, Przemyslaw; Kwasniewski, Miroslaw; Bernas, Tytus			Stimulatory Effect of Xenobiotics on Oxidative Electron Transport of Chemolithotrophic Nitrifying Bacteria Used as Biosensing Element	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; RIBOSOMAL-RNA GENE; NITROBACTER-HAMBURGENSIS; PSEUDOMONAS-AERUGINOSA; AEROMONAS-HYDROPHILA; GENOME SEQUENCE; ION CHANNELS; CYANIDE; HORMESIS; MITOCHONDRIAL	Electron transport chain (ETCh) of ammonium (AOB) and nitrite oxidizing bacteria (NOB) participates in oxidation of ammonium to nitrate (nitrification). Operation of ETCh may be perturbed by a range of water-soluble xenobiotics. Therefore, consortia of nitrifying bacteria may be used as a biosensor to detect water contamination. A surprising feature of this system is an increase of oxygen consumption, detected in the presence of certain inhibitors of ETCh. Thus, to shed light on the mechanism of this effect (and other differences between inhibitors) we monitored separately respiration of the bacteria of the first (AOB - Nitrosomonas) and second (NOB -Nitrobacter) stages of nitrification. Furthermore, we measured plasma membrane potential and the level of reduction of NAD(P)H. We propose a novel model of ETCh in NOB to explain the role of reverse electron transport in the stimulation of oxygen consumption (previously attributed to hormesis).	[Woznica, Andrzej; Nowak, Agnieszka; Ziemski, Przemyslaw] Univ Silesia, Fac Biol & Environm Protect, Dept Biochem, Katowice, Poland; [Kwasniewski, Miroslaw] Univ Silesia, Fac Biol & Environm Protect, Dept Genet, Katowice, Poland; [Bernas, Tytus] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	University of Silesia in Katowice; University of Silesia in Katowice; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Woznica, A (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Biochem, Katowice, Poland.	andrzej.woznica@us.edu.pl	Nowak, Agnieszka/AFN-1525-2022; Bernas, Tytus/P-2385-2016	Nowak, Agnieszka/0000-0002-5705-8938; Bernas, Tytus/0000-0003-0841-5940; Woznica, Andrzej/0000-0003-3051-1816	UE Innovate Economy Operational Programme, Priority 1 "Research and development of modern technologies" [POIG 01.01.02-24-078/09]; UE Innovate Economy Operational Programme, Subaction 1.1.2 "An integrated system supporting the management and protection of the water reservoir" [POIG 01.01.02-24-078/09]; Polish Ministry for Science and Higher Education (MNiSW) [N N301 463834]	UE Innovate Economy Operational Programme, Priority 1 "Research and development of modern technologies"; UE Innovate Economy Operational Programme, Subaction 1.1.2 "An integrated system supporting the management and protection of the water reservoir"; Polish Ministry for Science and Higher Education (MNiSW)(Ministry of Science and Higher Education, Poland)	This work was supported by the UE Innovate Economy Operational Programme, Priority 1 "Research and development of modern technologies", Subaction 1.1.2 "An integrated system supporting the management and protection of the water reservoir", Project number: POIG 01.01.02-24-078/09 (AW) and by the Polish Ministry for Science and Higher Education (MNiSW) grant Nr N N301 463834 (TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames J.R., 1986, J FREE RADIC BIOL ME, V2, P371; APHA, 1995, STANDARD METHODS EXA; Arp DJ, 2003, CRIT REV BIOCHEM MOL, V38, P471, DOI 10.1080/10409230390267446; Bergmeyer HU, 1989, METHOD ENZYMATIC ANA; Bibby K, 2010, WATER RES, V44, P4252, DOI 10.1016/j.watres.2010.05.039; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; Bothe H, 2000, FEMS MICROBIOL REV, V24, P673, DOI 10.1111/j.1574-6976.2000.tb00566.x; Calabrese EJ, 2008, ENVIRON TOXICOL CHEM, V27, P1451, DOI 10.1897/07-541; Calabrese EJ, 2009, ARCH TOXICOL, V83, P227, DOI 10.1007/s00204-009-0411-5; Calabrese EJ, 1999, RISK ANAL, V19, P261, DOI 10.1111/j.1539-6924.1999.tb00404.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cipollone R, 2007, APPL ENVIRON MICROB, V73, P390, DOI 10.1128/AEM.02143-06; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cooper M, 2003, MICROBIOL-SGM, V149, P1275, DOI 10.1099/mic.0.26017-0; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Do H, 2008, J IND MICROBIOL BIOT, V35, P1331, DOI 10.1007/s10295-008-0415-9; Elbehti A, 1999, J BIOL CHEM, V274, P16760, DOI 10.1074/jbc.274.24.16760; Ferguson SJ, 2002, BIOENERGETIC; Gieseke A, 2001, APPL ENVIRON MICROB, V67, P1351, DOI 10.1128/AEM.67.3.1351-1362.2001; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HADDOCK BA, 1977, BACTERIOL REV, V41, P47, DOI 10.1128/MMBR.41.1.47-99.1977; Hovanec TA, 1998, APPL ENVIRON MICROB, V64, P258; ILZUMI T, 1998, APPL ENVIRON MICROB, V64, P3656; Inoue M, 1998, AM J PHYSIOL-CELL PH, V274, pC105, DOI 10.1152/ajpcell.1998.274.1.C105; Knight V, 1998, ARCH MICROBIOL, V169, P239, DOI 10.1007/s002030050567; Koops HP, 2001, FEMS MICROBIOL ECOL, V37, P1, DOI 10.1111/j.1574-6941.2001.tb00847.x; Koprowski P, 2001, BIOESSAYS, V23, P1148, DOI 10.1002/bies.10017; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; MACDONALD RM, 1980, FEMS MICROBIOL LETT, V8, P143, DOI 10.1016/0378-1097(80)90018-X; Magnuson TS, 2000, FEMS MICROBIOL LETT, V185, P205, DOI 10.1016/S0378-1097(00)00081-1; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; MATSUNAGA T, 1993, APPL MICROBIOL BIOT, V39, P368; Mota C, 2005, APPL ENVIRON MICROB, V71, P8565, DOI 10.1128/AEM.71.12.8565-8572.2005; Sansom MSP, 2002, BBA-BIOMEMBRANES, V1565, P294, DOI 10.1016/S0005-2736(02)00576-X; Seligman L, 1971, J GEN MICROBIOL, V68, P135; Spieck E, 2006, ENVIRON MICROBIOL, V8, P405, DOI 10.1111/j.1462-2920.2005.00905.x; Spieck E, 1996, J STRUCT BIOL, V117, P117, DOI 10.1006/jsbi.1996.0076; Spieck E, 1998, ARCH MICROBIOL, V169, P225, DOI 10.1007/s002030050565; Spieck E, 2005, LITHOAUTOTROPHIC NIT, V2, P149; Starkenburg SR, 2008, APPL ENVIRON MICROB, V74, P2852, DOI 10.1128/AEM.02311-07; Starkenburg SR, 2006, APPL ENVIRON MICROB, V72, P2050, DOI 10.1128/AEM.72.3.2050-2063.2006; Subbarao GV, 2006, CRIT REV PLANT SCI, V25, P303, DOI 10.1080/07352680600794232; Thomas A. W., 2008, Proceedings of the Sendai International Symposium on Strangeness in Nuclear and Hadronic Systems - SENDAI08, P1, DOI 10.1017/S0033291708004042; Tolkatchev D, 1996, J BIOL CHEM, V271, P12356, DOI 10.1074/jbc.271.21.12356; Wang G, 2001, NEUROSCI LETT, V309, P125, DOI 10.1016/S0304-3940(01)02032-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woznica A, 2003, ANAEROBE, V9, P125, DOI 10.1016/S1075-9964(03)00059-3; Woznica A, 2006, ECOPOLE 06 JAMR POL; Woznica A, 2010, CHEMOSPHERE, V81, P767, DOI 10.1016/j.chemosphere.2010.07.011; Woznica A, 2010, CHEMOSPHERE, V78, P1121, DOI 10.1016/j.chemosphere.2009.12.035; Xia H, 1997, PHYS REV B, V55, P15018, DOI 10.1103/PhysRevB.55.15018	53	4	4	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53484	10.1371/journal.pone.0053484	http://dx.doi.org/10.1371/journal.pone.0053484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326438	gold, Green Submitted, Green Published			2022-12-27	WOS:000313551500077
J	Yuan, K; Cheng, P; Dong, T; Bi, YZ; Xing, LH; Yu, DH; Zhao, LM; Dong, MH; von Deneen, KM; Liu, YJ; Qin, W; Tian, J				Yuan, Kai; Cheng, Ping; Dong, Tao; Bi, Yanzhi; Xing, Lihong; Yu, Dahua; Zhao, Limei; Dong, Minghao; von Deneen, Karen M.; Liu, Yijun; Qin, Wei; Tian, Jie			Cortical Thickness Abnormalities in Late Adolescence with Online Gaming Addiction	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; PROBLEMATIC INTERNET USE; ORBITOFRONTAL CORTEX; CIGARETTE-SMOKING; FINGER MOVEMENT; DRUG-ADDICTION; TAXI DRIVERS; STROOP TASK; HUMAN BRAIN; SMOKERS	Online gaming addiction, as the most popular subtype of Internet addiction, had gained more and more attention from the whole world. However, the structural differences in cortical thickness of the brain between adolescents with online gaming addiction and healthy controls are not well unknown; neither was its association with the impaired cognitive control ability. High-resolution magnetic resonance imaging scans from late adolescence with online gaming addiction (n = 18) and age-, education- and gender-matched controls (n = 18) were acquired. The cortical thickness measurement method was employed to investigate alterations of cortical thickness in individuals with online gaming addiction. The color-word Stroop task was employed to investigate the functional implications of the cortical thickness abnormalities. Imaging data revealed increased cortical thickness in the left precentral cortex, precuneus, middle frontal cortex, inferior temporal and middle temporal cortices in late adolescence with online gaming addiction; meanwhile, the cortical thicknesses of the left lateral orbitofrontal cortex (OFC), insula, lingual gyrus, the right postcentral gyrus, entorhinal cortex and inferior parietal cortex were decreased. Correlation analysis demonstrated that the cortical thicknesses of the left precentral cortex, precuneus and lingual gyrus correlated with duration of online gaming addiction and the cortical thickness of the OFC correlated with the impaired task performance during the color-word Stroop task in adolescents with online gaming addiction. The findings in the current study suggested that the cortical thickness abnormalities of these regions may be implicated in the underlying pathophysiology of online gaming addiction.	[Yuan, Kai; Cheng, Ping; Dong, Tao; Bi, Yanzhi; Xing, Lihong; Yu, Dahua; Zhao, Limei; Dong, Minghao; von Deneen, Karen M.; Qin, Wei; Tian, Jie] Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Yu, Dahua] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Informat Proc Lab, Baotou, Inner Mongolia, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Inner Mongolia University of Science & Technology; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Automation, CAS	Qin, W (corresponding author), Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	wqin@xidian.edu.cn; tian@ieee.org	Tian, Jie/H-1190-2011; Dong, Minghao/A-6425-2014; Yuan, Kai/I-4150-2016; Life, PAM/M-9552-2013; Yuan, Kai/M-9403-2013; Yu, Dahua/N-7242-2013; 秦, 伟/J-9770-2016; tian, jie/M-6336-2013	Tian, Jie/0000-0003-0498-0432; Dong, Minghao/0000-0002-0190-6985; Yuan, Kai/0000-0002-3098-1124; Yu, Dahua/0000-0001-7850-7512; 秦, 伟/0000-0003-4583-0406; 	Project for the National Key Basic Research and Development Program (973) [2011CB707702, 2012CB518501]; National Natural Science Foundation of China [30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171]; Fundamental Research Funds for the Central Universities; Knowledge Innovation Program of the Chinese Academy of Sciences [KGCX2-YW-129]	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This study was supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2011CB707702 and 2012CB518501; the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108 and 31150110171; the Fundamental Research Funds for the Central Universities and the Knowledge Innovation Program of the Chinese Academy of Sciences under Grant No. KGCX2-YW-129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboujaoude E, 2010, WORLD PSYCHIATRY, V9, P85; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Cao FL, 2007, EUR PSYCHIAT, V22, P466, DOI 10.1016/j.eurpsy.2007.05.004; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chou C, 2005, EDUC PSYCHOL REV, V17, P363, DOI 10.1007/s10648-005-8138-1; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; Dong GH, 2011, NEUROSCI LETT, V499, P114, DOI 10.1016/j.neulet.2011.05.047; Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014703; Dong GH, 2010, NEUROSCI LETT, V485, P138, DOI 10.1016/j.neulet.2010.09.002; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Durkee T, 2012, ADDICTION, V107, P2210, DOI 10.1111/j.1360-0443.2012.03946.x; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Flisher C, 2010, J PAEDIATR CHILD H, V46, P557, DOI 10.1111/j.1440-1754.2010.01879.x; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Gilman JM, 2008, ADDICT BIOL, V13, P423, DOI 10.1111/j.1369-1600.2008.00111.x; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; JUN L, 2010, CHINESE MED J, V123, P1904; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Ko CH, 2013, ADDICT BIOL, V18, P559, DOI 10.1111/j.1369-1600.2011.00405.x; Ko CH, 2010, PSYCHIAT RES, V175, P121, DOI 10.1016/j.psychres.2008.10.004; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Kuhn S, 2010, BIOL PSYCHIAT, V68, P1061, DOI 10.1016/j.biopsych.2010.08.004; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; May A, 2011, TRENDS COGN SCI, V15, P475, DOI 10.1016/j.tics.2011.08.002; Morahan-Martin J, 2000, COMPUT HUM BEHAV, V16, P13, DOI 10.1016/S0747-5632(99)00049-7; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Park HS, 2010, CNS SPECTRUMS, V15, P159, DOI 10.1017/S1092852900027437; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pine D S, 2001, CNS Spectr, V6, P27; Primus RJ, 1997, J PHARMACOL EXP THER, V282, P1020; Rao SM, 1996, J CEREBR BLOOD F MET, V16, P1250, DOI 10.1097/00004647-199611000-00020; Recupero PR, 2008, J AM ACAD PSYCHIATRY, V36, P505; Schinka JA, 2002, AM J MED GENET, V114, P643, DOI 10.1002/ajmg.10649; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387; Silveri MM, 2004, ANN NY ACAD SCI, V1021, P363, DOI 10.1196/annals.1308.046; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Xu J, 2007, NEUROPSYCHOPHARMACOL, V32, P1421, DOI 10.1038/sj.npp.1301272; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young K S., 1999, INNOVATIONS CLIN PRA, P19; Young K, 2010, WORLD PSYCHIATRY, V9, P91; Yuan Kai, 2011, Commun Integr Biol, V4, P637; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Zhou Y, 2011, EUR J RADIOL, V79, P92, DOI 10.1016/j.ejrad.2009.10.025	57	90	94	5	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53055	10.1371/journal.pone.0053055	http://dx.doi.org/10.1371/journal.pone.0053055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326379	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500045
J	Jin, R; Zhu, WD; Cao, SB; Chen, R; Jin, H; Liu, Y; Wang, SB; Wang, W; Xiao, GF				Jin, Rui; Zhu, Wandi; Cao, Shengbo; Chen, Rui; Jin, Hui; Liu, Yang; Wang, Shaobo; Wang, Wei; Xiao, Gengfu			Japanese Encephalitis Virus Activates Autophagy as a Viral Immune Evasion Strategy	PLOS ONE			English	Article							NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; HEPATITIS-C VIRUS; MONITORING AUTOPHAGY; GENE-EXPRESSION; IN-VITRO; INTERFERON; REPLICATION; MACHINERY; INDUCTION	In addition to manipulating cellular homeostasis and survivability, autophagy also plays a crucial role in numerous viral infections. In this study, we discover that Japanese encephalitis virus (JEV) infection results in the accumulation of microtubule-associated protein 1 light chain 3-II (LC3-II) protein and GFP-LC3 puncta in vitro and an increase in autophagosomes/autolysosomes in vivo. The fusion between autophagosomes and lysosomes is essential for virus replication. Knockdown of autophagy-related genes reduced JEV replication in vitro, as indicated by viral RNA and protein levels. We also note that JEV infection in autophagy-impaired cells displayed active caspases cleavage and cell death. Moreover, we find that JEV induces higher type I interferon (IFN) activation in cells deficient in autophagy-related genes as the cells exhibited increased phosphorylation and dimerization of interferon regulatory factor 3 (IRF3) and mitochondrial antiviral signaling protein (MAVS) aggregation. Finally, we find that autophagy is indispensable for efficient JEV replication even in an IFN-defective background. Overall, our studies provide the first description of the mechanism of the autophagic innate immune signaling pathway during JEV infection.	[Jin, Rui; Zhu, Wandi; Chen, Rui; Jin, Hui; Liu, Yang; Wang, Shaobo; Wang, Wei; Xiao, Gengfu] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Cao, Shengbo] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Huazhong Agricultural University	Wang, W (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	429166911@qq.com; xiaogf@wh.iov.cn	Wang, Shaobo/AAB-2272-2020	Wang, Wei/0000-0002-8696-9773	National Key Scientific Program (973) [2010CB530100, 2011CB933600]; National Natural Science Foundation of China [31000089]	National Key Scientific Program (973); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Scientific Program (973)-(Nos. 2010CB530100 and 2011CB933600) and a grant from the National Natural Science Foundation of China (No. 31000089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chen R, 2011, AUTOPHAGY, V7, P205, DOI 10.4161/auto.7.2.14197; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Criollo A, 2012, CELL CYCLE, V11, P194, DOI 10.4161/cc.11.1.18669; Fujiwara K, 2008, J BIOL CHEM, V283, P388, DOI 10.1074/jbc.M611043200; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2010, AUTOPHAGY, V6, P438, DOI 10.4161/auto.6.4.12244; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001; Li YM, 2010, J VIROL METHODS, V168, P51, DOI 10.1016/j.jviromet.2010.04.015; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Lin RJ, 2004, J GEN VIROL, V85, P521, DOI 10.1099/vir.0.19496-0; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Takeshita F, 2008, AUTOPHAGY, V4, P67, DOI 10.4161/auto.5055; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Vossen MTM, 2002, IMMUNOGENETICS, V54, P527, DOI 10.1007/s00251-002-0493-1; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	45	63	66	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52909	10.1371/journal.pone.0052909	http://dx.doi.org/10.1371/journal.pone.0052909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320079	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800021
J	Bonhomme, CJ; Knopp, KA; Bederka, LH; Angelini, MM; Buchmeier, MJ				Bonhomme, Cyrille J.; Knopp, Kristeene A.; Bederka, Lydia H.; Angelini, Megan M.; Buchmeier, Michael J.			LCMV Glycosylation Modulates Viral Fitness and Cell Tropism	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; N-LINKED GLYCANS; MEMBRANE-FUSION; ENVELOPE GLYCOPROTEIN; HEMORRHAGIC-FEVER; RECEPTOR-BINDING; HIV-1 GP120; LASSA-VIRUS; WEST-AFRICA; ARENAVIRUS	The glycoprotein (GP) of arenaviruses is glycosylated at 11 conserved N-glycosylation sites. We constructed recombinant lymphocytic choriomeningitis virus (rLCMV) featuring either additions or deletions of these N-glycans to investigate their role in the viral life cycle. N-glycosylation at two sites, T87 and S97, were found to be necessary to rescue rLCMV. Three of nine successfully rescued mutants, S116A, T234A, and S373A, under selective pressures in either epithelial, neuronal, or macrophage cells reverted to WT sequence. Of the seven stable N-glycan deletion mutants, five of these led to altered viral fitness and cell tropism, assessed as growth in either mouse primary cortical neurons or bone marrow derived macrophages. These results demonstrate that the deletion of N-glycans in LCMV GP may confer an advantage to the virus for infection of neurons but a disadvantage in macrophages.	[Bonhomme, Cyrille J.; Knopp, Kristeene A.; Bederka, Lydia H.; Angelini, Megan M.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Buchmeier, Michael J.] Univ Calif Irvine, Dept Mol Biol, Irvine, CA 92717 USA; [Buchmeier, Michael J.] Univ Calif Irvine, Dept Biochem, Irvine, CA 92717 USA; [Buchmeier, Michael J.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Buchmeier, MJ (corresponding author), Univ Calif Irvine, Dept Mol Biol, Irvine, CA 92717 USA.	m.buchmeier@uci.edu	Pacific-Southwest, RCE/B-6155-2009	Bederka, Lydia/0000-0002-3006-9979	National Institutes of Health (NIH) Pacific Southwest Regional Center of Excellence [AI-065359]; National Science Foundation [DGE-0638751]; NIH [5T32A1007319-23]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Pacific Southwest Regional Center of Excellence; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) grant AI-065359 Pacific Southwest Regional Center of Excellence, National Science Foundation Grant DGE-0638751, and NIH grant 5T32A1007319-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2010, NAT STRUCT MOL BIOL, V17, P438, DOI 10.1038/nsmb.1772; Agnihothram SS, 2009, J VIROL, V83, P9890, DOI 10.1128/JVI.00837-09; AHMED R, 1988, J EXP MED, V167, P1719, DOI 10.1084/jem.167.5.1719; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Amman BR, 2007, EMERG INFECT DIS, V13, P719, DOI 10.3201/eid1305.061269; Auwerx J, 2008, VIROLOGY, V382, P10, DOI 10.1016/j.virol.2008.09.010; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Barton LL, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e35; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Bonhomme CJ, 2011, VIROLOGY, V409, P223, DOI 10.1016/j.virol.2010.10.011; Bonthius DJ, 2007, ANN NEUROL, V62, P347, DOI 10.1002/ana.21161; BORROW P, 1994, VIROLOGY, V198, P1, DOI 10.1006/viro.1994.1001; Bowden TA, 2009, J VIROL, V83, P8259, DOI 10.1128/JVI.00761-09; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; BUCKLEY SM, 1970, AM J TROP MED HYG, V19, P680, DOI 10.4269/ajtmh.1970.19.680; BUCKLEY SM, 1970, NATURE, V227, P174, DOI 10.1038/227174a0; BURNS JW, 1991, VIROLOGY, V183, P620, DOI 10.1016/0042-6822(91)90991-J; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Charrel RN, 2008, CURR OPIN MICROBIOL, V11, P362, DOI 10.1016/j.mib.2008.06.001; Charrel RN, 2006, ARCH INTERN MED, V166, P2044, DOI 10.1001/archinte.166.18.2044; COIMBRA TLM, 1994, LANCET, V343, P391, DOI 10.1016/S0140-6736(94)91226-2; DEIBEL R, 1975, JAMA-J AM MED ASSOC, V232, P501, DOI 10.1001/jama.232.5.501; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; DISIMONE C, 1995, VIROLOGY, V209, P3, DOI 10.1006/viro.1995.1225; DISIMONE C, 1994, VIROLOGY, V198, P455, DOI 10.1006/viro.1994.1057; Emonet S, 2007, EMERG INFECT DIS, V13, P472, DOI 10.3201/eid1303.061141; Emonet SE, 2011, VIROLOGY, V411, P416, DOI 10.1016/j.virol.2011.01.013; Eschli B, 2007, J VIROL, V81, P11650, DOI 10.1128/JVI.00955-07; EVANS CF, 1994, J VIROL, V68, P7367, DOI 10.1128/JVI.68.11.7367-7373.1994; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Flatz L, 2006, P NATL ACAD SCI USA, V103, P4663, DOI 10.1073/pnas.0600652103; Francois KO, 2011, J BIOL CHEM, V286, P42900, DOI 10.1074/jbc.M111.274456; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HIRANO N, 1974, ARCH GES VIRUSFORSCH, V44, P298, DOI 10.1007/BF01240618; Igonet S, 2011, P NATL ACAD SCI USA, V108, P19967, DOI 10.1073/pnas.1108910108; JOHNSON KM, 1964, P SOC EXP BIOL MED, V118, P113; Klewitz C, 2007, J GEN VIROL, V88, P2320, DOI 10.1099/vir.0.82950-0; Knoper RC, 2009, VIROLOGY, V391, P232, DOI 10.1016/j.virol.2009.06.015; Lecompte E, 2007, VIROLOGY, V364, P178, DOI 10.1016/j.virol.2007.02.008; Maisner A, 1996, J VIROL, V70, P4973, DOI 10.1128/JVI.70.8.4973-4977.1996; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Morgado P, 2011, INFECT IMMUN, V79, P4401, DOI 10.1128/IAI.05562-11; Neuman BW, 2005, J VIROL, V79, P3822, DOI 10.1128/JVI.79.6.3822-3830.2005; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; PARODI A S, 1959, Prensa Med Argent, V46, P2242; PARODI A S, 1958, Dia Med, V30, P2300; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Quinones-Kochs MI, 2002, J VIROL, V76, P4199, DOI 10.1128/JVI.76.9.4199-4211.2002; Radoshitzky SR, PLOS ONE, V6; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Salvato MSCJ, 2005, 8 REP ICTV, P725733; Sanchez AB, 2006, VIROLOGY, V350, P370, DOI 10.1016/j.virol.2006.01.012; Sevilla N, 2006, CURR TOP MICROBIOL, V299, P315; SUGAWARA K, 1988, J GEN VIROL, V69, P537, DOI 10.1099/0022-1317-69-3-537; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; TESH RB, 1994, AM J TROP MED HYG, V50, P452, DOI 10.4269/ajtmh.1994.50.452; van Opijnen T, 2005, REV MED VIROL, V15, P219, DOI 10.1002/rmv.472; WELSH RM, 1972, J GEN VIROL, V17, P355, DOI 10.1099/0022-1317-17-3-355; WRIGHT KE, 1990, VIROLOGY, V177, P175, DOI 10.1016/0042-6822(90)90471-3; WRIGHT KE, 1989, VIROLOGY, V171, P417, DOI 10.1016/0042-6822(89)90610-7; Wyss DF, 1996, CURR OPIN BIOTECH, V7, P409, DOI 10.1016/S0958-1669(96)80116-9; York J, 2008, J VIROL, V82, P10932, DOI 10.1128/JVI.01140-08	65	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53273	10.1371/journal.pone.0053273	http://dx.doi.org/10.1371/journal.pone.0053273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308183	Green Published, gold			2022-12-27	WOS:000313429100049
J	Chung, CL; Hsiao, SH; Hsiao, G; Sheu, JR; Chen, WL; Chang, SC				Chung, Chi-Li; Hsiao, Shih-Hsin; Hsiao, George; Sheu, Joen-Rong; Chen, Wei-Lin; Chang, Shi-Chuan			Clinical Importance of Angiogenic Cytokines, Fibrinolytic Activity and Effusion Size in Parapneumonic Effusions	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR INHIBITOR-1; PLEURAL EFFUSIONS; FACTOR VEGF; INFECTION; MANAGEMENT; EMPYEMA; PLEURODESIS; GUIDELINE; TURNOVER	Objective: To investigate the relationship among angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusion (PPE) and their clinical importance. Methods: From January 2008 through December 2010, 26 uncomplicated (UPPE) and 38 complicated (CPPE) PPE were studied. Based on chest ultrasonography, there were non-loculated in 30, uni-loculated in 12, and multi-loculated effusions in 22 patients. The effusion size radiological scores, and effusion vascular endothelial growth factor (VEGF), interleukin (IL)-8, plasminogen activator inhibitor type-1 (PAI-1) and tissue type plasminogen activator (tPA) were measured on admission. Treatment outcome and pleural fibrosis, defined as radiological residual pleural thickening (RPT), were assessed at 6-month follow-up. Results: The effusion size and effusion VEGF, IL-8 and PAI-1/tPA ratio were significantly higher in CPPE than in UPPE, and significantly higher in multi-loculated PPE than in non-locualted and uni-loculated PPE, respectively. VEGF (cutoff value 1975 pg/ml) and IL-8 (cutoff value 1937 pg/ml) seemed best to discriminate between UPPE and CPPE. VEGF, IL-8 and effusion size correlated positively with PAI-1/tPA ratio in both UPPE and CPPE. Moreover, the level of VEGF, but not IL-8, correlated positively with effusion size in all patients (r = 0.79, p<0.001) and in UPPE (r = 0.64, p<0.001) and CPPE (r = 0.71, p<0.001) groups. The patients with higher VEGF or greater effusion were prone to have medical treatment failure (n = 10; VEGF, odds ratio 1.01, p = 0.02; effusion size, odds ratio 1.26, p = 0.01). Additionally, ten patients with RPT had larger effusion size and higher levels of VEGF and PAI-1/tPA ratio than did those without. Conclusions: In PPE, VEGF and IL-8 levels are valuable to identify CPPE, and higher VEGF level or larger effusion is associated with decreased fibrinolytic activity, development of pleural loculation and fibrosis, and higher risk of medical treatment failure.	[Chung, Chi-Li; Hsiao, Shih-Hsin] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chung, Chi-Li] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Hsiao, George; Sheu, Joen-Rong; Chen, Wei-Lin] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Hsiao, George; Sheu, Joen-Rong; Chen, Wei-Lin] Taipei Med Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan; [Chang, Shi-Chuan] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Chang, Shi-Chuan] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei 112, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, SC (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.	scchang@vghtpe.gov.tw			National Science Council of Taiwan [NSC98-2314-B-038-022-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council of Taiwan (NSC98-2314-B-038-022-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman C, 2003, CLIN SCI, V105, P601, DOI 10.1042/CS20030115; Bithell TC, 1993, WINTROBES CLIN HEMAT, P566; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BROADDUS VC, 1994, J IMMUNOL, V152, P2960; Cameron R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002312.pub3; Castro DJ, 2003, EUR RESPIR J, V21, P952, DOI 10.1183/09031936.03.00099502; Cheng DS, 1999, CHEST, V116, P760, DOI 10.1378/chest.116.3.760; Chung CL, 2008, EUR RESPIR J, V31, P1261, DOI 10.1183/09031936.00122207; Chung CL, 2005, CHEST, V128, P690, DOI 10.1016/S0012-3692(15)50413-3; Colicc GL, 2000, CHEST, V118, P1158, DOI 10.1378/chest.118.4.1158; Davies CWH, 2003, THORAX, V58, pII18, DOI 10.1136/thorax.58.suppl_2.ii18; Davies CWH, 1999, AM J RESP CRIT CARE, V160, P1682, DOI 10.1164/ajrccm.160.5.9903002; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Economidou F, 2008, RESP MED, V102, P774, DOI 10.1016/j.rmed.2007.10.021; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Fukumoto T, 1998, J LEUKOCYTE BIOL, V63, P584, DOI 10.1002/jlb.63.5.584; Guo YBB, 2005, CHEST, V128, P1790, DOI 10.1378/chest.128.3.1790; Huang HC, 1999, CHEST, V115, P751, DOI 10.1378/chest.115.3.751; Idell S, 2001, AM J RESP CRIT CARE, V163, P578, DOI 10.1164/ajrccm.163.2.2005135; IDELL S, 1991, AM REV RESPIR DIS, V144, P187, DOI 10.1164/ajrccm/144.1.187; LEMENSE GP, 1995, CHEST, V107, P1532, DOI 10.1378/chest.107.6.1532; LOMAS DJ, 1993, BRIT J RADIOL, V66, P619, DOI 10.1259/0007-1285-66-787-619; Marchi E, 2012, CHEST, V141, P183, DOI 10.1378/chest.10-3181; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Mohammed KA, 2001, AM J PHYSIOL-LUNG C, V281, pL119, DOI 10.1152/ajplung.2001.281.1.L119; Nasreen N, 1998, AM J RESP CRIT CARE, V158, P971, DOI 10.1164/ajrccm.158.3.9801097; Papaioannou AI, 2010, RESPIRATION, V80, P472, DOI 10.1159/000270913; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Ribeiro SCC, 2009, RESPIROLOGY, V14, P1188, DOI 10.1111/j.1440-1843.2009.01628.x; Shetty S, 2009, TXB PLEURAL DIS, P101; Teixeira LR, 2011, LUNG CANCER, V74, P392, DOI 10.1016/j.lungcan.2011.04.015; Thickett DR, 1999, THORAX, V54, P707, DOI 10.1136/thx.54.8.707; Wu YD, 2004, AM J PHYSIOL-CELL PH, V286, pC905, DOI 10.1152/ajpcell.00200.2003	34	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53169	10.1371/journal.pone.0053169	http://dx.doi.org/10.1371/journal.pone.0053169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308155	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100032
J	Kapoor, N; Pawar, S; Sirakova, TD; Deb, C; Warren, WL; Kolattukudy, PE				Kapoor, Nidhi; Pawar, Santosh; Sirakova, Tatiana D.; Deb, Chirajyoti; Warren, William L.; Kolattukudy, Pappachan E.			Human Granuloma In Vitro Model, for TB Dormancy and Resuscitation	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; NECROSIS-FACTOR-ALPHA; CHRONIC MURINE TUBERCULOSIS; LATENT TUBERCULOSIS; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; CELLS; TNF; MICE; TRIACYLGLYCEROL	Tuberculosis (TB) is responsible for death of nearly two million people in the world annually. Upon infection, Mycobacterium tuberculosis (Mtb) causes formation of granuloma where the pathogen goes into dormant state and can live for decades before resuscitation to develop active disease when the immune system of the host is weakened and/or suppressed. In an attempt to better understand host-pathogen interactions, several groups have been developing in vitro models of human tuberculosis granuloma. However, to date, an in vitro granuloma model in which Mtb goes into dormancy and can subsequently resuscitate under conditions that mimic weakening of the immune system has not been reported. We describe the development of a biomimetic in vitro model of human tuberculosis granuloma using human primary leukocytes, in which the Mtb exhibited characteristics of dormant mycobacteria as demonstrated by (1) loss of acid-fastness, (2) accumulation of lipid bodies (3) development of rifampicin-tolerance and (4) gene expression changes. Further, when these micro granulomas were treated with immunosuppressant anti-tumor necrosis factor-alpha monoclonal antibodies (anti-TNF alpha mAbs), resuscitation of Mtb was observed as has been found in humans. In this human in vitro granuloma model triacylglycerol synthase 1deletion mutant (Delta tgs1) with impaired ability to accumulate triacylglycerides (TG), but not the complemented mutant, could not go into dormancy. Deletion mutant of lipY, with compromised ability to mobilize the stored TG, but not the complemented mutant, was unable to come out of dormancy upon treatment with anti-TNF alpha mAbs. In conclusion, we have developed an in vitro human tuberculosis granuloma model that largely exhibits functional features of dormancy and resuscitation observed in human tuberculosis.	[Kapoor, Nidhi; Sirakova, Tatiana D.; Deb, Chirajyoti; Kolattukudy, Pappachan E.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Pawar, Santosh; Warren, William L.] Sanofi Pasteur, Orlando, FL USA	State University System of Florida; University of Central Florida; Sanofi-Aventis	Kolattukudy, PE (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	pk@ucf.edu			U.S. Army, Department of Defense; National Institutes of Health [RO1A1035]; Department of Defense	U.S. Army, Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense)	This project was funded in part by the U.S. Army, Department of Defense and by grant number RO1A1035 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared the affiliation of Santosh Pawar and William L. Warren to Sanofi Pasteur in the online manuscript form. Dr. William Warren is employed in Sanofi Pasteur; however, this work, supported by Department of Defense with P.E. Kolattukudy as the Principal Investigator, had nothing to do with the activities of Sanofi Pasteur and there are no financial or intellectual property arrangements with Sanofi Pasteur. Dr. Pawar moved on from Sanofi Pasteur to a non-profit Cancer Research Center. Thus, no conflict of interest exists in either case. This does not alter the authors' adherence to all the PLOS ONE policies and sharing data and materials.	ADAMS LB, 1995, J INFECT DIS, V171, P400, DOI 10.1093/infdis/171.2.400; Aleman M, 2004, INFECT IMMUN, V72, P5150, DOI 10.1128/IAI.72.9.5150-5158.2004; Bean AGD, 1999, J IMMUNOL, V162, P3504; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Bergeron A, 1997, J IMMUNOL, V159, P3034; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Birkness KA, 2007, IMMUNOL CELL BIOL, V85, P160, DOI 10.1038/sj.icb.7100019; Botha T, 2003, J IMMUNOL, V171, P3110, DOI 10.4049/jimmunol.171.6.3110; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cardona PJ, 2000, SCAND J IMMUNOL, V52, P156, DOI 10.1046/j.1365-3083.2000.00763.x; Clark-Curtiss JE, 1998, CURR TOP MICROBIOL, V225, P57; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dreher D, 2002, AM J RESP CRIT CARE, V165, P1577, DOI 10.1164/rccm.2204010; Ebert EC, 2009, AM J PHYSIOL-GASTR L, V296, pG612, DOI 10.1152/ajpgi.90576.2008; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; GOLD R, 1994, LAB INVEST, V71, P219; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Heinemann DEH, 1997, SCAND J IMMUNOL, V45, P596, DOI 10.1046/j.1365-3083.1997.d01-435.x; Hernandez J, 2010, IMMUNOL INVEST, V39, P197, DOI 10.3109/08820130903586346; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Law K, 1996, AM J RESP CRIT CARE, V153, P799, DOI 10.1164/ajrccm.153.2.8564135; Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; Marino S, 2007, PLOS COMPUT BIOL, V3, P1909, DOI 10.1371/journal.pcbi.0030194; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Martinez ON, 2001, AM J GASTROENTEROL, V96, P1665; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Mohan AK, 2004, CLIN INFECT DIS, V39, P295, DOI 10.1086/421494; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; OZAKI T, 1992, CHEST, V102, P54, DOI 10.1378/chest.102.1.54; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Perskvist N, 2002, J IMMUNOL, V168, P6358, DOI 10.4049/jimmunol.168.12.6358; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pilheu JA, 1997, INT J TUBERC LUNG D, V1, P422; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; Plessner HL, 2007, J INFECT DIS, V195, P1643, DOI 10.1086/517519; Puissegur MP, 2007, J IMMUNOL, V178, P3161, DOI 10.4049/jimmunol.178.5.3161; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Ramos-Vara JA, 2011, METHODS MOL BIOL, V691, P83, DOI 10.1007/978-1-60761-849-2_5; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Saunders BM, 1999, IMMUNOLOGY, V98, P324; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Seitzer U, 2003, CELLS TISSUES ORGANS, V174, P110, DOI 10.1159/000071151; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Taflin C, 2009, AM J PATHOL, V174, P497, DOI 10.2353/ajpath.2009.080580; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Uppal SS, 2004, CYTOM PART B-CLIN CY, V61B, P20, DOI 10.1002/cyto.b.20018; Wallis RS, 2004, CLIN INFECT DIS, V39, P1254, DOI 10.1086/424455; Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594; Wu YE, 2009, J INT MED RES, V37, P1742; Zahrt TC, 2003, MICROBES INFECT, V5, P159, DOI 10.1016/S1286-4579(02)00083-7; 2010, CENT EUR J PUBLIC HL, V18, P237	66	111	118	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53657	10.1371/journal.pone.0053657	http://dx.doi.org/10.1371/journal.pone.0053657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308269	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100102
J	Lindstrom, T; Grear, DA; Buhnerkempe, M; Webb, CT; Miller, RS; Portacci, K; Wennergren, U				Lindstrom, Tom; Grear, Daniel A.; Buhnerkempe, Michael; Webb, Colleen T.; Miller, Ryan S.; Portacci, Katie; Wennergren, Uno			A Bayesian Approach for Modeling Cattle Movements in the United States: Scaling up a Partially Observed Network	PLOS ONE			English	Article							FOOT-AND-MOUTH; GREAT-BRITAIN; LIVESTOCK MOVEMENTS; DISEASE SPREAD; DYNAMICS; SHEEP; TRANSMISSION; INVASIONS; KERNEL; HERD	Networks are rarely completely observed and prediction of unobserved edges is an important problem, especially in disease spread modeling where networks are used to represent the pattern of contacts. We focus on a partially observed cattle movement network in the U.S. and present a method for scaling up to a full network based on Bayesian inference, with the aim of informing epidemic disease spread models in the United States. The observed network is a 10% state stratified sample of Interstate Certificates of Veterinary Inspection that are required for interstate movement; describing approximately 20,000 movements from 47 of the contiguous states, with origins and destinations aggregated at the county level. We address how to scale up the 10% sample and predict unobserved intrastate movements based on observed movement distances. Edge prediction based on a distance kernel is not straightforward because the probability of movement does not always decline monotonically with distance due to underlying industry infrastructure. Hence, we propose a spatially explicit model where the probability of movement depends on distance, number of premises per county and historical imports of animals. Our model performs well in recapturing overall metrics of the observed network at the node level (U.S. counties), including degree centrality and betweenness; and performs better compared to randomized networks. Kernel generated movement networks also recapture observed global network metrics, including network size, transitivity, reciprocity, and assortativity better than randomized networks. In addition, predicted movements are similar to observed when aggregated at the state level (a broader geographic level relevant for policy) and are concentrated around states where key infrastructures, such as feedlots, are common. We conclude that the method generally performs well in predicting both coarse geographical patterns and network structure and is a promising method to generate full networks that incorporate the uncertainty of sampled and unobserved contacts.	[Lindstrom, Tom; Wennergren, Uno] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Lindstrom, Tom] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Grear, Daniel A.; Buhnerkempe, Michael; Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Miller, Ryan S.; Portacci, Katie] US Anim & Plant Hlth Inspect Serv, USDA, Ctr Epidemiol & Anim Hlth, Ft Collins, CO USA	Linkoping University; University of Sydney; Colorado State University; United States Department of Agriculture (USDA)	Wennergren, U (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	uno.wennergren@liu.se	Lindström, Tom/AAX-6492-2020; Lindström, Tom/E-7599-2011; Buhnerkempe, Michael G./N-2411-2019; Miller, Ryan/H-9848-2019	Lindström, Tom/0000-0001-7856-2925; Buhnerkempe, Michael G./0000-0002-5996-8927; Miller, Ryan/0000-0003-3892-0251; Grear, Daniel/0000-0002-5478-1549	Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center, National Institutes of Health; Foreign Animal Disease Modeling Program, Science and Technology Directorate, U.S. Department of Homeland Security [ST-108-000017]; USDA [11-9208-0269-CA11-1, 09-9208-0235-CA]; U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services; NIH	Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Foreign Animal Disease Modeling Program, Science and Technology Directorate, U.S. Department of Homeland Security; USDA(United States Department of Agriculture (USDA)); U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, U.S. Department of Homeland Security, and Fogarty International Center, National Institutes of Health; Foreign Animal Disease Modeling Program, Science and Technology Directorate, U.S. Department of Homeland Security (Grant ST-108-000017); and USDA Cooperative Agreement 11-9208-0269-CA11-1 and 09-9208-0235-CA. Data was provided by the U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services; however, the analyses, views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the regulatory opinions, official policies, either expressed or implied, of the USDA-APHIS-Veterinary Services or the U.S. Department of Homeland Security. USDA APHIS employees are co-authors on this work (RM and KP) and were involved with data collection, manuscript preparation and decision to publish. DHS and NIH funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Craft Meggan E, 2011, Interdiscip Perspect Infect Dis, V2011, P676949, DOI 10.1155/2011/676949; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Gamerman D, 2006, MARKOV CHAIN MONTE C; Gelman A., 2004, BAYESIAN DATA ANAL; Goh KI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.017101; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Hakansson N, 2010, ADV COMPLEX SYST, V13, P239, DOI 10.1142/S0219525910002517; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Lindstrom T, 2008, ECOLOGY, V89, P1784, DOI 10.1890/07-1363.1; Lindstrom T, 2012, J R SOC INTERFACE, V9, P1287, DOI 10.1098/rsif.2011.0625; Lindstrom T, 2011, P ROY SOC B-BIOL SCI, V278, P1564, DOI 10.1098/rspb.2010.1902; Lindstrom T, 2011, PREV VET MED, V98, P230, DOI 10.1016/j.prevetmed.2010.11.005; Lindstrom T, 2009, PREV VET MED, V91, P85, DOI 10.1016/j.prevetmed.2009.05.022; Mitchell A, 2005, ANIM SCI, V80, P265, DOI 10.1079/ASC50020265; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Sanson RL, 2005, NEW ZEAL VET J, V53, P223, DOI 10.1080/00480169.2005.36550; Shields DA, 2003, LDPM10801 USDA ERS; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009; Webb CR, 2005, PREV VET MED, V68, P3, DOI 10.1016/j.prevetmed.2005.01.003; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250	26	34	34	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53432	10.1371/journal.pone.0053432	http://dx.doi.org/10.1371/journal.pone.0053432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308223	Green Submitted, Green Published, gold			2022-12-27	WOS:000313670100042
J	Xie, GS; Yang, B; Xu, ZD; Li, FC; Guo, K; Zhang, ML; Wang, LQ; Zou, WH; Wang, YT; Peng, LC				Xie, Guosheng; Yang, Bo; Xu, Zhengdan; Li, Fengcheng; Guo, Kai; Zhang, Mingliang; Wang, Lingqiang; Zou, Weihua; Wang, Yanting; Peng, Liangcai			Global Identification of Multiple OsGH9 Family Members and Their Involvement in Cellulose Crystallinity Modification in Rice	PLOS ONE			English	Article							MEMBRANE-ANCHORED ENDO-1,4-BETA-GLUCANASE; SECONDARY CELL-WALL; GLYCOSYL HYDROLASES; CATALYTIC SUBUNIT; POPLAR CELLULASE; EXPRESSION ATLAS; BRASSICA-NAPUS; GENES; KORRIGAN; ENDO-1,4-BETA-D-GLUCANASE	Plant glycoside hydrolase family 9 (GH9) comprises typical endo-beta-1,4-glucanase (EGases, EC3.2.1.4). Although GH9A (KORRIGAN) family genes have been reported to be involved in cellulose biosynthesis in plants, much remains unknown about other GH9 subclasses. In this study, we observed a global gene co-expression profiling and conducted a correlation analysis between OsGH9 and OsCESA among 66 tissues covering most periods of life cycles in 2 rice varieties. Our results showed that OsGH9A3 and B5 possessed an extremely high co-expression with OsCESA1, 3, and 8 typical for cellulose biosynthesis in rice. Using two distinct rice non-GH9 mutants and wild type, we performed integrative analysis of gene expression level by qRT-PCR, cellulase activities in situ and in vitro, and lignocellulose crystallinity index (CrI) in four internodes of stem tissues. For the first time, OsGH9B1, 3, and 16 were characterized with the potential role in lignocellulose crystallinity alteration in rice, whereas OsGH9A3 and B5 were suggested for cellulose biosynthesis. In addition, phylogenetic analysis and gene co-expression comparison revealed GH9 function similarity in Arabidopsis and rice. Hence, the data can provide insights into GH9 function in plants and offer the potential strategy for genetic manipulation of plant cell wall using the five aforementioned novel OsGH9 genes.	[Xie, Guosheng; Yang, Bo; Xu, Zhengdan; Li, Fengcheng; Guo, Kai; Zhang, Mingliang; Wang, Lingqiang; Zou, Weihua; Wang, Yanting; Peng, Liangcai] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Coll Plant Sci & Technol, Biomass & Bioenergy Res Ctr,Coll Life Sci & Techn, Wuhan, Peoples R China; [Xie, Guosheng; Yang, Bo; Xu, Zhengdan; Li, Fengcheng; Guo, Kai; Zhang, Mingliang; Wang, Lingqiang; Zou, Weihua; Wang, Yanting; Peng, Liangcai] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Coll Plant Sci & Technol, Biomass & Bioenergy Res Ctr,Coll Life Sci & Techn, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Peng, LC (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Coll Plant Sci & Technol, Biomass & Bioenergy Res Ctr,Coll Life Sci & Techn, Wuhan, Peoples R China.	lpeng@mail.hzau.edu.cn			National 973 pre-project [2010CB134401]; National Transgenic Project [2009ZX08009-119B]; National 111 Project [B08032]; HZAU Changjiang Scholar Promoting Project [52204-07022]	National 973 pre-project(National Basic Research Program of China); National Transgenic Project; National 111 Project; HZAU Changjiang Scholar Promoting Project	The project was supported in part by grants from the National 973 pre-project (2010CB134401), the National Transgenic Project (2009ZX08009-119B), the National 111 Project (B08032), and HZAU Changjiang Scholar Promoting Project (52204-07022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari S, 2006, PLANTA, V224, P828, DOI 10.1007/s00425-006-0269-1; Bosch M, 2011, J EXP BOT, V62, P3545, DOI 10.1093/jxb/err045; Burton RA, 2000, PLANT CELL, V12, P691, DOI 10.1105/tpc.12.5.691; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Crowell EF, 2010, CURR OPIN PLANT BIOL, V13, P700, DOI 10.1016/j.pbi.2010.07.005; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; Hartati S, 2008, PLANT PHYSIOL, V147, P552, DOI 10.1104/pp.108.116970; Hayashi T, 2005, INT REV CYTOL, V247, P1, DOI 10.1016/S0074-7696(05)47001-1; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ibatullin FM, 2009, PLANT PHYSIOL, V151, P1741, DOI 10.1104/pp.109.147439; Kaida R, 2009, MOL PLANT, V2, P904, DOI 10.1093/mp/ssp060; Karczmarek A, 2008, MOL PLANT MICROBE IN, V21, P791, DOI 10.1094/MPMI-21-6-0791; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Libertini E, 2004, J MOL EVOL, V58, P506, DOI 10.1007/s00239-003-2571-x; Loopstra CA, 1998, PLANT PHYSIOL, V116, P959, DOI 10.1104/pp.116.3.959; Lopez-Casado G, 2008, CURR OPIN PLANT BIOL, V11, P329, DOI 10.1016/j.pbi.2008.02.010; Maloney VJ, 2010, PLANT BIOTECHNOL J, V8, P294, DOI 10.1111/j.1467-7652.2009.00483.x; Molhoj M, 2002, PLANT CELL PHYSIOL, V43, P1399, DOI 10.1093/pcp/pcf163; Molhoj M, 2001, PLANT PHYSIOL, V127, P674, DOI 10.1104/pp.010269; Molhoj M, 2001, PLANT MOL BIOL, V45, P93, DOI 10.1023/A:1006475908000; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Ohmiya Y, 2000, PLANT J, V24, P147, DOI 10.1046/j.1365-313x.2000.00860.x; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Park YW, 2003, PLANT J, V33, P1099, DOI 10.1046/j.1365-313X.2003.01696.x; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; Ruprecht C, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00023; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Segal L., 1959, TEXT RES J, V29, P786, DOI [DOI 10.1177/004051755902901003, 10.1177/004051755902901003]; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Takahashi J, 2009, PLANT CELL PHYSIOL, V50, P1099, DOI 10.1093/pcp/pcp062; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Team RDC, 2009, R LANG ENV STAT COMP; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urbanowicz BR, 2007, PLANT PHYSIOL, V144, P1693, DOI 10.1104/pp.107.102574; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Xie GS, 2011, J INTEGR PLANT BIOL, V53, P143, DOI 10.1111/j.1744-7909.2010.01022.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Yoshida K, 2006, PLANT CELL PHYSIOL, V47, P1541, DOI 10.1093/pcp/pcl020; Zhang JW, 2012, MOL PLANT, V5, P176, DOI 10.1093/mp/ssr084; Zhou HL, 2006, PLANT MOL BIOL, V60, P137, DOI 10.1007/s11103-005-2972-x; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	59	47	50	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e50171	10.1371/journal.pone.0050171	http://dx.doi.org/10.1371/journal.pone.0050171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308094	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100002
J	Saponaro, C; Malfettone, A; Ranieri, G; Danza, K; Simone, G; Paradiso, A; Mangia, A				Saponaro, Concetta; Malfettone, Andrea; Ranieri, Girolamo; Danza, Katia; Simone, Giovanni; Paradiso, Angelo; Mangia, Anita			VEGF, HIF-1 alpha Expression and MVD as an Angiogenic Network in Familial Breast Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MICROVESSEL DENSITY; PROGNOSTIC-SIGNIFICANCE; TUMOR ANGIOGENESIS; COLORECTAL-CANCER; BRCA1; CARCINOMA; ALPHA; HIF-1	Angiogenesis, which plays an important role in tumor growth and progression of breast cancer, is regulated by a balance between pro- and anti-angiogenic factors. Expression of vascular endothelial growth factor (VEGF) is up-regulated during hypoxia by hypoxia-inducible factor-1 alpha (HIF-1 alpha). It is known that there is an interaction between HIF-1 alpha and BRCA1 carrier cancers, but little has been reported about angiogenesis in BRCA1-2 carrier and BRCAX breast cancers. In this study, we investigated the expression of VEGF and HIF-1 alpha and microvessel density (MVD) in 26 BRCA1-2 carriers and 58 BRCAX compared to 77 sporadic breast cancers, by immunohistochemistry. VEGF expression in BRCA1-2 carriers was higher than in BRCAX cancer tissues (p = 0.0001). Furthermore, VEGF expression was higher in both BRCA1-2 carriers and BRCAX than the sporadic group (p<0.0001). VEGF immunoreactivity was correlated with poor tumor grade (p = 0.0074), hormone receptors negativity (p = 0.0206, p = 0.0002 respectively), and MIB-1-labeling index (p = 0.0044) in familial cancers (BRCA1-2 and BRCAX). The percentage of nuclear HIF-1 alpha expression was higher in the BRCA1-2 carriers than in BRCAX cancers (p<0.05), and in all familial than in sporadic tumor tissues (p = 0.0045). A higher MVD was observed in BRCA1-2 carrier than in BRCAX and sporadic cancer tissues (p = 0.002, p = 0.0001 respectively), and in all familial tumors than in sporadic tumors (p = 0.01). MVD was positively related to HIF-1 alpha expression in BRCA1-2 carriers (r = 0.521, p = 0.006), and, in particular, we observed a highly significant correlation in the familial group (r = 0.421, p<0.0001). Our findings suggest that angiogenesis plays a crucial role in BRCA1-2 carrier breast cancers. Prospective studies in larger BRCA1-2 carrier series are needed to improve the best therapeutic strategies for this subgroup of breast cancer patients.	[Saponaro, Concetta; Malfettone, Andrea; Mangia, Anita] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Funct Biomorphol Lab, Bari, Italy; [Ranieri, Girolamo] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Unit Intervent Radiol, Bari, Italy; [Danza, Katia] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Mol Genet Lab, Bari, Italy; [Simone, Giovanni] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Dept Pathol, Bari, Italy; [Paradiso, Angelo] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Sci Direct, Bari, Italy	IRCCS Istituto Tumori Bari Giovanni Paolo II; IRCCS Istituto Tumori Bari Giovanni Paolo II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Istituto Tumori Bari Giovanni Paolo II; IRCCS Istituto Tumori Bari Giovanni Paolo II; IRCCS Istituto Tumori Bari Giovanni Paolo II	Mangia, A (corresponding author), Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Funct Biomorphol Lab, Bari, Italy.	a.mangia@oncologico.bari.it	paradiso, angelo V/J-9457-2018; Ranieri, Girolamo/AAJ-7929-2020; Danza, Katia/K-3182-2018; Malfettone, Andrea/AAK-9280-2021; Saponaro, Concetta/K-7886-2018; Mangia, Anita/K-3662-2018	Ranieri, Girolamo/0000-0002-7952-694X; Danza, Katia/0000-0001-6562-9094; Saponaro, Concetta/0000-0002-8196-3583; Mangia, Anita/0000-0003-4729-0888	Progetto Strategico Regionale Puglia- APQ "le biotecnologie applicate alla targeted therapy in oncologia (Biotecnoter)''	Progetto Strategico Regionale Puglia- APQ "le biotecnologie applicate alla targeted therapy in oncologia (Biotecnoter)''	This work was partially funded by Progetto Strategico Regionale Puglia- APQ "le biotecnologie applicate alla targeted therapy in oncologia (Biotecnoter)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahlgren J, 2002, EUR J CANCER, V38, P64, DOI 10.1016/S0959-8049(01)00349-5; Ali SH, 2000, CANCER RES, V60, P7094; Bluff JE, 2009, BRIT J CANCER, V101, P666, DOI 10.1038/sj.bjc.6605196; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Cao D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-432; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carpini JD, 2010, ANGIOGENESIS, V13, P43, DOI 10.1007/s10456-010-9163-3; Chaudary Naz, 2006, Breast Dis, V26, P55; COSTELLO P, 1995, HUM PATHOL, V26, P1181, DOI 10.1016/0046-8177(95)90190-6; El-Gendi Saba, 2009, J Egypt Natl Canc Inst, V21, P139; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fernandez-Ramires R, 2011, INT J CANCER, V128, P2635, DOI 10.1002/ijc.25603; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Garzetti GG, 1999, GYNECOL ONCOL, V73, P396, DOI 10.1006/gyno.1999.5377; Gronwald J, 2005, INT J CANCER, V114, P230, DOI 10.1002/ijc.20723; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hansen S, 2000, BRIT J CANCER, V82, P339; Isobe T, 2013, INT J CLIN ONCOL, V18, P293, DOI 10.1007/s10147-012-0378-8; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; Kawai H, 2002, ONCOGENE, V21, P7730, DOI 10.1038/sj.onc.1205971; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kranz A, 1999, INT J CANCER, V84, P293, DOI 10.1002/(SICI)1097-0215(19990621)84:3<293::AID-IJC16>3.0.CO;2-T; Kuwai T, 2003, INT J CANCER, V105, P176, DOI 10.1002/ijc.11068; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Lynch BJ, 1998, HUM PATHOL, V29, P1140, DOI 10.1016/S0046-8177(98)90427-0; Mangia A, 2009, HISTOPATHOLOGY, V55, P600, DOI 10.1111/j.1365-2559.2009.03424.x; Mangia A, 2009, HISTOL HISTOPATHOL, V24, P69, DOI 10.14670/HH-24.69; Medri L, 2000, INT J CANCER, V89, P74, DOI 10.1002/(SICI)1097-0215(20000120)89:1<74::AID-IJC12>3.0.CO;2-L; Mohammed RAA, 2011, MODERN PATHOL, V24, P774, DOI 10.1038/modpathol.2011.4; Mori T, 2011, INT J GYNECOL CANCER, V21, P609, DOI 10.1097/IGC.0b013e3182017e9b; Oda Y, 2006, MODERN PATHOL, V19, P738, DOI 10.1038/modpathol.3800587; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Prager GW, 2012, HAMOSTASEOLOGIE, V32, P105, DOI 10.5482/ha-1163; Ranieri G, 2002, INT J ONCOL, V21, P1317; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Tarnowski B, 2004, BREAST CANCER RES TR, V88, P287, DOI 10.1007/s10549-004-0779-0; Tayama M, 2011, WORLD J GASTROENTERO, V17, P4867, DOI 10.3748/wjg.v17.i44.4867; Tommasi S, 2005, MUTAT RES-FUND MOL M, V578, P395, DOI 10.1016/j.mrfmmm.2005.06.010; Trinh XB, 2011, CLIN TRANSL ONCOL, V13, P805, DOI 10.1007/s12094-011-0737-3; Tsutsui Shinichi, 2003, Breast Cancer, V10, P312, DOI 10.1007/BF02967651; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; van der Groep P, 2011, CELL ONCOL, V34, P71, DOI 10.1007/s13402-011-0010-3; Vargas AC, 2011, J MAMMARY GLAND BIOL, V16, P27, DOI 10.1007/s10911-011-9204-6; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yan M, 2009, BRIT J CANCER, V101, P1168, DOI 10.1038/sj.bjc.6605287; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x	56	58	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53070	10.1371/journal.pone.0053070	http://dx.doi.org/10.1371/journal.pone.0053070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326384	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800030
J	Valencia, CA; Ankala, A; Rhodenizer, D; Bhide, S; Littlejohn, MR; Keong, LM; Rutkowski, A; Sparks, S; Bonnemann, C; Hegde, M				Valencia, C. Alexander; Ankala, Arunkanth; Rhodenizer, Devin; Bhide, Shruti; Littlejohn, Martin Robert; Keong, Lisa Mari; Rutkowski, Anne; Sparks, Susan; Bonnemann, Carsten; Hegde, Madhuri			Comprehensive Mutation Analysis for Congenital Muscular Dystrophy: A Clinical PCR-Based Enrichment and Next-Generation Sequencing Panel	PLOS ONE			English	Article							HYBRID SELECTION; CAPTURE; GENE; DIAGNOSTICS	The congenital muscular dystrophies (CMDs) comprise a heterogeneous group of heritable muscle disorders with often difficult to interpret muscle pathology, making them challenging to diagnose. Serial Sanger sequencing of suspected CMD genes, while the current molecular diagnostic method of choice, can be slow and expensive. A comprehensive panel test for simultaneous screening of mutations in all known CMD-associated genes would be a more effective diagnostic strategy. Thus, the CMDs are a model disorder group for development and validation of next-generation sequencing (NGS) strategies for diagnostic and clinical care applications. Using a highly multiplexed PCR-based target enrichment method (RainDance) in conjunction with NGS, we performed mutation detection in all CMD genes of 26 samples and compared the results with Sanger sequencing. The RainDance NGS panel showed great consistency in coverage depth, on-target efficiency, versatility of mutation detection, and genotype concordance with Sanger sequencing, demonstrating the test's appropriateness for clinical use. Compared to single tests, a higher diagnostic yield was observed by panel implementation. The panel's limitation is the amplification failure of select gene-specific exons which require Sanger sequencing for test completion. Successful validation and application of the CMD NGS panel to improve the diagnostic yield in a clinical laboratory was shown.	[Valencia, C. Alexander; Ankala, Arunkanth; Rhodenizer, Devin; Bhide, Shruti; Littlejohn, Martin Robert; Keong, Lisa Mari; Hegde, Madhuri] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Valencia, C. Alexander] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; [Valencia, C. Alexander] Univ Cincinnati, Sch Med, Dept Pediat, Cincinnati, OH USA; [Rutkowski, Anne] Cure CMD, Los Angeles, CA USA; [Rutkowski, Anne] Kaiser SCPMG, Los Angeles, CA USA; [Sparks, Susan] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Bonnemann, Carsten] NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, Neurogenet Branch, NIH, Bethesda, MD 20892 USA	Emory University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Carolinas Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hegde, M (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	mhegde@emory.edu	Ankala, Arunkanth/G-6330-2011	Ankala, Arunkanth/0000-0002-6373-9916	PHS from the Clinical and Translational Science Award Program, National Institutes of Health (NIH), National Center for Research Resources [UL1 RR025008, KL2 R0025009, TL1 RR025010]; intramural program of the National Institute of Neurological Disorders and Stroke, NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000456, UL1TR000454, KL2TR000455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025010, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129] Funding Source: NIH RePORTER	PHS from the Clinical and Translational Science Award Program, National Institutes of Health (NIH), National Center for Research Resources; intramural program of the National Institute of Neurological Disorders and Stroke, NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by PHS Grants (UL1 RR025008, KL2 R0025009, or TL1 RR025010) from the Clinical and Translational Science Award Program, National Institutes of Health (NIH), National Center for Research Resources. CB is supported by the intramural program of the National Institute of Neurological Disorders and Stroke, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clement EM, 2012, NEUROMUSCULAR DISORD, V22, P522, DOI 10.1016/j.nmd.2012.01.010; Daiger SP, 2010, ADV EXP MED BIOL, V664, P325, DOI 10.1007/978-1-4419-1399-9_37; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goossens D, 2009, HUM MUTAT, V30, P472, DOI 10.1002/humu.20873; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; Hu Hao, 2009, Hugo J, V3, P41, DOI 10.1007/s11568-010-9137-y; Kirkness EF, 2009, NAT BIOTECHNOL, V27, P998, DOI 10.1038/nbt1109-998; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; Mendell JR, 2006, PEDIATR DEVEL PATHOL, V9, P427, DOI 10.2350/06-07-0127.1; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nikolaev SI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006659; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Reed UC, 2009, ARQ NEURO-PSIQUIAT, V67, P343, DOI 10.1590/S0004-282X2009000200035; Reed UC, 2009, ARQ NEURO-PSIQUIAT, V67, P144, DOI 10.1590/S0004-282X2009000100038; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Schessl Joachim, 2006, Semin Pediatr Neurol, V13, P80, DOI 10.1016/j.spen.2006.06.003; ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Valencia CA, 2012, J MOL DIAGN, V14, P233, DOI 10.1016/j.jmoldx.2012.01.009; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Volpi L, 2010, AM J HUM GENET, V86, P72, DOI 10.1016/j.ajhg.2009.11.014	33	56	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53083	10.1371/journal.pone.0053083	http://dx.doi.org/10.1371/journal.pone.0053083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326386	Green Published, gold			2022-12-27	WOS:000314705800032
J	Xie, F; Zhang, YH; Li, G; Zhou, L; Liu, SG; Wang, CL				Xie, Fang; Zhang, Yanhe; Li, Gang; Zhou, Long; Liu, Siguo; Wang, Chunlai			The ClpP Protease Is Required for the Stress Tolerance and Biofilm Formation in Actinobacillus pleuropneumoniae	PLOS ONE			English	Article							ATP-DEPENDENT PROTEASE; VIRULENCE FACTORS; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; MULTIPLE; SYSTEM; PATHOGENESIS; DEGRADATION; EXPRESSION; DELETIONS	In the respiratory tract and lung tissue, a balanced physiological response is essential for Actinobacillus pleuropneumoniae to survive various types of challenges. ClpP, the catalytic core of the Clp proteolytic complex, is involved in various stresses response and regulation of biofilm formation in many pathogenic bacteria. To investigate the role of ClpP in the virulence of A. pleuropneumoniae, the clpP gene was deleted by homologous recombination, resulting in the mutant strain S8 Delta clpP. The reduced growth of S8 Delta clpP mutant at high temperatures and under several other stress conditions suggests that the ClpP protein is required for the stress tolerance of A. pleuropneumoniae. Interestingly, we observed that the S8 Delta clpP mutant exhibited an increased ability to take up iron in vitro compared to the wild-type strain. We also found that the cells without ClpP displayed rough and irregular surfaces and increased cell volume relative to the wild-type strain using scanning electron microscopy (SEM). Confocal laser scanning microscopy (CLSM) revealed that the S8 Delta clpP mutant showed decreased biofilm formation compared to the wild-type strain. We examined the transcriptional profiles of the wild type S8 and the S8 Delta clpP mutant strains of A. pleuropneumoniae using RNA sequencing. Our analysis revealed that the expression of 16 genes was changed by the deletion of the clpP gene. The data presented in this study illustrate the important role of ClpP protease in the stress response, iron acquisition, cell morphology and biofilm formation related to A. pleuropneumoniae and further suggest a putative role of ClpP protease in virulence regulation.	[Xie, Fang; Zhang, Yanhe; Li, Gang; Zhou, Long; Liu, Siguo; Wang, Chunlai] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, CL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	chunlai.w@hvri.ac.cn		Xie, Fang/0000-0003-2041-2208	National Natural Science Foundation of China [31100103]; National High Technology Research and Development Program of China [2011AA10A210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (No. 31100103, http://www.nsfc.gov.cn) and the National High Technology Research and Development Program of China (No. 2011AA10A210, http://www.863.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baltes N, 2003, FEMS MICROBIOL LETT, V220, P41, DOI 10.1016/S0378-1097(03)00064-8; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Buettner FFR, 2008, VET MICROBIOL, V127, P106, DOI 10.1016/j.vetmic.2007.08.005; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Chiers K, 1998, VET QUART, V20, P65, DOI 10.1080/01652176.1998.9694841; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997; Deslandes V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-72; FENWICK B, 1994, J AM VET MED ASSOC, V204, P1334; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Gaillot O, 2000, MOL MICROBIOL, V35, P1286, DOI 10.1046/j.1365-2958.2000.01773.x; Haesebrouck F, 1997, VET MICROBIOL, V58, P239, DOI 10.1016/S0378-1135(97)00162-4; Hasona A, 2007, J BACTERIOL, V189, P1219, DOI 10.1128/JB.01146-06; HWANG BJ, 1987, P NATL ACAD SCI USA, V84, P5550, DOI 10.1073/pnas.84.16.5550; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Jackson MW, 2004, MOL MICROBIOL, V54, P1364, DOI 10.1111/j.1365-2958.2004.04353.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaplan JB, 2005, VET MICROBIOL, V108, P89, DOI 10.1016/j.vetmic.2005.02.011; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Lemos JAC, 2002, J BACTERIOL, V184, P6357, DOI 10.1128/JB.184.22.6357-6366.2002; Li L, 2008, MICROB PATHOGENESIS, V45, P192, DOI 10.1016/j.micpath.2008.05.008; Loughlin MF, 2009, MICROB PATHOGENESIS, V46, P53, DOI 10.1016/j.micpath.2008.10.004; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oswald W, 1999, FEMS MICROBIOL LETT, V179, P153, DOI 10.1111/j.1574-6968.1999.tb08721.x; Pruteanu M, 2009, MOL MICROBIOL, V71, P912, DOI 10.1111/j.1365-2958.2008.06574.x; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Roy S, 2012, FEMS IMMUNOL MED MIC, V65, P116, DOI 10.1111/j.1574-695X.2012.00933.x; Rycroft AN, 2000, VET J, V159, P18, DOI 10.1053/tvjl.1999.0403; SENANAYAKE SD, 1995, MOL BIOTECHNOL, V4, P13, DOI 10.1007/BF02907467; Thomsen LE, 2002, MICROBIOL-SGM, V148, P2727, DOI 10.1099/00221287-148-9-2727; Wang CZ, 2007, MICROBES INFECT, V9, P1376, DOI 10.1016/j.micinf.2007.06.012; WILLSON PJ, 1989, ANTIMICROB AGENTS CH, V33, P1627, DOI 10.1128/AAC.33.9.1627	39	37	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53600	10.1371/journal.pone.0053600	http://dx.doi.org/10.1371/journal.pone.0053600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326465	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800059
J	Fu, MQ; Lin, LJ; Kong, XX; Zhao, WD; Tang, L; Li, JY; Ouyang, J				Fu, Maoqing; Lin, Lijun; Kong, Xiangxue; Zhao, Weidong; Tang, Lei; Li, Jianyi; Ouyang, Jun			Construction and Accuracy Assessment of Patient-Specific Biocompatible Drill Template for Cervical Anterior Transpedicular Screw (ATPS) Insertion: An In Vitro Study	PLOS ONE			English	Article							GLASS-IONOMER CEMENTS; PEDICLE SCREW; BONE-CEMENT; PLACEMENT; SPINE; FIXATION; CORPECTOMY; RECONSTRUCTION; FEASIBILITY; STABILITY	Background: With the properties of three-column fixation and anterior-approach-only procedure, anterior transpedicular screw (ATPS) is ideal for severe multilevel traumatic cervical instabilities. However, the accurate insertion of ATPS remains challenging. Here we constructed a patient-specific biocompatible drill template and evaluated its accuracy in assisting ATPS insertion. Methods: After ethical approval, 24 formalin-preserved cervical vertebrae (C2-C7) were CT scanned. 3D reconstruction models of cervical vertebra were obtained with 2-mm-diameter virtual pin tracts at the central pedicles. The 3D models were used for rapid prototyping (RP) printing. A 2-mm-diameter Kirschner wire was then inserted into the pin tract of the RP model before polymethylmethacrylate was used to construct the patient-specific biocompatible drill template. After removal of the anterior soft tissue, a 2-mm-diameter Kirschner wire was inserted into the cervical pedicle with the assistance of drill template. Cadaveric cervical spines with pin tracts were subsequently scanned using the same CT scanner. A 3D reconstruction was performed of the scanned spines to get 3D models of the vertebrae containing the actual pin tracts. The deviations were calculated between 3D models with virtual and actual pin tracts at the middle point of the cervical pedicle. 3D models of 3.5 mm-diameter screws were used in simulated insertion to grade the screw positions. Findings: The patient-specific biocompatible drill template was constructed to assist ATPS insertion successfully. There were no significant differences between medial/lateral deviations (P=0.797) or between superior/inferior deviations (P=0.741). The absolute deviation values were 0.82 +/- 0.75 mm and 1.10 +/- 0.96 mm in axial and sagittal planes, respectively. In the simulated insertion, the screws in non-critical position were 44/48 (91.7%). Conclusions: The patient-specific drill template is biocompatible, easy-to-apply and accurate in assisting ATPS insertion. Its clinical applications should be further researched.	[Fu, Maoqing; Kong, Xiangxue; Zhao, Weidong; Tang, Lei; Li, Jianyi; Ouyang, Jun] So Med Univ, Sch Basic Med Sci, Dept Anat, Guangdong Prov Key Lab Med Biomech, Guangzhou, Guangdong, Peoples R China; [Lin, Lijun] So Med Univ, Zhujiang Hosp, Dept Orthoped, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Li, JY (corresponding author), So Med Univ, Sch Basic Med Sci, Dept Anat, Guangdong Prov Key Lab Med Biomech, Guangzhou, Guangdong, Peoples R China.	wuxili74@126.com			National Natural Science Foundation of China [6110920, 6110922, 6110923]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Projects 6110920, 6110922 and 6110923 were supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta FL, 2008, J SPINAL DISORD TECH, V21, P165, DOI 10.1097/BSD.0b013e3180654205; Aramomi M, 2008, ACTA NEUROCHIR, V150, P575, DOI 10.1007/s00701-008-1574-1; Berry E, 2005, P I MECH ENG H, V219, P111, DOI 10.1243/095441105X9273; Bozkus H, 2005, SPINE, V30, P915, DOI 10.1097/01.brs.0000158949.37281.d7; Brazenor GA, 2007, SPINE, V32, P63, DOI 10.1097/01.brs.0000250304.24001.24; Fallah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043407; Fraser JF, 2002, SPINE, V27, P675, DOI 10.1097/00007632-200204010-00002; Gelalis ID, 2012, EUR SPINE J, V21, P247, DOI 10.1007/s00586-011-2011-3; GERHART TN, 1988, J ORTHOPAED RES, V6, P585, DOI 10.1002/jor.1100060417; Henriques T, 2004, J SPINAL DISORD TECH, V17, P1, DOI 10.1097/00024720-200402000-00002; Ishikawa Y, 2010, J NEUROSURG-SPINE, V13, P606, DOI 10.3171/2010.5.SPINE09993; Jones EL, 1997, SPINE, V22, P977, DOI 10.1097/00007632-199705010-00009; Kim SM, 2004, J NEUROSURG-SPINE, V1, P108, DOI 10.3171/spi.2004.1.1.0108; Koller H, 2008, EUR SPINE J, V17, P523, DOI 10.1007/s00586-007-0572-y; Koller H, 2008, EUR SPINE J, V17, P539, DOI 10.1007/s00586-007-0573-x; Koller H, 2007, EUR SPINE J, V16, P2055, DOI 10.1007/s00586-007-0398-7; Koller H, 2009, EUR SPINE J, V18, P1300, DOI 10.1007/s00586-009-1054-1; Lu GH, 2009, CHIN J TRAUMATOL, V12, P148, DOI 10.3760/cma.j.issn.1008-1275.2009.03.005; Lu S, 2012, MED BIOL ENG COMPUT, V50, P751, DOI 10.1007/s11517-012-0900-1; Lu S, 2011, COMPUT AIDED SURG, V16, P240, DOI 10.3109/10929088.2011.605173; Lu S, 2009, CHIN J TRAUMATOL, V12, P173, DOI 10.3760/cma.j.issn.1008-1275.2009.03.011; Lu S, 2009, SPINE, V34, pE959, DOI 10.1097/BRS.0b013e3181c09985; Lu S, 2009, EUR SPINE J, V18, P1379, DOI 10.1007/s00586-009-1051-4; Lu S, 2009, INT J MED ROBOT COMP, V5, P184, DOI 10.1002/rcs.249; Lye KW, 2011, CLIN ORAL IMPLANTS R; Mac-Thiong JM, 2003, EUR SPINE J, V12, P542, DOI 10.1007/s00586-003-0549-4; Nicholson JW, 2008, DENT MATER, V24, P1702, DOI 10.1016/j.dental.2008.04.005; Ohnari Hiroyuki, 2006, Spine J, V6, P221, DOI 10.1016/j.spinee.2005.10.014; Ormsby R, 2012, ACTA BIOMATER, V8, P1201, DOI 10.1016/j.actbio.2011.10.010; Owen BD, 2007, COMPUT AIDED SURG, V12, P303, DOI 10.1080/10929080701662826; Ponnusamy KE, 2011, SPINE J, V11, P54, DOI 10.1016/j.spinee.2010.09.024; Radermacher K, 1998, CLIN ORTHOP RELAT R, P28; Rao RD, 2006, J BONE JOINT SURG AM, V88A, P1619, DOI 10.2106/JBJS.F.00014; Richter M, 2005, SPINE, V30, P2280, DOI 10.1097/01.brs.0000182275.31425.cd; Schmidt R, 2005, EUR SPINE J, V14, P372, DOI 10.1007/s00586-004-0763-8; Souza PPC, 2006, DENT MATER, V22, P838, DOI 10.1016/j.dental.2005.10.002; Tomasino A, 2010, J NEUROSURG-SPINE, V13, P52, DOI 10.3171/2010.3.SPINE09231; Wang CS, 2011, CHIN J TRAUMATOL, V14, P137, DOI 10.3760/cma.j.issn.1008-1275.2011.03.002; Yang BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035032; Yu DK, 2008, J KOREAN NEUROSURG S, V44, P303, DOI 10.3340/jkns.2008.44.5.303; Yukawa Y, 2009, EUR SPINE J, V18, P911, DOI 10.1007/s00586-009-0949-1	41	37	62	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53580	10.1371/journal.pone.0053580	http://dx.doi.org/10.1371/journal.pone.0053580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326461	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400029
J	Kajita, Y; Kato, T; Tamaki, S; Furu, M; Takahashi, R; Nagayama, S; Aoyama, T; Nishiyama, H; Nakamura, E; Katagiri, T; Nakamura, Y; Ogawa, O; Toguchida, J				Kajita, Yoichiro; Kato, Tomohisa, Jr.; Tamaki, Sakura; Furu, Moritoshi; Takahashi, Ryo; Nagayama, Satoshi; Aoyama, Tomoki; Nishiyama, Hiroyuki; Nakamura, Eijiro; Katagiri, Toyomasa; Nakamura, Yusuke; Ogawa, Osamu; Toguchida, Junya			The Transcription Factor Sp3 Regulates the Expression of a Metastasis-Related Marker of Sarcoma, Actin Filament-Associated Protein 1-Like 1 (AFAP1L1)	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; BINDING; PROMOTER; FAMILY; IDENTIFICATION; SURVIVAL	We previously identified actin filament-associated protein 1-like 1 (AFAP1L1) as a metastasis-predicting marker from the gene-expression profiles of 65 spindle cell sarcomas, and demonstrated the up-regulation of AFAP1L1 expression to be an independent risk factor for distant metastasis in multivariate analyses. Little is known, however, about how the expression of AFAP1L1 is regulated. Luciferase reporter assays showed tandem binding motives of a specificity protein (Sp) located at -85 to -75 relative to the transcriptional start site to be essential to the promoter activity. Overexpression of Sp1 and Sp3 proteins transactivated the proximal AFAP1L1 promoter construct, and electrophoretic mobility shift assays showed that both Sp1 and Sp3 were able to bind to this region in vitro. Chromatin immunoprecipitation experiments, however, revealed that Sp3 is the major factor binding to the proximal promoter region of the AFAP1L1 gene in AFAP1L1- positive cells. Treatment with mithramycin A, an inhibitor of proteins binding to GC-rich regions, prevented Sp3 from binding to the proximal promoter region of AFAP1L1 and decreased its expression in a dose-dependent manner. Finally, knocking down Sp3 using small inhibitory RNA duplex (siRNA) reduced AFAP1L1 expression significantly, which was partially restored by expressing siRNA-resistant Sp3. These findings indicate a novel role for Sp3 in sarcomas as a driver for expression of the metastasis-related gene AFAP1L1.	[Kajita, Yoichiro; Kato, Tomohisa, Jr.; Tamaki, Sakura; Furu, Moritoshi; Aoyama, Tomoki; Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan; [Kajita, Yoichiro; Nishiyama, Hiroyuki; Nakamura, Eijiro; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Furu, Moritoshi; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Takahashi, Ryo; Nagayama, Satoshi] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Katagiri, Toyomasa; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Toguchida, Junya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; University of Tokyo; Kyoto University	Toguchida, J (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan.	togjun@frontier.kyoto-u.ac.jp		Kato, Tomohisa/0000-0002-3047-9847	Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [24659133, 23592330] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Aoyama T, 2008, BIOCHEM BIOPH RES CO, V365, P124, DOI 10.1016/j.bbrc.2007.10.135; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chiefari E, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-35; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Essafi-Benkhadir K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004478; FLYNN DC, 1993, MOL CELL BIOL, V13, P7892, DOI 10.1128/MCB.13.12.7892; Furu M, 2011, ONCOGENE, V30, P4015, DOI 10.1038/onc.2011.108; Giatzakis C, 2007, BIOCHEMISTRY-US, V46, P4763, DOI 10.1021/bi062208o; Hosoi Y, 2004, INT J ONCOL, V25, P461; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kato T, 2008, GENES CELLS, V13, P509, DOI 10.1111/j.1365-2443.2008.01182.x; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Kohno Y, 2006, J BIOL CHEM, V281, P38941, DOI 10.1074/jbc.M608389200; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Shirasaki F, 1999, ONCOGENE, V18, P7755, DOI 10.1038/sj.onc.1203360; Snyder BN, 2011, EUR J CELL BIOL, V90, P376, DOI 10.1016/j.ejcb.2010.11.016; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Wang LW, 2003, CLIN CANCER RES, V9, P6371; WRIGHT C, 1987, J PATHOL, V153, P325, DOI 10.1002/path.1711530406; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yu B, 2003, NUCLEIC ACIDS RES, V31, P5368, DOI 10.1093/nar/gkg706	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e49709	10.1371/journal.pone.0049709	http://dx.doi.org/10.1371/journal.pone.0049709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326307	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500003
J	Oudman, I; Clark, JF; Brewster, LM				Oudman, Inge; Clark, Joseph F.; Brewster, Lizzy M.			The Effect of the Creatine Analogue Beta-guanidinopropionic Acid on Energy Metabolism: A Systematic Review	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; ACTIVATED PROTEIN-KINASE; NEUTROPHIL SUPEROXIDE-PRODUCTION; AND/OR HINDLIMB SUSPENSION; EXTENSOR DIGITORUM LONGUS; LEFT-VENTRICULAR FUNCTION; GUANIDINE PROPIONIC-ACID; ASCITES TUMOR-CELLS; FAST-TWITCH MUSCLE; RED-BLOOD-CELLS	Background: Creatine kinase plays a key role in cellular energy transport. The enzyme transfers high-energy phosphoryl groups from mitochondria to subcellular sites of ATP hydrolysis, where it buffers ADP concentration by catalyzing the reversible transfer of the high-energy phosphate moiety (P) between creatine and ADP. Cellular creatine uptake is competitively inhibited by beta-guanidinopropionic acid. This substance is marked as safe for human use, but the effects are unclear. Therefore, we systematically reviewed the effect of beta-guanidinopropionic acid on energy metabolism and function of tissues with high energy demands. Methods: We performed a systematic review and searched the electronic databases Pubmed, EMBASE, the Cochrane Library, and LILACS from their inception through March 2011. Furthermore, we searched the internet and explored references from textbooks and reviews. Results: After applying the inclusion criteria, we retrieved 131 publications, mainly considering the effect of chronic oral administration of beta-guanidinopropionic acid (0.5 to 3.5%) on skeletal muscle, the cardiovascular system, and brain tissue in animals. Beta-guanidinopropionic acid decreased intracellular creatine and phosphocreatine in all tissues studied. In skeletal muscle, this effect induced a shift from glycolytic to oxidative metabolism, increased cellular glucose uptake and increased fatigue tolerance. In heart tissue this shift to mitochondrial metabolism was less pronounced. Myocardial contractility was modestly reduced, including a decreased ventricular developed pressure, albeit with unchanged cardiac output. In brain tissue adaptations in energy metabolism resulted in enhanced ATP stability and survival during hypoxia. Conclusion: Chronic beta-guanidinopropionic acid increases fatigue tolerance of skeletal muscle and survival during ischaemia in animal studies, with modestly reduced myocardial contractility. Because it is marked as safe for human use, there is a need for human data.	[Oudman, Inge; Brewster, Lizzy M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Clark, Joseph F.] Univ Cincinnati, Dept Neurol, Cincinnati, OH USA; [Brewster, Lizzy M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University System of Ohio; University of Cincinnati; University of Amsterdam; Academic Medical Center Amsterdam	Oudman, I (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	i.oudman@amc.nl	Brewster, Lizzy M/K-7675-2019	Brewster, Lizzy M/0000-0002-7434-0038	Netherlands Organisation for Scientific Research (NWO) [916.10.156]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	LMB is a recipient of a VENI fellowship (grant number 916.10.156) awarded by the Netherlands Organisation for Scientific Research (NWO) as part of its Innovational Research Incentives Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou MJ, 1992, AM J PHYSIOL, V262, pR684; ADAMS GR, 1994, J APPL PHYSIOL, V77, P1198, DOI 10.1152/jappl.1994.77.3.1198; ADAMS GR, 1995, J APPL PHYSIOL, V79, P1002, DOI 10.1152/jappl.1995.79.3.1002; ADAMS GR, 1995, J APPL PHYSIOL, V78, P368, DOI 10.1152/jappl.1995.78.1.368; Ara G, 1998, IN VIVO, V12, P223; ARCHER SL, 1989, LIFE SCI, V45, P1081, DOI 10.1016/0024-3205(89)90165-3; Baggish AL, 2008, AM J PHYSIOL-HEART C, V295, pH1109, DOI 10.1152/ajpheart.00395.2008; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Boehm E, 2003, AM J PHYSIOL-ENDOC M, V284, pE399, DOI 10.1152/ajpendo.00259.2002; Boehm EA, 1996, BBA-BIOENERGETICS, V1274, P119, DOI 10.1016/0005-2728(96)00018-7; BOEHM EA, 1995, AM J PHYSIOL-CELL PH, V268, pC628, DOI 10.1152/ajpcell.1995.268.3.C628; Braissant O, 2011, AMINO ACIDS, V40, P1315, DOI 10.1007/s00726-011-0852-z; Brewster LM, 2000, J HYPERTENS, V18, P1537, DOI 10.1097/00004872-200018110-00002; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; CHEVLI R, 1979, BIOCHEM MED METAB B, V21, P162, DOI 10.1016/0006-2944(79)90068-1; CLARK JF, 1994, BIOCHEM J, V300, P211, DOI 10.1042/bj3000211; DEFALCO AJ, 1961, J NEUROCHEM, V7, P308, DOI 10.1111/j.1471-4159.1961.tb13518.x; DETATA V, 1989, ARCH INT PHYSIOL BIO, V97, P123, DOI 10.3109/13813458909075056; DETATA V, 1993, INT J EXP PATHOL, V74, P501; Dzeja PP, 1996, J BIOL CHEM, V271, P12847, DOI 10.1074/jbc.271.22.12847; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Ecochard L, 2004, ACTA PHYSIOL SCAND, V180, P71, DOI 10.1046/j.0001-6772.2003.01184.x; Eijnde BO, 2004, MUSCLE NERVE, V29, P428, DOI 10.1002/mus.10568; EKMEHAG BL, 1988, ACTA PHYSIOL SCAND, V133, P525, DOI 10.1111/j.1748-1716.1988.tb08437.x; EPPENBERGEREBERHARDT M, 1991, J CELL BIOL, V113, P289, DOI 10.1083/jcb.113.2.289; FIELD ML, 1991, BIOCHEM SOC T, V19, pS208, DOI 10.1042/bst019208s; FITCH CD, 1978, LIFE SCI, V23, P1285, DOI 10.1016/0024-3205(78)90507-6; FITCH CD, 1968, J BIOL CHEM, V243, P2024; FITCH CD, 1974, J BIOL CHEM, V249, P1060; FITCH CD, 1975, AM J PHYSIOL, V228, P1123, DOI 10.1152/ajplegacy.1975.228.4.1123; FOLEY JM, 1994, AM J PHYSIOL-CELL PH, V267, pC1177, DOI 10.1152/ajpcell.1994.267.5.C1177; FREYSSENET D, 1995, BBA-BIOENERGETICS, V1228, P211, DOI 10.1016/0005-2728(94)00177-7; FREYSSENET D, 1994, BBA-BIOENERGETICS, V1186, P232, DOI 10.1016/0005-2728(94)90182-1; Gagnon M, 2002, CLIN EXP PHARMACOL P, V29, P885, DOI 10.1046/j.1440-1681.2002.03745.x; GAINES G, 1987, J BIOL CHEM, V262, P1907; Galbraith RA, 2006, BRAIN RES, V1101, P85, DOI 10.1016/j.brainres.2006.05.032; Garcia-Delgado M, 2007, BBA-BIOMEMBRANES, V1768, P2841, DOI 10.1016/j.bbamem.2007.07.022; Garcia-Delgado M, 2001, J AM SOC NEPHROL, V12, P1819, DOI 10.1681/ASN.V1291819; GIOVANNETTI S, 1968, CLIN SCI, V34, P141; GORI Z, 1988, BRIT J EXP PATHOL, V69, P639; Gorman MW, 1997, AM J PHYSIOL-HEART C, V272, pH913, DOI 10.1152/ajpheart.1997.272.2.H913; Gorselink M, 2001, AM J PHYSIOL-ENDOC M, V281, pE619, DOI 10.1152/ajpendo.2001.281.3.E619; Hardie DG, 2011, BIOCHEM SOC T, V39, P1, DOI 10.1042/BST0390001; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Hirayama A, 2001, KIDNEY INT, V59, pS89, DOI 10.1046/j.1523-1755.2001.59780089.x; Hirayama A, 2000, J AM SOC NEPHROL, V11, P684, DOI 10.1681/ASN.V114684; Holtzman D, 1997, AM J PHYSIOL-CELL PH, V272, pC1567, DOI 10.1152/ajpcell.1997.272.5.C1567; HOLTZMAN D, 1989, BRAIN RES, V483, P68, DOI 10.1016/0006-8993(89)90035-8; Holtzman D, 1998, DEV NEUROSCI-BASEL, V20, P469, DOI 10.1159/000017345; Horn M, 2001, CIRCULATION, V104, P1844, DOI 10.1161/hc3901.095933; Horvath TL, 2011, NEUROBIOL DIS, V43, P152, DOI 10.1016/j.nbd.2011.03.005; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Ingwall JS, 1998, MAGN RESON MATER PHY, V6, P120; Kaasik A, 2003, FASEB J, V17, DOI 10.1096/fj.02-0684fje; KAMOUN PP, 1981, NEPHRON, V28, P26, DOI 10.1159/000182089; KAPELKO VI, 1989, J MOL CELL CARDIOL, V21, P79, DOI 10.1016/0022-2828(89)90840-7; KAPELKO VI, 1988, J MOL CELL CARDIOL, V20, P465, DOI 10.1016/S0022-2828(88)80074-9; Kim DW, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-141; KORECKY B, 1987, BASIC RES CARDIOL, V82, P103; KRAEMER WJ, 1995, J APPL PHYSIOL, V78, P976, DOI 10.1152/jappl.1995.78.3.976; KU CP, 1980, BIOCHIM BIOPHYS ACTA, V600, P212, DOI 10.1016/0005-2736(80)90426-5; Kuiper JWP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-73; KUPRIYANOV VV, 1987, BIOMED BIOCHIM ACTA, V46, pS493; LAI MM, 1990, J APPL PHYSIOL, V69, P843, DOI 10.1152/jappl.1990.69.3.843; Lara TM, 1998, ARCH SURG-CHICAGO, V133, P1316, DOI 10.1001/archsurg.133.12.1316; Levine S, 1996, AM J PHYSIOL-CELL PH, V271, pC1480, DOI 10.1152/ajpcell.1996.271.5.C1480; Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9; Lindbom M, 2008, J CARD FAIL, V14, P161, DOI 10.1016/j.cardfail.2007.10.020; Lorentzon M, 2007, J CARD FAIL, V13, P230, DOI 10.1016/j.cardfail.2006.11.012; Lunardi G, 2006, NEUROSCIENCE, V142, P991, DOI 10.1016/j.neuroscience.2006.06.058; MAHANNA DA, 1980, EXP NEUROL, V68, P114, DOI 10.1016/0014-4886(80)90070-9; Mainwood G W, 1986, Adv Exp Med Biol, V194, P519; MAINWOOD GW, 1982, CAN J PHYSIOL PHARM, V60, P114, DOI 10.1139/y82-019; MAINWOOD GW, 1982, CAN J PHYSIOL PHARM, V60, P120, DOI 10.1139/y82-020; MCKEE EE, 1990, AM J PHYSIOL, V258, pE503, DOI 10.1152/ajpendo.1990.258.3.E503; MEGLASSON MD, 1993, J PHARMACOL EXP THER, V266, P1454; MEKHFI H, 1990, AM J PHYSIOL, V258, pH1151, DOI 10.1152/ajpheart.1990.258.4.H1151; Metzner L, 2009, MOL PHARMACEUT, V6, P1006, DOI 10.1021/mp9000684; MEYER RA, 1989, AM J PHYSIOL, V257, pC1149, DOI 10.1152/ajpcell.1989.257.6.C1149; MEYER RA, 1986, AM J PHYSIOL, V250, pC264, DOI 10.1152/ajpcell.1986.250.2.C264; MOERLAND TS, 1989, AM J PHYSIOL, V257, pC810, DOI 10.1152/ajpcell.1989.257.4.C810; MOERLAND TS, 1994, AM J PHYSIOL, V267, pC127, DOI 10.1152/ajpcell.1994.267.1.C127; Mukhina A M, 2008, Aviakosm Ekolog Med, V42, P35; Murias JM, 2010, J APPL PHYSIOL, V108, P621, DOI 10.1152/japplphysiol.01152.2009; Nasledov G A, 1996, J Gravit Physiol, V3, P11; Nemirovskaia T L, 2000, Tsitologiia, V42, P79; Neubauer S, 1999, J MOL CELL CARDIOL, V31, P1845, DOI 10.1006/jmcc.1999.1016; Neubauer S, 1998, MAGN RESON MATER PHY, V6, P126; Nomura A, 2003, BRIT J PHARMACOL, V139, P715, DOI 10.1038/sj.bjp.0705316; OGorman E, 1996, BBA-BIOENERGETICS, V1276, P161, DOI 10.1016/0005-2728(96)00074-6; OGorman E, 1997, J CELL SCI, V110, P1403; Ohira Y, 2003, JPN J PHYSIOL, V53, P389, DOI 10.2170/jjphysiol.53.389; OHIRA Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P117, DOI 10.1016/0925-4439(91)90094-P; OHIRA Y, 1994, JPN J PHYSIOL, V44, P391, DOI 10.2170/jjphysiol.44.391; OHIRA Y, 1988, JPN J PHYSIOL, V38, P159, DOI 10.2170/jjphysiol.38.159; OHIRA Y, 1995, BBA-GEN SUBJECTS, V1243, P367, DOI 10.1016/0304-4165(94)00161-P; OTTEN JV, 1986, METABOLISM, V35, P481, DOI 10.1016/0026-0495(86)90001-6; Pandke KE, 2008, AM J PHYSIOL-REG I, V295, pR806, DOI 10.1152/ajpregu.90540.2008; Pelouch V, 1996, MOL CELL BIOCHEM, V164, P67, DOI 10.1007/BF00408642; Peral MJ, 2010, NEUROSCIENCE, V165, P53, DOI 10.1016/j.neuroscience.2009.10.001; PETROFSKY JS, 1980, PFLUG ARCH EUR J PHY, V384, P123, DOI 10.1007/BF00584427; REN JM, 1993, AM J PHYSIOL, V264, pC146, DOI 10.1152/ajpcell.1993.264.1.C146; REN JM, 1992, J APPL PHYSIOL, V73, P2713, DOI 10.1152/jappl.1992.73.6.2713; REN JM, 1995, PFLUG ARCH EUR J PHY, V430, P389, DOI 10.1007/BF00373914; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rimbaud S, 2009, J MOL CELL CARDIOL, V46, P952, DOI 10.1016/j.yjmcc.2009.01.013; Robinson DM, 2002, CLIN EXP PHARMACOL P, V29, P1105, DOI 10.1046/j.1440-1681.2002.03782.x; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Roussel D, 2000, BIOCHEM J, V350, P547, DOI 10.1042/0264-6021:3500547; Rush JWE, 1998, AM J PHYSIOL-CELL PH, V274, pC465, DOI 10.1152/ajpcell.1998.274.2.C465; Saks Valdur, 2007, V46, P27; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; SCHAUB MC, 1989, BIOMED BIOCHIM ACTA, V48, pS306; Schluter KD, 1998, J MOL CELL CARDIOL, V30, P763, DOI 10.1006/jmcc.1998.0640; Shainkin R, 1975, KIDNEY INT, V3, P302; SHAINKINKESTENBAUM R, 1986, NEPHRON, V44, P295, DOI 10.1159/000184009; SHAINKINKESTENBAUM R, 1982, NEPHRON, V31, P20, DOI 10.1159/000182603; SHIELDS RP, 1975, LAB INVEST, V33, P151; SHIELDS RP, 1973, CAN J BIOCHEM CELL B, V51, P1046, DOI 10.1139/o73-136; SHOUBRIDGE EA, 1985, BIOCHEM J, V232, P125, DOI 10.1042/bj2320125; SHOUBRIDGE EA, 1985, BIOCHIM BIOPHYS ACTA, V847, P25, DOI 10.1016/0167-4889(85)90148-X; SHOUBRIDGE EA, 1984, BIOCHIM BIOPHYS ACTA, V805, P79, DOI 10.1016/0167-4889(84)90039-9; Siu PM, 2003, J APPL PHYSIOL, V94, P555, DOI 10.1152/japplphysiol.00821.2002; Sun G, 2002, METABOLISM, V51, P451, DOI 10.1053/meta.2002.31324; SWEENEY HL, 1994, MED SCI SPORT EXER, V26, P30; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; TAKEKURA H, 1989, JPN J PHYSIOL, V39, P497, DOI 10.2170/jjphysiol.39.497; Tanaka T, 1997, J APPL PHYSIOL, V82, P1911, DOI 10.1152/jappl.1997.82.6.1911; Trappe S, 2006, J APPL PHYSIOL, V101, P721, DOI 10.1152/japplphysiol.01595.2005; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Tullson PC, 1996, AM J PHYSIOL-CELL PH, V270, pC76, DOI 10.1152/ajpcell.1996.270.1.C76; UNITT JF, 1990, BIOCHEM SOC T, V18, P606, DOI 10.1042/bst0180606; UNITT JF, 1993, BIOCHIM BIOPHYS ACTA, V1143, P91, DOI 10.1016/0005-2728(93)90220-A; Vaarmann A, 2008, BBA-BIOENERGETICS, V1777, P39, DOI 10.1016/j.bbabio.2007.11.003; VANDEURSEN J, 1994, BBA-BIOENERGETICS, V1185, P327, DOI 10.1016/0005-2728(94)90248-8; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; Ventura-Clapier R, 2004, MOL CELL BIOCHEM, V256, P29, DOI 10.1023/B:MCBI.0000009857.69730.97; WADE AJ, 1990, LANCET, V335, P805, DOI 10.1016/0140-6736(90)90933-V; WAKATSUKI T, 1994, JPN J PHYSIOL, V44, P193, DOI 10.2170/jjphysiol.44.193; Wakatsuki T, 1996, JPN J PHYSIOL, V46, P171, DOI 10.2170/jjphysiol.46.171; Wakatsuki T, 1995, JPN J PHYSIOL, V45, P979, DOI 10.2170/jjphysiol.45.979; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; Wallimann T, 1998, BIOFACTORS, V8, P229, DOI 10.1002/biof.5520080310; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Widrick JJ, 1996, AM J PHYSIOL-CELL PH, V271, pC666, DOI 10.1152/ajpcell.1996.271.2.C666; Wiesner RJ, 1999, J BIOENERG BIOMEMBR, V31, P559, DOI 10.1023/A:1005417011436; Williams DB, 2009, AM J PHYSIOL-ENDOC M, V296, pE1400, DOI 10.1152/ajpendo.90913.2008; Winder WW, 2006, MED SCI SPORT EXER, V38, P1945, DOI 10.1249/01.mss.0000233798.62153.50; YAMASHITA H, 1995, BBA-BIOENERGETICS, V1230, P69, DOI 10.1016/0005-2728(95)00067-S; Yaspelkis BB, 1998, ACTA PHYSIOL SCAND, V163, P251, DOI 10.1046/j.1365-201x.1998.00377.x; Zonderland ML, 1999, EUR J APPL PHYSIOL O, V79, P391, DOI 10.1007/s004210050527; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; ZWEIER JL, 1991, J BIOL CHEM, V266, P20296	156	57	60	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52879	10.1371/journal.pone.0052879	http://dx.doi.org/10.1371/journal.pone.0052879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326362	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500033
J	Sjoberg, V; Sandstrom, O; Hedberg, M; Hammarstrom, S; Hernell, O; Hammarstrom, ML				Sjoberg, Veronika; Sandstrom, Olof; Hedberg, Maria; Hammarstrom, Sten; Hernell, Olle; Hammarstrom, Marie-Louise			Intestinal T-cell Responses in Celiac Disease - Impact of Celiac Disease Associated Bacteria	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; GENE REARRANGEMENT; MESSENGER-RNA; TC17 CELLS; TH17 CELLS; EXPRESSION; IDENTIFICATION; MUCOSA; IL-17; IMMUNITY	A hallmark of active celiac disease (CD), an inflammatory small-bowel enteropathy caused by permanent intolerance to gluten, is cytokine production by intestinal T lymphocytes. Prerequisites for contracting CD are that the individual carries the MHC class II alleles HLA-DQ2 and/or HLA-DQ8 and is exposed to gluten in the diet. Dysbiosis in the resident microbiota has been suggested to be another risk factor for CD. In fact, rod shaped bacteria adhering to the small intestinal mucosa were frequently seen in patients with CD during the "Swedish CD epidemic'' and bacterial candidates could later be isolated from patients born during the epidemic suggesting long-lasting changes in the gut microbiota. Interleukin-17A (IL-17A) plays a role in both inflammation and anti-bacterial responses. In active CD IL-17A was produced by both CD8(+) T cells (Tc17) and CD4(+) T cells (Th17), with intraepithelial Tc17 cells being the dominant producers. Gluten peptides as well as CD associated bacteria induced IL-17A responses in ex vivo challenged biopsies from patients with inactive CD. The IL-17A response was suppressed in patients born during the epidemic when a mixture of CD associated bacteria was added to gluten, while the reverse was the case in patients born after the epidemic. Under these conditions Th17 cells were the dominant producers. Thus Tc17 and Th17 responses to gluten and bacteria seem to pave the way for the chronic disease with interferon-gamma-production by intraepithelial Tc1 cells and lamina propria Th1 cells. The CD associated bacteria and the dysbiosis they might cause in the resident microbiota may be a risk factor for CD either by directly influencing the immune responses in the mucosa or by enhancing inflammatory responses to gluten.	[Sjoberg, Veronika; Hedberg, Maria; Hammarstrom, Sten; Hammarstrom, Marie-Louise] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Sandstrom, Olof; Hernell, Olle] Umea Univ, Dept Clin Sci, Umea, Sweden	Umea University; Umea University	Hammarstrom, ML (corresponding author), Umea Univ, Dept Clin Microbiol, Umea, Sweden.	Marie-Louise.Hammarstrom@climi.umu.se		Sandstrom, Olof/0000-0003-0899-0531; Hammarstrom, Marie-Louise/0000-0001-6182-4423	Swedish Research Council, Natural Sciences and Engineering Sciences [2010-5669]; TORNADO-project within the 7th framework program theme [222720-2]; Fund for Biotechnology-oriented Basic Science at Umea University; County of Vasterbotten; Oskar's Fund; Kempe Foundation; Swedish Celiac Society; "Insamlingsstiftelsen'' at the Medical faculty of Umea University; Medical Faculty of Umea University	Swedish Research Council, Natural Sciences and Engineering Sciences(Swedish Research Council); TORNADO-project within the 7th framework program theme; Fund for Biotechnology-oriented Basic Science at Umea University; County of Vasterbotten; Oskar's Fund; Kempe Foundation; Swedish Celiac Society; "Insamlingsstiftelsen'' at the Medical faculty of Umea University; Medical Faculty of Umea University	Funding was provided by the Swedish Research Council, Natural Sciences and Engineering Sciences (to M.L.H. and S.H.) No. 2010-5669 [URL: www.vr.se]; the TORNADO-project within the 7th framework program theme, grant agreement no. 222720-2 (to M.L.H. and O.H.) [URL: www.fp7tornado.eu]; the Fund for Biotechnology-oriented Basic Science at Umea University (to M.L.H.) [URL: www.medfak.umu.se]; the County of Vasterbotten (to M.L.H. and O.H.) [URL: www.vll.se/default.aspx?id = 1456&refid = 1405]; the Oskar's Fund (to V.S.) [URL: www.oskarfonden.se]; the Kempe Foundation (to V.S.) [URL: www.umeastudentkar.se/default.asp?ML = 195]; the Swedish Celiac Society (to M.L.H.) [URL://celiaki.se/]; "Insamlingsstiftelsen'' at the Medical faculty of Umea University (to M.L.H.) [URL: www.medfak.umu.se]; a PhD-study support to V.S. from the Medical Faculty of Umea University [URL: www.medfak.umu.se]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Bas A, 2009, GUT, V58, P189, DOI 10.1136/gut.2007.125526; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bas A, 2003, J IMMUNOL, V171, P3359, DOI 10.4049/jimmunol.171.7.3359; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Costa VS, 2010, DIABETES RES CLIN PR, V88, P222, DOI 10.1016/j.diabres.2010.03.014; De Palma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030791; Di Sabatino A, 2011, AM J GASTROENTEROL, V106, P519, DOI 10.1038/ajg.2010.450; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fernandez S, 2011, AM J GASTROENTEROL, V106, P528, DOI 10.1038/ajg.2010.465; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355; Forsberg G, 2007, INT IMMUNOL, V19, P993, DOI 10.1093/intimm/dxm077; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrote JA, 2008, J PEDIAT GASTROENTER, V47, P27; Gianfrani C, 2003, J IMMUNOL, V170, P2719, DOI 10.4049/jimmunol.170.5.2719; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hedberg ME, 2012, INT J SYST EVOL MICR, V62, P2685, DOI 10.1099/ijs.0.033613-0; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; La Scaleia R, 2012, MUCOSAL IMMUNOL, V5, P513, DOI 10.1038/mi.2012.26; Lahdenpera AI, 2012, CLIN EXP IMMUNOL, V167, P226, DOI 10.1111/j.1365-2249.2011.04510.x; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; LUNDQVIST C, 1994, J IMMUNOL, V153, P2302; MARSH MN, 1990, GUT, V31, P111, DOI 10.1136/gut.31.1.111; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Myleus A, 2009, J PEDIATR GASTR NUTR, V49, P170, DOI 10.1097/MPG.0b013e31818c52cc; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Ou GW, 2009, AM J GASTROENTEROL, V104, P3058, DOI 10.1038/ajg.2009.524; Pamp SJ, 2012, GENOME RES, V22, P1107, DOI 10.1101/gr.131482.111; Rahman A, 2011, CLIN EXP IMMUNOL, V163, P123, DOI 10.1111/j.1365-2249.2010.04282.x; Sanz Y, 2011, INT REV IMMUNOL, V30, P207, DOI 10.3109/08830185.2011.599084; Sellitto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033387; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Sollid LM, 2011, J INTERN MED, V269, P604, DOI 10.1111/j.1365-2796.2011.02376.x; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Tack GJ, 2010, NAT REV GASTRO HEPAT, V7, P204, DOI 10.1038/nrgastro.2010.23; West CE, 2012, CLIN EXP ALLERGY, V42, P540, DOI 10.1111/j.1365-2222.2011.03941.x; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368	55	51	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53414	10.1371/journal.pone.0053414	http://dx.doi.org/10.1371/journal.pone.0053414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326425	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500069
J	Tomlin, D; Nedic, A; Prentice, DA; Holmes, P; Cohen, JD				Tomlin, Damon; Nedic, Andrea; Prentice, Deborah A.; Holmes, Philip; Cohen, Jonathan D.			The Neural Substrates of Social Influence on Decision Making	PLOS ONE			English	Article							FMRI; SYSTEMS; BRAIN	The mechanisms that govern human learning and decision making under uncertainty have been the focus of intense behavioral and, more recently, neuroscientific investigation. Substantial progress has been made in building models of the processes involved, and identifying underlying neural mechanisms using simple, two-alternative forced choice decision tasks. However, less attention has been given to how social information influences these processes, and the neural systems that mediate this influence. Here we sought to address these questions by using tasks similar to ones that have been used to study individual decision making behavior, and adding conditions in which participants were given trial-by-trial information about the performance of other individuals (their choices and/or their rewards) simultaneously playing the same tasks. We asked two questions: How does such information about the behavior of others influence performance in otherwise simple decision tasks, and what neural systems mediate this influence? We found that bilateral insula exhibited a parametric relationship to the degree of misalignment of the individual's performance with those of others in the group. Furthermore, activity in the bilateral insula significantly predicted participants' subsequent choices to align their behavior with others in the group when they were misaligned either in their choices (independent of success) or their degree of success (independent of specific choices). These findings add to the growing body of empirical data suggesting that the insula participates in an important way in social information processing and decision making.	[Tomlin, Damon; Holmes, Philip; Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Nedic, Andrea] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Prentice, Deborah A.; Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Holmes, Philip] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Holmes, Philip] Princeton Univ, Program Appl & Computat Math, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Princeton University; Princeton University	Tomlin, D (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	dtomlin@princeton.edu			Air Force Office of Scientific Research, MURI-16 Project [ONR BAA 06-028]; John Templeton Foundation	Air Force Office of Scientific Research, MURI-16 Project(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); John Templeton Foundation	This work was made possible by the Air Force Office of Scientific Research, MURI-16 Project, ONR BAA 06-028. In addition, this project/publication was made possible through the support of a grant from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Berns GS, 2010, NEUROIMAGE, V49, P2687, DOI 10.1016/j.neuroimage.2009.10.070; Berns GS, 2005, BIOL PSYCHIAT, V58, P245, DOI 10.1016/j.biopsych.2005.04.012; Bogacz R, 2007, BRAIN RES, V1153, P111, DOI 10.1016/j.brainres.2007.03.057; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Burke CJ, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00048; Campbell-Meiklejohn DK, 2010, CURR BIOL, V20, P1165, DOI 10.1016/j.cub.2010.04.055; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Egelman DM, 1998, J COGNITIVE NEUROSCI, V10, P623, DOI 10.1162/089892998563022; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Engelmann JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004957; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Li J, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000103; Mason MF, 2009, ORGAN BEHAV HUM DEC, V110, P152, DOI 10.1016/j.obhdp.2009.04.001; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nedic A, 2012, P IEEE, V100, P713, DOI 10.1109/JPROC.2011.2166437; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stewart A, 2012, P IEEE, V100, P751, DOI 10.1109/JPROC.2011.2173815; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Woodruff C, 2012, P IEEE, V100, P734, DOI 10.1109/JPROC.2011.2174105; Zaki J, 2011, PSYCHOL SCI, V22, P894, DOI 10.1177/0956797611411057; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	32	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52630	10.1371/journal.pone.0052630	http://dx.doi.org/10.1371/journal.pone.0052630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326346	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500024
J	Turner, J; Bowers, RG; Baylis, M				Turner, Joanne; Bowers, Roger G.; Baylis, Matthew			Two-Host, Two-Vector Basic Reproduction Ratio (R-0) for Bluetongue	PLOS ONE			English	Article							SOUTH-AFRICA; VECTORS; DIPTERA; CERATOPOGONIDAE; VIRUS; TRANSMISSION; TEMPERATURE; INFECTION; ABUNDANCE; LIVESTOCK	Mathematical formulations for the basic reproduction ratio (R-0) exist for several vector-borne diseases. Generally, these are based on models of one-host, one-vector systems or two-host, one-vector systems. For many vector borne diseases, however, two or more vector species often co-occur and, therefore, there is a need for more complex formulations. Here we derive a two-host, two-vector formulation for the R-0 of bluetongue, a vector-borne infection of ruminants that can have serious economic consequences; since 1998 for example, it has led to the deaths of well over 1 million sheep in Europe alone. We illustrate our results by considering the situation in South Africa, where there are two major hosts (sheep, cattle) and two vector species with differing ecologies and competencies as vectors, for which good data exist. We investigate the effects on R-0 of differences in vector abundance, vector competence and vector host preference between vector species. Our results indicate that R-0 can be underestimated if we assume that there is only one vector transmitting the infection (when there are in fact two or more) and/or vector host preferences are overlooked (unless the preferred host is less beneficial or more abundant). The two-host, one-vector formula provides a good approximation when the level of cross-infection between vector species is very small. As this approaches the level of intraspecies infection, a combination of the two-host, one-vector R-0 for each vector species becomes a better estimate. Otherwise, particularly when the level of cross-infection is high, the two-host, two-vector formula is required for accurate estimation of R-0. Our results are equally relevant to Europe, where at least two vector species, which co-occur in parts of the south, have been implicated in the recent epizootic of bluetongue.	[Turner, Joanne; Baylis, Matthew] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Leahurst, Neston, England; [Bowers, Roger G.] Univ Liverpool, Sch Phys Sci, Dept Math Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Turner, J (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Leahurst, Neston, England.	j.turner@liverpool.ac.uk	Baylis, Matthew/S-7694-2019	Baylis, Matthew/0000-0003-0335-187X; Bowers, Roger/0000-0001-8207-297X	Leverhulme Trust [F/0025/AC]; Biotechnology and Biological Sciences Research Council [BB/J015806/1] Funding Source: researchfish; BBSRC [BB/J015806/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by The Leverhulme Trust (http://www.leverhulme.ac.uk) through Research Leadership Award F/0025/AC "Predicting the effects of climate change on infectious diseases of animals", which was awarded to Matthew Baylis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Koeijer AA, 2007, ECOL CONT VECTOR-BOR, V1, P99; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; Garros C, 2011, INFECT GENET EVOL, V11, P1103, DOI 10.1016/j.meegid.2011.04.002; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2; Lord CC, 1996, MED VET ENTOMOL, V10, P19, DOI 10.1111/j.1365-2915.1996.tb00077.x; MACDONALD G, 1955, P ROY SOC MED, V48, P295, DOI 10.1177/003591575504800409; Pessanha JEM, 2011, REV SOC BRAS MED TRO, V44; Meiswinkel R, 2004, VETER ITAL SER, V40, P296; Murty US, 2010, J VECTOR DIS, V47, P26; NEVILL EM, 1978, J S AFR VET ASSOC, V49, P129; Paweska JT, 2002, MED VET ENTOMOL, V16, P10, DOI 10.1046/j.1365-2915.2002.00334.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; ROGERS DJ, 1988, PARASITOLOGY, V97, P193, DOI 10.1017/S0031182000066853; Tanga MC, 2011, TROP MED INT HEALTH, V16, P447, DOI 10.1111/j.1365-3156.2011.02726.x; Torina A, 2004, MED VET ENTOMOL, V18, P81, DOI 10.1111/j.0269-283X.2004.00493.x; VENTER GJ, 1994, ONDERSTEPOORT J VET, V61, P327; Venter GJ, 1996, ONDERSTEPOORT J VET, V63, P25; Venter GJ, 1998, MED VET ENTOMOL, V12, P378, DOI 10.1046/j.1365-2915.1998.00116.x; Venter GJ, 1996, ONDERSTEPOORT J VET, V63, P315	23	18	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53128	10.1371/journal.pone.0053128	http://dx.doi.org/10.1371/journal.pone.0053128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308149	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429800030
J	Buron, F; Malvezzi, P; Villar, E; Chauvet, C; Janbon, B; Denis, L; Brunet, M; Daoud, S; Cahen, R; Pouteil-Noble, C; Gagnieu, MC; Bienvenu, J; Bayle, F; Morelon, E; Thaunat, O				Buron, Fanny; Malvezzi, Paolo; Villar, Emmanuel; Chauvet, Cecile; Janbon, Benedicte; Denis, Laure; Brunet, Maria; Daoud, Sameh; Cahen, Remi; Pouteil-Noble, Claire; Gagnieu, Marie-Claude; Bienvenu, Jacques; Bayle, Francois; Morelon, Emmanuel; Thaunat, Olivier			Profiling Sirolimus-Induced Inflammatory Syndrome: A Prospective Tricentric Observational Study	PLOS ONE			English	Article							RENAL-TRANSPLANT RECIPIENTS; REGULATORY T-CELLS; CALCINEURIN INHIBITORS; MTOR INHIBITION; DENDRITIC CELLS; DE-NOVO; RAPAMYCIN; CYCLOSPORINE; ANEMIA; HEPCIDIN	Background: The use of the immunosuppressant sirolimus in kidney transplantation has been made problematic by the frequent occurrence of various side effects, including paradoxical inflammatory manifestations, the pathophysiology of which has remained elusive. Methods: 30 kidney transplant recipients that required a switch from calcineurin inhibitor to sirolimus-based immunosuppression, were prospectively followed for 3 months. Inflammatory symptoms were quantified by the patients using visual analogue scales and serum samples were collected before, 15, 30, and 90 days after the switch. Results: 66% of patients reported at least 1 inflammatory symptom, cutaneo-mucosal manifestations being the most frequent. Inflammatory symptoms were characterized by their lability and stochastic nature, each patient exhibiting a unique clinical presentation. The biochemical profile was more uniform with a drop of hemoglobin and a concomitant rise of inflammatory acute phase proteins, which peaked in the serum 1 month after the switch. Analyzing the impact of sirolimus introduction on cytokine microenvironment, we observed an increase of IL6 and TNF alpha without compensation of the negative feedback loops dependent on IL10 and soluble TNF receptors. IL6 and TNF alpha changes correlated with the intensity of biochemical and clinical inflammatory manifestations in a linear regression model. Conclusions: Sirolimus triggers a destabilization of the inflammatory cytokine balance in transplanted patients that promotes a paradoxical inflammatory response with mild stochastic clinical symptoms in the weeks following drug introduction. This pathophysiologic mechanism unifies the various individual inflammatory side effects recurrently reported with sirolimus suggesting that they should be considered as a single syndromic entity.	[Buron, Fanny; Chauvet, Cecile; Brunet, Maria; Daoud, Sameh; Pouteil-Noble, Claire; Morelon, Emmanuel; Thaunat, Olivier] Hosp Civils Lyon, Hop Edouard Herriot, Serv Transplantat Nephrol & Immunol Clin, Lyon, France; [Buron, Fanny; Pouteil-Noble, Claire; Gagnieu, Marie-Claude; Bienvenu, Jacques; Morelon, Emmanuel; Thaunat, Olivier] Univ Lyon, Lyon, France; [Malvezzi, Paolo; Janbon, Benedicte; Bayle, Francois] CHU Grenoble, Clin Nephrol Dialyse & Transplantat, F-38043 Grenoble, France; [Villar, Emmanuel; Cahen, Remi; Pouteil-Noble, Claire] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Nephrol, Pierre Benite, France; [Denis, Laure; Bienvenu, Jacques] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Immunol Lab, Pierre Benite, France; [Gagnieu, Marie-Claude] Hosp Civils Lyon, Hop Edouard Herriot, Pharmacol Lab, Lyon, France; [Bienvenu, Jacques; Morelon, Emmanuel; Thaunat, Olivier] INSERM, Unit 851, F-69008 Lyon, France	CHU Lyon; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Lyon; CHU Lyon; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Thaunat, O (corresponding author), Hosp Civils Lyon, Hop Edouard Herriot, Serv Transplantat Nephrol & Immunol Clin, Lyon, France.	olivier.thaunatpastu@free.fr	Thaunat, Olivier/M-2423-2014; bienvenu, jacques/F-2917-2013	Thaunat, Olivier/0000-0002-3648-8963	Wyeth Laboratory	Wyeth Laboratory	SIRILYGRE study was supported by an educational grant from Wyeth Laboratory. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy J, 2005, TRANSPLANTATION, V80, pS171, DOI 10.1097/01.tp.0000186912.23630.85; Anglicheau D, 2005, AM J TRANSPLANT, V5, P595, DOI 10.1111/j.1600-6143.2005.00745.x; Augustine JJ, 2008, TRANSPLANTATION, V86, P548, DOI 10.1097/TP.0b013e3181814a96; Baker AK, 2009, MOL IMMUNOL, V46, P2249, DOI 10.1016/j.molimm.2009.04.011; Brouard S, 2010, AM J TRANSPLANT, V10, P2604, DOI 10.1111/j.1600-6143.2010.03302.x; Champion L, 2006, ANN INTERN MED, V144, P505, DOI 10.7326/0003-4819-144-7-200604040-00009; Cravedi P, 2010, KIDNEY INT, V78, P1068, DOI 10.1038/ki.2010.268; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Fishbane S, 2009, KIDNEY INT, V76, P376, DOI 10.1038/ki.2009.231; Flechner SM, 2002, TRANSPLANTATION, V74, P1070, DOI 10.1097/00007890-200210270-00002; Gao W, 2007, AM J TRANSPLANT, V7, P1722, DOI 10.1111/j.1600-6143.2007.01842.x; Groth CG, 1999, TRANSPLANTATION, V67, P1036, DOI 10.1097/00007890-199904150-00017; Jorgensen PF, 2001, SCAND J IMMUNOL, V53, P184, DOI 10.1046/j.1365-3083.2001.00862.x; Letavernier E, 2007, CLIN J AM SOC NEPHRO, V2, P326, DOI 10.2215/CJN.03751106; Letavernier E, 2009, NEPHROL DIAL TRANSPL, V24, P630, DOI 10.1093/ndt/gfn574; Mahe E, 2005, TRANSPLANTATION, V79, P476, DOI 10.1097/01.TP.0000151630.25127.3A; Maiorano A, 2006, TRANSPLANTATION, V82, P908, DOI 10.1097/01.tp.0000235545.49391.1b; MALEFYT RD, 1991, J EXP MED, V174, P1209; Malyszko J, 2009, CLIN J AM SOC NEPHRO, V4, P1015, DOI 10.2215/CJN.02690409; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; Molinari M, 2005, AM J TRANSPLANT, V5, P2799, DOI 10.1111/j.1600-6143.2005.01082.x; Morath C, 2007, NEPHROL DIAL TRANSPL, V22, P61, DOI 10.1093/ndt/gfm652; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Rana JS, 2007, ANN ALLERG ASTHMA IM, V98, P201, DOI 10.1016/S1081-1206(10)60699-0; Segundo DS, 2006, TRANSPLANTATION, V82, P550, DOI 10.1097/01.tp.0000229473.95202.50; Stallone G, 2005, J AM SOC NEPHROL, V16, P3755, DOI 10.1681/ASN.2005060635; Taner T, 2005, AM J TRANSPLANT, V5, P228, DOI 10.1046/j.1600-6143.2004.00673.x; Thaunat O, 2005, TRANSPLANTATION, V80, P1212, DOI 10.1097/01.tp.0000179106.07382.6a; Thaunat O, 2007, TRANSPLANTATION, V83, P1283, DOI 10.1097/01.tp.0000260424.75005.c1; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Turnquist HR, 2007, J IMMUNOL, V178, P7018, DOI 10.4049/jimmunol.178.11.7018; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Zuber J, 2008, AM J TRANSPLANT, V8, P1471, DOI 10.1111/j.1600-6143.2008.02267.x	35	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53078	10.1371/journal.pone.0053078	http://dx.doi.org/10.1371/journal.pone.0053078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308138	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100026
J	Charoenthongtrakul, S; Gao, LL; Parvatiyar, K; Lee, D; Harhaj, EW				Charoenthongtrakul, Soratree; Gao, Linlin; Parvatiyar, Kislay; Lee, David; Harhaj, Edward W.			RING Finger Protein 11 Targets TBK1/IKKi Kinases to Inhibit Antiviral Signaling	PLOS ONE			English	Article							NF-KAPPA-B; IFN-BETA PRODUCTION; I INTERFERON-PRODUCTION; TUMOR-SUPPRESSOR CYLD; E3 UBIQUITIN LIGASE; RIG-I; NEGATIVE REGULATOR; TRANSCRIPTION FACTORS; INNATE IMMUNITY; RNF11	A key feature of the innate antiviral immune response is a rapid nonspecific response to virus infection largely mediated by the induction and extracellular secretion of type I interferons (IFNs) that restrict virus replication. Cytoplasmic sensors such as RIG-I recognize viral RNA and trigger antiviral signaling pathways that upregulate IFN transcription. However, it remains largely unknown how antiviral signaling is negatively regulated to maintain homeostasis after the elimination of virus. In this report, we have identified the RING domain-containing protein RING finger 11 (RNF11) as a novel negative regulator of innate antiviral signaling. Overexpression of RNF11 downregulated IFN-beta expression and enhanced viral replication whereas siRNA-mediated knockdown of RNF11 suppressed viral replication. RNF11 interacted with the noncanonical IKK kinases TBK1/IKKi and attenuated their Lys63-linked polyubiquitination by blocking interactions with the E3 ligase TRAF3. The inhibitory function of RNF11 was dependent on the ubiquitin-binding adaptor molecule TAX1BP1 which was required for RNF11 to target TBK1/IKKi. Collectively, these results indicate that RNF11 functions together with TAX1BP1 to restrict antiviral signaling and IFN-beta production.	[Charoenthongtrakul, Soratree; Parvatiyar, Kislay; Lee, David] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Gao, Linlin] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Grad Program Canc Biol, Miami, FL 33136 USA; [Harhaj, Edward W.] Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA	University of Miami; University of Miami; Johns Hopkins University; Johns Hopkins Medicine	Harhaj, EW (corresponding author), Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA.	eharhaj1@jhmi.edu	Gao, Linlin/S-8070-2019	Gao, Linlin/0000-0001-7332-3538	NIH [PO1CA128115, RO1GM083143]; NATIONAL CANCER INSTITUTE [P01CA128115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by NIH grants PO1CA128115 and RO1GM083143 and institutional support from the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Azmi P, 2005, EUR J CANCER, V41, P2549, DOI 10.1016/j.ejca.2005.08.020; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Charoenthongtrakul S, 2011, J VIROL, V85, P6955, DOI 10.1128/JVI.00007-11; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Connor MK, 2004, ONCOGENE, V23, P2089, DOI 10.1038/sj.onc.1207380; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao LL, 2011, J BIOL CHEM, V286, P36592, DOI 10.1074/jbc.M111.283762; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Harhaj NS, 2007, VIROLOGY, V362, P99, DOI 10.1016/j.virol.2006.12.020; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kitching R, 2003, BBA-MOL BASIS DIS, V1639, P104, DOI 10.1016/j.bbadis.2003.07.001; Li HX, 2004, ONCOGENE, V23, P1801, DOI 10.1038/sj.onc.1207319; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Ng MHJ, 2011, J IMMUNOL, V187, P6473, DOI 10.4049/jimmunol.1100719; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oliere S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001177; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Santonico E, 2010, ONCOGENE, V29, P5604, DOI 10.1038/onc.2010.294; Sartelet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002581; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Subramaniam V, 2003, BRIT J CANCER, V89, P1538, DOI 10.1038/sj.bjc.6601301; van Wijk SJL, 2012, MOL CELL, V47, P797, DOI 10.1016/j.molcel.2012.06.017; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506	62	30	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53717	10.1371/journal.pone.0053717	http://dx.doi.org/10.1371/journal.pone.0053717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308279	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100111
J	Li, HA; Zhao, CJ; Chen, HB; Zhang, FF; He, WQ; Wang, XJ; Wang, Q; Yang, RF; Zhou, DS; Wang, H				Li, Henan; Zhao, Chunjiang; Chen, Hongbin; Zhang, Feifei; He, Wenqiang; Wang, Xiaojuan; Wang, Qi; Yang, Ruifu; Zhou, Dongsheng; Wang, Hui			Identification of Gene Clusters Associated with Host Adaptation and Antibiotic Resistance in Chinese Staphylococcus aureus Isolates by Microarray-Based Comparative Genomics	PLOS ONE			English	Article							CHEMOTAXIS INHIBITORY PROTEIN; EVOLUTIONARY GENOMICS; INSIGHTS; STRAIN; EPIDERMIDIS; VIRULENCE; EPIDEMIC; CLONES; ORIGIN	A comparative genomic microarray comprising 2,457 genes from two whole genomes of S. aureus was employed for the comparative genome hybridization analysis of 50 strains of divergent clonal lineages, including methicillin-resistant S. aureus (MRSA), methicillin-susceptible S. aureus (MSSA), and swine strains in China. Large-scale validation was confirmed via polymerase chain reaction in 160 representative clinical strains. All of the 50 strains were clustered into seven different complexes by phylogenetic tree analysis. Thirteen gene clusters were specific to different S. aureus clones. Ten gene clusters, including seven known (vSa3, vSa4, vSa alpha, vSa beta, Tn5801, and phage phi Sa3) and three novel (C8, C9, and C10) gene clusters, were specific to human MRSA. Notably, two global regulators, sarH2 and sarH3, at cluster C9 were specific to human MRSA, and plasmid pUB110 at cluster C10 was specific to swine MRSA. Three clusters known to be part of SCCmec, vSa4 or Tn5801, and vSa alpha as well as one novel gene cluster C12 with homology with Tn554 of S. epidermidis were identified as MRSA-specific gene clusters. The replacement of ST239-spa t037 with ST239-spa t030 in Beijing may be a result of its acquisition of vSa4, phage phi Sa1, and phi Sa3. In summary, thirteen critical gene clusters were identified to be contributors to the evolution of host specificity and antibiotic resistance in Chinese S. aureus.	[Li, Henan; Zhao, Chunjiang; Chen, Hongbin; Zhang, Feifei; He, Wenqiang; Wang, Xiaojuan; Wang, Qi; Wang, Hui] Peking Univ, Peoples Hosp, Dept Clin Lab, Beijing 100871, Peoples R China; [Yang, Ruifu; Zhou, Dongsheng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Peking University; Beijing Institute of Microbiology & Epidemiology	Wang, H (corresponding author), Peking Univ, Peoples Hosp, Dept Clin Lab, Beijing 100871, Peoples R China.	dongshengzhou1977@gmail.com; whuibj@gmail.com	Li, Henan/AAI-6671-2020; Yang, Ruifu/A-2273-2011	Yang, Ruifu/0000-0003-3219-7269; he, wen-qiang/0000-0002-7475-8485; Zhou, Dongsheng/0000-0003-3827-5969; Wang, Hui/0000-0001-9220-0357	National Natural Science Foundation of China [30971571]; Program for New Century Excellent Talents in University [NCET-10-0205]; Beijing Natural Science Foundation [7102130]; Key Projects in the National Science & Technology Pillar Program [2012EP001002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Key Projects in the National Science & Technology Pillar Program	This study was supported by the National Natural Science Foundation of China (No. 30971571). It was partially supported by the Program for New Century Excellent Talents in University (NCET-10-0205), the Beijing Natural Science Foundation (No. 7102130) and Key Projects in the National Science & Technology Pillar Program (2012EP001002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Jamrozy DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040458; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lindsay JA, 2010, INT J MED MICROBIOL, V300, P98, DOI 10.1016/j.ijmm.2009.08.013; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; Manna AC, 2003, INFECT IMMUN, V71, P343, DOI 10.1128/IAI.71.1.343-353.2003; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Sun WJ, 2009, ANTIMICROB AGENTS CH, V53, P3642, DOI 10.1128/AAC.00206-09; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; TILLOTSON LE, 1989, ANTIMICROB AGENTS CH, V33, P541, DOI 10.1128/AAC.33.4.541; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108; Yamamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029187	25	9	10	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53341	10.1371/journal.pone.0053341	http://dx.doi.org/10.1371/journal.pone.0053341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308197	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100056
J	Pena, OM; Afacan, N; Pistolic, J; Chen, C; Madera, L; Falsafi, R; Fjell, CD; Hancock, REW				Pena, Olga M.; Afacan, Nicole; Pistolic, Jelena; Chen, Carol; Madera, Laurence; Falsafi, Reza; Fjell, Christopher D.; Hancock, Robert E. W.			Synthetic Cationic Peptide IDR-1018 Modulates Human Macrophage Differentiation	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; HUMAN MONOCYTES; M2 MACROPHAGES; POLARIZATION; CELLS; TRANSCRIPTION; RESPONSES	Macrophages play a critical role in the innate immune response. To respond in a rapid and efficient manner to challenges in the micro-environment, macrophages are able to differentiate towards classically (M1) or alternatively (M2) activated phenotypes. Synthetic, innate defense regulators (IDR) peptides, designed based on natural host defence peptides, have enhanced immunomodulatory activities and reduced toxicity leading to protection in infection and inflammation models that is dependent on innate immune cells like monocytes/macrophages. Here we tested the effect of IDR-1018 on macrophage differentiation, a process essential to macrophage function and the immune response. Using transcriptional, protein and systems biology analysis, we observed that differentiation in the presence of IDR-1018 induced a unique signature of immune responses including the production of specific pro and anti-inflammatory mediators, expression of wound healing associated genes, and increased phagocytosis of apoptotic cells. Transcription factor IRF4 appeared to play an important role in promoting this IDR-1018-induced phenotype. The data suggests that IDR-1018 drives macrophage differentiation towards an intermediate M1-M2 state, enhancing anti-inflammatory functions while maintaining certain proinflammatory activities important to the resolution of infection. Synthetic peptides like IDR-1018, which act by modulating the immune system, could represent a powerful new class of therapeutics capable of treating the rising number of multidrug resistant infections as well as disorders associated with dysregulated immune responses.	[Pena, Olga M.; Afacan, Nicole; Pistolic, Jelena; Chen, Carol; Madera, Laurence; Falsafi, Reza; Fjell, Christopher D.; Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Hancock, REW (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	bob@hancocklab.ubc.ca	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Fjell, Christopher/0000-0001-6304-2628	Canadian Institutes for Health Research; Cystic Fibrosis Canada; Cystic Fibrosis Canada's Translational Initiative; Canadian Institutes for Health Research Vanier Canada Graduate scholarship; Natural Sciences and Engineering Research Council Canada Graduate Studentship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Cystic Fibrosis Canada's Translational Initiative; Canadian Institutes for Health Research Vanier Canada Graduate scholarship(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council Canada Graduate Studentship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by funding from the Canadian Institutes for Health Research (www.cihr-irsc.gc.ca) and Cystic Fibrosis Canada (www.cysticfibrosis.ca) (REWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The only conflict of interest is that peptide IDR-1018, discovered by REWH and colleagues, has been filed for patent protection in multiple jurisdictions, assigned to UBC and licenced to Elanco for Animal Health applications and is also under development as a potential therapeutic for hyperinflammation in Cystic Fibrosis with funding from Cystic Fibrosis Canada's Translational Initiative. The peptide has received Notice of allowance in the United States of America and New Zealand. The authors' confirm that this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; We would like to thank Danay Maestre-Batlle, who help with some of the technical work. O.M.P. is the recipient of a Canadian Institutes for Health Research Vanier Canada Graduate scholarship; N.J.A is a holder of a Natural Sciences and Engineering Research Council Canada Graduate Studentship and R. E. W. H. is a Canada Research Chair in Genomics and Health.	Achtman AH, 2012, SCI TRANSL MED, V4; Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cassetta L, 2011, IMMUNOL RES, V53, P11; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; del Fresno C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002667; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P821, DOI 10.1016/j.imbio.2010.05.031; Escribese MM, 2012, J IMMUNOL IN PRESS; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Jersmann HPA, 2003, CYTOM PART A, V51A, P7, DOI 10.1002/cyto.a.10005; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lang R, 2005, IMMUNOBIOLOGY, V210, P63, DOI 10.1016/j.imbio.2005.05.001; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Nijnik A, 2009, J IMMUNOL, V183, P5788, DOI 10.4049/jimmunol.0901491; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramos R, 2011, PEPTIDES, V32, P1469, DOI 10.1016/j.peptides.2011.06.005; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Sica A, 2007, EXPERT OPIN THER TAR, V11, P1219, DOI 10.1517/14728222.11.9.1219; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Steinstraesser LHT, 2012, PLOS ONE IN PRESS; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Wieczorek M, 2010, CHEM BIOL, V17, P970, DOI 10.1016/j.chembiol.2010.07.007	47	54	60	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52449	10.1371/journal.pone.0052449	http://dx.doi.org/10.1371/journal.pone.0052449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308112	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100011
J	Gabba, M; Abbruzzetti, S; Spyrakis, F; Forti, F; Bruno, S; Mozzarelli, A; Luque, FJ; Viappiani, C; Cozzini, P; Nardini, M; Germani, F; Bolognesi, M; Moens, L; Dewilde, S				Gabba, Matteo; Abbruzzetti, Stefania; Spyrakis, Francesca; Forti, Flavio; Bruno, Stefano; Mozzarelli, Andrea; Javier Luque, F.; Viappiani, Cristiano; Cozzini, Pietro; Nardini, Marco; Germani, Francesca; Bolognesi, Martino; Moens, Luc; Dewilde, Sylvia			CO Rebinding Kinetics and Molecular Dynamics Simulations Highlight Dynamic Regulation of Internal Cavities in Human Cytoglobin	PLOS ONE			English	Article							LIGAND MIGRATION; NITRIC-OXIDE; HUMAN NEUROGLOBIN; TRUNCATED HEMOGLOBIN; OXYGEN-AFFINITY; GLOBIN; BINDING; PROTEIN; MYOGLOBIN; PATHWAYS	Cytoglobin (Cygb) was recently discovered in the human genome and localized in different tissues. It was suggested to play tissue-specific protective roles, spanning from scavenging of reactive oxygen species in neurons to supplying oxygen to enzymes in fibroblasts. To shed light on the functioning of such versatile machinery, we have studied the processes supporting transport of gaseous heme ligands in Cygb. Carbon monoxide rebinding shows a complex kinetic pattern with several distinct reaction intermediates, reflecting rebinding from temporary docking sites, second order recombination, and formation (and dissociation) of a bis-histidyl heme hexacoordinated reaction intermediate. Ligand exit to the solvent occurs through distinct pathways, some of which exploit temporary docking sites. The remarkable change in energetic barriers, linked to heme bis-histidyl hexacoordination by HisE7, may be responsible for active regulation of the flux of reactants and products to and from the reaction site on the distal side of the heme. A substantial change in both protein dynamics and inner cavities is observed upon transition from the CO-liganded to the pentacoordinated and bis-histidyl hexacoordinated species, which could be exploited as a signalling state. These findings are consistent with the expected versatility of the molecular activity of this protein.	[Gabba, Matteo] Forschungszentrum Julich, Inst Complex Syst Mol Biophys ICS 5, D-52425 Julich, Germany; [Abbruzzetti, Stefania; Viappiani, Cristiano] Univ Parma, Dipartimento Fis & Sci Terra, I-43100 Parma, Italy; [Spyrakis, Francesca; Cozzini, Pietro] Univ Parma, Dipartimento Sci Alimenti, I-43100 Parma, Italy; [Spyrakis, Francesca; Cozzini, Pietro] INBB, Rome, Italy; [Forti, Flavio; Javier Luque, F.] Univ Barcelona, Fac Med, Dept Fis Quin, Barcelona 7, Spain; [Forti, Flavio; Javier Luque, F.] Univ Barcelona, Fac Med, Inst Biomed IBUB, Barcelona 7, Spain; [Bruno, Stefano; Mozzarelli, Andrea] Univ Parma, Dipartimento Farm, I-43100 Parma, Italy; [Viappiani, Cristiano] CNR, Ist Nanosci, NEST, I-56100 Pisa, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dipartimento BioSci, CNR IBF, Milan, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, CIMAINA, Milan, Italy; [Germani, Francesca; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Helmholtz Association; Research Center Julich; University of Parma; University of Parma; University of Barcelona; University of Barcelona; University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan; University of Antwerp	Viappiani, C (corresponding author), Univ Parma, Dipartimento Fis & Sci Terra, I-43100 Parma, Italy.	cristiano.viappiani@fis.unipr.it	Viappiani, Cristiano/AAC-7579-2019; Bruno, Stefano/A-4582-2011; abbruzzetti, stefania/M-8640-2015; Nardini, Marco/B-7842-2017; abbruzzetti, stefania/AAE-5518-2020; Bolognesi, Martino/B-7924-2017; Luque, F. Javier/L-9652-2014; Mozzarelli, Andrea/C-3615-2014	Viappiani, Cristiano/0000-0001-7470-4770; Bruno, Stefano/0000-0002-7890-2472; abbruzzetti, stefania/0000-0001-7685-8554; Nardini, Marco/0000-0002-3718-2165; abbruzzetti, stefania/0000-0001-7685-8554; Bolognesi, Martino/0000-0002-9253-5170; Luque, F. Javier/0000-0002-8049-3567; Mozzarelli, Andrea/0000-0003-3762-0062; spyrakis, francesca/0000-0002-4016-227X	Italian MiUR [PRIN 2008, 2008BFJ34R, Azione Integrate Italia Spagna 2009 IT10L1M59M]; Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese; Fondazione Cariparma; Spanish MCINN [SAF2011-27642, IT2009-0010]; Generalitat de Catalunya [2009-SGR00298]; Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC); Barcelona Supercomputer Center	Italian MiUR(Ministry of Education, Universities and Research (MIUR)); Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese; Fondazione Cariparma(Fondazione Cariparma); Spanish MCINN(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC); Barcelona Supercomputer Center	This work has been supported by the Italian MiUR (PRIN 2008, 2008BFJ34R, and Azione Integrate Italia Spagna 2009 IT10L1M59M), Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina 2011 (a) over cap (sic)"2013), Fondazione Cariparma, the Spanish MCINN (SAF2011-27642, IT2009-0010), the Generalitat de Catalunya (2009-SGR00298), the Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC) and the Barcelona Supercomputer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2001, J NANOSCI NANOTECHNO, V1, P407, DOI 10.1166/jnn.2001.058; Abbruzzetti S, 2007, J PHYS CHEM B, V111, P12582, DOI 10.1021/jp074954o; Abbruzzetti S, 2006, PHOTOCH PHOTOBIO SCI, V5, P1109, DOI 10.1039/b610236k; Abbruzzetti S, 2009, P NATL ACAD SCI USA, V106, P18984, DOI 10.1073/pnas.0905433106; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bettati S, 1997, J BIOL CHEM, V272, P32050, DOI 10.1074/jbc.272.51.32050; BETTATI S, 2004, ENCY NANOSCIENCE NAN, V9, P81; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Boechi L, 2010, PROTEINS, V78, P962, DOI 10.1002/prot.22620; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; Bolognesi M, 1999, BIOPHYS J, V77, P1093, DOI 10.1016/S0006-3495(99)76959-6; Bruno S, 2001, PROTEIN SCI, V10, P2401, DOI 10.1110/ps.20501; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P209, DOI 10.1016/S0968-0004(01)01824-2; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P21, DOI 10.1016/S0968-0004(00)01698-4; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Case D, 2006, AMBER 9; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dewilde S, 2008, METHOD ENZYMOL, V436, P341, DOI 10.1016/S0076-6879(08)36019-4; Dordas C, 2009, PLANT SCI, V176, P433, DOI 10.1016/j.plantsci.2009.01.003; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hoy JA, 2007, J MOL BIOL, V371, P168, DOI 10.1016/j.jmb.2007.05.029; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Lechauve C, 2010, FEBS J; Liu XP, 2012, BIOCHEMISTRY-US, V51, P5072, DOI 10.1021/bi300291h; Makino M, 2011, PROTEINS, V79, P1143, DOI 10.1002/prot.22950; Maragliano L, 2010, J AM CHEM SOC, V132, P1010, DOI 10.1021/ja905671x; Nienhaus K, 2004, J BIOL CHEM, V279, P22944, DOI 10.1074/jbc.M401561200; Nishihara Y, 2004, J AM CHEM SOC, V126, P11877, DOI 10.1021/ja038877w; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Orlowski S, 2007, J MOL MODEL, V13, P715, DOI 10.1007/s00894-007-0203-x; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Sawai H, 2003, BIOCHEMISTRY-US, V42, P5133, DOI 10.1021/bi027067e; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Scott NL, 2002, BIOCHEMISTRY-US, V41, P6902, DOI 10.1021/bi025609m; SHIBAYAMA N, 1995, J MOL BIOL, V251, P203, DOI 10.1006/jmbi.1995.0427; Shivapurkar N, 2008, CANCER RES, V68, P7448, DOI 10.1158/0008-5472.CAN-08-0565; Smagghe BJ, 2009, BIOPOLYMERS, V91, P1083, DOI 10.1002/bip.21256; Sottini S, 2005, J PHYS CHEM B, V109, P19523, DOI 10.1021/jp0540981; Sottini S, 2005, J PHYS CHEM B, V109, P11411, DOI 10.1021/jp0514224; Steinbach PJ, 2002, BIOPHYS J, V82, P2244, DOI 10.1016/S0006-3495(02)75570-7; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Tetreau C, 2004, BIOPHYS J, V86, P435, DOI 10.1016/S0006-3495(04)74120-X; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Vallone B, 2004, P NATL ACAD SCI USA, V101, P17351, DOI 10.1073/pnas.0407633101; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101	61	24	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e49770	10.1371/journal.pone.0049770	http://dx.doi.org/10.1371/journal.pone.0049770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308092	Green Published, gold			2022-12-27	WOS:000313670100001
J	Iring, A; Ruisanchez, E; Leszl-Ishiguro, M; Horvath, B; Benko, R; Lacza, Z; Jarai, Z; Sandor, P; Di Marzo, V; Pacher, P; Benyo, Z				Iring, Andras; Ruisanchez, Eva; Leszl-Ishiguro, Miriam; Horvath, Bela; Benko, Rita; Lacza, Zsombor; Jarai, Zoltan; Sandor, Peter; Di Marzo, Vincenzo; Pacher, Pal; Benyo, Zoltan			Role of Endocannabinoids and Cannabinoid-1 Receptors in Cerebrocortical Blood Flow Regulation	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; CB1 RECEPTOR; ANANDAMIDE UPTAKE; RAT-BRAIN; ENDOGENOUS CANNABINOIDS; CARDIOVASCULAR FUNCTION; CONSTITUTIVE ACTIVITY; HEMODYNAMIC PROFILE; CARDIAC DYSFUNCTION; VANILLOID RECEPTOR	Background: Endocannabinoids are among the most intensively studied lipid mediators of cardiovascular functions. In the present study the effects of decreased and increased activity of the endocannabinoid system (achieved by cannabinoid-1 (CB1) receptor blockade and inhibition of cannabinoid reuptake, respectively) on the systemic and cerebral circulation were analyzed under steady-state physiological conditions and during hypoxia and hypercapnia (H/H). Methodology/Principal Findings: In anesthetized spontaneously ventilating rats the CB1-receptor antagonist/inverse agonist AM-251 (10 mg/kg, i.v.) failed to influence blood pressure (BP), cerebrocortical blood flow (CoBF, measured by laser-Doppler flowmetry) or arterial blood gas levels. In contrast, the putative cannabinoid reuptake inhibitor AM-404 (10 mg/kg, i.v.) induced triphasic responses, some of which could be blocked by AM-251. Hypertension during phase I was resistant to AM-251, whereas the concomitant CoBF-increase was attenuated. In contrast, hypotension during phase III was sensitive to AM-251, whereas the concomitant CoBF-decrease was not. Therefore, CoBF autoregulation appeared to shift towards higher BP levels after CB1-blockade. During phase II H/H developed due to respiratory depression, which could be inhibited by AM-251. Interestingly, however, the concomitant rise in CoBF remained unchanged after AM-251, indicating that CB1-blockade potentially enhanced the reactivity of the CoBF to H/H. In accordance with this hypothesis, AM-251 induced a significant enhancement of the CoBF responses during controlled stepwise H/H. Conclusion/Significance: Under resting physiological conditions CB1-receptor mediated mechanisms appear to have limited influence on systemic or cerebral circulation. Enhancement of endocannabinoid levels, however, induces transient CB1-independent hypertension and sustained CB1-mediated hypotension. Furthermore, enhanced endocannabinoid activity results in respiratory depression in a CB1-dependent manner. Finally, our data indicate for the first time the involvement of the endocannabinoid system and CB1-receptors in the regulation of the cerebral circulation during H/H and also raise the possibility of their contribution to the autoregulation of CoBF.	[Iring, Andras; Ruisanchez, Eva; Leszl-Ishiguro, Miriam; Horvath, Bela; Benko, Rita; Lacza, Zsombor; Sandor, Peter; Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, Budapest, Hungary; [Horvath, Bela] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Jarai, Zoltan] St Imre Teaching Hosp, Dept Cardiol, Budapest, Hungary; [Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Naples, Italy; [Pacher, Pal] NIAAA, NIH, Bethesda, MD USA	Semmelweis University; Cleveland Clinic Foundation; Consiglio Nazionale delle Ricerche (CNR); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Benyo, Z (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, Budapest, Hungary.	benyo.zoltan@med.semmelweis-univ.hu	Pacher, Pal/B-6378-2008; Di Marzo, Vincenzo/AAD-7742-2019; Horvath, Bela/A-7368-2009; Benko, Rita/I-9646-2017	Pacher, Pal/0000-0001-7036-8108; Di Marzo, Vincenzo/0000-0002-1490-3070; Benko, Rita/0000-0001-7740-9128; Benyo, Zoltan/0000-0001-6015-0359; Iring, Andras/0000-0002-3087-4337	Hungarian National Innovation Office [OMFB-00770/2009]; Hungarian Scientific Research Fund [OTKA K-62375, K-101775]; Health Science Council [ETT 427/2009]; National Development Agency [TAMOP-4.2.1.B-09/1/KMR-2010-0001]; EFSD/Servier research grant; Nation Institutes of Health/National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	Hungarian National Innovation Office; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Health Science Council; National Development Agency; EFSD/Servier research grant; Nation Institutes of Health/National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the Hungarian National Innovation Office (OMFB-00770/2009), the Hungarian Scientific Research Fund (OTKA K-62375 and K-101775), the Health Science Council (ETT 427/2009), the National Development Agency (TAMOP-4.2.1.B-09/1/KMR-2010-0001), by an EFSD/Servier research grant, and by the Intramural Research Program of the Nation Institutes of Health/National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH909, DOI 10.1152/ajpheart.00373.2007; BEACONSFIELD P, 1972, LANCET, V2, P1146; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Benyo Z, 1996, CEREBROVAS BRAIN MET, V8, P326; Bloom AS, 1997, PHARMACOL BIOCHEM BE, V57, P625, DOI 10.1016/S0091-3057(96)00475-3; Buckley NE, 2008, BRIT J PHARMACOL, V153, P309, DOI 10.1038/sj.bjp.0707527; BUSIJA DW, 1984, J PHYSIOL-LONDON, V347, P35, DOI 10.1113/jphysiol.1984.sp015051; Calignano A, 1997, EUR J PHARMACOL, V337, pR1, DOI 10.1016/S0014-2999(97)01297-1; CAVERO I, 1972, RES COMMUN CHEM PATH, V3, P483; Costa B, 2006, BRIT J PHARMACOL, V148, P1022, DOI 10.1038/sj.bjp.0706798; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; DESHMUKH VD, 1972, BRIT J SURG, V59, P897; DOHERTY PA, 1983, J PHARMACOL EXP THER, V227, P508; Duarte JMN, 2012, NEUROCHEM INT, V60, P1, DOI 10.1016/j.neuint.2011.10.019; Ellis EF, 1995, AM J PHYSIOL-HEART C, V269, pH1859, DOI 10.1152/ajpheart.1995.269.6.H1859; ESTRADA U, 1987, LIFE SCI, V41, P79, DOI 10.1016/0024-3205(87)90559-5; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Fowler CJ, 2012, TRENDS PHARMACOL SCI, V33, P181, DOI 10.1016/j.tips.2012.01.001; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gardiner SM, 2002, BRIT J PHARMACOL, V135, P1889, DOI 10.1038/sj.bjp.0704649; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Gebremedhin D, 1999, AM J PHYSIOL-HEART C, V276, pH2085, DOI 10.1152/ajpheart.1999.276.6.H2085; GOPLERUD JM, 1991, AM J PHYSIOL, V260, pH1575, DOI 10.1152/ajpheart.1991.260.5.H1575; GRAHAM JDP, 1973, BRIT J PHARMACOL, V49, P1; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hanlon KE, 2010, METHOD ENZYMOL, V484, P3, DOI [10.1016/B978-0-12-381298-8.00001-0, 10.1016/S0076-6879(10)84001-7]; HARPER AM, 1972, ARCH NEUROL-CHICAGO, V27, P1; Hillard CJ, 1999, FEBS LETT, V459, P277, DOI 10.1016/S0014-5793(99)01253-3; Hortobagyi L, 2007, BRAIN RES, V1131, P129, DOI 10.1016/j.brainres.2006.11.009; Horvath B, 2003, J CEREBR BLOOD F MET, V23, P653, DOI 10.1097/01.WCB.0000071890.63724.C9; Horvath B, 2008, NEUROREPORT, V19, P1601, DOI 10.1097/WNR.0b013e3283129790; Horvath B, 2012, BRIT J PHARMACOL, V165, P2462, DOI 10.1111/j.1476-5381.2011.01381.x; Horvath B, 2012, AM J PATHOL, V180, P432, DOI 10.1016/j.ajpath.2011.11.003; Horvath B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014477; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; King AR, 2009, CHEM BIOL, V16, P1045, DOI 10.1016/j.chembiol.2009.09.012; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Kopczynska B, 2007, LIFE SCI, V80, P1738, DOI 10.1016/j.lfs.2007.01.062; KOVACH AGB, 1992, J PHYSIOL-LONDON, V449, P183, DOI 10.1113/jphysiol.1992.sp019081; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kunos G, 2000, PROSTAG OTH LIPID M, V61, P71, DOI 10.1016/S0090-6980(00)00056-3; Kunos G, 2011, BRIT J PHARMACOL, V163, P1423, DOI 10.1111/j.1476-5381.2011.01352.x; Kwolek G, 2005, BRIT J PHARMACOL, V145, P567, DOI 10.1038/sj.bjp.0706195; Lake KD, 1997, HYPERTENSION, V29, P1204, DOI 10.1161/01.HYP.29.5.1204; Lake KD, 1997, J PHARMACOL EXP THER, V281, P1030; Lang WS, 1999, J MED CHEM, V42, P896, DOI 10.1021/jm980461j; LEE JG, 1994, ANESTH ANALG, V79, P58; Leffler CW, 2011, AM J PHYSIOL-HEART C, V301, pH1, DOI 10.1152/ajpheart.00230.2011; LEFFLER CW, 1987, SEMIN PERINATOL, V11, P31; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Malinowska B, 2001, N-S ARCH PHARMACOL, V364, P562, DOI 10.1007/s00210-001-0498-6; Mathew RJ, 1999, ACTA PSYCHIAT SCAND, V100, P67, DOI 10.1111/j.1600-0447.1999.tb10916.x; MATHEW RJ, 1992, J CEREBR BLOOD F MET, V12, P750, DOI 10.1038/jcbfm.1992.106; Mathew RJ, 2002, PSYCHIAT RES-NEUROIM, V116, P173, DOI 10.1016/S0925-4927(02)00069-0; McLaughlin PJ, 2003, BEHAV PHARMACOL, V14, P583, DOI 10.1097/00008877-200312000-00002; Mechoulam R, 1996, J LIPID MEDIAT CELL, V14, P45, DOI 10.1016/0929-7855(96)01507-6; Montecucco F, 2012, TRENDS PHARMACOL SCI, V33, P331, DOI 10.1016/j.tips.2012.03.002; MOSS IR, 1976, LIFE SCI, V19, P99, DOI 10.1016/0024-3205(76)90379-9; Mukhopadhyay P, 2010, CARDIOVASC RES, V85, P773, DOI 10.1093/cvr/cvp369; Niederhoffer N, 2003, N-S ARCH PHARMACOL, V367, P434, DOI 10.1007/s00210-003-0755-y; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pacher P, 2005, HANDB EXP PHARMACOL, V168, P599; Pacher P, 2005, AM J PHYSIOL-HEART C, V289, pH533, DOI 10.1152/ajpheart.00107.2005; Pacher P, 2004, J PHYSIOL-LONDON, V558, P647, DOI 10.1113/jphysiol.2004.064824; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pacher P, 2009, SEMIN IMMUNOPATHOL, V31, P63, DOI 10.1007/s00281-009-0145-8; Padley JR, 2003, BRIT J PHARMACOL, V140, P384, DOI 10.1038/sj.bjp.0705422; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Petrosino S, 2010, CURR OPIN INVEST DR, V11, P51; Pfitzer T, 2004, BRIT J PHARMACOL, V142, P943, DOI 10.1038/sj.bjp.0705874; PHILLIPS RN, 1971, P SOC EXP BIOL MED, V136, P260; Rajesh M, 2012, DIABETES, V61, P716, DOI 10.2337/db11-0477; Ralevic V, 2009, CURR VASC PHARMACOL, V7, P15, DOI 10.2174/157016109787354114; Randall MD, 2004, BRIT J PHARMACOL, V142, P20, DOI 10.1038/sj.bjp.0705725; Randall MD, 2002, PHARMACOL THERAPEUT, V95, P191, DOI 10.1016/S0163-7258(02)00258-9; ROSENKRANTZ H, 1974, TOXICOL APPL PHARM, V28, P18, DOI 10.1016/0041-008X(74)90126-4; Ruisanchez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037798; Sandor P, 1999, NEUROCHEM INT, V35, P237, DOI 10.1016/S0197-0186(99)00067-4; Savinainen JR, 2003, BRIT J PHARMACOL, V140, P1451, DOI 10.1038/sj.bjp.0705577; Schmid K, 2003, N-S ARCH PHARMACOL, V368, P301, DOI 10.1007/s00210-003-0787-3; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Seifert T, 2011, PROG NEUROBIOL, V95, P406, DOI 10.1016/j.pneurobio.2011.09.008; Stein EA, 1998, NEUROPSYCHOPHARMACOL, V19, P481, DOI 10.1016/S0893-133X(98)00043-8; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Toth A, 2009, VITAM HORM, V81, P389, DOI 10.1016/S0083-6729(09)81015-7; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Vangeison G, 2009, NEUROSCIENTIST, V15, P579, DOI 10.1177/1073858409332405; VARGA K, 1995, EUR J PHARMACOL, V278, P279, DOI 10.1016/0014-2999(95)00181-J; Varga K, 1996, HYPERTENSION, V28, P682, DOI 10.1161/01.HYP.28.4.682; WAGERLE LC, 1986, PEDIATR RES, V20, P131, DOI 10.1203/00006450-198602000-00007; Wagner JA, 2001, EUR J PHARMACOL, V423, P203, DOI 10.1016/S0014-2999(01)01112-8; Zakrzeska A, 2010, BRIT J PHARMACOL, V160, P574, DOI 10.1111/j.1476-5381.2009.00579.x	98	18	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53390	10.1371/journal.pone.0053390	http://dx.doi.org/10.1371/journal.pone.0053390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308211	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100036
J	Pardo, I; Pata, MP; Gomez, D; Garcia, MB				Pardo, Iker; Pata, Maria P.; Gomez, Daniel; Garcia, Maria B.			A Novel Method to Handle the Effect of Uneven Sampling Effort in Biodiversity Databases	PLOS ONE			English	Article							SPECIES RICHNESS ESTIMATORS; NONPARAMETRIC-ESTIMATION; ACCUMULATION FUNCTIONS; PLANT DIVERSITY; CONSERVATION; BIAS; INVENTORIES; COMPLETENESS; SENSITIVITY; SELECTION	How reliable are results on spatial distribution of biodiversity based on databases? Many studies have evidenced the uncertainty related to this kind of analysis due to sampling effort bias and the need for its quantification. Despite that a number of methods are available for that, little is known about their statistical limitations and discrimination capability, which could seriously constrain their use. We assess for the first time the discrimination capacity of two widely used methods and a proposed new one (FIDEGAM), all based on species accumulation curves, under different scenarios of sampling exhaustiveness using Receiver Operating Characteristic (ROC) analyses. Additionally, we examine to what extent the output of each method represents the sampling completeness in a simulated scenario where the true species richness is known. Finally, we apply FIDEGAM to a real situation and explore the spatial patterns of plant diversity in a National Park. FIDEGAM showed an excellent discrimination capability to distinguish between well and poorly sampled areas regardless of sampling exhaustiveness, whereas the other methods failed. Accordingly, FIDEGAM values were strongly correlated with the true percentage of species detected in a simulated scenario, whereas sampling completeness estimated with other methods showed no relationship due to null discrimination capability. Quantifying sampling effort is necessary to account for the uncertainty in biodiversity analyses, however, not all proposed methods are equally reliable. Our comparative analysis demonstrated that FIDEGAM was the most accurate discriminator method in all scenarios of sampling exhaustiveness, and therefore, it can be efficiently applied to most databases in order to enhance the reliability of biodiversity analyses.	[Pardo, Iker; Pata, Maria P.; Garcia, Maria B.] CSIC, Pyrenean Inst Ecol, Zaragoza, Spain; [Gomez, Daniel] CSIC, Pyrenean Inst Ecol, Jaca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Pardo, I (corresponding author), CSIC, Pyrenean Inst Ecol, Zaragoza, Spain.	iker.pardo@ipe.csic.es	Garcia, Maria Begoña/B-6630-2015; Pardo, Iker/AAX-6123-2020	Garcia, Maria Begoña/0000-0003-4231-6006; Pardo, Iker/0000-0001-7005-6411	Spanish Ministry of Science and Technology [AP2008-01449]; National Parks [018/2008, 430/211]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Parks	Funding: Funding was provided by the Spanish Ministry of Science and Technology through a doctoral grant(AP2008-01449), and two projects of National Parks (018/2008 and 430/211), (http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends A, 2011, DIVERS DISTRIB, V17, P191, DOI 10.1111/j.1472-4642.2010.00737.x; Aranda SC, 2010, BIODIVERS CONSERV, V19, P2469, DOI 10.1007/s10531-010-9854-5; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Brose U, 2003, ECOLOGY, V84, P2364, DOI 10.1890/02-0558; Brown CD, 2006, CHEMOMETR INTELL LAB, V80, P24, DOI 10.1016/j.chemolab.2005.05.004; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chiarucci A, 2001, BIOL CONSERV, V101, P305, DOI 10.1016/S0006-3207(01)00073-8; Christen JA, 2003, J AGRIC BIOL ENVIR S, V8, P184, DOI 10.1198/1085711031553; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; De Ornellas P, 2011, BIOL CONSERV, V144, P1980, DOI 10.1016/j.biocon.2011.04.018; Dennis RLH, 2001, BIODIVERS CONSERV, V10, P483, DOI 10.1023/A:1016602309983; Dennis RLH, 1999, J INSECT CONSERV, V3, P33, DOI 10.1023/A:1009678422145; Diaz-Frances E, 2005, CONSERV BIOL, V19, P569, DOI 10.1111/j.1523-1739.2005.00453.x; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Fagan WF, 1997, BIOL CONSERV, V80, P249, DOI 10.1016/S0006-3207(96)00144-9; Feeley KJ, 2011, GLOBAL CHANGE BIOL, V17, P626, DOI 10.1111/j.1365-2486.2010.02239.x; Follner K, 2006, THESIS; Font X, 2010, WALDOKOLOGIE LANDSCH, V9, P15; Freitag S, 1998, P ROY SOC B-BIOL SCI, V265, P1475, DOI 10.1098/rspb.1998.0460; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gaston KJ, 2003, CONSERV BIOL, V17, P188, DOI 10.1046/j.1523-1739.2003.01268.x; Gonzalez JA, 2009, ENVIRON ENTOMOL, V38, P608, DOI 10.1603/022.038.0312; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Grand J, 2007, ECOL LETT, V10, P364, DOI 10.1111/j.1461-0248.2007.01025.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HANLEY JA, 1989, CRIT REV DIAGN IMAG, V29, P307; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T., 1986, STAT SCI, V1, P297; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Hortal J, 2005, BIODIVERS CONSERV, V14, P2913, DOI 10.1007/s10531-004-0224-z; Hortal J, 2004, ECOGRAPHY, V27, P68, DOI 10.1111/j.0906-7590.2004.03635.x; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Jansen F, 2010, J VEG SCI, V21, P1179, DOI 10.1111/j.1654-1103.2010.01209.x; Jennings MD, 2008, BIODIVERS CONSERV, V17, P833, DOI 10.1007/s10531-008-9322-7; Jimenez-Valverde A, 2006, BIODIVERS CONSERV, V15, P177, DOI 10.1007/s10531-004-5016-y; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kleinbaum D. G., 2010, LOGISTIC REGRESSION; Knuppel L, 2010, ASTA-ADV STAT ANAL, V94, P53, DOI 10.1007/s10182-010-0122-5; Krishtalka L, 2000, BIOSCIENCE, V50, P611, DOI 10.1641/0006-3568(2000)050[0611:CNHMCT]2.0.CO;2; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; Lobo JM, 2002, CONSERV BIOL, V16, P158, DOI 10.1046/j.1523-1739.2002.00211.x; Lobo JM, 2008, BIODIVERS CONSERV, V17, P873, DOI 10.1007/s10531-008-9333-4; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Magurran A.E, 2004, MEASURING BIOL DIVER; Mao CX, 2005, BIOMETRICS, V61, P433, DOI 10.1111/j.1541-0420.2005.00316.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Moreno CE, 2000, J APPL ECOL, V37, P149, DOI 10.1046/j.1365-2664.2000.00483.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pepe M. S., 2003, STAT EVALUATION MED; Pepe MS, 2009, STATA J, V9, P1; Pepe MS, 2000, BIOMETRICS, V56, P352, DOI 10.1111/j.0006-341X.2000.00352.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Possingham HP, 2007, J BIOGEOGR, V34, P758, DOI 10.1111/j.1365-2699.2007.01717.x; Prendergast J.R., 1993, Biodiversity Letters, V1, P39, DOI 10.2307/2999649; R Development Core Team, 2011, R LANG ENV STAT; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Robertson MP, 2010, DIVERS DISTRIB, V16, P363, DOI 10.1111/j.1472-4642.2010.00639.x; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Romo H, 2006, ECOGRAPHY, V29, P873, DOI 10.1111/j.2006.0906-7590.04680.x; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Sanchez-Fernandez D, 2008, DIVERS DISTRIB, V14, P754, DOI 10.1111/j.1472-4642.2008.00474.x; Santos AMC, 2010, INSECT CONSERV DIVER, V3, P72, DOI 10.1111/j.1752-4598.2010.00079.x; Sastre P, 2009, BIOL CONSERV, V142, P462, DOI 10.1016/j.biocon.2008.11.002; Seber G., 1989, NONLINEAR REGRESSION; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; SOBERON J, 1993, CONSERV BIOL, V7, P480, DOI 10.1046/j.1523-1739.1993.07030480.x; Soberon J, 2007, ECOGRAPHY, V30, P152, DOI 10.1111/j.2006.0906-7590.04627.x; Stockwell David, 2003, Ecological Indicators, V3, P213, DOI 10.1016/S1470-160X(03)00045-1; Swets J., 1982, EVALUATION DIAGNOSTI; Tobler M, 2007, BIODIVERS CONSERV, V16, P659, DOI 10.1007/s10531-005-3373-9; Tucker CM, 2012, CONSERV BIOL, V26, P593, DOI 10.1111/j.1523-1739.2012.01845.x; Ulrich W, 2010, OIKOS, V119, P1149, DOI 10.1111/j.1600-0706.2009.18236.x; WAHBA G., 1990, SPLINE MODELS OBSERV, V59, DOI [10.1137/1.9781611970128, DOI 10.1137/1.9781611970128]; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams VL, 2007, BIODIVERS CONSERV, V16, P2495, DOI 10.1007/s10531-006-9026-9; Wood SN, 2006, GEN ADDITIVE MODELS; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zuur Alain F., 2009, P1	95	16	17	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52786	10.1371/journal.pone.0052786	http://dx.doi.org/10.1371/journal.pone.0052786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326357	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800025
J	Suzuki, M; Sugimura, Y; Yamada, S; Omori, Y; Miyamoto, M; Yamamoto, J				Suzuki, Makoto; Sugimura, Yuko; Yamada, Sumio; Omori, Yoshitsugu; Miyamoto, Masaaki; Yamamoto, Jun-ichi			Predicting Recovery of Cognitive Function Soon after Stroke: Differential Modeling of Logarithmic and Linear Regression	PLOS ONE			English	Article							MINI-MENTAL-STATE; WHITE-MATTER LESIONS; 2-YEAR FOLLOW-UP; IMPAIRMENT; POSTSTROKE; REHABILITATION; DEMENTIA; RISK; PROGRESSION; SURVIVORS	Cognitive disorders in the acute stage of stroke are common and are important independent predictors of adverse outcome in the long term. Despite the impact of cognitive disorders on both patients and their families, it is still difficult to predict the extent or duration of cognitive impairments. The objective of the present study was, therefore, to provide data on predicting the recovery of cognitive function soon after stroke by differential modeling with logarithmic and linear regression. This study included two rounds of data collection comprising 57 stroke patients enrolled in the first round for the purpose of identifying the time course of cognitive recovery in the early-phase group data, and 43 stroke patients in the second round for the purpose of ensuring that the correlation of the early-phase group data applied to the prediction of each individual's degree of cognitive recovery. In the first round, Mini-Mental State Examination (MMSE) scores were assessed 3 times during hospitalization, and the scores were regressed on the logarithm and linear of time. In the second round, calculations of MMSE scores were made for the first two scoring times after admission to tailor the structures of logarithmic and linear regression formulae to fit an individual's degree of functional recovery. The time course of early-phase recovery for cognitive functions resembled both logarithmic and linear functions. However, MMSE scores sampled at two baseline points based on logarithmic regression modeling could estimate prediction of cognitive recovery more accurately than could linear regression modeling (logarithmic modeling, R-2 = 0.676, P < 0.0001; linear regression modeling, R-2 = 0.598, P < 0.0001). Logarithmic modeling based on MMSE scores could accurately predict the recovery of cognitive function soon after the occurrence of stroke. This logarithmic modeling with mathematical procedures is simple enough to be adopted in daily clinical practice.	[Suzuki, Makoto] Niigata Univ Hlth & Welf, Fac Med Technol, Niigata, Japan; [Sugimura, Yuko] Kawasaki Municipal Tama Hosp, Dept Rehabil Med, Kawasaki, Kanagawa, Japan; [Yamada, Sumio] Nagoya Univ, Grad Sch Med, Dept Rehabil Sci, Nagoya, Aichi 4648601, Japan; [Omori, Yoshitsugu] St Marianna Univ, Yokohama City Seibu Hosp, Dept Rehabil Med, Yokohama, Kanagawa, Japan; [Miyamoto, Masaaki] Fuchinobe Gen Hosp, Dept Rehabil Med, Sagamihara, Kanagawa, Japan; [Yamamoto, Jun-ichi] Keio Univ, Grad Sch Human Relat, Minato Ku, Tokyo 108, Japan	Niigata University; Nagoya University; Saint Marianna University; Keio University	Suzuki, M (corresponding author), Niigata Univ Hlth & Welf, Fac Med Technol, Niigata, Japan.	mak-suzu@nuhw.ac.jp			Mitsubishi Foundation	Mitsubishi Foundation	This work was supported by Research Grants in the Humanities from the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard C, 2003, INT PSYCHOGERIATR, V15, P123, DOI 10.1017/S1041610203009074; Ballard C, 2003, STROKE, V34, P2440, DOI 10.1161/01.STR.0000089923.29724.CE; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; DAM M, 1993, STROKE, V24, P1186, DOI 10.1161/01.STR.24.8.1186; Desmond DW, 1996, STROKE, V27, P1798, DOI 10.1161/01.STR.27.10.1798; Donovan NJ, 2008, NEUROREHAB NEURAL RE, V22, P122, DOI 10.1177/1545968307306239; FERRUCCI L, 1993, STROKE, V24, P200, DOI 10.1161/01.STR.24.2.200; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fu JH, 2005, J NEUROL NEUROSUR PS, V76, P793, DOI 10.1136/jnnp.2003.032771; Goodwin N, 2003, CLIN REHABIL, V17, P69, DOI 10.1191/0269215503cr571oa; GRACE J, 1995, ARCH NEUROL-CHICAGO, V52, P477, DOI 10.1001/archneur.1995.00540290067019; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; Hochstenbach JB, 2003, ARCH PHYS MED REHAB, V84, P1499, DOI 10.1016/S0003-9993(03)00370-8; Hulley S. B., 1988, DESIGNING CLIN RES; Inzitari D, 1998, STROKE, V29, P2087, DOI 10.1161/01.STR.29.10.2087; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; JUNQUE C, 1990, ARCH NEUROL-CHICAGO, V47, P151, DOI 10.1001/archneur.1990.00530020047013; KOTILA M, 1984, STROKE, V15, P1039, DOI 10.1161/01.STR.15.6.1039; Koyama T, 2005, CLIN REHABIL, V19, P779, DOI 10.1191/0269215505cr876oa; Mok VCT, 2004, J NEUROL NEUROSUR PS, V75, P560, DOI 10.1136/jnnp.2003.015107; MOLLOY DW, 1991, AM J PSYCHIAT, V148, P102; Moss A, 2006, STROKE, V37, P3043, DOI 10.1161/01.STR.0000249427.74970.15; Narushima K, 2003, AM J PSYCHIAT, V160, P1157, DOI 10.1176/appi.ajp.160.6.1157; Nys GMS, 2005, NEUROLOGY, V64, P821, DOI 10.1212/01.WNL.0000152984.28420.5A; Nys GMS, 2005, ARCH CLIN NEUROPSYCH, V20, P623, DOI 10.1016/j.acn.2005.04.001; PANTONI L, 1995, STROKE, V26, P1293, DOI 10.1161/01.STR.26.7.1293; Portney LG, 2000, FDN CLIN RES, V2nd; Rasquin SMC, 2005, J NEUROL SCI, V229, P21, DOI 10.1016/j.jns.2004.11.015; Roth EJ, 1998, ARCH PHYS MED REHAB, V79, P329, DOI 10.1016/S0003-9993(98)90015-6; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Samuelsson M, 1996, STROKE, V27, P842, DOI 10.1161/01.STR.27.5.842; Sonohara K, 2008, GERIATR GERONTOL INT, V8, P93, DOI 10.1111/j.1447-0594.2008.00454.x; Subramanian SK, 2010, NEUROREHAB NEURAL RE, V24, P113, DOI 10.1177/1545968309349941; Suzuki M, 2008, AM J PHYS MED REHAB, V87, P740, DOI 10.1097/PHM.0b013e31818378b0; Suzuki M, 2006, ARCH PHYS MED REHAB, V87, P1496, DOI 10.1016/j.apmr.2006.07.267; Suzuki M, 2011, J REHABIL MED, V43, P935, DOI 10.2340/16501977-0877; TATEMICHI TK, 1990, STROKE, V21, P858, DOI 10.1161/01.STR.21.6.858; Taylor WD, 2003, AM J ROENTGENOL, V181, P571, DOI 10.2214/ajr.181.2.1810571; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tham W, 2002, J NEUROL SCI, V203, P49, DOI 10.1016/S0022-510X(02)00260-5; Tilling K, 2001, STROKE, V32, P2867, DOI 10.1161/hs1201.099413; WADE DT, 1985, J NEUROL NEUROSUR PS, V48, P7, DOI 10.1136/jnnp.48.1.7; YLIKOSKI R, 1993, ARCH NEUROL-CHICAGO, V50, P818, DOI 10.1001/archneur.1993.00540080029009; Zinn S, 2004, ARCH PHYS MED REHAB, V85, P1084, DOI 10.1016/j.apmr.2003.10.022	46	11	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53488	10.1371/journal.pone.0053488	http://dx.doi.org/10.1371/journal.pone.0053488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326439	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800048
J	Baronchelli, A; Chater, N; Christiansen, MH; Pastor-Satorras, R				Baronchelli, Andrea; Chater, Nick; Christiansen, Morten H.; Pastor-Satorras, Romualdo			Evolution in a Changing Environment	PLOS ONE			English	Article							CLIMATE-CHANGE; STATISTICAL PHYSICS; COEVOLUTION; ADAPTATION; EXTINCTION; SELECTION; LANGUAGE; GENES; TRAIT	We propose a simple model for genetic adaptation to a changing environment, describing a fitness landscape characterized by two maxima. One is associated with "specialist'' individuals that are adapted to the environment; this maximum moves over time as the environment changes. The other maximum is static, and represents "generalist'' individuals not affected by environmental changes. The rest of the landscape is occupied by "maladapted'' individuals. Our analysis considers the evolution of these three subpopulations. Our main result is that, in presence of a sufficiently stable environmental feature, as in the case of an unchanging aspect of a physical habitat, specialists can dominate the population. By contrast, rapidly changing environmental features, such as language or cultural habits, are a moving target for the genes; here, generalists dominate, because the best evolutionary strategy is to adopt neutral alleles not specialized for any specific environment. The model we propose is based on simple assumptions about evolutionary dynamics and describes all possible scenarios in a non-trivial phase diagram. The approach provides a general framework to address such fundamental issues as the Baldwin effect, the biological basis for language, or the ecological consequences of a rapid climate change.	[Baronchelli, Andrea] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA; [Chater, Nick] Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry CV4 7AL, W Midlands, England; [Christiansen, Morten H.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Christiansen, Morten H.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Pastor-Satorras, Romualdo] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain	Northeastern University; University of Warwick; Cornell University; The Santa Fe Institute; Universitat Politecnica de Catalunya	Pastor-Satorras, R (corresponding author), Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain.	romualdo.pastor@upc.edu	Baronchelli, Andrea/F-9550-2016; Pastor-Satorras, Romualdo/L-8837-2013; Chater, Nick/GRX-6742-2022	Baronchelli, Andrea/0000-0002-0255-0829; Pastor-Satorras, Romualdo/0000-0002-4051-6007; 	Spanish MEC (FEDER) [FIS2010-21781-C02-01]; Junta de Andalucia [P09-FQM4682]; ICREA Academia; Generalitat de Catalunya	Spanish MEC (FEDER)(Spanish GovernmentEuropean Commission); Junta de Andalucia(Junta de Andalucia); ICREA Academia(ICREA); Generalitat de Catalunya(Generalitat de Catalunya)	AB and RP-S acknowledge financial support from the Spanish MEC (FEDER), under project FIS2010-21781-C02-01, and the Junta de Andalucia, under project No. P09-FQM4682. RP-S acknowledges additional support through ICREA Academia, funded by the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 1999, J THEOR BIOL, V196, P197, DOI 10.1006/jtbi.1998.0833; Ancliff M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021904; Ancliff M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061910; Baldwin JM, 1896, AM NAT, V30, P441, DOI DOI 10.1086/276408; Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Chater N, 2009, P NATL ACAD SCI USA, V106, P1015, DOI 10.1073/pnas.0807191106; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; Crill WD, 2000, GENETICS, V154, P27; de Vladar HP, 2011, TRENDS ECOL EVOL, V26, P424, DOI 10.1016/j.tree.2011.04.002; Drossel B, 2001, ADV PHYS, V50, P209, DOI 10.1080/00018730110041365; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Gillespie J, 1994, OXFORD SERIES ECOLOG; Gilman RT, 2012, NATURE, V483, P328, DOI 10.1038/nature10853; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Kirkpatrick M, 2009, GENETICA, V136, P271, DOI 10.1007/s10709-008-9302-6; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Legros M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-159; LYNCH M, 1991, LIMNOL OCEANOGR, V36, P1301, DOI 10.4319/lo.1991.36.7.1301; Moran P., 1962, STAT PROCESSES EVOLU; Nilsson M, 2002, B MATH BIOL, V64, P1033, DOI 10.1006/bulm.2002.0314; Nilsson M, 2000, PHYS REV LETT, V84, P191, DOI 10.1103/PhysRevLett.84.191; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pinker S., 2003, LANGUAGE EVOLUTION, P16, DOI DOI 10.1093/ACPR0F:0S0/9780199244843.003.0002; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Saakian DB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041913; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Saunders MA, 2002, GENETICS, V162, P1849; Sawyer SA, 2007, P NATL ACAD SCI USA, V104, P6504, DOI 10.1073/pnas.0701572104; Sella G, 2005, P NATL ACAD SCI USA, V102, P9541, DOI 10.1073/pnas.0501865102; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Wagner N, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.188101; WIESENFELD SL, 1967, SCIENCE, V157, P1134, DOI 10.1126/science.157.3793.1134; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	43	10	10	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52742	10.1371/journal.pone.0052742	http://dx.doi.org/10.1371/journal.pone.0052742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326355	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000313552400009
J	You, BJ; Lee, MH; Tien, N; Lee, MS; Hsieh, HC; Tseng, LH; Chung, YL; Lee, HZ				You, Bang-Jau; Lee, Miin-Huey; Tien, Ni; Lee, Meng-Shiou; Hsieh, Hui-Chuan; Tseng, Lin-Hsien; Chung, Yu-Lin; Lee, Hong-Zin			A Novel Approach to Enhancing Ganoderic Acid Production by Ganoderma lucidum Using Apoptosis Induction	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; NATURAL-PRODUCTS; CELL-DEATH; BIOSYNTHESIS; PATHWAYS; KINASE; GENE	Ganoderma lucidum is one of most widely used herbal medicine and functional food in Asia, and ganoderic acids (GAs) are its active ingredients. Regulation of GA biosynthesis and enhancing GA production are critical to using G. lucidum as a medicine. However, regulation of GA biosynthesis by various signaling remains poorly understood. This study investigated the role of apoptosis signaling on GA biosynthesis and presented a novel approach, namely apoptosis induction, to increasing GA production. Aspirin was able to induce cell apoptosis in G. lucidum, which was identified by terminal deoxynucleotidyl transferase mediated dUPT nick end labeling assay positive staining and a condensed nuclear morphology. The maximum induction of lanosta-7,9(11), 24-trien-3 alpha-01-26-oic acid (ganoderic acid 24, GA24) production and total GA production by aspirin were 2.7-fold and 2.8-fold, respectively, after 1 day. Significantly lower levels of GA 24 and total GAs were obtained after regular fungal culture for 1.5 months. ROS accumulation and phosphorylation of Hog-1 kinase, a putative homolog of MAPK p38 in mammals, occurred after aspirin treatment indicating that both factors may be involved in GA biosynthetic regulation. However, aspirin also reduced expression of the squalene synthase and lanosterol synthase coding genes, suggesting that these genes are not critical for GA induction. To the best of our knowledge, this is the first report showing that GA biosynthesis is linked to fungal apoptosis and provides a new approach to enhancing secondary metabolite production in fungi.	[You, Bang-Jau; Lee, Meng-Shiou; Hsieh, Hui-Chuan; Tseng, Lin-Hsien; Chung, Yu-Lin] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Lee, Miin-Huey] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Tien, Ni] China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan; [Lee, Hong-Zin] China Med Univ, Sch Pharm, Taichung, Taiwan	China Medical University Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	You, BJ (corresponding author), China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan.	bangjau@mail.cmu.edu.tw; hong@mail.cmu.edu.tw		Lee, Miin-Huey/0000-0001-8073-0916; Lee, Meng-Shiou/0000-0003-3470-4121	National Science Council of the Republic of China in Taiwan [NSC 97-2313-B-039-004-MY3, NSC 99-2321-B-039-001-MY3]; China Medical University in Taiwan [CMU98-N1-10]	National Science Council of the Republic of China in Taiwan(Ministry of Science and Technology, Taiwan); China Medical University in Taiwan(China Medical University)	This research was funded by National Science Council of the Republic of China in Taiwan (NSC 97-2313-B-039-004-MY3 and NSC 99-2321-B-039-001-MY3) and China Medical University in Taiwan (CMU98-N1-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzan R, 2004, MICROBIOL-SGM, V150, P109, DOI 10.1099/mic.0.26578-0; Bilsland E, 2004, MOL MICROBIOL, V53, P1743, DOI 10.1111/j.1365-2958.2004.04238.x; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Chen NH, 2011, PHYTOMEDICINE, V18, P719, DOI 10.1016/j.phymed.2011.01.011; Delgado-Jarana J, 2006, MICROBIOL-SGM, V152, P1687, DOI 10.1099/mic.0.28729-0; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Frohlich KU, 2007, SEMIN CANCER BIOL, V17, P112, DOI 10.1016/j.semcancer.2006.11.006; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Hamann A, 2008, TRENDS MICROBIOL, V16, P276, DOI 10.1016/j.tim.2008.03.003; Handa N, 2010, PHYTOCHEMISTRY, V71, P1774, DOI 10.1016/j.phytochem.2010.07.005; HIROTANI M, 1990, J CHEM SOC PERK T 1, P2751, DOI 10.1039/p19900002751; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Jiang ZJ, 2011, PROCESS BIOCHEM, V46, P1307, DOI 10.1016/j.procbio.2011.02.023; Kawasaki L, 2002, MOL MICROBIOL, V45, P1153, DOI 10.1046/j.1365-2958.2002.03087.x; Li TH, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/128402; Liang CX, 2010, APPL MICROBIOL BIOT, V86, P1367, DOI 10.1007/s00253-009-2415-8; Liu RM, 2012, EUR J PHARMACOL, V681, P23, DOI 10.1016/j.ejphar.2012.02.007; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Ren A, 2010, BIORESOURCE TECHNOL, V101, P6785, DOI 10.1016/j.biortech.2010.03.118; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Sapienza K, 2008, CELL APOPTOSIS RES P, P49; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; SHIAO MS, 1992, J CHIN CHEM SOC-TAIP, V39, P669, DOI 10.1002/jccs.199200102; Shiao MS, 2003, CHEM REC, V3, P172, DOI 10.1002/tcr.10058; Shwab EK, 2008, MYCOL RES, V112, P225, DOI 10.1016/j.mycres.2007.08.021; Thoms HC, 2007, CANCER RES, V67, P1660, DOI 10.1158/0008-5472.CAN-06-1038; Wang JW, 2002, ACTA BOT SIN, V44, P1233; Xu JW, 2012, APPL ENVIRON MICROB, V78, P7968, DOI 10.1128/AEM.01263-12; Xu JW, 2010, APPL MICROBIOL BIOT, V87, P457, DOI 10.1007/s00253-010-2576-5; Xu JW, 2010, APPL MICROBIOL BIOT, V85, P941, DOI 10.1007/s00253-009-2106-5; Xu K, 2010, PROCESS BIOCHEM, V45, P1261, DOI 10.1016/j.procbio.2010.04.013; Xu YN, 2018, BIOTECHNOL ADV; You BJ, 2012, BIOSCI BIOTECH BIOCH, V76, P1529, DOI 10.1271/bbb.120270; You BJ, 2012, FOOD RES INT, DOI [10.1016/j.foodres.2012.1009.1003, DOI 10.1016/J.FOODRES.2012.1009.1003]; Yu YL, 2009, EUR J IMMUNOL, V39, P2482, DOI 10.1002/eji.200839039; Yuan YJ, 2002, PROCESS BIOCHEM, V38, P193, DOI 10.1016/S0032-9592(02)00071-7; Zhang WX, 2010, J BIOSCI BIOENG, V109, P37, DOI 10.1016/j.jbiosc.2009.06.024; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zhao J, 2007, NEW PHYTOL, V175, P215, DOI 10.1111/j.1469-8137.2007.02109.x; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106; Zhao W, 2011, BIORESOURCE TECHNOL, V102, P8185, DOI 10.1016/j.biortech.2011.06.043; Zhou L, 2011, PROCESS BIOCHEM, V46, P219, DOI 10.1016/j.procbio.2010.08.014	45	64	71	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53616	10.1371/journal.pone.0053616	http://dx.doi.org/10.1371/journal.pone.0053616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326470	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400031
J	Hinaux, H; Poulain, J; Da Silva, C; Noirot, C; Jeffery, WR; Casane, D; Retaux, S				Hinaux, Helene; Poulain, Julie; Da Silva, Corinne; Noirot, Celine; Jeffery, William R.; Casane, Didier; Retaux, Sylvie			De Novo Sequencing of Astyanax mexicanus Surface Fish and Pachon Cavefish Transcriptomes Reveals Enrichment of Mutations in Cavefish Putative Eye Genes	PLOS ONE			English	Article							BLIND CAVEFISH; PELVIC REDUCTION; FASCIATUS; LENS; DEGENERATION; CHARACIDAE; EVOLUTION; MODULES; PISCES; SYSTEM	Astyanax mexicanus, a teleost species with surface dwelling (surface fish) and cave adapted (cavefish) morphs, is an important model system in evolutionary developmental biology (evodevo). Astyanax cavefish differ from surface fish in numerous traits, including the enhancement of non-visual sensory systems, and the loss of eyes and pigmentation. The genetic bases for these differences are not fully understood as genomic and transcriptomic data are lacking. We here present de novo transcriptome sequencing of embryonic and larval stages of a surface fish population and a cavefish population originating from the Pachon cave using the Sanger method. This effort represents the first large scale sequence and clone resource for the Astyanax research community. The analysis of these sequences show low levels of polymorphism in cavefish compared to surface fish, confirming previous studies on a small number of genes. A high proportion of the genes mutated in cavefish are known to be expressed in the zebrafish visual system. Such a high number of mutations in cavefish putative eye genes may be explained by relaxed selection for vision during the evolution in the absence of light. Based on these sequence differences, we provide a list of 11 genes that are potential candidates for having a role in cavefish visual system degeneration.	[Hinaux, Helene; Retaux, Sylvie] CNRS, DECA Grp, N&D Lab, Gif Sur Yvette, France; [Poulain, Julie; Da Silva, Corinne] Genscope CEA Sequencing Ctr, Evry, France; [Noirot, Celine] INRA Bioinformat Platform, Toulouse, France; [Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Casane, Didier] CNRS Gif Sur Yvette, LEGS, Paris, France; [Casane, Didier] Univ Paris Diderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Retaux, S (corresponding author), CNRS, DECA Grp, N&D Lab, Gif Sur Yvette, France.	retaux@inaf.cnrs-gif.fr		DA SILVA, Corinne/0000-0002-7618-7831; Hinaux, Helene/0000-0003-0032-1405; Poulain, Julie/0000-0002-8744-3116	Agence Nationale de la Recherche [ASTYCO] grant; National Institutes of Health grant [EY014619]; NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER	Agence Nationale de la Recherche [ASTYCO] grant(French National Research Agency (ANR)); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by an Agence Nationale de la Recherche [ASTYCO] grant to SR and by a National Institutes of Health grant (EY014619) to WRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunni A, 2007, J COMP NEUROL, V505, P221, DOI 10.1002/cne.21488; Behrens M, 1997, MOL BIOL EVOL, V14, P299, DOI 10.1093/oxfordjournals.molbev.a025765; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Briggs JC, 2005, J BIOGEOGR, V32, P287, DOI 10.1111/j.1365-2699.2004.01170.x; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Hinaux H, 2011, ZEBRAFISH, V8, P155, DOI 10.1089/zeb.2011.0713; Hooven TA, 2004, INT J DEV BIOL, V48, P731, DOI 10.1387/ijdb.041874th; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; HUPPOP K, 1986, ENVIRON BIOL FISH, V17, P299, DOI 10.1007/BF00001496; Jeffery WR, 2010, HEREDITY, V105, P495, DOI 10.1038/hdy.2010.7; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitchell R.W., 1977, MEXICAN EYELESS CHAR; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Peng ZG, 2006, GENE, V370, P113, DOI 10.1016/j.gene.2005.11.024; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pottin K, 2011, DEVELOPMENT, V138, P2467, DOI 10.1242/dev.054106; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Salin K, 2010, COMP BIOCHEM PHYS A, V156, P451, DOI 10.1016/j.cbpa.2010.03.030; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Soares D, 2004, DEV NEUROSCI-BASEL, V26, P308, DOI 10.1159/000082272; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tempel Sebastien, 2012, Methods Mol Biol, V859, P29, DOI 10.1007/978-1-61779-603-6_2; Thisse B, 2004, ZFIN DIRECT DATA SUB; Wilkens H, 2010, HEREDITY, V105, P413, DOI 10.1038/hdy.2009.184; Yamamoto Y, 2000, SCIENCE, V289, P631, DOI 10.1126/science.289.5479.631; YOKOYAMA S, 1995, MOL BIOL EVOL, V12, P527; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017; Zhang XB, 2004, FEBS LETT, V559, P57, DOI 10.1016/S0014-5793(04)00024-9	41	66	66	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53553	10.1371/journal.pone.0053553	http://dx.doi.org/10.1371/journal.pone.0053553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326453	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500081
J	Terman, DS; Viglianti, BL; Zennadi, R; Fels, D; Boruta, RJ; Yuan, H; Dreher, MR; Grant, G; Rabbani, ZN; Moon, E; Lan, L; Eble, J; Cao, YT; Sorg, B; Ashcraft, K; Palmer, G; Telen, MJ; Dewhirst, MW				Terman, David S.; Viglianti, Benjamin L.; Zennadi, Rahima; Fels, Diane; Boruta, Richard J.; Yuan, Hong; Dreher, Mathew R.; Grant, Gerald; Rabbani, Zahid N.; Moon, Ejung; Lan, Lan; Eble, Joseph; Cao, Yiting; Sorg, Brian; Ashcraft, Kathleen; Palmer, Greg; Telen, Marilyn J.; Dewhirst, Mark W.			Sickle Erythrocytes Target Cytotoxics to Hypoxic Tumor Microvessels and Potentiate a Tumoricidal Response	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; ENDOTHELIAL-CELLS; ZINC PROTOPORPHYRIN; HEME OXYGENASE-1; SOLID TUMORS; BLOOD-CELLS; ACTIVATION; MICE; CANCER; DISEASE	Resistance of hypoxic solid tumor niches to chemotherapy and radiotherapy remains a major scientific challenge that calls for conceptually new approaches. Here we exploit a hitherto unrecognized ability of sickled erythrocytes (SSRBCs) but not normal RBCs (NLRBCs) to selectively target hypoxic tumor vascular microenviroment and induce diffuse vaso-occlusion. Within minutes after injection SSRBCs, but not NLRBCs, home and adhere to hypoxic 4T1 tumor vasculature with hemoglobin saturation levels at or below 10% that are distributed over 70% of the tumor space. The bound SSRBCs thereupon form microaggregates that obstruct/occlude up to 88% of tumor microvessels. Importantly, SSRBCs, but not normal RBCs, combined with exogenous prooxidant zinc protoporphyrin (ZnPP) induce a potent tumoricidal response via a mutual potentiating mechanism. In a clonogenic tumor cell survival assay, SSRBC surrogate hemin, along with H2O2 and ZnPP demonstrate a similar mutual potentiation and tumoricidal effect. In contrast to existing treatments directed only to the hypoxic tumor cell, the present approach targets the hypoxic tumor vascular environment and induces injury to both tumor microvessels and tumor cells using intrinsic SSRBC-derived oxidants and locally generated ROS. Thus, the SSRBC appears to be a potent new tool for treatment of hypoxic solid tumors, which are notable for their resistance to existing cancer treatments.	[Terman, David S.] Jenomic, Mol Genet Program, Carmel, CA USA; [Viglianti, Benjamin L.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Zennadi, Rahima; Telen, Marilyn J.] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA; [Fels, Diane; Rabbani, Zahid N.; Moon, Ejung; Ashcraft, Kathleen; Palmer, Greg; Dewhirst, Mark W.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Boruta, Richard J.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Yuan, Hong] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Dreher, Mathew R.] NIH, Ctr Clin, Dept Diagnost Radiol, Bethesda, MD 20892 USA; [Grant, Gerald] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA; [Lan, Lan] Duke Univ, Med Ctr, Dept Biostat, Durham, NC USA; [Eble, Joseph] Mayo Clin Fdn, Dept Radiol, Rochester, MN USA; [Cao, Yiting] Duke Univ, Med Ctr, Dept Surg, Div Neurooncol, Durham, NC 27710 USA; [Sorg, Brian] NCI, Canc Diag Program, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Duke University; Duke University; Mayo Clinic; Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Terman, DS (corresponding author), Jenomic, Mol Genet Program, Carmel, CA USA.	dst@sbcglobal.net; mark.dewhirst@duke.edu	Dewhirst, Mark/Q-1302-2019; Palmer, Gregory M/C-6910-2008; Moon, Eui Jung/AAM-3223-2021	Dewhirst, Mark/0000-0003-3459-6546; Palmer, Gregory M/0000-0003-2955-8297; Moon, Eui Jung/0000-0001-7916-7978; Telen, Marilyn/0000-0003-3809-1780; Yuan, Hong/0000-0002-0535-3214; Rabbani, zahid/0000-0002-4101-7947	National Institutes of Health (NIH) National Cancer Institute (NCI) [CA40355-23, CA40355-24, CA40355-25, CA40355-26, CA40355-27]; NATIONAL CANCER INSTITUTE [R01CA040355] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health (NIH) National Cancer Institute (NCI) CA40355-23, -24, -25, -26, 27 to M. W. Dewhirst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MF, 1999, INT J RADIAT ONCOL, V45, P171, DOI 10.1016/S0360-3016(99)00157-1; Agrawal A, 2008, PEDIATR NEUROSURG, V44, P471, DOI 10.1159/000180301; ALGIRE GH, 1949, J NATL CANCER I, V10, P225; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; BALLA G, 1991, LAB INVEST, V64, P648; Ballas SK, 2006, TRANSFUSION, V46, P105, DOI 10.1111/j.1537-2995.2006.00679.x; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Brown MD, 2001, PEDIATR PATHOL MOL M, V20, P47, DOI 10.1080/15513810109168817; Brown SL, 2003, MAGNET RESON MED, V50, P1209, DOI 10.1002/mrm.10646; Cao YT, 2005, CANCER RES, V65, P5498, DOI 10.1158/0008-5472.CAN-04-4553; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Dienst A, 2005, JNCI-J NATL CANCER I, V97, P733, DOI 10.1093/jnci/dji130; Du GJ, 2008, BIOCHEM BIOPH RES CO, V372, P497, DOI 10.1016/j.bbrc.2008.05.080; Embury SH, 2004, MICROCIRCULATION, V11, P101, DOI 10.1080/10739680490278277; Faller Douglas V., 1994, P235; Fang J, 2004, INT J CANCER, V109, P1, DOI 10.1002/ijc.11644; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; HEBBEL RP, 1982, J CLIN INVEST, V70, P1253, DOI 10.1172/JCI110724; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kalambur VS, 2004, AM J HEMATOL, V77, P117, DOI 10.1002/ajh.20143; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kaul DK, 2009, MICROCIRCULATION, V16, P97, DOI 10.1080/10739680802279394; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Labbe RF, 1999, CLIN CHEM, V45, P2060; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Milosevic M, 2001, GYNECOL ONCOL, V83, P428, DOI 10.1006/gyno.2001.6426; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Osarogiagbon UR, 2000, BLOOD, V96, P314, DOI 10.1182/blood.V96.1.314.013k39_314_320; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Reddy SB, 2009, EXPERT OPIN INV DRUG, V18, P77, DOI [10.1517/13543780802567250, 10.1517/13543780802567250 ]; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; REPKA T, 1991, BLOOD, V78, P2753; SIGGAARDANDERSEN O, 1984, CLIN CHEM, V30, P1646; Simizu S, 1998, J BIOL CHEM, V273, P26900, DOI 10.1074/jbc.273.41.26900; SMOLINSKI PA, 1995, BLOOD, V85, P2945, DOI 10.1182/blood.V85.10.2945.bloodjournal85102945; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; Sultana C, 1998, BLOOD, V92, P3924, DOI 10.1182/blood.V92.10.3924.422k07_3924_3935; Telen MJ, 2005, TRANSFUS MED REV, V19, P32, DOI 10.1016/j.tmrv.2004.09.006; Terada LS, 2002, CRIT CARE MED, V30, pS186, DOI 10.1097/00003246-200205001-00003; Terman DS, 1999, US patent Serial Number, Patent No. [7,803,637, 7803637]; UNTHANK JL, 1993, MICROVASC RES, V45, P193, DOI 10.1006/mvre.1993.1018; Vishwanath K, 2009, NEOPLASIA, V11, P889, DOI 10.1593/neo.09580; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wood KC, 2007, CLIN EXP PHARMACOL P, V34, P926, DOI 10.1111/j.1440-1681.2007.04639.x; Zennadi R, 2004, BLOOD, V104, P3774, DOI 10.1182/blood-2004-01-0042; Zennadi R, 2007, BLOOD, V110, P2708, DOI 10.1182/blood-2006-11-056101	57	17	20	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52543	10.1371/journal.pone.0052543	http://dx.doi.org/10.1371/journal.pone.0052543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326340	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500017
J	Lu, CC; Xu, MF; Wang, Y; Qin, YF; Du, GZ; Wu, W; Han, XM; Ji, C; Yang, YL; Gu, AH; Xia, YK; Song, L; Wang, SL; Wang, XR				Lu, Chuncheng; Xu, Miaofei; Wang, Ying; Qin, Yufeng; Du, Guizhen; Wu, Wei; Han, Xiumei; Ji, Chao; Yang, Yanli; Gu, Aihua; Xia, Yankai; Song, Ling; Wang, Shoulin; Wang, Xinru			Genetic Variants in Meiotic Program Initiation Pathway Genes Are Associated with Spermatogenic Impairment in a Han Chinese Population	PLOS ONE			English	Article							RETINOIC ACID; GERM-CELLS; SEX DETERMINATION; MEIOSIS; IDENTIFICATION	Background: The meiotic program initiation pathway genes (CYP26B1, NANOS1 and STRA8) have been proposed to play key roles in spermatogenesis. Objective: To elucidate the exact role of the genetic variants of the meiosis initiation genes in spermatogenesis, we genotyped the potential functional genetic variants of CYP26B1, NANOS1 and STRA8 genes, and evaluated their effects on spermatogenesis in our study population. Design, Setting, and Participants: In this study, all subjects were volunteers from the affiliated hospitals of Nanjing Medical University between March 2004 and July 2009 (NJMU Infertile Study). Total 719 idiopathic infertile cases were recruited and divided into three groups according to WHO semen parameters: 201 azoospermia patients (no sperm in the ejaculate even after centrifugation), 155 oligozoospermia patients (sperm counts <20x10(6)/ml) and 363 infertility/normozoospermia subjects (sperm counts >20x10(6)/ml). The control group consisted of 383 subjects with normal semen parameters, all of which had fathered at least one child without assisted reproductive technologies. Measurements: Eight single nucleotide polymorphisms (SNPs) in CYP26B1, NANOS1 and STRA8 genes were determined by TaqMan allelic discrimination assay in 719 idiopathic infertile men and 383 healthy controls. Results and Limitations: The genetic variant rs10269148 of STRA8 gene showed higher risk of spermatogenic impairment in the groups of abnormospermia (including azoospermia subgroup and oligozoospermia subgroup) and azoospermia than the controls with odds ratios and 95% confidence intervals of 2.52 (1.29-4.94) and 2.92 (1.41-6.06), respectively (P=0.006, 0.002 respective). Notably, larger sample size studies and in vivo or in vitro functional studies are needed to substantiate the biological roles of these variants. Conclusions: Our results provided epidemiological evidence supporting the involvement of genetic polymorphisms of the meiotic program initiation genes in modifying the risk of azoospermia and oligozoospermia in a Han-Chinese population.	[Lu, Chuncheng; Xu, Miaofei; Wang, Ying; Qin, Yufeng; Du, Guizhen; Wu, Wei; Han, Xiumei; Gu, Aihua; Xia, Yankai; Song, Ling; Wang, Shoulin; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Lu, Chuncheng; Xu, Miaofei; Wang, Ying; Qin, Yufeng; Du, Guizhen; Wu, Wei; Han, Xiumei; Gu, Aihua; Xia, Yankai; Song, Ling; Wang, Shoulin; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Ji, Chao] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Yang, Yanli] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, XR (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	xrwang@njmu.edu.cn	Wang, Xin/AAN-8435-2021; Wu, Wei/C-4409-2012; Yang, Ya-Li/GYU-4320-2022; yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022	Wang, Xin/0000-0002-4457-7376; Wu, Wei/0000-0002-0267-1284; 	National Basic Research Program of China (973 Program) [2009CB941703]; National Natural Science Foundation of China [30930079, 81100461, 810701297, 30671894]; Jiangsu Natural Science Foundation [BK2011774]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20113234120001]; University natural science research project in Jiangsu Province [11KJB330001]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); University natural science research project in Jiangsu Province; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	Funding was provided by grants from National Basic Research Program of China (973 Program) (2009CB941703), the National Natural Science Foundation of China (30930079, 81100461, 810701297 and 30671894), the Jiangsu Natural Science Foundation (BK2011774), Research Fund for the Doctoral Program of Higher Education of China (RFDP) (20113234120001), University natural science research project in Jiangsu Province (11KJB330001) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bolcun-Filas E, 2012, INT REV CEL MOL BIO, V298, P179, DOI 10.1016/B978-0-12-394309-5.00005-5; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brinkworth MH, 2000, MUTAT RES-FUND MOL M, V447, P149, DOI 10.1016/S0027-5107(99)00189-X; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; LI LB, 2008, NATL J ANDROL, V14, P211; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Ohta K, 2010, BIOL REPROD, V83, P1056, DOI 10.1095/biolreprod.110.085787; Okabe M, 1998, AM J HUM GENET, V62, P1274, DOI 10.1086/301895; Pawlowski WP, 2007, BIOESSAYS, V29, P511, DOI 10.1002/bies.20578; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Saga Y, 2008, DEV GROWTH DIFFER, V50, pS141, DOI 10.1111/j.1440-169X.2008.01009.x; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Swain A, 2006, CURR BIOL, V16, pR507, DOI 10.1016/j.cub.2006.06.009; Tahayato A, 2003, GENE EXPR PATTERNS, V3, P449, DOI 10.1016/S1567-133X(03)00066-8; Trautmann E, 2008, CELL CYCLE, V7, P656, DOI 10.4161/cc.7.5.5482; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Wolf G, 2001, NUTR REV, V59, P391, DOI 10.1111/j.1753-4887.2001.tb06968.x	25	7	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53443	10.1371/journal.pone.0053443	http://dx.doi.org/10.1371/journal.pone.0053443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320086	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800051
J	Pericolini, E; Alunno, A; Gabrielli, E; Bartoloni, E; Cenci, E; Chow, SK; Bistoni, G; Casadevall, A; Gerli, R; Vecchiarelli, A				Pericolini, Eva; Alunno, Alessia; Gabrielli, Elena; Bartoloni, Elena; Cenci, Elio; Chow, Siu-Kei; Bistoni, Giovanni; Casadevall, Arturo; Gerli, Roberto; Vecchiarelli, Anna			The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; MONOCLONAL-ANTIBODY; T(H)17 CELLS; CD4+T CELLS; APOPTOSIS; DISEASE; EXPRESSION; CYTOKINES; METHOTREXATE; AUTOIMMUNITY	The persistence of activated T cells in rheumatoid arthritis (RA) synovium may be attributable to increased homing, increased retention or a possible imbalance between cell proliferation and programmed cell death. Induction of apoptosis may represent a potential therapeutic approach. Galactoxylomannan (GalXM) from the opportunistic fungus Cryptococcus neoformans can interact with T cells and induce T-cell apoptosis through the inhibition of CD45 phosphatase activity. The aim of this study was to determine the effect of GalXM on circulating T cells from patients with RA and the underlying mechanisms. GalXM immunomodulating effect on apoptosis and signal transduction pathway involved in IL-17A production was evaluated on T cells. RA T-cell apoptosis, higher than that of control T cells, was further increased by GalXM through induction of caspase-3 activation. Activated T cells expressing the CD45RO molecule and producing IL-17A were the main target of GalXM-induced apoptosis. GalXM induced consistent impairment of IL-17A production and inhibition of STAT3, which was hyperactivated in RA. In conclusion, GalXM triggered apoptosis of activated memory T cells and interfered with IL-17A production in RA. These data suggest therapeutic targeting of deleterious Th17 cells in RA and other autoimmune diseases.	[Pericolini, Eva; Gabrielli, Elena; Cenci, Elio; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Alunno, Alessia; Bartoloni, Elena; Gerli, Roberto] Univ Perugia, Dept Clin & Expt Med, Rheumatol Unit, I-06100 Perugia, Italy; [Chow, Siu-Kei; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA; [Bistoni, Giovanni] Univ Rome, Dept Plast & Reconstruct Surg, La Sapienza Med Sch, Rome, Italy	University of Perugia; University of Perugia; Yeshiva University; Sapienza University Rome	Gerli, R (corresponding author), Univ Perugia, Dept Clin & Expt Med, Rheumatol Unit, I-06100 Perugia, Italy.	gerlir@unipg.it	Alunno, Alessia/AAC-8842-2022; Pericolini, Eva/AAZ-5848-2021; Bartoloni, Elena/R-5842-2019	Pericolini, Eva/0000-0002-5299-8197; CENCI, ELIO/0000-0003-0752-7262; Bartoloni, Elena/0000-0003-4776-2136; Vecchiarelli, Anna/0000-0002-3185-6720	European Commission: FINSysB Marie Curie Initial Training Network [PITNGA-2008-214004]; National Institutes of Health [AI033774, HL059842, AI033142]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033774, R01AI033142, R37AI033142] Funding Source: NIH RePORTER	European Commission: FINSysB Marie Curie Initial Training Network(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the European Commission: FINSysB Marie Curie Initial Training Network, PITNGA-2008-214004. AC was supported by National Institutes of Health awards AI033774, HL059842, and AI033142. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Berner B, 2000, ANN RHEUM DIS, V59, P190, DOI 10.1136/ard.59.3.190; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bremer E, 2011, IMMUNOL LETT, V138, P161, DOI 10.1016/j.imlet.2011.04.004; Chen SY, 2011, HUM GENE THER, V22, P145, DOI 10.1089/hum.2009.217; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Choy EHS, 2002, RHEUMATOLOGY, V41, P1142, DOI 10.1093/rheumatology/41.10.1142; De Jesus M, 2010, VIRULENCE, V1, P500, DOI 10.4161/viru.1.6.13451; De Jesus M, 2010, EUKARYOT CELL, V9, P1018, DOI 10.1128/EC.00268-09; De Jesus M, 2009, J IMMUNOL, V183, P3885, DOI 10.4049/jimmunol.0900449; De Jesus M, 2009, EUKARYOT CELL, V8, P96, DOI 10.1128/EC.00331-08; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Gabrielli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043972; Gabrielli E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008187; Gaston JSH, 2008, RHEUMATOLOGY, V47, P8, DOI 10.1093/rheumatology/kem203; Gerli R, 2004, CIRCULATION, V109, P2744, DOI 10.1161/01.CIR.0000131450.66017.B3; Gerli R, 2001, TRENDS IMMUNOL, V22, P72, DOI 10.1016/S1471-4906(00)01829-9; Hot A, 2011, ANN RHEUM DIS, V70, P727, DOI 10.1136/ard.2010.143768; Hwang SY, 2005, MOL CELLS, V19, P180; Islander U, 2011, MOL CELL ENDOCRINOL, V335, P14, DOI 10.1016/j.mce.2010.05.018; JAMES PG, 1992, INFECT IMMUN, V60, P1084, DOI 10.1128/IAI.60.3.1084-1088.1992; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Li X, 2010, BIOCHEM BIOPH RES CO, V397, P131, DOI 10.1016/j.bbrc.2010.05.111; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Mamoune A, 2000, HISTOL HISTOPATHOL, V15, P587, DOI 10.14670/HH-15.587; Marrelli A, 2011, AUTOIMMUN REV; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; MIGLIORATI G, 1993, BLOOD, V81, P1352; Monari C, 2005, J IMMUNOL, V174, P3461, DOI 10.4049/jimmunol.174.6.3461; Monari C, 2009, J IMMUNOL, V183, P191, DOI 10.4049/jimmunol.0804144; MORELAND LW, 1995, ARTHRITIS RHEUM, V38, P1581, DOI 10.1002/art.1780381109; Ogawa Y, 2003, ARTHRITIS RHEUM-US, V48, P3350, DOI 10.1002/art.11322; Peck A, 2009, CLIN IMMUNOL, V132, P295, DOI 10.1016/j.clim.2009.03.522; Peng SL, 2006, RHEUMATOLOGY, V45, P26, DOI 10.1093/rheumatology/kei113; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Pericolini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012720; Pericolini E, 2009, J IMMUNOL, V182, P6003, DOI 10.4049/jimmunol.0803833; Perlman Harris, 2001, Current Molecular Medicine (Hilversum), V1, P597, DOI 10.2174/1566524013363429; Raposo BR, 2010, ARTHRITIS RHEUM-US, V62, P2953, DOI 10.1002/art.27729; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Rep MHG, 1997, J CLIN INVEST, V99, P2225, DOI 10.1172/JCI119396; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Spurlock CF, 2011, ARTHRITIS RHEUM-US, V63, P2606, DOI 10.1002/art.30457; Vecchiarelli A, 2011, IMMUNOTHERAPY-UK, V3, P997, DOI [10.2217/IMT.11.86, 10.2217/imt.11.86]; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017766; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang N, 2005, CELL RES, V15, P749, DOI 10.1038/sj.cr.7290345	53	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53336	10.1371/journal.pone.0053336	http://dx.doi.org/10.1371/journal.pone.0053336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308194	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800039
J	Schwab, J; Hammerschmidt, C; Richter, D; Skerka, C; Matuschka, FR; Wallich, R; Zipfel, PF; Kraiczy, P				Schwab, Jasmin; Hammerschmidt, Claudia; Richter, Dania; Skerka, Christine; Matuschka, Franz-Rainer; Wallich, Reinhard; Zipfel, Peter F.; Kraiczy, Peter			Borrelia valaisiana Resist Complement-Mediated Killing Independently of the Recruitment of Immune Regulators and Inactivation of Complement Components	PLOS ONE			English	Article							ACQUIRING SURFACE PROTEIN-1; HUMAN-FACTOR-H; BURGDORFERI SENSU-LATO; C1 ESTERASE INHIBITOR; SPIELMANII SP-NOV; LYME-DISEASE; FUNCTIONAL-CHARACTERIZATION; SERUM RESISTANCE; CYSTEINE PROTEINASES; C4-BINDING PROTEIN	Spirochetes belonging to the Borrelia (B.) burgdorferi sensu lato complex differ in their resistance to complement-mediated killing, particularly in regard to human serum. In the present study, we elucidate the serum and complement susceptibility of B. valaisiana, a genospecies with the potential to cause Lyme disease in Europe as well as in Asia. Among the investigated isolates, growth of ZWU3 Ny3 was not affected while growth of VS116 and Bv9 was strongly inhibited in the presence of 50% human serum. Analyzing complement activation, complement components C3, C4 and C6 were deposited on the surface of isolates VS116 and Bv9, and similarly the membrane attack complex was formed on their surface. In contrast, no surface-deposited components and no aberrations in cell morphology were detected for serum-resistant ZWU3 Ny3. While further investigating the protective role of bound complement regulators in mediating complement resistance, we discovered that none of the B. valaisiana isolates analyzed bound complement regulators Factor H, Factor H-like protein 1, C4b binding protein or C1 esterase inhibitor. In addition, B. valaisiana also lacked intrinsic proteolytic activity to degrade complement components C3, C3b, C4, C4b, and C5. Taken together, these findings suggest that certain B. valaisiana isolates differ in their capability to resist complement-mediating killing by human serum. The molecular mechanism utilized by B. valaisiana to inhibit bacteriolysis appears not to involve binding of the key host complement regulators of the alternative, classical, and lectin pathways as already known for serum-resistant Lyme disease or relapsing fever borreliae.	[Schwab, Jasmin; Hammerschmidt, Claudia; Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Richter, Dania; Matuschka, Franz-Rainer] Charite Univ Med Berlin, Inst Pathol, Abt Parasitol, Berlin, Germany; [Skerka, Christine; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, Heidelberg, Germany; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hans Knoll Institute (HKI); Ruprecht Karls University Heidelberg; Friedrich Schiller University of Jena	Kraiczy, P (corresponding author), Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany.	Kraiczy@em.uni-frankfurt.de			Deutsche Forschungsgemeinschaft [Kr3383/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in part, by the Deutsche Forschungsgemeinschaft grant Kr3383/1-2 to PK. The funder had no role in study design, data collection, and decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alitalo A, 2004, J IMMUNOL, V172, P6195, DOI 10.4049/jimmunol.172.10.6195; Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Beinrohr L, 2008, TRENDS MOL MED, V14, P511, DOI 10.1016/j.molmed.2008.09.009; Bhide Mangesh R, 2009, BMC Res Notes, V2, P134, DOI 10.1186/1756-0500-2-134; Bhide MR, 2005, FEMS IMMUNOL MED MIC, V43, P165, DOI 10.1016/j.femsim.2004.07.012; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; BRADE V, 1992, IMMUNOBIOLOGY, V185, P453, DOI 10.1016/S0171-2985(11)80087-2; BreitnerRuddock S, 1997, MED MICROBIOL IMMUN, V185, P253, DOI 10.1007/s004300050038; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Dieterich R, 2010, INFECT IMMUN, V78, P4467, DOI 10.1128/IAI.00138-10; Discipio RG, 1996, IMMUNOLOGY, V87, P660, DOI 10.1046/j.1365-2567.1996.478594.x; Diza E, 2004, EMERG INFECT DIS, V10, P1692, DOI 10.3201/eid1009.030439; FUJITA T, 1979, J EXP MED, V150, P267, DOI 10.1084/jem.150.2.267; FUJITA T, 1978, J EXP MED, V148, P1044, DOI 10.1084/jem.148.4.1044; Grosskinsky S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000698; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Hammerschmidt C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/349657; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Herzberger P, 2009, INT J MED MICROBIOL, V299, P141, DOI 10.1016/j.ijmm.2008.06.005; Herzberger P, 2007, INFECT IMMUN, V75, P4817, DOI 10.1128/IAI.00532-07; Hovis KM, 2006, INFECT IMMUN, V74, P1967, DOI 10.1128/IAI.74.3.1967-1972.2006; Hunfeld KP, 2000, EUR J CLIN MICROBIOL, V19, P27, DOI 10.1007/s100960050005; Jiang HX, 2001, J EXP MED, V194, P1609, DOI 10.1084/jem.194.11.1609; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Jusko M, 2012, J IMMUNOL, V188, P2338, DOI 10.4049/jimmunol.1101240; Kenedy MR, 2009, INFECT IMMUN, V77, P2773, DOI 10.1128/IAI.00318-09; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2003, EUR J IMMUNOL, V33, P697, DOI 10.1002/eji.200323571; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; Kraiczy P, 2000, IMMUNOBIOLOGY, V201, P406, DOI 10.1016/S0171-2985(00)80094-7; KUHN S, 1995, J IMMUNOL, V155, P5663; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; Kurtenbach Klaus, 2002, P117, DOI 10.1079/9780851996325.0117; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Marr N, 2007, J INFECT DIS, V195, P585, DOI 10.1086/510913; McDowell JV, 2003, INFECT IMMUN, V71, P3597, DOI 10.1128/IAI.71.6.3597-3602.2003; Metts MS, 2003, INFECT IMMUN, V71, P3587, DOI 10.1128/IAI.71.6.3587-3596.2003; Michel H, 2004, MED MICROBIOL IMMUN, V193, P219, DOI 10.1007/s00430-003-0196-8; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pietikainen J, 2010, MOL IMMUNOL, V47, P1299, DOI 10.1016/j.molimm.2009.11.028; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Ramu P, 2007, FEBS LETT, V581, P1716, DOI 10.1016/j.febslet.2007.03.049; Rijpkema Sjoerd G. T., 1997, Clin Microbiol Infect, V3, P109; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Saito K, 2007, AM J TROP MED HYG, V77, P1124, DOI 10.4269/ajtmh.2007.77.1124; Seling A, 2009, INFECT IMMUN; Seling A, 2010, INFECT IMMUN, V78, P39, DOI 10.1128/IAI.00691-09; Siegel C, 2008, J BIOL CHEM, V283, P34855, DOI 10.1074/jbc.M805844200; Siegel C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013519; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Stevenson B, 2002, INFECT IMMUN, V70, P5307, DOI 10.1128/IAI.70.9.5307-5311.2002; Strle F, 1997, CLIN INFECT DIS, V25, P273, DOI 10.1086/514551; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; van Burgel ND, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-43; VanDam AP, 1997, INFECT IMMUN, V65, P1228, DOI 10.1128/IAI.65.4.1228-1236.1997; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; ZICCARDI RJ, 1981, J IMMUNOL, V126, P1769; Zipfel P.F., 2009, NAT REV IMMUNOL; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6	71	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53659	10.1371/journal.pone.0053659	http://dx.doi.org/10.1371/journal.pone.0053659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320099	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800064
J	Wasil, LR; Tomaszewski, MJ; Hoji, A; Rowe, DT				Wasil, Laura R.; Tomaszewski, Monica J.; Hoji, Aki; Rowe, David T.			The Effect of Epstein-Barr Virus Latent Membrane Protein 2 Expression on the Kinetics of Early B Cell Infection	PLOS ONE			English	Article							GROWTH TRANSFORMATION; IN-VIVO; SURFACE-IMMUNOGLOBULIN; LYMPHOCYTE-ACTIVATION; EPITHELIAL-CELLS; TRANSGENIC MICE; EBV PERSISTENCE; CROSS-LINKING; DNA FRAGMENT; BETA-CATENIN	Infection of human B cells with wild-type Epstein-Barr virus (EBV) in vitro leads to activation and proliferation that result in efficient production of lymphoblastoid cell lines (LCLs). Latent Membrane Protein 2 (LMP2) is expressed early after infection and previous research has suggested a possible role in this process. Therefore, we generated recombinant EBV with knockouts of either or both protein isoforms, LMP2A and LMP2B (D2A, D2B, D2A/D2B) to study the effect of LMP2 in early B cell infection. Infection of B cells with D2A and D2A/D2B viruses led to a marked decrease in activation and proliferation relative to wild-type (wt) viruses, and resulted in higher percentages of apoptotic B cells. D2B virus infection showed activation levels comparable to wt, but fewer numbers of proliferating B cells. Early B cell infection with wt, D2A and D2B viruses did not result in changes in latent gene expression, with the exception of elevated LMP2B transcript in D2A virus infection. Infection with D2A and D2B viruses did not affect viral latency, determined by changes in LMP1/Zebra expression following BCR stimulation. However, BCR stimulation of D2A/D2B cells resulted in decreased LMP1 expression, which suggests loss of stability in viral latency. Long-term outgrowth assays revealed that LMP2A, but not LMP2B, is critical for efficient long-term growth of B cells in vitro. The lowest levels of activation, proliferation, and LCL formation were observed when both isoforms were deleted. These results suggest that LMP2A appears to be critical for efficient activation, proliferation and survival of EBV-infected B cells at early times after infection, which impacts the efficient long-term growth of B cells in culture. In contrast, LMP2B did not appear to play a significant role in these processes, and long-term growth of infected B cells was not affected by the absence of this protein.	[Wasil, Laura R.; Tomaszewski, Monica J.; Hoji, Aki; Rowe, David T.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rowe, DT (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	rowe1@pitt.edu		Tomaszewski, Monica Jo/0000-0003-3940-1736	Department of Infectious Diseases and Microbiolgy at the University of Pittsburgh	Department of Infectious Diseases and Microbiolgy at the University of Pittsburgh	All studies in this research article are supported by the Department of Infectious Diseases and Microbiolgy at the University of Pittsburgh. There were no external funding sources that played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2005, J VIROL, V79, P1789, DOI 10.1128/JVI.79.3.1789-1802.2005; Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; BEAUFILS P, 1993, EMBO J, V12, P5105, DOI 10.1002/j.1460-2075.1993.tb06205.x; Bishop GA, 2003, CRIT REV IMMUNOL, V23, P149, DOI 10.1615/CritRevImmunol.v23.i3.10; Brielmeier M, 1996, J GEN VIROL, V77, P2807, DOI 10.1099/0022-1317-77-11-2807; Caldwell RG, 2000, J VIROL, V74, P1101, DOI 10.1128/JVI.74.3.1101-1113.2000; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Christian SL, 2002, J IMMUNOL, V169, P758, DOI 10.4049/jimmunol.169.2.758; COUNTRYMAN J, 1985, P NATL ACAD SCI USA, V82, P4085, DOI 10.1073/pnas.82.12.4085; Davies ML, 2010, VIROLOGY, V400, P53, DOI 10.1016/j.virol.2010.01.002; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Dirmeier U, 2003, CANCER RES, V63, P2982; Dolcetti R, 2007, AUTOIMMUN REV, V7, P96, DOI 10.1016/j.autrev.2007.02.012; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Engels N, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-9; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; Gradoville L, 2002, J VIROL, V76, P5612, DOI 10.1128/JVI.76.11.5612-5626.2002; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; GROGAN E, 1987, P NATL ACAD SCI USA, V84, P1332, DOI 10.1073/pnas.84.5.1332; Halder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007214; HAMMERSCHMIDT W, 1988, CELL, V55, P427, DOI 10.1016/0092-8674(88)90028-1; Joseph AM, 2000, J IMMUNOL, V165, P2975, DOI 10.4049/jimmunol.165.6.2975; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; KENNEY S, 1989, J VIROL, V63, P1729, DOI 10.1128/JVI.63.4.1729-1736.1989; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kieff Elliott, 1996, P1109; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KINTNER C, 1981, NATURE, V294, P458, DOI 10.1038/294458a0; Krenauer A, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-21; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LAUX G, 1988, EMBO J, V7, P769, DOI 10.1002/j.1460-2075.1988.tb02874.x; LENNETTE ET, 1995, EUR J CANCER, V31A, P1875, DOI 10.1016/0959-8049(95)00354-L; LONGNECKER R, 1993, J VIROL, V67, P2006, DOI 10.1128/JVI.67.4.2006-2013.1993; LONGNECKER R, 1993, J VIROL, V67, P5068, DOI 10.1128/JVI.67.8.5068-5074.1993; Longnecker R, 1998, HUMAN TUMOR VIRUSES, P133; Lynch DT, 2002, J GEN VIROL, V83, P1025, DOI 10.1099/0022-1317-83-5-1025; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; Maruo S, 2006, P NATL ACAD SCI USA, V103, P19500, DOI 10.1073/pnas.0604919104; Maruo S, 2011, P NATL ACAD SCI USA, V108, P1919, DOI 10.1073/pnas.1019599108; Merchant M, 2000, J VIROL, V74, P9115, DOI 10.1128/JVI.74.19.9115-9124.2000; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; MILLER CL, 1993, J VIROL, V67, P3087, DOI 10.1128/JVI.67.6.3087-3094.1993; Morrison JA, 2003, J VIROL, V77, P12276, DOI 10.1128/JVI.77.22.12276-12284.2003; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; PATARROYO M, 1986, INT J CANCER, V38, P539, DOI 10.1002/ijc.2910380414; Portis T, 2004, ONCOGENE, V23, P8619, DOI 10.1038/sj.onc.1207905; Portis T, 2004, TRENDS IMMUNOL, V25, P422, DOI 10.1016/j.it.2004.05.009; QU LR, 1992, J VIROL, V66, P3715, DOI 10.1128/JVI.66.6.3715-3724.1992; Rechsteiner MP, 2008, J VIROL, V82, P1739, DOI 10.1128/JVI.01723-07; RICKINSON AB, 1974, INT J CANCER, V14, P704, DOI 10.1002/ijc.2910140603; RICKINSON AB, 1977, INT J CANCER, V19, P775, DOI 10.1002/ijc.2910190606; Rickinson AB, 2007, FIELDS VIROLOGY, V5, P2655; Rovedo M, 2007, J VIROL, V81, P84, DOI 10.1128/JVI.01302-06; ROWE M, 1982, INT J CANCER, V29, P373, DOI 10.1002/ijc.2910290403; SAMPLE J, 1989, J VIROL, V63, P933, DOI 10.1128/JVI.63.2.933-937.1989; Scholle F, 2000, J VIROL, V74, P10681, DOI 10.1128/JVI.74.22.10681-10689.2000; Silva R, 2011, BLOOD, V117, P5870, DOI 10.1182/blood-2010-09-310318; SINCLAIR AJ, 1994, EMBO J, V13, P3321, DOI 10.1002/j.1460-2075.1994.tb06634.x; Speck P, 1999, J GEN VIROL, V80, P2193, DOI 10.1099/0022-1317-80-8-2193; TAKADA K, 1986, J VIROL, V57, P1016, DOI 10.1128/JVI.57.3.1016-1022.1986; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; THORLEYLAWSON DA, 1985, J EXP MED, V162, P45, DOI 10.1084/jem.162.1.45; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; White RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013979; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556	74	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54010	10.1371/journal.pone.0054010	http://dx.doi.org/10.1371/journal.pone.0054010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308294	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000313429800082
J	Cai, H; Chen, HY; Yi, T; Daimon, CM; Boyle, JP; Peers, C; Maudsley, S; Martin, B				Cai, Huan; Chen, Hongyu; Yi, Tie; Daimon, Caitlin M.; Boyle, John P.; Peers, Chris; Maudsley, Stuart; Martin, Bronwen			VennPlex-A Novel Venn Diagram Program for Comparing and Visualizing Datasets with Differentially Regulated Datapoints	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; EULER DIAGRAMS; HYPOXIA; EXPRESSION; ASTROCYTES	With the development of increasingly large and complex genomic and proteomic data sets, an enhancement in the complexity of available Venn diagram analytical programs is becoming increasingly important. Current freely available Venn diagram programs often fail to represent extra complexity among datasets, such as regulation pattern differences between different groups. Here we describe the development of VennPlex, a program that illustrates the often diverse numerical interactions among multiple, high-complexity datasets, using up to four data sets. VennPlex includes versatile output features, where grouped data points in specific regions can be easily exported into a spreadsheet. This program is able to facilitate the analysis of two to four gene sets and their corresponding expression values in a user-friendly manner. To demonstrate its unique experimental utility we applied VennPlex to a complex paradigm, i.e. a comparison of the effect of multiple oxygen tension environments (1-20% ambient oxygen) upon gene transcription of primary rat astrocytes. VennPlex accurately dissects complex data sets reliably into easily identifiable groups for straightforward analysis and data output. This program, which is an improvement over currently available Venn diagram programs, is able to rapidly extract important datasets that represent the variety of expression patterns available within the data sets, showing potential applications in fields like genomics, proteomics, and bioinformatics.	[Cai, Huan; Yi, Tie; Daimon, Caitlin M.; Martin, Bronwen] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Chen, Hongyu; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Boyle, John P.; Peers, Chris] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Inst Cardiovasc Res, Leeds, W Yorkshire, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Leeds	Martin, B (corresponding author), NIA, Metab Unit, NIH, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	chen, hongyu/HHS-4314-2022; Maudsley, Stuart/Q-4782-2019; Boyle, John/N-4868-2016; Maudsley, Stuart/AAV-9929-2021; Cai, Huan/B-6578-2016	Maudsley, Stuart/0000-0002-1868-184X; Cai, Huan/0000-0001-7731-8891; Martin, Bronwen/0000-0002-9185-6925; Peers, Chris/0000-0002-8354-346X	National Institute on Aging, National Institutes of Health; Alzheimers Research UK [ARUK-PPG2011B-1] Funding Source: researchfish	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021638; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cibella F, 2011, PEDIAT ALLERG IMM-UK, V22, P60, DOI 10.1111/j.1399-3038.2010.01097.x; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; Fang YC, 2006, J CEREBR BLOOD F MET, V26, P491, DOI 10.1038/sj.jcbfm.9600205; Homuth G, 2012, J ENDOCRINOL, V215, P17, DOI 10.1530/JOE-12-0144; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Kestler HA, 2005, BIOINFORMATICS, V21, P1592, DOI 10.1093/bioinformatics/bti169; Kestler HA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-67; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Loinard C, 2012, CIRCULATION, V125, P1014, DOI 10.1161/CIRCULATIONAHA.111.041830; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036911; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002398; Maudsley S, 2011, METHODS MOL BIOL, V756, P99, DOI 10.1007/978-1-61779-160-4_5; Ogunshola OO, 2009, CELL MOL LIFE SCI, V66, P3555, DOI 10.1007/s00018-009-0141-0; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Peers C, 2007, ESSAYS BIOCHEM, V43, P153, DOI 10.1042/bse0430153; Peers C, 2009, ANN NY ACAD SCI, V1177, P169, DOI 10.1111/j.1749-6632.2009.05026.x; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Schonemeier B, 2008, J NEUROIMMUNOL, V198, P39, DOI 10.1016/j.jneuroim.2008.04.010; Taylor SC, 1999, J BIOL CHEM, V274, P31217, DOI 10.1074/jbc.274.44.31217	25	71	74	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53388	10.1371/journal.pone.0053388	http://dx.doi.org/10.1371/journal.pone.0053388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308210	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100061
J	Dao, E; Davis, JC; Sharma, D; Chan, A; Nagamatsu, LS; Liu-Ambrose, T				Dao, Elizabeth; Davis, Jennifer C.; Sharma, Devika; Chan, Alison; Nagamatsu, Lindsay S.; Liu-Ambrose, Teresa			Change in Body Fat Mass Is Independently Associated with Executive Functions in Older Women: A Secondary Analysis of a 12-Month Randomized Controlled Trial	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; MINI-MENTAL-STATE; COGNITIVE FUNCTION; PHYSICAL-ACTIVITY; VASCULAR DEMENTIA; ALZHEIMER-DISEASE; CARDIOVASCULAR-DISEASE; CORTICAL PLASTICITY; WEIGHT-LOSS; OBESITY	Objectives: To investigate the independent contribution of change in sub-total body fat and lean mass to cognitive performance, specifically the executive processes of selective attention and conflict resolution, in community-dwelling older women. Methods: This secondary analysis included 114 women aged 65 to 75 years old. Participants were randomly allocated to once-weekly resistance training, twice-weekly resistance training, or twice-weekly balance and tone training. The primary outcome measure was the executive processes of selective attention and conflict resolution as assessed by the Stroop Test. Sub-total body fat and lean mass were measured by dual-energy x-ray absorptiometry (DXA) to determine the independent association of change in both sub-total body fat and sub-total body lean mass with Stroop Test performance at trial completion. Results: A multiple linear regression model showed reductions in sub-total body fat mass to be independently associated with better performance on the Stroop Test at trial completion after accounting for baseline Stroop performance, age, baseline global cognitive state, baseline number of comorbidities, baseline depression, and experimental group. The total variance explained was 39.5%; change in sub-total body fat mass explained 3.9% of the variance. Change in sub-total body lean mass was not independently associated with Stroop Test performance (P>0.05). Conclusion: Our findings suggest that reductions in sub-total body fat mass - not sub-total lean mass - is associated with better performance of selective attention and conflict resolution.	[Dao, Elizabeth; Davis, Jennifer C.; Sharma, Devika; Chan, Alison; Nagamatsu, Lindsay S.; Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Davis, Jennifer C.] Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada; [Nagamatsu, Lindsay S.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Nagamatsu, Lindsay S.; Liu-Ambrose, Teresa] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Liu-Ambrose, T (corresponding author), Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada.	tlambrose@exchange.ubc.ca	Dao, Elizabeth/AAB-4630-2020; Liu-Ambrose, Teresa/W-2332-2019	Liu-Ambrose, Teresa/0000-0002-8297-5308	Vancouver Foundation [BCM06- 0035]; Michael Smith Foundation for Health Research [CI-SCH-063[05- 0035]]	Vancouver Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study was supported by operating grants from The Vancouver Foundation (BCM06- 0035, TLA) and by an Establishment Grant from the Michael Smith Foundation for Health Research (CI-SCH-063[05- 0035], TLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Bagger YZ, 2004, OBES RES, V12, P1519, DOI 10.1038/oby.2004.189; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Dore GA, 2008, ANN BEHAV MED, V35, P341, DOI 10.1007/s12160-008-9038-7; Driscoll I, 2011, OBESITY, V19, P1595, DOI 10.1038/oby.2011.23; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Gustafson D, 2008, EUR J PHARMACOL, V585, P163, DOI 10.1016/j.ejphar.2008.01.052; HAARBO J, 1991, CLIN PHYSIOL, V11, P331, DOI 10.1111/j.1475-097X.1991.tb00662.x; Han Changsu, 2009, Arch Gerontol Geriatr, V49, pe133, DOI 10.1016/j.archger.2008.11.005; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Hughes TF, 2009, NEUROLOGY, V72, P1741, DOI 10.1212/WNL.0b013e3181a60a58; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Jellinger KA, 2008, J ALZHEIMERS DIS, V14, P107; Kanaya AM, 2009, ARCH NEUROL-CHICAGO, V66, P329, DOI 10.1001/archneurol.2008.570; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.107.151621; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Kuo HK, 2006, J AM GERIATR SOC, V54, P97, DOI 10.1111/j.1532-5415.2005.00522.x; Kyle UG, 2001, EUR J CLIN NUTR, V55, P663, DOI 10.1038/sj.ejcn.1601198; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Liu-Ambrose T, 2009, BRIT J SPORT MED, V43, P25, DOI 10.1136/bjsm.2008.055616; Liu-Ambrose T, 2008, J AM GERIATR SOC, V56, P1821, DOI [10.1111/j.1532-5415.2008.01931.x, 10.1111/j.1532-5415.2008.01984.x]; Liu-Ambrose T, 2007, CEREBROVASC DIS, V23, P203, DOI 10.1159/000097642; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Luterman JD, 2000, ARCH NEUROL-CHICAGO, V57, P1153, DOI 10.1001/archneur.57.8.1153; McCusker SM, 2001, LANCET, V357, P436, DOI 10.1016/S0140-6736(00)04008-3; Oguma Y, 2004, AM J PREV MED, V26, P407, DOI 10.1016/j.amepre.2004.02.007; Park KG, 2004, DIABETES RES CLIN PR, V63, P135, DOI 10.1016/j.diabres.2003.09.010; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Savaskan E, 2001, NEUROBIOL AGING, V22, P541, DOI 10.1016/S0197-4580(00)00259-1; Spreen O., 1998, COMPENDIUM NEUROLOGI, V2nd ed.; SVENDSEN OL, 1991, AM J CLIN NUTR, V53, P1117, DOI 10.1093/ajcn/53.5.1117; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Waldstein SR, 2006, INT J OBESITY, V30, P201, DOI 10.1038/sj.ijo.0803114; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Yoon DH, 2012, AGE AGEING, V41, P456, DOI 10.1093/ageing/afs018; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	55	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52831	10.1371/journal.pone.0052831	http://dx.doi.org/10.1371/journal.pone.0052831			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308123	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100017
J	Liu, T; Weng, ZY; Dong, XW; Chen, LJ; Ma, L; Cen, S; Zhou, NM; Hu, YZ				Liu, Tao; Weng, Zhiyong; Dong, Xiaowu; Chen, Linjie; Ma, Ling; Cen, Shan; Zhou, Naiming; Hu, Yongzhou			Design, Synthesis and Biological Evaluation of Novel Piperazine Derivatives as CCR5 Antagonists	PLOS ONE			English	Article							SMALL-MOLECULE CCR5; HIV-1; CORECEPTOR; TAK-220	By using a fragment-assembly strategy and bioisosteric-replacement principle, a series of novel piperazine derivatives were designed, synthesized, and evaluated for their cellular target-effector fusion activities and in vitro antiviral activities against HIV-1. Preliminary structure-activity relationships (SARs) of target compounds were concluded in this study, and five compounds were found to exhibited medium to potent CCR5 fusion activities with IC50 values in low micromolar level. Among evaluated compounds, 23 h was found to be a CCR5 antagonist with an IC50 value of 6.29 mu M and an anti-HIV-1 inhibitor with an IC50 value of 0.44 mu M.	[Liu, Tao; Weng, Zhiyong; Dong, Xiaowu; Hu, Yongzhou] Zhejiang Univ, Coll Pharmaceut Sci, Ecole Normale Super, Joint Lab Med Chem, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Linjie; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Ling; Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Ma, Ling; Cen, Shan] Peking Union Med Coll, Beijing 100021, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, T (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Ecole Normale Super, Joint Lab Med Chem, Hangzhou 310003, Zhejiang, Peoples R China.	Lt601@zju.edu.cn; znm2000@yahoo.com; Huyz@zju.edu.cn	Zhou, Naiming/AHC-1121-2022		National Nature Science Foundation of China [81072515]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Nature Science Foundation of China (number 81072515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LJ, 2010, ANAL BIOCHEM, V407, P180, DOI 10.1016/j.ab.2010.08.018; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dong MX, 2012, BIOORG MED CHEM LETT, V22, P3284, DOI 10.1016/j.bmcl.2012.03.019; Feng DZ, 2007, ORG BIOMOL CHEM, V5, P2690, DOI 10.1039/b707175b; Jiang XH, 2004, BIOORG MED CHEM LETT, V14, P3675, DOI 10.1016/j.bmcl.2004.05.014; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Nishikawa M, 2005, ANTIMICROB AGENTS CH, V49, P4708, DOI 10.1128/AAC.49.11.4708-4715.2005; Rodger DM, 2008, CLIN INFECT DIS, V47, P236; Takashima K, 2005, ANTIMICROB AGENTS CH, V49, P3474, DOI 10.1128/AAC.49.8.3474-3482.2005; Torre O, 2006, TETRAHEDRON-ASYMMETR, V17, P860, DOI 10.1016/j.tetasy.2006.02.022; Weng ZY, 2011, J CHEM RES, P43, DOI 10.3184/174751911X556828; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6	14	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53636	10.1371/journal.pone.0053636	http://dx.doi.org/10.1371/journal.pone.0053636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308267	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100100
J	Pieszek, M; Widmann, A; Gruber, T; Schroger, E				Pieszek, Marika; Widmann, Andreas; Gruber, Thomas; Schroeger, Erich			The Human Brain Maintains Contradictory and Redundant Auditory Sensory Predictions	PLOS ONE			English	Article							MISMATCH NEGATIVITY; MULTISENSORY INTEGRATION; INVOLUNTARY ATTENTION; STIMULUS DEVIANCE; EFFECT SIZE; SOUNDS; TASK; MMN; REPRESENTATIONS; POTENTIALS	Computational and experimental research has revealed that auditory sensory predictions are derived from regularities of the current environment by using internal generative models. However, so far, what has not been addressed is how the auditory system handles situations giving rise to redundant or even contradictory predictions derived from different sources of information. To this end, we measured error signals in the event-related brain potentials (ERPs) in response to violations of auditory predictions. Sounds could be predicted on the basis of overall probability, i.e., one sound was presented frequently and another sound rarely. Furthermore, each sound was predicted by an informative visual cue. Participants' task was to use the cue and to discriminate the two sounds as fast as possible. Violations of the probability based prediction (i.e., a rare sound) as well as violations of the visual-auditory prediction (i.e., an incongruent sound) elicited error signals in the ERPs (Mismatch Negativity [MMN] and Incongruency Response [IR]). Particular error signals were observed even in case the overall probability and the visual symbol predicted different sounds. That is, the auditory system concurrently maintains and tests contradictory predictions. Moreover, if the same sound was predicted, we observed an additive error signal (scalp potential and primary current density) equaling the sum of the specific error signals. Thus, the auditory system maintains and tolerates functionally independently represented redundant and contradictory predictions. We argue that the auditory system exploits all currently active regularities in order to optimally prepare for future events.	[Pieszek, Marika; Widmann, Andreas; Schroeger, Erich] Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany; [Gruber, Thomas] Univ Osnabruck, Inst Psychol, Osnabruck, Germany	Leipzig University; University Osnabruck	Pieszek, M (corresponding author), Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany.	marika.pieszek@uni-leipzig.de	Widmann, Andreas/AEN-2370-2022; Schröger, Erich/C-3079-2009; Pieszek, Marika/C-3860-2014	Widmann, Andreas/0000-0003-3664-8581; Schröger, Erich/0000-0002-8321-6629; 	Deutsche Forschungsgemeinschaft (DFG) [SCHR 375/20-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by a Deutsche Forschungsgemeinschaft (DFG) Reinhart-Koselleck grant to ES (SCHR 375/20-1), http://www.dfg.de/foerderung/programme/einzelfoerderung/reinhart_koselleck_projekte/kompakt/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres AJD, 2011, INT J PSYCHOPHYSIOL, V79, P137, DOI 10.1016/j.ijpsycho.2010.09.012; Aoyama A, 2006, BRAIN RES, V1068, P194, DOI 10.1016/j.brainres.2005.11.017; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Bendixen A, 2008, NEUROIMAGE, V41, P1111, DOI 10.1016/j.neuroimage.2008.03.040; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Besle J, 2005, EXP BRAIN RES, V166, P337, DOI 10.1007/s00221-005-2375-x; Boll S, 2009, PSYCHOPHYSIOLOGY, V46, P645, DOI 10.1111/j.1469-8986.2009.00803.x; Bosch-Bayard J, 2001, CLIN ELECTROENCEPHAL, V32, P47, DOI 10.1177/155005940103200203; Bregman AS, 1990, AUDITORY SCENE ANAL, Vxiii; Brown CR, 2007, INT J PSYCHOPHYSIOL, V65, P122, DOI 10.1016/j.ijpsycho.2007.04.002; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Deacon D, 1998, PSYCHOPHYSIOLOGY, V35, P413, DOI 10.1017/S004857729896053X; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deouell LY, 2007, J PSYCHOPHYSIOL, V21, P188, DOI 10.1027/0269-8803.21.34.188; Deouell LY, 1998, PSYCHOPHYSIOLOGY, V35, P355, DOI 10.1017/S0048577298970287; Dimoska A, 2006, BRAIN COGNITION, V62, P98, DOI 10.1016/j.bandc.2006.03.011; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Evans A. C., 1993, 3D STAT NEUROANATOMI; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friston KJ, 2012, INT J PSYCHOPHYSIOL, V83, P248, DOI 10.1016/j.ijpsycho.2011.11.014; Friston KJ, 2009, NEURAL NETWORKS, V22, P1093, DOI 10.1016/j.neunet.2009.07.023; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Froyen D, 2008, NEUROSCI LETT, V430, P23, DOI 10.1016/j.neulet.2007.10.014; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gondan M, 2006, BRAIN RES, V1073, P389, DOI 10.1016/j.brainres.2005.12.050; GRATTON G, 1990, ELECTROEN CLIN NEURO, V75, P419, DOI 10.1016/0013-4694(90)90087-Z; Grimm S, 2006, NEUROIMAGE, V32, P275, DOI 10.1016/j.neuroimage.2006.03.032; Gruendler TOJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025591; Horvath J, 2001, COGNITIVE BRAIN RES, V12, P131, DOI 10.1016/S0926-6410(01)00038-6; Luck S.J., 2005, INTRO EVENT RELATED; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Mittag M, 2011, EXP BRAIN RES, V211, P287, DOI 10.1007/s00221-011-2686-z; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Molholm S, 2006, J NEUROPHYSIOL, V96, P721, DOI 10.1152/jn.00285.2006; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1982, BIOL PSYCHOL, V14, P53, DOI 10.1016/0301-0511(82)90017-5; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; NOVAK GP, 1990, ELECTROEN CLIN NEURO, V75, P255, DOI 10.1016/0013-4694(90)90105-S; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Paavilainen P, 2001, NEUROSCI LETT, V301, P179, DOI 10.1016/S0304-3940(01)01635-4; Patel Salil H, 2005, Int J Med Sci, V2, P147; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Rahne T, 2007, BRAIN RES, V1144, P127, DOI 10.1016/j.brainres.2007.01.074; Rinne T, 2001, NEUROREPORT, V12, P2209, DOI 10.1097/00001756-200107200-00033; Ritter W, 1999, PSYCHOPHYSIOLOGY, V36, P835; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Schroger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001131; Schroger E, 2007, J PSYCHOPHYSIOL, V21, P138, DOI 10.1027/0269-8803.21.34.138; Schroger E, 1998, PSYCHOPHYSIOLOGY, V35, P755, DOI 10.1111/1469-8986.3560755; Schroger E, 2005, ACTA ACUST UNITED AC, V91, P490; SCHROGER E, 1995, PSYCHOPHYSIOLOGY, V32, P55, DOI 10.1111/j.1469-8986.1995.tb03406.x; Sinkkonen J., 1999, INFORM THEORY BRAIN, P241; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Sussman E, 2003, PSYCHON B REV, V10, P630, DOI 10.3758/BF03196525; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Todorovic A, 2011, J NEUROSCI, V31, P9118, DOI 10.1523/JNEUROSCI.1425-11.2011; Ullsperger P, 2006, INT J PSYCHOPHYSIOL, V59, P3, DOI 10.1016/j.ijpsycho.2005.06.007; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Widmann A, 2004, PSYCHOPHYSIOLOGY, V41, P709, DOI 10.1111/j.1469-8986.2004.00208.x; Widmann A, 2007, CEREB CORTEX, V17, P2696, DOI 10.1093/cercor/bhl178; Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233; Winkler I, 1996, BRAIN RES, V742, P239, DOI 10.1016/S0006-8993(96)01008-6; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Zmigrod S, 2009, PSYCHOL RES-PSYCH FO, V73, P674, DOI 10.1007/s00426-008-0163-5	79	27	27	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53634	10.1371/journal.pone.0053634	http://dx.doi.org/10.1371/journal.pone.0053634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308266	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100099
J	Thundyil, J; Manzanero, S; Pavlovski, D; Cully, TR; Lok, KZ; Widiapradja, A; Chunduri, P; Jo, DG; Naruse, C; Asano, M; Launikonis, BS; Sobey, CG; Coulthard, MG; Arumugam, TV				Thundyil, John; Manzanero, Silvia; Pavlovski, Dale; Cully, Tanya R.; Lok, Ker-Zhing; Widiapradja, Alexander; Chunduri, Prasad; Jo, Dong-Gyu; Naruse, Chie; Asano, Masahide; Launikonis, Bradley S.; Sobey, Christopher G.; Coulthard, Mark G.; Arumugam, Thiruma V.			Evidence That the EphA2 Receptor Exacerbates Ischemic Brain Injury	PLOS ONE			English	Article							IN-VITRO; VASCULAR-PERMEABILITY; CEREBRAL-ISCHEMIA; LUNG INJURY; EXPRESSION; EPHRINS; ANGIOGENESIS; MECHANISMS; DISEASE; STROKE	Ephrin (Eph) signaling within the central nervous system is known to modulate axon guidance, synaptic plasticity, and to promote long-term potentiation. We investigated the potential involvement of EphA2 receptors in ischemic stroke-induced brain inflammation in a mouse model of focal stroke. Cerebral ischemia was induced in male C57Bl6/J wild-type (WT) and EphA2-deficient (EphA2(-/-)) mice by middle cerebral artery occlusion (MCAO; 60 min), followed by reperfusion (24 or 72 h). Brain infarction was measured using triphenyltetrazolium chloride staining. Neurological deficit scores and brain infarct volumes were significantly less in EphA2(-/-) mice compared with WT controls. This protection by EphA2 deletion was associated with a comparative decrease in brain edema, blood-brain barrier damage, MMP-9 expression and leukocyte infiltration, and higher expression levels of the tight junction protein, zona occludens-1. Moreover, EphA2(-/-) brains had significantly lower levels of the pro-apoptotic proteins, cleaved caspase-3 and BAX, and higher levels of the anti-apoptotic protein, Bcl-2 as compared to WT group. We confirmed that isolated WT cortical neurons express the EphA2 receptor and its ligands (ephrin-A1-A3). Furthermore, expression of all four proteins was increased in WT primary cortical neurons following 24 h of glucose deprivation, and in the brains of WT mice following stroke. Glucose deprivation induced less cell death in primary neurons from EphA2(-/-) compared with WT mice. In conclusion, our data provide the first evidence that the EphA2 receptor directly contributes to blood-brain barrier damage and neuronal death following ischemic stroke.	[Thundyil, John; Manzanero, Silvia; Pavlovski, Dale; Cully, Tanya R.; Lok, Ker-Zhing; Widiapradja, Alexander; Chunduri, Prasad; Launikonis, Bradley S.; Arumugam, Thiruma V.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Jo, Dong-Gyu] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Naruse, Chie; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa, Japan; [Sobey, Christopher G.] Monash Univ, Dept Pharmacol, Vasc Biol & Immunopharmacol Grp, Clayton, Vic 3168, Australia; [Coulthard, Mark G.] Univ Queensland, Royal Childrens Hosp, Acad Discipline Paediat & Child Hlth, Herston, Qld, Australia; [Coulthard, Mark G.] Royal Childrens Hosp, Paediat Intens Care Unit, Herston, Qld, Australia; [Coulthard, Mark G.] Royal Childrens Hosp, Queensland Childrens Med Res Inst, Herston, Qld, Australia	University of Queensland; Sungkyunkwan University (SKKU); Kanazawa University; Monash University; Royal Children's Hospital Brisbane; University of Queensland; Royal Children's Hospital Brisbane; Royal Children's Hospital Brisbane	Arumugam, TV (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	t.arumugam@uq.edu.au	Sobey, Christopher G/A-2786-2008; Chunduri, Prasad/J-2141-2014; Coulthard, Mark G/AAT-7735-2021; Launikonis, Bradley/K-6256-2015; Arumugam, Thiruma Valavan/B-4898-2011; Jo, Dong-Gyu/AAN-9278-2021; Coulthard, Mark Graeme/E-9444-2010; Arumugam, Thiruma/AAG-6958-2019; Cully, Tanya/B-7920-2016	Sobey, Christopher G/0000-0001-6525-9097; Coulthard, Mark G/0000-0001-7400-5582; Launikonis, Bradley/0000-0003-0700-4867; Jo, Dong-Gyu/0000-0003-2271-1076; Coulthard, Mark Graeme/0000-0001-7400-5582; Cully, Tanya/0000-0002-7047-9913; Chunduri, Prasad/0000-0001-7297-7580; Arumugam, Thiruma/0000-0002-3377-0939; Manzanero, Silvia/0000-0002-5294-7082	ARC [FT100100427]	ARC(Australian Research Council)	This work was supported by the ARC Future Fellowship (FT100100427) awarded to TVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2000, STROKE, V31, P193, DOI 10.1161/01.STR.31.1.193; Arocho LC, 2011, CELL MOL NEUROBIOL, V31, P1057, DOI 10.1007/s10571-011-9705-2; Baum CL, 2005, DERMATOL SURG, V31, P674; Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Carpenter TC, 2012, AM J RESP CELL MOL, V46, P40, DOI 10.1165/rcmb.2011-0044OC; Cercone MA, 2009, AM J PHYSIOL-LUNG C, V297, pL856, DOI 10.1152/ajplung.00118.2009; Davy A, 2005, DEV DYNAM, V232, P1, DOI 10.1002/dvdy.20200; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feiler S, 2011, CEREBROVASC DIS, V32, P289, DOI 10.1159/000328248; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hafner C, 2005, WORLD J GASTROENTERO, V11, P4024, DOI 10.3748/wjg.v11.i26.4024; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Ivanov AI, 2006, IUBMB LIFE, V58, P389, DOI 10.1080/15216540600756004; Kitamura T, 2008, AM J PHYSIOL-CELL PH, V294, pC189, DOI 10.1152/ajpcell.00314.2007; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Larson J, 2008, AM J PHYSIOL-LUNG C, V295, pL431, DOI 10.1152/ajplung.90256.2008; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Naruse-Nakajima C, 2001, MECH DEVELOP, V102, P95, DOI 10.1016/S0925-4773(01)00290-8; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rohani N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000597; Thundyil J, 2012, NEUROMOL MED, V14, P30, DOI 10.1007/s12017-012-8167-0; Thundyil John, 2010, Exp Transl Stroke Med, V2, P15, DOI 10.1186/2040-7378-2-15; Widiapradja A, 2012, J NEUROCHEM, V122, P321, DOI 10.1111/j.1471-4159.2012.07754.x; Xu HS, 2005, AM J PHYSIOL-RENAL, V288, pF855, DOI 10.1152/ajprenal.00347.2004; Zhou N, 2011, MICROVASC RES, V82, P113, DOI 10.1016/j.mvr.2011.06.005	34	40	43	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53528	10.1371/journal.pone.0053528	http://dx.doi.org/10.1371/journal.pone.0053528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308246	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100084
J	Watson, JA; Bryan, K; Williams, R; Popov, S; Vujanic, G; Coulomb, A; Boccon-Gibod, L; Graf, N; Pritchard-Jones, K; O'Sullivan, M				Watson, Jenny A.; Bryan, Kenneth; Williams, Richard; Popov, Sergey; Vujanic, Gordan; Coulomb, Aurore; Boccon-Gibod, Liliane; Graf, Norbert; Pritchard-Jones, Kathy; O'Sullivan, Maureen			miRNA Profiles as a Predictor of Chemoresponsiveness in Wilms' Tumor Blastema	PLOS ONE			English	Article							TAMOXIFEN RESISTANCE; MICRORNAS; CANCER; NEPHROBLASTOMA; CHEMOTHERAPY; TRIAL; GENE	The current SIOP treatment protocol for Wilms' tumor involves pre-operative chemotherapy followed by nephrectomy. Not all patients benefit equally from such chemotherapy. The aim of this study was to generate a miRNA profile of chemo resistant blastemal cells in high risk Wilms' tumors which might serve as predictive markers of therapeutic response at the pre-treatment biopsy stage. We have shown here that unsupervised hierarchical clustering of genome-wide miRNA expression profiles can clearly separate intermediate risk tumors from high risk tumors. A total of 29 miRNAs were significantly differentially expressed between post-treatment intermediate risk and high risk groups, including miRNAs that have been previously linked to chemo resistance in other cancer types. Furthermore, 7 of these 29 miRNAs were already at the pre-treatment biopsy stage differentially expressed between cases ultimately deemed intermediate risk compared to high risk. These miRNA alterations include down-regulation in high risk cases of miR-193a. 5p, miR-27a and the up-regulation of miR-483.5p, miR-628.5p, miR-590.5p, miR-302a and miR-367. The demonstration of such miRNA markers at the pretreatment biopsy stage could permit stratification of patients to more tailored treatment regimens.	[Watson, Jenny A.; O'Sullivan, Maureen] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Bryan, Kenneth] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Williams, Richard; Pritchard-Jones, Kathy] UCL Inst Child Hlth, London, England; [Popov, Sergey] Inst Canc Res, Surrey, England; [Vujanic, Gordan] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Coulomb, Aurore; Boccon-Gibod, Liliane] Univ Paris 06, Hop Armand Trousseau, Paris, France; [Graf, Norbert] Univ Saarland, Dept Pediat Oncol & Hematol, Homburg, Germany; [O'Sullivan, Maureen] Our Ladys Childrens Hosp, Dept Pathol, Dublin, Ireland	National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Royal College of Surgeons - Ireland; University of London; University College London; University of London; Institute of Cancer Research - UK; Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Saarland University; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	O'Sullivan, M (corresponding author), Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland.	maureen.osullivan@tcd.ie	Vujanic, Gordan M./AFS-3176-2022; Vujanic, Gordan M./AAW-4712-2020; Graf, Norbert/H-1328-2011; Pritchard-Jones, Kathy/F-4286-2014	Vujanic, Gordan M./0000-0003-0726-6939; Vujanic, Gordan M./0000-0003-0726-6939; Graf, Norbert/0000-0002-2248-323X; Pritchard-Jones, Kathy/0000-0002-2384-9475; O'Sullivan, Maureen/0000-0001-5838-1609; Bryan, Kenneth/0000-0002-9550-8354	Health Research Board (HRB) of Ireland [HRB MRCG 2008/1]	Health Research Board (HRB) of Ireland	This project was funded by the Health Research Board (HRB) of Ireland, grant number: HRB MRCG 2008/1; website: http://www.hrb.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Baltayiannis G, 2008, J BUON, V13, P263; Barroca H, 2010, DIAGN CYTOPATHOL, V38, P477, DOI 10.1002/dc.21221; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Bjornsson HT, 2007, JNCI-J NATL CANCER I, V99, P1270, DOI 10.1093/jnci/djm069; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; de Kraker J, 2004, LANCET, V364, P1229, DOI 10.1016/S0140-6736(04)17139-0; Feng DD, 2011, J CELL MOL MED, V15, P2164, DOI 10.1111/j.1582-4934.2010.01213.x; Giovannetti E, 2012, CRIT REV ONCOL HEMAT, V81, P103, DOI 10.1016/j.critrevonc.2011.03.010; Godzinski J, 1998, EUR J PEDIATR SURG, V8, P83, DOI 10.1055/s-2008-1071127; Graf N, 2000, UROL CLIN N AM, V27, P443, DOI 10.1016/S0094-0143(05)70092-6; Isomoto H, 2009, DIGESTION, V79, P2, DOI 10.1159/000167859; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jesus ABD, 2009, CELL CYCLE, V8, P394; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEMERLE J, 1983, J CLIN ONCOL, V1, P604, DOI 10.1200/JCO.1983.1.10.604; Ma N, 2011, MOL CELL ENDOCRINOL, V333, P96, DOI 10.1016/j.mce.2010.11.027; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Ueda K, 1999, ANTI-CANCER DRUG DES, V14, P115; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782; Zirn B, 2006, INT J CANCER, V118, P1954, DOI 10.1002/ijc.21564; ZUPPAN CW, 1991, CANCER-AM CANCER SOC, V68, P385, DOI 10.1002/1097-0142(19910715)68:2<385::AID-CNCR2820680229>3.0.CO;2-T	32	54	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53417	10.1371/journal.pone.0053417	http://dx.doi.org/10.1371/journal.pone.0053417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308219	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100065
J	Cadavid, D; Jurgensen, S; Lee, S				Cadavid, Diego; Jurgensen, Stephanie; Lee, Sophia			Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							DISABILITY STATUS SCALE; FUNCTIONAL COMPOSITE; CONTROLLED-TRIAL; MENINGEAL INFLAMMATION; CORTICAL PATHOLOGY; INTERFERON BETA-1B; MS; IMPAIRMENT; DISEASE; EDSS	Background: There is an unmet need for disease-modifying therapies to improve ambulatory function in disabled subjects with multiple sclerosis. Objectives: Assess the effects of natalizumab on ambulatory function in disabled subjects with relapsing-remitting multiple sclerosis (RRMS) or secondary progressive multiple sclerosis (SPMS). Methods: We retrospectively reviewed ambulatory function as measured by timed 25-foot walk (T25FW) in clinical trial subjects with an Expanded Disability Status Scale score >= 3.5, including RRMS subjects from the phase 3 AFFIRM and SENTINEL trials, relapsing SPMS subjects from the phase 2 MS231 study, and nonrelapsing SPMS subjects from the phase 1b DELIVER study. For comparison, SPMS subjects from the intramuscular interferon beta-1a (IM IFN beta-1a) IMPACT study were also analyzed. Improvement in ambulation was measured using T25FW responder status; response was defined as faster walking times over shorter (6-9-month) or longer (24-30-month) treatment periods relative to subjects' best predose walking times. Results: There were two to four times more T25FW responders among disabled MS subjects in the natalizumab arms than in the placebo or IM IFNb-1a arms. Responders walked 25 feet an average of 24%-45% faster than nonresponders. Conclusion: Natalizumab improves ambulatory function in disabled RRMS subjects and may have efficacy in disabled SPMS subjects. Confirmation of the latter finding in a prospective SPMS study is warranted.	[Cadavid, Diego] Biogen Idec Inc, MS Clin Dev Grp, Cambridge, MA USA; [Jurgensen, Stephanie] Genzyme, MS Global Med Affairs, Cambridge, MA USA; [Lee, Sophia] Biogen Idec Inc, Biometr, Cambridge, MA USA	Biogen; Sanofi-Aventis; Genzyme Corporation; Biogen	Cadavid, D (corresponding author), Biogen Idec Inc, MS Clin Dev Grp, Cambridge, MA USA.	diego.cadavid@biogenidec.com			Biogen Idec Inc.; Elan Pharmaceuticals, Inc.	Biogen Idec Inc.(Biogen); Elan Pharmaceuticals, Inc.	The IMPACT trial was funded by Biogen Idec Inc.; the other trials were funded by Biogen Idec Inc. in partnership with Elan Pharmaceuticals, Inc. The funders had no role in study design, data collection and analysis, or decision to publish. Editorial support for preparation of the manuscript was funded by Biogen Idec Inc. and Elan Pharmaceuticals, Inc.	Aloisi F, 2008, J NEUROIMMUNOL, V198, P106, DOI 10.1016/j.jneuroim.2008.04.025; Cadavid D, 2010, REV NEUROLOGIA, V51, P321, DOI 10.33588/rn.5106.2010390; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; FISCHER JS, 1999, ADM SCORING MANUAL M; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Goldman Myla D, 2010, Ther Adv Neurol Disord, V3, P229, DOI 10.1177/1756285610374117; Goodman AD, 2010, ANN NEUROL, V68, P494, DOI 10.1002/ana.22240; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Hobart J, 2004, MULT SCLER J, V10, P41, DOI 10.1191/1352458504ms983oa; Hoogervorst ELJ, 2004, MULT SCLER, V10, P55, DOI 10.1191/1352458504ms972oa; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; King J, 2001, NEUROLOGY, V56, P1496; Kragt JJ, 2006, MULT SCLER J, V12, P594, DOI 10.1177/1352458506070768; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LaRocca NG, 2011, PATIENT, V4, P189, DOI 10.2165/11591150-000000000-00000; Leung G, 2011, EXP NEUROL, V227, P232, DOI 10.1016/j.expneurol.2010.11.004; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; Meuth SG, 2011, MULT SCLER J, V17, P198, DOI 10.1177/1352458510386998; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Munschauer F, 2009, 25 C EUR COMM TREATM; Orbach R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045409; Paltamaa J, 2008, ASSESSMENT PHYS FUNC; Paltamaa J, 2008, PHYS THER, V88, P176, DOI 10.2522/ptj.20070064; Panitch H, 2004, NEUROLOGY, V63, P1788; Phillips JT, 2011, MULT SCLER J, V17, P970, DOI 10.1177/1352458511399611; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rudick RA, 2009, MULT SCLER J, V15, P984, DOI 10.1177/1352458509106212; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Sutliff MH, 2010, CURR MED RES OPIN, V26, P109, DOI 10.1185/03007990903433528; Vermersch P, 2011, NEUROLOGY, V76, P1697, DOI 10.1212/WNL.0b013e31821a446b	36	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53297	10.1371/journal.pone.0053297	http://dx.doi.org/10.1371/journal.pone.0053297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308186	Green Submitted, Green Published, gold			2022-12-27	WOS:000313670100031
J	Cavallo, A; Priore, P; Gnoni, GV; Papa, S; Zanotti, F; Gnoni, A				Cavallo, Alessandro; Priore, Paola; Gnoni, Gabriele Vincenzo; Papa, Sergio; Zanotti, Franco; Gnoni, Antonio			3,5-Diiodo-L-Thyronine Administration To Hypothyroid Rats Rapidly Enhances Fatty Acid Oxidation Rate and Bioenergetic Parameters in Liver Cells	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; MITOCHONDRIAL F0F1-ATP SYNTHASE; THYROID-HORMONE ACTION; GENE-EXPRESSION; CARRIER ACTIVITY; HEPATOCYTES; METABOLISM; 3,5-DIIODOTHYRONINE; DIET; RESPIRATION	Growing evidence shows that, among triiodothyronine derivatives, 3,5 diiodo-L-thyronine (T-2) plays an important role in energy metabolism and fat storage. In the present study, short-term effects of T-2 administration to hypothyroid rats on fatty acid oxidation rate and bioenergetic parameters were investigated. Within 1 h following T-2 injection, state 3 and state 4 respiration rates, which were reduced in hypothyroid mitochondria, were noticeably increased particularly in succinate- with respect to glutamate/malate-energized mitochondria. Maximal respiratory activity, observed when glutamate/malate/succinate were simultaneously present in the respiratory medium, was significantly stimulated by T-2 treatment. A T-2-induced increase in respiratory rates was also observed when palmitoyl-CoA or L-palmitoylcarnitine were used as substrates. No significant change in respiratory control index and ADP/O ratio was observed. The activities of the mitochondrial respiratory chain complexes, especially Complex II, were increased in T-2-treated rats. In the latter, Complex V activities, assayed in both ATP synthesis and hydrolysis direction, were enhanced. The rate of fatty acid oxidation, followed by conversion of [C-14]palmitate to CO2 and ketone bodies, was higher in hepatocytes isolated from T-2-treated rats. This increase occurs in parallel with the raise in the activity of carnitine palmitoyltransferase-I, the rate limiting enzyme of fatty acid beta-oxidation, assayed in situ in digitonin-permeabilized hepatocytes. Overall, these results indicate that T-2 rapidly increases the ability of mitochondria to import and oxidize fatty acids. An emerging idea in the literature is the ability of T-2 to reduce adiposity and dyslipidemia and to prevent the development in liver steatosis. The results of the present study, showing a rapid T-2-induced increase in the ability of mitochondria to import and oxidize fatty acids, may contribute to understand the biochemical mechanisms of T-2-metabolic effects.	[Cavallo, Alessandro; Priore, Paola; Gnoni, Gabriele Vincenzo] Univ Salento, Dept Biol & Environm Sci & Technol, Biochem Lab, Lecce, Italy; [Papa, Sergio] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Zanotti, Franco; Gnoni, Antonio] Univ Bari Aldo Moro, Dept Basic Med Sci, Bari, Italy	University of Salento; Consiglio Nazionale delle Ricerche (CNR); Universita degli Studi di Bari Aldo Moro	Gnoni, A (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci, Bari, Italy.	antonio.gnoni@uniba.it	Gnoni, Antonio/C-8078-2014	Gnoni, Antonio/0000-0001-5071-611X; Papa, Sergio/0000-0002-4417-1763	PRIN	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was in part supported by PRIN 2007 to G.V. Gnoni. Ministero dell'Istruzione dell'Universita e Ricerca (MIUR) Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Cavallo A, 2011, J BIOENERG BIOMEMBR, V43, P349, DOI 10.1007/s10863-011-9366-3; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Cimmino M, 1996, J ENDOCRINOL, V149, P319, DOI 10.1677/joe.0.1490319; Cioffi F, 2010, CURR OPIN ENDOCRINOL, V17, P402, DOI 10.1097/MED.0b013e32833cf354; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Davis PJ, 1996, THYROID, V6, P497, DOI 10.1089/thy.1996.6.497; de Lange P, 2011, DIABETES, V60, P2730, DOI 10.2337/db11-0207; de Lange P, 2008, ENDOCRINOLOGY, V149, P6462, DOI 10.1210/en.2008-0202; Enriquez JA, 1999, MOL CELL BIOL, V19, P657; Fernandez-Vizarra E, 2008, CURR GENET, V54, P13, DOI 10.1007/s00294-008-0194-x; Ferreira FM, 2003, J BIOCHEM MOL TOXIC, V17, P214, DOI 10.1002/jbt.10081; Geelen MJH, 2005, ANAL BIOCHEM, V347, P1, DOI 10.1016/j.ab.2005.03.032; Giudetti AM, 2005, ENDOCRINOLOGY, V146, P3959, DOI 10.1210/en.2005-0345; Giudetti AM, 2006, BBA-MOL CELL BIOL L, V1761, P484, DOI 10.1016/j.bbalip.2006.03.021; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Goglia F, 1999, FEBS LETT, V452, P115, DOI 10.1016/S0014-5793(99)00642-0; Goglia F, 2005, BIOCHEMISTRY-MOSCOW+, V70, P164, DOI 10.1007/s10541-005-0097-0; Goglia F, 2002, BIOSCIENCE REP, V22, P17, DOI 10.1023/A:1016056905347; Grasselli E, 2008, EXP BIOL MED, V233, P549, DOI 10.3181/0710-RM-266; Grasselli E, 2011, J HEPATOL, V54, P1230, DOI 10.1016/j.jhep.2010.09.027; Guerrieri F, 1998, J BIOENERG BIOMEMBR, V30, P269, DOI 10.1023/A:1020548904384; GUZMAN M, 1992, BIOCHEM J, V287, P487, DOI 10.1042/bj2870487; HAFNER RP, 1990, BIOCHEM J, V265, P731, DOI 10.1042/bj2650731; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Kashfi K, 2011, BIOCHEM SOC T, V39, P833, DOI 10.1042/BST0390833; Kerner Janos, 2008, Archives of Physiology and Biochemistry, V114, P161, DOI [10.1080/13813450802181062, 10.1080/13813450802181062 ]; Lanni A, 2005, FASEB J, V19, DOI 10.1096/fj.05.3977fje; Leary SC, 1996, GEN COMP ENDOCR, V104, P61, DOI 10.1006/gcen.1996.0141; Lombardi A, 1998, BIOCHEM J, V330, P521, DOI 10.1042/bj3300521; Lombardi A, 2009, AM J PHYSIOL-ENDOC M, V296, pE497, DOI 10.1152/ajpendo.90642.2008; Lombardi A, 2007, FEBS LETT, V581, P5911, DOI 10.1016/j.febslet.2007.11.073; Louet JF, 2001, BIOCHEM SOC T, V29, P310, DOI 10.1042/0300-5127:0290310; Mangiullo R, 2008, BBA-BIOENERGETICS, V1777, P1326, DOI 10.1016/j.bbabio.2008.08.003; Mangiullo R, 2010, BBA-BIOENERGETICS, V1797, P233, DOI 10.1016/j.bbabio.2009.10.009; Mollica MP, 2009, J HEPATOL, V51, P363, DOI 10.1016/j.jhep.2009.03.023; Mracek T, 2005, BBA-GEN SUBJECTS, V1726, P217, DOI 10.1016/j.bbagen.2005.06.011; Nogueira V, 2002, J BIOENERG BIOMEMBR, V34, P55, DOI 10.1023/A:1013822820840; PARADIES G, 1991, BIOCHIM BIOPHYS ACTA, V1070, P180, DOI 10.1016/0005-2736(91)90161-Z; Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006; Priore P, 2007, BBA-MOL CELL BIOL L, V1771, P1299, DOI 10.1016/j.bbalip.2007.08.005; Priore P, 2012, BBA-MOL CELL BIOL L, V1821, P1341, DOI 10.1016/j.bbalip.2012.07.008; Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2; SAGGERSON ED, 1986, BIOCHEM J, V236, P137, DOI 10.1042/bj2360137; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; Siculella L, 2006, J BIOL CHEM, V281, P19072, DOI 10.1074/jbc.M507237200; Silvestri E, 2010, MOL BIOSYST, V6, P2256, DOI 10.1039/c0mb00040j; SOBOLL S, 1993, BIOCHIM BIOPHYS ACTA, V1144, P1, DOI 10.1016/0005-2728(93)90024-A; VEERKAMP JH, 1986, BIOCHEM MED METAB B, V35, P248, DOI 10.1016/0885-4505(86)90080-0; Weitzel JM, 2003, EXP PHYSIOL, V88, P121, DOI 10.1113/eph8802506; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200	54	38	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52328	10.1371/journal.pone.0052328	http://dx.doi.org/10.1371/journal.pone.0052328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308110	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100009
J	Federighi, G; Macchi, M; Bernardi, R; Scuri, R; Brunelli, M; Durante, M; Traina, G				Federighi, Giuseppe; Macchi, Monica; Bernardi, Rodolfo; Scuri, Rossana; Brunelli, Marcello; Durante, Mauro; Traina, Giovanna			Differentially Expressed Genes in Hirudo medicinalis Ganglia after Acetyl-L-Carnitine Treatment	PLOS ONE			English	Article							ALPHA-ACTININ GENE; L-ACETYLCARNITINE; RAT-BRAIN; AGED RATS; LEECH; HSP90; ALPHA-ACTININ-2; INACTIVATION; POTENTIATION; PROTEINS	Acetyl-L-carnitine (ALC) is a naturally occurring substance that, when administered at supra-physiological concentration, is neuroprotective. It is involved in membrane stabilization and in enhancement of mitochondrial functions. It is a molecule of considerable interest for its clinical application in various neural disorders, including Alzheimer's disease and painful neuropathies. ALC is known to improve the cognitive capability of aged animals chronically treated with the drug and, recently, it has been reported that it impairs forms of non-associative learning in the leech. In the present study the effects of ALC on gene expression have been analyzed in the leech Hirudo medicinalis. The suppression subtractive hybridisation methodology was used for the generation of subtracted cDNA libraries and the subsequent identification of differentially expressed transcripts in the leech nervous system after ALC treatment. The method detects differentially but also little expressed transcripts of genes whose sequence or identity is still unknown. We report that a single administration of ALC is able to modulate positively the expression of genes coding for functions that reveal a lasting effect of ALC on the invertebrate, and confirm the neuroprotective and neuromodulative role of the substance. In addition an important finding is the modulation of genes of vegetal origin. This might be considered an instance of ectosymbiotic mutualism.	[Federighi, Giuseppe; Scuri, Rossana] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy; [Macchi, Monica; Brunelli, Marcello] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Bernardi, Rodolfo; Durante, Mauro] Univ Pisa, Dipartimento Sci Agr Genet Alimentari & Agroambie, Pisa, Italy; [Traina, Giovanna] Univ Perugia, Sez Chim Bromatol Biochim Fisiol & Nutr, Dipartimento Sci Econ Estimat & Alimenti, I-06100 Perugia, Italy	University of Pisa; University of Pisa; University of Pisa; University of Perugia	Traina, G (corresponding author), Univ Perugia, Sez Chim Bromatol Biochim Fisiol & Nutr, Dipartimento Sci Econ Estimat & Alimenti, I-06100 Perugia, Italy.	traina@unipg.it	Durante, Marco/K-1315-2014; Traina, Giovanna/AAR-2179-2020	Durante, Marco/0000-0002-4615-553X; Traina, Giovanna/0000-0001-9996-3584	Sigma-Tau Laboratories (Pomezia, Italy)	Sigma-Tau Laboratories (Pomezia, Italy)	The work was supported by Sigma-Tau Laboratories (Pomezia, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aljamali MN, 2009, INSECT MOL BIOL, V18, P129, DOI 10.1111/j.1365-2583.2009.00863.x; Ando S, 2001, J NEUROSCI RES, V66, P266, DOI 10.1002/jnr.1220; BARNES CA, 1990, NEUROBIOL AGING, V11, P499, DOI 10.1016/0197-4580(90)90110-L; BARSTEAD RJ, 1991, CELL MOTIL CYTOSKEL, V20, P69, DOI 10.1002/cm.970200108; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; BENTON D, 1995, PSYCHOPHARMACOLOGY, V117, P298, DOI 10.1007/BF02246104; Blackshaw SE, 2004, J ANAT, V204, P13, DOI 10.1111/j.1469-7580.2004.00260.x; Bouhamdan M, 2006, J NEUROSCI, V26, P2522, DOI 10.1523/JNEUROSCI.4083-05.2006; BROMM K, 1995, NEUROPSYCHOBIOLOGY, V31, P156, DOI 10.1159/000119186; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Burrell BD, 2008, NEUROBIOL LEARN MEM, V90, P275, DOI 10.1016/j.nlm.2007.11.004; Calabrese V, 2003, AMINO ACIDS, V25, P437, DOI 10.1007/s00726-003-0048-2; Cataldo E, 2005, J COMPUT NEUROSCI, V18, P5, DOI 10.1007/s10827-005-5477-3; Chiechio S, 2002, MOL PHARMACOL, V61, P989, DOI 10.1124/mol.61.5.989; De Grandis Domenico, 2002, Drugs R D, V3, P223, DOI 10.2165/00126839-200203040-00001; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dixson JD, 2003, J MOL EVOL, V56, P1, DOI 10.1007/s00239-002-2374-5; FYRBERG E, 1990, J CELL BIOL, V110, P1999, DOI 10.1083/jcb.110.6.1999; Gadaleta MN, 1998, BIOCHIMIE, V80, P863, DOI 10.1016/S0300-9084(00)88881-1; GASS P, 1994, NEUROSCI LETT, V182, P188, DOI 10.1016/0304-3940(94)90794-3; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; GHIRARDI O, 1988, PHYSIOL BEHAV, V44, P769, DOI 10.1016/0031-9384(88)90060-1; HEYE N, 1994, INTENS CARE MED, V20, P282, DOI 10.1007/BF01708966; Kerney R, 2011, P NATL ACAD SCI USA, V108, P6497, DOI 10.1073/pnas.1018259108; Korneev Sergei, 1997, Invertebrate Neuroscience, V3, P185, DOI 10.1007/BF02480373; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Li Q, 2008, BRAIN RES, V1228, P43, DOI 10.1016/j.brainres.2008.06.035; Lombardo P, 2004, NEUROSCIENCE, V128, P293, DOI 10.1016/j.neuroscience.2004.06.028; Lombardo P, 2003, PFLUG ARCH EUR J PHY, V445, pR164; Macchi M, 2008, ARCH ITAL BIOL, V146, P205; MADER R, 1988, INT J VITAM NUTR RES, V58, P436; MARK J, 1975, GUIDE VITAMINS, P73; Meador K, 1993, J Geriatr Psychiatry Neurol, V6, P222; MEADOR KJ, 1993, ANN NEUROL, V34, P724, DOI 10.1002/ana.410340516; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Mineta K, 2003, P NATL ACAD SCI USA, V100, P7666, DOI 10.1073/pnas.1332513100; Nuriya M, 2005, J NEUROCHEM, V95, P544, DOI 10.1111/j.1471-4159.2005.03410.x; ONOFRJ M, 1995, INT J CLIN PHARM RES, V15, P9; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Ristori C, 2006, NEUROSCIENCE, V142, P931, DOI 10.1016/j.neuroscience.2006.07.002; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; Scarpini E, 1997, J Peripher Nerv Syst, V2, P250; Schulz D, 2004, EUR J NEUROSCI, V19, P1373, DOI 10.1111/j.1460-9568.2004.03234.x; Scuri R, 2002, J NEUROPHYSIOL, V88, P2490, DOI 10.1152/jn.01027.2001; Settembre E, 2003, CURR OPIN STRUC BIOL, V13, P739, DOI 10.1016/j.sbi.2003.10.006; Snoeckx LHEH, 2001, PHYSIOL REV, V81, P1461, DOI 10.1152/physrev.2001.81.4.1461; THOMSON AD, 1992, NUTR ALCOHOL, P75; Traina G, 2004, MOL BRAIN RES, V132, P57, DOI 10.1016/j.molbrainres.2004.09.006; Traina G, 2008, MOL NEUROBIOL, V38, P146, DOI 10.1007/s12035-008-8038-8; Traina G, 2006, NEUROCHEM INT, V48, P673, DOI 10.1016/j.neuint.2005.11.005; Traina G, 2011, NUTR DIET SUPPL, V3, P77, DOI 10.2147/NDS.S7119; Traina G, 2011, MOL NEUROBIOL, V44, P1, DOI 10.1007/s12035-011-8189-x; Traina G, 2009, MOL NEUROBIOL, V39, P101, DOI 10.1007/s12035-009-8056-1; Traina G, 2008, NEUROCHEM INT, V53, P244, DOI 10.1016/j.neuint.2008.08.001; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Wang ZB, 2003, J FASEB, P439; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Yasui F, 2002, NEUROSCI LETT, V334, P177, DOI 10.1016/S0304-3940(02)01127-8; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158	61	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53605	10.1371/journal.pone.0053605	http://dx.doi.org/10.1371/journal.pone.0053605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308261	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100051
J	Takahashi, T; Suzuki, H; Imai, T; Shibata, S; Tabuchi, Y; Tsuchimoto, K; Okano, H; Hibi, T				Takahashi, Tetsufumi; Suzuki, Hidekazu; Imai, Takao; Shibata, Shinsuke; Tabuchi, Yoshiaki; Tsuchimoto, Kanji; Okano, Hideyuki; Hibi, Toshifumi			Musashi-1 Post-Transcriptionally Enhances Phosphotyrosine-Binding Domain-Containing m-Numb Protein Expression in Regenerating Gastric Mucosa	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MTF-1; METALLOTHIONEIN-I; TRANSLATIONAL REPRESSION; MESSENGER-RNA; CELL-FATE; ISOFORMS; SWITCH; DIFFERENTIATION; SUSCEPTIBILITY; IDENTIFICATION	Objective: Upregulation of the RNA-binding protein Musashi-1 (Msi1) has been shown to occur in rat gastric corpus mucosa after ethanol-induced mucosal injury. However, there is no direct evidence linking Msi1 with gastric regeneration. We examined the process of tissue repair after acute gastric mucosal injury with Msi1-knock-out (KO) mice to clarify the role of Msi1 and Msi1-dependent regulation of m-Numb expression in regenerating gastric mucosa. Methods: Acute gastric injury was induced in Msi1-KO and wild-type ICR mice by administering absolute ethanol. Expression of the splicing variants of m-Numb mRNA and protein in the gastric mucosa were analyzed by quantitative RT-PCR and western blotting, respectively. Results: We demonstrated that phosphotyrosine-binding domain-containing m-Numb expression was significantly upregulated at both the mRNA and protein levels in wild-type mice at 3 h after ethanol-induced acute gastric injury. In contrast, in Msi1-KO mice, the m-Numb protein was expressed weakly, and was associated with delayed regeneration of the injured gastric mucosal epithelium. In the Msi1-KO mouse, the ratio of m-Numb mRNA to total m-Numb mRNA in the heavy polysome fractions was lower than that in the wild-type mouse. Further, we showed that m-Numb-enhancement in gastric mucous cells induced the expression of prostate stem cell antigen and metallothionein-2. Under the m-Numb enhancing condition, the gastric cells exhibited enhanced cell proliferation and were significantly more resistant to H2O2-induced cell death than control cells. Conclusions: Msi1-dependent post-transcriptional enhancement of m-Numb is crucial in gastric epithelial regeneration.	[Takahashi, Tetsufumi; Suzuki, Hidekazu; Hibi, Toshifumi] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Takahashi, Tetsufumi; Tsuchimoto, Kanji] Kitasato Univ, Sch Pharm, Lab Pathophysiol, Div Clin Med, Tokyo, Japan; [Imai, Takao; Shibata, Shinsuke; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Tabuchi, Yoshiaki] Toyama Univ, Life Sci Res Ctr, Div Mol Genet, Toyama 930, Japan	Keio University; Kitasato University; Keio University; University of Toyama	Suzuki, H (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	hsuzuki@a6.keio.jp	Okano, Hideyuki/I-7584-2019; Imai, Takao/L-1232-2013; SUZUKI, HIDEKAZU/S-9376-2019; Shibata, Shinsuke/AAM-6620-2020; Takahashi, Tetsufumi/AAW-1430-2021; Suzuki, Hidekazu/J-4396-2013; Suzuki, Hidekazu/AAO-6330-2020	Suzuki, Hidekazu/0000-0002-8994-6163; Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [22300169]; Funding Program for World-leading Innovative R&D on Science and Technology; Mitsukoshi Health and Welfare Foundation; Smoking Research Foundation; Keio Gijuku Academic Development Funds; Kitasato University Research Grant for Young Researchers;  [24659103]; Grants-in-Aid for Scientific Research [24601016] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for World-leading Innovative R&D on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsukoshi Health and Welfare Foundation; Smoking Research Foundation; Keio Gijuku Academic Development Funds; Kitasato University Research Grant for Young Researchers; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (22300169 to H.S.), Grant-in-Aid for challenging Exploratory Research (24659103 to H.S.), Funding Program for World-leading Innovative R&D on Science and Technology (to H.O.), a Research Fund from Mitsukoshi Health and Welfare Foundation (to H.S.), a grant from the Smoking Research Foundation (to H.S.), Keio Gijuku Academic Development Funds (to H.S.), and a Kitasato University Research Grant for Young Researchers (to T.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Bani-Yaghoub M, 2007, DEV DYNAM, V236, P696, DOI 10.1002/dvdy.21072; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Corallini S, 2006, REPRODUCTION, V132, P887, DOI 10.1530/REP-06-0062; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; ITO S, 1984, SCAND J GASTROENTERO, V19, P87; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Kyriazis GA, 2010, J BIOL CHEM, V285, P6811, DOI 10.1074/jbc.M109.074690; LACY ER, 1984, LAB INVEST, V51, P573; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Matsuda Y, 2005, DEVELOPMENT, V132, P2783, DOI 10.1242/dev.01853; Mita M, 2008, AM J PHYSIOL-GASTR L, V294, pG877, DOI 10.1152/ajpgi.00251.2007; MOORE R, 1989, LAB INVEST, V60, P237; Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431; Nagata H, 2006, FEBS LETT, V580, P27, DOI 10.1016/j.febslet.2005.11.041; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Nishimoto Y, 2010, CELL RES, V20, P1083, DOI 10.1038/cr.2010.122; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Tabuchi Y, 2003, DIGESTION, V67, P71, DOI 10.1159/000070396; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Toriya M, 2006, DEV NEUROSCI-BASEL, V28, P142, DOI 10.1159/000090760; Tran CD, 2003, HELICOBACTER, V8, P533, DOI 10.1046/j.1523-5378.2003.00174.x; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; WESTIN G, 1988, EMBO J, V7, P3763, DOI 10.1002/j.1460-2075.1988.tb03260.x; Zhao Z, 2011, UROL ONCOL, DOI 10.1016/j.urolonc.2011.02.004; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	45	19	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53540	10.1371/journal.pone.0053540	http://dx.doi.org/10.1371/journal.pone.0053540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308249	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100047
J	Hao, Z; Zhao, ZY; Berthoud, HR; Ye, JP				Hao, Zheng; Zhao, Zhiyun; Berthoud, Hans-Rudolf; Ye, Jianping			Development and Verification of a Mouse Model for Roux-en-Y Gastric Bypass Surgery with a Small Gastric Pouch	PLOS ONE			English	Article							HISTONE DEACETYLASE 3; BARIATRIC SURGERY; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; TRANSGENIC MICE; MEDICAL THERAPY; OBESITY; RAT	Existing mouse models of Roux-en-Y gastric bypass (RYGB) surgery are not comparable to human RYGB in gastric pouch volume for a large or absent gastric volume. The aim of this study was to develop and characterize a mouse RYGB model that closely replicates gastric pouch size of human RYGB surgery of about 5% of total gastric volume. We established this model in diet-induced obese (DIO) mice of C57BL/6J. This surgery resulted in a sustained 30% weight loss, entirely accounted for by decreased fat mass but not lean mass, compared to sham-operated mice on the high fat diet. Compared to sham-operated mice, energy expenditure corrected for total body weight was significantly increased by about 25%, and substrate utilization was shifted toward higher carbohydrate utilization at 8 weeks after RYGB when body weight had stabilized at the lower level. The energy expenditure persisted and carbohydrate utilization was even more pronounced when the mice were fed chow diet. Although significantly increased during daytime, overall locomotor activity was not significantly different. In response to cold exposure, RYGB mice exhibited an improved capacity to maintain the body temperature. In insulin tolerance test, exogenous insulin-induced suppression of plasma glucose levels was significantly greater in RYGB mice at 4 weeks after surgery. Paradoxically, food intake measured at 5 weeks after surgery was significantly increased, possibly in compensation for increased fecal energy loss and energy expenditure. In conclusion, this new model is a viable alternative to existing murine RYGB models and the model matches human RYGB surgery in anatomy. This model will be useful for studying molecular mechanisms involved in the beneficial effects of RYGB on body weight and glucose homeostasis.	[Hao, Zheng; Zhao, Zhiyun; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA USA; [Berthoud, Hans-Rudolf] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Neurobiol Nutr Lab, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA USA.	yej@pbrc.edu	Berthoud, Hans-Rudolf/N-1950-2017; Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X	National Institute of Health (NIH) [DK085495, DK068036, DK047348]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047348, R01DK068036, R01DK085495, P30DK072476, R56DK068036] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by the National Institute of Health (NIH) through three projects (DK085495; DK068036; DK047348). Those projects are listed under each the project number at NIH website: http://projectreporter.nih.gov/reporter.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Chandarana K, 2011, DIABETES, V60, P810, DOI 10.2337/db10-0566; Collins BJ, 2007, ARCH SURG-CHICAGO, V142, P1000, DOI 10.1001/archsurg.142.10.1000; Elder KA, 2007, GASTROENTEROLOGY, V132, P2253, DOI 10.1053/j.gastro.2007.03.057; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Hatoum IJ, 2012, J CLIN ENDOCRINOLOGY; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Linner JH, 2007, SURG OBES RELAT DIS, V3, P569, DOI 10.1016/j.soard.2007.06.007; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Nestoridi E, 2012, ENDOCRINOLOGY, V153, P2234, DOI 10.1210/en.2011-2041; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Xu Y, 2002, J SURG RES, V107, P56, DOI [10.1006/jsre.2002.6508, 10.1016/S0022-4804(02)96508-X]; Yin DP, 2011, ANN SURG, V254, P73, DOI 10.1097/SLA.0b013e3182197035; Zheng HY, 2009, AM J PHYSIOL-REG I, V297, pR1273, DOI 10.1152/ajpregu.00343.2009	20	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52922	10.1371/journal.pone.0052922	http://dx.doi.org/10.1371/journal.pone.0052922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326365	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800027
J	Krupovic, M; Gonnet, M; Ben Hania, W; Forterre, P; Erauso, G				Krupovic, Mart; Gonnet, Mathieu; Ben Hania, Wajdi; Forterre, Patrick; Erauso, Gael			Insights into Dynamics of Mobile Genetic Elements in Hyperthermophilic Environments from Five New Thermococcus Plasmids	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ROLLING-CIRCLE REPLICATION; VIRUS-LIKE PARTICLE; ESCHERICHIA-COLI; ARCHAEAL VIRUSES; SP. NOV.; PROTEIN; EVOLUTION; GENOME; SULFOLOBUS	Mobilome of hyperthermophilic archaea dwelling in deep-sea hydrothermal vents is poorly characterized. To gain insight into genetic diversity and dynamics of mobile genetic elements in these environments we have sequenced five new plasmids from different Thermococcus strains that have been isolated from geographically remote hydrothermal vents. The plasmids were ascribed to two subfamilies, pTN2-like and pEXT9a-like. Gene content and phylogenetic analyses illuminated a robust connection between pTN2-like plasmids and Pyrococcus abyssi virus 1 (PAV1), with roughly half of the viral genome being composed of genes that have homologues in plasmids. Unexpectedly, pEXT9a-like plasmids were found to be closely related to the previously sequenced plasmid pMETVU01 from Methanocaldococcus vulcanius M7. Our data suggests that the latter observation is most compatible with an unprecedented horizontal transfer of a pEXT9a-like plasmid from Thermococcales to Methanococcales. Gene content analysis revealed that thermococcal plasmids encode Hfq-like proteins and toxin-antitoxin (TA) systems of two different families, VapBC and RelBE. Notably, although abundant in archaeal genomes, to our knowledge, TA and hfq-like genes have not been previously found in archaeal plasmids or viruses. Finally, the plasmids described here might prove to be useful in developing new genetic tools for hyperthermophiles.	[Krupovic, Mart; Forterre, Patrick] Inst Pasteur, Dept Microbiol, Unite Biol Mol Gene Extremophiles, Paris, France; [Gonnet, Mathieu; Erauso, Gael] Univ Bretagne Occidentale, CNRS, IFREMER, Lab Microbiol Environm Extremes,UMR6197, Plouzane, France; [Ben Hania, Wajdi; Erauso, Gael] UMR CNRS IRD 7294 235, Mediterranean Inst Oceanog, Equipe Microbiol Environm & Biotechnol, Marseille, France; [Forterre, Patrick] Univ Paris 11, CNRS, UMR 8621, Lab Biol Mol Gene & Extremophiles,Inst Genet & Mi, F-91405 Orsay, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Erauso, G (corresponding author), Univ Bretagne Occidentale, CNRS, IFREMER, Lab Microbiol Environm Extremes,UMR6197, Plouzane, France.	gael.erauso@univ-amu.fr	Krupovic, Mart/ABD-6255-2021; Krupovic, Mart/I-4209-2012	Krupovic, Mart/0000-0001-5486-0098; Krupovic, Mart/0000-0001-5486-0098	CNRS; MESR; IFREMER; EU [PYRED QLK36CT-2001-01676]; Marine Genomic Europe MGE [GOCE-CT-2004-5054003]; ANR Genoarchaea [M2TFP]; Souchotheque de Bretagne; Region Bretagne	CNRS(Centre National de la Recherche Scientifique (CNRS)); MESR(Ministry of Research, France); IFREMER; EU(European Commission); Marine Genomic Europe MGE; ANR Genoarchaea(French National Research Agency (ANR)); Souchotheque de Bretagne; Region Bretagne(Region Bretagne)	Funding: This work was supported by the CNRS, the MESR, the IFREMER and grants from the EU projects PYRED QLK36CT-2001-01676 to GE and Marine Genomic Europe MGE GOCE-CT-2004-5054003, ANR Genoarchaea M2TFP and the Souchotheque de Bretagne (Brittany Microbe Culture Collection). MG has received a PhD Fellowship from the Region Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold HP, 1999, MOL MICROBIOL, V34, P217, DOI 10.1046/j.1365-2958.1999.01573.x; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Benbouzid-Rollet N, 1997, RES MICROBIOL, V148, P767, DOI 10.1016/S0923-2508(97)82452-7; Berkner S, 2007, J BACTERIOL, V189, P1711, DOI 10.1128/JB.01586-06; BERTANI G, 1987, J BACTERIOL, V169, P2730, DOI 10.1128/jb.169.6.2730-2738.1987; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Duffaud GD, 1998, SYST APPL MICROBIOL, V21, P40, DOI 10.1016/S0723-2020(98)80007-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erauso G, 1996, J BACTERIOL, V178, P3232, DOI 10.1128/jb.178.11.3232-3237.1996; Erauso G, 1995, THERMOPHILES ARCHAEA, P25; Erauso G, 2006, MICROBIOL-SGM, V152, P1951, DOI 10.1099/mic.0.28861-0; Friedberg I, 2006, PROTEIN SCI, V15, P1527, DOI 10.1110/ps.062158406; Gaudin M, 2012, ENV MICROBI IN PRESS; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Geslin C, 2007, J BACTERIOL, V189, P4510, DOI 10.1128/JB.01896-06; Geslin C, 2003, J BACTERIOL, V185, P3888, DOI 10.1128/JB.185.13.3888-3894.2003; Gonnet M, 2011, RES MICROBIOL, V162, P132, DOI 10.1016/j.resmic.2010.11.003; Gorlas A, 2012, ENVIRON MICROBIOL, V14, P503, DOI 10.1111/j.1462-2920.2011.02662.x; Greve Bo, 2005, Archaea, V1, P319, DOI 10.1155/2005/159218; Greve Bo, 2004, Archaea, V1, P231, DOI 10.1155/2004/151926; Gu X, 2005, BIOINFORMATICS, V21, P1713, DOI 10.1093/bioinformatics/bti208; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Jeanthon C, 1999, INT J SYST BACTERIOL, V49, P583, DOI 10.1099/00207713-49-2-583; Krupovic M, 2008, VIROLOGY, V375, P292, DOI 10.1016/j.virol.2008.01.043; Krupovic M, 2012, ADV VIRUS RES, V82, P33, DOI 10.1016/B978-0-12-394621-8.00012-1; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; Krupovic M, 2010, MOL BIOL EVOL, V27, P2716, DOI 10.1093/molbev/msq161; Krupovic M, 2010, J MOL BIOL, V397, P144, DOI 10.1016/j.jmb.2010.01.037; Krupovic M, 2009, NAT REV MICROBIOL, V7, P250, DOI 10.1038/nrmicro2030-c1; Le Derout J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-17; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lepage E, 2004, APPL ENVIRON MICROB, V70, P1277, DOI 10.1128/AEM.70.3.1277-1286.2004; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Marsin S, 1998, MOL MICROBIOL, V27, P1183, DOI 10.1046/j.1365-2958.1998.00759.x; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Prieur D, 2001, THERMOPHILES: BIODIVERSITY, ECOLOGY, AND EVOLUTION, P11; Prieur D, 2004, BIOCHEM SOC T, V32, P184, DOI 10.1042/BST0320184; Ravin NV, 2011, PLASMID, V65, P102, DOI 10.1016/j.plasmid.2010.12.004; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soler N, 2008, RES MICROBIOL, V159, P390, DOI 10.1016/j.resmic.2008.04.015; Soler N, 2007, MOL MICROBIOL, V66, P357, DOI 10.1111/j.1365-2958.2007.05912.x; Soler N, 2011, BIOCHEM SOC T, V39, P36, DOI 10.1042/BST0390036; Soler N, 2010, NUCLEIC ACIDS RES, V38, P5088, DOI 10.1093/nar/gkq236; TAKAHASHI S, 1979, CAN J BIOCHEM CELL B, V57, P855, DOI 10.1139/o79-105; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vannier P, 2011, J BACTERIOL, V193, P1481, DOI 10.1128/JB.01490-10; Wang Y, 2007, VIROLOGY, V363, P124, DOI 10.1016/j.virol.2007.01.035; Ward DE, 2002, J BACTERIOL, V184, P2561, DOI 10.1128/JB.184.9.2561-2566.2002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weigel C, 2006, FEMS MICROBIOL REV, V30, P321, DOI 10.1111/j.1574-6976.2006.00015.x; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	57	48	51	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e49044	10.1371/journal.pone.0049044	http://dx.doi.org/10.1371/journal.pone.0049044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326305	Green Published, gold			2022-12-27	WOS:000314705800006
J	Mairiang, D; Zhang, HM; Sodja, A; Murali, T; Suriyaphol, P; Malasit, P; Limjindaporn, T; Finley, RL				Mairiang, Dumrong; Zhang, Huamei; Sodja, Ann; Murali, Thilakam; Suriyaphol, Prapat; Malasit, Prida; Limjindaporn, Thawornchai; Finley, Russell L., Jr.			Identification of New Protein Interactions between Dengue Fever Virus and Its Hosts, Human and Mosquito	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; INNATE IMMUNE-RESPONSE; OPEN READING FRAMES; NF-KAPPA-B; ENDOPLASMIC-RETICULUM; WEST-NILE; CAPSID PROTEIN; NUCLEAR-LOCALIZATION; INTERACTION NETWORK; GENE-EXPRESSION	The four divergent serotypes of dengue virus are the causative agents of dengue fever, dengue hemorrhagic fever and dengue shock syndrome. About two-fifths of the world's population live in areas where dengue is prevalent, and thousands of deaths are caused by the viruses every year. Dengue virus is transmitted from one person to another primarily by the yellow fever mosquito, Aedes aegypti. Recent studies have begun to define how the dengue viral proteins interact with host proteins to mediate viral replication and pathogenesis. A combined analysis of these studies, however, suggests that many virus-host protein interactions remain to be identified, especially for the mosquito host. In this study, we used high-throughput yeast two-hybrid screening to identify mosquito and human proteins that physically interact with dengue proteins. We tested each identified host protein against the proteins from all four serotypes of dengue to identify interactions that are conserved across serotypes. We further confirmed many of the interactions using co-affinity purification assays. As in other large-scale screens, we identified some previously detected interactions and many new ones, moving us closer to a complete host - dengue protein interactome. To help summarize and prioritize the data for further study, we combined our interactions with other published data and identified a subset of the host-dengue interactions that are now supported by multiple forms of evidence. These data should be useful for understanding the interplay between dengue and its hosts and may provide candidates for drug targets and vector control strategies.	[Mairiang, Dumrong; Zhang, Huamei; Murali, Thilakam; Finley, Russell L., Jr.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Sodja, Ann] Wayne State Univ, Dept Biol, Detroit, MI USA; [Suriyaphol, Prapat] Mahidol Univ, Siriraj Hosp, Fac Med, Bioinformat & Data Management Res Unit, Bangkok 10700, Thailand; [Suriyaphol, Prapat] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand; [Malasit, Prida] Mahidol Univ, Dengue Hemorrhag Fever Res Unit, Off Res & Dev, Fac Med,Siriraj Hosp, Bangkok 10700, Thailand; [Malasit, Prida] Natl Sci & Technol Dev Agcy, Med Biotechnol Res Unit, Natl Ctr Genet Engn & Biotechnol, Bangkok, Thailand; [Limjindaporn, Thawornchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok 10700, Thailand; [Finley, Russell L., Jr.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA	Wayne State University; Wayne State University; Mahidol University; Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Wayne State University	Finley, RL (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA.	rfinley@wayne.edu		Finley, Russ/0000-0003-1144-6887	Mahidol University; Commission of Higher Education (CHE); Mahidol University under the National Research Universities Initiative; National Institutes of Health [HG001536]; Thailand Research Fund (TRF)-CHE; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001536, R01HG001536] Funding Source: NIH RePORTER	Mahidol University; Commission of Higher Education (CHE)(Office of Higher Education Commission (OHEC)); Mahidol University under the National Research Universities Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund (TRF)-CHE; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Dr. Thawornchai Limjindaporn is supported by Mahidol University and currently a Thailand Research Fund (TRF)-CHE research Scholar; Dr. Prapat Suriyaphol is supported by the Commission of Higher Education (CHE) and Mahidol University under the National Research Universities Initiative; This project was supported in part by the National Institutes of Health grant HG001536 to RLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; Arakawa R, 2010, BIOCHEM CELL BIOL, V88, P899, DOI 10.1139/O10-014; Aranda B, 2009, NUCLEIC ACIDS RES, V38, P22; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; ARIAS CF, 1993, VIROLOGY, V193, P888, DOI 10.1006/viro.1993.1198; Arita M, 2012, J VIROL, V86, P5541, DOI 10.1128/JVI.00114-12; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750; Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bhattacharya D, 2009, J VIROL, V83, P9195, DOI 10.1128/JVI.00271-09; Bhuvanakantham R, 2009, BIOCHEM BIOPH RES CO, V389, P63, DOI 10.1016/j.bbrc.2009.08.108; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brault JB, 2011, VIROLOGY, V417, P369, DOI 10.1016/j.virol.2011.06.022; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Ceol A, 2009, NUCLEIC ACIDS RES, V38, P6; Chang CJ, 2001, DNA CELL BIOL, V20, P569, DOI 10.1089/104454901317094981; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Chen YC, 2010, NAT METHODS, V7, P667, DOI 10.1038/nmeth0910-667; Chiu MW, 2007, J BIOMED SCI, V14, P429, DOI 10.1007/s11373-007-9151-9; Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025; Chua JJE, 2004, VIRUS RES, V102, P151, DOI 10.1016/j.virusres.2004.01.025; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365; Colpitts TM, 2011, VIROLOGY, V417, P179, DOI 10.1016/j.virol.2011.06.002; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Doolittle JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000954; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Ellencrona K, 2009, BIOL CHEM, V390, P319, DOI 10.1515/BC.2009.041; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012; Folly BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-34; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Garcia-Montalvo BM, 2004, VIRUS RES, V102, P141, DOI 10.1016/j.virusres.2004.01.024; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gifford R, 2005, J VIROL, V79, P6478, DOI 10.1128/JVI.79.10.6478-6486.2005; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goel R, 2011, MOL BIOTECHNOL, V48, P87, DOI 10.1007/s12033-010-9336-8; Golemis EA, 2001, CURR PROTOC MOL BIOL; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guo XA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-380; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Haw R, 2011, PROTEOMICS, V1002; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Hershkovitz O, 2009, J IMMUNOL, V183, P2610, DOI 10.4049/jimmunol.0802806; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Hiscox JA, 2010, PROTEOMICS, V10, P4077, DOI 10.1002/pmic.201000251; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jensen LJ, 2008, SCIENCE, V322, P56, DOI 10.1126/science.1164801; Jiang LB, 2009, BIOCHEM BIOPH RES CO, V385, P187, DOI 10.1016/j.bbrc.2009.05.036; Jiao BY, 2011, ARCH VIROL, V156, P2015, DOI 10.1007/s00705-011-1099-4; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Klueg KM, 2002, GENESIS, V34, P119, DOI 10.1002/gene.10148; Kolonin MG, 2000, METHOD ENZYMOL, V328, P26, DOI 10.1016/S0076-6879(00)28388-2; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; Kwofie SK, 2011, INFECT GENET EVOL, V11, P1971, DOI 10.1016/j.meegid.2011.09.001; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234; Le Negrate G, 2012, CELL MICROBIOL, V14, P168, DOI 10.1111/j.1462-5822.2011.01720.x; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070; Limjindaporn T, 2007, BIOCHEM BIOPH RES CO, V362, P334, DOI 10.1016/j.bbrc.2007.07.194; Lindenbach B. D., 2006, FIELDS VIROLOGY, P1153; Liu DM, 2010, GENETICS, V184, P1025, DOI 10.1534/genetics.110.114017; LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Munstermann L. E., 1997, The molecular biology of insect disease vectors: a methods manual., P13; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Nagila A, 2011, BIOCHEM BIOPH RES CO, V410, P428, DOI 10.1016/j.bbrc.2011.05.151; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Netsawang J, 2010, VIRUS RES, V147, P275, DOI 10.1016/j.virusres.2009.11.012; Noisakran S, 2008, BIOCHEM BIOPH RES CO, V372, P67, DOI 10.1016/j.bbrc.2008.04.165; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Parrish JR, 2004, J PROTEOME RES, V3, P582, DOI 10.1021/pr0341134; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017; Schwartz AS, 2009, NAT METHODS, V6, P55, DOI [10.1038/nmeth.1283, 10.1038/NMETH.1283]; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631; Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678; SMITH GW, 1985, J GEN VIROL, V66, P559, DOI 10.1099/0022-1317-66-3-559; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sodja A, 2007, J INSECT PHYSIOL, V53, P833, DOI 10.1016/j.jinsphys.2007.03.017; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Stanyon CA, 2003, BIOTECHNIQUES, V35, P520, DOI 10.2144/03353st05; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Tanigawa K, 2009, CLIN EXP IMMUNOL, V156, P495, DOI 10.1111/j.1365-2249.2009.03930.x; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Vasudevan SG, 2001, FARMACO, V56, P33, DOI 10.1016/S0014-827X(01)01014-X; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093; Wang SL, 1999, J VIROL, V73, P2547, DOI 10.1128/JVI.73.3.2547-2551.1999; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Westaway E. G., 1997, P147; Xu XF, 2009, INTERVIROLOGY, V52, P258, DOI 10.1159/000230669; Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10; Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Yu JK, 2012, METHODS MOL BIOL, V812, P161, DOI 10.1007/978-1-61779-455-1_9; Yu JK, 2009, BIOINFORMATICS, V25, P105, DOI 10.1093/bioinformatics/btn597; Zhong JH, 2003, GENOME RES, V13, P2691, DOI 10.1101/gr.1134603	167	82	84	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53535	10.1371/journal.pone.0053535	http://dx.doi.org/10.1371/journal.pone.0053535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326450	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800053
J	Yuan, QJ; Su, HX; Chau, WH; Ng, CT; Huang, JD; Wu, WT; Lin, ZX				Yuan, Qiuju; Su, Huanxing; Chau, Wing Hin; Cheung Toa Ng; Huang, Jian-Dong; Wu, Wutian; Lin, Zhi-Xiu			Behavioral Stress Fails to Accelerate the Onset and Progression of Plaque Pathology in the Brain of a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							REPEATED RESTRAINT STRESS; APOLIPOPROTEIN-E; PARAVENTRICULAR NUCLEUS; AMYLOID DEPOSITION; TRANSGENIC MICE; TG2576 MICE; COGNITIVE DEFICITS; GENE-EXPRESSION; TYPE-4 ALLELE; FEMALE RATS	Conflicting findings exist regarding the link between environmental factors and development of Alzheimer's disease (AD) in a variety of transgenic mouse models of AD. In the present study, we investigated the effect of behavioral stress on the onset and progression of A beta pathology in the brains of TgCRND8 mice, a transgenic mouse model of AD. One group of TgCRND8 mice was subjected to restraint stress starting at 1 month of age until they were 3 months old, while restraint stress in the second group started at 4 months of age until they were 6 months old. After 2 months of treatment, no differences in the soluble, formic acid extracted, or histologically detected A beta deposition in the cortical and hippocampal levels were found between non-stressed and stressed mice. These results showed that restraint stress alone failed to aggravate amyloid pathology when initiated either before or after the age of amyloid plaque deposition in TgCRND8 mice, suggesting that if stress aggravated AD phenotype, it may not be via an amyloid-related mechanism in the TgCRND8 mice. These findings are indicative that plaque load per se may not be used as a significant criterion for evaluating the effect of stress on AD patients.	[Yuan, Qiuju; Lin, Zhi-Xiu] Chinese Univ Hong Kong, Fac Sci, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Su, Huanxing] Univ Macau, State Key Lab Qual Res Chinese Med, Macao, Peoples R China; [Su, Huanxing] Univ Macau, Inst Chinese Med Sci, Macao, Peoples R China; [Chau, Wing Hin; Cheung Toa Ng; Huang, Jian-Dong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Jinan Univ, Inst Cent Nervous Syst Regenerat, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; University of Macau; University of Macau; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University	Wu, WT (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	wtwu@hkucc.hku.hk; linzx@cuhk.edu.hk	Su, Huanxing/X-3954-2019; Lin, Zhi-Xiu/H-2807-2016; Su, Huanxing/X-3980-2019; Yuan, Qiuju/AAJ-3101-2020; /C-4277-2009	Su, Huanxing/0000-0003-3254-825X; Su, Huanxing/0000-0002-0513-4943; /0000-0001-7531-2816	Chinese University of Hong Kong; University of Hong Kong	Chinese University of Hong Kong(Chinese University of Hong Kong); University of Hong Kong(University of Hong Kong)	This study was supported by a Direct Grant of The Chinese University of Hong Kong and the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Ambree O, 2006, AM J PATHOL, V169, P544, DOI 10.2353/ajpath.2006.051107; Arendash GW, 2004, BRAIN RES, V1012, P29, DOI 10.1016/j.brainres.2004.02.081; Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Chadda R, 2005, PHARMACOL BIOCHEM BE, V81, P854, DOI 10.1016/j.pbb.2005.06.009; Chagra SL, 2011, REGUL PEPTIDES, V167, P70, DOI 10.1016/j.regpep.2010.11.006; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Cotel MC, 2012, NEUROBIOL AGING, V33, P96, DOI 10.1016/j.neurobiolaging.2010.02.012; Cuadrado-Tejedor M, 2012, J ALZHEIMERS DIS, V28, P567, DOI 10.3233/JAD-2011-110572; D'Alton S, 2011, J ALZHEIMERS DIS, V25, P571, DOI 10.3233/JAD-2011-110089; Devi L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-34; Durairajan SS, 2012, NEUROBIOL AGING; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Harvey SC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-15; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hyman BT, 1996, ANN NY ACAD SCI, V802, P1, DOI 10.1111/j.1749-6632.1996.tb32592.x; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Jeong YH, 2011, J NEUROCHEM, V119, P1282, DOI 10.1111/j.1471-4159.2011.07514.x; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lee KW, 2009, J NEUROCHEM, V108, P165, DOI 10.1111/j.1471-4159.2008.05769.x; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Masuda J, 2004, NEUROSCI LETT, V358, P169, DOI 10.1016/j.neulet.2004.01.021; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nomura M, 2003, J NEUROENDOCRINOL, V15, P1054, DOI 10.1046/j.1365-2826.2003.01095.x; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Spires Tara L, 2005, NeuroRx, V2, P423, DOI 10.1602/neurorx.2.3.423; Sterrenburg L, 2012, J NEUROSCI RES, V90, P179, DOI 10.1002/jnr.22737; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Umriukhin PE, 2012, NEUROSCI LETT, V506, P184, DOI 10.1016/j.neulet.2011.11.001; Wilson RS, 2005, NEUROEPIDEMIOLOGY, V25, P8, DOI 10.1159/000085307; Wilson RS, 2003, NEUROLOGY, V61, P1102, DOI 10.1212/01.WNL.0000092914.04345.97; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Yuan QJ, 2003, DEV NEUROSCI-BASEL, V25, P72, DOI 10.1159/000071470; Zavala JK, 2011, PHYSIOL BEHAV, V104, P215, DOI 10.1016/j.physbeh.2011.03.022	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53480	10.1371/journal.pone.0053480	http://dx.doi.org/10.1371/journal.pone.0053480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326437	gold, Green Published			2022-12-27	WOS:000314705800047
J	Cizek, O; Vrba, P; Benes, J; Hrazsky, Z; Koptik, J; Kucera, T; Marhoul, P; Zamecnik, J; Konvicka, M				Cizek, Oldrich; Vrba, Pavel; Benes, Jiri; Hrazsky, Zaboj; Koptik, Jiri; Kucera, Tomas; Marhoul, Pavel; Zamecnik, Jaroslav; Konvicka, Martin			Conservation Potential of Abandoned Military Areas Matches That of Established Reserves: Plants and Butterflies in the Czech Republic	PLOS ONE			English	Article							RECONCILIATION ECOLOGY; TRAINING AREAS; DISTURBANCE; DYNAMICS; HABITAT; MANAGEMENT; EUROPE; BIODIVERSITY; RESTORATION; PERSISTENCE	Military training generates frequent and irregular disturbance followed by succession, resulting in fine-scaled mosaics of ecological conditions in military training areas (MTAs). The awareness that MTAs may represent important biodiversity sanctuaries is increasing recently. Concurrently, changes in military doctrine are leading to abandonment of many MTAs, which are being brought under civilian administration and opened for development. We surveyed vascular plants in 43 and butterflies in 41 MTAs in the Czech Republic and compared the records with plants and butterfly records from 301 and 125 nature reserves, respectively. After controlling for effects of area, geography, and climate, we found that plant species richness was equal in the two land use categories; butterfly richness was higher in MTAs; reserves hosted more endangered plants and more endangered butterflies. Ordination analyses, again controlled for potential nuisance effects, showed that MTAs and reserves differed also in species composition. While specialist species of nationally rarest habitat types inclined towards the reserves, MTAs hosted a high representation of endangered species depending on either disturbed ground, or successionaly transient conditions. These patterns reflect the history of the national nature reserves network, and the disturbance-succession dynamics within MTAs. The conservation value of formerly army-used lands is increasingly threatened by abandonment, and conservationists should support either alternative uses mimicking army activities, or sustainable management regimes.	[Cizek, Oldrich; Vrba, Pavel; Hrazsky, Zaboj; Kucera, Tomas; Konvicka, Martin] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Vrba, Pavel; Benes, Jiri; Konvicka, Martin] Acad Sci Czech Republic, Inst Entomol, Biol Ctr CAS, CR-37005 Ceske Budejovice, Czech Republic; [Cizek, Oldrich] Hutur NGO, Hradec Kralove, Czech Republic; [Hrazsky, Zaboj; Koptik, Jiri; Marhoul, Pavel] Daphne CR Inst Aplikovane Ekol, Ceske Budejovice, Czech Republic; [Zamecnik, Jaroslav] Museum Eastern Bohemia, Hradec Kralove, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Konvicka, M (corresponding author), Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	konva333@gmail.com	Vrba, Pavel/AAC-6024-2021; Konvicka, Martin/H-1446-2014	Vrba, Pavel/0000-0002-3537-5596; Kucera, Tomas/0000-0001-7587-7032; Benes, Jiri/0000-0003-2809-0389	Ministry of Environment of the Czech Republic [SP/2D3/153/08, VaV 620/2/03]; Grant Agency of the Czech Republic [P505/10/2167]; University of South Bohemia [144/2010/100]	Ministry of Environment of the Czech Republic; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); University of South Bohemia	The study was supported by the Ministry of Environment of the Czech Republic (SP/2D3/153/08 and VaV 620/2/03), the Grant Agency of the Czech Republic (P505/10/2167), and University of South Bohemia (144/2010/100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, PRIRODA; Benes J., 2006, OCHRANA PRIRODY, V61, P145; Benton N., 2008, CONSERVING BIODIVERS; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; Caforio G, 2006, HDB SOCIOLOGY MILITA, P323; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; Danihelka J, 2009, SEZNAM JMEN CEVNATYC; Davies H, 2007, BIODIVERS CONSERV, V16, P3719, DOI 10.1007/s10531-007-9176-4; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; Dover JW, 2010, J INSECT CONSERV, V14, P413, DOI 10.1007/s10841-010-9267-5; Farka J., 2005, CERVENY SEZNAM OHROZ; Gaertner M, 2010, J NAT CONSERV, V18, P63, DOI 10.1016/j.jnc.2009.03.001; Gazenbeek A., 2005, LIFE NATURA 2000 MIL; Haight RG, 2008, ENVIRON MODEL ASSESS, V13, P243, DOI 10.1007/s10666-007-9088-4; Hirst R. A., 2000, Aspects of Applied Biology, P293; Hirst RA, 2000, J ENVIRON MANAGE, V60, P181, DOI 10.1006/jema.2000.0356; Humbert JY, 2009, AGR ECOSYST ENVIRON, V130, P1, DOI 10.1016/j.agee.2008.11.014; Jarosik V, 2011, BIOL CONSERV, V144, P490, DOI 10.1016/j.biocon.2010.10.002; Jentsch A, 2009, RESTOR ECOL, V17, P107, DOI 10.1111/j.1526-100X.2007.00339.x; Kadlec T, 2008, LANDSCAPE URBAN PLAN, V85, P1, DOI 10.1016/j.landurbplan.2007.07.007; Konvicka M, 2008, J INSECT CONSERV, V12, P519, DOI 10.1007/s10841-007-9092-7; Kuras T, 2003, POPUL ECOL, V45, P115, DOI 10.1007/s10144-003-0144-x; Lundholm JT, 2010, J APPL ECOL, V47, P966, DOI 10.1111/j.1365-2664.2010.01857.x; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; Milchunas DG, 2000, ENVIRON MANAGE, V25, P525, DOI 10.1007/s002679910041; Morris MG, 2000, BIOL CONSERV, V95, P129, DOI 10.1016/S0006-3207(00)00028-8; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; PETRICEK V., 1999, PECE CHRANENA UZEMI; Pysek P, 2002, GLOBAL ECOL BIOGEOGR, V11, P279, DOI 10.1046/j.1466-822X.2002.00288.x; Pysek P, 2012, PRESLIA, V84, P575; R Core Development Team, 2009, R LANG ENV STAT COMP; Reif J, 2011, BIODIVERS CONSERV, V20, P3645, DOI 10.1007/s10531-011-0155-4; Rivers JW, 2010, ENVIRON MANAGE, V45, P203, DOI 10.1007/s00267-009-9421-6; Rosenzweig ML, 2003, ORYX, V37, P194, DOI 10.1017/S0030605303000371; Sadlo J, 2007, PRESLIA, V79, P303; Samways MJ, 2007, ANNU REV ENTOMOL, V52, P465, DOI 10.1146/annurev.ento.52.110405.091317; Stursa J, 1998, AMBIO, V27, P358; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; THOMAS JA, 1994, PHILOS T ROY SOC B, V344, P47, DOI 10.1098/rstb.1994.0050; Tropek R, 2010, J APPL ECOL, V47, P139, DOI 10.1111/j.1365-2664.2009.01746.x; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Vera FWM, 2000, GRAZING ECOLOGY FORE; Vesely J, 1954, OCHRANA CESKOSLOVENS; Vesely J, 1954, OCHRANA CESKOSLOVENS; WallisDeVries MF, 2002, BIOL CONSERV, V104, P265, DOI 10.1016/S0006-3207(01)00191-4; Warren SD, 2008, J INSECT CONSERV, V12, P671, DOI 10.1007/s10841-007-9109-2; Warren SD, 2007, RESTOR ECOL, V15, P606, DOI 10.1111/j.1526-100X.2007.00272.x; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x	49	46	48	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53124	10.1371/journal.pone.0053124	http://dx.doi.org/10.1371/journal.pone.0053124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326388	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500050
J	Elwer, S; Harryson, L; Bolin, M; Hammarstrom, A				Elwer, Sofia; Harryson, Lisa; Bolin, Malin; Hammarstrom, Anne			Patterns of Gender Equality at Workplaces and Psychological Distress	PLOS ONE			English	Article							SICKNESS ABSENCE; LIVING-CONDITIONS; SEX SEGREGATION; HEALTH; WORK; WOMEN; EDUCATION; FATHERS; LEAVE	Research in the field of occupational health often uses a risk factor approach which has been criticized by feminist researchers for not considering the combination of many different variables that are at play simultaneously. To overcome this shortcoming this study aims to identify patterns of gender equality at workplaces and to investigate how these patterns are associated with psychological distress. Questionnaire data from the Northern Swedish Cohort (n = 715) have been analysed and supplemented with register data about the participants' workplaces. The register data were used to create gender equality indicators of women/men ratios of number of employees, educational level, salary and parental leave. Cluster analysis was used to identify patterns of gender equality at the workplaces. Differences in psychological distress between the clusters were analysed by chi-square test and logistic regression analyses, adjusting for individual socio-demographics and previous psychological distress. The cluster analysis resulted in six distinctive clusters with different patterns of gender equality at the workplaces that were associated to psychological distress for women but not for men. For women the highest odds of psychological distress was found on traditionally gender unequal workplaces. The lowest overall occurrence of psychological distress as well as same occurrence for women and men was found on the most gender equal workplaces. The results from this study support the convergence hypothesis as gender equality at the workplace does not only relate to better mental health for women, but also more similar occurrence of mental ill-health between women and men. This study highlights the importance of utilizing a multidimensional view of gender equality to understand its association to health outcomes. Health policies need to consider gender equality at the workplace level as a social determinant of health that is of importance for reducing differences in health outcomes for women and men.	[Elwer, Sofia; Harryson, Lisa; Hammarstrom, Anne] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Harryson, Lisa] Umea Univ, Natl Grad Sch Gender Studies, Umea Ctr Gender Studies, Umea, Sweden; [Bolin, Malin] Mid Sweden Univ, Dept Social Sci, Sundsvall, Sweden	Umea University; Umea University; Mid-Sweden University	Harryson, L (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	lisa.harryson@fammed.umu.se		Hammarstrom, Anne/0000-0002-4095-7961	Swedish Council for Working Life and Social Research [Dnr 2007-2073]; National School for Gender Studies at Umea University	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); National School for Gender Studies at Umea University	Funders include: 1) Swedish Council for Working Life and Social Research, grant number Dnr 2007-2073 (URL: http://www.fas.se/sv/Projektkatalog/?arende=17071); and 2) National School for Gender Studies at Umea University, which is funding part of the salary for the corresponding author in the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IBM SPSS STATISTICS; Artazcoz L, 2007, J EPIDEMIOL COMMUN H, V61, P39, DOI 10.1136/jech.2007.059774; Backhans MC, 2007, SOC SCI MED, V64, P1892, DOI 10.1016/j.socscimed.2007.01.016; Backhans MC, 2009, SOC SCI MED, V68, P1388, DOI 10.1016/j.socscimed.2009.01.023; Bergman L. R., 2003, STUDYING INDIVIDUAL; Bergman LR, 1997, DEV PSYCHOPATHOL, V9, P291, DOI 10.1017/S095457949700206X; Brandth B., 2002, GENDER WORK ORGAN, V9, P186, DOI DOI 10.1111/1468-0432.00155; Bryngelson A, 2011, SCAND J PUBLIC HEALT, V39, P618, DOI 10.1177/1403494811414242; Bygren M, 2006, J MARRIAGE FAM, V68, P363, DOI 10.1111/j.1741-3737.2006.00258.x; Connell R., 2009, GENDER WORLD PERSPEC; Connell R, 2006, PUBLIC ADMIN REV, V66, P837, DOI 10.1111/j.1540-6210.2006.00652.x; Evans O, 2002, SOC SCI MED, V54, P481, DOI 10.1016/S0277-9536(01)00044-2; Haas Linda., 2002, COMMUNITY WORK FAMIL, V5, P319, DOI DOI 10.1080/1366880022000041801; Hammarstrom A, 2011, INT J EPIDEMIOLOGY; Harenstam A, 2003, WORK STRESS, V17, P73, DOI 10.1080/0267837031000099168; Harenstam A, 2009, SCAND J WORK ENV HEA, V35, P127; Hensing G, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2002.005504; Hunt K, 1998, WOMEN, STRESS, AND HEART DISEASE, P87; Lynch J, 2000, SOCIAL EPIDEMIOLOGY; Mansdotter A, 2006, J EPIDEMIOL COMMUN H, V60, P616, DOI 10.1136/jech.2005.041327; Mansdotter A, 2010, SOC SCI MED, V71, P576, DOI 10.1016/j.socscimed.2010.05.008; Messing K, 2006, GENDER EQUALITY WORK; Nielsen K, 2009, INT ARCH OCC ENV HEA, V82, P1229, DOI 10.1007/s00420-009-0464-z; Okin SM, 1989, JUSTICE GENDER AND T; Payne S, 2010, GENDER HLTH CARE, P21; Reine I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-159; Robert SA, 2000, SOCIAL STUDIES IN HE; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Savikko A, 2008, SUBST USE MISUSE, V43, P1151, DOI 10.1080/10826080801917918; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Sorlin A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-548; Statistics Sweden, 1982, SWEDISH SOCIOECONOMI; Statistics Sweden, 1980, SWEDISH SURVEY OF LI; Statistics Sweden, 2010, WOMEN AND MEN IN SWE; Svedberg P, 2009, J OCCUP HEALTH, V51, P223, DOI 10.1539/joh.L8033; Waldron I, 1999, GENDER INEQUALITIES IN HEALTH, P150; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; World Health Organization, 2002, MAINSTREAMING GENDER	38	19	20	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53246	10.1371/journal.pone.0053246	http://dx.doi.org/10.1371/journal.pone.0053246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326404	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500055
J	Gao, Y; Zhu, J; Zhang, XH; Wu, QQ; Jiang, SN; Liu, YQ; Hu, ZB; Liu, BR; Chen, XF				Gao, Yong; Zhu, Jing; Zhang, Xiaohui; Wu, Qingquan; Jiang, Shaoning; Liu, Yangqing; Hu, Zhibin; Liu, Baorui; Chen, Xiaofei			BRCA1 mRNA Expression as a Predictive and Prognostic Marker in Advanced Esophageal Squamous Cell Carcinoma Treated with Cisplatin- or Docetaxel-Based Chemotherapy/Chemoradiotherapy	PLOS ONE			English	Article							DNA-REPAIR; TRIMODALITY THERAPY; LUNG-CANCER; PHASE-II; CHEMOTHERAPY; ERCC1; SURVIVAL; CHEMOSENSITIVITY; CHEMORESISTANCE; INACTIVATION	Background: The molecular backgrounds that determine therapeutic effectiveness in esophageal cancer remain largely unknown. Breast cancer susceptibility gene 1 (BRCA1) expression has been found to switch the response to cisplatin- or paclitaxel-based chemotherapy. It remains unclear how variations in BRCA1 expression influence clinical outcomes in esophageal cancer. Patients and Methods: Quantitative real-time polymerase chain reaction (qPCR) was performed to examine BRCA1 mRNA expressions in paraffin-embedded specimens from 144 patients with advanced or metastatic esophageal squamous cell carcinoma who received cisplatin- or docetaxel-based first-line treatments. Results: Low BRCA1 mRNA expression correlated with increased response rate (RR; P = 0.025 and 0.017, respectively) and median overall survival (mOS; P = 0.002 and P<0.001, respectively) in cisplatin-based chemotherapy or chemoradiotherapy group and also correlated with decreased RR (P = 0.017 and 0.024, respectively) and mOS (both P<0.001) in docetaxel-based chemotherapy or chemoradiotherapy group. Multivariate analysis revealed that low BRCA1 expression was an independent prognostic factor in cisplatin-based chemotherapy (HR 0.29; 95%CI 0.12-0.71; P = 0.007) or chemoradiotherapy (HR 0.12; 95%CI 0.04-0.37; P<0.001) group and higher risk for mortality in docetaxel-based chemotherapy (HR 5.02; 95%CI 2.05-12.28; P<0.001) or chemoradiotherapy (HR 7.02; 95%CI 2.37-27.77; P<0.001) group. Conclusions: BRCA1 mRNA expression could be used as a predictive and prognostic marker in esophageal cancer who underwent first-line cisplatin- or docetaxel-based treatments.	[Gao, Yong; Zhu, Jing; Zhang, Xiaohui; Liu, Yangqing; Chen, Xiaofei] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Med Oncol, Huaian, Peoples R China; [Wu, Qingquan] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Thorac Surg, Huaian, Peoples R China; [Jiang, Shaoning] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Hu, Zhibin] Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Liu, Baorui] Nanjing Med Univ, Gulou Sch Clin Med, Ctr Comprehens Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; University of Alabama System; University of Alabama Birmingham; Nanjing Medical University; Nanjing Medical University	Liu, BR (corresponding author), Nanjing Med Univ, Gulou Sch Clin Med, Ctr Comprehens Canc, Nanjing, Jiangsu, Peoples R China.	baoruiliu@hotmail.com; hayycxf@163.com			Science Developing Foundation of Nanjing Medical University [09NJMUM063]; Science Developing Foundation of Huaian Government [HAS2011028]	Science Developing Foundation of Nanjing Medical University; Science Developing Foundation of Huaian Government	This work was supported in part by Science Developing Foundation of Nanjing Medical University (09NJMUM063 to Y.G.) and Science Developing Foundation of Huaian Government (HAS2011028 to X.F.C.). The funders had no role in study design, data collection and analysis.	AJANI JA, 1994, J NATL CANCER I, V86, P1086, DOI 10.1093/jnci/86.14.1086; Alexander BM, 2012, INT J RADIAT ONCOL, V83, P164, DOI 10.1016/j.ijrobp.2011.05.033; Byrski T, 2009, BREAST CANCER RES TR, V115, P359, DOI 10.1007/s10549-008-0128-9; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; Carser JE, 2011, GYNECOL ONCOL, V123, P492, DOI 10.1016/j.ygyno.2011.08.017; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; EZDINLI EZ, 1980, CANCER, V46, P2149, DOI 10.1002/1097-0142(19801115)46:10<2149::AID-CNCR2820461006>3.0.CO;2-W; Furuta T, 2002, CANCER RES, V62, P4899; Harpole DH, 2001, CLIN CANCER RES, V7, P562; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Husain A, 1998, CANCER RES, V58, P1120; Ilson DH, 1998, J CLIN ONCOL, V16, P1826, DOI 10.1200/JCO.1998.16.5.1826; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Kennedy RD, 2002, LANCET, V360, P1007, DOI 10.1016/S0140-6736(02)11087-7; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; LEICHMAN L, 1991, SEMIN ONCOL, V18, P64; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mullan PB, 2001, ONCOGENE, V20, P6123, DOI 10.1038/sj.onc.1204712; Muro K, 2004, ANN ONCOL, V15, P955, DOI 10.1093/annonc/mdh231; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; PANETTIERE FJ, 1984, CANCER TREAT REP, V68, P1023; Papadaki C, 2011, BRIT J CANCER, V104, P316, DOI 10.1038/sj.bjc.6606027; Quinn JE, 2003, CANCER RES, V63, P6221; Rosell R, 2003, ONCOGENE, V22, P3548, DOI 10.1038/sj.onc.1206419; Rosell R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005133; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Santarosa M, 2009, MOL CANCER THER, V8, P844, DOI 10.1158/1535-7163.MCT-08-0951; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Shibata T, 2011, NEOPLASIA, V13, P864, DOI 10.1593/neo.11750; Shim HJ, 2010, CANCER SCI, V101, P1247, DOI 10.1111/j.1349-7006.2010.01514.x; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-97; Weberpals JI, 2011, ANN ONCOL, V22, P2403, DOI 10.1093/annonc/mdq770; Weberpals J, 2009, INT J CANCER, V124, P806, DOI 10.1002/ijc.23987; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955	40	40	42	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52589	10.1371/journal.pone.0052589	http://dx.doi.org/10.1371/journal.pone.0052589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326344	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500022
J	Guilliere, F; Danioux, C; Jaubert, C; Desnoues, N; Delepierre, M; Prangishvili, D; Sezonov, G; Guijarro, JI				Guilliere, Florence; Danioux, Chloe; Jaubert, Carole; Desnoues, Nicole; Delepierre, Muriel; Prangishvili, David; Sezonov, Guennadi; Guijarro, J. Inaki			Solution Structure of an Archaeal DNA Binding Protein with an Eukaryotic Zinc Finger Fold	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; REGULATORY PROTEIN; BACKBONE DYNAMICS; GENOMIC ANALYSIS; CHEMICAL-SHIFTS; NMR EXPERIMENTS; RNA-POLYMERASE; DOMAIN; TRANSCRIPTION; RECOGNITION	While the basal transcription machinery in archaea is eukaryal-like, transcription factors in archaea and their viruses are usually related to bacterial transcription factors. Nevertheless, some of these organisms show predicted classical zinc fingers motifs of the C2H2 type, which are almost exclusively found in proteins of eukaryotes and most often associated with transcription regulators. In this work, we focused on the protein AFV1p06 from the hyperthermophilic archaeal virus AFV1. The sequence of the protein consists of the classical eukaryotic C2H2 motif with the fourth histidine coordinating zinc missing, as well as of N-and C-terminal extensions. We showed that the protein AFV1p06 binds zinc and solved its solution structure by NMR. AFV1p06 displays a zinc finger fold with a novel structure extension and disordered N- and C-termini. Structure calculations show that a glutamic acid residue that coordinates zinc replaces the fourth histidine of the C2H2 motif. Electromobility gel shift assays indicate that the protein binds to DNA with different affinities depending on the DNA sequence. AFV1p06 is the first experimentally characterised archaeal zinc finger protein with a DNA binding activity. The AFV1p06 protein family has homologues in diverse viruses of hyperthermophilic archaea. A phylogenetic analysis points out a common origin of archaeal and eukaryotic C2H2 zinc fingers.	[Guilliere, Florence; Delepierre, Muriel; Guijarro, J. Inaki] Inst Pasteur, Unite RMN Biomol, Dept Biol Struct & Chim, Paris, France; [Guilliere, Florence; Guijarro, J. Inaki] CNRS, UMR 3528, Paris, France; [Guilliere, Florence] Univ Paris 07, Paris, France; [Danioux, Chloe; Jaubert, Carole; Desnoues, Nicole; Prangishvili, David; Sezonov, Guennadi] Inst Pasteur, Unite Biol Mol Gene Extremophiles, Dept Microbiol, Paris, France; [Danioux, Chloe; Jaubert, Carole; Sezonov, Guennadi] Univ Paris 06, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Sezonov, G (corresponding author), Inst Pasteur, Unite Biol Mol Gene Extremophiles, Dept Microbiol, Paris, France.	guennadi.sezonov@pasteur.fr; inaki.guijarro@pasteur.fr	Sezonov, Guennadi/ABB-5734-2020; Guijarro, J. Inaki/E-6438-2019	Sezonov, Guennadi/0000-0002-2016-6126; Guijarro, J. Inaki/0000-0002-3826-5245; GUILLIERE, Florence/0000-0002-4025-2988	Institut Pasteur; Centre National de la Recherche Scientifique [CNRS UMR 3528]; French Ministere de l'Enseignement Superieur et de la Recherche; Region Ile de France	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Enseignement Superieur et de la Recherche; Region Ile de France(Region Ile-de-France)	This work was supported by the Institut Pasteur and the Centre National de la Recherche Scientifique (CNRS UMR 3528). FG, CD and CJ were supported by the French "Ministere de l'Enseignement Superieur et de la Recherche". The 600 MHz spectrometer was funded by the Region Ile de France and the Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella M, 2007, NUCLEIC ACIDS RES, V35, P6788, DOI 10.1093/nar/gkm782; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P4658, DOI 10.1093/nar/27.23.4658; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Barraud P, 2012, J BIOMOL NMR, V53, P93, DOI 10.1007/s10858-012-9625-6; Bell SD, 2005, TRENDS MICROBIOL, V13, P262, DOI 10.1016/j.tim.2005.03.015; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Bettstetter M, 2003, VIROLOGY, V315, P68, DOI 10.1016/S0042-6822(03)00481-1; Bowers PW, 1999, NAT STRUCT BIOL, V6, P478; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutnall RN, 1996, STRUCTURE, V4, P599, DOI 10.1016/S0969-2126(96)00064-0; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feng B, 1998, MOL CELL BIOL, V18, P3983, DOI 10.1128/MCB.18.7.3983; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; GRZESIEK S, 1995, J AM CHEM SOC, V117, P5312, DOI 10.1021/ja00124a014; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guilliere F, 2009, J BIOL CHEM, V284, P22222, DOI 10.1074/jbc.M109.029850; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Isalan M, 1998, BIOCHEMISTRY-US, V37, P12026, DOI 10.1021/bi981358z; Isalan M, 1997, P NATL ACAD SCI USA, V94, P5617, DOI 10.1073/pnas.94.11.5617; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kessler A, 2006, NUCLEIC ACIDS RES, V34, P4837, DOI 10.1093/nar/gkl502; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liew CK, 2005, P NATL ACAD SCI USA, V102, P583, DOI 10.1073/pnas.0407511102; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Mackay JP, 1998, J BIOL CHEM, V273, P30560, DOI 10.1074/jbc.273.46.30560; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Newton A, 2001, J BIOL CHEM, V276, P35794, DOI 10.1074/jbc.M106256200; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALM P, 1991, VIROLOGY, V185, P242, DOI 10.1016/0042-6822(91)90771-3; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Peng X, 2008, MICROBIOL-SGM, V154, P383, DOI 10.1099/mic.0.2007/012963-0; Perez-Rueda E, 2010, MOL BIOL EVOL, V27, P1449, DOI 10.1093/molbev/msq033; Prangishvili D, 2004, BIOCHEM SOC T, V32, P204, DOI 10.1042/BST0320204; Prangishvill D, 2006, VIRUS RES, V117, P52, DOI 10.1016/j.virusres.2006.01.007; Redder P, 2009, ENVIRON MICROBIOL, V11, P2849, DOI 10.1111/j.1462-2920.2009.02009.x; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Schanda P, 2006, MAGN RESON CHEM, V44, pS177, DOI 10.1002/mrc.1825; Schlenker C, 2012, BIOCHEMISTRY-US, V51, P2899, DOI 10.1021/bi201791s; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Simpson RJY, 2003, J BIOL CHEM, V278, P28011, DOI 10.1074/jbc.M211146200; Stedman KM, 2003, RES MICROBIOL, V154, P295, DOI 10.1016/S0923-2508(03)00074-3; Stoll R, 2007, J MOL BIOL, V372, P1227, DOI 10.1016/j.jmb.2007.07.017; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wiedenheft B, 2004, J VIROL, V78, P1954, DOI 10.1128/JVI.78.4.1954-1961.2004; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	63	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52908	10.1371/journal.pone.0052908	http://dx.doi.org/10.1371/journal.pone.0052908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326363	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500034
J	Rogers, TL; Ciaglia, MB; Klinck, H; Southwell, C				Rogers, Tracey L.; Ciaglia, Michaela B.; Klinck, Holger; Southwell, Colin			Density Can Be Misleading for Low-Density Species: Benefits of Passive Acoustic Monitoring	PLOS ONE			English	Article							SPERM-WHALE ABUNDANCE; PACK-ICE SEALS; LEOPARD SEALS; HYDRURGA-LEPTONYX; PRYDZ BAY; RESPONSES; VOCALIZATIONS; PROBABILITY; DIVERSITY; BEHAVIOR	Climate-induced changes may be more substantial within the marine environment, where following ecological change is logistically difficult, and typically expensive. As marine animals tend to produce stereotyped, long-range signals, they are ideal for repeatable surveying. In this study we illustrate the potential for calling rates to be used as a tool for determining habitat quality by using an Antarctic pack-ice seal, the leopard seal, as a model. With an understanding of the vocal behavior of a species, their seasonal and diurnal patterns, sex and age-related differences, an underwater passive-acoustic survey conducted alongside a visual survey in an arc of 4,225 km across the Davis Sea, Eastern Antarctica, showed that while acoustic and visual surveys identified similar regions as having high densities, the acoustic surveys surprisingly identified the opposite regions as being 'critical' habitats. Density surveys of species that cannot be differentiated into population classes may be misleading because overall density can be a negative indicator of habitat quality. Under special circumstances acoustics can offer enormous advantage over traditional techniques and open up monitoring to regions that are remote, difficult and expensive to work within, no longer restricting long-term community assessment to resource-wealthy communities. As climatic change affects a broad range of organisms across geographic boundaries we propose that capitalizing on the significant advances in passive acoustic technology, alongside physical acoustics and population modeling, can help in addressing ecological questions more broadly.	[Rogers, Tracey L.; Ciaglia, Michaela B.] Univ New S Wales, Sch BEES, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Klinck, Holger] Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR USA; [Klinck, Holger] Oregon State Univ, Hatfield Marine Sci Ctr, Natl Ocean & Atmospher Adm, Pacific Marine Environm Lab, Newport, OR 97365 USA; [Southwell, Colin] Australian Antarctic Div, Dept Sustainabil Environm Water Populat & Communi, Kingston, Tas, Australia	University of New South Wales Sydney; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; Australian Antarctic Division	Rogers, TL (corresponding author), Univ New S Wales, Sch BEES, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	tracey.rogers@unsw.edu.au	Rogers, Tracey L/C-3419-2008; Klinck, Holger/X-5214-2019	Klinck, Holger/0000-0003-1078-7268; Rogers, Tracey/0000-0002-7141-4177	Antarctic Scientific Advisory Committee [ASAC 552, 1140]; Sea World Research and Rescue Foundation Inc.; Scott Foundation; U.S. Office of Naval Research [N00014-11-1-0606]	Antarctic Scientific Advisory Committee; Sea World Research and Rescue Foundation Inc.; Scott Foundation; U.S. Office of Naval Research(Office of Naval Research)	This study was supported financially by the Antarctic Scientific Advisory Committee (ASAC 552 and 1140), the Sea World Research and Rescue Foundation Inc., the Scott Foundation and the U.S. Office of Naval Research grant # N00014-11-1-0606 this is NOAA PMEL contribution # 3836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; BESTER MN, 1995, ANTARCT SCI, V7, P357, DOI 10.1017/S0954102095000502; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Buckland S.T., 2001, pi; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; de Solla SR, 2005, BIOL CONSERV, V121, P585, DOI 10.1016/j.biocon.2004.06.018; Eklund C. R., 1962, Journal of Mammalogy, V43, P229, DOI 10.2307/1377094; Erickson A.W., 1990, P253; ERICKSON AW, 1974, ANTARCT J US, V9, P292; ERICKSON AW, 1973, ANTARCT J US, V8, P191; Erickson AW, 1983, POLAR STAR ANTARCTIC, V18, P163; Erickson JR, 1972, ANTARCT J US, V6, P98; Forcada J, 2012, BIOL CONSERV, V149, P40, DOI 10.1016/j.biocon.2012.02.002; Frankel AS, 2000, J ACOUST SOC AM, V108, P1930, DOI 10.1121/1.1289668; Gedamke J, 2001, J ACOUST SOC AM, V109, P3038, DOI 10.1121/1.1371763; Gilbert J, 1977, ADAPTATIONS ANTARCTI, P703; Gondy RR, 1976, STH AFRICAN J ANTARC, V6, P2; Gondy RR, 1977, STH AFRICAN J ANTARC, V7, P10; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Hall-Martin AJ, 1974, STH AFRICAN J ANTARC, V4, P34; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HAUSER MD, 1993, AM NAT, V142, P528, DOI 10.1086/285553; Heimlich SL, 2005, J ACOUST SOC AM, V118, P1830, DOI 10.1121/1.1992674; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Kusel ET, 2011, J ACOUST SOC AM, V129, P3610, DOI 10.1121/1.3583504; Laiolo P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001822; Lewis T, 2007, J MAR BIOL ASSOC UK, V87, P353, DOI 10.1017/S0025315407054896; LIEBERMAN PH, 1969, SCIENCE, V164, P1185, DOI 10.1126/science.164.3884.1185; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MARQUES T. A., 2010, J ORNITHOL, V152, pS445, DOI [10.1007/s10336-010-0535-7, DOI 10.1007/S10336-010-0535-7]; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; Mayer F, 2001, P ROY SOC B-BIOL SCI, V268, P1825, DOI 10.1098/rspb.2001.1744; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Oleson EM, 2007, ANIM BEHAV, V74, P881, DOI 10.1016/j.anbehav.2007.01.022; Oritsland T., 1970, P361; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Poole KG, 2007, ANIM BEHAV, V73, P513, DOI 10.1016/j.anbehav.2006.09.008; Ray G. C., 1970, ANTARCT ECOL, V1, P398; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Rogers TL, 2002, BEHAVIOUR, V139, P1267, DOI 10.1163/156853902321104154; Rogers TL, 1997, MAR MAMMAL SCI, V13, P293, DOI 10.1111/j.1748-7692.1997.tb00632.x; Rogers TL, 1996, MAR MAMMAL SCI, V12, P414, DOI 10.1111/j.1748-7692.1996.tb00593.x; Rogers TL, PLOSONE UNPUB; Rogers TL, PLOS ONE UNPUB; Rogers Tracey, 1995, P223; Rogers TL, 2007, J ACOUST SOC AM, V122, P596, DOI 10.1121/1.2736976; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Siniff DB, 1970, ANTARCT ECOL, V1, P37; SMITH NR, 1984, DEEP-SEA RES, V31, P1121, DOI 10.1016/0198-0149(84)90016-5; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Sousa-Lima RS, 2002, ANIM BEHAV, V63, P301, DOI 10.1006/anbe.2001.1873; Southwell C, 2004, MAR MAMMAL SCI, V20, P602, DOI 10.1111/j.1748-7692.2004.tb01182.x; Southwell C, 2003, POLAR BIOL, V26, P648, DOI 10.1007/s00300-003-0534-8; Southwell C, 2008, DEEP-SEA RES PT I, V55, P519, DOI 10.1016/j.dsr.2008.01.005; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stimpert AK, 2007, BIOL LETTERS, V3, P467, DOI 10.1098/rsbl.2007.0281; THOMAS JA, 1982, CAN J ZOOL, V60, P2028, DOI 10.1139/z82-260; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Titze IR, 1994, PRINCIPLES VOICE PRO; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; van Oort BEH, 2005, NATURE, V438, P1095, DOI 10.1038/4381095a; Van Parijs SM, 2002, J APPL ECOL, V39, P853, DOI 10.1046/j.1365-2664.2002.00756.x; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitehead H, 2009, J WILDLIFE MANAGE, V73, P1000, DOI 10.2193/2008-303; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277	73	31	31	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52542	10.1371/journal.pone.0052542	http://dx.doi.org/10.1371/journal.pone.0052542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326339	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500016
J	Esparza, JM; O'Toole, E; Li, LY; Giddings, TH; Kozak, B; Albee, AJ; Dutcher, SK				Esparza, Jessica M.; O'Toole, Eileen; Li, Linya; Giddings, Thomas H., Jr.; Kozak, Benjamin; Albee, Alison J.; Dutcher, Susan K.			Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii	PLOS ONE			English	Article							BASAL BODY CONNECTOR; FUNCTIONAL GENOMICS; DROSOPHILA SPD-2; EPSILON-TUBULIN; FINE-STRUCTURE; DELTA-TUBULIN; CELL-DIVISION; ALPHA-TUBULIN; WHOLE-GENOME; WILD-TYPE	Centrioles and basal bodies are essential for a variety of cellular processes that include the recruitment of proteins to these structures for both centrosomal and ciliary function. This recruitment is compromised when centriole/basal body assembly is defective. Mutations that cause basal body assembly defects confer supersensitivity to Taxol. These include bld2, bld10, bld12, uni3, vfl1, vfl2, and vfl3. Flagellar motility mutants do not confer sensitivity with the exception of mutations in the p60 (pf19) and p80 (pf15) subunits of the microtubule severing protein katanin. We have identified additional pf15 and bld2 (epsilon-tubulin) alleles in screens for Taxol sensitivity. Null pf15 and bld2 alleles are viable and are not essential genes in Chlamydomonas. Analysis of double mutant strains with the pf15-3 and bld2-6 null alleles suggests that basal bodies in Chlamydomonas may recruit additional proteins beyond katanin that affect spindle microtubule stability. The bld2-5 allele is a hypomorphic allele and its phenotype is modulated by nutritional cues. Basal bodies in bld2-5 cells are missing proximal ends. The basal body mutants show aberrant localization of an epitope-tagged p80 subunit of katanin. Unlike IFT proteins, katanin p80 does not localize to the transition fibers of the basal bodies based on an analysis of the uni1 mutant as well as the lack of colocalization of katanin p80 with IFT74. We suggest that the triplet microtubules are likely to play a key role in katanin p80 recruitment to the basal body of Chlamydomonas rather than the transition fibers that are needed for IFT localization.	[Esparza, Jessica M.; O'Toole, Eileen; Li, Linya; Giddings, Thomas H., Jr.; Kozak, Benjamin; Albee, Alison J.; Dutcher, Susan K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Dutcher, SK (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	dutcher@genetics.wustl.edu			National Institutes of Health [GM-32843, RR-00592]; National Institutes of Health Ruth L. Kirschstein National Research Service Award [GM093598]; Siteman Cancer Center Summer Opportunities Program; Ford Foundation Predoctoral fellowship; NIGMS, NIH [GM-32843]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093598, R01GM032843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siteman Cancer Center Summer Opportunities Program; Ford Foundation Predoctoral fellowship; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by 1) National Institutes of Health grants GM-32843 to SKD (www.nih.gov/); 2) National Institutes of Health RR-00592 to Andreas Hoenger; 3) National Institutes of Health Ruth L. Kirschstein National Research Service Award GM093598 to AJA; 4) Siteman Cancer Center Summer Opportunities Program Stipend to BK (http://www.siteman.wustl.edu/summerprogram.aspx); 5) a Ford Foundation Predoctoral fellowship to JME (http://sites.nationalacademies.org/pga/fordfellowships/); and 6) a diversity supplement to GM-32843 to support JME. (The supplement to JME was awarded by NIGMS as a supplement to NIH grant GM-32843.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GMW, 1982, GENETICS, V100, P579; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Cheng TS, 2007, EXP CELL RES, V313, P1710, DOI 10.1016/j.yexcr.2007.02.023; CLAES H, 1977, EXP CELL RES, V108, P221, DOI 10.1016/S0014-4827(77)80028-1; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Doles J, 2010, CANCER RES, V70, P1033, DOI 10.1158/0008-5472.CAN-09-2113; Dupuis-Williams P, 2002, J CELL BIOL, V158, P1183, DOI 10.1083/jcb.200205028; Dutcher SK, 1998, MOL BIOL CELL, V9, P1293, DOI 10.1091/mbc.9.6.1293; Dutcher SK, 2002, MOL BIOL CELL, V13, P3859, DOI 10.1091/mbc.E02-04-0205; DUTCHER SK, 1984, J CELL BIOL, V98, P229, DOI 10.1083/jcb.98.1.229; DUTCHER SK, 1995, METHOD CELL BIOL, V47, P531, DOI 10.1016/S0091-679X(08)60857-2; DUTCHER SK, 1995, METHOD CELL BIOL, V47, P323, DOI 10.1016/S0091-679X(08)60826-2; DUTCHER SK, 1992, GENETICS, V131, P593; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Dutcher SK, 2012, G3-GENES GENOM GENET, V2, P15, DOI 10.1534/g3.111.000919; Dymek EE, 2004, EUKARYOT CELL, V3, P870, DOI 10.1128/EC.3.4.870-879.2004; Dymek EE, 2012, J CELL SCI, V125, P3357, DOI 10.1242/jcs.096941; EHLER LL, 1995, GENETICS, V141, P945; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058; Good P, 2005, PERMUTATION PARAMETR; GOODENOUGH UW, 1975, J CELL BIOL, V66, P480, DOI 10.1083/jcb.66.3.480; GROSS CH, 1988, CURR GENET, V13, P503, DOI 10.1007/BF02427756; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; HOLMES JA, 1989, J CELL SCI, V94, P273; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; HUANG B, 1982, CELL, V29, P745, DOI 10.1016/0092-8674(82)90436-6; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Iomini C, 2006, CURR BIOL, V16, P1147, DOI 10.1016/j.cub.2006.04.035; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Iyaduri KB, 2004, J CELL BIOL, V45, pA167; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; JOHNSON UG, 1968, J CELL BIOL, V38, P403, DOI 10.1083/jcb.38.2.403; Kamiya R, 2002, INT REV CYTOL, V219, P115; Kirk, 1998, VOLVOX SEARCH MOL GE; KOZMINSKI KG, 1995, METHOD CELL BIOL, V47, P263, DOI 10.1016/S0091-679X(08)60819-5; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lechtreck KF, 2001, EUR J CELL BIOL, V80, P631, DOI 10.1078/0171-9335-00199; LEDIZET M, 1986, J CELL BIOL, V103, P13, DOI 10.1083/jcb.103.1.13; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; McNally FJ, 1996, J CELL SCI, V109, P561; Miller MS, 2005, MOL BIOL CELL, V16, P3810, DOI 10.1091/mbc.E05-05-0404; Mogensen MM, 2000, J CELL SCI, V113, P3013; Muller-Reichert T, 2003, J MICROSC-OXFORD, V212, P71, DOI 10.1046/j.1365-2818.2003.01250.x; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Njiaju UO, 2012, PHARMACOGENET GENOM, V22, P498, DOI 10.1097/FPC.0b013e328352f436; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; O'Toole E, 2003, MOL BIOL CELL; O'Toole ET, 2007, METHOD CELL BIOL, V79, P125, DOI 10.1016/S0091-679X(06)79005-7; O'Toole ET, 2003, MOL BIOL CELL, V14, P2999, DOI 10.1091/mbc.E02-11-0755; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Palombella AL, 1998, PLANT PHYSIOL, V117, P455, DOI 10.1104/pp.117.2.455; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Piasecki BP, 2008, MOL BIOL CELL, V19, P262, DOI 10.1091/mbc.E07-08-0798; Piasecki BP, 2009, MOL BIOL CELL, V20, P368, DOI 10.1091/mbc.E08-09-0900; Preble AM, 2001, GENETICS, V157, P163; Rasi MQ, 2009, MOL BIOL CELL, V20, P379, DOI 10.1091/mbc.E07-10-1007; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; SALISBURY JL, 1988, J PROTOZOOL, V35, P574; SCHIBLER MJ, 1991, J CELL BIOL, V113, P605, DOI 10.1083/jcb.113.3.605; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Shimogawara K, 1998, GENETICS, V148, P1821; Silflow CD, 2001, J CELL BIOL, V153, P63, DOI 10.1083/jcb.153.1.63; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Srayko M, 2000, GENE DEV, V14, P1072; Steg AD, 2012, MOL CANCER THER, V11, P1587, DOI 10.1158/1535-7163.MCT-11-1058; TAILLON BE, 1992, J CELL BIOL, V119, P1613, DOI 10.1083/jcb.119.6.1613; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; VALLETTE F, 1989, NUCLEIC ACIDS RES, V17, P723, DOI 10.1093/nar/17.2.723; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903; WRIGHT RL, 1989, CELL MOTIL CYTOSKEL, V14, P516, DOI 10.1002/cm.970140409; Xu ML, 2012, CANCER SCI, V103, P821, DOI 10.1111/j.1349-7006.2012.02221.x; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yin SH, 2012, PHARM RES-DORDR, V29, P2994, DOI 10.1007/s11095-012-0794-5; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	89	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53940	10.1371/journal.pone.0053940	http://dx.doi.org/10.1371/journal.pone.0053940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320108	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429800073
J	Borucki, MK; Allen, JE; Chen-Harris, H; Zemla, A; Vanier, G; Mabery, S; Torres, C; Hullinger, P; Slezak, T				Borucki, Monica K.; Allen, Jonathan E.; Chen-Harris, Haiyin; Zemla, Adam; Vanier, Gilda; Mabery, Shalini; Torres, Clinton; Hullinger, Pamela; Slezak, Tom			The Role of Viral Population Diversity in Adaptation of Bovine Coronavirus to New Host Environments	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; AMINO-ACID-SEQUENCES; HEPARAN-SULFATE; WINTER DYSENTERY; CROSS-PROTECTION; SPIKE PROTEIN; VIRUS; CELL; NUCLEOTIDE; INFECTION	The high mutation rate of RNA viruses enables a diverse genetic population of viral genotypes to exist within a single infected host. In-host genetic diversity could better position the virus population to respond and adapt to a diverse array of selective pressures such as host-switching events. Multiple new coronaviruses, including SARS, have been identified in human samples just within the last ten years, demonstrating the potential of coronaviruses as emergent human pathogens. Deep sequencing was used to characterize genomic changes in coronavirus quasispecies during simulated host-switching. Three bovine nasal samples infected with bovine coronavirus were used to infect human and bovine macrophage and lung cell lines. The virus reproduced relatively well in macrophages, but the lung cell lines were not infected efficiently enough to allow passage of non lab-adapted samples. Approximately 12 kb of the genome was amplified before and after passage and sequenced at average coverages of nearly 950x(454 sequencing) and 38,000x(Illumina). The consensus sequence of many of the passaged samples had a 12 nucleotide insert in the consensus sequence of the spike gene, and multiple point mutations were associated with the presence of the insert. Deep sequencing revealed that the insert was present but very rare in the unpassaged samples and could quickly shift to dominate the population when placed in a different environment. The insert coded for three arginine residues, occurred in a region associated with fusion entry into host cells, and may allow infection of new cell types via heparin sulfate binding. Analysis of the deep sequencing data indicated that two distinct genotypes circulated at different frequency levels in each sample, and support the hypothesis that the mutations present in passaged strains were "selected" from a pre-existing pool rather than through de novo mutation and subsequent population fixation.	[Borucki, Monica K.; Allen, Jonathan E.; Chen-Harris, Haiyin; Zemla, Adam; Vanier, Gilda; Mabery, Shalini; Torres, Clinton; Hullinger, Pamela; Slezak, Tom] Lawrence Livermore Natl Lab, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Borucki, MK (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA USA.	borucki2@llnl.gov		Allen, Jonathan/0000-0002-4359-8263	Lawrence Livermore National Laboratory [LDRD 10-LW-020]; Defense Threat Reduction Agency, Transformational Medical Technologies Initiative; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Defense Threat Reduction Agency, Transformational Medical Technologies Initiative(United States Department of DefenseDefense Threat Reduction Agency); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	Funding was provided by Lawrence Livermore National Laboratory internal funding (LDRD 10-LW-020) and a grant from the Defense Threat Reduction Agency, Transformational Medical Technologies Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Akaike T, 2000, FASEB J, V14, P1447, DOI 10.1096/fj.14.10.1447; Almeida MS, 2007, J VIROL, V81, P3151, DOI 10.1128/JVI.01939-06; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Borderia AV, 2011, CURR OPIN VIROL, V1, P643, DOI 10.1016/j.coviro.2011.09.012; Brockway SM, 2004, J VIROL, V78, P11551, DOI 10.1128/JVI.78.21.11551-11562.2004; Cho KO, 2001, ARCH VIROL, V146, P2401, DOI 10.1007/s007050170011; Chouljenko VN, 1998, VIRUS GENES, V17, P33, DOI 10.1023/A:1008048916808; Chouljenko VN, 2001, J GEN VIROL, V82, P2927, DOI 10.1099/0022-1317-82-12-2927; de Haan CAM, 2008, J VIROL, V82, P6078, DOI 10.1128/JVI.00074-08; de Haan CAM, 2005, J VIROL, V79, P14451, DOI 10.1128/JVI.79.22.14451-14456.2005; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Han MG, 2006, J VIROL, V80, P12350, DOI 10.1128/JVI.00402-06; HOFMANN MA, 1990, J VIROL, V64, P4108, DOI 10.1128/JVI.64.9.4108-4114.1990; Jacques A, 2009, IMMUNOLOGY, V128, pe181, DOI 10.1111/j.1365-2567.2008.02946.x; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Mcroy WC, 2008, J VIROL, V82, P1414, DOI 10.1128/JVI.01674-07; PARKER MD, 1990, J GEN VIROL, V71, P263, DOI 10.1099/0022-1317-71-2-263; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; SAIF LJ, 1988, VET REC, V123, P300, DOI 10.1136/vr.123.11.300; SCHULTZE B, 1992, J GEN VIROL, V73, P901, DOI 10.1099/0022-1317-73-4-901; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; STABEL JR, 1995, VET IMMUNOL IMMUNOP, V45, P211, DOI 10.1016/0165-2427(94)05348-V; STCYRCOATS K, 1988, ARCH VIROL, V103, P35, DOI 10.1007/BF01319807; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; Vijgen L, 2006, J VIROL, V80, P7270, DOI 10.1128/JVI.02675-05; Watanabe R, 2008, J VIROL, V82, P11985, DOI 10.1128/JVI.01412-08; Woolhouse MEJ, 2006, MICROBE, V1, P511, DOI 10.1128/microbe.1.511.1; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457; Zhang X, 2007, VIROLOGY, V363, P1, DOI 10.1016/j.virol.2007.03.018; ZHANG XM, 1991, VIROLOGY, V183, P397, DOI 10.1016/0042-6822(91)90154-4	43	26	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52752	10.1371/journal.pone.0052752	http://dx.doi.org/10.1371/journal.pone.0052752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308119	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100014
J	Weingaertner, IR; Koutnik, S; Ammer, H				Weingaertner, Inka Regine; Koutnik, Sarah; Ammer, Hermann			Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OPIOID RECEPTORS; TYROSINE KINASE; CARCINOMA CELLS; DOWN-REGULATION; EGF RECEPTOR; MECHANISMS; DESENSITIZATION; INHIBITION; RESISTANCE	Background: There is increasing evidence that opioid analgesics may interfere with tumour growth. It is currently thought that these effects are mediated by transactivation of receptor tyrosine kinase (RTK)-controlled ERK1/2 and Akt signalling. The growth of many breast cancer cells is dependent on hyperactive ErbB receptor networks and one of the most successful approaches in antineoplastic therapy during the last decade was the development of ErbB-targeted therapies. However, the response rates of single therapies are often poor and resistance mechanisms evolve rapidly. To date there is no information about the ability of opioid analgesics to interfere with the growth of ErbB-driven cancers. Methods and Principal Findings: Here we demonstrate that ErbB2 overexpressing BT474 human breast cancer cells carry fully functional endogenous mu-opioid receptors. Most interestingly, the acute opioid effects on basal and Heregulin-stimulated ERK1/2 and Akt phosphorylation changed considerably during chronic Morphine treatment. Investigation of the underlying mechanism by the use of protein kinase inhibitors and co-immunoprecipitation studies revealed that chronic Morphine treatment results in rearrangement of the ErbB signalling network leading to dissociation of ERK1/2 from Akt signalling and a switch from ErbB1/ErbB3 to ErbB1/ErbB2-dependent cell growth. In chronically Morphine-treated cells Heregulin-stimulated ERK1/2 signalling is redirected via a newly established PI3K- and metalloproteinase-dependent feedback loop. Together, these alterations result in apoptosis of BT474 cells. A similar switch in Heregulin-stimulated ERK1/2 signalling from an ErbB2-independent to an ErbB2-, PI3K-and metalloproteinase-dependent mechanism was also observed in k-opioid receptor expressing SKBR3 human mammary adenocarcinoma cells. Conclusions and Significance: The present data demonstrate that the ErbB receptor network of human breast cancer cells represents a target for chronic Morphine treatment. Rearrangement of ErbB signalling by chronic Morphine may provide a promising strategy to enhance the sensitivity of breast cancer cells to ErbB-directed therapies and to prevent the development of escape mechanisms.	[Weingaertner, Inka Regine; Koutnik, Sarah; Ammer, Hermann] Univ Munich, Inst Pharmacol Toxicol & Pharm, Munich, Germany	University of Munich	Ammer, H (corresponding author), Univ Munich, Inst Pharmacol Toxicol & Pharm, Munich, Germany.	h.ammer@lmu.de		Ammer, Hermann/0000-0003-4935-0207				Afsharimani B, 2011, CANCER METAST REV, V30, P225, DOI 10.1007/s10555-011-9285-0; Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Brockhoff G, 2001, CYTOMETRY, V44, P338, DOI 10.1002/1097-0320(20010801)44:4<338::AID-CYTO1125>3.0.CO;2-V; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chen XM, 2000, BIOCHEM BIOPH RES CO, V277, P757, DOI 10.1006/bbrc.2000.3731; Chen YL, 2008, CURR MED CHEM, V15, P772, DOI 10.2174/092986708783955518; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Eisinger DA, 2002, J NEUROSCI, V22, P10192; Eisinger DA, 2011, MOL PHARMACOL, V79, P326, DOI 10.1124/mol.110.064956; Eisinger DA, 2009, J BIOL CHEM, V284, P34819, DOI 10.1074/jbc.M109.042937; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Heiss A, 2009, EXP CELL RES, V315, P2115, DOI 10.1016/j.yexcr.2009.04.002; Hermanto U, 2001, ONCOGENE, V20, P7551, DOI 10.1038/sj.onc.1204964; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kerros C, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-77; Koltermann A, 2009, J CELL MOL MED, V13, P2122, DOI 10.1111/j.1582-4934.2008.00561.x; Kong A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002881; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lerdrup M, 2007, MOL BIOL CELL, V18, P3656, DOI 10.1091/mbc.e07-01-0025; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Nylund G, 2008, DIGEST DIS SCI, V53, P461, DOI 10.1007/s10620-007-9897-y; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Schulz R, 2004, EUR J PHARMACOL, V500, P487, DOI 10.1016/j.ejphar.2004.07.010; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Tegeder I, 2003, CANCER RES, V63, P1846; Tegeder I, 2004, PHARMACOL REV, V56, P351, DOI 10.1124/pr.56.3.2; Toll L, 1998, NIDA Res Monogr, V178, P440; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zagon IS, 2007, NEUROPEPTIDES, V41, P441, DOI 10.1016/j.npep.2007.08.002; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	39	14	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53510	10.1371/journal.pone.0053510	http://dx.doi.org/10.1371/journal.pone.0053510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308242	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100080
J	Zouikr, I; Tadros, MA; Clifton, VL; Beagley, KW; Hodgson, DM				Zouikr, Ihssane; Tadros, Melissa A.; Clifton, Vicki L.; Beagley, Kenneth W.; Hodgson, Deborah M.			Low Formalin Concentrations Induce Fine-Tuned Responses That Are Sex and Age-Dependent: A Developmental Study	PLOS ONE			English	Article							RAT DORSAL-HORN; SPINAL-CORD; INFANT RATS; NOCICEPTIVE RESPONSES; DIFFERENT INTENSITIES; BEHAVIORAL-RESPONSE; GENDER-DIFFERENCES; INFLAMMATORY PAIN; GONADAL-HORMONES; ANALGESIA	The formalin test is increasingly applied as a model of inflammatory pain using high formalin concentrations (5-15%). However, little is known about the effects of low formalin concentrations on related behavioural responses. To examine this, rat pups were subjected to various concentrations of formalin at four developmental stages: 7, 13, 22, and 82 days of age. At postnatal day (PND) 7, sex differences in flinching but not licking responses were observed with 0.5% formalin evoking higher flinching in males than in females. A dose response was evident in that 0.5% formalin also produced higher licking responses compared to 0.3% or 0.4% formalin. At PND 13, a concentration of 0.8% formalin evoked a biphasic response. At PND 22, a concentration of 1.1% evoked higher flinching and licking responses during the late phase (10-30 min) in both males and females. During the early phase (0-5 min), 1.1% evoked higher licking responses compared to 0.9% or 1% formalin. 1.1% formalin produced a biphasic response that was not evident with 0.9 or 1%. At PND 82, rats displayed a biphasic pattern in response to three formalin concentrations (1.25%, 1.75% and 2.25%) with the presence of an interphase for both 1.75% and 2.25% but not for 1.25%. These data suggest that low formalin concentrations induce fine-tuned responses that are not apparent with the high formalin concentration commonly used in the formalin test. These data also show that the developing nociceptive system is very sensitive to subtle changes in formalin concentrations.	[Zouikr, Ihssane; Hodgson, Deborah M.] Univ Newcastle, Lab Neuroimmunol, Sch Psychol, Newcastle, NSW 2300, Australia; [Tadros, Melissa A.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Clifton, Vicki L.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Beagley, Kenneth W.] Queensland Univ Technol, Inst Hlth Biomed Innovat, Brisbane, Qld 4001, Australia	University of Newcastle; University of Newcastle; Robinson Research Institute; University of Adelaide; Queensland University of Technology (QUT)	Zouikr, I (corresponding author), Univ Newcastle, Lab Neuroimmunol, Sch Psychol, Newcastle, NSW 2300, Australia.	Ihssane.zouikr@uon.edu.au	Zouikr, Ihssane/X-9165-2019; Clifton, Vicki/A-1445-2012; Clifton, Vicki/AAV-2749-2021; Hodgson, Deborah/C-1950-2008; Beagley, Kenneth/J-1129-2012	Clifton, Vicki/0000-0002-4892-6748; Clifton, Vicki/0000-0002-4892-6748; Hodgson, Deborah/0000-0002-1522-0212; Beagley, Kenneth/0000-0003-3112-6557	National Health and Medical Research Council(NHMRC) [ARC DP 09787599]	National Health and Medical Research Council(NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from National Health and Medical Research Council(NHMRC; ARC DP 09787599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT FV, 1995, PAIN, V60, P91, DOI 10.1016/0304-3959(94)00095-V; ALOISI AM, 1995, BRAIN RES, V699, P242, DOI 10.1016/0006-8993(95)00912-A; ALOISI AM, 1994, NEUROSCI LETT, V179, P79, DOI 10.1016/0304-3940(94)90939-3; Aloisi AM, 2000, NEUROSCIENCE, V95, P559; ALOISI AM, 1995, PHYSIOL BEHAV, V58, P603, DOI 10.1016/0031-9384(95)00099-5; Anand KJS, 1999, PHYSIOL BEHAV, V66, P627, DOI 10.1016/S0031-9384(98)00338-2; Barr GA, 1998, PHARMACOL BIOCHEM BE, V60, P329, DOI 10.1016/S0091-3057(97)00602-3; Berkley KJ, 2006, AM J PHYSIOL-REG I, V291, pR241, DOI 10.1152/ajpregu.00287.2006; Bhutta AT, 2001, PHYSIOL BEHAV, V73, P51, DOI 10.1016/S0031-9384(01)00432-2; Butkevich IP, 2007, EUR J PAIN, V11, P888, DOI 10.1016/j.ejpain.2007.02.001; Butkevich IP, 2009, BRAIN RES, V1286, P53, DOI 10.1016/j.brainres.2009.06.055; Chanda ML, 2006, AM J PHYSIOL-REG I, V291, pR335, DOI 10.1152/ajpregu.00902.2005; CODERRE TJ, 1993, PAIN, V54, P43, DOI 10.1016/0304-3959(93)90098-A; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; Craft RM, 2003, CLIN J PAIN, V19, P175, DOI 10.1097/00002508-200305000-00005; Craft RM, 2003, LIFE SCI, V72, P2675, DOI 10.1016/S0024-3205(03)00178-4; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fitzgerald M, 2001, NEUROSCIENTIST, V7, P246, DOI 10.1177/107385840100700309; FITZGERALD M, 1986, DEV BRAIN RES, V24, P261, DOI 10.1016/0165-3806(86)90194-X; FITZGERALD M, 1985, J PHYSIOL-LONDON, V364, P1; Gagliese L, 1999, NEUROBIOL AGING, V20, P699, DOI 10.1016/S0197-4580(99)00061-5; Gaumond I, 2002, BRAIN RES, V958, P139, DOI 10.1016/S0006-8993(02)03661-2; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; GUY ER, 1992, PAIN, V51, P81, DOI 10.1016/0304-3959(92)90012-Z; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; LaPrairie JL, 2007, PAIN, V132, pS124, DOI 10.1016/j.pain.2007.08.010; Lariviere WR, 2006, J NEUROPHYSIOL, V95, P2889, DOI 10.1152/jn.00608.2005; Lidow MS, 2002, PAIN, V99, P377, DOI 10.1016/S0304-3959(02)00258-0; McCall WD, 1996, NEUROSCI LETT, V208, P45, DOI 10.1016/0304-3940(96)12552-0; MCLAUGHLIN CR, 1990, PHARMACOL BIOCHEM BE, V36, P859, DOI 10.1016/0091-3057(90)90090-5; NADEL L, 1990, ANN NY ACAD SCI, V608, P613, DOI 10.1111/j.1749-6632.1990.tb48912.x; Ocvirk R, 2008, PAIN, V138, P402, DOI 10.1016/j.pain.2008.01.019; Okuda K, 2001, PAIN, V92, P107, DOI 10.1016/S0304-3959(00)00476-0; Perissin L, 2003, LIFE SCI, V72, P897, DOI 10.1016/S0024-3205(02)02344-5; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; RIVEST RW, 1991, EXPERIENTIA, V47, P1026, DOI 10.1007/BF01923338; ROSLAND JH, 1990, PAIN, V42, P235, DOI 10.1016/0304-3959(90)91167-H; SKILLING SR, 1988, J NEUROCHEM, V51, P127, DOI 10.1111/j.1471-4159.1988.tb04845.x; SMULLIN DH, 1990, PAIN, V42, P93, DOI 10.1016/0304-3959(90)91095-Z; Sominsky L, 2012, HORM BEHAV, V62, P345, DOI 10.1016/j.yhbeh.2012.02.005; Teng CJ, 1998, PAIN, V76, P337, DOI 10.1016/S0304-3959(98)00065-7; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Walker SM, 2003, PAIN, V105, P185, DOI 10.1016/S0304-3959(03)00201-X; Walsh MA, 2009, J NEUROPHYSIOL, V101, P1800, DOI 10.1152/jn.90755.2008; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; WHEELERACETO H, 1991, PSYCHOPHARMACOLOGY, V104, P35, DOI 10.1007/BF02244551; YI DK, 1995, PAIN, V60, P257, DOI 10.1016/0304-3959(94)00119-Y	48	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53384	10.1371/journal.pone.0053384	http://dx.doi.org/10.1371/journal.pone.0053384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308208	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100060
J	Manuel, DG; Rosella, LC; Tuna, M; Bennett, C; Stukel, TA				Manuel, Douglas G.; Rosella, Laura C.; Tuna, Meltem; Bennett, Carol; Stukel, Therese A.			Effectiveness of Community-Wide and Individual High-Risk Strategies to Prevent Diabetes: A Modelling Study	PLOS ONE			English	Article							LIFE-STYLE INTERVENTIONS; COST-EFFECTIVENESS; OBESITY; HEALTH; POPULATIONS; CANADA	Background: Diabetes has been described as one of the most important threats to the health of developed countries. Effective population strategies to prevent diabetes have not been determined but two broad strategies have been proposed: "high-risk'' and "community-wide'' strategies. Methods: We modelled the potential effectiveness of two strategies to prevent 10% of new cases of diabetes in Ontario, Canada over a 5-year period. The 5-year risk of developing physician-diagnosed diabetes was estimated for respondents to the Canadian Community Health Survey 2003 (CCHS 2.1, N = 26 232) using a validated and calibrated diabetes risk tool (Diabetes Population Risk Tool [DPoRT]). We estimated how many cases of diabetes could be prevented using two different strategies: a) a community-wide strategy that would uniformly reduce body mass index (BMI) in the entire population; and b) a high baseline risk strategy using either pharmacotherapy or lifestyle counselling to treat people who have an increased risk of developing diabetes. Results: In 2003, the 5-year risk of developing diabetes was 4.7% (383 600 new diagnosed cases of diabetes in 8 189 000 Ontarians aged 20+) and risk was moderately diffused (0.5%, 3.1% and 17.9% risk in the 1st, 5th (median) and 10th deciles of risk). A 10% reduction in new cases of diabetes would have been achieved under any of the following scenarios: if BMI was 3.5% lower in the entire population; if lifestyle counselling covered 32.2% of high-risk people (371 900 of 1 155 000 people with 5 year diabetes risk greater than 10%); or, if pharmacotherapy covered 65.2% of high-risk people. Conclusions: Prevention using pharmacotherapy alone requires unrealistically high coverage levels to achieve modest population reduction in new diabetes cases. On the other hand, in recent years few jurisdictions have been able to achieve a reduction in BMI at the population level, let alone a reduction of BMI of 3.5%.	[Manuel, Douglas G.; Tuna, Meltem; Bennett, Carol] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Manuel, Douglas G.; Rosella, Laura C.; Tuna, Meltem; Bennett, Carol; Stukel, Therese A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Manuel, Douglas G.; Rosella, Laura C.; Tuna, Meltem; Bennett, Carol; Stukel, Therese A.] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Manuel, Douglas G.; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rosella, Laura C.] Publ Hlth Ontario, Toronto, ON, Canada; [Stukel, Therese A.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Toronto; University of Toronto; University of Toronto	Manuel, DG (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	dmanuel@ohri.ca	; Manuel, Doug/D-7100-2014	Stukel, Therese/0000-0002-2951-1360; Bennett, Carol/0000-0002-3033-9860; Manuel, Doug/0000-0003-0912-0845	Simulation Technology for Applied Research, a CIHR New Emerging Team; Population Health Improvement Research Network; Ontario Ministry of Health and Long-term Care [06548]	Simulation Technology for Applied Research, a CIHR New Emerging Team(Canadian Institutes of Health Research (CIHR)); Population Health Improvement Research Network; Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario)	This study was supported by Simulation Technology for Applied Research, a CIHR New Emerging Team [http://www.cihr-irsc.gc.ca], and the Population Health Improvement Research Network [http://www.rrasp-phirn.ca/] that receives funding from the Ontario Ministry of Health and Long-term Care [Grant Number 06548]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram MY, 2010, DIABETOLOGIA, V53, P875, DOI 10.1007/s00125-010-1661-8; Branca F., 2007, CHALLENGE OBESITY WH; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Drummond MF, 2015, METHODS EC EVALUATIO; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Goldsmith L, 2004, EC EVALUATION 4 FACE; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Haby MM, 2006, INT J OBESITY, V30, P1463, DOI 10.1038/sj.ijo.0803469; Jain A, 2005, BMJ-BRIT MED J, V331, P1387, DOI 10.1136/bmj.331.7529.1387; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; Lindstrom J, 2010, PUBLIC HEALTH NUTR, V13, P993, DOI 10.1017/S1368980010000960; Manuel DG, 2010, INT J EPIDEMIOL, V39, P380, DOI 10.1093/ije/dyp373; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; McLaren L, 2010, INT J EPIDEMIOL, V39, P372, DOI 10.1093/ije/dyp315; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; ROSE G, 1991, J ROY COLL PHYS LOND, V25, P48; Rose G, 2001, B WORLD HEALTH ORGAN, V79, P990; Rose GA, 1992, STRATEGY PREVENTIVE, Vxii; Rosella LC, 2011, J EPIDEMIOL COMMUN H, V65, P613, DOI 10.1136/jech.2009.102244; RUSH B, 2002, CENSUS EC EVALUATION; Swinburn B, 2005, OBES REV, V6, P23, DOI 10.1111/j.1467-789X.2005.00184.x; WHO, 2000, OB PREV MAN GLOB EP	27	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52963	10.1371/journal.pone.0052963	http://dx.doi.org/10.1371/journal.pone.0052963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308127	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100014
J	Tayade, AB; Dhar, P; Kumar, J; Sharma, M; Chauhan, RS; Chaurasia, OP; Srivastava, RB				Tayade, Amol B.; Dhar, Priyanka; Kumar, Jatinder; Sharma, Manu; Chauhan, Rajinder S.; Chaurasia, Om P.; Srivastava, Ravi B.			Chemometric Profile of Root Extracts of Rhodiola imbricata Edgew. with Hyphenated Gas Chromatography Mass Spectrometric Technique	PLOS ONE			English	Article							AQUEOUS EXTRACT; RHIZOME; NUCLEAR	Rhodiola imbricata Edgew. (Rose root or Arctic root or Golden root or Shrolo), belonging to the family Crassulaceae, is an important food crop and medicinal plant in the Indian trans-Himalayan cold desert. Chemometric profile of the n-hexane, chloroform, dichloroethane, ethyl acetate, methanol, and 60% ethanol root extracts of R. imbricata were performed by hyphenated gas chromatography mass spectrometry (GC/MS) technique. GC/MS analysis was carried out using Thermo Finnigan PolarisQ Ion Trap GC/MS MS system comprising of an AS2000 liquid autosampler. Interpretation on mass spectrum of GC/MS was done using the NIST/EPA/NIH Mass Spectral Database, with NIST MS search program v.2.0g. Chemometric profile of root extracts revealed the presence of 63 phyto-chemotypes, among them, 1-pentacosanol; stigmast-5-en-3-ol, (3 beta,24S); 1-teracosanol; 1-henteracontanol; 17-pentatriacontene; 13-tetradecen-1-ol acetate; methyl tri-butyl ammonium chloride; bis(2-ethylhexyl) phthalate; 7,8-dimethylbenzocyclooctene; ethyl linoleate; 3-methoxy-5-methylphenol; hexadecanoic acid; camphor; 1,3-dimethoxybenzene; thujone; 1,3-benzenediol, 5-pentadecyl; benzenemethanol, 3-hydroxy, 5-methoxy; cholest-4-ene-3,6-dione; dodecanoic acid, 3-hydroxy; octadecane, 1-chloro; ethanone, 1-(4-hydroxyphenyl); alpha-tocopherol; ascaridole; campesterol; 1-dotriacontane; heptadecane, 9-hexyl were found to be present in major amount. Eventually, in the present study we have found phytosterols, terpenoids, fatty acids, fatty acid esters, alkyl halides, phenols, alcohols, ethers, alkanes, and alkenes as the major group of phyto-chemotypes in the different root extracts of R. imbricata. All these compounds identified by GC/MS analysis were further investigated for their biological activities and it was found that they possess a diverse range of positive pharmacological actions. In future, isolation of individual phyto-chemotypes and subjecting them to biological activity will definitely prove fruitful results in designing a novel drug.	[Tayade, Amol B.; Dhar, Priyanka; Kumar, Jatinder; Chaurasia, Om P.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India; [Sharma, Manu] Jaypee Univ Informat Technol, Dept Pharm, Waknaghat, Solan, India; [Chauhan, Rajinder S.] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Waknaghat, Solan, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR); Jaypee University of Information Technology; Jaypee University of Information Technology	Chaurasia, OP (corresponding author), Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India.	dropchaurasiadihardrdo@gmail.com	CHAURASIA, OM/AAW-6347-2021; CHAURASIA, OM PRAKASH/AAP-3358-2021; Sharma, Manu/GOJ-9290-2022; Chauhan, Rajinder Singh/HGB-5642-2022	CHAURASIA, OM PRAKASH/0000-0003-2921-2755; Sharma, Prof (Dr) Manu/0000-0003-3903-1683	Defence Research & Development Organization, Ministry of Defence, Government of India	Defence Research & Development Organization, Ministry of Defence, Government of India	Funding provided by Defence Research & Development Organization, Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2005, MOL CELL BIOCHEM, V273, P209, DOI 10.1007/s11010-005-0822-4; Arora Rajesh, 2008, Journal of Dietary Supplements, V5, P147, DOI 10.1080/19390210802332695; Carro N, 1997, ANALYST, V122, P325, DOI 10.1039/a605856f; Chawla R, 2010, J PHARM BIOALLIED SC, V2, P213, DOI 10.4103/0975-7406.68503; Gherman C, 2000, TALANTA, V53, P253, DOI 10.1016/S0039-9140(00)00458-6; Goel HC, 2006, J MED FOOD, V9, P154, DOI 10.1089/jmf.2006.9.154; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Gupta A, 2007, PLANTA MED, V73, P774, DOI 10.1055/s-2007-981546; Gupta V, 2008, FOOD CHEM TOXICOL, V46, P1645, DOI 10.1016/j.fct.2007.12.027; Gupta V, 2010, FOOD CHEM TOXICOL, V48, P1019, DOI 10.1016/j.fct.2010.01.012; Gupta V, 2009, FOOD CHEM TOXICOL, V47, P1239, DOI 10.1016/j.fct.2009.02.017; Iordache A, 2009, NUCL INSTRUM METH B, V267, P338, DOI 10.1016/j.nimb.2008.10.021; Kanupriya D, 2005, MOL CELL BIOCHEM, V275, P1, DOI 10.1007/s11010-005-7637-1; Khanum F, 2005, COMPR REV FOOD SCI F, V4, P55, DOI 10.1111/j.1541-4337.2005.tb00073.x; Kumar R, 2007, IND J CLIN BIOCH S, V22, P171; Mishra KP, 2008, IMMUNOBIOLOGY, V213, P125, DOI 10.1016/j.imbio.2007.07.003; Mishra KP, 2006, IMMUNOPHARM IMMUNOT, V28, P201, DOI 10.1080/08923970600815139; Mishra KP, 2012, IMMUNOPHARM IMMUNOT, V34, P513, DOI 10.3109/08923973.2011.638307; Mishra KP, 2010, IMMUNOPHARM IMMUNOT, V32, P141, DOI [10.3109/08923970903218874, 10.3109/08923970903503668]; Mishra KP, 2009, IMMUNOBIOLOGY, V214, P27, DOI 10.1016/j.imbio.2008.04.001; Pallado P, 1997, RAPID COMMUN MASS SP, V11, P1335; Raj K., 2010, Pharmacognosy Journal, V2, P431; Raj K., 2010, Pharmacognosy Journal, V2, P157; Robards K, 1997, ANALYST, V122, pR11, DOI 10.1039/a606499j; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Shellie RA, 2009, J SEP SCI, V32, P3720, DOI 10.1002/jssc.200900422; Tulsawani R, 2013, J APPL TOXICOL, V33, P350, DOI 10.1002/jat.1739	27	36	39	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52797	10.1371/journal.pone.0052797	http://dx.doi.org/10.1371/journal.pone.0052797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326358	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400010
J	Altincicek, B; Elashry, A; Guz, N; Grundler, FMW; Vilcinskas, A; Dehne, HW				Altincicek, Boran; Elashry, Abdelnaser; Guz, Nurper; Grundler, Florian M. W.; Vilcinskas, Andreas; Dehne, Heinz-Wilhelm			Next Generation Sequencing Based Transcriptome Analysis of Septic-Injury Responsive Genes in the Beetle Tribolium castaneum	PLOS ONE			English	Article							IMMUNE-INDUCIBLE GENES; GENOME-WIDE ANALYSIS; RED FLOUR BEETLE; MOLECULAR-CLONING; BINDING PROTEIN; DEFENSE; IDENTIFICATION; INSECT; RECOGNITION; COAGULATION	Beetles (Coleoptera) are the most diverse animal group on earth and interact with numerous symbiotic or pathogenic microbes in their environments. The red flour beetle Tribolium castaneum is a genetically tractable model beetle species and its whole genome sequence has recently been determined. To advance our understanding of the molecular basis of beetle immunity here we analyzed the whole transcriptome of T. castaneum by high-throughput next generation sequencing technology. Here, we demonstrate that the Illumina/Solexa sequencing approach of cDNA samples from T. castaneum including over 9.7 million reads with 72 base pairs (bp) length (approximately 700 million bp sequence information with about 30 x transcriptome coverage) confirms the expression of most predicted genes and enabled subsequent qualitative and quantitative transcriptome analysis. This approach recapitulates our recent quantitative real-time PCR studies of immune-challenged and naive T. castaneum beetles, validating our approach. Furthermore, this sequencing analysis resulted in the identification of 73 differentially expressed genes upon immune-challenge with statistical significance by comparing expression data to calculated values derived by fitting to generalized linear models. We identified up regulation of diverse immune-related genes (e.g. Toll receptor, serine proteinases, DOPA decarboxylase and thaumatin) and of numerous genes encoding proteins with yet unknown functions. Of note, septic-injury resulted also in the elevated expression of genes encoding heat-shock proteins or cytochrome P450s supporting the view that there is crosstalk between immune and stress responses in T. castaneum. The present study provides a first comprehensive overview of septic-injury responsive genes in T. castaneum beetles. Identified genes advance our understanding of T. castaneum specific gene expression alteration upon immune-challenge in particular and may help to understand beetle immunity in general.	[Altincicek, Boran; Elashry, Abdelnaser; Grundler, Florian M. W.; Dehne, Heinz-Wilhelm] Univ Bonn, INRES Phytomed, Bonn, Germany; [Guz, Nurper] Ankara Univ, Fac Agr, Dept Plant Protect, TR-06100 Ankara, Turkey; [Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany	University of Bonn; Ankara University; Justus Liebig University Giessen	Altincicek, B (corresponding author), Univ Bonn, INRES Phytomed, Nussallee 9, Bonn, Germany.	boran.altincicek@uni-bonn.de	Elashry, Abdelnaser/ABA-3330-2021; Guz, Nurper/AAD-8374-2022	Grundler, Florian M.W./0000-0001-8101-0558; Altincicek, Boran/0000-0003-2019-452X	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [AL902/4-1, AL902/2-1]; University of Bonn (Landwirtschaftliche Fakultat); excellence initiative of the Hessian Ministry of Science and Art, which encompasses a generous grant for the LOEWE research focus "Insect Biotechnology"	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); University of Bonn (Landwirtschaftliche Fakultat); excellence initiative of the Hessian Ministry of Science and Art, which encompasses a generous grant for the LOEWE research focus "Insect Biotechnology"	The authors acknowledge support by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) with a Heisenberg-fellowship to BA (AL902/4-1), a research grant to BA and AV (AL902/2-1), by the University of Bonn (Landwirtschaftliche Fakultat) with a start-up fund to BA and by the excellence initiative of the Hessian Ministry of Science and Art, which encompasses a generous grant for the LOEWE research focus "Insect Biotechnology" to AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Altincicek B, 2009, INSECT MOL BIOL, V18, P119, DOI 10.1111/j.1365-2583.2008.00856.x; Altincicek B, 2008, INSECT MOL BIOL, V17, P711, DOI 10.1111/j.1365-2583.2008.00835.x; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P1416, DOI 10.1016/j.dci.2008.06.004; Altincicek B, 2008, J IMMUNOL, V181, P2705, DOI 10.4049/jimmunol.181.4.2705; Altincicek B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-326; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Altincicek B, 2007, INSECT BIOCHEM MOLEC, V37, P726, DOI 10.1016/j.ibmb.2007.03.012; Altincicek B, 2009, BIOL CHEM, V390, P1303, DOI 10.1515/BC.2009.128; Anders S., 2010, ANAL RNA SEQ DATA DE; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Freitak D, 2012, BIOL LETTERS, V8, P860, DOI 10.1098/rsbl.2012.0273; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Johansson KC, 2005, EXP CELL RES, V305, P145, DOI 10.1016/j.yexcr.2004.12.018; JOMORI T, 1991, J BIOL CHEM, V266, P13318; Koizumi N, 1997, EUR J BIOCHEM, V248, P217, DOI 10.1111/j.1432-1033.1997.t01-1-00217.x; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; MUTA T, 1991, J BIOL CHEM, V266, P6554; Parker BJ, 2011, TRENDS ECOL EVOL, V26, P242, DOI 10.1016/j.tree.2011.02.005; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Pursall ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019972; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Roth O, 2008, J EVOLUTION BIOL, V21, P1703, DOI 10.1111/j.1420-9101.2008.01584.x; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Short SM, 2010, P ROY SOC B-BIOL SCI, V277, P3649, DOI 10.1098/rspb.2010.0937; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	40	39	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52004	10.1371/journal.pone.0052004	http://dx.doi.org/10.1371/journal.pone.0052004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326321	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500009
J	Fury, CA; Ruckstuhl, KE; Harrison, PL				Fury, Christine Ann; Ruckstuhl, Kathreen E.; Harrison, Peter L.			Spatial and Social Sexual Segregation Patterns in Indo-Pacific Bottlenose Dolphins (Tursiops aduncus)	PLOS ONE			English	Article							HABITAT USE; HOME-RANGE; MOVEMENT PATTERNS; PREDATION RISK; CARCHARHINUS-LEUCAS; ALLIANCE FORMATION; SITE FIDELITY; BULL SHARKS; GROUP-SIZE; FEMALE	Sexual segregation seems to be common in bottlenose dolphins, whereby males and females live in different pods that mix mainly for mating. Male dolphins often use aggressive behaviour to mate with females, while females with calves may have different activity and dietary requirements to males and different susceptibility to predation. We investigated the degree of spatial and social sexual segregation in Indo-Pacific bottlenose dolphins (Tursiops aduncus) in a subtropical estuary in Australia. Based on surveys completed over three years, dolphin groups were mostly mixed-sex or female. Mixed-sex groups were found in larger groups in mostly deeper water, whereas, female groups were foraging across all water depths in smaller groups. Aggressive coercive behaviour by males towards females was high, occurring mainly in deeper water, at higher tides, and outside the breeding season. Habitat use by female dolphin groups suggests that shallow tributaries may provide a sanctuary from aggressive males, access to suitable prey items and density for mothers and their calves, or a combination of these factors.	[Fury, Christine Ann; Harrison, Peter L.] So Cross Univ, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia; [Ruckstuhl, Kathreen E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Southern Cross University; University of Calgary	Fury, CA (corresponding author), So Cross Univ, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia.	cfury10@gmail.com	Ruckstuhl, Kathreen Eva/B-4469-2013; Harrison, Peter L/B-4763-2011	Harrison, Peter L/0000-0002-4048-2409; Ruckstuhl, Kathreen/0000-0002-2949-242X; Fury, Christine/0000-0002-0563-3136	Australian Geographic, Angourie Rainforest Resort, Project Aware; Southern Cross University Whale Research Centre	Australian Geographic, Angourie Rainforest Resort, Project Aware; Southern Cross University Whale Research Centre	This study was funded by Australian Geographic, Angourie Rainforest Resort, Project Aware and Southern Cross University Whale Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MC, 2001, MAR ECOL PROG SER, V222, P253, DOI 10.3354/meps222253; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2008, SPSS VERS 17; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Bon R, 1996, BEHAV PROCESS, V38, P131, DOI 10.1016/S0376-6357(96)00029-0; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Cartwright R, 2009, BEHAVIOUR, V146, P1573, DOI 10.1163/156853909X458377; Clark DA, 1998, URSUS-SERIES, V10, P243; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 1999, NATURE, V397, P571, DOI 10.1038/17501; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Connor RG, 2010, BIOL LETT; Connor Richard C., 1992, P415; Conradt Larissa, 2005, P11; Cransac N, 1998, J ZOOL, V244, P371, DOI 10.1111/j.1469-7998.1998.tb00042.x; Croft DP, 2006, AM NAT, V167, P867, DOI 10.1086/504853; Danilewicz D, 2009, J MAR BIOL ASSOC UK, V89, P943, DOI 10.1017/S002531540900054X; Darden SK, 2008, BIOL LETTERS, V4, P449, DOI 10.1098/rsbl.2008.0308; Dyall A, 2005, NEW S WALES COASTAL; Eyre BD, 2000, MAR ECOL PROG SER, V205, P61, DOI 10.3354/meps205061; Fury CA, 2009, THESIS SO CROSS U LI; Fury CA, 2011, ESTUAR COAST SHELF S, V93, P389, DOI 10.1016/j.ecss.2011.05.003; Fury CA, 2011, MAR MAMMAL SCI, V27, pE185, DOI 10.1111/j.1748-7692.2010.00447.x; Fury CA, 2008, MAR FRESHWATER RES, V59, P1015, DOI 10.1071/MF08109; Gubbins C, 2002, J MAMMAL, V83, P178, DOI 10.1644/1545-1542(2002)083<0178:UOHRBR>2.0.CO;2; Hancox D, 2010, ANIM BEHAV, V80, P845, DOI 10.1016/j.anbehav.2010.08.004; Heithaus MR, 2006, OIKOS, V114, P257; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Hildebrand B, 1997, WAYPOINT VERSION 1 8; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; Hooge PN, 2001, LOW WAKE FI, V17, P37; IRVINE AB, 1981, FISH B-NOAA, V79, P671; KOVACS KM, 1990, MAR MAMMAL SCI, V6, P204, DOI 10.1111/j.1748-7692.1990.tb00244.x; Laidre KL, 2009, ICES J MAR SCI, V66, P2253, DOI 10.1093/icesjms/fsp191; Last PR, 1994, SHARKS RAYS AUSTR, DOI 10.2307/1446735; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Loseto LL, 2006, CAN J ZOOL, V84, P1743, DOI 10.1139/Z06-160; MacFarlane AM, 2009, J ZOOL, V277, P37, DOI 10.1111/j.1469-7998.2008.00508.x; Main MB, 2008, ECOLOGY, V89, P693, DOI 10.1890/07-0645.1; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; Mann Janet, 2003, P236, DOI 10.1017/CBO9780511584022.010; Martin AR, 2004, J ZOOL, V263, P295, DOI 10.1017/S095283690400528X; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Michaud Robert, 2005, P303; Milner RNC, 2010, ANIM BEHAV, V79, P735, DOI 10.1016/j.anbehav.2009.12.030; Moller LM, 2001, P ROY SOC B-BIOL SCI, V268, P1941, DOI 10.1098/rspb.2001.1756; Moller LM, 2006, BEHAV ECOL SOCIOBIOL, V61, P109, DOI 10.1007/s00265-006-0241-x; Moller Luciana M., 2008, Research Letters in Ecology, V2008, P1, DOI 10.1155/2008/498390; Moquin P, 2010, ANIM BEHAV, V79, P1047, DOI 10.1016/j.anbehav.2010.01.020; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; Parsons KM, 2003, ANIM BEHAV, V66, P185, DOI 10.1006/anbe.2003.2186; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Ruckstuhl KE, 1998, ANIM BEHAV, V56, P99, DOI 10.1006/anbe.1998.0745; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Ruckstuhl KE, 2002, ANIM BEHAV, V64, P909, DOI 10.1006/anbe.2002.2015; SAS Institute Inc, 2009, JMP VERS 8; Scott M.D., 1990, P235; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Silverman B.W., 1986, DENSITY ESTIMATION S; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Stewart BS, 1997, J MAMMAL, V78, P1101, DOI 10.2307/1383053; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; WALSH S, 2004, MAJOR FISH KILLS NO; Webster Trudi A., 2009, Aquatic Mammals, V35, P212, DOI 10.1578/AM.35.2.2009.212; Weckerly FW, 2001, J MAMMAL, V82, P825, DOI 10.1644/1545-1542(2001)082<0825:SSIREC>2.0.CO;2; Weir JS, 2008, CAN J ZOOL, V86, P1225, DOI 10.1139/Z08-101; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; West RJ, 2002, FISH RES, V54, P409, DOI 10.1016/S0165-7836(01)00277-6; West RJ, 1996, ESTUARIES, V19, P31, DOI 10.2307/1352649; White G.C., 1990, ANAL WILDLIFE RADIO; Whitehead H, 2000, CETACEAN SOCIETIES, P154; WIELGUS RB, 1995, J WILDLIFE MANAGE, V59, P552, DOI 10.2307/3802462; WIELGUS RB, 1994, J WILDLIFE MANAGE, V58, P405, DOI 10.2307/3809310; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wilson Ben, 1993, European Research on Cetaceans, V7, P54; Wilson Ben, 1992, European Research on Cetaceans, V6, P114; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	84	35	35	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52987	10.1371/journal.pone.0052987	http://dx.doi.org/10.1371/journal.pone.0052987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326370	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500039
J	Gray, SM; McGeown, JG; McMurray, G; McCloskey, KD				Gray, Susannah M.; McGeown, J. Graham; McMurray, Gordon; McCloskey, Karen D.			Functional Innervation of Guinea-Pig Bladder Interstitial Cells of Cajal Subtypes: Neurogenic Stimulation Evokes In Situ Calcium Transients	PLOS ONE			English	Article							DETRUSOR SMOOTH MUSCLES; HUMAN URINARY-BLADDER; ALTERED DISTRIBUTION; MUSCULARIS MUCOSAE; GAP-JUNCTIONS; MYOFIBROBLAST; EXPRESSION	Several populations of interstitial cells of Cajal (ICC) exist in the bladder, associated with intramural nerves. Although ICC respond to exogenous agonists, there is currently no evidence of their functional innervation. The objective was to determine whether bladder ICC are functionally innervated. Guinea-pig bladder tissues, loaded with fluo-4AM were imaged with fluorescent microscopy and challenged with neurogenic electrical field stimulation (EFS). All subtypes of ICC and smooth muscle cells (SMC) displayed spontaneous Ca2+-oscillations. EFS (0.5 Hz, 2 Hz, 10 Hz) evoked tetrodotoxin (1 mu M)-sensitive Ca2+-transients in lamina propria ICC (ICC-LP), detrusor ICC and perivascular ICC (PICC) associated with mucosal microvessels. EFS responses in ICC-LP were significantly reduced by atropine or suramin. SMC and vascular SMC (VSM) also responded to EFS. Spontaneous Ca2+-oscillations in individual ICC-LP within networks occurred asynchronously whereas EFS evoked coordinated Ca2+-transients in all ICC-LP within a field of view. Non-correlated Ca2+-oscillations in detrusor ICC and adjacent SMC pre-EFS, contrasted with simultaneous neurogenic Ca2+ transients evoked by EFS. Spontaneous Ca2+-oscillations in PICC were little affected by EFS, whereas large Ca2+-transients were evoked in pre-EFS quiescent PICC. EFS also increased the frequency of VSM Ca2+-oscillations. In conclusion, ICC-LP, detrusor ICC and PICC are functionally innervated. Interestingly, Ca2+-activity within ICC-LP networks and between detrusor ICC and their adjacent SMC were synchronous under neural control. VSM and PICC Ca2+-activity was regulated by bladder nerves. These novel findings demonstrate functional neural control of bladder ICC. Similar studies should now be carried out on neurogenic bladder to elucidate the contribution of impaired nerve-ICC communication to bladder pathophysiology.	[Gray, Susannah M.; McGeown, J. Graham; McCloskey, Karen D.] Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [McMurray, Gordon] Pfizer Ltd, Neusentis, Cambridge, England	Pfizer	McCloskey, KD (corresponding author), Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	k.mccloskey@qub.ac.uk		McCloskey, Karen/0000-0002-9135-9013	European Union Framework 7, INComb grant [223234]; Pfizer-BBSRC CASE Studentship	European Union Framework 7, INComb grant; Pfizer-BBSRC CASE Studentship	Financial assistance from the European Union Framework 7, INComb grant (223234) is acknowledged. SM Gray is supported by a Pfizer-BBSRC CASE Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; BURNSTOCK G, 1986, J ANAT, V146, P1; BURNSTOCK G, 1977, J INVEST DERMATOL, V69, P47, DOI 10.1111/1523-1747.ep12497872; Cunningham RMJ, 2011, J UROLOGY, V185, P1123, DOI 10.1016/j.juro.2010.10.037; Davidson RA, 2005, J UROLOGY, V173, P1385, DOI 10.1097/01.ju.0000146272.80848.37; DIXON JS, 1983, J ANAT, V136, P265; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Fry GH, 2012, AM J PHYSL RENAL PHY; Hashitani H, 2004, J PHYSIOL-LONDON, V559, P567, DOI 10.1113/jphysiol.2004.065136; Hashitani H, 2004, BRIT J PHARMACOL, V141, P183, DOI 10.1038/sj.bjp.0705602; Hashitani H, 2003, BRIT J PHARMACOL, V140, P146, DOI 10.1038/sj.bjp.0705319; Hashitani H, 2011, J UROLOGY, V185, P2382, DOI 10.1016/j.juro.2011.02.046; Heppner TJ, 2011, AM J PHYSIOL-REG I, V301, pR351, DOI 10.1152/ajpregu.00656.2010; Johnston L, 2008, AM J PHYSIOL-RENAL, V294, pF645, DOI 10.1152/ajprenal.00526.2007; Johnston L, 2012, J CELL MOL MED, V16, P1533, DOI 10.1111/j.1582-4934.2011.01410.x; Johnston L, 2010, J UROLOGY, V184, P370, DOI 10.1016/j.juro.2010.03.005; Kubota Y, 2008, NEUROUROL URODYNAM, V27, P330, DOI 10.1002/nau.20502; McCloskey KD, 2002, J UROLOGY, V168, P832, DOI 10.1016/S0022-5347(05)64752-0; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Sui GP, 2008, AM J PHYSIOL-RENAL, V295, pF688, DOI 10.1152/ajprenal.00133.2008; Ward SM, 2004, NEUROGASTROENT MOTIL, V16, P112, DOI 10.1111/j.1743-3150.2004.00485.x; Wiseman OJ, 2003, BJU INT, V91, P89, DOI 10.1046/j.1464-410X.2003.03802.x; Wu C, 2004, J PHYSIOL-LONDON, V559, P231, DOI 10.1113/jphysiol.2004.067934; Young JS, 2008, J PHYSIOL-LONDON, V586, P5743, DOI 10.1113/jphysiol.2008.162040; Zagorodnyuk VP, 2009, BRIT J PHARMACOL, V157, P607, DOI 10.1111/j.1476-5381.2009.00166.x	25	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53423	10.1371/journal.pone.0053423	http://dx.doi.org/10.1371/journal.pone.0053423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326426	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500070
J	Ganguli, I; Collins, JE; Reichmann, WM; Losina, E; Katz, JN; Arbelaez, C; Donnell-Fink, LA; Walensky, RP				Ganguli, Ishani; Collins, Jamie E.; Reichmann, William M.; Losina, Elena; Katz, Jeffrey N.; Arbelaez, Christian; Donnell-Fink, Laurel A.; Walensky, Rochelle P.			Missed Opportunities: Refusal to Confirm Reactive Rapid HIV Tests in the Emergency Department	PLOS ONE			English	Article							PATIENT PERCEPTIONS; CARE; INFECTION; ACCEPTANCE; WOMEN	Background: HIV infection remains a major US public health concern. While HIV-infected individuals now benefit from earlier diagnosis and improved treatment options, progress is tempered by large numbers of newly diagnosed patients who are lost to follow-up prior to disease confirmation and linkage to care. Methodology: In the randomized, controlled USHER trial, we offered rapid HIV tests to patients presenting to a Boston, MA emergency department. Separate written informed consent was required for confirmatory testing. In a secondary analysis, we compared participants with reactive results who did and did not complete confirmatory testing to identify factors associated with refusal to complete the confirmation protocol. Principal Findings: Thirteen of 62 (21.0%, 95% CI (11.7%, 33.2%)) participants with reactive rapid HIV tests refused confirmation; women, younger participants, African Americans, and those with fewer HIV risks, with lower income, and without primary care doctors were more likely to refuse. We projected that up to four true HIV cases were lost at the confirmation stage. Conclusions: These findings underscore the need to better understand the factors associated with refusal to confirm reactive HIV testing and to identify interventions that will facilitate confirmatory testing and linkage to care among these populations.	[Ganguli, Ishani; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Collins, Jamie E.; Reichmann, William M.; Losina, Elena; Katz, Jeffrey N.; Donnell-Fink, Laurel A.] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Collins, Jamie E.; Reichmann, William M.; Losina, Elena] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA USA; [Losina, Elena; Katz, Jeffrey N.; Walensky, Rochelle P.] Harvard Univ, Sch Med, Boston, MA USA; [Losina, Elena; Walensky, Rochelle P.] Harvard Univ, Ctr AIDS Res, Boston, MA USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Arbelaez, Christian] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Harvard Medical School; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	rwalensky@partners.org		Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892	National Institute of Mental Health [R01 MH073445]; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073445] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the National Institute of Mental Health (http://www.nimh.nih.gov/) R01 MH073445 and The Doris Duke Charitable Foundation, Clinical Scientist Development Award (http://www.ddcf.org/mrp-csda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Morbidity and Mortality Weekly Report, V60, P689; [Anonymous], 2011, AIDS DRUG ASSISTANCE; [Anonymous], 2004, MMWR MORB MORTAL WKL; Aziz M, 2011, CLIN INFECT DIS, V52, pS231, DOI 10.1093/cid/ciq047; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson BM, 2006, 13TH CONFERENCE ON R; Brown J, 2008, PUBLIC HEALTH REP, V123, P21, DOI 10.1177/00333549081230S304; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Castel A, 2010, 17TH CONFERENCE ON R; Centers for Disease Control and Prevention, 2011, HIV AIDS GAY BIS MEN, P1; Centers for Disease Control and Prevention, 2010, EARLY RELEASE OF SEL; Christopoulos KA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-3; Clauss H, 2011, AIDS PATIENT CARE ST, V25, P207, DOI 10.1089/apc.2010.0196; Delaney K, 2011, 18TH CONFERENCE ON R; Donnell-Fink LA, 2012, PMC JOURNAL IN PROCE; Ehrenkranz PD, 2008, ACAD EMERG MED, V15, P144, DOI 10.1111/j.1553-2712.2008.00028.x; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Hutchinson AB, 2004, AIDS EDUC PREV, V16, P101, DOI 10.1521/aeap.16.2.101.29394; Liddicoat RV, 2006, AIDS PATIENT CARE ST, V20, P84, DOI 10.1089/apc.2006.20.84; Lyons MS, 2009, REPORT FROM THE 2007; Merchant RC, 2009, AM J EMERG MED, V27, P868, DOI 10.1016/j.ajem.2008.06.019; Merchant RC, 2009, AIDS CARE, V21, P490, DOI 10.1080/09540120802270284; Moore RD, 2011, CLIN INFECT DIS, V52, pS208, DOI 10.1093/cid/ciq044; Mugavero MJ, 2007, CLIN INFECT DIS, V45, P127, DOI 10.1086/518587; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Pai NP, 2012, HEAD TO HEAD COMPARI; Pisculli ML, 2011, AIDS BEHAV, V15, P734, DOI 10.1007/s10461-010-9837-2; Reichmann WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008728; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Samet JH, 2001, AIDS, V15, P77, DOI 10.1097/00002030-200101050-00012; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scott Victor F, 2009, Trans Am Clin Climatol Assoc, V120, P429; Ubhayakar ND, 2011, AM J EMERG MED, V29, P367, DOI 10.1016/j.ajem.2009.10.005; United States Census Bureau, POPULATION ESTIMATES; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; Walensky RP, 2011, ANN EMERG MED, V58, pS126, DOI 10.1016/j.annemergmed.2011.03.023; Walensky RP, 2008, 15TH CONFERENCE ON R; White DAE, 2009, AIDS PATIENT CARE ST, V23, P245, DOI 10.1089/apc.2008.0198; Wilson SR, 1999, AM J EMERG MED, V17, P354, DOI 10.1016/S0735-6757(99)90085-2	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53408	10.1371/journal.pone.0053408	http://dx.doi.org/10.1371/journal.pone.0053408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IY	23308216	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800048
J	Horakova, D; Zivadinov, R; Weinstock-Guttman, B; Havrdova, E; Qu, J; Tamano-Blanco, M; Badgett, D; Tyblova, M; Bergsland, N; Hussein, S; Willis, L; Krasensky, J; Vaneckova, M; Seidl, Z; Lelkova, P; Dwyer, MG; Zhang, M; Yu, HY; Duan, XT; Kalincik, T; Ramanathan, M				Horakova, Dana; Zivadinov, Robert; Weinstock-Guttman, Bianca; Havrdova, Eva; Qu, Jun; Tamano-Blanco, Miriam; Badgett, Darlene; Tyblova, Michaela; Bergsland, Niels; Hussein, Sara; Willis, Laura; Krasensky, Jan; Vaneckova, Manuela; Seidl, Zdenek; Lelkova, Petra; Dwyer, Michael G.; Zhang, Ming; Yu, Haoying; Duan, Xiaotao; Kalincik, Tomas; Ramanathan, Murali			Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; MULTIPLE-SCLEROSIS; BRAIN ATROPHY; RISK-FACTORS; SMOKING; CYTOMEGALOVIRUS; ANTIBODIES; INFECTION; DIAGNOSIS; AGE	Objectives: To investigate the associations of environmental MS risk factors with clinical and MRI measures of progression in high-risk clinically isolated syndromes (CIS) after the first demyelinating event. Methods: We analyzed 211 CIS patients (age: 28.9 +/- 7.8 years) enrolled in the SET study, a multi-center study of high-risk CIS patients. Pre-treatment samples were analyzed for IgG antibodies against cytomegalovirus (anti-CMV), Epstein Barr virus (EBV) early nuclear antigen-1 (EBNA-1), viral capsid antigen (VCA), early antigen-diffuse (EA-D), 25 hydroxy-vitamin D3 and cotinine levels and HLA DRB1*1501 status. The inclusion criteria required evaluation within 4 months of the initial demyelinating event, 2 or more brain MRI lesions and the presence of two or more oligoclonal bands in cerebrospinal fluid. All patients were treated with interferon-beta. Clinical and MRI assessments were obtained at baseline, 6, 12, and 24 months. Results: The time to first relapse decreased and the number of relapses increased with anti-CMV IgG positivity. Smoking was associated with increased number and volume of contrast-enhancing lesions (CEL) during the 2-year period. The cumulative number of CEL and T2 lesions during the 2-year period was greater for individuals in the highest quartile of anti-EBV VCA IgG antibodies. The percent loss of brain volume was increased for those in the highest quartile of with anti-EBV VCA IgG antibodies. Conclusions: Relapses in CIS patients were associated with CMV positivity whereas anti-EBV VCA positivity was associated with progression on MRI measures, including accumulation of CEL and T2 lesions and development of brain atrophy.	[Horakova, Dana; Havrdova, Eva; Tyblova, Michaela] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Horakova, Dana; Havrdova, Eva; Tyblova, Michaela] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Horakova, Dana; Havrdova, Eva; Tyblova, Michaela; Krasensky, Jan; Vaneckova, Manuela; Seidl, Zdenek; Lelkova, Petra] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic; [Zivadinov, Robert; Bergsland, Niels; Hussein, Sara; Willis, Laura; Dwyer, Michael G.; Ramanathan, Murali] SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Qu, Jun; Tamano-Blanco, Miriam; Badgett, Darlene; Zhang, Ming; Yu, Haoying; Duan, Xiaotao; Ramanathan, Murali] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Krasensky, Jan; Vaneckova, Manuela; Seidl, Zdenek] Charles Univ Prague, Fac Med 1, Dept Radiol, Prague, Czech Republic; [Lelkova, Petra] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague, Czech Republic; [Kalincik, Tomas] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne Brain Ctr, Melbourne, Vic 3010, Australia	Charles University Prague; Charles University Prague; Charles University Prague; General University Hospital Prague; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Charles University Prague; Charles University Prague; University of Melbourne	Ramanathan, M (corresponding author), SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA.	Murali@Buffalo.edu	Zivadinov, Robert/Q-2054-2019; Bergsland, Niels/H-3077-2019; Weinstock-Guttman, Bianca/AAI-4694-2021; Havrdova, Eva Kubala/P-4892-2017; Horakova, Dana/D-4649-2011; Horakova, Dana/O-3598-2017; Vaneckova, Manuela/M-1301-2017; Tyblova, Michaela/O-3170-2017	Zivadinov, Robert/0000-0002-7799-1485; Bergsland, Niels/0000-0002-7792-0433; Weinstock-Guttman, Bianca/0000-0001-6732-151X; Havrdova, Eva Kubala/0000-0002-9543-4359; Horakova, Dana/0000-0003-1915-0036; Vaneckova, Manuela/0000-0002-8784-7997; Tyblova, Michaela/0000-0002-9091-8629; Kalincik, Tomas/0000-0003-3778-1376; Duan, Xiaotao/0000-0001-9962-1234; Dwyer, Michael/0000-0003-4684-4658	Czech Ministries of Education and Health [NT13237-4/2012, MSM 0021620849, PRVOUK-P26/LF1/4, RVO-VFN64165/2012]; Biogen Idec Inc.; National Multiple Sclerosis Society [RG3743, RG4836]; Department of Defense Multiple Sclerosis Program [MS090122]; Pediatric MS Center of Excellence Center Grant; Biogen Idec; Novartis; Merck Serono; Teva; Bayer Schering; Teva Neurosciences; Questcor; Genzyme-Sanofi; Bracco; Bayer; EMD Serono; National Multiple Sclerosis Society; Department of Defense; Teva Neuroscience; Teva Pharmaceuticals; Greatbatch; National Institutes of Health; National Science Foundation; Cyberonics; Acorda; Jog for the Jake Foundation; Genzyme; Sanofi-Aventis; Roche; American Heart Association; Kinex; CH3; Pfizer; Abbott; Amgen; Allergan; Netezza; Monsanto the National Multiple Sclerosis Society	Czech Ministries of Education and Health; Biogen Idec Inc.(Biogen); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Department of Defense Multiple Sclerosis Program; Pediatric MS Center of Excellence Center Grant; Biogen Idec(Biogen); Novartis(Novartis); Merck Serono(Merck & Company); Teva(Teva Pharmaceutical Industries); Bayer Schering(Bayer AG); Teva Neurosciences(Teva Pharmaceutical Industries); Questcor; Genzyme-Sanofi(Sanofi-AventisGenzyme Corporation); Bracco; Bayer(Bayer AG); EMD Serono; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Department of Defense(United States Department of Defense); Teva Neuroscience(Teva Pharmaceutical Industries); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Greatbatch; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Cyberonics; Acorda; Jog for the Jake Foundation; Genzyme(Sanofi-AventisGenzyme Corporation); Sanofi-Aventis(Sanofi-Aventis); Roche(Roche Holding); American Heart Association(American Heart Association); Kinex; CH3; Pfizer(Pfizer); Abbott(Abbott Laboratories); Amgen(Amgen); Allergan(AbbVieAllergan); Netezza; Monsanto the National Multiple Sclerosis Society	Supported by Czech Ministries of Education and Health (NT13237-4/2012, MSM 0021620849, PRVOUK-P26/LF1/4, RVO-VFN64165/2012). The SET study is an investigator-initiated study supported by Biogen Idec Inc. Support from the National Multiple Sclerosis Society (RG3743 and RG4836), the Department of Defense Multiple Sclerosis Program (MS090122) and a Pediatric MS Center of Excellence Center Grant) is gratefully acknowledged. The funders had no role in data analysis, decision to publish, or preparation of the manuscript.; Dr. Dana Horakova received speaker honoraria and consultant fees from Biogen Idec, Novartis, Merck Serono, Teva and Bayer Schering and financial support for research activities from Biogen Idec. The SET study is an investigator-initiated study supported by Biogen Idec Inc. Dr. Zivadinov has received speaker honoraria and consultant fees from Teva Neurosciences, Biogen Idec, Questcor, Genzyme-Sanofi, Novartis, Bracco, Bayer and EMD Serono. He has received research support from the National Multiple Sclerosis Society, Department of Defense, Biogen Idec, Teva Neuroscience, Teva Pharmaceuticals, EMD Serono, Genzyme-Sanofi, Questcor, Bracco and Greatbatch. Dr. Weinstock-Guttman received honoraria for serving in advisory boards and educational programs from Teva Neuroscience, Biogen Idec, Novartis, Accorda EMD Serono, Pfizer, Novartis, Genzyme and Sanofi. She also received support for research activities from the National Institutes of Health, National Multiple Sclerosis Society, National Science Foundation, Department of Defense, EMD Serono, Biogen Idec, Teva Neuroscience, Cyberonics, Novartis, Acorda and the Jog for the Jake Foundation. Dr. Eva Havrdova received honoraria and consulting fees from Genzyme, Biogen Idec, Sanofi-Aventis, Merck Serono, Roche, Teva and Novartis for consulting services, speaking and serving on a scientific advisory boards. Dr. Jun Qu received research funding from the Department of Defense, the National Science Foundation, the National Institutes of Health, the American Heart Association, Kinex, CH3, Pfizer, Novartis, Abbott and Amgen. These are unrelated to the research presented in this report. Drs. Michaela Tyblova, Jan Krasensky, Manuela Vaneckova, and Zdenek Seidl have received financial support for research activities from Biogen Idec. Dr. Petra Lelkova has no conflicts to disclose. Dr. Tomas Kalincik received compensation for travel and honoraria from Novartis, Biogen Idec, Sanofi Aventis, Teva and Merck Serono. Dr. Murali Ramanathan received research funding or consulting fees from EMD Serono, Biogen Idec, Allergan, Netezza, Pfizer, Novartis, Monsanto the National Multiple Sclerosis Society, the Department of Defense, Jog for the Jake Foundation, the National Institutes of Health and National Science Foundation. He received compensation for serving as an Editor from the American Association of Pharmaceutical Scientists. These are unrelated to the research presented in this report. Miriam Tamano-Blanco, Darlene Badgett, Niels Bergsland, Sara Hussein, Laura Willis, Michael G. Dwyer, Haoying Yu, Ming Zhang and Xiaotao Duan have no conflicts to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aalto SM, 1998, J MED VIROL, V56, P186, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;186::AID-JMV2&gt;3.0.CO;2-3; [Anonymous], 2010, CONS REP DIET REF IN; Arcenas RC, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-20; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Celius EG, 2000, J NEUROL SCI, V178, P132, DOI 10.1016/S0022-510X(00)00389-0; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Di Pauli F, 2008, MULT SCLER J, V14, P1026, DOI 10.1177/1352458508093679; Duan XT, 2010, ANAL CHEM, V82, P2488, DOI 10.1021/ac902869y; Hensiek AE, 2002, J NEUROL NEUROSUR PS, V72, P184, DOI 10.1136/jnnp.72.2.184; Hernan MA, 2005, BRAIN, V128, P1461, DOI 10.1093/brain/awh471; Ingram G, 2010, EUR J NEUROL, V17, P1386, DOI 10.1111/j.1468-1331.2010.03083.x; Knoblach T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002016; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Okuda DT, 2009, BRAIN, V132, P250, DOI 10.1093/brain/awn301; Pekmezovic T, 2006, NEUROEPIDEMIOLOGY, V27, P212, DOI 10.1159/000096853; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Runia TF, 2012, NEUROLOGY; Saghafian-Hedengren S, 2009, J IMMUNOL, V182, P2511, DOI 10.4049/jimmunol.0801699; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Simon KC, 2010, NEUROLOGY, V74, P1365, DOI 10.1212/WNL.0b013e3181dad57e; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Singh N, 2005, CLIN INFECT DIS, V40, P430, DOI 10.1086/427214; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Stewart N, 2012, NEUROLOGY; Sundstrom P, 2008, EUR J NEUROL, V15, P579, DOI 10.1111/j.1468-1331.2008.02122.x; Vineis P, 2005, BRIT MED J, V330, P277, DOI 10.1136/bmj.38327.648472.82; Weatherby SJM, 2001, J NEUROL, V248, P304, DOI 10.1007/s004150170205; Weinshenker BG, 1998, NEUROLOGY, V51, P742, DOI 10.1212/WNL.51.3.742; Weinstock-Guttman B, 2011, J NEUROL SCI, V311, P86, DOI 10.1016/j.jns.2011.07.024; Weinstock-Guttman B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016802; Zivadinov R, 2009, NEUROLOGY, V73, P504, DOI 10.1212/WNL.0b013e3181b2a706; Zivadinov R, 2009, J NEUROL NEUROSUR PS, V80, P620, DOI 10.1136/jnnp.2008.154906; Zivadinov R, 2001, NEUROLOGY, V57, P1239, DOI 10.1212/WNL.57.7.1239; Zivadinov R, 2012, NEUROIMAGE, V59, P331, DOI 10.1016/j.neuroimage.2011.07.045; Zivadinov R, 2009, J NEUROIMMUNOL, V209, P123, DOI 10.1016/j.jneuroim.2009.01.023	37	60	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53996	10.1371/journal.pone.0053996	http://dx.doi.org/10.1371/journal.pone.0053996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320113	Green Published, gold			2022-12-27	WOS:000313429800079
J	Palstra, AP; Beltran, S; Burgerhout, E; Brittijn, SA; Magnoni, LJ; Henkel, CV; Jansen, HJ; van den Thillart, GEEJM; Spaink, HP; Planas, JV				Palstra, Arjan P.; Beltran, Sergi; Burgerhout, Erik; Brittijn, Sebastiaan A.; Magnoni, Leonardo J.; Henkel, Christiaan V.; Jansen, Hans J.; van den Thillart, Guido E. E. J. M.; Spaink, Herman P.; Planas, Josep V.			Deep RNA Sequencing of the Skeletal Muscle Transcriptome in Swimming Fish	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; GROWTH-HORMONE; LUTEINIZING-HORMONE; PROFILING ANALYSIS; ANDROGEN RECEPTOR; IN-VITRO; EXPRESSION; DIFFERENTIATION; PATHWAY	Deep RNA sequencing (RNA-seq) was performed to provide an in-depth view of the transcriptome of red and white skeletal muscle of exercised and non-exercised rainbow trout (Oncorhynchus mykiss) with the specific objective to identify expressed genes and quantify the transcriptomic effects of swimming-induced exercise. Pubertal autumn-spawning seawater-raised female rainbow trout were rested (n = 10) or swum (n = 10) for 1176 km at 0.75 body-lengths per second in a 6,000-L swim-flume under reproductive conditions for 40 days. Red and white muscle RNA of exercised and non-exercised fish (4 lanes) was sequenced and resulted in 15-17 million reads per lane that, after de novo assembly, yielded 149,159 red and 118,572 white muscle contigs. Most contigs were annotated using an iterative homology search strategy against salmonid ESTs, the zebrafish Danio rerio genome and general Metazoan genes. When selecting for large contigs (>500 nucleotides), a number of novel rainbow trout gene sequences were identified in this study: 1,085 and 1,228 novel gene sequences for red and white muscle, respectively, which included a number of important molecules for skeletal muscle function. Transcriptomic analysis revealed that sustained swimming increased transcriptional activity in skeletal muscle and specifically an up-regulation of genes involved in muscle growth and developmental processes in white muscle. The unique collection of transcripts will contribute to our understanding of red and white muscle physiology, specifically during the long-term reproductive migration of salmonids.	[Palstra, Arjan P.; Magnoni, Leonardo J.; Planas, Josep V.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; [Palstra, Arjan P.; Magnoni, Leonardo J.; Planas, Josep V.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Beltran, Sergi] Univ Barcelona, Ctr Cient & Tecnol CCiT UB, Unitat Bioinformat, Barcelona, Spain; [Burgerhout, Erik; Brittijn, Sebastiaan A.; van den Thillart, Guido E. E. J. M.; Spaink, Herman P.] Leiden Univ IBL, Inst Biol, Sylvius Lab, Leiden, Netherlands; [Burgerhout, Erik; Brittijn, Sebastiaan A.; Henkel, Christiaan V.; Jansen, Hans J.; van den Thillart, Guido E. E. J. M.; Spaink, Herman P.] ZF Screens, Leiden, Netherlands	University of Barcelona; University of Barcelona; University of Barcelona; Leiden University; Leiden University - Excl LUMC	Palstra, AP (corresponding author), Wageningen UR, Inst Marine Resources & Ecosyst Studies IMARES, Yerseke, Netherlands.	arjan.palstra@wur.nl	Beltran, Sergi/I-3408-2015; Spaink, Herman P./S-3586-2017; Magnoni, Leonardo Julián/A-6275-2011; Burgerhout, Erik/AAI-4527-2020	Beltran, Sergi/0000-0002-2810-3445; Spaink, Herman P./0000-0003-4128-9501; Magnoni, Leonardo Julián/0000-0001-8449-6071; Jansen, Hans/0000-0002-8563-4146; Henkel, Christiaan/0000-0001-9838-8215; Planas, Josep/0000-0002-6525-9617	Ministerio de Ciencia e Innovacion, Spain [AGL2009-07006, CSD2007-0002]; European Commission (REPRO-SWIM) [219971]; European Commission (Glucose Use In Fish) [235581]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission (REPRO-SWIM)(European CommissionEuropean Commission Joint Research Centre); European Commission (Glucose Use In Fish)	This study was supported by grants from the Ministerio de Ciencia e Innovacion, Spain (AGL2009-07006 and CSD2007-0002) to JVP. APP was supported by a Marie Curie Intra-European Fellowship from the European Commission (REPRO-SWIM) with Grant Agreement number 219971. LJM was supported by a Marie Curie International Incoming Fellowship from the European Commission (Glucose Use In Fish) with Grant Agreement number 235581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Bluthgen Nils, 2005, Genome Inform, V16, P106; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; CHEN XR, 1995, J BIOL CHEM, V270, P18285, DOI 10.1074/jbc.270.31.18285; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conte C, 2009, NUCLEIC ACIDS RES, V37, P5267, DOI 10.1093/nar/gkp550; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; Filby AL, 2008, BIOL REPROD, V78, P278, DOI 10.1095/biolreprod.107.063420; Gottsch ML, 2006, MOL CELL ENDOCRINOL, V254, P91, DOI 10.1016/j.mce.2006.04.030; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x; Gutierrez-Pascual E, 2007, J NEUROENDOCRINOL, V19, P521, DOI 10.1111/j.1365-2826.2007.01558.x; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hopitzan AA, 2006, MOL BIOL EVOL, V23, P46, DOI 10.1093/molbev/msj004; Hunt LC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-17; Ibrahim RM, 2008, J ANIM SCI, V86, P1426, DOI 10.2527/jas.2007-0618; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Klover P, 2009, FASEB J, V23, P3140, DOI 10.1096/fj.08-128215; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Lin J, 2009, INT J BIOCHEM CELL B, V41, P1613, DOI 10.1016/j.biocel.2009.02.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnoni LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031219; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901; Mommsen Thomas W., 2001, Fish Physiology, V18, P251; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; NAGAHAMA Y, 1994, INT J DEV BIOL, V38, P217; Namiki M, 1997, J BIOL CHEM, V272, P22046, DOI 10.1074/jbc.272.35.22046; Norbeck LA, 2011, GEN COMP ENDOCR, V173, P270, DOI 10.1016/j.ygcen.2011.06.009; Ordas A, 2011, FISH SHELLFISH IMMUN, V31, P716, DOI 10.1016/j.fsi.2010.08.022; Palstra AP, 2011, FISH PHYSIOL BIOCHEM, V37, P259, DOI 10.1007/s10695-011-9505-0; Palstra AP, 2010, AM J PHYSIOL-REG I, V299, pR486, DOI 10.1152/ajpregu.00109.2010; Palstra AP, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-27; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Planas JV, 2000, BIOL REPROD, V62, P1262, DOI 10.1095/biolreprod62.5.1262; Salem M, 2006, PHYSIOL GENOMICS, V28, P33, DOI 10.1152/physiolgenomics.00114.2006; Salem M, 2006, COMP BIOCHEM PHYS D, V1, P227, DOI 10.1016/j.cbd.2005.12.003; Siriett V, 2006, J CELL PHYSIOL, V206, P255, DOI 10.1002/jcp.20456; Ting HJ, 2002, P NATL ACAD SCI USA, V99, P661, DOI 10.1073/pnas.022469899; TYLER CR, 1991, GEN COMP ENDOCR, V84, P291, DOI 10.1016/0016-6480(91)90052-8; Ueda H, 2011, GEN COMP ENDOCR, V170, P222, DOI 10.1016/j.ygcen.2010.02.003; van Aerle R, 2008, PEPTIDES, V29, P57, DOI 10.1016/j.peptides.2007.10.018; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Videler JJ, 1993, FISH SWIMMING, P254; Vraskou Y, 2011, AM J PHYSIOL-REG I, V300, pR716, DOI 10.1152/ajpregu.00514.2010; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Wang LL, 2010, STEROIDS, V75, P368, DOI 10.1016/j.steroids.2010.01.021; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; YAMAGUCHI A, 1995, SEMIN CELL BIOL, V6, P165, DOI 10.1006/scel.1995.0023	60	49	50	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53171	10.1371/journal.pone.0053171	http://dx.doi.org/10.1371/journal.pone.0053171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308156	Green Published, gold			2022-12-27	WOS:000313429800031
J	Veerasamy, M; Phanish, M; Dockrell, MEC				Veerasamy, Mangalakumar; Phanish, Mysore; Dockrell, Mark E. C.			Smad Mediated Regulation of Inhibitor of DNA Binding 2 and Its Role in Phenotypic Maintenance of Human Renal Proximal Tubule Epithelial Cells	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; LOOP-HELIX PROTEINS; TRANSCRIPTION FACTORS; E-CADHERIN; IN-VITRO; FIBROSIS; EXPRESSION; GROWTH; BMP-7; FIBROBLASTS	The basic-Helix-Loop-Helix family (bHLH) of transcriptional factors plays a major role in regulating cellular proliferation, differentiation and phenotype maintenance. The downregulation of one of the members of bHLH family protein, inhibitor of DNA binding 2 (Id2) has been shown to induce de-differentiation of epithelial cells. Opposing regulators of epithelial/mesenchymal phenotype in renal proximal tubule epithelial cells (PTEC), TGF beta 1 and BMP7 also have counter-regulatory effects in models of renal fibrosis. We investigated the regulation of Id2 by these growth factors in human PTECs and its implication in the expression of markers of epithelial versus myofibroblastic phenotype. Cellular Id2 levels were reduced by TGF beta 1 treatment; this was prevented by co-incubation with BMP7. BMP7 alone increased cellular levels of Id2. TGF beta 1 and BMP7 regulated Id2 through Smad2/3 and Smad1/5 dependent mechanisms respectively. TGF beta 1 mediated Id2 suppression was essential for alpha-SMA induction in PTECs. Although Id2 over-expression prevented alpha-SMA induction, it did not prevent E-cadherin loss under the influence of TGF beta 1. This suggests that the loss of gate keeper function of E-cadherin alone may not necessarily result in complete EMT and further transcriptional re-programming is essential to attain mesenchymal phenotype. Although BMP7 abolished TGF beta 1 mediated alpha-SMA expression by restoring Id2 levels, the loss of Id2 was not sufficient to induce alpha-SMA expression even in the context of reduced E-cadherin expression. Hence, a reduction in Id2 is critical for TGF beta 1-induced alpha-SMA expression in this model of human PTECs but is not sufficient in it self to induce alpha-SMA even in the context of reduced E-cadherin.	[Veerasamy, Mangalakumar; Phanish, Mysore; Dockrell, Mark E. C.] St Helier Univ Hosp NHS Trust, S W Thames Inst Renal Res, Carshalton, Surrey, England		Veerasamy, M (corresponding author), St Helier Univ Hosp NHS Trust, S W Thames Inst Renal Res, Carshalton, Surrey, England.	vmangalakumar1@hotmail.com		phanish, mysore/0000-0001-8402-8286; Dockrell, Mark/0000-0003-3771-4464	Southwest Thames Kidney Fund; Genzyme Renal Innovations Program (GRIP)	Southwest Thames Kidney Fund; Genzyme Renal Innovations Program (GRIP)(Sanofi-AventisGenzyme Corporation)	This study was supported by grants from Southwest Thames Kidney Fund and the Genzyme Renal Innovations Program (GRIP). The funders had no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Cao Y, 2009, ONCOGENE, V28, P1089, DOI 10.1038/onc.2008.456; Duband JL, 1995, ACTA ANAT, V154, P63; Dudas PL, 2009, NEPHROL DIAL TRANSPL, V24, P1406, DOI 10.1093/ndt/gfn662; FESTING MFW, 1994, LAB ANIM, V28, P212, DOI 10.1258/002367794780681697; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Humphreys BD, AM J PATHOL, V176, P85; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jorda M, 2007, EXP CELL RES, V313, P2389, DOI 10.1016/j.yexcr.2007.04.001; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kinoshita K, 2007, GUT, V56, P706, DOI 10.1136/gut.2006.092460; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Li YJ, 2003, J CLIN INVEST, V112, P503, DOI 10.1172/JCI200317913; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Motazed R, 2008, PHARM RES-DORDR, V25, P2440, DOI 10.1007/s11095-008-9551-1; Niculescu-Duvaz I, 2007, NEPHRON EXP NEPHROL, V105, pE108, DOI 10.1159/000100492; Nigten J, 2005, LEUKEMIA, V19, P799, DOI 10.1038/sj.leu.2403699; Norton JD, 2000, J CELL SCI, V113, P3897; Parrinello S, 2001, J BIOL CHEM, V276, P39213, DOI 10.1074/jbc.M104473200; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Phanish MK, 2005, NEPHRON EXP NEPHROL, V100, pE156, DOI 10.1159/000085445; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Saika S, 2006, AM J PHYSIOL-CELL PH, V290, pC282, DOI 10.1152/ajpcell.00306.2005; SANDERS EJ, 1989, J CELL SCI, V92, P497; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Veerasamy M, 2009, AM J PHYSIOL-RENAL, V297, pF1238, DOI 10.1152/ajprenal.90539.2008; Vongwiwatana A, 2005, AM J TRANSPLANT, V5, P1367, DOI 10.1111/j.1600-6143.2005.00843.x; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; Wang SN, 2006, J AM SOC NEPHROL, V17, P2504, DOI 10.1681/ASN.2006030278; Wang SN, 2003, AM J PHYSIOL-RENAL, V284, pF1006, DOI 10.1152/ajprenal.00382.2002; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	45	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e51842	10.1371/journal.pone.0051842	http://dx.doi.org/10.1371/journal.pone.0051842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320068	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800010
J	Wheway, J; Obeid, S; Couraud, PO; Combes, V; Grau, GER				Wheway, Julie; Obeid, Stephanie; Couraud, Pierre-Olivier; Combes, Valery; Grau, Georges E. R.			The Brain Microvascular Endothelium Supports T Cell Proliferation and Has Potential for Alloantigen Presentation	PLOS ONE			English	Article							ANTIGEN PRESENTATION; CEREBRAL MALARIA; DENDRITIC CELLS; IN-VITRO; EXPRESSION; PATHOGENESIS; STIMULATION; ACTIVATION; INDUCTION; MOLECULES	Endothelial cells (EC) form the inner lining of blood vessels and are positioned between circulating lymphocytes and tissues. Hypotheses have formed that EC may act as antigen presenting cells based on the intimate interactions with T cells, which are seen in diseases like multiple sclerosis, cerebral malaria (CM) and viral neuropathologies. Here, we investigated how human brain microvascular EC (HBEC) interact with and support the proliferation of T cells. We found HBEC to express MHC II, CD40 and ICOSL, key molecules for antigen presentation and co-stimulation and to take up fluorescently labeled antigens via macropinocytosis. In co-cultures, we showed that HBEC support and promote the proliferation of CD4(+) and CD8(+) T cells, which both are key in CM pathogenesis, particularly following T cell receptor activation and co-stimulation. Our findings provide novel evidence that HBEC can trigger T cell activation, thereby providing a novel mechanism for neuroimmunological complications of infectious diseases.	[Wheway, Julie; Obeid, Stephanie; Combes, Valery; Grau, Georges E. R.] Univ Sydney, Sydney Med Sch, Discipline Pathol, Camperdown, NSW, Australia; [Couraud, Pierre-Olivier] Inst Cochin, Inst Natl Sante & Rech Med, U1016, Paris, France; [Couraud, Pierre-Olivier] CNRS, Unite Mixte Rech 8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Paris, France	University of Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Wheway, J (corresponding author), Univ Sydney, Sydney Med Sch, Discipline Pathol, Camperdown, NSW, Australia.	julie.wheway@sydney.edu.au	Grau, Georges/AGR-7139-2022	Grau, Georges/0000-0002-0442-0462; Combes, Valery/0000-0003-2178-3596	National Health and Medical Research Council of Australia [1009914, 571014, 1028241, 1022368, 571397]; Rebecca L. Cooper Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Foundation	The study was funded by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) project grants 1009914 and 571014 to VC and GEG; 1028241 to JW, VC and GEG; and 1022368 to GEG; fellowship 571397 to JW. Support was also provided through Rebecca L. Cooper Foundation equipment grants (http://www.cooperfoundation.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2009, AM J PATHOL, V175, P685, DOI 10.2353/ajpath.2009.081073; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Biedermann BC, 1999, J IMMUNOL, V162, P7022; BOURDOULOUS S, 1995, EUR J IMMUNOL, V25, P1176, DOI 10.1002/eji.1830250507; BURGER DR, 1981, HUM IMMUNOL, V3, P209, DOI 10.1016/0198-8859(81)90019-7; CHIZZOLINI C, 1990, CLIN EXP IMMUNOL, V79, P95, DOI 10.1111/j.1365-2249.1990.tb05133.x; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; Coureuil M, 2010, CELL, V143, P1149, DOI 10.1016/j.cell.2010.11.035; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; GRAU GE, 1986, J IMMUNOL, V137, P2348; HAUSS P, 1995, EUR J IMMUNOL, V25, P2285, DOI 10.1002/eji.1830250826; Hirayasu K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002565; HIRSCHBERG H, 1981, SCAND J IMMUNOL, V14, P545; HIRSCHBERG H, 1981, HUM IMMUNOL, V2, P235, DOI 10.1016/0198-8859(81)90015-X; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Jambou R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001021; Khayyamian S, 2002, P NATL ACAD SCI USA, V99, P6198, DOI 10.1073/pnas.092576699; Klingenberg R, 2005, EUR J IMMUNOL, V35, P1712, DOI 10.1002/eji.200425727; Knolle PA, 1998, CLIN EXP IMMUNOL, V114, P427; Lichtman A., 2007, ENDOTHELIAL BIOMEDIC, P1098; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Lohse AW, 1996, GASTROENTEROLOGY, V110, P1175, DOI 10.1053/gast.1996.v110.pm8613007; Lou J, 1996, EUR J IMMUNOL, V26, P3107, DOI 10.1002/eji.1830261242; Lou JN, 1997, AM J PATHOL, V151, P1397; MALE D, 1989, J NEUROIMMUNOL, V21, P87, DOI 10.1016/0165-5728(89)90163-X; MALE DK, 1987, IMMUNOLOGY, V60, P453; Manes TD, 2008, J IMMUNOL, V180, P8386, DOI 10.4049/jimmunol.180.12.8386; MonsoHinard C, 1997, IMMUNOLOGY, V92, P53, DOI 10.1046/j.1365-2567.1997.00297.x; MURRAY AG, 1995, J IMMUNOL, V154, P151; Omari KM, 2003, J NEUROIMMUNOL, V134, P166, DOI 10.1016/S0165-5728(02)00423-X; Perez VL, 1998, CELL IMMUNOL, V189, P31, DOI 10.1006/cimm.1998.1362; Pober JS, 1999, IMMUNOL RES, V19, P225, DOI 10.1007/BF02786490; POBER JS, 1982, P NATL ACAD SCI-BIOL, V79, P6641, DOI 10.1073/pnas.79.21.6641; REYNOLDS DJ, 1990, INFECT IMMUN, V58, P3208, DOI 10.1128/IAI.58.10.3208-3216.1990; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; TURNER RR, 1987, AM J CLIN PATHOL, V87, P569, DOI 10.1093/ajcp/87.5.569; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang XS, 2007, J INTERF CYTOK RES, V27, P329, DOI 10.1089/jir.2006.0154; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	46	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52586	10.1371/journal.pone.0052586	http://dx.doi.org/10.1371/journal.pone.0052586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320074	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800016
J	Yoneda, T; Kameyama, K; Esumi, K; Daimyo, Y; Watanabe, M; Hata, Y				Yoneda, Taisuke; Kameyama, Katsuro; Esumi, Kazusa; Daimyo, Yohei; Watanabe, Masahiko; Hata, Yoshio			Developmental and Visual Input-Dependent Regulation of the CB1 Cannabinoid Receptor in the Mouse Visual Cortex	PLOS ONE			English	Article							RAT BARREL CORTEX; CRITICAL-PERIOD; SYNAPTIC-TRANSMISSION; GABAERGIC TRANSMISSION; MONOCULAR DEPRIVATION; SOMATOSENSORY CORTEX; CORTICAL CIRCUITS; OCULAR DOMINANCE; DIFFERENT LAYERS; YOUNG MICE	The mammalian visual system exhibits significant experience-induced plasticity in the early postnatal period. While physiological studies have revealed the contribution of the CB1 cannabinoid receptor (CB1) to developmental plasticity in the primary visual cortex (V1), it remains unknown whether the expression and localization of CB1 is regulated during development or by visual experience. To explore a possible role of the endocannabinoid system in visual cortical plasticity, we examined the expression of CB1 in the visual cortex of mice. We found intense CB1 immunoreactivity in layers II/III and VI. CB1 mainly localized at vesicular GABA transporter-positive inhibitory nerve terminals. The amount of CB1 protein increased throughout development, and the specific laminar pattern of CB1 appeared at P20 and remained until adulthood. Dark rearing from birth to P30 decreased the amount of CB1 protein in V1 and altered the synaptic localization of CB1 in the deep layer. Dark rearing until P50, however, did not influence the expression of CB1. Brief monocular deprivation for 2 days upregulated the localization of CB1 at inhibitory nerve terminals in the deep layer. Taken together, the expression and the localization of CB1 are developmentally regulated, and both parameters are influenced by visual experience.	[Yoneda, Taisuke; Kameyama, Katsuro; Esumi, Kazusa; Hata, Yoshio] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Integrat Biosci, Yonago, Tottori, Japan; [Daimyo, Yohei; Hata, Yoshio] Tottori Univ, Fac Med, Sch Life Sci, Div Neurobiol, Yonago, Tottori 683, Japan; [Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan	Tottori University; Tottori University; Hokkaido University	Hata, Y (corresponding author), Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Integrat Biosci, Yonago, Tottori, Japan.	yhata@med.tottori-u.ac.jp	WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138	Ministry of Education, Culture, Sports, Science and Technology of Japan [22115010];  [10J06736]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas - Mesoscopic Neurocircuitry - from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22115010 to YH) and a Grant-in-Aid for JSPS Research Fellows (10J06736 to TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Chaves GP, 2008, J NEUROSCI RES, V86, P1626, DOI 10.1002/jnr.21613; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; Dahlhaus M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005413; Dasilva MA, 2012, PSYCHOPHARMACOLOGY, V219, P835, DOI 10.1007/s00213-011-2412-3; Deshmukh S, 2007, NEUROSCIENCE, V145, P279, DOI 10.1016/j.neuroscience.2006.11.033; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; FOX K, 1992, J NEUROSCI, V12, P1826; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hill EL, 2007, J NEUROPHYSIOL, V97, P2580, DOI 10.1152/jn.00603.2006; Huang Y, 2008, J NEUROSCI, V28, P7074, DOI 10.1523/JNEUROSCI.0899-08.2008; Jiang B, 2010, J NEUROSCI, V30, P14261, DOI 10.1523/JNEUROSCI.2979-10.2010; Jiang B, 2010, NEURON, V66, P248, DOI 10.1016/j.neuron.2010.03.021; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 1999, J NEUROSCI, V19, P4544; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Liu CH, 2008, NEURON, V58, P340, DOI 10.1016/j.neuron.2008.02.020; Lyckman AW, 2008, P NATL ACAD SCI USA, V105, P9409, DOI 10.1073/pnas.0710172105; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; OLSON CR, 1980, EXP BRAIN RES, V39, P17; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	35	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53082	10.1371/journal.pone.0053082	http://dx.doi.org/10.1371/journal.pone.0053082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308141	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800028
J	Birbach, A				Birbach, Andreas			Use of PB-Cre4 Mice for Mosaic Gene Deletion	PLOS ONE			English	Article							METASTATIC PROSTATE-CANCER; MOUSE PROSTATE; TRANSGENIC ANIMALS; SMOOTH-MUSCLE; MODEL; LEADS; PTEN; EXPRESSION; RECOMBINATION; INACTIVATION	Transgene expression from short promoters in transgenic animals can lead to unwanted transgene expression patterns, often as a byproduct of random integration of the expression cassette into the host genome. Here I demonstrate that the often used PB-Cre4 line (also referred to as "Probasin-Cre''), although expressing exclusively in the male prostate epithelium when transmitted through male mice, can lead to recombination of loxP-flanked alleles in a large variety of tissues when transmitted through female mice. This aberrant Cre activity due to Cre expression in the oocytes leads to different outcomes for maternally or paternally transmitted loxP-flanked alleles: Maternally inherited loxP-flanked alleles undergo recombination very efficiently, making female PB-Cre4 mice an efficient monoallelic "Cre deleter line''. However, paternally inherited loxP-flanked alleles are inefficiently recombined by maternal PB-Cre4, giving rise to mosaic expression patterns in the offspring. This mosaic recombination is difficult to detect with standard genotyping approaches of many mouse lines and should therefore caution researchers using PB-Cre4 to use additional approaches to exclude the presence of recombined alleles. However, mosaic recombination should also be useful in transgenic "knockout'' approaches for mosaic gene deletion experiments.	Med Univ Vienna, Dept Vasc Biol, Ctr Physiol & Pharmacol, Vienna, Austria	Medical University of Vienna	Birbach, A (corresponding author), Med Univ Vienna, Dept Vasc Biol, Ctr Physiol & Pharmacol, Vienna, Austria.	andreas.birbach@gmail.com			Austrian Science Fund FWF [P21919-B13]; Austrian Science Fund (FWF) [P 21919] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by a grant from the Austrian Science Fund FWF (project # P21919-B13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birbach A, 2011, NEOPLASIA, V13, P692, DOI 10.1593/neo.11524; Birbach A, 2009, GENESIS, V47, P757, DOI 10.1002/dvg.20558; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Francis JC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000995; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Houdebine LM, 2002, J BIOTECHNOL, V98, P145, DOI 10.1016/S0168-1656(02)00129-3; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kelavkar UP, 2006, NEOPLASIA, V8, P510, DOI 10.1593/neo.06202; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maddison LA, 2004, CANCER RES, V64, P6018, DOI 10.1158/0008-5472.CAN-03-2509; Pearson HB, 2009, CANCER RES, V69, P94, DOI 10.1158/0008-5472.CAN-08-2895; Ratnacaram CK, 2008, P NATL ACAD SCI USA, V105, P2521, DOI 10.1073/pnas.0712021105; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XY, 2011, DEV BIOL, V356, P337, DOI 10.1016/j.ydbio.2011.05.659; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	20	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53501	10.1371/journal.pone.0053501	http://dx.doi.org/10.1371/journal.pone.0053501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308238	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100076
J	den Reijer, PM; Lemmens-den Toom, N; Kant, S; Snijders, SV; Boelens, H; Tavakol, M; Verkaik, NJ; van Belkum, A; Verbrugh, HA; van Wamel, WJB				den Reijer, Paul Martijn; Lemmens-den Toom, Nicole; Kant, Samantha; Snijders, Susan V.; Boelens, Helene; Tavakol, Mehri; Verkaik, Nelianne J.; van Belkum, Alex; Verbrugh, Henri A.; van Wamel, Willem J. B.			Characterization of the Humoral Immune Response during Staphylococcus aureus Bacteremia and Global Gene Expression by Staphylococcus aureus in Human Blood	PLOS ONE			English	Article							GAMMA-HEMOLYSIN; METHICILLIN RESISTANCE; ANTIBODY-RESPONSES; STREAM INFECTIONS; RISK-FACTORS; ENDOCARDITIS; LEUKOCIDIN; PROTEIN; SUPERANTIGENS; HETEROGENEITY	Attempts to develop an efficient anti-staphylococcal vaccine in humans have so far been unsuccessful. Therefore, more knowledge of the antigens that are expressed by Staphylococcus aureus in human blood and induce an immune response in patients is required. In this study we further characterize the serial levels of IgG and IgA antibodies against 56 staphylococcal antigens in multiple serum samples of 21 patients with a S. aureus bacteremia, compare peak IgG levels between patients and 30 non-infected controls, and analyze the expression of 3626 genes by two genetically distinct isolates in human blood. The serum antibody levels were measured using a bead-based flow cytometry technique (xMAPH (R), Luminex corporation). Gene expression levels were analyzed using a microarray (B mu G@s microarray). The initial levels and time taken to reach peak IgG and IgA antibody levels were heterogeneous in bacteremia patients. The antigen SA0688 was associated with the highest median initial-to-peak antibody fold-increase for IgG (5.05-fold) and the second highest increase for IgA (2.07-fold). Peak IgG levels against 27 antigens, including the antigen SA0688, were significantly elevated in bacteremia patients versus controls (P <= 0.05). Expression of diverse genes, including SA0688, was ubiquitously high in both isolates at all time points during incubation in blood. However, only a limited number of genes were specifically up-or downregulated in both isolates when cultured in blood, compared to the start of incubation in blood or during incubation in BHI broth. In conclusion, most staphylococcal antigens tested in this study, including many known virulence factors, do not induce uniform increases in the antibody levels in bacteremia patients. In addition, the expression of these antigens by S. aureus is not significantly altered by incubation in human blood over time. One immunogenic and ubiquitously expressed antigen is the putative iron-regulated ABC transporter SA0688.	[den Reijer, Paul Martijn; Lemmens-den Toom, Nicole; Kant, Samantha; Snijders, Susan V.; Boelens, Helene; Tavakol, Mehri; Verkaik, Nelianne J.; van Belkum, Alex; Verbrugh, Henri A.; van Wamel, Willem J. B.] Erasmus Univ, Med Ctr Rotterdam, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	den Reijer, PM (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	p.denreijer@erasmusmc.nl		van Wamel, Willem/0000-0001-9145-9121; Verkaik, Nelianne/0000-0003-2351-2669	department of Medical Microbiology and Infectious Diseases of the Erasmus University Medical Center Rotterdam	department of Medical Microbiology and Infectious Diseases of the Erasmus University Medical Center Rotterdam	The work presented in this paper has been funded internally by the department of Medical Microbiology and Infectious Diseases of the Erasmus University Medical Center Rotterdam. No external funds were acquired for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brady RA, 2011, INFECT IMMUN, V79, P1797, DOI 10.1128/IAI.00451-10; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; Chung MC, 2007, MOL MICROBIOL, V66, P1342, DOI 10.1111/j.1365-2958.2007.05989.x; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; El-Ahdab F, 2005, AM J MED, V118, P225, DOI 10.1016/j.amjmed.2004.12.017; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Gouaux E, 1997, PROTEIN SCI, V6, P2631; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holtfreter S, 2006, J INFECT DIS, V193, P1275, DOI 10.1086/503048; Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002; Jacobsson G, 2010, EUR J CLIN MICROBIOL, V29, P715, DOI 10.1007/s10096-010-0919-x; KAMIO Y, 1993, FEBS LETT, V321, P15, DOI 10.1016/0014-5793(93)80611-W; Kolata J, PROTEOMICS, V11, P3914; Koning S, 2003, J CLIN MICROBIOL, V41, P3017, DOI 10.1128/JCM.41.7.3017-3021.2003; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; LAUTENSCHLAGER S, 1993, CLIN INFECT DIS, V16, P567, DOI 10.1093/clind/16.4.567; Malachowa N, PLOS ONE, V6; Martins TB, 2006, J IMMUNOL METHODS, V316, P97, DOI 10.1016/j.jim.2006.08.007; Otto M, 2010, EXPERT OPIN BIOL TH, V10, P1049, DOI 10.1517/14712598.2010.495115; Piddock LJ, LANCET INFECT DIS; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; Prat C, 2006, J IMMUNOL, V177, P8017, DOI 10.4049/jimmunol.177.11.8017; Prat C, 2009, J IMMUNOL, V183, P6569, DOI 10.4049/jimmunol.0801523; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Proctor R, VACCINE; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Sakoulas G, 2008, CLIN INFECT DIS, V46, pS360, DOI 10.1086/533592; Shannon O, 2005, THROMB HAEMOSTASIS, V93, P927, DOI 10.1160/TH04-08-0501; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Spellberg B, SEMIN IMMUNOPATHOL; Thomas D, 2009, INFECT IMMUN, V77, P2043, DOI 10.1128/IAI.01388-08; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; Verkaik NJ, 2010, EUR J CLIN MICROBIOL, V29, P509, DOI 10.1007/s10096-010-0888-0; Verkaik N, 2008, J IMMUNOL METHODS, V335, P121, DOI 10.1016/j.jim.2008.02.022; Verkaik NJ, 2010, CLIN INFECT DIS, V50, P61, DOI 10.1086/648673; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; Verkaik NJ, IMMUNOTHERAPY, V3, P1063; Vytvytska O, 2002, PROTEOMICS, V2, P580, DOI 10.1002/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Wayne P, 2006, M100S116 CLSI; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313	45	62	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53391	10.1371/journal.pone.0053391	http://dx.doi.org/10.1371/journal.pone.0053391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308212	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100062
J	Farias, ME; Rascovan, N; Toneatti, DM; Albarracin, VH; Flores, MR; Poire, DG; Collavino, MM; Aguilar, OM; Vazquez, MP; Polerecky, L				Farias, Maria E.; Rascovan, Nicolas; Toneatti, Diego M.; Albarracin, Virginia H.; Flores, Maria R.; Poire, Daniel G.; Collavino, Monica M.; Mario Aguilar, O.; Vazquez, Martin P.; Polerecky, Lubos			The Discovery of Stromatolites Developing at 3570 m above Sea Level in a High-Altitude Volcanic Lake Socompa, Argentinean Andes	PLOS ONE			English	Article							MODERN MARINE STROMATOLITES; AMMONIA-OXIDIZING ARCHAEA; MICROBIAL COMMUNITIES; CUATRO-CIENEGAS; SILICEOUS STROMATOLITES; BACTERIAL DIVERSITY; GUERRERO-NEGRO; ATACAMA DESERT; HIGHBORNE CAY; SEDIMENTS	We describe stromatolites forming at an altitude of 3570 m at the shore of a volcanic lake Socompa, Argentinean Andes. The water at the site of stromatolites formation is alkaline, hypersaline, rich in inorganic nutrients, very rich in arsenic, and warm (20-24 degrees C) due to a hydrothermal input. The stromatolites do not lithify, but form broad, rounded and low-domed bioherms dominated by diatom frustules and aragonite micro-crystals agglutinated by extracellular substances. In comparison to other modern stromatolites, they harbour an atypical microbial community characterized by highly abundant representatives of Deinococcus-Thermus, Rhodobacteraceae, Desulfobacterales and Spirochaetes. Additionally, a high proportion of the sequences that could not be classified at phylum level showed less than 80% identity to the best hit in the NCBI database, suggesting the presence of novel distant lineages. The primary production in the stromatolites is generally high and likely dominated by Microcoleus sp. Through negative phototaxis, the location of these cyanobacteria in the stromatolites is controlled by UV light, which greatly influences their photosynthetic activity. Diatoms, dominated by Amphora sp., are abundant in the anoxic, sulfidic and essentially dark parts of the stromatolites. Although their origin in the stromatolites is unclear, they are possibly an important source of anaerobically degraded organic matter that induces in situ aragonite precipitation. To the best of our knowledge, this is so far the highest altitude with documented actively forming stromatolites. Their generally rich, diverse and to a large extent novel microbial community likely harbours valuable genetic and proteomic reserves, and thus deserves active protection. Furthermore, since the stromatolites flourish in an environment characterized by a multitude of extremes, including high exposure to UV radiation, they can be an excellent model system for studying microbial adaptations under conditions that, at least in part, resemble those during the early phase of life evolution on Earth.	[Farias, Maria E.; Toneatti, Diego M.; Albarracin, Virginia H.; Flores, Maria R.] Consejo Nacl Invest Cient & Tecn, CCT, Planta Piloto Proc Ind Microbiol PROIMI, LIMLA, San Miguel De Tucuman, Tucuman, Argentina; [Rascovan, Nicolas; Vazquez, Martin P.] Inst Agrobiotecnol Rosario INDEAR, Rosario, Santa Fe, Argentina; [Albarracin, Virginia H.] Univ Nacl Tucuman, Fac Ciencias Nat, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Albarracin, Virginia H.] Univ Nacl Tucuman, Inst Miguel Lillo, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Albarracin, Virginia H.] Max Planck Inst Chem Energy Convers, Mulheim, Germany; [Poire, Daniel G.] Univ Nacl La Plata CONICET, Ctr Invest Geol, La Plata, Buenos Aires, Argentina; [Collavino, Monica M.; Mario Aguilar, O.] Univ Nacl La Plata CONICET, IBBM, La Plata, Buenos Aires, Argentina; [Polerecky, Lubos] Max Planck Inst Marine Microbiol, Bremen, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Miguel Lillo Foundation; Universidad Nacional de Tucuman; Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Max Planck Society	Farias, ME (corresponding author), Consejo Nacl Invest Cient & Tecn, CCT, Planta Piloto Proc Ind Microbiol PROIMI, LIMLA, San Miguel De Tucuman, Tucuman, Argentina.	mefarias2009@gmail.com; lpolerec@mpi-bremen.de	Albarracín, Virginia Helena/AAO-7847-2020; Rascovan, Nicolás/Q-4531-2018; Polerecky, Lubos/E-1134-2014	Rascovan, Nicolás/0000-0002-2129-5878; Polerecky, Lubos/0000-0003-4425-585X; Collavino, Monica Mariana/0000-0003-4534-2015; Poire, Daniel G./0000-0003-0966-122X; Albarracin, Virginia/0000-0002-4316-0720; Farias, Maria Eugenia/0000-0002-2771-8915	Tolar Grande municipality; Argentinean National Council for Science and Technology (CONICET); Argentinean National Fund for Science and Technology (FONCyT) [PICT 1788-1221]; Deutscher Akademischer Austauschdienst (DAAD); Marie Curie fellowship; Max-Planck Society; Biomaris	Tolar Grande municipality; Argentinean National Council for Science and Technology (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Argentinean National Fund for Science and Technology (FONCyT); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Marie Curie fellowship(European Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX); Biomaris	We thank the Tolar Grande municipality and people, especially Cacique Sr Cruz, and the members of the Gendarmeria National stationed at the Socompa frontier, for their support during the field campaign, and Veronica Lopez Agosti, Julia Arrouy, Jan Hadidom, Mohammad Al-Najjar, Soledad Cuello and Maria Ines Isla for their indispensable help during the field campaign and in the laboratory. We also thank two anonymous reviewers whose comments helped improve the manuscript.; This work was supported by the Argentinean National Council for Science and Technology (CONICET); Argentinean National Fund for Science and Technology (FONCyT; project number PICT 1788-1221); Deutscher Akademischer Austauschdienst (DAAD); Marie Curie fellowship; the Max-Planck Society; and Biomaris 2010 prize. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar MAA, 2010, ISME J, V4, P440, DOI 10.1038/ismej.2009.121; Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; AWRAMIK SM, 1971, SCIENCE, V174, P825, DOI 10.1126/science.174.4011.825; Baumgartner LK, 2009, ENVIRON MICROBIOL, V11, P2710, DOI 10.1111/j.1462-2920.2009.01998.x; BEBOUT BM, 1995, APPL ENVIRON MICROB, V61, P4215, DOI 10.1128/AEM.61.12.4215-4222.1995; Berelson WM, 2011, GEOBIOLOGY, V9, P411, DOI 10.1111/j.1472-4669.2011.00288.x; Berlanga M, 2009, INT MICROBIOL, V11, P267, DOI 10.2436/20.1501.01.71; BORREGO CM, 1994, PHOTOSYNTH RES, V41, P157, DOI 10.1007/BF02184156; Braissant O, 2010, BIOFILM FORMATION DE; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; BURNE R V, 1987, Palaios, V2, P241, DOI 10.2307/3514674; Burns JA, 2002, MICROBIAL ECOL, V44, P336, DOI 10.1007/s00248-002-1000-9; CABRERA S, 1995, J PHOTOCH PHOTOBIO B, V28, P137, DOI 10.1016/1011-1344(94)07103-U; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chennu A, 2011, INT S TROPH SIGN MIC; Choi JS, 1999, PHOTOCHEM PHOTOBIOL, V70, P95; Costello EK, 2009, APPL ENVIRON MICROB, V75, P735, DOI 10.1128/AEM.01469-08; de Beer D, 1997, LIMNOL OCEANOGR, V42, P1590, DOI 10.4319/lo.1997.42.7.1590; Decho AW, 2010, ECOL ENG, V36, P137, DOI 10.1016/j.ecoleng.2009.01.003; Demergasso C, 2004, FEMS MICROBIOL ECOL, V48, P57, DOI 10.1016/j.femsec.2003.12.013; Dorador C, 2010, FEMS MICROBIOL ECOL, V73, P291, DOI 10.1111/j.1574-6941.2010.00891.x; Dorador C, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000837; DRAVIS JJ, 1983, SCIENCE, V219, P385, DOI 10.1126/science.219.4583.385; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Emelyanov VV, 2003, EUR J BIOCHEM, V270, P1599, DOI 10.1046/j.1432-1033.2003.03499.x; Farias ME, 2011, CELL ORIG LIFE EXTRE, V18, P431; Falcon LI, 2007, MICROB ECOL, V54, P363, DOI 10.1007/s00248-007-9240-3; Foster JS, 2011, CELL ORIG LIFE EXTRE, V18, P385; Foster JS, 2009, ISME J, V3, P573, DOI 10.1038/ismej.2008.129; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Futuyma DJ, 2005, NAT HIST, V114, P64; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; GARRETT P, 1970, SCIENCE, V169, P171, DOI 10.1126/science.169.3941.171; Garrity G., 2005, BERGEYS MANUAL SYSTE; Goh F, 2009, ISME J, V3, P383, DOI 10.1038/ismej.2008.114; Gramain A, 2011, ENVIRON MICROBIOL, V13, P2105, DOI 10.1111/j.1462-2920.2011.02435.x; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; HALLOY S, 1991, ARCTIC ALPINE RES, V23, P247, DOI 10.2307/1551602; Hoffman P, 1976, STROMATOLITES, V20, P261, DOI DOI 10.1016/S0070-4571(08)71139-7; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; Houston J, 2003, INT J CLIMATOL, V23, P1453, DOI 10.1002/joc.938; Hu AY, 2010, FRESHWATER BIOL, V55, P2375, DOI 10.1111/j.1365-2427.2010.02454.x; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Jones B, 2005, SEDIMENTOLOGY, V52, P1229, DOI 10.1111/j.1365-3091.2005.00739.x; Junier P, 2008, FEMS MICROBIOL ECOL, V64, P141, DOI 10.1111/j.1574-6941.2007.00437.x; Kamp A, 2011, P NATL ACAD SCI USA, V108, P5649, DOI 10.1073/pnas.1015744108; Kano A., 2005, J GEOLOGICAL SOC JAP, V111, P751, DOI [10.5575/geosoc.111.751, DOI 10.5575/GEOSOC.111.751]; Kasting JF, 1991, PALAEOGEOGR PALAEOCL, V97, P125, DOI 10.1016/0031-0182(91)90188-W; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Krause-Jensen D, 1998, LIMNOL OCEANOGR, V43, P396, DOI 10.4319/lo.1998.43.3.0396; Kuhl M, 1998, AQUAT MICROB ECOL, V15, P201, DOI 10.3354/ame015201; Lanzen A, 2011, FEMS MICROBIOL ECOL, V77, P577, DOI 10.1111/j.1574-6941.2011.01138.x; LASSEN C, 1992, LIMNOL OCEANOGR, V37, P760, DOI 10.4319/lo.1992.37.4.0760; Lemee L, 1997, TETRAHEDRON, V53, P919, DOI 10.1016/S0040-4020(96)01036-8; Lewis J, 1999, J PLANKTON RES, V21, P343, DOI 10.1093/plankt/21.2.343; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Luccini E, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006580; Lynch RC, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001961; McKenzie RL, 2003, PHOTOCH PHOTOBIO SCI, V2, P5, DOI 10.1039/b211155c; McQuoid MR, 2002, EUR J PHYCOL, V37, P191, DOI 10.1017/S0967026202003670; Mobberley JM, 2012, ENVIRON MICROBIOL, V14, P82, DOI 10.1111/j.1462-2920.2011.02509.x; Moisander PH, 2006, ENVIRON MICROBIOL, V8, P1721, DOI 10.1111/j.1462-2920.2006.01108.x; Nadeau TL, 1999, AQUAT MICROB ECOL, V20, P231, DOI 10.3354/ame020231; Neilson JW, 2012, EXTREMOPHILES, V16, P553, DOI 10.1007/s00792-012-0454-z; Ng WO, 2003, J BACTERIOL, V185, P1599, DOI 10.1128/JB.185.5.1599-1607.2003; Omoregie EO, 2004, FEMS MICROBIOL ECOL, V47, P305, DOI 10.1016/S0168-6496(03)00301-5; Ordonez OF, 2009, MICROB ECOL, V58, P461, DOI 10.1007/s00248-009-9527-7; Papineau D, 2005, APPL ENVIRON MICROB, V71, P4822, DOI 10.1128/AEM.71.8.4822-4832.2005; Pedley M, 2000, MICROBIAL SEDIMENTS, P179; Pepe-Ranney C, 2012, ENVIRON MICROBIOL, V14, P1182, DOI 10.1111/j.1462-2920.2012.02698.x; Permentier HP, 2000, BBA-BIOENERGETICS, V1460, P338, DOI 10.1016/S0005-2728(00)00200-0; Piacentini RD, 2003, J ATMOS SOL-TERR PHY, V65, P727, DOI 10.1016/S1364-6826(03)00084-1; Playford P.E., 1976, STROMATOLITES, V20, P389, DOI DOI 10.1016/S0070-4571(08)71147-6; Polerecky L, 2007, ENVIRON MICROBIOL, V9, P2007, DOI 10.1111/j.1462-2920.2007.01317.x; Polerecky L, 2009, APPL ENVIRON MICROB, V75, P758, DOI 10.1128/AEM.00819-08; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; REID RP, 1995, FACIES, V33, P1, DOI 10.1007/BF02537442; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; Ribeiro S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1314; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Sahl JW, 2010, ASTROBIOLOGY, V10, P201, DOI 10.1089/ast.2009.0378; Santos F, 2010, SYST APPL MICROBIOL, V33, P209, DOI 10.1016/j.syapm.2010.02.006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmidt SK, 2009, EXTREMOPHILES, V13, P807, DOI 10.1007/s00792-009-0268-9; SODE K, 1991, J BIOTECHNOL, V21, P209, DOI 10.1016/0168-1656(91)90042-T; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Souza V, 2012, ASTROBIOLOGY, V12, P641, DOI 10.1089/ast.2011.0675; STANIER RY, 1960, BIOCHIM BIOPHYS ACTA, V41, P478, DOI 10.1016/0006-3002(60)90045-7; Steppe TF, 2002, AQUAT MICROB ECOL, V28, P1, DOI 10.3354/ame028001; Takashima C, 2008, SEDIMENT GEOL, V208, P114, DOI 10.1016/j.sedgeo.2008.06.001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; Walter M. R., 1976, STROMATOLITES; WALTER MR, 1985, PRECAMBRIAN RES, V29, P149, DOI 10.1016/0301-9268(85)90066-X; WALTER MR, 1972, SCIENCE, V178, P402, DOI 10.1126/science.178.4059.402; Weber M, 2007, ENVIRON SCI TECHNOL, V41, P6210, DOI 10.1021/es070200b; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; Zappettini E, 2001, SERV GEOLOGICO MIN A, V26, P65; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989	107	78	82	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53497	10.1371/journal.pone.0053497	http://dx.doi.org/10.1371/journal.pone.0053497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308236	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100075
J	Risbud, RM; Porter, BE				Risbud, Rashmi M.; Porter, Brenda E.			Changes in MicroRNA Expression in the Whole Hippocampus and Hippocampal Synaptoneurosome Fraction following Pilocarpine Induced Status Epilepticus	PLOS ONE			English	Article							KINASE-II ACTIVITY; CONTROLS DENDRITIC PLASTICITY; ACTIVITY-REGULATED MICRORNA; TRAUMATIC BRAIN-INJURY; NEURONAL CULTURE MODEL; TEMPORAL-LOBE EPILEPSY; IN-VIVO; SEIZURES; MORPHOGENESIS; DECREASE	MicroRNAs regulate protein synthesis by binding non-translated regions of mRNAs and suppressing translation and/or increasing mRNA degradation. MicroRNAs play an important role in the nervous system including controlling synaptic plasticity. Their expression is altered in disease states including stroke, head injury and epilepsy. To better understand microRNA expression changes that might contribute to the development of epilepsy, microRNA arrays were performed on rat hippocampus 4 hours, 48 hours and 3 weeks following an episode of pilocarpine induced status epilepticus. Eighty microRNAs increased at one or more of the time points. No microRNAs decreased at 4 hours, and only a few decreased at 3 weeks, but 188 decreased 48 hours after status epilepticus. The large number of microRNAs with altered expression following status epilepticus suggests that microRNA regulation of translation has the potential to contribute to changes in protein expression during epileptogenesis. We carried out a second set of array's comparing microRNA expression at 48 hours in synaptoneurosome and nuclear fractions of the hippocampus. In control rat hippocampi multiple microRNAs were enriched in the synaptoneurosomal fraction as compared to the nuclear fraction. In contrast, 48 hours after status epilepticus only one microRNA was enriched in the synaptoneurosome fraction. The loss of microRNAs enriched in the synaptoneurosomal fraction implies a dramatic change in translational regulation in synapses 48 hours after status epilepticus.	[Risbud, Rashmi M.; Porter, Brenda E.] Childrens Hosp Philadelphia, Dept Pediat, Div Pediat Neurol, Philadelphia, PA 19104 USA; [Porter, Brenda E.] Univ Penn, Perelman Sch Med, Dept Neurol, Div Pediat Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Porter, BE (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Pediat Neurol, Philadelphia, PA 19104 USA.	Brenda2@stanford.edu		Porter, Brenda/0000-0001-6346-7327	NINDS	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman Naomi, 2005, Appl Bioinformatics, V4, P33, DOI 10.2165/00822942-200504010-00004; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Blair RE, 1999, BRAIN RES, V851, P54, DOI 10.1016/S0006-8993(99)02100-9; Blair RE, 2008, EUR J PHARMACOL, V588, P64, DOI 10.1016/j.ejphar.2008.04.021; Booth RFG, 1978, BIOCHEM SOC T, V6, P128, DOI 10.1042/bst0060128; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; Ceman S, 2011, PHARMACOL THERAPEUT, V130, P26, DOI 10.1016/j.pharmthera.2011.01.004; Churn SB, 2000, BRAIN RES, V875, P66, DOI 10.1016/S0006-8993(00)02623-8; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Guo DJ, 2012, NEUROBIOL DIS, V45, P348, DOI 10.1016/j.nbd.2011.08.020; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Huang YF, 2002, J NEUROSCI, V22, P8422; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Kim YK, 2011, MOL CELL, V43, P1005, DOI 10.1016/j.molcel.2011.07.031; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Kye MJ, 2007, RNA, V13, P1224, DOI 10.1261/rna.480407; Lambert TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015182; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Lippi G, 2011, J CELL BIOL, V194, P889, DOI 10.1083/jcb.201103006; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; McKiernan RC, 2012, EXP NEUROL, V237, P346, DOI 10.1016/j.expneurol.2012.06.029; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; MULTANI P, 1994, EPILEPSIA, V35, P728, DOI 10.1111/j.1528-1157.1994.tb02503.x; Pichardo-Casas I, 2012, BRAIN RES, V1436, P20, DOI 10.1016/j.brainres.2011.12.001; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raol YH, 2006, J NEUROSCI, V26, P11342, DOI 10.1523/JNEUROSCI.3329-06.2006; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rensing N, 2005, ANN NEUROL, V58, P888, DOI 10.1002/ana.20658; Risbud RM, 2011, BRAIN RES, V1424, P53, DOI 10.1016/j.brainres.2011.09.039; Ross JR, 2011, J NEUROCHEM, V117, P812, DOI 10.1111/j.1471-4159.2011.07233.x; Sano T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.23; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Tsai CA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng052; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wong M, 2012, NEUROSCIENCE; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007	47	69	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53464	10.1371/journal.pone.0053464	http://dx.doi.org/10.1371/journal.pone.0053464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308228	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100071
J	Shao, Y; Zou, DH; Li, ZD; Wan, L; Qin, ZQ; Liu, NG; Zhang, JH; Zhong, LW; Huang, P; Chen, YJ				Shao, Yu; Zou, Donghua; Li, Zhengdong; Wan, Lei; Qin, Zhiqiang; Liu, Ningguo; Zhang, Jianhua; Zhong, Liangwei; Huang, Ping; Chen, Yijiu			Blunt Liver Injury with Intact Ribs under Impacts on the Abdomen: A Biomechanical Investigation	PLOS ONE			English	Article							FINITE-ELEMENT MODEL; RUPTURE; ORGANS; FORCE	Abdominal trauma accounts for nearly 20% of all severe traffic injuries and can often result from intentional physical violence, from which blunt liver injury is regarded as the most common result and is associated with a high mortality rate. Liver injury may be caused by a direct impact with a certain velocity and energy on the abdomen, which may result in a lacerated liver by penetration of fractured ribs. However, liver ruptures without rib cage fractures were found in autopsies in a series of cases. All the victims sustained punches on the abdomen by fist. Many studies have been dedicated to determining the mechanism underlying hepatic injury following abdominal trauma, but most have been empirical. The actual process and biomechanism of liver injury induced by blunt impact on the abdomen, especially with intact ribs remained, are still inexhaustive. In order to investigate this, finite element methods and numerical simulation technology were used. A finite element human torso model was developed from high resolution CT data. The model consists of geometrically-detailed liver and rib cage models and simplified models of soft tissues, thoracic and abdominal organs. Then, the torso model was used in simulations in which the right hypochondrium was punched by a fist from the frontal, lateral, and rear directions, and in each direction with several impact velocities. Overall, the results showed that liver rupture was primarily caused by a direct strike of the ribs induced by blunt impact to the abdomen. Among three impact directions, a lateral impact was most likely to cause liver injury with a minimum punch speed of 5 m/s (the momentum was about 2.447 kg.m/s). Liver injuries could occur in isolation and were not accompanied by rib fractures due to different material characteristics and injury tolerance.	[Shao, Yu; Zou, Donghua; Li, Zhengdong; Wan, Lei; Qin, Zhiqiang; Liu, Ningguo; Zhang, Jianhua; Huang, Ping; Chen, Yijiu] Minist Justice, Inst Forens Sci, Dept Forens Pathol, Shanghai, Peoples R China; [Shao, Yu] Fudan Univ, Shanghai Med Coll, Dept Forens Sci, Shanghai 200433, Peoples R China; [Zhong, Liangwei] Shanghai Univ Sci & Technol, Coll Mech Engn, Shanghai 201800, Peoples R China	Institute of Forensic Science Ministry of Justice PRC; Fudan University; University of Shanghai for Science & Technology	Huang, P (corresponding author), Minist Justice, Inst Forens Sci, Dept Forens Pathol, Shanghai, Peoples R China.	huangpingifs@gmail.com; yijiuchen@gmail.com	Huang, Ping/L-1193-2019		Key Projects in the National Science & Technology Pillar Program [2012BAK16B02]; National Natural Science Foundation of China [81102300, 81273338]; Science and Technology Commission of Shanghai Municipality [12DZ2271500, 10ZR1431200]; Central Research Institute Public Project of the Scientific Institution of Ministry of Science and Technology [GY1105]	Key Projects in the National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Central Research Institute Public Project of the Scientific Institution of Ministry of Science and Technology	Financial support for this work were provided by Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period, No. 2012BAK16B02, and by programs of the National Natural Science Foundation of China, No. 81102300 and No. 81273338, and by programs of the Science and Technology Commission of Shanghai Municipality, No. 12DZ2271500 and No. 10ZR1431200, also by Central Research Institute Public Project of the Scientific Institution of Ministry of Science and Technology, No. GY1105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourke J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002200; Bright JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031769; Brock KK, 2005, MED PHYS, V32, P1647, DOI 10.1118/1.1915012; Cronin DS, 2010, MAT PROPERTIES NUMER; de Dios ED, 2011, INT J CRASHWORTHINES, V16, P169, DOI 10.1080/13588265.2010.542335; Gao Z, 2010, ANN BIOMED ENG, V38, P505, DOI 10.1007/s10439-009-9812-0; Grimal Q, 2004, INT J IMPACT ENG, V30, P665, DOI 10.1016/j.ijimpeng.2003.08.002; Kindig M, 2011, TRAFFIC INJ PREV, V12, P377, DOI 10.1080/15389588.2011.583960; Leroy A, 2001, P BBE; Li ZP, 2010, J BIOMECH, V43, P228, DOI 10.1016/j.jbiomech.2009.08.040; Melvin J.W., 1973, SAE TECHNICAL PAPER; Miller K, 2000, J BIOMECH, V33, P367, DOI 10.1016/S0021-9290(99)00196-7; Mollemans W, 2006, LECT NOTES COMPUT SC, V4072, P159; Nava A, 2008, MED IMAGE ANAL, V12, P203, DOI 10.1016/j.media.2007.10.001; Richens D, 2004, EUR J CARDIO-THORAC, V25, P1039, DOI 10.1016/j.ejcts.2004.01.059; Rouhana SW, 2002, ACCIDENTAL INJURY BI, P391; Shigeta K, 2009, DEV NEXT GENERATION; Snedeker JG, 2007, J TRAUMA, V62, P1240, DOI 10.1097/01.ta.0000215531.05677.19; Snedeker JG, 2005, J BIOMECH, V38, P993, DOI 10.1016/j.jbiomech.2004.05.030; Sparks J.L., 2007, BIOMECHANICS BLUNT L; Tseng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019171; Tungjitkusolmun S, 2002, IEEE T BIO-MED ENG, V49, P3, DOI 10.1109/10.972834; Vock R, 2001, INT J LEGAL MED, V114, P244, DOI 10.1007/s004140000191; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490	24	18	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52366	10.1371/journal.pone.0052366	http://dx.doi.org/10.1371/journal.pone.0052366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308111	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100010
J	Wei, JCC; Hsu, YW; Hung, KS; Wong, RH; Huang, CH; Liu, YT; Guo, YC; Ikegawa, S; Chang, WC				Wei, James Cheng-Chung; Hsu, Yu-Wen; Hung, Kuo-Sheng; Wong, Ruey-Hong; Huang, Chun-Huang; Liu, Yi-Tzu; Guo, Yuh-Cherng; Ikegawa, Shiro; Chang, Wei-Chiao			Association Study of Polymorphisms rs4552569 and rs17095830 and the Risk of Ankylosing Spondylitis in a Taiwanese Population	PLOS ONE			English	Article							T-CELLS; SUSCEPTIBILITY; COHORT; ERAP1; IL23R; GENE	Ankylosing spondylitis (AS) is a chronic inflammation of the sacroiliac joints, spine and peripheral joints. However, the development of anklosing spondylitis is unclear. Human leukocyte antigens HLA-B27 and ERAP1 have been widely reported to be associated with AS susceptibility. A recent genome-wide association study (GWAS) showed that two new susceptibility loci between EDIL3 and HAPLN1 at 5q14.3 (rs4552569) and within ANO6 at 12q12 (rs17095830) contribute to the risk of AS in Han Chinese. In this study, we enrolled 475 AS patients and 475 healthy subjects to assess whether these genetic variations contribute to the susceptibility and the severity of AS in the Taiwanese population. The correlation between genetic polymorphisms, AS activity indexes, (namely, BASDAI, BASFI and BAS-G) and AS complications (uveitis and inflammatory bowel disease) were tested using the markers, rs4552569 and rs17095830. Although no association between rs4552569/rs17095830 genetic polymorphisms and AS susceptibility/severity was found, a significant association between rs17095830 and inflammatory bowel disease was observed in a Taiwanese population.	[Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsu, Yu-Wen; Liu, Yi-Tzu; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Hung, Kuo-Sheng] Taipei Med Univ, Ctr Excellence Clin Trial & Res, Grad Inst Injury Prevent & Control, Wan Fang Med Ctr,Dept Neurosurg, Taipei, Taiwan; [Wong, Ruey-Hong; Huang, Chun-Huang] Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Guo, Yuh-Cherng] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Tokyo, Japan; [Chang, Wei-Chiao] Taipei Med Univ, Wanfang Hosp, Dept Pharm, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Changhua Christian Hospital; RIKEN; Taipei Medical University; Taipei Municipal WanFang Hospital	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw	Ikegawa, Shiro/N-6895-2015; Wei, James Cheng-Chung/AAL-8947-2020	Ikegawa, Shiro/0000-0003-0316-2147; Wei, James Cheng-Chung/0000-0002-1235-0679; Chang, Wei-Chiao/0000-0002-8573-5924	Chung Shan Medical University Hospital grant [CSH-2010-C-004]; Center of Excellence for Clinical Trial and Research in Neuroscience from the Department of Health, Taiwan [DOH101-TD-B-111-003]; National Science Council of Taiwan [NSC 101-2320-B-038-029-MY3]	Chung Shan Medical University Hospital grant; Center of Excellence for Clinical Trial and Research in Neuroscience from the Department of Health, Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a Chung Shan Medical University Hospital grant (CSH-2010-C-004), a grant of Center of Excellence for Clinical Trial and Research in Neuroscience from the Department of Health, Taiwan, (DOH101-TD-B-111-003) and a grant from National Science Council of Taiwan (NSC 101-2320-B-038-029-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; BREWERTON DA, 1973, LANCET, V1, P904; Calin A, 1999, LANCET, V354, P1687, DOI 10.1016/S0140-6736(99)03219-5; Chen C, 2012, RHEUMATOL INT, V32, P15, DOI 10.1007/s00296-010-1566-3; Davidson SI, 2011, ANN RHEUM DIS, V70, P289, DOI 10.1136/ard.2010.133322; Davidson SI, 2009, ARTHRITIS RHEUM-US, V60, P3263, DOI 10.1002/art.24933; Duftner C, 2003, ARTHRITIS RES THER, V5, pR292, DOI 10.1186/ar793; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Guo ZS, 2010, INT J IMMUNOGENET, V37, P33, DOI 10.1111/j.1744-313X.2009.00889.x; Huang CH, 2011, RHEUMATOLOGY, V50, P1809, DOI 10.1093/rheumatology/ker211; Khan MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Safrany E, 2009, SCAND J IMMUNOL, V70, P68, DOI 10.1111/j.1365-3083.2009.02265.x; Schirmer M, 2002, ARTHRITIS RES, V4, P71, DOI 10.1186/ar386; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wei JCC, 2007, CLIN RHEUMATOL, V26, P1685, DOI 10.1007/s10067-007-0573-6; Wei JCC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020426; Wei JCC, 2004, RHEUMATOLOGY, V43, P839, DOI 10.1093/rheumatology/keh193; Wong RH, 2012, J RHEUMATOL, V39, P135, DOI 10.3899/jrheum.110613	20	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52801	10.1371/journal.pone.0052801	http://dx.doi.org/10.1371/journal.pone.0052801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308121	gold, Green Published, Green Submitted			2022-12-27	WOS:000313670100013
J	Behere, GT; Tay, WT; Russell, DA; Kranthi, KR; Batterham, P				Behere, Gajanan Tryambak; Tay, Wee Tek; Russell, Derek Alan; Kranthi, Keshav Raj; Batterham, Philip			Population Genetic Structure of the Cotton Bollworm Helicoverpa armigera (Hubner) (Lepidoptera: Noctuidae) in India as Inferred from EPIC-PCR DNA Markers	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; PYRETHROID-RESISTANCE; INSECTICIDE RESISTANCE; BEMISIA-TABACI; HELIOTHIS; MIGRATION; DYNAMICS; MOTH; FLOW; CROPS	Helicoverpa armigera is an important pest of cotton and other agricultural crops in the Old World. Its wide host range, high mobility and fecundity, and the ability to adapt and develop resistance against all common groups of insecticides used for its management have exacerbated its pest status. An understanding of the population genetic structure in H. armigera under Indian agricultural conditions will help ascertain gene flow patterns across different agricultural zones. This study inferred the population genetic structure of Indian H. armigera using five Exon-Primed Intron-Crossing (EPIC)-PCR markers. Nested alternative EPIC markers detected moderate null allele frequencies (4.3% to 9.4%) in loci used to infer population genetic structure but the apparently genome-wide heterozygote deficit suggests in-breeding or a Wahlund effect rather than a null allele effect. Population genetic analysis of the 26 populations suggested significant genetic differentiation within India but especially in cotton-feeding populations in the 2006-07 cropping season. In contrast, overall pair-wise F-ST estimates from populations feeding on food crops indicated no significant population substructure irrespective of cropping seasons. A Baysian cluster analysis was used to assign the genetic make-up of individuals to likely membership of population clusters. Some evidence was found for four major clusters with individuals in two populations from cotton in one year (from two populations in northern India) showing especially high homogeneity. Taken as a whole, this study found evidence of population substructure at host crop, temporal and spatial levels in Indian H. armigera, without, however, a clear biological rationale for these structures being evident.	[Behere, Gajanan Tryambak; Batterham, Philip] Univ Melbourne, Dept Genet, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Tay, Wee Tek] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Russell, Derek Alan] Univ Melbourne, Dept Agr & Food Syst, Melbourne, Vic, Australia; [Behere, Gajanan Tryambak] Indian Council Agr Res, Div Entomol, Shilong, Meghalaya, India; [Kranthi, Keshav Raj] Cent Inst Cotton Res, Nagpur, Maharashtra, India	University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne; Indian Council of Agricultural Research (ICAR); Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Cotton Research	Tay, WT (corresponding author), CSIRO Ecosyst Sci, Canberra, ACT, Australia.	weetek.tay@csiro.au	Tay, Wee Tek/C-1818-2008; Batterham, Philip/G-5914-2012; Tay, Wee Tek/GPF-6142-2022; Behere, Gajanan Tryambak/AAP-5289-2020	Tay, Wee Tek/0000-0002-8451-0811; Batterham, Philip/0000-0001-9840-9119; Tay, Wee Tek/0000-0002-8451-0811; Behere, Gajanan Tryambak/0000-0003-0222-7367	Melbourne International Research Scholarship (MIRS); Melbourne International Fee Remission Scholarship (MIFRS); Albert Shimmins Post Graduate Writing-up Award (Faculty of Science, University of Melbourne); Australian Research Council (ARC)	Melbourne International Research Scholarship (MIRS); Melbourne International Fee Remission Scholarship (MIFRS); Albert Shimmins Post Graduate Writing-up Award (Faculty of Science, University of Melbourne); Australian Research Council (ARC)(Australian Research Council)	GTB was supported by grants from the Melbourne International Research Scholarship (MIRS), the Melbourne International Fee Remission Scholarship (MIFRS), and the Albert Shimmins Post Graduate Writing-up Award (Faculty of Science, University of Melbourne). The Australian Research Council (ARC) provided funding to the Special Research Centre for Environmental Stress and Adaptation Research (CESAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMES NJ, 1992, PESTIC SCI, V34, P355, DOI 10.1002/ps.2780340409; Armes NJ, 1996, B ENTOMOL RES, V86, P499, DOI 10.1017/S0007485300039298; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Bhatnagar VS, 1980, REPORT RES HELIOTHIS; Bhattacherjee NS, 1972, ENTOMOL NEWSLETT, V2, P3; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chowda-Reddy RV, 2012, J INTEGR AGR, V11, P235, DOI 10.1016/S2095-3119(12)60008-2; DALY JC, 1985, B ENTOMOL RES, V75, P169, DOI 10.1017/S0007485300014243; De Barro PJ, 2005, MOL ECOL, V14, P3695, DOI 10.1111/j.1365-294X.2005.02700.x; DeSouza K, 1995, ECOL ENTOMOL, V20, P333, DOI 10.1111/j.1365-2311.1995.tb00465.x; Durairaj C., 2005, Heliothis/Helicoverpa management: emerging trends and strategies for future research, P91; Endersby NM, 2007, ENTOMOL EXP APPL, V122, P253, DOI 10.1111/j.1570-7458.2006.00515.x; Endersby NM, 2006, MOL ECOL, V15, P107, DOI 10.1111/j.1365-294X.2005.02789.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fakrudin B, 2004, CURR SCI INDIA, V87, P1654; FIREMPONG S, 1990, AUST J ZOOL, V37, P665, DOI 10.1071/ZO9890665; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gordon K, 2009, MOL BIOL GENETICS LE, P219; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Jallow MFA, 2004, CROP PROT, V23, P955, DOI 10.1016/j.cropro.2004.02.008; Jallow MFA, 1996, AUST J ZOOL, V44, P503, DOI 10.1071/ZO9960503; Jayaraj S, 1982, BIOLOGICAL AND ECOLO, P17; Ji YJ, 2003, MOL ECOL NOTES, V3, P102, DOI 10.1046/j.1471-8286.2003.00366.x; JOHNSON MS, 1984, MAR BIOL, V79, P295, DOI 10.1007/BF00393261; Khadi BM, 2003, STRENGTHS WEAKNESSES, P393; Kranthi KR, 2004, CURR SCI INDIA, V87, P1096; Kranthi KR, 2002, CROP PROT, V21, P449, DOI 10.1016/S0261-2194(01)00131-4; Kranthi KR, 2001, B ENTOMOL RES, V91, P37; Kranthi KR, 1997, PESTIC SCI, V50, P91, DOI 10.1002/(SICI)1096-9063(199706)50:2&lt;91::AID-PS570&gt;3.0.CO;2-X; Kranthi S, 2009, CROP PROT, V28, P371, DOI 10.1016/j.cropro.2008.12.001; LESSA EP, 1992, MOL BIOL EVOL, V9, P323; MADDEN AD, 1995, ECOL MODEL, V82, P61, DOI 10.1016/0304-3800(94)00071-O; Manjunath TH, 1970, CIBC TECH B, V13, P111; Manjunath TM, 1989, INDIA ASSESSMENT THE, P197; McKechnie SW, 1993, P BELTW COTT C NEW O, P838; Nibouche S, 1998, HEREDITY, V80, P438, DOI 10.1046/j.1365-2540.1998.00273.x; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; PALUMBI SR, 1994, MOL BIOL EVOL, V11, P426; PEDGLEY DE, 1987, INSECT SCI APPL, V8, P599, DOI 10.1017/S1742758400022669; Pritchard JK, 2000, GENETICS, V155, P945; Ravi KC, 2005, ENVIRON ENTOMOL, V34, P59, DOI 10.1603/0046-225X-34.1.59; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed W, 1982, HELIOTHIS A GLOBAL P, P9; Reyes PFM, 2007, MOL ECOL, V16, P3554, DOI 10.1111/j.1365-294X.2007.03410.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sachan J.N., 1987, P91; Schneider S, 2000, ARLEQUIN A SOFTWARE; Scott KD, 2005, B ENTOMOL RES, V95, P381, DOI 10.1079/BER2005369; Scott KD, 2005, J ECON ENTOMOL, V98, P2210, DOI 10.1603/0022-0493-98.6.2210; Scott KD, 2004, MOL ECOL NOTES, V4, P204, DOI 10.1111/j.1471-8286.2004.00617.x; Scott KD, 2003, AUST J AGR RES, V54, P739, DOI 10.1071/AR02164; Scott LJ, 2006, J ECON ENTOMOL, V99, P155, DOI 10.1603/0022-0493(2006)099[0155:PDAGFO]2.0.CO;2; Singh J., 1990, Journal of Insect Science, V3, P47; SINGH J, 1986, Indian Journal of Ecology, V13, P113; Singh J, 1992, P 1 NAT WORKSH, P92; Stipanovic RD, 2006, J CHEM ECOL, V32, P959, DOI 10.1007/s10886-006-9052-9; Stokes NH, 1997, AUST J ENTOMOL, V36, P191, DOI 10.1111/j.1440-6055.1997.tb01454.x; Tamhankar AJ, 2003, CURR SCI INDIA, V84, P448; Tay WT, 2008, B ENTOMOL RES, V98, P509, DOI 10.1017/S000748530800583X; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Vassal Jean-Michel, 2008, Commun Agric Appl Biol Sci, V73, P433; Verma A.K., 1993, Pest Management and Economic Zoology, V1, P43; Weeks AR, 2010, B ENTOMOL RES, V100, P445, DOI 10.1017/S0007485309990460; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zalucki MP, 2012, B ENTOMOL RES, V102, P468, DOI 10.1017/S0007485311000848; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x; Zhou XF, 2000, HEREDITY, V85, P251, DOI 10.1046/j.1365-2540.2000.00738.x; Zraket CA, 1989, GENETIC LINKAGE MAPP, P13	72	38	41	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53448	10.1371/journal.pone.0053448	http://dx.doi.org/10.1371/journal.pone.0053448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326431	gold, Green Published			2022-12-27	WOS:000314705800045
J	Ai, JH; Jin, Y; Wang, ZZ; Yang, L; Luo, D				Ai Junhua; Jin Yun; Wang Zhenzhou; Yang Ling; Luo Ding			Treatment of Malignant Liver Tumors by Radiofrequency Ablation Combined with Low-Frequency Ultrasound Radiation with Microbubbles	PLOS ONE			English	Article								Objective: To explore the therapeutic efficacy and safety of malignant liver tumor treatment by radiofrequency ablation (RA) combined with low frequency ultrasound radiation with microbubbles (LFURM). Methods: Retrospective analysis of 25 patients with malignant hepatic tumors treated by RA/LFURM in the Department of Hepatobiliary Surgery of Kunming General Hospital affiliated to Chengdu Military District, PLA from January 2010 to June 2011. Ultrasound guided RA was performed, which was followed one week later by LFURM. Basal contrast ultrasound, liver function tests, and serum alpha fetoprotein (AFP) were obtained, and repeated 3 and 6 months after treatment. T-test and chi-square were used to compare parametric and non-parametric variables respectively. Results: In 17 cases, gross tumor volume was significantly reduced 6 months after treatment while mean tumor showed a reduction of 50% compared to pre-treatment values. In 7 cases gross tumor volumes reduction was partial, but surrounding tumor tissue showed blood flow signals. One patient had no reduction in gross tumor volume. Levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), alpha fetoprotein (AFP) decreased significantly 6 months after treatment (all p<0.05). No tumor recurrence was seen during the 6 month follow-up. Quality of life scores (QOL) were good in 21 patients (84%), improved in 2 patients (8%), unchanged in 1 patient (4%) and got worst in 1 patient (4%). Karnofsky scores (KPS) improved in 19 patients (76%), remained unchanged in 5 patients (2%) and got worst in 1 patient (4%). Both QOL and KPS changes were statistically significant (P<0.05). Conclusion: RA/LFURM treatment of liver tumors is efficient and safe, and can reduce the gross tumor volumes and protect liver function.	[Ai Junhua] Chinese Peoples Armed Police Force 8710 Hosp, Dept Gen Surg, Putian, Fujian Province, Peoples R China; [Jin Yun; Luo Ding] Chengdu Mil Dist Chinese Peoples Liberat Army, Kunming Gen Hosp Affiliated, Dept Hepatobiliary Surg, Kunming, Yunnan Province, Peoples R China; [Wang Zhenzhou] Chengdu Mil Dist Chinese Peoples Liberat Army, Kunming Gen Hosp Affiliated, Dept Med Engn, Kunming, Yunnan Province, Peoples R China; [Yang Ling] Chengdu Mil Dist Chinese Peoples Liberat Army, Kunming Gen Hosp Affiliated, Dept Special Diag, Kunming, Yunnan Province, Peoples R China		Luo, D (corresponding author), Chengdu Mil Dist Chinese Peoples Liberat Army, Kunming Gen Hosp Affiliated, Dept Hepatobiliary Surg, Kunming, Yunnan Province, Peoples R China.	digluo@sohu.com						Chen MH, 2004, RADIOLOGY, V232, P260, DOI 10.1148/radiol.2321030821; Chen MH, 2008, JOURNAL OF CHINESE A, V30, P15; Chen XiaoPing, 2009, Chinese Journal of Digestive Surgery, V8, P88; Chiou Yi-You, 2005, Kaohsiung Journal of Medical Sciences, V21, P304; Fang LH, 2011, J CLIN ONCOL, V16, P510; Jiang Z, 2005, MODERN MEDICINE, V33, P171; Kamphues C, 2011, J HEPATOBILIARY PANC, V17, P509; Kang JA, 2010, J ULTRAS MED, V29, P61, DOI 10.7863/jum.2010.29.1.61; Kim JH, 2011, EUR J RADIOL, V80, pE221, DOI 10.1016/j.ejrad.2010.09.019; Kim JH, 2011, AM J ROENTGENOL, V196, pW205, DOI 10.2214/AJR.10.4937; Kudo M, 2010, ONCOLOGY-BASEL, V78, P113, DOI 10.1159/000315239; Liang TingBo, 2010, Chinese Journal of Digestive Surgery, V9, P15; Mason T, 2007, J GASTROINTEST SURG, V11, P1333, DOI 10.1007/s11605-007-0214-z; Massarweh NN, 2012, ANN SURG ONCOL, V19, P1058, DOI 10.1245/s10434-011-2067-7; Park Donghee, 2010, Open Biomed Eng J, V4, P56, DOI 10.2174/1874120701004010056; Poon RT, 2004, ANN SURG, V239, P441, DOI 10.1097/01.sla.0000118565.21298.0a; Rai R, 2005, WORLD J GASTROENTERO, V11, P612; Roberts WW, 2006, J UROLOGY, V175, P447; Saiura A, 2011, AM J SURG, V201, P203, DOI 10.1016/j.amjsurg.2008.12.035; Slakey DP, 2002, AM SURGEON, V68, P395; Wang L, 2011, INTERNATIONAL JOURNA, V34, P364; Wang Y, 2011, MODERN ONCOLOGICAL M, V19, P1063; Yu MA, 2011, EUR J RADIOL, V80, P548, DOI 10.1016/j.ejrad.2011.01.014; Zgodzinski W, 2005, WORLD J GASTROENTERO, V11, P5239	24	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53351	10.1371/journal.pone.0053351	http://dx.doi.org/10.1371/journal.pone.0053351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326418	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400019
J	Zhang, XM; Lepelley, A; Azria, E; Lebon, P; Roguet, G; Schwartz, O; Launay, O; Leclerc, C; Lo-Man, R				Zhang, Xiaoming; Lepelley, Alice; Azria, Elie; Lebon, Pierre; Roguet, Gwenaelle; Schwartz, Olivier; Launay, Odile; Leclerc, Claude; Lo-Man, Richard			Neonatal Plasmacytoid Dendritic Cells (pDCs) Display Subset Variation but Can Elicit Potent Anti-Viral Innate Responses	PLOS ONE			English	Article							RECOGNITION; CAPACITY; IMMUNITY; DISTINCT; DEFECT	Neonates are highly susceptible to infectious diseases and defective antiviral pDC immune responses have been proposed to contribute to this phenomenon. Isolated cord blood pDCs innately responded to a variety of TLR7 and TLR9 dependent viruses, including influenza A virus (IAV), human immunodeficiency virus (HIV) or herpes-simplex virus (HSV) by efficiently producing IFN-alpha, TNF-alpha as well as chemokines. Interestingly, following activation by CpGA, but not viruses, cord pDCs tend to survive less efficiently. We found that a hallmark of pDCs in neonates is an extended CD2+pDCs compartment compared to adult pDCs without affecting the antiviral IFN-alpha response. Within CD2+pDCs, we identified a subpopulation expressing CD5 and responsible for IL-12p40 production, however this population is significantly decreased in cord blood compared to adult blood. Therefore, neonatal pDCs clearly display variation in phenotype and subset composition, but without major consequences for their antiviral responses.	[Zhang, Xiaoming; Lepelley, Alice; Schwartz, Olivier; Leclerc, Claude; Lo-Man, Richard] Inst Pasteur, Paris, France; [Zhang, Xiaoming; Leclerc, Claude; Lo-Man, Richard] INSERM, U1041, Paris, France; [Zhang, Xiaoming; Schwartz, Olivier] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Unit Innate Def & Immune Modulat, Shanghai, Peoples R China; [Lepelley, Alice] URA CNRS 3015, Paris, France; [Azria, Elie] Grp Hosp Bichat Claude Bernard, Dept Obstet & Gynecol, Paris, France; [Azria, Elie] Univ Paris 07, Paris, France; [Lebon, Pierre] Hop Cochin St Vincent de Paul, Assistance Publ Hop Paris, Virol & EA1833, Paris, France; [Roguet, Gwenaelle; Launay, Odile] Hop Cochin, Assistance Publ Hop Paris, CIC BT505, F-75674 Paris, France; [Launay, Odile] Univ Paris 05, Fac Med, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lo-Man, R (corresponding author), Inst Pasteur, Paris, France.	richard.lo-man@pasteur.fr	Schwartz, Olivier/AAZ-3765-2021; Lepelley, Alice/P-1197-2018	Schwartz, Olivier/0000-0002-0729-1475; Lepelley, Alice/0000-0001-8656-7291; Azria, Elie/0000-0002-6159-6253	Agence Nationale pour la Recherche [ANR 09-MIEN-017]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; ANRS; Sidaction; Areva Foundation; Center for Human Immunology at Institut Pasteur	Agence Nationale pour la Recherche(French National Research Agency (ANR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; Areva Foundation; Center for Human Immunology at Institut Pasteur	This work was supported by grants from Agence Nationale pour la Recherche (ANR 09-MIEN-017) and has received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID)). Work in the O.S. lab is also supported by ANRS, Sidaction and Areva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to F. Goffinet (CIC Mere-Enfant) for the cord blood sample collections. This work was supported by grants from Agence Nationale pour la Recherche (ANR 09-MIEN-017) and has received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID)). Work in the O.S. lab is also supported by ANRS, Sidaction and Areva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials. We acknowledge the Center for Human Immunology at Institut Pasteur for support in conducting these studies.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Blom B, 2000, J EXP MED, V192, P1785, DOI 10.1084/jem.192.12.1785; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Ghirelli C, 2010, BLOOD, V115, P5037, DOI 10.1182/blood-2010-01-266932; Gold MC, 2006, PEDIATR RES, V60, P34, DOI 10.1203/01.pdr.0000220352.13547.f4; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Renneson J, 2009, EUR J IMMUNOL, V39, P2789, DOI 10.1002/eji.200939414; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; Wang YM, 2011, IMMUNOL REV, V243, P74, DOI 10.1111/j.1600-065X.2011.01049.x; Zhang XM, 2007, J EXP MED, V204, P1107, DOI 10.1084/jem.20062013	28	24	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e52003	10.1371/journal.pone.0052003	http://dx.doi.org/10.1371/journal.pone.0052003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326320	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400005
J	Phalan, B; Bertzky, M; Butchart, SHM; Donald, PF; Scharlemann, JPW; Stattersfield, AJ; Balmford, A				Phalan, Ben; Bertzky, Monika; Butchart, Stuart H. M.; Donald, Paul F.; Scharlemann, Joern P. W.; Stattersfield, Alison J.; Balmford, Andrew			Crop Expansion and Conservation Priorities in Tropical Countries	PLOS ONE			English	Article							GLOBAL LAND-COVER; BIODIVERSITY CONSERVATION; DEFORESTATION; FOREST; AGRICULTURE; HABITAT; INTENSIFICATION; QUANTIFICATION; ECOREGIONS; POPULATION	Expansion of cropland in tropical countries is one of the principal causes of biodiversity loss, and threatens to undermine progress towards meeting the Aichi Biodiversity Targets. To understand this threat better, we analysed data on crop distribution and expansion in 128 tropical countries, assessed changes in area of the main crops and mapped overlaps between conservation priorities and cultivation potential. Rice was the single crop grown over the largest area, especially in tropical forest biomes. Cropland in tropical countries expanded by c. 48,000 km(2) per year from 1999-2008. The countries which added the greatest area of new cropland were Nigeria, Indonesia, Ethiopia, Sudan and Brazil. Soybeans and maize are the crops which expanded most in absolute area. Other crops with large increases included rice, sorghum, oil palm, beans, sugar cane, cow peas, wheat and cassava. Areas of high cultivation potential-while bearing in mind that political and socio-economic conditions can be as influential as biophysical ones-may be vulnerable to conversion in the future. These include some priority areas for biodiversity conservation in tropical countries (e. g., Frontier Forests and High Biodiversity Wilderness Areas), which have previously been identified as having 'low vulnerability', in particular in central Africa and northern Australia. There are also many other smaller areas which are important for biodiversity and which have high cultivation potential (e. g., in the fringes of the Amazon basin, in the Paraguayan Chaco, and in the savanna woodlands of the Sahel and East Africa). We highlight the urgent need for more effective sustainability standards and policies addressing both production and consumption of tropical commodities, including robust land-use planning in agricultural frontiers, establishment of new protected areas or REDD+ projects in places agriculture has not yet reached, and reduction or elimination of incentives for land-demanding bioenergy feedstocks.	[Phalan, Ben; Balmford, Andrew] Univ Cambridge, Dept Zool, Cambridge, England; [Bertzky, Monika; Scharlemann, Joern P. W.] United Nations Environm Programme, World Conservat Monitoring Ctr, Cambridge, England; [Butchart, Stuart H. M.; Stattersfield, Alison J.] BirdLife Int, Cambridge, England; [Donald, Paul F.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Scharlemann, Joern P. W.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Cambridge; BirdLife International; Royal Society for Protection of Birds; University of Sussex	Phalan, B (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	btp22@cam.ac.uk	Scharlemann, Jorn/A-4737-2008; Phalan, Ben/A-5783-2009; Butchart, Stuart HM/Y-2711-2018; Butchart, Stuart/AAJ-1852-2021	Scharlemann, Jorn/0000-0002-2834-6367; Phalan, Ben/0000-0001-7876-7226; Butchart, Stuart/0000-0002-1140-4049; Donald, Paul F./0000-0003-0023-6200; Balmford, Andrew/0000-0002-0144-3589	Isaac Newton Trust; Royal Society for the Protection of Birds; United Nations Environment Programme World Conservation Monitoring Centre	Isaac Newton Trust; Royal Society for the Protection of Birds; United Nations Environment Programme World Conservation Monitoring Centre	BP was funded by the Isaac Newton Trust, the Royal Society for the Protection of Birds and the United Nations Environment Programme World Conservation Monitoring Centre. Other than the direct involvement of authors from the named institutions in this research, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous P, 2004, NATURE, V432, P144, DOI 10.1038/432144a; [Anonymous], 2010, ECONOMIST; [Anonymous], FAOSTAT STAT DAT; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Balmford Andrew, 2012, P R SOC B; Barona E, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024002; Baudron F, 2011, BIOL CONSERV, V144, P1481, DOI 10.1016/j.biocon.2011.01.017; BirdLife International, 2011, BIRDLIFE SPEC FACTSH; Boakes EH, 2010, P ROY SOC B-BIOL SCI, V277, P1081, DOI 10.1098/rspb.2009.1771; Bongaarts J, 2011, SCIENCE, V333, P574, DOI 10.1126/science.1207558; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brown HCP, 2011, J ENVIRON DEV, V20, P381, DOI 10.1177/1070496511426480; Bryant D., 1997, LAST FRONTIER FOREST; Butler RA, 2008, TRENDS ECOL EVOL, V23, P469, DOI 10.1016/j.tree.2008.05.006; Carrere R., 1996, PULPING S IND TREE P; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; CHOMITZ K, 2006, LOGGERHEADS AGR EXPA; Chowdhury J. A., 2006, BETTER FOREST MANAGE; Clay J., 2004, WORLD AGR ENV COMMOD; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Cook G, 2009, NO AUSTR LAND WATER; Davalos LM, 2011, ENVIRON SCI TECHNOL, V45, P1219, DOI 10.1021/es102373d; de Araujo LM, 2011, NATURE, V469, P299, DOI 10.1038/469299d; Deininger K, 2011, RISING GLOBAL INTERE; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Duveiller G, 2008, REMOTE SENS ENVIRON, V112, P1969, DOI 10.1016/j.rse.2007.07.026; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; ESRI, 2009, ARCGIS DESKT REL 9 3; Ewers RM, 2009, GLOBAL CHANGE BIOL, V15, P1716, DOI 10.1111/j.1365-2486.2009.01849.x; FAO, 2010, WORLD PROGR CENS A 2; FAO, 2011, TREE CROPS GUID EST; FAO, 2011, CROPS STAT CONC DEF; FAO, 2002, WORLD AGR 2015 2030; FAO,, 2010, WORLD PROGR CENS AGR; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Fischer G, 2002, GLOBAL AGROECOLOGICA; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fritz S, 2008, GLOBAL CHANGE BIOL, V14, P1057, DOI 10.1111/j.1365-2486.2007.01519.x; Galford GL, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI327.1; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Gomez MI, 2011, SCIENCE, V332, P1154, DOI 10.1126/science.1202543; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Havlik P, 2011, ENERG POLICY, V39, P5690, DOI 10.1016/j.enpol.2010.03.030; Hellmann F, 2010, J ENVIRON MANAGE, V91, P1389, DOI 10.1016/j.jenvman.2010.02.022; Herold M, 2008, REMOTE SENS ENVIRON, V112, P2538, DOI 10.1016/j.rse.2007.11.013; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IMAGE Team, 2001, NETH ENV ASS AG MNP; Kaptue Tchuente AT, 2011, INT J APPL EARTH OBS, V13, P207, DOI 10.1016/j.jag.2010.11.005; Karsenty A., 2010, LARGE SCALE ACQUISIT; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Koh LP, 2007, CONSERV BIOL, V21, P1373, DOI 10.1111/j.1523-1739.2007.00771.x; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Lee JSH, 2011, BIOL CONSERV, V144, P2512, DOI 10.1016/j.biocon.2011.07.006; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Martinelli LA, 2011, NATURE, V474, P579, DOI 10.1038/474579a; McCallum I, 2006, INT J APPL EARTH OBS, V8, P246, DOI 10.1016/j.jag.2005.12.002; McIntyre B.D., 2009, AGR CROSSROADS INT A; Melillo JM, 2009, SCIENCE, V326, P1397, DOI 10.1126/science.1180251; Mertens B, 2000, ANN ASSOC AM GEOGR, V90, P467, DOI 10.1111/0004-5608.00205; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Mittermeier R. A., 1997, MEGADIVERSITY; Mittermeier R.A., 2004, HOTSPOTS REVISITED; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Muller R, 2013, LAND USE POLICY, V30, P895, DOI 10.1016/j.landusepol.2012.06.019; Muok B. O., 2010, ENV SUITABILITY AGRO; NEMA, 2010, POT BIOF UG ASS LAND; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Organisation for Economic Cooperation and Development (OECD), 2017, OECD EC SURV UK; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phalan B, 2011, FOOD POLICY, V36, pS62, DOI 10.1016/j.foodpol.2010.11.008; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Ramankutty N, 2004, EARTH INTERACT, V8; Rappole JH, 2003, CONSERV BIOL, V17, P334, DOI 10.1046/j.1523-1739.2003.01548.x; Rudel T., 2005, TROPICAL FORESTS REG; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scales IR, 2011, ENVIRON HIST-UK, V17, P499, DOI 10.3197/096734011X13150366551481; Scarlat N, 2011, ENERG POLICY, V39, P1630, DOI 10.1016/j.enpol.2010.12.039; Scharlemann JPW, 2004, GLOBAL CHANGE BIOL, V10, P2046, DOI 10.1111/j.1365-2486.2004.00860.x; Schroth G, 2007, BIODIVERS CONSERV, V16, P2237, DOI 10.1007/s10531-007-9195-1; Seddon N, 2000, ORYX, V34, P287, DOI 10.1017/S0030605300031355; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; SPEHAR CR, 1995, FIELD CROP RES, V41, P141, DOI 10.1016/0378-4290(95)00007-D; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; Tabor K, 2010, ECOL APPL, V20, P554, DOI 10.1890/09-0173.1; Thoenes P, 2011, FAO PRICE POLICY B; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Toth G, 2011, GLOBAL AGROECOLOGICA; UNEP, 2011, UNEPCBDCOP1027; United Nations Population Division, 2011, WORLD POP PROSP 2010; Wilcove DS, 2010, BIODIVERS CONSERV, V19, P999, DOI 10.1007/s10531-009-9760-x; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; Wirsenius S, 2010, AGR SYST, V103, P621, DOI 10.1016/j.agsy.2010.07.005; Wolfire D., 1998, FORESTS DEMOCRATIC R; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x; Wunder S., 2004, LAND USE NATURE CONS, P3; WWF IUCN, 1997, CTR PLANT DIV; Yang L., 1985, ZOOL RES, V6, P353; You L., 2010, SPATIAL PRODUCTION A; Zhang QF, 2005, ENVIRON MONIT ASSESS, V101, P69	116	155	162	1	345	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e51759	10.1371/journal.pone.0051759	http://dx.doi.org/10.1371/journal.pone.0051759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326316	gold, Green Published, Green Accepted			2022-12-27	WOS:000313551500007
J	Dong, JH; Otsuki, T; Kato, T; Kohsaka, T; Ike, K; Park, EY				Dong, Jinhua; Otsuki, Takahiro; Kato, Tatsuya; Kohsaka, Tetsuya; Ike, Kazunori; Park, Enoch Y.			Development of Two Murine Antibodies against Neospora caninum Using Phage Display Technology and Application on the Detection of N. caninum	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; INFECTION; TACHYZOITES; ELISA; ABORTIONS; SELECTION; PROTEINS; ANTIGENS; SURFACE; FUSION	Neosporosis, caused by an intracellular parasite, Neospora caninum, is an infectious disease primarily of cattle and dogs. It occurs worldwide and causes huge damages to dairy farms. In this study, we immunized mice with recombinant surface-associated protein 1 of N. caninum (rNcSAG1) and developed two novel monoclonal antibodies, A10 and H3, against NcSAG1 using phage-display technology. Both clones bound to purified rNcSAG1 and the half maximal inhibitory concentrations of A10 and H3 are 50 and 72 nM of rNcSAG1, respectively. In immunofluorescence assays, both A10 and H3 Fabs bound to N. caninum parasites. Direct detection of N. caninum parasites was developed firstly using an enzyme-linked immunosorbent assay (ELISA) with A10 and H3. Binding of A10 and H3 antibodies to rNcSAG1 was also inhibited by some certain anti-N. caninum antibodies in the neosporosis-positive cattle sera, suggesting they might bind to the same epitopes of NcSAG1 with those anti-N. caninum antibodies of bovine. These antibodies were demonstrated to have a potential for monitoring the N. caninum parasites in a dairy farm, which may lead to protect livestock from parasite-infection.	[Dong, Jinhua; Park, Enoch Y.] Shizuoka Univ, Grad Sch Sci & Technol, Biotechnol Lab, Shizuoka, Japan; [Otsuki, Takahiro; Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Biotechnol Lab, Shizuoka 4228529, Japan; [Kohsaka, Tetsuya] Shizuoka Univ, Fac Agr, Lab Anim Reprod & Physiol, Shizuoka 4228529, Japan; [Ike, Kazunori] Nippon Vet & Life Univ, Lab Vet Parasitol, Tokyo, Japan	Shizuoka University; Shizuoka University; Shizuoka University	Park, EY (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Biotechnol Lab, Shizuoka, Japan.	acypark@ipc.shizuoka.ac.jp	Kato, Tatsuya/E-3095-2010; Park, Enoch/AAU-2614-2020; Dong, Jinhua/D-2510-2015; Kohsaka, Tetsuya/I-1377-2019	Kato, Tatsuya/0000-0001-7990-2557; Dong, Jinhua/0000-0002-7417-1932; Kohsaka, Tetsuya/0000-0001-9093-8243; Park, Enoch Y./0000-0002-7840-1424	Ministry of Education, Culture, Sports, Science and Technology, Japan [22248009]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research (A) grant number 22248009 from the Ministry of Education, Culture, Sports, Science and Technology, Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson R, 2000, PARASITOL TODAY, V16, P110, DOI 10.1016/S0169-4758(99)01604-X; Baszler TV, 1996, J CLIN MICROBIOL, V34, P1423, DOI 10.1128/JCM.34.6.1423-1428.1996; BJERKAS I, 1984, Z PARASITENKD, V70, P271, DOI 10.1007/BF00942230; Bjorkman C, 1999, J VET DIAGN INVEST, V11, P41; Buxton D, 1997, J COMP PATHOL, V117, P1, DOI 10.1016/S0021-9975(97)80062-X; Debache K, 2008, INT J PARASITOL, V38, P1455, DOI 10.1016/j.ijpara.2008.04.001; Dong JH, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-19; Dong J, 2009, ANAL BIOCHEM, V386, P36, DOI 10.1016/j.ab.2008.11.045; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; DUBEY JP, 1988, J AM VET MED ASSOC, V193, P1259; DUBEY JP, 1990, J PARASITOL, V76, P127, DOI 10.2307/3282640; Hosseininejad M, 2009, VET PARASITOL, V164, P315, DOI 10.1016/j.vetpar.2009.05.029; Howe DK, 1998, INFECT IMMUN, V66, P5322, DOI 10.1128/IAI.66.11.5322-5328.1998; KOHLER G, 1976, EUR J IMMUNOL, V6, P511, DOI 10.1002/eji.1830060713; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDSAY DS, 1995, AM J VET RES, V56, P1176; LITMAN GW, 1993, MOL BIOL EVOL, V10, P60; Osawa T, 1998, VET PARASITOL, V79, P19, DOI 10.1016/S0304-4017(98)00156-3; Packham AE, 1998, CLIN DIAGN LAB IMMUN, V5, P467, DOI 10.1128/CDLI.5.4.467-473.1998; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Schier R, 1996, J MOL BIOL, V255, P28, DOI 10.1006/jmbi.1996.0004; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Venturini MC, 1999, INT J PARASITOL, V29, P1705, DOI 10.1016/S0020-7519(99)00143-5; WILLIAMSON RA, 1993, P NATL ACAD SCI USA, V90, P4141, DOI 10.1073/pnas.90.9.4141; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626	26	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53264	10.1371/journal.pone.0053264	http://dx.doi.org/10.1371/journal.pone.0053264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308179	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429800034
J	Du, LY; Zhao, GY; Sun, SH; Zhang, XJ; Zhou, XJ; Guo, Y; Li, Y; Zhou, YS; Jiang, SB				Du, Lanying; Zhao, Guangyu; Sun, Shihui; Zhang, Xiujuan; Zhou, Xiaojun; Guo, Yan; Li, Ye; Zhou, Yusen; Jiang, Shibo			A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; VIRUS HEMAGGLUTININ; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; SURFACE DISPLAY; FC-RECEPTORS; DNA VACCINE; ELICITS; FERRETS; THERAPEUTICS	The highly pathogenic avian influenza (HPAI) H5N1 viruses, especially the laboratory-generated H5N1 mutants, have demonstrated the potential to cross the species barrier and infect mammals and humans. Consequently, the design of an effective and safe anti-H5N1 vaccine is essential. We previously demonstrated that the full-length hemagglutinin 1 (HA1) could induce significant neutralizing antibody response and protection. Here, we intended to identify the critical neutralizing domain (CND) in an optimal conformation that can elicit strong cross-neutralizing antibodies and protection against divergent H5N1 strains. We thus constructed six recombinant proteins covering different regions of HA1 of A/Anhui/1/2005(H5N1), each of which was fused with foldon (Fd) and Fc of human IgG. We found that the critical fragment fused with Fd/Fc (HA-13-263-Fdc, H5 numbering) that could elicit the strongest neutralizing antibody response is located in the N-terminal region of HA1 (residues 13-263), which covers the receptor-binding domain (RBD, residues 112-263). We then constructed three additional recombinants fused with Fd plus His tag (HA-13-263-Fd-His), Fc only (HA-13-263-Fc), and His tag only (HA-13-263-His), respectively. We found that the HA-13-263-Fdc, which formed an oligomeric conformation, induced the strongest neutralizing antibody response and cross-protection against challenges of two tested H5N1 virus strains covering clade 1:A/VietNam/1194/2004 (VN/1194) or clade 2.3.4: A/Shenzhen/406H/06 (SZ/406H), while HA-13-263-Fc dimer and HA-13-263-Fd-His trimer elicited higher neutralizing antibody response and protection than HA-13-263-His monomer. These results suggest that the oligomeric form of the CND containing the RBD can be further developed as an effective and safe vaccine for cross-protection against divergent strains of H5N1 viruses.	[Du, Lanying; Zhang, Xiujuan; Li, Ye; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Zhao, Guangyu; Sun, Shihui; Zhou, Xiaojun; Guo, Yan; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Li, Ye] Wenzhou Med Coll, Sch Med Lab Sci, Wenzhou, Zhejiang, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Hlth, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China	New York Blood Center; Beijing Institute of Microbiology & Epidemiology; Wenzhou Medical University; Fudan University; Fudan University; Fudan University	Zhou, YS (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	yszhou@bmi.ac.cn; sjiang@nybloodcenter.org	Zhang, Xiujuan/AAG-9780-2020; Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) of the United States [R03AI088449]; National 973 Basic Research Program of China [2005CB523001]; Chinese Ministry of Science & Technology, Hong Kong, Macau, and Taiwan Collaborative Programs [201200007673]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI088449] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) of the United States; National 973 Basic Research Program of China(National Basic Research Program of China); Chinese Ministry of Science & Technology, Hong Kong, Macau, and Taiwan Collaborative Programs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) of the United States (R03AI088449) to LD, from the National 973 Basic Research Program of China (2005CB523001) to YZ, and from the Chinese Ministry of Science & Technology, Hong Kong, Macau, and Taiwan Collaborative Programs (201200007673) to SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns KI, 2012, SCIENCE, V335, P660, DOI 10.1126/science.1217994; Berns KI, 2012, NATURE, V482, P153, DOI DOI 10.1038/482153A; Bodewes R, 2010, J VIROL, V84, P7943, DOI 10.1128/JVI.00549-10; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Chen X, 2010, J BIOL CHEM, V285, P25506, DOI 10.1074/jbc.M110.101170; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; Du LY, 2008, J IMMUNOL, V180, P948, DOI 10.4049/jimmunol.180.2.948; Du LY, 2007, VACCINE, V25, P2832, DOI 10.1016/j.vaccine.2006.10.031; Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555; Du LY, 2010, BIOCHEM BIOPH RES CO, V397, P580, DOI 10.1016/j.bbrc.2010.05.161; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Faden RR, 2012, SCIENCE, V335, P802, DOI 10.1126/science.1219668; Fouchier R, 2012, NATURE, V481, P257, DOI 10.1038/481257a; Garcia JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007918; Han T, 2011, BIOCHEM BIOPH RES CO, V409, P253, DOI 10.1016/j.bbrc.2011.04.139; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hessel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016247; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jiang SB, 2010, PROTEIN CELL, V1, P342, DOI 10.1007/s13238-010-0054-6; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Khurana S, 2011, VACCINE, V29, P5657, DOI 10.1016/j.vaccine.2011.06.014; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Langley JM, 2011, J INFECT DIS, V203, P1729, DOI 10.1093/infdis/jir172; Le Duc JW, 2012, BIOSECUR BIOTERROR, V10, P153, DOI 10.1089/bsp.2012.0006; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Loureiro S, 2011, J VIROL, V85, P3010, DOI 10.1128/JVI.01241-10; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Martyn JC, 2009, ARCH VIROL, V154, P1129, DOI 10.1007/s00705-009-0423-8; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; Osterholm MT, 2012, SCIENCE, V335, P801, DOI 10.1126/science.1218612; Patel A, 2009, VACCINE, V27, P3083, DOI 10.1016/j.vaccine.2009.03.023; Pleass RJ, 2009, PARASITE IMMUNOL, V31, P529, DOI 10.1111/j.1365-3024.2009.01101.x; Qi Z, 2010, BIOCHEM BIOPH RES CO, V398, P506, DOI 10.1016/j.bbrc.2010.06.109; Santiago FW, 2011, VACCINE, V29, P8888, DOI 10.1016/j.vaccine.2011.09.069; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tambyah PA, 2012, VACCINE, V30, P329, DOI 10.1016/j.vaccine.2011.10.088; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; Yen HL, 2009, P NATL ACAD SCI USA, V106, P286, DOI 10.1073/pnas.0811052106; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zhao GY, 2010, VACCINE, V28, P7233, DOI 10.1016/j.vaccine.2010.08.049; Zhou F, 2012, J VIROL, V86, P6970, DOI 10.1128/JVI.06930-11	48	25	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53568	10.1371/journal.pone.0053568	http://dx.doi.org/10.1371/journal.pone.0053568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320093	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429800058
J	How, J; Zhang, A; Phillips, M; Reynaud, A; Lu, SY; Pan, LX; Ho, HT; Yau, YH; Guskov, A; Pervushin, K; Shochat, SG; Eshaghi, S				How, Jonathan; Zhang, Ai; Phillips, Margaret; Reynaud, Aline; Lu, Si Yan; Pan, Lucy Xin; Ho, Hai Ting; Yau, Yin Hoe; Guskov, Albert; Pervushin, Konstantin; Shochat, Susana Geifman; Eshaghi, Said			Comprehensive Analysis and Identification of the Human STIM1 Domains for Structural and Functional Studies	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; HIGH-THROUGHPUT EXPRESSION; CRAC CHANNEL; MECHANISTIC INSIGHTS; ORAI1; PURIFICATION; CRYSTALLIZATION; ACTIVATION; STRATEGY	STIM1 is a Ca2+ sensor within the ER membrane known to activate the plasma membrane store-operated Ca2+ channel upon depletion of its target ion in the ER lumen. This activation is a crucial step to initiate the Ca2+ signaling cascades within various cell types. Human STIM1 is a 77.4 kDa protein consisting of various domains that are involved in Ca2+ sensing, oligomerization, and channel activation and deactivation. In this study, we identify the domains and boundaries in which functional and stable recombinant human STIM1 can be produced in large quantities. To achieve this goal, we cloned nearly 200 constructs that vary in their initial and terminal residues, length and presence of the transmembrane domain, and we conducted expression and purification analyses using these constructs. The results revealed that nearly half of the constructs could be expressed and purified with high quality, out of which 25% contained the integral membrane domain. Further analyses using surface plasmon resonance, nuclear magnetic resonance and a thermostability assay verified the functionality and integrity of these constructs. Thus, we have been able to identify the most stable and well-behaved domains of the hSTIM1 protein, which can be used for future in vitro biochemical and biophysical studies.	[How, Jonathan; Zhang, Ai; Phillips, Margaret; Reynaud, Aline; Lu, Si Yan; Pan, Lucy Xin; Ho, Hai Ting; Yau, Yin Hoe; Guskov, Albert; Pervushin, Konstantin; Shochat, Susana Geifman; Eshaghi, Said] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Eshaghi, S (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore.	said.eshaghi@ntu.edu.sg	Phillips, Margaret/AAZ-2298-2021; Pervushin, Konstantin/AAJ-6580-2020; Hoe, YAU Yin/A-2817-2011; Guskov, Albert/G-1286-2016	Phillips, Margaret/0000-0003-1654-8583; Pervushin, Konstantin/0000-0002-6393-4340; Hoe, YAU Yin/0000-0001-8136-2393; Guskov, Albert/0000-0003-2340-2216; Zhang, Ai/0000-0001-9372-0266	Nanyang Technological University; National Research Foundation [NRF-CRP4-2008-02]; Biomedical Research Council	Nanyang Technological University(Nanyang Technological University); National Research Foundation; Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by funding from Nanyang Technological University, the National Research Foundation grant NRF-CRP4-2008-02, and the Biomedical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Eshaghi Said, 2009, V498, P265, DOI 10.1007/978-1-59745-196-3_17; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Lecchi P, 1999, ANAL CHEM, V71, P2951, DOI 10.1021/ac981098r; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Niegowski D, 2006, INT J BIOL MACROMOL, V39, P83, DOI 10.1016/j.ijbiomac.2006.02.011; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; Shaw PJ, 2012, J PHYSL; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842	23	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53979	10.1371/journal.pone.0053979	http://dx.doi.org/10.1371/journal.pone.0053979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320111	Green Published, gold			2022-12-27	WOS:000313429800076
J	Mavroeidi, A; Aucott, L; Black, AJ; Fraser, WD; Reid, DM; Macdonald, HM				Mavroeidi, Alexandra; Aucott, Lorna; Black, Alison J.; Fraser, William D.; Reid, David M.; Macdonald, Helen M.			Seasonal Variation in 25(OH) D at Aberdeen (57 degrees N) and Bone Health Indicators- Could Holidays in the Sun and Cod Liver Oil Supplements Alleviate Deficiency?	PLOS ONE			English	Article							VITAMIN-D STATUS; FOOD-FREQUENCY QUESTIONNAIRES; DIETARY ASSESSMENT METHODS; POSTMENOPAUSAL WOMEN; 25-HYDROXYVITAMIN-D LEVELS; WEIGHED RECORDS; MINERAL DENSITY; EXPOSURE; SKIN; OSTEOPOROSIS	Vitamin D has been linked with many health outcomes. The aim of this longitudinal study, was to assess predictors of seasonal variation of 25-hydroxy-vitamin D (25(OH) D) (including use of supplements and holidays in sunny destinations) at a northerly latitude in the UK (57 degrees N) in relation to bone health indicators. 365 healthy postmenopausal women (mean age 62.0 y (SD 1.4)) had 25(OH) D measurements by immunoassay, serum C-telopeptide (CTX), estimates of sunlight exposure (badges of polysulphone film), information regarding holidays in sunny destinations, and diet (from food diaries, including use of supplements such as cod liver oil (CLO)) at fixed 3-monthly intervals over 15 months (subject retention 88%) with an additional 25(OH) D assessment in spring 2008. Bone mineral density (BMD) at the lumbar spine (LS) and dual hip was measured in autumn 2006 and spring 2007 (Lunar I-DXA). Deficiency prevalence (25(OH) D<25 nmol/L) was reduced in women who went on holiday to sunny destinations 3 months prior to their visit, compared to women who did not go on holidays [5.4% vs. 24.6% in Spring (p<0.001) and 3.8% vs. 25.6% in Winter (p = 0.001), respectively]. Similarly deficiency was lower amongst those who took CLO supplements compared to women that did not consume these supplements [2.0% vs. 23.7% in Spring (p = 0.001) and 4.5% vs. 24.8% in winter (p = 0.005), respectively]. There was no seasonal variation in CTX; 25(OH) D predicted a small proportion (1.8% variation) of LS BMD in spring 2007 [unstandardized beta (SE): 0.039 (0.016), p = 0.017]. Seasonal variation of 25(OH) D had little effect on BMD and no effect on CTX. It appears that small increments in vitamin D (e. g. those that can be achieved by cod liver oil supplements of 5 mu g/day) are sufficient to ensure that 25(OH) D is above 25 nmol/L for most people throughout the year. Similarly, holidays in sunny destinations show benefit.	[Mavroeidi, Alexandra; Aucott, Lorna; Black, Alison J.; Reid, David M.; Macdonald, Helen M.] Univ Aberdeen, Musculoskeletal Res Programme, Aberdeen, Scotland; [Fraser, William D.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Aberdeen; University of East Anglia	Macdonald, HM (corresponding author), Univ Aberdeen, Musculoskeletal Res Programme, Aberdeen, Scotland.	h.macdonald@abdn.ac.uk	Mavroeidi, Alexandra/AAW-8827-2020	Aucott, Lorna/0000-0001-6277-7972; Mavroeidi, Alexandra/0000-0001-5213-1596	United Kingdom Food Standards Agency [N05062]	United Kingdom Food Standards Agency	This work was funded by the United Kingdom Food Standards Agency (N05062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Department of Health, 1998, NUTR BON HLTH PART R; Engelsen O, 2005, PHOTOCHEM PHOTOBIOL, V81, P1287, DOI 10.1562/2004-11-19-RN-375; Giovannucci E, 2009, ANN EPIDEMIOL, V19, P84, DOI 10.1016/j.annepidem.2007.12.002; Hall LM, 2010, J NUTR, V140, P542, DOI 10.3945/jn.109.115253; Harrison GI, 2002, METHODS, V28, P14, DOI 10.1016/S1046-2023(02)00205-0; Henderson L, 2009, NATL DIET NUTR SURVE, P3; Hill TR, 2007, INT J VITAM NUTR RES, V77, P320, DOI 10.1024/0300-9831.77.5.320; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Kuchuk NO, 2009, J BONE MINER RES, V24, P693, DOI 10.1359/JBMR.081209; Macdonald HM, 2011, OSTEOPOROSIS INT, V22, P2461, DOI 10.1007/s00198-010-1467-z; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; Macdonald HM, 2011, J CLIN ENDOCR METAB, V96, P1677, DOI 10.1210/jc.2010-2032; Macdonald HM, 2006, J BONE MINER RES, V21, P151, DOI 10.1359/JBMR.050906; MacDonald HM, 2005, PUBLIC HEALTH NUTR, V8, P409, DOI 10.1079/PHN2005705; Mavroeidi A, 2010, J STEROID BIOCHEM, V121, P459, DOI 10.1016/j.jsbmb.2010.03.038; Mavroeidi A, 2009, OSTEOPOROSIS INT, V20, P409, DOI 10.1007/s00198-008-0681-4; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; MetOffice, 2012, UK ACT AN MAPS; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Pasco JA, 2004, J BONE MINER RES, V19, P752, DOI 10.1359/JBMR.040125; Pasco JA, 2001, MED J AUSTRALIA, V175, P401, DOI 10.5694/j.1326-5377.2001.tb143643.x; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Rapuri PB, 2002, J CLIN ENDOCR METAB, V87, P2024, DOI 10.1210/jc.87.5.2024; Rhodes LE, 2010, J INVEST DERMATOL; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Thieden E, 2006, BRIT J DERMATOL, V154, P133, DOI 10.1111/j.1365-2133.2005.06961.x; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	33	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53381	10.1371/journal.pone.0053381	http://dx.doi.org/10.1371/journal.pone.0053381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308207	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800044
J	Chellappa, V; Taylor, KN; Pedrick, K; Donado, C; Netravali, IA; Haider, K; Cariappa, A; Dalomba, NF; Pillai, S				Chellappa, Vasant; Taylor, Kendra N.; Pedrick, Kathryn; Donado, Carlos; Netravali, Ilka Arun; Haider, Khaleda; Cariappa, Annaiah; Dalomba, Natasha F.; Pillai, Shiv			M89V Sialic Acid Acetyl Esterase (SIAE) and All Other Non-Synonymous Common Variants of This Gene Are Catalytically Normal	PLOS ONE			English	Article							DISEASE	Catalytically defective rare variants of Sialic acid Acetyl Esterase (SIAE) have previously been linked to autoimmunity. Studies presented here confirm that the M89V SIAE protein and all other products of common variant alleles of SIAE are catalytically normal. Although overexpressing transfected non-lymphoid cells secrete small amounts of SIAE that can associate with the cell surface, normal human lymphocytes do not exhibit cell surface SIAE, supporting genetic evidence in mice that indicates that this protein functions in a lymphocyte intrinsic manner. Analyses of the plasma proteome also indicate that SIAE is not secreted in vivo. A re-analysis exclusively of catalytically defective rare variant alleles of SIAE in subjects in which this gene was completely sequenced confirmed an association of SIAE with autoimmunity. A subset of catalytically defective rare variant SIAE alleles has previously been typed in a large genotyping study comparing a diverse group of disease subjects and controls; our re-analysis of this data shows that catalytically defective alleles are enriched in disease subjects. These data suggest that SIAE may be associated with autoimmunity and that further study of catalytically defective rare variant SIAE alleles in terms of autoimmune disease susceptibility is strongly warranted.	[Chellappa, Vasant; Taylor, Kendra N.; Pedrick, Kathryn; Donado, Carlos; Netravali, Ilka Arun; Haider, Khaleda; Cariappa, Annaiah; Dalomba, Natasha F.; Pillai, Shiv] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Pillai, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA.	pillai@helix.mgh.harvard.edu			National Institutes of Health [AI076505, AR058481, AI064930]; Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076505, R01AI064930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC1AR058481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funds supporting this study were received from grants from the National Institutes of Health - www.nih.gov (grants AI076505, AR058481 and AI064930) and a grant from the Alliance for Lupus Research (www.lupusresearch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cariappa A, 2009, J EXP MED, V206, P125, DOI 10.1084/jem.20081399; Higa HH, 1989, J BIOL CHEM, V264; Hirschfield GM, 2012, GENES IMMUN, V13, P328, DOI 10.1038/gene.2011.89; Hunt KA, 2012, NAT GENET, V44, P3, DOI 10.1038/ng.1037; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Pillai S, 2009, TRENDS IMMUNOL, V30, P488, DOI 10.1016/j.it.2009.07.006; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Surolia I, 2010, NATURE, V466, P243, DOI 10.1038/nature09115; Szymanski K, 2011, TISSUE ANTIGENS, V78, P214, DOI 10.1111/j.1399-0039.2011.01703.x	10	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53453	10.1371/journal.pone.0053453	http://dx.doi.org/10.1371/journal.pone.0053453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308225	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100068
J	Guarnieri, S; Morabito, C; Paolini, C; Boncompagni, S; Pilla, R; Fano-Illic, G; Mariggio, MA				Guarnieri, Simone; Morabito, Caterina; Paolini, Cecilia; Boncompagni, Simona; Pilla, Raffaele; Fano-Illic, Giorgio; Mariggio, Maria A.			Growth Associated Protein 43 Is Expressed in Skeletal Muscle Fibers and Is Localized in Proximity of Mitochondria and Calcium Release Units	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; 3-DIMENSIONAL STRUCTURE; PHOSPHOPROTEIN B-50; GENE-EXPRESSION; MAMMALIAN RED; GAP-43; CELLS; BIN1; IDENTIFICATION; NEUROMODULIN	The neuronal Growth Associated Protein 43 (GAP43), also known as B-50 or neuromodulin, is involved in mechanisms controlling pathfinding and branching of neurons during development and regeneration. For many years this protein was classified as neuron-specific, but recent evidences suggest that a) GAP43 is expressed in the nervous system not only in neurons, but also in glial cells, and b) probably it is present also in other tissues. In particular, its expression was revealed in muscles from patients affected by various myopathies, indicating that GAP43 can no-longer considered only as a neuron-specific molecule. We have investigated the expression and subcellular localization of GAP43 in mouse satellite cells, myotubes, and adult muscle (extensor digitorum longus or EDL) using Western blotting, immuno-fluorescence combined to confocal microscopy and electron microscopy. Our in vitro results indicated that GAP43 is indeed expressed in both myoblasts and differentiating myotubes, and its cellular localization changes dramatically during maturation: in myoblasts the localization appeared to be mostly nuclear, whereas with differentiation the protein started to display a sarcomeric-like pattern. In adult fibers, GAP43 expression was evident with the protein labeling forming (in longitudinal views) a double cross striation reminiscent of the staining pattern of other organelles, such as calcium release units (CRUs) and mitochondria. Double immuno-staining and experiments done in EDL muscles fixed at different sarcomere lengths, allowed us to determine the localization, from the sarcomere Z-line, of GAP43 positive foci, falling between that of CRUs and of mitochondria. Staining of cross sections added a detail to the puzzle: GAP43 labeling formed a reticular pattern surrounding individual myofibrils, but excluding contractile elements. This work leads the way to further investigation about the possible physiological and structural role of GAP43 protein in adult fiber function and disease.	[Guarnieri, Simone; Morabito, Caterina; Paolini, Cecilia; Boncompagni, Simona; Fano-Illic, Giorgio; Mariggio, Maria A.] Univ G DAnnunzio, DNI, Chieti, Italy; [Guarnieri, Simone; Morabito, Caterina; Paolini, Cecilia; Boncompagni, Simona; Pilla, Raffaele; Fano-Illic, Giorgio; Mariggio, Maria A.] Univ G DAnnunzio, Ctr Res Ageing CeSI, Chieti, Italy; [Guarnieri, Simone; Morabito, Caterina; Paolini, Cecilia; Boncompagni, Simona; Pilla, Raffaele; Fano-Illic, Giorgio; Mariggio, Maria A.] Univ G DAnnunzio, IIM, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Mariggio, MA (corresponding author), Univ G DAnnunzio, DNI, Chieti, Italy.	mariggio@unich.it	Pilla, Raffaele/I-4459-2019; Mariggiò, Maria Addolorata/T-9047-2017; Fanò-Illic, Giorgio/AAU-5731-2021; Paolini, Cecilia/AAI-4444-2021; Guarnieri, Simone/AAA-5921-2020	Pilla, Raffaele/0000-0002-4326-3279; Mariggiò, Maria Addolorata/0000-0001-5306-7143; Morabito, Caterina/0000-0002-5144-2584; Mariggio, Maria Addolorata/0000-0002-3508-8706; Guarnieri, Simone/0000-0002-2916-2965; Fano Illic, Giorgio/0000-0002-8753-5707	G. d'Annunzio University	G. d'Annunzio University	This work was supported by G. d'Annunzio University research funds to SG and MAM. The authors have no conflicts of interest or financial ties to disclose. No external funding sources were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; AIREY JA, 1990, J BIOL CHEM, V265, P14187; Al-Shanti N, 2009, BIOL REV, V84, P637, DOI 10.1111/j.1469-185X.2009.00090.x; ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; DACUNHA A, 1990, J CELL BIOL, V111, P209, DOI 10.1083/jcb.111.1.209; DELOULME JC, 1990, J CELL BIOL, V111, P1559, DOI 10.1083/jcb.111.4.1559; Dent EW, 1998, J NEUROBIOL, V35, P287, DOI 10.1002/(SICI)1097-4695(19980605)35:3<287::AID-NEU6>3.0.CO;2-V; Fanzani A, 2007, BIOCHEM BIOPH RES CO, V357, P314, DOI 10.1016/j.bbrc.2007.03.148; FLUCHER BE, 1993, J CELL BIOL, V123, P1161, DOI 10.1083/jcb.123.5.1161; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Gardner KL, 2006, J CELL PHYSIOL, V206, P196, DOI 10.1002/jcp.20449; HEUB D, 1995, VIRCHOWS ARCH, V426, P69, DOI 10.1007/BF00194700; HEUSS D, 1994, VIRCHOWS ARCH, V425, P101; Heuss D, 1998, NEUROL RES, V20, P360; Korshunova I, 2007, J NEUROCHEM, V100, P1599, DOI 10.1111/j.1471-4159.2006.04316.x; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Ma JJ, 2007, J ORTHOP RES, V25, P1498, DOI 10.1002/jor.20414; Ma JJ, 2005, J ORTHOP RES, V23, P302, DOI 10.1016/j.orthres.2004.08.027; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Morabito C, 2010, FREE RADICAL BIO MED, V48, P579, DOI 10.1016/j.freeradbiomed.2009.12.005; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Musaro A, 2010, METHODS MOL BIOL, V633, P101, DOI 10.1007/978-1-59745-019-5_8; Neve RL, 1998, J NEUROSCI, V18, P7757; OESTREICHER AB, 1981, BRAIN RES BULL, V6, P145, DOI 10.1016/S0361-9230(81)80040-8; OESTREICHER AB, 1982, J NEUROCHEM, V39, P683, DOI 10.1111/j.1471-4159.1982.tb07947.x; OGATA T, 1985, CELL TISSUE RES, V242, P461; OGATA T, 1985, CELL TISSUE RES, V241, P251, DOI 10.1007/BF00217168; Ohsawa S, 2008, BIOCHEM BIOPH RES CO, V371, P639, DOI 10.1016/j.bbrc.2008.04.056; Salamon M, 2003, J MOL BIOL, V326, P137, DOI 10.1016/S0022-2836(02)01335-9; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Shen YP, 2002, J NEUROSCI, V22, P239, DOI 10.1523/JNEUROSCI.22-01-00239.2002; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Stocker K M, 1992, Perspect Dev Neurobiol, V1, P53; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Stroffekova K, 2008, PFLUG ARCH EUR J PHY, V455, P873, DOI 10.1007/s00424-007-0344-x; Tjondrokoesoemo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025740; Toussaint A, 2011, ACTA NEUROPATHOL, V121, P253, DOI 10.1007/s00401-010-0754-2; VITKOVIC L, 1988, P NATL ACAD SCI USA, V85, P8296, DOI 10.1073/pnas.85.21.8296; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; Yamaguchi N, 2011, AM J PHYSIOL-CELL PH, V300, pC998, DOI 10.1152/ajpcell.00370.2010; Zhang F, 2000, DEVELOPMENT, V127, P969	46	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53267	10.1371/journal.pone.0053267	http://dx.doi.org/10.1371/journal.pone.0053267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308181	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429100048
J	Jain, P; Vig, S; Datta, M; Jindel, D; Mathur, AK; Mathur, SK; Sharma, A				Jain, Priyanka; Vig, Saurabh; Datta, Malabika; Jindel, Dinesh; Mathur, Ashok Kumar; Mathur, Sandeep Kumar; Sharma, Abhay			Systems Biology Approach Reveals Genome to Phenome Correlation in Type 2 Diabetes	PLOS ONE			English	Article							DYSTROPHIN-DYSTROGLYCAN COMPLEX; BETA-CELL DYSFUNCTION; WIDE ASSOCIATION DATA; INSULIN-RESISTANCE; COMMON VARIANTS; ADIPOSE-TISSUE; METABOLIC SYNDROME; FUNCTIONAL IMPACT; SKELETAL-MUSCLE; GENE-EXPRESSION	Genome-wide association studies (GWASs) have discovered association of several loci with Type 2 diabetes (T2D), a common complex disease characterized by impaired insulin secretion by pancreatic beta cells and insulin signaling in target tissues. However, effect of genetic risk variants on continuous glycemic measures in nondiabetic subjects mainly elucidates perturbation of insulin secretion. Also, the disease associated genes do not clearly converge on functional categories consistent with the known aspects of T2D pathophysiology. We used a systems biology approach to unravel genome to phenome correlation in T2D. We first examined enrichment of pathways in genes identified in T2D GWASs at genome-wide or lower levels of significance. Genes at lower significance threshold showed enrichment of insulin secretion related pathway. Notably, physical and genetic interaction network of these genes showed robust enrichment of insulin signaling and other T2D pathophysiology related pathways including insulin secretion. The network also overrepresented genes reported to interact with insulin secretion and insulin action targeting antidiabetic drugs. The drug interacting genes themselves showed overrepresentation of insulin signaling and other T2D relevant pathways. Next, we generated genome-wide expression profiles of multiple insulin responsive tissues from nondiabetic and diabetic patients. Remarkably, the differentially expressed genes showed significant overlap with the network genes, with the intersection showing enrichment of insulin signaling and other pathways consistent with T2D pathophysiology. Literature search led our genomic, interactomic, transcriptomic and toxicogenomic evidence to converge on TGF-beta signaling, a pathway known to play a crucial role in pancreatic islets development and function, and insulin signaling. Cumulatively, we find that GWAS genes relate directly to insulin secretion and indirectly, through collaborating with other genes, to insulin resistance. This seems to support the epidemiological evidence that environmentally triggered insulin resistance interacts with genetically programmed beta cell dysfunction to precipitate diabetes.	[Jain, Priyanka; Vig, Saurabh; Datta, Malabika; Sharma, Abhay] CSIR, Funct Genom Unit, CSIR Inst Genom & Integrat Biol, Delhi, India; [Jindel, Dinesh; Mathur, Ashok Kumar] Sawai Man Singh Med Coll, Dept Surg, Jaipur, Rajasthan, India; [Mathur, Sandeep Kumar] Sawai Man Singh Med Coll, Dept Endocrinol, Jaipur, Rajasthan, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); SMS Medical College & Hospital; SMS Medical College & Hospital	Sharma, A (corresponding author), CSIR, Funct Genom Unit, CSIR Inst Genom & Integrat Biol, Delhi, India.	abhaysharma@igib.res.in	Jain, Priyanka/GPT-4181-2022	Jain, Priyanka/0000-0002-2679-1889; Sharma, Abhay/0000-0003-1306-1497; vig, saurabh/0000-0002-0352-987X	Council of Scientific and Industrial Research, Government of India [NWP0032]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The research was funded by NWP0032 network project entitled "Diabetes mellitus - New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors" of Council of Scientific and Industrial Research, Government of India (http://rdpp.csir.res.in/csir_acsir/Home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NAT GENET, V44, P733, DOI 10.1038/ng.2345; Bajaj M, 2007, DIABETES, V56, P743, DOI 10.2337/db06-0840; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergholdt R, 2012, DIABETES, V61, P954, DOI 10.2337/db11-1263; Berria R, 2006, AM J PHYSIOL-ENDOC M, V290, pE560, DOI 10.1152/ajpendo.00202.2005; Billings LK, ANN NY ACAD SCI, V1212, P59; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Brown ML, 2010, TRENDS ENDOCRIN MET, V21, P441, DOI 10.1016/j.tem.2010.02.008; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Chatr-aryamontri A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S8; Chen T, 2011, J ENDOCRINOL INVEST, V34, P742; Coletta DK, 2011, AM J PHYSIOL-ENDOC M, V301, pE749, DOI 10.1152/ajpendo.00363.2011; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Davis AP, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar065; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Diamond-Stanic MK, 2011, BIOCHEM BIOPH RES CO, V405, P439, DOI 10.1016/j.bbrc.2011.01.049; Diaz E, 2011, JOVE-J VIS EXP, DOI 10.3791/2546; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Edlund H, 2001, DIABETES, V50, pS5, DOI 10.2337/diabetes.50.2007.S5; Eyster CA, 2009, VITAM HORM, V80, P193, DOI 10.1016/S0083-6729(08)00608-0; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Friedrich N, 2012, J ENDOCRINOL, V215, P29, DOI 10.1530/JOE-12-0120; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gupta D, 2012, CURR DIABETES REV, V8, P76, DOI 10.2174/157339912799424564; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hayden MR, 2010, OXID MED CELL LONGEV, V3, P290, DOI 10.4161/oxim.3.5.13653; Hinault C, 2011, DIABETES, V60, P1210, DOI 10.2337/db09-1379; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2011, ANNU REV MED, V62, P11, DOI 10.1146/annurev.med.091708.162036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim W, 2010, BIOCHEM BIOPH RES CO, V392, P247, DOI 10.1016/j.bbrc.2009.12.115; Klutstein M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-478; Kodama K, 2012, P NATL ACAD SCI USA, V109, P7049, DOI 10.1073/pnas.1114513109; Kolb H, 2012, NAT REV ENDOCRINOL, V8, P183, DOI 10.1038/nrendo.2011.158; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Li HZ, 2012, HUM GENET, V131, P1395, DOI 10.1007/s00439-012-1178-y; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Lolmede K, 2011, DIABETES METAB, V37, P283, DOI 10.1016/j.diabet.2011.03.002; Lopez D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-282; Luo R, 2012, AM J HUM GENET, V91, P38, DOI 10.1016/j.ajhg.2012.05.011; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marian AJ, 2012, TRANSL RES, V159, P64, DOI 10.1016/j.trsl.2011.08.001; Martha VS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S7; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mulvey C, 2005, EUR J CELL BIOL, V84, P867, DOI 10.1016/j.ejcb.2005.06.007; Mulvey C, 2008, MOL MED REP, V1, P297; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; Nikolajczyk BS, 2011, GENES IMMUN, V12, P239, DOI 10.1038/gene.2011.14; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Osier MV, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-124; Oussaief L, 2009, J BIOL CHEM, V284, P23912, DOI 10.1074/jbc.M109.036483; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Palsgaard J, 2012, J BIOL CHEM, V287, P12016, DOI 10.1074/jbc.M111.337048; Patel CJ, 2012, BIOINFORMATICS, V28, pI121, DOI 10.1093/bioinformatics/bts229; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; PIMENTA W, 1995, JAMA-J AM MED ASSOC, V273, P1855, DOI 10.1001/jama.273.23.1855; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Rao AA, 2007, LIPIDS HLTH DIS, V14, P6; Richard AJ, 2011, TRENDS ENDOCRIN MET, V22, P325, DOI 10.1016/j.tem.2011.03.007; Rogers C, 2012, J CLIN ENDOCR METAB, V97, pE329, DOI 10.1210/jc.2011-1033; Roman AA, 2012, ENDOCRINE, V42, P243, DOI 10.1007/s12020-012-9698-8; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Shen N, 2011, J BIOL CHEM, V286, P14508, DOI 10.1074/jbc.M110.190165; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Swallow CJ, 2004, CANCER RES, V64, P6402, DOI 10.1158/0008-5472.CAN-04-1117; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Tabassum R, 2012, DIABETES IN PRESS; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Tavana O, 2011, CELL CYCLE, V10, P2471, DOI 10.4161/cc.10.15.16741; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Watada H, 2010, ENDOCR J, V57, P185, DOI 10.1507/endocrj.K09E-035; Weiss Ram, 2006, Curr Diab Rep, V6, P182, DOI 10.1007/s11892-006-0032-9; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Winter AG, 2011, BIOINFORMATICS, V27, P1043, DOI 10.1093/bioinformatics/btr062; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yamagata K, 2003, ENDOCR J, V50, P491, DOI 10.1507/endocrj.50.491; You HJ, 2007, CARCINOGENESIS, V28, P2491, DOI 10.1093/carcin/bgm195; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	90	34	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53522	10.1371/journal.pone.0053522	http://dx.doi.org/10.1371/journal.pone.0053522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308243	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100081
J	Womac, DJ; Palanisamy, AP; Eslick, R; Schimpf, DK; Chavin, KD				Womac, Daniel John; Palanisamy, Arun Prathap; Eslick, Rene; Schimpf, Dennis Kenneth; Chavin, Kenneth David			Development of a Mouse Model of Abdominal Cutaneous Flaps for Breast Reconstruction	PLOS ONE			English	Article							DONOR-SITE COMPLICATIONS; ISLAND SKIN FLAP; BODY-WEIGHT; OBESITY; CANCER; RAT; MORTALITY; STAGE; RISK	Autologous tissue transfer, in addition to replacing tissue that was lost during injury or surgery, offers women an excellent option to improve cosmetic appearance and self-confidence following mastectomy due to breast cancer. However, flap necrosis is a complication in obese patients undergoing this procedure. We created a mouse model to study the flap-related complications that leads to decreased flap survival in autologous breast reconstruction. Methods: Left superficial inferior epigastric (SIE) pedicle abdominal-cutaneous flaps were elevated in 8 week-old, obese ob/ob male mice and their lean littermates. Flaps were followed by serial photography. Area of flap necrosis was measured at 7 days. Statistical analysis was performed. Results: Necrosis was observed at the distal margin of the flaps, in both lean and obese groups. Lean left SIE flaps (n = 8) had a total area flap necrosis of 9.1% at 7 days whereas obese left SIE flaps (n = 8) had a total area flap necrosis of 45.5% at 7 days. Obese flaps had a statistically significant increase in necrosis compared to the lean flaps, p = 0.001. Conclusions: There was a significant difference between flap survival in lean and obese SIE pedicle flaps in our mouse model. We have developed the first flap model of obesity utilizing the superficial epigastric pedicle in the mouse. This model is optimal for future studies to dissect out mechanisms that lead to the complications related to flap survival for breast reconstruction, especially in obese subjects.	[Womac, Daniel John; Palanisamy, Arun Prathap; Eslick, Rene; Chavin, Kenneth David] Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA; [Schimpf, Dennis Kenneth] Med Univ S Carolina, Dept Surg, Div Plast Surg, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Palanisamy, AP (corresponding author), Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA.	arunp@musc.edu	Palanisamy, Arun/I-7712-2019; Palanisamy, Arun/L-2019-2014	Palanisamy, Arun/0000-0002-7793-0682; Palanisamy, Arun/0000-0002-7793-0682	American Cancer Society [RSG-06-262-01-CCE]	American Cancer Society(American Cancer Society)	This study was supported by the American Cancer Society grant titled "Effects of Obesity on Musculocutaneous Flaps Used for Breast Reconstruction", Grant # RSG-06-262-01-CCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chang DW, 2000, PLAST RECONSTR SURG, V105, P1640, DOI 10.1097/00006534-200004050-00007; Cui YD, 2002, INT J CANCER, V98, P279, DOI 10.1002/ijc.10209; DUNN RM, 1992, PLAST RECONSTR SURG, V90, P319, DOI 10.1097/00006534-199290020-00026; Enger SM, 2004, ARCH SURG-CHICAGO, V139, P954, DOI 10.1001/archsurg.139.9.954; FINSETH F, 1978, PLAST RECONSTR SURG, V61, P412, DOI 10.1097/00006534-197803000-00016; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Harder Y, 2004, J SURG RES, V121, P197, DOI 10.1016/j.jss.2004.03.026; Ingalls AM, 1996, OBES RES, V4, P101, DOI 10.1002/j.1550-8528.1996.tb00519.x; Kroll SS, 1998, PLAST RECONSTR SURG, V102, P1502, DOI 10.1097/00006534-199810000-00024; KROLL SS, 1989, PLAST RECONSTR SURG, V84, P886, DOI 10.1097/00006534-198912000-00003; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Losken A, 2001, PLAST RECONSTR SURG, V107, P1504, DOI 10.1097/00006534-200105000-00032; MCFARLANE R M, 1965, Plast Reconstr Surg, V35, P177, DOI 10.1097/00006534-196502000-00007; Moran SL, 2001, PLAST RECONSTR SURG, V108, P1954, DOI 10.1097/00006534-200112000-00017; OZCAN G, 1991, ANN PLAS SURG, V27, P332, DOI 10.1097/00000637-199110000-00008; Padubidri AN, 1997, ANN PLAS SURG, V39, P500, DOI 10.1097/00000637-199711000-00010; Reyna RE, 2006, AM SURGEON, V72, P764; Selber JC, 2006, ANN PLAS SURG, V56, P492, DOI 10.1097/01.sap.0000210180.72721.4a; Spear SL, 2007, PLAST RECONSTR SURG, V119, P788, DOI 10.1097/01.prs.0000252003.14537.d2; Stoll BA, 1998, INT J OBESITY, V22, P1035, DOI 10.1038/sj.ijo.0800769; Tatlidede S, 2009, J SURG RES, V154, P112, DOI 10.1016/j.jss.2008.05.029; Wingo PA, 2000, CANCER CAUSE CONTROL, V11, P497, DOI 10.1023/A:1008944209648	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52829	10.1371/journal.pone.0052829	http://dx.doi.org/10.1371/journal.pone.0052829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308122	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100016
J	Yang, H; Chen, HZ; Liu, ZH; Ma, H; Qin, LH; Jin, RL; Zheng, RJ; Feng, YH; Cui, ZL; Wang, J; Liu, JM; Hu, ZY				Yang, Hua; Chen, Haizhen; Liu, Zhonghua; Ma, Hui; Qin, Lianhua; Jin, Ruiliang; Zheng, Ruijuan; Feng, Yonghong; Cui, Zhenling; Wang, Jie; Liu, Jinming; Hu, Zhongyi			A Novel B-Cell Epitope Identified within Mycobacterium tuberculosis CFP10/ESAT-6 Protein	PLOS ONE			English	Article							PEPTIDE MIMOTOPES; IMMUNOLOGICAL DIAGNOSIS; ANTIBODY-RESPONSES; ANTIGENS; ESAT-6; SERODIAGNOSIS; PATHOGENESIS; PREDICTION; SELECTION; COMPLEX	Background: The 10-kDa culture filtrate protein (CFP10) and 6-kDa early-secreted target antigen (ESAT-6) play important roles in mycobacterial virulence and pathogenesis through a 1:1 complex formation (CFP10/ESAT-6 protein, CE protein), which have been used in discriminating TB patients from BCG-vaccinated individuals. The B-cell epitopes of CFP10 and ESAT-6 separately have been analyzed before, however, the epitopes of the CE protein are unclear and the precise epitope in the positions 40 to 62 of ESAT-6 is still unknown. Methods: In the present study, we searched for the B-cell epitopes of CE protein by using phage-display library biopanning with the anti-CE polyclonal antibodies. The epitopes were identified by sequence alignment, binding affinity and specificity detection, generation of polyclonal mouse sera and detection of TB patient sera. Results: One linear B-cell epitope (KWDAT) consistent with the 162nd-166th sequence of CE and the 57th-61st sequence of ESAT-6 protein was selected and identified. Significantly higher titers of E5 peptide-binding antibodies were found in the sera of TB patients compared with those of healthy individuals. Conclusion: There was a B-cell epitope for CE and ESAT-6 protein in the position 40 to 62 of ESAT-6. E5 peptide may be useful in the serodiagnosis of tuberculosis, which need to be further confirmed by more sera samples.	[Yang, Hua; Liu, Zhonghua; Ma, Hui; Qin, Lianhua; Jin, Ruiliang; Zheng, Ruijuan; Feng, Yonghong; Cui, Zhenling; Wang, Jie; Hu, Zhongyi] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Shanghai Key Lab TB, Shanghai 200092, Peoples R China; [Liu, Jinming] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Resp Med, Shanghai 200092, Peoples R China; [Chen, Haizhen] Shanxi Med Univ, Clin Lab Diagnost, Taiyuan, Peoples R China	Tongji University; Tongji University; Shanxi Medical University	Liu, JM (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Resp Med, Shanghai 200092, Peoples R China.	jinmingliu_sh@hotmail.com; shhuzy@163.com			National Key Project for Infectious Disease [2012ZX10003002-008]; Science and Technology Commission of Shanghai Municipality, Shanghai, PR China [124119a1500]; Fundamental Research Funds for the Central Universities [1511219013]	National Key Project for Infectious Disease; Science and Technology Commission of Shanghai Municipality, Shanghai, PR China(Science & Technology Commission of Shanghai Municipality (STCSM)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grant from the National Key Project for Infectious Disease (No. 2012ZX10003002-008), the Science and Technology Commission of Shanghai Municipality, Shanghai, PR China (No. 124119a1500), and the Fundamental Research Funds for the Central Universities (No. 1511219013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodari NY, 2011, CLIN VACCINE IMMUNOL, V18, P477, DOI 10.1128/CVI.00405-10; Baassi L, 2009, INT J TUBERC LUNG D, V13, P848; Barenholz A, 2007, J MED MICROBIOL, V56, P579, DOI 10.1099/jmm.0.46920-0; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Chan ED, 2000, TUBERCLE LUNG DIS, V80, P131, DOI 10.1054/tuld.2000.0243; *CHIN ANT ASS, 1995, CHIN LAB SCI PROC DI, P9; Fuchs S, 2003, ANN NY ACAD SCI, V998, P93, DOI 10.1196/annals.1254.011; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Gennaro ML, 2000, CLIN INFECT DIS, V30, pS243, DOI 10.1086/313868; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; Gevorkian G, 2005, BIOCHEM J, V387, P411, DOI 10.1042/BJ20041139; Harboe M, 1998, INFECT IMMUN, V66, P717, DOI 10.1128/IAI.66.2.717-723.1998; Hoff ST, 2007, CLIN INFECT DIS, V45, P575, DOI 10.1086/520662; Huang YX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-538; Khan IH, 2008, CLIN VACCINE IMMUNOL, V15, P433, DOI 10.1128/CVI.00354-07; Kumar G, 2010, ARCH IMMUNOL THER EX, V58, P57, DOI 10.1007/s00005-009-0055-4; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lightbody KL, 2004, FEMS MICROBIOL LETT, V238, P255, DOI 10.1016/j.femsle.2004.07.043; Nahtman T, 2007, J IMMUNOL METHODS, V328, P1, DOI 10.1016/j.jim.2007.07.015; Pacios LF, 2008, MOL IMMUNOL, V45, P2269, DOI 10.1016/j.molimm.2007.11.022; Prudencio CR, 2010, VACCINE, V28, P5398, DOI 10.1016/j.vaccine.2010.06.021; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Saha A, 2005, APPL ENVIRON MICROB, V71, P7334, DOI 10.1128/AEM.71.11.7334-7344.2005; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Scala G, 1999, J IMMUNOL, V162, P6155; Sharma A, 2006, CLIN VACCINE IMMUNOL, V13, P1143, DOI 10.1128/CVI.00127-06; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Specter M., 2010, NEW YORKER, V86, P48; Spencer JS, 2004, INFECT IMMUN, V72, P3161, DOI 10.1128/IAI.72.6.3161-3170.2004; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Tordesillas L, 2009, MOL IMMUNOL, V47, P534, DOI 10.1016/j.molimm.2009.07.028; Ulises HC, 2009, PEPTIDES, V30, P2127, DOI 10.1016/j.peptides.2009.09.019; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000; Waters WR, 2004, CLIN DIAGN LAB IMMUN, V11, P729, DOI 10.1128/CDLI.11.4.729-735.2004; Weldingh K, 1999, FEMS IMMUNOL MED MIC, V23, P159, DOI 10.1111/j.1574-695X.1999.tb01235.x; Weldingh K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001978; WHO, 2011, COMM SER TESTS DIAGN; World Health Organisation, 2011, WHOHTMTB201116; Wu XQ, 2010, CLIN VACCINE IMMUNOL, V17, P372, DOI [10.1128/CVI.00287-09, 10.3785/j.issn.1006-754X.2010.05.011]; Yang H, 2011, J MED MICROBIOL, V60, P69, DOI 10.1099/jmm.0.025098-0	43	69	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52848	10.1371/journal.pone.0052848	http://dx.doi.org/10.1371/journal.pone.0052848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308124	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100018
J	Lei, GS; Zhang, C; Shao, SJ; Jung, HW; Durant, PJ; Lee, CH				Lei, Guang-Sheng; Zhang, Chen; Shao, Shoujin; Jung, Hsin-Wei; Durant, Pamela J.; Lee, Chao-Hung			All-Trans Retinoic Acid in Combination with Primaquine Clears Pneumocystis Infection	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; CARINII-PNEUMONIA; MYELOID CELLS; SUPPRESSOR-CELLS; ORGANISM BURDEN; DOWN-REGULATION; CANCER-PATIENTS; IMMUNE-SYSTEM; PU.1; EXPRESSION	Pneumocystis pneumonia (PcP) develops in immunocompromised patients. Alveolar macrophages play a key role in the recognition, phagocytosis, and degradation of Pneumocystis, but their number is decreased in PcP. Our study of various inflammatory components during PcP found that myeloid-derived suppressor cells (MDSCs) accumulate in the lungs of mice and rats with Pneumocystis pneumonia (PcP). We hypothesized that treatment with all-trans retinoic acid (ATRA), a metabolite of vitamin A, may effectively control Pneumocystis (Pc) infection by inducing MDSCs to differentiate to AMs. In rodent models of PcP, we found that 5 weeks of ATRA treatment reduced the number of MDSCs in the lungs and increased the number of AMs which cleared Pc infection. We also found that ATRA in combination with primaquine was as effective as the combination of trimethoprim and sulfamethaxazole for treatment of PcP and completely eliminated MDSCs and Pc organisms in the lungs in two weeks. No relapse of PcP was seen after three weeks of the ATRA-primaquine combination treatment. Prolonged survival of Pc-infected animals was also achieved by this regimen. This is the very first successful development of a therapeutic regimen for PcP that combines an immune modulator with an antibiotic, enabling the hosts to effectively defend the infection. Results of our study may serve as a model for development of novel therapies for other infections with MDSC accumulation.	[Lei, Guang-Sheng; Zhang, Chen; Shao, Shoujin; Jung, Hsin-Wei; Durant, Pamela J.; Lee, Chao-Hung] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington	Lee, CH (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA.	chlee@iupui.edu			National Institutes of Health [R01 AI062259, R03 AI091418]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062259, R03AI091418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by grants R01 AI062259 and R03 AI091418 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhagwat SP, 2010, J IMMUNOL, V184, P497, DOI 10.4049/jimmunol.0901864; Center for Drug Evaluation and Research FDA, 2005, GUID IND EST MAX SAF; CHEN WX, 1992, INT J EXP PATHOL, V73, P709; Eichbaum Q, 1997, BLOOD, V90, P4135, DOI 10.1182/blood.V90.10.4135; EICHBAUM QG, 1994, J EXP MED, V179, P1985, DOI 10.1084/jem.179.6.1985; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gigliotti F, 2006, INFECT IMMUN, V74, P6310, DOI 10.1128/IAI.00668-06; Gomez-Garcia L, 2005, PARASITE IMMUNOL, V27, P395, DOI 10.1111/j.1365-3024.2005.00790.x; GORDIN FM, 1984, ANN INTERN MED, V100, P495, DOI 10.7326/0003-4819-100-4-495; Helweg-Larsen J, 2009, J ANTIMICROB CHEMOTH, V64, P1282, DOI 10.1093/jac/dkp372; Jakubzick C, 2006, J IMMUNOL, V176, P3578, DOI 10.4049/jimmunol.176.6.3578; Kalyoncu U, 2007, SCAND J INFECT DIS, V39, P475, DOI 10.1080/00365540601071867; Komano Y, 2009, ARTHRIT RHEUM-ARTHR, V61, P305, DOI 10.1002/art.24283; Kovacs JA, 2009, JAMA-J AM MED ASSOC, V301, P2578, DOI 10.1001/jama.2009.880; Koziel H, 1998, J CLIN INVEST, V102, P1332, DOI 10.1172/JCI560; Kusmartsev S, 2003, CANCER RES, V63, P4441; Lasbury ME, 2007, J BIOL CHEM, V282, P11009, DOI 10.1074/jbc.M611686200; Lasbury ME, 2011, AM J RESP CELL MOL, V44, P540, DOI 10.1165/rcmb.2009-0367OC; Lasbury ME, 2004, INFECT IMMUN, V72, P2140, DOI 10.1128/IAI.72.4.2140-2147.2004; Lasbury ME, 2003, CLIN DIAGN LAB IMMUN, V10, P293, DOI 10.1128/CDLI.10.2.293-302.2003; Lathers DMR, 2004, CANCER IMMUNOL IMMUN, V53, P422, DOI 10.1007/s00262-003-0459-7; LEE JS, 1993, J CLIN ONCOL, V11, P959, DOI 10.1200/JCO.1993.11.5.959; Lee JM, 2012, INT J CANCER, V131, P741, DOI 10.1002/ijc.26411; Liao CP, 2009, J BIOL CHEM, V284, P8174, DOI 10.1074/jbc.M805787200; LU JJ, 1995, J CLIN MICROBIOL, V33, P2785, DOI 10.1128/JCM.33.10.2785-2788.1995; Martin SI, 2009, AM J TRANSPLANT, V9, pS227, DOI 10.1111/j.1600-6143.2009.02914.x; Mencacci A, 2002, J IMMUNOL, V169, P3180, DOI 10.4049/jimmunol.169.6.3180; Miller RF, 1999, CURR OPIN INFECT DIS, V12, P371, DOI 10.1097/00001432-199908000-00011; Mirza N, 2006, CANCER RES, V66, P9299, DOI 10.1158/0008-5472.CAN-06-1690; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; Nefedova Y, 2007, CANCER RES, V67, P11021, DOI 10.1158/0008-5472.CAN-07-2593; Panopoulos AD, 2002, J BIOL CHEM, V277, P19001, DOI 10.1074/jbc.M112271200; Patatanian E, 2008, J CLIN PHARM THER, V33, P331, DOI 10.1111/j.1365-2710.2008.00935.x; QUEENER SF, 1988, ANTIMICROB AGENTS CH, V32, P807, DOI 10.1128/AAC.32.6.807; Shiohira H, 2010, INT J MOL MED, V26, P393, DOI 10.3892/ijmm_00000478; Slatore CG, 2004, IMMUNOL ALLERGY CLIN, V24, P477, DOI 10.1016/j.iac.2004.03.011; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swain SD, 2006, AM J PATHOL, V168, P466, DOI 10.2353/ajpath.2006.050724; Terrazas LI, 2001, J IMMUNOL, V167, P5294, DOI 10.4049/jimmunol.167.9.5294; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011; Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Wang J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001058; Wright TW, 1999, J CLIN INVEST, V104, P1307, DOI 10.1172/JCI6688; Youn JI, 2011, J LEUKOC BIOL; Zhang C, 2006, INFECT IMMUN, V74, P1857, DOI 10.1128/IAI.74.3.1857-1864.2006; Zhang C, 2012, INFECT IMMUN; Zhang C, 2010, INFECT IMMUN, V78, P1058, DOI 10.1128/IAI.01141-09	49	20	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53479	10.1371/journal.pone.0053479	http://dx.doi.org/10.1371/journal.pone.0053479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308231	gold, Green Submitted, Green Published			2022-12-27	WOS:000313670100043
J	Ramachandran, A; Gangopadhyay, SS; Krishnan, R; Ranpura, SA; Rajendran, K; Ram-Mohan, S; Mulone, M; Gong, EM; Adam, RM				Ramachandran, Aruna; Gangopadhyay, Samudra S.; Krishnan, Ramaswamy; Ranpura, Sandeep A.; Rajendran, Kavitha; Ram-Mohan, Sumati; Mulone, Michelle; Gong, Edward M.; Adam, Rosalyn M.			JunB Mediates Basal- and TGF beta 1-Induced Smooth Muscle Cell Contractility	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; GROWTH-FACTOR-BETA; GENE-EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; ACTIN; FIBROBLASTS; MODULATION; INDUCTION; REGULATOR; PROTEINS	Smooth muscle contraction is a dynamic process driven by acto-myosin interactions that are controlled by multiple regulatory proteins. Our studies have shown that members of the AP-1 transcription factor family control discrete behaviors of smooth muscle cells (SMC) such as growth, migration and fibrosis. However, the role of AP-1 in regulation of smooth muscle contractility is incompletely understood. In this study we show that the AP-1 family member JunB regulates contractility in visceral SMC by altering actin polymerization and myosin light chain phosphorylation. JunB levels are robustly upregulated downstream of transforming growth factor beta-1 (TGF beta 1), a known inducer of SMC contractility. RNAi-mediated silencing of JunB in primary human bladder SMC (pBSMC) inhibited cell contractility under both basal and TGF beta 1-stimulated conditions, as determined using gel contraction and traction force microscopy assays. JunB knockdown did not alter expression of the contractile proteins alpha-SMA, calponin or SM22 alpha. However, JunB silencing decreased levels of Rho kinase (ROCK) and myosin light chain (MLC20). Moreover, JunB silencing attenuated phosphorylation of the MLC20 regulatory phosphatase subunit MYPT1 and the actin severing protein cofilin. Consistent with these changes, cells in which JunB was knocked down showed a reduction in the F:G actin ratio in response to TGF beta 1. Together these findings demonstrate a novel function for JunB in regulating visceral smooth muscle cell contractility through effects on both myosin and the actin cytoskeleton.	[Ramachandran, Aruna; Gangopadhyay, Samudra S.; Ranpura, Sandeep A.; Mulone, Michelle; Gong, Edward M.; Adam, Rosalyn M.] Boston Childrens Hosp, Urol Dis Res Ctr, Boston, MA USA; [Ramachandran, Aruna; Gangopadhyay, Samudra S.; Ranpura, Sandeep A.; Gong, Edward M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Krishnan, Ramaswamy; Rajendran, Kavitha; Ram-Mohan, Sumati] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Krishnan, Ramaswamy] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Adam, RM (corresponding author), Boston Childrens Hosp, Urol Dis Res Ctr, Boston, MA USA.	rosalyn.adam@childrens.harvard.edu			National Institutes of Health (NIH) [R21 DK66412, NIH R01 DK077195]; Edwin Beer Fellowship from the New York Academy of Medicine; AUA Foundation Research Scholar Program; Children's Hospital Boston Office of Fellowship Training; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK066412, R01DK077195] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edwin Beer Fellowship from the New York Academy of Medicine; AUA Foundation Research Scholar Program; Children's Hospital Boston Office of Fellowship Training; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) R21 DK66412, NIH R01 DK077195, Edwin Beer Fellowship from the New York Academy of Medicine, AUA Foundation Research Scholar Program, and the Children's Hospital Boston Office of Fellowship Training. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves SS, 2010, J ALLERGY CLIN IMMUN, V126, P1198, DOI 10.1016/j.jaci.2010.08.050; Adam RM, 2004, PHYSIOL GENOMICS, V20, P36, DOI 10.1152/physiolgenomics.00181.2004; Akiho H, 2005, GASTROENTEROLOGY, V129, P131, DOI 10.1053/j.gastro.2005.03.049; Avouac J, 2012, ARTHRITIS RHEUM-US, V64, P1642, DOI 10.1002/art.33501; Baskin LS, 1996, LAB INVEST, V75, P157; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Borer JG, 1999, LAB INVEST, V79, P1335; Camoretti-Mercado B, 2003, RESP PHYSIOL NEUROBI, V137, P223, DOI 10.1016/S1569-9048(03)00149-6; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Fitzgibbon J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-2; Gervasi M, 2012, J CELL BIOL, V196, P589, DOI 10.1083/jcb.201109045; Grainger DJ, 1998, J CELL SCI, V111, P2977; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Guo Xia, 2012, World J Biol Chem, V3, P41, DOI 10.4331/wjbc.v3.i3.41; Hocevar BA, 2000, METH MOL B, V142, P97; Hu YB, 2006, LUNG, V184, P33, DOI 10.1007/s00408-005-2560-5; Kim JH, 2005, AM J PHYSIOL-LUNG C, V289, pL511, DOI 10.1152/ajplung.00027.2005; Kropp BP, 1999, J UROLOGY, V162, P1779, DOI 10.1016/S0022-5347(05)68237-7; LAIHO M, 1991, MOL CELL BIOL, V11, P972, DOI 10.1128/MCB.11.2.972; Langlois D, 2010, TRANSGENIC RES, V19, P1069, DOI 10.1007/s11248-010-9379-4; Licht AH, 2010, J CLIN INVEST, V120, P2307, DOI 10.1172/JCI41749; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Mauviel A, 1996, J BIOL CHEM, V271, P10917, DOI 10.1074/jbc.271.18.10917; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Parekh A, 2009, J UROLOGY, V182, P1210, DOI 10.1016/j.juro.2009.05.002; PERTOVAARA L, 1989, MOL CELL BIOL, V9, P1255, DOI 10.1128/MCB.9.3.1255; Ramachandran A, 2011, AM J PATHOL, V179, P2977, DOI 10.1016/j.ajpath.2011.08.034; Ramachandran A, 2010, AM J PATHOL, V177, P119, DOI 10.2353/ajpath.2010.090772; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stehr M, 2004, J UROLOGY, V172, P2451, DOI 10.1097/01.ju.0000138084.53577.ca; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Zderic SA, 2012, J CELL MOL MED, V16, P203, DOI 10.1111/j.1582-4934.2011.01368.x	37	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53430	10.1371/journal.pone.0053430	http://dx.doi.org/10.1371/journal.pone.0053430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308222	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100041
J	Stein, ED; White, BP; Mazor, RD; Miller, PE; Pilgrim, EM				Stein, Eric D.; White, Bryan P.; Mazor, Raphael D.; Miller, Peter E.; Pilgrim, Erik M.			Evaluating Ethanol-based Sample Preservation to Facilitate Use of DNA Barcoding in Routine Freshwater Biomonitoring Programs Using Benthic Macroinvertebrates	PLOS ONE			English	Article							PLANT; LIFE	Molecular methods, such as DNA barcoding, have the potential to enhance biomonitoring programs worldwide. Altering routinely used sample preservation methods to protect DNA from degradation may pose a potential impediment to application of DNA barcoding and metagenomics for biomonitoring using benthic macroinvertebrates. Using higher volumes or concentrations of ethanol, requirements for shorter holding times, or the need to include additional filtering may increase cost and logistical constraints to existing biomonitoring programs. To address this issue we evaluated the efficacy of various ethanol-based sample preservation methods at maintaining DNA integrity. We evaluated a series of methods that were minimally modified from typical field protocols in order to identify an approach that can be readily incorporated into existing monitoring programs. Benthic macroinvertebrates were collected from a minimally disturbed stream in southern California, USA and subjected to one of six preservation treatments. Ten individuals from five taxa were selected from each treatment and processed to produce DNA barcodes from the mitochondrial gene cytochrome c oxidase I (COI). On average, we obtained successful COI sequences (i.e. either full or partial barcodes) for between 93-99% of all specimens across all six treatments. As long as samples were initially preserved in 95% ethanol, successful sequencing of COI barcodes was not affected by a low dilution ratio of 2: 1, transfer to 70% ethanol, presence of abundant organic matter, or holding times of up to six months. Barcoding success varied by taxa, with Leptohyphidae (Ephemeroptera) producing the lowest barcode success rate, most likely due to poor PCR primer efficiency. Differential barcoding success rates have the potential to introduce spurious results. However, routine preservation methods can largely be used without adverse effects on DNA integrity.	[Stein, Eric D.; White, Bryan P.; Mazor, Raphael D.] So Calif Coastal Water Res Project, Costa Mesa, CA USA; [Miller, Peter E.] Univ Guelph, Canadian Ctr DNA Barcoding, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Pilgrim, Erik M.] US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA	Southern California Coastal Water Research Project; University of Guelph; United States Environmental Protection Agency	Stein, ED (corresponding author), So Calif Coastal Water Res Project, Costa Mesa, CA USA.	erics@sccwrp.org	Stein, Eric D./A-9362-2008	Stein, Eric D./0000-0002-4729-809X; White, Bryan/0000-0003-4191-3511	Southern California Coastal Water Research Project, general research budget	Southern California Coastal Water Research Project, general research budget	The work was supported by internal agency funding from the Southern California Coastal Water Research Project as part of the general research budget. Molecular analysis was conducted by the Canadian Centre for DNA Barcoding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainard LD, 2010, J MICROBIOL METH, V82, P124, DOI 10.1016/j.mimet.2010.05.001; Baird DJ, 2011, J N AM BENTHOL SOC, V30, P125, DOI 10.1899/10-013.1; Borisenko AV, 2009, MOL ECOL RESOUR, V9, P27, DOI 10.1111/j.1755-0998.2009.02629.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flournoy LE, 1996, BIOTECHNIQUES, V20, P657; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaston GR, 1996, ESTUARIES, V19, P674, DOI 10.2307/1352527; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hauer F. Richard, 1996, P339; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konig U, 2012, J APPL ICHTHYOL, P1; Merritt RW, 2008, INTRO AQUATIC INSECT, p15 to 37; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Morris K, 2012, ANGELES RIVER STATE; Nagy ZT, 2010, ORG DIVERS EVOL, V10, P91, DOI 10.1007/s13127-010-0012-4; Pilgrim EM, 2011, J N AM BENTHOL SOC, V30, P217, DOI 10.1899/10-012.1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Stoeckle MY, 2008, SCI AM, V299, P82; Sweeney BW, 2011, J N AM BENTHOL SOC, V30, P195, DOI 10.1899/10-016.1; Szinwelski N, 2012, ZOOKEYS, P11, DOI 10.3897/zookeys.196.3130; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	26	47	51	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e51273	10.1371/journal.pone.0051273	http://dx.doi.org/10.1371/journal.pone.0051273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308097	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100003
J	Mall, JT; Morey, CC				Mall, Jonathan T.; Morey, Candice C.			High Working Memory Capacity Predicts Less Retrieval Induced Forgetting	PLOS ONE			English	Article							LONG-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; PROACTIVE-INTERFERENCE; EXECUTIVE CONTROL; ITEM STRENGTH; INHIBITION; SUPPRESSION; DYNAMICS; SPAN; RECOGNITION	Background : Working Memory Capacity (WMC) is thought to be related to executive control and focused memory search abilities. These two hypotheses make contrasting predictions regarding the effects of retrieval on forgetting. Executive control during memory retrieval is believed to lead to retrieval induced forgetting (RIFO) because inhibition of competing memory traces during retrieval renders them temporarily less accessible. According to this suggestion, superior executive control should increase RIFO. Alternatively, superior focused search abilities could diminish RIFO, because delimiting the search set reduces the amount of competition between traces and thus the need for inhibition. Some evidence suggests that high WMC is related to more RIFO, which is inconsistent with the focused search hypothesis. Methodology/Principal Findings: Using the RIFO paradigm, we created distinct and overlapping categories to manipulate the amount of competition between them. This overlap increased competition between some categories while exclusive use of weak exemplars ensured negligible effects of output interference and integration. Low WMC individuals exhibited RIFO within and between overlapping categories, indicating the effect of resolving competition during retrieval. High WMC individuals only exhibited between-category RIFO, suggesting they experienced reduced competition resolution demands. Low WMC Individuals exhibited the strongest RIFO and no retrieval benefits when interference resolution demands were high. Conclusions/Significance: Our findings qualify the inhibitory explanation for RIFO by incorporating the focused search hypothesis for materials that are likely to pose extraordinary challenges at retrieval. The results highlight the importance of considering individual differences in retrieval-induced effects and qualify existing models of these effects.	[Mall, Jonathan T.; Morey, Candice C.] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands	University of Groningen	Mall, JT (corresponding author), Univ Groningen, Dept Expt Psychol, Groningen, Netherlands.	j.t.mall@rug.nl		Morey, Candice/0000-0002-7644-5239				Anderson MC, 2000, J EXP PSYCHOL LEARN, V26, P1141, DOI 10.1037/0278-7393.26.5.1141; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Anderson MC, 1999, J EXP PSYCHOL LEARN, V25, P608, DOI 10.1037/0278-7393.25.3.608; Anderson MC, 2001, J EXP PSYCHOL GEN, V130, P544, DOI 10.1037//0096-3445.130.3.544; Anderson MC, 2000, PSYCHON B REV, V7, P522, DOI 10.3758/BF03214366; Aslan A, 2011, J EXP PSYCHOL LEARN, V37, P264, DOI 10.1037/a0021324; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bauml KH, 2007, PSYCHOL SCI, V18, P111, DOI 10.1111/j.1467-9280.2007.01857.x; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; Bauml KH, 1998, PSYCHON B REV, V5, P459, DOI 10.3758/BF03208822; Bauml KH, 2004, MEM COGNITION, V32, P610, DOI 10.3758/BF03195852; Bauml KH, 2002, MEMORY, V10, P215, DOI 10.1080/09658210143000362; Brewin CR, 2005, J BEHAV THER EXP PSY, V36, P61, DOI 10.1016/j.jbtep.2004.11.006; Brewin CR, 2002, BEHAV RES THER, V40, P923, DOI 10.1016/S0005-7967(01)00127-9; Bunting M, 2006, J EXP PSYCHOL LEARN, V32, P183, DOI 10.1037/0278-7393.32.2.183; Butler KM, 2001, J EXP PSYCHOL LEARN, V27, P1314, DOI 10.1037/0278-7393.27.5.1314; Ciranni MA, 1999, J EXP PSYCHOL LEARN, V25, P1403, DOI 10.1037/0278-7393.25.6.1403; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Conway ARA, 2001, PSYCHON B REV, V8, P331, DOI 10.3758/BF03196169; Ford RM, 2004, BRIT J DEV PSYCHOL, V22, P585, DOI 10.1348/0261510042378272; FRANKEL MT, 1982, J EXP CHILD PSYCHOL, V34, P113, DOI 10.1016/0022-0965(82)90034-0; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Gomez-Ariza CJ, 2005, MEM COGNITION, V33, P1431, DOI 10.3758/BF03193376; Goodmon LB, 2011, J EXP PSYCHOL LEARN, V37, P416, DOI 10.1037/a0021963; Groome D, 2008, EUR J COGN PSYCHOL, V20, P723, DOI 10.1080/09541440701811965; Hanslmayr S, 2010, COGN AFFECT BEHAV NE, V10, P329, DOI 10.3758/CABN.10.3.329; Healey MK, 2010, PSYCHOL SCI, V21, P1464, DOI 10.1177/0956797610382120; Hicks JL, 2004, PSYCHON B REV, V11, P125, DOI 10.3758/BF03206471; Jakab E, 2009, J EXP PSYCHOL LEARN, V35, P607, DOI 10.1037/a0015264; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kareken D A, 1996, J Int Neuropsychol Soc, V2, P486; Koessler S, 2009, PSYCHOL SCI, V20, P1356, DOI 10.1111/j.1467-9280.2009.02450.x; Kuhl BA, 2008, COGN AFFECT BEHAV NE, V8, P211, DOI 10.3758/CABN.8.2.211; Levy BJ, 2008, ACTA PSYCHOL, V127, P623, DOI 10.1016/j.actpsy.2007.12.004; Lustig C, 2001, J EXP PSYCHOL GEN, V130, P199, DOI 10.1037//0096-3445.130.2.199; Moulin CJA, 2002, NEUROPSYCHOLOGIA, V40, P862, DOI 10.1016/S0028-3932(01)00168-3; Perfect TJ, 2004, J MEM LANG, V51, P399, DOI 10.1016/j.jml.2004.06.003; Racsmany M, 2008, SCHIZOPHR RES, V101, P218, DOI 10.1016/j.schres.2008.01.002; Redick TS, 2007, INHIBITION COGNITION; Roman P, 2009, PSYCHOL SCI, V20, P1053, DOI 10.1111/j.1467-9280.2009.02415.x; Saunders J, 2006, MEM COGNITION, V34, P307, DOI 10.3758/BF03193409; Schneider W., 2002, PSYCHOL SOFTWARE TOO; Spitzer B, 2009, J EXP PSYCHOL LEARN, V35, P286, DOI 10.1037/a0014363; Staudigl T, 2010, J NEUROSCI, V30, P11356, DOI 10.1523/JNEUROSCI.0637-10.2010; Storm BC, 2006, PSYCHON B REV, V13, P1023, DOI 10.3758/BF03213919; Storm BC, 2010, MEMORY, V18, P265, DOI 10.1080/09658210903547884; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Unsworth N, 2007, FOUNDATIONS OF REMEMBERING: ESSAYS IN HONOR OF HENRY L. ROEDIGER, III, P241; Unsworth N, 2010, J EXP PSYCHOL LEARN, V36, P240, DOI 10.1037/a0017739; Unsworth N, 2009, MEMORY, V17, P635, DOI 10.1080/09658210902998047; Unsworth N, 2009, MEMORY, V17, P386, DOI 10.1080/09658210902802959; Veling H, 2004, J EXP PSYCHOL LEARN, V30, P315, DOI 10.1037/0278-7393.30.2.315; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wimber M, 2008, J NEUROSCI, V28, P13419, DOI 10.1523/JNEUROSCI.1916-08.2008; Zellner M, 2005, MEM COGNITION, V33, P396, DOI 10.3758/BF03193058	61	9	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52806	10.1371/journal.pone.0052806	http://dx.doi.org/10.1371/journal.pone.0052806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326359	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800026
J	Norberg, MM; Kezelman, S; Lim-Howe, N				Norberg, Melissa M.; Kezelman, Sarah; Lim-Howe, Nicholas			Primary Prevention of Cannabis Use: A Systematic Review of Randomized Controlled Trials	PLOS ONE			English	Review							COGNITIVE-BEHAVIORAL APPROACH; SUBSTANCE-ABUSE PREVENTION; SCHOOL-BASED PREVENTION; HEALTH-RISK BEHAVIORS; AGE-OF-ONSET; DRUG PREVENTION; PROJECT ALERT; EFFECT SIZE; MARIJUANA; PROGRAMS	A systematic review of primary prevention was conducted for cannabis use outcomes in youth and young adults. The aim of the review was to develop a comprehensive understanding of prevention programming by assessing universal, targeted, uni-modal, and multi-modal approaches as well as individual program characteristics. Twenty-eight articles, representing 25 unique studies, identified from eight electronic databases (EMBASE, MEDLINE, CINAHL, ERIC, PsycINFO, DRUG, EBM Reviews, and Project CORK), were eligible for inclusion. Results indicated that primary prevention programs can be effective in reducing cannabis use in youth populations, with statistically significant effect sizes ranging from trivial (0.07) to extremely large (5.26), with the majority of significant effect sizes being trivial to small. Given that the preponderance of significant effect sizes were trivial to small and that percentages of statistically significant and non-statistically significant findings were often equivalent across program type and individual components, the effectiveness of primary prevention for cannabis use should be interpreted with caution. Universal multi-modal programs appeared to outperform other program types (i.e, universal uni-modal, targeted multi-modal, targeted unimodal). Specifically, universal multi-modal programs that targeted early adolescents (10-13 year olds), utilised non-teacher or multiple facilitators, were short in duration (10 sessions or less), and implemented boosters sessions were associated with large median effect sizes. While there were studies in these areas that contradicted these results, the results highlight the importance of assessing the interdependent relationship of program components and program types. Finally, results indicated that the overall quality of included studies was poor, with an average quality rating of 4.64 out of 9. Thus, further quality research and reporting and the development of new innovative programs are required.	[Norberg, Melissa M.; Kezelman, Sarah; Lim-Howe, Nicholas] Univ New S Wales, Natl Cannabis Prevent & Informat Ctr, Randwick, NSW, Australia	University of New South Wales Sydney	Norberg, MM (corresponding author), Univ New S Wales, Natl Cannabis Prevent & Informat Ctr, Randwick, NSW, Australia.	m.norberg@unsw.edu.au	Norberg, Melissa/H-8365-2014	Norberg, Melissa/0000-0001-7840-9007	Department of Health and Aging (DoHA)	Department of Health and Aging (DoHA)	The authors gratefully acknowledge the Department of Health and Aging (DoHA; http://www.health.gov.au/) for providing funding for the National Cannabis Prevention and Information Centre, and subsequently, the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti V, 2004, AM J DRUG ALCOHOL AB, V30, P121, DOI 10.1081/ADA-120029869; AIHW, 2011, 2010 NAT DRUG STRAT; Australian Institute of Health and Welfare, 2011, YOUNG AUSTR THEIR HL; Australian Institute of Health and Welfare (AIHW), 2008, 2007 NAT DRUG STRAT; Bond L, 2004, J EPIDEMIOL COMMUN H, V58, P997, DOI 10.1136/jech.2003.009449; BOTVIN GJ, 1990, J CONSULT CLIN PSYCH, V58, P437, DOI 10.1037/0022-006X.58.4.437; BOTVIN GJ, 1990, ADDICT BEHAV, V15, P47, DOI 10.1016/0306-4603(90)90006-J; BOTVIN GJ, 1983, J BEHAV MED, V6, P359, DOI 10.1007/BF00846324; BOTVIN GJ, 1995, JAMA-J AM MED ASSOC, V273, P1106, DOI 10.1001/jama.273.14.1106; BOTVIN GJ, 1984, ADDICT BEHAV, V9, P137, DOI 10.1016/0306-4603(84)90051-0; Byrne, 2008, HLTH PSYCHOL BIOPSYC; Carroll KM, 2006, J CONSULT CLIN PSYCH, V74, P955, DOI 10.1037/0022-006X.74.5.955; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Cohen J, 1988, STAT POWER ANAL BEAH; COIE JD, 1993, AM PSYCHOL, V48, P1013, DOI 10.1037/0003-066X.48.10.1013; Conrod PJ, 2010, ARCH GEN PSYCHIAT, V67, P85, DOI 10.1001/archgenpsychiatry.2009.173; Crombie I.K., 2009, HAYWARD MED COMMUN, V1, P1; Cuijpers P, 2002, ADDICT BEHAV, V27, P1009, DOI 10.1016/S0306-4603(02)00295-2; de Graaf R, 2010, AM J EPIDEMIOL, V172, P149, DOI 10.1093/aje/kwq096; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Dent CW, 2001, PREV MED, V32, P514, DOI 10.1006/pmed.2001.0834; Dragt S, 2010, CAN J PSYCHIAT, V55, P165, DOI 10.1177/070674371005500308; DuRant RH, 1999, ARCH PEDIAT ADOL MED, V153, P286; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Ellickson PL, 2004, PREV MED, V39, P976, DOI 10.1016/j.ypmed.2004.04.013; Ellickson PL, 2003, AM J PUBLIC HEALTH, V93, P1830, DOI 10.2105/AJPH.93.11.1830; Elliot Diane L, 2008, J Alcohol Drug Educ, V52, P73; EPOC, 2009, DAT COLL CHECKL 64 R; Faggiano F, 2008, PREV MED, V47, P537, DOI 10.1016/j.ypmed.2008.06.018; Faggiano F, 2008, PREV MED, V46, P385, DOI 10.1016/j.ypmed.2007.11.012; Faggiano F, 2010, DRUG ALCOHOL DEPEN, V108, P56, DOI 10.1016/j.drugalcdep.2009.11.018; Fergusson DM, 2008, ADDICTION, V103, P969, DOI 10.1111/j.1360-0443.2008.02221.x; Fergusson DM, 2002, ADDICTION, V97, P1123, DOI 10.1046/j.1360-0443.2002.00103.x; Foxcroft DR, 2003, ADDICTION, V98, P397, DOI 10.1046/j.1360-0443.2003.00355.x; Gates S, 2006, COCHRANE DATABASE SY; GORMAN DM, 1992, ALCOHOL ALCOHOLISM, V27, P583; Gottfredson Denise C, 2003, Prev Sci, V4, P27, DOI 10.1023/A:1021782710278; Griffin JR, 2009, J HEALTH CARE POOR U, V20, P798, DOI 10.1353/hpu.0.0174; Griffin KW, 2003, PREV MED, V36, P1, DOI 10.1006/pmed.2002.1133; Griffin KW, 2006, SALUD DROGAS, V6, P9; Grossbard JR, 2010, J SUBST ABUSE TREAT, V39, P384, DOI 10.1016/j.jsat.2010.07.001; Hansen WB, 1990, EVALUATION REV, V14, P667; Hecht Michael L, 2003, Prev Sci, V4, P233, DOI 10.1023/A:1026016131401; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; JESSOR R, 1992, DEV REV, V12, P374, DOI 10.1016/0273-2297(92)90014-S; JOHNSON CA, 1990, J CONSULT CLIN PSYCH, V58, P447, DOI 10.1037/0022-006X.58.4.447; Lemstra M, 2010, ADDICT RES THEORY, V18, P84, DOI 10.3109/16066350802673224; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; MARMOR JK, 1991, J CLIN EPIDEMIOL, V44, P531, DOI 10.1016/0895-4356(91)90216-V; Mayet A, 2010, ADDICT BEHAV, V35, P890, DOI 10.1016/j.addbeh.2010.06.001; Naar-King S, 2006, AIDS EDUC PREV, V18, P1, DOI 10.1521/aeap.2006.18.1.1; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nation M, 2003, AM PSYCHOL, V58, P449, DOI 10.1037/0003-066X.58.6-7.449; Newton NC, 2010, ADDICTION, V105, P749, DOI 10.1111/j.1360-0443.2009.02853.x; OMALLEY PM, 1983, INT J ADDICT, V18, P805, DOI 10.3109/10826088309033049; Palinkas LA, 1996, PREV MED, V25, P692, DOI 10.1006/pmed.1996.0108; Porath-Waller AJ, 2010, HEALTH EDUC BEHAV, V37, P709, DOI 10.1177/1090198110361315; Ringwalt CL, 2009, ARCH PEDIAT ADOL MED, V163, P625, DOI 10.1001/archpediatrics.2009.88; Rohrbach LA, 2010, PREV MED, V51, P313, DOI 10.1016/j.ypmed.2010.07.016; ROSENTHAL R, 1986, PSYCHOL BULL, V99, P400, DOI 10.1037/0033-2909.99.3.400; Sanderson CA, 2004, HLTH PSYCHOL; Schinke SP, 2004, J STUD ALCOHOL, V65, P443, DOI 10.15288/jsa.2004.65.443; Schinke SP, 2009, PREV MED, V49, P429, DOI 10.1016/j.ypmed.2009.08.001; Schwinn TM, 2010, PREV SCI, V11, P24, DOI 10.1007/s11121-009-0146-9; Scott CK, 2004, DRUG ALCOHOL DEPEN, V74, P21, DOI 10.1016/j.drugalcdep.2003.11.007; Spoth RL, 2002, PSYCHOL ADDICT BEHAV, V16, P129, DOI 10.1037//0893-164X.16.2.129; Spoth RL, 2001, J CONSULT CLIN PSYCH, V69, P627, DOI 10.1037//0022-006X.69.4.627; Stanton B, 2004, ARCH PEDIAT ADOLESC, V158; STEPHENS RS, 1994, J CONSULT CLIN PSYCH, V62, P92, DOI 10.1037/0022-006X.62.1.92; Substance Abuse and Mental Health Services Administration (SAMHSA), 2011, RES 2010 NAT SURV DR, VH-41; TOBLER N S, 1992, Journal of Addictive Diseases, V11, P1; Tobler N.S., 2000, J PRIM PREV, V20, P275, DOI [DOI 10.1023/A:1021314704811, 10.1023/A:1021314704811]; TOBLER NS, 1986, J DRUG ISSUES, V16, P537, DOI 10.1177/002204268601600405; Tobler NS, 1999, SCHOOL PSYCHOL INT, V20, P105, DOI 10.1177/0143034399201008; Tobler NS., 1997, J PRIM PREV, V18, P71, DOI DOI 10.1023/A:1024630205999; United Nations, 2003, WORLD YOUTH REP 2003; UNODC, 2011, WORLD DRUG REP 2011; von Sydow K, 2002, DRUG ALCOHOL DEPEN, V68, P49, DOI 10.1016/S0376-8716(02)00102-3; Werch CC, 2005, PREV SCI, V6, P213, DOI 10.1007/s11121-005-0012-3; Werch CEC, 2005, SUBST USE MISUSE, V40, P1085, DOI 10.1081/JA-200030814; White D, 1998, ADDICTION, V93, P1475, DOI 10.1046/j.1360-0443.1998.931014754.x	81	42	43	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53187	10.1371/journal.pone.0053187	http://dx.doi.org/10.1371/journal.pone.0053187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326396	gold, Green Submitted, Green Published			2022-12-27	WOS:000314705800035
J	Kleisner, K; Priplatova, L; Frost, P; Flegr, J				Kleisner, Karel; Priplatova, Lenka; Frost, Peter; Flegr, Jaroslav			Trustworthy-Looking Face Meets Brown Eyes	PLOS ONE			English	Article							IRIS PIGMENTATION; UNIQUE MORPHOLOGY; COLOR; BLUE; HAIR; PERCEPTION; DOMINANCE; GENDER; BEAUTY	We tested whether eye color influences perception of trustworthiness. Facial photographs of 40 female and 40 male students were rated for perceived trustworthiness. Eye color had a significant effect, the brown-eyed faces being perceived as more trustworthy than the blue-eyed ones. Geometric morphometrics, however, revealed significant correlations between eye color and face shape. Thus, face shape likewise had a significant effect on perceived trustworthiness but only for male faces, the effect for female faces not being significant. To determine whether perception of trustworthiness was being influenced primarily by eye color or by face shape, we recolored the eyes on the same male facial photos and repeated the test procedure. Eye color now had no effect on perceived trustworthiness. We concluded that although the brown-eyed faces were perceived as more trustworthy than the blue-eyed ones, it was not brown eye color per se that caused the stronger perception of trustworthiness but rather the facial features associated with brown eyes.	[Kleisner, Karel; Priplatova, Lenka; Flegr, Jaroslav] Charles Univ Prague, Dept Philosophy & Hist Sci, Prague, Czech Republic; [Frost, Peter] Univ Laval, Dept Anthropol, Quebec City, PQ, Canada	Charles University Prague; Laval University	Kleisner, K (corresponding author), Charles Univ Prague, Dept Philosophy & Hist Sci, Prague, Czech Republic.	kleisner@seznam.cz	Flegr, Jaroslav/AAG-7568-2021; Frost, Peter/AAQ-4107-2020; Kleisner, Karel/M-2718-2017; Flegr, Jaroslav/A-1564-2008	Flegr, Jaroslav/0000-0002-0822-0126; Frost, Peter/0000-0002-5498-1866; Kleisner, Karel/0000-0002-3277-8365; Flegr, Jaroslav/0000-0002-0822-0126; Priplatova, Lenka/0000-0002-2860-3853	Czech Grant Agency [P407/11/1464]; Charles University in Prague project of University Center [204004]	Czech Grant Agency(Grant Agency of the Czech Republic); Charles University in Prague project of University Center	This research was supported by Czech Grant Agency project P407/11/1464 and by Charles University in Prague project of University Center 204004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Buckingham G, 2006, EVOL HUM BEHAV, V27, P381, DOI 10.1016/j.evolhumbehav.2006.03.001; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Coplan RJ, 1998, DEV PSYCHOBIOL, V32, P37, DOI 10.1002/(SICI)1098-2302(199801)32:1<37::AID-DEV4>3.0.CO;2-U; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; FOOTE M, 1993, PALEOBIOLOGY, V19, P403, DOI 10.1017/S0094837300014056; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Frost P, 2006, EVOL HUM BEHAV, V27, P85, DOI 10.1016/j.evolhumbehav.2005.07.002; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Kagan J., 2004, LONG SHADOW TEMPERAM; Keating CF, 2002, J EXP SOC PSYCHOL, V38, P414, DOI 10.1016/S0022-1031(02)00007-0; Kleisner K, 2010, PERS INDIV DIFFER, V49, P59, DOI 10.1016/j.paid.2010.03.011; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Laeng B, 2007, BEHAV ECOL SOCIOBIOL, V61, P371, DOI 10.1007/s00265-006-0266-1; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lehre AC, 2009, DEV PSYCHOBIOL, V51, P198, DOI 10.1002/dev.20358; Liu F, 2009, CURR BIOL, V19, pR192, DOI 10.1016/j.cub.2009.01.027; Oksanen J., 2016, R PACKAG; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Rezlescu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034293; Rohlf J., 2008, TPSRELW VERSION 1 46; Rohlf J. F., 2009, TPSDIG2 VERSION 2 14; Rohlf J. F., 2009, TPSREGR VERSION 1 36; ROSENBERG A, 1987, DEV PSYCHOBIOL, V20, P377, DOI 10.1002/dev.420200403; ROSENBERG AA, 1989, DEV PSYCHOBIOL, V22, P753, DOI 10.1002/dev.420220802; Schaefer K, 2006, AM J PHYS ANTHROPOL, V129, P132, DOI 10.1002/ajpa.20224; Shekar SN, 2008, PHOTOCHEM PHOTOBIOL, V84, P719, DOI 10.1111/j.1751-1097.2007.00237.x; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; WAGATSUMA H, 1967, DAEDALUS, V96, P407; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zhu Q, 2010, CURR BIOL, V20, P137, DOI 10.1016/j.cub.2009.11.067	45	45	47	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53285	10.1371/journal.pone.0053285	http://dx.doi.org/10.1371/journal.pone.0053285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326406	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500057
J	Wesolowski, A; Buckee, CO; Pindolia, DK; Eagle, N; Smith, DL; Garcia, AJ; Tatem, AJ				Wesolowski, Amy; Buckee, Caroline O.; Pindolia, Deepa K.; Eagle, Nathan; Smith, David L.; Garcia, Andres J.; Tatem, Andrew J.			The Use of Census Migration Data to Approximate Human Movement Patterns across Temporal Scales	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TRAVEL BEHAVIOR; HUMAN MOBILITY; DISEASE; INFLUENZA; NETWORKS; MODEL	Human movement plays a key role in economies and development, the delivery of services, and the spread of infectious diseases. However, it remains poorly quantified partly because reliable data are often lacking, particularly for low-income countries. The most widely available are migration data from human population censuses, which provide valuable information on relatively long timescale relocations across countries, but do not capture the shorter-scale patterns, trips less than a year, that make up the bulk of human movement. Census-derived migration data may provide valuable proxies for shorter-term movements however, as substantial migration between regions can be indicative of well connected places exhibiting high levels of movement at finer time scales, but this has never been examined in detail. Here, an extensive mobile phone usage data set for Kenya was processed to extract movements between counties in 2009 on weekly, monthly, and annual time scales and compared to data on change in residence from the national census conducted during the same time period. We find that the relative ordering across Kenyan counties for incoming, outgoing and between-county movements shows strong correlations. Moreover, the distributions of trip durations from both sources of data are similar, and a spatial interaction model fit to the data reveals the relationships of different parameters over a range of movement time scales. Significant relationships between census migration data and fine temporal scale movement patterns exist, and results suggest that census data can be used to approximate certain features of movement patterns across multiple temporal scales, extending the utility of census-derived migration data.	[Wesolowski, Amy] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA; [Buckee, Caroline O.; Eagle, Nathan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Pindolia, Deepa K.; Garcia, Andres J.; Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Pindolia, Deepa K.; Garcia, Andres J.; Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Pindolia, Deepa K.] KEMRI Wellcome Trust Univ Oxford Collaborat Progr, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; [Eagle, Nathan] Northeastern Univ, Dept Comp Sci, Boston, MA 02115 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Smith, David L.; Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Carnegie Mellon University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Northeastern University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Wesolowski, A (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.	awesolow@andrew.cmu.edu	Smith, David L/L-8850-2013	Smith, David L/0000-0003-4367-3849; Tatem, Andrew/0000-0002-7270-941X	National Science Foundation Graduate Research Fellowship [0750271]; Models of Infectious Disease Agent Study program [1U54GM088558]; Bill and Melinda Gates Foundation [49446]; NIH/NIAID [U19AI089674]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; National Science Foundation in the Quantitative Spatial Ecology, Evolution, and Environment Program at the University of Florida [0801544];  [1032350]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Models of Infectious Disease Agent Study program; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Science Foundation in the Quantitative Spatial Ecology, Evolution, and Environment Program at the University of Florida; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	APW is supported by a National Science Foundation Graduate Research Fellowship (#0750271). COB was supported by the Models of Infectious Disease Agent Study program (cooperative agreement 1U54GM088558). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences or the National Institutes of Health (NIH). DLS, AJT, and DKP are supported by a grant from the Bill and Melinda Gates Foundation (#49446) that supported DKP, and AJT is supported by an additional grant (#1032350). DLS and AJT also acknowledge funding support from NIH/NIAID (U19AI089674) and the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health (http://www.fic.nih.gov). AJG was partially supported by the National Science Foundation under Grant No. 0801544 in the Quantitative Spatial Ecology, Evolution, and Environment Program at the University of Florida. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Bharti N, 2011, SCIENCE, V334, P1424, DOI 10.1126/science.1210554; Bryceson DF, 2006, DEV POL REV, V26, P1; Buliung RN, 2008, J GEOGR SYST, V10, P191, DOI 10.1007/s10109-008-0063-7; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FLOWERDEW R, 1982, J REGIONAL SCI, V22, P191, DOI 10.1111/j.1467-9787.1982.tb00744.x; GODDARD A D, 1975, Geografiska Annaler Series B Human Geography, V57, P26; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Henry S, 2003, APPL GEOGR, V23, P115, DOI 10.1016/j.apgeog.2002.08.001; Hollingsworth TD, 2007, EMERG INFECT DIS, V13, P1288, DOI 10.3201/eid1309.070081; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Le Menach A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00093; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Okwi PO, 2007, P NATL ACAD SCI USA, V104, P16769, DOI 10.1073/pnas.0611107104; PARSONS CR, 2007, 4165 WORLD BANK; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205; PROTHERO RM, 1977, INT J EPIDEMIOL, V6, P259, DOI 10.1093/ije/6.3.259; Riley S, 2006, P NATL ACAD SCI USA, V103, P12637, DOI 10.1073/pnas.0510873103; Schlich R, 2003, TRANSPORTATION, V30, P13, DOI 10.1023/A:1021230507071; Shanks GD, 2002, EMERG INFECT DIS, V8, P1404, DOI 10.3201/eid0812.020077; Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tatem AJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-8; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; Vazquez-Prokopec GM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-68; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; WesolowsH A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035319, DOI 10.1371/JOURNAL.P0NE.0035319]; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; World Bank, 2008, WORLD DEV REP 2009 R; Yang Y, 2008, J R SOC INTERFACE, V5, P759, DOI 10.1098/rsif.2007.1218; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	41	52	52	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52971	10.1371/journal.pone.0052971	http://dx.doi.org/10.1371/journal.pone.0052971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326367	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000313551500037
J	Kalirai, SS; Bazylinski, DA; Hitchcock, AP				Kalirai, Samanbir S.; Bazylinski, Dennis A.; Hitchcock, Adam P.			Anomalous Magnetic Orientations of Magnetosome Chains in a Magnetotactic Bacterium: Magnetovibrio blakemorei Strain MV-1	PLOS ONE			English	Article							REMANENCE MEASUREMENTS; MOLECULAR-MECHANISMS; PROTEIN; BIOMINERALIZATION; BEAMLINE; MARINE; FE3O4; GENE	There is a good deal of published evidence that indicates that all magnetosomes within a single cell of a magnetotactic bacterium are magnetically oriented in the same direction so that they form a single magnetic dipole believed to assist navigation of the cell to optimal environments for their growth and survival. Some cells of the cultured magnetotactic bacterium Magnetovibrio blakemorei strain MV-1 are known to have relatively wide gaps between groups of magnetosomes that do not seem to interfere with the larger, overall linear arrangement of the magnetosomes along the long axis of the cell. We determined the magnetic orientation of the magnetosomes in individual cells of this bacterium using Fe 2p X-ray magnetic circular dichroism (XMCD) spectra measured with scanning transmission X-ray microscopy (STXM). We observed a significant number of cases in which there are sub-chains in a single cell, with spatial gaps between them, in which one or more sub-chains are magnetically polarized opposite to other sub-chains in the same cell. These occur with an estimated frequency of 4.0 +/- 0.2%, based on a sample size of 150 cells. We propose possible explanations for these anomalous cases which shed insight into the mechanisms of chain formation and magnetic alignment.	[Kalirai, Samanbir S.; Hitchcock, Adam P.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [Bazylinski, Dennis A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	McMaster University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Hitchcock, AP (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada.	aph@mcmaster.ca			Canada Foundation for Innovation (CFI); NSERC; Canadian Institutes of Health Research (CIHR); National Research Council (NRC); University of Saskatchewan; U.S. National Science Foundation (NSF) [EAR-0920718]; Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy [DE-AC02-05CH11231]; Division Of Earth Sciences [0920718] Funding Source: National Science Foundation	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Research Council (NRC); University of Saskatchewan; U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy(United States Department of Energy (DOE)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	CLS is supported by the Canada Foundation for Innovation (CFI), NSERC, Canadian Institutes of Health Research (CIHR), National Research Council (NRC) and the University of Saskatchewan. DAB is supported by U.S. National Science Foundation (NSF) grant EAR-0920718. The ALS is supported by the Director, Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy, under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade H, 2008, POLYMER, V49, P643, DOI 10.1016/j.polymer.2007.10.030; Alphandery E, 2009, ACS NANO, V3, P1539, DOI 10.1021/nn900289n; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; Bazylinski DA, 2012, PROKARYOTES IN PRESS; Bazylinski DA, 2013, INT J SYST EVOL MICR, V63, P1824, DOI 10.1099/ijs.0.044453-0; Bellini S., 1963, PARTICOLARE COMPORTA; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Dean AJ, 1999, CURR MICROBIOL, V39, P219, DOI 10.1007/s002849900448; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Dunin-Borkowski RE, 2004, MICROSC RES TECHNIQ, V64, P390, DOI 10.1002/jemt.20098; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Faivre D, 2008, AM MINERAL, V93, P463, DOI 10.2138/am.2008.2678; Faivre D, 2007, ANGEW CHEM INT EDIT, V46, P8495, DOI 10.1002/anie.200700927; Faivre D, 2010, BIOPHYS J, V99, P1268, DOI 10.1016/j.bpj.2010.05.034; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; FRANKEL RB, 1983, BIOCHIM BIOPHYS ACTA, V763, P147, DOI 10.1016/0167-4889(83)90038-1; FRANKEL RB, 1984, ANNU REV BIOPHYS BIO, V13, P85; Grunberg K, 2001, APPL ENVIRON MICROB, V67, P4573, DOI 10.1128/AEM.67.10.4573-4582.2001; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; Hanzlik M, 2002, J MAGN MAGN MATER, V248, P258, DOI 10.1016/S0304-8853(02)00353-0; Hitchcock AP, 2012, HDB NANOSCOPY, V2; Howells M., 2007, SCI MICROSCOPY, P835, DOI [10.1007/978-0-387-49762-4_13, DOI 10.1007/978-0-387-49762-4_13]; Kalirai SS, 2012, CHEM GEOL, V300, P14, DOI 10.1016/j.chemgeo.2012.01.005; Katzmann E, 2011, MOL MICROBIOL, V82, P1316, DOI 10.1111/j.1365-2958.2011.07874.x; Kaznatcheev KV, 2007, NUCL INSTRUM METH A, V582, P96, DOI 10.1016/j.nima.2007.08.083; Klumpp S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033562; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Lam KP, 2010, CHEM GEOL, V270, P110, DOI 10.1016/j.chemgeo.2009.11.009; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; MOSKOWITZ BM, 1988, J MAGN MAGN MATER, V73, P273, DOI 10.1016/0304-8853(88)90093-5; NAKAMURA C, 1995, J BIOL CHEM, V270, P28392; PENNINGA I, 1995, J MAGN MAGN MATER, V149, P279, DOI 10.1016/0304-8853(95)00078-X; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Skinner HCW, 2005, TREATISE ON GEOCHEMISTRY, VOL 8: BIOGEOCHEMISTRY, P117; Smith MJ, 2006, BIOPHYS J, V91, P1098, DOI 10.1529/biophysj.106.085167; SODHI RNS, 1984, J ELECTRON SPECTROSC, V34, P363, DOI 10.1016/0368-2048(84)80050-X; Sonkaria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034189; Stohr J., 2006, MAGNETISM FUNDAMENTA; Vincent JFV, 2009, P I MECH ENG H, V223, P919, DOI 10.1243/09544119JEIM561; Warwick T, 2004, AIP CONF PROC, V705, P458, DOI 10.1063/1.1757833; Winklhofer M, 2007, BIOPHYS J, V92, P661, DOI 10.1529/biophysj.106.093823	45	23	23	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53368	10.1371/journal.pone.0053368	http://dx.doi.org/10.1371/journal.pone.0053368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308202	Green Published, gold			2022-12-27	WOS:000313429800042
J	Li, Q; Li, YM; Han, S; Liu, YZ; Song, DX; Hao, D; Wang, JJ; Qu, YH; Zheng, YX				Li Qiang; Li Yumei; Han Sheng; Liu Yingzi; Song Dongxue; Hao Dake; Wang Jiajia; Qu Yanhong; Zheng Yuxia			Optimization of Fermentation Conditions and Properties of an Exopolysaccharide from Klebsiella sp H-207 and Application in Adsorption of Hexavalent Chromium	PLOS ONE			English	Article							POLYSACCHARIDE; CULTURE	The novel exopolysaccharide HZ-7 is produced by Klebsiella sp. H-207, and its fermentation conditions were optimized by response surface methodology (RSM). In this study, the optimized medium consisted of sucrose 31.93 g/L, KNO3 2.17 g/L and K2HPO4 5.47 g/L; while the optimized culture conditions consisted of seed age 13 h, with an inoculum size of 10.6% and incubation temperature of 28.9 degrees C. A maximum HZ-7 yield of about 15.05 g/L was achieved under the optimized conditions using RSM and single-factor experiments. Next the exopolysaccharide HZ-7 was partially purified and characterized. The resulting product showed good properties, such as high concentration of uronic acid (41.67%), low average molecular weight (about 1.94x10(5) Da) and porous surface structure, were very advantageous to biosorption. Therefore HZ-7 was applied to absorb hexavalent chromium (Cr(VI)). The maximum adsorption efficiency (99.2%) which was obtained at an initial pH of 1.0 along with an initial Cr(VI) concentration of 20 mg/L, was not affected by ordinary metal ions and temperature. These data suggest Klebsiella sp. H-207 exopolysaccharide will be promising potential for industrial application.	[Li Qiang; Li Yumei; Song Dongxue; Hao Dake; Zheng Yuxia] Univ Jinan, Sch Med & Life Sci, Jinan, Peoples R China; [Li Qiang; Han Sheng; Wang Jiajia; Qu Yanhong] Univ Jinan, Sch Chem & Chem Engn, Jinan, Peoples R China; [Liu Yingzi] Shandong Police Coll, Dept Criminal Sci & Technol, Jinan, Peoples R China	University of Jinan; University of Jinan; Shandong Police College	Li, Q (corresponding author), Univ Jinan, Sch Med & Life Sci, Jinan, Peoples R China.	chm_lq@ujn.edu.cn; mls_liym@ujn.edu.cn	LIU, YING/GZL-7252-2022		National Natural Science Foundation of China [31100088]; Ministry of Public security of the People's Republic of China [2010YYCXSDST054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Public security of the People's Republic of China	This work was supported by National Natural Science Foundation of China (Project No. 31100088), and Application and Innovation Program from the Ministry of Public security of the People's Republic of China (Project No. 2010YYCXSDST054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgio JF, 2009, AFR J BIOTECHNOL, V8, P5454; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaplin M F, 1986, CARBOHYDRATE ANAL PR, P129; Cui JD, 2012, J AGR FOOD CHEM, V60, P4865, DOI 10.1021/jf3006273; Dai J, 2012, INT J ENV RES PUB HE, V9, P1757, DOI 10.3390/ijerph9051757; Dermlim W, 1999, APPL MICROBIOL BIOT, V52, P698, DOI 10.1007/s002530051581; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Feng XL, 1995, CHINESE J BIOCH PHAR, V5, P210; Ferreira SLC, 2007, ANAL CHIM ACTA, V597, P179, DOI 10.1016/j.aca.2007.07.011; Freire-Nordi CS, 2005, PROCESS BIOCHEM, V40, P2215, DOI 10.1016/j.procbio.2004.09.003; Freitas F, 2011, TRENDS BIOTECHNOL, V29, P388, DOI 10.1016/j.tibtech.2011.03.008; Freitas F, 2010, PROCESS BIOCHEM, V45, P297, DOI 10.1016/j.procbio.2009.09.020; Ghosh M, 2009, WATER ENVIRON RES, V81, P160, DOI 10.2175/106143008X325818; Iyer A, 2005, MAR POLLUT BULL, V50, P340, DOI 10.1016/j.marpolbul.2004.11.012; Jaehrig SC, 2008, LWT-FOOD SCI TECHNOL, V41, P868, DOI 10.1016/j.lwt.2007.06.004; JAMES BR, 1995, ENVIRON SCI TECHNOL, V29, P2377, DOI 10.1021/es00009a033; Kantar C, 2011, CHEMOSPHERE, V82, P1489, DOI 10.1016/j.chemosphere.2011.01.009; Khuri AI, 2010, WIRES COMPUT STAT, V2, P128, DOI 10.1002/wics.73; Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007; Kong JY, 1998, J MAR BIOTECHNOL, V6, P99; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; Lin YC, 2012, CHEM ENG J, V181, P479, DOI 10.1016/j.cej.2011.12.005; Llamas I, 2010, MAR DRUGS, V8, P2240, DOI 10.3390/md8082240; Manna B, 1996, LETT APPL MICROBIOL, V138, P605; MORIN A, 1998, POLYSACCHARIDES STRU, P275; MOZZI F, 1995, MILCHWISSENSCHAFT, V50, P186; Prasertsan P, 2008, CARBOHYD POLYM, V71, P468, DOI 10.1016/j.carbpol.2007.06.017; Satpute SK, 2010, BIOTECHNOL ADV, V28, P436, DOI 10.1016/j.biotechadv.2010.02.006; Sun SS, 2011, BIORESOURCE TECHNOL, V102, P6153, DOI 10.1016/j.biortech.2011.03.005; Yoon S, 2012, BIOPROC BIOSYST ENG, V35, P167, DOI 10.1007/s00449-011-0620-1; Yuksekdag ZN, 2008, BRAZ ARCH BIOL TECHN, V51, P581, DOI 10.1590/S1516-89132008000300019	31	14	20	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53542	10.1371/journal.pone.0053542	http://dx.doi.org/10.1371/journal.pone.0053542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320092	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429800057
J	Xu, BS; Schones, DE; Wang, YM; Liang, HJ; Li, GH				Xu, Beisi; Schones, Dustin E.; Wang, Yongmei; Liang, Haojun; Li, Guohui			A Structural-Based Strategy for Recognition of Transcription Factor Binding Sites	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; STRUCTURE-BASED PREDICTION; SACCHAROMYCES-CEREVISIAE; ENERGY FUNCTION; ALL-ATOM; REGULATORY PROTEINS; TARGET SITES; SPECIFICITY; COMPLEXES; PROFILES	Scanning through genomes for potential transcription factor binding sites (TFBSs) is becoming increasingly important in this post-genomic era. The position weight matrix (PWM) is the standard representation of TFBSs utilized when scanning through sequences for potential binding sites. However, many transcription factor (TF) motifs are short and highly degenerate, and methods utilizing PWMs to scan for sites are plagued by false positives. Furthermore, many important TFs do not have well-characterized PWMs, making identification of potential binding sites even more difficult. One approach to the identification of sites for these TFs has been to use the 3D structure of the TF to predict the DNA structure around the TF and then to generate a PWM from the predicted 3D complex structure. However, this approach is dependent on the similarity of the predicted structure to the native structure. We introduce here a novel approach to identify TFBSs utilizing structure information that can be applied to TFs without characterized PWMs, as long as a 3D complex structure (TF/DNA) exists. This approach utilizes an energy function that is uniquely trained on each structure. Our approach leads to increased prediction accuracy and robustness compared with those using a more general energy function. The software is freely available upon request.	[Xu, Beisi; Li, Guohui] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian, Liaoning, Peoples R China; [Xu, Beisi] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Xu, Beisi] Univ Tennessee, Ctr Hlth Sci, Ctr Integrat & Translat Gen, Memphis, TN 38163 USA; [Schones, Dustin E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Wang, Yongmei] Univ Memphis, Dept Chem, Memphis, TN 38152 USA; [Liang, Haojun] Univ Sci & Technol China, Dept Polymer Sci & Engn, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; City of Hope; Beckman Research Institute of City of Hope; University of Memphis; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, GH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian, Liaoning, Peoples R China.	ghli@dicp.ac.cn	Liang, Haojun/F-5960-2010; Xu, Beisi/C-8560-2009; Wang, Yongmei/B-7071-2008	Xu, Beisi/0000-0003-0099-858X; Wang, Yongmei/0000-0002-7418-9489	National Sciences Foundation of China [31070641]; National 973 Program of China [2012CB721000]; SKLMRD; DICP, CAS (Chinese Academy of Sciences)	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); SKLMRD; DICP, CAS (Chinese Academy of Sciences)	GL thanks the fundings supported by the National Sciences Foundation of China (no. 31070641) and National 973 Program of China (no. 2012CB721000) and start-up funding from SKLMRD and DICP, CAS (Chinese Academy of Sciences). The funders offered most of the costs of study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Alamanova D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-225; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernard B, 2009, PROTEINS, V76, P115, DOI 10.1002/prot.22323; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Chen CY, 2008, P NATL ACAD SCI USA, V105, P2527, DOI 10.1073/pnas.0712188105; Chen CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030446; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Donald JE, 2007, NUCLEIC ACIDS RES, V35, P1039, DOI 10.1093/nar/gkl1103; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Endres RG, 2004, PROTEINS, V57, P262, DOI 10.1002/prot.20199; Angarica VE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-436; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000341; Hieb AR, 2007, J MOL BIOL, V372, P619, DOI 10.1016/j.jmb.2007.06.061; Huang N, 2005, J MOL BIOL, V345, P265, DOI 10.1016/j.jmb.2004.10.042; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jagannathan V, 2006, NUCLEIC ACIDS RES, V34, pD90, DOI 10.1093/nar/gkj049; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S13; Kono H, 1999, PROTEINS, V35, P114, DOI 10.1002/(SICI)1097-0134(19990401)35:1<114::AID-PROT11>3.0.CO;2-T; Kussell E, 2002, P NATL ACAD SCI USA, V99, P5343, DOI 10.1073/pnas.072665799; Liu X, 2001, Pac Symp Biocomput, P127; Liu ZJ, 2008, PROTEINS, V72, P1114, DOI 10.1002/prot.22002; Liu ZJ, 2005, NUCLEIC ACIDS RES, V33, P546, DOI 10.1093/nar/gki204; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mandel-Gutfreund Y, 2001, Pac Symp Biocomput, P139; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Paillard G, 2004, STRUCTURE, V12, P113, DOI 10.1016/j.str.2003.11.022; Parisien M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032647; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Ponomarenko JV, 2000, NUCLEIC ACIDS RES, V28, P205, DOI 10.1093/nar/28.1.205; Robertson TA, 2007, PROTEINS, V66, P359, DOI 10.1002/prot.21162; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Selvaraj S, 2002, J MOL BIOL, V322, P907, DOI 10.1016/S0022-2836(02)00846-X; Siggers TW, 2007, NUCLEIC ACIDS RES, V35, P1085, DOI 10.1093/nar/gkl1155; Siggers TW, 2005, J MOL BIOL, V345, P1027, DOI 10.1016/j.jmb.2004.11.010; Skolnick J, 2006, CURR OPIN STRUC BIOL, V16, P166, DOI 10.1016/j.sbi.2006.02.004; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Xu BS, 2009, PROTEINS, V76, P718, DOI 10.1002/prot.22384; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d; Zhang C, 2004, PROTEIN SCI, V13, P400, DOI 10.1110/ps.03348304; Zhao H, 2010, BIOINFORMATICS; Zhou HY, 2003, PROTEIN SCI, V12, P2121, DOI 10.1002/pro.122121; Zhou Y, 2006, CELL BIOCHEM BIOPHYS, V46, P165, DOI 10.1385/CBB:46:2:165; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607; Zhu X, 2012, J PHYS CHEM B, V116, P13672, DOI 10.1021/jp3084887	56	33	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52460	10.1371/journal.pone.0052460	http://dx.doi.org/10.1371/journal.pone.0052460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320072	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429800015
J	Beltrami, S; Branchetti, E; Sariyer, IK; Otte, J; Weaver, M; Gordon, J				Beltrami, Sarah; Branchetti, Emanuela; Sariyer, Ilker K.; Otte, Jessica; Weaver, Michael; Gordon, Jennifer			Neurofibromatosis Type 2 Tumor Suppressor Protein, NF2, Induces Proteasome-Mediated Degradation of JC Virus T-Antigen in Human Glioblastoma	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; CONTACT INHIBITION; GENE-PRODUCT; SIMIAN-VIRUS-40 LARGE; CELL-PROLIFERATION; BINDING PROTEIN; TRANSGENIC MICE; MOUSE MODEL; MERLIN; GROWTH	Neurofibromatosis type 2 protein (NF2) has been shown to act as tumor suppressor primarily through its functions as a cytoskeletal scaffold. However, NF2 can also be found in the nucleus, where its role is less clear. Previously, our group has identified JC virus (JCV) tumor antigen (T-antigen) as a nuclear binding partner for NF2 in tumors derived from JCV T-antigen transgenic mice. The association of NF2 with T-antigen in neuronal origin tumors suggests a potential role for NF2 in regulating the expression of the JCV T-antigen. Here, we report that NF2 suppresses T-antigen protein expression in U-87 MG human glioblastoma cells, which subsequently reduces T-antigen-mediated regulation of the JCV promoter. When T-antigen mRNA was quantified, it was determined that increasing expression of NF2 correlated with an accumulation of T-antigen mRNA; however, a decrease in T-antigen at the protein level was observed. NF2 was found to promote degradation of ubiquitin bound T-antigen protein via a proteasome dependent pathway concomitant with the accumulation of the JCV early mRNA encoding T-antigen. The interaction between T-antigen and NF2 maps to the FERM domain of NF2, which has been shown previously to be responsible for its tumor suppressor activity. Co-immunoprecipitation assays revealed a ternary complex among NF2, T-antigen, and the tumor suppressor protein, p53 within a glioblastoma cell line. Further, these proteins were detected in various degrees in patient tumor tissue, suggesting that these associations may occur in vivo. Collectively, these results demonstrate that NF2 negatively regulates JCV T-antigen expression by proteasome-mediated degradation, and suggest a novel role for NF2 as a suppressor of JCV T-antigen-induced cell cycle regulation.	[Beltrami, Sarah; Branchetti, Emanuela; Sariyer, Ilker K.; Otte, Jessica; Gordon, Jennifer] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Beltrami, Sarah; Branchetti, Emanuela; Sariyer, Ilker K.; Otte, Jessica; Gordon, Jennifer] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA USA; [Beltrami, Sarah] Temple Univ, Sch Med, Biomed Neurosci Grad Program, Philadelphia, PA USA; [Weaver, Michael] Temple Univ, Sch Med, Dept Neurosurg, Philadelphia, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gordon, J (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	jennifer.gordon@temple.edu	Sariyer, Ilker/AAE-7677-2020		National Institutes of Health under a Ruth L. Kirchstein National Research Service Award [1T32MH079785]; Comprehensive NeuroAIDS Center (CNAC NIMH) at Temple University School of Medicine [P30MH092177]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, T32MH079785] Funding Source: NIH RePORTER	National Institutes of Health under a Ruth L. Kirchstein National Research Service Award; Comprehensive NeuroAIDS Center (CNAC NIMH) at Temple University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This investigation was sponsored by the National Institutes of Health under a Ruth L. Kirchstein National Research Service Award (1T32MH079785) providing support to Sarah Beltrami. This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC NIMH Grant Number P30MH092177) at Temple University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bhattacharyya R, 2007, ONCOGENE, V26, P7628, DOI 10.1038/sj.onc.1210576; Bosco EE, 2010, ONCOGENE, V29, P2540, DOI 10.1038/onc.2010.20; Chang Z, 2009, J NEURO-ONCOL, V91, P265, DOI 10.1007/s11060-008-9721-3; Cole BK, 2008, MOL CELL BIOL, V28, P1274, DOI 10.1128/MCB.01139-07; EVANS DGR, 1992, Q J MED, V84, P603; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Gordon J, 2000, ONCOGENE, V19, P4840, DOI 10.1038/sj.onc.1203849; Gronholm M, 2005, MOL CELL NEUROSCI, V28, P683, DOI 10.1016/j.mcn.2004.11.014; Houshmandi SS, 2009, MOL CELL BIOL, V29, P1472, DOI 10.1128/MCB.01392-08; Ikeda K, 1999, J NEUROSURG, V91, P85, DOI 10.3171/jns.1999.91.1.0085; Johnson KC, 2002, ONCOGENE, V21, P5990, DOI 10.1038/sj.onc.1205693; Kalamarides M, 2011, ACTA NEUROPATHOL, V123, P369; Kim H, 2004, J BIOL CHEM, V279, P7812, DOI 10.1074/jbc.M305526200; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kressel M, 2002, HUM MOL GENET, V11, P2269, DOI 10.1093/hmg/11.19.2269; Krynska B, 2000, VIROLOGY, V274, P65, DOI 10.1006/viro.2000.0450; Krynska B, 1997, J CELL BIOCHEM, V67, P223, DOI 10.1002/(SICI)1097-4644(19971101)67:2<223::AID-JCB7>3.0.CO;2-Z; Lassak A, 2002, J BIOL CHEM, V277, P17231, DOI 10.1074/jbc.M110885200; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Lee H, 2007, MOL CELL BIOL, V27, P2103, DOI 10.1128/MCB.00572-06; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Mani T, 2011, MOL CELL BIOL, V31, P1983, DOI 10.1128/MCB.00609-10; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Morales FC, 2010, NEURO-ONCOLOGY, V12, P528, DOI 10.1093/neuonc/nop060; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Muranen T, 2005, ONCOGENE, V24, P1150, DOI 10.1038/sj.onc.1208283; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; PADGETT BL, 1976, J INFECT DIS, V133, P686, DOI 10.1093/infdis/133.6.686; Poulin DL, 2004, J VIROL, V78, P8245, DOI 10.1128/JVI.78.15.8245-8253.2004; Riddick G, 2011, NAT REV NEUROL, V7, P439, DOI 10.1038/nrneurol.2011.100; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sariyer IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014630; Scoles DR, 2006, HUM MOL GENET, V15, P1059, DOI 10.1093/hmg/ddl021; Sekido Y, 2011, PATHOL INT, V61, P331, DOI 10.1111/j.1440-1827.2011.02666.x; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shimazu T, 2006, ONCOGENE, V25, P7391, DOI 10.1038/sj.onc.1209731; Shollar D, 2004, ONCOGENE, V23, P5459, DOI 10.1038/sj.onc.1207728; Staib C, 1996, VIROLOGY, V219, P237, DOI 10.1006/viro.1996.0241; Stettner MR, 2009, J GEN VIROL, V90, P2005, DOI 10.1099/vir.0.011072-0; Trofatter J A, 1993, Cell, V75, P826; Trojanek J, 2006, J CELL PHYSIOL, V206, P35, DOI 10.1002/jcp.20425; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Uleri Elena, 2011, Genes Cancer, V2, P728, DOI 10.1177/1947601911424578; White MK, 2005, BRAIN RES REV, V50, P69, DOI 10.1016/j.brainresrev.2005.04.007; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Yu YJ, 2005, J VIROL, V79, P6882, DOI 10.1128/JVI.79.11.6882-6889.2005	57	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53447	10.1371/journal.pone.0053447	http://dx.doi.org/10.1371/journal.pone.0053447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308224	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100067
J	Dastidar, EG; Dzeyk, K; Krijgsveld, J; Malmquist, NA; Doerig, C; Scherf, A; Lopez-Rubio, JJ				Dastidar, Eeshita G.; Dzeyk, Kristina; Krijgsveld, Jeroen; Malmquist, Nicholas A.; Doerig, Christian; Scherf, Artur; Lopez-Rubio, Jose-Juan			Comprehensive Histone Phosphorylation Analysis and Identification of Pf14-3-3 Protein as a Histone H3 Phosphorylation Reader in Malaria Parasites	PLOS ONE			English	Article							MUTUALLY EXCLUSIVE EXPRESSION; PLASMODIUM-FALCIPARUM; MASS-SPECTROMETRY; MODIFICATION PATTERNS; STRUCTURAL BASIS; GENE-REGULATION; GENOME-WIDE; I-TASSER; CHROMATIN; ACETYLATION	The important role of histone posttranslational modifications, particularly methylation and acetylation, in Plasmodium falciparum gene regulation has been established. However, the role of histone phosphorylation remains understudied. Here, we investigate histone phosphorylation utilizing liquid chromatography and tandem mass spectrometry to analyze histones extracted from asexual blood stages using two improved protocols to enhance preservation of PTMs. Enrichment for phosphopeptides lead to the detection of 14 histone phospho-modifications in P. falciparum. The majority of phosphorylation sites were observed at the N-terminal regions of various histones and were frequently observed adjacent to acetylated lysines. We also report the identification of one novel member of the P. falciparum histone phosphosite binding protein repertoire, Pf14-3-3I. Recombinant Pf14-3-3I protein bound to purified parasite histones. In silico structural analysis of Pf14-3-3 proteins revealed that residues responsible for binding to histone H3 S10ph and/or S28ph are conserved at the primary and the tertiary structure levels. Using a battery of H3 specific phosphopeptides, we demonstrate that Pf14-3-3I preferentially binds to H3S28ph over H3S10ph, independent of modification of neighbouring residues like H3S10phK14ac and H3S28phS32ph. Our data provide key insight into histone phosphorylation sites. The identification of a second member of the histone modification reading machinery suggests a widespread use of histone phosphorylation in the control of various nuclear processes in malaria parasites.	[Dastidar, Eeshita G.; Malmquist, Nicholas A.; Scherf, Artur; Lopez-Rubio, Jose-Juan] Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France; [Dastidar, Eeshita G.; Malmquist, Nicholas A.; Scherf, Artur; Lopez-Rubio, Jose-Juan] CNRS, Unite Rech Associe 2581, Paris, France; [Dzeyk, Kristina; Krijgsveld, Jeroen] European Mol Biol Lab, Prote Core Facil, D-69012 Heidelberg, Germany; [Doerig, Christian] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); Monash University	Scherf, A (corresponding author), Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France.	artur.scherf@pasteur.fr; jjlopez@pasteur.fr	Scherf, Artur/A-9674-2014; Doerig, Christian/Q-9900-2019; lopez-rubio, jose juan/A-4509-2014	Krijgsveld, Jeroen/0000-0001-7549-9326; Doerig, Christian/0000-0002-3188-094X; Malmquist, Nicholas/0000-0003-2822-8245; Scherf, Artur/0000-0003-2411-3328; lopez-rubio, jose juan/0000-0002-0555-1122	European Union [215281]	European Union(European Commission)	EGD benefits from a PhD fellowship funded by the European Union Framework Program 7 Marie Curie Initial Training Network "Intervention strategies against malaria (InterMalTraining)", contract number 215281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Al-Khedery B, 1999, MOL BIOCHEM PARASIT, V102, P117, DOI 10.1016/S0166-6851(99)00090-0; Andrews KT, 2012, CURR PHARM DES; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Berger SL, 2010, COLD SH Q B, V75, P23, DOI 10.1101/sqb.2010.75.044; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Brokx SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014827; CARY C, 1994, PARASITOL RES, V80, P255, DOI 10.1007/BF00932684; Cherblanc F, 2012, FUTURE MED CHEM, V4, P425, DOI [10.4155/fmc.12.7, 10.4155/FMC.12.7]; Cui LW, 2010, EUKARYOT CELL, V9, P1138, DOI 10.1128/EC.00036-10; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Dastidar EG, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-5; Di Girolamo F, 2008, PROTEOMICS, V8, P2500, DOI 10.1002/pmic.200700763; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Healy S, 2011, DISCOV MED, V11, P349; Iqbal J, 2010, ANN NY ACAD SCI, V1192, P238, DOI 10.1111/j.1749-6632.2010.05388.x; Issar N, 2009, MICROBES INFECT, V11, P403, DOI 10.1016/j.micinf.2008.12.010; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krebs JE, 2007, MOL BIOSYST, V3, P590, DOI 10.1039/b703923a; Kutateladze TG, 2011, CELL, V146, DOI 10.1016/j.cell.2011.08.022; Lalle M, 2011, J BIOL CHEM, V286, P1227, DOI 10.1074/jbc.M110.194613; LANZER M, 1992, NUCLEIC ACIDS RES, V20, P3051, DOI 10.1093/nar/20.12.3051; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Llinas M, 2008, TRENDS PARASITOL, V24, P551, DOI 10.1016/j.pt.2008.08.010; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Miao J, 2006, GENE, V369, P53, DOI 10.1016/j.gene.2005.10.022; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Trelle MB, 2009, J PROTEOME RES, V8, P3439, DOI 10.1021/pr9000898; Truong AB, 2002, PROTEINS, V49, P321, DOI 10.1002/prot.10210; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Winter S, 2008, CELL CYCLE, V7, P1336, DOI 10.4161/cc.7.10.5946; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	53	28	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53179	10.1371/journal.pone.0053179	http://dx.doi.org/10.1371/journal.pone.0053179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308157	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100033
J	Perez-Faginas, P; Aranda, MT; Garcia-Lopez, MT; Infantes, L; Fernandez-Carvajal, A; Gonzalez-Ros, JM; Ferrer-Montiel, A; Gonzalez-Muniz, R				Perez-Faginas, Paula; Teresa Aranda, M.; Teresa Garcia-Lopez, M.; Infantes, Lourdes; Fernandez-Carvajal, Asia; Manuel Gonzalez-Ros, Jose; Ferrer-Montiel, Antonio; Gonzalez-Muniz, Rosario			Highly Functionalized 1,2-Diamino Compounds through Reductive Amination of Amino Acid-Derived beta-Keto Esters	PLOS ONE			English	Article							ASYMMETRIC-SYNTHESIS; EFFICIENT SYNTHESIS; ALPHA; HYDROGENATION; DIPEPTIDES; ALDEHYDES; CATALYST; HYDRIDE; POTENT; ROUTE	1,2-Diamine derivatives are valuable building blocks to heterocyclic compounds and important precursors of biologically relevant compounds. In this respect, amino acid-derived beta-keto esters are a suitable starting point for the synthesis of beta,gamma-diamino ester derivatives through a two-step reductive amination procedure with either simple amines or alpha-amino esters. AcOH and NaBH3CN are the additive and reducing agents of choice. The stereoselectivity of the reaction is still an issue, due to the slow imine-enamine equilibria through which the reaction occurs, affording mixtures of diastereoisomers that can be chromatographically separated. Transformation of the beta,gamma-diamino esters into pyrrolidinone derivatives allows the configuration assignment of the linear compounds, and constitutes an example of their potential application in the generation of molecular diversity.	[Perez-Faginas, Paula; Teresa Aranda, M.; Teresa Garcia-Lopez, M.; Gonzalez-Muniz, Rosario] CSIC, Inst Quim Med, E-28006 Madrid, Spain; [Infantes, Lourdes] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Fernandez-Carvajal, Asia; Manuel Gonzalez-Ros, Jose; Ferrer-Montiel, Antonio] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Universidad Miguel Hernandez de Elche	Gonzalez-Muniz, R (corresponding author), CSIC, Inst Quim Med, Juan Cierva 3, E-28006 Madrid, Spain.	rosario.gonzalezmuniz@iqm.csic.es	Gonzalez-Muñiz, Rosario/L-9074-2014; Ferrer-Montiel, Antonio/C-3072-2015; Infantes, Lourdes/P-7566-2014; Carvajal, Asia Fernandez/G-8877-2015	Gonzalez-Muñiz, Rosario/0000-0001-8833-4328; Ferrer-Montiel, Antonio/0000-0002-2973-6607; Infantes, Lourdes/0000-0001-6932-4212; Gonzalez Ros, Jose Manuel/0000-0002-4804-6855; Fernandez-Carvajal, Asia/0000-0003-2741-1427	Spanish Ministry of Science and Innovation [SAF2009-09323]; Consolider-Ingenio CSD (Spanish Ion Channel Initiative) [2008-00005]; Consolider-Ingenio CSD (Crystallization Factory) [CSD2006-00015]; Consejo Superior de Investigaciones Cientificas (CSIC); ESF; Program Junta para la Ampliacion de Estudios	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio CSD (Spanish Ion Channel Initiative); Consolider-Ingenio CSD (Crystallization Factory); Consejo Superior de Investigaciones Cientificas (CSIC); ESF(European Commission); Program Junta para la Ampliacion de Estudios	This work was supported by the Spanish Ministry of Science and Innovation, SAF2009-09323 and Consolider-Ingenio CSD 2008-00005 (Spanish Ion Channel Initiative) and CSD2006-00015 (Crystallization Factory). P.P.-F. and M. T. A. thank the Consejo Superior de Investigaciones Cientificas (CSIC) for a JAE-predoc fellowship and a JAEdoc contract, respectively, both from the Program Junta para la Ampliacion de Estudios co-financed by the ESF. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abdel-Magid AF, 2006, ORG PROCESS RES DEV, V10, P971, DOI 10.1021/op0601013; AbdelMagid AF, 1996, J ORG CHEM, V61, P3849, DOI 10.1021/jo960057x; Belot S, 2008, CHEM COMMUN, P4694, DOI 10.1039/b810789k; Bisol TB, 2011, J ORG CHEM, V76, P948, DOI 10.1021/jo102267h; Bunlaksananusorn T, 2005, SYNLETT, P2682, DOI 10.1055/s-2005-917108; Busscher GF, 2010, TETRAHEDRON-ASYMMETR, V21, P1709, DOI 10.1016/j.tetasy.2010.04.013; Cimarelli C, 1996, J ORG CHEM, V61, P5557, DOI 10.1021/jo960107y; Davies SG, 2012, ORG LETT, V14, P218, DOI 10.1021/ol203011u; DEVANT RM, 1988, TETRAHEDRON LETT, V29, P2307, DOI 10.1016/S0040-4039(00)86044-X; Fellah M, 2010, J ORG CHEM, V75, P7803, DOI 10.1021/jo101668k; Fitch DM, 2005, ORG LETT, V7, P5521, DOI 10.1021/ol052371w; Gautier FM, 2011, ORG BIOMOL CHEM, V9, P7860, DOI 10.1039/c1ob05965c; Gomez S, 2002, ADV SYNTH CATAL, V344, P1037, DOI 10.1002/1615-4169(200212)344:10<1037::AID-ADSC1037>3.0.CO;2-3; GOMEZMONTERREY I, 1993, TETRAHEDRON LETT, V34, P3593, DOI 10.1016/S0040-4039(00)73644-6; Hoang CT, 2009, J ORG CHEM, V74, P4177, DOI 10.1021/jo900324d; Iden HS, 2008, J COMB CHEM, V10, P691, DOI 10.1021/cc8001052; Kim HO, 1997, SYNTHETIC COMMUN, V27, P2505, DOI 10.1080/00397919708004114; KIM S, 1985, J ORG CHEM, V50, P1927, DOI 10.1021/jo00211a028; Kuhl A, 2005, AMINO ACIDS, V29, P89, DOI 10.1007/s00726-005-0212-y; Lee HS, 2001, J ORG CHEM, V66, P3597, DOI 10.1021/jo001534l; Lee OY, 2009, ORG LETT, V11, P3302, DOI 10.1021/ol901111g; Lelais G, 2004, BIOPOLYMERS, V76, P206, DOI 10.1002/bip.20088; Lenin R, 2007, ARKIVOC, P204, DOI 10.3998/ark.5550190.0008.d23; Li XH, 2007, J AM CHEM SOC, V129, P14152, DOI 10.1021/ja076155p; MANSOUR TS, 1990, SYNTHETIC COMMUN, V20, P773, DOI 10.1080/00397919008052321; MartinMartinez M, 1997, J MED CHEM, V40, P3402, DOI 10.1021/jm9703247; NARDELLI M, 1983, COMPUT CHEM, V7, P95, DOI 10.1016/0097-8485(83)85001-3; Nardelli M., 1995, J APPL CRYSTALLOGR, V28, P659, DOI [10.1107/s0021889895007138, 10.1107/S0021889895007138, DOI 10.1107/S0021889895007138]; Nugent TC, 2006, ADV SYNTH CATAL, V348, P1289, DOI 10.1002/adsc.200606073; Nugent TC, 2011, ADV SYNTH CATAL, V353, P2085, DOI 10.1002/adsc.201100250; Nugent TC, 2007, EUR J ORG CHEM, V2007, P3863, DOI 10.1002/ejoc.200700345; Nugent TC, 2010, ADV SYNTH CATAL, V352, P753, DOI 10.1002/adsc.200900719; Patino-Molina R, 2000, LETT PEPT SCI, V7, P143; Patino-Molina R, 1999, TETRAHEDRON, V55, P15001, DOI 10.1016/S0040-4020(99)00957-6; Patino-Molina R, 2007, SYNTHESIS-STUTTGART, P1047, DOI 10.1055/s-2007-965962; SETOI H, 1989, CHEM PHARM BULL, V37, P1126; Shibata I, 1998, SYNLETT, P1081; Sridharan V, 2007, SYNLETT, P881, DOI 10.1055/s-2007-973862; Theberge CR, 2003, TETRAHEDRON, V59, P1521, DOI 10.1016/S0040-4020(03)00052-8; Tripathi RP, 2008, CURR ORG CHEM, V12, P1093, DOI 10.2174/138527208785740283; Wang C, 2010, ANGEW CHEM INT EDIT, V49, P7548, DOI 10.1002/anie.201002944; Wen JJ, 1997, J PEPT RES, V49, P3; Xu DQ, 1997, TETRAHEDRON-ASYMMETR, V8, P1445, DOI 10.1016/S0957-4166(97)00160-2; Zivec M, 2009, CURR MED CHEM, V16, P2289, DOI 10.2174/092986709788453113	44	4	4	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53231	10.1371/journal.pone.0053231	http://dx.doi.org/10.1371/journal.pone.0053231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308167	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100042
J	Wondimu, Z; Omrani, S; Ishikawa, T; Javed, F; Oikawa, Y; Virtanen, I; Juronen, E; Ingerpuu, S; Patarroyo, M				Wondimu, Zenebech; Omrani, Shahin; Ishikawa, Taichi; Javed, Fawad; Oikawa, Yuko; Virtanen, Ismo; Juronen, Erkki; Ingerpuu, Sulev; Patarroyo, Manuel			A Novel Monoclonal Antibody to Human Laminin alpha 5 Chain Strongly Inhibits Integrin-Mediated Cell Adhesion and Migration on Laminins 511 and 521	PLOS ONE			English	Article							HUMAN LUNG-CARCINOMA; RESTRICTED DISTRIBUTION; BASEMENT-MEMBRANES; BINDING-SITE; EXPRESSION; IDENTIFICATION; MOLECULE; ISOFORMS; DOMAIN; ALPHA-5-LAMININS	Laminins, a large family of alpha beta gamma heterotrimeric proteins mainly found in basement membranes, are strong promoters of adhesion and migration of multiple cell types, such as tumor and immune cells, via several integrin receptors. Among laminin alpha (LM alpha) chains, alpha 5 displays the widest tissue distribution in adult life and is synthesized by most cell types. Here, we have generated and characterized five novel monoclonal antibodies (mAbs) to the human LM alpha 5 chain to further study the biological relevance of alpha 5 laminins, such as laminins 511 (alpha 5 beta 1 gamma 1) and 521 (alpha 5 beta 2 gamma 1). As detected by ELISA, immunohistochemistry, immunoprecipitation and Western blotting, each antibody displayed unique properties when compared to mAb 4C7, the prototype LM alpha 5 antibody. Of greatest interest, mAb 8G9, but not any other antibody, strongly inhibited alpha 3 beta 1/alpha 6 beta 1 integrin-mediated adhesion and migration of glioma, melanoma, and carcinoma cells on laminin-511 and, together with mAb 4C7, on laminin-521. Accordingly, mAb 8G9 abolished the interaction of soluble alpha 3 beta 1 integrin with immobilized laminins 511 and 521. Binding of mAb 8G9 to laminin-511 was unaffected by the other mAbs to the LMa5 chain but largely hindered by mAb 4E10 to a LM beta 1 chain epitope near the globular domain of laminin-511. Thus, mAb 8G9 defines a novel epitope localized at or near the integrin-binding globular domain of the LM alpha 5 chain, which is essential for cell adhesion and migration, and identifies a potential therapeutic target in malignant and inflammatory diseases.	[Wondimu, Zenebech; Omrani, Shahin; Ishikawa, Taichi; Javed, Fawad; Oikawa, Yuko; Patarroyo, Manuel] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Virtanen, Ismo] Univ Helsinki, Inst Biomed Anat, Helsinki, Finland; [Juronen, Erkki] Univ Tartu, Inst Biomed, EE-50090 Tartu, Estonia; [Ingerpuu, Sulev] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	Karolinska Institutet; University of Helsinki; University of Tartu; University of Tartu	Patarroyo, M (corresponding author), Karolinska Inst, Dept Dent Med, Stockholm, Sweden.	Manuel.Patarroyo@ki.se	Javed, Fawad/A-6608-2012; Ishikawa, Taichi/AAU-4916-2021	Javed, Fawad/0000-0002-9253-1989; Ishikawa, Taichi/0000-0002-6229-0379	Karolinska Institutet; Cancerfonden	Karolinska Institutet(Karolinska Institutet); Cancerfonden(Swedish Cancer Society)	The present work was supported by Karolinska Institutet and Cancerfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; CHANDRASEKARAN EV, 1979, CANCER RES, V39, P870; Chia J, 2007, AM J PATHOL, V170, P2135, DOI 10.2353/ajpath.2007.060709; Church HJ, 1998, BIOCHEM J, V332, P491, DOI 10.1042/bj3320491; Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; ENGVALL E, 1986, J CELL BIOL, V103, P2457, DOI 10.1083/jcb.103.6.2457; Falk M, 1999, MATRIX BIOL, V18, P557, DOI 10.1016/S0945-053X(99)00047-5; Ferletta M, 1999, J CELL SCI, V112, P1; Geberhiwot T, 2000, MATRIX BIOL, V19, P163, DOI 10.1016/S0945-053X(00)00056-1; Genersch E, 2003, EUR J CELL BIOL, V82, P105, DOI 10.1078/0171-9335-00297; Gorfu G, 2008, J LEUKOCYTE BIOL, V84, P701, DOI 10.1189/jlb.0108048; Gu YC, 1999, BLOOD, V93, P2533, DOI 10.1182/blood.V93.8.2533.408k22_2533_2542; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2006, MATRIX BIOL, V25, P112, DOI 10.1016/j.matbio.2005.10.003; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lee SP, 1998, BLOOD, V92, P2951, DOI 10.1182/blood.V92.8.2951.420k30_2951_2958; Li J, 2003, EMBO J, V22, P2400, DOI 10.1093/emboj/cdg239; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Maatta M, 2001, J HISTOCHEM CYTOCHEM, V49, P711; Miner JH, 1999, INT J BIOCHEM CELL B, V31, P811, DOI 10.1016/S1357-2725(99)00030-8; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Nigatu A, 2006, THROMB HAEMOSTASIS, V95, P85, DOI 10.1160/TH05-04-0281; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Oikawa Y, 2011, EXP CELL RES, V317, P1119, DOI 10.1016/j.yexcr.2010.12.019; Parsons SF, 1999, BEST PRACT RES CL HA, V12, P729, DOI 10.1053/beha.1999.0050; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Petajaniemi N, 2002, J HISTOCHEM CYTOCHEM, V50, P1113, DOI 10.1177/002215540205000813; Plopper GE, 1998, BREAST CANCER RES TR, V51, P57, DOI 10.1023/A:1006086218174; Pouliot N, 2000, EXP CELL RES, V261, P360, DOI 10.1006/excr.2000.5065; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Salo S, 2009, INT J CANCER, V125, P1814, DOI 10.1002/ijc.24532; Sasaki T, 2001, FEBS LETT, V509, P181, DOI 10.1016/S0014-5793(01)03167-2; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Sime W, 2009, J IMMUNOL, V183, P4657, DOI 10.4049/jimmunol.0901738; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Tani T, 1999, EXP CELL RES, V248, P115, DOI 10.1006/excr.1999.4399; Taniguchi Y, 2009, J BIOL CHEM, V284, P7820, DOI 10.1074/jbc.M809332200; Tiger CF, 1997, J BIOL CHEM, V272, P28590, DOI 10.1074/jbc.272.45.28590; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Tran M, 2008, CANCER RES, V68, P2885, DOI 10.1158/0008-5472.CAN-07-6160; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Virtanen I, 2000, EXP CELL RES, V257, P298, DOI 10.1006/excr.2000.4883; Wondimu Z, 2004, BLOOD, V104, P1859, DOI 10.1182/blood-2004-01-0396; Yamashita H, 2010, J CELL PHYSIOL, V223, P541, DOI 10.1002/jcp.22107	52	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53648	10.1371/journal.pone.0053648	http://dx.doi.org/10.1371/journal.pone.0053648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308268	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100101
J	Iorio, RA; Del Duca, S; Calamelli, E; Pula, C; Lodolini, M; Scamardella, F; Pession, A; Ricci, G				Iorio, Rosa Anna; Del Duca, Stefano; Calamelli, Elisabetta; Pula, Chiara; Lodolini, Magda; Scamardella, Fortuna; Pession, Andrea; Ricci, Giampaolo			Citrus Allergy from Pollen to Clinical Symptoms	PLOS ONE			English	Article							EICOSANOID-LIKE SUBSTANCES; LIPID-TRANSFER PROTEINS; FOOD ALLERGY; PROFILIN CIT-S-2; MAJOR ALLERGENS; IGE; REACTIVITY; PCR; SENSITIZATION; ANAPHYLAXIS	Allergy to citrus fruits is often associated with pollinosis and sensitization to other plants due to a phenomenon of cross-reactivity. The aims of the present study were to highlight the cross-reactivity among citrus and the major allergenic pollens/fruits, throughout clinical and molecular investigations, and to evaluate the sensitization frequency to citrus fruits in a population of children and adults with pollinosis. We found a relevant percentage of sensitisation (39%) to citrus fruits in the patients recruited and in all of them the IgE-mediated mechanism has been confirmed by the positive response to the prick-to-prick test. RT-PCR experiments showed the expression of Cit s 1, Cit s 3 and a profilin isoform, already described in apple, also in Citrus clementine pollen. Data of multiple sequence alignments demonstrated that Citrus allergens shared high percentage identity values with other clinically relevant species (i.e. Triticum aestivum, Malus domestica), confirming the possible cross-allergenicity citrus/grasses and citrus/apple. Finally, a novelty of the present work has been the expression of two phospholipaseA2 isoforms (PLA2 alpha and beta) in Citrus as well as in Triticum pollens; being PLA2 able to generate proinflammatory factors, this enzyme could participate in the activation of the allergenic inflammatory cascade.	[Iorio, Rosa Anna; Del Duca, Stefano] Univ Bologna, Dept Biol Earth & Environm Sci, Bologna, Italy; [Calamelli, Elisabetta; Pula, Chiara; Pession, Andrea; Ricci, Giampaolo] Univ Bologna, Womens Childrens & Adolescents Hlth Gozzadini Chi, Dept Pediat Allergol, Bologna, Italy; [Lodolini, Magda; Scamardella, Fortuna] Maggiore Hosp, Lab Anal Unit, Bologna, Italy	University of Bologna; University of Bologna; AUSL di Bologna	Del Duca, S (corresponding author), Univ Bologna, Dept Biol Earth & Environm Sci, Bologna, Italy.	stefano.delduca@unibo.it	Calamelli, Elisabetta/AAL-8143-2021; Del Duca, Stefano/K-5980-2017; Pession, Andrea/O-3200-2013	Del Duca, Stefano/0000-0002-5981-520X; Pession, Andrea/0000-0002-0379-9562; CALAMELLI, ELISABETTA/0000-0002-7809-5543; Calamelli, Elisabetta/0000-0003-4888-0839	Programma Operativo Regionale (POR FESR) of Regione Calabria "My Darling Clementine": un prodotto salutistico nuovo e innovativo dalle clementine e dal limone di Calabria''	Programma Operativo Regionale (POR FESR) of Regione Calabria "My Darling Clementine": un prodotto salutistico nuovo e innovativo dalle clementine e dal limone di Calabria''	This work was supported by the Programma Operativo Regionale (POR FESR 2007-2013) of Regione Calabria "My Darling Clementine": un prodotto salutistico nuovo e innovativo dalle clementine e dal limone di Calabria''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER BR, 1991, CLIN EXP ALLERGY, V21, P683, DOI 10.1111/j.1365-2222.1991.tb03196.x; Ahrazem O, 2006, INT ARCH ALLERGY IMM, V139, P96, DOI 10.1159/000090384; Ahrazem O, 2005, INT ARCH ALLERGY IMM, V137, P201, DOI 10.1159/000086332; Asero R, 2008, CLIN EXP ALLERGY, V38, P1033, DOI 10.1111/j.1365-2222.2008.02980.x; BAGNI N, 1981, PLANT PHYSIOL, V68, P727, DOI 10.1104/pp.68.3.727; Behrendt H, 2001, INT ARCH ALLERGY IMM, V124, P121, DOI 10.1159/000053688; Bohle B, 2007, ALLERGY, V62, P3, DOI 10.1111/j.1398-9995.2006.01258.x; Bolhaar STHP, 2005, J ALLERGY CLIN IMMUN, V116, P1080, DOI 10.1016/j.jaci.2005.07.004; Botton A, 2002, PLANT SCI, V163, P993, DOI 10.1016/S0168-9452(02)00271-6; Crespo JF, 2006, MOL NUTR FOOD RES, V50, P282, DOI 10.1002/mnfr.200500200; D'Amato G, 2010, J INVEST ALLERG CLIN, V20, P95; Ebo DG, 2007, INT ARCH ALLERGY IMM, V144, P39, DOI 10.1159/000102612; Enrique E, 2004, J INVEST ALLERG CLIN, V14, P335; Eriksson NE, 2003, ALLERGOL INT, V52, P199; Garcia BE, 2011, J INVEST ALLERG CLIN, V21, P162; Glaspole IN, 2007, ANN ALLERG ASTHMA IM, V98, P286, DOI 10.1016/S1081-1206(10)60720-X; Gunawan H, 2008, INT ARCH ALLERGY IMM, V147, P276, DOI 10.1159/000144035; Hyun TK, 2011, PLANT OMICS, V4, P428; Ibanez MD, 2004, J ALLERGY CLIN IMMUN, V113, P175, DOI 10.1016/j.jaci.2003.10.059; Iorio RA, 2012, AMINO ACIDS, V42, P1007, DOI 10.1007/s00726-011-1043-7; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kim HJ, 2011, PLANT CELL, V23, P94, DOI 10.1105/tpc.110.074799; Knekt P, 2000, EUR J CLIN NUTR, V54, P415, DOI 10.1038/sj.ejcn.1600974; Krishnan Kannan, 2009, Biophys Rev, V1, P71, DOI 10.1007/s12551-009-0010-y; Kumar R, 2006, ASIAN PAC J ALLERGY, V24, P191; Le Marchand L, 2000, JNCI-J NATL CANCER I, V92, P154, DOI 10.1093/jnci/92.2.154; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez DEQ, 2006, J INVEST ALLERG CLIN, V16, P140; Lopez-Torrejon G, 2005, ALLERGY, V60, P1424, DOI 10.1111/j.1398-9995.2005.00903.x; Mari A, 2001, INT ARCH ALLERGY IMM, V125, P57, DOI 10.1159/000053797; Marzban G, 2005, PLANT SCI, V169, P387, DOI 10.1016/j.plantsci.2005.03.027; Mills ENC, 2007, ALLERGY, V62, P717, DOI 10.1111/j.1398-9995.2007.01425.x; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; Paris R, 2009, TREE GENET GENOMES, V5, P81, DOI 10.1007/s11295-008-0177-6; Pignataro V, 2010, J AGR FOOD CHEM, V58, P7239, DOI 10.1021/jf1006825; Radauer C, 2004, PLANT FOOD ALLERGENS, P105; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ricci G, 2005, MOL IMMUNOL, V42, P1251, DOI 10.1016/j.molimm.2004.11.011; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; SLOAN AE, 1986, J ALLERGY CLIN IMMUN, V78, P127, DOI 10.1016/0091-6749(86)90002-3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANREE R, 1992, INT ARCH ALLERGY IMM, V98, P97, DOI 10.1159/000236171; Wilkins TA, 1996, ISOLATION RNA PLANT, P21; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9	45	14	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53680	10.1371/journal.pone.0053680	http://dx.doi.org/10.1371/journal.pone.0053680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308273	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100052
J	Li, E; Yue, F; Chang, Q; Guo, XN; He, XP; Zhang, BR				Li, Ee; Yue, Feng; Chang, Qi; Guo, Xuena; He, Xiuping; Zhang, Borun			Deletion of Intragenic Tandem Repeats in Unit C of FLO1 of Saccharomyces cerevisiae Increases the Conformational Stability of Flocculin under Acidic and Alkaline Conditions	PLOS ONE			English	Article							YEAST FLOCCULATION; CELL-SURFACE; GENE FLO1; EXPRESSION; BREWERS; PHENOTYPE; STRAINS; PROTEIN	Flocculation is an attractive property for Saccaromyces cerevisiae, which plays important roles in fermentation industry and environmental remediation. The process of flocculation is mediated by a family of cell surface flocculins. As one member of flocculins, Flo1 is characterized by four families of repeats (designated as repeat units A, B, C and D) in the central domain. It is generally accepted that variation of repeat unit A in length in Flo1 influences the degree of flocculation or specificity for sugar recognization. However, no reports were observed for other repeat units. Here, we compared the flocculation ability and its sensitivity to environmental factors between yeast strain YSF1 carrying the intact FLO1 gene and yeast strains carrying the derived forms of FLO1 with partial or complete deletion of repeats in unit C. No obvious differences in flocculation ability and specificity of carbohydrate recognition were observed among these yeast strains, which indicates the truncated flocculins can stride across the cell wall and cluster the N-terminal domain on the surface of yeast cells as the intact Flo1 thereby improving intercellular binding. However, yeast strains with the truncated flocculins required more mannose to inhibit completely the flocculation, displayed broad tolerance of flocculation to pH fluctuation, and the fewer the repeats in unit C, the stronger adaptability of flocculation to pH change, which was not relevant to the position of deletion. This suggests that more stable active conformation is obtained for flocculin by deletion the repeat unit C in the central domain of Flo1, which was validated further by the higher hydrophobicity on the surface of cells of YSF1c with complete deletion of unit C under neutral and alkaline conditions and the stabilization of GFP conformation by fusion with flocculin with complete deletion of unit C in the central domain.	[Li, Ee; Yue, Feng; Chang, Qi; Guo, Xuena; He, Xiuping; Zhang, Borun] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Li, Ee; Yue, Feng; Chang, Qi] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, XP (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	hexp@im.ac.cn			National Natural Science Foundation of China [30970087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 30970087, http://nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Bauer FF, 2010, APPL MICROBIOL BIOT, V88, P31, DOI 10.1007/s00253-010-2783-0; Bester MC, 2006, CURR GENET, V49, P375, DOI 10.1007/s00294-006-0068-z; Bizzarri R, 2009, ANAL BIOANAL CHEM, V393, P1107, DOI 10.1007/s00216-008-2515-9; Ehrmann MA, 2001, LETT APPL MICROBIOL, V32, P230, DOI 10.1046/j.1472-765X.2001.00892.x; Fidalgo M, 2006, P NATL ACAD SCI USA, V103, P11228, DOI 10.1073/pnas.0601713103; Govender P, 2008, APPL ENVIRON MICROB, V74, P6041, DOI 10.1128/AEM.00394-08; [何秀萍 He Xiuping], 2002, [微生物学报, Acta Microbiologica Sinica], V42, P242; Jin YL, 2000, J AM SOC BREW CHEM, V58, P108; Kobayashi O, 1998, J BACTERIOL, V180, P6503, DOI 10.1128/JB.180.24.6503-6510.1998; Kobayashi O, 1999, CURR GENET, V36, P256, DOI 10.1007/s002940050498; Li Ee, 2012, Weishengwu Xuebao, V52, P69; Liu N, 2007, FEMS YEAST RES, V7, P1362, DOI 10.1111/j.1567-1364.2007.00294.x; Lo WS, 1996, J BACTERIOL, V178, P7144, DOI 10.1128/jb.178.24.7144-7151.1996; Ma K, 2009, BIORESOURCE TECHNOL, V100, P2289, DOI 10.1016/j.biortech.2008.11.010; Machado MD, 2008, BIORESOURCE TECHNOL, V99, P2107, DOI 10.1016/j.biortech.2007.05.047; MASY CL, 1992, CAN J MICROBIOL, V38, P1298, DOI 10.1139/m92-214; Patelakis SJJ, 1998, LETT APPL MICROBIOL, V26, P279; Sambrook J., 2001, MOL CLONING LAB MANU; Sato M, 2001, J AM SOC BREW CHEM, V59, P130; Sieiro C, 1997, FEMS MICROBIOL LETT, V146, P109, DOI 10.1016/S0378-1097(96)00462-4; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Soares EV, 2000, BIOTECHNOL LETT, V22, P1827, DOI 10.1023/A:1005665427163; STRATFORD M, 1991, YEAST, V7, P559, DOI 10.1002/yea.320070604; STRATFORD M, 1989, YEAST, V5, P441; TEUNISSEN AWRH, 1993, YEAST, V9, P1, DOI 10.1002/yea.320090102; Van Holle A, 2012, APPL MICROBIOL BIOT, V93, P1221, DOI 10.1007/s00253-011-3502-1; Veelders M, 2010, P NATL ACAD SCI USA, V107, P22511, DOI 10.1073/pnas.1013210108; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Verstrepen KJ, 2003, APPL MICROBIOL BIOT, V61, P197, DOI 10.1007/s00253-002-1200-8; WATARI J, 1994, YEAST, V10, P211, DOI 10.1002/yea.320100208; WATARI J, 1991, AGR BIOL CHEM TOKYO, V55, P1547, DOI 10.1080/00021369.1991.10870834	34	7	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53428	10.1371/journal.pone.0053428	http://dx.doi.org/10.1371/journal.pone.0053428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308221	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100040
J	Buckle, T; Kuil, J; van den Berg, NS; Bunschoten, A; Lamb, HJ; Yuan, HH; Josephson, L; Jonkers, J; Borowsky, AD; van Leeuwen, FWB				Buckle, Tessa; Kuil, Joeri; van den Berg, Nynke S.; Bunschoten, Anton; Lamb, Hildo J.; Yuan, Hushan; Josephson, Lee; Jonkers, Jos; Borowsky, Alexander D.; van Leeuwen, Fijs W. B.			Use of a Single Hybrid Imaging Agent for Integration of Target Validation with In Vivo and Ex Vivo Imaging of Mouse Tumor Lesions Resembling Human DCIS	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; PROSTATE-CANCER; FLOW-CYTOMETRY; PROGRESSION; EXPRESSION; CARCINOMA; GROWTH; MODEL; OVEREXPRESSION	Screening of biomarker expression levels in tumor biopsy samples not only provides an assessment of prognostic and predictive factors, but may also be used for selection of biomarker-specific imaging strategies. To assess the feasibility of using a biopsy specimen for a personalized selection of an imaging agent, the chemokine receptor 4 (CXCR4) was used as a reference biomarker. Methods: A hybrid CXCR4 targeting peptide (MSAP-Ac-TZ14011) containing a fluorescent dye and a chelate for radioactive labeling was used to directly compare initial flow cytometry-based target validation in fresh tumor tissue to in vivo single photon emission computed tomography (SPECT) imaging and in vivo and ex vivo fluorescence imaging. Results: Flow cytometric analysis of mouse tumor derived cell suspensions enabled discrimination between 4T1 control tumor lesions (with low levels of CXCR4 expression) and CXCR4 positive early, intermediate and late stage MIN-O lesions based on their CXCR4 expression levels; CXCR4(basal), CXCR4(+) and CXCR4(++) cell populations could be accurately discriminated. Mean fluorescent intensity ratios between expression in MIN-O and 4T1 tissue found with flow cytometry were comparable to ratios obtained with in vivo SPECT/CT and fluorescence imaging, ex vivo fluorescence evaluation and standard immunohistochemistry. Conclusion: The hybrid nature of a targeting imaging agent like MSAP-Ac-TZ14011 enables integration of target selection, in vivo imaging and ex vivo validation using a single agent. The use of biopsy tissue for biomarker screening can readily be expanded to other targeting hybrid imaging agents and can possibly help increase the clinical applicability of tumor-specific imaging approaches.	[Buckle, Tessa; Kuil, Joeri; van den Berg, Nynke S.; Bunschoten, Anton; van Leeuwen, Fijs W. B.] Leiden Univ, Med Ctr, Dept Radiol, Intervent Mol Imaging Lab, Leiden, Netherlands; [Buckle, Tessa; Kuil, Joeri; van den Berg, Nynke S.; Bunschoten, Anton; van Leeuwen, Fijs W. B.] Netherlands Canc Inst Antoni van Leeuwenhoekhuis, Dept Radiol, Amsterdam, Netherlands; [Buckle, Tessa; Kuil, Joeri; van den Berg, Nynke S.; Bunschoten, Anton; van Leeuwen, Fijs W. B.] Netherlands Canc Inst Antoni van Leeuwenhoekhuis, Dept Nucl Med, Amsterdam, Netherlands; [Lamb, Hildo J.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Yuan, Hushan; Josephson, Lee] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA; [Yuan, Hushan; Josephson, Lee] Harvard Univ, Sch Med, Charlestown, MA USA; [Jonkers, Jos] Netherlands Canc Inst Antoni van Leeuwenhoek Hosp, Div Cell Biol, Amsterdam, Netherlands; [Borowsky, Alexander D.] Univ Calif Davis, Sch Med, Ctr Comparat Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Massachusetts General Hospital; Harvard University; Netherlands Cancer Institute; University of California System; University of California Davis	van Leeuwen, FWB (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Intervent Mol Imaging Lab, Leiden, Netherlands.	F.W.B.van_Leeuwen@lumc.nl	Borowsky, Alexander D/S-5404-2017; Jonkers, Jos/AAG-3246-2019; Lamb, Hildo/ABE-1171-2021; van leeuwen, Fijs/AAX-2098-2021	Jonkers, Jos/0000-0002-9264-9792; Lamb, Hildo/0000-0002-6969-2418; van leeuwen, Fijs/0000-0002-6844-4025; Bunschoten, Anton/0000-0002-4167-5077; Buckle, Tessa/0000-0003-2980-6895	Dutch Cancer Society [PGF 2009-4344]; VIDI grant [STW11272]; FP7-HYPERImage [201651]; Centre for Translational Molecular Medicine grant, project Breast CARE [030-104]; National Center for Research resources grant [K26 RR0243037]; National Institutes of Health [R01 EB-009691, EB011996]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009691, R01EB011996] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); VIDI grant; FP7-HYPERImage; Centre for Translational Molecular Medicine grant, project Breast CARE; National Center for Research resources grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding: This research is supported by a Dutch Cancer Society translational research award (Grant No. PGF 2009-4344; FvL), a VIDI grant (Grant No. STW11272, FvL) and via FP7-HYPERImage (Grant No. 201651; TB), a Centre for Translational Molecular Medicine grant, project Breast CARE (Grant No. 030-104; JK) a National Center for Research resources grant (K26 RR0243037; ADB), and by National Institutes of Health grants R01 EB-009691 and EB011996 (LJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey CK, 2004, P NATL ACAD SCI USA, V101, P11438, DOI 10.1073/pnas.0404396101; Allred DC, 2010, MODERN PATHOL, V23, pS52, DOI 10.1038/modpathol.2010.55; Azhdarinia A, 2012, MOL IMAGING BIOL, V14, P261, DOI 10.1007/s11307-011-0528-9; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Banerjee SR, 2011, ANGEW CHEM INT EDIT, V50, P9167, DOI 10.1002/anie.201102872; Brouwer OR, 2012, J NUCL MED, V53, P1; Brouwer OR, 2012, ANN SURG ONCOL, V19, P1988, DOI 10.1245/s10434-011-2180-7; Buckle T, 2012, AM J NUCL MED MOLEC, V2, P99; Buckle T, 2012, J NUCL MED, V53, P1026, DOI 10.2967/jnumed.111.098517; Bunschoten A, 2012, CHEMBIOCHEM, V13, P1039, DOI 10.1002/cbic.201200034; Bunschoten A, 2012, BIOMATERIALS, V33, P867, DOI 10.1016/j.biomaterials.2011.10.005; Carlisle AJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-126; Chu QD, 2011, SURGERY, V149, P193, DOI 10.1016/j.surg.2010.05.016; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Estey EH, 2012, AM J HEMATOL, V87, P90, DOI 10.1002/ajh.22246; Goldhirsch A, 2002, JNCI-J NATL CANCER I, V94, P1054; Hanaoka H, 2006, NUCL MED BIOL, V33, P489, DOI 10.1016/j.nucmedbio.2006.01.006; Hassan S, 2009, AM J PATHOL, V175, P66, DOI 10.2353/ajpath.2009.080948; Holm NT, 2007, J SURG RES, V141, P53, DOI 10.1016/j.jss.2007.03.015; Kang H, 2005, BREAST, V14, P360, DOI 10.1016/j.breast.2004.12.007; Kuil J, 2012, CHEM SOC REV, V41, P5239, DOI 10.1039/c2cs35085h; Kuil J, 2011, MOL PHARMACEUT, V8, P2444, DOI 10.1021/mp200401p; Kuil J, 2011, BIOCONJUGATE CHEM, V22, P859, DOI 10.1021/bc2000947; Kuil J, 2010, BIOCONJUGATE CHEM, V21, P1709, DOI 10.1021/bc100276j; Leong ASY, 2011, PATHOBIOLOGY, V78, P99, DOI 10.1159/000292644; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Namba R, 2006, CLIN CANCER RES, V12, P2613, DOI 10.1158/1078-0432.CCR-05-2170; Namba R, 2005, BREAST CANCER RES, V7, pR881, DOI 10.1186/bcr1317; Nolan GR, 2011, BEST PRACT RES CL HA, V24, P505, DOI 10.1016/j.beha.2011.09.005; Penault-Llorca F, 2003, INT J ONCOL, V22, P1319; Pritchard KI, 2006, NEW ENGL J MED, V354, P2103, DOI 10.1056/NEJMoa054504; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; Sampath L, 2007, J NUCL MED, V48, P1501, DOI 10.2967/jnumed.107.042234; Taly V, 2012, TRENDS MOL MED, V18, P405, DOI 10.1016/j.molmed.2012.05.001; van den Berg NS, 2012, EUR J NUCL MED MOL I, V39, P1128, DOI 10.1007/s00259-012-2129-5; van den Berg NS, 2011, TRANSL ONCOL, V4, P224, DOI 10.1593/tlo.11115; van der Poel HG, 2011, EUR UROL, V60, P826, DOI 10.1016/j.eururo.2011.03.024; van Leeuwen AC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528027; Yura H, 2006, J BIOCHEM, V139, P637, DOI 10.1093/jb/mvj077; Zare H, 2012, AM J CLIN PATHOL, V137, P75, DOI 10.1309/AJCPMMLQ67YOMGEW	40	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e48324	10.1371/journal.pone.0048324	http://dx.doi.org/10.1371/journal.pone.0048324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326303	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800005
J	Ji, SY; Hao, JX; Li, L; Zhang, J; Zheng, QS; Li, XX; Wang, XN; Han, CS; Gao, F; Liu, YX				Ji, Shao-Yang; Hao, Jian-Xiu; Li, Lei; Zhang, Jun; Zheng, Qiao-Song; Li, Xi-Xia; Wang, Xiao-Na; Han, Chun-Sheng; Gao, Fei; Liu, Yi-Xun			Expression of Inhibin-Alpha Is Regulated Synergistically by Wilms' Tumor Gene 1 (Wt1) and Steroidogenic Factor-1 (Sf1) in Sertoli Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SUPPRESSOR GENE; PROTEIN WT1; RAT INHIBIN; REPRESSION; PROMOTER; RECEPTOR; ACTIVATION; SUBUNITS; LOCALIZATION	Wt1 encodes a zinc finger nuclear transcriptional factor, which is specifically expressed in testicular Sertoli cells and knockdown of Wt1 in Sertoli cells causes male mice subfertility. However, the underlying mechanism is still unclear. In this study, we found that expression of inhibin-alpha is significantly reduced in Wt1-deficient Sertoli cells. Luciferase assays using the inhibin-alpha promoter indicated that the inhibin-alpha promoter is transactivated by the Wt1 A, and B isoforms (-KTS), but not the C, and D isoforms (+KTS). Analysis of the Wt1 responsive element of the inhibin-alpha promoter region using site-directed mutagenesis showed that the nucleotides between -58 and -49 are essential for Wt1-dependent transactivation of the inhibin-alpha promoter. ChIP assays indicated that Wt1 directly interacts with the inhibin-alpha promoter. In addition, the inhibin-alpha promoter is activated synergistically by Wt1 and Sf1. Mutation of the ligand binding domain (LBD) of Sf1 (residues 235-238) completely abolished the synergistic action between Wt1 and Sf1, but did not affect the physical interaction between these two proteins, suggesting that other factor(s) may also be involved in the regulation of inhibin-alpha in Sertoli cells. Further studies demonstrated that beta-catenin enhances the synergistic activation of Wt1 and Sf1 on the inhibin-alpha promoter. Given the fact that inhibin-alpha, a subunit of inhibin, is known to be involved in the regulation of spermatogenesis and testicular steroidogenesis, this study reveals a new regulatory mechanism of inhibin-alpha in Sertoli cells and also sheds light on the physiological functions of Wt1 in gonad development and spermatogenesis.	[Ji, Shao-Yang; Hao, Jian-Xiu; Li, Lei; Zhang, Jun; Zheng, Qiao-Song; Li, Xi-Xia; Wang, Xiao-Na; Han, Chun-Sheng; Gao, Fei; Liu, Yi-Xun] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Ji, Shao-Yang; Hao, Jian-Xiu; Li, Lei; Zhang, Jun; Zheng, Qiao-Song; Li, Xi-Xia; Wang, Xiao-Na] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	gaof@ioz.ac.cn; Liuyx@ioz.ac.cn			Major Research Plan [2011CB944300, 2013CB945001]; CAS Innovation Project [KSCX2-YW-R-081]; National Natural Science Foundation of China [31071271, 31071018, 31171373, 31171380]	Major Research Plan; CAS Innovation Project(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Research Plan (2011CB944300 and 2013CB945001), the CAS Innovation Project (KSCX2-YW-R-081), and the National Natural Science Foundation of China (31071271, 31071018, 31171373, and 31171380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blount MA, 2010, AM J PHYSIOL-RENAL, V298, pF857, DOI 10.1152/ajprenal.00725.2009; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cho BN, 2001, ENDOCRINOLOGY, V142, P4994, DOI 10.1210/en.142.11.4994; Cook DM, 1996, ONCOGENE, V13, P1789; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; Englert C, 1997, CANCER RES, V57, P1429; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Englert C, 1998, TRENDS BIOCHEM SCI, V23, P389, DOI 10.1016/S0968-0004(98)01277-8; FORAGE RG, 1986, P NATL ACAD SCI USA, V83, P3091, DOI 10.1073/pnas.83.10.3091; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Gummow BM, 2003, J BIOL CHEM, V278, P26572, DOI 10.1074/jbc.M212677200; HSU SY, 1995, MOL ENDOCRINOL, V9, P1356, DOI 10.1210/me.9.10.1356; Ito M, 2000, MOL ENDOCRINOL, V14, P66, DOI 10.1210/me.14.1.66; Iversen PO, 2010, AM J PHYSIOL-REG I, V298, pR808, DOI 10.1152/ajpregu.00250.2009; KUDOH T, 1995, P NATL ACAD SCI USA, V92, P4517, DOI 10.1073/pnas.92.10.4517; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; Lu CL, 2009, MOL CELL ENDOCRINOL, V298, P48, DOI 10.1016/j.mce.2008.09.039; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; MAYO KE, 1986, P NATL ACAD SCI USA, V83, P5849, DOI 10.1073/pnas.83.16.5849; MEUNIER H, 1988, MOL ENDOCRINOL, V2, P1352, DOI 10.1210/mend-2-12-1352; Mizusaki H, 2003, MOL ENDOCRINOL, V17, P507, DOI 10.1210/me.2002-0362; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; MORRIS JF, 1991, ONCOGENE, V6, P2339; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; NICHOLS KE, 1995, CANCER RES, V55, P4540; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; PELLETIER J, 1991, GENE DEV, V5, P1345, DOI 10.1101/gad.5.8.1345; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; Reddy JC, 1996, BBA-REV CANCER, V1287, P1, DOI 10.1016/0304-419X(95)00014-7; RIVIER C, 1986, SCIENCE, V234, P205, DOI 10.1126/science.3092356; RYAN G, 1995, DEVELOPMENT, V121, P867; WANG ZY, 1992, J BIOL CHEM, V267, P21999; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; WOODRUFF TK, 1987, MOL ENDOCRINOL, V1, P561, DOI 10.1210/mend-1-8-561; WOODRUFF TK, 1988, SCIENCE, V239, P1296, DOI 10.1126/science.3125611	41	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53140	10.1371/journal.pone.0053140	http://dx.doi.org/10.1371/journal.pone.0053140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326390	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800033
J	Tombari, W; Paul, M; Bettaieb, J; Larbi, I; Nsiri, J; Elbehi, I; Gribaa, L; Ghram, A				Tombari, Wafa; Paul, Mathilde; Bettaieb, Jihene; Larbi, Imen; Nsiri, Jihene; Elbehi, Imen; Gribaa, Latifa; Ghram, Abdeljelil			Risk Factors and Characteristics of Low Pathogenic Avian Influenza Virus Isolated from Commercial Poultry in Tunisia	PLOS ONE			English	Article							COMPETITIVE ELISA; A VIRUSES; HUMAN INFECTION; H9 SUBTYPE; PCR ASSAY; HONG-KONG; SURVEILLANCE; NUCLEOPROTEIN; ANTIBODIES; FLOCKS	Objective: Estimate the seroprevalence of influenza A virus in various commercial poultry farms and evaluate specific risk factors as well as analyze their genetic nature using molecular assays. Materials and Methods: This report summarizes the findings of a national survey realized from October 2010 to May 2011 on 800 flocks in 20 governorates. Serum samples were screened for the presence of specific influenza virus antibodies using cELISA test. Additionally, swab samples were tested by real time and conventional RT-PCR and compared with results obtained by others assays. Phylogenetic and genetic analyses of the glycoproteins were established for some strains. Results: Out of the 800 chicken and turkey flocks tested by cELISA, 223 showed positive anti-NP antibodies (28.7%, 95% CI: 25.6-32.1). Significantly higher seroprevalence was found among the coastal areas compared to inland and during the autumn and winter. Broiler flocks showed significantly lower seroprevalence than layers and broiler breeders. The influenza virus infection prevalence increased after the laying phase among layer flocks. In addition, AIV seropositivity was significantly associated with low biosecurity measures. The Ag EIA and rRT-PCR tests revealed significantly higher numbers of AI positive samples as compared to cell cultures or egg inoculation. All new strains were subtyped as H9N2 by real time and conventional RT-PCR. Drift mutations, addition or deletion of glycosylation sites were likely to have occurred in the HA and NA glycoproteins of Tunisian strains resulting in multiple new amino acid substitutions. This fact may reflect different evolutionary pressures affecting these glycoproteins. The role of these newly detected substitutions should be tested. Conclusion: Our findings highlight the potential risk of AIV to avian health. Strict enforcement of biosecurity measures and possible vaccination of all poultry flocks with continuous monitoring of poultry stations may ensure reduction of AIV prevalence and avoid emergence of more pathogenic strains.	[Tombari, Wafa; Larbi, Imen; Nsiri, Jihene; Elbehi, Imen; Gribaa, Latifa; Ghram, Abdeljelil] Univ Tunis El Manar, Inst Pasteur Tunis, Vet Microbiol Lab, Tunis, Tunisia; [Paul, Mathilde] INRA, UMR IHAP 1225, F-31931 Toulouse, France; [Paul, Mathilde] Univ Toulouse INP, Ecole Natl Vet Toulouse, Toulouse, France; [Bettaieb, Jihene] Pasteur Inst Tunis, Med Epidemiol Unit, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis	Ghram, A (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Vet Microbiol Lab, Tunis, Tunisia.	abdeljelil.ghram@pasteur.rns.tn		PAUL, Mathilde C./0000-0003-2940-8547	Tunisian Ministry of Research and Technology;  [MEV09]	Tunisian Ministry of Research and Technology; 	This work has been developed under the MEV09 project and the research platform Vet Microbiol and benefited from funds from the Tunisian Ministry of Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Afifi MAA, 2013, TROP ANIM HEALTH PRO, V45, P687, DOI 10.1007/s11250-012-0243-9; Al-Natour MQ, 2005, PREV VET MED, V70, P45, DOI 10.1016/j.prevetmed.2005.02.009; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Alexander DJ, 2000, REV SCI TECH OIE, V19, P197, DOI 10.20506/rst.19.1.1220; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Capua I, 2004, AVIAN PATHOL, V33, P393, DOI 10.1080/03079450410001724085; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Couacy-Hymann E, 2012, EMERG INFECT DIS, V18, P1446, DOI 10.3201/eid1809.111296; FAO, 2008, TUN REV SECT AV; Feare CJ, 2010, AVIAN DIS, V54, P201, DOI 10.1637/8766-033109-ResNote.1; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Goffard A, 2008, PATHOL BIOL, V56, P482, DOI 10.1016/j.patbio.2008.07.030; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ji K, 2010, J VIROL METHODS, V163, P186, DOI 10.1016/j.jviromet.2009.09.013; Kwon HJ, 2006, AVIAN PATHOL, V35, P309, DOI 10.1080/03079450600821166; Lee CW, 2008, J VIROL METHODS, V153, P22, DOI 10.1016/j.jviromet.2008.06.019; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Molia S, AVIAN DIS, V55, P650; Monne I, 2008, J CLIN MICROBIOL, V46, P1769, DOI 10.1128/JCM.02204-07; Naeem K, 2003, AVIAN PATHOL, V32, P285, DOI [10.1080/1030794503100009788, 10.1080/0307945031000097886]; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Roussan DA, 2009, PREV VET MED, V88, P77, DOI 10.1016/j.prevetmed.2008.06.021; Sergeant ESG, 2012, EPITOOLS EPIDEMIOLOG; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Soliman A, 2012, J WILDLIFE DIS, V48, P669, DOI 10.7589/0090-3558-48.3.669; Song DS, 2009, J VET SCI, V10, P323, DOI 10.4142/jvs.2009.10.4.323; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Starick E, 2006, J VET MED B, V53, P370, DOI 10.1111/j.1439-0450.2006.01007.x; Swayne D. E, 2003, AVIAN INFLUENZA DIS, P135; Toennessen R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-21; Tombari W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-467; Velarde R, 2010, AVIAN DIS, V54, P411, DOI 10.1637/8808-040109-Reg.1; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; Zhou EM, 1998, AVIAN DIS, V42, P517, DOI 10.2307/1592678	38	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53524	10.1371/journal.pone.0053524	http://dx.doi.org/10.1371/journal.pone.0053524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326449	Green Published, gold			2022-12-27	WOS:000314705800052
J	Castegren, M; Skorup, P; Lipcsey, M; Larsson, A; Sjolin, J				Castegren, Markus; Skorup, Paul; Lipcsey, Miklos; Larsson, Anders; Sjolin, Jan			Endotoxin Tolerance Variation over 24 h during Porcine Endotoxemia: Association with Changes in Circulation and Organ Dysfunction	PLOS ONE			English	Article							SHWARTZMAN REACTION; CLINICAL-RELEVANCE; ANESTHETIZED PIG; INJURY; INTERLEUKIN-10; RESPONSES; SHOCK; LIPOPOLYSACCHARIDE; PRETREATMENT; ISCHEMIA	Endotoxin tolerance (ET), defined as reduced inflammatory responsiveness to endotoxin challenge following a first encounter with endotoxin, is an extensively studied phenomenon. Although reduced mortality and morbidity in the presence of ET has been demonstrated in animal studies, little is known about the temporal development of ET. Further, in acute respiratory distress syndrome ET correlates to the severity of the disease, suggesting a complicated relation between ET and organ dysfunction. Eighteen pigs were subjected to intensive care and a continuous endotoxin infusion for 24 h with the aim to study the time course of early ET and to relate ET to outcome in organ dysfunction. Three animals served as non-endotoxemic controls. Blood samples for cytokine analyses were taken and physiological variables registered every third hour. Production of TNF-alpha, IL-6, and IL-10 before and after endotoxin stimulation ex vivo was measured. The difference between cytokine values after and before ex vivo LPS stimulation (Delta-values) was calculated for all time points. Delta TNF-alpha was employed as the principal marker of ET and lower Delta TNF-alpha values were interpreted as higher levels of ET. During endotoxin infusion, there was suppression of ex vivo productions of TNF-alpha and IL-6 but not of IL-10 in comparison with that at 0 h. The ex vivo TNF-alpha values followed another time concentration curve than those in vivo. Delta TNF-alpha was at the lowest already at 6 h, followed by an increase during the ensuing hours. Delta TNF-alpha at 6 h correlated positively to blood pressure and systemic vascular resistance and negatively to cardiac index at 24 h. In this study a temporal variation of ET was demonstrated that did not follow changes in plasma TNF-alpha concentrations. Maximal ET occurred early in the course and the higher the ET, the more hyperdynamic the circulation 18 h later.	[Castegren, Markus] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [Castegren, Markus; Skorup, Paul; Sjolin, Jan] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Lipcsey, Miklos] Uppsala Univ, Dept Surg Sci, Sect Anesthesiol & Intens Care, Uppsala, Sweden; [Larsson, Anders] Uppsala Univ, Dept Med Sci, Sect Clin Chem, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	Castegren, M (corresponding author), Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden.	markus.castegren@dll.se	Castegren, Markus/AAF-2620-2019; Lipcsey, Miklos/K-4308-2012	Lipcsey, Miklos/0000-0002-1976-4129; skorup, paul/0000-0002-5407-6612; Castegren, Markus/0000-0002-9292-0298	Sormland County Council; Uppsala University Hospital; Olinder-Nielsen Family fund	Sormland County Council; Uppsala University Hospital; Olinder-Nielsen Family fund	The R&D funds of the Sormland County Council and Uppsala University Hospital as well as the Olinder-Nielsen Family fund contributed with financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J ENDOTOXIN RES, V7, P105, DOI 10.1177/09680519010070020401; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Allen ML, 2006, CRIT CARE MED, V34, P2658, DOI 10.1097/01.CCM.0000240243.28129.36; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BROWN JM, 1989, P NATL ACAD SCI USA, V86, P2516, DOI 10.1073/pnas.86.7.2516; BROZNA JP, 1990, SEMIN THROMB HEMOST, V16, P326, DOI 10.1055/s-2007-1002685; Buttenschoen K, 2008, LANGENBECK ARCH SURG, V393, P473, DOI 10.1007/s00423-008-0317-3; Carlsson M, 2009, CRIT CARE MED, V37, P1031, DOI 10.1097/CCM.0b013e31819b5683; Castegren M, 2012, SHOCK, V37, P501, DOI 10.1097/SHK.0b013e318249bb0d; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Chang Y, 2005, TOXICOL APPL PHARM, V204, P27, DOI 10.1016/j.taap.2004.08.011; Dias MB, 2005, J APPL PHYSIOL, V98, P1322, DOI 10.1152/japplphysiol.01243.2004; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Friedrich I, 2003, AM J PHYSIOL-LUNG C, V284, pL224, DOI 10.1152/ajplung.00138.2002; Fu Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002526; Fujii E, 2000, BRIT J PHARMACOL, V130, P90, DOI 10.1038/sj.bjp.0703277; Gao J, 2010, INFLAMM RES, V59, P491, DOI 10.1007/s00011-009-0110-y; Godet C, 2006, SHOCK, V25, P384, DOI 10.1097/01.shk.0000209528.35743.54; Greisman S E, 1975, Trans Am Clin Climatol Assoc, V86, P43; HE W, 1992, J INFECT DIS, V165, P859, DOI 10.1093/infdis/165.5.859; Heemann U, 2000, AM J PATHOL, V156, P287, DOI 10.1016/S0002-9440(10)64729-3; Hollenberg SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7706; KOFF WC, 1986, LYMPHOKINE RES, V5, P239; Lipcsey M, 2006, J ENDOTOXIN RES, V12, P99, DOI 10.1179/096805106X89053; Lipcsey M, 2008, SHOCK, V29, P173, DOI 10.1097/SHK.0b013e318067dfbc; LOVETT EJ, 1980, J SURG ONCOL, V15, P327, DOI 10.1002/jso.2930150405; Madera-Salcedo IK, 2011, J NEUROIMMUNOL, V232, P101, DOI 10.1016/j.jneuroim.2010.10.017; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Protti A, 2006, CRIT CARE, V10, DOI 10.1186/cc5014; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Riviere J.E., 2018, VET PHARM THERAPEUTI; Rocksen D, 2004, SHOCK, V22, P482, DOI 10.1097/01.shk.0000142183.42353.58; Schmidhammer R, 2006, SHOCK, V25, P389, DOI 10.1097/01.shk.0000209529.43367.00; Wang WM, 2011, INFLAMMATION, V34, P509, DOI 10.1007/s10753-010-9258-4; WATSON DW, 1963, J EXP MED, V118, P425, DOI 10.1084/jem.118.3.425; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; West MA, 2008, J TRAUMA, V65, P893, DOI 10.1097/TA.0b013e3181877fde	40	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53221	10.1371/journal.pone.0053221	http://dx.doi.org/10.1371/journal.pone.0053221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326400	gold, Green Submitted, Green Published			2022-12-27	WOS:000313552400016
J	Kistler, AD; Serra, AL; Siwy, J; Poster, D; Krauer, F; Torres, VE; Mrug, M; Grantham, JJ; Bae, KT; Bost, JE; Mullen, W; Wuthrich, RP; Mischak, H; Chapman, AB				Kistler, Andreas D.; Serra, Andreas L.; Siwy, Justyna; Poster, Diane; Krauer, Fabienne; Torres, Vicente E.; Mrug, Michal; Grantham, Jared J.; Bae, Kyongtae T.; Bost, James E.; Mullen, William; Wuethrich, Rudolf P.; Mischak, Harald; Chapman, Arlene B.			Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CORONARY-ARTERY-DISEASE; RENAL-DISEASE; VOLUME PROGRESSION; MASS-SPECTROMETRY; DISCOVERY; ADPKD; IDENTIFICATION; CANCER; GENES	Treatment options for autosomal dominant polycystic kidney disease (ADPKD) will likely become available in the near future, hence reliable diagnostic and prognostic biomarkers for the disease are strongly needed. Here, we aimed to define urinary proteomic patterns in ADPKD patients, which aid diagnosis and risk stratification. By capillary electrophoresis online coupled to mass spectrometry (CE-MS), we compared the urinary peptidome of 41 ADPKD patients to 189 healthy controls and identified 657 peptides with significantly altered excretion, of which 209 could be sequenced using tandem mass spectrometry. A support-vector-machine based diagnostic biomarker model based on the 142 most consistent peptide markers achieved a diagnostic sensitivity of 84.5% and specificity of 94.2% in an independent validation cohort, consisting of 251 ADPKD patients from five different centers and 86 healthy controls. The proteomic alterations in ADPKD included, but were not limited to markers previously associated with acute kidney injury (AKI). The diagnostic biomarker model was highly specific for ADPKD when tested in a cohort consisting of 481 patients with a variety of renal and extrarenal diseases, including AKI. Similar to ultrasound, sensitivity and specificity of the diagnostic score depended on patient age and genotype. We were furthermore able to identify biomarkers for disease severity and progression. A proteomic severity score was developed to predict height adjusted total kidney volume (htTKV) based on proteomic analysis of 134 ADPKD patients and showed a correlation of r = 0.415 (p<0.0001) with htTKV in an independent validation cohort consisting of 158 ADPKD patients. In conclusion, the performance of peptidomic biomarker scores is superior to any other biochemical markers of ADPKD and the proteomic biomarker patterns are a promising tool for prognostic evaluation of ADPKD.	[Kistler, Andreas D.; Serra, Andreas L.; Poster, Diane; Krauer, Fabienne; Wuethrich, Rudolf P.] Univ Hosp, Div Nephrol, Zurich, Switzerland; [Siwy, Justyna; Mischak, Harald] Mosa Diagnost & Therapeut AG, Hannover, Germany; [Torres, Vicente E.] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA; [Mrug, Michal] Univ Alabama, Div Nephrol, Birmingham, MN USA; [Mrug, Michal] Med Ctr, Dept Vet Affairs, Birmingham, MN USA; [Grantham, Jared J.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, MO USA; [Grantham, Jared J.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, MO USA; [Bae, Kyongtae T.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA USA; [Bost, James E.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Bost, James E.] Booz Allen Hamilton, Rockville, MD USA; [Mullen, William; Mischak, Harald] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Chapman, Arlene B.] Emory Univ, Sch Med, Dept Med, Div Nephrol, Atlanta, GA USA	University of Zurich; University Zurich Hospital; Mayo Clinic; University of Kansas; University of Kansas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Booz Allen Hamilton Holding Corporation; University of Glasgow; Emory University	Kistler, AD (corresponding author), Univ Hosp, Div Nephrol, Zurich, Switzerland.	andreas.kistler@usz.ch	Mullen, William/GWC-8078-2022	Krauer, Fabienne/0000-0001-8341-4011; Mischak, Harald/0000-0003-0323-0306; Mullen, William/0000-0002-5685-1563; Kistler, Andreas/0000-0002-4114-9560; Siwy, Justyna/0000-0003-1407-2534	Association pour l'Information et la Recherche sur les maladies Renales d'origine Genetique (AIRG), section Suisse Romande; Binelli and Ehrsam Foundation; Swiss National Science Foundation [3100030_132597/1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK056956, U01DK056957, R01DK044863] Funding Source: NIH RePORTER	Association pour l'Information et la Recherche sur les maladies Renales d'origine Genetique (AIRG), section Suisse Romande; Binelli and Ehrsam Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study was supported by the Association pour l'Information et la Recherche sur les maladies Renales d'origine Genetique (AIRG), section Suisse Romande, the Binelli and Ehrsam Foundation, and the Swiss National Science Foundation (No 3100030_132597/1) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalaf A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013421; Bolignano D, 2007, AM J NEPHROL, V27, P373, DOI 10.1159/000103912; Chalmers MJ, 2005, ANAL CHEM, V77, P7163, DOI 10.1021/ac050983o; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; CHAPMAN AB, 1994, J AM SOC NEPHROL, V5, P1349; Chapman AB, 2012, CLIN J AM SOC NEPHRO; Cowley BD, 2001, KIDNEY INT, V60, P2087, DOI 10.1046/j.1523-1755.2001.00065.x; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; Decramer S, 2006, NAT MED, V12, P398, DOI 10.1038/nm1384; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Drube J, 2009, NEPHROL DIAL TRANSPL, V24, P2161, DOI 10.1093/ndt/gfp063; Fliser D, 2007, J AM SOC NEPHROL, V18, P1057, DOI 10.1681/ASN.2006090956; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Goon J, 2008, PROTEOMICS IN PRESS; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Gronwald W, 2011, KIDNEY INT, V79, P1244, DOI 10.1038/ki.2011.30; Harris PC, 2010, ADV CHRONIC KIDNEY D, V17, P131, DOI 10.1053/j.ackd.2009.12.004; Harris PC, 2010, NAT REV NEPHROL, V6, P197, DOI 10.1038/nrneph.2010.18; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; IGLESIAS CG, 1983, AM J KIDNEY DIS, V2, P630; Johnson AM, 1997, J AM SOC NEPHROL, V8, P1560; Kistler AD, 2009, KIDNEY INT; Kistler AD, 2009, KIDNEY INT, V76, P89, DOI 10.1038/ki.2009.93; Kistler AD, 2009, KIDNEY INT, V75, P235, DOI 10.1038/ki.2008.558; Kuehn EW, 2007, BIOCHEM BIOPH RES CO, V364, P861, DOI 10.1016/j.bbrc.2007.10.103; Mangos S, 2010, DIS MODEL MECH, V3, P354, DOI 10.1242/dmm.003194; Meijer E, 2011, CLIN J AM SOC NEPHRO, V6, P361, DOI 10.2215/CJN.04560510; Meijer E, 2010, AM J KIDNEY DIS, V56, P883, DOI 10.1053/j.ajkd.2010.06.023; Metzger J, 2010, KIDNEY INT; Mischak H, 2012, CLIN BIOCH; Mischak H, 2009, MASS SPECTROM REV, V28, P703, DOI 10.1002/mas.20205; Mrug M, 2008, KIDNEY INT, V73, P63, DOI 10.1038/sj.ki.5002627; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Parikh GR, 2012, KIDNEY INT; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Schieren G, 2006, NEPHROL DIAL TRANSPL, V21, P1816, DOI 10.1093/ndt/gfl071; Schiffer E, 2009, CLIN CANCER RES, V15, P4935, DOI 10.1158/1078-0432.CCR-09-0226; Serra AL, 2010, NEW ENGL J MED; Serra Andreas L, 2007, BMC Nephrol, V8, P13, DOI 10.1186/1471-2369-8-13; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Siwy J, 2011, PROTEOM CLIN APPL, V5, P367, DOI 10.1002/prca.201000155; Snell-Bergeon JK, 2009, DIABETES TECHNOL THE, V11, P1, DOI 10.1089/dia.2008.0040; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Theodorescu D, 2005, ELECTROPHORESIS, V26, P2797, DOI 10.1002/elps.200400208; Therezo ALS, 1998, APPL IMMUNOHISTO M M, V6, P219, DOI 10.1097/00022744-199812000-00008; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Wuthrich RP, 2009, KIDNEY BLOOD PRESS R, V32, P380, DOI 10.1159/000254338; Zheng D, 2003, J AM SOC NEPHROL, V14, P2588, DOI 10.1097/01.ASN.0000088720.61783.19; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827; Zurbig P, 2012, DIABETES	55	55	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53016	10.1371/journal.pone.0053016	http://dx.doi.org/10.1371/journal.pone.0053016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326375	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000313552400013
J	Maguire, CT; Demarest, BL; Hill, JT; Palmer, JD; Brothman, AR; Yost, HJ; Condic, ML				Maguire, Colin T.; Demarest, Bradley L.; Hill, Jonathon T.; Palmer, James D.; Brothman, Arthur R.; Yost, H. Joseph; Condic, Maureen L.			Genome-Wide Analysis Reveals the Unique Stem Cell Identity of Human Amniocytes	PLOS ONE			English	Article							HUMAN AMNIOTIC-FLUID; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; HETEROGENEITY; PLURIPOTENCY; ORIGIN; EFFICIENCY; ENDODERM; CAPACITY; NANOG	Human amniotic fluid contains cells that potentially have important stem cell characteristics, yet the programs controlling their developmental potency are unclear. Here, we provide evidence that amniocytes derived from multiple patients are marked by heterogeneity and variability in expression levels of pluripotency markers. Clonal analysis from multiple patients indicates that amniocytes have large pools of self-renewing cells that have an inherent property to give rise to a distinct amniocyte phenotype with a heterogeneity of pluripotent markers. Significant to their therapeutic potential, genome-wide profiles are distinct at different gestational ages and times in culture, but do not differ between genders. Based on hierarchical clustering and differential expression analyses of the entire transcriptome, amniocytes express canonical regulators associated with pluripotency and stem cell repression. Their profiles are distinct from human embryonic stem cells (ESCs), induced-pluripotent stem cells (iPSCs), and newborn foreskin fibroblasts. Amniocytes have a complex molecular signature, coexpressing trophoblastic, ectodermal, mesodermal, and endodermal cell-type-specific regulators. In contrast to the current view of the ground state of stem cells, ESCs and iPSCs also express high levels of a wide range of cell-typespecific regulators. The coexpression of multilineage differentiation markers combined with the strong expression of a subset of ES cell repressors in amniocytes suggests that these cells have a distinct phenotype that is unlike any other known cell-type or lineage.	[Maguire, Colin T.; Demarest, Bradley L.; Hill, Jonathon T.; Palmer, James D.; Yost, H. Joseph; Condic, Maureen L.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Brothman, Arthur R.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Brothman, Arthur R.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Brothman, Arthur R.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Maguire, Colin T.; Demarest, Bradley L.; Hill, Jonathon T.; Palmer, James D.; Yost, H. Joseph] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Brothman, Arthur R.] Univ Utah, Sch Med, ARUP Labs, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories	Maguire, CT (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	cmaguire@genetics.utah.edu		Hill, Jonathon/0000-0003-1190-6302	National Institutes of Health [T32HL007576]; National Institute of Neurological Disorders and Stroke [5R01NS048382]; National Heart, Lung, and Blood Institute Bench-to-Bassinet Consortium [5U01HL098160]; Bench-to-Bassinet core facilities support grant [U01HL098188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098188, T32HL007576, U01HL098160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute Bench-to-Bassinet Consortium; Bench-to-Bassinet core facilities support grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by postdoctoral training fellowship T32HL007576 (National Institutes of Health) to CTM, 5R01NS048382 (National Institute of Neurological Disorders and Stroke) to MLC, 5U01HL098160 (National Heart, Lung, and Blood Institute Bench-to-Bassinet Consortium: URL http://www.benchtobassinet.com) to HJY and U01HL098188 (a Bench-to-Bassinet core facilities support grant) to New England Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Anchan RM, 2011, HUM MOL GENET, V20, P962, DOI 10.1093/hmg/ddq542; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Antonucci I, 2012, CURR PHARM DESIGN, V18, P1846, DOI 10.2174/138161212799859602; AULA P, 1980, BRIT MED J, V281, P1456, DOI 10.1136/bmj.281.6253.1456; Bilic J, 2012, STEM CELLS, V30, P33, DOI 10.1002/stem.700; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Bottai D, 2012, RESTOR NEUROL NEUROS, V30, P55, DOI 10.3233/RNN-2011-0620; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; CHEN WW, 1982, J MED GENET, V19, P433, DOI 10.1136/jmg.19.6.433; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Santis M, 2011, Minerva Ginecol, V63, P387; Decembrini S, 2011, STEM CELLS DEV, V20, P851, DOI 10.1089/scd.2010.0291; Ditadi A, 2009, BLOOD, V113, P3953, DOI 10.1182/blood-2008-10-182105; Dobreva MP, 2010, INT J DEV BIOL, V54, P761, DOI 10.1387/ijdb.092935md; Easley CA, 2012, CELL REPROGRAM, V14, P193, DOI 10.1089/cell.2011.0106; Eckmann-Scholz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039014; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Galende E, 2010, CELL REPROGRAM, V12, P117, DOI 10.1089/cell.2009.0077; Ge X, 2012, STEM CELLS DEV, V21, P2798, DOI 10.1089/scd.2011.0435; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; GOOI HC, 1981, NATURE, V292, P156, DOI 10.1038/292156a0; GOSDEN CM, 1983, BRIT MED BULL, V39, P348, DOI 10.1093/oxfordjournals.bmb.a071847; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Grisafi D, 2008, STEM CELLS DEV, V17, P953, DOI 10.1089/scd.2007.0188; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; HEIKINHEIMO M, 1980, J CLIN ENDOCR METAB, V51, P1432, DOI 10.1210/jcem-51-6-1432; HOEHN H, 1982, METHOD CELL BIOL, V26, P11; Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kolambkar YM, 2007, J MOL HISTOL, V38, P405, DOI 10.1007/s10735-007-9118-1; Kunisaki SM, 2012, ORGANOGENESIS, V1, P8; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Liu T, 2012, STEM CELLS DEV, V21, P2322, DOI 10.1089/scd.2011.0715; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Moschidou D, 2012, MOL THER, V20, P1953, DOI 10.1038/mt.2012.117; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Perin L, 2008, PEDIATR RES, V63, P467, DOI 10.1203/PDR.0b013e3181660653; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; PLOUZEK CA, 1993, PLACENTA, V14, P277, DOI 10.1016/S0143-4004(05)80427-8; Pozzobon M, 2010, PEDIATR SURG INT, V26, P3, DOI 10.1007/s00383-009-2478-8; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramirez JM, 2011, STEM CELLS, V29, P1469, DOI 10.1002/stem.681; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Shaw SWS, 2011, CURR OPIN OBSTET GYN, V23, P109, DOI 10.1097/GCO.0b013e32834457b1; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Suzuki R, 2012, PVCLUST HIERARCHICAL; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; VONKOSKULL H, 1981, PRENATAL DIAG, V1, P259, DOI 10.1002/pd.1970010405; Walther G, 2009, CATHETER CARDIO INTE, V73, P917, DOI 10.1002/ccd.22016; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Williams SA, 2009, GLYCOCONJUGATE J, V26, P335, DOI 10.1007/s10719-008-9181-1; Wolfrum K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013703; Woodbury D, 2006, MOL REPROD DEV, V73, P1463, DOI 10.1002/mrd.20587; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	72	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53372	10.1371/journal.pone.0053372	http://dx.doi.org/10.1371/journal.pone.0053372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326421	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400021
J	Wafa, K; MacLean, J; Zhang, FX; Pasumarthi, KBS				Wafa, Karim; MacLean, Jessica; Zhang, Feixiong; Pasumarthi, Kishore B. S.			Characterization of Growth Suppressive Functions of a Splice Variant of Cyclin D2	PLOS ONE			English	Article							CELL-CYCLE; KINASE-ACTIVITY; SUBCELLULAR-LOCALIZATION; PROTEIN AGGREGATION; HEMATOPOIETIC-CELLS; HUMAN FIBROBLASTS; I-TASSER; HA-RAS; D1; AUTOPHAGY	We have recently cloned a novel splice variant of cyclin D2 termed as cycD2SV. CycD2SV overexpression in several immortalized cell lines led to formation of ubiquitinated protein aggregates accompanied by a significant decrease in cell proliferation. Based on immuno co-localization and ultrastructural analysis experiments, cycD2SV protein aggregates were frequently found in various subcellular compartments such as endosomes, autophagosomes, lysosomes and the microtubule organizing centre. Secondary structure analysis revealed that the amino terminal alpha-helix in cycD2SV is not tightly packed with the cyclin box suggesting a misfolded conformation compared to other cyclins. Deletion analysis suggests that 1-53 amino acid region of cycD2SV may be required for protein aggregation and 54-136 amino acid region may mediate cell cycle inhibition. Based on co-immunoprecipitation experiments, we have shown that cycD2SV binds to cycD2 as well as CDK4. In addition, gene expression analysis demonstrated an upregulation in GADD45 alpha and dynamin 2 mRNA levels in cycD2SV overexpressing cells. These two proteins are known to play critical roles in the DNA damage response and apoptosis pathways. TUNEL experiments were negative for apoptosis, however, cycD2SV expressing cells were more sensitive to cell death induced by external stressors such as trypsinization. Collectively our results suggest that cycD2SV mediates cell cycle inhibition by sequestering endogenous cell cycle proteins, such as cycD2 and CDK4, and possibly targeting them for ubiquitin mediated protein degradation.	[Wafa, Karim; MacLean, Jessica; Zhang, Feixiong; Pasumarthi, Kishore B. S.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada	Dalhousie University	Pasumarthi, KBS (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada.	kpasumar@dal.ca		Pasumarthi, Kishore/0000-0001-9317-076X	Heart and Stroke Foundation of Nova Scotia; Canada Foundation for Innovation	Heart and Stroke Foundation of Nova Scotia; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by grants from the Heart and Stroke Foundation of Nova Scotia and Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-7; ATADJA P, 1995, EXP CELL RES, V217, P205, DOI 10.1006/excr.1995.1080; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Denicourt C, 2008, ONCOGENE, V27, P1253, DOI 10.1038/sj.onc.1210750; Denicourt C, 2003, J VIROL, V77, P37, DOI 10.1128/JVI.77.1.37-44.2003; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; EVANS DL, 1990, DEV COMP IMMUNOL, V14, P223, DOI 10.1016/0145-305X(90)90093-T; Fish KN, 2000, J CELL BIOL, V150, P145, DOI 10.1083/jcb.150.1.145; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Garkavtsev I, 1998, EXP GERONTOL, V33, P81, DOI 10.1016/S0531-5565(97)00086-7; Han EKH, 1999, APOPTOSIS, V4, P213, DOI 10.1023/A:1009618824145; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Huang HL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-36; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Kajitani K, 2010, NEUROSCI LETT, V477, P100, DOI 10.1016/j.neulet.2010.04.042; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2010, DEV CELL, V19, P11, DOI 10.1016/j.devcel.2010.07.005; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Liebermann DA, 2007, BLOOD CELL MOL DIS, V39, P329, DOI 10.1016/j.bcmd.2007.06.006; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATSUOKA S, 1994, J BIOL CHEM, V269, P11030; McMullen NM, 2009, DEV DYNAM, V238, P2787, DOI 10.1002/dvdy.22112; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; Mohney RP, 2003, J BIOL CHEM, V278, P47038, DOI 10.1074/jbc.M303895200; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; PAGANO M, 1994, GENE DEV, V8, P1627, DOI 10.1101/gad.8.14.1627; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Reynaud EG, 2000, ONCOGENE, V19, P1147, DOI 10.1038/sj.onc.1203403; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Sun Q, 2009, J CELL SCI, V122, P1563, DOI 10.1242/jcs.047738; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; von Bergwelt-Baildon MS, 2011, EXPERT REV VACCINES, V10, P389, DOI [10.1586/ERV.10.170, 10.1586/erv.10.170]; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wedegaertner PB, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-12; Wei S, 1999, CANCER RES, V59, P1539; Williams O, 2004, APOPTOSIS METHODS PR, P31; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang FX, 2007, J CELL MOL MED, V11, P552, DOI 10.1111/j.1582-4934.2007.00044.x; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zwicker J, 1999, ONCOGENE, V18, P19, DOI 10.1038/sj.onc.1202286	54	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53503	10.1371/journal.pone.0053503	http://dx.doi.org/10.1371/journal.pone.0053503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326442	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400024
J	Hellmich, HL; Rojo, DR; Micci, MA; Sell, SL; Boone, DR; Crookshanks, JM; DeWitt, DS; Masel, BE; Prough, DS				Hellmich, Helen L.; Rojo, Daniel R.; Micci, Maria-Adelaide; Sell, Stacy L.; Boone, Deborah R.; Crookshanks, Jeanna M.; DeWitt, Douglas S.; Masel, Brent E.; Prough, Donald S.			Pathway Analysis Reveals Common Pro-Survival Mechanisms of Metyrapone and Carbenoxolone after Traumatic Brain Injury	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; COGNITIVE FUNCTION; MESSENGER-RNA; ALZHEIMERS; NEUROPROTECTION; GLUCOCORTICOIDS; IMPAIRMENT; INHIBITOR	Developing new pharmacotherapies for traumatic brain injury (TBI) requires elucidation of the neuroprotective mechanisms of many structurally and functionally diverse compounds. To test our hypothesis that diverse neuroprotective drugs similarly affect common gene targets after TBI, we compared the effects of two drugs, metyrapone (MT) and carbenoxolone (CB), which, though used clinically for noncognitive conditions, improved learning and memory in rats and humans. Although structurally different, both MT and CB inhibit a common molecular target, 11 beta hydroxysteroid dehydrogenase type 1, which converts inactive cortisone to cortisol, thereby effectively reducing glucocorticoid levels. We examined injury-induced signaling pathways to determine how the effects of these two compounds correlate with pro-survival effects in surviving neurons of the injured rat hippocampus. We found that treatment of TBI rats with MT or CB acutely induced in hippocampal neurons transcriptional profiles that were remarkably similar (i.e., a coordinated attenuation of gene expression across multiple injury-induced cell signaling networks). We also found, to a lesser extent, a coordinated increase in cell survival signals. Analysis of injury-induced gene expression altered by MT and CB provided additional insight into the protective effects of each. Both drugs attenuated expression of genes in the apoptosis, death receptor and stress signaling pathways, as well as multiple genes in the oxidative phosphorylation pathway such as subunits of NADH dehydrogenase (Complex1), cytochrome c oxidase (Complex IV) and ATP synthase (Complex V). This suggests an overall inhibition of mitochondrial function. Complex 1 is the primary source of reactive oxygen species in the mitochondrial oxidative phosphorylation pathway, thus linking the protective effects of these drugs to a reduction in oxidative stress. The net effect of the drug-induced transcriptional changes observed here indicates that suppressing expression of potentially harmful genes, and also, surprisingly, reduced expression of pro-survival genes may be a hallmark of neuroprotective therapeutic effects.	[Hellmich, Helen L.; Rojo, Daniel R.; Micci, Maria-Adelaide; Sell, Stacy L.; Boone, Deborah R.; Crookshanks, Jeanna M.; DeWitt, Douglas S.; Masel, Brent E.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	Department of Anesthesiology; Moody Foundation; Moody Center for Traumatic Brain Injury and Spinal Cord Injury Research	Department of Anesthesiology; Moody Foundation; Moody Center for Traumatic Brain Injury and Spinal Cord Injury Research	This study was supported by the Department of Anesthesiology, the Moody Foundation and the Moody Center for Traumatic Brain Injury and Spinal Cord Injury Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Aubrecht J, 1996, RES COMMUN MOL PATH, V94, P47; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BRODY TM, 1955, PHARMACOL REV, V7, P335; CAMPISI D, 1985, PHARMATHERAPEUTICA, V4, P166; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cole GM, 2010, CNS NEUROL DISORD-DR, V9, P140, DOI 10.2174/187152710791011991; Cote S, 2012, ALZHEIMERS DEMENT, V8, P219, DOI 10.1016/j.jalz.2011.03.012; DAVIES GJ, 1974, BRIT MED J, V3, P400, DOI 10.1136/bmj.3.5927.400; De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Finkbeiner S, 2006, J NEUROSCI, V26, P10349, DOI 10.1523/JNEUROSCI.3829-06.2006; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Gareri P, 2004, NEUROPHARMACOLOGY, V47, P1205, DOI 10.1016/j.neuropharm.2004.08.021; Gohil M, 2010, NAT BIOTECHNOL, V28, P249; Gomes E, 2007, MOL CELL BIOCHEM, V305, P179, DOI 10.1007/s11010-007-9542-2; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Jahn H, 2004, ARCH GEN PSYCHIAT, V61, P1235, DOI 10.1001/archpsyc.61.12.1235; Jahn H, 2003, SLEEP, V26, P823, DOI 10.1093/sleep/26.7.823; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kadenbach B, 2003, BBA-BIOENERGETICS, V1604, P77, DOI 10.1016/S0005-2728(03)00027-6; Kasarskis A, 2011, PHARMACOGENOMICS, V12, P1695, DOI [10.2217/pgs.11.115, 10.2217/PGS.11.115]; KENNEDY JA, 1990, BRIT J ADDICT, V85, P1133; Khorasani MZ, 2009, PAK J PHARM SCI, V22, P349; Krugers HJ, 2000, STROKE, V31, P1162, DOI 10.1161/01.STR.31.5.1162; Laborie C, 2003, J NEUROENDOCRINOL, V15, P15, DOI 10.1046/j.1365-2826.2003.00859.x; Laborie C, 1995, NEUROENDOCRINOLOGY, V62, P601, DOI 10.1159/000127056; Lui JC, 2010, FASEB J, V24, P3083, DOI 10.1096/fj.09-152835; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Mahmud T, 1996, ARTHRITIS RHEUM, V39, P1998, DOI 10.1002/art.1780391208; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nagayama S, 2001, LIFE SCI, V69, P2867, DOI 10.1016/S0024-3205(01)01362-5; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Pilipovic K, 2011, NEUROCHEM RES, V36, P913, DOI 10.1007/s11064-011-0424-3; Pivato LS, 2006, J BIOCHEM MOL TOXIC, V20, P230, DOI 10.1002/jbt.20139; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Riepe MW, 1997, J CEREBR BLOOD F MET, V17, P257, DOI 10.1097/00004647-199703000-00002; Rogoz Z, 2007, PHARMACOL REP, V59, P588; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Roozendaal B, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn766; Rotllant D, 2002, EUR J NEUROSCI, V16, P693, DOI 10.1046/j.1460-9568.2002.02120.x; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; SAS Institute, 2004, SAS STAT 9 1 US GUID; Sato H, 2010, J CLIN BIOCHEM NUTR, V47, P224, DOI 10.3164/jcbn.10-58; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Srivastava S, 2011, CURR PHARM DESIGN, V17, P3418, DOI 10.2174/138161211798072526; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Tovar KR, 2009, J NEUROPHYSIOL, V102, P974, DOI 10.1152/jn.00060.2009; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Whitehead D, 1997, J MOL ENDOCRINOL, V19, P291, DOI 10.1677/jme.0.0190291; YOUNG EA, 1994, ARCH GEN PSYCHIAT, V51, P701; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16	72	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53230	10.1371/journal.pone.0053230	http://dx.doi.org/10.1371/journal.pone.0053230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326402	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500054
J	Chassy, P; Gobet, F				Chassy, Philippe; Gobet, Fernand			Visual Search in Ecological and Non-Ecological Displays: Evidence for a Non-Monotonic Effect of Complexity on Performance	PLOS ONE			English	Article							EXPERT CHESS PLAYERS	Considerable research has been carried out on visual search, with single or multiple targets. However, most studies have used artificial stimuli with low ecological validity. In addition, little is known about the effects of target complexity and expertise in visual search. Here, we investigate visual search in three conditions of complexity (detecting a king, detecting a check, and detecting a checkmate) with chess players of two levels of expertise (novices and club players). Results show that the influence of target complexity depends on level of structure of the visual display. Different functional relationships were found between artificial (random chess positions) and ecologically valid (game positions) stimuli: With artificial, but not with ecologically valid stimuli, a "pop out" effect was present when a target was visually more complex than distractors but could be captured by a memory chunk. This suggests that caution should be exercised when generalising from experiments using artificial stimuli with low ecological validity to real-life stimuli.	[Chassy, Philippe] Liverpool Hope Univ, Dept Psychol, Liverpool, Merseyside, England; [Gobet, Fernand] Brunel Univ, Ctr Study Expertise, Uxbridge UB8 3PH, Middx, England	Liverpool Hope University; University of Liverpool; Brunel University	Chassy, P (corresponding author), Liverpool Hope Univ, Dept Psychol, Liverpool, Merseyside, England.	chassyp@hope.ac.uk		Gobet, Fernand/0000-0002-9317-6886	Brunel University; Economic and Social Research Council [ES/G026203/1] Funding Source: researchfish; ESRC [ES/G026203/1] Funding Source: UKRI	Brunel University; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work was funded by Brunel University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilalic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016202; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Church R. M., 1977, Chess skill in man and machine, P131; De Groot A, 1996, PERCEPTION AND MEMOR; Elo AE, 1978, THE RATING OF CHESSP; Gigerenzer G., 2002, BOUNDED RATIONALITY; Gilchrist ID, 2006, VIS COGN, V14, P704, DOI 10.1080/13506280500193719; Gobet F, 1996, COGNITIVE PSYCHOL, V31, P1, DOI 10.1006/cogp.1996.0011; Gobet F, 2004, MOVES IN MIND: THE PSYCHOLOGY OF BOARD GAMES; Gobet F, 1996, MEM COGNITION, V24, P493, DOI 10.3758/BF03200937; Gobet F, 2011, PSYCHOLOGIE DU TALEN; Gobet F, 2009, MIND MACH, V19, P151, DOI 10.1007/s11023-008-9131-5; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Milojkovic J.D., 1982, J MENTAL IMAG, V6, P125; Neider MB, 2006, VISION RES, V46, P614, DOI 10.1016/j.visres.2005.08.025; Neisser U., 1976, COGNITION AND REALIT; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Reingold EM, 2001, PSYCHON B REV, V8, P504, DOI 10.3758/BF03196185; SAARILUOMA P, 1985, MEM COGNITION, V13, P385, DOI 10.3758/BF03198451; Saariluoma P, 1984, CODING PROBLEM SPACE; Schwaninger A, 2004, 38TH ANNUAL 2004 INTERNATIONAL CARNAHAN CONFERENCE ON SECURITY TECHNOLOGY, PROCEEDINGS, P258, DOI 10.1109/CCST.2004.1405402; Shen J, 2001, PERCEPT PSYCHOPHYS, V63, P464, DOI 10.3758/BF03194413; Simon HA, 1991, ORGAN SCI, V2, P125, DOI 10.1287/orsc.2.1.125; Wolfe J. M., 2007, INTEGRATED MODELS CO, V10, P99, DOI [DOI 10.1093/ACPROF:OSO/9780195189193.003.0008, 10.1093/acprof:oso/9780195189193.003.0008]	24	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53420	10.1371/journal.pone.0053420	http://dx.doi.org/10.1371/journal.pone.0053420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IY	23320084	Green Published, Green Accepted, gold			2022-12-27	WOS:000313429800049
J	Kwak, MK; Johnson, DT; Zhu, CF; Lee, SH; Ye, DW; Luong, R; Sun, ZJ				Kwak, Mi Kyung; Johnson, Daniel T.; Zhu, Chunfang; Lee, Suk Hyung; Ye, Ding-Wei; Luong, Richard; Sun, Zijie			Conditional Deletion of the Pten Gene in the Mouse Prostate Induces Prostatic Intraepithelial Neoplasms at Early Ages but a Slow Progression to Prostate Tumors	PLOS ONE			English	Article							SUPPRESSOR GENE; ANDROGEN RECEPTOR; TRANSGENIC MOUSE; CANCER; CELL; PTEN/MMAC1; MICE; INACTIVATION; APOPTOSIS; MUTATION	The PTEN tumor suppressor gene is frequently inactivated in human prostate cancer. Using Osr1 (odd skipped related 1)-Cre mice, we generated a novel conditional Pten knockout mouse strain, Pten(LoxP):Osr1-Cre. Conditional biallelic and monoallelic Pten knockout mice were viable. Deletion of Pten expression was detected in the prostate of Pten(LoxP/LoxP):Osr1-Cre mice as early as 2 weeks of age. Intriguingly, Pten(LoxP/LoxP):Osr1-Cre mice develop high-grade prostatic intraepithelial neoplasms (PINs) with high penetrance as early as one-month of age, and locally invasive prostatic tumors after 12-months of age. Pten(LoxP/+):Osr1-Cre mice show only mild oncogenic changes after 8-weeks of age. Castration of Pten(LoxP/LoxP):Osr1-Cre mice shows no significant regression of prostate tumors, although a shift of androgen receptor (AR) staining from the nuclei to cytoplasm is observed in Pten null tumor cells of castrated mice. Enhanced Akt activity is observed in Pten null tumor cells of castrated Pten(LoxP/LoxP):Osr1-Cre. This study provides a novel mouse model that can be used to investigate a primary role of Pten in initiating oncogenic transformation in the prostate and to examine other genetic and epigenetic changes that are required for tumor progression in the mouse prostate.	[Kwak, Mi Kyung; Johnson, Daniel T.; Zhu, Chunfang; Lee, Suk Hyung; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Kwak, Mi Kyung; Johnson, Daniel T.; Zhu, Chunfang; Lee, Suk Hyung; Sun, Zijie] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Ye, Ding-Wei] Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Stanford University; Stanford University; Stanford University; Fudan University	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	zsun@stanford.edu		Johnson, Daniel/0000-0003-4669-037X	Public Health Service from the National Cancer Institute [CA-070297, CA-151623]; NATIONAL CANCER INSTITUTE [R01CA151623, R01CA070297, R29CA070297] Funding Source: NIH RePORTER	Public Health Service from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service grants CA-070297 and CA-151623 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Cairns P, 1997, CANCER RES, V57, P4997; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Grieshammer U, 2008, GENESIS, V46, P69, DOI 10.1002/dvg.20366; Kasper S, 2008, STEM CELL REV, V4, P193, DOI 10.1007/s12015-008-9033-1; Kishimoto H, 2003, CELL STRUCT FUNCT, V28, P11; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li PF, 2001, J BIOL CHEM, V276, P20444, DOI 10.1074/jbc.M010226200; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; McMenamin ME, 1999, CANCER RES, V59, P4291; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nardella C, 2011, CURR TOP MICROBIOL, V347, P135, DOI 10.1007/82_2010_62; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shen MM, 2007, CANCER RES, V67, P6535, DOI 10.1158/0008-5472.CAN-07-1271; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Suzuki H, 1998, CANCER RES, V58, P204; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7	34	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53476	10.1371/journal.pone.0053476	http://dx.doi.org/10.1371/journal.pone.0053476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308230	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800053
J	Alhaddad, H; Khan, R; Grahn, RA; Gandolfi, B; Mullikin, JC; Cole, SA; Gruffydd-Jones, TJ; Haggstrom, J; Lohi, H; Longeri, M; Lyons, LA				Alhaddad, Hasan; Khan, Razib; Grahn, Robert A.; Gandolfi, Barbara; Mullikin, James C.; Cole, Shelley A.; Gruffydd-Jones, Timothy J.; Haggstrom, Jens; Lohi, Hannes; Longeri, Maria; Lyons, Leslie A.			Extent of Linkage Disequilibrium in the Domestic Cat, Felis silvestris catus, and Its Breeds	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; GENOME-WIDE ASSOCIATION; GENETIC DIVERSITY; PIG BREEDS; DEVON REX; MUTATIONS; SEQUENCE; MICROSATELLITES; ANCESTRY; PATTERNS	Domestic cats have a unique breeding history and can be used as models for human hereditary and infectious diseases. In the current era of genome-wide association studies, insights regarding linkage disequilibrium (LD) are essential for efficient association studies. The objective of this study is to investigate the extent of LD in the domestic cat, Felis silvestris catus, particularly within its breeds. A custom illumina GoldenGate Assay consisting of 1536 single nucleotide polymorphisms (SNPs) equally divided over ten 1 Mb chromosomal regions was developed, and genotyped across 18 globally recognized cat breeds and two distinct random bred populations. The pair-wise LD descriptive measure (r(2)) was calculated between the SNPs in each region and within each population independently. LD decay was estimated by determining the non-linear least-squares of all pair-wise estimates as a function of distance using established models. The point of 50% decay of r(2) was used to compare the extent of LD between breeds. The longest extent of LD was observed in the Burmese breed, where the distance at which r(2) approximate to 0.25 was similar to 380 kb, comparable to several horse and dog breeds. The shortest extent of LD was found in the Siberian breed, with an r(2) approximate to 0.25 at approximately 17 kb, comparable to random bred cats and human populations. A comprehensive haplotype analysis was also conducted. The haplotype structure of each region within each breed mirrored the LD estimates. The LD of cat breeds largely reflects the breeds' population history and breeding strategies. Understanding LD in diverse populations will contribute to an efficient use of the newly developed SNP array for the cat in the design of genome-wide association studies, as well as to the interpretation of results for the fine mapping of disease and phenotypic traits.	[Alhaddad, Hasan; Khan, Razib; Grahn, Robert A.; Gandolfi, Barbara; Lyons, Leslie A.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Mullikin, James C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Cole, Shelley A.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Gruffydd-Jones, Timothy J.] Univ Bristol, Sch Vet Sci, Feline Ctr, Bristol BS18 7DU, Avon, England; [Haggstrom, Jens] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Res Programs Unit, Helsinki, Finland; [Lohi, Hannes] Folkhalsan Res Ctr, Helsinki, Finland; [Longeri, Maria] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy	University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Texas Biomedical Research Institute; University of Bristol; Swedish University of Agricultural Sciences; University of Helsinki; Folkhalsan Research Center; University of Milan	Lyons, LA (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	lalyons@ucdavis.edu	Longeri, Maria/L-1557-2017; Lohi, Hannes/F-4596-2011	Longeri, Maria/0000-0001-7863-1855; Lohi, Hannes/0000-0003-1087-5532; Lyons, Leslie/0000-0002-1628-7726; Alhaddad, Hasan/0000-0001-7904-2913; Haggstrom, Jens/0000-0003-3402-023X	National Center for Research Resources (NCRR) [R24 RR016094, C06 RR13556]; Office of Research Infrastructure Programs/OD [R24OD010928]; Center for Companion Animal Health (CCAH) at the University of California Davis; George and Phyllis Miller Feline Health Fund of the San Francisco Foundation; National Human Genome Research Institute, National Institutes of Health; Finnish Cat Association; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016094, C06RR013556] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010928] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; Center for Companion Animal Health (CCAH) at the University of California Davis; George and Phyllis Miller Feline Health Fund of the San Francisco Foundation; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Finnish Cat Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by funding from the National Center for Research Resources (NCRR) R24 RR016094 and is currently supported by the Office of Research Infrastructure Programs/OD R24OD010928, the Center for Companion Animal Health (CCAH) at the University of California Davis and the George and Phyllis Miller Feline Health Fund of the San Francisco Foundation. This research was also supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. Genotyping was conducted in facilities constructed with support from Research Facilities Improvement Program Grant Number C06 RR13556 from the NCRR. HL's contribution was funded by the Finnish Cat Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bach LH, 2012, CYTOGENET GENOME RES, V137, P7, DOI 10.1159/000339416; Bach LH, 2010, ANAL FGF5 CONSTRUCTI; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; BLAXTER A, 1986, VET REC, V118, P619, DOI 10.1136/vr.118.22.619; CFA, 1993, CAT FANC ASS CAT ENC; Corbin LJ, 2010, ANIM GENET, V41, P8, DOI 10.1111/j.1365-2052.2010.02092.x; DOW SW, 1987, J AM VET MED ASSOC, V191, P1563; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Drogemuller C, 2007, ANIM GENET, V38, P218, DOI 10.1111/j.1365-2052.2007.01590.x; Farnir F, 2000, GENOME RES, V10, P220, DOI 10.1101/gr.10.2.220; Filler S, 2012, J HERED; Fox Jr J., 2015, APPL REGRESSION ANAL; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Gillespie J. H., 2004, POPULATION GENETICS; Gray MM, 2009, GENETICS, V181, P1493, DOI 10.1534/genetics.108.098830; Heath S, 2001, VET REC, V149, P660; HEDRICK PW, 1987, GENETICS, V117, P331; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; Johnson G, 1991, BENGAL CAT; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kehler JS, 2007, J HERED, V98, P555, DOI 10.1093/jhered/esm072; Kurushima JD, 2012, ANIM GENET; Kurushima JD, 2011, GENETIC ANAL DOMESTI; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipinski MJ, 2008, GENOMICS, V91, P12, DOI 10.1016/j.ygeno.2007.10.009; LUTZ TA, 1995, VET CLIN N AM-SMALL, V25, P527, DOI 10.1016/S0195-5616(95)50051-8; Lykkjen S, 2010, ANIM GENET, V41, P111, DOI 10.1111/j.1365-2052.2010.02117.x; Lyons LA, 2005, ANIM GENET, V36, P119, DOI 10.1111/j.1365-2052.2005.01253.x; Lyons LA, 2010, TOP COMPANION ANIM M, V25, P203, DOI 10.1053/j.tcam.2010.09.002; Marroni F, 2011, TREE GENET GENOMES, V7, P1011, DOI 10.1007/s11295-011-0391-5; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; McEvoy BP, 2010, AM J HUM GENET, V87, P297, DOI 10.1016/j.ajhg.2010.07.008; McRae AF, 2002, GENETICS, V160, P1113; Meadows JRS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-61; Menotti-Raymond M, 2003, CYTOGENET GENOME RES, V102, P272, DOI 10.1159/000075762; Menotti-Raymond M, 2003, J HERED, V94, P95, DOI 10.1093/jhered/esg008; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Menotti-Raymond M, 2008, SOURCEBOOK MODELS BI, P221; Menotti-Raymond MA, 2005, J FORENSIC SCI, V50, P1061, DOI 10.1520/JFS2004317; Menotti-Raymond M, 2008, GENOMICS, V91, P1, DOI 10.1016/j.ygeno.2007.08.008; Menotti-Raymond M, 2009, GENOMICS, V93, P305, DOI 10.1016/j.ygeno.2008.11.004; Morris D, 1997, CAT WORLD FELINE ENC; Mullikin JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-406; NODEN DM, 1986, J CRAN GENET DEV BIO, P249; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Randi E, 2001, MOL BIOL EVOL, V18, P1679, DOI 10.1093/oxfordjournals.molbev.a003956; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; ROBINSON R, 1969, GENETICA, V40, P597, DOI 10.1007/BF01787384; ROBINSON R, 1993, J HERED, V84, P170, DOI 10.1093/oxfordjournals.jhered.a111311; Robinson R, 1991, GENETICS CAT BREEDER; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; Vigne JD, 2004, SCIENCE, V304, P259, DOI 10.1126/science.1095335; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Warnes GR, 2003, R NEWS, V3, P9; Weir B. S., 1996, GENETIC DATA ANAL; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451	68	46	46	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53537	10.1371/journal.pone.0053537	http://dx.doi.org/10.1371/journal.pone.0053537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308248	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100086
J	Bonekamp, NA; Grille, S; Cardoso, MJ; Almeida, M; Aroso, M; Gomes, S; Magalhaes, AC; Ribeiro, D; Islinger, M; Schrader, M				Bonekamp, Nina A.; Grille, Sandra; Cardoso, Maria Joao; Almeida, Monica; Aroso, Miguel; Gomes, Silvia; Magalhaes, Ana Cristina; Ribeiro, Daniela; Islinger, Markus; Schrader, Michael			Self-Interaction of Human Pex11p beta during Peroxisomal Growth and Division	PLOS ONE			English	Article							DYNAMIN-LIKE PROTEIN-1; MEMBRANE-PROTEIN; DOCOSAHEXAENOIC ACID; BIOGENESIS DISORDERS; MAMMALIAN-CELLS; MOLECULAR-BASIS; PEX11 PROTEINS; CDNA CLONING; FISSION; PROLIFERATION	Pex11 proteins are involved in membrane elongation and division processes associated with the multiplication of peroxisomes. Human Pex11p beta has recently been linked to a new disorder affecting peroxisome morphology and dynamics. Here, we have analyzed the exact membrane topology of Pex11p beta. Studies with an epitope-specific antibody and protease protection assays show that Pex11p beta is an integral membrane protein with two transmembrane domains flanking an internal region exposed to the peroxisomal matrix and N-and C-termini facing the cytosol. A glycine-rich internal region within Pex11p beta is dispensable for peroxisome membrane elongation and division. However, we demonstrate that an amphipathic helix (Helix 2) within the first N-terminal 40 amino acids is crucial for membrane elongation and self-interaction of Pex11p beta. Interestingly, we find that Pex11p beta self-interaction strongly depends on the detergent used for solubilization. We also show that N-terminal cysteines are not essential for membrane elongation, and that putative N-terminal phosphorylation sites are dispensable for Pex11p beta function. We propose that self-interaction of Pex11p beta regulates its membrane deforming activity in conjunction with membrane lipids.	[Bonekamp, Nina A.; Grille, Sandra; Cardoso, Maria Joao; Almeida, Monica; Aroso, Miguel; Gomes, Silvia; Magalhaes, Ana Cristina; Ribeiro, Daniela; Islinger, Markus; Schrader, Michael] Univ Aveiro, Ctr Cell Biol, P-3800 Aveiro, Portugal; [Bonekamp, Nina A.; Grille, Sandra; Cardoso, Maria Joao; Almeida, Monica; Aroso, Miguel; Gomes, Silvia; Magalhaes, Ana Cristina; Ribeiro, Daniela; Islinger, Markus; Schrader, Michael] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Schrader, Michael] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	Universidade de Aveiro; Universidade de Aveiro; University of Exeter	Schrader, M (corresponding author), Univ Aveiro, Ctr Cell Biol, Campus Univ Santiago, P-3800 Aveiro, Portugal.	m.schrader@exeter.ac.uk	Almeida, Mónica/B-4486-2018; Bonekamp, Nina/AAX-3670-2020; Ribeiro, Daniela/I-7825-2013	Almeida, Mónica/0000-0001-5734-4021; Ribeiro, Daniela/0000-0003-3397-0460; Fernandes Gomes, Silvia Catarina/0000-0001-8473-4420; Magalhaes, Ana/0000-0002-3988-3280; Aroso, Miguel/0000-0002-3118-0185; Ribeiro Cardoso, Maria Joao/0000-0002-2215-7768; Bonekamp, Nina/0000-0001-9748-8089	Portuguese Foundation for Science and Technology (FCT); FEDER [PTDC/BIA-BCM/099613/2008, SFRH/BD/37647/2007, SFRH/BD/45427/2008, SFRH/BD/80542/2011, SFRH/BD/48722/2008, SFRH/BD/81223/2011, SFRH/BPD/77619/2011, SFRH/BPD/74428/2010]; CRUP/DAAD (ACCOES INTEGRADAS) [A-29/11]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FEDER(European Commission); CRUP/DAAD (ACCOES INTEGRADAS)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) and FEDER (PTDC/BIA-BCM/099613/2008 to M. S., SFRH/BD/37647/2007 to N. A. B., SFRH/BD/45427/2008 to M. J. C., SFRH/BD/80542/2011 to M. Almeida, SFRH/BD/48722/2008 to M. Aroso, SFRH/BD/81223/2011 to A. G., SFRH/BPD/77619/2011 to D. R., SFRH/BPD/74428/2010 to M. I.) and CRUP/DAAD (ACCOES INTEGRADAS 2010, A-29/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 1998, BIOCHEM BIOPH RES CO, V252, P529, DOI 10.1006/bbrc.1998.9684; Abe I, 1998, FEBS LETT, V431, P468, DOI 10.1016/S0014-5793(98)00815-1; Camoes F, 2009, J INHERIT METAB DIS, V32, P163, DOI 10.1007/s10545-008-1018-3; Cepinska MN, 2011, TRAFFIC, V12, P925, DOI 10.1111/j.1600-0854.2011.01198.x; Delille Hannah K, 2011, Commun Integr Biol, V4, P51, DOI 10.4161/cib.4.1.13647; Delille HK, 2010, J CELL SCI, V123, P2750, DOI 10.1242/jcs.062109; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Ebberink MS, 2010, J MED GENET, V47, P608, DOI 10.1136/jmg.2009.074302; Ebberink MS, 2012, J MED GENET, V49, P307, DOI 10.1136/jmedgenet-2012-100778; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Ferdinandusse S, 2007, HUM MUTAT, V28, P904, DOI 10.1002/humu.20535; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Hu JP, 2010, INT REV CEL MOL BIO, V279, P79, DOI 10.1016/S1937-6448(10)79003-1; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Itoyama A, 2012, J CELL SCI, V125, P589, DOI 10.1242/jcs.087452; Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919; Joshi S, 2012, MOL BIOL CELL, V23, P1307, DOI 10.1091/mbc.E11-09-0782; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Knoblach B, 2010, J BIOL CHEM, V285, P6670, DOI 10.1074/jbc.M109.094805; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koch J, 2012, J CELL SCI, V125, P3813, DOI 10.1242/jcs.102178; Koch Johannes, 2011, Biomol Concepts, V2, P353; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Lingard MJ, 2006, J CELL SCI, V119, P1961, DOI 10.1242/jcs.02904; Lizard G, 2012, J ALZHEIMERS DIS, V29, P241, DOI 10.3233/JAD-2011-111163; LUERS G, 1993, J CELL BIOL, V121, P1271, DOI 10.1083/jcb.121.6.1271; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Opalinski L, 2011, EMBO J, V30, P5, DOI 10.1038/emboj.2010.299; Ribeiro D, 2012, HISTOL HISTOPATHOL, V27, P661, DOI 10.14670/HH-27.661; Schrader M, 1996, ANN NY ACAD SCI, V804, P669, DOI 10.1111/j.1749-6632.1996.tb18660.x; Schrader M, 1996, EUR J CELL BIOL, V69, P24; SCHRADER M, 1994, EUR J CELL BIOL, V64, P281; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schrader M, 2007, BIOESSAYS, V29, P1105, DOI 10.1002/bies.20659; Schrader M, 2006, INT REV CYTOL, V255, P237, DOI 10.1016/S0074-7696(06)55005-3; Schrader M, 2012, HISTOCHEM CELL BIOL, V138, P541, DOI 10.1007/s00418-012-1010-8; Serasinghe MN, 2008, EXP CELL RES, V314, P3494, DOI 10.1016/j.yexcr.2008.09.009; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Tanaka A, 2003, BIOCHEM BIOPH RES CO, V300, P819, DOI 10.1016/S0006-291X(02)02936-4; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Waterham HR, 2012, BBA-MOL BASIS DIS, V1822, P1430, DOI 10.1016/j.bbadis.2012.04.006	53	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53424	10.1371/journal.pone.0053424	http://dx.doi.org/10.1371/journal.pone.0053424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308220	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100066
J	Chen, M; He, MA; Min, XW; Pan, A; Zhang, XM; Yao, P; Li, XL; Liu, YW; Yuan, J; Chen, WH; Zhou, L; Fang, WM; Liang, Y; Wang, YJ; Miao, XP; Lang, MJ; Zhang, P; Li, DF; Guo, H; Yang, HD; Hu, FB; Wu, TC				Chen, Mu; He, Meian; Min, Xinwen; Pan, An; Zhang, Xiaomin; Yao, Ping; Li, Xiulou; Liu, Yuewei; Yuan, Jing; Chen, Weihong; Zhou, Li; Fang, Weimin; Liang, Yuan; Wang, Youjie; Miao, Xiaoping; Lang, Mingjian; Zhang, Peng; Li, Dongfeng; Guo, Huan; Yang, Handong; Hu, Frank B.; Wu, Tangchun			Different Physical Activity Subtypes and Risk of Metabolic Syndrome in Middle-Aged and Older Chinese People	PLOS ONE			English	Article							TAI CHI EXERCISE; CARDIOVASCULAR-DISEASE; ADULTS; HEALTH; TRIAL; ASSOCIATION; STATEMENT; STRESS; WOMEN	Background: The prevalence of metabolic syndrome (MetS) is growing rapidly in China. Tai chi and dancing are common types of exercise among middle-aged and elderly Chinese. It remains unclear whether these activities are associated with a lower risk of MetS. Methodology/Principal Findings: A total of 15,514 individuals (6,952 men, 8,562 women) aged 50 to 70 years from the Dongfeng-Tongji Cohort in Shiyan, China participated in a cross-sectional study. Physical activity and other lifestyle factors were assessed with semi-structured questionnaires during face-to-face interviews. MetS was defined by the current National Cholesterol Education Program/Adult treatment Panel III criteria for Asian Americans. The prevalence of MetS was 33.2% in the study population. In the multivariable-adjusted logistic regression analyses, total physical activity levels were monotonically associated with a lower odds of MetS [OR 0.75 comparing extreme quintiles, 95% confidence interval (CI) 0.66-0.86, P<0.001]. Compared with non-exercisers in a specific exercise type, jogging (OR 0.82, 95% CI 0.68-1.00, P = 0.046), tai chi (OR 0.72, 95% CI 0.60-0.88, P<0.001), and dancing (OR 0.56, 95% CI 0.47-0.67, P<0.001) were associated with significantly lower odds of MetS. Furthermore, each 1-h/week increment in tai chi and dancing was associated with a 5% (95% CI 2%-9%) and a 9% (95% CI 6%, 12%) lower risk of MetS. Conclusions/Significance: Jogging, tai chi and dancing are associated with a significantly lower risk of having MetS in middle-aged and older Chinese. Future intervention studies should consider the role of jogging, tai chi and dancing in preventing MetS.	[Chen, Mu; He, Meian; Zhang, Xiaomin; Yao, Ping; Liu, Yuewei; Yuan, Jing; Chen, Weihong; Zhou, Li; Fang, Weimin; Liang, Yuan; Wang, Youjie; Miao, Xiaoping; Guo, Huan; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Chen, Mu; Pan, An; Li, Xiulou; Lang, Mingjian; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chen, Mu; Pan, An; Li, Xiulou; Lang, Mingjian; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Min, Xinwen; Zhang, Peng; Li, Dongfeng; Yang, Handong] Dongfeng Motor Corp, Dongfeng Cent Hosp, Shiyan, Hubei, Peoples R China; [Min, Xinwen; Zhang, Peng; Li, Dongfeng; Yang, Handong] Hubei Univ Med, Shiyan, Hubei, Peoples R China	Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Dongfeng Motor; Hubei University of Medicine	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu; wut@mails.tjmu.edu.cn	Liu, Yuewei/J-5147-2019; Pan, An/C-5572-2011; Zhang, Xiaomin/GVT-8927-2022; Chen, Mu/L-8745-2014; miao, xiaoping/C-4336-2011; Chen, Weihong/D-2177-2011; Zhang, Xiaomin/F-3206-2018	Liu, Yuewei/0000-0001-5970-4262; Pan, An/0000-0002-1089-7945; Chen, Mu/0000-0003-2743-1014; miao, xiaoping/0000-0002-6818-9722; Chen, Weihong/0000-0001-8689-7311; Min, Xinwen/0000-0002-8429-6560; Li, Dongfeng/0000-0003-2583-1727	Huazhong University of Science and Technology Foundation for Educational Development and Research; National Basic Research Program [2011CB503800]	Huazhong University of Science and Technology Foundation for Educational Development and Research; National Basic Research Program(National Basic Research Program of China)	This work was supported by Huazhong University of Science and Technology Foundation for Educational Development and Research and the National Basic Research Program grant 2011CB503800. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Blake Holly, 2012, Curr Aging Sci, V5, P19; Chen SC, 2010, J ALTERN COMPLEM MED, V16, P1153, DOI 10.1089/acm.2009.0560; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hu FB, 2011, OBES REV, V12, P552, DOI 10.1111/j.1467-789X.2011.00863.x; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Irwin MR, 2007, J AM GERIATR SOC, V55, P511, DOI 10.1111/j.1532-5415.2007.01109.x; Kinder LS, 2004, PSYCHOSOM MED, V66, P316, DOI 10.1097/01.psy.0000124755.91880.f4; King DE, 2003, MED SCI SPORT EXER, V35, P575, DOI 10.1249/01.MSS.0000058440.28108.CC; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Li FZ, 2012, NEW ENGL J MED, V366, P511, DOI 10.1056/NEJMoa1107911; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Ma G, 2008, OBES REV, V9, P113, DOI 10.1111/j.1467-789X.2007.00451.x; Muntner P, 2005, AM J PUBLIC HEALTH, V95, P1631, DOI 10.2105/AJPH.2004.044743; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Pachucki MA, 2011, AM J PUBLIC HEALTH, V101, P2170, DOI 10.2105/AJPH.2011.300282; Raikkonen K, 2002, METABOLISM, V51, P1573, DOI 10.1053/meta.2002.36301; Rennie KL, 2003, INT J EPIDEMIOL, V32, P600, DOI 10.1093/ije/dyg179; Strassel JK, 2011, ALTERN THER HEALTH M, V17, P50; Wang CC, 2010, NEW ENGL J MED, V363, P743, DOI 10.1056/NEJMoa0912611; Wang CC, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-23; Wang F, 2012, INT J EPIDEMIOL; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; West J, 2004, ANN BEHAV MED, V28, P114, DOI 10.1207/s15324796abm2802_6; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yeh GY, 2011, ARCH INTERN MED, V171, P750, DOI 10.1001/archinternmed.2011.150; Yu ZJ, 2009, CIRCULATION, V119, P2969, DOI 10.1161/CIRCULATIONAHA.108.833574	30	27	30	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53258	10.1371/journal.pone.0053258	http://dx.doi.org/10.1371/journal.pone.0053258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	069IS	23308175	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100046
J	Huang, Y; Zhen, ZL; Song, YY; Zhu, Q; Wang, S; Liu, J				Huang, Yi; Zhen, Zonglei; Song, Yiying; Zhu, Qi; Wang, Song; Liu, Jia			Motor Training Increases the Stability of Activation Patterns in the Primary Motor Cortex	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; OBJECT REPRESENTATIONS; NEURONAL POPULATION; FINGER MOVEMENTS; FUNCTIONAL MRI; VISUAL FORMS; TIME-COURSE; MONKEY; PLASTICITY; ALTERS	Learning to be skillful is an endowed talent of humans, but neural mechanisms underlying behavioral improvement remain largely unknown. Some studies have reported that the mean magnitude of neural activation is increased after learning, whereas others have instead shown decreased activation. In this study, we used functional magnetic resonance imaging (fMRI) to investigate learning-induced changes in the neural activation in the human brain with a classic motor training task. Specifically, instead of comparing the mean magnitudes of activation before and after training, we analyzed the learning-induced changes in multi-voxel spatial patterns of neural activation. We observed that the stability of the activation patterns, or the similarity of the activation patterns between the even and odd runs of the fMRI scans, was significantly increased in the primary motor cortex (M1) after training. By contrast, the mean magnitude of neural activation remained unchanged. Therefore, our study suggests that learning shapes the brain by increasing the stability of the activation patterns, therefore providing a new perspective in understanding the neural mechanisms underlying learning.	[Huang, Yi; Zhen, Zonglei; Song, Yiying; Zhu, Qi; Wang, Song; Liu, Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Liu, Jia] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS	Liu, J (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn	Zhen, Zonglei/GPG-1239-2022; Zhu, Qi/AAW-9090-2021	Zhu, Qi/0000-0002-0993-3400; Liu, Jia/0000-0003-0383-0934; Wang, Song/0000-0002-4476-1915	National Natural Science Foundation of China [31230031, 91132703, 30800295, 31100808]; National Basic Research Program of China [2010CB833903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (31230031, 91132703, 30800295, 31100808) and the National Basic Research Program of China (2010CB833903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Ben Hamed S, 2007, J NEUROPHYSIOL, V98, P327, DOI 10.1152/jn.00760.2006; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Dechent P, 2003, HUM BRAIN MAPP, V18, P272, DOI 10.1002/hbm.10084; Dinstein I, 2012, NEURON, V75, P981, DOI 10.1016/j.neuron.2012.07.026; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Landau SM, 2004, NEUROIMAGE, V22, P211, DOI 10.1016/j.neuroimage.2004.01.003; Li S, 2012, CEREB CORTEX, V22, P2322, DOI 10.1093/cercor/bhr309; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; MIYASHITA Y, 1993, NEUROPSYCHOLOGIA, V31, P1119, DOI 10.1016/0028-3932(93)90036-Y; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Op De Beeck HP, 2007, NEUROSCIENCE, V145, P775, DOI 10.1016/j.neuroscience.2006.12.058; Op de Beeck H.P., 2010, TRENDS COGN SCI, V14, P22; Op de Beeck HP, 2008, CEREB CORTEX, V18, P1676, DOI 10.1093/cercor/bhm196; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Peissig JJ, 2007, CEREB CORTEX, V17, P1323, DOI 10.1093/cercor/bhl043; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; SAKAI K, 1994, NEUROREPORT, V5, P829, DOI 10.1097/00001756-199403000-00023; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Sheinberg DL, 2002, PERCEPTUAL LEARNING, P95; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Song YY, 2012, J NEUROSCI, V32, P12277, DOI 10.1523/JNEUROSCI.1874-12.2012; Song YY, 2010, J NEUROSCI, V30, P9869, DOI 10.1523/JNEUROSCI.0140-10.2010; Swisher JD, 2010, J NEUROSCI, V30, P325, DOI 10.1523/JNEUROSCI.4811-09.2010; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Visser RM, 2011, J NEUROSCI, V31, P12021, DOI 10.1523/JNEUROSCI.2178-11.2011; Xiong JH, 2009, NEUROIMAGE, V45, P75, DOI 10.1016/j.neuroimage.2008.11.016; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; Zhang JX, 2010, J NEUROSCI, V30, P14127, DOI 10.1523/JNEUROSCI.2204-10.2010; Zhang JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040390	53	37	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53555	10.1371/journal.pone.0053555	http://dx.doi.org/10.1371/journal.pone.0053555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308252	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100089
J	Ribeiro, RF; Potratz, FF; Pavan, BMM; Forechi, L; Lugon, F; Lima, M; Fiorim, J; Fernandes, AA; Vassallo, DV; Stefanon, I				Ribeiro, Rogerio Faustino, Jr.; Potratz, Felipe F.; Pavan, Brunella M. M.; Forechi, Ludimila; Lugon, Filipe; Lima, Moulin; Fiorim, Jonaina; Fernandes, Aurelia Araujo; Vassallo, Dalton Valentim; Stefanon, Ivanita			Carvedilol Prevents Ovariectomy-Induced Myocardial Contractile Dysfunction in Female Rat	PLOS ONE			English	Article							ADRENERGIC-RECEPTOR BLOCKADE; HORMONE REPLACEMENT THERAPY; CONVERTING-ENZYME-ACTIVITY; HEART-FAILURE; GENDER-DIFFERENCES; OXIDATIVE STRESS; POSTMENOPAUSAL WOMEN; ANTIOXIDANT ACTIVITY; CARDIAC-FUNCTION; REACTIVE OXYGEN	Carvedilol has beneficial effects on cardiac function in patients with heart failure but its effect on ovariectomy-induced myocardial contractile dysfunction remains unclear. Estrogen deficiency induces myocardial contractile dysfunction and increases cardiovascular disease risk in postmenopausal women. Our aim was to investigate whether carvedilol, a beta receptor blocker, would prevent ovariectomy-induced myocardial contractile dysfunction. Female rats (8 weeks old) that underwent bilateral ovariectomy were randomly assigned to receive daily treatment with carvedilol (OVX+CAR, 20 mg/kg), placebo (OVX) and SHAM for 58 days. Left ventricle papillary muscle was mounted for isometric tension recordings. The inotropic response to Ca2+ (0.62 to 3.75 mM) and isoproterenol (Iso 10(-8) to 10(-2) M) were assessed. Expression of calcium handling proteins was measured by western blot analysis. Carvedilol treatment in the OVX animals: prevented weight gain and slight hypertrophy, restored the reduced positive inotropic responses to Ca2+ and isoproterenol, prevented the reduction in SERCA2a expression, abolished the increase in superoxide anion production, normalized the increase in p22(phox) expression, and decreased serum angiotensin converting enzyme (ACE) activity. This study demonstrated that myocardial contractile dysfunction and SERCA2a down regulation were prevented by carvedilol treatment. Superoxide anion production and NADPH oxidase seem to be involved in this response.	[Ribeiro, Rogerio Faustino, Jr.; Potratz, Felipe F.; Pavan, Brunella M. M.; Forechi, Ludimila; Lugon, Filipe; Lima, Moulin; Fiorim, Jonaina; Fernandes, Aurelia Araujo; Vassallo, Dalton Valentim; Stefanon, Ivanita] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Brazil; [Vassallo, Dalton Valentim] EMESCAM, Dept Physiol Sci, Vitoria, Brazil	Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria	Ribeiro, RF (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Brazil.	rogeriofaustinoribeiro@hotmail.com	Ribeiro, Rogerio/F-7116-2012; Stefanon, Ivanita/J-4729-2014; Vassallo, Dalton/K-8289-2016	Ribeiro, Rogerio/0000-0002-9725-3869; Stefanon, Ivanita/0000-0003-2638-5183; Vassallo, Dalton/0000-0002-4463-4174; Forechi, Ludimila/0000-0002-6657-0503	National Council for Scientific and Technological Development (CNPq, Brazil); Espirito Santo Research Foundation (FAPES/FUNCITEC, Brazil)	National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Espirito Santo Research Foundation (FAPES/FUNCITEC, Brazil)	This work was supported by grants from The National Council for Scientific and Technological Development (CNPq, Brazil) and the Espirito Santo Research Foundation (FAPES/FUNCITEC, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Bartholomeu JB, 2008, J MOL CELL CARDIOL, V45, P240, DOI 10.1016/j.yjmcc.2008.05.011; Blumenfeld JD, 1999, AM J HYPERTENS, V12, P451, DOI 10.1016/S0895-7061(99)00005-9; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; BUHLER FR, 1972, NEW ENGL J MED, V287, P1209, DOI 10.1056/NEJM197212142872401; Bupha-Intr T, 2006, AM J PHYSIOL-HEART C, V291, pH1101, DOI 10.1152/ajpheart.00660.2005; Bupha-Intr T, 2009, J APPL PHYSIOL, V107, P1105, DOI 10.1152/japplphysiol.00407.2009; Cherednichenko G, 2004, CIRC RES, V94, P478, DOI 10.1161/01.RES.0000115554.65513.7C; Dandona P, 2007, J HYPERTENS, V25, P731, DOI 10.1097/HJH.0b013e3280127948; Dantas APV, 2004, CARDIOVASC RES, V61, P22, DOI 10.1016/j.cardiores.2003.10.010; De Mello WC, 2011, REGUL PEPTIDES, V166, P9, DOI 10.1016/j.regpep.2010.10.003; Domenighetti AA, 2005, HYPERTENSION, V46, P426, DOI 10.1161/01.HYP.0000173069.53699.d9; Farrell SR, 2010, AM J PHYSIOL-HEART C, V299, pH36, DOI 10.1152/ajpheart.00299.2010; Fiorim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017117; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; Freshour JR, 2002, AM J PHYSIOL-HEART C, V283, pH1997, DOI 10.1152/ajpheart.01054.2001; Gallagher PE, 1999, HYPERTENSION, V33, P323, DOI 10.1161/01.HYP.33.1.323; GILL JS, 1995, EUR J PHARM-ENVIRON, V292, P337, DOI 10.1016/0926-6917(95)90042-X; Giuberti K, 2007, ARCH MED RES, V38, P170, DOI 10.1016/j.arcmed.2006.09.015; Goldhaber JI, 1996, AM J PHYSIOL-HEART C, V271, pH823, DOI 10.1152/ajpheart.1996.271.3.H823; Gomes A, 2006, BIOORGAN MED CHEM, V14, P4568, DOI 10.1016/j.bmc.2006.02.023; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; KANEKO M, 1989, AM J PHYSIOL, V257, pH804, DOI 10.1152/ajpheart.1989.257.3.H804; Koitabashi N, 2005, BIOCHEM BIOPH RES CO, V328, P116, DOI 10.1016/j.bbrc.2004.12.139; Koss KL, 1997, BASIC RES CARDIOL, V92, P17, DOI 10.1007/BF00794064; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; KUKREJA RC, 1991, CIRC RES, V69, P1003, DOI 10.1161/01.RES.69.4.1003; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Louis A, 2001, EUR J HEART FAIL, V3, P381, DOI 10.1016/S1388-9842(01)00149-0; MICHELAKIS AM, 1972, J CLIN ENDOCR METAB, V34, P386, DOI 10.1210/jcem-34-2-386; Murphy E, 2011, CIRC RES, V109, P687, DOI 10.1161/CIRCRESAHA.110.236687; Nickenig G, 2000, CIRCULATION, V102, P1828; Paigel AS, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-54; Palomeque J, 2006, AM J PHYSIOL-HEART C, V290, pH96, DOI 10.1152/ajpheart.00324.2005; Palomeque J, 2009, CIRC RES, V105, P1204, DOI 10.1161/CIRCRESAHA.109.204172; PINES A, 1993, AM J CARDIOL, V72, P240, DOI 10.1016/0002-9149(93)90171-8; PRELEVIC GM, 1994, MATURITAS, V20, P37, DOI 10.1016/0378-5122(94)90099-X; PROUDLER AJ, 1995, LANCET, V346, P89, DOI 10.1016/S0140-6736(95)92114-1; Remme WJ, 2007, J AM COLL CARDIOL, V49, P963, DOI 10.1016/j.jacc.2006.10.059; Ribeiro RF, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-53; Ribeiro RF, 2012, CELL PHYSIOL BIOCHEM, V30, P1, DOI 10.1159/000339041; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rueckschloss U, 2010, EXP GERONTOL, V45, P788, DOI 10.1016/j.exger.2010.05.002; Sartorio CL, 2007, HYPERTENSION, V50, P919, DOI 10.1161/HYPERTENSIONAHA.107.093450; SCHEUER J, 1987, CIRC RES, V61, P12, DOI 10.1161/01.RES.61.1.12; Serneri GGN, 2001, CIRC RES, V88, P961, DOI 10.1161/hh0901.089882; Shenoy V, 2009, PEPTIDES, V30, P2309, DOI 10.1016/j.peptides.2009.09.005; Shlipak MG, 2003, AM HEART J, V146, P870, DOI 10.1016/S0002-8703(03)00412-5; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Simoes MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018730; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stanley WC, 2012, CIRC RES, V110, P764, DOI [10.1161/CIRCRESAHA.111.253104, 10.1161/circresaha.111.253104]; Sumino H, 2003, HYPERTENS RES, V26, P53; Sun YL, 2005, CHEST, V128, P1812, DOI 10.1378/chest.128.3.1812; Wattanapermpool J, 1999, AM J PHYSIOL-HEART C, V277, pH467, DOI 10.1152/ajpheart.1999.277.2.H467; Wei S, 2000, J AM COLL CARDIOL, V36, P276, DOI 10.1016/S0735-1097(00)00671-9; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Yue TL, 1998, EUR J PHARMACOL, V345, P61, DOI 10.1016/S0014-2999(98)00053-3; Zhou L, 2007, EUR J PHARMACOL, V567, P186, DOI 10.1016/j.ejphar.2007.03.047; Zhuang XF, 2009, J INT MED RES, V37, P1354, DOI 10.1177/147323000903700510; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	63	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53226	10.1371/journal.pone.0053226	http://dx.doi.org/10.1371/journal.pone.0053226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308166	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100041
J	Boves, TJ; Buehler, DA; Sheehan, J; Wood, PB; Rodewald, AD; Larkin, JL; Keyser, PD; Newell, FL; George, GA; Bakermans, MH; Evans, A; Beachy, TA; McDermott, ME; Perkins, KA; White, M; Wigley, TB				Boves, Than J.; Buehler, David A.; Sheehan, James; Wood, Petra Bohall; Rodewald, Amanda D.; Larkin, Jeffrey L.; Keyser, Patrick D.; Newell, Felicity L.; George, Gregory A.; Bakermans, Marja H.; Evans, Andrea; Beachy, Tiffany A.; McDermott, Molly E.; Perkins, Kelly A.; White, Matthew; Wigley, T. Bently			Emulating Natural Disturbances for Declining Late-Successional Species: A Case Study of the Consequences for Cerulean Warblers (Setophaga cerulea)	PLOS ONE			English	Article							FOREST MANAGEMENT; BIRD COMMUNITIES; ECOLOGICAL TRAPS; GRASSLAND BIRDS; AGE STRUCTURE; HABITAT USE; SURVIVAL; POPULATION; CONSERVATION; RESPONSES	Forest cover in the eastern United States has increased over the past century and while some late-successional species have benefited from this process as expected, others have experienced population declines. These declines may be in part related to contemporary reductions in small-scale forest interior disturbances such as fire, windthrow, and treefalls. To mitigate the negative impacts of disturbance alteration and suppression on some late-successional species, strategies that emulate natural disturbance regimes are often advocated, but large-scale evaluations of these practices are rare. Here, we assessed the consequences of experimental disturbance (using partial timber harvest) on a severely declining late-successional species, the cerulean warbler (Setophaga cerulea), across the core of its breeding range in the Appalachian Mountains. We measured numerical (density), physiological (body condition), and demographic (age structure and reproduction) responses to three levels of disturbance and explored the potential impacts of disturbance on source-sink dynamics. Breeding densities of warblers increased one to four years after all canopy disturbances (vs. controls) and males occupying territories on treatment plots were in better condition than those on control plots. However, these beneficial effects of disturbance did not correspond to improvements in reproduction; nest success was lower on all treatment plots than on control plots in the southern region and marginally lower on light disturbance plots in the northern region. Our data suggest that only habitats in the southern region acted as sources, and interior disturbances in this region have the potential to create ecological traps at a local scale, but sources when viewed at broader scales. Thus, cerulean warblers would likely benefit from management that strikes a landscape-level balance between emulating natural disturbances in order to attract individuals into areas where current structure is inappropriate, and limiting anthropogenic disturbance in forests that already possess appropriate structural attributes in order to maintain maximum productivity.	[Boves, Than J.; Buehler, David A.; Keyser, Patrick D.; Beachy, Tiffany A.] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN USA; [Sheehan, James; George, Gregory A.; McDermott, Molly E.; Perkins, Kelly A.] W Virginia Univ, W Virginia Cooperat Fish & Wildlife Res Unit, Div Forestry & Nat Resources, Morgantown, WV 26506 USA; [Wood, Petra Bohall] W Virginia Univ, US Geol Survey, W Virginia Cooperat Fish & Wildlife Res Unit, Morgantown, WV 26506 USA; [Rodewald, Amanda D.; Newell, Felicity L.; Bakermans, Marja H.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Larkin, Jeffrey L.; Evans, Andrea; White, Matthew] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA; [Wigley, T. Bently] Natl Council Air & Stream Improvement Inc, Clemson, SC USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; West Virginia University; United States Department of the Interior; United States Geological Survey; West Virginia University; University System of Ohio; Ohio State University; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania	Boves, TJ (corresponding author), Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA.	tboves@illinois.edu	Rodewald, Amanda D/I-6308-2016; Newell, Felicity L/ABC-8690-2021	Rodewald, Amanda D/0000-0002-6719-6306; Newell, Felicity L./0000-0002-7944-8603; Bakermans, Marja/0000-0002-4879-7771	Department of Forestry, Wildlife, and Fisheries at the University of Tennessee; United States Geological Survey West Virginia Cooperative Fish and Wildlife Research Unit; School of the Environment and Natural Resources at Ohio State University; Department of Biology at Indiana University of Pennsylvania; Tennessee Wildlife Resources Agency; Ohio Division of Wildlife; Kentucky Department of Fish and Wildlife Resources; West Virginia Division of Natural Resources Wildlife Diversity Program; U.S. Fish and Wildlife Service; National Council for Air and Stream Improvement, Inc.; National Fish and Wildlife Foundation [2005-0064-000, 2006-0042-000, 2007-0004-000, 2008-0009-000]; Nature Conservancy (through a USFWS Habitat Conservation Plan planning grant with the Tennessee Wildlife Resources Agency); MeadWestvaco Corporation; U.S. Forest Service	Department of Forestry, Wildlife, and Fisheries at the University of Tennessee; United States Geological Survey West Virginia Cooperative Fish and Wildlife Research Unit; School of the Environment and Natural Resources at Ohio State University; Department of Biology at Indiana University of Pennsylvania; Tennessee Wildlife Resources Agency; Ohio Division of Wildlife; Kentucky Department of Fish and Wildlife Resources; West Virginia Division of Natural Resources Wildlife Diversity Program; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); National Council for Air and Stream Improvement, Inc.; National Fish and Wildlife Foundation; Nature Conservancy (through a USFWS Habitat Conservation Plan planning grant with the Tennessee Wildlife Resources Agency); MeadWestvaco Corporation; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This research was funded and supported by the Department of Forestry, Wildlife, and Fisheries at the University of Tennessee; the United States Geological Survey West Virginia Cooperative Fish and Wildlife Research Unit; the School of the Environment and Natural Resources at Ohio State University; the Department of Biology at Indiana University of Pennsylvania; Tennessee Wildlife Resources Agency; Ohio Division of Wildlife; Kentucky Department of Fish and Wildlife Resources; West Virginia Division of Natural Resources Wildlife Diversity Program; U.S. Fish and Wildlife Service; National Council for Air and Stream Improvement, Inc.; National Fish and Wildlife Foundation (grant numbers 2005-0064-000, 2006-0042-000, 2007-0004-000, and 2008-0009-000); The Nature Conservancy (through a USFWS Habitat Conservation Plan planning grant with the Tennessee Wildlife Resources Agency); MeadWestvaco Corporation; and U.S. Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 2003, BIOSCIENCE, V53, P927, DOI 10.1641/0006-3568(2003)053[0927:WHATWO]2.0.CO;2; [Anonymous], 1989, AM THEIR FORESTS HIS; Artman Vanessa L., 2005, Studies in Avian Biology, V30, P127; Askins RA, 1999, STUD AVIAN BIOL-SER, P60; Bakermans MH, 2009, BIOL CONSERV, V142, P2476, DOI 10.1016/j.biocon.2009.05.018; Bakermans MH, 2009, FOREST ECOL MANAG, V258, P224, DOI 10.1016/j.foreco.2009.04.010; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; BirdLife International, 2010, IUCN RED LIST THREAT; Bormann F.H., 1979, PATTERN PROCESS FORE, DOI DOI 10.1007/978-1-4612-6232-9; Braun E., 1942, ECOL MONOG, V12, P413, DOI 10.2307/1943039; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Buehler DA, 2008, J WILDLIFE MANAGE, V72, P646, DOI 10.2193/2006-339; Buehler DA, 2006, J WILDLIFE MANAGE, V70, P1763, DOI 10.2193/0022-541X(2006)70[1763:PCWHUI]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chalfoun AD, 2012, AUK, V129, P589, DOI 10.1525/auk.2012.129.4.589; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DeLong SC, 1996, BIODIVERS CONSERV, V5, P1191, DOI 10.1007/BF00051571; Doligez B, 2008, ECOLOGY, V89, P1436, DOI 10.1890/07-0113.1; DWERNYCHUK LW, 1972, CAN J ZOOLOG, V50, P559, DOI 10.1139/z72-076; Edler AU, 2010, BIOL J LINN SOC, V99, P384, DOI 10.1111/j.1095-8312.2009.01354.x; Evans KL, 2009, OIKOS, V118, P774, DOI 10.1111/j.1600-0706.2008.17226.x; Fenneman N.M., 1938, PHYSIOGRAPHY E US; Fralish JS, 2003, US FOR SERV T R NC, V234, P1; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gardali T, 2003, AUK, V120, P1188, DOI 10.1642/0004-8038(2003)120[1188:JAASOS]2.0.CO;2; George G.A., 2009, THESIS W VIRGINIA U; Girvan MK, 2007, AVIAN CONSERV ECOL, V2; Gram WK, 2003, CONSERV BIOL, V17, P1324, DOI 10.1046/j.1523-1739.2003.02171.x; Greenberg CH, 2003, SOUTHEAST NAT, V2, P591, DOI 10.1656/1528-7092(2003)002[0591:SAOGMI]2.0.CO;2; Hamel P.B., 2000, BIRDS N AM ONLINE; Hamel Paul B., 2007, U S Forest Service General Technical Report SRS, V101, P364; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; HINES J E, 1989, U S Fish and Wildlife Service Fish and Wildlife Technical Report, P1; Hollander FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025703; Holmes SB, 2007, FOREST ECOL MANAG, V238, P280, DOI 10.1016/j.foreco.2006.10.022; Howell S. N, 1997, IDENTIFICATION GUIDE; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones J, 2004, AUK, V121, P15, DOI 10.1642/0004-8038(2004)121[0015:MEOSAP]2.0.CO;2; Jones J, 2001, ECOLOGY, V82, P2628, DOI 10.1890/0012-9658(2001)082[2628:ATEOND]2.0.CO;2; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Lampila P, 2005, CONSERV BIOL, V19, P1537, DOI 10.1111/j.1523-1739.2005.00201.x; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Long JN, 2009, FOREST ECOL MANAG, V257, P1868, DOI 10.1016/j.foreco.2008.12.019; LORIMER CG, 1994, J FOREST, V92, P33; LORIMER CG, 1980, ECOLOGY, V61, P1169, DOI 10.2307/1936836; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Menzel JM, 1985, AM MIDL NAT, V151, P355; Miller GW, 2006, FOREST ECOL MANAG, V224, P241, DOI 10.1016/j.foreco.2005.12.035; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; NEWTON SF, 1993, J ZOOL, V229, P561, DOI 10.1111/j.1469-7998.1993.tb02657.x; Noon BR, 2001, WILDLIFE 2001 POPULA, P441; Oliarnyk CJ, 1996, WILSON BULL, V108, P673; OLIVER CD, 1981, FOREST ECOL MANAG, V3, P153; PARKER G R, 1989, Natural Areas Journal, V9, P5; Pelicice FM, 2008, CONSERV BIOL, V22, P180, DOI 10.1111/j.1523-1739.2007.00849.x; Perera A. H., 2004, EMULATING NATURAL FO; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Powell LL, 2010, CONDOR, V112, P800, DOI 10.1525/cond.2010.100152; Reed J. Michael, 1999, Current Ornithology, V15, P189; Robertson BA, 2007, CONDOR, V109, P109, DOI 10.1650/0010-5422(2007)109[109:ISHFAE]2.0.CO;2; Rodewald AD, 2008, J ANIM ECOL, V77, P83, DOI 10.1111/j.1365-2656.2007.01313.x; Sauer J.R., 2008, N AM BREEDING BIRD S; Schamber JL, 2009, J AVIAN BIOL, V40, P49, DOI 10.1111/j.1600-048X.2008.04462.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Seymour RS, 2002, FOREST ECOL MANAG, V155, P357, DOI 10.1016/S0378-1127(01)00572-2; Short KC, 2003, ECOLOGICAL RESTORATION OF SOUTHWESTERN PONDEROSA PINE FORESTS, P286; SPIES TA, 1994, ECOL APPL, V4, P555, DOI 10.2307/1941957; Stephens SE, 2004, BIOL CONSERV, V115, P101, DOI 10.1016/S0006-3207(03)00098-3; Streby HM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00187.1; Strong TF, 1997, NE238 USDA FOR SERV; U.S. Fish and Wildlife Service, 2007, IND BAT MYO IN PRESS; U.S. Fish and Wildlife Service, 2008, BIRDS CONS CONC; Vanderwel MC, 2007, CONSERV BIOL, V21, P1230, DOI 10.1111/j.1523-1739.2007.00756.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vickery PD, 1999, STUD AVIAN BIOL, P2; Vitz AC, 2011, CONDOR, V113, P400, DOI 10.1525/cond.2011.100023; Weldon AJ, 2005, ECOLOGY, V86, P1422, DOI 10.1890/04-0913; WILSON A., 1811, AM ORNITHOLOGY, V3; Wood PB, 2005, WILDLIFE SOC B, V33, P851, DOI 10.2193/0091-7648(2005)33[851:CWUORC]2.0.CO;2; Wood PB, 2006, CONDOR, V108, P154, DOI 10.1650/0010-5422(2006)108[0154:CWAAOR]2.0.CO;2; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Ziolkowski Jr D.J., 2010, BIRD POPULATIONS, V10, P90; [No title captured]	85	18	18	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e52107	10.1371/journal.pone.0052107	http://dx.doi.org/10.1371/journal.pone.0052107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308104	Green Published, gold, Green Submitted			2022-12-27	WOS:000313670100006
J	Shin, J; Lee, SH; Kwon, MC; Yang, DK; Seo, HR; Kim, J; Kim, YY; Im, SK; Abel, ED; Kim, KT; Park, WJ; Kong, YY				Shin, Juhee; Lee, Seok Hong; Kwon, Min-Chul; Yang, Dong Kwon; Seo, Ha-Rim; Kim, Jaetaek; Kim, Yoon-Young; Im, Sun-Kyoung; Abel, Evan Dale; Kim, Kyong-Tai; Park, Woo Jin; Kong, Young-Yun			Cardiomyocyte Specific Deletion of Crif1 Causes Mitochondrial Cardiomyopathy in Mice	PLOS ONE			English	Article							CR6-INTERACTING FACTOR-1 INTERACTS; COMPLEX-I; RESPIRATORY-CHAIN; DISEASE; PROTEIN; DISORDERS; RECEPTOR; HEART; CHLORAMPHENICOL; BIOGENESIS	Mitochondria are key organelles dedicated to energy production. Crif1, which interacts with the large subunit of the mitochondrial ribosome, is indispensable for the mitochondrial translation and membrane insertion of respiratory subunits. To explore the physiological function of Crif1 in the heart, Crif1(f/f) mice were crossed with Myh6-cre/Esr1 transgenic mice, which harbor cardiomyocyte-specific Cre activity in a tamoxifen-dependent manner. The tamoxifen injections were given at six weeks postnatal, and the mutant mice survived only five months due to hypertrophic heart failure. In the mutant cardiac muscles, mitochondrial mass dramatically increased, while the inner structure was altered with lack of cristae. Mutant cardiac muscles showed decreased rates of oxygen consumption and ATP production, suggesting that Crif1 plays a critical role in the maintenance of both mitochondrial structure and respiration in cardiac muscles.	[Shin, Juhee; Kwon, Min-Chul; Seo, Ha-Rim; Kim, Yoon-Young; Im, Sun-Kyoung; Kong, Young-Yun] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Shin, Juhee; Kim, Yoon-Young; Im, Sun-Kyoung; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Kyungbuk, South Korea; [Lee, Seok Hong; Kim, Jaetaek] Chung Ang Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 156756, South Korea; [Yang, Dong Kwon; Park, Woo Jin] Gwangju Inst Sci & Technol, Global Res Lab, Kwangju, South Korea; [Yang, Dong Kwon; Park, Woo Jin] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju, South Korea; [Abel, Evan Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Chung Ang University; Chung Ang University Hospital; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Utah System of Higher Education; University of Utah	Kong, YY (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	ykong@snu.ac.kr	Kim, Jaetaek/AAE-7147-2020	Kim, Jaetaek/0000-0001-5247-0408; Abel, E. Dale/0000-0001-5290-0738; KIM, KYONG-TAI/0000-0001-7292-2627	National Research Foundation of Korea [2012-0000121]; Bio and Medical Technology Development Program of National Research Foundation [2011-0019269]; Korean Government [NRF-M1AXA002-2011-0028413]; National Research Foundation of Korea Grant	National Research Foundation of Korea(National Research Foundation of Korea); Bio and Medical Technology Development Program of National Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); National Research Foundation of Korea Grant(National Research Foundation of Korea)	This work was supported by grants from the Basic Science Research Program through the National Research Foundation of Korea (2012-0000121); the Bio and Medical Technology Development Program (2011-0019269) of National Research Foundation funded by the Korean Government; and the National Research Foundation of Korea Grant funded by the Korean Government (NRF-M1AXA002-2011-0028413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOUTTE A, 1972, Journal of Cell Biology, V54, P8, DOI 10.1083/jcb.54.1.8; Antozzi C, 1997, CARDIOVASC RES, V35, P184, DOI 10.1016/S0008-6363(97)00141-7; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; CLARKWAL.GD, 1967, J CELL BIOL, V34, P1, DOI 10.1083/jcb.34.1.1; Cramer WA, 2006, ANNU REV BIOCHEM, V75, P769, DOI 10.1146/annurev.biochem.75.103004.142756; Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391; Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Kwon MC, 2009, J BIOL CHEM, V284, P33634, DOI 10.1074/jbc.M109.059840; Lee SH, 2009, J MOL CELL CARDIOL, V46, P596, DOI 10.1016/j.yjmcc.2008.12.021; LENK R, 1971, J CELL BIOL, V49, P541, DOI 10.1083/jcb.49.2.541; Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7; Li CH, 2005, J BIOL CHEM, V280, P26193, DOI 10.1074/jbc.M501371200; LIPTON JH, 1977, BIOCHIM BIOPHYS ACTA, V477, P264, DOI 10.1016/0005-2787(77)90051-X; MarinGarcia J, 1997, PEDIATR CARDIOL, V18, P251, DOI 10.1007/s002469900169; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park KC, 2005, MOL ENDOCRINOL, V19, P12, DOI 10.1210/me.2004-0107; Pfeffer G, 2011, ANN MED; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Suh JH, 2008, MOL ENDOCRINOL, V22, P33, DOI 10.1210/me.2007-0194; Sumegi B, 1988, J Mol Recognit, V1, P19, DOI 10.1002/jmr.300010105; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909	41	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53577	10.1371/journal.pone.0053577	http://dx.doi.org/10.1371/journal.pone.0053577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308255	gold, Green Published, Green Submitted			2022-12-27	WOS:000313670100048
J	Wang, YH; Engel, MS; Rafael, JA; Dang, K; Wu, HY; Wang, Y; Xie, Q; Bu, WJ				Wang, Yanhui; Engel, Michael S.; Rafael, Jose A.; Dang, Kai; Wu, Haoyang; Wang, Ying; Xie, Qiang; Bu, Wenjun			A Unique Box in 28S rRNA Is Shared by the Enigmatic Insect Order Zoraptera and Dictyoptera	PLOS ONE			English	Article							SECONDARY-STRUCTURE MODEL; PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; COMPENSATORY MUTATIONS; MOLECULAR PHYLOGENY; NUCLEOTIDE-SEQUENCE; BAYESIAN-INFERENCE; EVIDENCE CONVERGE; SMALL-SUBUNIT; ALIGNED 18S	The position of the Zoraptera remains one of the most challenging and uncertain concerns in ordinal-level phylogenies of the insects. Zoraptera have been viewed as having a close relationship with five different groups of Polyneoptera, or as being allied to the Paraneoptera or even Holometabola. Although rDNAs have been widely used in phylogenetic studies of insects, the application of the complete 28S rDNA are still scattered in only a few orders. In this study, a secondary structure model of the complete 28S rRNAs of insects was reconstructed based on all orders of Insecta. It was found that one length-variable region, D3-4, is particularly distinctive. The length and/or sequence of D3-4 is conservative within each order of Polyneoptera, but it can be divided into two types between the different orders of the supercohort, of which the enigmatic order Zoraptera and Dictyoptera share one type, while the remaining orders of Polyneoptera share the other. Additionally, independent evidence from phylogenetic results support the clade (Zoraptera+Dictyoptera) as well. Thus, the similarity of D3-4 between Zoraptera and Dictyoptera can serve as potentially valuable autapomorphy or synapomorphy in phylogeny reconstruction. The clades of (Plecoptera+Dermaptera) and ((Grylloblattodea+Mantophasmatodea)+(Embiodea+Phasmatodea)) were also recovered in the phylogenetic study. In addition, considering the other studies based on rDNAs, this study reached the highest congruence with previous phylogenetic studies of Holometabola based on nuclear protein coding genes or morphology characters. Future comparative studies of secondary structures across deep divergences and additional taxa are likely to reveal conserved patterns, structures and motifs that can provide support for major phylogenetic lineages.	[Wang, Yanhui; Dang, Kai; Wu, Haoyang; Wang, Ying; Xie, Qiang; Bu, Wenjun] Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China; [Engel, Michael S.] Nat Hist Museum, Div Entomol Paleoentomol, London SW7 5BD, England; [Engel, Michael S.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Rafael, Jose A.] INPA, Manaus, Amazonas, Brazil	Nankai University; Natural History Museum London; University of Kansas; Institute Nacional de Pesquisas da Amazonia	Xie, Q (corresponding author), Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China.	qiangxie@nankai.edu.cn; wenjunbu@nankai.edu.cn	Engel, Michael S/C-5461-2012; Rafael, Jose/ABD-8405-2021	Engel, Michael S/0000-0003-3067-077X; Rafael, Jose/0000-0002-0170-0514; Xie, Qiang/0000-0001-6376-8808	National Science Foundation of China [J0930005, 30970350, 30725005]; U.S. National Science Foundation grant [DEB-0542909]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472237/2009-8]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) [Edital 016/2006, Proc. 1437/2007]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Science Foundation grant(National Science Foundation (NSF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM))	This work was supported by the National Science Foundation of China (grant numbers J0930005, 30970350, 30725005). The participation of Michael S. Engel was supported by U.S. National Science Foundation grant DEB-0542909. Jose A. Rafael was financially supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number 472237/2009-8 and Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) by the financial support to the Project PRONEX, Edital 016/2006, Proc. 1437/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako D, 1996, J MOL EVOL, V43, P469, DOI 10.1007/BF02337519; Andrew DR, 2011, ARTHROPOD STRUCT DEV, V40, P289, DOI 10.1016/j.asd.2011.02.001; Arillo A, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3539[1:RCIBAN]2.0.CO;2; Bethoux O., 2002, ZOOTAXA, V96, P1, DOI DOI 10.11646/ZOOTAXA.96.1.1; Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x; Beutel Rolf G., 2006, Arthropod Systematics & Phylogeny, V64, P3; Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Bonneton F, 2006, INSECT MOL BIOL, V15, P351, DOI 10.1111/j.1365-2583.2006.00654.x; Boudreaux H. B., 1979, ARTHROPOD PHYLOGENY; Buckley TR, 2000, INSECT MOL BIOL, V9, P565, DOI 10.1046/j.1365-2583.2000.00220.x; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Carmean D, 1992, MOL PHYLOGENET EVOL, V1, P270, DOI 10.1016/1055-7903(92)90002-X; Caterino MS, 2000, ANNU REV ENTOMOL, V45, P1, DOI 10.1146/annurev.ento.45.1.1; Chalwatzis N, 1996, ANN ENTOMOL SOC AM, V89, P788, DOI 10.1093/aesa/89.6.788; CLARK CG, 1984, NUCLEIC ACIDS RES, V12, P6197, DOI 10.1093/nar/12.15.6197; Crampton G. C., 1938, Psyche Cambridge Mass, V45, P165, DOI 10.1155/1938/18939; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis RB, 2010, P ROY SOC B-BIOL SCI, V277, P1597, DOI 10.1098/rspb.2009.2299; DERIJK P, 1995, J MOL EVOL, V41, P366, DOI 10.1007/BF01215184; DIXON MT, 1993, MOL BIOL EVOL, V10, P256; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; ELLIS RE, 1986, NUCLEIC ACIDS RES, V14, P2345, DOI 10.1093/nar/14.5.2345; Engel M. S., 2000, Acta Geologica Hispanica, V35, P149; Engel MS, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)431<0001:ANRCIB>2.0.CO;2; Engel MS, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)362<0001:TFMZI>2.0.CO;2; Gillespie J, 2004, INSECT MOL BIOL, V13, P495, DOI 10.1111/j.0962-1075.2004.00509.x; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Gillespie JJ, 2005, J MOL EVOL, V61, P114, DOI 10.1007/s00239-004-0246-x; Gillespie JJ, 2005, INSECT MOL BIOL, V14, P625, DOI 10.1111/j.1365-2583.2005.00591.x; Grimaldi David, 2005, pi; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; GUTELL RR, 1985, PROG NUCLEIC ACID RE, V32, P155, DOI 10.1016/S0079-6603(08)60348-7; Gutell RR, 2000, J MOL BIOL, V300, P791, DOI 10.1006/jmbi.2000.3900; Hall T, BIOEDIT VERSION 7 1; HAMILTON KGA, 1981, CAN ENTOMOL, V113, P953, DOI 10.4039/Ent113953-11; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; Handlirsch A, 1908, FOSSILEN INSEKTEN PH; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Hennig W., 1953, Beitraege zur Entomologie Berlin, V3, P1; Hennig W., 1981, INSECT PHYLOGENY; Hennig W., 1969, STAMMESGESCHICHTE IN; Hickson RE, 2000, MOL BIOL EVOL, V17, P530, DOI 10.1093/oxfordjournals.molbev.a026333; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; Jobb G., 2011, TREEFINDER VERSION M; Johnson KP, 2000, MOL PHYLOGENET EVOL, V14, P141, DOI 10.1006/mpev.1999.0682; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; KJER KM, 1994, BBA-GENE STRUCT EXPR, V1217, P147, DOI 10.1016/0167-4781(94)90028-0; KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Klass KD, 2002, SCIENCE, V296, P1456, DOI 10.1126/science.1069397; KRISTENSEN N P, 1975, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V13, P1; Kristensen N.P., 1991, P125; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; Kristensen NP, 1995, ZOOL BEITR, V36, P83; Kukalova-Peck J., 1991, P141; KUKALOVAPECK J, 1993, SYST ENTOMOL, V18, P333, DOI 10.1111/j.1365-3113.1993.tb00670.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letsch HO, 2012, P ROY SOC B-BIOL SCI, V279, P3282, DOI 10.1098/rspb.2012.0744; Letsch HO, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-146; Letsch HO, 2010, MOL BIOL EVOL, V27, P2507, DOI 10.1093/molbev/msq140; Letsch HO, 2009, MOL PHYLOGENET EVOL, V53, P758, DOI 10.1016/j.ympev.2009.07.033; Longhorn SJ, 2010, MOL PHYLOGENET EVOL, V55, P846, DOI 10.1016/j.ympev.2010.03.024; LYAL CHC, 1985, SYST ENTOMOL, V10, P145; Maddison W.P., MESQUITE MODULAR SYS; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Martynov A. V., 1925, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V4, P465, DOI 10.1007/BF00408465; McKenna DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011887; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Minet J., 1986, CAHIERS LIAISON OPIE, V20, P23; Misof B, 2006, J EXP ZOOL PART B, V306B, P70, DOI 10.1002/jez.b.21040; Misof B, 2007, ZOOLOGY, V110, P409, DOI 10.1016/j.zool.2007.08.003; Morgan MJ, 2010, MOL PHYLOGENET EVOL, V56, P305, DOI 10.1016/j.ympev.2010.03.032; Nagaswamy U, 2000, NUCLEIC ACIDS RES, V28, P375, DOI 10.1093/nar/28.1.375; Niehuis O, 2012, CURR BIOL, V22, P1309, DOI 10.1016/j.cub.2012.05.018; PASHLEY DP, 1993, MOL PHYLOGENET EVOL, V2, P132, DOI 10.1006/mpev.1993.1013; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Plazzi F, 2011, MOL PHYLOGENET EVOL, V58, P304, DOI 10.1016/j.ympev.2010.12.005; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rafael Jost A., 2008, Transactions of the Kansas Academy of Science, V111, P193, DOI 10.1660/0022-8443-111.3.193; Rahle W, 1970, ZOOL JB ABT ANAT ONT, V87, P248; Rasnitsyn AP, 1998, ZOOL ANZ, V237, P185; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Richards O.W., 1977, IMMS GEN TXB ENTOMOL; Roeding F, 2007, MOL PHYLOGENET EVOL, V45, P942, DOI 10.1016/j.ympev.2007.09.002; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SHAROV AG, 1968, T PALEONTOL I ACAD S, V118, P1; Simmons MP, 2004, MOL PHYLOGENET EVOL, V31, P874, DOI 10.1016/j.ympev.2003.10.008; Simon S, 2009, MOL BIOL EVOL, V26, P2719, DOI 10.1093/molbev/msp191; Smithers C.N., 1991, P410; Snodgrass RE, 1935, PRINCIPLES INSECTA M; Talavera G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Thomas MA, 2000, P NATL ACAD SCI USA, V97, P13178, DOI 10.1073/pnas.230296997; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; von Reumont BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-119; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Whitfield JB, 2008, ANNU REV ENTOMOL, V53, P449, DOI 10.1146/annurev.ento.53.103106.093304; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Willmann R, 2004, ASSEMBLING THE TREE OF LIFE, P330; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia X, 2000, DATA ANAL MOL BIOL E, P276; Xie Q, 2005, MOL PHYLOGENET EVOL, V34, P448, DOI 10.1016/j.ympev.2004.10.015; Xie Q, 2008, MOL PHYLOGENET EVOL, V47, P463, DOI 10.1016/j.ympev.2008.01.024; Xie Q, 2011, PROTEIN CELL, V2, P161, DOI 10.1007/s13238-011-1017-2; Xie Q, 2009, MOL PHYLOGENET EVOL, V50, P310, DOI 10.1016/j.ympev.2008.10.025; Yoshizawa K, 2005, MOL PHYLOGENET EVOL, V37, P572, DOI 10.1016/j.ympev.2005.05.008; Yoshizawa K, 2001, SYST ENTOMOL, V26, P1, DOI 10.1046/j.1365-3113.2001.00133.x; Yoshizawa K, 2011, TAXA P JAPANESE SOC, V30, P17; Yoshizawa K, 2007, SYST ENTOMOL, V32, P197, DOI 10.1111/j.1365-3113.2007.00379.x; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x; Yoshizawa K, 2010, SYST ENTOMOL, V35, P199, DOI 10.1111/j.1365-3113.2010.00526.x; Zhou JF, 2011, BIOINFORMATICS, V27, P1255, DOI 10.1093/bioinformatics/btr140	124	28	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e53679	10.1371/journal.pone.0053679	http://dx.doi.org/10.1371/journal.pone.0053679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301099	gold, Green Published			2022-12-27	WOS:000313480000075
J	Mastropasqua, T; Turatto, M				Mastropasqua, Tommaso; Turatto, Massimo			Perceptual Grouping Enhances Visual Plasticity	PLOS ONE			English	Article							ORIENTATION; ATTENTION; SPECIFICITY; CORTEX; DISCRIMINATION; IMPROVEMENT; MODULATION; RESPONSES	Visual perceptual learning, a manifestation of neural plasticity, refers to improvements in performance on a visual task achieved by training. Attention is known to play an important role in perceptual learning, given that the observer's discriminative ability improves only for those stimulus feature that are attended. However, the distribution of attention can be severely constrained by perceptual grouping, a process whereby the visual system organizes the initial retinal input into candidate objects. Taken together, these two pieces of evidence suggest the interesting possibility that perceptual grouping might also affect perceptual learning, either directly or via attentional mechanisms. To address this issue, we conducted two experiments. During the training phase, participants attended to the contrast of the task-relevant stimulus (oriented grating), while two similar task-irrelevant stimuli were presented in the adjacent positions. One of the two flanking stimuli was perceptually grouped with the attended stimulus as a consequence of its similar orientation (Experiment 1) or because it was part of the same perceptual object (Experiment 2). A test phase followed the training phase at each location. Compared to the task-irrelevant no-grouping stimulus, orientation discrimination improved at the attended location. Critically, a perceptual learning effect equivalent to the one observed for the attended location also emerged for the task-irrelevant grouping stimulus, indicating that perceptual grouping induced a transfer of learning to the stimulus (or feature) being perceptually grouped with the task-relevant one. Our findings indicate that no voluntary effort to direct attention to the grouping stimulus or feature is necessary to enhance visual plasticity.	[Mastropasqua, Tommaso; Turatto, Massimo] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Turatto, Massimo] Univ Trento, Dept Cognit Sci & Educ, Rovereto, Italy	University of Trento; University of Trento	Turatto, M (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy.	massimo.turatto@unitn.it			"Ministero dell'Istruzione dell' Universita e della Ricerca"	"Ministero dell'Istruzione dell' Universita e della Ricerca"(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the "Ministero dell'Istruzione dell' Universita e della Ricerca" to Massimo Turatto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KC, 2009, VISION RES, V49, P2087, DOI 10.1016/j.visres.2009.05.020; AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BAYLIS GC, 1992, PERCEPT PSYCHOPHYS, V51, P145, DOI 10.3758/BF03212239; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; de-Wit LH, 2011, J VISION, V11, DOI 10.1167/11.4.13; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; Fahle M, 2002, PERCEPTUAL LEARNING; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Gilbert CD, 2009, J PHYSIOL-LONDON, V587, P2743, DOI 10.1113/jphysiol.2009.171488; Gutnisky DA, 2009, CURR BIOL, V19, P555, DOI 10.1016/j.cub.2009.01.063; Jeter PE, 2010, VISION RES, V50, P1928, DOI 10.1016/j.visres.2010.06.016; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Karni A, 1997, CURR OPIN NEUROBIOL, V7, P530, DOI 10.1016/S0959-4388(97)80033-5; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimchi R, 2009, PROG BRAIN RES, V176, P15, DOI 10.1016/S0079-6123(09)17602-1; Lamy D, 2006, PERCEPT PSYCHOPHYS, V68, P17, DOI 10.3758/BF03193652; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Marr D., 1982, VISION COMPUTATIONAL; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Neisser U., 1967, COGNITIVE PSYCHOL; Nishina S, 2007, J VISION, V7, DOI 10.1167/7.13.2; Otto TU, 2010, PSYCHOL SCI, V21, P1058, DOI 10.1177/0956797610376074; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; ROCK I, 1990, SCI AM, V263, P84, DOI 10.1038/scientificamerican1290-84; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Wannig A, 2011, NAT NEUROSCI, V14, P1243, DOI 10.1038/nn.2910; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	47	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53683	10.1371/journal.pone.0053683	http://dx.doi.org/10.1371/journal.pone.0053683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23301100	Green Submitted, Green Published, gold			2022-12-27	WOS:000313320900088
J	Franceschini, A; Vilotti, S; Ferrari, MD; van den Maagdenberg, AMJM; Nistri, A; Fabbretti, E				Franceschini, Alessia; Vilotti, Sandra; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.; Nistri, Andrea; Fabbretti, Elsa			TNF alpha Levels and Macrophages Expression Reflect an Inflammatory Potential of Trigeminal Ganglia in a Mouse Model of Familial Hemiplegic Migraine	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; DORSAL-ROOT GANGLION; MOLECULAR-MECHANISMS; SPREADING DEPRESSION; SODIUM-CHANNELS; NEURONS; MICROGLIA; RESPONSES; RECEPTOR; PAIN	Latent changes in trigeminal ganglion structure and function resembling inflammatory conditions may predispose to acute attacks of migraine pain. Here, we investigated whether, in trigeminal sensory ganglia, cytokines such as TNF alpha might contribute to a local inflammatory phenotype of a transgenic knock-in (KI) mouse model of familial hemiplegic migraine type-1 (FHM-1). To this end, macrophage occurrence and cytokine expression in trigeminal ganglia were compared between wild type (WT) and R192Q mutant CaV2.1 Ca2+ channel (R192Q KI) mice, a genetic model of FHM-1. Cellular and molecular characterization was performed using a combination of confocal immunohistochemistry and cytokine assays. With respect to WT, R192Q KI trigeminal ganglia were enriched in activated macrophages as suggested by their morphology and immunoreactivity to the markers Iba1, CD11b, and ED1. R192Q KI trigeminal ganglia constitutively expressed higher mRNA levels of IL1 beta, IL6, IL10 and TNF alpha cytokines and the MCP-1 chemokine. Consistent with the report that TNF alpha is a major factor to sensitize trigeminal ganglia, we observed that, following an inflammatory reaction evoked by LPS injection, TNF alpha expression and macrophage occurrence were significantly higher in R192Q KI ganglia with respect to WT ganglia. Our data suggest that, in KI trigeminal ganglia, the complex cellular and molecular environment could support a new tissue phenotype compatible with a neuroinflammatory profile. We propose that, in FHM patients, this condition might contribute to trigeminal pain pathophysiology through release of soluble mediators, including TNF alpha, that may modulate the crosstalk between sensory neurons and resident glia, underlying the process of neuronal sensitisation.	[Franceschini, Alessia; Vilotti, Sandra; Nistri, Andrea; Fabbretti, Elsa] Scuola Int Super Studi Avanzati, Dept Neurosci, Trieste, Italy; [Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [van den Maagdenberg, Arn M. J. M.] Leiden Genet Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Fabbretti, Elsa] Univ Nova Gorica, Ctr Biomed Sci & Engn, Nova Gorica, Slovenia	International School for Advanced Studies (SISSA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Nova Gorica	Fabbretti, E (corresponding author), Scuola Int Super Studi Avanzati, Dept Neurosci, Trieste, Italy.	fabbre@sissa.it	Ferrari, Michel D./ABE-3758-2021; Franceschini, Alessia/H-4992-2017; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Franceschini, Alessia/K-3426-2018	Ferrari, Michel D./0000-0001-9691-9449; Franceschini, Alessia/0000-0001-7122-6232; Franceschini, Alessia/0000-0001-7122-6232	Telethon - Italy [GGP10082]; Italian Institute of Technology; Cariplo Foundation [2011-0505]; Research Agency of the Republic of Slovenia [J3-2376-1540]; Centre for Medical Systems Biology	Telethon - Italy(Fondazione Telethon); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Cariplo Foundation(Fondazione Cariplo); Research Agency of the Republic of Slovenia(Slovenian Research Agency - Slovenia); Centre for Medical Systems Biology	Funding: The financial support of Telethon - Italy (Grant no. GGP10082 to AN) is gratefully acknowledged. This work was also supported by the Italian Institute of Technology and Cariplo Foundation Grant no. 2011-0505 (to AN), and by the Research Agency of the Republic of Slovenia grant J3-2376-1540 (to EF), and by a grant from the Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (to AMJMVDM and MDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-8; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Balkowiec-Iskra E, 2011, NEUROSCIENCE, V180, P322, DOI 10.1016/j.neuroscience.2011.02.028; Beutler B, 2001, DRUG METAB DISPOS, V29, P474; Bo SH, 2009, CEPHALALGIA, V29, P365, DOI 10.1111/j.1468-2982.2008.01727.x; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Bolay Hayrunnisa, 2010, Handb Clin Neurol, V97, P47, DOI 10.1016/S0072-9752(10)97004-8; Bowen EJ, 2006, J NEUROCHEM, V96, P65, DOI 10.1111/j.1471-4159.2005.03524.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Ceruti S, 2011, J NEUROSCI, V31, P3638, DOI 10.1523/JNEUROSCI.6440-10.2011; Chen X, 2011, EXP NEUROL, V227, P279, DOI 10.1016/j.expneurol.2010.11.017; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Fioretti B, 2011, J PHYSIOL-LONDON, V589, P5879, DOI 10.1113/jphysiol.2011.220533; Franceschini A, 2012, PURINERGIC SIGNAL; Friedman MH, 2004, HEADACHE, V44, P767, DOI 10.1111/j.1526-4610.2004.04143.x; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Giniatullin R, 2008, MOL NEUROBIOL, V37, P83, DOI 10.1007/s12035-008-8020-5; GLENN JA, 1993, J ANAT, V183, P475; Goadsby PJ, 2005, HEADACHE, V45, pS14, DOI 10.1111/j.1526-4610.2005.4501003.x; Gordon R, 2011, J NEUROSCI METH, V194, P287, DOI 10.1016/j.jneumeth.2010.11.001; Hanani M, 2010, BRAIN RES REV, V64, P304, DOI 10.1016/j.brainresrev.2010.04.009; Hansen JM, 2008, CEPHALALGIA, V28, P496, DOI 10.1111/j.1468-2982.2008.01559.x; Hansen JM, 2008, NEUROLOGY, V71, P841, DOI 10.1212/01.wnl.0000325482.64106.3f; Heinsbroek SEM, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001069; HOLNESS CL, 1993, BLOOD, V81, P1607; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Jurkat-Rott K, 2010, ADV EXP MED BIOL, V686, P305, DOI 10.1007/978-90-481-9485-8_18; Kalita J, 2009, CLIN J PAIN, V25, P696, DOI 10.1097/AJP.0b013e3181b12dd3; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li YZ, 2004, J NEUROSCI, V24, P9623, DOI 10.1523/JNEUROSCI.2392-04.2004; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; MartinezPomares L, 1996, IMMUNOBIOLOGY, V195, P407, DOI 10.1016/S0171-2985(96)80012-X; Mathew R, 2011, CEPHALALGIA, V31, P1368, DOI 10.1177/0333102411418847; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; MOSKOWITZ MA, 1993, NEUROLOGY, V43, P16; Nair A, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-48; Olesen J, 2011, TRENDS PHARMACOL SCI, V32, P352, DOI 10.1016/j.tips.2011.02.016; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; Pietrobon D, 2010, J PHYSIOL-LONDON, V588, P1871, DOI 10.1113/jphysiol.2010.188003; PUIL E, 1988, NEUROSCIENCE, V24, P635, DOI 10.1016/0306-4522(88)90357-0; PUIL E, 1988, J NEUROPHYSIOL, V59, P77, DOI 10.1152/jn.1988.59.1.77; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490; Reuter U, 2002, ANN NEUROL, V51, P507, DOI 10.1002/ana.10159; Rowe BH, 2008, HEADACHE, V48, P333, DOI 10.1111/j.1526-4610.2007.00959.x; Russell MB, 2011, LANCET NEUROL, V10, P457, DOI 10.1016/S1474-4422(11)70048-5; Salegio EAA, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-11; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Sarchielli P, 2006, HEADACHE, V46, P200, DOI 10.1111/j.1526-4610.2006.00337.x; Sarchielli P, 2004, HEADACHE, V44, P961, DOI 10.1111/j.1526-4610.2004.04189.x; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Simonetti M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-11; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Sun JH, 2006, J NEUROPHYSIOL, V96, P2189, DOI 10.1152/jn.00222.2006; Tfelt-Hansen PC, 2011, HEADACHE, V51, P752, DOI 10.1111/j.1526-4610.2011.01892.x; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; Thompson WL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-35; Tietjen GE, 2009, HEADACHE, V49, P1333, DOI 10.1111/j.1526-4610.2009.01521.x; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Tsuda M, 2012, CURR OPIN PHARMACOL, V12, P74, DOI 10.1016/j.coph.2011.10.014; Tvedskov JF, 2010, CEPHALALGIA, V30, P928, DOI 10.1111/j.1468-2982.2009.02014.x; Uceyler N, 2009, EXP BRAIN RES, V196, P67, DOI 10.1007/s00221-009-1755-z; van den Berg TK, 2005, TRENDS IMMUNOL, V26, P506, DOI 10.1016/j.it.2005.07.008; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; van den Maagdenberg AMJM, 2007, CURR OPIN NEUROL, V20, P299, DOI 10.1097/WCO.0b013e3281338d1f; van Velzen M, 2009, J IMMUNOL, V183, P2456, DOI 10.4049/jimmunol.0900890; Vecchia D, 2012, TRENDS NEUROSCI, V35, P507, DOI 10.1016/j.tins.2012.04.007; Vega-Avelaira D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-70; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Villa G, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-89; Waeber C, 2005, NEUROLOGY, V64, pS9, DOI 10.1212/WNL.64.10_suppl_2.S9; Yang GA, 2011, BRAIN PATHOL, V21, P279, DOI 10.1111/j.1750-3639.2010.00445.x; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang XC, 2011, PAIN, V152, P140, DOI 10.1016/j.pain.2010.10.002	90	62	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52394	10.1371/journal.pone.0052394	http://dx.doi.org/10.1371/journal.pone.0052394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326332	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800017
J	Dvorsky, M; Dolezal, J; Kopecky, M; Chlumska, Z; Janatkova, K; Altman, J; de Bello, F; Rehakova, K				Dvorsky, Miroslav; Dolezal, Jiri; Kopecky, Martin; Chlumska, Zuzana; Janatkova, Katerina; Altman, Jan; de Bello, Francesco; Rehakova, Klara			Testing the Stress-Gradient Hypothesis at the Roof of the World: Effects of the Cushion Plant Thylacospermum caespitosum on Species Assemblages	PLOS ONE			English	Article							CHILEAN PATAGONIAN ANDES; POSITIVE ASSOCIATIONS; ECOSYSTEM ENGINEERS; ALPINE ENVIRONMENT; ARID ENVIRONMENTS; AZORELLA-MONANTHA; ABIOTIC STRESS; NURSE PLANTS; VEGETATION; COMMUNITIES	Many cushion plants ameliorate the harsh environment they inhabit in alpine ecosystems and act as nurse plants, with significantly more species growing within their canopy than outside. These facilitative interactions seem to increase with the abiotic stress, thus supporting the stress-gradient hypothesis. We tested this prediction by exploring the association pattern of vascular plants with the dominant cushion plant Thylacospermum caespitosum (Caryophyllaceae) in the arid Trans-Himalaya, where vascular plants occur at one of the highest worldwide elevational limits. We compared plant composition between 1112 pair-plots placed both inside cushions and in surrounding open areas, in communities from cold steppes to subnival zones along two elevational gradients (East Karakoram: 4850-5250 m and Little Tibet: 5350-5850 m). We used PERMANOVA to assess differences in species composition, Friedman-based permutation tests to determine individual species habitat preferences, species-area curves to assess whether interactions are size-dependent and competitive intensity and importance indices to evaluate plant-plant interactions. No indications for net facilitation were found along the elevation gradients. The open areas were not only richer in species, but not a single species preferred to grow exclusively inside cushions, while 39-60% of 56 species detected had a significant preference for the habitat outside cushions. Across the entire elevation range of T. caespitosum, the number and abundance of species were greater outside cushions, suggesting that competitive rather than facilitative interactions prevail. This was supported by lower soil nutrient contents inside cushions, indicating a resource preemption, and little thermal amelioration at the extreme end of the elevational gradient. We attribute the negative associations to competition for limited resources, a strong environmental filter in arid high-mountain environment selecting the stress-tolerant species that do not rely on help from other plants during their life cycle and to the fact the cushions do not provide a better microhabitat to grow in.	[Dvorsky, Miroslav; Dolezal, Jiri; Chlumska, Zuzana; Janatkova, Katerina; Altman, Jan; de Bello, Francesco; Rehakova, Klara] Acad Sci Czech Republic, Inst Bot, Sect Plant Ecol, Trebon, Czech Republic; [Dvorsky, Miroslav; Dolezal, Jiri; Chlumska, Zuzana; Janatkova, Katerina; Altman, Jan] Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Kopecky, Martin] Acad Sci Czech Republic, Inst Bot, Dept Vegetat Ecol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Dolezal, J (corresponding author), Acad Sci Czech Republic, Inst Bot, Sect Plant Ecol, Trebon, Czech Republic.	jiriddolezal@gmail.com	de Bello, Francesco/H-1582-2014; Kopecký, Martin/A-1466-2009; Altman, Jan/B-4305-2015; Doležal, Jiří/H-1583-2014; Rehakova, Klara/B-2143-2012; de Bello, Francesco/AFQ-8650-2022; de Bello, Francesco/HCI-1196-2022; Čapková, Kateřina/M-1430-2014	de Bello, Francesco/0000-0001-9202-8198; Kopecký, Martin/0000-0002-1018-9316; de Bello, Francesco/0000-0001-9202-8198; Čapková, Kateřina/0000-0002-8928-5983; Rehakova, Klara/0000-0002-8871-9989; Dolezal, Jiri/0000-0002-5829-4051	Institute of Botany, Academy of Sciences of the Czech Republic [AV0Z60050516, GD206/08/H044]; Grant Agency of the Academy of Sciences of the Czech Republic [GAAV-IAA600050802]; French National Center for Scientific Research [CNRS-PICs4876]; Grant Agency of the Czech Republic [GD206/08/H044]; Grant Agency of the University of South Bohemia [GAJU-138/2010/P]	Institute of Botany, Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the University of South Bohemia	This study was funded by the Institute of Botany, Academy of Sciences of the Czech Republic (AV0Z60050516, GD206/08/H044) and by the projects funded by the Grant Agency of the Academy of Sciences of the Czech Republic (GAAV-IAA600050802), French National Center for Scientific Research (CNRS-PICs4876), Grant Agency of the Czech Republic (GD206/08/H044) and Grant Agency of the University of South Bohemia (GAJU-138/2010/P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Rodriguez IS, 2006, REV CHIL HIST NAT, V79, P329; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Anthelme F, 2012, J VEG SCI, V23, P62, DOI 10.1111/j.1654-1103.2011.01333.x; Antonsson H, 2009, PLANT ECOL DIVERS, V2, P17, DOI 10.1080/17550870902926504; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Arredondo-Nunez A, 2009, COMMUNITY ECOL, V10, P1, DOI 10.1556/ComEc.10.2009.1.1; Arroyo MTK, 2003, PLANT ECOL, V169, P121, DOI 10.1023/A:1026281405115; Badano EI, 2006, J BIOGEOGR, V33, P304, DOI 10.1111/j.1365-2699.2005.01384.x; Badano EI, 2002, REV CHIL HIST NAT, V75, P757; Badano EI, 2008, OECOLOGIA, V155, P821, DOI 10.1007/s00442-007-0953-2; Badano EI, 2006, OIKOS, V115, P369, DOI 10.1111/j.2006.0030-1299.15132.x; Badano EI, 2006, DIVERS DISTRIB, V12, P388, DOI 10.1111/j.1366-9516.2006.00248.x; Bates D., 2010, LME4 LINEAR MIXED EF; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Cavieres L, 2002, J VEG SCI, V13, P547, DOI 10.1111/j.1654-1103.2002.tb02081.x; Cavieres LA, 2005, PERSPECT PLANT ECOL, V7, P217, DOI 10.1016/j.ppees.2005.09.002; Cavieres LA, 2006, NEW PHYTOL, V169, P59, DOI 10.1111/j.1469-8137.2005.01573.x; Cavieres LA, 2007, ARCT ANTARCT ALP RES, V39, P229, DOI 10.1657/1523-0430(2007)39[229:MMOCPA]2.0.CO;2; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; de Bello F, 2011, ANN BOT-LONDON, V108, P567, DOI 10.1093/aob/mcr183; Dvorsky M, 2011, APPL VEG SCI, V14, P132, DOI 10.1111/j.1654-109X.2010.01103.x; Erschbamer B, 2011, PRESLIA, V83, P387; Fajardo A, 2008, J VEG SCI, V19, P87, DOI 10.3170/2007-8-18332; GOLD WG, 1995, ECOLOGY, V76, P1558, DOI 10.2307/1938157; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Guo YR, 2008, ENVIRON GEOL, V54, P653, DOI 10.1007/s00254-007-1130-y; Hager J., 1990, PARODIANA, V6, P109; Hartmann H., 1983, JB VER SCHUTZ BERGWE, V48, P131; Haussmann NS, 2010, ACTA OECOL, V36, P299, DOI 10.1016/j.actao.2010.02.001; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Hothorn T, 2008, J STAT SOFTW, V28, P1; Kleier C, 2004, AUSTRAL ECOL, V29, P461, DOI 10.1111/j.1442-9993.2004.01386.x; Klimes L, 2006, FLORA LADAKH JAMMU K; Klimes L, 2010, ECOGRAPHY, V33, P590, DOI 10.1111/j.1600-0587.2009.05967.x; Klimesova J, 2011, FOLIA GEOBOT, V46, P191, DOI 10.1007/s12224-010-9076-3; le Roux PC, 2004, ARCT ANTARCT ALP RES, V36, P509, DOI 10.1657/1523-0430(2004)36[509:TUOSAA]2.0.CO;2; Leps J, 2005, VEGETATION ECOLOGY, P199; Lortie CJ, 2006, J ECOL, V94, P7, DOI 10.1111/j.1365-2745.2005.01066.x; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2006, J ECOL, V94, P17, DOI 10.1111/j.1365-2745.2005.01089.x; Michalet R, 2007, NEW PHYTOL, V173, P3, DOI 10.1111/j.1469-8137.2006.01949.x; Miehe G., 1991, OKOLOGIE ERDE, P181; Miehe G., 2001, ERDKUNDE, V55, P94, DOI [10.3112/erdkunde.2001.01.06, DOI 10.3112/ERDKUNDE.2001.01.06]; Nunez CI, 1999, J VEG SCI, V10, P357, DOI 10.2307/3237064; Oksanen J., 2016, R PACKAG; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Phillips RJ, 2008, J MAPS, V4, P21, DOI 10.4113/jom.2008.98; PYSEK P, 1991, ARCTIC ALPINE RES, V23, P263, DOI 10.2307/1551603; Quiroz CL, 2009, REV CHIL HIST NAT, V82, P171; R Development Core Team, 2010, R LANG ENV STAT COMP; Rehakova K, 2011, MICROB ECOL, V62, P337, DOI 10.1007/s00248-011-9878-8; Romdal TS, 2007, ECOGRAPHY, V30, P440, DOI [10.1111/j.2007.0906-7590.04954.x, 10.1111/j.0906-7590.2007.04954.x]; Seifan M, 2010, J ECOL, V98, P356, DOI 10.1111/j.1365-2745.2009.01621.x; Sklenar P, 2009, FLORA, V204, P270, DOI 10.1016/j.flora.2008.04.001; Tichy L, 2002, J VEG SCI, V13, P451, DOI 10.1111/j.1654-1103.2002.tb02069.x; WANG JT, 1988, VEGETATIO, V75, P135; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Yang Y, 2010, J VEG SCI, V21, P1048, DOI 10.1111/j.1654-1103.2010.01215.x; Zingg T, 1954, BESTIMMUNG KLIMATISC; Zoller H, 2006, BOT HELV, V116, P31, DOI 10.1007/s00035-006-0734-2	67	52	54	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53514	10.1371/journal.pone.0053514	http://dx.doi.org/10.1371/journal.pone.0053514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326446	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400026
J	Embleton, L; Atwoli, L; Ayuku, D; Braitstein, P				Embleton, Lonnie; Atwoli, Lukoye; Ayuku, David; Braitstein, Paula			The Journey of Addiction: Barriers to and Facilitators of Drug Use Cessation among Street Children and Youths in Western Kenya	PLOS ONE			English	Article							VOLATILE SUBSTANCE MISUSE; RISK BEHAVIORS; BRAZIL; ABUSE; INDIA; LIFE; HIV; INTERVENTIONS; PAKISTAN; KHARTOUM	This mixed-methods study examined barriers to and facilitators of street children's drug use cessation in Eldoret, Kenya utilizing a cross-sectional survey and focus group discussions with a community-based sample of street-involved children and youth. The primary objective of this study was to describe factors that may assist or impede cessation of drug use that can be utilized in developing substance use interventions for this marginalized population. In 2011, 146 children and youth ages 10-19 years, classified as either children on the street or children of the street were recruited to participate in the cross-sectional survey. Of the 146 children that participated in the survey 40 were invited to participate in focus group discussion; 30 returned voluntarily to participate in the discussions. Several themes were derived from children's narratives that described the barriers to and facilitators of drug cessation. Specifically, our findings reveal the strength of the addiction to inhalants, the dual role that peers and family play in substance use, and how the social, cultural, and economic context influence or impede cessation. Our findings demonstrate the need to integrate community, family and peers into any intervention in addition to traditional medical and psychological models for treatment of substance use dependence.	[Embleton, Lonnie; Braitstein, Paula] Moi Univ, Sch Med, Coll Hlth Sci, Dept Med, Eldoret, Kenya; [Atwoli, Lukoye] Moi Univ, Sch Med, Coll Hlth Sci, Dept Mental Hlth, Eldoret, Kenya; [Ayuku, David] Moi Univ, Sch Med, Coll Hlth Sci, Dept Behav Sci, Eldoret, Kenya; [Braitstein, Paula] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Braitstein, Paula] Regenstrief Inst Inc, Indianapolis, IN USA	Moi University; Moi University; Moi University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Braitstein, P (corresponding author), Moi Univ, Sch Med, Coll Hlth Sci, Dept Med, Eldoret, Kenya.	pbraitst@iupui.edu	Ayuku, David/AAB-8485-2019	Atwoli, Lukoye/0000-0001-7710-9723	Eunice Kennedy Shriver National Institute Of Child Health & Human Development [R01HD060478]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060478] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute Of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project described was supported in part by Award Number R01HD060478 from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2008, STAT AFR CIT FRAM AD; Atwoli L, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-34; Ayaya S O, 2001, East Afr Med J, V78, P624; Ayuku D, 2003, HEALTH POLICY PLANN, V18, P109, DOI 10.1093/heapol/18.1.109; Ayuku D, 2004, AFRICAN J FOOD AGR N, V4, P1; Ayuku DO, 2004, INT SOC WORK, V47, P293, DOI 10.1177/0020872804041428; Bal B, 2010, SUBST USE MISUSE, V45, P1668, DOI 10.3109/10826081003674856; Baldivieso L E, 1995, NIDA Res Monogr, V148, P50; Cairney S, 2010, J PAEDIATR CHILD H, V46, P510, DOI 10.1111/j.1440-1754.2010.01850.x; Carlini-Cotrim B, 1995, NIDA Res Monogr, V148, P64; Coleman H, 2001, J CHILD ADOLESCENT S, V10; Cottrell-Boyce J, 2010, AFR J DRUG ALCOHOL S, V9, P93; de Carvalho FT, 2006, AIDS BEHAV, V10, pS57, DOI 10.1007/s10461-006-9124-4; Dell C. A., 2006, YOUTH VOLATILE SOLVE; Dybicz P, 2005, INT SOC WORK, V48, P763, DOI 10.1177/0020872805057083; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Elkoussi A, 2011, SUBST USE MISUSE, V46, P35, DOI 10.3109/10826084.2011.580202; Embleton L, 2012, SUBST USE MISUSE, V47, P1234, DOI 10.3109/10826084.2012.700678; Fernandes GT, 2008, INT SOC WORK, V51, P669, DOI 10.1177/0020872808093344; Forster LMK, 1996, DRUG ALCOHOL DEPEN, V43, P57, DOI 10.1016/S0376-8716(96)01288-4; HUSELID RF, 1991, AM J DRUG ALCOHOL AB, V17, P89, DOI 10.3109/00952999108992812; Inciardi JA, 1998, SUBST USE MISUSE, V33, P1461, DOI 10.3109/10826089809069809; Jumper-Thurman P, 1995, NIDA Res Monogr, V148, P250; Kaime-Atterhog W, 2008, CHILD YOUTH SERV REV, V30, P1345, DOI 10.1016/j.childyouth.2008.04.003; Kudrati M, 2008, CHILD ABUSE NEGLECT, V32, P439, DOI 10.1016/j.chiabu.2007.07.009; Lerner R, 1995, NIDA Res Monogr, V148, P191; Ling Minhua, 2019, INCONVENIENT GENERAT; Moos RH, 1997, J SUBST ABUSE TREAT, V14, P71, DOI 10.1016/S0740-5472(96)00189-4; Morakinyo J, 2003, DRUG ALCOHOL DEPEN, V71, P109, DOI 10.1016/S0376-8716(03)00093-0; Nada KH, 2010, AIDS, V24, pS39, DOI 10.1097/01.aids.0000386732.02425.d1; Njord L, 2010, ASIA-PAC J PUBLIC HE, V22, P203, DOI 10.1177/1010539510361515; Olley BO, 2006, CHILD ABUSE NEGLECT, V30, P271, DOI 10.1016/j.chiabu.2005.10.011; Pagare Deepti, 2004, Indian Pediatr, V41, P221; Papas RK, 2010, AIDS BEHAV, V14, P836, DOI 10.1007/s10461-008-9492-z; PARTANEN J, 1993, ADDICTION, V88, pS129, DOI 10.1111/j.1360-0443.1993.tb02171.x; Plummer ML, 2007, CHILD YOUTH SERV REV, V29, P1520, DOI 10.1016/j.childyouth.2007.06.008; Project. KOD, 2011, KEN OP DAT PROJ; Seth R, 2005, SUBST USE MISUSE, V40, P1659, DOI 10.1080/10826080500222792; Sharma S, 2011, SUBST USE MISUSE, V46, P46, DOI 10.3109/10826084.2011.580206; Sherman SS, 2005, J URBAN HEALTH, V82, pIV113, DOI 10.1093/jurban/jti113; Souza R, 2010, INT J SOC PSYCHIAT; Towe VL, 2009, J ADOLESCENT HEALTH, V44, P222, DOI 10.1016/j.jadohealth.2008.09.003; UNICEF, 2006, STAT WORLDS CHILDR 2; Vederhus JK, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-35; Wittig MCW, 1997, SUBST USE MISUSE, V32, P805, DOI 10.3109/10826089709055860	45	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53435	10.1371/journal.pone.0053435	http://dx.doi.org/10.1371/journal.pone.0053435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326428	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500072
J	Fang, XL; Shu, G; Yu, JJ; Wang, LN; Yang, J; Zeng, QJ; Cheng, X; Zhang, ZQ; Wang, SB; Gao, P; Zhu, XT; Xi, QY; Zhang, YL; Jiang, QY				Fang, Xin-Ling; Shu, Gang; Yu, Jian-Jian; Wang, Li-Na; Yang, Jing; Zeng, Qing-Jie; Cheng, Xiao; Zhang, Zhi-Qi; Wang, Song-Bo; Gao, Ping; Zhu, Xiao-Tong; Xi, Qian-Yun; Zhang, Yong-Liang; Jiang, Qing-Yan			The Anorexigenic Effect of Serotonin Is Mediated by the Generation of NADPH Oxidase-Dependent ROS	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2; PARAVENTRICULAR NUCLEUS; NEUROPEPTIDE-Y; FOOD-INTAKE; PROOPIOMELANOCORTIN NEURONS; OXIDATIVE STRESS; GENE-EXPRESSION; D-FENFLURAMINE; RAT; ACTIVATION	Serotonin (5-HT) is a central inhibitor of food intake in mammals. Thus far, the intracellular mechanisms for the effect of serotonin on appetite regulation remain unclear. It has been recently demonstrated that reactive oxygen species (ROS) in the hypothalamus are a crucial integrative target for the regulation of food intake. To investigate the role of ROS in the serotonin-induced anorexigenic effects, conscious mice were treated with 5-HT alone or combination with Trolox (a ROS scavenger) or Apocynin (an NADPH oxidase inhibitor) by acute intracerebroventricular injection. Both Trolox and Apocynin reversed the anorexigenic action of 5-HT and the 5-HT-induced hypothalamic ROS elevation. The mRNA and protein expression levels of pro-opiomelanocortin (POMC) were dramatically increased after ICV injection with 5-HT. The anorexigenic action of 5-HT was accompanied by markedly elevated hypothalamic MDA levels and GSH-Px activity, while the SOD activity was decreased. Moreover, 5-HT significantly increased the mRNA expression of UCP-2 but reduced the levels of UCP-3. Both Trolox and Apocynin could block the 5-HT-induced changes in UCP-2 and UCP-3 gene expression. Our study demonstrates for the first time that the anorexigenic effect of 5-HT is mediated by the generation of ROS in the hypothalamus through an NADPH oxidase-dependent pathway.	[Fang, Xin-Ling; Shu, Gang; Yu, Jian-Jian; Wang, Li-Na; Yang, Jing; Zeng, Qing-Jie; Cheng, Xiao; Zhang, Zhi-Qi; Wang, Song-Bo; Gao, Ping; Zhu, Xiao-Tong; Xi, Qian-Yun; Zhang, Yong-Liang; Jiang, Qing-Yan] S China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Jiang, QY (corresponding author), S China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China.	380197470@qq.com			National Basic Research Program of China- the 973 Program [2012CB124701, 2009CB941601]; National Natural Science Foundation of China [30871845]	National Basic Research Program of China- the 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China- the 973 Program (2012CB124701; 2009CB941601) and the National Natural Science Foundation of China (30871845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Asaba K, 2004, ENDOCRINOLOGY, V145, P39, DOI 10.1210/en.2003-0375; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Choi SJ, 2002, BRAIN RES, V928, P30, DOI 10.1016/S0006-8993(01)03330-3; COON MJ, 1992, FASEB J, V6, P669, DOI 10.1096/fasebj.6.2.1537454; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Currie PJ, 2002, PHARMACOL BIOCHEM BE, V71, P709, DOI 10.1016/S0091-3057(01)00671-2; DUBE MG, 1992, BRAIN RES BULL, V29, P865, DOI 10.1016/0361-9230(92)90157-S; Fetissov SO, 2000, NEUROSCIENCE, V101, P657, DOI 10.1016/S0306-4522(00)00374-2; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Freitas JJS, 2001, J NEUROCHEM, V77, P655, DOI 10.1046/j.1471-4159.2001.00280.x; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Horvath TL, 1999, J NEUROSCI, V19, P10417; HUTSON PH, 1988, PSYCHOPHARMACOLOGY, V95, P550; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Jaillard T, 2009, DIABETES, V58, P1544, DOI 10.2337/db08-1039; Kageyama K, 1998, NEUROSCI LETT, V243, P17, DOI 10.1016/S0304-3940(98)00097-4; KENNETT GA, 1988, PSYCHOPHARMACOLOGY, V96, P93, DOI 10.1007/BF02431539; Kim MJ, 2005, BRAIN RES, V1040, P178, DOI 10.1016/j.brainres.2005.01.066; Kullisaar T, 2002, INT J FOOD MICROBIOL, V72, P215, DOI 10.1016/S0168-1605(01)00674-2; Kuo DY, 2011, ANTIOXID REDOX SIGN, V15, P2147, DOI 10.1089/ars.2010.3738; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lee SL, 1998, FREE RADICAL BIO MED, V24, P855, DOI 10.1016/S0891-5849(97)00359-6; Lee SL, 1997, AM J PHYSIOL-CELL PH, V272, pC223, DOI 10.1152/ajpcell.1997.272.1.C223; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Leloup C, 2006, DIABETES, V55, P2084, DOI 10.2337/db06-0086; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mukhin YV, 2000, BIOCHEM J, V347, P61, DOI 10.1042/0264-6021:3470061; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nonogaki K, 2007, INT J NEUROPSYCHOPH, V10, P675, DOI 10.1017/S1461145706007206; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Pietri M, 2005, FASEB J, V19, P1078, DOI 10.1096/fj.04-3631com; Richard D, 1998, J COMP NEUROL, V397, P549; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Simansky KJ, 1996, BEHAV BRAIN RES, V73, P37, DOI 10.1016/0166-4328(96)00066-6; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Steffens SM, 1997, BRAIN RES BULL, V44, P681, DOI 10.1016/S0361-9230(97)00199-8; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Usuki F, 2001, NEUROSCI LETT, V304, P199, DOI 10.1016/S0304-3940(01)01764-5; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Vickers SP, 2001, NEUROPHARMACOLOGY, V41, P200, DOI 10.1016/S0028-3908(01)00063-6; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Voight JP, 2002, PHARMACOL BIOCHEM BE, V72, P403, DOI 10.1016/S0091-3057(01)00763-8; Wang HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019790; Wang JH, 2008, NEUROSCIENCE, V156, P89, DOI 10.1016/j.neuroscience.2008.04.079; Wolfgang MJ, 2007, P NATL ACAD SCI USA, V104, P19285, DOI 10.1073/pnas.0709778104; YOKOYAMA Y, 1990, AM J PHYSIOL, V258, pG564, DOI 10.1152/ajpgi.1990.258.4.G564	52	25	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53142	10.1371/journal.pone.0053142	http://dx.doi.org/10.1371/journal.pone.0053142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326391	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500052
J	Irandoust, M; Zarate, JA; Hubeek, I; van Beek, EM; Schornagel, K; Broekhuizen, AJF; Akyuz, M; van de Loosdrecht, AA; Delwel, R; Valk, PJ; Sonneveld, E; Kearns, P; Creutzig, U; Reinhardt, D; de Bont, ESJM; Coenen, EA; van den Heuvel-Eibrink, MM; Zwaan, CM; Kaspers, GJL; Cloos, J; van den Berg, TK				Irandoust, Mahban; Zarate, Julian Alvarez; Hubeek, Isabelle; van Beek, Ellen M.; Schornagel, Karin; Broekhuizen, Aart J. F.; Akyuz, Mercan; van de Loosdrecht, Arjan A.; Delwel, Ruud; Valk, Peter J.; Sonneveld, Edwin; Kearns, Pamela; Creutzig, Ursula; Reinhardt, Dirk; de Bont, Eveline S. J. M.; Coenen, Eva A.; van den Heuvel-Eibrink, Marry M.; Zwaan, C. Michel; Kaspers, Gertjan J. L.; Cloos, Jacqueline; van den Berg, Timo K.			Engagement of SIRP alpha Inhibits Growth and Induces Programmed Cell Death in Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							SIGNAL-REGULATORY-PROTEIN; INTEGRIN-ASSOCIATED PROTEIN; GENE-EXPRESSION; VALPROIC ACID; IN-VITRO; DRUG RESISTANCE; STEM-CELLS; CD47; RECEPTOR; ANTIBODY	Background: Recent studies show the importance of interactions between CD47 expressed on acute myeloid leukemia (AML) cells and the inhibitory immunoreceptor, signal regulatory protein-alpha (SIRP alpha) on macrophages. Although AML cells express SIRP alpha, its function has not been investigated in these cells. In this study we aimed to determine the role of the SIRP alpha in acute myeloid leukemia. Design and Methods: We analyzed the expression of SIRP alpha, both on mRNA and protein level in AML patients and we further investigated whether the expression of SIRP alpha on two low SIRP alpha expressing AML cell lines could be upregulated upon differentiation of the cells. We determined the effect of chimeric SIRP alpha expression on tumor cell growth and programmed cell death by its triggering with an agonistic antibody in these cells. Moreover, we examined the efficacy of agonistic antibody in combination with established antileukemic drugs. Results: By microarray analysis of an extensive cohort of primary AML samples, we demonstrated that SIRP alpha is differentially expressed in AML subgroups and its expression level is dependent on differentiation stage, with high levels in FAB M4/M5 AML and low levels in FAB M0-M3. Interestingly, AML patients with high SIRP alpha expression had a poor prognosis. Our results also showed that SIRP alpha is upregulated upon differentiation of NB4 and Kasumi cells. In addition, triggering of SIRP alpha with an agonistic antibody in the cells stably expressing chimeric SIRP alpha, led to inhibition of growth and induction of programmed cell death. Finally, the SIRP alpha-derived signaling synergized with the activity of established antileukemic drugs. Conclusions: Our data indicate that triggering of SIRP alpha has antileukemic effect and may function as a potential therapeutic target in AML.	[Irandoust, Mahban; Hubeek, Isabelle; Broekhuizen, Aart J. F.; Akyuz, Mercan; Kaspers, Gertjan J. L.; Cloos, Jacqueline] Vrije Univ Amsterdam, Dept Pediat Hematol Oncol, Med Ctr, Amsterdam, Netherlands; [Irandoust, Mahban; Hubeek, Isabelle; van de Loosdrecht, Arjan A.; Cloos, Jacqueline] Vrije Univ Amsterdam, Dept Hematol, Med Ctr, Amsterdam, Netherlands; [Zarate, Julian Alvarez; van Beek, Ellen M.; Schornagel, Karin; van den Berg, Timo K.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Delwel, Ruud; Valk, Peter J.] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands; [Sonneveld, Edwin] DCOG, The Hague, Netherlands; [Kearns, Pamela] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Creutzig, Ursula; Reinhardt, Dirk] Hannover Med Sch, Dept Pediat Hematol Oncol, Hannover, Germany; [de Bont, Eveline S. J. M.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Coenen, Eva A.; van den Heuvel-Eibrink, Marry M.; Zwaan, C. Michel] Erasmus MC Sophia Childrens Hosp, Dept Pediat Hematol Oncol, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Dutch Childhood Oncology Group; University of Birmingham; Hannover Medical School; University of Groningen; Erasmus University Rotterdam; Erasmus MC	van den Berg, TK (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.k.vandenberg@sanquin.nl	Valk, Peter/AAX-2823-2020; Reinhardt, Dirk/N-7003-2016; Kearns, Pamela/AAD-6011-2021; Reinhardt, Dirk/D-3939-2011; van den Berg, Timo K/AAC-2479-2022; Kaspers, Gertjan/ABC-5334-2020	Reinhardt, Dirk/0000-0002-7027-4483; Reinhardt, Dirk/0000-0003-4313-9056; Kaspers, Gertjan/0000-0001-7716-8475; Cloos, Jacqueline/0000-0001-9150-8026; Kearns, Pamela/0000-0003-2756-5813	KiKa, Children Cancer Free(stichting Kinderen Kankervrij)	KiKa, Children Cancer Free(stichting Kinderen Kankervrij)	This study was supported by KiKa, Children Cancer Free(stichting Kinderen Kankervrij). website: http://kika.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 1998, J IMMUNOL, V161, P1853; Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Balgobind BV, 2011, HAEMATOL-HEMATOL J, V96, P221, DOI 10.3324/haematol.2010.029660; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Carter BZ, 2003, BLOOD, V102, P4179, DOI 10.1182/blood-2003-03-0960; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; CHOMIENNE C, 1990, BLOOD, V76, P1710; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; DAMOISEAUX JGMC, 1989, J LEUKOCYTE BIOL, V46, P556, DOI 10.1002/jlb.46.6.556; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Edris B, 2012, P NATL ACAD SCI US; Fukunaga A, 2004, J IMMUNOL, V172, P4091, DOI 10.4049/jimmunol.172.7.4091; Galbaugh T, 2010, MOL CANCER RES, V8, P1413, DOI 10.1158/1541-7786.MCR-10-0130; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Goyama S, 2011, INT J HEMATOL, V94, P126, DOI 10.1007/s12185-011-0858-z; Gozzini A, 2005, ANN HEMATOL, V84, P54, DOI 10.1007/s00277-005-0006-z; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Hann I. M., 2004, Annals of Hematology, V83, pS108; Hann IM, 1997, BLOOD, V89, P2311, DOI 10.1182/blood.V89.7.2311; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Heemskerk MHM, 1999, CELL IMMUNOL, V195, P10, DOI 10.1006/cimm.1999.1520; Hubeek I, 2008, ONCOL REP, V19, P1517; Isenberg JS, 2008, AM J PATHOL, V173, P1100, DOI 10.2353/ajpath.2008.080237; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kaspers GJL, 2007, HAEMATOLOGICA, V92, P1519, DOI 10.3324/haematol.11203; Kaspers GJL, 1999, ADV EXP MED BIOL, V457, P415; KASPERS GJL, 1994, BRIT J CANCER, V70, P1047, DOI 10.1038/bjc.1994.446; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kircher B, 2009, EUR J HAEMATOL, V83, P48, DOI 10.1111/j.1600-0609.2009.01242.x; Larizza L, 2005, LEUKEMIA LYMPHOMA, V46, P247, DOI 10.1080/10428190400007565; Liu SJ, 2007, J PHARMACOL EXP THER, V321, P953, DOI 10.1124/jpet.106.118406; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Martens JHA, 2010, FEBS LETT, V584, P2662, DOI 10.1016/j.febslet.2010.04.002; Maxhimer JB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000139; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Nagahara M, 2010, CLIN CANCER RES, V16, P4625, DOI 10.1158/1078-0432.CCR-10-0349; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Ravindranath Y, 2003, CURR OPIN ONCOL, V15, P23, DOI 10.1097/00001622-200301000-00004; Roos D, 1986, Methods Enzymol, V132, P250; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; Soto-Pantoja DR, 2012, AUTOPHAGY, V8, P1628, DOI 10.4161/auto.21562; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Uno S, 2007, ONCOL REP, V17, P1189; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307; Willingham S. B., 2012, P NATL ACAD SCI US; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	63	13	18	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52143	10.1371/journal.pone.0052143	http://dx.doi.org/10.1371/journal.pone.0052143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320069	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800011
J	Wang, DR; Chen, CW; Chen, J; Xu, YX; Wang, L; Zhu, Z; Deng, DH; Chen, J; Long, AH; Tang, D; Liu, J				Wang, Daorong; Chen, Chaowu; Chen, Jie; Xu, Yaxiang; Wang, Lu; Zhu, Zhen; Deng, Denghao; Chen, Juan; Long, Aihua; Tang, Dong; Liu, Jun			The Use of Propofol as a Sedative Agent in Gastrointestinal Endoscopy: A Meta-Analysis	PLOS ONE			English	Article							PATIENT-CONTROLLED SEDATION; NURSE-ADMINISTERED PROPOFOL; RANDOMIZED CONTROLLED-TRIAL; MONITORED ANESTHESIA CARE; HIGH-RISK OCTOGENARIANS; CONSCIOUS SEDATION; RETROGRADE CHOLANGIOPANCREATOGRAPHY; OUTPATIENT COLONOSCOPY; CIRRHOTIC-PATIENTS; DEEP SEDATION	Objectives: To assess the efficacy and safety of propofol sedation for gastrointestinal endoscopy, we conducted a meta-analysis of randomized controlled trials (RCTs) comparing propofol with traditional sedative agents. Methods: RCTs comparing the effects of propofol and traditional sedative agents during gastrointestinal endoscopy were found on MEDLINE, the Cochrane Central Register of Controlled Trials, and EMBASE. Cardiopulmonary complications (i.e., hypoxia, hypotension, arrhythmia, and apnea) and sedation profiles were assessed. Results: Twenty-two original RCTs investigating a total of 1,798 patients, of whom 912 received propofol only and 886 received traditional sedative agents only, met the inclusion criteria. Propofol use was associated with shorter recovery (13 studies, 1,165 patients; WMD -19.75; 95% CI -27.65, 11.86) and discharge times (seven studies, 471 patients; WMD -29.48; 95% CI -44.13, -14.83), higher post-anesthesia recovery scores (four studies, 503 patients; WMD 2.03; 95% CI 1.59, 2.46), better sedation (nine studies, 592 patients; OR 4.78; 95% CI 2.56, 8.93), and greater patient cooperation (six studies, 709 patients; WMD 1.27; 95% CI 0.53, 2.02), as well as more local pain on injection (six studies, 547 patients; OR 10.19; 95% CI 3.93, 26.39). Effects of propofol on cardiopulmonary complications, procedure duration, amnesia, pain during endoscopy, and patient satisfaction were not found to be significantly different from those of traditional sedative agents. Conclusions: Propofol is safe and effective for gastrointestinal endoscopy procedures and is associated with shorter recovery and discharge periods, higher post-anesthesia recovery scores, better sedation, and greater patient cooperation than traditional sedation, without an increase in cardiopulmonary complications. Care should be taken when extrapolating our results to specific practice settings and high-risk patient subgroups.	[Wang, Daorong; Chen, Jie; Xu, Yaxiang; Tang, Dong] Yangzhou Univ, Clin Med Coll, Dept Gastrointestinal Surg, Subei Peoples Hosp Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China; [Chen, Chaowu; Wang, Lu; Zhu, Zhen; Deng, Denghao; Chen, Juan; Long, Aihua; Liu, Jun] Yangzhou Univ, Clin Med Coll, Dept Gastroenterol, Subei Peoples Hosp Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Tang, D (corresponding author), Yangzhou Univ, Clin Med Coll, Dept Gastrointestinal Surg, Subei Peoples Hosp Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China.	tangdong1981@hotmail.com; 83392785@qq.com			National Natural Science Foundation of China [81201885, 81172279]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (no. 81201885 & no. 81172279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni M, 2011, GASTROINTEST ENDOSC, V74, P266, DOI 10.1016/j.gie.2011.04.028; Amornyotin S, 2011, HEPATOB PANCREAT DIS, V10, P313, DOI 10.1016/S1499-3872(11)60052-0; CARLSSON U, 1995, ENDOSCOPY, V27, P240, DOI 10.1055/s-2007-1005678; Chen Wei-Xing, 2005, Hepatobiliary Pancreat Dis Int, V4, P437; Chin N. M., 1992, Singapore Medical Journal, V33, P478; Choudhary A, 2011, GASTROINTEST ENDOSC, V73, P275, DOI 10.1016/j.gie.2010.10.039; Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x; DeWitt J, 2008, GASTROINTEST ENDOSC, V68, P499, DOI 10.1016/j.gie.2008.02.092; Ellett MLC, 2010, GASTROENTEROL NURS, V33, P111, DOI 10.1097/SGA.0b013e3181d601fb; Graber RG, 1999, GASTROINTEST ENDOSC, V49, P803, DOI 10.1016/S0016-5107(99)70308-1; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Hsieh YH, 2009, J CLIN GASTROENTEROL, V43, P753, DOI 10.1097/MCG.0b013e3181862a8c; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jung M, 2000, ENDOSCOPY, V32, P233, DOI 10.1055/s-2000-96; KEEFFE EB, 1995, GASTROENTEROLOGY, V108, P932, DOI 10.1016/0016-5085(95)90471-9; Khamaysi I, 2011, J HEPATOL, V54, P72, DOI 10.1016/j.jhep.2010.06.023; Kiriyama S, 2010, J GASTROENTEROL, V45, P831, DOI 10.1007/s00535-010-0222-8; Kongkam P, 2008, J GASTROINTEST LIVER, V17, P291; Krugliak P, 2000, ENDOSCOPY, V32, P677; Lee DWH, 2002, GASTROINTEST ENDOSC, V56, P629, DOI 10.1067/mge.2002.128919; Leslie K, 2008, Anesth Analg, V107, P2089, DOI 10.1213/ANE.0b013e3181891464; Mayer J, 2008, EUR J ANAESTH, V25, P741, DOI 10.1017/S0265021508004328; Mazanikov M, 2011, GASTROINTEST ENDOSC, V73, P260, DOI 10.1016/j.gie.2010.10.005; Meining A, 2007, ENDOSCOPY, V39, P345, DOI 10.1055/s-2006-945195; Moerman AT, 2004, J CLIN ANESTH, V16, P237, DOI 10.1016/j.jclinane.2003.08.005; Moerman AT, 2003, EUR J ANAESTH, V20, P461, DOI 10.1097/00003643-200306000-00006; Ng JM, 2001, GASTROINTEST ENDOSC, V54, P8, DOI 10.1067/mge.2001.116110; Oei-Lim VLB, 1998, EUR J ANAESTH, V15, P535, DOI 10.1046/j.1365-2346.1998.00349.x; Padmanabhan U, 2009, ANESTH ANALG, V109, P1448, DOI 10.1213/ane.0b013e3181a6ad31; Paspatis GA, 2009, ENDOSCOPY, V41, P1046, DOI 10.1055/s-0029-1215342; PATTERSON KW, 1991, BRIT J ANAESTH, V67, P108, DOI 10.1093/bja/67.1.108; Qadeer MA, 2005, CLIN GASTROENTEROL H, V3, P1049, DOI 10.1016/S1542-3565(05)00742-1; Riphaus A, 2006, ENDOSCOPY, V38, P677, DOI 10.1055/s-2006-925244; Riphaus A, 2005, AM J GASTROENTEROL, V100, P1957, DOI 10.1111/j.1572-0241.2005.41672.x; Riphaus A, 2009, SCAND J GASTROENTERO, V44, P1244, DOI 10.1080/00365520903194591; Schilling D, 2009, ENDOSCOPY, V41, P295, DOI 10.1055/s-0028-1119671; Seifert H, 2000, ALIMENT PHARM THERAP, V14, P1207; Shafer S. L., 2008, V182, P409, DOI 10.1007/978-3-540-74806-9_19; Singh H, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006268.pub2; Sipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636; Ulmer BJ, 2003, CLIN GASTROENTEROL H, V1, P425, DOI 10.1016/S1542-3565(03)00226-X; Vargo JJ, 2002, GASTROENTEROLOGY, V123, P8, DOI 10.1053/gast.2002.34232; Wehrmann T, 1999, GASTROINTEST ENDOSC, V49, P677, DOI 10.1016/S0016-5107(99)70281-6; Wehrmann T, 2002, GASTROINTEST ENDOSC, V56, P817, DOI 10.1067/mge.2002.129603; Wehrmann T, 2008, SCAND J GASTROENTERO, V43, P368, DOI 10.1080/00365520701679181; Weston BR, 2003, AM J GASTROENTEROL, V98, P2440, DOI 10.1016/S0002-9270(03)01701-5	46	72	76	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53311	10.1371/journal.pone.0053311	http://dx.doi.org/10.1371/journal.pone.0053311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308191	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429800036
J	Hariharan, N; Ikeda, Y; Hong, C; Alcendor, RR; Usui, S; Gao, SM; Maejima, Y; Sadoshima, J				Hariharan, Nirmala; Ikeda, Yoshiyuki; Hong, Chull; Alcendor, Ralph R.; Usui, Soichiro; Gao, Shumin; Maejima, Yasuhiro; Sadoshima, Junichi			Autophagy Plays an Essential Role in Mediating Regression of Hypertrophy during Unloading of the Heart	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; CARDIAC-HYPERTROPHY; IN-VIVO; HEMODYNAMIC STRESS; PRESSURE-OVERLOAD; DISTINCT ROLES; EXPRESSION; MYOCYTES; GROWTH; CELLS	Autophagy is a bulk degradation mechanism for cytosolic proteins and organelles. The heart undergoes hypertrophy in response to mechanical load but hypertrophy can regress upon unloading. We hypothesize that autophagy plays an important role in mediating regression of cardiac hypertrophy during unloading. Mice were subjected to transverse aortic constriction (TAC) for 1 week, after which the constriction was removed (DeTAC). Regression of cardiac hypertrophy was observed after DeTAC, as indicated by reduction of LVW/BW and cardiomyocyte cross-sectional area. Indicators of autophagy, including LC3-II expression, p62 degradation and GFP-LC3 dots/cell, were significantly increased after DeTAC, suggesting that autophagy is induced. Stimulation of autophagy during DeTAC was accompanied by upregulation of FoxO1. Upregulation of FoxO1 and autophagy was also observed in vitro when cultured cardiomyocytes were subjected to mechanical stretch followed by incubation without stretch (de-stretch). Transgenic mice with cardiac-specific overexpression of FoxO1 exhibited smaller hearts and upregulation of autophagy. Overexpression of FoxO1 in cultured cardiomyocytes significantly reduced cell size, an effect which was attenuated when autophagy was inhibited. To further examine the role of autophagy and FoxO1 in mediating the regression of cardiac hypertrophy, beclin1+/- mice and cultured cardiomyocytes transduced with adenoviruses harboring shRNA-beclin1 or shRNA-FoxO1 were subjected to TAC/stretch followed by DeTAC/de-stretch. Regression of cardiac hypertrophy achieved after DeTAC/de-stretch was significantly attenuated when autophagy was suppressed through downregulation of beclin1 or FoxO1. These results suggest that autophagy and FoxO1 play an essential role in mediating regression of cardiac hypertrophy during mechanical unloading.	[Hariharan, Nirmala; Ikeda, Yoshiyuki; Hong, Chull; Alcendor, Ralph R.; Usui, Soichiro; Gao, Shumin; Maejima, Yasuhiro; Sadoshima, Junichi] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, 185 S Orange Ave, Newark, NJ 07103 USA.	sadoshju@umdnj.edu	Hariharan, Nirmala/J-6736-2013; USUI, Soichiro/GQH-4849-2022; Maejima, Yasuhiro/AAG-5580-2020	Usui, Soichiro/0000-0003-1752-8082; Sadoshima, Junichi/0000-0003-3724-4132	United States Public Health Service [HL59139, HL67724, HL69020, HL91469, HL102738, AG27211]; Foundation of Leducq Transatlantic Network of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091469, R01HL102738, P01HL059139, R01HL112330, P01HL069020, R01HL067724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027211] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Foundation of Leducq Transatlantic Network of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Health Service grants HL59139, HL67724, HL69020, HL91469, HL102738, AG27211 and the Foundation of Leducq Transatlantic Network of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Friddle CJ, 2000, P NATL ACAD SCI USA, V97, P6745, DOI 10.1073/pnas.100127897; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Morisco C, 2003, AM J PHYSIOL-HEART C, V284, pH1043, DOI 10.1152/ajpheart.00990.2002; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Su HB, 2010, CARDIOVASC RES, V85, P253, DOI 10.1093/cvr/cvp287; Zafeiridis A, 1998, CIRCULATION, V98, P656, DOI 10.1161/01.CIR.98.7.656; Zhai PY, 2007, J BIOL CHEM, V282, P33181, DOI 10.1074/jbc.M705133200; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	24	67	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e51632	10.1371/journal.pone.0051632	http://dx.doi.org/10.1371/journal.pone.0051632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308102	Green Published, gold			2022-12-27	WOS:000313429100007
J	Rugani, T; Diaci, J; Hladnik, D				Rugani, Tihomir; Diaci, Jurij; Hladnik, David			Gap Dynamics and Structure of Two Old-Growth Beech Forest Remnants in Slovenia	PLOS ONE			English	Article							NATURAL FORESTS; REPLACEMENT; PATTERNS; LIGHT	Context: Due to a long history of intensive forest exploitation, few European beech (Fagus sylvatica L.) old-growth forests have been preserved in Europe. Material and Methods: We studied two beech forest reserves in southern Slovenia. We examined the structural characteristics of the two forest reserves based on data from sample plots and complete inventory obtained from four previous forest management plans. To gain a better understanding of disturbance dynamics, we used aerial imagery to study the characteristics of canopy gaps over an 11-year period in the Kopa forest reserve and a 20-year period in the Gorjanci forest reserve. Results: The results suggest that these forests are structurally heterogeneous over small spatial scales. Gap size analysis showed that gaps smaller than 500 m(2) are the dominant driving force of stand development. The percentage of forest area in canopy gaps ranged from 3.2 to 4.5% in the Kopa forest reserve and from 9.1 to 10.6% in the Gorjanci forest reserve. These forests exhibit relatively high annual rates of coverage by newly established (0.15 and 0.25%) and closed (0.08 and 0.16%) canopy gaps. New gap formation is dependant on senescent trees located throughout the reserve. Conclusion: We conclude that these stands are not even-sized, but rather unevenly structured. This is due to the fact that the disturbance regime is characterized by low intensity, small-scale disturbances.	[Rugani, Tihomir; Diaci, Jurij; Hladnik, David] Univ Ljubljana, Biotech Fac, Dept Forestry & Renewable Forest Resources, Ljubljana, Slovenia	University of Ljubljana	Rugani, T (corresponding author), Univ Ljubljana, Biotech Fac, Dept Forestry & Renewable Forest Resources, Ljubljana, Slovenia.	tihomir.rugani@bf.uni-lj.si			Novo mesto Regional Unit of the Slovenia Forestry Service; Slovenian Ministry of Agriculture, Forestry, and Food [V4-0346]; Programme research group Forest, Forestry, and Renewable Forest Resources	Novo mesto Regional Unit of the Slovenia Forestry Service; Slovenian Ministry of Agriculture, Forestry, and Food; Programme research group Forest, Forestry, and Renewable Forest Resources	We would like to thank the Novo mesto Regional Unit of the Slovenia Forestry Service for all the data and support they provided.; Field research and manuscript preparation was partly funded by the Slovenian Ministry of Agriculture, Forestry, and Food through project grant (project V4-0346) and by the Programme research group Forest, Forestry, and Renewable Forest Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, FOREST MANAGEMENT PL; [Anonymous], 2010, FOREST MANAGEMENT PL; Aszalos R, 2003, STUDY GAP CHARACTERI, P1; Battles JJ, 2000, ECOL APPL, V10, P760, DOI 10.1890/1051-0761(2000)010[0760:GDFFDA]2.0.CO;2; Borrmann K, 1996, ALLG FORST JAGDZTG, V23, P5; Christensen M, 2005, FOREST ECOL MANAG, V210, P267, DOI 10.1016/j.foreco.2005.02.032; Christensen M, 2006, ECO B, V52, P1; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Commarmot Brigitte, 2005, Forest Snow and Landscape Research, V79, P45; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Drossler L., 2005, Journal of Forest Science, V51, P446; Drossler VL, 2007, ALLG FORST JAGDZTG, V178, P121; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Ellenberg H, 1996, VEGETATION MITTELEUR; Emborg J, 1998, FOREST ECOL MANAG, V106, P83, DOI 10.1016/S0378-1127(97)00299-5; FAO, 2010, GLOBAL FOREST RESOUR; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Fueldner K, 1995, FORSTARCHIV, V66, P235; Kenderes K, 2009, ECOSCIENCE, V16, P39, DOI 10.2980/16-1-3178; Korpel S., 1995, URWALDER WESTKARPATE; Kotar M, 1993, ZBORNIK GOZDARSTVA L, V42, P121; Kral K, 2010, FOREST ECOL MANAG, V260, P2196, DOI 10.1016/j.foreco.2010.09.020; Kucbel S, 2010, EUR J FOREST RES, V129, P249, DOI 10.1007/s10342-009-0322-2; Leibundgut H., 1982, EUROPAISCHE URWALDER; Leibundgut H., 1959, SCHWEIZERISCHE Z FOR, V110, P111; Lemoine D, 2002, ANN FOR SCI, V59, P761, DOI 10.1051/forest:2002062; LERTZMAN KP, 1992, ECOLOGY, V73, P657, DOI 10.2307/1940772; LORIMER CG, 1989, CAN J FOREST RES, V19, P651, DOI 10.1139/x89-102; Manning DB, 2003, GAP STUDIES WEBER ST, P1; Marinsek A., 2004, Zbornik Gozdarstva in Lesarstva, P31; Mlinkk D., 1980, GOZDNI REZERVATI SLO; Nagel TA, 2008, CAN J FOREST RES, V38, P2728, DOI 10.1139/X08-110; PENTTINEN A, 1992, FOREST SCI, V38, P806; Peters R., 1997, BEECH FORESTS; Piovesan G, 2005, J VEG SCI, V16, P13, DOI 10.1111/j.1654-1103.2005.tb02334.x; Pommerening A, 2002, FORESTRY, V75, P305, DOI 10.1093/forestry/75.3.305; Pontailler JY, 1997, FOREST ECOL MANAG, V98, P1, DOI 10.1016/S0378-1127(97)00073-X; Prusa E., 1985, BOHMISCHEN MAHRISCHE; Puhek V, 1993, ZBORNIK GOZDARSTVA L, V42, P155; Puhek V, 1998, PROCJENA STRUKTURNIH; RUNKLE JR, 1982, ECOLOGY, V63, P1533, DOI 10.2307/1938878; Schutz JP, 2011, ANN FOREST SCI, V68, P1105, DOI 10.1007/s13595-011-0126-7; Sharma M, 2002, FOREST ECOL MANAG, V168, P163, DOI 10.1016/S0378-1127(01)00737-X; SZWAGRZYK J, 1993, J VEG SCI, V4, P469, DOI 10.2307/3236074; Tabaku V., 1999, Forstarchiv, V70, P87; THOMPSON HR, 1956, ECOLOGY, V37, P391, DOI 10.2307/1933159; von Oheimb G, 2005, FOREST ECOL MANAG, V212, P253, DOI 10.1016/j.foreco.2005.03.033; Waser LT, 2011, REMOTE SENS ENVIRON, V115, P76, DOI 10.1016/j.rse.2010.08.006; Yamamoto S, 1999, PLANT ECOL, V140, P167, DOI 10.1023/A:1009713002039; Zeibig Andre, 2005, Forest Snow and Landscape Research, V79, P69; Zingg A, 1994, MIXED STANDS RES PLO, P69	51	48	52	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52641	10.1371/journal.pone.0052641	http://dx.doi.org/10.1371/journal.pone.0052641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308115	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100012
J	Sullivan, JT; Brown, SD; Ronson, CW				Sullivan, John T.; Brown, Steven D.; Ronson, Clive W.			The NifA-RpoN Regulon of Mesorhizobium loti Strain R7A and Its Symbiotic Activation by a Novel LacI/GalR-Family Regulator	PLOS ONE			English	Article							RHIZOBIUM-ETLI; BRADYRHIZOBIUM-JAPONICUM; NITROGEN-FIXATION; KLEBSIELLA-PNEUMONIAE; SEQUENCE-ANALYSIS; GENE-EXPRESSION; PROTEIN; LEGUMINOSARUM; GENOME; ISLAND	Mesorhizobium loti is the microsymbiont of Lotus species, including the model legume L. japonicus. M. loti differs from other rhizobia in that it contains two copies of the key nitrogen fixation regulatory gene nifA, nifA1 and nifA2, both of which are located on the symbiosis island ICEMlSym(R7A). M. loti R7A also contains two rpoN genes, rpoN1 located on the chromosome outside of ICEMlSym(R7A) and rpoN2 that is located on ICEMlSym(R7A). The aims of the current work were to establish how nifA expression was activated in M. loti and to characterise the NifA-RpoN regulon. The nifA2 and rpoN2 genes were essential for nitrogen fixation whereas nifA1 and rpoN1 were dispensable. Expression of nifA2 was activated, possibly in response to an inositol derivative, by a novel regulator of the LacI/GalR family encoded by the fixV gene located upstream of nifA2. Other than the well-characterized nif/fix genes, most NifA2-regulated genes were not required for nitrogen fixation although they were strongly expressed in nodules. The NifA-regulated nifZ and fixU genes, along with nifQ which was not NifA-regulated, were required in M. loti for a fully effective symbiosis although they are not present in some other rhizobia. The NifA-regulated gene msi158 that encodes a porin was also required for a fully effective symbiosis. Several metabolic genes that lacked NifA-regulated promoters were strongly expressed in nodules in a NifA2-dependent manner but again mutants did not have an overt symbiotic phenotype. In summary, many genes encoded on ICEMlSym(R7A) were strongly expressed in nodules but not free-living rhizobia, but were not essential for symbiotic nitrogen fixation. It seems likely that some of these genes have functional homologues elsewhere in the genome and that bacteroid metabolism may be sufficiently plastic to adapt to loss of certain enzymatic functions.	[Sullivan, John T.; Brown, Steven D.; Ronson, Clive W.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand	University of Otago	Ronson, CW (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	Clive.Ronson@otago.ac.nz	Brown, Steven D/A-6792-2011	Brown, Steven D/0000-0002-9281-3898; Ronson, Clive/0000-0002-2217-9676	Marsden Fund; University of Otago	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Otago	This work was supported by a grant from the Marsden Fund administered by the Royal Society of New Zealand and grants from the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1970, MANUAL PRACTICAL STU; Antoine R, 2000, J BACTERIOL, V182, P5902, DOI 10.1128/JB.182.20.5902-5905.2000; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; BATUT J, 1985, MOL GEN GENET, V199, P232, DOI 10.1007/BF00330264; Bauer E, 1998, J BACTERIOL, V180, P3853, DOI 10.1128/JB.180.15.3853-3863.1998; Baumberger IC, 2003, MOL PLANT MICROBE IN, V16, P342, DOI 10.1094/MPMI.2003.16.4.342; Becker A, 1995, MOL GEN GENET, V249, P487, DOI 10.1007/BF00290574; Benhassine T, 2007, FEMS MICROBIOL LETT, V271, P20, DOI 10.1111/j.1574-6968.2007.00699.x; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Buchko GW, 2009, BBA-PROTEINS PROTEOM, V1794, P627, DOI 10.1016/j.bbapap.2009.01.002; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Clark SRD, 2001, MOL GEN GENET, V264, P623, DOI 10.1007/s004380000348; Cotton MS, 2009, J AM CHEM SOC, V131, P4558, DOI 10.1021/ja807525m; DAVID M, 1987, J BACTERIOL, V169, P2239, DOI 10.1128/jb.169.5.2239-2244.1987; Dombrecht B, 2005, MOL MICROBIOL, V55, P1207, DOI 10.1111/j.1365-2958.2005.04457.x; Dombrecht B, 2002, MOL GENET GENOMICS, V267, P820, DOI 10.1007/s00438-002-0715-0; Dombrecht B, 2001, MOL PLANT MICROBE IN, V14, P426, DOI 10.1094/MPMI.2001.14.3.426; Dombrecht B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-12-research0076; FELLAY R, 1989, GENE, V76, P215, DOI 10.1016/0378-1119(89)90162-5; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Fukami-Kobayashi K, 2003, MOL BIOL EVOL, V20, P267, DOI 10.1093/molbev/msg038; Fumeaux C, 2011, MICROBIOL-SGM, V157, P2745, DOI 10.1099/mic.0.049999-0; Gil F, 2009, MICROBIOL-SGM, V155, P2490, DOI 10.1099/mic.0.027433-0; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Gonzalez V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r36; HARRIS GS, 1990, J BIOL CHEM, V265, P15909; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; Hernandez JA, 2008, P NATL ACAD SCI USA, V105, P11679, DOI 10.1073/pnas.0803576105; HIRSCH PR, 1984, PLASMID, V12, P139, DOI 10.1016/0147-619X(84)90059-3; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Hubber A, 2004, MOL MICROBIOL, V54, P561, DOI 10.1111/j.1365-2958.2004.04292.x; Hussain AKMA, 1999, PLANT CELL PHYSIOL, V40, P894, DOI 10.1093/oxfordjournals.pcp.a029619; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; KLIPP W, 1989, MOL GEN GENET, V216, P293, DOI 10.1007/BF00334368; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LIU YN, 1990, MOL GEN GENET, V220, P433, DOI 10.1007/BF00391750; Lucas S, 2011, COMPLETE SEQUE UNPUB; Martinez M, 2004, J BACTERIOL, V186, P6586, DOI 10.1128/JB.186.19.6586-6594.2004; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Michiels J, 1998, J BACTERIOL, V180, P1729, DOI 10.1128/JB.180.7.1729-1740.1998; Michiels J, 1998, J BACTERIOL, V180, P3620, DOI 10.1128/JB.180.14.3620-3628.1998; MURPHY PJ, 1988, P NATL ACAD SCI USA, V85, P9133, DOI 10.1073/pnas.85.23.9133; Nguyen CC, 1995, FEBS LETT, V377, P98, DOI 10.1016/0014-5793(95)01344-X; Nukui N, 2006, APPL ENVIRON MICROB, V72, P4964, DOI 10.1128/AEM.02745-05; Poggio S, 2006, J BIOL CHEM, V281, P27205, DOI 10.1074/jbc.M601735200; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Ramsay JP, 2006, MOL MICROBIOL, V62, P723, DOI 10.1111/j.1365-2958.2006.05396.x; Reeve W, 2010, STAND GENOMIC SCI, V2, P347, DOI 10.4056/sigs.852027; RONSON CW, 1987, J BACTERIOL, V169, P2424, DOI 10.1128/jb.169.6.2424-2431.1987; RONSON CW, 1987, NUCLEIC ACIDS RES, V15, P7921, DOI 10.1093/nar/15.19.7921; RUVKUN GB, 1981, NATURE, V289, P85, DOI 10.1038/289085a0; Salazar E, 2010, APPL ENVIRON MICROB, V76, P4510, DOI 10.1128/AEM.02007-09; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCOTT KF, 1983, DNA-J MOLEC CELL BIO, V2, P149, DOI 10.1089/dna.1983.2.149; Simon HM, 1996, J BACTERIOL, V178, P2975, DOI 10.1128/jb.178.10.2975-2977.1996; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sullivan JT, 1998, P NATL ACAD SCI USA, V95, P5145, DOI 10.1073/pnas.95.9.5145; Sullivan JT, 2002, J BACTERIOL, V184, P3086, DOI 10.1128/JB.184.11.3086-3095.2002; SULLIVAN JT, 1995, P NATL ACAD SCI USA, V92, P8985, DOI 10.1073/pnas.92.19.8985; Sullivan JT, 2001, MICROBIOL-SGM, V147, P1315, DOI 10.1099/00221287-147-5-1315; Tejima K, 2003, SOIL SCI PLANT NUTR, V49, P239, DOI 10.1080/00380768.2003.10410003; Uchiumi T, 2004, J BACTERIOL, V186, P2439, DOI 10.1128/JB.186.8.2439-2448.2004; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	71	26	27	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53762	10.1371/journal.pone.0053762	http://dx.doi.org/10.1371/journal.pone.0053762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308282	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100114
J	Wynne, JW; Di Rubbo, A; Shiell, BJ; Beddome, G; Cowled, C; Peck, GR; Huang, J; Grimley, SL; Baker, ML; Michalski, WP				Wynne, James W.; Di Rubbo, Antonio; Shiell, Brian J.; Beddome, Gary; Cowled, Christopher; Peck, Grantley R.; Huang, Jing; Grimley, Samantha L.; Baker, Michelle L.; Michalski, Wojtek P.			Purification and Characterisation of Immunoglobulins from the Australian Black Flying Fox (Pteropus alecto) Using Anti-Fab Affinity Chromatography Reveals the Low Abundance of IgA	PLOS ONE			English	Article							NIPAH VIRUS-INFECTION; NECROSIS-FACTOR-ALPHA; IMMUNE-RESPONSE; HENDRA VIRUS; FRUIT BATS; EQUINE MORBILLIVIRUS; GENE REPERTOIRE; HUMAN MONOCYTES; FC-RECEPTOR; EBOLA-VIRUS	There is now an overwhelming body of evidence that implicates bats in the dissemination of a long list of emerging and re-emerging viral agents, often causing illnesses or death in both animals and humans. Despite this, there is a paucity of information regarding the immunological mechanisms by which bats coexist with highly pathogenic viruses. Immunoglobulins are major components of the adaptive immune system. Early studies found bats may have quantitatively lower antibody responses to model antigens compared to conventional laboratory animals. To further understand the antibody response of bats, the present study purified and characterised the major immunoglobulin classes from healthy black flying foxes, Pteropus alecto. We employed a novel strategy, where IgG was initially purified and used to generate anti-Fab specific antibodies. Immobilised anti-Fab specific antibodies were then used to capture other immunoglobulins from IgG depleted serum. While high quantities of IgM were successfully isolated from serum, IgA was not. Only trace quantities of IgA were detected in the serum by mass spectrometry. Immobilised ligands specific to IgA (Jacalin, Peptide M and staphylococcal superantigen-like protein) also failed to capture P. alecto IgA from serum. IgM was the second most abundant serum antibody after IgG. A survey of mucosal secretions found IgG was the dominant antibody class rather than IgA. Our study demonstrates healthy P. alecto bats have markedly less serum IgA than expected. Higher quantities of IgG in mucosal secretions may be compensation for this low abundance or lack of IgA. Knowledge and reagents developed within this study can be used in the future to examine class-specific antibody response within this important viral host.	[Wynne, James W.; Di Rubbo, Antonio; Shiell, Brian J.; Beddome, Gary; Cowled, Christopher; Peck, Grantley R.; Huang, Jing; Grimley, Samantha L.; Baker, Michelle L.; Michalski, Wojtek P.] CSIRO, Anim Food & Hlth Sci, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Huang, Jing] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); East China Normal University	Michalski, WP (corresponding author), CSIRO, Anim Food & Hlth Sci, Australian Anim Hlth Lab, Geelong, Vic, Australia.	wojtek.michalski@csiro.au	Cowled, Christopher JE/H-5308-2013; Baker, Michelle/AAX-9171-2020; Peck, Grantley/H-2318-2013; Michalski, Wojtek/H-3544-2013; Wynne, James W/H-7957-2013; Baker, Michelle L/C-9694-2013	Cowled, Christopher JE/0000-0002-1969-9371; Baker, Michelle/0000-0002-7993-9971; Wynne, James W/0000-0001-6846-757X; Baker, Michelle L/0000-0002-7993-9971	CSIRO; Australian Biosecurity Cooperative Research Centre	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Biosecurity Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was funded mainly by CSIRO. The Australian Biosecurity Cooperative Research Centre provided a student stipend for ADR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Baker K, 2010, MUCOSAL IMMUNOL, V3, P324, DOI 10.1038/mi.2010.15; Baker ML, 2010, IMMUNOGENETICS, V62, P173, DOI 10.1007/s00251-010-0425-4; BJORCK L, 1984, J IMMUNOL, V133, P969; BRANDTZAEG P, 1974, NATURE, V252, P418, DOI 10.1038/252418a0; Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; Butler JE, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1763, DOI 10.1016/B978-012491543-5/50107-8; Butler JE, 2011, DEV COMP IMMUNOL, V35, P273, DOI 10.1016/j.dci.2010.08.011; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; CHAKRABORTY AK, 1984, DEV COMP IMMUNOL, V8, P415, DOI 10.1016/0145-305X(84)90048-X; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Clayton BA, 2012, ZOONOSES PU IN PRESS; Cowled C, 2011, DEV COMP IMMUNOL, V35, P7, DOI 10.1016/j.dci.2010.07.006; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; FERNANDES FRC, 1995, J INVEST ALLERG CLIN, V5, P151; Field H, 1999, EMERG INFECT DIS, V5, P438, DOI 10.3201/eid0503.990316; Deza FG, 2007, DEV COMP IMMUNOL, V31, P596, DOI 10.1016/j.dci.2006.09.005; GREGORY RL, 1987, J IMMUNOL METHODS, V99, P101, DOI 10.1016/0022-1759(87)90037-8; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; HATTEN BA, 1968, J IMMUNOL, V101, P141; HSU E, 1985, J IMMUNOL, V135, P1998; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Lydyard P, 2004, IMMUNOLOGY; Marsh GA, 2012, PLOS PATHOG IN PRESS; Mbawuike IN, 1999, J IMMUNOL, V162, P2530; McColl KA, 2002, AUST VET J, V80, P636, DOI 10.1111/j.1751-0813.2002.tb10973.x; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; NIKOLOVA EB, 1995, J LEUKOCYTE BIOL, V57, P875, DOI 10.1002/jlb.57.6.875; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Nor MNM, 2000, REV SCI TECH OIE, V19, P160; NORHAGEN G, 1989, J CLIN IMMUNOL, V9, P279, DOI 10.1007/BF00918659; Page M, 2009, PURIFICATION IGG USI; Papenfuss AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-261; Peel AJ, 2012, PLOS ONE, V7; Penno M, 2012, COMP 2D DIGE ANAL DE; Petraityte R, 2009, VIRUS RES, V145, P92, DOI 10.1016/j.virusres.2009.06.013; Prowse S, 2000, ANZCCART NEWS, V13, P7; Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006; Sambrook J., 2001, MOL CLONING LAB MANU; Sandin C, 2002, J IMMUNOL, V169, P1357, DOI 10.4049/jimmunol.169.3.1357; Shiell BJ, 2002, J VIROL METHODS, V102, P27, DOI 10.1016/S0166-0934(01)00441-4; SULKIN SE, 1966, AM J TROP MED HYG, V15, P418, DOI 10.4269/ajtmh.1966.15.418; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Uren TK, 2005, EUR J IMMUNOL, V35, P180, DOI 10.1002/eji.200425492; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; WILTON JMA, 1978, CLIN EXP IMMUNOL, V34, P423; Wolf HM, 1996, CLIN EXP IMMUNOL, V105, P537, DOI 10.1046/j.1365-2249.1996.d01-793.x; WOLF HM, 1994, BLOOD, V83, P1278; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	61	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52930	10.1371/journal.pone.0052930	http://dx.doi.org/10.1371/journal.pone.0052930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308125	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100020
J	Zhang, JL; Zheng, QC; Li, ZQ; Zhang, HX				Zhang, Ji-Long; Zheng, Qing-Chuan; Li, Zheng-Qiang; Zhang, Hong-Xing			How Does (E)-2-(Acetamidomethylene)succinate Bind to Its Hydrolase? From the Binding Process to the Final Result	PLOS ONE			English	Article							MESORHIZOBIUM-LOTI MAFF303099; FIXING SYMBIOTIC BACTERIUM; 4-PYRIDOXIC ACID DEHYDROGENASE; MOLECULAR-DYNAMICS SIMULATIONS; GENE IDENTIFICATION; FREE-ENERGIES; PLP CATABOLISM; PYRIDOXAL; ENZYME; DENSITY	The binding of (E)-2-(acetamidomethylene)succinate (E-2AMS) to E-2AMS hydrolase is crucial for biological function of the enzyme and the last step reaction of vitamin B-6 biological degradation. In the present study, several molecular simulation methods, including molecular docking, conventional molecular dynamics (MD), steered MD (SMD), and free energy calculation methods, were properly integrated to investigate the detailed binding process of E-2AMS to its hydrolase and to assign the optimal enzyme-substrate complex conformation. It was demonstrated that the substrate binding conformation with trans-form amide bond is energetically preferred conformation, in which E-2AMS's pose not only ensures hydrogen bond formation of its amide oxygen atom with the vicinal oxyanion hole but also provides probability of the hydrophobic interaction between its methyl moiety and the related enzyme's hydrophobic cavity. Several key residues, Arg146, Arg167, Tyr168, Arg179, and Tyr259, orientate the E-2AMS's pose and stabilize its conformation in the active site via the hydrogen bond interaction with E-2AMS. Sequentially, the binding process of E-2AMS to E-2AMS hydrolase was studied by SMD simulation, which shows the surprising conformational reversal of E-2AMS. Several important intermediate structures and some significant residues were identified in the simulation. It is stressed that Arg146 and Arg167 are two pivotal residues responsible for the conformational reversal of E-2AMS in the binding or unbinding. Our research has shed light onto the full binding process of the substrate to E-2AMS hydrolase, which could provide more penetrating insight into the interaction of E-2AMS with the enzyme and would help in the further exploration on the catalysis mechanism.	[Zhang, Ji-Long; Zheng, Qing-Chuan; Zhang, Hong-Xing] Jilin Univ, Inst Theoret Chem, State Key Lab Theoret & Computat Chem, Changchun, Jilin, Peoples R China; [Zhang, Ji-Long; Li, Zheng-Qiang] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University	Zhang, HX (corresponding author), Jilin Univ, Inst Theoret Chem, State Key Lab Theoret & Computat Chem, Changchun, Jilin, Peoples R China.	zhanghx@mail.jlu.edu.cn			Natural Science Foundation of China [21173096, 20903045, 20973076]; Specialized Research Fund for the Doctoral Program of Higher Education [20110061110018]; Specialized Fund for the Basic Research of Jilin University [201003044]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Specialized Fund for the Basic Research of Jilin University(Jilin University)	This work is supported by the Natural Science Foundation of China (Grant Nos. 21173096, 20903045, and 20973076), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20110061110018), and the Specialized Fund for the Basic Research of Jilin University (Grant No. 201003044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; [Anonymous], 2008, DISC STUD 2 5; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Combs G.F., 2008, VITAMINS FUNDAMENTAL; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; den Otter WK, 2000, J CHEM PHYS, V112, P7283, DOI 10.1063/1.481329; Dunn G, 2005, J MOL BIOL, V346, P253, DOI 10.1016/j.jmb.2004.11.033; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frisch G. W., 2013, GAUSSIAN 09; Funami J, 2005, BBA-PROTEINS PROTEOM, V1753, P234, DOI 10.1016/j.bbapap.2005.08.026; Ge F, 2008, J BIOCHEM, V143, P603, DOI 10.1093/jb/mvn010; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; James W., 1990, ANDREWS DIS SKIN, V66, P984; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; McCulloch KM, 2010, BIOCHEMISTRY-US, V49, P1226, DOI 10.1021/bi901812p; McCulloch KM, 2009, BIOCHEMISTRY-US, V48, P4139, DOI 10.1021/bi900149f; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Mukherjee T, 2008, BIOCHEMISTRY-US, V47, P6233, DOI 10.1021/bi8004158; Mukherjee T, 2007, BIOORG CHEM, V35, P458, DOI 10.1016/j.bioorg.2007.07.003; Mukherjee T, 2007, BIOCHEMISTRY-US, V46, P13606, DOI 10.1021/bi701439j; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; Park SY, 2008, J MOL BIOL, V376, P1426, DOI 10.1016/j.jmb.2007.12.062; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607; RODWELL VW, 1958, J BIOL CHEM, V233, P1548; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SNELL E, 1971, COMPREHENSIVE BIOCH, V21; Snell EE, 1944, J BIOL CHEM, V154, P313; Toukmaji AY, 1996, COMPUT PHYS COMMUN, V95, P73, DOI 10.1016/0010-4655(96)00016-1; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yokochi N, 2006, ARCH BIOCHEM BIOPHYS, V452, P1, DOI 10.1016/j.abb.2006.06.002; Yoshikane Y, 2008, J BIOL CHEM, V283, P1120, DOI 10.1074/jbc.M708061200; Yuan B, 2008, J NUTR SCI VITAMINOL, V54, P185, DOI 10.3177/jnsv.54.185; Yuan BQ, 2006, J BIOSCI BIOENG, V102, P504, DOI 10.1263/jbb.102.504; Yuan BQ, 2004, FEMS MICROBIOL LETT, V234, P225, DOI 10.1016/j.femsle.2004.03.031; Zhang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039546; Zhang JL, 2010, CHEM PHYS LETT, V484, P338, DOI 10.1016/j.cplett.2009.12.022; Zhang JL, 2010, J PHYS CHEM B, V114, P7383, DOI 10.1021/jp9113078	45	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53811	10.1371/journal.pone.0053811	http://dx.doi.org/10.1371/journal.pone.0053811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308285	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100117
J	Paulsen, VS; Blencke, HM; Benincasa, M; Haug, T; Eksteen, JJ; Styrvold, OB; Scocchi, M; Stensvag, K				Paulsen, Victoria S.; Blencke, Hans-Matti; Benincasa, Monica; Haug, Tor; Eksteen, Jacobus J.; Styrvold, Olaf B.; Scocchi, Marco; Stensvag, Klara			Structure-Activity Relationships of the Antimicrobial Peptide Arasin 1-And Mode of Action Studies of the N-Terminal, Proline-Rich Region	PLOS ONE			English	Article							CHITIN-BINDING ACTIVITY; ANTIBACTERIAL PEPTIDE; HYAS-ARANEUS; SPIDER CRAB; SECONDARY STRUCTURE; PIG INTESTINE; CECROPIN P1; MEMBRANE; PR-39; SEQUENCE	Arasin 1 is a 37 amino acid long proline-rich antimicrobial peptide isolated from the spider crab, Hyas araneus. In this work the active region of arasin 1 was identified through structure-activity studies using different peptide fragments derived from the arasin 1 sequence. The pharmacophore was found to be located in the proline/arginine-rich NH2 terminus of the peptide and the fragment arasin 1(1-23) was almost equally active to the full length peptide. Arasin 1 and its active fragment arasin 1(1-23) were shown to be non-toxic to human red blood cells and arasin 1(1-23) was able to bind chitin, a component of fungal cell walls and the crustacean shell. The mode of action of the fully active N-terminal arasin 1(1-23) was explored through killing kinetic and membrane permeabilization studies. At the minimal inhibitory concentration (MIC), arasin 1(1-23) was not bactericidal and had no membrane disruptive effect. In contrast, at concentrations of 5xMIC and above it was bactericidal and interfered with membrane integrity. We conclude that arasin 1(1-23) has a different mode of action than lytic peptides, like cecropin P1. Thus, we suggest a dual mode of action for arasin 1(1-23) involving membrane disruption at peptide concentrations above MIC, and an alternative mechanism of action, possibly involving intracellular targets, at MIC.	[Paulsen, Victoria S.; Blencke, Hans-Matti; Haug, Tor; Styrvold, Olaf B.; Stensvag, Klara] Univ Tromso, Norwegian Coll Fishery Sci, Tromso, Norway; [Benincasa, Monica; Scocchi, Marco] Univ Trieste, Dept Life Sci, Trieste, Italy; [Eksteen, Jacobus J.] Univ Tromso, Dept Med Biol, Tromso, Norway	UiT The Arctic University of Tromso; University of Trieste; UiT The Arctic University of Tromso	Stensvag, K (corresponding author), Univ Tromso, Norwegian Coll Fishery Sci, Tromso, Norway.	klara.stensvag@uit.no	Benincasa, Monica/R-6457-2016; Haug, Tor/J-2498-2017; Haug, Tor/I-8163-2019	Benincasa, Monica/0000-0001-6087-4461; Haug, Tor/0000-0003-1104-5813; Haug, Tor/0000-0003-1104-5813; Stensvag, Klara/0000-0002-4717-6711; Eksteen, Jacobus Johannes/0000-0002-5735-3582; Blencke, Hans-Matti/0000-0002-6759-4566	Norwegian Research Council [184688/S40]; University of Tromso; regional FUGE-N (Functional genomics in Norway, the Norwegian Research Council)	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Tromso; regional FUGE-N (Functional genomics in Norway, the Norwegian Research Council)	The present work was supported by the Norwegian Research Council (project number 184688/S40) (http://www.forskningsradet.no/servlet/Satellite?c = Page&cid = 1177315753906&p = 1177315753906&pagename = ForskningsradetEngelsk%2FHovedsidemal), grants from the University of Tromso (http://uit.no/startsida) and the regional FUGE-N (Functional genomics in Norway, the Norwegian Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; Andersson M, 2003, CELL MOL LIFE SCI, V60, P599, DOI 10.1007/s000180300051; Benincasa M, 2004, PEPTIDES, V25, P2055, DOI 10.1016/j.peptides.2004.08.004; BOMAN HG, 1993, INFECT IMMUN, V61, P2978, DOI 10.1128/IAI.61.7.2978-2984.1993; Bormann C, 1999, J BACTERIOL, V181, P7421, DOI 10.1128/JB.181.24.7421-7429.1999; Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023; Bulet P, 1996, EUR J BIOCHEM, V238, P64, DOI 10.1111/j.1432-1033.1996.0064q.x; BULET P, 1993, J BIOL CHEM, V268, P14893; CABIAUX V, 1994, EUR J BIOCHEM, V224, P1019, DOI 10.1111/j.1432-1033.1994.01019.x; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; Chan YR, 2001, J INVEST DERMATOL, V116, P230, DOI 10.1046/j.1523-1747.2001.01231.x; COCIANCICH S, 1994, BIOCHEM J, V300, P567, DOI 10.1042/bj3000567; Cuthbertson BJ, 2004, BIOCHEM J, V381, P79, DOI 10.1042/BJ20040330; Destoumieux D, 2000, J CELL SCI, V113, P461; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Destoumieux D, 1999, EUR J BIOCHEM, V266, P335, DOI 10.1046/j.1432-1327.1999.00855.x; Dutta RC, 2008, INT J BIOCHEM CELL B, V40, P1005, DOI 10.1016/j.biocel.2007.11.005; Galluzzi L, 2007, J BIOTECHNOL, V127, P188, DOI 10.1016/j.jbiotec.2006.06.019; GAZIT E, 1995, BIOCHEMISTRY-US, V34, P11479, DOI 10.1021/bi00036a021; GENNARO R, 1989, INFECT IMMUN, V57, P3142, DOI 10.1128/IAI.57.10.3142-3146.1989; Gennaro R, 1994, P 13 AM PEPT S PEPT; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Kjuul AK, 1999, J FISH DIS, V22, P387, DOI 10.1046/j.1365-2761.1999.00191.x; Kolbe S, 1998, MICROBIOL-SGM, V144, P1291, DOI 10.1099/00221287-144-5-1291; Kragol G, 2002, EUR J BIOCHEM, V269, P4226, DOI 10.1046/j.1432-1033.2002.03119.x; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; LEAH R, 1991, J BIOL CHEM, V266, P1564; Li WF, 2006, PEPTIDES, V27, P2350, DOI 10.1016/j.peptides.2006.03.016; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Osaki T, 1999, J BIOL CHEM, V274, P26172, DOI 10.1074/jbc.274.37.26172; Otvos L, 2000, BIOCHEMISTRY-US, V39, P14150, DOI 10.1021/bi0012843; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Podda E, 2006, BBA-GEN SUBJECTS, V1760, P1732, DOI 10.1016/j.bbagen.2006.09.006; Sadler K, 2002, BIOCHEMISTRY-US, V41, P14150, DOI 10.1021/bi026661l; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Scocchi M, 2009, INT J PEPT RES THER, V15, P147, DOI 10.1007/s10989-009-9182-3; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shi JH, 1996, ANTIMICROB AGENTS CH, V40, P115, DOI 10.1128/AAC.40.1.115; Shi JS, 1996, P NATL ACAD SCI USA, V93, P6014, DOI 10.1073/pnas.93.12.6014; Sperstad SV, 2009, MOL IMMUNOL, V46, P2604, DOI 10.1016/j.molimm.2009.05.002; Sperstad SV, 2009, DEV COMP IMMUNOL, V33, P583, DOI 10.1016/j.dci.2008.10.010; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Stensvag K, 2008, DEV COMP IMMUNOL, V32, P275, DOI 10.1016/j.dci.2007.06.002; Strom MB, 2000, J PEPT RES, V56, P265, DOI 10.1034/j.1399-3011.2000.00770.x; TANI A, 1995, J BIOCHEM-TOKYO, V117, P560, DOI 10.1093/oxfordjournals.jbchem.a124744; Tokunaga Y, 2001, J PEPT SCI, V7, P297, DOI 10.1002/psc.317; VIRTA M, 1995, J ANTIMICROB CHEMOTH, V36, P303, DOI 10.1093/jac/36.2.303; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; WESTERHOFF HV, 1989, P NATL ACAD SCI USA, V86, P6597, DOI 10.1073/pnas.86.17.6597; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0	56	55	58	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53326	10.1371/journal.pone.0053326	http://dx.doi.org/10.1371/journal.pone.0053326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326415	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800041
J	Alcoba, G; Kerac, M; Breysse, S; Salpeteur, C; Galetto-Lacour, A; Briend, A; Gervaix, A				Alcoba, Gabriel; Kerac, Marko; Breysse, Serge; Salpeteur, Cecile; Galetto-Lacour, Annick; Briend, Andre; Gervaix, Alain			Do Children with Uncomplicated Severe Acute Malnutrition Need Antibiotics? A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; URINARY-TRACT-INFECTIONS; MALNOURISHED CHILDREN; OPPORTUNISTIC INFECTIONS; HOSPITALIZED CHILDREN; ZAMBIAN CHILDREN; BACTEREMIA; HIV; MANAGEMENT; COTRIMOXAZOLE	Background: Current (1999) World Health Organization guidelines recommend giving routine antibiotics (AB) for all children with severe acute malnutrition (SAM), even if they have uncomplicated disease with no clinically obvious infections. We examined the evidence behind this recommendation. Methods and Findings: OVID-MEDLINE, EMBASE, COCHRANE, GLOBAL-HEALTH, CINAHL, POPLINE, AFRICA-WIDE-NiPAD, and LILACS were searched for AB efficacy, bacterial resistance, and infection rates in SAM. Following PRISMA guidelines, a systematic review and meta-analysis were performed. Three randomised controlled trials (RCT), five Cochrane reviews, and 37 observational studies were identified. One cohort-study showed no increase in nutritional-cure and mortality in uncomplicated SAM where no AB were used. (p > 0.05). However, an unpublished RCT in this setting did show mortality benefits. Another RCT did not show superiority of ceftriaxone over amoxicilllin for these same outcomes, but adressed SAM children with and without complications (p = 0.27). Another RCT showed no difference between amoxicillin and cotrimoxazole efficacies for pneumonia in underweight, but not SAM. Our meta-analysis of 12 pooled susceptibility-studies for all types of bacterial isolates, including 2767 stricly SAM children, favoured amoxicillin over cotrimoxazole for susceptibility medians: 42% (IQR 27-55%) vs 22% (IQR 17-23%) and population-weighted-means 52.9% (range 23-57%) vs 35.4% (range 6.7-42%). Susceptibilities to second-line AB were better, above 80%. Prevalence of serious infections in SAM, pooled from 24 studies, ranged from 17% to 35.2%. No study infered any association of infection prevalence with AB regimens in SAM. Conclusions: The evidence underlying current antibiotic recommendations for uncomplicated SAM is weak. Susceptibility-studies favour amoxicillin over cotrimoxazole. However, given that these antibiotics have side-effects, costs, and risks as well as benefits, their routine use needs urgent testing. With reliable monitoring, we believe that there is sufficient equipoise for placebo controlled RCTs, the only robust way to demonstrate true efficacy.	[Alcoba, Gabriel; Galetto-Lacour, Annick; Gervaix, Alain] Univ Hosp Geneva, Child & Adolescent Dept, Paediat Emergency Div, Geneva, Switzerland; [Kerac, Marko] UCL, Ctr Int Hlth & Dev, London, England; [Breysse, Serge; Salpeteur, Cecile] Act Contre Faim, Direct Sci & Tech, Paris, France; [Briend, Andre] Univ Tampere, Dept Int Hlth, FIN-33101 Tampere, Finland	University of Geneva; University of London; University College London; Tampere University	Alcoba, G (corresponding author), Univ Hosp Geneva, Child & Adolescent Dept, Paediat Emergency Div, Geneva, Switzerland.	Gabriel.Alcoba@hcuge.ch	Kerac, Marko/GQR-1136-2022; Kerac, Marko/G-1777-2010; ALCOBA, Gabriel/AAQ-6918-2021; Alcoba, Gabriel/AAY-5264-2021	Kerac, Marko/0000-0002-3745-7317; Alcoba, Gabriel/0000-0002-9423-1533; SALPETEUR, Cecile C./0000-0002-8135-6169	Action Contre la Faim; Geneva University Hospital, Child and Adolescent Department; National Institute for Health Research [CL-2012-18-005, ACF-2008-18-010] Funding Source: researchfish	Action Contre la Faim; Geneva University Hospital, Child and Adolescent Department; National Institute for Health Research(National Institute for Health Research (NIHR))	GA started this review as part of his self-funded MSc in Public Health (MPH) in Developing Countries at the London School of Hygiene and Tropical Medicine, and was funded in 2009 by Action Contre la Faim to conduct this review with the co-authors. Since 2010, GA is funded by the Geneva University Hospital, Child and Adolescent Department, where the full review and manuscript have been completed, under the supervision of AG, a paediatric infectious diseases specialist. The other authors did not receive any specific funding for this review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACF International, 2011, GUID INT MAN SEV AC; Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Amadi B, 2001, J PEDIATR GASTR NUTR, V32, P550, DOI 10.1097/00005176-200105000-00011; Archibald LK, 2003, J INFECT DIS, V188, P202, DOI 10.1086/376507; Ashraf H, 2007, J TROP PEDIATRICS, V53, P171, DOI 10.1093/tropej/fmm005; Babirekere-Iriso E, 2006, ANN TROP PAEDIATR, V26, P319, DOI 10.1179/146532806X152845; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Bachou H, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-27; Bagga A, 2003, PEDIATR NEPHROL, V18, P366, DOI 10.1007/s00467-003-1118-0; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Banapurmath C R, 1994, Indian Pediatr, V31, P679; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Berkowitz F E, 1983, Ann Trop Paediatr, V3, P79; BERKOWITZ FE, 1992, PEDIATR INFECT DIS J, V11, P750, DOI 10.1097/00006454-199209000-00015; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Caksen H., 2000, Ceylon Medical Journal, V45, P77; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; CHRISTIE CDC, 1988, J TROP MED HYG, V91, P173; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Dubray C, 2008, ANN TROP PAEDIATR, V28, P13, DOI 10.1179/146532808X270635; Echave P, 2003, J TROP PEDIATRICS, V49, P28, DOI 10.1093/tropej/49.1.28; FRIEDLAND IR, 1992, ANN TROP PAEDIATR, V12, P433, DOI 10.1080/02724936.1992.11747610; Garly ML, 2006, BMJ-BRIT MED J, V333, P1245, DOI 10.1136/bmj.38989.684178.AE; Golden BE, 2000, T ROY SOC TROP MED H, V94, P12, DOI 10.1016/S0035-9203(00)90420-6; Golden MHN, 2002, J NUTR, V132, p2117S, DOI 10.1093/jn/132.7.2117S; GOLDEN MHN, 1993, LANCET, V342, P360, DOI 10.1016/0140-6736(93)91491-4; Grimwade K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003508.pub2; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Iyer SS, 2012, J IMMUNOL, V188, P77, DOI 10.4049/jimmunol.1004027; JEENA PM, 1995, ANN TROP PAEDIATR, V15, P153, DOI 10.1080/02724936.1995.11747764; Johnson AWBR, 2008, J NATL MED ASSOC, V100, P370, DOI 10.1016/S0027-9684(15)31269-4; Kabra SK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004874.pub2; Kabra SK, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001477.pub3; Kahigwa E, 2002, T ROY SOC TROP MED H, V96, P162, DOI 10.1016/S0035-9203(02)90290-7; KALA UK, 1992, ANN TROP PAEDIATR, V12, P75, DOI 10.1080/02724936.1992.11747549; Lazzerini M, 2011, B WORLD HEALTH ORGAN, V89, P593, DOI 10.2471/BLT.10.084715; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mirabeau TY, 2003, EMIRATES MED J, V21, P172; MSF, 2010, CLIN GUID; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Noorani N, 2005, East Afr Med J, V82, P343; Nutrition Division Ministry of Health Malaysia, 2015, GUID REH PROGR MALN; Prudhon C, 2006, FOOD NUTR BULL, V27, pS99, DOI 10.1177/15648265060273S307; Qazi SA, 2002, ARCH DIS CHILD, V86, P113, DOI 10.1136/adc.86.2.113; Rabasa AI, 2002, J TROP PEDIATRICS, V48, P359, DOI 10.1093/tropej/48.6.359; Reed RP, 1996, ANN TROP PAEDIATR, V16, P61, DOI 10.1080/02724936.1996.11747805; Robinson D, 1996, Afr Health, V18, P20; SHIMELES D, 1994, E AFR MED J, V71, P264; Sunguya B F P, 2006, Tanzan Health Res Bull, V8, P189; Thame M, 2001, W INDIAN MED J, V50, P140; Thuo N, 2010, ARCH DIS CHILD, V95, P422, DOI 10.1136/adc.2009.168211; Trehan I, 2010, TROP MED INT HLTH; TUPASI TE, 1990, REV INFECT DIS, V12, pS940; Valid, 2006, COMMUNITY BASED THER; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; WHO-UNIGEF, 2006, WHO UNICEF SCN INF C; Wolff O, 2007, J TROP PEDIATRICS, V53, P150, DOI 10.1093/tropej/fmm030; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Yatsunenko T, 2011, RANDOMIZED DOUBLE BL	63	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53184	10.1371/journal.pone.0053184	http://dx.doi.org/10.1371/journal.pone.0053184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326395	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000313551500053
J	Brandlova, K; Bartos, L; Haberova, T				Brandlova, Karolina; Bartos, Ludek; Haberova, Tamara			Camel Calves as Opportunistic Milk Thefts? The First Description of Allosuckling in Domestic Bactrian Camel (Camelus bactrianus)	PLOS ONE			English	Article							GUANACOS LAMA-GUANICOE; DEER CERVUS-ELAPHUS; RED DEER; BUBALUS-BUBALIS; RIVER BUFFALO; FALLOW DEER; BEHAVIOR; ADOPTION; DROMEDARIUS; GROWTH	Allosuckling is a situation when a female nurses a non-filial offspring. It was described in various ungulate species; however for camels this is the first description of this behaviour. The aim of the study was to assess the occurrence of allosuckling in captive camels (Camelus bactrianus) and to test whether it can be explained as a 'milk-theft' (opportunistic behaviour of calves) or alternatively as an altruistic behaviour of females. During 2005 and 2007, nine camel females and ten calves in four zoological gardens in the Czech Republic were observed. In total, 373 sucking bouts were recorded, from which 32 were non-filial (the calf sucked from the non-maternal female). Allosuckling regularly appeared in captive camel herds. As predicted for the milk-theft explanation, the non-filial calves sucked more often in the lateral position and even did not suck in the antiparallel position at all. The non-filial calves preferably joined the filial calf when sucking but in five cases (15.6% of non-filial sucking bouts) the calves sucked from non-maternal dam without the presence of filial calf. We then expected the differences in terminations of sucking bouts by females but did not find any difference in sucking terminations for filial and non-filial calves. As the calves were getting older, the incidence of allosucking increased. This was probably because skills of the calf to outwit the non-maternal dam increased and/or the older calves might be more motivated for allosucking due to the weaning process. Finally, duration of a sucking bout was shorter with non-filial than filial calves. The results of the study support the hypothesis of 'milk theft', being mostly performed by calves behaving as opportunistic parasites, but we cannot reject certain level of altruism from the allonursing females or their increased degree of tolerance to non-filial calves.	[Brandlova, Karolina; Haberova, Tamara] Czech Univ Life Sci Prague, Inst Trop & Subtrop, Dept Anim Sci & Food Proc Trop & Subtrop, Prague, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Bartos, Ludek] Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Czech University of Life Sciences Prague	Brandlova, K (corresponding author), Czech Univ Life Sci Prague, Inst Trop & Subtrop, Dept Anim Sci & Food Proc Trop & Subtrop, Prague, Czech Republic.	brandlova@its.czu.cz	Brandlova, Karolina/B-7839-2013; Brandlova, Karolina/E-3802-2016	Brandlova, Karolina/0000-0002-2014-7275; Fedorova, Tamara/0000-0003-3209-6572	grants IGA [51120/1312/513103]; Ministry of Agriculture of the Czech Republic [MZe 0002701404]	grants IGA; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The project was a part of the work in the Czech University of Life Sciences Prague, Institute of Tropics and Subtropics, and was supported by grants IGA 51120/1312/513103 and the Ministry of Agriculture of the Czech Republic (MZe 0002701404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Eknah MM, 2000, ANIM REPROD SCI, V60, P583, DOI 10.1016/S0378-4320(00)00134-2; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bartos L, 2001, ANIM SCI, V72, P483, DOI 10.1017/S1357729800052000; Bartos L, 2001, ANIM SCI, V72, P493, DOI 10.1017/S1357729800052012; BIRGERSSON B, 1991, ANIM BEHAV, V42, P326, DOI 10.1016/S0003-3472(05)80567-6; Boness DJ, 1998, J MAMMAL, V79, P1060, DOI 10.2307/1383115; Cameron EZ, 2003, BEHAV ECOL SOCIOBIOL, V53, P92, DOI 10.1007/s00265-002-0556-1; Cassinello J, 1999, Z SAUGETIERKD, V64, P363; da Costa MJRP, 2000, APPL ANIM BEHAV SCI, V66, P1, DOI 10.1016/S0168-1591(99)00083-0; DEGEN AA, 1987, ANIM PROD, V45, P301, DOI 10.1017/S0003356100018870; Dorges B, 1992, 1992 P 1 INT CAM C D, P317; Drabkova J, 2008, APPL ANIM BEHAV SCI, V113, P215, DOI 10.1016/j.applanim.2007.10.009; Ekvall K, 1998, ANIM BEHAV, V56, P695, DOI 10.1006/anbe.1998.0825; ELIAS E, 1986, COMP BIOCHEM PHYS A, V84, P413, DOI 10.1016/0300-9629(86)90339-7; Gentry A, 2004, J ARCHAEOL SCI, V31, P645, DOI 10.1016/j.jas.2003.10.006; Hare J, 2008, CAMELUS FERUS IUCN R; Hayes LD, 2000, ANIM BEHAV, V59, P677, DOI 10.1006/anbe.1999.1390; Landete-Castillejos T, 2000, ANIM BEHAV, V60, P679, DOI 10.1006/anbe.2000.1515; MURPHEY RM, 1991, APPL ANIM BEHAV SCI, V28, P341, DOI 10.1016/0168-1591(91)90166-U; MURPHEY RM, 1995, ANIM BEHAV, V49, P1611, DOI 10.1016/0003-3472(95)90083-7; Olleova M, 2012, J ZOOL, V288, P127, DOI 10.1111/j.1469-7998.2012.00930.x; PACKER C, 1992, ANIM BEHAV, V43, P265, DOI 10.1016/S0003-3472(05)80222-2; Pluhacek J, 2011, MAMM BIOL, V76, P380, DOI 10.1016/j.mambio.2010.06.007; Pluhacek J, 2011, BEHAV PROCESS, V86, P174, DOI 10.1016/j.beproc.2010.11.003; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; REITER J, 1978, BEHAV ECOL SOCIOBIOL, V3, P337, DOI 10.1007/BF00303199; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Roulin A, 2002, ANIM BEHAV, V63, P201, DOI 10.1006/anbe.2001.1895; Sambraus HH, 1995, J ANIM BREED GENET, V112, P469; Schaller GB., 1998, WILDLIFE TIBETAN STE; SPINKA M, 1992, APPL ANIM BEHAV SCI, V33, P165, DOI 10.1016/S0168-1591(05)80005-X; TIBARY A, 2001, RECENT ADV CAMELID R; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Vichova J, 2005, APPL ANIM BEHAV SCI, V94, P223, DOI 10.1016/j.applanim.2005.02.015; WILKINSON GS, 1992, BEHAV ECOL SOCIOBIOL, V31, P225; Zapata B, 2006, ACT 4 C MUND CAM CAT, P45; Zapata B, 2010, APPL ANIM BEHAV SCI, V122, P119, DOI 10.1016/j.applanim.2009.12.004; Zapata B, 2009, J ETHOL, V27, P295, DOI 10.1007/s10164-008-0127-7; Zapata B, 2009, ETHOLOGY, V115, P731, DOI 10.1111/j.1439-0310.2009.01660.x	39	18	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53052	10.1371/journal.pone.0053052	http://dx.doi.org/10.1371/journal.pone.0053052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326378	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500044
J	Pradhan, S; Mallick, SK; Chowdhury, R				Pradhan, Subhra; Mallick, Sanjaya K.; Chowdhury, Rukhsana			Vibrio cholerae Classical Biotype Is Converted to the Viable Non-Culturable State when Cultured with the El Tor Biotype	PLOS ONE			English	Article							CONTACT-DEPENDENT INHIBITION; ESCHERICHIA-COLI; STATIONARY-PHASE; GENE-EXPRESSION; NONCULTURABLE STATE; GROWTH ADVANTAGE; SECRETION SYSTEM; BACTERIA; BANGLADESH; ENVIRONMENT	A unique event in bacterial epidemiology was the emergence of the El Tor biotype of Vibrio cholerae O1 and the subsequent rapid displacement of the existing classical biotype as the predominant cause of epidemic cholera. We demonstrate that when the El Tor and classical biotypes were cocultured in standard laboratory medium a precipitous decline in colony forming units (CFU) of the classical biotype occurred in a contact dependent manner. Several lines of evidence including DNA release, microscopy and flow cytometric analysis indicated that the drastic reduction in CFU of the classical biotype in cocultures was not accompanied by lysis, although when the classical biotype was grown individually in monocultures, lysis of the cells occurred concomitant with decrease in CFU starting from late stationary phase. Furthermore, uptake of a membrane potential sensitive dye and protection of genomic DNA from extracellular DNase strongly suggested that the classical biotype cells in cocultures retained viability in spite of loss of culturability. These results suggest that coculturing the classical biotype with the El Tor biotype protects the former from lysis allowing the cells to remain viable in spite of the loss of culturability. The stationary phase sigma factor RpoS may have a role in the loss of culturability of the classical biotype in cocultures. Although competitive exclusion of closely related strains has been reported for several bacterial species, conversion of the target bacterial population to the viable non-culturable state has not been demonstrated previously and may have important implications in the evolution of bacterial strains.	[Pradhan, Subhra; Chowdhury, Rukhsana] CSIR, Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, India; [Mallick, Sanjaya K.] Univ Calcutta, Ctr Res Nanosci & Nanotechnol, CU BD Ctr Excellence Nanobiotechnol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Calcutta	Chowdhury, R (corresponding author), CSIR, Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, India.	rukhsana@iicb.res.in		Pradhan, Subhra/0000-0002-5751-4016	Indian Council for Medical Research [5/8-1(196)/D/2004-ECD-II]; Council of Scientific and Industrial Research (CSIR), India; CSIR	Indian Council for Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by a research grant [5/8-1(196)/D/2004-ECD-II] from the Indian Council for Medical Research, and a grant from Council of Scientific and Industrial Research (CSIR), India. Subhra Pradhan received a research fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Basu A, 2000, EMERG INFECT DIS, V6, P139, DOI 10.3201/eid0602.000206; Beyhan S, 2006, INFECT IMMUN, V74, P3633, DOI 10.1128/IAI.01750-05; BISWAS SK, 1992, J BACTERIOL, V174, P6221, DOI 10.1128/JB.174.19.6221-6229.1992; Blokesch M, 2008, J BACTERIOL, V190, P7232, DOI 10.1128/JB.00959-08; CHOWDHURY R, 1989, J VIROL, V63, P392, DOI 10.1128/JVI.63.1.392-397.1989; COLWELL RR, 1985, BIO-TECHNOL, V3, P817, DOI 10.1038/nbt0985-817; Colwell RR, 1996, WORLD J MICROB BIOT, V12, P28, DOI 10.1007/BF00327795; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; DiRita VJ, 1996, P NATL ACAD SCI USA, V93, P7991, DOI 10.1073/pnas.93.15.7991; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Faruque SM, 2003, P NATL ACAD SCI USA, V100, P1304, DOI 10.1073/pnas.0337468100; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; FARUQUE SM, 1993, J CLIN MICROBIOL, V31, P2513, DOI 10.1128/JCM.31.9.2513-2516.1993; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Gunasekera TS, 2002, APPL ENVIRON MICROB, V68, P1988, DOI 10.1128/AEM.68.4.1988-1993.2002; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KEASLER SP, 1993, LANCET, V341, P1661, DOI 10.1016/0140-6736(93)90792-F; Kimsey HH, 1998, P NATL ACAD SCI USA, V95, P7035, DOI 10.1073/pnas.95.12.7035; Lemonnier M, 2008, P R SOC B, V275, P3, DOI 10.1098/rspb.2007.1234; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; MCFALL E, 1996, ESCHERICHIA COLI SAL, P358; Murley YM, 2000, INFECT IMMUN, V68, P3010, DOI 10.1128/IAI.68.5.3010-3014.2000; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Oliver James D., 2005, Journal of Water and Health, V3, P249; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; Pawlowski DR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017585, 10.1371/journal.pone.0018169]; Pradhan S, 2010, J BACTERIOL, V192, P955, DOI 10.1128/JB.01180-09; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Ryan ET, 2011, EMERG INFECT DIS, V17, P2175, DOI 10.3201/eid1711.110849; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SAMADI AR, 1983, LANCET, V1, P805; Senoh M, 2010, MICROBIOL IMMUNOL, V54, P502, DOI 10.1111/j.1348-0421.2010.00245.x; SIDDIQUE AK, 1991, LANCET, V337, P1125, DOI 10.1016/0140-6736(91)92789-5; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; TAKEYA K, 1981, J CLIN MICROBIOL, V14, P222, DOI 10.1128/JCM.14.2.222-224.1981; Udden SMN, 2008, P NATL ACAD SCI USA, V105, P11951, DOI 10.1073/pnas.0805560105; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671; Yoon SS, 2006, INFECT IMMUN, V74, P6547, DOI 10.1128/IAI.00695-06; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	46	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53504	10.1371/journal.pone.0053504	http://dx.doi.org/10.1371/journal.pone.0053504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326443	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500078
J	Attoub, S; Arafat, K; Gelaude, A; Al Sultan, MA; Bracke, M; Collin, P; Takahashi, T; Adrian, TE; De Wever, O				Attoub, Samir; Arafat, Kholoud; Gelaude, An; Al Sultan, Mahmood Ahmed; Bracke, Marc; Collin, Peter; Takahashi, Takashi; Adrian, Thomas E.; De Wever, Olivier			Frondoside A Suppressive Effects on Lung Cancer Survival, Tumor Growth, Angiogenesis, Invasion, and Metastasis	PLOS ONE			English	Article							CUCUMARIA-FRONDOSA; SEA-CUCUMBER; TRITERPENE GLYCOSIDE; PANCREATIC-CANCER; NATURAL-PRODUCTS; DRUG DEVELOPMENT; EXTRACT	A major challenge for oncologists and pharmacologists is to develop less toxic drugs that will improve the survival of lung cancer patients. Frondoside A is a triterpenoid glycoside isolated from the sea cucumber, Cucumaria frondosa and was shown to be a highly safe compound. We investigated the impact of Frondoside A on survival, migration and invasion in vitro, and on tumor growth, metastasis and angiogenesis in vivo alone and in combination with cisplatin. Frondoside A caused concentration-dependent reduction in viability of LNM35, A549, NCI-H460-Luc2, MDA-MB-435, MCF-7, and HepG2 over 24 hours through a caspase 3/7-dependent cell death pathway. The IC50 concentrations (producing half-maximal inhibition) at 24 h were between 1.7 and 2.5 mu M of Frondoside A. In addition, Frondoside A induced a time- and concentration-dependent inhibition of cell migration, invasion and angiogenesis in vitro. Frondoside A (0.01 and 1 mg/kg/day i.p. for 25 days) significantly decreased the growth, the angiogenesis and lymph node metastasis of LNM35 tumor xenografts in athymic mice, without obvious toxic side-effects. Frondoside A (0.1-0.5 mu M) also significantly prevented basal and bFGF induced angiogenesis in the CAM angiogenesis assay. Moreover, Frondoside A enhanced the inhibition of lung tumor growth induced by the chemotherapeutic agent cisplatin. These findings identify Frondoside A as a promising novel therapeutic agent for lung cancer.	[Attoub, Samir; Arafat, Kholoud; Al Sultan, Mahmood Ahmed] UAE Univ, Fac Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates; [Gelaude, An; Bracke, Marc; De Wever, Olivier] Univ Hosp, Lab Expt Canc Res, Ghent, Belgium; [Collin, Peter] Coastside Bio Resources, Stonington, ME USA; [Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Ctr Neurol Dis & Canc, Nagoya, Aichi 4648601, Japan; [Adrian, Thomas E.] UAE Univ, Fac Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates	United Arab Emirates University; Ghent University; Ghent University Hospital; Nagoya University; United Arab Emirates University	Attoub, S (corresponding author), UAE Univ, Fac Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates.	samir.attoub@uaeu.ac.ae	Takahashi, Takashi/I-7262-2014; Attoub, Samir/N-6852-2018; Collin, Peter D/AAG-6923-2020; de wever, olivier/J-3094-2013	Takahashi, Takashi/0000-0003-0615-7001; Collin, Peter D/0000-0003-1636-8806; de wever, olivier/0000-0002-5453-760X; Adrian, Thomas/0000-0002-5051-1111	FMHS [NP/08/27]; UAE University grant [01-04-8-11/09]; Terry Fox Fund for Cancer Research; UAEU-NRF [21MO72]; Maine Technology Institute, Gardiner, Maine, USA; National Cancer Institute, RAPID Program	FMHS; UAE University grant; Terry Fox Fund for Cancer Research; UAEU-NRF; Maine Technology Institute, Gardiner, Maine, USA; National Cancer Institute, RAPID Program	This work was financially supported by the FMHS grant number NP/08/27 (SA), the UAE University grant under a contract no. 01-04-8-11/09 (SA), the Terry Fox Fund for Cancer Research (SA and TA), the UAEU-NRF 09/10 grant number 21MO72 (SA), and the Maine Technology Institute, Gardiner, Maine, USA, and the National Cancer Institute, RAPID Program (PC). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Marzouqi N, 2011, EUR J PHARMACOL, V668, P25, DOI 10.1016/j.ejphar.2011.06.023; Aminin DL, 2008, J MED FOOD, V11, P443, DOI 10.1089/jmf.2007.0530; Aminin DL, 2009, J PROTEOMICS, V72, P886, DOI 10.1016/j.jprot.2009.04.004; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Derycke L, 2006, CLIN EXP METASTAS, V23, P187, DOI 10.1007/s10585-006-9029-7; GIRARD M, 1990, CAN J CHEM, V68, P11, DOI 10.1139/v90-003; Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144; HARRISHOOKER SA, 1983, J CELL PHYSIOL, V114, P302, DOI 10.1002/jcp.1041140308; Janakiram NB, 2010, CANCER PREV RES, V3, P82, DOI 10.1158/1940-6207.CAPR-09-0112; Jin JO, 2009, FEBS LETT, V583, P697, DOI 10.1016/j.febslet.2009.01.010; Korpanty Grzegorz, 2011, J Thorac Dis, V3, P19, DOI 10.3978/j.issn.2072-1439.2010.11.11; Kozaki K, 2000, CANCER RES, V60, P2535; Kuno T., 2012, Journal of Biophysical Chemistry, V3, P156, DOI 10.4236/jbpc.2012.32018; Li X, 2008, ANN NY ACAD SCI, V1138, P181, DOI 10.1196/annals.1414.025; Ma X, BREAST CANC RES TREA; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Roginsky AB, 2010, PANCREAS, V39, P646, DOI 10.1097/MPA.0b013e3181c72baf; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536	19	44	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53087	10.1371/journal.pone.0053087	http://dx.doi.org/10.1371/journal.pone.0053087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308143	Green Published, gold			2022-12-27	WOS:000313429800029
J	Hornus, S; Levy, B; Lariviere, D; Fourmentin, E				Hornus, Samuel; Levy, Bruno; Lariviere, Damien; Fourmentin, Eric			Easy DNA Modeling and More with GraphiteLifeExplorer	PLOS ONE			English	Article							MUTL; CELLS	The GraphiteLifeExplorer tool enables biologists to reconstruct 3D cellular complexes built from proteins and DNA molecules. Models of DNA molecules can be drawn in an intuitive way and assembled to proteins or others globular structures. Real time navigation and immersion offer a unique view to the reconstructed biological machinery.	[Hornus, Samuel; Levy, Bruno] Inria Nancy Grand Est, Equipe ALICE, Villers Les Nancy, France; [Lariviere, Damien; Fourmentin, Eric] Fourmentin Guilbert Sci Fdn, Noisy Le Grand, France		Hornus, S (corresponding author), Inria Nancy Grand Est, Equipe ALICE, Villers Les Nancy, France.	samuel.hornus@inria.fr; damien.lariviere@fourmentinguilbert.org		Lariviere, Damien/0000-0002-0892-5118; Levy, Bruno/0000-0002-7007-3219	European Research Council [GOOD- SHAPE FP7-ERC-StG-205693]; Fourmentin-Guilbert Scientific Foundation	European Research Council(European Research Council (ERC)European Commission); Fourmentin-Guilbert Scientific Foundation	This work was partially funded by the European Research Council (GOOD- SHAPE FP7-ERC-StG-205693)(http://erc.europa.eu/starting-grants/). This work was partially funded by the Fourmentin-Guilbert Scientific Foundation which had a role in software design, software test, decision to publish, and preparation of the manuscript (http://www.fourmentinguilbert.org/?set_language = en).	Ahrends R, 2006, NUCLEIC ACIDS RES, V34, P3169, DOI 10.1093/nar/gkl407; Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Boissonnat JD, 2005, GRAPH MODELS, V67, P405, DOI 10.1016/j.gmod.2005.01.004; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Foley J.D., 1995, COMPUTER GRAPHICS PR; Goodsell D. S., 2009, MACHINERY LIFE; Goodsell DS, 2009, BIOCHEM MOL BIOL EDU, V37, P325, DOI 10.1002/bmb.20345; Goodsell DS, 2007, PLOS BIOL, V5, P2759, DOI 10.1371/journal.pbio.0050308; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Harold FM, 2005, MICROBIOL MOL BIOL R, V69, P544, DOI 10.1128/MMBR.69.4.544-564.2005; Harold FM, 2007, CURR OPIN MICROBIOL, V10, P591, DOI 10.1016/j.mib.2007.07.003; Johnson GT, 2011, STRUCTURE, V19, P293, DOI 10.1016/j.str.2010.12.023; Junier I, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000678; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kreyszig E., 1991, DIFFERENTIAL GEOMETR; Loriot S, 2010, BIOINFORMATICS, V26, P1127, DOI 10.1093/bioinformatics/btq083; Lu X-J, 2009, NATURE PROTOCOLS, V3, P1213; Macke TJ, 1998, ACS SYM SER, V682, P379; McGill G, 2008, CELL, V133, P1127, DOI 10.1016/j.cell.2008.06.013; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schofield MJ, 2001, J BIOL CHEM, V276, P28291, DOI 10.1074/jbc.M103148200; Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014; Tarini M, 2006, IEEE T VIS COMPUT GR, V12, P1237, DOI 10.1109/TVCG.2006.115; Thiel A, 2012, PLOS GENET, V8, P564, DOI 10.1371/journal.pgen.1002672; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Vendeville A, 2011, FEMS MICROBIOL REV, V35, P395, DOI 10.1111/j.1574-6976.2010.00254.x; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Wang WP, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1330511.1330513; Winkler I, 2011, J BIOL CHEM, V286, P17326, DOI 10.1074/jbc.M110.187641; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358	32	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53609	10.1371/journal.pone.0053609	http://dx.doi.org/10.1371/journal.pone.0053609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308263	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100096
J	Huang, YJ; Yin, XR; Zhu, CQ; Wang, WW; Grierson, D; Xu, CJ; Chen, KS				Huang, Yuji; Yin, Xueren; Zhu, Changqing; Wang, Weiwei; Grierson, Donald; Xu, Changjie; Chen, Kunsong			Standard Addition Quantitative Real-Time PCR (SAQPCR): A Novel Approach for Determination of Transgene Copy Number Avoiding PCR Efficiency Estimation	PLOS ONE			English	Article							GENE; PLANTS; ASSAY; EXPRESSION; ETHYLENE; RICE; DNA	Quantitative real-time polymerase chain reaction (qPCR) has been previously applied to estimate transgene copy number in transgenic plants. However, the results can be erroneous owing to inaccurate estimation of PCR efficiency. Here, a novel qPCR approach, named standard addition qPCR (SAQPCR), was devised to accurately determine transgene copy number without the necessity of obtaining PCR efficiency data. The procedures and the mathematical basis for the approach are described. A recombinant plasmid harboring both the internal reference gene and the integrated target gene was constructed to serve as the standard DNA. It was found that addition of suitable amounts of standard DNA to test samples did not affect PCR efficiency, and the guidance for selection of suitable cycle numbers for analysis was established. Samples from six individual T-0 tomato (Solanum lycopersicum) plants were analyzed by SAQPCR, and the results confirmed by Southern blot analysis. The approach produced accurate results and required only small amounts of plant tissue. It can be generally applied to analysis of different plants and transgenes. In addition, it can also be applied to zygosity analysis.	[Huang, Yuji; Yin, Xueren; Zhu, Changqing; Wang, Weiwei; Grierson, Donald; Xu, Changjie; Chen, Kunsong] Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist Lab Hort Plant Growth Dev & Qual, Hangzhou 310058, Zhejiang, Peoples R China; [Grierson, Donald] Univ Nottingham, Sch Biosci, Plant & Crop Sci Div, Loughborough, Leics, England	Zhejiang University; University of Nottingham	Xu, CJ (corresponding author), Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist Lab Hort Plant Growth Dev & Qual, Hangzhou 310058, Zhejiang, Peoples R China.	chjxu@zju.edu.cn	Yin, Xue-ren/B-3893-2008; Xu, Changjie/D-2656-2009	Yin, Xue-ren/0000-0002-1282-4432; 	National Basic Research Program of China (973 Program) [2011CB100600]; Program of International Science and Technology Cooperation [2011DFB31580]; National Natural Science Foundation of China [31030052]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Program of International Science and Technology Cooperation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) [2011CB100600]; the Program of International Science and Technology Cooperation [2011DFB31580] and the National Natural Science Foundation of China [31030052]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng106; Bar T, 2012, NUCLEIC ACIDS RES, V40, P1395, DOI 10.1093/nar/gkr778; Beltran J, 2009, IN VITRO CELL DEV-PL, V45, P48, DOI 10.1007/s11627-008-9159-5; Bruno AK, 2004, J EXP BOT, V55, P2541, DOI 10.1093/jxb/erh273; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; Bubner B, 2004, PLANT CELL REP, V23, P263, DOI 10.1007/s00299-004-0859-y; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Canel C, 1996, PLANT MOL BIOL, V31, P143, DOI 10.1007/BF00020613; Casu RE, 2012, PLANT CELL REP, V31, P167, DOI 10.1007/s00299-011-1150-7; Chen Kun-Song, 2004, Yichuan, V26, P529; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; HAMILTON AJ, 1991, P NATL ACAD SCI USA, V88, P7434, DOI 10.1073/pnas.88.16.7434; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Harris D. C., 2006, QUANTITATIVE CHEM AN; Ingham DJ, 2001, BIOTECHNIQUES, V31, P132, DOI 10.2144/01311rr04; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Li ZW, 2004, PLANT MOL BIOL REP, V22, P179, DOI 10.1007/BF02772725; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Mason Giovanna, 2002, BMC Biotechnol, V2, P20, DOI 10.1186/1472-6750-2-20; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Omar AA, 2008, BIOTECHNOL PROGR, V24, P1241, DOI 10.1002/btpr.62; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sambrook J., 2001, MOL CLONING LAB MANU; Sha Y, 2004, THEOR APPL GENET, V108, P306, DOI 10.1007/s00122-003-1423-9; Song P, 2002, PLANT CELL REP, V20, P948, DOI 10.1007/s00299-001-0432-x; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Wang Wei-Wei, 2011, Yichuan, V33, P1017, DOI 10.3724/SP.J.1005.2011.01017; Yang L, 2007, BIOL PLANTARUM, V51, P541, DOI 10.1007/s10535-007-0117-6; Yang LT, 2005, PLANT CELL REP, V23, P759, DOI 10.1007/s00299-004-0881-0; Yi CX, 2008, ANAL BIOCHEM, V375, P150, DOI 10.1016/j.ab.2007.11.022	30	10	11	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53489	10.1371/journal.pone.0053489	http://dx.doi.org/10.1371/journal.pone.0053489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308234	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100074
J	Islam, MA; Lutken, H; Haugslien, S; Blystad, DR; Torre, S; Rolcik, J; Rasmussen, SK; Olsen, JE; Clarke, JL				Islam, M. Ashraful; Lutken, Henrik; Haugslien, Sissel; Blystad, Dag-Ragnar; Torre, Sissel; Rolcik, Jakub; Rasmussen, Soren K.; Olsen, Jorunn E.; Clarke, Jihong Liu			Overexpression of the AtSHI Gene in Poinsettia, Euphorbia pulcherrima, Results in Compact Plants	PLOS ONE			English	Article							ARABIDOPSIS GYNOECIUM DEVELOPMENT; SHI FAMILY GENES; AUXIN BIOSYNTHESIS; GIBBERELLIN METABOLISM; TRANSCRIPTIONAL REGULATION; STEM ELONGATION; FLOWERING TIME; EXPRESSION; THALIANA; GROWTH	Euphorbia pulcherrima, poinsettia, is a non-food and non-feed vegetatively propagated ornamental plant. Appropriate plant height is one of the most important traits in poinsettia production and is commonly achieved by application of chemical growth retardants. To produce compact poinsettia plants with desirable height and reduce the utilization of growth retardants, the Arabidopsis SHORT INTERNODE (AtSHI) gene controlled by the cauliflower mosaic virus 35S promoter was introduced into poinsettia by Agrobacterium-mediated transformation. Three independent transgenic lines were produced and stable integration of transgene was verified by PCR and Southern blot analysis. Reduced plant height (21-52%) and internode lengths (31-49%) were obtained in the transgenic lines compared to control plants. This correlates positively with the AtSHI transcript levels, with the highest levels in the most dwarfed transgenic line (TL1). The indole-3-acetic acid (IAA) content appeared lower (11-31% reduction) in the transgenic lines compared to the wild type (WT) controls, with the lowest level (31% reduction) in TL1. Total internode numbers, bract numbers and bract area were significantly reduced in all transgenic lines in comparison with the WT controls. Only TL1 showed significantly lower plant diameter, total leaf area and total dry weight, whereas none of the AtSHI expressing lines showed altered timing of flower initiation, cyathia abscission or bract necrosis. This study demonstrated that introduction of the AtSHI gene into poinsettia by genetic engineering can be an effective approach in controlling plant height without negatively affecting flowering time. This can help to reduce or avoid the use of toxic growth retardants of environmental and human health concern. This is the first report that AtSHI gene was overexpressed in poinsettia and transgenic poinsettia plants with compact growth were produced.	[Islam, M. Ashraful; Haugslien, Sissel; Blystad, Dag-Ragnar; Clarke, Jihong Liu] Bioforsk Norwegian Inst Agr & Environm Res, As, Norway; [Lutken, Henrik; Rasmussen, Soren K.] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Torre, Sissel; Olsen, Jorunn E.] Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway; [Rolcik, Jakub] Palacky Univ, CR-77147 Olomouc, Czech Republic	Bioforsk; University of Copenhagen; Norwegian University of Life Sciences; Palacky University Olomouc	Clarke, JL (corresponding author), Bioforsk Norwegian Inst Agr & Environm Res, As, Norway.	jihong.liu-clarke@bioforsk.no	Lütken, Henrik/F-9449-2014; Clarke, Jihong Liu/J-1278-2014; Rasmussen, Soren K./F-6728-2014	Lütken, Henrik/0000-0003-3719-8324; Rasmussen, Soren K./0000-0001-6169-2504; Blystad, Dag-Ragnar/0000-0001-5490-3334	Danish grant "Joint Proof-of-Concept Fund"; Research Council of Norway [KMB 199398/I10]	Danish grant "Joint Proof-of-Concept Fund"; Research Council of Norway(Research Council of Norway)	This research was supported by the Danish grant "Joint Proof-of-Concept Fund" to Professor Soren K Rasmussen and the Research Council of Norway grant KMB 199398/I10 to Dr Jihong Liu Clarke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascough GD, 2008, S AFR J BOT, V74, P357, DOI 10.1016/j.sajb.2008.01.012; Chandler S, 2007, CRIT REV PLANT SCI, V26, P169, DOI 10.1080/07352680701429381; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Clarke JL, 2008, PLANT CELL REP, V27, P1027, DOI 10.1007/s00299-008-0526-9; Clifford SC, 2004, HORTSCIENCE, V39, P383, DOI 10.21273/HORTSCI.39.2.383; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; Curtis IS, 2005, PLANTA, V222, P957, DOI 10.1007/s00425-005-0037-7; de Castro VL, 2004, INT J ENVIRON HEAL R, V14, P371, DOI 10.1080/09603120400004055; Dijkstra C, 2008, PLANT CELL REP, V27, P463, DOI 10.1007/s00299-007-0471-z; Ecke IP, 2004, ECKE POINSETTIA MANU, P1; Ecke P, 1990, POINSETTIA MANUAL, P1; Eklund DM, 2010, PLANT CELL, V22, P349, DOI 10.1105/tpc.108.064816; Eklund DM, 2010, DEVELOPMENT, V137, P1275, DOI 10.1242/dev.039594; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Fridborg I, 1999, PLANT CELL, V11, P1019, DOI 10.1105/tpc.11.6.1019; Fridborg I, 2001, PLANT PHYSIOL, V127, P937, DOI 10.1104/pp.010388; Fujita T, 2008, EVOL DEV, V10, P176, DOI 10.1111/j.1525-142X.2008.00225.x; Hong JK, 2010, GENES GENOM, V32, P309, DOI 10.1007/s13258-010-0011-z; Islam MA, 2012, SCI HORTIC-AMSTERDAM, V147, P136, DOI 10.1016/j.scienta.2012.08.034; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Kim SG, 2010, PLANT MOL BIOL, V74, P337, DOI 10.1007/s11103-010-9677-5; KOORNNEEF M, 1985, PHYSIOL PLANTARUM, V65, P33, DOI 10.1111/j.1399-3054.1985.tb02355.x; Kuusk S, 2002, DEVELOPMENT, V129, P4707; Kuusk S, 2006, PLANT J, V47, P99, DOI 10.1111/j.1365-313X.2006.02774.x; Lee M, 1997, NAT BIOTECHNOL, V15, P178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutken H, 2012, PLANT CELL REP, V31, P1141, DOI 10.1007/s00299-012-1265-5; Lutken H, 2010, PLANT BIOTECHNOL J, V8, P211, DOI 10.1111/j.1467-7652.2009.00478.x; Mata DA, 2009, HORTSCIENCE, V44, P702, DOI 10.21273/HORTSCI.44.3.702; MOE R, 1992, SCI HORTIC-AMSTERDAM, V50, P127, DOI 10.1016/S0304-4238(05)80015-9; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Muller R, 2011, THESIS U COPENHAGEN; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; O'Neill DP, 2002, PLANT PHYSIOL, V130, P1974, DOI 10.1104/pp.010587; Pencik A, 2009, TALANTA, V80, P651, DOI 10.1016/j.talanta.2009.07.043; Petty LM, 2001, ACTA HORTIC, P87, DOI 10.17660/ActaHortic.2001.560.9; Potera C, 2007, NAT BIOTECHNOL, V25, P963, DOI 10.1038/nbt0907-963; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Ross JJ, 1998, J PLANT GROWTH REGUL, V17, P141, DOI 10.1007/PL00007027; Ross JJ, 2000, PLANT J, V21, P547, DOI 10.1046/j.1365-313x.2000.00702.x; Sakamoto T, 2003, NAT BIOTECHNOL, V21, P909, DOI 10.1038/nbt847; Sambrook J., 2002, MOL CLONING LAB MANU; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Sorensen MT, 2006, INT J ANDROL, V29, P129, DOI 10.1111/j.1365-2605.2005.00629.x; Staldal V, 2008, NEW PHYTOL, V180, P798, DOI 10.1111/j.1469-8137.2008.02625.x; Staldal V, 2012, PLANT MOL BIOL, V78, P545, DOI 10.1007/s11103-012-9888-z; Stavang JA, 2005, PLANT PHYSIOL, V138, P2344, DOI 10.1104/pp.105.063149; Stavang JA, 2009, PLANT J, V60, P589, DOI 10.1111/j.1365-313X.2009.03983.x; Taiz L., 2010, PLANT PHYSIOL, P545; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Wolbang CM, 2004, PLANT PHYSIOL, V134, P769, DOI 10.1104/pp.103.030460; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zawaski C, 2011, NEW PHYTOL, V191, P678, DOI 10.1111/j.1469-8137.2011.03742.x; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zhu LH, 2008, PLANT CELL REP, V27, P289, DOI 10.1007/s00299-007-0462-0	61	15	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53377	10.1371/journal.pone.0053377	http://dx.doi.org/10.1371/journal.pone.0053377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308204	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100059
J	Okoshi, R; Shu, CL; Ihara, S; Fukui, Y				Okoshi, Rintaro; Shu, Chung-Li; Ihara, Sayoko; Fukui, Yasuhisa			Scattering of MCF7 Cells by Heregulin beta-1 Depends on the MEK and p38 MAP Kinase Pathway	PLOS ONE			English	Article							TIGHT JUNCTIONS; BREAST-CANCER; E-CADHERIN; ADHERENS JUNCTIONS; SIGNALING PATHWAY; EPITHELIAL-CELLS; GROWTH-FACTOR; ADHESION; RAC; MOLECULES	Heregulin (HRG) beta 1 signaling promotes scattering of MCF7 cells by inducing breakdown of adherens and tight junctions. Here, we show that stimulation with HRG-beta 1 causes the F-actin backbone of junctions to destabilize prior to the loss of adherent proteins and scattering of the cells. The adherent proteins dissociate and translocate from cell-cell junctions to the cytosol. Moreover, using inhibitors we show that the MEK1 pathway is required for the disappearance of F-actin from junctions and p38 MAP kinase activity is essential for scattering of the cells. Upon treatment with a p38 MAP kinase inhibitor, adherens junction complexes immediately reassemble, most likely in the cytoplasm, and move to the plasma membrane in cells dissociated by HRG-beta 1 stimulation. Subsequently, tight junction complexes form, most likely in the cytoplasm, and move to the plasma membrane. Thus, the p38 MAP kinase inhibitor causes a re-aggregation of scattered cells, even in the presence of HRG-beta 1. These results suggest that p38 MAP kinase signaling to adherens junction proteins regulates cell aggregation, providing a novel understanding of the regulation of cell-cell adhesion.	[Okoshi, Rintaro; Shu, Chung-Li; Fukui, Yasuhisa] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ihara, Sayoko] Univ Tokyo, Grad Sch Agr & Life Sci, Div Appl Biol Chem, Tokyo, Japan; [Fukui, Yasuhisa] Hoshi Univ, Lab Signal Transduct, Tokyo 142, Japan	National Health Research Institutes - Taiwan; University of Tokyo; Hoshi University	Fukui, Y (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	990412@nhri.org.tw	Fukui, Yasuhisa/E-8806-2010		Japan's Ministry of Education, Culture, Sports, Science and Technology [20013044]; National Institute of Biomedical Innovation, Japan; National Health Research Institutes, Taiwan	Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants-in-aid from Japan's Ministry of Education, Culture, Sports, Science and Technology, #20013044; a grant from the National Institute of Biomedical Innovation, Japan; and a grant from the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Comoglio PM, 1996, GENES CELLS, V1, P347, DOI 10.1046/j.1365-2443.1996.37037.x; Edme N, 2002, J CELL SCI, V115, P2591; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hutcheson IR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1754; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Khwaja A, 1998, J BIOL CHEM, V273, P18793, DOI 10.1074/jbc.273.30.18793; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Lynch EA, 2006, MOL BIOL CELL, V17, P2236, DOI 10.1091/mbc.E05-08-0779; McNeil C, 1998, J NATL CANCER I, V90, P882, DOI 10.1093/jnci/90.12.882; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Paumelle R, 2000, MOL BIOL CELL, V11, P3751, DOI 10.1091/mbc.11.11.3751; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Soldati C, 2008, J NEUROSCI RES, V86, P1044, DOI 10.1002/jnr.21557; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Vadlamudi R, 1999, ONCOGENE, V18, P7253, DOI 10.1038/sj.onc.1203163; Xu QY, 2003, ONCOGENE, V22, P5537, DOI 10.1038/sj.onc.1206796; Yonezawa M, 2009, DIGESTION, V80, P215, DOI 10.1159/000229775	36	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53298	10.1371/journal.pone.0053298	http://dx.doi.org/10.1371/journal.pone.0053298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308187	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100051
J	Sapsutthipas, S; Tsuchiya, N; Pathipavanich, P; Ariyoshi, K; Sawanpanyalert, P; Takeda, N; Isarangkura-na-ayuthaya, P; Kameoka, M				Sapsutthipas, Sompong; Tsuchiya, Naho; Pathipavanich, Panita; Ariyoshi, Koya; Sawanpanyalert, Pathom; Takeda, Naokazu; Isarangkura-na-ayuthaya, Panasda; Kameoka, Masanori			CRF01_AE-Specific Neutralizing Activity Observed in Plasma Derived from HIV-1-Infected Thai Patients Residing in Northern Thailand: Comparison of Neutralizing Breadth and Potency between Plasma Derived from Rapid and Slow Progressors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; FUSION INHIBITOR; ENV CLONES; INFECTION; HIV-1; GP41; DIVERSITY; RESPONSES; SELECTION	Background: Development of a protective vaccine against human immunodeficiency virus type 1 (HIV-1) is an important subject in the field of medical sciences; however, it has not yet been achieved. Potent and broadly neutralizing antibodies are found in the plasma of some HIV-1-infected patients, whereas such antibody responses have failed to be induced by currently used vaccine antigens. In order to develop effective vaccine antigens, it is important to reveal the molecular mechanism of how strong humoral immune responses are induced in infected patients. As part of such studies, we examined the correlation between the anti-HIV-1 neutralizing antibody response and disease progression. Methodology/Principal Findings: We evaluated the anti-HIV-1 neutralizing activity of plasma derived from 33 rapid and 34 slow progressors residing in northern Thailand. The level of neutralizing activity varied considerably among plasmas, and no statistically significant differences in the potency and breadth of neutralizing activities were observed overall between plasma derived from rapid and slow progressors; however, plasma of 4 slow progressors showed neutralizing activity against all target viruses, whereas none of the plasma of rapid progressors showed such neutralizing activity. In addition, 21% and 9% of plasmas derived from slow and rapid progressors inhibited the replication of more than 80% of CRF01_AE Env-recombinant viruses tested, respectively. Neutralization of subtype B and C Env-recombinant viruses by the selected plasma was also examined; however, these plasma samples inhibited the replication of only a few viruses tested. Conclusions/Significance: Although no statistically significant differences were observed in the potency and breadth of anti-HIV-1 neutralizing activities between plasma derived from rapid and slow progressors, several plasma samples derived from slow progressors neutralized CRF01_AE Env-recombinant viruses more frequently than those from rapid progressors. In addition, plasma derived from HIV-1-infected Thai patients showed CRF01_AE-specific neutralizing activity.	[Sapsutthipas, Sompong; Takeda, Naokazu; Kameoka, Masanori] Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand; [Tsuchiya, Naho; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Pathipavanich, Panita] Lampang Hosp, Lampang, Thailand; [Sawanpanyalert, Pathom; Isarangkura-na-ayuthaya, Panasda] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Nonthaburi, Thailand; [Takeda, Naokazu; Kameoka, Masanori] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Kameoka, Masanori] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo, Japan	Nagasaki University; Ministry of Public Health - Thailand; Osaka University; Kobe University	Kameoka, M (corresponding author), Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand.	mkameoka@port.kobe-u.ac.jp		Kameoka, Masanori/0000-0001-5525-9915	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Department of Medical Sciences, Ministry of Public Health of Thailand	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Department of Medical Sciences, Ministry of Public Health of Thailand	This work was supported by the program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the research budget of the Department of Medical Sciences, Ministry of Public Health of Thailand. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo MA, 2010, AIDS RES HUM RETROV, V26, P5, DOI 10.1089/aid.2009.0150; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Bjorndal A, 1997, J VIROL, V71, P7478; Boonchawalit S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027098; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Euler Z, 2012, J VIROL, V86, P2045, DOI 10.1128/JVI.06091-11; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Girard MP, 2011, VACCINE, V29, P6191, DOI [10.1016/j.vaccine.2011.08.031, 10.1016/j.vaccine.2011.06.085]; Gnanakaran S, 2007, J VIROL, V81, P4886, DOI 10.1128/JVI.01954-06; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kinomoto M, 2005, J VIROL, V79, P5996, DOI 10.1128/JVI.79.10.5996-6004.2005; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Utachee P, 2009, MICROBES INFECT, V11, P334, DOI 10.1016/j.micinf.2008.12.008; Utachee P, 2009, AIDS RES HUM RETROV, V25, P229, DOI 10.1089/aid.2008.0232; Vaine M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013916; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53920	10.1371/journal.pone.0053920	http://dx.doi.org/10.1371/journal.pone.0053920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308290	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429100122
J	Si, YL; de Boer, WF; Gong, P				Si, Yali; de Boer, Willem F.; Gong, Peng			Different Environmental Drivers of Highly Pathogenic Avian Influenza H5N1 Outbreaks in Poultry and Wild Birds	PLOS ONE			English	Article							SPREAD; VIRUS; PERSISTENCE; EUROPE	A large number of highly pathogenic avian influenza (HPAI) H5N1 outbreaks in poultry and wild birds have been reported in Europe since 2005. Distinct spatial patterns in poultry and wild birds suggest that different environmental drivers and potentially different spread mechanisms are operating. However, previous studies found no difference between these two outbreak types when only the effect of physical environmental factors was analysed. The influence of physical and anthropogenic environmental variables and interactions between the two has only been investigated for wild bird outbreaks. We therefore tested the effect of these environmental factors on HPAI H5N1 outbreaks in poultry, and the potential spread mechanism, and discussed how these differ from those observed in wild birds. Logistic regression analyses were used to quantify the relationship between HPAI H5N1 outbreaks in poultry and environmental factors. Poultry outbreaks increased with an increasing human population density combined with close proximity to lakes or wetlands, increased temperatures and reduced precipitation during the cold season. A risk map was generated based on the identified key factors. In wild birds, outbreaks were strongly associated with an increased Normalized Difference Vegetation Index (NDVI) and lower elevation, though they were similarly affected by climatic conditions as poultry outbreaks. This is the first study that analyses the differences in environmental drivers and spread mechanisms between poultry and wild bird outbreaks. Outbreaks in poultry mostly occurred in areas where the location of farms or trade areas overlapped with habitats for wild birds, whereas outbreaks in wild birds were mainly found in areas where food and shelters are available. The different environmental drivers suggest that different spread mechanisms might be involved: HPAI H5N1 spread to poultry via both poultry and wild birds, whereas contact with wild birds alone seems to drive the outbreaks in wild birds.	[Si, Yali; Gong, Peng] Tsinghua Univ, Key Lab Earth Syst Modeling, Minist Educ, Beijing 100084, Peoples R China; [Si, Yali; Gong, Peng] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [de Boer, Willem F.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands	Tsinghua University; Tsinghua University; Wageningen University & Research	Si, YL (corresponding author), Tsinghua Univ, Key Lab Earth Syst Modeling, Minist Educ, Beijing 100084, Peoples R China.	siyali82@gmail.com	Si, Yali/B-3573-2012; Gong, Peng/AAM-1516-2021	Si, Yali/0000-0001-7107-9850; Gong, Peng/0000-0003-1513-3765	National High Technology Programme of China [2009AA12200101]; Fund for Talents of Tsinghua [553407001]	National High Technology Programme of China; Fund for Talents of Tsinghua	This research is supported by the National High Technology Programme of China (Grant No. 2009AA12200101) and the Fund for Talents of Tsinghua (Grant No. 553407001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardona CJ, 2009, COMP IMMUNOL MICROB, V32, P255, DOI 10.1016/j.cimid.2008.01.001; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Farnsworth ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032729; Ge E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029617; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Kutner M., 2004, APPL LINEAR STAT MOD; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; OIE, 2009, HIGHLY PATHOGENIC AV; Ottaviani D, 2010, ECOHEALTH, V7, P226, DOI 10.1007/s10393-010-0316-z; Pittman M, 2008, ZOONOSES PUBLIC HLTH, V55, P29, DOI 10.1111/j.1863-2378.2007.01087.x; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Si YL, 2010, ECOL SOC, V15, DOI 10.5751/es-03622-150326; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Ward M, 2008, VET RES COMMUN, V32, P627, DOI 10.1007/s11259-008-9064-8; Williams RAJ, 2011, GEOSPATIAL HEALTH, V5, P247, DOI 10.4081/gh.2011.177	17	51	52	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53362	10.1371/journal.pone.0053362	http://dx.doi.org/10.1371/journal.pone.0053362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308201	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100057
J	Umhau, JC; George, DT; Heaney, RP; Lewis, MD; Ursano, RJ; Heilig, M; Hibbeln, JR; Schwandt, ML				Umhau, John C.; George, David T.; Heaney, Robert P.; Lewis, Michael D.; Ursano, Robert J.; Heilig, Markus; Hibbeln, Joseph R.; Schwandt, Melanie L.			Low Vitamin D Status and Suicide: A Case-Control Study of Active Duty Military Service Members	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; D DEFICIENCY; DEPRESSION; SYMPTOMS; ASSOCIATION; SAMPLE; RISK	Objective: Considering that epidemiological studies show that suicide rates in many countries are highest in the spring when vitamin D status is lowest, and that low vitamin D status can affect brain function, we sought to evaluate if a low level of 25-hydroxyvitamin D [25(OH)D] could be a predisposing factor for suicide. \Method: We conducted a prospective, nested, case-control study using serum samples stored in the Department of Defense Serum Repository. Participants were previously deployed active duty US military personnel (2002-2008) who had a recent archived serum sample available for analysis. Vitamin D status was estimated by measuring 25(OH) D levels in serum samples drawn within 24 months of the suicide. Each verified suicide case (n = 495) was matched to a control (n = 495) by rank, age and sex. We calculated odds ratio of suicide associated with categorical levels (octiles) of 25(OH) D, adjusted by season of serum collection. Findings: More than 30% of all subjects had 25(OH) D values below 20 ng/mL. Although mean serum 25(OH) D concentrations did not differ between suicide cases and controls, risk estimates indicated that subjects in the lowest octile of season-adjusted 25(OH) D(<15.5 ng/mL) had the highest risk of suicide, with subjects in the subsequent higher octiles showing approximately the same level of decreased risk (combined odds ratio compared to lowest octile = 0.49; 95% C.I.: 0.315-0.768). Conclusions: Low vitamin D status is common in active duty service members. The lowest 25(OH) D levels are associated with an increased risk for suicide. Future studies could determine if additional sunlight exposure and vitamin D supplementation might reduce suicide by increasing 25(OH) D levels.	[Umhau, John C.; George, David T.; Heilig, Markus; Hibbeln, Joseph R.; Schwandt, Melanie L.] NIAAA, NIH, Bethesda, MD USA; [Heaney, Robert P.] Creighton Univ, Med Ctr, Osteoporosis Res Ctr, Omaha, NE USA; [Lewis, Michael D.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med, Bethesda, MD 20814 USA; [Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Creighton University; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Umhau, JC (corresponding author), NIAAA, NIH, Bethesda, MD USA.	umhau@jhu.edu	Schwandt, Melanie L/L-9866-2016; Ursano, Robert J/ABE-6533-2020	Heilig, Markus/0000-0003-2706-2482; Ursano, Robert/0000-0002-1861-9173	Division of Intramural Basic and Clinical Research; NIAAA; NIH; Defense Advanced projects Agency, Arlington, Virginia; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000115, ZIAAA000213] Funding Source: NIH RePORTER	Division of Intramural Basic and Clinical Research; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced projects Agency, Arlington, Virginia; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The Division of Intramural Basic and Clinical Research, NIAAA and NIH supported this study and were responsible for design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. The Defense Advanced projects Agency, Arlington, Virginia, gave a grant to support this work.	Andersen NE, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-38; Annweiler C, 2010, NEUROLOGY, V74, P27, DOI 10.1212/WNL.0b013e3181beecd3; Bertone-Johnson ER, 2011, AM J CLIN NUTR, V94, P1104, DOI 10.3945/ajcn.111.017384; BREWERTON TD, 1988, PSYCHIAT RES, V23, P257, DOI 10.1016/0165-1781(88)90016-9; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Deisenhammer EA, 2009, J CLIN PSYCHIAT, V70, P19, DOI 10.4088/JCP.07m03904; Havaki-Kontaxaki B J, 2010, Psychiatriki, V21, P324; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Heaney RP, 2012, N ENGL J MED; Hedelin M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-38; Hoang MT, 2011, MAYO CLIN PROC, V86, P1050, DOI 10.4065/mcp.2011.0208; Holick MF, 2010, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60327-303-9; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Jaddou HY, 2011, EUR ARCH PSYCHIAT CL; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Kjaergaard M, 2011, PSYCHIAT RES, V190, P221, DOI 10.1016/j.psychres.2011.06.024; Kuningas M, 2009, NEUROBIOL AGING, V30, P466, DOI 10.1016/j.neurobiolaging.2007.07.001; Lam RW, 2000, J CLIN PSYCHIAT, V61, P30, DOI 10.4088/JCP.v61n0108; Lappe J, 2008, J BONE MINER RES, V23, P741, DOI 10.1359/jbmr.080102; Lappe JM, 2006, J AM COLL NUTR, V25, P395, DOI 10.1080/07315724.2006.10719551; Lewis MD, 2011, J CLIN PSYCHIAT; Lindqvist D, 2011, ACTA PSYCHIAT SCAND, V124, P52, DOI 10.1111/j.1600-0447.2010.01655.x; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; May HT, 2010, AM HEART J, V159, P1037, DOI 10.1016/j.ahj.2010.03.017; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a; Postolache TT, 2010, J AFFECT DISORDERS, V121, P88, DOI 10.1016/j.jad.2009.05.015; Preti A, 1998, PSYCHIAT RES, V78, P9, DOI 10.1016/S0165-1781(97)00154-6; Snellman G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007747; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086	31	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e51543	10.1371/journal.pone.0051543	http://dx.doi.org/10.1371/journal.pone.0051543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072KP	23308099	Green Published, gold			2022-12-27	WOS:000313670100004
J	Goodbody-Gringley, G; Wetzel, DL; Gillon, D; Pulster, E; Miller, A; Ritchie, KB				Goodbody-Gringley, Gretchen; Wetzel, Dana L.; Gillon, Daniel; Pulster, Erin; Miller, Allison; Ritchie, Kim B.			Toxicity of Deepwater Horizon Source Oil and the Chemical Dispersant, Corexit (R) 9500, to Coral Larvae	PLOS ONE			English	Article							CRUDE-OIL; REEF; METAMORPHOSIS; SPILLS; IMPACT	Acute catastrophic events can cause significant damage to marine environments in a short time period and may have devastating long-term impacts. In April 2010 the BP-operated Deepwater Horizon (DWH) offshore oil rig exploded, releasing an estimated 760 million liters of crude oil into the Gulf of Mexico. This study examines the potential effects of oil spill exposure on coral larvae of the Florida Keys. Larvae of the brooding coral, Porites astreoides, and the broadcast spawning coral, Montastraea faveolata, were exposed to multiple concentrations of BP Horizon source oil (crude, weathered and WAF), oil in combination with the dispersant Corexit (R) 9500 (CEWAF), and dispersant alone, and analyzed for behavior, settlement, and survival. Settlement and survival of P. astreoides and M. faveolata larvae decreased with increasing concentrations of WAF, CEWAF and Corexit (R) 9500, however the degree of the response varied by species and solution. P. astreoides larvae experienced decreased settlement and survival following exposure to 0.62 ppm source oil, while M. faveolata larvae were negatively impacted by 0.65, 1.34 and 1.5 ppm, suggesting that P. astreoides larvae may be more tolerant to WAF exposure than M. faveolata larvae. Exposure to medium and high concentrations of CEWAF (4.28/18.56 and 30.99/35.76 ppm) and dispersant Corexit (R) 9500 (50 and 100 ppm), significantly decreased larval settlement and survival for both species. Furthermore, exposure to Corexit (R) 9500 resulted in settlement failure and complete larval mortality after exposure to 50 and 100 ppm for M. faveolata and 100 ppm for P. astreoides. These results indicate that exposure of coral larvae to oil spill related contaminants, particularly the dispersant Corexit (R) 9500, has the potential to negatively impact coral settlement and survival, thereby affecting the resilience and recovery of coral reefs following exposure to oil and dispersants.	[Goodbody-Gringley, Gretchen; Wetzel, Dana L.; Gillon, Daniel; Pulster, Erin; Miller, Allison; Ritchie, Kim B.] Mote Marine Lab, Sarasota, FL 34236 USA	Mote Marine Laboratory & Aquarium	Ritchie, KB (corresponding author), Mote Marine Lab, Sarasota, FL 34236 USA.	ritchie@mote.org			Protect Our Reefs Emergency; NSF (National Science Foundation) [REU-1004181]; NSF [OCE-0926822]; Dart Foundation	Protect Our Reefs Emergency; NSF (National Science Foundation)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Dart Foundation	Funding for this project was provided via Protect Our Reefs 2010 Emergency funding to KB Ritchie, NSF (National Science Foundation) REU-1004181 funding to DG, NSF OCE-0926822 funding to Mary Alice Coffroth, and the Dart Foundation to KBR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, OIL SEA; Aurand D, 2006, 0703 EC MAN ASS INC, P105; Birkeland G, 1976, SURVEY MARINE COMMUN, P76; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Chandrasekar S, 2006, ICES J MAR SCI, V63, P1418, DOI 10.1016/j.icesjms.2006.04.019; CHIA F-S, 1973, Marine Pollution Bulletin, V4, P29, DOI 10.1016/0025-326X(73)90208-7; Edmunds PJ, 2001, MAR BIOL, V139, P981; Epstein N, 2000, MAR POLLUT BULL, V40, P497, DOI 10.1016/S0025-326X(99)00232-5; Fiocco RJ, 1999, PURE APPL CHEM, V71, P27, DOI 10.1351/pac199971010027; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GRIFFIN LF, 1977, APPL ENVIRON MICROB, V33, P1092, DOI 10.1128/AEM.33.5.1092-1096.1977; Harrison P., 1999, OIL POLLUTANTS INHIB, P8; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Heubeck M, 2003, MAR POLLUT BULL, V46, P900, DOI 10.1016/S0025-326X(03)00098-5; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Klemas V, 2010, J COASTAL RES, V26, P789, DOI 10.2112/10A-00012.1; LOYA Y, 1980, MAR ECOL PROG SER, V3, P167, DOI 10.3354/meps003167; LOYA Y, 1979, MAR ECOL PROG SER, V1, P77, DOI 10.3354/meps001077; MANAHAN DT, 1990, AM ZOOL, V30, P147; Mearns A., 2003, P INT OIL SPILL C, P523; Minerals Management Service, 2009, 2009012 OCS MMS; Munn C, 2004, MARINE MICROBIOLOGY; Negri AP, 2000, MAR POLLUT BULL, V41, P420, DOI 10.1016/S0025-326X(00)00139-9; NRC, 2005, OIL SPILL DISP EFF E, P193, DOI 10.17226/11283; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Payne J. R., 1985, PETROLEUM SPILLS MAR; PORTER JW, 1992, AM ZOOL, V32, P625; Ramseur J.L., 2011, FATE OIL DEEP HORIZ, P1; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Shafir S, 2007, ENVIRON SCI TECHNOL, V41, P5571, DOI 10.1021/es0704582; Sharp KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010898; Shinegaka G, 2001, 8 NOAA NOS OR R; SINGER MM, 1990, WATER RES, V24, P899, DOI 10.1016/0043-1354(90)90140-2; Szmant AM, 1997, MAR BIOL, V129, P561, DOI 10.1007/s002270050197; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wetzel D.L., 2001, P 2001 INT OIL SPILL, P1237, DOI DOI 10.7901/2169-3358-2001-2-1237	40	117	117	2	367	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e45574	10.1371/journal.pone.0045574	http://dx.doi.org/10.1371/journal.pone.0045574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326298	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500001
J	Hatala, KG; Dingwall, HL; Wunderlich, RE; Richmond, BG				Hatala, Kevin G.; Dingwall, Heather L.; Wunderlich, Roshna E.; Richmond, Brian G.			Variation in Foot Strike Patterns during Running among Habitually Barefoot Populations	PLOS ONE			English	Article							HUMAN FOOTPRINTS; EVOLUTION; HYPOTHESIS; RUNNERS; HOMINID; FORCES; KENYA	Endurance running may have a long evolutionary history in the hominin clade but it was not until very recently that humans ran wearing shoes. Research on modern habitually unshod runners has suggested that they utilize a different biomechanical strategy than runners who wear shoes, namely that barefoot runners typically use a forefoot strike in order to avoid generating the high impact forces that would be experienced if they were to strike the ground with their heels first. This finding suggests that our habitually unshod ancestors may have run in a similar way. However, this research was conducted on a single population and we know little about variation in running form among habitually barefoot people, including the effects of running speed, which has been shown to affect strike patterns in shod runners. Here, we present the results of our investigation into the selection of running foot strike patterns among another modern habitually unshod group, the Daasanach of northern Kenya. Data were collected from 38 consenting adults as they ran along a trackway with a plantar pressure pad placed midway along its length. Subjects ran at self-selected endurance running and sprinting speeds. Our data support the hypothesis that a forefoot strike reduces the magnitude of impact loading, but the majority of subjects instead used a rearfoot strike at endurance running speeds. Their percentages of midfoot and forefoot strikes increased significantly with speed. These results indicate that not all habitually barefoot people prefer running with a forefoot strike, and suggest that other factors such as running speed, training level, substrate mechanical properties, running distance, and running frequency, influence the selection of foot strike patterns.	[Hatala, Kevin G.] George Washington Univ, Hominid Paleobiol Doctoral Program, Washington, DC 20052 USA; [Hatala, Kevin G.; Dingwall, Heather L.; Richmond, Brian G.] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC USA; [Wunderlich, Roshna E.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Richmond, Brian G.] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA	George Washington University; George Washington University; James Madison University; Smithsonian Institution; Smithsonian National Museum of Natural History	Hatala, KG (corresponding author), George Washington Univ, Hominid Paleobiol Doctoral Program, Washington, DC 20052 USA.	kghatala@gwmail.gwu.edu		Hatala, Kevin/0000-0001-9131-5304	National Science Foundation [BCS-0924476, DGE-0801634]; George Washington University Lewis N. Cotlow Fund	National Science Foundation(National Science Foundation (NSF)); George Washington University Lewis N. Cotlow Fund	This research was funded by the National Science Foundation, grants BCS-0924476 and DGE-0801634, and the George Washington University Lewis N. Cotlow Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; Ashizawa K, 1997, ANN HUM BIOL, V24, P117, DOI 10.1080/03014469700004862; BARNETT CH, 1962, J ANAT, V96, P489; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; Cunningham CB, 2010, J EXP BIOL, V213, P790, DOI 10.1242/jeb.038984; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; Daoud AI, 2012, MED SCI SPORT EXER, V44, P1325, DOI 10.1249/MSS.0b013e3182465115; Davis I., 2010, ANN M AM SOC BIOM; Hatala KG, 2011, AM J PHYS ANTHROPOL, V144, P158; Herzog W, 1979, INFLUENCE RUNNING SP; Hoffmann P., 1905, J BONE JT SURG AM, V2, P105; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Kuttruff JT, 1998, SCIENCE, V281, P72, DOI 10.1126/science.281.5373.72; Liebenberg L, 2006, CURR ANTHROPOL, V47, P1017, DOI 10.1086/508695; Lieberman DE, 2007, J HUM EVOL, V53, P439, DOI 10.1016/j.jhevol.2007.07.002; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; NIGG BM, 1987, J BIOMECH, V20, P951, DOI 10.1016/0021-9290(87)90324-1; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; Pickering TR, 2007, J HUM EVOL, V53, P434, DOI 10.1016/j.jhevol.2007.01.012; Richmond BG, 2011, PALEOANTHROPOLOGY, pA31; Richmond BG, 2010, AM J PHYS ANTHROPOL, P197; Roberts D, 2008, ICHNOS, V15, P190, DOI 10.1080/10420940802470482; Steudel-Numbers KL, 2009, J HUM EVOL, V56, P355, DOI 10.1016/j.jhevol.2008.11.002; Trinkaus E, 2008, J ARCHAEOL SCI, V35, P1928, DOI 10.1016/j.jas.2007.12.002; Webb S, 2006, J HUM EVOL, V50, P405, DOI 10.1016/j.jhevol.2005.10.002	28	84	84	1	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52548	10.1371/journal.pone.0052548	http://dx.doi.org/10.1371/journal.pone.0052548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326341	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500018
J	Sun, XS; Lai, R; Li, JX; Luo, M; Wang, YF; Sheng, WL				Sun, Xunsha; Lai, Rong; Li, Jiaoxing; Luo, Man; Wang, Yufang; Sheng, Wenli			The-7351C/T Polymorphism in the TPA Gene and Ischemic Stroke Risk: A Meta-Analysis	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; TISSUE-PLASMINOGEN-ACTIVATOR; T-PA; ENHANCER POLYMORPHISM; MYOCARDIAL-INFARCTION; THROMBOLYTIC THERAPY; LACUNAR STROKE; ASSOCIATION; SUBTYPES; RELEASE	Background: A number of studies assessed the association of tissue plasminogen activator(TPA) gene polymorphisms with ischemic stroke, but the results were contradictory. We aimed to explore the role of TPA -7351C/T SNP in the susceptibility to ischemic stroke through a meta-analysis. Methods: The PubMed, MEDLINE, EMBASE, China Biological Medicine Database and WANFANG DATA databases were searched until August 2012. The strict selection criteria and exclusion criteria were determined, and odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations. Stroke subtype was determined using Trial of Org 10172 in Acute Treatment criteria (TOAST). Statistical analyses were performed using the STATA12.0 software. Results: A total of 2,299 ischemic stroke cases and 1,948 controls in seven case-control studies were included in the meta-analysis. Significant association between -7351C/T polymorphism in the TPA gene and ischemic stroke was observed in all comparison models (TT+CT versus CC, TT versus CT+CC and T versus C). In the subgroup analysis by ethnicity, TT homozygote carriers had a 142% increased risk of ischemic stroke compared with the C allele carriers among East-Asians (TT versus CT+CC: OR = 2.42, 95% CI = 1.07-5.48), but not in South-Asians and Caucasians, and significantly increased risks were found for T versus C among both East-Asians (OR = 1.33, 95% CI = 1.05-1.68) and Caucasians(OR = 1.16, 95% CI = 1.02-1.31). Further stratification for stroke subtype in three Caucasian studies showed the association between -7351C/T polymorphism and Large-artery atherosclerosis (LAA), but not Small-vessel occlusion (SVO) and Cardioembolism (CE). Conclusions: This meta-analysis suggested that the -7351C/T polymorphism in TPA gene would be a risk factor for ischemic stroke, especially among East-Asians compared with Caucasians, but not in South-Asians, and it may play a role in the pathogenesis of LAA in Caucasians, but not in SVO and CE.	[Sun, Xunsha; Lai, Rong; Li, Jiaoxing; Luo, Man; Wang, Yufang; Sheng, Wenli] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Sheng, WL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	shengwl@mail.sysu.edu.cn	luo, man/HGC-7868-2022; Luo, Man/GWQ-4789-2022	Sheng, Wenli/0000-0001-6867-371X	National Natural Science Foundation of China [81070912]; Shandong Province Excellent Young Scientist Research Award Fund [2012BSA07022]; Self-financing Science Foundation of Guangxi Health Bureau [Z2012096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Excellent Young Scientist Research Award Fund; Self-financing Science Foundation of Guangxi Health Bureau	This study was supported by grants #81070912 from the National Natural Science Foundation of China and grant #2012BSA07022 from the Shandong Province Excellent Young Scientist Research Award Fund and grant #Z2012096 from Self-financing Science Foundation of Guangxi Health Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Armstrong CA, 2006, STROKE, V37, P329, DOI 10.1161/01.STR.0000199663.64894.4f; Attia John, 2007, J Stroke Cerebrovasc Dis, V16, P173, DOI 10.1016/j.jstrokecerebrovasdis.2007.03.002; Babu MS, 2012, GENE, V495, P76, DOI 10.1016/j.gene.2011.12.046; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Del BA, 2012, INT J STROKE, V7, P321; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Geng Z., 2008, CHIN J CLIN NEUROSCI, V16, P134; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Holliday EG, 2012, NAT GENET, V44, P1147, DOI 10.1038/ng.2397; Horsley T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000026.pub2; Ihle-Hansen H, 2012, FUNCT NEUROL, V27, P35; Jannes J, 2004, STROKE, V35, P1090, DOI 10.1161/01.STR.0000124123.76658.6c; Jern C, 1999, ARTERIOSCL THROM VAS, V19, P454, DOI 10.1161/01.ATV.19.2.454; Jood K, 2005, STROKE, V36, P2077, DOI 10.1161/01.STR.0000183617.54752.69; KOOISTRA T, 1994, INT J HEMATOL, V59, P233; Kristensen B, 1998, STROKE, V29, P2261, DOI 10.1161/01.STR.29.11.2261; Ladenvall P, 2002, THROMB HAEMOSTASIS, V87, P105; Ladenvall P, 2000, THROMB HAEMOSTASIS, V84, P150, DOI 10.1055/s-0037-1613990; Lee Brian, 2012, J Med Assoc Thai, V95 Suppl 2, pS227; Macko RF, 1999, STROKE, V30, P7, DOI 10.1161/01.STR.30.1.7; Maguire J, 2011, J STROKE CEREBROVASC, V20, P134, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.011; Olson DM, 2011, J NEUROSCI NURS, V43, P329, DOI 10.1097/JNN.0b013e318234e7fb; RIDKER PM, 1994, LANCET, V343, P940, DOI 10.1016/S0140-6736(94)90064-7; Roquer J, 2012, CEREBROVASC DIS, V33, P310, DOI 10.1159/000335306; Sharma VK, 2012, EXPERT REV NEUROTHER, V12, P209, DOI [10.1586/ern.11.148, 10.1586/ERN.11.148]; Tuttolomondo A, 2012, CYTOKINE, V58, P398, DOI 10.1016/j.cyto.2012.02.012; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang YY, 2006, RELATIONSHIP SINGLE; Wardlaw JM, 1997, LANCET, V350, P607, DOI 10.1016/S0140-6736(97)03022-5; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804	34	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53558	10.1371/journal.pone.0053558	http://dx.doi.org/10.1371/journal.pone.0053558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326456	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500083
J	Bult, W; Kroeze, SGC; Elschot, M; Seevinck, PR; Beekman, FJ; de Jong, HWAM; Uges, DRA; Kosterink, JGW; Luijten, PR; Hennink, WE; Schip, ADV; Bosch, JLHR; Nijsen, JFW; Jans, JJM				Bult, Wouter; Kroeze, Stephanie G. C.; Elschot, Mattijs; Seevinck, Peter R.; Beekman, Freek J.; de Jong, Hugo W. A. M.; Uges, Donald R. A.; Kosterink, Jos G. W.; Luijten, Peter R.; Hennink, Wim E.; Schip, Alfred D. van Het; Bosch, J. L. H. Ruud; Nijsen, J. Frank W.; Jans, Judith J. M.			Intratumoral Administration of Holmium-166 Acetylacetonate Microspheres: Antitumor Efficacy and Feasibility of Multimodality Imaging in Renal Cancer	PLOS ONE			English	Article							POLY(L-LACTIC ACID) MICROSPHERES; CELL CARCINOMA; RADIOFREQUENCY ABLATION; RADIONUCLIDE THERAPY; SPECT; TUMORS; SURVIVAL; PINHOLE; KIDNEY; RADIOEMBOLIZATION	Purpose: The increasing incidence of small renal tumors in an aging population with comorbidities has stimulated the development of minimally invasive treatments. This study aimed to assess the efficacy and demonstrate feasibility of multimodality imaging of intratumoral administration of holmium-166 microspheres ((HoAcAcMS)-Ho-166). This new technique locally ablates renal tumors through high-energy beta particles, while the gamma rays allow for nuclear imaging and the paramagnetism of holmium allows for MRI. Methods: (HoAcAcMS)-Ho-166 were administered intratumorally in orthotopic renal tumors (Balb/C mice). Post administration CT, SPECT and MRI was performed. At several time points (2 h, 1, 2, 3, 7 and 14 days) after MS administration, tumors were measured and histologically analyzed. Holmium accumulation in organs was measured using inductively coupled plasma mass spectrometry. Results: (HoAcAcMS)-Ho-166 were successfully administered to tumor bearing mice. A striking near-complete tumor-control was observed in (HoAcAcMS)-Ho-166 treated mice (0.10 +/- 0.01 cm(3) vs. 4.15 +/- 0.3 cm(3) for control tumors). Focal necrosis and inflammation was present from 24 h following treatment. Renal parenchyma outside the radiated region showed no histological alterations. Post administration CT, MRI and SPECT imaging revealed clear deposits of (HoAcAcMS)-Ho-166 in the kidney. Conclusions: Intratumorally administered (HoAcAcMS)-Ho-166 has great potential as a new local treatment of renal tumors for surgically unfit patients. In addition to strong cancer control, it provides powerful multimodality imaging opportunities.	[Bult, Wouter; Elschot, Mattijs; de Jong, Hugo W. A. M.; Luijten, Peter R.; Schip, Alfred D. van Het; Nijsen, J. Frank W.] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Imaging Div, Utrecht, Netherlands; [Bult, Wouter; Uges, Donald R. A.; Kosterink, Jos G. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Hosp & Clin Pharm, NL-9713 AV Groningen, Netherlands; [Kroeze, Stephanie G. C.; Bosch, J. L. H. Ruud; Jans, Judith J. M.] Univ Med Ctr Utrecht, Dept Urol, Utrecht, Netherlands; [Kroeze, Stephanie G. C.; Jans, Judith J. M.] Univ Med Ctr Utrecht, Expt Oncol Lab, Utrecht, Netherlands; [Seevinck, Peter R.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Beekman, Freek J.] Milabs, Utrecht, Netherlands; [Beekman, Freek J.] Delft Univ Technol, Fac Sci Appl, Sect Radiat Detect & Med Imaging, Delft, Netherlands; [Hennink, Wim E.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Delft University of Technology; Utrecht University	Nijsen, JFW (corresponding author), Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Imaging Div, Utrecht, Netherlands.	f.nijsen@umcutrecht.nl	Elschot, Mattijs/AAD-4362-2021; Nijsen, Frank/C-2839-2018; Hennink, Wim/O-8632-2016	Elschot, Mattijs/0000-0002-8056-9103; Nijsen, Frank/0000-0001-7625-2253; Jans, Judith/0000-0003-0960-6263; Kosterink, Jos/0000-0001-8358-765X	Foundation for Advancement of Research in Hospital Pharmacy University Medical Center Groningen (Stichting OZG); Dutch technology foundation STW [06069]	Foundation for Advancement of Research in Hospital Pharmacy University Medical Center Groningen (Stichting OZG); Dutch technology foundation STW(Technologiestichting STW)	This work was supported by the Foundation for Advancement of Research in Hospital Pharmacy University Medical Center Groningen (Stichting OZG) and the Dutch technology foundation STW (grant number 06069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolch WE, 1999, J NUCL MED, V40, p11S; Branderhorst W, 2010, PHYS MED BIOL, V55, P2023, DOI 10.1088/0031-9155/55/7/015; Bult W, 2009, PHARM RES-DORDR, V26, P1371, DOI 10.1007/s11095-009-9848-8; Bult W, 2012, PHARM RES-DORDR, V29, P827, DOI 10.1007/s11095-011-0610-7; Coldwell D, 2012, AM J CLIN ONCOL-CANC, V35, P167, DOI 10.1097/COC.0b013e3181f47923; D'Asseler Y, 2009, Q J NUCL MED MOL IM, V53, P343; de Wit TC, 2006, PHYS MED BIOL, V51, P4773, DOI 10.1088/0031-9155/51/19/004; Forrer F, 2007, CANCER BIOTHER RADIO, V22, P40, DOI 10.1089/cbr.2006.353; Gao W, 2010, CANCER BIOTHER RADIO, V25, P215, DOI 10.1089/cbr.2008.0596; Gervais DA, 2005, AM J ROENTGENOL, V185, P64, DOI 10.2214/ajr.185.1.01850064; Hendricks JSM, 2005, LAUR052675 LOS AL NA, P1; Heuer R, 2010, EUR UROL, V57, P223, DOI 10.1016/j.eururo.2009.10.023; Hollingsworth JM, 2006, JNCI-J NATL CANCER I, V98, P1331, DOI 10.1093/jnci/djj362; Hung AJ, 2012, BJU INT, V109, P1398, DOI 10.1111/j.1464-410X.2011.10648.x; Kerkhof EM, 2011, BJU INT, V107, P63, DOI 10.1111/j.1464-410X.2010.09458.x; Kutikov A, 2010, J CLIN ONCOL, V28, P311, DOI 10.1200/JCO.2009.22.4816; Lane BR, 2010, CANCER-AM CANCER SOC, V116, P3119, DOI 10.1002/cncr.25184; Lin WY, 2000, J NUCL MED, V41, P1892; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Luboldt Wolfgang, 2009, Current Drug Delivery, V6, P255; MacKie S, 2011, J UROLOGY, V185, P285, DOI 10.1016/j.juro.2010.09.001; MADRAZO A, 1969, AM J PATHOL, V54, P507; Muto G, 2011, EUR UROL, V60, P173, DOI 10.1016/j.eururo.2011.04.028; Nijsen JFW, 1999, EUR J NUCL MED, V26, P699, DOI 10.1007/s002590050440; O'Donoghue J, 2004, CANCER BIOTHER RADIO, V19, P378, DOI 10.1089/1084978041425025; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Arrontes D, 2008, J UROLOGY, V179, P857, DOI 10.1016/j.juro.2007.10.048; Seevinck PR, 2007, ANTI-CANCER AGENT ME, V7, P317, DOI 10.2174/187152007780618153; Seevinck PR, 2012, INT J RADIAT ONCOL, V83, pE437, DOI 10.1016/j.ijrobp.2011.12.085; Smits MLJ, 2012, LANCET ONCOL, V13, P1025, DOI 10.1016/S1470-2045(12)70334-0; Smits MLJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-70; Tian JH, 1996, J NUCL MED, V37, P958; van der Have F, 2008, IEEE T MED IMAGING, V27, P960, DOI 10.1109/TMI.2008.924644; van der Have F, 2009, J NUCL MED, V50, P599, DOI 10.2967/jnumed.108.056606; Vanhove C, 2009, EUR J NUCL MED MOL I, V36, P1049, DOI 10.1007/s00259-009-1062-8; Vente MAD, 2008, EUR J NUCL MED MOL I, V35, P1259, DOI 10.1007/s00259-008-0747-8; Vente MAD, 2009, EUR RADIOL, V19, P951, DOI 10.1007/s00330-008-1211-7; Zielhuis SW, 2007, BIOMATERIALS, V28, P4591, DOI 10.1016/j.biomaterials.2007.07.012; Zielhuis SW, 2005, BIOMATERIALS, V26, P925, DOI 10.1016/j.biomaterials.2004.03.028	39	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52178	10.1371/journal.pone.0052178	http://dx.doi.org/10.1371/journal.pone.0052178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320070	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429800012
J	Perea-Martinez, I; Nagai, T; Chaudhari, N				Perea-Martinez, Isabel; Nagai, Takatoshi; Chaudhari, Nirupa			Functional Cell Types in Taste Buds Have Distinct Longevities	PLOS ONE			English	Article							RAT CIRCUMVALLATE PAPILLAE; RECEPTOR-CELLS; LINEAGE RELATIONSHIPS; ALPHA-GUSTDUCIN; POPULATIONS; EXPRESSION; STEM; RENEWAL; IMMUNOREACTIVITY; EPITHELIUM	Taste buds are clusters of polarized sensory cells embedded in stratified oral epithelium. In adult mammals, taste buds turn over continuously and are replenished through the birth of new cells in the basal layer of the surrounding non-sensory epithelium. The half-life of cells in mammalian taste buds has been estimated as 8-12 days on average. Yet, earlier studies did not address whether the now well-defined functional taste bud cell types all exhibit the same lifetime. We employed a recently developed thymidine analog, 5-ethynil-2'-deoxyuridine (EdU) to re-evaluate the incorporation of newly born cells into circumvallate taste buds of adult mice. By combining EdU-labeling with immunostaining for selected markers, we tracked the differentiation and lifespan of the constituent cell types of taste buds. EdU was primarily incorporated into basal extragemmal cells, the principal source for replenishing taste bud cells. Undifferentiated EdU-labeled cells began migrating into circumvallate taste buds within 1 day of their birth. Type II (Receptor) taste cells began to differentiate from EdU-labeled precursors beginning 2 days after birth and then were eliminated with a half-life of 8 days. Type III (Presynaptic) taste cells began differentiating after a delay of 3 days after EdU-labeling, and they survived much longer, with a half-life of 22 days. We also scored taste bud cells that belong to neither Type II nor Type III, a heterogeneous group that includes mostly Type I cells, and also undifferentiated or immature cells. A non-linear decay fit described these cells as two sub-populations with half-lives of 8 and 24 days respectively. Our data suggest that many post-mitotic cells may remain quiescent within taste buds before differentiating into mature taste cells. A small number of slow-cycling cells may also exist within the perimeter of the taste bud. Based on their incidence, we hypothesize that these may be progenitors for Type III cells.	[Perea-Martinez, Isabel; Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Nagai, Takatoshi] Keio Univ, Sch Med, Dept Biol, Yokohama, Kanagawa 223, Japan; [Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA	University of Miami; Keio University; University of Miami	Chaudhari, N (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA.	nchaudhari@med.miami.edu	Nagai, Takatoshi/L-1162-2013		National Institutes of Health/National Institute on Deafness and Other Communication Disorders (NIH/NIDCD) [R01 DC6308]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006308] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders (NIH/NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health/National Institute on Deafness and Other Communication Disorders (NIH/NIDCD) grant R01 DC6308 (NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano-Miyoshi M, 2008, J MOL HISTOL, V39, P193, DOI 10.1007/s10735-007-9151-0; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Boughter JD, 1997, J NEUROSCI, V17, P2852; BURNS ER, 1976, ANAT REC, V184, P265, DOI 10.1002/ar.1091840302; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Cho YK, 1998, CHEM SENSES, V23, P735, DOI 10.1093/chemse/23.6.735; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Cohn ZJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-72; CONGER AD, 1969, RADIAT RES, V37, P31, DOI 10.2307/3572749; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; DELAY RJ, 1986, J COMP NEUROL, V253, P242, DOI 10.1002/cne.902530210; Dvoryanchikov G, 2012, CHEM SENSES, V37; Dvoryanchikov G, 2009, J COMP NEUROL, V517, P1, DOI 10.1002/cne.22152; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Gaillard D, 2011, GENESIS, V49, P295, DOI 10.1002/dvg.20731; GANCHROW JR, 1993, MICROSC RES TECHNIQ, V26, P106, DOI 10.1002/jemt.1070260204; Hamamichi R, 2006, NEUROSCIENCE, V141, P2129, DOI 10.1016/j.neuroscience.2006.05.061; Ichimori Y, 2009, ARCH HISTOL CYTOL, V72, P91, DOI 10.1679/aohc.72.91; Kim JW, 2006, CHEM SENSES, V31, P213, DOI 10.1093/chemse/bjj021; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Miura H, 2005, CHEM SENSES, V30, P367, DOI 10.1093/chemse/bji031; MURRAY R G, 1969, Journal of Ultrastructure Research, V27, P444, DOI 10.1016/S0022-5320(69)80043-2; MURRAY RG, 1993, MICROSC RES TECHNIQ, V26, P209, DOI 10.1002/jemt.1070260304; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Packard D S Jr, 1973, Differentiation, V1, P397, DOI 10.1111/j.1432-0436.1973.tb00137.x; Pumplin DW, 1997, J COMP NEUROL, V378, P389, DOI 10.1002/(SICI)1096-9861(19970217)378:3<389::AID-CNE7>3.0.CO;2-#; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Stone LM, 2002, J NEUROSCI, V22, P4522, DOI 10.1523/JNEUROSCI.22-11-04522.2002; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916; Sullivan JM, 2010, EUR J NEUROSCI, V31, P1549, DOI 10.1111/j.1460-9568.2010.07184.x; TAKEDA M, 1977, ARCH HISTOL JAPON, V40, P243, DOI 10.1679/aohc1950.40.243; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Taniguchi R, 2005, ARCH HISTOL CYTOL, V68, P243, DOI 10.1679/aohc.68.243; Thirumangalathu S, 2009, DEVELOPMENT, V136, P1519, DOI 10.1242/dev.029090; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang H, 2009, J COMP NEUROL, V512, P384, DOI 10.1002/cne.21899; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	40	111	114	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53399	10.1371/journal.pone.0053399	http://dx.doi.org/10.1371/journal.pone.0053399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320081	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429800045
J	Quesada, V; Sarmiento-Manus, R; Gonzalez-Bayon, R; Hricova, A; Ponce, MR; Micol, JL				Quesada, Victor; Sarmiento-Manus, Raquel; Gonzalez-Bayon, Rebeca; Hricova, Andrea; Ponce, Maria Rosa; Micol, Jose Luis			PORPHOBILINOGEN DEAMINASE Deficiency Alters Vegetative and Reproductive Development and Causes Lesions in Arabidopsis	PLOS ONE			English	Article							MG-PROTOPORPHYRIN IX; RNA-SYNTHESIS LEADS; GENE-EXPRESSION; SALICYLIC-ACID; ANTISENSE RNA; CELL-DEATH; TETRAPYRROLE BIOSYNTHESIS; UROPORPHYRINOGEN DECARBOXYLASE; SUBCELLULAR-LOCALIZATION; ACQUIRED-RESISTANCE	The Arabidopsis rugosa1 (rug1) mutant has irregularly shaped leaves and reduced growth. In the absence of pathogens, leaves of rug1 plants have spontaneous lesions reminiscent of those seen in lesion-mimic mutants; rug1 plants also express cytological and molecular markers associated with defence against pathogens. These rug1 phenotypes are made stronger by dark/light transitions. The rug1 mutant also has delayed flowering time, upregulation of the floral repressor FLOWERING LOCUS C (FLC) and downregulation of the flowering promoters FT and SOC1/AGL20. Vernalization suppresses the late flowering phenotype of rug1 by repressing FLC. Microarray analysis revealed that 280 nuclear genes are differentially expressed between rug1 and wild type; almost a quarter of these genes are involved in plant defence. In rug1, the auxin response is also affected and several auxin-responsive genes are downregulated. We identified the RUG1 gene by map-based cloning and found that it encodes porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase, an enzyme of the tetrapyrrole biosynthesis pathway, which produces chlorophyll, heme, siroheme and phytochromobilin in plants. PBGD activity is reduced in rug1 plants, which accumulate porphobilinogen. Our results indicate that Arabidopsis PBGD deficiency impairs the porphyrin pathway and triggers constitutive activation of plant defence mechanisms leading to leaf lesions and affecting vegetative and reproductive development.	[Quesada, Victor; Sarmiento-Manus, Raquel; Gonzalez-Bayon, Rebeca; Hricova, Andrea; Ponce, Maria Rosa; Micol, Jose Luis] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain	Universidad Miguel Hernandez de Elche	Micol, JL (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Campus Elche, Elche, Spain.	jlmicol@umh.es	Ponce, María Rosa/C-8203-2014; Hricova, Andrea/Z-5792-2019; Gonzalez-Bayon, Rebeca/I-4605-2012; Micol, José Luis/B-4832-2010; Sarmiento, Raquel/L-3129-2017	Ponce, María Rosa/0000-0003-0770-4230; Hricova, Andrea/0000-0001-5879-0912; Micol, José Luis/0000-0002-0396-1750; quesada, victor/0000-0002-0965-8680; Sarmiento, Raquel/0000-0001-6929-8034; Gonzalez-Bayon, Rebeca/0000-0002-9939-0795	Ministerio de Economia y Competitividad of Spain [BIO2008-04075, BFU2011-22825]; Generalitat Valenciana [Prometeo/2009/112]; European Research Training Network [HPRN-CT-2002-00267 (DAGOLIGN)]	Ministerio de Economia y Competitividad of Spain(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Research Training Network	This work was supported by research grants to JLM from the Ministerio de Economia y Competitividad of Spain (BIO2008-04075 and BFU2011-22825), the Generalitat Valenciana (Prometeo/2009/112) and the European Research Training Network HPRN-CT-2002-00267 (DAGOLIGN). RSM is indebted to the Ministerio de Ciencia e Innovacion of Spain for her Ph.D. scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Peral MM, 2006, DEVELOPMENT, V133, P3755, DOI 10.1242/dev.02554; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BATTERSBY AR, 1979, J CHEM SOC CHEM COMM, P1155, DOI 10.1039/c39790001155; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berna G, 1999, GENETICS, V152, P729; Clark AM, 1999, PLANT CELL PHYSIOL, V40, P69, DOI 10.1093/oxfordjournals.pcp.a029476; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Gong ZZ, 2001, PLANT PHYSIOL, V126, P363, DOI 10.1104/pp.126.1.363; GOUGH SP, 1979, CARLSBERG RES COMMUN, V44, P403, DOI 10.1007/BF02906189; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; Guan Y, 2004, PLANT PHYSIOL, V135, P1346, DOI 10.1104/pp.104.039370; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; He YH, 2002, PLANT CELL, V14, P805, DOI 10.1105/tpc.010422; Hricova A, 2006, PLANT PHYSIOL, V141, P942, DOI 10.1104/pp.106.080069; Hu GS, 1998, PLANT CELL, V10, P1095, DOI 10.1105/tpc.10.7.1095; Huang MS, 2010, AM J BOT, V97, P357, DOI 10.3732/ajb.0900233; Huang MS, 2009, MOL PLANT, V2, P773, DOI 10.1093/mp/ssp029; Ishikawa A, 2001, PLANT J, V27, P89, DOI 10.1046/j.1365-313x.2001.01058.x; JONES RM, 1994, BIOCHEM J, V299, P895, DOI 10.1042/bj2990895; JORDAN PM, 1979, J CHEM SOC CHEM COMM, P204, DOI 10.1039/c39790000204; Kant S, 2009, PLANT SIGNAL BEHAV, V4, P1174, DOI 10.4161/psb.4.12.10043; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; KRUSE E, 1995, EMBO J, V14, P3712, DOI 10.1002/j.1460-2075.1995.tb00041.x; KUC J, 1982, BIOSCIENCE, V32, P854, DOI 10.2307/1309008; Kumar AM, 2000, PLANT PHYSIOL, V122, P49, DOI 10.1104/pp.122.1.49; Lermontova I, 2006, PLANT J, V48, P499, DOI 10.1111/j.1365-313X.2006.02894.x; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; LIM SH, 1994, PLANT MOL BIOL, V26, P863, DOI 10.1007/BF00028854; Lin CSY, 2011, CLIN NEUROPHYSIOL, V122, P2336, DOI 10.1016/j.clinph.2011.07.036; Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Miller JD, 1999, PLANT PHYSIOL, V120, P1015, DOI 10.1104/pp.120.4.1015; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Mock HP, 1999, J BIOL CHEM, V274, P4231, DOI 10.1074/jbc.274.7.4231; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; Moeder W, 2008, PLANT SIGNAL BEHAV, V3, P764, DOI 10.4161/psb.3.10.6545; Molina A, 1999, PLANT J, V17, P667, DOI 10.1046/j.1365-313X.1999.00420.x; Moulin M, 2005, BIOCHEM SOC T, V33, P737, DOI 10.1042/BST0330737; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Papenbrock J, 2001, PLANT J, V28, P41, DOI 10.1046/j.1365-313X.2001.01126.x; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Ponce MR, 1998, PLANT J, V14, P497, DOI 10.1046/j.1365-313X.1998.00146.x; Quesada V, 1999, FEBS LETT, V461, P101, DOI 10.1016/S0014-5793(99)01426-X; Quesada V, 2011, PLANT J, V68, P738, DOI 10.1111/j.1365-313X.2011.04726.x; Robles P, 2001, MOL GENET GENOMICS, V266, P12, DOI [10.1007/s004380100353, 10.1007/s004380100535]; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tanaka Ryouichi, 2011, Arabidopsis Book, V9, pe0145, DOI 10.1199/tab.0145; Tanaka T, 2004, PLANT J, V37, P139, DOI 10.1046/j.1365-313X.2003.01946.x; TERRAS FRG, 1993, FEBS LETT, V316, P233, DOI 10.1016/0014-5793(93)81299-F; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Vandeputte O, 2005, APPL ENVIRON MICROB, V71, P1169, DOI 10.1128/AEM.71.3.1169-1177.2005; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Weigel RR, 2005, PLANT CELL, V17, P1279, DOI 10.1105/tpc.104.027441; Weymann K, 1995, PLANT CELL, V7, P2013, DOI 10.1105/tpc.7.12.2013; WITTY M, 1993, PLANT PHYSIOL, V103, P139, DOI 10.1104/pp.103.1.139; Witty M, 1996, PLANTA, V199, P557, DOI 10.1007/BF00195187; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	82	25	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53378	10.1371/journal.pone.0053378	http://dx.doi.org/10.1371/journal.pone.0053378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308205	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800043
J	Almenara, DP; de Moura, JP; Scarabotto, CP; Zingali, RB; Winter, CE				Almenara, Daniela P.; de Moura, Joselene P.; Scarabotto, Cristiane P.; Zingali, Russolina B.; Winter, Carlos E.			The Molecular and Structural Characterization of Two Vitellogenins from the Free-Living Nematode Oscheius tipulae	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; YOLK PROTEINS; SEQUENCE; PRECURSOR; INSECT; EVOLUTION; BINDING; GENE; IDENTIFICATION; LIPOVITELLIN	This paper describes the purification of yolk proteins, which are important for the reproduction of egg-laying animals, and the structural characterization of two vitellogenins, VT1 and OTI-VIT-6, of the nematode Oscheius tipulae. O. tipulae is an alternative model organism to its relative, the widely used Caenorhabditis elegans, and is a good model to understand reproduction in insect parasitic nematodes of the genus Heterorhabditis. The native purified O. tipulae vitellogenin is composed of three polypeptides (VT1, VT2 and VT3), whereas in C. elegans, vitellogenin is composed of four polypeptides. The gene (Oti-vit-1) encoding yolk polypeptide VT1 has been recently identified in the genome of O. tipulae. Immunoblotting and N-terminal sequencing confirmed that VT1 is indeed coded by Oti-vit-1. Utilizing the same experimental approaches, we showed that the polypeptides VT2 and VT3 are derived from the proteolytic processing of the C-and N-terminal portions of the precursor OTI-VIT-6, respectively. We also showed that the recombinant polypeptide (P40), corresponding to the N-terminal sequence of OTI-VIT-6, preferentially interacts with a 100-kDa polypeptide found in adult worm extracts, as we have previously shown for the native vitellins of O. tipulae. Using the putative nematode vitellogenin amino acid sequences available in the UniProtKB database, we constructed a phylogenetic tree and showed that the O. tipulae vitellogenins characterized in this study are orthologous to those of the Caenorhabditis spp. Together, these results represent the first structural and functional comparative study of nematode yolk proteins outside the Caenorhabditis genus and provide insight into the evolution of these lipoproteins within the Nematode Phylum.	[Almenara, Daniela P.; de Moura, Joselene P.; Scarabotto, Cristiane P.; Winter, Carlos E.] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil; [Zingali, Russolina B.] Inst Med Biochem UFRJ CCS Bloco H, Lab Prote & Prot & Peptide Microsequencing, Rio De Janeiro, Brazil	Universidade de Sao Paulo	Winter, CE (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil.	cewinter@icb.usp.br	Winter, Carlos E./A-3085-2008; Zingali, Russolina/G-4862-2012	Winter, Carlos E./0000-0002-0055-2484; Zingali, Russolina/0000-0003-3156-6923	CNPq; FAPESP	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP (http://www.fapesp.br/en/) and CNPq (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IY, 2006, GENOME, V49, P1007, DOI 10.1139/G06-045; Akamine RN, 2008, J MOL EVOL, V67, P278, DOI 10.1007/s00239-008-9147-8; Almenara DP, 2009, THESIS U SAO PAULO; Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; Babin PJ, 1999, J MOL EVOL, V49, P150, DOI 10.1007/PL00006528; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; BLUMENTHAL T, 1984, J MOL BIOL, V174, P1, DOI 10.1016/0022-2836(84)90361-9; Branicky R, 2001, GENETICS, V159, P997; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; Chen JS, 1997, J MOL EVOL, V44, P440, DOI 10.1007/PL00006164; Cheon HM, 2001, INSECT BIOCHEM MOLEC, V31, P753, DOI 10.1016/S0965-1748(01)00068-6; Choi Byung-Kwon, 2009, V462, P181, DOI 10.1007/978-1-60327-115-8_12; Crompton D.W.T., 1989, P9; Felix M.-A., 2006, OSCHEIUS TIPULAE WOR, DOI [DOI 10.1895/WORMBOOK.1.119.1, 10.1895/wormbook.1.119.1]; Felix MA, 2012, 959 NEMATODE GENOMES; GERBERHUBER S, 1987, NUCLEIC ACIDS RES, V15, P4737, DOI 10.1093/nar/15.12.4737; GLASS WF, 1981, ANAL BIOCHEM, V115, P219, DOI 10.1016/0003-2697(81)90549-2; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Grant Barth D, 2006, WormBook, P1; Hagedorn HH, 1998, ADV INSECT PHYSIOL, V27, P335, DOI 10.1016/S0065-2806(08)60015-6; Harris Todd W., 2006, V351, P31; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; Hiramatsu N, 2002, J EXP ZOOL, V292, P11, DOI 10.1002/jez.1138; Jira W, 1998, CHEM PHYS LIPIDS, V91, P1, DOI 10.1016/S0009-3084(97)00095-9; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Komatsu M, 1996, COMP BIOCHEM PHYS B, V113, P561, DOI 10.1016/0305-0491(95)02079-9; LAFLEUR GJ, 1995, J MOL EVOL, V41, P505, DOI 10.1007/BF00160323; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Nakamura A, 1999, BIOCHEM BIOPH RES CO, V264, P580, DOI 10.1006/bbrc.1999.1549; Nico JA, 2009, THESIS U SAO PAULO; PAN ML, 1969, SCIENCE, V165, P393, DOI 10.1126/science.165.3891.393; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Sappington TW, 2002, REPRO BIOL, V12, P69; Sappington TW, 2002, REPROD BIOL INVERTEB, VXII A, P235; Schneider WJ, 1996, INT REV CYTOL, V166, P103, DOI 10.1016/S0074-7696(08)62507-3; Sellers JA, 2005, J BIOL CHEM, V280, P13902, DOI 10.1074/jbc.M500769200; Serino JC, 2008, COMP BIOCHEM PHYS B, V151, P330, DOI 10.1016/j.cbpb.2008.07.017; SHARROCK WJ, 1992, J MOL BIOL, V226, P903, DOI 10.1016/0022-2836(92)90642-W; SHARROCK WJ, 1990, J BIOL CHEM, V265, P14422; SHARROCK WJ, 1984, J MOL BIOL, V174, P419, DOI 10.1016/0022-2836(84)90329-2; SHARROCK WJ, 1983, DEV BIOL, V96, P182, DOI 10.1016/0012-1606(83)90321-4; Shibata Y, 2003, SCIENCE, V302, P1779, DOI 10.1126/science.1087167; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smolenaars MMW, 2007, J LIPID RES, V48, P489, DOI 10.1194/jlr.R600028-JLR200; SPIETH J, 1985, NUCLEIC ACIDS RES, V13, P7129, DOI 10.1093/nar/13.19.7129; SULSTON JE, 1974, GENETICS, V77, P95; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telfer WH, 2002, REPRO BIOL, V12, P29; Thompson JR, 2002, BIOCHEMISTRY-US, V41, P9398, DOI 10.1021/bi025674w; Tong Y, 2004, GENE, V328, P25, DOI 10.1016/j.gene.2003.12.001; VANHETSCHIP FD, 1987, J MOL BIOL, V196, P245, DOI 10.1016/0022-2836(87)90688-7; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; Wang H, 2000, GENE, V256, P303, DOI 10.1016/S0378-1119(00)00376-0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler JR, 2005, TOXICOL MECH METHOD, V15, P293, DOI 10.1080/15376520590968789; Winter CE, 2002, REPRO BIOL, V12, P1; Winter CE, 1996, MOL BIOL EVOL, V13, P674, DOI 10.1093/oxfordjournals.molbev.a025628; WINTER CE, 1992, COMP BIOCHEM PHYS B, V103, P189, DOI 10.1016/0305-0491(92)90430-Y; Wood W.B., 1988, Cold Spring Harbor Monograph Series, V17, P1	64	6	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53460	10.1371/journal.pone.0053460	http://dx.doi.org/10.1371/journal.pone.0053460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308227	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100070
J	Culver, JC; Vadakkan, TJ; Dickinson, ME				Culver, James C.; Vadakkan, Tegy J.; Dickinson, Mary E.			A Specialized Microvascular Domain in the Mouse Neural Stem Cell Niche	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; VASCULAR NICHE; SUBVENTRICULAR ZONE; ENDOTHELIAL-CELLS; STEM/PROGENITOR CELLS; SELF-RENEWAL; BONE-MARROW; HUMAN BRAIN; ADULT; NEUROGENESIS	The microenvironment of the subependymal zone (SEZ) neural stem cell niche is necessary for regulating adult neurogenesis. In particular, signaling from the microvasculature is essential for adult neural stem cell maintenance, but microvascular structure and blood flow dynamics in the SEZ are not well understood. In this work, we show that the mouse SEZ constitutes a specialized microvascular domain defined by unique vessel architecture and reduced rates of blood flow. Additionally, we demonstrate that hypoxic conditions are detectable in the ependymal layer that lines the ventricle, and in a subpopulation of neurons throughout the SEZ and striatum. Together, these data highlight previously unidentified features of the SEZ neural stem cell niche, and further demonstrate the extent of microvascular specialization in the SEZ microenvironment.	[Culver, James C.; Vadakkan, Tegy J.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine	Dickinson, ME (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	mdickins@bcm.edu			NIH [P20 EB007076, U54 CA149196, T32 HL007676]; Optical Imaging and Vital Microscopy Core (OIVM) at BCM; NATIONAL CANCER INSTITUTE [U54CA149196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097520, T32HL007676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P20EB007076] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Optical Imaging and Vital Microscopy Core (OIVM) at BCM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the following NIH grants: P20 EB007076, U54 CA149196, and T32 HL007676 (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Joshua S. Goldberg for sharing immunostaining protocols, and to members of the Dickinson lab for critical reading of the manuscript. We also acknowledge support from the Optical Imaging and Vital Microscopy Core (OIVM) at BCM.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; De Visscher G, 2006, NAT PROTOC, V1, P2162, DOI 10.1038/nprot.2006.332; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; DOWELL RT, 1992, AM J PHYSIOL, V262, pR666, DOI 10.1152/ajpregu.1992.262.4.R666; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Goldberg JS, 2009, REGEN MED, V4, P879, DOI [10.2217/rme.09.61, 10.2217/RME.09.61]; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; Gomez-Gaviro MV, 2012, J CARDIOVASC TRANSL; Gotts JE, 2005, EXP NEUROL, V194, P139, DOI 10.1016/j.expneurol.2005.02.001; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; Gurkan UA, 2008, ANN BIOMED ENG, V36, P1978, DOI 10.1007/s10439-008-9577-x; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Lacar B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031960; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Li WL, 2008, DEV NEUROBIOL, V68, P1474, DOI 10.1002/dneu.20674; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; MILLER B, 1993, EXP NEUROL, V124, P326, DOI 10.1006/exnr.1993.1203; Mirzadeh Z., 2010, J VIS EXP; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Miyamoto N, 2009, NEUROSCIENCE, V162, P525, DOI 10.1016/j.neuroscience.2009.05.004; Mobley AK, 2009, J CELL SCI, V122, P1842, DOI 10.1242/jcs.043257; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161; Neubauer JA, 2004, J APPL PHYSIOL, V96, P367, DOI 10.1152/japplphysiol.00831.2003; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Ohura Norihiko, 2003, J Atheroscler Thromb, V10, P304; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; QUINN B, 1995, NEUROSCI LETT, V184, P169, DOI 10.1016/0304-3940(94)11198-R; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Rodriguez-Jimenez FJ, 2012, STEM CELLS; Roitbak T, 2008, J CEREBR BLOOD F MET, V28, P1530, DOI 10.1038/jcbfm.2008.38; Roitbak T, 2011, CELL MOL NEUROBIOL, V31, P119, DOI 10.1007/s10571-010-9561-5; ROSENBLUM WI, 1977, STROKE, V8, P103, DOI 10.1161/01.STR.8.1.103; RUDOLPH AM, 1967, CIRC RES, V21, P163, DOI 10.1161/01.RES.21.2.163; San Martin N, 2011, STEM CELLS, V29, P1064, DOI 10.1002/stem.654; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; SARIN SK, 1990, AM J PHYSIOL, V258, pG365, DOI 10.1152/ajpgi.1990.258.3.G365; Sawada M, 2000, J CEREBR BLOOD F MET, V20, P112, DOI 10.1097/00004647-200001000-00015; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Tabrizchi R, 2000, J PHARMACOL TOX MET, V44, P375, DOI 10.1016/S1056-8719(00)00123-4; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; TORACK RM, 1976, J NEUROPATH EXP NEUR, V35, P385, DOI 10.1097/00005072-197607000-00001; Tormos KV, 2010, J CELL MOL MED, V14, P795, DOI 10.1111/j.1582-4934.2010.01031.x; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Wang L, 2007, EXP EYE RES, V84, P108, DOI 10.1016/j.exer.2006.09.005; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Zhu CL, 2009, J CEREBR BLOOD F MET, V29, P342, DOI 10.1038/jcbfm.2008.124	77	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53546	10.1371/journal.pone.0053546	http://dx.doi.org/10.1371/journal.pone.0053546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308251	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429100088
J	Garcia-Montojo, M; Dominguez-Mozo, M; Arias-Leal, A; Garcia-Martinez, A; De las Heras, V; Casanova, I; Faucard, R; Gehin, N; Madeira, A; Arroyo, R; Curtin, F; Alvarez-Lafuente, R; Perron, H				Garcia-Montojo, Marta; Dominguez-Mozo, Maria; Arias-Leal, Ana; Garcia-Martinez, Angel; De las Heras, Virginia; Casanova, Ignacio; Faucard, Raphael; Gehin, Nadege; Madeira, Alexandra; Arroyo, Rafael; Curtin, Francois; Alvarez-Lafuente, Roberto; Perron, Herve			The DNA Copy Number of Human Endogenous Retrovirus-W (MSRV-Type) Is Increased in Multiple Sclerosis Patients and Is Influenced by Gender and Disease Severity	PLOS ONE			English	Article							REAL-TIME PCR; MOLECULAR CHARACTERIZATION; PROCESSED PSEUDOGENES; REVERSE-TRANSCRIPTASE; ENVELOPE PROTEIN; EXPRESSION; PARTICLES; ORIGIN; ENV; SEQUENCES	Background: Multiple Sclerosis is an autoimmune disease more prevalent in women than in men. Multiple Sclerosis Associated Retrovirus element (MSRV) is a member of type-W endogenous retrovirus family (HERV-W), known to be associated to MS. Most HERVs are unable to replicate but MSRV expression associated with reverse-transcriptase activity in MS would explain reported DNA copy number increase in MS patients. A potential link between HERV-W copies on chromosome X and gender differential prevalence has been suggested. The present study addresses MSRV-type DNA load in relation with the gender differences and clinical status in MS and healthy controls. Results: 178 MS patients (62.9% women) and 124 controls (56.5% women) were included. MSRV env load (copies/pg of DNA) was analyzed by real time qPCR with specific primers and probe for its env gene, in DNA from peripheral blood mononuclear cells (PBMCs). MSRV load was more elevated in MS patients than in controls (p = 4.15e-7). MS women presented higher MSRV load than control women (p = 0.009) and MS men also had higher load than control men (p = 2.77e-6). Besides, women had higher levels than men, both among patients (p = 0.007) and controls (p = 1.24e-6). Concordantly, EDSS and MSSS scores were higher among female patients with an elevated MSRV load (p = 0.03 and p = 0.04, respectively). Conclusions: MSRV increases its copy number in PBMC of MS patients and particularly in women with high clinical scores. This may explain causes underlying the higher prevalence of MS in women. The association with the clinical severity calls for further investigations on MSRV load in PBMCs as a biomarker for MS.	[Garcia-Montojo, Marta; Dominguez-Mozo, Maria; Arias-Leal, Ana; Garcia-Martinez, Angel; De las Heras, Virginia; Casanova, Ignacio; Arroyo, Rafael; Alvarez-Lafuente, Roberto] Hosp Clin San Carlos, Inst Invest Sanitaria, Multiple Sclerosis Unit, Madrid, Spain; [Faucard, Raphael; Gehin, Nadege; Madeira, Alexandra; Curtin, Francois; Perron, Herve] Geneuro Innovat, Lyon, France	Hospital Clinico San Carlos	Garcia-Montojo, M (corresponding author), Hosp Clin San Carlos, Inst Invest Sanitaria, Multiple Sclerosis Unit, Madrid, Spain.	mgarciamon.hcsc@salud.madrid.org	Alvarez-Lafuente, Roberto/AAJ-9980-2020; Perron, Herve/AAN-5887-2020	Perron, Herve/0000-0002-2551-7685; Dominguez-Mozo, Maria Inmaculada/0000-0001-9236-5717; Alvarez-Lafuente, Roberto/0000-0002-3132-1486; Garcia-Montojo, Marta/0000-0003-0664-3480	Fundacion para la Investigacion Biomedica-Hospital Clinico San Carlos; Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) [CP07/00273]; REEM: Red Espanola de Esclerosis Multiple [RETICS-REEM RD07/0060]; Geneuro; Instituto de Salud Carlos III-Fondo Investigaciones Sanitarias FIS [09/02074]; Fundacion Mutua Madrilena; Fundacion LAIR; Geneuro Innovation	Fundacion para la Investigacion Biomedica-Hospital Clinico San Carlos; Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder)(European Commission); REEM: Red Espanola de Esclerosis Multiple; Geneuro; Instituto de Salud Carlos III-Fondo Investigaciones Sanitarias FIS; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion LAIR; Geneuro Innovation	MGM, MDM and AAL are recipients of a contract of "Fundacion para la Investigacion Biomedica-Hospital Clinico San Carlos". RAL is recipient of a research contract of the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) (CP07/00273). AGM is recipient of a technician contract from "REEM: Red Espanola de Esclerosis Multiple" (RETICS-REEM RD07/0060; www.reem.es.) This work was supported by Geneuro and by grants from: Instituto de Salud Carlos III-Fondo Investigaciones Sanitarias FIS (09/02074), "Fundacion Mutua Madrilena", and "Fundacion LAIR". All of the funders but Geneuro had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RF, NG, AM, FC and HP are employees of Geneuro and MGM received honoraria from this company for scientific consultancy. The study has been funded in part by Geneuro Innovation, a company developing therapies and diagnostic tools for diseases associated with the expression of human endogenous retroviruses, with a primary focus on the Nervous System diseases and Multiple Sclerosis. There are no patents, further products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], DATA BASE OF GENOME; [Anonymous], ENSEMBL GENOME BROWS; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2006, AIDS RES HUM RETROV, V22, P1253, DOI 10.1089/aid.2006.22.1253; Brudek T, 2007, J NEUROIMMUNOL, V187, P147, DOI 10.1016/j.jneuroim.2007.04.003; Brudek T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-104; Christensen T, 2000, ACTA NEUROL SCAND, V101, P229, DOI 10.1034/j.1600-0404.2000.101004229.x; Cossburn M, 2012, MULT SCLER J, V18, P45, DOI 10.1177/1352458511417479; de Villiers JNP, 2006, METAB BRAIN DIS, V21, P163, DOI 10.1007/s11011-006-9016-3; Deb-Rinker P, 1999, GENOMICS, V61, P133, DOI 10.1006/geno.1999.5946; Dolei A, 2002, NEUROLOGY, V58, P471, DOI 10.1212/WNL.58.3.471; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Firouzi R, 2003, J NEUROVIROL, V9, P79, DOI 10.1080/13550280390173328; Garson JA, 2009, AIDS RES HUM RETROV, V25, P377, DOI 10.1089/aid.2008.0270; Greer JM, 2011, J NEUROIMMUNOL, V234, P7, DOI 10.1016/j.jneuroim.2011.03.003; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Herrera BM, 2008, NEUROLOGY, V71, P799, DOI 10.1212/01.wnl.0000312377.50395.00; Komurian-Pradel F, 1999, VIROLOGY, V260, P1, DOI 10.1006/viro.1999.9792; Krokki O, 2011, MULT SCLER J, V17, P133, DOI 10.1177/1352458510384012; Kurtzke JF, 1983, NEUROLOGY, P33; Laska MJ, 2012, J VIROL, V86, P3713, DOI 10.1128/JVI.06723-11; Laufer G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-37; Lleo A, 2008, AUTOIMMUN REV, V7, P626, DOI 10.1016/j.autrev.2008.06.009; Mameli G, 2008, J NEUROVIROL, V14, P73, DOI 10.1080/13550280701801107; Mameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0; Mameli G, 2009, J VIROL METHODS, V161, P98, DOI 10.1016/j.jviromet.2009.05.024; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nowak J, 2003, J NEUROVIROL, V9, P112, DOI 10.1080/13550280390173355; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Otowa T, 2006, NEUROSCI LETT, V408, P226, DOI 10.1016/j.neulet.2006.09.004; Pavlicek A, 2002, GENOME RES, V12, P391, DOI 10.1101/gr.216902; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Perron H, 2001, VIROLOGY, V287, P321, DOI 10.1006/viro.2001.1045; PERRON H, 1989, RES VIROLOGY, V140, P551, DOI 10.1016/S0923-2516(89)80141-4; PERRON H, 1991, LANCET, V337, P862, DOI 10.1016/0140-6736(91)92579-Q; PERRON H, 1997, ACTA NEUROL SCAND  S, V169, P22; Perron H, 2012, MULT SCLER; Perron H, 2010, CLIN REV ALLERG IMMU, V39, P51, DOI 10.1007/s12016-009-8170-x; Perron H, 2009, J NEUROL SCI, V286, P65, DOI 10.1016/j.jns.2009.04.034; Petersen T, 2009, J NEUROIMMUNOL, V215, P108, DOI 10.1016/j.jneuroim.2009.08.015; Ramagopalan SV, 2009, NEUROLOGY, V73, P602, DOI 10.1212/WNL.0b013e3181af33cf; Roebke C, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-69; Rolland A, 2006, J IMMUNOL, V176, P7636, DOI 10.4049/jimmunol.176.12.7636; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Ruprecht K, 2006, J NEUROVIROL, V12, P65, DOI 10.1080/13550280600614973; Sadovnick AD, 2009, J NEUROL SCI, V286, P1, DOI 10.1016/j.jns.2009.09.005; Sotgiu S, 2006, MULT SCLER J, V12, P698, DOI 10.1177/1352458506070773; Sotgiu S, 2002, NEUROLOGY, V59, P1071, DOI 10.1212/WNL.59.7.1071; Sutkowski N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2; Tai AK, 2008, MULT SCLER J, V14, P1175, DOI 10.1177/1352458508094641; Tai AK, 2009, J CLIN VIROL, V46, P47, DOI 10.1016/j.jcv.2009.05.019; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007	56	48	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53623	10.1371/journal.pone.0053623	http://dx.doi.org/10.1371/journal.pone.0053623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308264	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429100097
J	Gray, C; Li, ML; Reynolds, CM; Vickers, MH				Gray, Clint; Li, Minglan; Reynolds, Clare M.; Vickers, Mark H.			Pre-Weaning Growth Hormone Treatment Reverses Hypertension and Endothelial Dysfunction in Adult Male Offspring of Mothers Undernourished during Pregnancy	PLOS ONE			English	Article							CHRONIC MATERNAL UNDERNUTRITION; LOW-PROTEIN DIET; BLOOD-PRESSURE; GAP-JUNCTIONS; NITRIC-OXIDE; DEPENDENT HYPERPOLARIZATION; DOUBLE-BLIND; GUINEA-PIG; FACTOR-I; RAT	Maternal undernutrition results in elevated blood pressure (BP) and endothelial dysfunction in adult offspring. However, few studies have investigated interventions during early life to ameliorate the programming of hypertension and vascular disorders. We have utilised a model of maternal undernutrition to examine the effects of pre-weaning growth hormone (GH) treatment on BP and vascular function in adulthood. Female Sprague-Dawley rats were fed either a standard control diet (CON) or 50% of CON intake throughout pregnancy (UN). From neonatal day 3 until weaning (day 21), CON and UN pups received either saline (CON-S, UN-S) or GH (2.5 ug/g/day)(CON-GH, UN-GH). All dams were fed ad libitum throughout lactation. Male offspring were fed a standard diet until the end of the study. Systolic blood pressure (SBP) was measured at day 150 by tail cuff plethysmography. At day 160, intact mesenteric vessels mounted on a pressure myograph. Responses to pressure, agonist-induced constriction and endothelium-dependent vasodilators were investigated to determine vascular function. SBP was increased in UN-S groups and normalised in UN-GH groups (CON-S 121 +/- 2 mmHg, CON-GH 115 +/- 3, UN-S 146 +/- 3, UN-GH 127 +/- 2). Pressure mediated dilation was reduced in UN-S offspring and normalised in UN-GH groups. Vessels from UN-S offspring demonstrated a reduced constrictor response to phenylephrine and reduced vasodilator response to acetylcholine (ACh). Furthermore, UN-S offspring vessels displayed a reduced vasodilator response in the presence of L-NG-Nitroarginine Methyl Ester (L-NAME), carbenoxolone (CBX), L-NAME and CBX, Tram-34 and Apamin. UN-GH vessels showed little difference in responses when compared to CON and significantly increased vasodilator responses when compared to UN-S offspring. Pre-weaning GH treatment reverses the negative effects of maternal UN on SBP and vasomotor function in adult offspring. These data suggest that developmental cardiovascular programming is potentially reversible by early life GH treatment and that GH can reverse the vascular adaptations resulting from maternal undernutrition.	[Gray, Clint; Li, Minglan; Reynolds, Clare M.; Vickers, Mark H.] Univ Auckland, Liggins Inst & Gravida, Natl Ctr Growth & Dev, Auckland 1, New Zealand	University of Auckland	Gray, C (corresponding author), Univ Auckland, Liggins Inst & Gravida, Natl Ctr Growth & Dev, Auckland 1, New Zealand.	c.gray@auckland.ac.nz		Reynolds, Clare/0000-0001-5782-6303; Vickers, Mark/0000-0003-4876-9356; Li, Minglan/0000-0002-3095-7490	National Research Centre of Growth & development (NRCGD); Capex; Liggins Institute; University of Auckland; Gravida: National Centre for Growth and Development	National Research Centre of Growth & development (NRCGD); Capex; Liggins Institute; University of Auckland; Gravida: National Centre for Growth and Development	Minglan Li was supported by a National Research Centre of Growth & development (NRCGD) doctoral training grant. Clint Gray received equipment grant support from Capex, Liggins Institute and University of Auckland. This work was funded by Gravida: National Centre for Growth and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves J G, 1999, J Perinatol, V19, P593; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Boger RH, 1996, J CLIN INVEST, V98, P2706, DOI 10.1172/JCI119095; Brawley L., 2003, Archives of Physiology and Biochemistry, V111, P23, DOI 10.1076/apab.111.1.23.15138; Chadha PS, 2011, J PHARMACOL EXP THER, V336, P701, DOI 10.1124/jpet.110.165795; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Chaytor AT, 1999, J PHYSIOL-LONDON, V520, P539, DOI 10.1111/j.1469-7793.1999.00539.x; CHEN GF, 1992, CIRC RES, V70, P257, DOI 10.1161/01.RES.70.2.257; Coleman HA, 2001, J PHYSIOL-LONDON, V531, P359, DOI 10.1111/j.1469-7793.2001.0359i.x; Connors BW, 2012, EPILEPSY CURR, V12, P66, DOI 10.5698/1535-7511-12.2.66; Edwards G, 1999, BRIT J PHARMACOL, V128, P1788, DOI 10.1038/sj.bjp.0703009; Egecioglu E, 2005, AM J PHYSIOL-ENDOC M, pE317; Fazio S, 1997, EUR HEART J, V18, P340; Franco MDP, 2002, CARDIOVASC RES, V56, P145, DOI 10.1016/S0008-6363(02)00508-4; Gangula PRR, 2004, BIOL REPROD, V71, P1739, DOI 10.1095/biolreprod.104.031369; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Goto K, 2002, CLIN EXP PHARMACOL P, V29, P595, DOI 10.1046/j.1440-1681.2002.03689.x; Hadoke PWF, 2006, J ENDOCRINOL, V188, P435, DOI 10.1677/joe.1.06506; Howie GJ, 2012, BRIT J NUTR, V108, P298, DOI 10.1017/S000711451100554X; Isgaard J, 1998, EUR HEART J, V19, P1704, DOI 10.1053/euhj.1998.1123; Jackson AA, 2002, CLIN SCI, V103, P633, DOI 10.1042/cs1030633; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kansui Y, 2008, CELL CALCIUM, V44, P135, DOI 10.1016/j.ceca.2007.11.012; Kenny LC, 2002, BRIT J PHARMACOL, V136, P1085, DOI 10.1038/sj.bjp.0704817; Khan AS, 2002, CARDIOVASC RES, V54, P25, DOI 10.1016/S0008-6363(01)00533-8; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Laborie C, 2011, J NEUROENDOCRINOL, V23, P711, DOI 10.1111/j.1365-2826.2011.02159.x; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Li J, 2009, J NUTR, V139, P447, DOI 10.3945/jn.108.097451; Longobardi S, 2000, GROWTH HORM IGF RES, V10, P242, DOI 10.1054/ghir.2000.0160; LUCAS A, 1991, CIBA F SYMP, V156, P38; McCallum RW, 2002, CLIN ENDOCRINOL, V57, P11, DOI 10.1046/j.1365-2265.2002.01559.x; MONCADA S, 1991, P NATL ACAD SCI USA, V88, P2166, DOI 10.1073/pnas.88.6.2166; MULVANY MJ, 1984, HYPERTENSION, V6, P13; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Murphy ME, 1995, J PHYSIOL-LONDON, V489, P723, DOI 10.1113/jphysiol.1995.sp021086; Nystrom Henrik C, 2005, BMC Physiol, V5, P17, DOI 10.1186/1472-6793-5-17; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Pladys P, 2004, PEDIATR RES, V55, P1042, DOI 10.1203/01.PDR.0000127012.37315.36; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Rossoni G, 1999, J CARDIOVASC PHARM, V34, P454, DOI 10.1097/00005344-199909000-00021; Rozental R, 2001, METH MOL B, V154, P447; Sas T, 1999, J CLIN ENDOCR METAB, V84, P3064, DOI 10.1210/jc.84.9.3064; Schilling T, 2007, PFLUG ARCH EUR J PHY, V454, P559, DOI 10.1007/s00424-007-0232-4; Schreuder MF, 2006, J HYPERTENS, V24, P1337, DOI 10.1097/01.hjh.0000234114.33025.fd; Sherman RC, 1998, CLIN SCI, V94, P373, DOI 10.1042/cs0940373; Stankevicius E, 2011, JPET; TAKEZAWA H, 1994, AM J PHYSIOL-REG I, V267, pR1250, DOI 10.1152/ajpregu.1994.267.5.R1250; Tivesten A, 2001, GROWTH HORM IGF RES, V11, P187, DOI 10.1054/ghir.2001.0202; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Torrens C, 2009, BRIT J NUTR, V101, P27, DOI 10.1017/S0007114508988760; Torrens C, 2009, HYPERTENSION, V53, P661, DOI 10.1161/HYPERTENSIONAHA.108.122820; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vickers MH, 2002, J ENDOCRINOL, V175, P615, DOI 10.1677/joe.0.1750615; Vickers MH, 2001, ENDOCRINOLOGY, V142, P3964, DOI 10.1210/en.142.9.3964; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Wolfe D, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.033; Woodall SM, 1996, J ENDOCRINOL, V150, P231, DOI 10.1677/joe.0.1500231; Woodall SM, 1996, PEDIATR RES, V40, P438, DOI 10.1203/00006450-199609000-00012; Wulff H, 2001, J BIOL CHEM, V276, P32040, DOI 10.1074/jbc.M105231200; YANG RH, 1995, CIRCULATION, V92, P262, DOI 10.1161/01.CIR.92.2.262	63	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53505	10.1371/journal.pone.0053505	http://dx.doi.org/10.1371/journal.pone.0053505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308239	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429100077
J	Shukla, S; Sharma, H; Abbas, A; MacLennan, GT; Fu, PF; Danielpour, D; Gupta, S				Shukla, Sanjeev; Sharma, Haripaul; Abbas, Ata; MacLennan, Gregory T.; Fu, Pingfu; Danielpour, David; Gupta, Sanjay			Upregulation of SATB1 Is Associated with Prostate Cancer Aggressiveness and Disease Progression	PLOS ONE			English	Article							DNA-BINDING PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; CARCINOMA CELLS; NUCLEAR-MATRIX; E-CADHERIN; RICH; REGION; DIFFERENTIATION; OVEREXPRESSION	Disease aggressiveness remains a critical factor to the progression of prostate cancer. Transformation of epithelial cells to mesenchymal lineage, associated with the loss of E-cadherin, offers significant invasive potential and migration capability. Recently, Special AT-rich binding protein (SATB1) has been linked to tumor progression. SATB1 is a cell-type restricted nuclear protein, which functions as a tissue-specific organizer of DNA sequences during cellular differentiation. Our results demonstrate that SATB1 plays significant role in prostate tumor invasion and migration and its nuclear localization correlates with disease aggressiveness. Clinical specimen analysis showed that SATB1 was predominantly expressed in the nucleus of high-grade tumors compared to low-grade tumor and benign tissue. A progressive increase in the nuclear levels of SATB1 was observed in cancer tissues compared to benign specimens. Similarly, SATB1 protein levels were higher in a number of prostate cancer cells viz. HPV-CA-10, DU145, DUPro, PC-3, PC-3M, LNCaP and C4-2B, compared to non-tumorigenic PZ-HPV-7 cells. Nuclear expression of SATB1 was higher in biologically aggressive subclones of prostate cancer cells with their respective parental cell lines. Furthermore, ectopic SATB1 transfection conferred increased cell motility and invasiveness in immortalized human prostate epithelial PZ-HPV-7 cells which correlated with the loss of E-cadherin expression. Consequently, knockdown of SATB1 in highly aggressive human prostate cancer PC-3M cells inhibited invasiveness and tumor growth in vivo along with increase in E-cadherin protein expression. Our findings demonstrate that SATB1 has ability to promote prostate cancer aggressiveness through epithelial-mesenchymal transition.	[Shukla, Sanjeev; Sharma, Haripaul; Abbas, Ata; Gupta, Sanjay] Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA; [Shukla, Sanjeev; Sharma, Haripaul; Abbas, Ata; MacLennan, Gregory T.; Gupta, Sanjay] Univ Hosp Case, Med Ctr, Cleveland, OH USA; [MacLennan, Gregory T.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Fu, Pingfu] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Danielpour, David] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Fu, Pingfu; Danielpour, David; Gupta, Sanjay] Case Comprehens Canc Ctr, Div Gen Med Sci, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Gupta, S (corresponding author), Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA.	sanjay.gupta@case.edu	Fu, Pingfu/O-5415-2019	Fu, Pingfu/0000-0002-2334-5218; Gupta, Sanjay/0000-0002-9492-3249; MacLennan, Gregory T./0000-0003-0089-449X; Abbas, Ata/0000-0001-8272-1853	United States Public Health Service [RO1CA115491]; Endowment funds; NATIONAL CANCER INSTITUTE [R01CA115491] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Endowment funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by United States Public Health Service Grants RO1CA115491 and Endowment funds to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; American Cancer Society, 2011, CANC FACTS FIG 2011; Barboro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040617; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; CUNNINGHAM JM, 1994, BLOOD, V84, P1298; GINGRICH JR, 1991, J UROLOGY, V146, P915, DOI 10.1016/S0022-5347(17)37960-0; Glynne R, 2000, IMMUNOL REV, V176, P216; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hsiao W, 2010, J UROLOGY, V184, P512, DOI 10.1016/j.juro.2010.04.010; Iorns E, 2010, JNCI-J NATL CANCER I, V102, P1284, DOI 10.1093/jnci/djq243; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; LaTulippe E, 2002, CANCER RES, V62, P4499; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Li QQ, 2010, CANCER SCI, V101, P80, DOI 10.1111/j.1349-7006.2009.01372.x; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Notani D, 2010, METHODS MOL BIOL, V647, P317, DOI 10.1007/978-1-60761-738-9_20; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Ramakrishnan M, 2000, MOL CELL BIOL, V20, P868, DOI 10.1128/MCB.20.3.868-877.2000; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Selinger CI, 2011, J THORAC ONCOL, V6, P1179, DOI 10.1097/JTO.0b013e31821b4ce0; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Sun J, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-1561; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Thompson EW, 2008, CLIN EXP METASTAS, V25, P591, DOI 10.1007/s10585-008-9189-8; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Yanagisawa J, 1996, CANCER RES, V56, P457; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang C, 2011, PROSTATE, V71, P157, DOI 10.1002/pros.21231; Zhao Xiao-lan, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P82; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777; Zhou Lai-Yong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P534	39	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53527	10.1371/journal.pone.0053527	http://dx.doi.org/10.1371/journal.pone.0053527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308245	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429100083
J	Zhao, XY; Wang, ZM; Zhang, JY; Hua, JM; He, W; Zhu, SK				Zhao, Xinyu; Wang, ZiMian; Zhang, Junyi; Hua, Jianming; He, Wei; Zhu, Shankuan			Estimation of Total Body Skeletal Muscle Mass in Chinese Adults: Prediction Model by Dual-Energy X-Ray Absorptiometry	PLOS ONE			English	Article							ADIPOSE-TISSUE INFILTRATION; LEG MUSCLE; MEN; AGE; RESISTANCE; STRENGTH; GENDER; INDEX	Background: There are few reports on total body skeletal muscle mass (SM) in Chinese. The objective of this study is to establish a prediction model of SM for Chinese adults. Methodology: Appendicular lean soft tissue (ALST) was measured by dual energy X-ray absorptiometry (DXA) and SM by magnetic resonance image (MRI) in 66 Chinese adults (52 men and 14 women). Images of MRI were segmented into compartments including intermuscular adipose tissue (IMAT) and IMAT-free SM. Regression was used to fit the prediction model SM = c + k x ALST. Age and gender were adjusted in the fitted model. The piece-wise linear function was performed to further explore the effect of age on SM. 'Leave-One-Out Cross Validation' was utilized to evaluate the prediction performance. The significance of observed differences between predicted and actual SM was tested by t test and the level of agreement was assessed by the method of Bland and Altman. Results: Men had greater ALST and IMAT-free SM than women. ALST was the primary predictor and highly correlated with IMAT-free SM (R-2 = 0.94, SEE = 1.11 kg, P < 0.001). Age was an additional predictor (SM prediction model with age adjusted R-2 = 0.95, SEE = 1.05 kg, P < 0.001). There was a piece-wise linear relationship between age and IMAT-free SM: IMAT-free SM = 1.21 x ALST-0.98, (Age <45 years) and IMAT-free SM = 1.21 x ALST-0.98-0.04x (Age=45), (Age >= 45years). The prediction performance of this age-adjusted model was good due to 'Leave-One-Out Cross Validation'. No significant difference between measured and predicted IMAT-free SM was detected. Conclusion: Previous SM prediction model developed in multi-ethnic groups underestimated SM by 2.3% and 3.4% for Chinese men and women. A new prediction model by DXA has been established to predict SM in Chinese adults.	[Zhao, Xinyu; He, Wei; Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Chron Dis Res Inst, Obes & Body Composit Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Xinyu; Wang, ZiMian] Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Obes Res Ctr, New York, NY 10027 USA; [Zhang, Junyi] Columbia Univ, Dept Stat, New York, NY USA; [Hua, Jianming] Zhejiang Univ, Affiliated Hosp 2, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Columbia University; Zhejiang University; Zhejiang University	Wang, ZM (corresponding author), Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Obes Res Ctr, New York, NY 10027 USA.	zw28@columbia.edu; zsk@zju.edu.cn	He, Wei/C-8441-2015; Zhang, Junyi/HDN-7815-2022	He, Wei/0000-0003-0161-3274; 	China Medical Board [10-014]; China Scholarship Council [2011632118]	China Medical Board; China Scholarship Council(China Scholarship Council)	This study is supported by China Medical Board (No. 10-014) Research Project (2011) and China Scholarship Council (No. 2011632118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsley DA, 2005, WILEY SERIES PROBABI; BEMBEN M G, 1991, Medicine and Science in Sports and Exercise, V23, P1302; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bogin B, 2008, INT J EPIDEMIOL, V37, P201, DOI 10.1093/ije/dym254; CLEMENT FJ, 1974, J GERONTOL, V29, P423, DOI 10.1093/geronj/29.4.423; Cook RD, 1982, RESIDUALS INFLUENCE; Deurenberg P, 1999, INT J OBESITY, V23, P537, DOI 10.1038/sj.ijo.0800868; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; Eveleth PB, 1990, WORLDWIDE VARIATION; Forbes G, 1987, HUMAN BODY COMPOSITI; FULLER NJ, 1992, CLIN PHYSIOL, V12, P253, DOI 10.1111/j.1475-097X.1992.tb00831.x; Gallagher D, 2005, AM J CLIN NUTR, V81, P903, DOI 10.1093/ajcn/81.4.903; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Hamill PVV, 1973, DHEW PUBLICATION 11, V11; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; HEYMSFIELD SB, 1995, J GERONTOL A-BIOL, V50, P23; HURLEY BF, 1995, J GERONTOL A-BIOL, V50, P41; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kehayias JJ, 1997, AM J CLIN NUTR, V66, P904, DOI 10.1093/ajcn/66.4.904; Kim J, 2004, J APPL PHYSIOL, V97, P655, DOI 10.1152/japplphysiol.00260.2004; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Levine JA, 2000, J APPL PHYSIOL, V88, P452, DOI 10.1152/jappl.2000.88.2.452; LEXELL J, 1986, J NEUROL SCI, V72, P211, DOI 10.1016/0022-510X(86)90009-2; Lin YC, 2004, APPL ERGON, V35, P173, DOI 10.1016/j.apergo.2004.01.004; Lukasaki HC, 2005, HUMAN BODY COMPOSITI, P203; Malina R.M., 1996, HUMAN BODY COMPOSITI, P217; Miljkovic I, 2009, J CLIN ENDOCR METAB, V94, P2735, DOI 10.1210/jc.2008-2541; Miljkovic-Gacic I, 2008, AM J CLIN NUTR, V87, P1590, DOI 10.1093/ajcn/87.6.1590; Ross R, 1996, CAN J PHYSIOL PHARM, V74, P778, DOI 10.1139/cjpp-74-6-778; Ryan AS, 2002, OBES RES, V10, P336, DOI 10.1038/oby.2002.47; Shen W, 2003, OBES RES, V11, P217, DOI 10.1038/oby.2003.34; Shih R, 2000, J APPL PHYSIOL, V89, P1380, DOI 10.1152/jappl.2000.89.4.1380; Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956; Snyder WS, 1975, REPORT TASK GROUP RE; Song MY, 2004, AM J CLIN NUTR, V79, P874; Song MY, 2002, J APPL PHYSIOL, V92, P2285, DOI 10.1152/japplphysiol.01066.2001; TSENG BS, 1995, J GERONTOL A-BIOL, V50, P113; Visser M, 1999, J APPL PHYSIOL, V87, P1513, DOI 10.1152/jappl.1999.87.4.1513; Wang W, 1999, J APPL PHYSIOL, V87, P1163, DOI 10.1152/jappl.1999.87.3.1163; Wang ZM, 1996, J APPL PHYSIOL, V80, P824, DOI 10.1152/jappl.1996.80.3.824; WANG ZM, 1992, AM J CLIN NUTR, V56, P19, DOI 10.1093/ajcn/56.1.19	45	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e53561	10.1371/journal.pone.0053561	http://dx.doi.org/10.1371/journal.pone.0053561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23308254	Green Published, gold			2022-12-27	WOS:000313429100091
J	Hoekstra, EJ; Mesman, S; de Munnik, WA; Smidt, MP				Hoekstra, Elisa J.; Mesman, Simone; de Munnik, Willem A.; Smidt, Marten P.			LMX1B Is Part of a Transcriptional Complex with PSPC1 and PSF	PLOS ONE			English	Article							MESENCEPHALIC DOPAMINERGIC-NEURONS; LIM-HOMEODOMAIN PROTEINS; NAIL-PATELLA-SYNDROME; ISTHMIC ORGANIZER; WNT1 EXPRESSION; DIFFERENTIATION; CELLS; RNA; PARASPECKLES; PROGENITORS	The LIM homeodomain transcription factor Lmx1b is essential for the development of the isthmic organizer and mesodiencephalic dopaminergic neurons. The uncoupling of Pitx3 and Th expression, in the Lmx1b null mutant, suggests that Lmx1b may act as a positional activator of the mdDA domain, eventually leading to properly differentiating mdDA neurons. In this study, we aimed to elucidate how Lmx1b functions mechanistically in this developmental process, by searching for molecular interactors of Lmx1b at the protein level. Initially, affinity-purification of LMX1B-HIS overexpressed protein in MN9D dopaminergic cells followed by mass-spectrometry analysis, resulted in the identification of PSPC1 protein as a possible binding partner of LMX1B. Subsequent immunoprecipitation experiments revealed an interaction between LMX1B and PSPC1 in a larger protein complex also containing PSF. This complex was observed in vitro and in vivo, and we hypothesize that, via PSF and PSPC1, LMX1B may be part of the previously identified Nurr1 transcriptional complex wherein interaction with the co-repressor PSF and the transcription factor Pitx3 is needed to drive expression of Nurr1 target genes in specifying the dopaminergic phenotype. Furthermore, we identified GRLF1, DHX9, MYO1C, HSP70 and TMPO as potential LMX1B interactors. DHX9 and GRLF1 are highly expressed in the developing mdDA neuronal field, and GRLF1 and MYO1C have both been linked to neurite outgrowth. The identification of these proteins suggests that Lmx1b may act directly in the transcriptional activation of Nurr1 target genes and be involved in other processes like neurite outgrowth as well.	[Hoekstra, Elisa J.; Mesman, Simone; de Munnik, Willem A.; Smidt, Marten P.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Hoekstra, Elisa J.; Mesman, Simone; Smidt, Marten P.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam	Smidt, MP (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	m.p.smidt@uva.nl		Mesman, Simone/0000-0002-9728-5828; Smidt, Marten/0000-0002-8815-747X	VICI-grant [865.09.002]; TI Pharma grant (The Netherlands) [T5-207]	VICI-grant; TI Pharma grant (The Netherlands)	This work was supported by a VICI-grant (no. 865.09.002 to M.P. Smidt) and by a TI Pharma grant (no. T5-207, The Netherlands) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KA, 2000, DEVELOPMENT, V127, P1857; Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Berger R, 1996, GENOME RES, V6, P361, DOI 10.1101/gr.6.5.361; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Brandstaetter H, 2012, J CELL SCI; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Burbach JPH, 2003, ANN NY ACAD SCI, V991, P61; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Guo C, 2007, DEVELOPMENT, V134, P317, DOI 10.1242/dev.02745; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Jeon CY, 2010, J CELL PHYSIOL, V224, P786, DOI 10.1002/jcp.22184; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li JZ, 1999, P NATL ACAD SCI USA, V96, P709, DOI 10.1073/pnas.96.2.709; Lin W, 2009, DEV BIOL, V333, P386, DOI 10.1016/j.ydbio.2009.07.006; Marini M, 2005, EUR J HUM GENET, V13, P789, DOI 10.1038/sj.ejhg.5201405; Marini M, 2003, INT J MOL MED, V12, P79; Metzakopian E, 2012, DEVELOPMENT, V139, P2625, DOI 10.1242/dev.081034; Myojin R, 2004, BIOL REPROD, V71, P926, DOI 10.1095/biolreprod.104.028159; Nagel F, 2008, J NEUROCHEM, V105, P853, DOI 10.1111/j.1471-4159.2007.05204.x; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; SHERR EH, 1993, J CELL BIOL, V120, P1405, DOI 10.1083/jcb.120.6.1405; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smidt MP, 2003, EUR J PHARMACOL, V480, P75, DOI 10.1016/j.ejphar.2003.08.094; Tzchori I, 2009, DEVELOPMENT, V136, P1375, DOI 10.1242/dev.026476; Yan CH, 2011, J NEUROSCI, V31, P12413, DOI 10.1523/JNEUROSCI.1077-11.2011; Zhao Y, 2007, P NATL ACAD SCI USA, V104, P13182, DOI 10.1073/pnas.0705464104; Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200	32	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2013	8	1							e53122	10.1371/journal.pone.0053122	http://dx.doi.org/10.1371/journal.pone.0053122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KP	23308148	Green Published, Green Submitted, gold			2022-12-27	WOS:000313670100019
J	Zeng, JG; Liu, YS; Liu, W; Liu, XB; Liu, FQ; Huang, P; Zhu, PC; Chen, JJ; Shi, MM; Guo, F; Cheng, P; Zeng, J; Liao, YF; Gong, J; Zhang, HM; Wang, DP; Guo, AY; Xiong, XY				Zeng, Jianguo; Liu, Yisong; Liu, Wei; Liu, Xiubing; Liu, Fuqing; Huang, Peng; Zhu, Pengcheng; Chen, Jinjun; Shi, Mingming; Guo, Fang; Cheng, Pi; Zeng, Jing; Liao, Yifang; Gong, Jing; Zhang, Hong-Mei; Wang, Depeng; Guo, An-Yuan; Xiong, Xingyao			Integration of Transcriptome, Proteome and Metabolism Data Reveals the Alkaloids Biosynthesis in Macleaya cordata and Macleaya microcarpa	PLOS ONE			English	Article							CANADENSIS CELL-CULTURES; RNA-SEQ DATA; OPIUM POPPY; DIHYDROBENZOPHENANTHRIDINE OXIDASE; SANGUINARINE REDUCTASE; MASS-SPECTROMETRY; MOLECULAR-CLONING; SAFETY ASSESSMENT; REFERENCE GENOME; SIEVE ELEMENTS	Background: The Macleaya spp., including Macleaya cordata and Macleaya microcarpa, are traditional anti-virus, inflammation eliminating, and insecticide herb medicines for their isoquinoline alkaloids. They are also known as the basis of the popular natural animal food addictive in Europe. However, few studies especially at genomics level were conducted on them. Hence, we performed the Macleaya spp. transcriptome and integrated it with iTRAQ proteome analysis in order to identify potential genes involved in alkaloids biosynthesis. Methodology and Principal Findings: We elaborately designed the transcriptome, proteome and metabolism profiling for 10 samples of both species to explore their alkaloids biosynthesis. From the transcriptome data, we obtained 69367 and 78255 unigenes for M. cordata and M. microcarpa, in which about two thirds of them were similar to sequences in public databases. By metabolism profiling, reverse patterns for alkaloids sanguinarine, chelerythrine, protopine, and allocryptopine were observed in different organs of two species. We characterized the expressions of enzymes in alkaloid biosynthesis pathways. We also identified more than 1000 proteins from iTRAQ proteome data. Our results strongly suggest that the root maybe the organ for major alkaloids biosynthesis of Macleaya spp. Except for biosynthesis, the alkaloids storage and transport were also important for their accumulation. The ultrastructure of laticifers by SEM helps us to prove the alkaloids maybe accumulated in the mature roots. Conclusions/Significance: To our knowledge this is the first study to elucidate the genetic makeup of Macleaya spp. This work provides clues to the identification of the potential modulate genes involved in alkaloids biosynthesis in Macleaya spp., and sheds light on researches for non-model medicinal plants by integrating different high-throughput technologies.	[Zeng, Jianguo; Liu, Yisong; Liu, Xiubing; Zhu, Pengcheng; Chen, Jinjun; Xiong, Xingyao] Hunan Agr Univ, Hunan Prov Key Lab Crop Germplasm Innovat & Utili, Changsha, Hunan, Peoples R China; [Zeng, Jianguo; Liu, Yisong; Liu, Xiubing; Zhu, Pengcheng; Chen, Jinjun; Xiong, Xingyao] Hunan Agr Univ, Natl Chinese Med Herbs Hunan Technol Ctr, Changsha, Hunan, Peoples R China; [Liu, Wei; Liao, Yifang; Gong, Jing; Zhang, Hong-Mei; Guo, An-Yuan] Huazhong Univ Sci & Technol, Dept Biomed Engn, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Liu, Wei; Liao, Yifang; Gong, Jing; Zhang, Hong-Mei; Wang, Depeng] Next Biosci Co Ltd, Wuhan, Peoples R China; [Shi, Mingming; Guo, Fang] BGI Shenzhen, Shenzhen, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Huazhong University of Science & Technology; Beijing Genomics Institute (BGI)	Guo, AY (corresponding author), Huazhong Univ Sci & Technol, Dept Biomed Engn, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	zengjianguo@hunau.net; guoay@mail.hust.edu.cn; xiongxy@hunau.net	Huang, Peng/AAJ-9432-2021; Guo, An-Yuan/K-3656-2012; Feng, Yuan/F-7295-2012	Huang, Peng/0000-0002-8367-8196; Chen, Wei/0000-0003-2275-4527; , Jinjun/0000-0001-5495-051X; Feng, Yuan/0000-0002-6369-0737	China-Belgium Cooperation Research on Plants Medicine Utilization & Crop Pests Forecasting and Control Technology [2010DFA32810]; National Key technology R&D Program for demonstration of neotype Chinese herbal veterinary drugs [2011BAD34B02]; National Natural Science Foundation of China [31171271]; Young Teachers' Fund for Doctor Stations; Ministry of Education of China [20110142120042]	China-Belgium Cooperation Research on Plants Medicine Utilization & Crop Pests Forecasting and Control Technology; National Key technology R&D Program for demonstration of neotype Chinese herbal veterinary drugs(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teachers' Fund for Doctor Stations; Ministry of Education of China(Ministry of Education, China)	This work was supported by China-Belgium Cooperation Research on Plants Medicine Utilization & Crop Pests Forecasting and Control Technology (2010DFA32810), the National Key technology R&D Program (2011BAD34B02) for demonstration of neotype Chinese herbal veterinary drugs, National Natural Science Foundation of China (31171271), Young Teachers' Fund for Doctor Stations, Ministry of Education of China (20110142120042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA H, 1992, ARCH BIOCHEM BIOPHYS, V299, P1, DOI 10.1016/0003-9861(92)90236-P; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barkan A, 2009, METHODS MOL BIOL, V553, P13, DOI 10.1007/978-1-60327-563-7_2; Bird DA, 2003, PLANT CELL, V15, P2626, DOI 10.1105/tpc.015396; Chen YZ, 2009, J CHROMATOGR A, V1216, P2104, DOI 10.1016/j.chroma.2008.08.066; Chow KS, 2011, J EXP BOT; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Facchini Peter J., 2007, Phytochemistry Reviews, V6, P97, DOI 10.1007/s11101-006-9042-0; Franz C, 2005, CFTEFSAFEEDAP200501; Fuchino H, 2010, CHEM PHARM BULL, V58, P1047, DOI 10.1248/cpb.58.1047; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Ignatov A, 1996, PHYTOCHEMISTRY, V43, P1141, DOI 10.1016/S0031-9422(96)00540-7; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Juskiewicz J, 2011, J ANIM PHYSIOL AN N, V95, P171, DOI 10.1111/j.1439-0396.2010.01037.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kosina P, 2010, FITOTERAPIA, V81, P1006, DOI 10.1016/j.fitote.2010.06.020; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liu H, 2009, NAT PROD COMMUN, V4, P1557; NESSLER CL, 1992, PLANT MOL BIOL, V20, P749, DOI 10.1007/BF00046460; Park SU, 2002, PLANT PHYSIOL, V128, P696, DOI 10.1104/pp.010741; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Psotova J, 2006, VET MED-CZECH, V51, P145, DOI 10.17221/5534-VETMED; RUEFFER M, 1987, TETRAHEDRON LETT, V28, P5307, DOI 10.1016/S0040-4039(00)96715-7; Samanani N, 2006, PLANT J, V47, P547, DOI 10.1111/j.1365-313X.2006.02801.x; Shitan N, 2007, CURR PHARM BIOTECHNO, V8, P244; Stiborova M, 2008, BIOMED PAP, V152, P35, DOI 10.5507/bp.2008.005; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Urbanczyk-Wochniak E, 2003, EMBO REP, V4, P989, DOI 10.1038/sj.embor.embor944; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Vichkanova S.A., 1982, PHARM CHEM J+, V16, P925, DOI [10.1007/BF00767855, DOI 10.1007/BF00767855]; Vogel M, 2010, J BIOL CHEM, V285, P18397, DOI 10.1074/jbc.M109.088989; Vrba J, 2011, TOXICOL LETT, V203, P135, DOI 10.1016/j.toxlet.2011.03.015; Weiss D, 2006, PLANT CELL ENVIRON, V29, P291, DOI 10.1111/j.1365-3040.2005.01421.x; Yang J, 1999, Zhong Yao Cai, V22, P82; Yao JY, 2010, PARASITOL RES, V107, P1035, DOI 10.1007/s00436-010-1966-z; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Ye Fengzhi, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1683; Ye HG, 2010, MOL CELL BIOCHEM, V343, P91, DOI 10.1007/s11010-010-0502-x; Zdarilova A, 2008, FOOD CHEM TOXICOL, V46, P3721, DOI 10.1016/j.fct.2008.09.054; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5	47	86	103	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53409	10.1371/journal.pone.0053409	http://dx.doi.org/10.1371/journal.pone.0053409			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326424	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500068
J	Wang, JF; Hu, MG; Xu, CD; Christakos, G; Zhao, Y				Wang, Jin-Feng; Hu, Mao-Gui; Xu, Cheng-Dong; Christakos, George; Zhao, Yu			Estimation of Citywide Air Pollution in Beijing	PLOS ONE			English	Article							PARTICULATE MATTER; SOURCE APPORTIONMENT; AMBIENT AIR; PM2.5; PM10; PARTICLES; QUALITY; ATMOSPHERE; ILLNESS	There has been discrepancies between the daily air quality reports of the Beijing municipal government, observations recorded at the U. S. Embassy in Beijing, and Beijing residents' perceptions of air quality. This study estimates Beijing's daily area PM2.5 mass concentration by means of a novel technique SPA (Single Point Areal Estimation) that uses data from the single PM2.5 observation station of the U. S Embassy and the 18 PM10 observation stations of the Beijing Municipal Environmental Protection Bureau. The proposed technique accounts for empirical relationships between different types of observations, and generates best linear unbiased pollution estimates (in a statistical sense). The technique extends the daily PM2.5 mass concentrations obtained at a single station (U. S. Embassy) to a citywide scale using physical relations between pollutant concentrations at the embassy PM2.5 monitoring station and at the 18 official PM10 stations that are evenly distributed across the city. Insight about the technique's spatial estimation accuracy (uncertainty) is gained by means of theoretical considerations and numerical validations involving real data. The technique was used to study citywide PM2.5 pollution during the 423-day period of interest (May 10, 2010 to December 6, 2011). Finally, a freely downloadable software library is provided that performs all relevant calculations of pollution estimation.	[Wang, Jin-Feng; Hu, Mao-Gui; Xu, Cheng-Dong; Zhao, Yu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Christakos, George] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Zhao, Yu] Cent S Univ, Sch Geosci & Infophys, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; California State University System; San Diego State University; Central South University	Wang, JF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	wangjf@lreis.ac.cn	Hu, Maogui/N-7105-2013; xu, chengdong/O-8200-2017	Hu, Maogui/0000-0002-7671-7863; xu, chengdong/0000-0002-9266-7309; Wang, Jinfeng/0000-0002-6687-9420; Christakos, George/0000-0002-1865-5764	NSFC [41023010, 41271404]; MOST [2012CB955503, 2011AA120305]; CAS [XDA05090102]; Yongqian Chair Professorship (Zhejiang University, China)	NSFC(National Natural Science Foundation of China (NSFC)); MOST; CAS(Chinese Academy of Sciences); Yongqian Chair Professorship (Zhejiang University, China)	This study was supported by the following grants: NSFC (41023010; 41271404), MOST (2012CB955503; 2011AA120305) and CAS (XDA05090102). George Christakos was supported by a Yongqian Chair Professorship (Zhejiang University, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Bayraktar H, 2010, STOCH ENV RES RISK A, V24, P57, DOI 10.1007/s00477-008-0299-2; BJ-EPB, 2011, BEIJ MUN ENV PROT BU; Brook JR, 1997, J AIR WASTE MANAGE, V47, P2, DOI 10.1080/10473289.1997.10464407; Christakos G, 1998, ATMOS ENVIRON, V32, P2845, DOI 10.1016/S1352-2310(98)00407-5; Fu BJ, 2008, SCIENCE, V321, P611, DOI 10.1126/science.1162213; Gomiscek B, 2004, ATMOS ENVIRON, V38, P3917, DOI 10.1016/j.atmosenv.2004.03.056; Guzman F, 1996, SCIENCE, V271, P1040, DOI 10.1126/science.271.5252.1040; Isaaks E.H., 1989, ISA; Jerrett M, 2007, STOCH ENV RES RISK A, V21, P511, DOI 10.1007/s00477-007-0133-2; Kaiser J, 2000, SCIENCE, V289, P22, DOI 10.1126/science.289.5476.22; Kaiser J, 1997, SCIENCE, V276, P33, DOI 10.1126/science.276.5309.33; Kumar N, 2009, ATMOS ENVIRON, V43, P1153, DOI 10.1016/j.atmosenv.2008.10.055; Kumar R, 2006, ENVIRON MONIT ASSESS, V119, P191, DOI 10.1007/s10661-005-9022-7; Lelieveld J, 2002, SCIENCE, V298, P794, DOI 10.1126/science.1075457; Li CS, 2002, AEROSOL SCI TECH, V36, P469, DOI 10.1080/027868202753571287; Lundgren DA, 1996, AEROSOL SCI TECH, V25, P353, DOI 10.1080/02786829608965401; Maraziotis E, 2008, GLOBAL NEST J, V10, P123; Marcazzan GM, 2001, ATMOS ENVIRON, V35, P4639, DOI 10.1016/S1352-2310(01)00124-8; Marshall JD, 2008, ATMOS ENVIRON, V42, P1359, DOI 10.1016/j.atmosenv.2007.08.012; MEP-PRC, 1996, GB30951996 MEPPRC, P2; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Ostro B., 2004, OUTDOOR AIR POLLUTIO; Pandey P, 2012, B ENVIRON CONTAM TOX, V88, P265, DOI 10.1007/s00128-011-0466-x; Pyne S, 2002, SCIENCE, V295, P1994; Reis BY, 2007, PLOS MED, V4, P1019, DOI 10.1371/journal.pmed.0040210; Song Y, 2007, J HAZARD MATER, V146, P124, DOI 10.1016/j.jhazmat.2006.11.058; Tiwari S, 2012, AEROSOL AIR QUAL RES, V12, P20, DOI 10.4209/aaqr.2011.06.0075; US-Embassy-in-Beijing, 2011, US EMB BEIJ AIR QUAL; van de Kassteele J, 2006, STOCH ENV RES RISK A, V21, P183, DOI 10.1007/s00477-006-0055-4; Wang HL, 2008, J ENVIRON SCI, V20, P1323, DOI 10.1016/S1001-0742(08)62228-7; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024498; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; WHO-Europe, 2006, AIR QUAL GUID GLOB U; Wiwanitkit V, 2008, STOCH ENV RES RISK A, V22, P437, DOI 10.1007/s00477-007-0149-7; XinHuaNet, 2011, CHIN US EXP EXPL BEI; Zheng M, 2005, ATMOS ENVIRON, V39, P3967, DOI 10.1016/j.atmosenv.2005.03.036	37	139	148	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53400	10.1371/journal.pone.0053400	http://dx.doi.org/10.1371/journal.pone.0053400			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23894665	gold, Green Published			2022-12-27	WOS:000313429800046
J	Tan, TC; Spadiut, O; Wongnate, T; Sucharitakul, J; Krondorfer, I; Sygmund, C; Haltrich, D; Chaiyen, P; Peterbauer, CK; Divne, C				Tan, Tien Chye; Spadiut, Oliver; Wongnate, Thanyaporn; Sucharitakul, Jeerus; Krondorfer, Iris; Sygmund, Christoph; Haltrich, Dietmar; Chaiyen, Pimchai; Peterbauer, Clemens K.; Divne, Christina			The 1.6 angstrom Crystal Structure of Pyranose Dehydrogenase from Agaricus meleagris Rationalizes Substrate Specificity and Reveals a Flavin Intermediate	PLOS ONE			English	Article							FLAVOPROTEIN OXIDASES; OXYGEN ACTIVATION; PROTEIN-STRUCTURE; HYDRIDE TRANSFER; ALCOHOL OXIDASE; C-3 OXIDATION; ACTIVE-SITE; MECHANISM; 2-OXIDASE; SUGAR	Pyranose dehydrogenases (PDHs) are extracellular flavin-dependent oxidoreductases secreted by litter-decomposing fungi with a role in natural recycling of plant matter. All major monosaccharides in lignocellulose are oxidized by PDH at comparable yields and efficiencies. Oxidation takes place as single-oxidation or sequential double-oxidation reactions of the carbohydrates, resulting in sugar derivatives oxidized primarily at C2, C3 or C2/3 with the concomitant reduction of the flavin. A suitable electron acceptor then reoxidizes the reduced flavin. Whereas oxygen is a poor electron acceptor for PDH, several alternative acceptors, e. g., quinone compounds, naturally present during lignocellulose degradation, can be used. We have determined the 1.6-angstrom crystal structure of PDH from Agaricus meleagris. Interestingly, the flavin ring in PDH is modified by a covalent mono- or di-atomic species at the C(4a) position. Under normal conditions, PDH is not oxidized by oxygen; however, the related enzyme pyranose 2-oxidase (P2O) activates oxygen by a mechanism that proceeds via a covalent flavin C(4a)-hydroperoxide intermediate. Although the flavin C(4a) adduct is common in monooxygenases, it is unusual for flavoprotein oxidases, and it has been proposed that formation of the intermediate would be unfavorable in these oxidases. Thus, the flavin adduct in PDH not only shows that the adduct can be favorably accommodated in the active site, but also provides important details regarding the structural, spatial and physicochemical requirements for formation of this flavin intermediate in related oxidases. Extensive in silico modeling of carbohydrates in the PDH active site allowed us to rationalize the previously reported patterns of substrate specificity and regioselectivity. To evaluate the regioselectivity of D-glucose oxidation, reduction experiments were performed using fluorinated glucose. PDH was rapidly reduced by 3-fluorinated glucose, which has the C2 position accessible for oxidation, whereas 2-fluorinated glucose performed poorly (C3 accessible), indicating that the glucose C2 position is the primary site of attack.	[Tan, Tien Chye; Spadiut, Oliver; Divne, Christina] KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Tan, Tien Chye; Divne, Christina] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Wongnate, Thanyaporn; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Wongnate, Thanyaporn; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok, Thailand; [Krondorfer, Iris; Sygmund, Christoph; Haltrich, Dietmar; Peterbauer, Clemens K.] BOKU Univ Nat Resources & Life Sci, Food Biotechnol Lab, Vienna, Austria	Royal Institute of Technology; Karolinska Institutet; Mahidol University; Mahidol University; Chulalongkorn University; University of Natural Resources & Life Sciences, Vienna	Divne, C (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden.	divne@biotech.kth.se	Divne, Christina/E-8646-2010; Chaiyen, Pimchai/R-5052-2019; Haltrich, Dietmar/N-2624-2019	Divne, Christina/0000-0002-5805-2693; Chaiyen, Pimchai/0000-0002-8533-1604; Haltrich, Dietmar/0000-0002-8722-8176; Peterbauer, Clemens/0000-0002-8033-198X	Swedish Research Council Formas; Swedish Research Council VR; Carl Tryggers Foundation; Thailand Research Fund [BRG5480001]; Faculty of Science, Mahidol University; Austrian Science Fund (FWF) [P22094]; BioTop (Biomolecular Technology of Proteins; Austrian Science Fund) [FWF W1224]; Austrian Science Fund (FWF) [P 22094] Funding Source: researchfish	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council VR(Swedish Research Council); Carl Tryggers Foundation; Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); BioTop (Biomolecular Technology of Proteins; Austrian Science Fund); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors acknowledge support to CD and TCT from the Swedish Research Council Formas, the Swedish Research Council VR, and the Carl Tryggers Foundation. PC acknowledges research support by the Thailand Research Fund (BRG5480001) and the Faculty of Science, Mahidol University. CKP thanks the Austrian Science Fund (FWF) for financial support (grant P22094). IK is part of the doctoral program BioTop (Biomolecular Technology of Proteins; Austrian Science Fund FWF W1224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ander P, 1997, J BIOTECHNOL, V53, P115, DOI 10.1016/S0168-1656(97)01680-5; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dix NJ, 1995, FUNGAL ECOL, P549; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez IS, 2009, ACTA CRYSTALLOGR D, V65, P1196, DOI 10.1107/S0907444909035860; Finnegan S, 2010, ARCH BIOCHEM BIOPHYS, V501, P207, DOI 10.1016/j.abb.2010.06.014; Finnegan S, 2010, BIOCHEMISTRY-US, V49, P2952, DOI 10.1021/bi902048c; Forneris F, 2008, BIOCHEMISTRY-US, V47, P978, DOI 10.1021/bi701886t; Fraaije MW, 1998, TRENDS BIOCHEM SCI, V23, P206, DOI 10.1016/S0968-0004(98)01210-9; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Gadda G, 2008, BIOCHEMISTRY-US, V47, P13745, DOI 10.1021/bi801994c; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Hallberg BM, 2003, J BIOL CHEM, V278, P7160, DOI 10.1074/jbc.M210961200; Hallberg BM, 2002, J MOL BIOL, V315, P421, DOI 10.1006/jmbi.2001.5246; Hernandez-Ortega A, 2011, J BIOL CHEM, V286, P41105, DOI 10.1074/jbc.M111.282467; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kittl R, 2008, CURR GENET, V53, P117, DOI 10.1007/s00294-007-0171-9; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Kommoju PR, 2011, BIOCHEMISTRY-US, V50, P5521, DOI 10.1021/bi200388g; Kujawa M, 2007, FEBS J, V274, P879, DOI 10.1111/j.1742-4658.2007.05634.x; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MASSEY V, 1994, J BIOL CHEM, V269, P22459; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Menova P, 2011, J MOL STRUCT, V1004, P178, DOI 10.1016/j.molstruc.2011.08.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peterbauer CK, 2010, APPL MICROBIOL BIOT, V85, P837, DOI 10.1007/s00253-009-2226-y; Pisanelli I, 2012, APPL MICROBIOL BIOT, V93, P1157, DOI 10.1007/s00253-011-3568-9; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; Quaye O, 2008, BIOCHEMISTRY-US, V47, P243, DOI 10.1021/bi7017943; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Sedmera P, 2004, TETRAHEDRON LETT, V45, P8677, DOI 10.1016/j.tetlet.2004.09.149; Sedmera P, 2006, J MOL CATAL B-ENZYM, V41, P32, DOI 10.1016/j.molcatb.2006.04.004; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Sucharitakul J, 2011, J BIOL CHEM, V286, P16900, DOI 10.1074/jbc.M111.222976; Sucharitakul J, 2010, BIOCHEMISTRY-US, V49, P3753, DOI 10.1021/bi100187b; Sygmund C, 2008, J BIOTECHNOL, V133, P334, DOI 10.1016/j.jbiotec.2007.10.013; Sygmund C, 2012, APPL MICROBIOL BIOT, V94, P695, DOI 10.1007/s00253-011-3667-7; Tan TC, 2011, J MOL BIOL, V409, P588, DOI 10.1016/j.jmb.2011.04.019; Tan TC, 2010, J MOL BIOL, V402, P578, DOI 10.1016/j.jmb.2010.08.011; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; UENO K, 1984, ACTA CRYSTALLOGR C, V40, P1726, DOI 10.1107/S0108270184009306; Volc J, 2004, J MOL CATAL B-ENZYM, V30, P177, DOI 10.1016/j.molcatb.2004.05.006; Volc J, 2002, J MOL CATAL B-ENZYM, V17, P91, DOI 10.1016/S1381-1177(02)00014-0; VOLC J, 1985, FOLIA MICROBIOL, V30, P141, DOI 10.1007/BF02922207; Volc J, 1998, CARBOHYD RES, V310, P151, DOI 10.1016/S0008-6215(98)00151-7; Volc J, 2000, CARBOHYD RES, V329, P219, DOI 10.1016/S0008-6215(00)00167-1; Volc J, 2001, ARCH MICROBIOL, V176, P178, DOI 10.1007/s002030100308; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wohlfahrt G, 1999, ACTA CRYSTALLOGR D, V55, P969, DOI 10.1107/S0907444999003431; Wong CM, 2008, APPL MICROBIOL BIOT, V78, P927, DOI 10.1007/s00253-008-1407-4; Wongnate T, 2011, CHEMBIOCHEM, V12, P2577, DOI 10.1002/cbic.201100564	68	38	39	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53567	10.1371/journal.pone.0053567	http://dx.doi.org/10.1371/journal.pone.0053567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	24039879	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500085
J	Zhang, L; Xiao, RJ; Xiong, J; Leng, J; Ehtisham, A; Hu, Y; Ding, QS; Xu, H; Liu, SW; Wang, J; Tang, DG; Zhang, QP				Zhang, Li; Xiao, Ruijing; Xiong, Jie; Leng, Jun; Ehtisham, Altaf; Hu, Yi; Ding, Qianshan; Xu, Hui; Liu, Shengwu; Wang, Jin; Tang, Dean G.; Zhang, Qiuping			Activated ERM Protein Plays a Critical Role in Drug Resistance of MOLT4 Cells Induced by CCL25	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; ACTIN CYTOSKELETON; MYELOID-LEUKEMIA; IN-VITRO; EXPRESSION; TRANSPORTERS; MECHANISM; APOPTOSIS; EZRIN	We have previously demonstrated that the CCR9/CCL25 signaling pathway plays an important role in drug resistance in human acute T-lymphocytic leukemia (T-ALL) by inducing activation of ERM protein with polarized distribution in T-ALL cell line MOLT4. However, the mechanism of action of the activated ERM protein in the drug resistance of MOLT4 cells induced by CCL25 remains uncharacterized. Here we investigated the mechanism of CCR9/CCL25-initiated drug resistance in CCR9-high-expressing T-ALL cells. Our results showed that 1) the function of P-gp was increased after treatment with CCL25; 2) P-gp colocalized and co-immunoprecipitated with p-ERM and F-actin in CCL25 treated cells; and 3) ERM-shRNA conferred drug sensitivity coincident with release of ERM interactions with P-gp and F-actin after treatment with CCL25. These data suggest it is pivotal that P-gp associate with the F-actin cytoskeleton through p-ERM in CCR9/CCL25 induced multidrug resistance of T-ALL cells. Strategies aimed at inhibiting P-gp-F-actin cytoskeleton association may be helpful in increasing the efficiency of therapies in T-ALL.	[Zhang, Li; Xiao, Ruijing; Xiong, Jie; Leng, Jun; Ehtisham, Altaf; Hu, Yi; Ding, Qianshan; Xu, Hui; Liu, Shengwu; Wang, Jin; Zhang, Qiuping] Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan 430072, Peoples R China; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA	Wuhan University; University of Texas System; UTMD Anderson Cancer Center	Zhang, QP (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan 430072, Peoples R China.	qpzhang@whu.edu.cn	zhang, qiu/GXG-5600-2022; Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174	National Science Foundation of China [30570780, 30971280, 30801336]; National Ministry of Doctoral Fund [200804860039]; Fundamental Research Funds for the Central Universities [301274622]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Doctoral Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Science Foundation of China (No.30570780, 30971280, 30801336), National Ministry of Doctoral Fund (No.200804860039) and the Fundamental Research Funds for the Central Universities (No.301274622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2004, CARCINOGENESIS, V25, P941, DOI 10.1093/carcin/bgh060; Asakura K, 2004, MOL CANCER RES, V2, P339; Brambilla D, 2012, INT J CANCER, V130, P2824, DOI 10.1002/ijc.26285; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Cohen JD, 2011, TOXICOL SCI, V122, P361, DOI 10.1093/toxsci/kfr118; Ding KF, 2009, CARCINOGENESIS, V30, P35, DOI 10.1093/carcin/bgn251; Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006; Galski H, 2006, LEUKEMIA RES, V30, P1151, DOI 10.1016/j.leukres.2006.02.016; Goler-Baron V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016007; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hayashi K, 1999, J CELL SCI, V112, P1149; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Villar VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037735; Kater L, 2012, TOXICOL IN VITRO, V26, P119, DOI 10.1016/j.tiv.2011.09.010; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Liu ZL, 2002, CANCER CHEMOTH PHARM, V49, P391, DOI 10.1007/s00280-001-0411-5; Luciani F, 2002, BLOOD, V99, P641, DOI 10.1182/blood.V99.2.641; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Meschini S, 2000, INT J CANCER, V87, P615, DOI 10.1002/1097-0215(20000901)87:5<615::AID-IJC1>3.3.CO;2-W; Molinari A, 2002, CURR PROTEIN PEPT SC, V3, P653, DOI 10.2174/1389203023380413; Padanyi R, 2010, J BIOL CHEM, V285, P31704, DOI 10.1074/jbc.M110.164137; PUI CH, 1993, BLOOD, V82, P343; Raaijmakers MHGP, 2007, LEUKEMIA, V21, P2094, DOI 10.1038/sj.leu.2404859; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Rudd LP, 2011, CHEM-BIOL INTERACT, V194, P113, DOI 10.1016/j.cbi.2011.08.012; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Stege A, 2004, CANCER GENE THER, V11, P699, DOI 10.1038/sj.cgt.7700751; Tong XL, 2009, CELL MOL IMMUNOL, V6, P181, DOI 10.1038/cmi.2009.25; TSURUO T, 1981, CANCER RES, V41, P1967; Walter RB, 2007, BLOOD, V109, P4168, DOI 10.1182/blood-2006-09-047399; Willemse MJ, 2002, BLOOD, V99, P4386, DOI 10.1182/blood.V99.12.4386; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Zhang QP, 2004, CANCER RES, V64, P7579, DOI 10.1158/0008-5472.CAN-04-0641; Zhou BB, 2010, LEUKEMIA RES, V34, P769, DOI 10.1016/j.leukres.2009.11.025	37	104	111	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52384	10.1371/journal.pone.0052384	http://dx.doi.org/10.1371/journal.pone.0052384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326330	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500013
J	Cheng, HR; Liu, CJ; Tseng, TC; Su, TH; Yang, HI; Chen, CJ; Kao, JH				Cheng, Huei-Ru; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Yang, Hwai-I; Chen, Chien-Jen; Kao, Jia-Horng			Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients	PLOS ONE			English	Article							SURFACE-ANTIGEN SEROCLEARANCE; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; FOLLOW-UP; DNA LEVEL; DETERMINANTS; ASSOCIATION; CLEARANCE; PROGNOSIS; TAIWAN	Spontaneous clearance of hepatitis B surface antigen (HBsAg) in chronic hepatitis B (CHB) patients usually indicates a remission of hepatitis activity and a favorable outcome. Two single nucleotide polymorphisms (SNP), rs3077 near HLA-DPA1 region and rs9277535 near HLA-DPB1 region, have been shown to be associated with HBV persistence after acute HBV infection. However, little is known about the impact of these 2 SNPs on spontaneous HBsAg clearance in CHB patients. In this case-control study, a total of 100 male HBeAg-negative chronic HBV carriers who cleared HBsAg spontaneously (case group) and 100 age-matched HBeAg-negative male patients with persistent HBsAg positivity (control group) were enrolled. We investigated the relationship between these 2 SNPs and HBsAg clearance. There was a higher frequency of rs9277535 non-GG genotype in the case group (57% vs. 42%). Patients with rs9277535 non-GG genotype had a higher chance to clear HBsAg [Odds ratio (OR): 1.83, 95% confidence interval (CI): 1.04 similar to 3.21, P = 0.034]. Compared to GG haplotype of rs3077 and rs9277535, GA haplotype had a higher chance of achieving spontaneous HBsAg loss (OR: 2.17, 95% CI: 1.14 similar to 4.16, P = 0.030). In conclusion, rs9277535 non-GG genotype is associated with a higher likelihood of spontaneous HBsAg seroclearance in CHB patients.	[Cheng, Huei-Ru; Liu, Chun-Jen; Kao, Jia-Horng] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan; [Liu, Chun-Jen; Su, Tung-Hung; Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 10764, Taiwan; [Liu, Chun-Jen; Su, Tung-Hung; Kao, Jia-Horng] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Liu, Chun-Jen; Su, Tung-Hung; Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 10764, Taiwan; [Kao, Jia-Horng] Natl Taiwan Univ, Dept Med Res, Coll Med, Taipei 10764, Taiwan; [Tseng, Tai-Chung] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, Taipei, Taiwan; [Yang, Hwai-I] China Med Univ Hosp, Mol & Genom Epidemiol Ctr, Taichung, Taiwan; [Yang, Hwai-I] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Yang, Hwai-I; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Buddhist Tzu Chi General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan	Kao, JH (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan.	kaojh@ntu.edu.tw	Kao, Jia-Horng/AAB-8947-2019; Ekanayake, Kanchana/P-8817-2016; Rooney, Kieron/I-6252-2018; Cheng, Hoi Lun/AAK-8937-2021; O'Connor, Helen/C-1289-2014; Research Institute, ANZAC/CAE-9030-2022; Steinbeck, Kate/AAX-6197-2020; Chen, Chien-Jen/C-6976-2008; Yang, Hwai-I/A-9470-2008; Chen, Chien-Jen/N-4723-2019	Kao, Jia-Horng/0000-0002-2442-7952; Rooney, Kieron/0000-0001-6563-7617; Cheng, Hoi Lun/0000-0002-2144-9195; O'Connor, Helen/0000-0002-6198-4141; Yang, Hwai-I/0000-0002-3433-942X; LIU, CHUN-JEN/0000-0002-6202-0993; SU, TUNG-HUNG/0000-0002-6747-7941	National Taiwan University; National Science Council, and Department of Health, Executive Yuan, Taiwan; National Taiwan University Hospital, Taiwan	National Taiwan University(National Taiwan University); National Science Council, and Department of Health, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taiwan	The work was supported by grants from the National Taiwan University; the National Science Council, and Department of Health, Executive Yuan, Taiwan; National Taiwan University Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Chu CM, 2010, ANTIVIR THER, V15, P133, DOI 10.3851/IMP1497; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Handunnetthi L, 2010, GENES IMMUN, V11, P99, DOI 10.1038/gene.2009.83; HSU HY, 1986, J MED VIROL, V18, P301, DOI 10.1002/jmv.1890180402; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kao JH, 2003, INTERVIROLOGY, V46, P400, DOI 10.1159/000074999; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim JH, 2008, HEPATO-GASTROENTEROL, V55, P578; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; LIAW YF, 1991, HEPATOLOGY, V13, P627, DOI 10.1002/hep.1840130403; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Simonetti J, 2010, HEPATOLOGY, V51, P1531, DOI 10.1002/hep.23464; Su TH, 2010, ANTIVIR THER, V15, P1133, DOI 10.3851/IMP1696; Tseng TC, 2012, HEPATOLOGY, V55, P68, DOI 10.1002/hep.24615; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yeh SH, 2004, J HEPATOL, V41, P659, DOI 10.1016/j.jhep.2004.06.031	27	91	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53008	10.1371/journal.pone.0053008	http://dx.doi.org/10.1371/journal.pone.0053008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23861932	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800028
J	Wennstrom, M; Surova, Y; Hall, S; Nilsson, C; Minthon, L; Bostrom, F; Hansson, O; Nielsen, HM				Wennstrom, Malin; Surova, Yulia; Hall, Sara; Nilsson, Christer; Minthon, Lennart; Bostrom, Fredrik; Hansson, Oskar; Nielsen, Henrietta M.			Low CSF Levels of Both alpha-Synuclein and the alpha-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy	PLOS ONE			English	Article							MULTIPLE-SYSTEM ATROPHY; HUMAN CEREBROSPINAL-FLUID; HUMAN KALLIKREIN 6; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; LEWY BODIES; SERINE-PROTEASE; NEURODEGENERATIVE DISORDERS; SUBSTRATE-SPECIFICITY; DIAGNOSTIC-CRITERIA	Neurosin is a protease that in vitro degrades alpha-synuclein, the main constituent of Lewy bodies found in brains of patients with synucleinopathy including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Several studies have reported reduced cerebrospinal fluid (CSF) levels of alpha-synuclein in synucleinopathy patients and recent data also proposes a significant role of alpha-synuclein in the pathophysiology of Alzheimer's disease (AD). To investigate potential links between neurosin and its substrate alpha-synuclein in vivo we used a commercially available sandwich ELISA and an in-house developed direct ELISA to quantify CSF levels of alpha-synuclein and neurosin in patients diagnosed with DLB, PD and PD dementia (PDD) versus AD patients and non-demented controls. We found that patients with synucleinopathy displayed lower CSF levels of neurosin and alpha-synuclein compared to controls and AD patients. In contrast, AD patients demonstrated significantly increased CSF alpha-synuclein but similar neurosin levels compared to non-demented controls. Further, CSF neurosin and alpha-synuclein concentrations were positively associated in controls, PD and PDD patients and both proteins were highly correlated to CSF levels of phosphorylated tau in all investigated groups. We observed no effect of gender or presence of the apolipoprotein E epsilon 4 allele on neither neurosin or alpha-synuclein CSF levels. In concordance with the current literature our study demonstrates decreased CSF levels of alpha-synuclein in synucleinopathy patients versus AD patients and controls. Importantly, decreased alpha-synuclein levels in patients with synucleinopathy appear linked to low levels of the alpha-synuclein cleaving enzyme neurosin. In contrast, elevated levels of alpha-synuclein in AD patients were not related to any altered CSF neurosin levels. Thus, altered CSF levels of alpha-synuclein and neurosin in patients with synucleinopathy versus AD may not only mirror disease-specific neuropathological mechanisms but may also serve as fit candidates for future biomarker studies aiming at identifying specific markers of synucleinopathy.	[Wennstrom, Malin; Minthon, Lennart; Nielsen, Henrietta M.] Lund Univ, Dept Clin Sci Malmo, Mol Memory Res Unit, Skane Univ Hosp,Wellenberg Lab, Malmo, Sweden; [Surova, Yulia; Hall, Sara; Hansson, Oskar] Lund Univ, Dept Clin Sci Lund, Neurol Clin, Skane Univ Hosp, Malmo, Sweden; [Nilsson, Christer; Minthon, Lennart; Bostrom, Fredrik; Hansson, Oskar] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Memory Clin,Skane Univ Hosp, Malmo, Sweden; [Nielsen, Henrietta M.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Mayo Clinic	Nielsen, HM (corresponding author), Lund Univ, Dept Clin Sci Malmo, Mol Memory Res Unit, Skane Univ Hosp,Wellenberg Lab, Malmo, Sweden.	nielsen.henrietta@mayo.edu	Hansson, Oskar/A-7134-2013; Nielsen, Henrietta M/B-1746-2013	Hansson, Oskar/0000-0001-8467-7286; Brundin, Lena/0000-0002-8327-6242; Bay-Richter, Cecilie/0000-0002-2254-4020; Nielsen, Henrietta M/0000-0001-9664-7068	Swedish Dementia Foundation; Swedish Alzheimer Foundation; Swedish Research Council; Gamla tjanarinnor; Torsten and Ragnar Soderberg Foundation; Swedish Society of Medicine; Skane County Council; Lund University; Swedish Brain Power	Swedish Dementia Foundation; Swedish Alzheimer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gamla tjanarinnor; Torsten and Ragnar Soderberg Foundation; Swedish Society of Medicine; Skane County Council; Lund University; Swedish Brain Power	The Swedish Dementia Foundation (H.M.N.), the Swedish Alzheimer Foundation (H.M.N., O.H.), the Swedish Research Council (O.H.), Gamla tjanarinnor (H.M.N., O.H.), Torsten and Ragnar Soderberg Foundation (O.H.), the Swedish Society of Medicine (O.H.), the regional agreement on medical training and clinical research (A. L. F.) between the Skane County Council and Lund University (L. M., M. W., H.M.N., O.H.) and Swedish Brain Power (L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Anisowicz A, 1996, MOL MED, V2, P624, DOI 10.1007/BF03401646; Ashby EL, 2010, BRAIN RES, V1363, P1, DOI 10.1016/j.brainres.2010.09.017; Bayani J, 2012, CLIN CHEM LAB MED, V50, P211, DOI 10.1515/CCLM.2011.750; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cheng FR, 2011, J CHEM NEUROANAT, V42, P242, DOI 10.1016/j.jchemneu.2010.12.001; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Diamandis EP, 2000, CLIN BIOCHEM, V33, P369, DOI 10.1016/S0009-9120(00)00145-4; Diamandis EP, 2000, CLIN BIOCHEM, V33, P663, DOI 10.1016/S0009-9120(00)00185-5; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Gai WP, 1998, LANCET, V352, P547, DOI 10.1016/S0140-6736(05)79256-4; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kasai T, 2008, NEUROSCI LETT, V436, P52, DOI 10.1016/j.neulet.2008.02.057; Kasuga K, 2010, J NEUROL NEUROSUR PS, V81, P608, DOI 10.1136/jnnp.2009.197483; Kawakami F, 2011, FEBS J, V278, P4895, DOI 10.1111/j.1742-4658.2011.08389.x; Kim CY, 2008, J NEUROCHEM, V107, P303, DOI 10.1111/j.1471-4159.2008.05612.x; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Little SP, 1997, J BIOL CHEM, V272, P25135, DOI 10.1074/jbc.272.40.25135; Magklara A, 2003, BIOCHEM BIOPH RES CO, V307, P948, DOI 10.1016/S0006-291X(03)01271-3; McKeith Ian G, 2003, Semin Clin Neuropsychiatry, V8, P46; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Menendez-Gonzalez M, 2008, J ALZHEIMERS DIS, V14, P59; Mitsui S, 2002, ANN NY ACAD SCI, V977, P216, DOI 10.1111/j.1749-6632.2002.tb04818.x; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Mollenhauer B, 2010, BIOMARK MED, V4, P683, DOI 10.2217/BMM.10.90; Mukaetova-Ladinska E.B., 2010, INT J ALZHEIMERS DIS; Nielsen HM, 2010, ALZHEIMERS DEMENT S1, V6, P363; Ogawa K, 2000, PSYCHIAT CLIN NEUROS, V54, P419, DOI 10.1046/j.1440-1819.2000.00731.x; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Okui A, 2001, NEUROREPORT, V12, P1345, DOI 10.1097/00001756-200105250-00011; Pampalakis G, 2004, BIOCHEM BIOPH RES CO, V320, P54, DOI 10.1016/j.bbrc.2004.04.205; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Reesink FE, 2010, J ALZHEIMERS DIS, V22, P87, DOI 10.3233/JAD-2010-100186; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Spencer B, 2012, MOL THERAPY J AM SOC; Spies PE, 2009, J ALZHEIMERS DIS, V16, P363, DOI 10.3233/JAD-2009-0955; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Takeda A, 1998, AM J PATHOL, V152, P367; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Tateno F, 2011, ALZHEIMER DIS ASS DI; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Trojanowski JQ, 2007, NEUROPATH APPL NEURO, V33, P615, DOI 10.1111/j.1365-2990.2007.00907.x; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Wennstrom M, 2012, J ALZHEIMERS DIS, V29, P125, DOI [10.3233/JAD-2011-111655, 10.3233/JAD-2012-111655]; Yamashiro K, 1997, BBA-GENE STRUCT EXPR, V1350, P11, DOI 10.1016/S0167-4781(96)00187-X	58	133	135	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53250	10.1371/journal.pone.0053250	http://dx.doi.org/10.1371/journal.pone.0053250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308173	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429800033
J	Cheng, HL; Bryant, CE; Rooney, KB; Steinbeck, KS; Griffin, HJ; Petocz, P; O'Connor, HT				Cheng, Hoi Lun; Bryant, Christian E.; Rooney, Kieron B.; Steinbeck, Katharine S.; Griffin, Hayley J.; Petocz, Peter; O'Connor, Helen T.			Iron, Hepcidin and Inflammatory Status of Young Healthy Overweight and Obese Women in Australia	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR; SERUM HEPCIDIN; DEFICIENCY; HYPOFERREMIA; ADULTS; LEVEL; RISK; DIET	Background and Aims: Evidence suggests obesity-related inflammation alters iron metabolism potentially increasing the risk of iron deficiency. This cross-sectional study aimed to investigate iron, hepcidin and inflammatory status in young, healthy overweight and obese women. Methods: 114 young (18-25 years), healthy comorbidity-free women with a body mass index (BMI) >= 27.5 kg/m(2) were recruited. Biochemical data were analysed using mean +/- standard deviation or median (interquartile range) and multivariate modelling. Biochemical markers were also stratified according to varying degrees of overweight and obesity. Results: Anaemia (haemoglobin <120 g/l) and iron deficiency (serum ferritin <15.0 mu g/l) were prevalent in 10% and 17% of participants respectively. Mean/median soluble transferrin receptor was 1.61 +/- 0.44 mg/l; hepcidin 6.40 (7.85) ng/ml and C-reactive protein (CRP) 3.58 (5.81) mg/l. Multivariate modelling showed that BMI was a significant predictor of serum iron (coefficient = -0.379; standard error = 0.139; p = 0.008), transferrin saturation (coefficient = -0.588; standard error = 0.222; p = 0.009) and CRP (coefficient = 0.127; standard error = 0.024; p<0.001). Stratification of participants according to BMI showed those with >= 35.0 kg/m(2) had significantly higher CRP (p<0.001) than those in lower BMI categories. Conclusions: Increasing obesity was associated with minor disturbances in iron metabolism. However, overall outcomes indicated simple iron deficiency (hypoferritinaemia) was the primary iron-related abnormality with no apparent contribution of inflammation or hepcidin, even in those with BMI >35.0 kg/m(2). This indicates that obesity alone may not be sufficient to induce clinically significant disturbances to iron metabolism as previously described. This may be attributed to the lack of comorbidity in this cohort.	[Cheng, Hoi Lun; Rooney, Kieron B.; Griffin, Hayley J.; O'Connor, Helen T.] Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW 2006, Australia; [Bryant, Christian E.] Univ Sydney, Anzac Res Inst, Sydney, NSW 2006, Australia; [Steinbeck, Katharine S.] Univ Sydney, Acad Dept Adolescent Med, Sydney, NSW 2006, Australia; [Petocz, Peter] Macquarie Univ, Dept Stat, Sydney, NSW 2109, Australia	University of Sydney; University of Sydney; ANZAC Research Institute; University of Sydney; Macquarie University	Cheng, HL (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW 2006, Australia.	hche3056@uni.sydney.edu.au	Kao, Jia-Horng/AAB-8947-2019; Ekanayake, Kanchana/P-8817-2016; Rooney, Kieron/I-6252-2018; Cheng, Hoi Lun/AAK-8937-2021; O'Connor, Helen/C-1289-2014; Research Institute, ANZAC/CAE-9030-2022; Steinbeck, Kate/AAX-6197-2020; Chen, Chien-Jen/C-6976-2008; Yang, Hwai-I/A-9470-2008; Chen, Chien-Jen/N-4723-2019	Kao, Jia-Horng/0000-0002-2442-7952; Rooney, Kieron/0000-0001-6563-7617; Cheng, Hoi Lun/0000-0002-2144-9195; O'Connor, Helen/0000-0002-6198-4141; Yang, Hwai-I/0000-0002-3433-942X; LIU, CHUN-JEN/0000-0002-6202-0993; SU, TUNG-HUNG/0000-0002-6747-7941	Meat and Livestock Australia	Meat and Livestock Australia(Meat and Livestock Australia)	This work was supported by a grant from Meat and Livestock Australia. The authors declare that Meat and Livestock Australia had no influence on any part of the analysis or interpretation of data, including the conclusions drawn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeberli I, 2009, INT J OBESITY, V33, P1111, DOI 10.1038/ijo.2009.146; Ahmed F, 2008, ASIA PAC J CLIN NUTR, V17, P40; [Anonymous], 2000, WHO TECH REP SER, P894; ARBER N, 1994, DIGEST DIS SCI, V39, P2656, DOI 10.1007/BF02087705; Ausk KJ, 2008, OBESITY, V16, P2356, DOI 10.1038/oby.2008.353; Ball K, 2009, OBESITY, V17, P66, DOI 10.1038/oby.2008.497; Bansal SS, 2010, RAPID COMMUN MASS SP, V24, P1251, DOI 10.1002/rcm.4512; Cheng HL, 2012, OBES REV, V13, P150, DOI 10.1111/j.1467-789X.2011.00938.x; Corwin EJ, 2003, J NUTR, V133, P4139, DOI 10.1093/jn/133.12.4139; Franklin M, 2010, CLIN CHEM, V57, pA171; Ganz Tomas, 2012, Biochim Biophys Acta, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Griffin HJ, 2013, DIABETES OBES METAB, V15, P572, DOI 10.1111/dom.12056; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; Karl JP, 2009, J AM COLL NUTR, V28, P37, DOI 10.1080/07315724.2009.10719759; Koulaouzidis A, 2009, SCAND J GASTROENTERO, V44, P126, DOI 10.1080/00365520802555983; Lagergren J, 2011, NAT REV GASTRO HEPAT, V8, P340, DOI 10.1038/nrgastro.2011.73; Macdougall IC, 2010, CLIN J AM SOC NEPHRO, V5, P1681, DOI 10.2215/CJN.05990809; Murray-Kolb LE, 2007, AM J CLIN NUTR, V85, P778, DOI 10.1093/ajcn/85.3.778; O'Connor H, 2011, ASIA PAC J CLIN NUTR, V20, P206; Pasricha SR, 2011, HAEMATOL-HEMATOL J, V96, P1099, DOI 10.3324/haematol.2010.037960; Pynaert I, 2007, ANN NUTR METAB, V51, P172, DOI 10.1159/000103278; Skikne BS, 2008, AM J HEMATOL, V83, P872, DOI 10.1002/ajh.21279; Suominen P, 1998, BLOOD, V92, P2934, DOI 10.1182/blood.V92.8.2934.420k07_2934_2939; Tussing-Humphreys LM, 2010, OBESITY, V18, P2010, DOI 10.1038/oby.2009.490; Tussing-Humphreys LM, 2009, J AM DIET ASSOC, V109, P297, DOI 10.1016/j.jada.2008.10.044; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; WHO, 2001, AN DEF; World Health Organization, 2011, WAIST CIRC WAIST HIP, Vi-vi; Yanoff LB, 2007, INT J OBESITY, V31, P1412, DOI 10.1038/sj.ijo.0803625	29	91	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68675	10.1371/journal.pone.0068675	http://dx.doi.org/10.1371/journal.pone.0068675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861932	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700097
J	Wang, XL; Falkner, B; Zhu, HD; Shi, HD; Su, SY; Xu, XJ; Sharma, AK; Dong, YB; Treiber, F; Gutin, B; Harshfield, G; Snieder, H				Wang, Xiaoling; Falkner, Bonita; Zhu, Haidong; Shi, Huidong; Su, Shaoyong; Xu, Xiaojing; Sharma, Ashok Kumar; Dong, Yanbin; Treiber, Frank; Gutin, Bernard; Harshfield, Gregory; Snieder, Harold			A Genome-Wide Methylation Study on Essential Hypertension in Young African American Males	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; BLOOD-PRESSURE; DNA METHYLATION; MALE TWINS; HSULF-1; CANCER; GENE; VARIANTS; HEMODYNAMICS; INFLAMMATION	Objective: There is emerging evidence from animal studies suggesting a key role for methylation in the pathogenesis of essential hypertension. However, to date, very few studies have investigated the role of methylation in the development of human hypertension, and none has taken a genome-wide approach. Based on the recent studies that highlight the involvement of inflammation in the development of hypertension, we hypothesize that changes in DNA methylation of leukocytes are involved in the pathogenesis of hypertension. Method & Results: We conducted a genome-wide methylation analysis on 8 hypertensive cases and 8 normotensive age-matched controls aged 14-23 years and performed validation of the most significant CpG sites in 2 genes in an independent sample of 36 hypertensive cases and 60 normotensive controls aged 14-30 years. Validation of the CpG sites in the SULF1 gene was further conducted in a second replication sample of 36 hypertensive cases and 34 controls aged 15.8-40 years. A CpG site in the SULF1 gene showed higher methylation levels in cases than in healthy controls in the genome-wide step (p = 6.2 x 10(-5)), which was confirmed in the validation step (p = 0.011) for subjects <= 30 years old but was not significant for subjects of all ages combined (p = 0.095). Conclusion: The identification of a difference in a blood leukocyte DNA methylation site between hypertensive cases and normotensive controls suggests that changes in DNA methylation may play an important role in the pathogenesis of hypertension. The age dependency of the effect further suggests complexity of epigenetic regulation in this age-related disease.	[Wang, Xiaoling; Zhu, Haidong; Su, Shaoyong; Xu, Xiaojing; Dong, Yanbin; Gutin, Bernard; Harshfield, Gregory] Georgia Hlth Sci Univ, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA; [Falkner, Bonita] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Shi, Huidong] Georgia Hlth Sci Univ, Sch Med, Canc Res Ctr, Augusta, GA USA; [Sharma, Ashok Kumar] Georgia Hlth Sci Univ, Sch Med, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Treiber, Frank] Med Univ S Carolina, Coll Nursing, Technol Applicat Ctr Healthful Lifestyles, Charleston, SC 29425 USA; [Treiber, Frank] Med Univ S Carolina, Coll Med, Technol Applicat Ctr Healthful Lifestyles, Charleston, SC 29425 USA; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands	University System of Georgia; Augusta University; Jefferson University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Medical University of South Carolina; Medical University of South Carolina; University of Groningen	Wang, XL (corresponding author), Georgia Hlth Sci Univ, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA.	xwang@georgiahealth.edu	xu, xiaojing/C-2759-2014; Falkner, Bonita/Y-8451-2019	Shi, Huidong/0000-0003-1137-3390; Sanfacon, Helene/0000-0003-3807-3590; Sharma, Ashok/0000-0001-9597-4374	National Institutes of Health [HL69999, HL56622, HL077230, HL64157, DK046107, HL092030]; NLHBI [HL105689]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104125, R01HL092030, P01HL069999, R01HL056622, R01HL105689, R01HL064157, R01HL077230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLHBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The participants in this study were recruited by several National Institutes of Health funded projects including HL69999, HL56622, HL077230, HL64157, DK046107 & HL092030. The current study is funded by the NLHBI HL105689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Baty F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-422; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Cantarin MPM, 2010, CTS-CLIN TRANSL SCI, V3, P279, DOI 10.1111/j.1752-8062.2010.00242.x; CARMELLI D, 1994, J HYPERTENS, V12, P323; CARMELLI D, 1994, AM J HUM GENET, V55, P566; Chen Z, 2009, INT J CANCER, V124, P739, DOI 10.1002/ijc.23960; COLLETTO GMDD, 1993, GENET EPIDEMIOL, V10, P533, DOI 10.1002/gepi.1370100634; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Falkner B, 2012, J PEADIAT IN PRESS; Frey FJ, 2005, NEPHROL DIAL TRANSPL, V20, P868, DOI 10.1093/ndt/gfh746; Friso S, 2008, ATHEROSCLEROSIS, V199, P323, DOI 10.1016/j.atherosclerosis.2007.11.029; Ge DL, 2006, TWIN RES HUM GENET, V9, P965, DOI 10.1375/twin.9.6.965; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Groom A, 2011, ARCH DIS CHILD, V96, P863, DOI 10.1136/adc.2009.165712; Gutin B, 2007, OBESITY, V15, P1029, DOI 10.1038/oby.2007.602; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Kapur G, 2010, CLIN HYPERTENSION VA, P241; Koestler DC, 2012, CANCER EPIDEM BIOMAR, V21, P1293, DOI 10.1158/1055-9965.EPI-12-0361; Kupper N, 2006, HYPERTENSION, V47, P948, DOI 10.1161/01.HYP.0000217521.79447.9a; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Pauletto P, 2006, NEPHROL DIAL TRANSPL, V21, P850, DOI 10.1093/ndt/gfl019; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152, DOI 10.1097/01.mnh.0000203189.57513.76; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Snieder H, 2002, AM J HYPERTENS, V15, P973, DOI 10.1016/S0895-7061(02)02991-6; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Wang X, 2010, CLIN HYPERTENSION VA, P241; Wang XL, 2006, CIRCULATION, V114, P2780, DOI 10.1161/CIRCULATIONAHA.106.643940; Zhang DY, 2009, KIDNEY INT, V75, P260, DOI 10.1038/ki.2008.475; Zhu HD, 2009, PEDIATR RES, V65, P443, DOI 10.1203/PDR.0b013e3181994b85	41	163	175	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53938	10.1371/journal.pone.0053938	http://dx.doi.org/10.1371/journal.pone.0053938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23325143	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400062
J	Li, RM; Xie, W; Wang, SL; Wu, QJ; Yang, NN; Yang, X; Pan, HP; Zhou, XM; Bai, LY; Xu, BY; Zhou, XG; Zhang, YJ				Li, Rumei; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Yang, Nina; Yang, Xin; Pan, Huipeng; Zhou, Xiaomao; Bai, Lianyang; Xu, Baoyun; Zhou, Xuguo; Zhang, Youjun			Reference Gene Selection for qRT-PCR Analysis in the Sweetpotato Whitefly, Bemisia tabaci (Hemiptera: Aleyrodidae)	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; HOUSEKEEPING GENES; QUANTITATIVE PCR; Q-BIOTYPE; EXPRESSION; RNA; NORMALIZATION; QUANTIFICATION; SUSCEPTIBILITY	Background: Accurate evaluation of gene expression requires normalization relative to the expression of reliable reference genes. Expression levels of "classical" reference genes can differ, however, across experimental conditions. Although quantitative real-time PCR (qRT-PCR) has been used extensively to decipher gene function in the sweetpotato whitefly Bemisia tabaci, a world-wide pest in many agricultural systems, the stability of its reference genes has rarely been validated. Results: In this study, 15 candidate reference genes from B. tabaci were evaluated using two Excel-based algorithms geNorm and Normfinder under a diverse set of biotic and abiotic conditions. At least two reference genes were selected to normalize gene expressions in B. tabaci under experimental conditions. Specifically, for biotic conditions including host plant, acquisition of a plant virus, developmental stage, tissue (body region of the adult), and whitefly biotype, ribosomal protein L29 was the most stable reference gene. In contrast, the expression of elongation factor 1 alpha, peptidylprolyl isomerase A, NADH dehydrogenase, succinate dehydrogenase complex subunit A and heat shock protein 40 were consistently stable across various abiotic conditions including photoperiod, temperature, and insecticide susceptibility. Conclusion: Our finding is the first step toward establishing a standardized quantitative real-time PCR procedure following the MIQE (Minimum Information for publication of Quantitative real time PCR Experiments) guideline in an agriculturally important insect pest, and provides a solid foundation for future RNA interference based functional study in B. tabaci.	[Li, Rumei; Zhou, Xiaomao; Bai, Lianyang] Hunan Agr Univ, Inst Pesticide, Changsha, Hunan, Peoples R China; [Li, Rumei; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Yang, Nina; Yang, Xin; Pan, Huipeng; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Pan, Huipeng; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Kentucky	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu; zhangyj@mail.caas.net.cn	Zhang, Youjun/AAY-7948-2020; Yang, Xin/AAG-5375-2020	Zhang, Youjun/0000-0003-3508-6695; 	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2013CB127602]; National Natural Science Foundation of China [30900153]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2013CB127602), and the National Natural Science Foundation of China (No. 30900153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Ghanim M, 1998, VIROLOGY, V240, P295, DOI 10.1006/viro.1997.8937; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kylee J, 2011, PLOS ONE, V6; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lu ZC, 2011, J EXP BIOL, V214, P764, DOI 10.1242/jeb.047415; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mahadav A, 2009, INSECT BIOCHEM MOLEC, V39, P668, DOI 10.1016/j.ibmb.2009.08.002; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tatsumi K, 2008, BIOCHEM BIOPH RES CO, V374, P106, DOI 10.1016/j.bbrc.2008.06.103; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Wu JB, 2006, PLANT DIS, V90, P1359, DOI 10.1094/PD-90-1359C; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Xie W, 2011, PEST MANAG SCI, V67, P87, DOI 10.1002/ps.2037; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002	53	156	166	3	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53006	10.1371/journal.pone.0053006	http://dx.doi.org/10.1371/journal.pone.0053006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308130	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800024
J	Lee, HY; Seo, JS; Cho, JH; Jung, H; Kim, JK; Lee, JS; Rhee, S; Choi, YD				Lee, Han Yong; Seo, Ju-Seok; Cho, Jang Hee; Jung, Harin; Kim, Ju-Kon; Lee, Jong Seob; Rhee, Sangkee; Choi, Yang Do			Oryza sativa COI Homologues Restore Jasmonate Signal Transduction in Arabidopsis coi1-1 Mutants	PLOS ONE			English	Article							METHYL JASMONATE; TRANSCRIPTION FACTOR; ACID BIOSYNTHESIS; MALE-STERILITY; GENE ENCODES; PROTEINS; DEFENSE	CORONATINE INSENSITIVE 1 (COI1) encodes an E3 ubiquitin ligase complex component that interacts with JAZ proteins and targets them for degradation in response to JA signaling. The Arabidopsis genome has a single copy of COI1, but the Oryza sativa genome has three closely related COI homologs. To examine the functions of the three OsCOIs, we used yeast two-hybrid assays to examine their interactions with JAZ proteins and found that OsCOIs interacted with OsJAZs and with JAZs, in a coronatine dependent manner. We also tested whether OsCOI1a and OsCOI1b could complement Arabidopsis coi1-1 mutants and found that overexpression of either gene in the coi1-1 mutant resulted in restoration of JA signal transduction and production of seeds, indicating successful complementation. Although OsCOI2 interacted with a few OsJAZs, we were not able to successfully complement the coi1-1 mutant with OsCOI2. Molecular modeling revealed that the three OsCOIs adopt 3D structures similar to COI1. Structural differences resulting from amino acid variations, especially among amino acid residues involved in the interaction with coronatine and JAZ proteins, were tested by mutation analysis. When His-391 in OsCOI2 was substituted with Tyr-391, OsCOI2 interacted with a wider range of JAZ proteins, including OsJAZ1, 2, 5 similar to 9 and 11, and complemented coi1-1 mutants at a higher frequency than the other OsCOIs and COI1. These results indicate that the three OsCOIs are orthologues of COI1 and play key roles in JA signaling.	[Lee, Han Yong; Seo, Ju-Seok; Cho, Jang Hee; Rhee, Sangkee; Choi, Yang Do] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Jung, Harin; Kim, Ju-Kon] Myongji Univ, Sch Biotechnol & Environm Engn, Yongin, South Korea; [Lee, Jong Seob] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Seoul National University (SNU); Myongji University; Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	srheesnu@snu.ac.kr; choiyngd@snu.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea through the National Center for GM Crops [PJ008053, PJ007971]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea through the National Center for GM Crops	This work was supported by a grant from the Next-Generation BioGreen 21 Program (project nos. PJ008053 to YDC and PJ007971 to JKK), Rural Development Administration, Republic of Korea through the National Center for GM Crops. A graduate research assistantship to HYL, JSS and HJ from the Brain Korea 21 project of the MOEST is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2010, JASMONATES ARABIDOPS, P1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Carpenter CD, 1998, METH MOL B, V82, P85; Cheong JJ, 2003, TRENDS GENET, V19, P409, DOI 10.1016/S0168-9525(03)00138-0; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; Koo AJK, 2009, PHYTOCHEMISTRY, V70, P1571, DOI 10.1016/j.phytochem.2009.07.018; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shin B, 2002, PLANT J, V30, P23, DOI 10.1046/j.1365-313X.2002.01264.x; Steiner-Lange S, 2003, PLANT J, V34, P519, DOI 10.1046/j.1365-313X.2003.01745.x; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Yang XY, 2007, PLANT CELL REP, V26, P219, DOI 10.1007/s00299-006-0229-z; Ye M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036214	28	70	92	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52802	10.1371/journal.pone.0052802	http://dx.doi.org/10.1371/journal.pone.0052802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320078	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429800020
J	Chen, WF; Chang, KP; Chen, CH; Shyu, VBH; Kao, HK				Chen, Wei F.; Chang, Kai-Ping; Chen, Chih-Hao; Shyu, Victor Bong-Hang; Kao, Huang-Kai			Outcomes of Anterolateral Thigh Flap Reconstruction for Salvage Laryngopharyngectomy for Hypopharyngeal Cancer after Concurrent Chemoradiotherapy	PLOS ONE			English	Article							FUNCTIONAL OUTCOMES; PHARYNGOESOPHAGEAL RECONSTRUCTION; CARCINOMA; HEAD; RESECTION	Objective: To evaluate the functional and oncological outcomes of anterolateral thigh flap reconstruction for salvage laryngopharyngectomy after concurrent chemoradiotherapy for patients with hypopharyngeal carcinoma. Materials/Methods: A retrospective review was conducted on patients who underwent pharyngoesophageal reconstruction using anterolateral thigh flap after salvage laryngopharyngectomy for recurrent hypopharyngeal carcinoma between June 2003 and May 2010 at Chang Gung Memorial Hospital. The perioperative morbidity, mortality, functional outcomes, and oncological outcomes were evaluated. Results: 33 patients were entered into the study. The mean follow-up time was 19.5 +/- 12.3 months. Recurrent pathological TNM stages included 3 (9.1%), 2 (6.1%), and 28 (84.8%) patients with stage II, III, and IV disease, respectively. Mean ICU stay was 10.3 days and the mean hospital stay was 39.9 days. Peri-operative mortality occurred in one patient (3%). 16 patients (48.5%) developed recipient site complications. Among them, 14 patients (42.4%) developed fistulas and 9 patients (27.3%) developed strictures. Except for 4 patients (12.1%), all achieved varying degree of oral intake with 29 patients (60.6%) being completely independent from tube feeding. The mean interval to start oral intake was 15.1 days. The 5-year overall survival and disease-free survival rates were 51.8% and 53.7%, respectively. The pN status is an independent predictor of overall survival and disease-free survival (P = 0.027 and 0.038, respectively). Conclusion: Pharyngoesophageal reconstruction after salvage laryngopharyngectomy remains challenging even in the experienced hands. Reconstructive microsurgeons who are prepared to take on these cases should be equally well prepared to manage the potential postoperative complications.	[Chen, Wei F.] Univ Iowa Hosp & Clin, Dept Surg, Div Plast & Reconstruct Surg, Iowa City, IA 52242 USA; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Chang, Kai-Ping; Chen, Chih-Hao; Shyu, Victor Bong-Hang; Kao, Huang-Kai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chen, Chih-Hao; Shyu, Victor Bong-Hang; Kao, Huang-Kai] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Tao Yuan, Taiwan	University of Iowa; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Kao, HK (corresponding author), Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Tao Yuan, Taiwan.	kai3488@gmail.com		Chen, Wei/0000-0002-4163-6641; Liu, Jianping/0000-0002-0320-061X; Liu, Bo/0000-0003-3101-650X; Yang, Guoyan (Emily)/0000-0002-8012-2379	NCCIH NIH HHS [R24 AT001293] Funding Source: Medline	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Ali Rozina S, 2009, Plast Reconstr Surg, V124, pe395, DOI 10.1097/PRS.0b013e3181bcf05c; Chan YW, 2011, J PLAST RECONSTR AES, V64, P1022, DOI 10.1016/j.bjps.2011.03.021; Chang MFT, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-91; Chen KT, 2007, PLAST RECONSTR SURG, V120, P187, DOI 10.1097/01.prs.0000264077.07779.50; Chu PY, 2005, HEAD NECK-J SCI SPEC, V27, P901, DOI 10.1002/hed.20262; Guibert M, 2011, EUR ANN OTORHINOLARY, V128, P218, DOI 10.1016/j.anorl.2011.02.010; Kadota H, 2010, LARYNGOSCOPE, V120, P1103, DOI 10.1002/lary.20887; Kao HK, 2009, ORAL ONCOL, V45, P1058, DOI 10.1016/j.oraloncology.2009.07.010; Lewin JS, 2005, LARYNGOSCOPE, V115, P1266, DOI 10.1097/01.MLG.0000165456.01648.B8; Lutz BS, 2005, CLIN PLAST SURG, V32, P421, DOI 10.1016/j.cps.2005.02.006; Murray DJ, 2007, HEAD NECK-J SCI SPEC, V29, P147, DOI 10.1002/hed.20489; Paximadis P, 2012, INT J RADIAT ONCOL, V82, P1515, DOI 10.1016/j.ijrobp.2011.04.064; Relic A, 2009, EUR ARCH OTO-RHINO-L, V266, P1799, DOI 10.1007/s00405-009-0946-3; Sagar B, 2010, J PLAST RECONSTR AES, V63, P970, DOI 10.1016/j.bjps.2009.04.019; Shellenberger TD, 2011, ARCH OTOLARYNGOL, V137, P1086, DOI 10.1001/archoto.2011.177; Takes RP, 2012, HEAD NECK-J SCI SPEC, V34, P270, DOI 10.1002/hed.21613; Tsou YA, 2010, HEAD NECK-J SCI SPEC, V32, P1494, DOI 10.1002/hed.21352; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Wong CH, 2010, HEAD NECK-J SCI SPEC, V32, P1236, DOI 10.1002/hed.21284; Yu PR, 2006, PLAST RECONSTR SURG, V117, P968, DOI 10.1097/01.prs.0000200622.13312.d3	20	205	209	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53985	10.1371/journal.pone.0053985	http://dx.doi.org/10.1371/journal.pone.0053985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23437162	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429800078
J	Liu, JY				Liu, J. Y.			Status of Marine Biodiversity of the China Seas	PLOS ONE			English	Review								China's seas cover nearly 5 million square kilometers extending from the tropical to the temperate climate zones and bordering on 32,000 km of coastline, including islands. Comprehensive systematic study of the marine biodiversity within this region began in the early 1950s with the establishment of the Qingdao Marine Biological Laboratory of the Chinese Academy of Sciences. Since that time scientists have carried out intensive multidisciplinary research on marine life in the China seas and have recorded 22,629 species belonging to 46 phyla. The marine flora and fauna of the China seas are characterized by high biodiversity, including tropical and subtropical elements of the Indo-West Pacific warm-water fauna in the South and East China seas, and temperate elements of North Pacific temperate fauna mainly in the Yellow Sea. The southern South China Sea fauna is characterized by typical tropical elements paralleled with the Philippine-New Guinea-Indonesia Coral triangle typical tropical faunal center. This paper summarizes advances in studies of marine biodiversity in China's seas and discusses current research mainly on characteristics and changes in marine biodiversity, including the monitoring, assessment, and conservation of endangered species and particularly the strengthening of effective management. Studies of (1) a tidal flat in a semi-enclosed embayment, (2) the impact of global climate change on a cold-water ecosystem, (3) coral reefs of Hainan Island and Xisha-Nansha atolls, (4) mangrove forests of the South China Sea, (5) a threatened seagrass field, and (6) an example of stock enhancement practices of the Chinese shrimp fishery are briefly introduced. Besides the overexploitation of living resources (more than 12.4 million tons yielded in 2007), the major threat to the biodiversity of the China seas is environmental deterioration (pollution, coastal construction), particularly in the brackish waters of estuarine environments, which are characterized by high productivity and represent spawning and nursery areas for several economically important species. In the long term, climate change is also a major threat. Finally, challenges in marine biodiversity studies are briefly discussed along with suggestions to strengthen the field. Since 2004, China has participated in the Census of Marine Life, through which advances in the study of zooplankton and zoobenthos biodiversity were finally summarized.	Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Liu, JY (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	pmilos@usb.ve		Pedrosa Domellof, Fatima/0000-0002-0648-4996	External Cooperation Program of the Chinese Academy of Sciences [GJHZ200808]; Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences [KZCX2-YW-417, KSCX2-EW-Z-5]; Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China [2006FY110500-4]; Alfred P. Sloan Foundation	External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Dr. Liu received funding for this study from the following organizations: The External Cooperation Program of the Chinese Academy of Sciences (GJHZ200808); Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences (KZCX2-YW-417), (KSCX2-EW-Z-5); Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China (2006FY110500-4); and The Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, DIVERSITY SPECIES XI; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Bureau of Fisheries Ministry of Agriculture of China, 2007, CHIN FISH STAT YB; Bureau of Fisheries Ministry of Agriculture of China, 2009, CHIN FISH STAT YB; Chen Q, 2003, LATIN CHINESE NAMES; Cheng J, 2003, LIVING RESOURCES OCE; Department of Marine Geology Institute of Oceanology Chinese Academy of Sciences, 1982, GEOL YELL E CHIN SEA; Fang J, 1996, MAR FISH RES, V17, P95; FUJIAN Marine Environment and Fishery Resources Monitor Center, 2010, MAR BIOD SURV REP QU; Guan BX, 2006, J OCEANOGR, V62, P1, DOI 10.1007/s10872-006-0028-8; Gurjanova E. F., 1958, Bull Inst mar Biol Peking, V1, P1; Huang X, 2007, STUDY SEAGRASS S CHI; HUANG Z, 1994, MARINE SPECIES THEIR; Huang Z. G, 2004, BIODIVERSITY MARINE; Jia X, 2004, FISHERY ECOLOGICAL E; Jin X, 2005, LIVING RESOURCES HAB; Lee YC, 1998, YELLOW SEA ATLAS; Li G, 2004, MARINE ECOLOGY; Li J. J., 2011, J ZHEJIANG OCEAN U N, V30, P381; Liao K., 1999, NATL PHYS ATLAS CHIN; Lin AK, 2008, SATELLITE REMOTE SEN; LIN P, 1999, MANGROVE ECOSYSTEM C; Liu R, 1983, P INT S SED CONT SHE; Liu R, 1991, P 2 INT S MAR SCI YE, P240; Liu R, 2006, J MARINE SCI BIOTECH, V1, P40; Liu R, 1998, P EUR AS WORKSH INV, P351; Liu R. Y., 1963, OCEANOLOGIA LIMNOLOG, V5, P306; Liu R.Y., 1992, ECOLOGY LIVING RESOU, P2; Liu RuiYu, 2011, Biodiversity Science, V19, P614, DOI 10.3724/SP.J.1003.2011.13185; Liu Ruiyu, 2007, P103; Liu RY., 2008, CHECKLIST MARINE BIO; Ng PKL, 2000, RAFFLES B ZOOL, P3; Ning X, 2002, RES EVALUATION AQUAC; Qi Y, 2003, RED TIDES CHINESE CO; SHAW PT, 1994, DEEP-SEA RES PT I, V41, P1663, DOI 10.1016/0967-0637(94)90067-1; Song Haitang, 2003, ACTA OCEANOLOGICA S, V1, P8; Song Haitang, 2006, EC SHRIMP CRAB SPECI, P1; Sun S, 2007, P WORKSH BIOD MARG S, P97; Tang Q, 2006, MARINE BIOL RESOURCE; Ushakov PV, 1955, VESTN AN SSSR+, V56, P14; WANG S., 2005, CHINA SPECIES RED LI, VIII; Wang S, 2009, CHINA SPECIES RED A, V2; Wang S, 1999, CHINA RED DATA BOOK; Wang S, 2009, CHINA SPECIES RED B, V2; Wang S, 2004, CHINA SPECIES RED LI, VI; Wang WQ, 2007, MANGROVES CHINA; WANG Y, 1987, CONT SHELF RES, V7, P329, DOI 10.1016/0278-4343(87)90104-X; Wang Y. S. J., 2012, OCEANOGRAPHY CHINA; Xu G.Z., 1989, ENV RESOURCES DAYA B; Yu Cun-gen, 2009, Marine Fisheries, V31, P27; Yue P. Q., 1998, CHINA RED DATA BOOK; Zhang S., 2007, ECOLOGICAL ENV BIORE; Zheng Q.N., 2006, J GEOPHYS RES OCEANS, V111; Zheng T, 1982, GEOLOGY HUANGHAI DON, P198; Zheng Y., 2003, BIOL RESOURCES ENV E; Zhong Zhenru, 1986, MARINE FIEHERIES, V3, P99; ZHOU D, 1994, OCEANOLOGY CHINA SEA; Zhou M, 2012, OCEANOGRAPHY CHINA; Zhou MJ, 2008, CONT SHELF RES, V28, P1483, DOI 10.1016/j.csr.2007.02.009; Zhuang Q, 1984, STUDIA MARINA SINICA, V22, P79; Zhuang Q., 1981, OCEANOLOGIA LIMNOLOG, V12, P341; Zou R, 1966, OCEANOLOGIA LIMNOLOG, V2, P153; Zuo T., 2003, COMMUNITY STRUCTURE	63	232	256	27	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e50719	10.1371/journal.pone.0050719	http://dx.doi.org/10.1371/journal.pone.0050719			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23468993	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800005
J	Nakamura, K; Aizawa, K; Nakabayashi, K; Kato, N; Yamauchi, J; Hata, K; Tanoue, A				Nakamura, Kazuaki; Aizawa, Kazuko; Nakabayashi, Kazuhiko; Kato, Natsuko; Yamauchi, Junji; Hata, Kenichiro; Tanoue, Akito			DNA Methyltransferase Inhibitor Zebularine Inhibits Human Hepatic Carcinoma Cells Proliferation and Induces Apoptosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CYCLE ARREST; METHYLATION INHIBITOR; CANCER-CELLS; G(1) ARREST; HEPG2 CELLS; IN-VITRO; EXPRESSION; ACTIVATION; INDUCTION	Hepatocellular carcinoma is one of the most common cancers worldwide. During tumorigenesis, tumor suppressor and cancer-related genes are commonly silenced by aberrant DNA methylation in their promoter regions. Zebularine (1-(beta-(D)-ribofuranosyl)- 1,2-dihydropyrimidin-2-one) acts as an inhibitor of DNA methylation and exhibits chemical stability and minimal cytotoxicity both in vitro and in vivo. In this study, we explore the effect and possible mechanism of action of zebularine on hepatocellular carcinoma cell line HepG2. We demonstrate that zebularine exhibits antitumor activity on HepG2 cells by inhibiting cell proliferation and inducing apoptosis, however, it has little effect on DNA methylation in HepG2 cells. On the other hand, zebularine treatment downregulated CDK2 and the phosphorylation of retinoblastoma protein (Rb), and upregulated p21(WAF/CIP1) and p53. We also found that zebularine treatment upregulated the phosphorylation of p44/42 mitogen-activated protein kinase (MAPK). These results suggest that the p44/42 MAPK pathway plays a role in zebularine-induced cell-cycle arrest by regulating the activity of p21(WAF/CIP1) and Rb. Furthermore, although the proapoptotic protein Bax levels were not affected, the antiapoptotic protein Bcl-2 level was downregulated with zebularine treatment. In addition, the data in the present study indicate that inhibition of the double-stranded RNA-dependent protein kinase (PKR) is involved in inducing apoptosis with zebularine. These results suggest a novel mechanism of zebularine-induced cell growth arrest and apoptosis via a DNA methylation-independent pathway in hepatocellular carcinoma.	[Nakamura, Kazuaki; Aizawa, Kazuko; Kato, Natsuko; Yamauchi, Junji; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan; [Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Nakamura, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan.	nakamura-kz@ncchd.go.jp		Nakayama, Karina/0000-0001-5426-7446	Takeda Science Foundation (Osaka, Japan); Grant of National Center for Child Health and Development (Tokyo, Japan) [22A-6]	Takeda Science Foundation (Osaka, Japan)(Takeda Science Foundation (TSF)); Grant of National Center for Child Health and Development (Tokyo, Japan)	This work was supported in part by research grants from the Takeda Science Foundation (Osaka, Japan, http://www.takeda-sci.or.jp/index.html), and The Grant of National Center for Child Health and Development (22A-6) (Tokyo, Japan, http://www.ncchd.go.jp/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Andersen JB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001338; Ben-Kasus T, 2005, BIOCHEM PHARMACOL, V70, P121, DOI 10.1016/j.bcp.2005.04.010; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Billam M, 2010, BREAST CANCER RES TR, V120, P581, DOI 10.1007/s10549-009-0420-3; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; Dai XY, 2012, CELL PHYSIOL BIOCHEM, V29, P281, DOI 10.1159/000337609; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dote H, 2005, CLIN CANCER RES, V11, P4571, DOI 10.1158/1078-0432.CCR-05-0050; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fandy TE, 2009, CURR MED CHEM, V16, P2075, DOI 10.2174/092986709788612738; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016916; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gravina GL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-305; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hubina E, 2006, EUR J ENDOCRINOL, V155, P371, DOI 10.1530/eje.1.02213; Hurd PJ, 1999, J MOL BIOL, V286, P389, DOI 10.1006/jmbi.1998.2491; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kouroumalis E, 1998, GUT, V42, P442, DOI 10.1136/gut.42.3.442; LEIST M, 1994, J IMMUNOL, V153, P1778; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Marques CJ, 2011, EPIGENETICS-US, V6, P1354, DOI 10.4161/epi.6.11.17993; MICHIELI P, 1994, CANCER RES, V54, P3391; Motomura W, 2005, BIOCHEM BIOPH RES CO, V332, P89, DOI 10.1016/j.bbrc.2005.04.095; Neureiter D, 2007, SCAND J GASTROENTERO, V42, P103, DOI 10.1080/00365520600874198; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281, DOI 10.1016/0165-6147(89)90029-1; PINTO A, 1993, LEUKEMIA, V7, P51; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; Qu Y, 2010, AM J CLIN PATHOL, V134, P826, DOI 10.1309/AJCPHGQ69FXDFWII; RUSSO T, 1995, J BIOL CHEM, V270, P29386, DOI 10.1074/jbc.270.49.29386; Samali A, 1999, BIOCHEM BIOPH RES CO, V255, P6, DOI 10.1006/bbrc.1998.0139; Samonakis DN, 2002, ONCOL REP, V9, P903; Schwartsmann G, 2000, INVEST NEW DRUG, V18, P83, DOI 10.1023/A:1006388031954; Serfas MS, 1997, CELL GROWTH DIFFER, V8, P951; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Taya Y, 1997, TRENDS BIOCHEM SCI, V22, P14, DOI 10.1016/S0968-0004(96)10070-0; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Tsagarakis NJ, 2011, WORLD J GASTROENTERO, V17, P313, DOI 10.3748/wjg.v17.i3.313; Tsukada Y, 2004, J BIOCHEM, V136, P701, DOI 10.1093/jb/mvh177; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Yang XR, 2009, CELL RES, V19, P469, DOI 10.1038/cr.2009.25; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; You BR, 2012, MOL BIOL REP, V39, P9723, DOI 10.1007/s11033-012-1837-z	59	113	118	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54036	10.1371/journal.pone.0054036	http://dx.doi.org/10.1371/journal.pone.0054036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	24086366	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800086
J	Chen, WK; Miao, CH				Chen, Wan-Kun; Miao, Chang-Hong			The Effect of Anesthetic Technique on Survival in Human Cancers: A Meta-Analysis of Retrospective and Prospective Studies	PLOS ONE			English	Article							EPIDURAL-ANESTHESIA; COLORECTAL-CANCER; NEURAXIAL ANESTHESIA; SPINAL-ANESTHESIA; SURGERY; RECURRENCE; ANALGESIA; REDUCTION; ASSOCIATION; MORTALITY	Animal models have shown that regional anesthesia (combined with or without general anesthesia) would attenuate the surgical stress response by preserving immune function and result in better long-term outcome. In order to test the hypothesis that cancer patients who had surgery with epidural anesthesia (EA) would have better outcome (either overall survival [OS] or recurrence-free survival [RFS]) than those who were general anesthesia (GA), we performed this meta-analysis. By searching relevant literature, a total of 14 studies containing 18 sub-studies (seven in OS analysis and eleven in RFS analysis) were identified and meta-analyzed. Adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were used to assess the strength of association. For OS, the random-effects model was used to analyze the data and demonstrated an OS benefit in favor of EA compared with GA alone (HR = 0.84, 95% CI 0.74-0.96, P = 0.013). The influence analysis showed the robustness of the results. Specifically, a significantly positive association between EA and improved OS was observed in colorectal cancer (HR = 0.65, 95% CI 0.43-0.99, P = 0.045). For RFS, the random-effects model was used to analyze the data and no significant relationship between RFS benefit and EA (HR = 0.88, 95% CI 0.64-1.22, P = 0.457) was detected. In conclusion, our meta-analysis suggests that epidural anesthesia and/or analgesia might be associated with improved overall survival in patients with operable cancer undergoing surgery (especially in colorectal cancer), but it does not support an association between epidural anesthesia and cancer control. Prospective studies are needed to determine whether the association between epidural use and survival is causative.	[Chen, Wan-Kun] Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; Fudan Univ, Inst Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Chen, WK (corresponding author), Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	wkchen1981@hotmail.com; miaochh@yahoo.com.cn		Chen, Wei/0000-0002-4163-6641; Liu, Jianping/0000-0002-0320-061X; Liu, Bo/0000-0003-3101-650X; Yang, Guoyan (Emily)/0000-0002-8012-2379	Shanghai Committee of Science and Technology [114119a4400]; NCCIH NIH HHS [R24 AT001293] Funding Source: Medline	Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research is supported by grants from Guide Project of Shanghai Committee of Science and Technology (2011-2013, 114119a4400). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Yosef S, 2001, ANESTHESIOLOGY, V94, P1066, DOI 10.1097/00000542-200106000-00022; BEILIN B, 1989, Brain Behavior and Immunity, V3, P129, DOI 10.1016/0889-1591(89)90013-5; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Christopherson R, 2008, ANESTH ANALG, V107, P325, DOI 10.1213/ane.0b013e3181770f55; Cummings KC, 2012, ANESTHESIOLOGY, V116, P797, DOI 10.1097/ALN.0b013e31824674f6; de Oliveira GS, 2011, REGION ANESTH PAIN M, V36, P271, DOI 10.1097/AAP.0b013e318217aada; ERSKINE R, 1992, CAN J ANAESTH, V39, P905, DOI 10.1007/BF03008337; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Gottschalk A, 2010, ANESTHESIOLOGY, V113, P27, DOI 10.1097/ALN.0b013e3181de6d0d; Gupta A, 2011, BRIT J ANAESTH, V107, P164, DOI 10.1093/bja/aer100; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ismail H, 2010, BRIT J ANAESTH, V105, P145, DOI 10.1093/bja/aeq156; Koodie L, 2010, AM J PATHOL, V177, P984, DOI 10.2353/ajpath.2010.090621; Lai RC, 2012, ANESTH ANALG, V114, P290, DOI 10.1213/ANE.0b013e318239c2e3; Landoni G, 2012, J CARDIOTHOR VASC AN, V26, P764, DOI 10.1053/j.jvca.2012.04.018; Larsson SC, 2010, JAMA-J AM MED ASSOC, V303, P1077, DOI 10.1001/jama.2010.263; LEWIS J W, 1983, Natural Immunity and Cell Growth Regulation, V3, P43; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin L, 2011, BRIT J ANAESTH, V106, P814, DOI 10.1093/bja/aer055; Luo CF, 2010, EUR J ANAESTH, V27, P212, DOI 10.1097/00003643-201006121-00682; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MARKOVIC SN, 1993, ANESTHESIOLOGY, V78, P700, DOI 10.1097/00000542-199304000-00013; Myles PS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1491; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Snyder GL, 2010, BRIT J ANAESTH, V105, P106, DOI 10.1093/bja/aeq164; Tsui BCH, 2010, CAN J ANAESTH, V57, P107, DOI 10.1007/s12630-009-9214-7; Urwin SC, 2000, BRIT J ANAESTH, V84, P450, DOI 10.1093/oxfordjournals.bja.a013468; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Wuethrich PY, 2010, ANESTHESIOLOGY, V113, P570, DOI 10.1097/ALN.0b013e3181e4f6ec; Zhou D, 2012, WORLD J GASTROENTERO, V18, P3089, DOI 10.3748/wjg.v18.i24.3089	31	205	209	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56540	10.1371/journal.pone.0056540	http://dx.doi.org/10.1371/journal.pone.0056540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437162	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200100
J	Liu, L; Boffa, MB; Koschinsky, ML				Liu, Lei; Boffa, Michael B.; Koschinsky, Marlys L.			Apolipoprotein(a) Inhibits In Vitro Tube Formation in Endothelial Cells: Identification of Roles for Kringle V and the Plasminogen Activation System	PLOS ONE			English	Article							LYSINE-BINDING SITE; FIBRIN FRAGMENT-E; TUMOR-GROWTH; MATRIX METALLOPROTEINASES; MAMMALIAN-CELLS; NITRIC-OXIDE; RISK-FACTOR; ANGIOGENESIS; LIPOPROTEIN(A); ATHEROSCLEROSIS	Elevated plasma concentrations of lipoprotein(a) are associated with increased risk for atherothrombotic diseases. Apolipoprotein(a), the unique glycoprotein component of lipoprotein(a), is characterized by the presence of multiple kringle domains, and shares a high degree of sequence homology with the serine protease zymogen plasminogen. It has been shown that angiostatin, a proteolytic fragment of plasminogen containing kringles 1-4, can effectively inhibit angiogenesis. Moreover, proteolytic fragments of plasminogen containing kringle 5 are even more potent inhibitors of angiogenesis than angiostatin. Despite its strong similarity with plasminogen, the role of apolipoprotein(a) in angiogenesis remains controversial, with both pro-and anti-angiogenic effects reported. In the current study, we evaluated the ability of apolipoprotein(a) to inhibit VEGF-and angiopoietin-induced tube formation in human umbilical cord endothelial cells. A 17 kringle-containing form of recombinant apo(a) (17K), corresponding to a well-characterized, physiologically-relevant form of the molecule, effectively inhibited tube formation induced by either VEGF or angiopoietin-1. Using additional recombinant apolipoprotein(a) (r-apo(a)) variants, we demonstrated that this effect was dependent on the presence of an intact lysine-binding site in kringle V domain of apo(a), but not on the presence of the functional lysine-binding site in apo(a) kringle IV type 10; sequences within in the amino-terminal half of the molecule were also not required for the inhibitory effects of apo(a). We also showed that the apo(a)-mediated inhibition tube formation could be reversed, in part by the addition of plasmin or urokinase plasminogen activator, or by removal of plasminogen from the system. Further, we demonstrated that apo(a) treated with glycosidases to remove sialic acid was significantly less effective in inhibiting tube formation. This is the first report of a functional role for the glycosylation of apo(a) although the mechanisms underlying this observation remain to be determined in the context of angiogenesis.	[Liu, Lei] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Boffa, Michael B.; Koschinsky, Marlys L.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	Queens University - Canada; University of Windsor	Boffa, MB (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	mboffa@uwindsor.ca	Boffa, Michael/N-6539-2019; Liu, Lei/J-7929-2017; Gundersen, Per/B-2192-2008	Boffa, Michael/0000-0003-1211-3064; Koschinsky, Marlys/0000-0002-2643-2288; Liu, Lei/0000-0002-8063-610X; Gundersen, Per/0000-0002-9199-4033; Qu, Cunmin/0000-0003-2413-2350	Heart and Stroke Foundation of Ontario [T5916]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	Funding: This work was funded by a grant (T5916) from the Heart and Stroke Foundation of Ontario to Dr. Koschinsky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; Babaei S, 1998, CIRC RES, V82, P1007, DOI 10.1161/01.RES.82.9.1007; Becker L, 2004, BIOCHEMISTRY-US, V43, P9978, DOI 10.1021/bi049536d; Belczewski AR, 2005, BIOCHEMISTRY-US, V44, P555, DOI 10.1021/bi048156p; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cho T, 2008, J BIOL CHEM, V283, P30503, DOI 10.1074/jbc.M802648200; Edelstein C, 2003, J BIOL CHEM, V278, P52841, DOI 10.1074/jbc.M310425200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FLESS GM, 1986, J BIOL CHEM, V261, P8712; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GRAINGER DJ, 1993, SCIENCE, V260, P1655, DOI 10.1126/science.8503012; Hancock MA, 2003, J BIOL CHEM, V278, P23260, DOI 10.1074/jbc.M302780200; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3847, DOI 10.1073/pnas.86.10.3847; Ji WR, 1998, BIOCHEM BIOPH RES CO, V247, P414, DOI 10.1006/bbrc.1998.8825; Kim JS, 2004, BIOCHEM BIOPH RES CO, V313, P534, DOI 10.1016/j.bbrc.2003.11.148; Kim JS, 2003, J BIOL CHEM, V278, P29000, DOI 10.1074/jbc.M301042200; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; KOSCHINSKY ML, 1991, BIOCHEMISTRY-US, V30, P5044, DOI 10.1021/bi00234a029; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; Koschinsky ML, 2009, CLIN LIPIDOLOGY COMP, P130; Kostner KM, 1996, ARTERIOSCL THROM VAS, V16, P905, DOI 10.1161/01.ATV.16.8.905; KRATZIN H, 1987, BIOL CHEM H-S, V368, P1533, DOI 10.1515/bchm3.1987.368.2.1533; Kroon Marielle E., 2002, Angiogenesis, V5, P257, DOI 10.1023/A:1024540701634; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Lee K, 2006, HEPATOLOGY, V43, P1063, DOI 10.1002/hep.21149; Lim YM, 2012, DIABETES, V61, P1599, DOI 10.2337/db11-1541; Liu L, 2009, BIOCHEM J, V418, P325, DOI 10.1042/BJ20080744; Lou XJ, 1998, EXP MOL PATHOL, V65, P53, DOI 10.1006/exmp.1998.2230; Marcovina SM, 2003, CURR OPIN LIPIDOL, V14, P361, DOI 10.1097/00041433-200308000-00004; MCCANCE SG, 1994, J BIOL CHEM, V269, P32405; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Morishita R, 2002, CIRCULATION, V105, P1491, DOI 10.1161/01.CIR.0000012146.07240.FD; O'Neil CH, 2004, J BIOL CHEM, V279, P55187, DOI 10.1074/jbc.M409860200; O'Reilly M S, 1997, EXS, V79, P273; Pepper M S, 1996, Vasc Med, V1, P259; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Perri SR, 2007, MOL CANCER THER, V6, P441, DOI 10.1158/1535-7163.MCT-06-0434; Ribatti D, 1998, EUR J CLIN INVEST, V28, P533; SANGRAR W, 1994, PROTEIN ENG, V7, P723, DOI 10.1093/protein/7.5.723; Sangrar W, 1997, BIOCHEMISTRY-US, V36, P10353, DOI 10.1021/bi962433d; Schulter V, 2001, ARTERIOSCL THROM VAS, V21, P433, DOI 10.1161/01.ATV.21.3.433; Shen L, 2008, BIOL CHEM, V389, P135, DOI 10.1515/BC.2008.016; Stirk CM, 2000, GEN PHARMACOL-VASC S, V35, P261, DOI 10.1016/S0306-3623(01)00114-8; THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V257, P714, DOI 10.1006/bbrc.1999.0519; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; Yang BH, 2004, J CELL PHYSIOL, V200, P360, DOI 10.1002/jcp.20025; Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027	57	242	254	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52287	10.1371/journal.pone.0052287	http://dx.doi.org/10.1371/journal.pone.0052287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23593427	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800014
